Citrus Sinensis ID: 046750
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 723 | 2.2.26 [Sep-21-2011] | |||||||
| Q9CAL8 | 710 | Proline-rich receptor-lik | yes | no | 0.622 | 0.633 | 0.676 | 0.0 | |
| Q9ZUE0 | 720 | Proline-rich receptor-lik | no | no | 0.612 | 0.615 | 0.665 | 0.0 | |
| Q9SGY7 | 718 | Putative proline-rich rec | no | no | 0.627 | 0.632 | 0.610 | 1e-170 | |
| Q9FFW5 | 681 | Proline-rich receptor-lik | no | no | 0.625 | 0.663 | 0.541 | 1e-146 | |
| Q9SX31 | 708 | Proline-rich receptor-lik | no | no | 0.573 | 0.586 | 0.562 | 1e-141 | |
| Q9C660 | 762 | Proline-rich receptor-lik | no | no | 0.565 | 0.536 | 0.573 | 1e-139 | |
| Q9LV48 | 652 | Proline-rich receptor-lik | no | no | 0.477 | 0.529 | 0.656 | 1e-138 | |
| Q9C821 | 509 | Proline-rich receptor-lik | no | no | 0.452 | 0.642 | 0.607 | 1e-126 | |
| Q9LK03 | 717 | Proline-rich receptor-lik | no | no | 0.457 | 0.461 | 0.623 | 1e-124 | |
| Q9LS95 | 700 | Putative proline-rich rec | no | no | 0.456 | 0.471 | 0.634 | 1e-120 |
| >sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 674 bits (1738), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 324/479 (67%), Positives = 378/479 (78%), Gaps = 29/479 (6%)
Query: 263 QAIIGATAAGVVLIVLIAIFFLARGRRRRR-DAYATHYMPPPNNFNEKTVDTYYGS---- 317
+ + G AG +I L+A+ FL R +++R DAY+ PP+NF+ K+ YG
Sbjct: 234 KTMAGFAIAGFAVIALMAVVFLVRRKKKRNIDAYSDSQYLPPSNFSIKSDGFLYGQNPTK 293
Query: 318 ------------QTPQMHSYGSQRGVGYH---GGGPDSGVLGGSKSFFTYEELMEITNGF 362
Q+ +S+GSQRG G + G PDS V+G ++ FTYEEL +IT GF
Sbjct: 294 GYSGPGGYNSQQQSNSGNSFGSQRGGGGYTRSGSAPDSAVMGSGQTHFTYEELTDITEGF 353
Query: 363 ARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLV 422
++ N++GEGGFGCVYKG L +GK+VAVKQLK GSGQG+REF+AEVEIISRVHHRHLVSLV
Sbjct: 354 SKHNILGEGGFGCVYKGKLNDGKLVAVKQLKVGSGQGDREFKAEVEIISRVHHRHLVSLV 413
Query: 423 GYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKI 482
GYCI++ RLLIYE+VPN LEHHLHGKG+PVLEW +RV+IA+G+AKGLAYLHEDCHPKI
Sbjct: 414 GYCIADSERLLIYEYVPNQTLEHHLHGKGRPVLEWARRVRIAIGSAKGLAYLHEDCHPKI 473
Query: 483 IHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDR 542
IHRDIKSANIL+DDEFEAQVADFGLAKLND+TQTHVSTRVMGTFGYLAPEYA SGKLTDR
Sbjct: 474 IHRDIKSANILLDDEFEAQVADFGLAKLNDSTQTHVSTRVMGTFGYLAPEYAQSGKLTDR 533
Query: 543 SDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEKHY 602
SDVFSFGVVLLELITGRKPVD QPLG+ESLVEWARP+L +AIETGD SE+VD RLEKHY
Sbjct: 534 SDVFSFGVVLLELITGRKPVDQYQPLGEESLVEWARPLLHKAIETGDFSELVDRRLEKHY 593
Query: 603 VESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEMSDLSNGVKYGQSTVYDSGQYN 662
VE+E+FRMIE AAACVRHSGPKRPRMVQVVRALDSEG+M D+SNG K GQS+ YDSGQYN
Sbjct: 594 VENEVFRMIETAAACVRHSGPKRPRMVQVVRALDSEGDMGDISNGNKVGQSSAYDSGQYN 653
Query: 663 QDIMMFRKMALGLGDSSD---MSGEYTSREASRGRSGSFMSQGTSSEFTSGESETRAMN 718
D M FRKMA G DSSD SG+Y+ +++ +G S G SSEFT E+E R N
Sbjct: 654 NDTMKFRKMAFGFDDSSDSGMYSGDYSVQDSRKG------SNGASSEFTRNETENRNFN 706
|
Regulates negatively root hairs elongation. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9ZUE0|PEK12_ARATH Proline-rich receptor-like protein kinase PERK12 OS=Arabidopsis thaliana GN=PERK12 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 655 bits (1691), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 323/485 (66%), Positives = 381/485 (78%), Gaps = 42/485 (8%)
Query: 263 QAIIGATAAGVVLIVLIAIFFLARGRRRRR-DAY-ATHYMPPPNNFNEKTVDTYYGS--- 317
+ ++G AG ++ LI + FL R +++R D+Y + Y+P PN F+ K+ YG
Sbjct: 245 KTMVGMAVAGFAIMALIGVVFLVRRKKKRNIDSYNHSQYLPHPN-FSVKSDGFLYGQDPG 303
Query: 318 ------------------QTPQMHSYGSQRGVGY------HGGGPDSGVLGGSKSFFTYE 353
Q+ +SYG+ G GY G PDS +LG ++ F+YE
Sbjct: 304 KGYSSGPNGSMYNNSQQQQSSMGNSYGTAGG-GYPHHQMQSSGTPDSAILGSGQTHFSYE 362
Query: 354 ELMEITNGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRV 413
EL EIT GFAR+N++GEGGFGCVYKG L +GKVVAVKQLK+GSGQG+REF+AEVEIISRV
Sbjct: 363 ELAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVKQLKAGSGQGDREFKAEVEIISRV 422
Query: 414 HHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAY 473
HHRHLVSLVGYCIS+++RLLIYE+V N LEHHLHGKG PVLEW+KRV+IA+G+AKGLAY
Sbjct: 423 HHRHLVSLVGYCISDQHRLLIYEYVSNQTLEHHLHGKGLPVLEWSKRVRIAIGSAKGLAY 482
Query: 474 LHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEY 533
LHEDCHPKIIHRDIKSANIL+DDE+EAQVADFGLA+LNDTTQTHVSTRVMGTFGYLAPEY
Sbjct: 483 LHEDCHPKIIHRDIKSANILLDDEYEAQVADFGLARLNDTTQTHVSTRVMGTFGYLAPEY 542
Query: 534 ASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEI 593
ASSGKLTDRSDVFSFGVVLLEL+TGRKPVD TQPLG+ESLVEWARP+L++AIETGDLSE+
Sbjct: 543 ASSGKLTDRSDVFSFGVVLLELVTGRKPVDQTQPLGEESLVEWARPLLLKAIETGDLSEL 602
Query: 594 VDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEMSDLSNGVKYGQS 653
+D RLEK YVE E+FRMIE AAACVRHSGPKRPRMVQVVRALD +G+ D+SNG+K GQS
Sbjct: 603 IDTRLEKRYVEHEVFRMIETAAACVRHSGPKRPRMVQVVRALDCDGDSGDISNGIKIGQS 662
Query: 654 TVYDSGQYNQDIMMFRKMALGLGDSSDMSGEYTSREASRGRSGSFMSQGTSSEFTSGESE 713
T YDSGQYN+DIM FRKMA G GD+S SG Y SG++ S +SS+F+ ESE
Sbjct: 663 TTYDSGQYNEDIMKFRKMAFG-GDNSVESGLY---------SGNY-SAKSSSDFSGNESE 711
Query: 714 TRAMN 718
TR N
Sbjct: 712 TRPFN 716
|
Regulates the auxin-related MAX (More Axillary Growth) pathway during the shoot branching. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SGY7|PEK11_ARATH Putative proline-rich receptor-like protein kinase PERK11 OS=Arabidopsis thaliana GN=PERK11 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 599 bits (1545), Expect = e-170, Method: Compositional matrix adjust.
Identities = 307/503 (61%), Positives = 375/503 (74%), Gaps = 49/503 (9%)
Query: 239 SKKTPTSSSGHSSDSTKGSSSN-DDQAIIGATAAGVVLIVLIA-IFFLARGRRR-----R 291
S + +S+G S + + SN ++ +IG AGV++I+ IA +FF+ R +++ R
Sbjct: 236 SNRHNANSNGDGGTSQQSNESNYTEKTVIGIGIAGVLVILFIAGVFFVRRKQKKGSSSPR 295
Query: 292 RDAYA------------THYMPPPNNFNEKTVDTYYGSQTPQMHSYGSQRGVGYHG-GGP 338
+ Y HY P N N ++ +P +S G+ + HG G P
Sbjct: 296 SNQYLPPANVSVNTEGFIHYRQKPGNGNSSAQNS-----SPDTNSLGNPK----HGRGTP 346
Query: 339 DSGVLGGSKSFFTYEELMEITNGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQ 398
DS V+G SK FTYEEL +IT GF + V+GEGGFGCVYKG L EGK VA+KQLKS S +
Sbjct: 347 DSAVIGTSKIHFTYEELSQITEGFCKSFVVGEGGFGCVYKGILFEGKPVAIKQLKSVSAE 406
Query: 399 GEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWT 458
G REF+AEVEIISRVHHRHLVSLVGYCISE++R LIYEFVPNN L++HLHGK PVLEW+
Sbjct: 407 GYREFKAEVEIISRVHHRHLVSLVGYCISEQHRFLIYEFVPNNTLDYHLHGKNLPVLEWS 466
Query: 459 KRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHV 518
+RV+IA+GAAKGLAYLHEDCHPKIIHRDIKS+NIL+DDEFEAQVADFGLA+LNDT Q+H+
Sbjct: 467 RRVRIAIGAAKGLAYLHEDCHPKIIHRDIKSSNILLDDEFEAQVADFGLARLNDTAQSHI 526
Query: 519 STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWAR 578
STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVD +QPLG+ESLVEWAR
Sbjct: 527 STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDTSQPLGEESLVEWAR 586
Query: 579 PVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSE 638
P L+ AIE GD+SE+VDPRLE YVESE+++MIE AA+CVRHS KRPRMVQVVRALD+
Sbjct: 587 PRLIEAIEKGDISEVVDPRLENDYVESEVYKMIETAASCVRHSALKRPRMVQVVRALDTR 646
Query: 639 GEMSDLSNGVKYGQSTVYDSGQYNQDIMMFRKMALGLGDSSDM---SGEYTSREASRGRS 695
++SDL+NGVK GQS VYDSGQY+ +I +FR+ + DSSD+ +G Y S++ +
Sbjct: 647 DDLSDLTNGVKVGQSRVYDSGQYSNEIRIFRRAS---EDSSDLGTNTGYYPSQDYA---- 699
Query: 696 GSFMSQGTSSEFTSGESETRAMN 718
TS E+ ESE+RA N
Sbjct: 700 -------TSHEY---ESESRAFN 712
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FFW5|PERK8_ARATH Proline-rich receptor-like protein kinase PERK8 OS=Arabidopsis thaliana GN=PERK8 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 519 bits (1337), Expect = e-146, Method: Compositional matrix adjust.
Identities = 255/471 (54%), Positives = 338/471 (71%), Gaps = 19/471 (4%)
Query: 234 SSHSNSKKTPTSSSGHSSDSTKGSSSNDDQAIIGATAAGVVLIVLIAIFFLARGRRRRRD 293
+S++ + P+SS G S T G + IG V L + + + R R+R+
Sbjct: 215 ASNNGNNTLPSSSPGKSEVGTGGIVA------IGVIVGLVFLSLFVMGVWFTRKRKRKDP 268
Query: 294 AYATHYMPPPNNFN-----EKTVDTYYGSQTPQMHSYGSQRGVGYHGGGPDSGVLGGSKS 348
Y PP+ ++ + + S P+M S+ G Y DSG++ +S
Sbjct: 269 GTFVGYTMPPSAYSSPQGSDVVLFNSRSSAPPKMRSHS---GSDYMYASSDSGMVSNQRS 325
Query: 349 FFTYEELMEITNGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVE 408
+F+Y+EL ++T+GF+ +N++GEGGFGCVYKG L +G+ VAVKQLK G QGEREF+AEVE
Sbjct: 326 WFSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGEREFKAEVE 385
Query: 409 IISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAA 468
IISRVHHRHLV+LVGYCISE++RLL+Y++VPNN L +HLH G+PV+ W RV++A GAA
Sbjct: 386 IISRVHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLHAPGRPVMTWETRVRVAAGAA 445
Query: 469 KGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLND--TTQTHVSTRVMGTF 526
+G+AYLHEDCHP+IIHRDIKS+NIL+D+ FEA VADFGLAK+ THVSTRVMGTF
Sbjct: 446 RGIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVSTRVMGTF 505
Query: 527 GYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIE 586
GY+APEYA+SGKL++++DV+S+GV+LLELITGRKPVD +QPLGDESLVEWARP+L +AIE
Sbjct: 506 GYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDESLVEWARPLLGQAIE 565
Query: 587 TGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEMSDLSN 646
+ E+VDPRL K+++ EMFRM+EAAAACVRHS KRP+M QVVRALD+ E +D++N
Sbjct: 566 NEEFDELVDPRLGKNFIPGEMFRMVEAAAACVRHSAAKRPKMSQVVRALDTLEEATDITN 625
Query: 647 GVKYGQSTVYDSGQYNQDIMMFRKMALGLGDSSDMSGEYTSREASRGRSGS 697
G++ GQS V+DS Q + I MF++MA G S D S ++ R S GS
Sbjct: 626 GMRPGQSQVFDSRQQSAQIRMFQRMAFG---SQDYSSDFFDRSQSHSSWGS 673
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SX31|PERK9_ARATH Proline-rich receptor-like protein kinase PERK9 OS=Arabidopsis thaliana GN=PERK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 504 bits (1297), Expect = e-141, Method: Compositional matrix adjust.
Identities = 248/441 (56%), Positives = 324/441 (73%), Gaps = 26/441 (5%)
Query: 264 AIIG-ATAAGVVLIVLIAIFFLARGRRRRRDAYAT--HYMPPPNNFNEKTVDTYYGSQT- 319
A++G + A +V+ L IF +R +R + + P P + ++ ++ Q+
Sbjct: 280 AVVGISVAVALVVFTLFGIFVWCLRKREKRLSAVSGGDVTPSPMSSTARSDSAFFRMQSS 339
Query: 320 ------PQMHSYGSQRGVGYHGGGPDSGVLGGSKSFFTYEELMEITNGFARENVIGEGGF 373
+ SY SQ SG LG SK+ F+YEEL++ TNGF++EN++GEGGF
Sbjct: 340 APVGASKRSGSYQSQ-----------SGGLGNSKALFSYEELVKATNGFSQENLLGEGGF 388
Query: 374 GCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLL 433
GCVYKG LP+G+VVAVKQLK G GQG+REF+AEVE +SR+HHRHLVS+VG+CIS RLL
Sbjct: 389 GCVYKGILPDGRVVAVKQLKIGGGQGDREFKAEVETLSRIHHRHLVSIVGHCISGDRRLL 448
Query: 434 IYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANIL 493
IY++V NN+L HLHG+ + VL+W RVKIA GAA+GLAYLHEDCHP+IIHRDIKS+NIL
Sbjct: 449 IYDYVSNNDLYFHLHGE-KSVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNIL 507
Query: 494 VDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLL 553
++D F+A+V+DFGLA+L TH++TRV+GTFGY+APEYASSGKLT++SDVFSFGVVLL
Sbjct: 508 LEDNFDARVSDFGLARLALDCNTHITTRVIGTFGYMAPEYASSGKLTEKSDVFSFGVVLL 567
Query: 554 ELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEA 613
ELITGRKPVD +QPLGDESLVEWARP++ AIET + + DP+L +YVESEMFRMIEA
Sbjct: 568 ELITGRKPVDTSQPLGDESLVEWARPLISHAIETEEFDSLADPKLGGNYVESEMFRMIEA 627
Query: 614 AAACVRHSGPKRPRMVQVVRALDSEGEMSDLSNGVKYGQSTVYDSGQYNQDIMMFRKMAL 673
A ACVRH KRPRM Q+VRA +S DL+NG++ G+S V++S Q + +I +FR+MA
Sbjct: 628 AGACVRHLATKRPRMGQIVRAFESLAA-EDLTNGMRLGESEVFNSAQQSAEIRLFRRMAF 686
Query: 674 GLGD-SSDMSGE--YTSREAS 691
G + S+D Y SR+A+
Sbjct: 687 GSQNYSTDFFSHSSYNSRDAN 707
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9C660|PEK10_ARATH Proline-rich receptor-like protein kinase PERK10 OS=Arabidopsis thaliana GN=PERK10 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 496 bits (1278), Expect = e-139, Method: Compositional matrix adjust.
Identities = 237/413 (57%), Positives = 303/413 (73%), Gaps = 4/413 (0%)
Query: 265 IIGATA-AGVVLIVLIAIFFLARGRRRRRDAYAT--HYMPPPNNFNEKTVDTYYGSQTPQ 321
++G + +VL+ LI + +R++R + + MP P + D+
Sbjct: 330 VVGVSIGVALVLLTLIGVVVCCLKKRKKRLSTIGGGYVMPTPMESSSPRSDSALLKTQSS 389
Query: 322 MHSYGSQRGVGYHGGGPDSGVLGGSKSFFTYEELMEITNGFARENVIGEGGFGCVYKGNL 381
G++ + + G G S+ F+YEEL+ TNGF+ EN++GEGGFG VYKG L
Sbjct: 390 APLVGNRSSNRTYLSQSEPGGFGQSRELFSYEELVIATNGFSDENLLGEGGFGRVYKGVL 449
Query: 382 PEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPNN 441
P+ +VVAVKQLK G GQG+REF+AEV+ ISRVHHR+L+S+VGYCISE RLLIY++VPNN
Sbjct: 450 PDERVVAVKQLKIGGGQGDREFKAEVDTISRVHHRNLLSMVGYCISENRRLLIYDYVPNN 509
Query: 442 NLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQ 501
NL HLH G P L+W RVKIA GAA+GLAYLHEDCHP+IIHRDIKS+NIL+++ F A
Sbjct: 510 NLYFHLHAAGTPGLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLENNFHAL 569
Query: 502 VADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKP 561
V+DFGLAKL TH++TRVMGTFGY+APEYASSGKLT++SDVFSFGVVLLELITGRKP
Sbjct: 570 VSDFGLAKLALDCNTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKP 629
Query: 562 VDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHS 621
VD +QPLGDESLVEWARP+L A ET + + + DP+L ++YV EMFRMIEAAAAC+RHS
Sbjct: 630 VDASQPLGDESLVEWARPLLSNATETEEFTALADPKLGRNYVGVEMFRMIEAAAACIRHS 689
Query: 622 GPKRPRMVQVVRALDSEGEMSDLSNGVKYGQSTVYDSGQYNQDIMMFRKMALG 674
KRPRM Q+VRA DS E DL+NG++ G+S + +S Q + +I +FR+MA G
Sbjct: 690 ATKRPRMSQIVRAFDSLAE-EDLTNGMRLGESEIINSAQQSAEIRLFRRMAFG 741
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 493 bits (1270), Expect = e-138, Method: Compositional matrix adjust.
Identities = 233/355 (65%), Positives = 282/355 (79%), Gaps = 10/355 (2%)
Query: 342 VLGGSKSFFTYEELMEITNGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGER 401
VLG SKS FTYEEL TNGF+ N++G+GGFG V+KG LP GK VAVKQLK+GSGQGER
Sbjct: 260 VLGFSKSTFTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSGQGER 319
Query: 402 EFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRV 461
EF+AEVEIISRVHHRHLVSL+GYC++ RLL+YEFVPNNNLE HLHGKG+P +EW+ R+
Sbjct: 320 EFQAEVEIISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHGKGRPTMEWSTRL 379
Query: 462 KIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTR 521
KIALG+AKGL+YLHEDC+PKIIHRDIK++NIL+D +FEA+VADFGLAK+ T THVSTR
Sbjct: 380 KIALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVSTR 439
Query: 522 VMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVL 581
VMGTFGYLAPEYA+SGKLT++SDVFSFGVVLLELITGR+PVD D+SLV+WARP+L
Sbjct: 440 VMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPLL 499
Query: 582 VRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEM 641
RA E GD + D ++ Y EM RM+ AAACVRHS +RPRM Q+VRAL+ +
Sbjct: 500 NRASEEGDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMSQIVRALEGNVSL 559
Query: 642 SDLSNGVK---------YGQSTVYDSGQYNQDIMMFRKMALGLGDSSDMSGEYTS 687
SDL+ G++ YG ST YD+ QYN D++ FRKMALG + +GEY++
Sbjct: 560 SDLNEGMRPGHSNVYSSYGGSTDYDTSQYNDDMIKFRKMALGTQEYGT-TGEYSN 613
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9C821|PEK15_ARATH Proline-rich receptor-like protein kinase PERK15 OS=Arabidopsis thaliana GN=PERK15 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 453 bits (1165), Expect = e-126, Method: Compositional matrix adjust.
Identities = 204/336 (60%), Positives = 266/336 (79%), Gaps = 9/336 (2%)
Query: 347 KSFFTYEELMEITNGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAE 406
++ FTYE+L + T+ F+ N++G+GGFG V++G L +G +VA+KQLKSGSGQGEREF+AE
Sbjct: 128 QNLFTYEDLSKATSNFSNTNLLGQGGFGYVHRGVLVDGTLVAIKQLKSGSGQGEREFQAE 187
Query: 407 VEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALG 466
++ ISRVHHRHLVSL+GYCI+ RLL+YEFVPN LE HLH K +PV+EW+KR+KIALG
Sbjct: 188 IQTISRVHHRHLVSLLGYCITGAQRLLVYEFVPNKTLEFHLHEKERPVMEWSKRMKIALG 247
Query: 467 AAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTF 526
AAKGLAYLHEDC+PK IHRD+K+ANIL+DD +EA++ADFGLA+ + T THVSTR+MGTF
Sbjct: 248 AAKGLAYLHEDCNPKTIHRDVKAANILIDDSYEAKLADFGLARSSLDTDTHVSTRIMGTF 307
Query: 527 GYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLG-DESLVEWARPVLVRAI 585
GYLAPEYASSGKLT++SDVFS GVVLLELITGR+PVD +QP D+S+V+WA+P++++A+
Sbjct: 308 GYLAPEYASSGKLTEKSDVFSIGVVLLELITGRRPVDKSQPFADDDSIVDWAKPLMIQAL 367
Query: 586 ETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEMSDLS 645
G+ +VDPRLE + +EM RM+ AAA VRHS +RP+M Q+VRA + + DL+
Sbjct: 368 NDGNFDGLVDPRLENDFDINEMTRMVACAAASVRHSAKRRPKMSQIVRAFEGNISIDDLT 427
Query: 646 NGVKYGQSTV--------YDSGQYNQDIMMFRKMAL 673
G GQST+ Y S QY +D+ F+KMA
Sbjct: 428 EGAAPGQSTIYSLDGSSDYSSTQYKEDLKKFKKMAF 463
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LK03|PERK2_ARATH Proline-rich receptor-like protein kinase PERK2 OS=Arabidopsis thaliana GN=PERK2 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 447 bits (1149), Expect = e-124, Method: Compositional matrix adjust.
Identities = 212/340 (62%), Positives = 258/340 (75%), Gaps = 9/340 (2%)
Query: 343 LGGSKSFFTYEELMEITNGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGERE 402
LG + F YEEL TNGF+ N++G+GGFG V+KG L GK VAVKQLK GS QGERE
Sbjct: 335 LGIYQGTFNYEELSRATNGFSEANLLGQGGFGYVFKGMLRNGKEVAVKQLKEGSSQGERE 394
Query: 403 FRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVK 462
F+AEV IISRVHHRHLV+LVGYCI++ RLL+YEFVPNN LE HLHGKG+P +EW+ R+K
Sbjct: 395 FQAEVGIISRVHHRHLVALVGYCIADAQRLLVYEFVPNNTLEFHLHGKGRPTMEWSSRLK 454
Query: 463 IALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRV 522
IA+G+AKGL+YLHE+C+PKIIHRDIK++NIL+D +FEA+VADFGLAK+ T THVSTRV
Sbjct: 455 IAVGSAKGLSYLHENCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVSTRV 514
Query: 523 MGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLV 582
MGTFGYLAPEYASSGKLT++SDVFSFGVVLLELITGR+P+D D SLV+WARP+L
Sbjct: 515 MGTFGYLAPEYASSGKLTEKSDVFSFGVVLLELITGRRPIDVNNVHADNSLVDWARPLLN 574
Query: 583 RAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEMS 642
+ E G+ +VD +L Y + EM RM+ AAACVR + P+RPRM QV R L+ S
Sbjct: 575 QVSELGNFEVVVDKKLNNEYDKEEMARMVACAAACVRSTAPRRPRMDQVARVLEGNISPS 634
Query: 643 DLSNGVKYGQSTV---------YDSGQYNQDIMMFRKMAL 673
DL+ G+ G S V YDS Q N+ + FRK+ L
Sbjct: 635 DLNQGITPGHSNVYGSSGGSTDYDSSQDNEGMNKFRKVGL 674
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LS95|PERK6_ARATH Putative proline-rich receptor-like protein kinase PERK6 OS=Arabidopsis thaliana GN=PERK6 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 434 bits (1115), Expect = e-120, Method: Compositional matrix adjust.
Identities = 215/339 (63%), Positives = 264/339 (77%), Gaps = 9/339 (2%)
Query: 343 LGGSKSFFTYEELMEITNGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGERE 402
LG +KS FTY+EL T GF++ ++G+GGFG V+KG LP GK +AVK LK+GSGQGERE
Sbjct: 318 LGFNKSTFTYDELAAATQGFSQSRLLGQGGFGYVHKGILPNGKEIAVKSLKAGSGQGERE 377
Query: 403 FRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVK 462
F+AEV+IISRVHHR LVSLVGYCI+ R+L+YEF+PN+ LE HLHGK VL+W R+K
Sbjct: 378 FQAEVDIISRVHHRFLVSLVGYCIAGGQRMLVYEFLPNDTLEFHLHGKSGKVLDWPTRLK 437
Query: 463 IALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRV 522
IALG+AKGLAYLHEDCHP+IIHRDIK++NIL+D+ FEA+VADFGLAKL+ THVSTR+
Sbjct: 438 IALGSAKGLAYLHEDCHPRIIHRDIKASNILLDESFEAKVADFGLAKLSQDNVTHVSTRI 497
Query: 523 MGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLV 582
MGTFGYLAPEYASSGKLTDRSDVFSFGV+LLEL+TGR+PVD T + D SLV+WARP+ +
Sbjct: 498 MGTFGYLAPEYASSGKLTDRSDVFSFGVMLLELVTGRRPVDLTGEMED-SLVDWARPICL 556
Query: 583 RAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEMS 642
A + GD SE+VDPRLE Y EM +M+ AAA VRHS +RP+M Q+VRAL+ + +
Sbjct: 557 NAAQDGDYSELVDPRLENQYEPHEMAQMVACAAAAVRHSARRRPKMSQIVRALEGDATLD 616
Query: 643 DLSNGVKYGQSTVYDSGQYNQ--------DIMMFRKMAL 673
DLS G K GQS+ G + D+ FRK+AL
Sbjct: 617 DLSEGGKAGQSSFLGRGSSSDYDSSTYSADMKKFRKVAL 655
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 723 | ||||||
| 449434927 | 774 | PREDICTED: LOW QUALITY PROTEIN: proline- | 0.720 | 0.673 | 0.638 | 0.0 | |
| 449521092 | 777 | PREDICTED: proline-rich receptor-like pr | 0.720 | 0.670 | 0.638 | 0.0 | |
| 307135975 | 766 | protein kinase family protein [Cucumis m | 0.762 | 0.719 | 0.611 | 0.0 | |
| 224102467 | 710 | predicted protein [Populus trichocarpa] | 0.737 | 0.750 | 0.616 | 0.0 | |
| 15223161 | 710 | protein root hair specific 10 [Arabidops | 0.622 | 0.633 | 0.676 | 0.0 | |
| 297838841 | 686 | hypothetical protein ARALYDRAFT_476166 [ | 0.622 | 0.655 | 0.669 | 0.0 | |
| 255568804 | 724 | ATP binding protein, putative [Ricinus c | 0.596 | 0.595 | 0.704 | 0.0 | |
| 42562273 | 720 | protein kinase domain-containing protein | 0.612 | 0.615 | 0.665 | 0.0 | |
| 297850814 | 724 | hypothetical protein ARALYDRAFT_472617 [ | 0.614 | 0.613 | 0.646 | 0.0 | |
| 4056437 | 731 | Strong similarity to PFAM PF|00069 Eukar | 0.603 | 0.596 | 0.630 | 1e-176 |
| >gi|449434927|ref|XP_004135247.1| PREDICTED: LOW QUALITY PROTEIN: proline-rich receptor-like protein kinase PERK12-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 679 bits (1752), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 355/556 (63%), Positives = 414/556 (74%), Gaps = 35/556 (6%)
Query: 182 APPSNPGS-PPSPSTSQSGTPSTPNENSSPNELSPPSNSKSPTSKSSPEESSSSSHSNSK 240
+P +NP + +PS+ GT +TP S N LSPP+ TS S+P S SS S
Sbjct: 218 SPGANPATGKQTPSSPDQGTITTPTSES--NILSPPT----ATSTSTPNNSPHSSDSTPV 271
Query: 241 KTPTSSSGHSSDSTKGSSSNDDQAIIGATAAGVVLIVLIAIFFLARGRRRRRDAYATHYM 300
K+P G S+ + G S+ D A+ A A V+ + IF +R ++RR Y YM
Sbjct: 272 KSPL---GQSNAPSTGLRSHTDVAVGAAVAGVFVIALFAVIFVFSRKKKRRGKMYTGPYM 328
Query: 301 PPPNNFNEKTVDTYY--------GS---------QTPQMHSYGSQRGVGYHGGGPDSGVL 343
PP NF K YY GS TP +S+GSQ+G GY G G +S V+
Sbjct: 329 PP-KNFCVKADGNYYPQEHGGNSGSSEGFYTQVPHTPLGNSFGSQKGTGYSGSGMESSVI 387
Query: 344 GGSKSFFTYEELMEITNGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREF 403
+K +F+YEELME+T+GF+R+N++GEGGFGCVY+G LPEGK VAVKQLK+GSGQGEREF
Sbjct: 388 NSAKFYFSYEELMEVTSGFSRQNILGEGGFGCVYQGWLPEGKTVAVKQLKAGSGQGEREF 447
Query: 404 RAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKI 463
+AEVEIISRVHHRHLVSLVGYC++E++RLLIYEFVPN LEHHLHGKG PVL+W+KR+KI
Sbjct: 448 KAEVEIISRVHHRHLVSLVGYCVAERHRLLIYEFVPNKTLEHHLHGKGVPVLDWSKRLKI 507
Query: 464 ALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVM 523
ALG+AKGLAYLHEDCHP+IIHRDIKSANIL+DD FEAQVADFGLAKL + T THVSTRVM
Sbjct: 508 ALGSAKGLAYLHEDCHPRIIHRDIKSANILLDDAFEAQVADFGLAKLTNDTNTHVSTRVM 567
Query: 524 GTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVR 583
GTFGY+APEYASSGKLTDRSDVFSFGVVLLELITGRKPVD TQPLGDESLVEWARP L+
Sbjct: 568 GTFGYMAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDSTQPLGDESLVEWARPHLLH 627
Query: 584 AIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEMSD 643
A+ETG+ +VDPRL K YVESEMFRMIEAAAACVRHS PKRPRMVQVVRA+D E +MSD
Sbjct: 628 ALETGEFDGLVDPRLGKQYVESEMFRMIEAAAACVRHSAPKRPRMVQVVRAIDIESDMSD 687
Query: 644 LSNGVKYGQSTVYDSGQYNQDIMMFRKMALGLG--DSSDMSGEYTSREASRGRSGSFMSQ 701
LSNGVKYGQST+YDSGQYNQDI FR+MALG D S EY S E + R+ S+ Q
Sbjct: 688 LSNGVKYGQSTIYDSGQYNQDISRFRRMALGTDSFDYDSYSSEYNSGEMNASRA-SWRFQ 746
Query: 702 GTSSEFTSGESETRAM 717
S SGESET+A
Sbjct: 747 NNS----SGESETQAF 758
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449521092|ref|XP_004167565.1| PREDICTED: proline-rich receptor-like protein kinase PERK13-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 679 bits (1752), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 355/556 (63%), Positives = 414/556 (74%), Gaps = 35/556 (6%)
Query: 182 APPSNPGS-PPSPSTSQSGTPSTPNENSSPNELSPPSNSKSPTSKSSPEESSSSSHSNSK 240
+P +NP + +PS+ GT +TP S N LSPP+ TS S+P S SS S
Sbjct: 221 SPGANPATGKQTPSSPDQGTITTPTSES--NILSPPT----ATSTSTPNNSPHSSDSTPV 274
Query: 241 KTPTSSSGHSSDSTKGSSSNDDQAIIGATAAGVVLIVLIAIFFLARGRRRRRDAYATHYM 300
K+P G S+ + G S+ D A+ A A V+ + IF +R ++RR Y YM
Sbjct: 275 KSPL---GQSNAPSTGLRSHTDVAVGAAVAGVFVIALFAVIFVFSRKKKRRGKMYTGPYM 331
Query: 301 PPPNNFNEKTVDTYY--------GS---------QTPQMHSYGSQRGVGYHGGGPDSGVL 343
PP NF K YY GS TP +S+GSQ+G GY G G +S V+
Sbjct: 332 PP-KNFCVKADGNYYPQEHGGNSGSSEGFYTQVPHTPLGNSFGSQKGTGYSGSGMESSVI 390
Query: 344 GGSKSFFTYEELMEITNGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREF 403
+K +F+YEELME+T+GF+R+N++GEGGFGCVY+G LPEGK VAVKQLK+GSGQGEREF
Sbjct: 391 NSAKFYFSYEELMEVTSGFSRQNILGEGGFGCVYQGWLPEGKTVAVKQLKAGSGQGEREF 450
Query: 404 RAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKI 463
+AEVEIISRVHHRHLVSLVGYC++E++RLLIYEFVPN LEHHLHGKG PVL+W+KR+KI
Sbjct: 451 KAEVEIISRVHHRHLVSLVGYCVAERHRLLIYEFVPNKTLEHHLHGKGVPVLDWSKRLKI 510
Query: 464 ALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVM 523
ALG+AKGLAYLHEDCHP+IIHRDIKSANIL+DD FEAQVADFGLAKL + T THVSTRVM
Sbjct: 511 ALGSAKGLAYLHEDCHPRIIHRDIKSANILLDDAFEAQVADFGLAKLTNDTNTHVSTRVM 570
Query: 524 GTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVR 583
GTFGY+APEYASSGKLTDRSDVFSFGVVLLELITGRKPVD TQPLGDESLVEWARP L+
Sbjct: 571 GTFGYMAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDSTQPLGDESLVEWARPHLLH 630
Query: 584 AIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEMSD 643
A+ETG+ +VDPRL K YVESEMFRMIEAAAACVRHS PKRPRMVQVVRA+D E +MSD
Sbjct: 631 ALETGEFDGLVDPRLGKQYVESEMFRMIEAAAACVRHSAPKRPRMVQVVRAIDIESDMSD 690
Query: 644 LSNGVKYGQSTVYDSGQYNQDIMMFRKMALGLG--DSSDMSGEYTSREASRGRSGSFMSQ 701
LSNGVKYGQST+YDSGQYNQDI FR+MALG D S EY S E + R+ S+ Q
Sbjct: 691 LSNGVKYGQSTIYDSGQYNQDISRFRRMALGTDSFDYDSYSSEYNSGEMNASRA-SWRFQ 749
Query: 702 GTSSEFTSGESETRAM 717
S SGESET+A
Sbjct: 750 NNS----SGESETQAF 761
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|307135975|gb|ADN33834.1| protein kinase family protein [Cucumis melo subsp. melo] | Back alignment and taxonomy information |
|---|
Score = 678 bits (1750), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 374/612 (61%), Positives = 429/612 (70%), Gaps = 61/612 (9%)
Query: 126 PGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPV--PSNGTTDSRDTKWAP 183
P D A P K +PP STP D PP NPV PS G A
Sbjct: 180 PVDQSAIQAPNTPKETPP------STPTDPLPP-----SQNPVVIPSPG---------AN 219
Query: 184 PSNPGSPPSPSTSQSGTPSTPNENSSPNELSPPSNSKSPTSKSSPEESSSSSHSNSKKTP 243
P+ P+P GT +TP S N LSPP+ + + T +SP S S TP
Sbjct: 220 PATGKQTPNPP---QGTITTPTSES--NILSPPTATSTRTPNNSPHSSDS--------TP 266
Query: 244 TSSS-GHSSDSTKGSSSNDDQAIIGATAAGVVLIVLIAIFFLARGRRRRRDAYATHYMPP 302
SS G S+ + G SS+ D A+ A A + + IF R ++RR Y YMPP
Sbjct: 267 VKSSLGQSNAPSSGLSSHTDVAVGAAVAGVFAIALFAVIFIFTRKKKRRVKMYTGPYMPP 326
Query: 303 PNNFNEKTVDTYYGSQ-----------------TPQMHSYGSQRGVGYHGGGPDSGVLGG 345
NNF K YY Q TP +S+GSQ+G GY G G +SGV+
Sbjct: 327 -NNFCVKADGNYYPQQHGGNSGSTEGFYTQVPHTPLGNSFGSQKGTGYSGSGMESGVINS 385
Query: 346 SKSFFTYEELMEITNGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRA 405
+K FF+YEELME+T+GF+R+N++GEGGFGCVY+G LPEGK VAVKQLK+GSGQGEREF+A
Sbjct: 386 AKFFFSYEELMEVTSGFSRQNILGEGGFGCVYQGWLPEGKSVAVKQLKAGSGQGEREFKA 445
Query: 406 EVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIAL 465
EVEIISRVHHRHLVSLVGYC+SE++RLLIYEFVPN LEHHLHG G PVL+W+KR+KIAL
Sbjct: 446 EVEIISRVHHRHLVSLVGYCVSERHRLLIYEFVPNKTLEHHLHGNGVPVLDWSKRLKIAL 505
Query: 466 GAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGT 525
G+AKGLAYLHEDCHP+IIHRDIKSANIL+DD FEAQVADFGLAKL + T THVSTRVMGT
Sbjct: 506 GSAKGLAYLHEDCHPRIIHRDIKSANILLDDAFEAQVADFGLAKLTNDTHTHVSTRVMGT 565
Query: 526 FGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAI 585
FGY+APEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARP L+ A+
Sbjct: 566 FGYMAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPHLLHAL 625
Query: 586 ETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEMSDLS 645
ETG+ +VDPRL K YVESEMFRMIEAAAACVRHS PKRPRM+QVVRALD E +MSDLS
Sbjct: 626 ETGEFDGLVDPRLGKQYVESEMFRMIEAAAACVRHSAPKRPRMIQVVRALDIESDMSDLS 685
Query: 646 NGVKYGQSTVYDSGQYNQDIMMFRKMALGLGDSSDMSGEYTSREASRGRSGSFMSQGTSS 705
NGVKYGQST+YDSGQYNQDI FR+MALG DS D Y+S E + R S+ Q S
Sbjct: 686 NGVKYGQSTMYDSGQYNQDISKFRRMALGT-DSFDYD-SYSSGEINASRE-SWRFQNIS- 741
Query: 706 EFTSGESETRAM 717
SGE ET+A
Sbjct: 742 ---SGELETQAF 750
|
Source: Cucumis melo subsp. melo Species: Cucumis melo Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224102467|ref|XP_002312688.1| predicted protein [Populus trichocarpa] gi|222852508|gb|EEE90055.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 674 bits (1738), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 362/587 (61%), Positives = 432/587 (73%), Gaps = 54/587 (9%)
Query: 176 SRDTKWAPPSNPGSPPSPSTS---QSGTPSTPNENSSP-NELSPPSNSKS---PTSKSSP 228
SRD + +PP P + PS S + +P T + NS+P N P++S+ P +SP
Sbjct: 134 SRDVQQSPP--PPAEFKPSLSPPISNVSPKTLDSNSNPSNSGRVPTDSRFHSPPVPGASP 191
Query: 229 EE--SSSSSHSNSKKTPTSSSGHSSDSTKGSSSNDDQAIIGATAAGVVLIVLIAIFFLAR 286
+ SS+S+ + + P + ++S + A +GA G+ L+ LIA FL
Sbjct: 192 SDHPSSTSTDATNHNVPRTPPAPGNESNEAGGKTIIAAAVGAAVTGLFLLTLIAAIFLVV 251
Query: 287 GRRRRRDAYAT-HYMPPPNNFNEKTVDTYYGSQ----------TPQMH-------SYGSQ 328
R++R A A+ HYMPP +F KT +YG Q +P H S+GSQ
Sbjct: 252 KSRKKRVANASGHYMPP-KSFTLKTDGYHYGQQQQSVRLTGPGSPSYHLQSAPSESHGSQ 310
Query: 329 RGVGYHGGGPDSGVLGGSKSFFTYEELMEITNGFARENVIGEGGFGCVYKGNLPEGKVVA 388
RG Y+GGGPDS V+G K+FF+Y ELMEIT+GFAR+N+IGEGGFGCVYKG + +GKVVA
Sbjct: 311 RGNMYNGGGPDSDVIGTGKTFFSYHELMEITSGFARQNIIGEGGFGCVYKGCMADGKVVA 370
Query: 389 VKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLH 448
VKQLK+GSGQG+REF+AEVEIISRVHHRHLVSLVGYCIS+ RLLIYEFVPN LE+HLH
Sbjct: 371 VKQLKAGSGQGDREFKAEVEIISRVHHRHLVSLVGYCISDNQRLLIYEFVPNKTLENHLH 430
Query: 449 -GKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQ------ 501
GK PVL+W KR+KIA+G+AKGLAYLHEDCHPKIIHRDIKSANIL+DD FEAQ
Sbjct: 431 AGKELPVLDWPKRLKIAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDAFEAQASLRLS 490
Query: 502 -------VADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLE 554
VADFGLA+LNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLE
Sbjct: 491 MLDSLQNVADFGLARLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLE 550
Query: 555 LITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAA 614
LITGRKPVD +QPLGDESLVEWARP+L+ A+ETG+L E+VD RLEKHYVESE+FRM+E A
Sbjct: 551 LITGRKPVDASQPLGDESLVEWARPLLIHALETGELGELVDTRLEKHYVESELFRMVETA 610
Query: 615 AACVRHSGPKRPRMVQVVRALDSEGEMSDLSNGVKYGQSTVYDSGQYNQDIMMFRKMALG 674
AACVRH PKRPRM+QVVRALDS GE+SDLSNGVK+GQST YDSGQYNQ+I FR+MAL
Sbjct: 611 AACVRHLAPKRPRMMQVVRALDSGGELSDLSNGVKFGQSTAYDSGQYNQEISNFRRMALV 670
Query: 675 LGDSSD---MSGEYTSREASRGRSGSFMSQGTSSEFTSGESETRAMN 718
SS+ SG+Y++R+ SR Q TS ++TS ESETRAMN
Sbjct: 671 SNGSSEFDTFSGDYSARDTSR-------EQPTSGDYTSSESETRAMN 710
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15223161|ref|NP_177203.1| protein root hair specific 10 [Arabidopsis thaliana] gi|75333660|sp|Q9CAL8.1|PEK13_ARATH RecName: Full=Proline-rich receptor-like protein kinase PERK13; AltName: Full=Proline-rich extensin-like receptor kinase 13; Short=AtPERK13; AltName: Full=Protein ROOT HAIR SPECIFIC 10 gi|12325052|gb|AAG52479.1|AC010796_18 putative protein kinase; 6068-8907 [Arabidopsis thaliana] gi|332196943|gb|AEE35064.1| protein root hair specific 10 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 674 bits (1738), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 324/479 (67%), Positives = 378/479 (78%), Gaps = 29/479 (6%)
Query: 263 QAIIGATAAGVVLIVLIAIFFLARGRRRRR-DAYATHYMPPPNNFNEKTVDTYYGS---- 317
+ + G AG +I L+A+ FL R +++R DAY+ PP+NF+ K+ YG
Sbjct: 234 KTMAGFAIAGFAVIALMAVVFLVRRKKKRNIDAYSDSQYLPPSNFSIKSDGFLYGQNPTK 293
Query: 318 ------------QTPQMHSYGSQRGVGYH---GGGPDSGVLGGSKSFFTYEELMEITNGF 362
Q+ +S+GSQRG G + G PDS V+G ++ FTYEEL +IT GF
Sbjct: 294 GYSGPGGYNSQQQSNSGNSFGSQRGGGGYTRSGSAPDSAVMGSGQTHFTYEELTDITEGF 353
Query: 363 ARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLV 422
++ N++GEGGFGCVYKG L +GK+VAVKQLK GSGQG+REF+AEVEIISRVHHRHLVSLV
Sbjct: 354 SKHNILGEGGFGCVYKGKLNDGKLVAVKQLKVGSGQGDREFKAEVEIISRVHHRHLVSLV 413
Query: 423 GYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKI 482
GYCI++ RLLIYE+VPN LEHHLHGKG+PVLEW +RV+IA+G+AKGLAYLHEDCHPKI
Sbjct: 414 GYCIADSERLLIYEYVPNQTLEHHLHGKGRPVLEWARRVRIAIGSAKGLAYLHEDCHPKI 473
Query: 483 IHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDR 542
IHRDIKSANIL+DDEFEAQVADFGLAKLND+TQTHVSTRVMGTFGYLAPEYA SGKLTDR
Sbjct: 474 IHRDIKSANILLDDEFEAQVADFGLAKLNDSTQTHVSTRVMGTFGYLAPEYAQSGKLTDR 533
Query: 543 SDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEKHY 602
SDVFSFGVVLLELITGRKPVD QPLG+ESLVEWARP+L +AIETGD SE+VD RLEKHY
Sbjct: 534 SDVFSFGVVLLELITGRKPVDQYQPLGEESLVEWARPLLHKAIETGDFSELVDRRLEKHY 593
Query: 603 VESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEMSDLSNGVKYGQSTVYDSGQYN 662
VE+E+FRMIE AAACVRHSGPKRPRMVQVVRALDSEG+M D+SNG K GQS+ YDSGQYN
Sbjct: 594 VENEVFRMIETAAACVRHSGPKRPRMVQVVRALDSEGDMGDISNGNKVGQSSAYDSGQYN 653
Query: 663 QDIMMFRKMALGLGDSSD---MSGEYTSREASRGRSGSFMSQGTSSEFTSGESETRAMN 718
D M FRKMA G DSSD SG+Y+ +++ +G S G SSEFT E+E R N
Sbjct: 654 NDTMKFRKMAFGFDDSSDSGMYSGDYSVQDSRKG------SNGASSEFTRNETENRNFN 706
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297838841|ref|XP_002887302.1| hypothetical protein ARALYDRAFT_476166 [Arabidopsis lyrata subsp. lyrata] gi|297333143|gb|EFH63561.1| hypothetical protein ARALYDRAFT_476166 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 666 bits (1719), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 322/481 (66%), Positives = 379/481 (78%), Gaps = 31/481 (6%)
Query: 263 QAIIGATAAGVVLIVLIAIFFLARGRRRRR-DAYATHYMPPPNNFNEKTVDTYYGSQTPQ 321
+ ++G AG +I L+A+ FL R +++R DAY+ PP+NF+ K+ YG + +
Sbjct: 208 KTMVGFAVAGFAVIALMAVVFLVRRKKKRNIDAYSDSQYLPPSNFSIKSDGFLYGQNSTK 267
Query: 322 MHS----------------YGSQRGVGY--HGGGPDSGVLGGSKSFFTYEELMEITNGFA 363
++S +GSQRG GY G PDS V+G ++ FTYEEL +IT GF+
Sbjct: 268 VYSGPGGYNSQQQSNSGNSFGSQRGGGYTRSGSAPDSAVMGSGQTHFTYEELTDITEGFS 327
Query: 364 RENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVG 423
++N++GEGGFGCVYKG L +GK+VAVKQLK GSGQG+REF+AEVEIISRVHHRHLVSLVG
Sbjct: 328 KQNILGEGGFGCVYKGKLNDGKLVAVKQLKVGSGQGDREFKAEVEIISRVHHRHLVSLVG 387
Query: 424 YCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKII 483
YCI++ RLLIYE+VPN LEHHLHGKG+PVLEW +RV+IA+G+AKGLAYLHEDCHPKII
Sbjct: 388 YCIADSERLLIYEYVPNQTLEHHLHGKGRPVLEWARRVRIAIGSAKGLAYLHEDCHPKII 447
Query: 484 HRDIKSANILVDDEFEAQV---ADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLT 540
HRDIKSANIL+DD+F ++V ADFGLAKLND+TQTHVSTRVMGTFGYLAPEYA SGKLT
Sbjct: 448 HRDIKSANILLDDDFGSEVLLVADFGLAKLNDSTQTHVSTRVMGTFGYLAPEYAQSGKLT 507
Query: 541 DRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEK 600
DRSDVFSFGVVLLELITGRKPVD QPLG+ESLVEWARP+L +AIETGD SE+VD RLEK
Sbjct: 508 DRSDVFSFGVVLLELITGRKPVDQYQPLGEESLVEWARPLLHKAIETGDFSELVDRRLEK 567
Query: 601 HYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEMSDLSNGVKYGQSTVYDSGQ 660
HYVE+E+FRMIE AAACVRHSGPKRPRMVQVVRALDSEG+M D+SNG K GQS+ YDSGQ
Sbjct: 568 HYVENEVFRMIETAAACVRHSGPKRPRMVQVVRALDSEGDMGDISNGNKVGQSSAYDSGQ 627
Query: 661 YNQDIMMFRKMALGLGDSSD---MSGEYTSREASRGRSGSFMSQGTSSEFTSGESETRAM 717
YN D M FRKMA G DSSD SGEY ++ + +G S G SSEFT ESE R
Sbjct: 628 YNNDTMKFRKMAFGFDDSSDSGMYSGEYFAQGSRKG------SNGASSEFTRNESENRNF 681
Query: 718 N 718
N
Sbjct: 682 N 682
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255568804|ref|XP_002525373.1| ATP binding protein, putative [Ricinus communis] gi|223535336|gb|EEF37011.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 661 bits (1706), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 324/460 (70%), Positives = 374/460 (81%), Gaps = 29/460 (6%)
Query: 275 LIVLIAIFFLARGRRRRRDAYATHYMPPPNNFNEKTVDTYYGS-------QTPQMHSYGS 327
LI ++A+FF+ + R+++ D YA HYMPP NF +T YYG P SYGS
Sbjct: 256 LIAVVAMFFVLKKRKKKNDYYAPHYMPP-KNFTVQTDGYYYGQPPHGAGFSGPMNFSYGS 314
Query: 328 Q---RGVGYHGGGP----DSGVLGGSKSFFTYEELMEITNGFARENVIGEGGFGCVYKGN 380
Q + GG +SGV+GG K+ F+YEE+ME+T+GF+R N++GEGGFGCV+KG
Sbjct: 315 QLPSQSPDSFGGSQQFNGESGVIGGGKTHFSYEEVMEMTDGFSRHNIVGEGGFGCVFKGQ 374
Query: 381 LPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPN 440
+GK+VAVKQLK+GSGQGEREF+AEVEIISRVHHRHLVSLVGYCIS++ RLL+YEF+PN
Sbjct: 375 TSDGKIVAVKQLKAGSGQGEREFKAEVEIISRVHHRHLVSLVGYCISDRERLLLYEFLPN 434
Query: 441 NNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEA 500
N LEHHLHG PVL+W +R+KIA+G+AKGLAYLHEDC+PKIIHRDIKSANIL+DD FEA
Sbjct: 435 NTLEHHLHGT--PVLDWPQRLKIAIGSAKGLAYLHEDCNPKIIHRDIKSANILLDDNFEA 492
Query: 501 QVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRK 560
QVADFGLA+LNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDV+SFGVVLLELITGRK
Sbjct: 493 QVADFGLARLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVYSFGVVLLELITGRK 552
Query: 561 PVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRH 620
PVD TQPLGDESLVEWARP L+RA+ETGDLS IVD RLEKHYVESE+ RMIE AAACVRH
Sbjct: 553 PVDSTQPLGDESLVEWARPQLIRAMETGDLSNIVDLRLEKHYVESEVIRMIETAAACVRH 612
Query: 621 SGPKRPRMVQVVRALDSEGEMSDLSNGVKYGQSTVYDSGQYNQDIMMFRKMALGLGDSSD 680
S PKRPRMVQVVRALDS+ +M D+SNGVKYGQST YDSGQYNQDI+ FR+MA +SS+
Sbjct: 613 SAPKRPRMVQVVRALDSD-DMCDISNGVKYGQSTAYDSGQYNQDIIKFRRMAFSSAESSE 671
Query: 681 ---MSGEYTSREASRGRSGSFMSQGTSSEFTSGESETRAM 717
MSGEYTSRE SRG S FT+ E ET+AM
Sbjct: 672 FDTMSGEYTSREVSRGPP--------ISNFTTEELETQAM 703
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|42562273|ref|NP_173768.2| protein kinase domain-containing protein [Arabidopsis thaliana] gi|310947345|sp|Q9ZUE0.2|PEK12_ARATH RecName: Full=Proline-rich receptor-like protein kinase PERK12; AltName: Full=Proline-rich extensin-like receptor kinase 12; Short=AtPERK12; AltName: Full=Protein INFLORESCENCE GROWTH INHIBITOR 1 gi|332192280|gb|AEE30401.1| protein kinase domain-containing protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 655 bits (1691), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 323/485 (66%), Positives = 381/485 (78%), Gaps = 42/485 (8%)
Query: 263 QAIIGATAAGVVLIVLIAIFFLARGRRRRR-DAY-ATHYMPPPNNFNEKTVDTYYGS--- 317
+ ++G AG ++ LI + FL R +++R D+Y + Y+P PN F+ K+ YG
Sbjct: 245 KTMVGMAVAGFAIMALIGVVFLVRRKKKRNIDSYNHSQYLPHPN-FSVKSDGFLYGQDPG 303
Query: 318 ------------------QTPQMHSYGSQRGVGY------HGGGPDSGVLGGSKSFFTYE 353
Q+ +SYG+ G GY G PDS +LG ++ F+YE
Sbjct: 304 KGYSSGPNGSMYNNSQQQQSSMGNSYGTAGG-GYPHHQMQSSGTPDSAILGSGQTHFSYE 362
Query: 354 ELMEITNGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRV 413
EL EIT GFAR+N++GEGGFGCVYKG L +GKVVAVKQLK+GSGQG+REF+AEVEIISRV
Sbjct: 363 ELAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVKQLKAGSGQGDREFKAEVEIISRV 422
Query: 414 HHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAY 473
HHRHLVSLVGYCIS+++RLLIYE+V N LEHHLHGKG PVLEW+KRV+IA+G+AKGLAY
Sbjct: 423 HHRHLVSLVGYCISDQHRLLIYEYVSNQTLEHHLHGKGLPVLEWSKRVRIAIGSAKGLAY 482
Query: 474 LHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEY 533
LHEDCHPKIIHRDIKSANIL+DDE+EAQVADFGLA+LNDTTQTHVSTRVMGTFGYLAPEY
Sbjct: 483 LHEDCHPKIIHRDIKSANILLDDEYEAQVADFGLARLNDTTQTHVSTRVMGTFGYLAPEY 542
Query: 534 ASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEI 593
ASSGKLTDRSDVFSFGVVLLEL+TGRKPVD TQPLG+ESLVEWARP+L++AIETGDLSE+
Sbjct: 543 ASSGKLTDRSDVFSFGVVLLELVTGRKPVDQTQPLGEESLVEWARPLLLKAIETGDLSEL 602
Query: 594 VDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEMSDLSNGVKYGQS 653
+D RLEK YVE E+FRMIE AAACVRHSGPKRPRMVQVVRALD +G+ D+SNG+K GQS
Sbjct: 603 IDTRLEKRYVEHEVFRMIETAAACVRHSGPKRPRMVQVVRALDCDGDSGDISNGIKIGQS 662
Query: 654 TVYDSGQYNQDIMMFRKMALGLGDSSDMSGEYTSREASRGRSGSFMSQGTSSEFTSGESE 713
T YDSGQYN+DIM FRKMA G GD+S SG Y SG++ S +SS+F+ ESE
Sbjct: 663 TTYDSGQYNEDIMKFRKMAFG-GDNSVESGLY---------SGNY-SAKSSSDFSGNESE 711
Query: 714 TRAMN 718
TR N
Sbjct: 712 TRPFN 716
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297850814|ref|XP_002893288.1| hypothetical protein ARALYDRAFT_472617 [Arabidopsis lyrata subsp. lyrata] gi|297339130|gb|EFH69547.1| hypothetical protein ARALYDRAFT_472617 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 650 bits (1678), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 322/498 (64%), Positives = 384/498 (77%), Gaps = 54/498 (10%)
Query: 263 QAIIGATAAGVVLIVLIAIFFLARGRRRRR-DAY-ATHYMPPPNNFNEKTVDTYYGS--- 317
+ ++G AG ++ LIA+ FL R +++R D+Y + Y+P PN F+ K+ YG
Sbjct: 235 KTMVGMAVAGFAIMALIAVVFLVRRKKKRNIDSYNHSQYLPHPN-FSVKSDGFLYGQDPG 293
Query: 318 ------------QTPQMHS-----YGSQRGVGYH----GGGPDSGVLGGSKSFFTYEELM 356
+ Q HS +G+Q G +H G PDS +LG ++ F+YEEL
Sbjct: 294 KGYSSGPGGSMYNSQQQHSSMGNSFGTQGGYPHHQMQSSGTPDSAILGSGQTHFSYEELA 353
Query: 357 EITNGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHR 416
EIT GFAR+N++GEGGFGCVYKG L +GKVVAVKQLK+GSGQG+REF+AEVEIISRVHHR
Sbjct: 354 EITQGFARQNILGEGGFGCVYKGTLQDGKVVAVKQLKAGSGQGDREFKAEVEIISRVHHR 413
Query: 417 HLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHE 476
HLVSLVGYCIS+++RLLIYE+V N LEHHLHGKG PVLEW+KRV+IA+G+AKGLAYLHE
Sbjct: 414 HLVSLVGYCISDQHRLLIYEYVSNQTLEHHLHGKGLPVLEWSKRVRIAIGSAKGLAYLHE 473
Query: 477 DCHPKIIHRDIKSANILVDDEFEAQ----------------VADFGLAKLNDTTQTHVST 520
DCHPKIIHRDIKSANIL+DDE+EAQ VADFGLA+LNDTTQTHVST
Sbjct: 474 DCHPKIIHRDIKSANILLDDEYEAQAIMKSPFLYTHLMTLKVADFGLARLNDTTQTHVST 533
Query: 521 RVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPV 580
RVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLEL+TGRKPVD +QPLG+ESLVEWARP+
Sbjct: 534 RVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELVTGRKPVDQSQPLGEESLVEWARPL 593
Query: 581 LVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGE 640
L++AIETGDLSE++D RLE+HYVE E+FRMIE AAACVRHSGPKRPRMVQVVRALD +G+
Sbjct: 594 LLKAIETGDLSELIDRRLEQHYVEQEVFRMIETAAACVRHSGPKRPRMVQVVRALDCDGD 653
Query: 641 MSDLSNGVKYGQSTVYDSGQYNQDIMMFRKMALGLGDSSDMSGEYTSREASRGRSGSFMS 700
D+SNG+K GQST YDSGQYN+DIM FRKMA G+ D+S SG Y SG++ S
Sbjct: 654 SGDISNGIKVGQSTTYDSGQYNEDIMKFRKMAFGV-DNSVESGLY---------SGNY-S 702
Query: 701 QGTSSEFTSGESETRAMN 718
+SS+F+ ESETR N
Sbjct: 703 AKSSSDFSGNESETRPFN 720
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|4056437|gb|AAC98010.1| Strong similarity to PFAM PF|00069 Eukaryotic protein kinase domain [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 626 bits (1615), Expect = e-176, Method: Compositional matrix adjust.
Identities = 317/503 (63%), Positives = 375/503 (74%), Gaps = 67/503 (13%)
Query: 263 QAIIGATAAGVVLIVLIAIFFLARGRRRRR-DAY-ATHYMPPPNNFNEKTVDTYYGS--- 317
+ ++G AG ++ LI + FL R +++R D+Y + Y+P PN F+ K+ YG
Sbjct: 245 KTMVGMAVAGFAIMALIGVVFLVRRKKKRNIDSYNHSQYLPHPN-FSVKSDGFLYGQDPG 303
Query: 318 ------------------QTPQMHSYGSQRGVGY------HGGGPDSGVLGGSKSFFTYE 353
Q+ +SYG+ G GY G PDS +LG ++ F+YE
Sbjct: 304 KGYSSGPNGSMYNNSQQQQSSMGNSYGTAGG-GYPHHQMQSSGTPDSAILGSGQTHFSYE 362
Query: 354 ELMEITNGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRV 413
EL EIT GFAR+N++GEGGFGCVYKG L +GKVVAVKQLK+GSGQG+REF+AEVEIISRV
Sbjct: 363 ELAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVKQLKAGSGQGDREFKAEVEIISRV 422
Query: 414 HHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAY 473
HHRHLVSLVGYCIS+++RLLIYE+V N LEHHLH EW+KRV+IA+G+AKGLAY
Sbjct: 423 HHRHLVSLVGYCISDQHRLLIYEYVSNQTLEHHLH-------EWSKRVRIAIGSAKGLAY 475
Query: 474 LHEDCHPKIIHRDIKSANILVDDEFEAQ------------------VADFGLAKLNDTTQ 515
LHEDCHPKIIHRDIKSANIL+DDE+EAQ VADFGLA+LNDTTQ
Sbjct: 476 LHEDCHPKIIHRDIKSANILLDDEYEAQAIMKSSFSLNLSYDCKVLVADFGLARLNDTTQ 535
Query: 516 THVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVE 575
THVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLEL+TGRKPVD TQPLG+ESLVE
Sbjct: 536 THVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELVTGRKPVDQTQPLGEESLVE 595
Query: 576 WARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRAL 635
WARP+L++AIETGDLSE++D RLEK YVE E+FRMIE AAACVRHSGPKRPRMVQVVRAL
Sbjct: 596 WARPLLLKAIETGDLSELIDTRLEKRYVEHEVFRMIETAAACVRHSGPKRPRMVQVVRAL 655
Query: 636 DSEGEMSDLSNGVKYGQSTVYDSGQYNQDIMMFRKMALGLGDSSDMSGEYTSREASRGRS 695
D +G+ D+SNG+K GQST YDSGQYN+DIM FRKMA G GD+S SG Y S
Sbjct: 656 DCDGDSGDISNGIKIGQSTTYDSGQYNEDIMKFRKMAFG-GDNSVESGLY---------S 705
Query: 696 GSFMSQGTSSEFTSGESETRAMN 718
G++ S +SS+F+ ESETR N
Sbjct: 706 GNY-SAKSSSDFSGNESETRPFN 727
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 723 | ||||||
| TAIR|locus:2026846 | 710 | PERK13 "proline-rich extensin- | 0.525 | 0.535 | 0.746 | 5.3e-163 | |
| TAIR|locus:2028911 | 720 | PERK12 "proline-rich extensin- | 0.525 | 0.527 | 0.744 | 6e-162 | |
| TAIR|locus:2019938 | 718 | PERK11 "proline-rich extensin- | 0.587 | 0.591 | 0.632 | 2e-143 | |
| TAIR|locus:2016154 | 394 | AT1G70450 [Arabidopsis thalian | 0.441 | 0.809 | 0.757 | 9.3e-130 | |
| UNIPROTKB|Q9ARH1 | 647 | Q9ARH1 "Receptor protein kinas | 0.485 | 0.542 | 0.650 | 1.7e-129 | |
| TAIR|locus:2091722 | 652 | PERK1 "proline-rich extensin-l | 0.485 | 0.538 | 0.644 | 3.5e-129 | |
| TAIR|locus:2159873 | 681 | PERK8 "proline-rich extensin-l | 0.591 | 0.628 | 0.552 | 1e-128 | |
| TAIR|locus:2026925 | 708 | PERK9 "proline-rich extensin-l | 0.583 | 0.596 | 0.557 | 8.1e-125 | |
| TAIR|locus:2028756 | 762 | PERK10 "proline-rich extensin- | 0.565 | 0.536 | 0.568 | 2.2e-122 | |
| TAIR|locus:2139474 | 670 | PERK5 "proline-rich extensin-l | 0.466 | 0.502 | 0.633 | 1.6e-117 |
| TAIR|locus:2026846 PERK13 "proline-rich extensin-like receptor kinase 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1512 (537.3 bits), Expect = 5.3e-163, Sum P(3) = 5.3e-163
Identities = 288/386 (74%), Positives = 330/386 (85%)
Query: 318 QTPQMHSYGSQRGVGYHXXXXXXXXXX---XSKSFFTYEELMEITNGFARENVIGEGGFG 374
Q+ +S+GSQRG G + ++ FTYEEL +IT GF++ N++GEGGFG
Sbjct: 306 QSNSGNSFGSQRGGGGYTRSGSAPDSAVMGSGQTHFTYEELTDITEGFSKHNILGEGGFG 365
Query: 375 CVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLI 434
CVYKG L +GK+VAVKQLK GSGQG+REF+AEVEIISRVHHRHLVSLVGYCI++ RLLI
Sbjct: 366 CVYKGKLNDGKLVAVKQLKVGSGQGDREFKAEVEIISRVHHRHLVSLVGYCIADSERLLI 425
Query: 435 YEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILV 494
YE+VPN LEHHLHGKG+PVLEW +RV+IA+G+AKGLAYLHEDCHPKIIHRDIKSANIL+
Sbjct: 426 YEYVPNQTLEHHLHGKGRPVLEWARRVRIAIGSAKGLAYLHEDCHPKIIHRDIKSANILL 485
Query: 495 DDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLE 554
DDEFEAQVADFGLAKLND+TQTHVSTRVMGTFGYLAPEYA SGKLTDRSDVFSFGVVLLE
Sbjct: 486 DDEFEAQVADFGLAKLNDSTQTHVSTRVMGTFGYLAPEYAQSGKLTDRSDVFSFGVVLLE 545
Query: 555 LITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAA 614
LITGRKPVD QPLG+ESLVEWARP+L +AIETGD SE+VD RLEKHYVE+E+FRMIE A
Sbjct: 546 LITGRKPVDQYQPLGEESLVEWARPLLHKAIETGDFSELVDRRLEKHYVENEVFRMIETA 605
Query: 615 AACVRHSGPKRPRMVQVVRALDSEGEMSDLSNGVKYGQSTVYDSGQYNQDIMMFRKMALG 674
AACVRHSGPKRPRMVQVVRALDSEG+M D+SNG K GQS+ YDSGQYN D M FRKMA G
Sbjct: 606 AACVRHSGPKRPRMVQVVRALDSEGDMGDISNGNKVGQSSAYDSGQYNNDTMKFRKMAFG 665
Query: 675 LGDSSDM---SGEYTSREASRGRSGS 697
DSSD SG+Y+ +++ +G +G+
Sbjct: 666 FDDSSDSGMYSGDYSVQDSRKGSNGA 691
|
|
| TAIR|locus:2028911 PERK12 "proline-rich extensin-like receptor kinase 12" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1500 (533.1 bits), Expect = 6.0e-162, Sum P(3) = 6.0e-162
Identities = 291/391 (74%), Positives = 332/391 (84%)
Query: 314 YYGSQTPQM---HSYGSQRGVGY--HXXXXX----XXXXXXSKSFFTYEELMEITNGFAR 364
Y SQ Q +SYG+ G GY H ++ F+YEEL EIT GFAR
Sbjct: 315 YNNSQQQQSSMGNSYGTAGG-GYPHHQMQSSGTPDSAILGSGQTHFSYEELAEITQGFAR 373
Query: 365 ENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGY 424
+N++GEGGFGCVYKG L +GKVVAVKQLK+GSGQG+REF+AEVEIISRVHHRHLVSLVGY
Sbjct: 374 KNILGEGGFGCVYKGTLQDGKVVAVKQLKAGSGQGDREFKAEVEIISRVHHRHLVSLVGY 433
Query: 425 CISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIH 484
CIS+++RLLIYE+V N LEHHLHGKG PVLEW+KRV+IA+G+AKGLAYLHEDCHPKIIH
Sbjct: 434 CISDQHRLLIYEYVSNQTLEHHLHGKGLPVLEWSKRVRIAIGSAKGLAYLHEDCHPKIIH 493
Query: 485 RDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSD 544
RDIKSANIL+DDE+EAQVADFGLA+LNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSD
Sbjct: 494 RDIKSANILLDDEYEAQVADFGLARLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSD 553
Query: 545 VFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEKHYVE 604
VFSFGVVLLEL+TGRKPVD TQPLG+ESLVEWARP+L++AIETGDLSE++D RLEK YVE
Sbjct: 554 VFSFGVVLLELVTGRKPVDQTQPLGEESLVEWARPLLLKAIETGDLSELIDTRLEKRYVE 613
Query: 605 SEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEMSDLSNGVKYGQSTVYDSGQYNQD 664
E+FRMIE AAACVRHSGPKRPRMVQVVRALD +G+ D+SNG+K GQST YDSGQYN+D
Sbjct: 614 HEVFRMIETAAACVRHSGPKRPRMVQVVRALDCDGDSGDISNGIKIGQSTTYDSGQYNED 673
Query: 665 IMMFRKMALGLGDSSDMSGEYTSREASRGRS 695
IM FRKMA G GD+S SG Y+ +++ S
Sbjct: 674 IMKFRKMAFG-GDNSVESGLYSGNYSAKSSS 703
|
|
| TAIR|locus:2019938 PERK11 "proline-rich extensin-like receptor kinase 11" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1402 (498.6 bits), Expect = 2.0e-143, P = 2.0e-143
Identities = 279/441 (63%), Positives = 340/441 (77%)
Query: 262 DQAIIGATAAGVVLIVLIA-IFFLAXXXXXXXDA-YATHYMPPPN---------NFNEKT 310
++ +IG AGV++I+ IA +FF+ + + Y+PP N ++ +K
Sbjct: 260 EKTVIGIGIAGVLVILFIAGVFFVRRKQKKGSSSPRSNQYLPPANVSVNTEGFIHYRQKP 319
Query: 311 VDTYYGSQ--TPQMHSYGSQRGVGYHXXXXXXXXXXXSKSFFTYEELMEITNGFARENVI 368
+ +Q +P +S G+ + + SK FTYEEL +IT GF + V+
Sbjct: 320 GNGNSSAQNSSPDTNSLGNPK---HGRGTPDSAVIGTSKIHFTYEELSQITEGFCKSFVV 376
Query: 369 GEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISE 428
GEGGFGCVYKG L EGK VA+KQLKS S +G REF+AEVEIISRVHHRHLVSLVGYCISE
Sbjct: 377 GEGGFGCVYKGILFEGKPVAIKQLKSVSAEGYREFKAEVEIISRVHHRHLVSLVGYCISE 436
Query: 429 KNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIK 488
++R LIYEFVPNN L++HLHGK PVLEW++RV+IA+GAAKGLAYLHEDCHPKIIHRDIK
Sbjct: 437 QHRFLIYEFVPNNTLDYHLHGKNLPVLEWSRRVRIAIGAAKGLAYLHEDCHPKIIHRDIK 496
Query: 489 SANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSF 548
S+NIL+DDEFEAQVADFGLA+LNDT Q+H+STRVMGTFGYLAPEYASSGKLTDRSDVFSF
Sbjct: 497 SSNILLDDEFEAQVADFGLARLNDTAQSHISTRVMGTFGYLAPEYASSGKLTDRSDVFSF 556
Query: 549 GVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMF 608
GVVLLELITGRKPVD +QPLG+ESLVEWARP L+ AIE GD+SE+VDPRLE YVESE++
Sbjct: 557 GVVLLELITGRKPVDTSQPLGEESLVEWARPRLIEAIEKGDISEVVDPRLENDYVESEVY 616
Query: 609 RMIEAAAACVRHSGPKRPRMVQVVRALDSEGEMSDLSNGVKYGQSTVYDSGQYNQDIMMF 668
+MIE AA+CVRHS KRPRMVQVVRALD+ ++SDL+NGVK GQS VYDSGQY+ +I +F
Sbjct: 617 KMIETAASCVRHSALKRPRMVQVVRALDTRDDLSDLTNGVKVGQSRVYDSGQYSNEIRIF 676
Query: 669 RKMALGLGDSSDMSGEYTSRE 689
R+ + D +G Y S++
Sbjct: 677 RRASEDSSDLGTNTGYYPSQD 697
|
|
| TAIR|locus:2016154 AT1G70450 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1273 (453.2 bits), Expect = 9.3e-130, P = 9.3e-130
Identities = 244/322 (75%), Positives = 281/322 (87%)
Query: 347 KSFFTYEELMEITNGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAE 406
++ FTYEEL +IT GF+++N++GEGGFGCVYKG L +GK+VAVKQLK GSGQG+REF+AE
Sbjct: 34 QTHFTYEELEDITEGFSKQNILGEGGFGCVYKGKLKDGKLVAVKQLKVGSGQGDREFKAE 93
Query: 407 VEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALG 466
VEIISRVHHRHLVSLVGYCI++ RLLIYE+VPN LEHHLHGKG+PVLEW +RV+IA+
Sbjct: 94 VEIISRVHHRHLVSLVGYCIADSERLLIYEYVPNQTLEHHLHGKGRPVLEWARRVRIAIV 153
Query: 467 AAKGLAYLHEDC-HPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGT 525
K + HPKIIHRDIKSANIL+DDEFE QVADFGLAK+NDTTQTHVSTRVMGT
Sbjct: 154 LPKVWRICTKTVSHPKIIHRDIKSANILLDDEFEVQVADFGLAKVNDTTQTHVSTRVMGT 213
Query: 526 FGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAI 585
FGYLAPEYA SG+LTDRSDVFSFGVVLLELITGRKPVD QPLG+ESLV WARP+L +AI
Sbjct: 214 FGYLAPEYAQSGQLTDRSDVFSFGVVLLELITGRKPVDRNQPLGEESLVGWARPLLKKAI 273
Query: 586 ETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEMSDLS 645
ETGD SE+VD RLEKHYV++E+FRMIE AAACVR+SGPKRPRMVQV+RALDSEG+M D+
Sbjct: 274 ETGDFSELVDRRLEKHYVKNEVFRMIETAAACVRYSGPKRPRMVQVLRALDSEGDMGDIC 333
Query: 646 NGVKYGQS-TVYDSGQYNQDIM 666
NG+K GQS T DSGQ N ++
Sbjct: 334 NGIKVGQSSTCDDSGQ-NHSVI 354
|
|
| UNIPROTKB|Q9ARH1 Q9ARH1 "Receptor protein kinase PERK1" [Brassica napus (taxid:3708)] | Back alignment and assigned GO terms |
|---|
Score = 1196 (426.1 bits), Expect = 1.7e-129, Sum P(3) = 1.7e-129
Identities = 236/363 (65%), Positives = 284/363 (78%)
Query: 346 SKSFFTYEELMEITNGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRA 405
SKS FTYEEL TNGF+ N++G+GGFG V+KG LP GK VAVKQLK GSGQGEREF+A
Sbjct: 259 SKSTFTYEELARATNGFSEANLLGQGGFGYVHKGVLPSGKEVAVKQLKVGSGQGEREFQA 318
Query: 406 EVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIAL 465
EVEIISRVHHRHLVSLVGYCI+ RLL+YEFVPNNNLE HLHG+G+P +EW+ R+KIAL
Sbjct: 319 EVEIISRVHHRHLVSLVGYCIAGAKRLLVYEFVPNNNLELHLHGEGRPTMEWSTRLKIAL 378
Query: 466 GAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGT 525
G+AKGL+YLHEDC+PKIIHRDIK++NIL+D +FEA+VADFGLAK+ T THVSTRVMGT
Sbjct: 379 GSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVSTRVMGT 438
Query: 526 FGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAI 585
FGYLAPEYA+SGKLT++SDVFSFGVVLLELITGR+PVD D+SLV+WARP+L RA
Sbjct: 439 FGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPLLNRAS 498
Query: 586 ETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEMSDLS 645
E GD + D ++ Y EM RM+ AAACVRHS +RPRM Q+VRAL+ +SDL+
Sbjct: 499 EQGDFEGLADAKMNNGYDREEMARMVACAAACVRHSARRRPRMSQIVRALEGNVSLSDLN 558
Query: 646 NGVK---------YGQSTVYDSGQYNQDIMMFRKMALGLGDSSDMSGEYTSREASRGR-- 694
G++ YG ST YDS QYN+D+ FRKMALG + + +GEY++ + G
Sbjct: 559 EGMRPGQSNVYSSYGGSTDYDSSQYNEDMKKFRKMALGTQEYN-ATGEYSNPTSDYGLYP 617
Query: 695 SGS 697
SGS
Sbjct: 618 SGS 620
|
|
| TAIR|locus:2091722 PERK1 "proline-rich extensin-like receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1196 (426.1 bits), Expect = 3.5e-129, Sum P(3) = 3.5e-129
Identities = 234/363 (64%), Positives = 284/363 (78%)
Query: 346 SKSFFTYEELMEITNGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRA 405
SKS FTYEEL TNGF+ N++G+GGFG V+KG LP GK VAVKQLK+GSGQGEREF+A
Sbjct: 264 SKSTFTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSGQGEREFQA 323
Query: 406 EVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIAL 465
EVEIISRVHHRHLVSL+GYC++ RLL+YEFVPNNNLE HLHGKG+P +EW+ R+KIAL
Sbjct: 324 EVEIISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHGKGRPTMEWSTRLKIAL 383
Query: 466 GAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGT 525
G+AKGL+YLHEDC+PKIIHRDIK++NIL+D +FEA+VADFGLAK+ T THVSTRVMGT
Sbjct: 384 GSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVSTRVMGT 443
Query: 526 FGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAI 585
FGYLAPEYA+SGKLT++SDVFSFGVVLLELITGR+PVD D+SLV+WARP+L RA
Sbjct: 444 FGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPLLNRAS 503
Query: 586 ETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEMSDLS 645
E GD + D ++ Y EM RM+ AAACVRHS +RPRM Q+VRAL+ +SDL+
Sbjct: 504 EEGDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMSQIVRALEGNVSLSDLN 563
Query: 646 NGVK---------YGQSTVYDSGQYNQDIMMFRKMALGLGDSSDMSGEYTSREASRGR-- 694
G++ YG ST YD+ QYN D++ FRKMALG + +GEY++ + G
Sbjct: 564 EGMRPGHSNVYSSYGGSTDYDTSQYNDDMIKFRKMALGTQEYGT-TGEYSNPTSDYGLYP 622
Query: 695 SGS 697
SGS
Sbjct: 623 SGS 625
|
|
| TAIR|locus:2159873 PERK8 "proline-rich extensin-like receptor kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1245 (443.3 bits), Expect = 1.0e-128, Sum P(2) = 1.0e-128
Identities = 243/440 (55%), Positives = 319/440 (72%)
Query: 267 GATAAGVVL-IVLIAIF-----FLAXXXXXXXDAYATHYMPPPNNFNEKTVDTY-YGSQT 319
G A GV++ +V +++F F + + MPP + + D + S++
Sbjct: 237 GIVAIGVIVGLVFLSLFVMGVWFTRKRKRKDPGTFVGYTMPPSAYSSPQGSDVVLFNSRS 296
Query: 320 PQMHSYGSQRGVGYHXXXXXXXXXXXSKSFFTYEELMEITNGFARENVIGEGGFGCVYKG 379
S G Y +S+F+Y+EL ++T+GF+ +N++GEGGFGCVYKG
Sbjct: 297 SAPPKMRSHSGSDYMYASSDSGMVSNQRSWFSYDELSQVTSGFSEKNLLGEGGFGCVYKG 356
Query: 380 NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVP 439
L +G+ VAVKQLK G QGEREF+AEVEIISRVHHRHLV+LVGYCISE++RLL+Y++VP
Sbjct: 357 VLSDGREVAVKQLKIGGSQGEREFKAEVEIISRVHHRHLVTLVGYCISEQHRLLVYDYVP 416
Query: 440 NNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFE 499
NN L +HLH G+PV+ W RV++A GAA+G+AYLHEDCHP+IIHRDIKS+NIL+D+ FE
Sbjct: 417 NNTLHYHLHAPGRPVMTWETRVRVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDNSFE 476
Query: 500 AQVADFGLAKLNDTTQ--THVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT 557
A VADFGLAK+ THVSTRVMGTFGY+APEYA+SGKL++++DV+S+GV+LLELIT
Sbjct: 477 ALVADFGLAKIAQELDLNTHVSTRVMGTFGYMAPEYATSGKLSEKADVYSYGVILLELIT 536
Query: 558 GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAAC 617
GRKPVD +QPLGDESLVEWARP+L +AIE + E+VDPRL K+++ EMFRM+EAAAAC
Sbjct: 537 GRKPVDTSQPLGDESLVEWARPLLGQAIENEEFDELVDPRLGKNFIPGEMFRMVEAAAAC 596
Query: 618 VRHSGPKRPRMVQVVRALDSEGEMSDLSNGVKYGQSTVYDSGQYNQDIMMFRKMALGLGD 677
VRHS KRP+M QVVRALD+ E +D++NG++ GQS V+DS Q + I MF++MA G
Sbjct: 597 VRHSAAKRPKMSQVVRALDTLEEATDITNGMRPGQSQVFDSRQQSAQIRMFQRMAFG--- 653
Query: 678 SSDMSGEYTSREASRGRSGS 697
S D S ++ R S GS
Sbjct: 654 SQDYSSDFFDRSQSHSSWGS 673
|
|
| TAIR|locus:2026925 PERK9 "proline-rich extensin-like receptor kinase 9" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1205 (429.2 bits), Expect = 8.1e-125, Sum P(2) = 8.1e-125
Identities = 242/434 (55%), Positives = 314/434 (72%)
Query: 264 AIIG-ATAAGVVLIVLIAIFF--LAXXXXXXXDAYATHYMPPPNNFNEKTVDTYYGSQTP 320
A++G + A +V+ L IF L P P + ++ ++ Q+
Sbjct: 280 AVVGISVAVALVVFTLFGIFVWCLRKREKRLSAVSGGDVTPSPMSSTARSDSAFFRMQSS 339
Query: 321 QMHSYGSQRGVGYHXXXXXXXXXXXSKSFFTYEELMEITNGFARENVIGEGGFGCVYKGN 380
S+R Y SK+ F+YEEL++ TNGF++EN++GEGGFGCVYKG
Sbjct: 340 APVG-ASKRSGSYQSQSGGLGN---SKALFSYEELVKATNGFSQENLLGEGGFGCVYKGI 395
Query: 381 LPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPN 440
LP+G+VVAVKQLK G GQG+REF+AEVE +SR+HHRHLVS+VG+CIS RLLIY++V N
Sbjct: 396 LPDGRVVAVKQLKIGGGQGDREFKAEVETLSRIHHRHLVSIVGHCISGDRRLLIYDYVSN 455
Query: 441 NNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEA 500
N+L HLHG+ + VL+W RVKIA GAA+GLAYLHEDCHP+IIHRDIKS+NIL++D F+A
Sbjct: 456 NDLYFHLHGE-KSVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLEDNFDA 514
Query: 501 QVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRK 560
+V+DFGLA+L TH++TRV+GTFGY+APEYASSGKLT++SDVFSFGVVLLELITGRK
Sbjct: 515 RVSDFGLARLALDCNTHITTRVIGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRK 574
Query: 561 PVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRH 620
PVD +QPLGDESLVEWARP++ AIET + + DP+L +YVESEMFRMIEAA ACVRH
Sbjct: 575 PVDTSQPLGDESLVEWARPLISHAIETEEFDSLADPKLGGNYVESEMFRMIEAAGACVRH 634
Query: 621 SGPKRPRMVQVVRALDSEGEMSDLSNGVKYGQSTVYDSGQYNQDIMMFRKMALGLGD-SS 679
KRPRM Q+VRA +S DL+NG++ G+S V++S Q + +I +FR+MA G + S+
Sbjct: 635 LATKRPRMGQIVRAFESLAA-EDLTNGMRLGESEVFNSAQQSAEIRLFRRMAFGSQNYST 693
Query: 680 DM--SGEYTSREAS 691
D Y SR+A+
Sbjct: 694 DFFSHSSYNSRDAN 707
|
|
| TAIR|locus:2028756 PERK10 "proline-rich extensin-like receptor kinase 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1183 (421.5 bits), Expect = 2.2e-122, Sum P(2) = 2.2e-122
Identities = 236/415 (56%), Positives = 298/415 (71%)
Query: 264 AIIGATAAGVVLIVLIAIFFLAXXXXXXXDAYAT----HYMPPPNNFNEKTVDTYYGSQT 319
A++G + GV L++L I + +T + MP P + D+
Sbjct: 329 AVVGVSI-GVALVLLTLIGVVVCCLKKRKKRLSTIGGGYVMPTPMESSSPRSDSALLKTQ 387
Query: 320 PQMHSYGSQRGVGYHXXXXXXXXXXXSKSFFTYEELMEITNGFARENVIGEGGFGCVYKG 379
G++ + S+ F+YEEL+ TNGF+ EN++GEGGFG VYKG
Sbjct: 388 SSAPLVGNRSSNRTYLSQSEPGGFGQSRELFSYEELVIATNGFSDENLLGEGGFGRVYKG 447
Query: 380 NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVP 439
LP+ +VVAVKQLK G GQG+REF+AEV+ ISRVHHR+L+S+VGYCISE RLLIY++VP
Sbjct: 448 VLPDERVVAVKQLKIGGGQGDREFKAEVDTISRVHHRNLLSMVGYCISENRRLLIYDYVP 507
Query: 440 NNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFE 499
NNNL HLH G P L+W RVKIA GAA+GLAYLHEDCHP+IIHRDIKS+NIL+++ F
Sbjct: 508 NNNLYFHLHAAGTPGLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLENNFH 567
Query: 500 AQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGR 559
A V+DFGLAKL TH++TRVMGTFGY+APEYASSGKLT++SDVFSFGVVLLELITGR
Sbjct: 568 ALVSDFGLAKLALDCNTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGR 627
Query: 560 KPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVR 619
KPVD +QPLGDESLVEWARP+L A ET + + + DP+L ++YV EMFRMIEAAAAC+R
Sbjct: 628 KPVDASQPLGDESLVEWARPLLSNATETEEFTALADPKLGRNYVGVEMFRMIEAAAACIR 687
Query: 620 HSGPKRPRMVQVVRALDSEGEMSDLSNGVKYGQSTVYDSGQYNQDIMMFRKMALG 674
HS KRPRM Q+VRA DS E DL+NG++ G+S + +S Q + +I +FR+MA G
Sbjct: 688 HSATKRPRMSQIVRAFDSLAE-EDLTNGMRLGESEIINSAQQSAEIRLFRRMAFG 741
|
|
| TAIR|locus:2139474 PERK5 "proline-rich extensin-like receptor kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1128 (402.1 bits), Expect = 1.6e-117, Sum P(2) = 1.6e-117
Identities = 221/349 (63%), Positives = 269/349 (77%)
Query: 346 SKSFFTYEELMEITNGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRA 405
++S FTY+EL T GFA+ N++G+GGFG V+KG LP GK VAVK LK GSGQGEREF+A
Sbjct: 296 NQSTFTYDELSIATEGFAQSNLLGQGGFGYVHKGVLPSGKEVAVKSLKLGSGQGEREFQA 355
Query: 406 EVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIAL 465
EV+IISRVHHRHLVSLVGYCIS RLL+YEF+PNN LE HLHGKG+PVL+W RVKIAL
Sbjct: 356 EVDIISRVHHRHLVSLVGYCISGGQRLLVYEFIPNNTLEFHLHGKGRPVLDWPTRVKIAL 415
Query: 466 GAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGT 525
G+A+GLAYLHEDCHP+IIHRDIK+ANIL+D FE +VADFGLAKL+ THVSTRVMGT
Sbjct: 416 GSARGLAYLHEDCHPRIIHRDIKAANILLDFSFETKVADFGLAKLSQDNYTHVSTRVMGT 475
Query: 526 FGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAI 585
FGYLAPEYASSGKL+D+SDVFSFGV+LLELITGR P+D T + D SLV+WARP+ ++A
Sbjct: 476 FGYLAPEYASSGKLSDKSDVFSFGVMLLELITGRPPLDLTGEMED-SLVDWARPLCLKAA 534
Query: 586 ETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEMSDLS 645
+ GD +++ DPRLE +Y EM +M AAA +RHS +RP+M Q+VRAL+ + M DLS
Sbjct: 535 QDGDYNQLADPRLELNYSHQEMVQMASCAAAAIRHSARRRPKMSQIVRALEGDMSMDDLS 594
Query: 646 NGVKYGQSTV---------YDSGQYNQDIMMFRKMALGLGDSSDMSGEY 685
G + GQST YD+ Y D+ F+K+AL + S EY
Sbjct: 595 EGTRPGQSTYLSPGSVSSEYDASSYTADMKKFKKLALE--NKEYQSSEY 641
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| Q9CAL8 | PEK13_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6764 | 0.6224 | 0.6338 | yes | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 723 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-55 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 9e-54 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-52 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-50 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-49 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-49 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-49 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-44 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-38 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-37 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-37 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-33 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-32 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-32 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 6e-32 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-31 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 9e-31 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-30 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-29 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-29 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-29 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-29 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-28 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-28 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 7e-28 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-27 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 9e-27 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-26 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-26 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-26 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-25 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-25 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-25 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-25 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-25 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-25 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 6e-25 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 8e-25 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 8e-25 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-24 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-24 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-24 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-24 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-24 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 7e-24 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 7e-24 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 7e-24 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 8e-24 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-23 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-23 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-23 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-23 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-23 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 6e-23 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 6e-23 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-23 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-22 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-22 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-22 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-22 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-22 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-22 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-22 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 7e-22 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 7e-22 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-21 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-21 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-21 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-21 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-21 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-21 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-21 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-21 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-21 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 8e-21 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-20 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-20 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-20 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-20 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-20 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-20 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-20 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-20 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-20 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 7e-20 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 7e-20 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 7e-20 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 8e-20 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-19 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-19 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-19 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-19 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-19 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-19 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-19 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-19 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 5e-19 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 6e-19 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 6e-19 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 8e-19 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 9e-19 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-18 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-18 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-18 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-18 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-18 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-18 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-18 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-18 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-18 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-18 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 3e-18 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-18 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-18 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-18 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-18 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-18 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-18 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-18 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-18 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-18 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 8e-18 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 8e-18 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 8e-18 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-17 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-17 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-17 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-17 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-17 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-17 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-17 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 3e-17 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-17 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 6e-17 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-16 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-16 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-16 | |
| PRK12323 | 700 | PRK12323, PRK12323, DNA polymerase III subunits ga | 2e-16 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-16 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-16 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-16 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 3e-16 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-16 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-16 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-16 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-16 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-16 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-16 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 6e-16 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 8e-16 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-15 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-15 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 2e-15 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 2e-15 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-15 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-15 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-15 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-15 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-15 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-15 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-15 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 3e-15 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-15 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-15 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-15 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-15 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 6e-15 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 6e-15 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 7e-15 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 7e-15 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 7e-15 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 7e-15 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 7e-15 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 8e-15 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-14 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-14 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-14 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-14 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-14 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 3e-14 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-14 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-14 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-14 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-14 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-14 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-14 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 9e-14 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-13 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-13 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-13 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 2e-13 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-13 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 2e-13 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-13 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-13 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-13 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-13 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 4e-13 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 5e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-13 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 5e-13 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 6e-13 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 7e-13 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 7e-13 | |
| PRK07003 | 830 | PRK07003, PRK07003, DNA polymerase III subunits ga | 9e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-12 | |
| PRK12323 | 700 | PRK12323, PRK12323, DNA polymerase III subunits ga | 2e-12 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 2e-12 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 2e-12 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 3e-12 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-12 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-12 | |
| PRK07003 | 830 | PRK07003, PRK07003, DNA polymerase III subunits ga | 7e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 7e-12 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 8e-12 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 8e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 8e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 9e-12 | |
| PRK12323 | 700 | PRK12323, PRK12323, DNA polymerase III subunits ga | 1e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-11 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-11 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-11 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-11 | |
| PRK14086 | 617 | PRK14086, dnaA, chromosomal replication initiation | 1e-11 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 2e-11 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 2e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-11 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-11 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-11 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-11 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-11 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-11 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-11 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 4e-11 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 4e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-11 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-11 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 4e-11 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-11 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-11 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 6e-11 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 6e-11 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 7e-11 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 7e-11 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 9e-11 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 9e-11 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-10 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-10 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 2e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-10 | |
| PHA03378 | 991 | PHA03378, PHA03378, EBNA-3B; Provisional | 2e-10 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-10 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 3e-10 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 3e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-10 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-10 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-10 | |
| PRK07003 | 830 | PRK07003, PRK07003, DNA polymerase III subunits ga | 5e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-10 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-10 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 6e-10 | |
| PRK07003 | 830 | PRK07003, PRK07003, DNA polymerase III subunits ga | 6e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 6e-10 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 7e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 9e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 9e-10 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 9e-10 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-09 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 2e-09 | |
| pfam09770 | 804 | pfam09770, PAT1, Topoisomerase II-associated prote | 2e-09 | |
| pfam07223 | 357 | pfam07223, DUF1421, Protein of unknown function (D | 2e-09 | |
| pfam03153 | 332 | pfam03153, TFIIA, Transcription factor IIA, alpha/ | 2e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-09 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 3e-09 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 3e-09 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-09 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-09 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-09 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-09 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 5e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 5e-09 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 6e-09 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 6e-09 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 6e-09 | |
| PRK07003 | 830 | PRK07003, PRK07003, DNA polymerase III subunits ga | 6e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 6e-09 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 7e-09 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 8e-09 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 8e-09 | |
| PLN03209 | 576 | PLN03209, PLN03209, translocon at the inner envelo | 8e-09 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 9e-09 | |
| PRK07003 | 830 | PRK07003, PRK07003, DNA polymerase III subunits ga | 1e-08 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 1e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-08 | |
| PHA03378 | 991 | PHA03378, PHA03378, EBNA-3B; Provisional | 2e-08 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 2e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-08 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 2e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-08 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 3e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-08 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 4e-08 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 4e-08 | |
| pfam07174 | 297 | pfam07174, FAP, Fibronectin-attachment protein (FA | 4e-08 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 5e-08 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 5e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-08 | |
| PTZ00441 | 576 | PTZ00441, PTZ00441, sporozoite surface protein 2 ( | 5e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 5e-08 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 5e-08 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 6e-08 | |
| pfam03154 | 979 | pfam03154, Atrophin-1, Atrophin-1 family | 6e-08 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 6e-08 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 7e-08 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 8e-08 | |
| pfam05109 | 830 | pfam05109, Herpes_BLLF1, Herpes virus major outer | 9e-08 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 1e-07 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 1e-07 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 1e-07 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 1e-07 | |
| pfam07174 | 297 | pfam07174, FAP, Fibronectin-attachment protein (FA | 1e-07 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 1e-07 | |
| PRK14959 | 624 | PRK14959, PRK14959, DNA polymerase III subunits ga | 1e-07 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 2e-07 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 2e-07 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 2e-07 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 2e-07 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 2e-07 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 2e-07 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 2e-07 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 2e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-07 | |
| PRK14954 | 620 | PRK14954, PRK14954, DNA polymerase III subunits ga | 2e-07 | |
| pfam09770 | 804 | pfam09770, PAT1, Topoisomerase II-associated prote | 3e-07 | |
| pfam05109 | 830 | pfam05109, Herpes_BLLF1, Herpes virus major outer | 3e-07 | |
| PLN02983 | 274 | PLN02983, PLN02983, biotin carboxyl carrier protei | 3e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-07 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 3e-07 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 4e-07 | |
| PLN02983 | 274 | PLN02983, PLN02983, biotin carboxyl carrier protei | 4e-07 | |
| PRK09111 | 598 | PRK09111, PRK09111, DNA polymerase III subunits ga | 4e-07 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 5e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 5e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 6e-07 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 7e-07 | |
| pfam03154 | 979 | pfam03154, Atrophin-1, Atrophin-1 family | 7e-07 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 8e-07 | |
| PLN03209 | 576 | PLN03209, PLN03209, translocon at the inner envelo | 8e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 9e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 9e-07 | |
| PRK06975 | 656 | PRK06975, PRK06975, bifunctional uroporphyrinogen- | 9e-07 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 1e-06 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 1e-06 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-06 | |
| PRK03427 | 333 | PRK03427, PRK03427, cell division protein ZipA; Pr | 1e-06 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 2e-06 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 2e-06 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 2e-06 | |
| PLN03209 | 576 | PLN03209, PLN03209, translocon at the inner envelo | 2e-06 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 2e-06 | |
| pfam07174 | 297 | pfam07174, FAP, Fibronectin-attachment protein (FA | 2e-06 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-06 | |
| PHA03419 | 200 | PHA03419, PHA03419, E4 protein; Provisional | 2e-06 | |
| PHA02682 | 280 | PHA02682, PHA02682, ORF080 virion core protein; Pr | 2e-06 | |
| PRK14086 | 617 | PRK14086, dnaA, chromosomal replication initiation | 3e-06 | |
| pfam09770 | 804 | pfam09770, PAT1, Topoisomerase II-associated prote | 3e-06 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 3e-06 | |
| pfam03154 | 979 | pfam03154, Atrophin-1, Atrophin-1 family | 3e-06 | |
| pfam05109 | 830 | pfam05109, Herpes_BLLF1, Herpes virus major outer | 3e-06 | |
| PRK09111 | 598 | PRK09111, PRK09111, DNA polymerase III subunits ga | 4e-06 | |
| PRK09111 | 598 | PRK09111, PRK09111, DNA polymerase III subunits ga | 4e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-06 | |
| PTZ00436 | 357 | PTZ00436, PTZ00436, 60S ribosomal protein L19-like | 4e-06 | |
| pfam06075 | 564 | pfam06075, DUF936, Plant protein of unknown functi | 4e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 4e-06 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 5e-06 | |
| PLN03209 | 576 | PLN03209, PLN03209, translocon at the inner envelo | 5e-06 | |
| pfam03154 | 979 | pfam03154, Atrophin-1, Atrophin-1 family | 5e-06 | |
| PRK11855 | 547 | PRK11855, PRK11855, dihydrolipoamide acetyltransfe | 5e-06 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 6e-06 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 6e-06 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 6e-06 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 6e-06 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 6e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 6e-06 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 7e-06 | |
| PTZ00436 | 357 | PTZ00436, PTZ00436, 60S ribosomal protein L19-like | 7e-06 | |
| PHA03291 | 401 | PHA03291, PHA03291, envelope glycoprotein I; Provi | 7e-06 | |
| PRK00404 | 141 | PRK00404, tatB, sec-independent translocase; Provi | 7e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 7e-06 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 8e-06 | |
| pfam03154 | 979 | pfam03154, Atrophin-1, Atrophin-1 family | 8e-06 | |
| PRK11633 | 226 | PRK11633, PRK11633, cell division protein DedD; Pr | 8e-06 | |
| PRK07003 | 830 | PRK07003, PRK07003, DNA polymerase III subunits ga | 9e-06 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 9e-06 | |
| PRK14954 | 620 | PRK14954, PRK14954, DNA polymerase III subunits ga | 9e-06 | |
| PTZ00436 | 357 | PTZ00436, PTZ00436, 60S ribosomal protein L19-like | 9e-06 | |
| PRK00404 | 141 | PRK00404, tatB, sec-independent translocase; Provi | 9e-06 | |
| PHA03132 | 580 | PHA03132, PHA03132, thymidine kinase; Provisional | 9e-06 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 1e-05 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 1e-05 | |
| pfam09770 | 804 | pfam09770, PAT1, Topoisomerase II-associated prote | 1e-05 | |
| pfam07223 | 357 | pfam07223, DUF1421, Protein of unknown function (D | 1e-05 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 1e-05 | |
| PRK14954 | 620 | PRK14954, PRK14954, DNA polymerase III subunits ga | 1e-05 | |
| pfam05518 | 753 | pfam05518, Totivirus_coat, Totivirus coat protein | 1e-05 | |
| pfam04484 | 313 | pfam04484, DUF566, Family of unknown function (DUF | 1e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-05 | |
| TIGR00601 | 378 | TIGR00601, rad23, UV excision repair protein Rad23 | 1e-05 | |
| pfam12526 | 115 | pfam12526, DUF3729, Protein of unknown function (D | 1e-05 | |
| COG5068 | 412 | COG5068, ARG80, Regulator of arginine metabolism a | 1e-05 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 2e-05 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 2e-05 | |
| pfam09770 | 804 | pfam09770, PAT1, Topoisomerase II-associated prote | 2e-05 | |
| pfam03153 | 332 | pfam03153, TFIIA, Transcription factor IIA, alpha/ | 2e-05 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 2e-05 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 2e-05 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 2e-05 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 2e-05 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 2e-05 | |
| PRK14959 | 624 | PRK14959, PRK14959, DNA polymerase III subunits ga | 2e-05 | |
| PLN02983 | 274 | PLN02983, PLN02983, biotin carboxyl carrier protei | 2e-05 | |
| PHA03291 | 401 | PHA03291, PHA03291, envelope glycoprotein I; Provi | 2e-05 | |
| PHA03132 | 580 | PHA03132, PHA03132, thymidine kinase; Provisional | 2e-05 | |
| pfam12526 | 115 | pfam12526, DUF3729, Protein of unknown function (D | 2e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-05 | |
| COG5373 | 931 | COG5373, COG5373, Predicted membrane protein [Func | 2e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-05 | |
| PRK10263 | 1355 | PRK10263, PRK10263, DNA translocase FtsK; Provisio | 2e-05 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 3e-05 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 3e-05 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 3e-05 | |
| PRK11892 | 464 | PRK11892, PRK11892, pyruvate dehydrogenase subunit | 3e-05 | |
| pfam04388 | 667 | pfam04388, Hamartin, Hamartin protein | 3e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-05 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 4e-05 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 4e-05 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 4e-05 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 4e-05 | |
| PRK09111 | 598 | PRK09111, PRK09111, DNA polymerase III subunits ga | 4e-05 | |
| PRK00404 | 141 | PRK00404, tatB, sec-independent translocase; Provi | 4e-05 | |
| pfam11725 | 1771 | pfam11725, AvrE, Pathogenicity factor | 4e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-05 | |
| PRK14949 | 944 | PRK14949, PRK14949, DNA polymerase III subunits ga | 4e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-05 | |
| pfam12737 | 418 | pfam12737, Mating_C, C-terminal domain of homeodom | 4e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-05 | |
| TIGR02927 | 579 | TIGR02927, SucB_Actino, 2-oxoglutarate dehydrogena | 4e-05 | |
| PRK14086 | 617 | PRK14086, dnaA, chromosomal replication initiation | 5e-05 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 5e-05 | |
| pfam05518 | 753 | pfam05518, Totivirus_coat, Totivirus coat protein | 5e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-05 | |
| PHA03375 | 844 | PHA03375, PHA03375, hypothetical protein; Provisio | 5e-05 | |
| PRK12799 | 421 | PRK12799, motB, flagellar motor protein MotB; Revi | 5e-05 | |
| PHA03201 | 318 | PHA03201, PHA03201, uracil DNA glycosylase; Provis | 5e-05 | |
| PRK01297 | 475 | PRK01297, PRK01297, ATP-dependent RNA helicase Rhl | 5e-05 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 6e-05 | |
| PTZ00449 | 943 | PTZ00449, PTZ00449, 104 kDa microneme/rhoptry anti | 6e-05 | |
| PRK00404 | 141 | PRK00404, tatB, sec-independent translocase; Provi | 7e-05 | |
| PRK08691 | 709 | PRK08691, PRK08691, DNA polymerase III subunits ga | 7e-05 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 8e-05 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 8e-05 | |
| PTZ00449 | 943 | PTZ00449, PTZ00449, 104 kDa microneme/rhoptry anti | 8e-05 | |
| PLN02217 | 670 | PLN02217, PLN02217, probable pectinesterase/pectin | 8e-05 | |
| PRK11892 | 464 | PRK11892, PRK11892, pyruvate dehydrogenase subunit | 9e-05 | |
| PHA03378 | 991 | PHA03378, PHA03378, EBNA-3B; Provisional | 1e-04 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 1e-04 | |
| pfam05109 | 830 | pfam05109, Herpes_BLLF1, Herpes virus major outer | 1e-04 | |
| PRK14959 | 624 | PRK14959, PRK14959, DNA polymerase III subunits ga | 1e-04 | |
| PRK11855 | 547 | PRK11855, PRK11855, dihydrolipoamide acetyltransfe | 1e-04 | |
| COG5373 | 931 | COG5373, COG5373, Predicted membrane protein [Func | 1e-04 | |
| PRK12438 | 991 | PRK12438, PRK12438, hypothetical protein; Provisio | 1e-04 | |
| PTZ00395 | 1560 | PTZ00395, PTZ00395, Sec24-related protein; Provisi | 1e-04 | |
| COG5178 | 2365 | COG5178, PRP8, U5 snRNP spliceosome subunit [RNA p | 1e-04 | |
| PRK11901 | 327 | PRK11901, PRK11901, hypothetical protein; Reviewed | 1e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-04 | |
| PTZ00144 | 418 | PTZ00144, PTZ00144, dihydrolipoamide succinyltrans | 1e-04 | |
| PRK11856 | 411 | PRK11856, PRK11856, branched-chain alpha-keto acid | 1e-04 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 2e-04 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 2e-04 | |
| pfam07223 | 357 | pfam07223, DUF1421, Protein of unknown function (D | 2e-04 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 2e-04 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 2e-04 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 2e-04 | |
| PLN02983 | 274 | PLN02983, PLN02983, biotin carboxyl carrier protei | 2e-04 | |
| PRK03427 | 333 | PRK03427, PRK03427, cell division protein ZipA; Pr | 2e-04 | |
| PRK03427 | 333 | PRK03427, PRK03427, cell division protein ZipA; Pr | 2e-04 | |
| PRK01297 | 475 | PRK01297, PRK01297, ATP-dependent RNA helicase Rhl | 2e-04 | |
| PHA03321 | 694 | PHA03321, PHA03321, tegument protein VP11/12; Prov | 2e-04 | |
| TIGR01347 | 403 | TIGR01347, sucB, 2-oxoglutarate dehydrogenase comp | 2e-04 | |
| COG3147 | 226 | COG3147, DedD, Uncharacterized protein conserved i | 2e-04 | |
| pfam08580 | 626 | pfam08580, KAR9, Yeast cortical protein KAR9 | 2e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-04 | |
| pfam10428 | 419 | pfam10428, SOG2, RAM signalling pathway protein | 2e-04 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 3e-04 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 3e-04 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 3e-04 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 3e-04 | |
| PRK09111 | 598 | PRK09111, PRK09111, DNA polymerase III subunits ga | 3e-04 | |
| PRK09111 | 598 | PRK09111, PRK09111, DNA polymerase III subunits ga | 3e-04 | |
| PHA03291 | 401 | PHA03291, PHA03291, envelope glycoprotein I; Provi | 3e-04 | |
| pfam11725 | 1771 | pfam11725, AvrE, Pathogenicity factor | 3e-04 | |
| PRK14949 | 944 | PRK14949, PRK14949, DNA polymerase III subunits ga | 3e-04 | |
| PRK01297 | 475 | PRK01297, PRK01297, ATP-dependent RNA helicase Rhl | 3e-04 | |
| COG5178 | 2365 | COG5178, PRP8, U5 snRNP spliceosome subunit [RNA p | 3e-04 | |
| PRK11856 | 411 | PRK11856, PRK11856, branched-chain alpha-keto acid | 3e-04 | |
| PHA03377 | 1000 | PHA03377, PHA03377, EBNA-3C; Provisional | 3e-04 | |
| PHA03325 | 418 | PHA03325, PHA03325, nuclear-egress-membrane-like p | 3e-04 | |
| PRK00708 | 209 | PRK00708, PRK00708, sec-independent translocase; P | 3e-04 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 4e-04 | |
| PRK00404 | 141 | PRK00404, tatB, sec-independent translocase; Provi | 4e-04 | |
| COG5373 | 931 | COG5373, COG5373, Predicted membrane protein [Func | 4e-04 | |
| PRK14949 | 944 | PRK14949, PRK14949, DNA polymerase III subunits ga | 4e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 4e-04 | |
| PRK12372 | 413 | PRK12372, PRK12372, ribonuclease III; Reviewed | 4e-04 | |
| COG0810 | 244 | COG0810, TonB, Periplasmic protein TonB, links inn | 4e-04 | |
| pfam03153 | 332 | pfam03153, TFIIA, Transcription factor IIA, alpha/ | 5e-04 | |
| PRK06975 | 656 | PRK06975, PRK06975, bifunctional uroporphyrinogen- | 5e-04 | |
| pfam12737 | 418 | pfam12737, Mating_C, C-terminal domain of homeodom | 5e-04 | |
| pfam10152 | 147 | pfam10152, DUF2360, Predicted coiled-coil domain-c | 5e-04 | |
| TIGR01348 | 546 | TIGR01348, PDHac_trf_long, pyruvate dehydrogenase | 5e-04 | |
| PLN03237 | 1465 | PLN03237, PLN03237, DNA topoisomerase 2; Provision | 5e-04 | |
| pfam03276 | 582 | pfam03276, Gag_spuma, Spumavirus gag protein | 5e-04 | |
| PRK03427 | 333 | PRK03427, PRK03427, cell division protein ZipA; Pr | 6e-04 | |
| PRK12438 | 991 | PRK12438, PRK12438, hypothetical protein; Provisio | 6e-04 | |
| PTZ00144 | 418 | PTZ00144, PTZ00144, dihydrolipoamide succinyltrans | 6e-04 | |
| PTZ00144 | 418 | PTZ00144, PTZ00144, dihydrolipoamide succinyltrans | 6e-04 | |
| PRK12372 | 413 | PRK12372, PRK12372, ribonuclease III; Reviewed | 6e-04 | |
| pfam03276 | 582 | pfam03276, Gag_spuma, Spumavirus gag protein | 6e-04 | |
| PRK10547 | 670 | PRK10547, PRK10547, chemotaxis protein CheA; Provi | 6e-04 | |
| pfam10873 | 154 | pfam10873, DUF2668, Protein of unknown function (D | 6e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 7e-04 | |
| PRK13729 | 475 | PRK13729, PRK13729, conjugal transfer pilus assemb | 7e-04 | |
| PRK10819 | 246 | PRK10819, PRK10819, transport protein TonB; Provis | 7e-04 | |
| pfam10349 | 111 | pfam10349, WWbp, WW-domain ligand protein | 7e-04 | |
| PRK06549 | 130 | PRK06549, PRK06549, acetyl-CoA carboxylase biotin | 7e-04 | |
| pfam05539 | 408 | pfam05539, Pneumo_att_G, Pneumovirinae attachment | 7e-04 | |
| pfam07223 | 357 | pfam07223, DUF1421, Protein of unknown function (D | 8e-04 | |
| PRK14959 | 624 | PRK14959, PRK14959, DNA polymerase III subunits ga | 8e-04 | |
| PTZ00436 | 357 | PTZ00436, PTZ00436, 60S ribosomal protein L19-like | 8e-04 | |
| PRK00708 | 209 | PRK00708, PRK00708, sec-independent translocase; P | 8e-04 | |
| pfam10349 | 111 | pfam10349, WWbp, WW-domain ligand protein | 8e-04 | |
| pfam05539 | 408 | pfam05539, Pneumo_att_G, Pneumovirinae attachment | 8e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 8e-04 | |
| pfam12526 | 115 | pfam12526, DUF3729, Protein of unknown function (D | 9e-04 | |
| PHA03369 | 663 | PHA03369, PHA03369, capsid maturational protease; | 9e-04 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 0.001 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 0.001 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 0.001 | |
| PRK03427 | 333 | PRK03427, PRK03427, cell division protein ZipA; Pr | 0.001 | |
| PHA03291 | 401 | PHA03291, PHA03291, envelope glycoprotein I; Provi | 0.001 | |
| PHA03132 | 580 | PHA03132, PHA03132, thymidine kinase; Provisional | 0.001 | |
| pfam04484 | 313 | pfam04484, DUF566, Family of unknown function (DUF | 0.001 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.001 | |
| PRK01297 | 475 | PRK01297, PRK01297, ATP-dependent RNA helicase Rhl | 0.001 | |
| COG5178 | 2365 | COG5178, PRP8, U5 snRNP spliceosome subunit [RNA p | 0.001 | |
| PTZ00144 | 418 | PTZ00144, PTZ00144, dihydrolipoamide succinyltrans | 0.001 | |
| pfam10428 | 419 | pfam10428, SOG2, RAM signalling pathway protein | 0.001 | |
| pfam10428 | 419 | pfam10428, SOG2, RAM signalling pathway protein | 0.001 | |
| pfam10428 | 419 | pfam10428, SOG2, RAM signalling pathway protein | 0.001 | |
| pfam10152 | 147 | pfam10152, DUF2360, Predicted coiled-coil domain-c | 0.001 | |
| PRK10547 | 670 | PRK10547, PRK10547, chemotaxis protein CheA; Provi | 0.001 | |
| PRK14952 | 584 | PRK14952, PRK14952, DNA polymerase III subunits ga | 0.001 | |
| PHA01929 | 306 | PHA01929, PHA01929, putative scaffolding protein | 0.001 | |
| COG5099 | 777 | COG5099, COG5099, RNA-binding protein of the Puf f | 0.001 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.001 | |
| PRK14723 | 767 | PRK14723, flhF, flagellar biosynthesis regulator F | 0.001 | |
| pfam03999 | 619 | pfam03999, MAP65_ASE1, Microtubule associated prot | 0.001 | |
| PHA03269 | 566 | PHA03269, PHA03269, envelope glycoprotein C; Provi | 0.001 | |
| pfam11029 | 136 | pfam11029, DAZAP2, DAZ associated protein 2 (DAZAP | 0.001 | |
| TIGR03657 | 644 | TIGR03657, IsdB, heme uptake protein IsdB | 0.001 | |
| PRK10905 | 328 | PRK10905, PRK10905, cell division protein DamX; Va | 0.001 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 0.002 | |
| pfam07174 | 297 | pfam07174, FAP, Fibronectin-attachment protein (FA | 0.002 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 0.002 | |
| PRK14954 | 620 | PRK14954, PRK14954, DNA polymerase III subunits ga | 0.002 | |
| PRK09111 | 598 | PRK09111, PRK09111, DNA polymerase III subunits ga | 0.002 | |
| PRK06975 | 656 | PRK06975, PRK06975, bifunctional uroporphyrinogen- | 0.002 | |
| PHA03419 | 200 | PHA03419, PHA03419, E4 protein; Provisional | 0.002 | |
| PRK11855 | 547 | PRK11855, PRK11855, dihydrolipoamide acetyltransfe | 0.002 | |
| pfam12526 | 115 | pfam12526, DUF3729, Protein of unknown function (D | 0.002 | |
| COG5373 | 931 | COG5373, COG5373, Predicted membrane protein [Func | 0.002 | |
| COG5373 | 931 | COG5373, COG5373, Predicted membrane protein [Func | 0.002 | |
| PRK11892 | 464 | PRK11892, PRK11892, pyruvate dehydrogenase subunit | 0.002 | |
| TIGR02927 | 579 | TIGR02927, SucB_Actino, 2-oxoglutarate dehydrogena | 0.002 | |
| PHA03201 | 318 | PHA03201, PHA03201, uracil DNA glycosylase; Provis | 0.002 | |
| PLN02217 | 670 | PLN02217, PLN02217, probable pectinesterase/pectin | 0.002 | |
| PTZ00144 | 418 | PTZ00144, PTZ00144, dihydrolipoamide succinyltrans | 0.002 | |
| pfam10152 | 147 | pfam10152, DUF2360, Predicted coiled-coil domain-c | 0.002 | |
| TIGR01348 | 546 | TIGR01348, PDHac_trf_long, pyruvate dehydrogenase | 0.002 | |
| PRK14952 | 584 | PRK14952, PRK14952, DNA polymerase III subunits ga | 0.002 | |
| PRK14723 | 767 | PRK14723, flhF, flagellar biosynthesis regulator F | 0.002 | |
| PHA03269 | 566 | PHA03269, PHA03269, envelope glycoprotein C; Provi | 0.002 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 0.002 | |
| PRK13042 | 291 | PRK13042, PRK13042, superantigen-like protein; Rev | 0.002 | |
| pfam04625 | 407 | pfam04625, DEC-1_N, DEC-1 protein, N-terminal regi | 0.002 | |
| pfam05110 | 1154 | pfam05110, AF-4, AF-4 proto-oncoprotein | 0.002 | |
| pfam05110 | 1154 | pfam05110, AF-4, AF-4 proto-oncoprotein | 0.002 | |
| pfam05110 | 1154 | pfam05110, AF-4, AF-4 proto-oncoprotein | 0.002 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.002 | |
| PRK12373 | 400 | PRK12373, PRK12373, NADH dehydrogenase subunit E; | 0.002 | |
| pfam04487 | 206 | pfam04487, CITED, CITED | 0.002 | |
| PHA03169 | 413 | PHA03169, PHA03169, hypothetical protein; Provisio | 0.002 | |
| COG5422 | 1175 | COG5422, ROM1, RhoGEF, Guanine nucleotide exchange | 0.002 | |
| pfam02993 | 238 | pfam02993, MCPVI, Minor capsid protein VI | 0.002 | |
| pfam05795 | 348 | pfam05795, Plasmodium_Vir, Plasmodium vivax Vir pr | 0.002 | |
| pfam07415 | 489 | pfam07415, Herpes_LMP2, Gammaherpesvirus latent me | 0.002 | |
| pfam06070 | 777 | pfam06070, Herpes_UL32, Herpesvirus large structur | 0.002 | |
| PRK14963 | 504 | PRK14963, PRK14963, DNA polymerase III subunits ga | 0.002 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 0.003 | |
| PHA03291 | 401 | PHA03291, PHA03291, envelope glycoprotein I; Provi | 0.003 | |
| PRK11633 | 226 | PRK11633, PRK11633, cell division protein DedD; Pr | 0.003 | |
| pfam12526 | 115 | pfam12526, DUF3729, Protein of unknown function (D | 0.003 | |
| TIGR01348 | 546 | TIGR01348, PDHac_trf_long, pyruvate dehydrogenase | 0.003 | |
| PRK06549 | 130 | PRK06549, PRK06549, acetyl-CoA carboxylase biotin | 0.003 | |
| PRK13042 | 291 | PRK13042, PRK13042, superantigen-like protein; Rev | 0.003 | |
| pfam04625 | 407 | pfam04625, DEC-1_N, DEC-1 protein, N-terminal regi | 0.003 | |
| PRK14963 | 504 | PRK14963, PRK14963, DNA polymerase III subunits ga | 0.003 | |
| PRK12495 | 226 | PRK12495, PRK12495, hypothetical protein; Provisio | 0.003 | |
| pfam11679 | 211 | pfam11679, DUF3275, Protein of unknown function (D | 0.003 | |
| pfam06682 | 317 | pfam06682, DUF1183, Protein of unknown function (D | 0.003 | |
| pfam13388 | 422 | pfam13388, DUF4106, Protein of unknown function (D | 0.003 | |
| pfam00716 | 326 | pfam00716, Peptidase_S21, Assemblin (Peptidase fam | 0.003 | |
| pfam08601 | 344 | pfam08601, PAP1, Transcription factor PAP1 | 0.003 | |
| PHA03379 | 935 | PHA03379, PHA03379, EBNA-3A; Provisional | 0.003 | |
| PRK12757 | 256 | PRK12757, PRK12757, cell division protein FtsN; Pr | 0.003 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 0.004 | |
| PRK14954 | 620 | PRK14954, PRK14954, DNA polymerase III subunits ga | 0.004 | |
| TIGR00601 | 378 | TIGR00601, rad23, UV excision repair protein Rad23 | 0.004 | |
| PHA03325 | 418 | PHA03325, PHA03325, nuclear-egress-membrane-like p | 0.004 | |
| PRK12372 | 413 | PRK12372, PRK12372, ribonuclease III; Reviewed | 0.004 | |
| pfam10152 | 147 | pfam10152, DUF2360, Predicted coiled-coil domain-c | 0.004 | |
| pfam10349 | 111 | pfam10349, WWbp, WW-domain ligand protein | 0.004 | |
| pfam06070 | 777 | pfam06070, Herpes_UL32, Herpesvirus large structur | 0.004 | |
| PRK12495 | 226 | PRK12495, PRK12495, hypothetical protein; Provisio | 0.004 | |
| pfam00716 | 326 | pfam00716, Peptidase_S21, Assemblin (Peptidase fam | 0.004 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.004 | |
| PLN02744 | 539 | PLN02744, PLN02744, dihydrolipoyllysine-residue ac | 0.004 | |
| TIGR01628 | 562 | TIGR01628, PABP-1234, polyadenylate binding protei | 0.004 | |
| pfam03251 | 458 | pfam03251, Tymo_45kd_70kd, Tymovirus 45/70Kd prote | 0.004 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 187 bits (478), Expect = 4e-55
Identities = 71/192 (36%), Positives = 109/192 (56%), Gaps = 9/192 (4%)
Query: 368 IGEGGFGCVYKG-NLPEGKVVAVKQL-KSGSGQGEREFRAEVEIISRVHHRHLVSLVGYC 425
+GEGGFG VY + GK VA+K + K S E E+EI+ +++H ++V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 426 ISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHR 485
E + L+ E+ +L+ L L + ++I L +GL YLH + IIHR
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGK-LSEDEILRILLQILEGLEYLHS--N-GIIHR 116
Query: 486 DIKSANILVD-DEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPE-YASSGKLTDRS 543
D+K NIL+D D + ++ADFGL+KL + ++ + T V GT Y+APE G +++S
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTPAYMAPEVLLGKGYYSEKS 175
Query: 544 DVFSFGVVLLEL 555
D++S GV+L EL
Sbjct: 176 DIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 185 bits (472), Expect = 9e-54
Identities = 79/278 (28%), Positives = 126/278 (45%), Gaps = 30/278 (10%)
Query: 365 ENVIGEGGFGCVYKG----NLPEGKV-VAVKQLKSG-SGQGEREFRAEVEIISRVHHRHL 418
+GEG FG VYKG +V VAVK LK S Q EF E I+ ++ H ++
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 419 VSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDC 478
V L+G C E+ +++ E++P +L +L L + + AL A+G+ YL
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK- 122
Query: 479 HPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGK 538
IHRD+ + N LV + +++DFGL++ + ++APE GK
Sbjct: 123 --NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGK 180
Query: 539 LTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRL 598
T +SDV+SFGV+L E+ T +P S E ++ ++ G RL
Sbjct: 181 FTSKSDVWSFGVLLWEIFT-----LGEEPYPGMSNAE-----VLEYLKKGY-------RL 223
Query: 599 EK-HYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRAL 635
K E+++++ C RP ++V L
Sbjct: 224 PKPPNCPPELYKLML---QCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 181 bits (462), Expect = 2e-52
Identities = 79/278 (28%), Positives = 127/278 (45%), Gaps = 31/278 (11%)
Query: 365 ENVIGEGGFGCVYKG--NLPEGKV---VAVKQLKSGSGQGER-EFRAEVEIISRVHHRHL 418
+GEG FG VYKG GK VAVK LK + + + EF E I+ ++ H ++
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 419 VSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDC 478
V L+G C E+ ++ E++ +L +L K +P L + + AL A+G+ YL
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYLR-KNRPKLSLSDLLSFALQIARGMEYLESK- 121
Query: 479 HPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGK 538
IHRD+ + N LV + +++DFGL++ + ++APE GK
Sbjct: 122 --NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGK 179
Query: 539 LTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRL 598
T +SDV+SFGV+L E+ T QP S E ++ ++ G RL
Sbjct: 180 FTSKSDVWSFGVLLWEIFT-----LGEQPYPGMSNEE-----VLEYLKNGY-------RL 222
Query: 599 EK-HYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRAL 635
+ E++ ++ C RP ++V L
Sbjct: 223 PQPPNCPPELYDLML---QCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 176 bits (448), Expect = 3e-50
Identities = 72/209 (34%), Positives = 110/209 (52%), Gaps = 24/209 (11%)
Query: 367 VIGEGGFGCVYKG---NLPEGKV--VAVKQLKSGSGQGER-EFRAEVEIISRVHHRHLVS 420
+GEG FG VYKG EG VAVK LK G+ + ER EF E I+ ++ H ++V
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 421 LVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHP 480
L+G C + ++ E++P +L L G+ L +++AL AKG+ YL
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEK-LTLKDLLQMALQIAKGMEYLESK--- 121
Query: 481 KIIHRDIKSANILVDDEFEAQVADFGLAKL---NDTTQTHVSTRV----MGTFGYLAPEY 533
+HRD+ + N LV + +++DFGL++ +D + ++ M APE
Sbjct: 122 NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWM------APES 175
Query: 534 ASSGKLTDRSDVFSFGVVLLELIT-GRKP 561
GK T +SDV+SFGV+L E+ T G +P
Sbjct: 176 LKDGKFTSKSDVWSFGVLLWEIFTLGEQP 204
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 173 bits (442), Expect = 2e-49
Identities = 74/199 (37%), Positives = 110/199 (55%), Gaps = 10/199 (5%)
Query: 367 VIGEGGFGCVYKG-NLPEGKVVAVKQLK--SGSGQGEREFRAEVEIISRVHHRHLVSLVG 423
+G G FG VYK + GK+VAVK LK S + ++ R E+ I+ R+ H ++V L+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 424 YCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKII 483
+ + L+ E+ +L +L G L + KIAL +GL YLH + II
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSRGG--PLSEDEAKKIALQILRGLEYLHSN---GII 120
Query: 484 HRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPE-YASSGKLTDR 542
HRD+K NIL+D+ ++ADFGLAK + + ++T V GT Y+APE +
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNGYGPK 179
Query: 543 SDVFSFGVVLLELITGRKP 561
DV+S GV+L EL+TG+ P
Sbjct: 180 VDVWSLGVILYELLTGKPP 198
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 173 bits (441), Expect = 2e-49
Identities = 64/198 (32%), Positives = 101/198 (51%), Gaps = 9/198 (4%)
Query: 366 NVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGERE-FRAEVEIISRVHHRHLVSLVG 423
+GEG FG VY + GK+VA+K +K + +RE E++I+ ++ H ++V L
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 424 YCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKII 483
E L+ E+ +L L +G+ + + L YLH I+
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEAR--FYLRQILSALEYLHSK---GIV 119
Query: 484 HRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRS 543
HRD+K NIL+D++ ++ADFGLA+ D + +T V GT Y+APE
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLARQLDPGEKL-TTFV-GTPEYMAPEVLLGKGYGKAV 177
Query: 544 DVFSFGVVLLELITGRKP 561
D++S GV+L EL+TG+ P
Sbjct: 178 DIWSLGVILYELLTGKPP 195
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 173 bits (441), Expect = 2e-49
Identities = 78/295 (26%), Positives = 129/295 (43%), Gaps = 57/295 (19%)
Query: 366 NVIGEGGFGCVYKGNL---PEGKV-VAVKQLKSGSGQGER-EFRAEVEIISRVHHRHLVS 420
+GEG FG VYKG L VAVK LK + + ER +F E ++ ++ H ++V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 421 LVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPV-------LEWTKRVKIALGAAKGLAY 473
L+G C E+ L+ E++ +L +L L + A+ AKG+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 474 LHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKL-------NDTTQTHVSTRVMGTF 526
L K +HRD+ + N LV ++ +++DFGL++ T + R
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR----- 172
Query: 527 GYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKP---VDPTQPLGDESLVEWARPVLV 582
++APE G T +SDV+SFGV+L E+ T G P + + ++
Sbjct: 173 -WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE--------------VL 217
Query: 583 RAIETGDLSEIVDPRLEK-HYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALD 636
+ G RL K Y E++ ++ +C + RP ++V L+
Sbjct: 218 EYLRKGY-------RLPKPEYCPDELYELML---SCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 2e-44
Identities = 70/208 (33%), Positives = 109/208 (52%), Gaps = 19/208 (9%)
Query: 364 RENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGE--REFRAEVEIISRVHHRHLVS 420
R ++G G FG VY + G+++AVK ++ E E+ I+S + H ++V
Sbjct: 4 RGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVR 63
Query: 421 LVGYCIS-EKNRLLIY-EFVPNNNLEHHLHGKGQ---PVLE-WTKRVKIALGAAKGLAYL 474
G EKN L I+ E+V +L L G+ PV+ +T+++ +GLAYL
Sbjct: 64 YYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQI------LEGLAYL 117
Query: 475 HEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK-LNDTTQTHVSTRVMGTFGYLAPEY 533
H + I+HRDIK ANILVD + ++ADFG AK L D + V GT ++APE
Sbjct: 118 HSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEV 174
Query: 534 ASSGKLTDRSDVFSFGVVLLELITGRKP 561
+ +D++S G ++E+ TG+ P
Sbjct: 175 IRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 6e-38
Identities = 74/262 (28%), Positives = 118/262 (45%), Gaps = 45/262 (17%)
Query: 362 FARENVIGEGGFGCVYKG-NLPEGKVVAVKQLK-SGSGQGEREF-RAEVEIISRVHHRHL 418
+ IG+G FG VY +GK+ +K++ S + ERE EV+I+ +++H ++
Sbjct: 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61
Query: 419 VSLVGYCISEKNRLLI-YEFVPNNNLEHHLH---GKGQP-----VLEWTKRVKIALGAAK 469
+ EK +L I E+ +L + +G+P +L+W V++ L
Sbjct: 62 IKYYE-SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWF--VQLCLA--- 115
Query: 470 GLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYL 529
L YLH KI+HRDIK NI + ++ DFG++K+ +T T V GT YL
Sbjct: 116 -LKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYL 170
Query: 530 APEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETG- 588
+PE + +SD++S G VL EL T + P + L L I G
Sbjct: 171 SPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE-----------LALKILKGQ 219
Query: 589 ----------DLSEIVDPRLEK 600
+L +V L+K
Sbjct: 220 YPPIPSQYSSELRNLVSSLLQK 241
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 2e-37
Identities = 67/203 (33%), Positives = 111/203 (54%), Gaps = 11/203 (5%)
Query: 362 FARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVS 420
F IG+GGFG VYK + GK VA+K +K S + + + E++I+ + H ++V
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 421 LVGYCISEKNRL-LIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCH 479
G +K+ L ++ EF +L+ L Q + E ++ + KGL YLH +
Sbjct: 62 YYG-SYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTE-SQIAYVCKELLKGLEYLHSN-- 117
Query: 480 PKIIHRDIKSANILVDDEFEAQVADFGLAK-LNDTTQTHVSTRVMGTFGYLAPEYASSGK 538
IIHRDIK+ANIL+ + E ++ DFGL+ L+DT + ++GT ++APE +
Sbjct: 118 -GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN---TMVGTPYWMAPEVINGKP 173
Query: 539 LTDRSDVFSFGVVLLELITGRKP 561
++D++S G+ +EL G+ P
Sbjct: 174 YDYKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 4e-37
Identities = 72/222 (32%), Positives = 119/222 (53%), Gaps = 21/222 (9%)
Query: 368 IGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCIS 427
IG+G FG V G+ G+ VAVK LK S + F AE +++ + H +LV L+G +
Sbjct: 14 IGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAAQ-AFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 428 EKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDI 487
++ E++ +L +L +G+ V+ +++ AL +G+ YL E +HRD+
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDL 128
Query: 488 KSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFS 547
+ N+LV ++ A+V+DFGLAK + +Q S ++ + APE K + +SDV+S
Sbjct: 129 AARNVLVSEDLVAKVSDFGLAK--EASQGQDSGKL--PVKWTAPEALREKKFSTKSDVWS 184
Query: 548 FGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETG 588
FG++L E+ + GR P P PL D +V +E G
Sbjct: 185 FGILLWEIYSFGRVPY-PRIPLKD----------VVPHVEKG 215
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 5e-33
Identities = 68/197 (34%), Positives = 106/197 (53%), Gaps = 6/197 (3%)
Query: 362 FARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSL 421
F E +G G FG V++G VA+K LKS +++F+ EV+ + R+ H+HL+SL
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 422 VGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPK 481
C + +I E + +L L VL + +A A+G+AYL E
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---N 124
Query: 482 IIHRDIKSANILVDDEFEAQVADFGLAKL-NDTTQTHVSTRVMGTFGYLAPEYASSGKLT 540
IHRD+ + NILV ++ +VADFGLA+L + ++ + + APE AS G +
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTFS 182
Query: 541 DRSDVFSFGVVLLELIT 557
+SDV+SFG++L E+ T
Sbjct: 183 TKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 3e-32
Identities = 68/210 (32%), Positives = 112/210 (53%), Gaps = 21/210 (10%)
Query: 364 RENVIGEGGFGCVYKG--NLPEGKV--VAVKQLKSGSGQGER-EFRAEVEIISRVHHRHL 418
E VIG G FG V +G LP K VA+K LK+GS +R +F E I+ + H ++
Sbjct: 8 IEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNI 67
Query: 419 VSLVGYCISEKNRLLIYEFVPNNNLEHHL-HGKGQPVLEWTKRVKIALGAAKGLAYLHED 477
+ L G + ++I E++ N +L+ L G+ + V + G A G+ YL E
Sbjct: 68 IRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGK--FTVGQLVGMLRGIASGMKYLSEM 125
Query: 478 CHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTR-----VMGTFGYLAPE 532
+ +HRD+ + NILV+ +V+DFGL++ + ++ +T+ + T APE
Sbjct: 126 NY---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT----APE 178
Query: 533 YASSGKLTDRSDVFSFGVVLLELIT-GRKP 561
+ K T SDV+SFG+V+ E+++ G +P
Sbjct: 179 AIAYRKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 3e-32
Identities = 71/234 (30%), Positives = 112/234 (47%), Gaps = 17/234 (7%)
Query: 366 NVIGEGGFGCVYKGNL-PE----GKVVAVKQLK-SGSGQGEREFRAEVEIISRVHHRHLV 419
+GEG FG V P G+ VAVK L SG Q +F E+EI+ + H ++V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 420 SLVGYCIS--EKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHED 477
G C ++ LI E++P+ +L +L + + + + + + KG+ YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQ-RHRDQINLKRLLLFSSQICKGMDYLGSQ 128
Query: 478 CHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMG---TFGYLAPEYA 534
+ IHRD+ + NILV+ E +++DFGLAK+ + + + G F Y APE
Sbjct: 129 ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECL 184
Query: 535 SSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIET 587
+ K + SDV+SFGV L EL T G P + + ++ R +E
Sbjct: 185 RTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 6e-32
Identities = 70/201 (34%), Positives = 108/201 (53%), Gaps = 13/201 (6%)
Query: 366 NVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGE--REFRAEVEIISRVHHRHLVSLV 422
++IG G FG VYKG NL G VA+KQ+ + E + E++++ + H ++V +
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 423 GYCISEKNRLLIYEFVPNNNLEHHLHGKGQ-PVLEWTKRVKIALGAAKGLAYLHEDCHPK 481
G + + +I E+ N +L + G P V L +GLAYLHE
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVL---QGLAYLHEQ---G 119
Query: 482 IIHRDIKSANILVDDEFEAQVADFGLA-KLNDTTQTHVSTRVMGTFGYLAPEYASSGKLT 540
+IHRDIK+ANIL + ++ADFG+A KLND ++ V+GT ++APE +
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYWMAPEVIEMSGAS 177
Query: 541 DRSDVFSFGVVLLELITGRKP 561
SD++S G ++EL+TG P
Sbjct: 178 TASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 69/210 (32%), Positives = 111/210 (52%), Gaps = 23/210 (10%)
Query: 367 VIGEGGFGCVYKGN-LPEG---KV-VAVKQLKSGSG-QGEREFRAEVEIISRVHHRHLVS 420
V+G G FG VYKG +PEG K+ VA+K L+ + + +E E +++ V H H+V
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73
Query: 421 LVGYCISEKNRLLIYEFVPNNNLEHHLHG-----KGQPVLEWTKRVKIALGAAKGLAYLH 475
L+G C+S + LI + +P L ++ Q +L W ++ AKG++YL
Sbjct: 74 LLGICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKGMSYLE 126
Query: 476 EDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHV-STRVMGTFGYLAPEYA 534
E +++HRD+ + N+LV ++ DFGLAKL D + + ++A E
Sbjct: 127 EK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESI 183
Query: 535 SSGKLTDRSDVFSFGVVLLELIT-GRKPVD 563
T +SDV+S+GV + EL+T G KP +
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 9e-31
Identities = 64/197 (32%), Positives = 105/197 (53%), Gaps = 9/197 (4%)
Query: 368 IGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCIS 427
+G G FG V++G VAVK LK G+ + +F AE +I+ ++ H L+ L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK-DFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 428 EKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDI 487
E+ ++ E + +L +L G L+ + + +A A G+AYL + IHRD+
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNY---IHRDL 129
Query: 488 KSANILVDDEFEAQVADFGLAKL--NDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDV 545
+ N+LV + +VADFGLA++ D + + + APE A + + +SDV
Sbjct: 130 AARNVLVGENNICKVADFGLARVIKEDIYEAREGAKF--PIKWTAPEAALYNRFSIKSDV 187
Query: 546 FSFGVVLLELIT-GRKP 561
+SFG++L E++T GR P
Sbjct: 188 WSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 3e-30
Identities = 68/197 (34%), Positives = 102/197 (51%), Gaps = 9/197 (4%)
Query: 368 IGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCIS 427
+G G FG V+ G VAVK LK G+ E F E +I+ ++ H LV L C
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE-AFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 428 EKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDI 487
E+ ++ E++ +L L L + V +A A+G+AYL IHRD+
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDL 129
Query: 488 KSANILVDDEFEAQVADFGLAKL--NDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDV 545
+ NILV + ++ADFGLA+L +D + + APE A+ G+ T +SDV
Sbjct: 130 AARNILVGENLVCKIADFGLARLIEDDEYTAREGAKF--PIKWTAPEAANYGRFTIKSDV 187
Query: 546 FSFGVVLLELIT-GRKP 561
+SFG++L E++T GR P
Sbjct: 188 WSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 67/216 (31%), Positives = 106/216 (49%), Gaps = 24/216 (11%)
Query: 367 VIGEGGFGCVYKGNL----PEGK--VVAVKQLKSGSGQGERE-FRAEVEIISRVHHRHLV 419
+GEG FG V+ G PE +VAVK LK + R+ F E E+++ H ++V
Sbjct: 12 ELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIV 71
Query: 420 SLVGYCISEKNRLLIYEFVPNNNLEHHL--HG--------KGQPVLEWTKR--VKIALGA 467
G C ++++E++ + +L L HG P+ E T ++IA+
Sbjct: 72 KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131
Query: 468 AKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTH-VSTRVMGTF 526
A G+ YL +HRD+ + N LV + ++ DFG+++ TT + V M
Sbjct: 132 ASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPI 188
Query: 527 GYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKP 561
++ PE K T SDV+SFGVVL E+ T G++P
Sbjct: 189 RWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 3e-29
Identities = 70/222 (31%), Positives = 104/222 (46%), Gaps = 19/222 (8%)
Query: 367 VIGEGGFGCVYKGNLPEGKVVAVKQLK---SGSGQGEREFRAEVEIISRV-HHRHLVSLV 422
+GEG FG VY + K+VA+K L + F E++I++ + H ++V L
Sbjct: 7 KLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 423 GYCISEKNRLLIYEFVPNNNLEHHL-HGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPK 481
+ E + L+ E+V +LE L + L ++ + I L YLH
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--- 121
Query: 482 IIHRDIKSANILVD-DEFEAQVADFGLAKLNDTTQTHVSTR-----VMGTFGYLAPEYAS 535
IIHRDIK NIL+D D ++ DFGLAKL + S +GT GY+APE
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181
Query: 536 SGKL---TDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLV 574
L + SD++S G+ L EL+TG P + + S
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQT 223
|
Length = 384 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 83/270 (30%), Positives = 129/270 (47%), Gaps = 29/270 (10%)
Query: 362 FARENVIGEGGFGCVYKG-NLPEGKVVAVKQLK-SGSGQGEREFRAEVEIISRVHHRHLV 419
R V+G+G G VYK + P GK+ A+K++ G + ++ E++ + ++V
Sbjct: 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVV 62
Query: 420 SLVGYCISEKNRLLIYEFVPNNNLEHHL--HGK-GQPVLEWTKRVKIALGAAKGLAYLHE 476
G E ++ E++ +L L GK +PVL IA KGL YLH
Sbjct: 63 KCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLA-----YIARQILKGLDYLHT 117
Query: 477 DCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASS 536
H IIHRDIK +N+L++ + E ++ADFG++K+ + T +T V GT Y++PE
Sbjct: 118 KRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQG 174
Query: 537 GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDP 596
+ +D++S G+ LLE G+ P P G S E L++AI G P
Sbjct: 175 ESYSYAADIWSLGLTLLECALGKFPF---LPPGQPSFFE-----LMQAICDGPP-----P 221
Query: 597 RLEKHYVESEMFRMIEAAAACVRHSGPKRP 626
L E I +AC++ KRP
Sbjct: 222 SLPAEEFSPEFRDFI---SACLQKDPKKRP 248
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 5e-29
Identities = 67/210 (31%), Positives = 111/210 (52%), Gaps = 17/210 (8%)
Query: 362 FARENVIGEGGFGCVYKG-NLPEGKVVAVKQ--LKSGSGQGEREFRAEVEIISRVHHRHL 418
F N IG+G FG V+K + +V A+KQ L + + E E +++++ ++
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 419 VSLVGYCISEKNRL-LIYEFVPNNNLEHHLHG-KGQPVLE---WTKRVKIALGAAKGLAY 473
+ +K +L ++ E+ N +L L +G+P+ E W ++I LG LA+
Sbjct: 62 IRYYE-SFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG----LAH 116
Query: 474 LHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEY 533
LH KI+HRDIKS N+ +D ++ D G+AKL + T+ + ++GT YL+PE
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLL-SDNTNFANTIVGTPYYLSPEL 172
Query: 534 ASSGKLTDRSDVFSFGVVLLELITGRKPVD 563
++SDV++ GVVL E TG+ P D
Sbjct: 173 CEDKPYNEKSDVWALGVVLYECCTGKHPFD 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 67/204 (32%), Positives = 98/204 (48%), Gaps = 22/204 (10%)
Query: 368 IGEGGFGCVY----KGNLPEGKVVAVKQLKSGS---GQGEREFRAEVEIISRVHHRHLVS 420
+G+G FG V K GK+ A+K LK + E I+SR++H +V
Sbjct: 1 LGKGSFGKVLLVRKKDT---GKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK 57
Query: 421 LVGYCISEKNRL-LIYEFVPNNNLEHHLHGKGQPVLEWTKR--VKIALGAAKGLAYLHED 477
L Y + +L L+ E+ P L HL +G+ E + +I L L YLH
Sbjct: 58 LH-YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLA----LEYLHSL 112
Query: 478 CHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSG 537
II+RD+K NIL+D + ++ DFGLAK + + +T GT YLAPE
Sbjct: 113 ---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVLLGK 168
Query: 538 KLTDRSDVFSFGVVLLELITGRKP 561
D +S GV+L E++TG+ P
Sbjct: 169 GYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 67/209 (32%), Positives = 105/209 (50%), Gaps = 16/209 (7%)
Query: 363 ARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGE--REFRAEVEIISRVHHRHLV 419
R N IG G FG VY NL G+++AVK+++ + +E E++++ + H +LV
Sbjct: 3 QRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLV 62
Query: 420 SLVGYCISEKNRLLIY-EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDC 478
G + + ++ I+ E+ LE L + + L +GLAYLH
Sbjct: 63 KYYGVEV-HREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQL--LEGLAYLHSH- 118
Query: 479 HPKIIHRDIKSANILVDDEFEAQVADFGLAK-LNDTTQTHVST--RVMGTFGYLAPEYAS 535
I+HRDIK ANI +D ++ DFG A L + T T + GT Y+APE +
Sbjct: 119 --GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVIT 176
Query: 536 SGKLTDR---SDVFSFGVVLLELITGRKP 561
GK +D++S G V+LE+ TG++P
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 7e-28
Identities = 63/216 (29%), Positives = 106/216 (49%), Gaps = 47/216 (21%)
Query: 368 IGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGERE-F-----RAEVEIISRVHHRHLVS 420
IGEG +G VYK N G++VA+K+++ + E+E F R E++++ ++ H ++V
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIR---MENEKEGFPITAIR-EIKLLQKLRHPNIVR 62
Query: 421 LVGYCISEK--NRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAK--------G 470
L S+ + +++E+ ++H L G +L+ + VK K G
Sbjct: 63 LKEIVTSKGKGSIYMVFEY-----MDHDLTG----LLD-SPEVKFTESQIKCYMKQLLEG 112
Query: 471 LAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLA 530
L YLH I+HRDIK +NIL++++ ++ADFGLA+ + T + T Y
Sbjct: 113 LQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRP 169
Query: 531 PE-------YASSGKLTDRSDVFSFGVVLLELITGR 559
PE Y D++S G +L EL G+
Sbjct: 170 PELLLGATRYGPE------VDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 76/247 (30%), Positives = 122/247 (49%), Gaps = 22/247 (8%)
Query: 366 NVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGER-EFRAEVEIISRVHHRHLVSLVG 423
+G G G V K + P GK++AVK ++ + + + E++I+ + + ++V G
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66
Query: 424 YCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRV--KIALGAAKGLAYLHEDCHPK 481
+ + + E++ +L+ L + E R+ KIA+ KGL YLHE H K
Sbjct: 67 AFYNNGDISICMEYMDGGSLDKILKEVQGRIPE---RILGKIAVAVLKGLTYLHEK-H-K 121
Query: 482 IIHRDIKSANILVDDEFEAQVADFGLAK--LNDTTQTHVSTRVMGTFGYLAPEYASSGKL 539
IIHRD+K +NILV+ + ++ DFG++ +N +T V GT Y+APE
Sbjct: 122 IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV-----GTSSYMAPERIQGNDY 176
Query: 540 TDRSDVFSFGVVLLELITGRKPVDPTQ--PLGDESL----VEWARPVLVRAIETGDLSEI 593
+ +SD++S G+ L+EL TGR P P P G L V P L + D +
Sbjct: 177 SVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDF 236
Query: 594 VDPRLEK 600
V+ L K
Sbjct: 237 VNLCLIK 243
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 9e-27
Identities = 71/203 (34%), Positives = 107/203 (52%), Gaps = 21/203 (10%)
Query: 368 IGEGGFG----CVYKGNLP----EGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLV 419
+G+G FG C Y P G+VVAVK+L+ + + R+F E+EI+ + H ++V
Sbjct: 12 LGKGNFGSVELCRYD---PLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIV 68
Query: 420 SLVGYCIS--EKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHED 477
G C S +N L+ E++P +L +L K + L+ K + A KG+ YL
Sbjct: 69 KYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQ-KHRERLDHRKLLLYASQICKGMEYLGSK 127
Query: 478 CHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMG---TFGYLAPEYA 534
+ +HRD+ + NILV+ E ++ DFGL K+ + + R G F Y APE
Sbjct: 128 ---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY-APESL 183
Query: 535 SSGKLTDRSDVFSFGVVLLELIT 557
+ K + SDV+SFGVVL EL T
Sbjct: 184 TESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 60/217 (27%), Positives = 107/217 (49%), Gaps = 24/217 (11%)
Query: 362 FARENV-----IGEGGFGCVYKG---NLPEGKV---VAVKQLKSGSGQGER-EFRAEVEI 409
RE + +G+G FG VY+G + +G+ VA+K + + ER EF E +
Sbjct: 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASV 62
Query: 410 ISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGK--------GQPVLEWTKRV 461
+ + H+V L+G + + L++ E + +L+ +L + G K +
Sbjct: 63 MKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFI 122
Query: 462 KIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK-LNDTTQTHVST 520
++A A G+AYL K +HRD+ + N +V ++ ++ DFG+ + + +T
Sbjct: 123 QMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGG 179
Query: 521 RVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT 557
+ + ++APE G T +SDV+SFGVVL E+ T
Sbjct: 180 KGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 62/215 (28%), Positives = 112/215 (52%), Gaps = 36/215 (16%)
Query: 362 FARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREF-----RAEVEIISRVHH 415
+ + +GEG +G VYK + G++VA+K+++ E R E+ ++ + H
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLD--NEEEGIPSTALR-EISLLKELKH 57
Query: 416 RHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVK-IALGAAKGLAYL 474
++V L+ +E+ L++E+ + +L+ +L + P+ +K I +GLAY
Sbjct: 58 PNIVKLLDVIHTERKLYLVFEYC-DMDLKKYLDKRPGPLSP--NLIKSIMYQLLRGLAYC 114
Query: 475 HEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK---LNDTTQTHVSTRVMGTFGYLAP 531
H H +I+HRD+K NIL++ + ++ADFGLA+ + T TH V+ T Y AP
Sbjct: 115 HS--H-RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTH---EVV-TLWYRAP 167
Query: 532 E-------YASSGKLTDRSDVFSFGVVLLELITGR 559
E Y+++ D++S G + E+ITG+
Sbjct: 168 EILLGSKHYSTA------VDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 3e-26
Identities = 66/201 (32%), Positives = 113/201 (56%), Gaps = 22/201 (10%)
Query: 367 VIGEGGFGCVYKGNLPEGKVVAVKQLKSG-SGQGEREFRAEVEIISRVHHRHLVSLVGYC 425
+IGEG FG V +G G+ VAVK +K + Q F E +++++HH++LV L+G
Sbjct: 13 IIGEGEFGAVLQGEY-TGQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLG-V 67
Query: 426 ISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHR 485
I ++ E + NL + L +G+ ++ + ++ +L A+G+ YL K++HR
Sbjct: 68 ILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHR 124
Query: 486 DIKSANILVDDEFEAQVADFGLAKLN----DTTQTHVSTRVMGTFGYLAPEYASSGKLTD 541
D+ + NILV ++ A+V+DFGLA++ D ++ V + APE K +
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK--------WTAPEALKHKKFSS 176
Query: 542 RSDVFSFGVVLLELIT-GRKP 561
+SDV+S+GV+L E+ + GR P
Sbjct: 177 KSDVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 59/197 (29%), Positives = 101/197 (51%), Gaps = 6/197 (3%)
Query: 368 IGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCIS 427
IG G FG V+ G E + VA+K ++ G+ E +F E +++ ++ H LV L G C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 428 EKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDI 487
L++EF+ + L +L + + + + L +G+AYL +IHRD+
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRAQ-RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDL 126
Query: 488 KSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFS 547
+ N LV + +V+DFG+ + Q ST + +PE S K + +SDV+S
Sbjct: 127 AARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWS 186
Query: 548 FGVVLLELIT-GRKPVD 563
FGV++ E+ + G+ P +
Sbjct: 187 FGVLMWEVFSEGKTPYE 203
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 67/211 (31%), Positives = 103/211 (48%), Gaps = 34/211 (16%)
Query: 368 IGEGGFGCVYKG-NLPEGKVVAVKQLK----SGSGQGE-REFRAEVEIISRVHHRHLVSL 421
+G G FG VY+G NL +G AVK++ +GQ ++ E+ ++S++ H ++V
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 422 VGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLE-----WTKRVKIALGAAKGLAYLHE 476
+G E N + E VP +L L K E +T+++ GL YLH+
Sbjct: 68 LGTEREEDNLYIFLELVPGGSL-AKLLKKYGSFPEPVIRLYTRQI------LLGLEYLHD 120
Query: 477 DCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVM-----GTFGYLAP 531
+HRDIK ANILVD ++ADFG+AK V G+ ++AP
Sbjct: 121 R---NTVHRDIKGANILVDTNGVVKLADFGMAK-------QVVEFSFAKSFKGSPYWMAP 170
Query: 532 EY-ASSGKLTDRSDVFSFGVVLLELITGRKP 561
E A G +D++S G +LE+ TG+ P
Sbjct: 171 EVIAQQGGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 1e-25
Identities = 71/208 (34%), Positives = 112/208 (53%), Gaps = 13/208 (6%)
Query: 365 ENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGY 424
IG+G FG V G+ G VAVK +K+ + + F AE +++++ H +LV L+G
Sbjct: 11 LQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV 67
Query: 425 CISEKNRLLIY-EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKII 483
+ EK L I E++ +L +L +G+ VL +K +L + + YL + +
Sbjct: 68 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFV 124
Query: 484 HRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRS 543
HRD+ + N+LV ++ A+V+DFGL K +TQ V T APE K + +S
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFSTKS 180
Query: 544 DVFSFGVVLLELIT-GRKPVDPTQPLGD 570
DV+SFG++L E+ + GR P P PL D
Sbjct: 181 DVWSFGILLWEIYSFGRVPY-PRIPLKD 207
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-25
Identities = 85/297 (28%), Positives = 136/297 (45%), Gaps = 31/297 (10%)
Query: 346 SKSFFTYEELMEITNGFARENVIGEGGFGCVYKGNLPEGKV-VAVKQLKSGSGQGEREFR 404
SKS + L + ENVI G G YKG + + VK++ + E
Sbjct: 680 SKSITINDILSSLKE----ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIA 735
Query: 405 AEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIA 464
+ ++ H ++V L+G C SEK LI+E++ NL L L W +R KIA
Sbjct: 736 D----MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIA 786
Query: 465 LGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKL--NDTTQTHVSTRV 522
+G AK L +LH C P ++ ++ I++D + E + L L DT S
Sbjct: 787 IGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS--- 842
Query: 523 MGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLV 582
Y+APE + +T++SD++ FG++L+EL+TG+ P D + S+VEWAR
Sbjct: 843 ----AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA-EFGVHGSIVEWAR---- 893
Query: 583 RAIETGDLSEIVDPRLEKHYV--ESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDS 637
L +DP + ++E+ ++ A C RP V++ L+S
Sbjct: 894 YCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLES 950
|
Length = 968 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 74/222 (33%), Positives = 113/222 (50%), Gaps = 35/222 (15%)
Query: 366 NVIGEGGFGCVYKGNLP------EGKV-VAVKQLKSGSGQGER-EFRAEVEIISRVHHRH 417
N +G G FG VY+G G + VAVK L+ G+ E+ EF E ++S +H +
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 418 LVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGK-----GQPVLEWTKRVKIALGAAKGLA 472
+V L+G C+ + + +I E + +L +L G P+L + + I L AKG
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 473 YLHEDCHPKIIHRDIKSANILV-----DDEFEAQVADFGLAK---LNDTTQTH----VST 520
YL E H IHRD+ + N LV D + ++ DFGLA+ +D + +
Sbjct: 121 YL-EQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177
Query: 521 RVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKP 561
R M APE GK T +SDV+SFGV++ E++T G++P
Sbjct: 178 RWM------APESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 64/213 (30%), Positives = 106/213 (49%), Gaps = 31/213 (14%)
Query: 368 IGEGGFGCVYKGNL--PEGK----VVAVKQLK-SGSGQGEREFRAEVEIISRVHHRHLVS 420
+GEG FG VYKG L P + VA+K LK + + ++EFR E E++S + H ++V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 421 LVGYCISEKNRLLIYEFVPNNNLEHHL--------------HGKGQPVLEWTKRVKIALG 466
L+G C E+ +++E++ + +L L + L+ + + IA+
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 467 AAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGT- 525
A G+ YL +HRD+ + N LV + +++DFGL++ + RV
Sbjct: 133 IAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRD---IYSADYYRVQSKS 186
Query: 526 ---FGYLAPEYASSGKLTDRSDVFSFGVVLLEL 555
++ PE GK T SD++SFGVVL E+
Sbjct: 187 LLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 6e-25
Identities = 67/195 (34%), Positives = 104/195 (53%), Gaps = 6/195 (3%)
Query: 368 IGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCIS 427
+G+G FG V+ G VA+K LK G+ E F E +++ ++ H LV L +S
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYA-VVS 71
Query: 428 EKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDI 487
E+ ++ E++ +L L G+ L + V +A A G+AY+ +HRD+
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDL 128
Query: 488 KSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFS 547
++ANILV + +VADFGLA+L + + + APE A G+ T +SDV+S
Sbjct: 129 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 188
Query: 548 FGVVLLELIT-GRKP 561
FG++L EL T GR P
Sbjct: 189 FGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 8e-25
Identities = 70/195 (35%), Positives = 102/195 (52%), Gaps = 6/195 (3%)
Query: 368 IGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCIS 427
+G G FG V+ G VAVK LK G+ E F E +I+ ++ H LV L +S
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPE-SFLEEAQIMKKLRHDKLVQLYA-VVS 71
Query: 428 EKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDI 487
E+ ++ E++ +L L L+ V +A A G+AY+ IHRD+
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDL 128
Query: 488 KSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFS 547
+SANILV D ++ADFGLA+L + + + APE A G+ T +SDV+S
Sbjct: 129 RSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 188
Query: 548 FGVVLLELIT-GRKP 561
FG++L EL+T GR P
Sbjct: 189 FGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 8e-25
Identities = 62/193 (32%), Positives = 100/193 (51%), Gaps = 6/193 (3%)
Query: 368 IGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGERE-FRAEVEIISRVHHRHLVSLVGYCI 426
IG+G FG VYKG L VAVK +S + F E EI+ + H ++V L+G C+
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62
Query: 427 SEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRD 486
++ ++ E VP +L L K L K ++++L AA G+ YL IHRD
Sbjct: 63 QKQPIYIVMELVPGGSLLTFLRKKKNR-LTVKKLLQMSLDAAAGMEYLESKN---CIHRD 118
Query: 487 IKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGT-FGYLAPEYASSGKLTDRSDV 545
+ + N LV + +++DFG+++ + VS + + APE + G+ T SDV
Sbjct: 119 LAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDV 178
Query: 546 FSFGVVLLELITG 558
+S+G++L E +
Sbjct: 179 WSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 62/196 (31%), Positives = 100/196 (51%), Gaps = 9/196 (4%)
Query: 365 ENVIGEGGFGCVYKGNLPE-GKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVG 423
++ +G G +G VY+G + VAVK LK + + E EF E ++ + H +LV L+G
Sbjct: 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLG 69
Query: 424 YCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKII 483
C E +I EF+ NL +L + + + +A + + YL + I
Sbjct: 70 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 126
Query: 484 HRDIKSANILVDDEFEAQVADFGLAKL--NDTTQTHVSTRVMGTFGYLAPEYASSGKLTD 541
HRD+ + N LV + +VADFGL++L DT H + + APE + K +
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSI 184
Query: 542 RSDVFSFGVVLLELIT 557
+SDV++FGV+L E+ T
Sbjct: 185 KSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 65/206 (31%), Positives = 106/206 (51%), Gaps = 22/206 (10%)
Query: 368 IGEGGFGCVYKG--NLPEGKV--VAVKQLKSG-SGQGEREFRAEVEIISRVHHRHLVSLV 422
+G G FG V KG + GK VAVK LK G++EF E +++++ H +V L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 423 GYCISEKNRLLIYEFVPNNNLEHHLHGKGQ----PVLEWTKRVKIALGAAKGLAYLHEDC 478
G C E +L+ E P L +L + + + E +V A G+AYL E
Sbjct: 63 GVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV------AMGMAYL-ESK 114
Query: 479 HPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTF--GYLAPEYASS 536
H +HRD+ + N+L+ + +A+++DFG+++ + G + + APE +
Sbjct: 115 H--FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY 172
Query: 537 GKLTDRSDVFSFGVVLLELIT-GRKP 561
GK + +SDV+S+GV L E + G KP
Sbjct: 173 GKFSSKSDVWSYGVTLWEAFSYGAKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 3e-24
Identities = 69/202 (34%), Positives = 99/202 (49%), Gaps = 18/202 (8%)
Query: 367 VIGEGGFG-----CVYKGNLPEGKVVAVKQLKSGSGQGERE-FRAEVEIISRVHHRHLVS 420
V+GEG FG C N G++VAVK LK GQ ++ E+ I+ ++H ++V
Sbjct: 11 VLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVK 70
Query: 421 LVGYCIS--EKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDC 478
G C K LI E+VP +L +L L + + A +G+AYLH
Sbjct: 71 YKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK---LNLAQLLLFAQQICEGMAYLHSQ- 126
Query: 479 HPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMG---TFGYLAPEYAS 535
IHRD+ + N+L+D++ ++ DFGLAK + R G F Y A E
Sbjct: 127 --HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-AVECLK 183
Query: 536 SGKLTDRSDVFSFGVVLLELIT 557
K + SDV+SFGV L EL+T
Sbjct: 184 ENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 66/211 (31%), Positives = 109/211 (51%), Gaps = 22/211 (10%)
Query: 367 VIGEGGFGCVYKG-NLPEGKVVAVKQ--LKSGSGQGEREFRA-------EVEIISRVHHR 416
+IG G FG VY G N G+++AVKQ L S S + R+ E+ ++ + H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 417 HLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHE 476
++V +G + + + E+VP ++ L+ G E T KGL YLH
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYG--AFEETLVRNFVRQILKGLNYLHN 124
Query: 477 DCHPKIIHRDIKSANILVDDEFEAQVADFGLAK------LNDTTQTHVSTRVMGTFGYLA 530
IIHRDIK ANILVD++ +++DFG++K L+ T + + G+ ++A
Sbjct: 125 R---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPS-LQGSVFWMA 180
Query: 531 PEYASSGKLTDRSDVFSFGVVLLELITGRKP 561
PE T ++D++S G +++E++TG+ P
Sbjct: 181 PEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 6e-24
Identities = 73/287 (25%), Positives = 137/287 (47%), Gaps = 42/287 (14%)
Query: 362 FARENVIGEGGFGCVYKGNLPEGKVVAVKQLK---SGSGQGEREFRA---EVEIISRVHH 415
+ + V+G+G +G VY G +G+++AVKQ++ S E+E+ EV+++ + H
Sbjct: 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61
Query: 416 RHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKG---QPVL-EWTKRVKIALGAAKGL 471
++V +G C+ + + EFVP ++ L+ G +PV ++TK++ G+
Sbjct: 62 VNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQI------LDGV 115
Query: 472 AYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVM-----GTF 526
AYLH +C ++HRDIK N+++ ++ DFG A+ H + M GT
Sbjct: 116 AYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTP 172
Query: 527 GYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIE 586
++APE + +SD++S G + E+ TG+ P+ L + R ++
Sbjct: 173 YWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLM----- 227
Query: 587 TGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVR 633
PRL + + I+ +C+ +RP +Q++R
Sbjct: 228 ---------PRLPDSFSAAA----IDFVTSCLTRDQHERPSALQLLR 261
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 65/195 (33%), Positives = 104/195 (53%), Gaps = 6/195 (3%)
Query: 368 IGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCIS 427
+G G FG V+ G VA+K LK GS E F AE ++ ++ H LV L ++
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPE-AFLAEANLMKQLQHPRLVRLYA-VVT 71
Query: 428 EKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDI 487
++ +I E++ N +L L L K + +A A+G+A++ + IHRD+
Sbjct: 72 QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNY---IHRDL 128
Query: 488 KSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFS 547
++ANILV + ++ADFGLA+L + + + APE + G T +SDV+S
Sbjct: 129 RAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 188
Query: 548 FGVVLLELIT-GRKP 561
FG++L E++T GR P
Sbjct: 189 FGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 65/210 (30%), Positives = 115/210 (54%), Gaps = 12/210 (5%)
Query: 360 NGFARENVIGEGGFGCVYKGNLP-EGK---VVAVKQLKSGSGQGER-EFRAEVEIISRVH 414
+ ++ VIG G FG V++G L G+ VA+K LK G + +R +F +E I+ +
Sbjct: 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS 64
Query: 415 HRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYL 474
H +++ L G K ++I E++ N L+ +L + + V + G A G+ YL
Sbjct: 65 HHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSY-QLVGMLRGIAAGMKYL 123
Query: 475 HEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKL--NDTTQTHVSTRVMGTFGYLAPE 532
+ + +HRD+ + NILV+ E +V+DFGL+++ +D T+ ++ + APE
Sbjct: 124 SDMNY---VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPE 180
Query: 533 YASSGKLTDRSDVFSFGVVLLELIT-GRKP 561
+ K T SDV+SFG+V+ E+++ G +P
Sbjct: 181 AIAYRKFTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 68/215 (31%), Positives = 107/215 (49%), Gaps = 24/215 (11%)
Query: 368 IGEGGFGCVYKGN----LPEGK--VVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSL 421
+GEG FG V+ LPE +VAVK LK S ++F+ E E+++ + H+H+V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 422 VGYCISEKNRLLIYEFVPNNNLEHHL--HGKGQPVLEWTKRV-----------KIALGAA 468
G C + L+++E++ + +L L HG +L + V IA A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 469 KGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK-LNDTTQTHVSTRVMGTFG 527
G+ YL H +HRD+ + N LV ++ DFG+++ + T V R M
Sbjct: 133 SGMVYL-ASLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 528 YLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKP 561
++ PE K T SD++SFGVVL E+ T G++P
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 8e-24
Identities = 60/208 (28%), Positives = 108/208 (51%), Gaps = 15/208 (7%)
Query: 356 MEITNGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHH 415
E+T F +E +G G FG V+ G VA+K ++ G+ E +F E +++ ++ H
Sbjct: 4 SELT--FLKE--LGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSH 58
Query: 416 RHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHG-KGQPVLEWTKRVKIALGAAKGLAYL 474
+LV L G C ++ ++ E++ N L ++L KG+ EW + + + + YL
Sbjct: 59 PNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWL--LDMCSDVCEAMEYL 116
Query: 475 HEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK--LNDTTQTHVSTRVMGTFGYLAPE 532
+ IHRD+ + N LV ++ +V+DFGLA+ L+D + T+ + PE
Sbjct: 117 ESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKF--PVKWAPPE 171
Query: 533 YASSGKLTDRSDVFSFGVVLLELITGRK 560
+ + +SDV+SFGV++ E+ + K
Sbjct: 172 VFDYSRFSSKSDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 61/204 (29%), Positives = 103/204 (50%), Gaps = 24/204 (11%)
Query: 367 VIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYC 425
+GEG +G VYK + G+VVA+K + E E+ I+ + ++V G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEII--KEISILKQCDSPYIVKYYG-S 66
Query: 426 ISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRV----KIAL---GAAKGLAYLHEDC 478
+ L I +E+ G +++ T + +IA KGL YLH +
Sbjct: 67 YFKNTDLWIV-------MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN- 118
Query: 479 HPKIIHRDIKSANILVDDEFEAQVADFGLA-KLNDTTQTHVSTRVMGTFGYLAPEYASSG 537
K IHRDIK+ NIL+++E +A++ADFG++ +L DT V+GT ++APE
Sbjct: 119 --KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK--RNTVIGTPFWMAPEVIQEI 174
Query: 538 KLTDRSDVFSFGVVLLELITGRKP 561
+++D++S G+ +E+ G+ P
Sbjct: 175 GYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 79/296 (26%), Positives = 132/296 (44%), Gaps = 53/296 (17%)
Query: 368 IGEGGFGCVYKG------NLPEGKVVAVKQLKSGSGQGE-REFRAEVEIISRV-HHRHLV 419
+GEG FG V K N E VAVK LK + + + + +E+E++ + H++++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 420 SLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKR--------------VKIAL 465
+L+G C E ++ E+ + NL L + P + V A
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139
Query: 466 GAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK---LNDTTQTHVSTRV 522
A+G+ +L K IHRD+ + N+LV ++ ++ADFGLA+ D + + R+
Sbjct: 140 QVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRL 196
Query: 523 MGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVL 581
++APE T +SDV+SFGV+L E+ T G P P P+ L
Sbjct: 197 --PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY-PGIPV----------EEL 243
Query: 582 VRAIETGDLSEIVDPRLEK-HYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALD 636
+ ++ G R+EK E++ ++ C +RP Q+V LD
Sbjct: 244 FKLLKEGY-------RMEKPQNCTQELYHLM---RDCWHEVPSQRPTFKQLVEDLD 289
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 62/200 (31%), Positives = 101/200 (50%), Gaps = 13/200 (6%)
Query: 368 IGEGGFGCVYKGNLPE-GKVVAVKQL---KSGSGQGEREFRAEVEIISRVHHRHLVSLVG 423
+G+GGFG V + GK+ A K+L + +GE+ E +I+ +V R +VSL
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 424 YCISEKNRL-LIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKI 482
Y K+ L L+ + +L++H++ G+P + + A GL +LH+ +I
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RI 116
Query: 483 IHRDIKSANILVDDEFEAQVADFGLA-KLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTD 541
++RD+K N+L+DD +++D GLA +L + GT GY+APE
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA---GTPGYMAPEVLQGEVYDF 173
Query: 542 RSDVFSFGVVLLELITGRKP 561
D F+ G L E+I GR P
Sbjct: 174 SVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 3e-23
Identities = 61/204 (29%), Positives = 96/204 (47%), Gaps = 16/204 (7%)
Query: 368 IGEGGFGCVYKG--NLPEGKV--VAVKQLKSGSGQG-EREFRAEVEIISRVHHRHLVSLV 422
+G+G FG V +G + GKV VAVK LKS +F E I+ + H +L+ L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 423 GYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKI 482
G ++ +++ E P +L L + A+ A G+ YL +
Sbjct: 63 GVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RF 118
Query: 483 IHRDIKSANILVDDEFEAQVADFGLAK-LNDTTQTHVST---RVMGTFGYLAPEYASSGK 538
IHRD+ + NIL+ + + ++ DFGL + L +V +V F + APE +
Sbjct: 119 IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPESLRTRT 176
Query: 539 LTDRSDVFSFGVVLLELIT-GRKP 561
+ SDV+ FGV L E+ T G +P
Sbjct: 177 FSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 99.4 bits (247), Expect = 5e-23
Identities = 67/213 (31%), Positives = 106/213 (49%), Gaps = 22/213 (10%)
Query: 368 IGEGGFGCVYKG---NL-PEGK--VVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSL 421
+GEG FG V+ NL PE +VAVK LK S ++F E E+++ + H H+V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 422 VGYCISEKNRLLIYEFVPNNNLEHHL--HG-------KGQPVLEWTKR--VKIALGAAKG 470
G C+ ++++E++ + +L L HG +G E T+ + IA A G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 471 LAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK-LNDTTQTHVSTRVMGTFGYL 529
+ YL +HRD+ + N LV + ++ DFG+++ + T V M ++
Sbjct: 133 MVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189
Query: 530 APEYASSGKLTDRSDVFSFGVVLLELIT-GRKP 561
PE K T SDV+S GVVL E+ T G++P
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 6e-23
Identities = 68/204 (33%), Positives = 109/204 (53%), Gaps = 20/204 (9%)
Query: 368 IGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCIS 427
+G G FG V G VA+K +K GS E EF E +++ ++ H LV L G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 428 EKNRLLIYEFVPNNNLEHHL--HGKG-QPV--LEWTKRVKIALGAAKGLAYLHEDCHPKI 482
++ ++ E++ N L ++L HGK QP LE K V +G+AYL +
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDV------CEGMAYLESK---QF 121
Query: 483 IHRDIKSANILVDDEFEAQVADFGLAK--LNDTTQTHVSTRVMGTFGYLAPEYASSGKLT 540
IHRD+ + N LVDD+ +V+DFGL++ L+D + V ++ + PE K +
Sbjct: 122 IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKF--PVRWSPPEVLLYSKFS 179
Query: 541 DRSDVFSFGVVLLELIT-GRKPVD 563
+SDV++FGV++ E+ + G+ P +
Sbjct: 180 SKSDVWAFGVLMWEVYSLGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 99.8 bits (248), Expect = 6e-23
Identities = 77/223 (34%), Positives = 119/223 (53%), Gaps = 27/223 (12%)
Query: 364 RENVIGEGGFGCVYKGN-LPEGKVV----AVKQLKSGSG-QGEREFRAEVEIISRVHHRH 417
R V+G G FG VYKG +PEG+ V A+K L +G + EF E I++ + H H
Sbjct: 11 RVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPH 70
Query: 418 LVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGK-----GQPVLEWTKRVKIALGAAKGLA 472
LV L+G C+S +L + + +P+ L ++H Q +L W ++ AKG+
Sbjct: 71 LVRLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMM 123
Query: 473 YLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKL--NDTTQTHVSTRVMGTFGYLA 530
YL E +++HRD+ + N+LV ++ DFGLA+L D + + M ++A
Sbjct: 124 YLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKM-PIKWMA 179
Query: 531 PEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVD--PTQPLGD 570
E K T +SDV+S+GV + EL+T G KP D PT+ + D
Sbjct: 180 LECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPD 222
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 6e-23
Identities = 69/195 (35%), Positives = 104/195 (53%), Gaps = 6/195 (3%)
Query: 368 IGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCIS 427
+G+G FG V+ G VA+K LK G+ E F E +I+ ++ H LV L +S
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPE-AFLQEAQIMKKLRHDKLVPLYA-VVS 71
Query: 428 EKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDI 487
E+ ++ EF+ +L L L+ + V +A A G+AY+ IHRD+
Sbjct: 72 EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDL 128
Query: 488 KSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFS 547
++ANILV D ++ADFGLA+L + + + APE A G+ T +SDV+S
Sbjct: 129 RAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 188
Query: 548 FGVVLLELIT-GRKP 561
FG++L EL+T GR P
Sbjct: 189 FGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 1e-22
Identities = 73/209 (34%), Positives = 113/209 (54%), Gaps = 18/209 (8%)
Query: 365 ENVIGEGGFGCVYKGNL-PEGK---VVAVKQLKSG-SGQGEREFRAEVEIISRVHHRHLV 419
E VIG G FG V +G L GK VA+K LKSG + + R+F +E I+ + H +++
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 420 SLVGYCISEKNRLLIYEFVPNNNLEHHLH-GKGQ-PVLEWTKRVKIALGAAKGLAYLHED 477
L G + ++I EF+ N L+ L GQ V++ V + G A G+ YL E
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL---VGMLRGIAAGMKYLSEM 125
Query: 478 CHPKIIHRDIKSANILVDDEFEAQVADFGLAK-LNDTTQTHVSTRVMG---TFGYLAPEY 533
+ +HRD+ + NILV+ +V+DFGL++ L D T T +G + APE
Sbjct: 126 NY---VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEA 182
Query: 534 ASSGKLTDRSDVFSFGVVLLELIT-GRKP 561
+ K T SDV+S+G+V+ E+++ G +P
Sbjct: 183 IAYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 3e-22
Identities = 74/276 (26%), Positives = 124/276 (44%), Gaps = 28/276 (10%)
Query: 362 FARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSL 421
F +E +G G FG V+ G VA+K + G+ E +F E +++ ++ H LV L
Sbjct: 8 FMKE--LGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQL 64
Query: 422 VGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPK 481
G C +K ++ EF+ N L ++L + Q L + + +G+ YL +
Sbjct: 65 YGVCTQQKPLYIVTEFMENGCLLNYLRQR-QGKLSKDMLLSMCQDVCEGMEYLERN---S 120
Query: 482 IIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTD 541
IHRD+ + N LV +V+DFG+ + + S+ + PE + K +
Sbjct: 121 FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSS 180
Query: 542 RSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEKH 601
+SDV+SFGV++ E+ T K P +S E +V I G + P+L
Sbjct: 181 KSDVWSFGVLMWEVFTEGK-----MPFEKKSNYE-----VVEMISRGF--RLYRPKLASM 228
Query: 602 YVESEMFRMIEAAAACVRHSGPK-RPRMVQVVRALD 636
V M+ C H P+ RP +++RA+
Sbjct: 229 TVYEVMYS-------C-WHEKPEGRPTFAELLRAIT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 96.5 bits (241), Expect = 3e-22
Identities = 71/300 (23%), Positives = 119/300 (39%), Gaps = 72/300 (24%)
Query: 352 YEELMEITNGFARENVIGEGGFGCVYK-GNLPEGKVVAVKQLKSGS-GQGERE-FRAEVE 408
YE L IG+G FG V K +GK++ K++ G+ + E++ +EV
Sbjct: 2 YEVL----------ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVN 51
Query: 409 IISRVHHRHLVSLVGYCISEKNRLL-IYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGA 467
I+ + H ++V I N+ L I +E+ G +++ K+ +
Sbjct: 52 ILRELKHPNIVRYYDRIIDRSNQTLYIV-------MEYCEGGDLAQLIQKCKKER----- 99
Query: 468 AKGLAYLHED---------------CH------PKIIHRDIKSANILVDDEFEAQVADFG 506
Y+ E+ CH ++HRD+K ANI +D ++ DFG
Sbjct: 100 ----KYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFG 155
Query: 507 LAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQ 566
LAK+ + T V GT Y++PE + ++SD++S G ++ EL P
Sbjct: 156 LAKILGHDSSFAKTYV-GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN 214
Query: 567 PLGDESLVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRP 626
L L I+ G R+ Y SE+ +I + + KRP
Sbjct: 215 QL-----------QLASKIKEGKF-----RRIPYRY-SSELNEVI---KSMLNVDPDKRP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 4e-22
Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 28/211 (13%)
Query: 368 IGEGGFGCVY---KGNLPEGKVVAVKQLKSGSGQGEREFR---AEVEIISRVHHRHLVSL 421
I +G +G V+ K + G + A+K +K + + E +I+S+ ++V L
Sbjct: 1 ISKGAYGRVFLAKKKST--GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58
Query: 422 VGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVL-EWTKRVKIALGAAKGLAYLHEDCHP 480
+KN L+ E++P +L L G L E R+ IA L YLH +
Sbjct: 59 YYSFQGKKNLYLVMEYLPGGDLASLLENVG--SLDEDVARIYIA-EIVLALEYLHSN--- 112
Query: 481 KIIHRDIKSANILVDDEFEAQVADFGLAKL----------NDTTQTHVSTRVMGTFGYLA 530
IIHRD+K NIL+D ++ DFGL+K+ +D + R++GT Y+A
Sbjct: 113 GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDK---RIVGTPDYIA 169
Query: 531 PEYASSGKLTDRSDVFSFGVVLLELITGRKP 561
PE + D +S G +L E + G P
Sbjct: 170 PEVILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 4e-22
Identities = 64/270 (23%), Positives = 124/270 (45%), Gaps = 29/270 (10%)
Query: 367 VIGEGGFG--CVYKGNLPEGKVVAVKQ--LKSGSGQGEREFRAEVEIISRVHHRHLVSLV 422
V+G+G FG +Y+ + +V K+ L S + R+ E+ I+S + H ++++
Sbjct: 7 VLGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65
Query: 423 GYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKI 482
+ + + L+ E+ L + + + E + ++Y+H+ I
Sbjct: 66 NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GI 122
Query: 483 IHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDR 542
+HRDIK+ NI + ++ DFG++K+ + + T V+GT Y++PE K +
Sbjct: 123 LHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYYMSPELCQGVKYNFK 181
Query: 543 SDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEKHY 602
SD+++ G VL EL+T ++ D T PL LV I G+ + +V
Sbjct: 182 SDIWALGCVLYELLTLKRTFDATNPLN-----------LVVKIVQGNYTPVVSV------ 224
Query: 603 VESEMFRMIEAAAACVRHSGPKRPRMVQVV 632
SE+ ++ + ++ KRP +V+
Sbjct: 225 YSSELISLVH---SLLQQDPEKRPTADEVL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 5e-22
Identities = 75/307 (24%), Positives = 125/307 (40%), Gaps = 40/307 (13%)
Query: 360 NGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGE--REFRAEVEIISRVHHRH 417
+ +GEG G V K L ++ + + + ++ E+EI +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 418 LVSLVGYCISEKNRLL--IYEFVPNNNLEHHLHGKGQPVLEWTKRV------KIALGAAK 469
+V G + E + + E+ +L+ ++ K V + R+ KIA K
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYKK---VKKRGGRIGEKVLGKIAESVLK 116
Query: 470 GLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK--LNDTTQTHVSTRVMGTFG 527
GL+YLH KIIHRDIK +NIL+ + + ++ DFG++ +N T GT
Sbjct: 117 GLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT-----GTSF 168
Query: 528 YLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDP--TQPLGDESLVEWARPVLVRAI 585
Y+APE + SDV+S G+ LLE+ R P P PLG L+ + I
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSY--------I 220
Query: 586 ETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRP---RMVQVVRALDSEGEMS 642
E+ D SE F+ + C+ +RP M++ +
Sbjct: 221 VNMPNPELKD-EPGNGIKWSEEFK--DFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKKV 277
Query: 643 DLSNGVK 649
+++ V
Sbjct: 278 NMAKFVA 284
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 5e-22
Identities = 63/205 (30%), Positives = 94/205 (45%), Gaps = 21/205 (10%)
Query: 366 NVIGEGGFG--CVYKGNLPEGKVVAVKQL---KSGSGQGEREFRAEVEIISRVHHRHLVS 420
VIG+G FG C+ + K+ A+K + K R E I+ ++H LV+
Sbjct: 6 RVIGKGAFGKVCIVQKR-DTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVN 64
Query: 421 LVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKR---VKIALGAAKGLAYLHED 477
L E+N L+ + + +L +HL + E + +I L L YLH
Sbjct: 65 LWYSFQDEENMYLVVDLLLGGDLRYHL-SQKVKFSEEQVKFWICEIVLA----LEYLHSK 119
Query: 478 CHPKIIHRDIKSANILVDDEFEAQVADFGLA-KLNDTTQTHVSTRVMGTFGYLAPEYASS 536
IIHRDIK NIL+D++ + DF +A K+ T T T GT GY+APE
Sbjct: 120 ---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TSTSGTPGYMAPEVLCR 173
Query: 537 GKLTDRSDVFSFGVVLLELITGRKP 561
+ D +S GV E + G++P
Sbjct: 174 QGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 7e-22
Identities = 62/190 (32%), Positives = 101/190 (53%), Gaps = 7/190 (3%)
Query: 367 VIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGER-EFRAEVEIISRVHHRHLVSLVGYC 425
++G+G FG V+KG L + VAVK K Q + +F +E I+ + H ++V L+G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 426 ISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLH-EDCHPKIIH 484
+ ++ E VP + L K L+ + VK AL AA G+AYL ++C IH
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKKDE-LKTKQLVKFALDAAAGMAYLESKNC----IH 116
Query: 485 RDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSD 544
RD+ + N LV + +++DFG+++ D S + APE + G+ + SD
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESD 176
Query: 545 VFSFGVVLLE 554
V+S+G++L E
Sbjct: 177 VWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 7e-22
Identities = 66/209 (31%), Positives = 107/209 (51%), Gaps = 31/209 (14%)
Query: 368 IGEGGFGCVYK-GNLPEGKVVAVKQLKSGS-GQGEREFRA-EVEIISRVHHRHLVS---- 420
+G+G +G VYK L + + A+K++ GS Q ERE E+ I++ V+H +++S
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67
Query: 421 -LVGYCISEKNRLLI-YEFVPNNNLEHHL---HGKGQPVLE---WTKRVKIALGAAKGLA 472
L G N+L I E+ P +L + K + + E W +I + +GL
Sbjct: 68 FLDG------NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIW----RIFIQLLRGLQ 117
Query: 473 YLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPE 532
LHE KI+HRD+KSANIL+ ++ D G++K+ + T +GT Y+APE
Sbjct: 118 ALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKV--LKKNMAKT-QIGTPHYMAPE 171
Query: 533 YASSGKLTDRSDVFSFGVVLLELITGRKP 561
+ +SD++S G +L E+ T P
Sbjct: 172 VWKGRPYSYKSDIWSLGCLLYEMATFAPP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 1e-21
Identities = 66/216 (30%), Positives = 106/216 (49%), Gaps = 25/216 (11%)
Query: 368 IGEGGFGCVYKG---NLPEGK---VVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSL 421
+GEG FG V+ NL K +VAVK LK + ++F+ E E+++ + H H+V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 422 VGYCISEKNRLLIYEFVPNNNLEHHL--HG-------KGQPV-----LEWTKRVKIALGA 467
G C ++++E++ + +L L HG GQP L ++ + IA
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 468 AKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK-LNDTTQTHVSTRVMGTF 526
A G+ YL +HRD+ + N LV ++ DFG+++ + T V M
Sbjct: 133 ASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 527 GYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKP 561
++ PE K T SDV+SFGV+L E+ T G++P
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 1e-21
Identities = 59/195 (30%), Positives = 98/195 (50%), Gaps = 5/195 (2%)
Query: 368 IGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCIS 427
+G G FG V+ G VAVK LK G+ + F E ++ + H LV L
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 428 EKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDI 487
E+ +I E++ +L L + K + + A+G+AY+ + IHRD+
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNY---IHRDL 129
Query: 488 KSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFS 547
++AN+LV + ++ADFGLA++ + + + APE + G T +SDV+S
Sbjct: 130 RAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWS 189
Query: 548 FGVVLLELIT-GRKP 561
FG++L E++T G+ P
Sbjct: 190 FGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 94.6 bits (236), Expect = 2e-21
Identities = 59/230 (25%), Positives = 96/230 (41%), Gaps = 41/230 (17%)
Query: 362 FARENVIGEGGFGCVYKGNLPE-GKVVAVKQL---------KSGSGQGEREFRAEVEIIS 411
F +IGEG F V E K A+K L K + E+E +++
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKE------VLT 56
Query: 412 RV-HHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKG 470
R+ H ++ L E+N + E+ PN L ++ G + T+ A
Sbjct: 57 RLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRF--YAAEILLA 114
Query: 471 LAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVM------- 523
L YLH IIHRD+K NIL+D + ++ DFG AK+ D + S +
Sbjct: 115 LEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQ 171
Query: 524 ------------GTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKP 561
GT Y++PE + SD+++ G ++ +++TG+ P
Sbjct: 172 IEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 4e-21
Identities = 72/215 (33%), Positives = 113/215 (52%), Gaps = 23/215 (10%)
Query: 366 NVIGEGGFGCVYKGNL--PEGKVV--AVKQLKSGSGQGERE-FRAEVEIISRVHHRHLVS 420
VIG+G FGCVY G L +G+ + AVK L + E E F E I+ H +++S
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 421 LVGYCI-SEKNRLLIYEFVPNNNLEHHLHG-KGQPVLEWTKRVKIALGAAKGLAYLHEDC 478
L+G C+ SE + L++ ++ + +L + + P ++ + L AKG+ YL
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVK--DLIGFGLQVAKGMEYLASK- 117
Query: 479 HPKIIHRDIKSANILVDDEFEAQVADFGLA-----KLNDTTQTHVSTRVMGTFGYLAPEY 533
K +HRD+ + N ++D+ F +VADFGLA K + H ++ ++A E
Sbjct: 118 --KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKL--PVKWMALES 173
Query: 534 ASSGKLTDRSDVFSFGVVLLELIT-GRKP---VDP 564
+ K T +SDV+SFGV+L EL+T G P VD
Sbjct: 174 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS 208
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 5e-21
Identities = 64/212 (30%), Positives = 103/212 (48%), Gaps = 16/212 (7%)
Query: 361 GFARENV-----IGEGGFGCVYKG--NLPEGKV--VAVKQLKSGSGQGERE-FRAEVEII 410
RE++ IGEG FG VY+G PE + VAVK K+ + RE F E I+
Sbjct: 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIM 61
Query: 411 SRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKG 470
+ H H+V L+G +E ++ E P L +L + L+ + + +
Sbjct: 62 RQFDHPHIVKLIGVI-TENPVWIVMELAPLGELRSYLQ-VNKYSLDLASLILYSYQLSTA 119
Query: 471 LAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLA 530
LAYL + +HRDI + N+LV ++ DFGL++ + + +++ ++A
Sbjct: 120 LAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMA 176
Query: 531 PEYASSGKLTDRSDVFSFGVVLLE-LITGRKP 561
PE + + T SDV+ FGV + E L+ G KP
Sbjct: 177 PESINFRRFTSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 5e-21
Identities = 68/204 (33%), Positives = 107/204 (52%), Gaps = 22/204 (10%)
Query: 368 IGEGGFG----CVYKGNLPEG----KVVAVKQLKSGSGQGE-REFRAEVEIISRVHHRHL 418
+GEG FG C Y PEG + VAVK LK SG + + E+EI+ ++H ++
Sbjct: 12 LGEGHFGKVELCRYD---PEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 68
Query: 419 VSLVGYCISEKNR--LLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHE 476
V G C + LI EF+P+ +L+ +L + + + +++K A+ KG+ YL
Sbjct: 69 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PRNKNKINLKQQLKYAVQICKGMDYLGS 127
Query: 477 DCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVST---RVMGTFGYLAPEY 533
+ +HRD+ + N+LV+ E + ++ DFGL K +T + + + F Y APE
Sbjct: 128 R---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APEC 183
Query: 534 ASSGKLTDRSDVFSFGVVLLELIT 557
K SDV+SFGV L EL+T
Sbjct: 184 LIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 6e-21
Identities = 63/213 (29%), Positives = 116/213 (54%), Gaps = 27/213 (12%)
Query: 367 VIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGERE----------FRAEVEIISRVHH 415
+IG+G +G VY N+ G+++AVKQ++ + R R+E+E + + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 416 RHLVSLVGYCISEKNRLLIYEFVPNNNLEHHL--HGKGQP--VLEWTKRVKIALGAAKGL 471
++V +G+ +E+ + E+VP ++ L +G+ + V +T++V +GL
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQV------LEGL 121
Query: 472 AYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVM-GTFGYLA 530
AYLH I+HRD+K+ N+LVD + +++DFG++K +D + M G+ ++A
Sbjct: 122 AYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMA 178
Query: 531 PEYASSGK--LTDRSDVFSFGVVLLELITGRKP 561
PE S + + D++S G V+LE+ GR+P
Sbjct: 179 PEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 6e-21
Identities = 77/275 (28%), Positives = 129/275 (46%), Gaps = 31/275 (11%)
Query: 368 IGEGGFGCVYK-GNLPEGKVVAVKQLKSGSGQG-EREFRAEVEIISRVHHRHLVSLVGYC 425
+G G G V K ++P G V+A K + G+ ++ E++I+ ++VS G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 426 ISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRV--KIALGAAKGLAYLHEDCHPKII 483
++E N + EF+ +L+ ++ KG P+ + KIA+ +GL YL+ I+
Sbjct: 73 LNENNICMCMEFMDCGSLDR-IYKKGGPI---PVEILGKIAVAVVEGLTYLYNVHR--IM 126
Query: 484 HRDIKSANILVDDEFEAQVADFGLAK--LNDTTQTHVSTRVMGTFGYLAPEYASSGKLTD 541
HRDIK +NILV+ + ++ DFG++ +N T V GT Y++PE GK T
Sbjct: 127 HRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV-----GTSTYMSPERIQGGKYTV 181
Query: 542 RSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVD---PRL 598
+SDV+S G+ ++EL G+ P + D L L +IV PRL
Sbjct: 182 KSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDL--------LQQIVQEPPPRL 233
Query: 599 EKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVR 633
++ ++ AC+ +RP Q+
Sbjct: 234 PSSDFPEDLRDFVD---ACLLKDPTERPTPQQLCA 265
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 7e-21
Identities = 62/207 (29%), Positives = 97/207 (46%), Gaps = 29/207 (14%)
Query: 367 VIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGE--REFRAEVEIISRVHHRHLVSLVG 423
V+GEG +G V K N G++VA+K+ K + + EV+++ ++ H ++V+L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 424 YCISEKNRL-LIYEFVPNNNLEH-HLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPK 481
K RL L++E+V LE G P + + L + +AY H
Sbjct: 68 AFRR-KGRLYLVFEYVERTLLELLEASPGGLPP-DAVRSYIWQL--LQAIAYCHSH---N 120
Query: 482 IIHRDIKSANILVDDEFEAQVADFGLAKL-----NDTTQTHVSTRVMGTFGYLAPE---- 532
IIHRDIK NILV + ++ DFG A+ +V+TR Y APE
Sbjct: 121 IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATR-----WYRAPELLVG 175
Query: 533 YASSGKLTDRSDVFSFGVVLLELITGR 559
+ GK DV++ G ++ EL+ G
Sbjct: 176 DTNYGKPV---DVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 8e-21
Identities = 62/222 (27%), Positives = 110/222 (49%), Gaps = 29/222 (13%)
Query: 368 IGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRA--EVEIISRVHHRHLVSLVGY 424
IGEG +G VYK + G++VA+K++K A E++++ ++H +++ L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD- 65
Query: 425 CISEKNRL-LIYEFVPNNNLEHHLHGKGQPVLEWTKRVK-IALGAAKGLAYLHEDCHPKI 482
K L L++EF+ + +L + + + + E +K +GLA+ H I
Sbjct: 66 VFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPE--SLIKSYLYQLLQGLAFCHSH---GI 119
Query: 483 IHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ---TH-VSTRVMGTFGYLAPE--YASS 536
+HRD+K N+L++ E ++ADFGLA+ + TH V TR Y APE
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WYRAPELLLGDK 174
Query: 537 GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWAR 578
G + D++S G + EL++ R P+ P G + + +
Sbjct: 175 G-YSTPVDIWSVGCIFAELLSRR-PLFP----GKSEIDQLFK 210
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 92.6 bits (231), Expect = 1e-20
Identities = 65/220 (29%), Positives = 99/220 (45%), Gaps = 29/220 (13%)
Query: 362 FARENVIGEGGFGCV----YKGNLPEGKVVAVKQLKSG----SGQGEREFRAEVEIISRV 413
F +G G FG V +KG+ GK A+K L Q E E I+ +
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGS---GKYYALKILSKAKIVKLKQVE-HVLNEKRILQSI 58
Query: 414 HHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTK--RVKIALGAAKGL 471
H LV+L G + N L+ E+VP L HL G+ + ++ L L
Sbjct: 59 RHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLA----L 114
Query: 472 AYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK-LNDTTQTHVSTRVMGTFGYLA 530
YLH I++RD+K N+L+D + ++ DFG AK + T T + GT YLA
Sbjct: 115 EYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYT-----LCGTPEYLA 166
Query: 531 PEYASSGKLTDRS-DVFSFGVVLLELITGRKPVDPTQPLG 569
PE S K ++ D ++ G+++ E++ G P P+
Sbjct: 167 PEIILS-KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ 205
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 1e-20
Identities = 59/206 (28%), Positives = 107/206 (51%), Gaps = 16/206 (7%)
Query: 367 VIGEGGFGCVYKG-NLPEGKVVAVKQLK----SGSGQGE--REFRAEVEIISRVHHRHLV 419
+G G F Y+ ++ G ++AVKQ+ + S Q E R E+ +++R++H H++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 420 SLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCH 479
++G + + L E++ ++ H L G + + +GL+YLHE+
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGA--FKEAVIINYTEQLLRGLSYLHEN-- 122
Query: 480 PKIIHRDIKSANILVDDEFE-AQVADFGLA-KLND--TTQTHVSTRVMGTFGYLAPEYAS 535
+IIHRD+K AN+L+D + ++ADFG A +L T +++GT ++APE
Sbjct: 123 -QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLR 181
Query: 536 SGKLTDRSDVFSFGVVLLELITGRKP 561
+ DV+S G V++E+ T + P
Sbjct: 182 GEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 2e-20
Identities = 67/208 (32%), Positives = 100/208 (48%), Gaps = 32/208 (15%)
Query: 368 IGEGGFGCVYKG-NLPEGKVVAVKQLK-SGSGQGER--EFRAEVEIISRVHHRHLVSLVG 423
IG G FG VY ++ +VVA+K++ SG E+ + EV + ++ H + + G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 424 YCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKR----VKIA---LGAAKGLAYLHE 476
+ E L+ E+ G +LE K+ V+IA GA +GLAYLH
Sbjct: 83 CYLREHTAWLVMEYCL---------GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHS 133
Query: 477 DCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEY--- 533
IHRDIK+ NIL+ + ++ADFG A L + V GT ++APE
Sbjct: 134 HER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVILA 185
Query: 534 ASSGKLTDRSDVFSFGVVLLELITGRKP 561
G+ + DV+S G+ +EL RKP
Sbjct: 186 MDEGQYDGKVDVWSLGITCIEL-AERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 2e-20
Identities = 58/208 (27%), Positives = 100/208 (48%), Gaps = 13/208 (6%)
Query: 368 IGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCI 426
+G+G FG VYK + G A K ++ S + +F E++I+S H ++V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 427 SEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRD 486
E ++ EF L+ + + + E R + + L +LH K+IHRD
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERGLTEPQIRY-VCRQMLEALNFLHSH---KVIHRD 128
Query: 487 IKSANILVDDEFEAQVADFGL-AKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTD---- 541
+K+ NIL+ + + ++ADFG+ AK T Q + +GT ++APE + D
Sbjct: 129 LKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVACETFKDNPYD 186
Query: 542 -RSDVFSFGVVLLELITGRKPVDPTQPL 568
++D++S G+ L+EL P P+
Sbjct: 187 YKADIWSLGITLIELAQMEPPHHELNPM 214
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 2e-20
Identities = 61/205 (29%), Positives = 97/205 (47%), Gaps = 14/205 (6%)
Query: 366 NVIGEGGFGCVYKGN-LPEGKVVAVKQLKSGSGQGE-REFRAEVEIISRVHHRHLVSLVG 423
VIG G VY LP + VA+K++ Q E R EV+ +S+ +H ++V
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKY-- 64
Query: 424 YC-ISEKNRL-LIYEFVPNNNLEHHL-HGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHP 480
Y + L L+ ++ +L + + L+ + KGL YLH +
Sbjct: 65 YTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ- 123
Query: 481 KIIHRDIKSANILVDDEFEAQVADFGL-AKLNDTTQTHVSTR--VMGTFGYLAPEYASSG 537
IHRDIK+ NIL+ ++ ++ADFG+ A L D R +GT ++APE
Sbjct: 124 --IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQV 181
Query: 538 K-LTDRSDVFSFGVVLLELITGRKP 561
++D++SFG+ +EL TG P
Sbjct: 182 HGYDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 3e-20
Identities = 67/221 (30%), Positives = 109/221 (49%), Gaps = 21/221 (9%)
Query: 350 FTYEELMEITNGFARENVIGEGGFGCVYKGNLPE-GKVVAVKQLKSGSGQGE-REFRAEV 407
FT E+L + IG G FG V K G ++AVK+++S + E + ++
Sbjct: 1 FTAEDLKD-------LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDL 53
Query: 408 EIISRVHH-RHLVSLVGYCISEKNRLLIYEFVPN--NNLEHHLHGKGQPVLEWTKRVKIA 464
+++ R ++V G E + + E + + +++ + V+ KIA
Sbjct: 54 DVVMRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIA 113
Query: 465 LGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLA-KLNDTTQTHVSTRVM 523
+ K L YL E+ KIIHRD+K +NIL+D ++ DFG++ +L D+ TR
Sbjct: 114 VATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI---AKTRDA 168
Query: 524 GTFGYLAPEY--ASSGKLTD-RSDVFSFGVVLLELITGRKP 561
G Y+APE S+ D RSDV+S G+ L E+ TG+ P
Sbjct: 169 GCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 3e-20
Identities = 68/205 (33%), Positives = 109/205 (53%), Gaps = 11/205 (5%)
Query: 362 FARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSG---SGQGEREFRAEVEIISRVHHRH 417
F + V+G+GGFG V + GK+ A K+L+ +GE E +I+ +V+ R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 418 LVSLVGYCISEKNRL-LIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHE 476
+VSL Y K+ L L+ + +L+ H++ G+ E + V A GL LH+
Sbjct: 62 VVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ 120
Query: 477 DCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASS 536
+ +I++RD+K NIL+DD +++D GLA QT + RV GT GY+APE +
Sbjct: 121 E---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEVVKN 175
Query: 537 GKLTDRSDVFSFGVVLLELITGRKP 561
+ T D ++ G +L E+I G+ P
Sbjct: 176 ERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 4e-20
Identities = 61/214 (28%), Positives = 109/214 (50%), Gaps = 28/214 (13%)
Query: 365 ENVIGEGGFGCVYKGNLPEGKV---VAVKQLKSGSGQGE-REFRAEVEIISRV-HHRHLV 419
++VIGEG FG V K + + + A+K++K + + + R+F E+E++ ++ HH +++
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 420 SLVGYCISEKNRLLIYEFVPNNNLEHHLHG----KGQPVLEWTKRVKIALGA-------- 467
+L+G C L E+ P+ NL L + P L +
Sbjct: 72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 468 --AKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGT 525
A+G+ YL + + IHRD+ + NILV + + A++ADFGL++ Q + MG
Sbjct: 132 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKKTMGR 184
Query: 526 FG--YLAPEYASSGKLTDRSDVFSFGVVLLELIT 557
++A E + T SDV+S+GV+L E+++
Sbjct: 185 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 90.7 bits (226), Expect = 5e-20
Identities = 60/223 (26%), Positives = 106/223 (47%), Gaps = 46/223 (20%)
Query: 362 FARENVIGEGGFGCVYKGNLPE-GKVVAVKQLKSGSGQGERE---FRA--EVEIISRVHH 415
+ + +GEG + VYK E G++VA+K++K G + ++ F A E++++ + H
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61
Query: 416 RHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAA------- 468
+++ L+ + N L++EF+ + LE + K I L A
Sbjct: 62 PNIIGLLDVFGHKSNINLVFEFMETD-LEKVI-----------KDKSIVLTPADIKSYML 109
Query: 469 ---KGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGT 525
+GL YLH + I+HRD+K N+L+ + ++ADFGLA+ + ++ +V+ T
Sbjct: 110 MTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-T 165
Query: 526 FGYLAPE-------YASSGKLTDRSDVFSFGVVLLELITGRKP 561
Y APE Y D++S G + EL+ R P
Sbjct: 166 RWYRAPELLFGARHYGVG------VDMWSVGCIFAELLL-RVP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 7e-20
Identities = 65/201 (32%), Positives = 93/201 (46%), Gaps = 17/201 (8%)
Query: 368 IGEGGFGCVYK-GNLPEGKVVAVKQLKSGS----GQGEREFRAEVEIISRVHHRHLVSLV 422
+G GGFG V + + A+K +K GQ + +E EI+ +H +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQ-QEHIFSEKEILEECNHPFIVKLY 59
Query: 423 GYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKI 482
+K ++ E+ L L +G E+T R IA YLH I
Sbjct: 60 RTFKDKKYIYMLMEYCLGGELWTILRDRGL-FDEYTARFYIA-CVVLAFEYLHNR---GI 114
Query: 483 IHRDIKSANILVDDEFEAQVADFGLAK-LNDTTQTHVSTRVMGTFGYLAPEYASSGKLTD 541
I+RD+K N+L+D ++ DFG AK L +T T GT Y+APE K D
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW--TFC-GTPEYVAPEII-LNKGYD 170
Query: 542 RS-DVFSFGVVLLELITGRKP 561
S D +S G++L EL+TGR P
Sbjct: 171 FSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 7e-20
Identities = 71/216 (32%), Positives = 113/216 (52%), Gaps = 25/216 (11%)
Query: 362 FARENVIGEGGFGCVYKGN-LPEGK----VVAVKQLKSG-SGQGEREFRAEVEIISRVHH 415
F + V+G G FG VYKG +PEG+ VA+K+L+ S + +E E +++ V +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 416 RHLVSLVGYCISEKNRLLIYEFVPNNNL-----EHHLHGKGQPVLEWTKRVKIALGAAKG 470
H+ L+G C++ +L I + +P L EH + Q +L W ++ AKG
Sbjct: 69 PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 121
Query: 471 LAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKL--NDTTQTHVSTRVMGTFGY 528
+ YL E +++HRD+ + N+LV ++ DFGLAKL D + H + +
Sbjct: 122 MNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKV-PIKW 177
Query: 529 LAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVD 563
+A E T +SDV+S+GV + EL+T G KP D
Sbjct: 178 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 7e-20
Identities = 59/203 (29%), Positives = 100/203 (49%), Gaps = 23/203 (11%)
Query: 368 IGEGGFGCVYK-GNLPEGKVVAVKQ--LKSGSGQGEREFRAEVEIISRVHHRHLVSL--- 421
IGEG G V+K + G+ VA+K+ L+ G + E++ + H ++V L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 422 --VGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLE-WTKRVKIALGAAKGLAYLHEDC 478
G L+ E++P++ L L + +P+ E K L KG+AY+H +
Sbjct: 68 FPHGSGFV-----LVMEYMPSD-LSEVLRDEERPLPEAQVKSYMRML--LKGVAYMHAN- 118
Query: 479 HPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPE--YASS 536
I+HRD+K AN+L+ + ++ADFGLA+L + + + + T Y APE Y +
Sbjct: 119 --GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGAR 176
Query: 537 GKLTDRSDVFSFGVVLLELITGR 559
K D+++ G + EL+ G
Sbjct: 177 -KYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 8e-20
Identities = 67/218 (30%), Positives = 113/218 (51%), Gaps = 36/218 (16%)
Query: 365 ENVIGEGGFGCVYKGNLPEGKV---VAVKQLKS-GSGQGEREFRAEVEIISRV-HHRHLV 419
E+VIGEG FG V + + + + A+K LK S R+F E+E++ ++ HH +++
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 420 SLVGYCISEKNRLLIY---EFVPNNNLEHHL---------------HGKGQPVLEWTKRV 461
+L+G C +NR +Y E+ P NL L HG L + +
Sbjct: 67 NLLGAC---ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTAS-TLTSQQLL 122
Query: 462 KIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTR 521
+ A A G+ YL E + IHRD+ + N+LV + +++ADFGL++ + +V +
Sbjct: 123 QFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVK-K 175
Query: 522 VMGTFG--YLAPEYASSGKLTDRSDVFSFGVVLLELIT 557
MG ++A E + T +SDV+SFGV+L E+++
Sbjct: 176 TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.2 bits (222), Expect = 1e-19
Identities = 61/203 (30%), Positives = 99/203 (48%), Gaps = 11/203 (5%)
Query: 362 FARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRA-EVEIISRVHHRHLV 419
F IG+G FG VYK + +VVA+K + + E E E++ +S+ ++
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 420 SLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCH 479
G + +I E+ + L K + E I GL YLHE+
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSCLDLL--KPGKLDETYIAF-ILREVLLGLEYLHEE-- 117
Query: 480 PKIIHRDIKSANILVDDEFEAQVADFGLA-KLNDTTQTHVSTRVMGTFGYLAPEYASSGK 538
IHRDIK+ANIL+ +E + ++ADFG++ +L T + +T V GT ++APE
Sbjct: 118 -GKIHRDIKAANILLSEEGDVKLADFGVSGQLTS-TMSKRNTFV-GTPFWMAPEVIKQSG 174
Query: 539 LTDRSDVFSFGVVLLELITGRKP 561
+++D++S G+ +EL G P
Sbjct: 175 YDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-19
Identities = 67/236 (28%), Positives = 119/236 (50%), Gaps = 28/236 (11%)
Query: 363 ARENV-----IGEGGFGCVYKG-------NLPEGKVVAVKQLKSGSGQGER-EFRAEVEI 409
ARE + +G+G FG VY+G + PE +V A+K + + ER EF E +
Sbjct: 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRV-AIKTVNEAASMRERIEFLNEASV 62
Query: 410 ISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHG-----KGQPVLE---WTKRV 461
+ + H+V L+G + L+I E + +L+ +L + PV K +
Sbjct: 63 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMI 122
Query: 462 KIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK-LNDTTQTHVST 520
++A A G+AYL+ + K +HRD+ + N +V ++F ++ DFG+ + + +T
Sbjct: 123 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 179
Query: 521 RVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEW 576
+ + +++PE G T SDV+SFGVVL E+ T + P Q + +E ++ +
Sbjct: 180 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE--QPYQGMSNEQVLRF 233
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-19
Identities = 59/202 (29%), Positives = 103/202 (50%), Gaps = 16/202 (7%)
Query: 386 VVAVKQLKSGSGQGER-EFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNLE 444
+VAVK L++ + R +F E++I+SR+ + +++ L+G C+S+ +I E++ N +L
Sbjct: 46 LVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLN 105
Query: 445 HHL----------HGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILV 494
L H P + + +A+ A G+ YL +HRD+ + N LV
Sbjct: 106 QFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLV 162
Query: 495 DDEFEAQVADFGLAK-LNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLL 553
+ + ++ADFG+++ L + R + ++A E GK T SDV++FGV L
Sbjct: 163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLW 222
Query: 554 ELITGRKPVDPTQPLGDESLVE 575
E+ T K P L DE ++E
Sbjct: 223 EMFTLCKE-QPYSLLSDEQVIE 243
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 62/213 (29%), Positives = 107/213 (50%), Gaps = 21/213 (9%)
Query: 366 NVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGY 424
IG G +G VYK ++ G++VA+K +K G + E+ ++ H ++V+ G
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68
Query: 425 CISEKNRLLI-YEFVPNNNLEHHLHGKGQPVLEWTKRVKIAL---GAAKGLAYLHEDCHP 480
+ ++L I E+ +L+ P+ E ++IA KGLAYLHE
Sbjct: 69 YLRR-DKLWIVMEYCGGGSLQDIYQVTRGPLSE----LQIAYVCRETLKGLAYLHET--- 120
Query: 481 KIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTR--VMGTFGYLAPEYA---S 535
IHRDIK ANIL+ ++ + ++ADFG++ T ++ R +GT ++APE A
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT---IAKRKSFIGTPYWMAPEVAAVER 177
Query: 536 SGKLTDRSDVFSFGVVLLELITGRKPVDPTQPL 568
G + D+++ G+ +EL + P+ P+
Sbjct: 178 KGGYDGKCDIWALGITAIELAELQPPMFDLHPM 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 3e-19
Identities = 64/211 (30%), Positives = 112/211 (53%), Gaps = 23/211 (10%)
Query: 362 FARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGE-REFRAEVEIISRVHHRHLV 419
+ R +IG G +G VY+G ++P G+VVA+K + + + + + EV ++S++
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 420 SLVGY--CISEKNRL-LIYEFVPNNNLEHHLHGKGQPVLE-----WTKRVKIALGAAKGL 471
++ Y + RL +I E+ ++ + K P+ E + V +A L
Sbjct: 63 NITKYYGSYLKGPRLWIIMEYAEGGSVRTLM--KAGPIAEKYISVIIREVLVA------L 114
Query: 472 AYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAP 531
Y+H+ +IHRDIK+ANILV + ++ DFG+A L + + ST V GT ++AP
Sbjct: 115 KYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAP 170
Query: 532 EYASSGKLTD-RSDVFSFGVVLLELITGRKP 561
E + GK D ++D++S G+ + E+ TG P
Sbjct: 171 EVITEGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 3e-19
Identities = 59/201 (29%), Positives = 108/201 (53%), Gaps = 12/201 (5%)
Query: 368 IGEGGFGCVYKG--NLPEGKV-VAVKQLKSGSGQGER-EFRAEVEIISRVHHRHLVSLVG 423
+G G FGCV KG + + ++ VA+K LK+ + + R E E EI+ ++ + ++V ++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 424 YCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKII 483
C +E +L+ E L L GK + + V++ + G+ YL +
Sbjct: 63 VCEAE-ALMLVMEMASGGPLNKFLSGKKDEITV-SNVVELMHQVSMGMKYLEGK---NFV 117
Query: 484 HRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTF--GYLAPEYASSGKLTD 541
HRD+ + N+L+ ++ A+++DFGL+K ++ R G + + APE + K +
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSS 177
Query: 542 RSDVFSFGVVLLELIT-GRKP 561
RSDV+S+G+ + E + G+KP
Sbjct: 178 RSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 4e-19
Identities = 64/223 (28%), Positives = 102/223 (45%), Gaps = 32/223 (14%)
Query: 368 IGEGGFGCVYKGNLP------EGKVVAVKQLKSG-SGQGEREFRAEVEIISRVHHRHLVS 420
IG+G FG V++ P +VAVK LK S + +F+ E +++ H ++V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 421 LVGYCISEKNRLLIYEFVP----NNNLEHH----------------LHGKGQPVLEWTKR 460
L+G C K L++E++ N L H G L T++
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 461 VKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLA-KLNDTTQTHVS 519
+ IA A G+AYL E K +HRD+ + N LV + ++ADFGL+ + S
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 520 TRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKP 561
++ PE + T SDV+++GVVL E+ + G +P
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP 232
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 88.0 bits (219), Expect = 4e-19
Identities = 54/204 (26%), Positives = 89/204 (43%), Gaps = 23/204 (11%)
Query: 367 VIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYC 425
IGEG G VYK + GK VA+K+++ E E+ I+ H ++V
Sbjct: 26 KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIIN-EILIMKDCKHPNIVDYYDSY 84
Query: 426 ISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKR-------VKIALGAAKGLAYLHEDC 478
+ ++ E++ +L ++ + +GL YLH
Sbjct: 85 LVGDELWVVMEYMDGGSLTD--------IITQNFVRMNEPQIAYVCREVLQGLEYLHSQ- 135
Query: 479 HPKIIHRDIKSANILVDDEFEAQVADFGL-AKLNDTTQTHVSTRVMGTFGYLAPEYASSG 537
+IHRDIKS NIL+ + ++ADFG A+L S V+GT ++APE
Sbjct: 136 --NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYWMAPEVIKRK 191
Query: 538 KLTDRSDVFSFGVVLLELITGRKP 561
+ D++S G++ +E+ G P
Sbjct: 192 DYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 5e-19
Identities = 60/277 (21%), Positives = 98/277 (35%), Gaps = 27/277 (9%)
Query: 2 ANSAETPGPPVANNASSGLGERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNS 61
A + + PP G E+++ P + T P + + G
Sbjct: 59 AAACDRFEPPTGPPPGPGTEAPANESRSTPTWSLST----LAPASPAREGSPTPPGP--- 111
Query: 62 TTPAASPPPASPP---PASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRS 118
+ PPP PP P SP P PPPA+ PPA+G++ AS +
Sbjct: 112 -SSPDPPPPTPPPASPPPSPAPDLSEMLRPVGSPGPPPAASPPAAGASPAAVASDAASSR 170
Query: 119 ES--------QSSPPPGDGGASPPPEQSKNSPPAPPG--------QASTPPDSPPPGIQS 162
++ +++ P A PPP + P AS+P +P
Sbjct: 171 QAALPLSSPEETARAPSSPPAEPPPSTPPAAASPRPPRRSSPISASASSPAPAPGRSAAD 230
Query: 163 NQGNPVPSNGTTDSRDTKWAPPSNPGSPPSPSTSQSGTPSTPNENSSPNELSPPSNSKSP 222
+ G + +++S W P + P + + + P+ P++S S
Sbjct: 231 DAGASSSDSSSSESSGCGWGPENECPLPRPAPITLPTRIWEASGWNGPSSRPGPASSSSS 290
Query: 223 TSKSSPEESSSSSHSNSKKTPTSSSGHSSDSTKGSSS 259
+ SP S SS S + +S SS S + SSS
Sbjct: 291 PRERSPSPSPSSPGSGPAPSSPRASSSSSSSRESSSS 327
|
Length = 1352 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 6e-19
Identities = 67/205 (32%), Positives = 110/205 (53%), Gaps = 12/205 (5%)
Query: 365 ENVIGEGGFGCVYKGNLP-EGK---VVAVKQLKSG-SGQGEREFRAEVEIISRVHHRHLV 419
E VIG G FG V G L GK VA+K LK+G + + R+F +E I+ + H +++
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 420 SLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCH 479
L G K +++ E++ N +L+ L K + V + G A G+ YL + +
Sbjct: 69 HLEGVVTKSKPVMIVTEYMENGSLDAFLR-KHDGQFTVIQLVGMLRGIASGMKYLSDMGY 127
Query: 480 PKIIHRDIKSANILVDDEFEAQVADFGLAK-LNDTTQTHVSTRVMGT-FGYLAPEYASSG 537
+HRD+ + NILV+ +V+DFGL++ L D + +TR + APE +
Sbjct: 128 ---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR 184
Query: 538 KLTDRSDVFSFGVVLLELIT-GRKP 561
K T SDV+S+G+V+ E+++ G +P
Sbjct: 185 KFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 6e-19
Identities = 61/216 (28%), Positives = 101/216 (46%), Gaps = 27/216 (12%)
Query: 367 VIGEGGFGCVYKGNL--PEGKV--VAVKQLK-SGSGQGE-REFRAEVEIISRVHHRHLVS 420
++GEG FG V +G L +G VAVK +K E EF +E + H +++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 421 LVGYCI--SEKNR----LLIYEFVPNNNLEHHL---HGKGQPV-LEWTKRVKIALGAAKG 470
L+G C S + ++I F+ + +L L G P L +K + A G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 471 LAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKL----NDTTQTHVSTRVMGTF 526
+ YL IHRD+ + N ++ ++ VADFGL+K + Q ++ +
Sbjct: 126 MEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV--- 179
Query: 527 GYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKP 561
++A E + T +SDV++FGV + E+ T G+ P
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 8e-19
Identities = 60/223 (26%), Positives = 99/223 (44%), Gaps = 37/223 (16%)
Query: 367 VIGEGGFGCVYKG------NLPEGKVVAVKQLKSGSGQGE-REFRAEVEIISRVHHRHLV 419
+GEG FG V K VAVK LK + E R+ +E ++ +V+H H++
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66
Query: 420 SLVGYCISEKNRLLIYEFVPNNNLEHHLH----------------------GKGQPVLEW 457
L G C + LLI E+ +L L + L
Sbjct: 67 KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126
Query: 458 TKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK---LNDTT 514
+ A ++G+ YL E K++HRD+ + N+LV + + +++DFGL++ D+
Sbjct: 127 GDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183
Query: 515 QTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT 557
R+ ++A E T +SDV+SFGV+L E++T
Sbjct: 184 VKRSKGRI--PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 9e-19
Identities = 66/208 (31%), Positives = 106/208 (50%), Gaps = 17/208 (8%)
Query: 362 FARENVIGEGGFG----CVYKGNLPEGKVVAVKQLKSG---SGQGEREFRAEVEIISRVH 414
F V+G+GGFG C + GK+ A K+L+ +GE E +I+ +V+
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRAT---GKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN 58
Query: 415 HRHLVSLVGYCISEKNRL-LIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAY 473
R +VSL Y K+ L L+ + +L+ H++ G P + + V A GL
Sbjct: 59 SRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLED 117
Query: 474 LHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEY 533
LH + +I++RD+K NIL+DD +++D GLA +T + RV GT GY+APE
Sbjct: 118 LHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-IRGRV-GTVGYMAPEV 172
Query: 534 ASSGKLTDRSDVFSFGVVLLELITGRKP 561
+ + T D + G ++ E+I G+ P
Sbjct: 173 VKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 1e-18
Identities = 63/204 (30%), Positives = 106/204 (51%), Gaps = 19/204 (9%)
Query: 368 IGEGGFGCVYKGN-LPEGKVVAVKQL-KSGSGQGEREFRAEVEIISRVHH-RHLVSLVGY 424
IG G G VYK G V+AVKQ+ ++G+ + + +++++ + H ++V GY
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGY 82
Query: 425 CISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRV--KIALGAAKGLAYLHEDCHPKI 482
I++ + + E + + L+ L P+ E + K+ + K L YL E H +
Sbjct: 83 FITDSDVFICMELM-STCLDKLLKRIQGPIPE---DILGKMTVAIVKALHYLKEK-H-GV 136
Query: 483 IHRDIKSANILVDDEFEAQVADFGLA-KLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTD 541
IHRD+K +NIL+D ++ DFG++ +L D ++ TR G Y+APE
Sbjct: 137 IHRDVKPSNILLDASGNVKLCDFGISGRLVD-SKAK--TRSAGCAAYMAPERIDPPDPNP 193
Query: 542 ----RSDVFSFGVVLLELITGRKP 561
R+DV+S G+ L+EL TG+ P
Sbjct: 194 KYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 1e-18
Identities = 63/203 (31%), Positives = 110/203 (54%), Gaps = 22/203 (10%)
Query: 365 ENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSG-SGQGEREFRAEVEIISRVHHRHLVSLV 422
+ ++G G G VYK +L +++AVK + + + +++ +E+EI+ + +++
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFY 65
Query: 423 GYCISEKNRLLI-YEFVPNNNLEHHLHGK-GQPVLEWTKRVKIALGAAKGLAYLHEDCHP 480
G E NR+ I EF+ +L+ ++ K + VL +IA+ KGL YL
Sbjct: 66 GAFFVE-NRISICTEFMDGGSLD--VYRKIPEHVLG-----RIAVAVVKGLTYLWS---L 114
Query: 481 KIIHRDIKSANILVDDEFEAQVADFGLAK--LNDTTQTHVSTRVMGTFGYLAPEYASSGK 538
KI+HRD+K +N+LV+ + ++ DFG++ +N +T+V GT Y+APE S +
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV-----GTNAYMAPERISGEQ 169
Query: 539 LTDRSDVFSFGVVLLELITGRKP 561
SDV+S G+ +EL GR P
Sbjct: 170 YGIHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 1e-18
Identities = 63/211 (29%), Positives = 106/211 (50%), Gaps = 31/211 (14%)
Query: 367 VIGEGGFGCVYKGNLPEGKV-VAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYC 425
V+G+G +G VY +V +A+K++ + + E+ + S + HR++V +G
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLG-S 73
Query: 426 ISEKNRLLIY-EFVPNNNLEHHLHGKGQPVLE-------WTKRVKIALGAAKGLAYLHED 477
SE I+ E VP +L L K P+ + +TK++ +GL YLH++
Sbjct: 74 DSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQI------LEGLKYLHDN 127
Query: 478 CHPKIIHRDIKSANILVDD-EFEAQVADFG----LAKLNDTTQTHVSTRVMGTFGYLAPE 532
+I+HRDIK N+LV+ +++DFG LA +N T+T GT Y+APE
Sbjct: 128 ---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT-----GTLQYMAPE 179
Query: 533 YASSGK--LTDRSDVFSFGVVLLELITGRKP 561
G +D++S G ++E+ TG+ P
Sbjct: 180 VIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 66/205 (32%), Positives = 105/205 (51%), Gaps = 11/205 (5%)
Query: 362 FARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSG---SGQGEREFRAEVEIISRVHHRH 417
F V+G+GGFG V + GK+ A K+L+ +GE E I+ +V+ R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 418 LVSLVGYCISEKNRL-LIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHE 476
+VSL Y K+ L L+ + +L+ H++ G P + + + A GL L
Sbjct: 62 VVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR 120
Query: 477 DCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASS 536
+ +I++RD+K NIL+DD +++D GLA +T V RV GT GY+APE ++
Sbjct: 121 E---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-VRGRV-GTVGYMAPEVINN 175
Query: 537 GKLTDRSDVFSFGVVLLELITGRKP 561
K T D + G ++ E+I G+ P
Sbjct: 176 EKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 2e-18
Identities = 67/220 (30%), Positives = 110/220 (50%), Gaps = 35/220 (15%)
Query: 362 FARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGERE------FRAEVEIISRVH 414
F + N IGEG +G VY+ + G++VA+K+++ ER+ R E+ ++ +
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRM---DNERDGIPISSLR-EITLLLNLR 64
Query: 415 HRHLVSL----VGYCISEKNRL----LIYEFVPNNNLEHHLHGKGQPVLEWTKRVK-IAL 465
H ++V L VG L L+ E+ +L L P E +VK + L
Sbjct: 65 HPNIVELKEVVVG------KHLDSIFLVMEYC-EQDLASLLDNMPTPFSE--SQVKCLML 115
Query: 466 GAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGT 525
+GL YLHE+ IIHRD+K +N+L+ D+ ++ADFGLA+ ++ +V+ T
Sbjct: 116 QLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-T 171
Query: 526 FGYLAPEYASSGKLTDRS-DVFSFGVVLLELITGRKPVDP 564
Y APE + D+++ G +L EL+ KP+ P
Sbjct: 172 LWYRAPELLLGCTTYTTAIDMWAVGCILAELLAH-KPLLP 210
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 58/217 (26%), Positives = 108/217 (49%), Gaps = 26/217 (11%)
Query: 368 IGEGGFGCVYKGNL-----PEGKVVAVKQLKS-GSGQGEREFRAEVEIISRVHHRHLVSL 421
+GE FG +YKG+L ++VA+K LK + Q EF+ E +++ +HH ++V L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 422 VGYCISEKNRLLIYEFVPNNNLEHHL---------------HGKGQPVLEWTKRVKIALG 466
+G E+ +++E++ +L L G + L+ + IA+
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 467 AAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK-LNDTTQTHVSTRVMGT 525
A G+ YL +H+D+ + NIL+ ++ +++D GL++ + V + +
Sbjct: 133 IAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 526 FGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKP 561
++ PE GK + SD++SFGVVL E+ + G +P
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 62/204 (30%), Positives = 108/204 (52%), Gaps = 17/204 (8%)
Query: 368 IGEGGFGCVYKG-NLPEGKVVAVKQLKSG--SGQGEREFRA---EVEIISRVHHRHLVSL 421
+G+G FG VY ++ G+ +AVKQ+ S + ++E A E++++ + H +V
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 422 VGYCISEKNRLLIY-EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHP 480
G C+ + L I+ E++P +++ L G + E R K +G+ YLH +
Sbjct: 70 YG-CLRDDETLSIFMEYMPGGSVKDQLKAYG-ALTETVTR-KYTRQILEGVEYLHSN--- 123
Query: 481 KIIHRDIKSANILVDDEFEAQVADFGLAKLNDT---TQTHVSTRVMGTFGYLAPEYASSG 537
I+HRDIK ANIL D ++ DFG +K T + T + + V GT +++PE S
Sbjct: 124 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS-VTGTPYWMSPEVISGE 182
Query: 538 KLTDRSDVFSFGVVLLELITGRKP 561
++DV+S G ++E++T + P
Sbjct: 183 GYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 64/239 (26%), Positives = 109/239 (45%), Gaps = 38/239 (15%)
Query: 368 IGEGGFGCVY--KGNLPEGKV---------------VAVKQLKSGSGQGER-EFRAEVEI 409
+GEG FG V+ + + + VAVK L+ + R +F EV+I
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72
Query: 410 ISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLH---------GKGQPVLEWTKR 460
+SR+ ++ L+G C + +I E++ N +L L L ++
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132
Query: 461 VKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGL---AKLNDTTQTH 517
+ +A A G+ YL +HRD+ + N LV + ++ADFG+ +D +
Sbjct: 133 LYMATQIASGMRYLES---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYR-- 187
Query: 518 VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVE 575
V R ++A E GK T +SDV++FGV L E++T R+ P + L D+ ++E
Sbjct: 188 VQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQ--PYEHLTDQQVIE 244
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 2e-18
Identities = 71/246 (28%), Positives = 119/246 (48%), Gaps = 40/246 (16%)
Query: 368 IGEGGFGCV---------------YKGNLPEGK--VVAVKQLKSGSGQGER-EFRAEVEI 409
+GEG FG V + N+ +G+ +VAVK L+ + + R +F EV+I
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 410 ISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNLE-----HHLHGKGQ------------ 452
+SR+ +++ L+G C+ E +I E++ N +L HHL K +
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132
Query: 453 PVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK-LN 511
P + ++ + +AL A G+ YL +HRD+ + N LV + ++ADFG+++ L
Sbjct: 133 PAISYSSLLHVALQIASGMKYLSS---LNFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189
Query: 512 DTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDE 571
+ R + ++A E GK T SDV++FGV L E++ K P L DE
Sbjct: 190 AGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE-QPYGELTDE 248
Query: 572 SLVEWA 577
++E A
Sbjct: 249 QVIENA 254
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 2e-18
Identities = 62/198 (31%), Positives = 102/198 (51%), Gaps = 6/198 (3%)
Query: 365 ENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGY 424
E +G G FG V+ + VAVK +K GS E F AE ++ + H LV L
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHA- 68
Query: 425 CISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIH 484
++++ +I EF+ +L L K + + A+G+A++ + + IH
Sbjct: 69 VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY---IH 125
Query: 485 RDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSD 544
RD+++ANILV ++ADFGLA++ + + + APE + G T +SD
Sbjct: 126 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 185
Query: 545 VFSFGVVLLELIT-GRKP 561
V+SFG++L+E++T GR P
Sbjct: 186 VWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 3e-18
Identities = 55/252 (21%), Positives = 91/252 (36%), Gaps = 4/252 (1%)
Query: 9 GPPVANNASSGLGERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAASP 68
P + + + P PA SP ++ + G S A +
Sbjct: 99 SPAREGSPTPPGPSSPDPPPPTPPPASPPPSPAPDLSEMLRPVGSPGPPPAASPPAAGAS 158
Query: 69 PPASPPPASPPPASPPPAASPPPGSPPPASPPPAS-GSASPPPASPPPTRSESQSSPPPG 127
P A A+ + P +SP + P+SPP S P ASP P R S S
Sbjct: 159 PAAVASDAASSRQAALPLSSPEETARAPSSPPAEPPPSTPPAAASPRPPRRSSPISASAS 218
Query: 128 DGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPSNP 187
+P + ++ + +S+ G ++ P P+ T +R + + + P
Sbjct: 219 SPAPAPGRSAADDAGASSSDSSSSESSGCGWGPENECPLPRPAPITLPTRIWEASGWNGP 278
Query: 188 GSPPSPSTSQSGTPSTPNENSSPNELSPPSNSKSPTSKSSPEESSSSSHSNSKKTPTSSS 247
S P P++S S S + S P+ S +S SSS S+S + +S S
Sbjct: 279 SSRPGPASSSSSPRERSPSPSPSSPGSGPAPSSPR---ASSSSSSSRESSSSSTSSSSES 335
Query: 248 GHSSDSTKGSSS 259
+ + G S
Sbjct: 336 SRGAAVSPGPSP 347
|
Length = 1352 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 3e-18
Identities = 60/220 (27%), Positives = 98/220 (44%), Gaps = 32/220 (14%)
Query: 361 GFARENVIGEGGFGCVYKG---NLPEGKVVAVKQLKSGSGQGE-------REFRAEVEII 410
+ E IG G +G VYK N +GK A+K+ K Q RE + ++
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACRE----IALL 56
Query: 411 SRVHHRHLVSLVGYCISEKNRL--LIYEFVPNNNLE---HHLHGKGQPVLEWTKRVKIAL 465
+ H ++VSLV + ++ L++++ ++ + H K + VK L
Sbjct: 57 RELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSM--VKSLL 114
Query: 466 -GAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQ----VADFGLAKL-NDTTQTHVS 519
G+ YLH + ++HRD+K ANILV E + + D GLA+L N +
Sbjct: 115 WQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLAD 171
Query: 520 -TRVMGTFGYLAPEYASSGK-LTDRSDVFSFGVVLLELIT 557
V+ T Y APE + T D+++ G + EL+T
Sbjct: 172 LDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 3e-18
Identities = 64/227 (28%), Positives = 114/227 (50%), Gaps = 27/227 (11%)
Query: 364 RENVIGEGGFGCVYKGN-LPEGKV----VAVKQLKSGSG-QGEREFRAEVEIISRVHHRH 417
+ ++G G FG V+KG +PEG VA+K ++ SG Q +E + + + H +
Sbjct: 11 KLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAY 70
Query: 418 LVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKG-----QPVLEWTKRVKIALGAAKGLA 472
+V L+G C +L + + P +L H+ Q +L W ++ AKG+
Sbjct: 71 IVRLLGICPGASLQL-VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI------AKGMY 123
Query: 473 YLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKL---NDTTQTHVSTRVMGTFGYL 529
YL E ++HR++ + NIL+ + Q+ADFG+A L +D + + + ++
Sbjct: 124 YLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDD--KKYFYSEHKTPIKWM 178
Query: 530 APEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVE 575
A E G+ T +SDV+S+GV + E+++ G +P +P L+E
Sbjct: 179 ALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE 225
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 3e-18
Identities = 73/228 (32%), Positives = 111/228 (48%), Gaps = 39/228 (17%)
Query: 354 ELMEITNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISR 412
EL+E VIGEG +G VYK + G++VA+K + E E + E I+ +
Sbjct: 9 ELVE---------VIGEGTYGKVYKARHKKTGQLVAIKIMDI-IEDEEEEIKEEYNILRK 58
Query: 413 V-HHRHLVSLVGYCISEKNRL------LIYEFVPNN---NLEHHLHGKGQPVLE-WTKRV 461
+H ++ + G I + L+ E +L L KG+ + E W
Sbjct: 59 YSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEW---- 114
Query: 462 KIAL---GAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHV 518
IA +GLAYLHE+ K+IHRDIK NIL+ E ++ DFG++ D+T
Sbjct: 115 -IAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRR 170
Query: 519 STRVMGTFGYLAPEYASSGKLTD-----RSDVFSFGVVLLELITGRKP 561
+T + GT ++APE + + D RSDV+S G+ +EL G+ P
Sbjct: 171 NTFI-GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.9 bits (211), Expect = 4e-18
Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 50/216 (23%)
Query: 368 IGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRA--------EVEIISRV-HHRH 417
+G+G FG VY N G++VA+K++K ++F + EV+ + ++ H +
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMK-------KKFYSWEECMNLREVKSLRKLNEHPN 59
Query: 418 LVSL--VGYCISEKNRL-LIYEFVPNNNLEHHLHGKGQPVLEWTKRVK-IALGAAKGLAY 473
+V L V E + L ++E++ N + KG+P E ++ I +GLA+
Sbjct: 60 IVKLKEV---FRENDELYFVFEYMEGNLYQLMKDRKGKPFSE--SVIRSIIYQILQGLAH 114
Query: 474 LHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK---LNDTTQTHVSTRVMGTFGYLA 530
+H+ H HRD+K N+LV ++ADFGLA+ +VSTR Y A
Sbjct: 115 IHK--H-GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTR-----WYRA 166
Query: 531 PE-------YASSGKLTDRSDVFSFGVVLLELITGR 559
PE Y+S D+++ G ++ EL T R
Sbjct: 167 PEILLRSTSYSSP------VDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 4e-18
Identities = 66/243 (27%), Positives = 111/243 (45%), Gaps = 32/243 (13%)
Query: 350 FTYEELMEITNGFARENVIGEGGFGCVY----KGNLPEGK--VVAVKQLKSGSGQG-ERE 402
F L EIT +G G FG V+ KG EG +V VK L+ + + E
Sbjct: 2 FPRSNLQEIT-------TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSE 54
Query: 403 FRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHL--------HGKGQPV 454
FR E+++ ++ H+++V L+G C + +I E+ +L+ L K P
Sbjct: 55 FRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPP- 113
Query: 455 LEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK--LND 512
L ++V + A G+ +L + +HRD+ + N LV + E +V+ L+K N
Sbjct: 114 LSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNS 170
Query: 513 TTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDES 572
+ + +LAPE + +SDV+SFGV++ E+ T + P L DE
Sbjct: 171 EYYKLRNALI--PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT--QGELPFYGLSDEE 226
Query: 573 LVE 575
++
Sbjct: 227 VLN 229
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 4e-18
Identities = 60/215 (27%), Positives = 112/215 (52%), Gaps = 32/215 (14%)
Query: 366 NVIGEGGFGCVYKGNLPEGKV---VAVKQLKSGSGQGE-REFRAEVEIISRV-HHRHLVS 420
+VIGEG FG V K + + + A+K++K + + + R+F E+E++ ++ HH ++++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 421 LVGYCISEKNRLLIY---EFVPNNNLEHHL---------------HGKGQPVLEWTKRVK 462
L+G C ++R +Y E+ P+ NL L + L + +
Sbjct: 61 LLGAC---EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS-TLSSQQLLH 116
Query: 463 IALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRV 522
A A+G+ YL + + IHRD+ + NILV + + A++ADFGL++ + R+
Sbjct: 117 FAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL 173
Query: 523 MGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT 557
++A E + T SDV+S+GV+L E+++
Sbjct: 174 --PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 5e-18
Identities = 62/205 (30%), Positives = 105/205 (51%), Gaps = 11/205 (5%)
Query: 362 FARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSG---SGQGEREFRAEVEIISRVHHRH 417
F + V+G+GGFG V + GK+ A K+L+ +GE E +I+ +V+ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 418 LVSLVGYCISEKNRL-LIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHE 476
+V+L Y K+ L L+ + +L+ H++ G P E + + A GL LH
Sbjct: 62 VVNL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR 120
Query: 477 DCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASS 536
+ ++RD+K NIL+DD +++D GLA + + RV GT GY+APE ++
Sbjct: 121 E---NTVYRDLKPENILLDDYGHIRISDLGLA-VKIPEGESIRGRV-GTVGYMAPEVLNN 175
Query: 537 GKLTDRSDVFSFGVVLLELITGRKP 561
+ T D + G ++ E+I G+ P
Sbjct: 176 QRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 5e-18
Identities = 69/282 (24%), Positives = 123/282 (43%), Gaps = 43/282 (15%)
Query: 359 TNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLK----SGSGQGEREFRAEVEIISRV 413
F E IG+G F VYK L +G+VVA+K+++ + + + E++++ ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK-EIDLLKQL 59
Query: 414 HHRHLVSLVGYCISEKNRLLIYEFVPNNNLEH---HLHGKGQPVLE---WTKRVKIALGA 467
H +++ + I ++ E +L H + + + E W V++
Sbjct: 60 DHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC--- 116
Query: 468 AKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKL--NDTTQTHVSTRVMGT 525
L ++H +I+HRDIK AN+ + ++ D GL + + TT H ++GT
Sbjct: 117 -SALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH---SLVGT 169
Query: 526 FGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDE-SLVEWARPVLVRA 584
Y++PE +SD++S G +L E+ + P GD+ +L L +
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY-----GDKMNLYS-----LCKK 219
Query: 585 IETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRP 626
IE D P HY SE R + + C+ KRP
Sbjct: 220 IEKCDYP----PLPADHY--SEELR--DLVSRCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 5e-18
Identities = 66/212 (31%), Positives = 111/212 (52%), Gaps = 27/212 (12%)
Query: 367 VIGEGGFGCVYKGN-LPEGK----VVAVKQLKSG-SGQGEREFRAEVEIISRVHHRHLVS 420
V+G G FG VYKG +P+G+ VA+K L+ S + +E E +++ V ++
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 421 LVGYCISEKNRLLIYEFVPNNNL-----EHHLHGKGQPVLEWTKRVKIALGAAKGLAYLH 475
L+G C++ +L + + +P L E+ Q +L W ++ AKG++YL
Sbjct: 74 LLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYLE 126
Query: 476 EDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVST---RVMGTFGYLAPE 532
E +++HRD+ + N+LV ++ DFGLA+L D +T +V ++A E
Sbjct: 127 E---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKV--PIKWMALE 181
Query: 533 YASSGKLTDRSDVFSFGVVLLELIT-GRKPVD 563
+ T +SDV+S+GV + EL+T G KP D
Sbjct: 182 SILHRRFTHQSDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 8e-18
Identities = 61/260 (23%), Positives = 94/260 (36%), Gaps = 7/260 (2%)
Query: 4 SAETPGPPVANNASSGLGERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTT 63
+P P A + S + P PA + +D ++ ++
Sbjct: 122 PPASPPPSPAPDLSE---MLRPVGSPGPPPAASPPAAGASPAAVASDAASSRQAALPLSS 178
Query: 64 PAASPPPASPPPASPPPASPPPAASPPPGSP-PPASPPPASGSASPPPASPPPTRSESQS 122
P + S PPA PPP++PP AASP P P S +S + +P ++ + S
Sbjct: 179 PEETARAPSSPPAEPPPSTPPAAASPRPPRRSSPISASASSPAPAPGRSAADDAGASSSD 238
Query: 123 SPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWA 182
S G PE P P T + S+ ++ +
Sbjct: 239 SSSSESSGCGWGPENECPLPRPAPITLPTRIWEASGWNGPSSRPGPASSSSSPRERSPSP 298
Query: 183 PPSNPGSPPSPST---SQSGTPSTPNENSSPNELSPPSNSKSPTSKSSPEESSSSSHSNS 239
PS+PGS P+PS+ S S + S + +SS + S S + + SP S S S
Sbjct: 299 SPSSPGSGPAPSSPRASSSSSSSRESSSSSTSSSSESSRGAAVSPGPSPSRSPSPSRPPP 358
Query: 240 KKTPTSSSGHSSDSTKGSSS 259
P+S S SS
Sbjct: 359 PADPSSPRKRPRPSRAPSSP 378
|
Length = 1352 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 8e-18
Identities = 67/210 (31%), Positives = 97/210 (46%), Gaps = 30/210 (14%)
Query: 367 VIGEGGFGCV----YKGNLPEGKVVAVKQLKSGS--GQGERE-FRAE---VEIISRVHHR 416
V+G G FG V YK G++ A+K LK G + E E E E + H
Sbjct: 6 VLGRGHFGKVLLAEYK---KTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHP 62
Query: 417 HLVSLVGYCISEKNRL-LIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLH 475
LV+L C ++ + + E+ +L H+H V + V A GL YLH
Sbjct: 63 FLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIH---TDVFSEPRAVFYAACVVLGLQYLH 118
Query: 476 EDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLN----DTTQTHVSTRVMGTFGYLAP 531
E+ KI++RD+K N+L+D E ++ADFGL K D T T GT +LAP
Sbjct: 119 EN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFC-----GTPEFLAP 170
Query: 532 EYASSGKLTDRSDVFSFGVVLLELITGRKP 561
E + T D + GV++ E++ G P
Sbjct: 171 EVLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 8e-18
Identities = 57/192 (29%), Positives = 95/192 (49%), Gaps = 18/192 (9%)
Query: 384 GKVVAVKQLKSGSGQGERE---FRAEVEIISRVHHRHLVSLVGYCISEKNRLL-IYEFVP 439
G VA+K L++ + + E + FR E + +R++H ++V+L+ + L ++E+VP
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 440 NNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILV---DD 496
L L G L + ++ L LA H I+HRD+K NI+V
Sbjct: 63 GRTLREVLAADG--ALPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQTGV 117
Query: 497 EFEAQVADFGLAKL------NDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGV 550
A+V DFG+ L D +T V+GT Y APE +T SD++++G+
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGL 177
Query: 551 VLLELITGRKPV 562
+ LE +TG++ V
Sbjct: 178 IFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 1e-17
Identities = 69/238 (28%), Positives = 118/238 (49%), Gaps = 55/238 (23%)
Query: 357 EITNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGERE------FRAEVEI 409
+ + + + IG+G FG V+K + ++VA+K++ + E+E R E++I
Sbjct: 9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMEN---EKEGFPITALR-EIKI 64
Query: 410 ISRVHHRHLVSLVGYCISEK---NR-----LLIYEFVPNNNLEHHLHGKGQPVLEWTKRV 461
+ + H ++V+L+ C ++ NR L++EF EH L G L K V
Sbjct: 65 LQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFC-----EHDLAG-----LLSNKNV 114
Query: 462 KIALGAAK--------GLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK---L 510
K L K GL Y+H + KI+HRD+K+ANIL+ + ++ADFGLA+ L
Sbjct: 115 KFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSL 171
Query: 511 NDTTQTH-VSTRVMGTFGYLAPEYASSGKLTDRS-----DVFSFGVVLLELITGRKPV 562
+ ++ + + RV+ T Y PE L +R D++ G ++ E+ T R P+
Sbjct: 172 SKNSKPNRYTNRVV-TLWYRPPELL----LGERDYGPPIDMWGAGCIMAEMWT-RSPI 223
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 2e-17
Identities = 67/223 (30%), Positives = 107/223 (47%), Gaps = 45/223 (20%)
Query: 368 IGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGERE------FRAEVEIISRVHHRHLVS 420
+GEG FG VYK + G+VVA+K++ + E++ R E++I+ ++ H ++V
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHN---EKDGFPITALR-EIKILKKLKHPNVVP 71
Query: 421 LVGYCISE-----KNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAK------ 469
L+ + + R +Y P ++H L G +LE VK+ K
Sbjct: 72 LIDMAVERPDKSKRKRGSVYMVTPY--MDHDLSG----LLE-NPSVKLTESQIKCYMLQL 124
Query: 470 --GLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLND----------TTQTH 517
G+ YLHE+ I+HRDIK+ANIL+D++ ++ADFGLA+ D T
Sbjct: 125 LEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTR 181
Query: 518 VSTRVMGTFGYLAPEY-ASSGKLTDRSDVFSFGVVLLELITGR 559
T ++ T Y PE + T D++ G V E+ T R
Sbjct: 182 KYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 60/218 (27%), Positives = 106/218 (48%), Gaps = 35/218 (16%)
Query: 367 VIGEGGFGCVYK-GNLPEGKVVAVKQLKSGSGQGEREFRA--EVEIISRVHHRHLVSLVG 423
++GEG +G V K + G++VA+K+ + A E+ ++ ++ H +LV+L+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 424 YCISEKNRLLIYEFVPN---NNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHP 480
+K L++EFV + ++LE + +G L+ ++ K +G+ + H
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDLEKYPNG-----LDESRVRKYLFQILRGIEFCHSH--- 119
Query: 481 KIIHRDIKSANILVDDEFEAQVADFGLAKL----NDTTQTHVSTRVMGTFGYLAPEY--- 533
IIHRDIK NILV ++ DFG A+ + +V+TR Y APE
Sbjct: 120 NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATR-----WYRAPELLVG 174
Query: 534 -ASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGD 570
G+ D+++ G ++ E++TG +P P GD
Sbjct: 175 DTKYGRAV---DIWAVGCLVTEMLTG----EPLFP-GD 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 61/207 (29%), Positives = 103/207 (49%), Gaps = 11/207 (5%)
Query: 368 IGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGERE-FRAEVEIISRVHHRHLVSLVGYCI 426
+G+G FG VYK E V+A ++ + E E + E++I++ H ++V L+
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 427 SEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRD 486
E N ++ EF ++ + +P+ E RV + + L YLHE+ KIIHRD
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRV-VCKQTLEALNYLHEN---KIIHRD 128
Query: 487 IKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDR---- 542
+K+ NIL + + ++ADFG++ N T + +GT ++APE DR
Sbjct: 129 LKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS-FIGTPYWMAPEVVMCETSKDRPYDY 187
Query: 543 -SDVFSFGVVLLELITGRKPVDPTQPL 568
+DV+S G+ L+E+ P P+
Sbjct: 188 KADVWSLGITLIEMAQIEPPHHELNPM 214
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 66/213 (30%), Positives = 103/213 (48%), Gaps = 20/213 (9%)
Query: 366 NVIGEGGFGCVYKG------NLPEGKVVAVKQL-KSGSGQGEREFRAEVEIISRVHHRHL 418
+G G FG VY+G VAVK L +S S Q E +F E I+S+ +H+++
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 419 VSLVGYCISEKNRLLIYEFVPNNNLEHHL-HGKGQPV----LEWTKRVKIALGAAKGLAY 473
V L+G R ++ E + +L+ L + +P L + A AKG Y
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 474 LHEDCHPKIIHRDIKSANILVDDEFE---AQVADFGLAK-LNDTTQTHVSTRVMGTFGYL 529
L E+ IHRDI + N L+ + A++ADFG+A+ + + R M ++
Sbjct: 132 LEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWM 188
Query: 530 APEYASSGKLTDRSDVFSFGVVLLELIT-GRKP 561
PE G T ++DV+SFGV+L E+ + G P
Sbjct: 189 PPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP 221
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 63/226 (27%), Positives = 114/226 (50%), Gaps = 23/226 (10%)
Query: 368 IGEGGFGCVYKGNL-------PEGKVVAVKQLKSGSGQGER-EFRAEVEIISRVHHRHLV 419
+G+G FG VY+GN E +V AVK + + ER EF E ++ H+V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRV-AVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 420 SLVGYCISEKNRLLIYEFVPNNNLEHHL--------HGKGQPVLEWTKRVKIALGAAKGL 471
L+G + L++ E + + +L+ +L + G+P + +++A A G+
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 472 AYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK-LNDTTQTHVSTRVMGTFGYLA 530
AYL+ K +HRD+ + N +V +F ++ DFG+ + + +T + + ++A
Sbjct: 133 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 189
Query: 531 PEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEW 576
PE G T SD++SFGVVL E+ + + P Q L +E ++++
Sbjct: 190 PESLKDGVFTTSSDMWSFGVVLWEITSLAE--QPYQGLSNEQVLKF 233
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 65/213 (30%), Positives = 109/213 (51%), Gaps = 23/213 (10%)
Query: 362 FAREN-----VIGEGGFGCVYK----GNLPEGKV--VAVKQLKSGSGQGERE-FRAEVEI 409
F R N +G G FG V + G V VAVK LK + ERE +E++I
Sbjct: 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKI 91
Query: 410 ISRV-HHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAA 468
+S + +H ++V+L+G C L+I E+ +L + L K + L + + A
Sbjct: 92 MSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVA 151
Query: 469 KGLAYL-HEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK--LNDTTQ-THVSTRVMG 524
KG+A+L ++C IHRD+ + N+L+ ++ DFGLA+ +ND+ + R+
Sbjct: 152 KGMAFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL-- 205
Query: 525 TFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT 557
++APE + T SDV+S+G++L E+ +
Sbjct: 206 PVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 3e-17
Identities = 69/287 (24%), Positives = 94/287 (32%), Gaps = 32/287 (11%)
Query: 2 ANSAETPGPPVANNASSGLGERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNS 61
A T GPP ++ P + PAD +
Sbjct: 2758 ARPPTTAGPPAPAPPAAPAAGPPRRLTRPAVASLSESRESLPSPWDPADPPAAVLAPAAA 2817
Query: 62 TTPAASPPPASPPPASPPPASPPPAASPPPGS----------------PPPASPPPASGS 105
PAASP PPP S P +PPP PPP S PP SP +
Sbjct: 2818 LPPAASPAGPLPPPTSAQPTAPPPPPGPPPPSLPLGGSVAPGGDVRRRPPSRSPAAKPAA 2877
Query: 106 ASPPPAS----PPPTRS-ESQSSPPPGDGGASPP--PEQSKNSPPAPPGQASTPPDSPPP 158
+ PP P +RS ES + PP P P + P PP PP PPP
Sbjct: 2878 PARPPVRRLARPAVSRSTESFALPPDQPERPPQPQAPPPPQPQPQPPPPPQPQPPPPPPP 2937
Query: 159 GIQSN---QGNPVPSNGTTDSRDTKWAPPSNPGSPPSPSTSQSGTPSTPNENSSPNELSP 215
Q +P + + + W PG P + P+ E + S
Sbjct: 2938 RPQPPLAPTTDPAGAGEPSGAVPQPWLGALVPGRVAVPRF-RVPQPAPSREAPAS---ST 2993
Query: 216 PSNSKSPTSKSSPEESSSSSHSNSKKTPTS--SSGHSSDSTKGSSSN 260
P + S+ S SS + H + P S + D T+ S ++
Sbjct: 2994 PPLTGHSLSRVSSWASSLALHEETDPPPVSLKQTLWPPDDTEDSDAD 3040
|
Length = 3151 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 5e-17
Identities = 62/212 (29%), Positives = 106/212 (50%), Gaps = 30/212 (14%)
Query: 367 VIGEGGFGCVYKGNLPEGK------VVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVS 420
IGEG FG +Y L + K V+ L + + + EV +++++ H ++V+
Sbjct: 7 KIGEGSFGKIY---LAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVT 63
Query: 421 LVGYCISEKNRLLIY-------EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAY 473
E RL I + + N + + +L W V+I+LG L +
Sbjct: 64 FFA-SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWF--VQISLG----LKH 116
Query: 474 LHEDCHPKIIHRDIKSANI-LVDDEFEAQVADFGLAK-LNDTTQTHVSTRVMGTFGYLAP 531
+H+ KI+HRDIKS NI L + A++ DFG+A+ LND+ + ++ +GT YL+P
Sbjct: 117 IHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME--LAYTCVGTPYYLSP 171
Query: 532 EYASSGKLTDRSDVFSFGVVLLELITGRKPVD 563
E + +++D++S G VL EL T + P +
Sbjct: 172 EICQNRPYNNKTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 6e-17
Identities = 71/243 (29%), Positives = 117/243 (48%), Gaps = 13/243 (5%)
Query: 362 FARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGERE-FRAEVEIISRVHHRHLV 419
F + IG+G FG V+KG + KVVA+K + + E E + E+ ++S+ ++
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 420 SLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQP-VLEWTKRVKIALGAAKGLAYLHEDC 478
G + + +I E++ + L +P L+ T+ I KGL YLH +
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHSE- 120
Query: 479 HPKIIHRDIKSANILVDDEFEAQVADFGLA-KLNDTTQTHVSTRVMGTFGYLAPEYASSG 537
K IHRDIK+AN+L+ + E ++ADFG+A +L DT +GT ++APE
Sbjct: 121 --KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPEVIKQS 176
Query: 538 KLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPR 597
++D++S G+ +EL G P P+ L+ P + + L E V+
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEAC 236
Query: 598 LEK 600
L K
Sbjct: 237 LNK 239
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 60/208 (28%), Positives = 107/208 (51%), Gaps = 13/208 (6%)
Query: 368 IGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCI 426
+G+G FG VYK N G + A K +++ S + ++ E+EI++ +H ++V L+G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 427 SEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRD 486
+ ++ EF P ++ + + + E +V I + L YLH KIIHRD
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-ICRQMLEALQYLHSM---KIIHRD 135
Query: 487 IKSANILVDDEFEAQVADFGL-AKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTD---- 541
+K+ N+L+ + + ++ADFG+ AK T Q S +GT ++APE + D
Sbjct: 136 LKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS--FIGTPYWMAPEVVMCETMKDTPYD 193
Query: 542 -RSDVFSFGVVLLELITGRKPVDPTQPL 568
++D++S G+ L+E+ P P+
Sbjct: 194 YKADIWSLGITLIEMAQIEPPHHELNPM 221
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-16
Identities = 72/241 (29%), Positives = 114/241 (47%), Gaps = 9/241 (3%)
Query: 362 FARENVIGEGGFGCVYKGNLPEGK-VVAVKQLKSGSGQGERE-FRAEVEIISRVHHRHLV 419
F + IG+G FG VYKG K VVA+K + + E E + E+ ++S+ ++
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 420 SLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCH 479
G + +I E++ + L K P LE T I KGL YLH +
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLL--KPGP-LEETYIATILREILKGLDYLHSE-- 120
Query: 480 PKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKL 539
+ IHRDIK+AN+L+ ++ + ++ADFG+A TQ +T V GT ++APE
Sbjct: 121 -RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAY 178
Query: 540 TDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLE 599
++D++S G+ +EL G P P+ L+ P + + E V+ L
Sbjct: 179 DFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLN 238
Query: 600 K 600
K
Sbjct: 239 K 239
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 61/209 (29%), Positives = 108/209 (51%), Gaps = 26/209 (12%)
Query: 368 IGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGERE------FRAEVEIISRVHHRHLVS 420
IGEG +G VYK + G++VA+K+++ + E E R E+ ++ ++H ++V
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRL---ETEDEGVPSTAIR-EISLLKELNHPNIVR 62
Query: 421 LVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHP 480
L+ SE L++EF+ + +L+ ++ L+ +G+AY CH
Sbjct: 63 LLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAY----CHS 117
Query: 481 -KIIHRDIKSANILVDDEFEAQVADFGLAK---LNDTTQTHVSTRVMGTFGYLAPEYASS 536
+++HRD+K N+L+D E ++ADFGLA+ + T TH V+ T Y APE
Sbjct: 118 HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH---EVV-TLWYRAPEILLG 173
Query: 537 GKLTDRS-DVFSFGVVLLELITGRKPVDP 564
+ D++S G + E++ R+P+ P
Sbjct: 174 SRQYSTPVDIWSIGCIFAEMVN-RRPLFP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|237057 PRK12323, PRK12323, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 2e-16
Identities = 48/232 (20%), Positives = 68/232 (29%), Gaps = 26/232 (11%)
Query: 2 ANSAETPGPPVANNASSGLGERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNS 61
A A PVA A + PA +P
Sbjct: 372 AGPATAAAAPVAQPAPAAAAPAAAAPAPAAPPAAPAAAPAAAAAARA------------- 418
Query: 62 TTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQ 121
AA+P SP P + A A P P +P A +A+ P A+ P + +
Sbjct: 419 --VAAAPARRSPAPEALAAARQASARGPGGAPAPAPAPAAAPAAAARPAAAGPRPVAAAA 476
Query: 122 SSPPPGDGGASPPPEQSKNSPP---APPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRD 178
++ P A+ P + PP PP AS P P +P T D D
Sbjct: 477 AAAPARAAPAAAPAPADDDPPPWEELPPEFASPAPAQPDAAPAGWVAESIPDPATADPDD 536
Query: 179 TKWAPPSNPGSPPSPSTSQSGTPSTPNENSSPNELSPPSNSKSPTSKSSPEE 230
P + P+P + + P PP S S +
Sbjct: 537 AFETLAPAPAAAPAPRAAAATEPVVAP--------RPPRASASGLPDMFDGD 580
|
Length = 700 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 2e-16
Identities = 60/200 (30%), Positives = 102/200 (51%), Gaps = 13/200 (6%)
Query: 368 IGEGGFGCVYKGNLPE-GKVVAVKQL---KSGSGQGEREFRAEVEIISRVHHRHLVSLVG 423
+G+GGFG V + GK+ A K+L + GE+ E EI+ +V+ +V+L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-A 59
Query: 424 YCISEKNRL-LIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKI 482
Y K L L+ + +L++H++ G+ LE + + + G+ +LH I
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDI 116
Query: 483 IHRDIKSANILVDDEFEAQVADFGLA-KLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTD 541
++RD+K N+L+DD+ +++D GLA +L D T+ GT GY+APE +
Sbjct: 117 VYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI---TQRAGTNGYMAPEILKEEPYSY 173
Query: 542 RSDVFSFGVVLLELITGRKP 561
D F+ G + E++ GR P
Sbjct: 174 PVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 69/232 (29%), Positives = 112/232 (48%), Gaps = 50/232 (21%)
Query: 352 YEELMEITNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLK-SGSGQGE-----REFR 404
YEEL IGEG +G VYK +L G+ VA+K+++ S +G RE
Sbjct: 1 YEEL----------AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREI- 49
Query: 405 AEVEIISRVHHRHLVSLVGYCISEKNRL-------LIYEFVPNNNLEHHLHGKGQPVLEW 457
A ++ + H ++V L + R L++E V + +L +L +P L
Sbjct: 50 ALLKQLESFEHPNIVRL--LDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLP- 105
Query: 458 TKRVK-IALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQT 516
+ +K + +G+ +LH H +I+HRD+K NILV + + ++ADFGLA++
Sbjct: 106 PETIKDLMRQLLRGVDFLH--SH-RIVHRDLKPQNILVTSDGQVKIADFGLARIYS---F 159
Query: 517 HVS-TRVMGTFGYLAPE------YASSGKLTDRSDVFSFGVVLLELITGRKP 561
++ T V+ T Y APE YA+ D++S G + EL R+P
Sbjct: 160 EMALTSVVVTLWYRAPEVLLQSSYATP------VDMWSVGCIFAELFR-RRP 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 2e-16
Identities = 57/218 (26%), Positives = 96/218 (44%), Gaps = 43/218 (19%)
Query: 366 NVIGEGGFGCVYKG-NLPEGKVVAVKQLK---SGSGQGEREFRAEVEIISRVHHRHLVSL 421
IG G +G V + G+ VA+K++ +R R E++++ + H +++ L
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR-EIKLLRHLRHENIIGL 64
Query: 422 VGYCISEKNRLLIYEFVPNNN--------LEHHLHG---KGQPVLEWTKRVK-IALGAAK 469
+L + N +E LH QP+ + ++ +
Sbjct: 65 --------LDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTD--DHIQYFLYQILR 114
Query: 470 GLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQT-------HVSTRV 522
GL YLH +IHRD+K +NILV+ + ++ DFGLA+ D + +V TR
Sbjct: 115 GLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRW 171
Query: 523 MGTFGYLAPE-YASSGKLTDRSDVFSFGVVLLELITGR 559
Y APE SS + T D++S G + EL+T +
Sbjct: 172 -----YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 3e-16
Identities = 60/249 (24%), Positives = 81/249 (32%), Gaps = 20/249 (8%)
Query: 2 ANSAETPGPPVANNASSGLGERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNS 61
A ++ P P A +G A PP P +P V+ P +
Sbjct: 2674 AQASSPPQRPRRRAARPTVGSLTSLADPPPPPPTPEPAPHALVSATPLPPGPAAARQASP 2733
Query: 62 TTPAASPPPASP----------PPASPPPASPPPAASPP---PGSPPPASPPPASGSASP 108
PAA PPA P PA PP + PPA +PP PP PA S S
Sbjct: 2734 ALPAAPAPPAVPAGPATPGGPARPARPPTTAGPPAPAPPAAPAAGPPRRLTRPAVASLSE 2793
Query: 109 PPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPPG---QASTPPDSPPPGIQSNQG 165
S P + A+ PP S P PP + PP PP G
Sbjct: 2794 SRESLPSPWDPADPPAAVLAPAAALPPAASPAGPLPPPTSAQPTAPPPPPGPPPPSLPLG 2853
Query: 166 NPVPSNGTTDSRDTKWAPPSNPGSPPSPSTSQSGTPSTPNENSS----PNELSPPSNSKS 221
V G R +P + P +P P + P+ S P++ P ++
Sbjct: 2854 GSVAPGGDVRRRPPSRSPAAKPAAPARPPVRRLARPAVSRSTESFALPPDQPERPPQPQA 2913
Query: 222 PTSKSSPEE 230
P +
Sbjct: 2914 PPPPQPQPQ 2922
|
Length = 3151 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 3e-16
Identities = 64/204 (31%), Positives = 101/204 (49%), Gaps = 24/204 (11%)
Query: 368 IGEGGFGCVY-KGNLPEGKVVAVKQLKSGSGQGEREFR---AEVEIISRVHHRHLVSLVG 423
IG G FG VY N +VVAVK++ Q +++ EV+ + ++ H + + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 424 YCISEKNRLLIYEFV---PNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHP 480
+ E L+ E+ ++ LE H + L+ + I GA +GLAYLH
Sbjct: 89 CYLKEHTAWLVMEYCLGSASDLLEVH-----KKPLQEVEIAAITHGALQGLAYLHSHN-- 141
Query: 481 KIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEY---ASSG 537
+IHRDIK+ NIL+ + + ++ADFG A + + V GT ++APE G
Sbjct: 142 -MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAMDEG 195
Query: 538 KLTDRSDVFSFGVVLLELITGRKP 561
+ + DV+S G+ +EL RKP
Sbjct: 196 QYDGKVDVWSLGITCIEL-AERKP 218
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 4e-16
Identities = 61/209 (29%), Positives = 103/209 (49%), Gaps = 9/209 (4%)
Query: 362 FARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGERE-FRAEVEIISRVHHRHLV 419
F + IG+G FG V+KG + +VVA+K + + E E + E+ ++S+ ++
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 420 SLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCH 479
G + +I E++ + L + +K L KGL YLH +
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL---KGLDYLHSE-- 120
Query: 480 PKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKL 539
K IHRDIK+AN+L+ ++ + ++ADFG+A TQ +T V GT ++APE
Sbjct: 121 -KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSAY 178
Query: 540 TDRSDVFSFGVVLLELITGRKPVDPTQPL 568
++D++S G+ +EL G P P+
Sbjct: 179 DSKADIWSLGITAIELAKGEPPNSDMHPM 207
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 4e-16
Identities = 59/206 (28%), Positives = 105/206 (50%), Gaps = 21/206 (10%)
Query: 362 FARENVIGEGGFG-CVYKGNLPEGKVVAVKQLK-SGSGQGER-EFRAEVEIISRVHHRHL 418
+ + IGEG FG + + +GK +K++ S ER E R EV ++S + H ++
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61
Query: 419 VSLVGYCISEKNRLLIYEFVPNNNLEHHLHG-KGQP-----VLEWTKRVKIALGAAKGLA 472
V N ++ ++ +L ++ +G +L+W V+I L L
Sbjct: 62 VQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWF--VQICLA----LK 115
Query: 473 YLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK-LNDTTQTHVSTRVMGTFGYLAP 531
++H+ KI+HRDIKS NI + + ++ DFG+A+ LN T + ++ +GT YL+P
Sbjct: 116 HVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE--LARTCIGTPYYLSP 170
Query: 532 EYASSGKLTDRSDVFSFGVVLLELIT 557
E + ++SD+++ G VL E+ T
Sbjct: 171 EICENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 4e-16
Identities = 65/217 (29%), Positives = 94/217 (43%), Gaps = 41/217 (18%)
Query: 367 VIGEGGFGCV----YKGNLPEGKVVAVKQLKSG---------SGQGEREFRAEVEIISRV 413
V+G+G FG V KG ++ AVK LK E+ A
Sbjct: 2 VLGKGSFGKVLLAELKGT---DELYAVKVLKKDVILQDDDVECTMTEKRVLALAG----- 53
Query: 414 HHRHLVSLVGYCISEKNRL-LIYEFVPNNNLEHHLHGKGQPVLEWTK--RVKIALGAAKG 470
H L L C K+RL + E+V +L H+ G+ + +I LG
Sbjct: 54 KHPFLTQLHS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLG---- 108
Query: 471 LAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLN----DTTQTHVSTRVMGTF 526
L +LHE II+RD+K N+L+D E ++ADFG+ K TT T GT
Sbjct: 109 LQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC-----GTP 160
Query: 527 GYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVD 563
Y+APE S D ++ GV+L E++ G+ P +
Sbjct: 161 DYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFE 197
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 4e-16
Identities = 58/206 (28%), Positives = 105/206 (50%), Gaps = 22/206 (10%)
Query: 368 IGEGGFGCVYKG---NLPEGKVVAVKQLKSGSGQG--EREFRAEVEIISRVHHRHLVSLV 422
+G G FG V KG K VAVK LK+ + + E E ++ ++ + ++V ++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 423 GYCISEKNRLLIYEFVP----NNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDC 478
G C +E + +L+ E N L+ + H + + E +V + G+ YL E
Sbjct: 63 GICEAE-SWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSM------GMKYLEET- 114
Query: 479 HPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTF--GYLAPEYASS 536
+HRD+ + N+L+ + A+++DFGL+K + + + G + + APE +
Sbjct: 115 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNY 172
Query: 537 GKLTDRSDVFSFGVVLLELIT-GRKP 561
K + +SDV+SFGV++ E + G+KP
Sbjct: 173 YKFSSKSDVWSFGVLMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 5e-16
Identities = 61/209 (29%), Positives = 111/209 (53%), Gaps = 14/209 (6%)
Query: 368 IGEGGFGCVYKGNLP-EGKVVAVKQLKSGSGQGE--REFRAEVEIISRVHHRHLVSLVGY 424
+GEG + V+KG +VA+K+++ +G R EV ++ + H ++V+L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTLHDI 71
Query: 425 CISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIAL-GAAKGLAYLHEDCHPKII 483
+E+ L++E++ +++L+ +L G L VKI + +GL+Y H KI+
Sbjct: 72 IHTERCLTLVFEYL-DSDLKQYLDNCGN--LMSMHNVKIFMFQLLRGLSYCH---KRKIL 125
Query: 484 HRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPE-YASSGKLTDR 542
HRD+K N+L++++ E ++ADFGLA+ S V+ T Y P+ S + +
Sbjct: 126 HRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTEYSTP 184
Query: 543 SDVFSFGVVLLELITGRKPVDPTQPLGDE 571
D++ G +L E+ TGR P+ P + +E
Sbjct: 185 IDMWGVGCILYEMATGR-PMFPGSTVKEE 212
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 78.8 bits (195), Expect = 5e-16
Identities = 64/227 (28%), Positives = 115/227 (50%), Gaps = 53/227 (23%)
Query: 362 FARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGERE------FRAEVEIISRVH 414
+ + N I EG +G VY+ + G++VA+K+LK E+E R E+ I+ ++
Sbjct: 7 YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEK---EKEGFPITSLR-EINILLKLQ 62
Query: 415 HRHLVSL----VGYCISEKNRL-LIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAK 469
H ++V++ VG S +++ ++ E+V EH L ++E T + K
Sbjct: 63 HPNIVTVKEVVVG---SNLDKIYMVMEYV-----EHDLKS----LME-TMKQPFLQSEVK 109
Query: 470 --------GLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK-----LNDTTQT 516
G+A+LH++ I+HRD+K++N+L+++ ++ DFGLA+ L TQ
Sbjct: 110 CLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQL 166
Query: 517 HVSTRVMGTFGYLAPE-YASSGKLTDRSDVFSFGVVLLELITGRKPV 562
V T Y APE + + + D++S G + EL+T +KP+
Sbjct: 167 VV------TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLT-KKPL 206
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 6e-16
Identities = 64/238 (26%), Positives = 111/238 (46%), Gaps = 36/238 (15%)
Query: 368 IGEGGFGCVY-------------------KGNLPEGKVVAVKQLKSGSGQGER-EFRAEV 407
+GEG FG V+ GN P +VAVK L+ + + R +F E+
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQP--VLVAVKMLREDANKNARNDFLKEI 70
Query: 408 EIISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNL-----EHHLHGKGQ----PVLEWT 458
+I+SR+ +++ L+ CI+ +I E++ N +L H + + ++
Sbjct: 71 KIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYS 130
Query: 459 KRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK-LNDTTQTH 517
+ +A A G+ YL +HRD+ + N LV + ++ADFG+++ L
Sbjct: 131 TLIFMATQIASGMKYLSS---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYR 187
Query: 518 VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVE 575
+ R + +++ E GK T SDV++FGV L E++T K P L DE ++E
Sbjct: 188 IQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKE-QPYSQLSDEQVIE 244
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 8e-16
Identities = 66/210 (31%), Positives = 115/210 (54%), Gaps = 31/210 (14%)
Query: 368 IGEGGFGCVYKG-NLPEGKVVAVKQLKSGS---GQGEREFRAEVEIISRVHHRHLVSLVG 423
IGEG +G VYKG N G++VA+K+++ S G R E+ ++ + H ++V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIR-EISLLKELQHPNIVCLQD 66
Query: 424 YCISEKNRL-LIYEFVPNNNLEHHLH--GKGQPVLEWTKRVKIALGAAKGLAYLHED--- 477
+ +++RL LI+EF+ + +L+ +L KGQ ++ + VK +YL++
Sbjct: 67 -VLMQESRLYLIFEFL-SMDLKKYLDSLPKGQ-YMD-AELVK---------SYLYQILQG 113
Query: 478 ---CHP-KIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPE- 532
CH +++HRD+K N+L+D++ ++ADFGLA+ V T + T Y APE
Sbjct: 114 ILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP-VRVYTHEVVTLWYRAPEV 172
Query: 533 YASSGKLTDRSDVFSFGVVLLELITGRKPV 562
S + + D++S G + E+ T +KP+
Sbjct: 173 LLGSPRYSTPVDIWSIGTIFAEMAT-KKPL 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 1e-15
Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 28/215 (13%)
Query: 368 IGEGGFGCVY--------KGNLPEGKVVAVKQLKSGSGQGE-REFRAEVEIISRV-HHRH 417
+GEG FG V K E VAVK LK + + + + +E+E++ + H++
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 418 LVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWT--------------KRVKI 463
+++L+G C + +I E+ NL +L + P +E++ V
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 464 ALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK-LNDTTQTHVSTRV 522
A+G+ YL K IHRD+ + N+LV + ++ADFGLA+ +N+ +T
Sbjct: 143 TYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 523 MGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT 557
++APE T +SDV+SFGV++ E+ T
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 56/191 (29%), Positives = 97/191 (50%), Gaps = 9/191 (4%)
Query: 368 IGEGGFGCVYKGNL-PEGKVVAVKQLKSG-SGQGEREFRAEVEIISRVHHRHLVSLVGYC 425
IG G FG V+ G L + VAVK + + +F E I+ + H ++V L+G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 426 ISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHR 485
++ ++ E V + L +G P L+ + +++ AA G+ YL IHR
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEG-PRLKVKELIQMVENAAAGMEYLESKH---CIHR 118
Query: 486 DIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTF--GYLAPEYASSGKLTDRS 543
D+ + N LV ++ +++DFG+++ + + ST M + APE + G+ + S
Sbjct: 119 DLAARNCLVTEKNVLKISDFGMSR-EEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSES 177
Query: 544 DVFSFGVVLLE 554
DV+SFG++L E
Sbjct: 178 DVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 2e-15
Identities = 62/271 (22%), Positives = 78/271 (28%), Gaps = 31/271 (11%)
Query: 10 PPVANNASSGLGERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAA-SP 68
P V ++ G + A P PP + + + SP
Sbjct: 2742 PAVPAGPATPGGPARPARPPTTAGPPAPAPPAAPAAGPPRRLTRPAVASLSESRESLPSP 2801
Query: 69 PPASPPPA--SPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPP 126
+ PPA P A+ PPAASP PPP S P + PPP PPP+ S P
Sbjct: 2802 WDPADPPAAVLAPAAALPPAASPAGPLPPPTSAQPTA--PPPPPGPPPPSLPLGGSVAPG 2859
Query: 127 GDGGASPPPEQSKNSP-----------PAPPGQAST-----PPDSPPPGIQSNQGNPVPS 170
GD PP P P ST PPD P Q P
Sbjct: 2860 GDVRRRPPSRSPAAKPAAPARPPVRRLARPAVSRSTESFALPPDQPERPPQPQAPPPPQP 2919
Query: 171 NGTTDSRDTKWAPPSNPGSPPSPSTSQSGT----------PSTPNENSSPNELSPPSNSK 220
PP P P P + P P ++ P
Sbjct: 2920 QPQPPPPPQPQPPPPPPPRPQPPLAPTTDPAGAGEPSGAVPQPWLGALVPGRVAVPRFRV 2979
Query: 221 SPTSKSSPEESSSSSHSNSKKTPTSSSGHSS 251
+ S +SS+ SS SS
Sbjct: 2980 PQPAPSREAPASSTPPLTGHSLSRVSSWASS 3010
|
Length = 3151 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 2e-15
Identities = 54/243 (22%), Positives = 77/243 (31%), Gaps = 25/243 (10%)
Query: 2 ANSAETPGPPVANNASSGLGERK----EEAKAPPAPAEKTESPEKKVTPPPADNNNNGGG 57
++ A P PP+ A +R A P PA + + P A
Sbjct: 2545 SDDAGDPPPPLPPAAPPAAPDRSVPPPRPAPRPSEPAVTSRARRPDAPPQSARPRAPVD- 2603
Query: 58 GNNSTTPAASPPPASPPPASPPPASPPPAASP-----PPGSPPPASPPPASGSASPPPAS 112
+ P PP+ PP + P PPP+ SP P PP PP P
Sbjct: 2604 --DRGDPRGPAPPSPLPPDTHAPDPPPPSPSPAANEPDPHPPPTVPPPERPRDDPAPGRV 2661
Query: 113 PPPTRSESQSSPPPGDGG-------ASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQG 165
P R+ A+ P S S PP TP +P + +
Sbjct: 2662 SRPRRARRLGRAAQASSPPQRPRRRAARPTVGSLTSLADPPPPPPTPEPAPHALVSATPL 2721
Query: 166 NPVPSNGTTDSRDTKWAPPSNPGSPPSPSTSQSGTPSTPNENSSPNELSPPSNSKSPTSK 225
P P+ R A P+ P P P+ TP P + P + P P +
Sbjct: 2722 PPGPAAA----RQASPALPAAPAPPAVPAG--PATPGGPARPARPPTTAGPPAPAPPAAP 2775
Query: 226 SSP 228
++
Sbjct: 2776 AAG 2778
|
Length = 3151 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 60/210 (28%), Positives = 102/210 (48%), Gaps = 14/210 (6%)
Query: 368 IGEGGFGCVYKG-NLPEGKVVAVKQLK---SGSGQGEREFRAEVEIISRVHHRHLVSLVG 423
IGEG +G V+K N ++VA+K+++ G R E+ ++ + H+++V L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRLYD 66
Query: 424 YCISEKNRLLIYEFVPNNNLEHHLHG-KGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKI 482
S+K L++E+ + +L+ + G E K L KGLA+ H +
Sbjct: 67 VLHSDKKLTLVFEYC-DQDLKKYFDSCNGDIDPEIVKSFMFQL--LKGLAFCHSH---NV 120
Query: 483 IHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDR 542
+HRD+K N+L++ E ++ADFGLA+ S V+ T Y P+ KL
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLYST 179
Query: 543 S-DVFSFGVVLLELITGRKPVDPTQPLGDE 571
S D++S G + EL +P+ P + D+
Sbjct: 180 SIDMWSAGCIFAELANAGRPLFPGNDVDDQ 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 2e-15
Identities = 59/202 (29%), Positives = 98/202 (48%), Gaps = 14/202 (6%)
Query: 368 IGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQGEREFRA---EVEIISRVHHRHLVSLVG 423
+G+GGFG V + GK+ A K+L + + + E I+++VH R +VSL
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL-A 59
Query: 424 YCISEKNRL-LIYEFVPNNNLEHHLHG--KGQPVLEWTKRVKIALGAAKGLAYLHEDCHP 480
Y K L L+ + +L +H++ + P + GL +LH+
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR--- 116
Query: 481 KIIHRDIKSANILVDDEFEAQVADFGLA-KLNDTTQTHVSTRVMGTFGYLAPEYASSGKL 539
+II+RD+K N+L+D++ +++D GLA +L D + GT G++APE +
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGFMAPELLQGEEY 174
Query: 540 TDRSDVFSFGVVLLELITGRKP 561
D F+ GV L E+I R P
Sbjct: 175 DFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 61/205 (29%), Positives = 102/205 (49%), Gaps = 23/205 (11%)
Query: 368 IGEGGFGCVY-KGNLPEGKVVAVKQLKSGSGQGEREFR---AEVEIISRVHHRHLVSLVG 423
IG G FG VY ++ +VVA+K++ Q +++ EV+ + R+ H + + G
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 424 YCISEKNRLLIYEFV---PNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHP 480
+ E L+ E+ ++ LE H + L+ + I GA +GLAYLH
Sbjct: 93 CYLREHTAWLVMEYCLGSASDLLEVH-----KKPLQEVEIAAITHGALQGLAYLHSH--- 144
Query: 481 KIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEY---ASSG 537
+IHRDIK+ NIL+ + + ++ADFG A + + V GT ++APE G
Sbjct: 145 NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEVILAMDEG 199
Query: 538 KLTDRSDVFSFGVVLLELITGRKPV 562
+ + DV+S G+ +EL + P+
Sbjct: 200 QYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 62/206 (30%), Positives = 104/206 (50%), Gaps = 12/206 (5%)
Query: 368 IGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCI 426
+G G +G VYK NL G++ AVK +K G + E+ ++ H ++V+ G +
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 427 SEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRD 486
S + + E+ +L+ H G P+ E + + +GLAYLH +HRD
Sbjct: 77 SREKLWICMEYCGGGSLQDIYHVTG-PLSE-LQIAYVCRETLQGLAYLHSKGK---MHRD 131
Query: 487 IKSANILVDDEFEAQVADFGL-AKLNDTTQTHVSTRVMGTFGYLAPEYAS---SGKLTDR 542
IK ANIL+ D + ++ADFG+ AK+ T S +GT ++APE A+ +G
Sbjct: 132 IKGANILLTDNGDVKLADFGVAAKITATIAKRKS--FIGTPYWMAPEVAAVEKNGGYNQL 189
Query: 543 SDVFSFGVVLLELITGRKPVDPTQPL 568
D+++ G+ +EL + P+ P+
Sbjct: 190 CDIWAVGITAIELAELQPPMFDLHPM 215
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 2e-15
Identities = 73/288 (25%), Positives = 119/288 (41%), Gaps = 43/288 (14%)
Query: 368 IGEGGFGCVYKGNLPEGKVVA---VKQLK-SGSGQGEREFRAEVEIISRVHHRHLVSLVG 423
IG G FG V G G A VK+L+ S + + F EV+ ++H +++ +G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 424 YCISEKNRLLIYEFVPNNNLEHHLH-------GKGQPVLEWTKRVKIALGAAKGLAYLHE 476
CI LL+ EF P +L+++L Q + ++A A GL +LH+
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVL----QRMACEVASGLLWLHQ 118
Query: 477 DCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFG--YLAPEYA 534
IH D+ N + + ++ D+GLA L + + T+ +LAPE
Sbjct: 119 A---DFIHSDLALRNCQLTADLSVKIGDYGLA-LEQYPEDYYITKDCHAVPLRWLAPELV 174
Query: 535 SS-------GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIET 587
T +S+++S GV + EL T QP D S + VL + +
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWELFT-----AADQPYPDLSDEQ----VLKQVVRE 225
Query: 588 GDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRAL 635
D+ ++ P+L+ Y + R E C RP +V L
Sbjct: 226 QDI-KLPKPQLDLKYSD----RWYEVMQFCWLDP-ETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 56/225 (24%), Positives = 110/225 (48%), Gaps = 37/225 (16%)
Query: 366 NVIGEGGFGCVYKGNLPEGKV-----VAVKQLKSGSGQGERE-FRAEVEIISRVHHRHLV 419
+++ EG FG ++ G L + K V VK +K + + + E ++ + H++++
Sbjct: 12 DLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNIL 71
Query: 420 SLVGYCISEKNR-LLIYEFVPNNNLEHHL----HGKGQPVLEWTKR--VKIALGAAKGLA 472
++ CI + ++Y ++ NL+ L G+ + + V +A+ A G++
Sbjct: 72 PILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMS 131
Query: 473 YLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK---------LNDTTQTHVSTRVM 523
YLH+ +IH+DI + N ++D+E + ++ D L++ L D V
Sbjct: 132 YLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK---- 184
Query: 524 GTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKP---VDP 564
++A E + + + SDV+SFGV+L EL+T G+ P +DP
Sbjct: 185 ----WMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP 225
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 2e-15
Identities = 63/276 (22%), Positives = 134/276 (48%), Gaps = 31/276 (11%)
Query: 362 FARENVIGEGGFGCVYK-GNLPEGKVVAVKQLK-SGSGQGERE-FRAEVEIISRVHHRHL 418
+ + V+G G FG V+ + K+V +KQ+ + ER + E +++ + H ++
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI 61
Query: 419 VSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDC 478
+ + +K +++ E+ P L ++ + +L+ + + L ++H
Sbjct: 62 IEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK- 120
Query: 479 HPKIIHRDIKSANILVDD-EFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSG 537
I+HRD+K+ NIL+D + ++ DFG++K+ ++++ T V+GT Y++PE
Sbjct: 121 --LILHRDLKTQNILLDKHKMVVKIGDFGISKIL-SSKSKAYT-VVGTPCYISPELCEGK 176
Query: 538 KLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPR 597
+SD+++ G VL EL + ++ + +L P LV I +G + I D
Sbjct: 177 PYNQKSDIWALGCVLYELASLKRAFEA------ANL-----PALVLKIMSGTFAPISD-- 223
Query: 598 LEKHYVESEMFRMIEAAAACVRHSGP-KRPRMVQVV 632
Y ++ ++I + + + P KRP++ Q++
Sbjct: 224 ---RYSP-DLRQLILS----MLNLDPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 3e-15
Identities = 30/205 (14%), Positives = 50/205 (24%), Gaps = 4/205 (1%)
Query: 8 PGPPVANNASSGLGERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAAS 67
P P A + PA P A+
Sbjct: 590 PAPGAAGGEGPPAPASSGPPEEAARPAAPAAPAAPAAPAPAGAAAAPAEASAAPAPGVAA 649
Query: 68 PPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSP--P 125
P A P + G PA+PPPA A+P + + + P
Sbjct: 650 PEHHPKHVAVPDASDGGDGWPAKAGGAAPAAPPPAPAPAAPAAPAGAAPAQPAPAPAATP 709
Query: 126 PGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPS 185
P P + + + A + P P + P P+ P+
Sbjct: 710 PAGQADDPAAQPPQAAQGASAPSPAADDPVPLPPEPDDP--PDPAGAPAQPPPPPAPAPA 767
Query: 186 NPGSPPSPSTSQSGTPSTPNENSSP 210
+ P + S +++
Sbjct: 768 AAPAAAPPPSPPSEEEEMAEDDAPS 792
|
Length = 824 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 3e-15
Identities = 68/228 (29%), Positives = 117/228 (51%), Gaps = 46/228 (20%)
Query: 362 FARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGERE------FRAEVEIISRVH 414
F IGEG +G VYK + G++VA+K+++ E+E R E++I+ +++
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRL---DNEKEGFPITAIR-EIKILRQLN 64
Query: 415 HRHLVSLVGYCISEKNRL----------LIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIA 464
HR++V+L +++ L L++E++ +H L G +LE + V +
Sbjct: 65 HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-----DHDLMG----LLE-SGLVHFS 114
Query: 465 LGAAK--------GLAYLHEDCHPK-IIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ 515
K GL Y CH K +HRDIK +NIL++++ + ++ADFGLA+L ++ +
Sbjct: 115 EDHIKSFMKQLLEGLNY----CHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEE 170
Query: 516 THVSTRVMGTFGYLAPE-YASSGKLTDRSDVFSFGVVLLELITGRKPV 562
+ T + T Y PE + DV+S G +L EL T +KP+
Sbjct: 171 SRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 71/285 (24%), Positives = 126/285 (44%), Gaps = 37/285 (12%)
Query: 362 FARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRV-HHRHLV 419
F V+G G +G VYKG ++ G++ A+K + + E E + E+ ++ + HHR++
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE-EEEIKLEINMLKKYSHHRNIA 76
Query: 420 SLVGYCIS------EKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAY 473
+ G I + L+ EF ++ + L+ I +GLA+
Sbjct: 77 TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAH 136
Query: 474 LHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEY 533
LH K+IHRDIK N+L+ + E ++ DFG++ D T +T +GT ++APE
Sbjct: 137 LHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWMAPEV 192
Query: 534 ASSGKLTD-----RSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETG 588
+ + D RSD++S G+ +E+ G P+ P+ L+ P
Sbjct: 193 IACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPP--------- 243
Query: 589 DLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVR 633
P+L+ + IE C+ + RP Q+++
Sbjct: 244 -------PKLKSKKWSKKFIDFIE---GCLVKNYLSRPSTEQLLK 278
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 3e-15
Identities = 59/220 (26%), Positives = 109/220 (49%), Gaps = 18/220 (8%)
Query: 362 FARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRV-HHRHLV 419
F ++G G +G VYKG ++ G++ A+K + +G E E + E+ ++ + HHR++
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQEINMLKKYSHHRNIA 66
Query: 420 SLVGYCIS------EKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAY 473
+ G I + L+ EF ++ + L+ I +GL++
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSH 126
Query: 474 LHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEY 533
LH+ K+IHRDIK N+L+ + E ++ DFG++ D T +T +GT ++APE
Sbjct: 127 LHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWMAPEV 182
Query: 534 ASSGKLTD-----RSDVFSFGVVLLELITGRKPVDPTQPL 568
+ + D +SD++S G+ +E+ G P+ P+
Sbjct: 183 IACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM 222
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 62/215 (28%), Positives = 104/215 (48%), Gaps = 28/215 (13%)
Query: 368 IGEGGFGCVY--------KGNLPEGKVVAVKQLKSGSGQGE-REFRAEVEIISRV-HHRH 417
+GEG FG V K VAVK LKS + + + + +E+E++ + H++
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 418 LVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKR--------------VKI 463
+++L+G C + +I E+ NL +L + P +E+ V
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 464 ALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK-LNDTTQTHVSTRV 522
A A+G+ YL K IHRD+ + N+LV ++ ++ADFGLA+ ++ +T
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 523 MGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT 557
++APE T +SDV+SFGV+L E+ T
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 5e-15
Identities = 41/113 (36%), Positives = 68/113 (60%), Gaps = 7/113 (6%)
Query: 462 KIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLA-KLNDTTQTHVST 520
KI++ +GL YL E H KI+HRD+K +NILV+ E ++ DFG++ +L D+ ++
Sbjct: 103 KISIAVLRGLTYLREK-H-KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MAN 156
Query: 521 RVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESL 573
+GT Y++PE T +SD++S G+ L+E+ GR P+ P E++
Sbjct: 157 SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAM 209
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 6e-15
Identities = 63/209 (30%), Positives = 106/209 (50%), Gaps = 23/209 (11%)
Query: 362 FARENVIGEGGFGCVYKG-NLPEGKVVAVKQLK---SGSGQGEREFRAEVEIISRVHHRH 417
F + IGEG +G VYK N G+VVA+K+++ G R E+ ++ ++H +
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 60
Query: 418 LVSLVGYCISEKNRLLIYEFVPNNNLEHHLHG--KGQPVLEWTKRVKIALGAAKGLAYLH 475
+V L+ +E L++EF+ + +L+ + L K L +GLA+
Sbjct: 61 IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQL--LQGLAF-- 115
Query: 476 EDCHP-KIIHRDIKSANILVDDEFEAQVADFGLAK---LNDTTQTHVSTRVMGTFGYLAP 531
CH +++HRD+K N+L++ E ++ADFGLA+ + T TH V+ T Y AP
Sbjct: 116 --CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH---EVV-TLWYRAP 169
Query: 532 EYASSGKL-TDRSDVFSFGVVLLELITGR 559
E K + D++S G + E++T R
Sbjct: 170 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 6e-15
Identities = 62/226 (27%), Positives = 111/226 (49%), Gaps = 33/226 (14%)
Query: 362 FARENVI-----GEGGFGCVYKG-------NLPEGKV-VAVKQLK-SGSGQGEREFRAEV 407
F R+ ++ GEG FG V + + P+ V VAVK LK + + + + +E+
Sbjct: 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEM 68
Query: 408 EIISRV-HHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWT-------- 458
E++ + H+++++L+G C E +I E+ NL L + P ++T
Sbjct: 69 ELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPE 128
Query: 459 ------KRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK-LN 511
V A A+G+ YL + IHRD+ + N+LV ++ ++ADFGLA+ ++
Sbjct: 129 EQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVH 185
Query: 512 DTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT 557
D ++ ++APE T +SDV+SFG+++ E+ T
Sbjct: 186 DIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 7e-15
Identities = 50/238 (21%), Positives = 74/238 (31%), Gaps = 22/238 (9%)
Query: 8 PGPPVANNASSGLGERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAAS 67
P PP + + + P P + P P G S+ P
Sbjct: 2624 PDPPPPSPSPAANEPDPHPPPTVPPPERPRDDPAPGRVSRPRRARRLGRAAQASSPPQRP 2683
Query: 68 PPPASPPP-------ASPPPASPPPAASPP---PGSPPPASPPPASGSASPPPASPPPTR 117
A+ P A PPP P P +P +P P P A ++ PA+P P
Sbjct: 2684 RRRAARPTVGSLTSLADPPPPPPTPEPAPHALVSATPLPPGPAAARQASPALPAAPAP-- 2741
Query: 118 SESQSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSR 177
P G A+P PP G + P + P + ++SR
Sbjct: 2742 ------PAVPAGPATPGGPARPARPPTTAGPPAPAPPAAPAAGPPRRLTRPAVASLSESR 2795
Query: 178 DTKWAPPSNPGSPPSPSTSQSGTPSTPNENSSPNELSPPSNSKSPTSKSSPEESSSSS 235
++ +P P P + + +SP PP S PT+ P S
Sbjct: 2796 ESLPSPW----DPADPPAAVLAPAAALPPAASPAGPLPPPTSAQPTAPPPPPGPPPPS 2849
|
Length = 3151 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 7e-15
Identities = 35/193 (18%), Positives = 56/193 (29%), Gaps = 1/193 (0%)
Query: 43 KVTPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPA 102
+V GG ++ PP + PA+P + P A +P + PA A
Sbjct: 583 QVEAVVGPAPGAAGGEGPPAPASSGPPEEAARPAAPAAPAAPAAPAPAGAAAAPAEASAA 642
Query: 103 SGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQS 162
P P + +S A PPAP A P P +
Sbjct: 643 PAPGVAAPEHHPKHVAVPDASDGGDGWPAKAGGAAPAAPPPAPAPAAPAAPAGAAPAQPA 702
Query: 163 NQGNPVPSNGTTDSRDTKWAPPSNPGSPPSPSTSQSGT-PSTPNENSSPNELSPPSNSKS 221
P G D + + S PSP+ P P++ P
Sbjct: 703 PAPAATPPAGQADDPAAQPPQAAQGASAPSPAADDPVPLPPEPDDPPDPAGAPAQPPPPP 762
Query: 222 PTSKSSPEESSSS 234
+ ++ ++
Sbjct: 763 APAPAAAPAAAPP 775
|
Length = 824 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 7e-15
Identities = 60/220 (27%), Positives = 106/220 (48%), Gaps = 32/220 (14%)
Query: 368 IGEGGFGCVYKGNL------PEGKVVAVKQLK-SGSGQGEREFRAEVEIISRVHHRHLVS 420
+GE FG VYKG+L + + VA+K LK G EF+ E + SR+ H ++V
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 421 LVGYCISEKNRLLIYEFVPNNNLEHHLHGKG--------------QPVLEWTKRVKIALG 466
L+G E+ +I+ + +++L L + + LE V I
Sbjct: 73 LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132
Query: 467 AAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGT- 525
A G+ +L ++H+D+ + N+LV D+ +++D GL + + ++MG
Sbjct: 133 IAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYY---KLMGNS 186
Query: 526 ---FGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKP 561
+++PE GK + SD++S+GVVL E+ + G +P
Sbjct: 187 LLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 7e-15
Identities = 40/150 (26%), Positives = 50/150 (33%), Gaps = 8/150 (5%)
Query: 41 EKKVTPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPP 100
K+ P + + S A P ASP S PG P SPP
Sbjct: 142 LKEGEDPNPGPPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPP 201
Query: 101 PASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGI 160
S S P P+ +S + PP + +P P +PP PP Q P + P
Sbjct: 202 EDPSSPSDSSLPPAPSSFQSDTPPPSPESPTNPSPPPGPAAPPPPPVQQVPPLSTAKPTP 261
Query: 161 QSNQGNPVPSNGTTDSRD--------TKWA 182
S P P G T D KWA
Sbjct: 262 PSASATPAPIGGITLDDDAIAKAQKHAKWA 291
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 7e-15
Identities = 56/205 (27%), Positives = 86/205 (41%), Gaps = 15/205 (7%)
Query: 368 IGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGERE---FRAEVEIISRVHHRHLVSLVG 423
I +G FG VY G A+K LK + + +AE I+ V+ +
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 424 YCISEKNRL-LIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKI 482
Y K+ L L+ E++ + + G +W K + G+ LH+ I
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAK--QYIAEVVLGVEDLHQR---GI 118
Query: 483 IHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDR 542
IHRDIK N+L+D ++ DFGL++ + + +GT YLAPE
Sbjct: 119 IHRDIKPENLLIDQTGHLKLTDFGLSRNG-----LENKKFVGTPDYLAPETILGVGDDKM 173
Query: 543 SDVFSFGVVLLELITGRKPVDPTQP 567
SD +S G V+ E + G P P
Sbjct: 174 SDWWSLGCVIFEFLFGYPPFHAETP 198
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 8e-15
Identities = 44/209 (21%), Positives = 61/209 (29%), Gaps = 14/209 (6%)
Query: 4 SAETPGPPVANNASSGLGERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTT 63
A P A AP E P P + +
Sbjct: 601 PAPASSGPPEEAARPAAPAAPAAPAAPAPAGAAAAPAEASAAPAPGVAAPEHHPKHVAVP 660
Query: 64 PAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSS 123
A+ P A + PP A P PA PA + +P P + +
Sbjct: 661 DASDGGDGWPAKAGGAAPAAPPPAPAPAAPAAPAGAAPAQPAPAPAATPPAGQADDPAAQ 720
Query: 124 PPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAP 183
PP GAS P + + P PP P D P P Q P P+ AP
Sbjct: 721 PPQAAQGASAPSPAADDPVPLPP----EPDDPPDPAGAPAQPPPPPAP----------AP 766
Query: 184 PSNPGSPPSPSTSQSGTPSTPNENSSPNE 212
+ P + P PS ++ S ++
Sbjct: 767 AAAPAAAPPPSPPSEEEEMAEDDAPSMDD 795
|
Length = 824 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 23/211 (10%)
Query: 362 FARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFR---AEVEIISRVHHRH 417
F+ IG G FG VY ++ +VVA+K++ Q +++ EV + ++ H +
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 418 LVSLVGYCISEKNRLLIYEFV---PNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYL 474
+ G + E L+ E+ ++ LE H + L+ + + GA +GLAYL
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVH-----KKPLQEVEIAAVTHGALQGLAYL 131
Query: 475 HEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEY- 533
H +IHRD+K+ NIL+ + ++ DFG A + V GT ++APE
Sbjct: 132 HSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVI 183
Query: 534 --ASSGKLTDRSDVFSFGVVLLELITGRKPV 562
G+ + DV+S G+ +EL + P+
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 57/197 (28%), Positives = 105/197 (53%), Gaps = 11/197 (5%)
Query: 368 IGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQG--EREFRAEVEIISRVHHRHLVSLVGY 424
+GEG + VYKG N G++VA+K++ + +G R E+ ++ + H ++V L
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR-EISLMKELKHENIVRLHDV 66
Query: 425 CISEKNRLLIYEFVPNNNLEHHLHGKGQP-VLEWTKRVKIALGAAKGLAYLHEDCHPKII 483
+E +L++E++ + +L+ ++ G L+ KG+A+ HE+ +++
Sbjct: 67 IHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVL 122
Query: 484 HRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRS 543
HRD+K N+L++ E ++ADFGLA+ S V+ T Y AP+ + S
Sbjct: 123 HRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLLGSRTYSTS 181
Query: 544 -DVFSFGVVLLELITGR 559
D++S G ++ E+ITGR
Sbjct: 182 IDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 2e-14
Identities = 65/240 (27%), Positives = 97/240 (40%), Gaps = 49/240 (20%)
Query: 360 NGFARENVIGEGGFGCVYKGNLPE-GKVVAVKQLKSG----SGQGEREFRAEVEIISRVH 414
+ F VIG G FG V+ + G+V A+K L+ Q RAE +I++
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQ-IAHVRAERDILADAD 59
Query: 415 HRHLVSLVGYCISEKNRL-LIYEFVPNNNLEHHLHGKGQPVLEWTK----RVKIALGAAK 469
+V L Y ++ L L+ E++P +L + L K E + + +AL +
Sbjct: 60 SPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVH 118
Query: 470 GLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK-----------------LND 512
L + IHRDIK NIL+D + ++ADFGL K L
Sbjct: 119 KLGF---------IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLF 169
Query: 513 TTQTHVSTR-----------VMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKP 561
V R +GT Y+APE D +S GV+L E++ G P
Sbjct: 170 RDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 57/216 (26%), Positives = 108/216 (50%), Gaps = 32/216 (14%)
Query: 367 VIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQ---GEREFRAEVEIISRVHHRHLVSLV 422
IG G +G V + GK VA+K++ +R R E++I+ H +++++
Sbjct: 12 NIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLR-ELKILRHFKHDNIIAIR 70
Query: 423 GYCISE----KNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAA-KGLAYLHED 477
K+ ++ + + ++L H +H QP+ E + ++ L +GL Y+H
Sbjct: 71 DILRPPGADFKDVYVVMDLM-ESDLHHIIHS-DQPLTE--EHIRYFLYQLLRGLKYIHSA 126
Query: 478 CHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQT--------HVSTRVMGTFGYL 529
+IHRD+K +N+LV+++ E ++ DFG+A+ ++ T +V+TR Y
Sbjct: 127 N---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATR-----WYR 178
Query: 530 APEYA-SSGKLTDRSDVFSFGVVLLELITGRKPVDP 564
APE S + T D++S G + E++ GR+ + P
Sbjct: 179 APELLLSLPEYTTAIDMWSVGCIFAEML-GRRQLFP 213
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 66/222 (29%), Positives = 104/222 (46%), Gaps = 31/222 (13%)
Query: 361 GFARENVIGEGGFGCVYK-------GNLPEGKVVAVKQLKSGSGQGERE-----FRAEVE 408
+A +G G FGCVYK NL K + V G + ER+ +EV
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 409 IISRVHHRHLVSLVGY--CISEKNRL-LIYEFVPNNNLEHH---LHGKGQPVLE---WTK 459
II + RH ++V Y E +RL ++ + + L H L K Q E W
Sbjct: 61 II-KEQLRH-PNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNI 118
Query: 460 RVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVS 519
V++ L L YLH++ +I+HRD+ NI++ ++ + + DFGLAK
Sbjct: 119 FVQMVLA----LRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKL 170
Query: 520 TRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKP 561
T V+GT Y PE + +++DV++FG +L ++ T + P
Sbjct: 171 TSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 3e-14
Identities = 31/105 (29%), Positives = 42/105 (40%)
Query: 54 NGGGGNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASP 113
GG + AA A+ P A+P PA+ PAA+ P P PA A PP+
Sbjct: 386 GVAGGAGAPAAAAPSAAAAAPAAAPAPAAAAPAAAAAPAPAAAPQPAPAPAPAPAPPSPA 445
Query: 114 PPTRSESQSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPP 158
+ SPPP ++ P +P A PP +P P
Sbjct: 446 GNAPAGGAPSPPPAAAPSAQPAPAPAAAPEPTAAPAPAPPAAPAP 490
|
Length = 824 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 3e-14
Identities = 66/239 (27%), Positives = 105/239 (43%), Gaps = 64/239 (26%)
Query: 368 IGEGGFGCVYK-GNLPEGKVVAVKQLKSGSGQGERE---------FRAEVEIISRVHHRH 417
IGEG +G V+K N G++VA+K+ E E R E+ ++ ++ H +
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFV------ESEDDPVIKKIALR-EIRMLKQLKHPN 61
Query: 418 LVSLVGYCISEKNRL-LIYEFVPN---NNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAY 473
LV+L+ K +L L++E+ + N LE + G + KI + + +
Sbjct: 62 LVNLI-EVFRRKRKLHLVFEYCDHTVLNELEKNPRG-----VPEHLIKKIIWQTLQAVNF 115
Query: 474 LHEDCHP-KIIHRDIKSANILVDDEFEAQVADFGLAKL----NDTTQTHVSTRVMGTFGY 528
CH IHRD+K NIL+ + + ++ DFG A++ D +V+TR Y
Sbjct: 116 ----CHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR-----WY 166
Query: 529 LAPE-------YASSGKLTDRSDVFSFGVVLLELIT------GRKPVDP----TQPLGD 570
APE Y DV++ G V EL+T G+ VD + LGD
Sbjct: 167 RAPELLVGDTQYGPP------VDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGD 219
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 3e-14
Identities = 61/209 (29%), Positives = 107/209 (51%), Gaps = 17/209 (8%)
Query: 364 RENVIGEGGFGCVYKG-NLPEGKVVAVKQLK--SGSGQGEREFRA---EVEIISRVHHRH 417
R ++G+G FG VY ++ G+ +A KQ++ S + +E A E++++ + H
Sbjct: 6 RGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHER 65
Query: 418 LVSLVGYCI---SEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYL 474
+V G C+ +EK + E++P +++ L G T+ K +G++YL
Sbjct: 66 IVQYYG-CLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTR--KYTRQILEGMSYL 122
Query: 475 HEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK-LNDTTQTHVSTR-VMGTFGYLAPE 532
H + I+HRDIK ANIL D ++ DFG +K L + R V GT +++PE
Sbjct: 123 HSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPE 179
Query: 533 YASSGKLTDRSDVFSFGVVLLELITGRKP 561
S ++DV+S G ++E++T + P
Sbjct: 180 VISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 3e-14
Identities = 43/143 (30%), Positives = 74/143 (51%), Gaps = 14/143 (9%)
Query: 424 YCI--SEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAK---GLAYLHEDC 478
+C ++++ + E++ +L H+ G+ + AA+ GL +LH+
Sbjct: 62 FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARAR-----FYAAEIICGLQFLHKK- 115
Query: 479 HPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGK 538
II+RD+K N+L+D + ++ADFG+ K N + ST GT Y+APE K
Sbjct: 116 --GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGTPDYIAPEILKGQK 172
Query: 539 LTDRSDVFSFGVVLLELITGRKP 561
+ D +SFGV+L E++ G+ P
Sbjct: 173 YNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 60/210 (28%), Positives = 110/210 (52%), Gaps = 16/210 (7%)
Query: 368 IGEGGFGCVYKG--NLPEGKVVAVKQLKSGSGQGE--REFRAEVEIISRVHHRHLVSLVG 423
+GEG + VYKG L + +VA+K+++ +G R EV ++ + H ++V+L
Sbjct: 14 LGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHD 71
Query: 424 YCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIAL-GAAKGLAYLHEDCHPKI 482
+EK+ L++E++ + +L+ +L G + VK+ L +GL Y H K+
Sbjct: 72 IIHTEKSLTLVFEYL-DKDLKQYLDDCGNSIN--MHNVKLFLFQLLRGLNYCHRR---KV 125
Query: 483 IHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPE-YASSGKLTD 541
+HRD+K N+L+++ E ++ADFGLA+ S V+ T Y P+ S +
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGSTDYST 184
Query: 542 RSDVFSFGVVLLELITGRKPVDPTQPLGDE 571
+ D++ G + E+ TGR P+ P + ++
Sbjct: 185 QIDMWGVGCIFYEMSTGR-PLFPGSTVEEQ 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 4e-14
Identities = 63/213 (29%), Positives = 94/213 (44%), Gaps = 20/213 (9%)
Query: 362 FARENVIGEGGFGCVY----KGNLPEGKVVAVKQLKSGS----GQGEREFRAEVEIISRV 413
F V+G G +G V+ G GK+ A+K LK + + R E +++ V
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 414 HHR-HLVSLVGYCISEKNRL-LIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGA-AKG 470
LV+L Y +L LI ++V L HL+ + V++ +
Sbjct: 62 RRCPFLVTL-HYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES---EVRVYIAEIVLA 117
Query: 471 LAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLA 530
L +LH+ II+RDIK NIL+D E + DFGL+K + + GT Y+A
Sbjct: 118 LDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMA 174
Query: 531 PEYASSGKL--TDRSDVFSFGVVLLELITGRKP 561
PE G D +S GV+ EL+TG P
Sbjct: 175 PEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 4e-14
Identities = 66/205 (32%), Positives = 109/205 (53%), Gaps = 20/205 (9%)
Query: 367 VIGEGGFGCVY---KGNLPE-GKVVAVKQLKSGSGQGEREFRAEVE--IISRVHHRHLVS 420
V+G+G FG V+ K P+ G++ A+K LK + + R ++E I++ V+H +V
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 421 LVGYCISEKNRL-LIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGA-AKGLAYLHEDC 478
L Y + +L LI +F+ +L L + V+ + VK L A L +LH
Sbjct: 63 L-HYAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELALALDHLHS-- 116
Query: 479 HPKIIHRDIKSANILVDDEFEAQVADFGLAK--LNDTTQTHVSTRVMGTFGYLAPEYASS 536
II+RD+K NIL+D+E ++ DFGL+K ++ + + GT Y+APE +
Sbjct: 117 -LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY---SFCGTVEYMAPEVVNR 172
Query: 537 GKLTDRSDVFSFGVVLLELITGRKP 561
T +D +SFGV++ E++TG P
Sbjct: 173 RGHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 5e-14
Identities = 74/256 (28%), Positives = 128/256 (50%), Gaps = 32/256 (12%)
Query: 368 IGEGGFGCVYK-GNLPEGKVVAVKQLKSG-SGQGEREFRAEVEIISR-VHHRHLVSLVGY 424
+G G +G V K ++P G ++AVK++++ + Q ++ +++I R V + V+ G
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGA 68
Query: 425 CISEKNRLLIYEFVPNNNLEH-----HLHGK--GQPVLEWTKRVKIALGAAKGLAYLHED 477
E + + E V + +L+ + G + +L KIA+ K L YLH
Sbjct: 69 LFREGDVWICME-VMDTSLDKFYKKVYDKGLTIPEDILG-----KIAVSIVKALEYLHSK 122
Query: 478 CHPKIIHRDIKSANILVDDEFEAQVADFGLA-KLNDTTQTHVSTRVMGTFGYLAPEY--- 533
+IHRD+K +N+L++ + ++ DFG++ L D+ T G Y+APE
Sbjct: 123 L--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV---AKTIDAGCKPYMAPERINP 177
Query: 534 ASSGKLTD-RSDVFSFGVVLLELITGRKPVD----PTQPLGDESLVEWARPVLVRAIETG 588
+ K D +SDV+S G+ ++EL TGR P D P Q L + +VE P L +
Sbjct: 178 ELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQL--KQVVEEPSPQLPAEKFSP 235
Query: 589 DLSEIVDPRLEKHYVE 604
+ + V+ L+K+Y E
Sbjct: 236 EFQDFVNKCLKKNYKE 251
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 9e-14
Identities = 63/212 (29%), Positives = 102/212 (48%), Gaps = 31/212 (14%)
Query: 368 IGEGGFGCVYKG-NLPEGKVVAVKQLKS--GSGQGEREFRAEVEIISRV-HHRHLVSLVG 423
IGEG F V K + GK A+K +K S + R E++ + R+ H +++ L+
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLR-EIQALRRLSPHPNILRLIE 65
Query: 424 YCISEK-NRL-LIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIAL-GAAKGLAYLHEDCHP 480
K RL L++E + + NL + G+ +P+ E KRVK + K L ++H
Sbjct: 66 VLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPE--KRVKSYMYQLLKSLDHMH---RN 119
Query: 481 KIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTH---VSTRVMGTFGYLAPE-YASS 536
I HRDIK NIL+ D+ ++ADFG + + + +STR Y APE +
Sbjct: 120 GIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYISTR-----WYRAPECLLTD 173
Query: 537 GKLTDRSDVFSFGVVLLELITGRKPVDPTQPL 568
G + D+++ G V E+++ PL
Sbjct: 174 GYYGPKMDIWAVGCVFFEILS-------LFPL 198
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 61/207 (29%), Positives = 108/207 (52%), Gaps = 19/207 (9%)
Query: 367 VIGEGGFGCVYKG-NLPEGKVVAVKQL--KSGSGQGEREFRA---EVEIISRVHHRHLVS 420
++G G FG VY + G+ +AVKQ+ S + +E A E++++ + H +V
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 421 LVGYCIS--EKNRLLIY-EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHED 477
G C+ E+ +L I+ E++P +++ L G T+R + +G++YLH +
Sbjct: 69 YYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQI--LQGVSYLHSN 125
Query: 478 CHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDT---TQTHVSTRVMGTFGYLAPEYA 534
I+HRDIK ANIL D ++ DFG +K T + T + + V GT +++PE
Sbjct: 126 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS-VTGTPYWMSPEVI 181
Query: 535 SSGKLTDRSDVFSFGVVLLELITGRKP 561
S ++DV+S ++E++T + P
Sbjct: 182 SGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 1e-13
Identities = 62/212 (29%), Positives = 108/212 (50%), Gaps = 27/212 (12%)
Query: 368 IGEGGFGCVYKG-NLPEGKVVAVKQLK---SGSGQGEREFRAEVEIISRV-HHRHLVSLV 422
+G+G +G V+K + +VVA+K++ + +R FR E+ + + H ++V L+
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFR-EIMFLQELGDHPNIVKLL 73
Query: 423 GYCISEKNR--LLIYEFVPNNNLEHHLHG---KGQPVLEWTKRVKIALGAAKGLAYLHED 477
+E ++ L++E+ +E LH +LE + I K L Y+H
Sbjct: 74 NVIKAENDKDIYLVFEY-----METDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSG 126
Query: 478 CHPKIIHRDIKSANILVDDEFEAQVADFGLAK----LNDTTQTHVSTRVMGTFGYLAPE- 532
+IHRD+K +NIL++ + ++ADFGLA+ L + + V T + T Y APE
Sbjct: 127 ---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEI 183
Query: 533 YASSGKLTDRSDVFSFGVVLLELITGRKPVDP 564
S + T D++S G +L E++ G KP+ P
Sbjct: 184 LLGSTRYTKGVDMWSVGCILGEMLLG-KPLFP 214
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 68/206 (33%), Positives = 96/206 (46%), Gaps = 23/206 (11%)
Query: 367 VIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFR---AEVEI-ISRVHHRHLVSL 421
VIG+G FG V + +GK AVK L+ + ++E + AE + + V H LV L
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 422 VGYCISEKNRL-LIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHP 480
Y ++L + ++V L HL + + E R A A L YLH
Sbjct: 62 -HYSFQTADKLYFVLDYVNGGELFFHLQ-RERSFPEPRARF-YAAEIASALGYLHS---L 115
Query: 481 KIIHRDIKSANILVDDEFEAQVADFGLAK----LNDTTQTHVSTRVMGTFGYLAPEYASS 536
II+RD+K NIL+D + + DFGL K + TT T GT YLAPE
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC-----GTPEYLAPEVLRK 170
Query: 537 GKLTDRS-DVFSFGVVLLELITGRKP 561
+ DR+ D + G VL E++ G P
Sbjct: 171 -QPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 62/205 (30%), Positives = 97/205 (47%), Gaps = 20/205 (9%)
Query: 367 VIGEGGFGCVYKGNLPE-GKVVAVK-------QLKSGSGQGEREFRAEVEIISRVHHRHL 418
+IG GGFG VY + GK+ A+K ++K G E R + ++S +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE-RIMLSLVSTGDCPFI 59
Query: 419 VSLVGYCISEKNRL-LIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHED 477
V + Y ++L I + + +L +HL G V + A GL ++H
Sbjct: 60 VCMT-YAFHTPDKLCFILDLMNGGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMHNR 116
Query: 478 CHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSG 537
+++RD+K ANIL+D+ +++D GLA + H S +GT GY+APE G
Sbjct: 117 F---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMAPEVLQKG 170
Query: 538 KLTDRS-DVFSFGVVLLELITGRKP 561
D S D FS G +L +L+ G P
Sbjct: 171 TAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-13
Identities = 59/215 (27%), Positives = 105/215 (48%), Gaps = 28/215 (13%)
Query: 368 IGEGGFGCVY--------KGNLPEGKVVAVKQLKS-GSGQGEREFRAEVEIISRV-HHRH 417
+GEG FG V K + VAVK LK + + + +E+E++ + H++
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 418 LVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWT--------------KRVKI 463
+++L+G C + ++ E+ NL +L + P ++++ V
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 464 ALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK-LNDTTQTHVSTRV 522
A A+G+ YL K IHRD+ + N+LV ++ ++ADFGLA+ +++ +T
Sbjct: 140 AYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 523 MGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT 557
++APE T +SDV+SFGV+L E+ T
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-13
Identities = 64/296 (21%), Positives = 100/296 (33%), Gaps = 57/296 (19%)
Query: 5 AETPGPPVANNASSGLGERKEEAKAPPAPAEK-----TESPEKKVTPPP--------ADN 51
AE P A A G + APPAP+ + P + P +
Sbjct: 2484 AEARFPFAAGAAPDPGGGGPPDPDAPPAPSRLAPAILPDEPVGEPVHPRMLTWIRGLEEL 2543
Query: 52 NNNGGGGNNSTTPAASPPPAS----PPPASPP-------------PASPPPAASP----- 89
++ G P A+PP A PPP P P +PP +A P
Sbjct: 2544 ASDDAGDPPPPLPPAAPPAAPDRSVPPPRPAPRPSEPAVTSRARRPDAPPQSARPRAPVD 2603
Query: 90 PPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSP------- 142
G P +PP + P PPP+ S + + P P PPPE+ ++ P
Sbjct: 2604 DRGDPRGPAPPSPLPPDTHAPDPPPPSPSPAANEPDPHPPPTVPPPERPRDDPAPGRVSR 2663
Query: 143 ------PAPPGQASTPPDSPPP-------GIQSNQGNPVPSNGTTDSRDTKWAPPSNPGS 189
QAS+PP P G ++ +P P T + +
Sbjct: 2664 PRRARRLGRAAQASSPPQRPRRRAARPTVGSLTSLADPPPPPPTPEPAPHALVSATP--L 2721
Query: 190 PPSPSTSQSGTPSTPNENSSPNELSPPSNSKSPTSKSSPEESSSSSHSNSKKTPTS 245
PP P+ ++ +P+ P + P + P+ P + P ++ P +
Sbjct: 2722 PPGPAAARQASPALPAAPAPPAVPAGPATPGGPARPARPPTTAGPPAPAPPAAPAA 2777
|
Length = 3151 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 2e-13
Identities = 61/210 (29%), Positives = 112/210 (53%), Gaps = 16/210 (7%)
Query: 368 IGEGGFGCVYKG--NLPEGKVVAVKQLKSGSGQGE--REFRAEVEIISRVHHRHLVSLVG 423
+GEG + V+KG L E +VA+K+++ +G R EV ++ + H ++V+L
Sbjct: 14 LGEGTYATVFKGRSKLTE-NLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHD 71
Query: 424 YCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIAL-GAAKGLAYLHEDCHPKI 482
++K+ L++E++ + +L+ ++ G + VKI L +GLAY H K+
Sbjct: 72 IVHTDKSLTLVFEYL-DKDLKQYMDDCGN--IMSMHNVKIFLYQILRGLAYCHRR---KV 125
Query: 483 IHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPE-YASSGKLTD 541
+HRD+K N+L+++ E ++ADFGLA+ S V+ T Y P+ S + +
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSSEYST 184
Query: 542 RSDVFSFGVVLLELITGRKPVDPTQPLGDE 571
+ D++ G + E+ +GR P+ P + DE
Sbjct: 185 QIDMWGVGCIFFEMASGR-PLFPGSTVEDE 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 2e-13
Identities = 35/137 (25%), Positives = 45/137 (32%), Gaps = 21/137 (15%)
Query: 30 PPAPAEKTESPEKK-VTPPPADNNNNGGGGNNSTTPAASPPPASPPP----ASPPPASPP 84
P A AE EKK P A PAA+P + A+P A+
Sbjct: 366 PAAAAEAAAPAEKKTPARPEA------------AAPAAAPVAQAAAAPAPAAAPAAAASA 413
Query: 85 PAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPP----PEQSKN 140
PAA P P P + P A+ A+ P A+P + P PE +
Sbjct: 414 PAAPPAAAPPAPVAAPAAAAPAAAPAAAPAAVALAPAPPAQAAPETVAIPVRVAPEPAVA 473
Query: 141 SPPAPPGQASTPPDSPP 157
S P A P
Sbjct: 474 SAAPAPAAAPAAARLTP 490
|
Length = 618 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 60/219 (27%), Positives = 100/219 (45%), Gaps = 40/219 (18%)
Query: 368 IGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGE-REFRAEVEIISRVHHRHLVSLVGYC 425
+G+G +G VYK + P G +A+K+++ + + + E++I+ + ++V G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 426 ISEKNRLLIYEFVPNNNLE------HHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCH 479
E + E++ +L+ G + VL +I KGL +L E+ +
Sbjct: 69 FIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLR-----RITYAVVKGLKFLKEEHN 123
Query: 480 PKIIHRDIKSANILVDDEFEAQVADFG--------LAKLNDTTQTHVSTRVMGTFGYLAP 531
IIHRD+K N+LV+ + ++ DFG LAK N +G Y+AP
Sbjct: 124 --IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN-----------IGCQSYMAP 170
Query: 532 EYASSGKLTDR------SDVFSFGVVLLELITGRKPVDP 564
E SG SDV+S G+ +LE+ GR P P
Sbjct: 171 ERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPP 209
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 2e-13
Identities = 59/200 (29%), Positives = 94/200 (47%), Gaps = 11/200 (5%)
Query: 367 VIGEGGFGCVYKGNLP-EGKVVAVKQLKSGSGQGEREFR---AEVEIISRVHHRHLVSLV 422
V+G+G FG V L +G+ AVK LK + + E +++ ++ +
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 423 GYCISEKNRLL-IYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPK 481
K L + EF+ +L H+ KG+ + + A GL +LH
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGR--FDLYRATFYAAEIVCGLQFLHSK---G 116
Query: 482 IIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTD 541
II+RD+K N+++D + ++ADFG+ K N ST GT Y+APE K T
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTPDYIAPEILQGLKYTF 175
Query: 542 RSDVFSFGVVLLELITGRKP 561
D +SFGV+L E++ G+ P
Sbjct: 176 SVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 3e-13
Identities = 62/216 (28%), Positives = 106/216 (49%), Gaps = 19/216 (8%)
Query: 357 EITNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLK---SGSGQGEREFRAEVEIISR 412
EITN + +G G FG V + G+ VA+K++ S +R +R E++++
Sbjct: 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR-ELKLLKH 65
Query: 413 VHHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLA 472
+ H +++SL IS + + +L L +P LE +GL
Sbjct: 66 LRHENIISLSDIFISPLEDIYFVTELLGTDLHRLL--TSRP-LEKQFIQYFLYQILRGLK 122
Query: 473 YLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQT-HVSTRVMGTFGYLAP 531
Y+H ++HRD+K +NIL+++ + ++ DFGLA++ D T +VSTR Y AP
Sbjct: 123 YVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY-----YRAP 174
Query: 532 EYASS-GKLTDRSDVFSFGVVLLELITGRKPVDPTQ 566
E + K D++S G + E++ G KP+ P +
Sbjct: 175 EIMLTWQKYDVEVDIWSAGCIFAEMLEG-KPLFPGK 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 63/229 (27%), Positives = 94/229 (41%), Gaps = 47/229 (20%)
Query: 362 FARENVIGEGGFGCVYKG--------------NLPEGKVVAVKQLKSGSGQGEREFRAEV 407
R +G G FG V+ +PE V+ +KQ E+ E
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPE--VIRLKQ--------EQHVHNEK 52
Query: 408 EIISRVHHRHLVSLVGYCISEKNRLL--IYEFVPNNNLEHHLHGKG----QPVLEWTKRV 461
++ V H ++ L + R L + E+VP L +L G L + +
Sbjct: 53 RVLKEVSHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEI 110
Query: 462 KIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK-LNDTTQTHVST 520
AL YLH +I++RD+K NIL+D E ++ DFG AK L D T T
Sbjct: 111 VCAL------EYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWT---- 157
Query: 521 RVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLG 569
+ GT YLAPE S D ++ G+++ E++ G P P G
Sbjct: 158 -LCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG 205
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 3e-13
Identities = 68/262 (25%), Positives = 118/262 (45%), Gaps = 31/262 (11%)
Query: 367 VIGEGGFGCVYKG-NLPEGKVVAVKQLK--SGSGQGEREFRA---EVEIISRVHHRHLVS 420
++G+G FG VY + G+ +AVKQ++ S + +E A E++++ + H +V
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 421 LVGYCISEKNRLL--IYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDC 478
G R L E +P +++ L G T++ + +G++YLH +
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQI--LEGVSYLHSN- 125
Query: 479 HPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDT---TQTHVSTRVMGTFGYLAPEYAS 535
I+HRDIK ANIL D ++ DFG +K T + T + + V GT +++PE S
Sbjct: 126 --MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS-VTGTPYWMSPEVIS 182
Query: 536 SGKLTDRSDVFSFGVVLLELITGRKP--------------VDPTQPLGDESLVEWARPVL 581
++D++S G ++E++T + P PT P+ + + R L
Sbjct: 183 GEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFL 242
Query: 582 VRAIETGDLSEIVDPRLEKHYV 603
R L D L +V
Sbjct: 243 KRIFVEAKLRPSADELLRHTFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 61/234 (26%), Positives = 102/234 (43%), Gaps = 48/234 (20%)
Query: 366 NVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRA--------------EVEII 410
+GEG +G V K + GK+VA+K++K + E++I+
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 411 SRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKR-----VK-IA 464
+ + H +++ LV + +F+ N + + + V++ R VK I
Sbjct: 75 NEIKHENIMGLVDVYVEG-------DFI--NLVMDIMASDLKKVVDRKIRLTESQVKCIL 125
Query: 465 LGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK------LNDTT---Q 515
L GL LH+ +HRD+ ANI ++ + ++ADFGLA+ +DT +
Sbjct: 126 LQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDE 182
Query: 516 THVSTRVMG----TFGYLAPE-YASSGKLTDRSDVFSFGVVLLELITGRKPVDP 564
T M T Y APE + K D++S G + EL+TG KP+ P
Sbjct: 183 TMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG-KPLFP 235
|
Length = 335 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 4e-13
Identities = 50/146 (34%), Positives = 82/146 (56%), Gaps = 15/146 (10%)
Query: 443 LEHHLHGKGQPVLEWTKRV------KIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDD 496
+EH G VL+ KR+ K+++ +GLAYL E +I+HRD+K +NILV+
Sbjct: 82 MEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNS 139
Query: 497 EFEAQVADFGLA-KLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLEL 555
E ++ DFG++ +L D+ ++ +GT Y++PE + +SD++S G+ L+EL
Sbjct: 140 RGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEL 195
Query: 556 ITGRKPVDPTQPLGDESLVEWARPVL 581
GR P+ P P E + RPV+
Sbjct: 196 AIGRYPIPP--PDAKELEAIFGRPVV 219
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 4e-13
Identities = 60/223 (26%), Positives = 100/223 (44%), Gaps = 59/223 (26%)
Query: 366 NVIGEGGFGCVYKGNLPEGKV-VAVKQLKSGSGQGE----REFRAEVEIISRVHHRHLVS 420
+ +G G +G V + VA+K+L S Q R +R E+ ++ + H +++
Sbjct: 21 SPVGSGAYGQVCSAFDTKTGRKVAIKKL-SRPFQSAIHAKRTYR-ELRLLKHMDHENVIG 78
Query: 421 LVGYCISEKNRLLIYEFVPNNNLEH--------HLHG-------KGQPVLEWTKRVK-IA 464
L+ F P ++LE HL G K Q + + ++ +
Sbjct: 79 LLDV------------FTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSD--DHIQFLV 124
Query: 465 LGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQT-HVSTRVM 523
+GL Y+H IIHRD+K +NI V+++ E ++ DFGLA+ D T +V+TR
Sbjct: 125 YQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR-- 179
Query: 524 GTFGYLAPE-------YASSGKLTDRSDVFSFGVVLLELITGR 559
Y APE Y D++S G ++ EL+TG+
Sbjct: 180 ---WYRAPEIMLNWMHY------NQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (171), Expect = 4e-13
Identities = 61/219 (27%), Positives = 98/219 (44%), Gaps = 45/219 (20%)
Query: 370 EGGFG--CVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVH-----HRHLVSLV 422
+G FG V K + P K+ K +K + F A +E + VH + + + L
Sbjct: 26 DGKFGKVSVLK-HKPTQKLFVQKIIK------AKNFNA-IEPM--VHQLMKDNPNFIKLY 75
Query: 423 GYCI-SEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPK 481
Y + + K +LI +++ + +L L +G+ L + KI + L LH+ H
Sbjct: 76 -YSVTTLKGHVLIMDYIKDGDLFDLLKKEGK--LSEAEVKKIIRQLVEALNDLHK--H-N 129
Query: 482 IIHRDIKSANILVDDEFEAQV--ADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKL 539
IIH DIK N+L D + ++ D+GL K+ T + GT Y +PE K+
Sbjct: 130 IIHNDIKLENVLY-DRAKDRIYLCDYGLCKIIGTPSCY-----DGTLDYFSPE-----KI 178
Query: 540 TDRSDVFSF-----GVVLLELITGRKPVDPTQPLGDESL 573
+ SF GV+ EL+TG+ P + DE L
Sbjct: 179 KGHNYDVSFDWWAVGVLTYELLTGKHPFKEDE---DEEL 214
|
Length = 267 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 5e-13
Identities = 53/271 (19%), Positives = 84/271 (30%), Gaps = 31/271 (11%)
Query: 5 AETPGPPVANNASSGLGERKEEAKAPPAPAEKTESPEKKVTPPPADN---NNNGGGGNNS 61
A P P + + + + + P P+ PPP+ + N +
Sbjct: 2586 ARRPDAPPQSARPRAPVDDRGDPRGPAPPSPLPPDTHAPDPPPPSPSPAANEPDPHPPPT 2645
Query: 62 TTPAASPPPASPPPASPPP-----ASPPPAASPPPGSPPPASPPPASGS----ASPPP-- 110
P P P P AS PP P + P GS A PPP
Sbjct: 2646 VPPPERPRDDPAPGRVSRPRRARRLGRAAQASSPPQRPRRRAARPTVGSLTSLADPPPPP 2705
Query: 111 ----ASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPPGQASTP-PDSPPPGIQSNQG 165
+P S + P P + P + +PPA P +TP + P + G
Sbjct: 2706 PTPEPAPHALVSATPLPPGPAAARQASPALPAAPAPPAVPAGPATPGGPARPARPPTTAG 2765
Query: 166 NPVPSNGTTDSRDTKWAPPSNPGSPPSPSTSQSGTPSTPNENSSPNELSPPSNSKSPTSK 225
P P APP+ P + P ++ S S P++ +
Sbjct: 2766 PPAP------------APPAAPAAGPPRRLTRPAVASLSESRESLPSPWDPADPPAAVLA 2813
Query: 226 SSPEESSSSSHSNSKKTPTSSSGHSSDSTKG 256
+ ++S + PTS+ + G
Sbjct: 2814 PAAALPPAASPAGPLPPPTSAQPTAPPPPPG 2844
|
Length = 3151 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 5e-13
Identities = 59/206 (28%), Positives = 102/206 (49%), Gaps = 12/206 (5%)
Query: 368 IGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCI 426
IG G +G VYK N+ G++ A+K +K G+ + E+ ++ H ++V+ G +
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 427 SEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRD 486
+ EF +L+ H G P+ E ++ ++ +GL YLH +HRD
Sbjct: 77 RRDKLWICMEFCGGGSLQDIYHVTG-PLSE-SQIAYVSRETLQGLYYLHSKGK---MHRD 131
Query: 487 IKSANILVDDEFEAQVADFGL-AKLNDTTQTHVSTRVMGTFGYLAPEYAS---SGKLTDR 542
IK ANIL+ D ++ADFG+ A++ T S +GT ++APE A+ G
Sbjct: 132 IKGANILLTDNGHVKLADFGVSAQITATIAKRKS--FIGTPYWMAPEVAAVERKGGYNQL 189
Query: 543 SDVFSFGVVLLELITGRKPVDPTQPL 568
D+++ G+ +EL + P+ P+
Sbjct: 190 CDIWAVGITAIELAELQPPMFDLHPM 215
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 5e-13
Identities = 63/203 (31%), Positives = 95/203 (46%), Gaps = 16/203 (7%)
Query: 367 VIGEGGFGCVYKGNLPE-GKVVAVKQLKSGS---GQGEREFRAEVEIISRVHHRH--LVS 420
+IG GGFG VY + GK+ A+K L QGE E ++S V +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 421 LVGYCISEKNRL-LIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCH 479
+ Y ++L I + + +L +HL G V + A GL ++H
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG--VFSEAEMRFYAAEIILGLEHMHNRF- 117
Query: 480 PKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKL 539
+++RD+K ANIL+D+ +++D GLA + H S +GT GY+APE G
Sbjct: 118 --VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMAPEVLQKGVA 172
Query: 540 TDRS-DVFSFGVVLLELITGRKP 561
D S D FS G +L +L+ G P
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 6e-13
Identities = 61/206 (29%), Positives = 96/206 (46%), Gaps = 18/206 (8%)
Query: 368 IGEGGFGCVYKGNLPE-GKVVAVKQLKSGSGQGEREFRA--EVEIISRVH---HRHLVSL 421
IG G +G VYK P G VA+K ++ + + EV ++ R+ H ++V L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 422 VGYCIS-----EKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHE 476
+ C + E L++E V + +L +L P L + +GL +LH
Sbjct: 68 MDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA 126
Query: 477 DCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASS 536
+C I+HRD+K NILV + ++ADFGLA++ T V+ T Y APE
Sbjct: 127 NC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA--LTPVVVTLWYRAPEVLLQ 181
Query: 537 GKLTDRSDVFSFGVVLLELITGRKPV 562
D++S G + E+ RKP+
Sbjct: 182 STYATPVDMWSVGCIFAEMFR-RKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 7e-13
Identities = 24/118 (20%), Positives = 39/118 (33%)
Query: 57 GGNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPT 116
+ A A A+ P A+P PAA+ P + PA + +P PA PP+
Sbjct: 384 RLGVAGGAGAPAAAAPSAAAAAPAAAPAPAAAAPAAAAAPAPAAAPQPAPAPAPAPAPPS 443
Query: 117 RSESQSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTT 174
+ + + + P PA + + P PP + P
Sbjct: 444 PAGNAPAGGAPSPPPAAAPSAQPAPAPAAAPEPTAAPAPAPPAAPAPAAAPAAPAAPA 501
|
Length = 824 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 7e-13
Identities = 67/222 (30%), Positives = 102/222 (45%), Gaps = 24/222 (10%)
Query: 368 IGEGGFGCVYKGNLPEG-KVVAVKQLKSGSGQGEREFR---AEVEIISRVHHRHLVSLVG 423
IG+G FG V + + ++ A+K ++ E AE ++++V+ +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 424 YCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKII 483
S + L+ F+ L HHL +G+ L + L A L LH+ +I
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCA--LENLHK---FNVI 115
Query: 484 HRDIKSANILVDDEFEAQVADFGLAKLN----DTTQTHVSTRVMGTFGYLAPEYASSGKL 539
+RD+K NIL+D + + DFGL KLN D T T GT YLAPE
Sbjct: 116 YRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC-----GTPEYLAPELLLGHGY 170
Query: 540 TDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVL 581
T D ++ GV+L E++TG P DE++ E R +L
Sbjct: 171 TKAVDWWTLGVLLYEMLTG------LPPFYDENVNEMYRKIL 206
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|235906 PRK07003, PRK07003, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 9e-13
Identities = 35/192 (18%), Positives = 61/192 (31%), Gaps = 7/192 (3%)
Query: 48 PADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSAS 107
PA GG A + P A+ AS PA + G+ A P A+ +A+
Sbjct: 360 PAVTGGGAPGGGVPARVAGAVPAPGARAAAAVGASAVPAVTAVTGAAGAALAPKAAAAAA 419
Query: 108 PPPASPPPTRSE-SQSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGN 166
A PP ++ D P +K + A D+ PP +
Sbjct: 420 ATRAEAPPAAPAPPATADRGDDAADGDAPVPAKANARASADSRCDERDAQPPADSGSASA 479
Query: 167 PVPSNGTTDSRDTKWAPPSNPGSPPSPSTSQ-SGTPSTPNENSSPNELSPPSNSKSPTSK 225
P D+ P+ + PS +T P S + + +
Sbjct: 480 PAS-----DAPPDAAFEPAPRAAAPSAATPAAVPDARAPAAASREDAPAAAAPPAPEARP 534
Query: 226 SSPEESSSSSHS 237
+P ++ ++ +
Sbjct: 535 PTPAAAAPAARA 546
|
Length = 830 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-12
Identities = 61/202 (30%), Positives = 93/202 (46%), Gaps = 11/202 (5%)
Query: 367 VIGEGGFGCVYKGNLPE-GKVVAVKQLKSGSGQGEREFRA---EVEIISRVHHRHLVSLV 422
V+G+G FG V L E G++ AVK LK + + E I+S + ++ +
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 423 GYCISEKNRLL-IYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPK 481
C +RL + EFV +L H+ K + E R A L +LH+
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQ-KSRRFDEARARF-YAAEITSALMFLHDK---G 116
Query: 482 IIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTD 541
II+RD+K N+L+D E ++ADFG+ K ST GT Y+APE
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST-FCGTPDYIAPEILQEMLYGP 175
Query: 542 RSDVFSFGVVLLELITGRKPVD 563
D ++ GV+L E++ G P +
Sbjct: 176 SVDWWAMGVLLYEMLCGHAPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|237057 PRK12323, PRK12323, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 2e-12
Identities = 41/213 (19%), Positives = 81/213 (38%), Gaps = 10/213 (4%)
Query: 55 GGGGNNSTTPAASPPPASPPPASPPPASPPPAASPP--PGSPPPASPPPASGSASPPPAS 112
GGG T AA+P P A+ P A+ P A+PP P + P A+ + +A+P S
Sbjct: 368 SGGGAGPATAAAAPVAQPAPAAAAPAAAAPAPAAPPAAPAAAPAAAAAARAVAAAPARRS 427
Query: 113 PPPTRSESQSSPPPGDGGASPPPEQSKNS-------PPAPPGQASTPPDSPPPGIQSNQG 165
P P + G +P P + + P A + + P +
Sbjct: 428 PAPEALAAARQASARGPGGAPAPAPAPAAAPAAAARPAAAGPRPVAAAAAAAPARAAPAA 487
Query: 166 NPVPS-NGTTDSRDTKWAPPSNPGSPPSPSTSQSGTPSTPNENSSPNELSPPSNSKSPTS 224
P P+ + + S + P + + S P+ ++ + + + + +P +
Sbjct: 488 APAPADDDPPPWEELPPEFASPAPAQPDAAPAGWVAESIPDPATADPDDAFETLAPAPAA 547
Query: 225 KSSPEESSSSSHSNSKKTPTSSSGHSSDSTKGS 257
+P ++++ + + P +S+ D G
Sbjct: 548 APAPRAAAATEPVVAPRPPRASASGLPDMFDGD 580
|
Length = 700 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 2e-12
Identities = 43/185 (23%), Positives = 61/185 (32%), Gaps = 8/185 (4%)
Query: 2 ANSAETPGPPVANNASSGLGERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNS 61
A A P A + + A P A P+ P +D +
Sbjct: 616 AAPAAPAAPAAPAPAGAAAAPAEASAAPAPGVAAPEHHPKHVAVPDASDGGDGWPAKAGG 675
Query: 62 TTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPA---SPPPTRS 118
PAA PP +P + P + P +P P + PPA + P A S P +
Sbjct: 676 AAPAAPPPAPAPAAPAAPAGAAPAQPAPAPAATPPAGQADDPAAQPPQAAQGASAPSPAA 735
Query: 119 ESQSSPPP-----GDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGT 173
+ PP D +P +P A+ PP SPP + + PS
Sbjct: 736 DDPVPLPPEPDDPPDPAGAPAQPPPPPAPAPAAAPAAAPPPSPPSEEEEMAEDDAPSMDD 795
Query: 174 TDSRD 178
D RD
Sbjct: 796 EDRRD 800
|
Length = 824 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 2e-12
Identities = 28/132 (21%), Positives = 42/132 (31%), Gaps = 13/132 (9%)
Query: 65 AASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSP 124
A + PA + P A+ P AA + PA + +AS P A P ++P
Sbjct: 370 AEAAAPAEKKTPARPEAAAPAAAPVAQAAAAPAPAAAPAAAASAPAAPPAAAPPAPVAAP 429
Query: 125 PPGDGGASPPP-EQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAP 183
A+P + PAPP QA+ + P + AP
Sbjct: 430 AAAAPAAAPAAAPAAVALAPAPPAQAAPETVAIPVRVAPEPAVASA------------AP 477
Query: 184 PSNPGSPPSPST 195
+ T
Sbjct: 478 APAAAPAAARLT 489
|
Length = 618 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-12
Identities = 44/262 (16%), Positives = 80/262 (30%), Gaps = 19/262 (7%)
Query: 4 SAETPGPPVANNASSG----LGERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGN 59
P P + + R + + P ++ P G +
Sbjct: 2643 PPTVPPPERPRDDPAPGRVSRPRRARRLGRAAQASSPPQRPRRRAARPTV-----GSLTS 2697
Query: 60 NSTTPAASPPPASPPPASPPPASPPPAASPPPGSPP-----PASPPPASGSASPPPASPP 114
+ P P P P A PP + + P PA P +G A+P + P
Sbjct: 2698 LADPPPPPPTPEPAPHALVSATPLPPGPAAARQASPALPAAPAPPAVPAGPATPGGPARP 2757
Query: 115 PTRSESQSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTT 174
+ P P A + + PA + + P P ++ V +
Sbjct: 2758 ARPPTTAGPPAPAPPAAPAAGPPRRLTRPAVASLSESRESLPSPWDPADPPAAVLAPAAA 2817
Query: 175 DSRDTKWAPPSNPGSPPSPSTSQSGTPSTPNENSSPNE--LSPPSN-SKSPTSKSSPEES 231
A P P P S + P P S P ++P + + P S+S +
Sbjct: 2818 LPPAASPAGPLPP--PTSAQPTAPPPPPGPPPPSLPLGGSVAPGGDVRRRPPSRSPAAKP 2875
Query: 232 SSSSHSNSKKTPTSSSGHSSDS 253
++ + ++ + S++S
Sbjct: 2876 AAPARPPVRRLARPAVSRSTES 2897
|
Length = 3151 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 4e-12
Identities = 50/203 (24%), Positives = 99/203 (48%), Gaps = 10/203 (4%)
Query: 365 ENVIGEGGFGCVYKG--NLPEGK--VVAVKQLKSG-SGQGEREFRAEVEIISRVHHRHLV 419
E ++G G FG + +G LP + VA+ L++G S + R F AE + + H ++V
Sbjct: 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIV 69
Query: 420 SLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCH 479
L G +++ E++ N L+ L K + L + + + G A G+ YL E +
Sbjct: 70 RLEGVITRGNTMMIVTEYMSNGALDSFLR-KHEGQLVAGQLMGMLPGLASGMKYLSEMGY 128
Query: 480 PKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKL 539
+H+ + + +LV+ + +++ F + + + + + + APE
Sbjct: 129 ---VHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHF 185
Query: 540 TDRSDVFSFGVVLLELIT-GRKP 561
+ SDV+SFG+V+ E+++ G +P
Sbjct: 186 SSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 15/202 (7%)
Query: 367 VIGEGGFGCVYKGNLP-EGKVVAVKQLKSGSGQGEREFR---AEVEIISRV-HHRHLVSL 421
++G+G FG V+ L + A+K LK + + E ++S H L L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 422 VGYCI--SEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCH 479
YC +++N + E++ +L H+ + + + A GL +LH
Sbjct: 62 --YCTFQTKENLFFVMEYLNGGDLMFHIQSCHK--FDLPRATFYAAEIICGLQFLHSK-- 115
Query: 480 PKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKL 539
I++RD+K NIL+D + ++ADFG+ K N T GT Y+APE K
Sbjct: 116 -GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT-FCGTPDYIAPEILLGQKY 173
Query: 540 TDRSDVFSFGVVLLELITGRKP 561
D +SFGV+L E++ G+ P
Sbjct: 174 NTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|235906 PRK07003, PRK07003, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 7e-12
Identities = 34/157 (21%), Positives = 54/157 (34%), Gaps = 1/157 (0%)
Query: 2 ANSAETPGPPVANNASSGLGERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNS 61
A + P + G A A A + E+P PP + + ++
Sbjct: 388 AAAVGASAVPAVTAVTGAAGAALAPKAAAAAAATRAEAPPAAPAPPATADRGDDAADGDA 447
Query: 62 TTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQ 121
PA + AS + PPA S +P +PP A+ P A+ P + +
Sbjct: 448 PVPAKANARASADSRCDERDAQPPADSGSASAPASDAPPDAA-FEPAPRAAAPSAATPAA 506
Query: 122 SSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPP 158
AS + +PPAP + TP + P
Sbjct: 507 VPDARAPAAASREDAPAAAAPPAPEARPPTPAAAAPA 543
|
Length = 830 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 7e-12
Identities = 56/231 (24%), Positives = 104/231 (45%), Gaps = 44/231 (19%)
Query: 357 EITNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQ--GEREFRAEVEIISRV 413
++ + + IGEG +G V + P G VA+K++ Q +R R E++I+ R
Sbjct: 2 DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR-EIKILRRF 60
Query: 414 HHRHLVSLVGYCISE-----KNRLLIYEFVPNNNLEHHLHG--KGQPV--------LEWT 458
H +++ ++ + ++ E +E L+ K Q + L
Sbjct: 61 KHENIIGILDIIRPPSFESFNDVYIVQEL-----METDLYKLIKTQHLSNDHIQYFLYQI 115
Query: 459 KRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHV 518
R GL Y+H ++HRD+K +N+L++ + ++ DFGLA++ H
Sbjct: 116 LR---------GLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARI--ADPEHD 161
Query: 519 STRVM----GTFGYLAPEYASSGKLTDRS-DVFSFGVVLLELITGRKPVDP 564
T + T Y APE + K ++ D++S G +L E+++ R P+ P
Sbjct: 162 HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR-PLFP 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 8e-12
Identities = 29/128 (22%), Positives = 38/128 (29%), Gaps = 2/128 (1%)
Query: 22 ERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPA 81
ER+ P A + A P PA P
Sbjct: 382 ERRLGVAGGAGAPAAAAPSAAAAAPAAAPAP--AAAAPAAAAAPAPAAAPQPAPAPAPAP 439
Query: 82 SPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNS 141
+PP A P P+ PP A+ SA P PA + +P P A + +
Sbjct: 440 APPSPAGNAPAGGAPSPPPAAAPSAQPAPAPAAAPEPTAAPAPAPPAAPAPAAAPAAPAA 499
Query: 142 PPAPPGQA 149
P AP G
Sbjct: 500 PAAPAGAD 507
|
Length = 824 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 8e-12
Identities = 38/149 (25%), Positives = 50/149 (33%), Gaps = 25/149 (16%)
Query: 4 SAETPGPPVANNASSGLGERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTT 63
+A A + E A AP A A + P
Sbjct: 367 AAAAEAAAPAEKKTPARPEAAAPAAAPVAQA----AAAPAPAAAP--------------- 407
Query: 64 PAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSS 123
AA+ PA+PP A+PP PAA+ P +P A A A P A+P + +
Sbjct: 408 AAAASAPAAPPAAAPPAPVAAPAAAAPAAAPAAAPAAVALAPAPPAQAAPETVAIPVRVA 467
Query: 124 PPPGDGGASPPPEQSKNSPPAPPGQASTP 152
P P A+P P AP TP
Sbjct: 468 PEPAVASAAPAP------AAAPAAARLTP 490
|
Length = 618 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 8e-12
Identities = 56/201 (27%), Positives = 105/201 (52%), Gaps = 20/201 (9%)
Query: 367 VIGEGGFGCV-YKGNLPEGKVVAVKQL--KSGSGQGEREFRAEVEIISRVHHRHLVSLVG 423
V+G+G +G V + +GK +K+L ++ S + + E +++S++ H ++V+
Sbjct: 7 VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66
Query: 424 YCISEKNRL-LIYEFVPNNNLEHHL-HGKGQ-----PVLEWTKRVKIALGAAKGLAYLHE 476
E L ++ F +L H L KG+ V+EW V+IA+ L YLHE
Sbjct: 67 SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWF--VQIAMA----LQYLHE 120
Query: 477 DCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASS 536
I+HRD+K+ N+ + +V D G+A++ + Q +++ ++GT Y++PE S+
Sbjct: 121 K---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN-QCDMASTLIGTPYYMSPELFSN 176
Query: 537 GKLTDRSDVFSFGVVLLELIT 557
+SDV++ G + E+ T
Sbjct: 177 KPYNYKSDVWALGCCVYEMAT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 9e-12
Identities = 59/206 (28%), Positives = 107/206 (51%), Gaps = 11/206 (5%)
Query: 362 FARENVIGEGGFGCVYK-GNLPEGKVVAVKQLKSGSGQGER-EFRAEVEIISRVHHRHLV 419
F + + +G G G V+K + P G ++A K + R + E++++ + ++V
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 420 SLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCH 479
G S+ + E + +L+ L G+ + +V IA+ KGL YL E
Sbjct: 67 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV--IKGLTYLREK-- 122
Query: 480 PKIIHRDIKSANILVDDEFEAQVADFGLA-KLNDTTQTHVSTRVMGTFGYLAPEYASSGK 538
KI+HRD+K +NILV+ E ++ DFG++ +L D+ ++ +GT Y++PE
Sbjct: 123 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTH 178
Query: 539 LTDRSDVFSFGVVLLELITGRKPVDP 564
+ +SD++S G+ L+E+ GR P+ P
Sbjct: 179 YSVQSDIWSMGLSLVEMAIGRYPIPP 204
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|237057 PRK12323, PRK12323, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 1e-11
Identities = 40/185 (21%), Positives = 62/185 (33%), Gaps = 4/185 (2%)
Query: 10 PPVANNASSGLGERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNN--STTPAAS 67
P A A+ A A A SP + + G GG + PAA+
Sbjct: 398 APAAPPAAPAAAPAAAAAARAVAAAPARRSPAPEALAAARQASARGPGGAPAPAPAPAAA 457
Query: 68 PPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPP--PTRSESQSSPP 125
P A+ P A+ P AA+ P + P A+P PA P PP + + +Q
Sbjct: 458 PAAAARPAAAGPRPVAAAAAAAPARAAPAAAPAPADDDPPPWEELPPEFASPAPAQPDAA 517
Query: 126 PGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPS 185
P A P+ + P + P + P + PV + + +
Sbjct: 518 PAGWVAESIPDPATADPDDAFETLAPAPAAAPAPRAAAATEPVVAPRPPRASASGLPDMF 577
Query: 186 NPGSP 190
+ P
Sbjct: 578 DGDWP 582
|
Length = 700 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 63/211 (29%), Positives = 100/211 (47%), Gaps = 30/211 (14%)
Query: 367 VIGEGGFGCVYKGNLPEG----KVVAVKQLKSG----SGQGEREFRAEVEIISRVHHRHL 418
V+G+GG+G V++ G K+ A+K LK + + +AE I+ V H +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 419 VSLVGYCISEKNRL-LIYEFVPNNNLEHHLHGKGQPVLEWT-----KRVKIALGAAKGLA 472
V L+ Y +L LI E++ L HL +G +E T + +AL
Sbjct: 63 VDLI-YAFQTGGKLYLILEYLSGGELFMHLEREGI-FMEDTACFYLSEISLALE------ 114
Query: 473 YLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK--LNDTTQTHVSTRVMGTFGYLA 530
+LH II+RD+K NIL+D + ++ DFGL K +++ T TH GT Y+A
Sbjct: 115 HLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT---FCGTIEYMA 168
Query: 531 PEYASSGKLTDRSDVFSFGVVLLELITGRKP 561
PE D +S G ++ +++TG P
Sbjct: 169 PEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 19/207 (9%)
Query: 368 IGEGGFGCVY---KGNLPEGKVVAVKQLKSGSGQGEREFR---AEVEIISRVHHRHLVSL 421
+G+GG+G V+ K + G++VA+K++K E R E +I++ LV L
Sbjct: 9 VGQGGYGQVFLAKKKD--TGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKL 66
Query: 422 VGYCISEKNRL-LIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHP 480
+ Y + L L E+VP + L+ G + + + A + LHE
Sbjct: 67 L-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEA--VDALHE---L 120
Query: 481 KIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLT 540
IHRD+K N L+D ++ DFGL+K T + V+G+ Y+APE
Sbjct: 121 GYIHRDLKPENFLIDASGHIKLTDFGLSK-GIVTYAN---SVVGSPDYMAPEVLRGKGYD 176
Query: 541 DRSDVFSFGVVLLELITGRKPVDPTQP 567
D +S G +L E + G P + P
Sbjct: 177 FTVDYWSLGCMLYEFLCGFPPFSGSTP 203
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 60/213 (28%), Positives = 111/213 (52%), Gaps = 34/213 (15%)
Query: 367 VIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRA--EVEIISRVHHRHLVSLVG 423
+GEG + VYKG + G++VA+K+++ +G F A E ++ + H ++V+L
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA-PFTAIREASLLKDLKHANIVTLHD 70
Query: 424 YCISEKNRLLIYEFVPNNNLEHHL--HGKG-QPVLEWTKRVKIAL-GAAKGLAYLHEDCH 479
++K L++E++ + +L+ ++ G G V++ L +GLAY H
Sbjct: 71 IIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSM-----HNVRLFLFQLLRGLAYCH---Q 121
Query: 480 PKIIHRDIKSANILVDDEFEAQVADFGLAKLNDT-TQTHVSTRVMGTFGYLAP------- 531
+++HRD+K N+L+ + E ++ADFGLA+ ++T+ + V T Y P
Sbjct: 122 RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV--TLWYRPPDVLLGST 179
Query: 532 EYASSGKLTDRSDVFSFGVVLLELITGRKPVDP 564
EY++S D++ G + E+ TGR P+ P
Sbjct: 180 EYSTS------LDMWGVGCIFYEMATGR-PLFP 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 51/150 (34%), Positives = 75/150 (50%), Gaps = 27/150 (18%)
Query: 425 CISEKNRL-LIYEFVPNNNLEHHLHGKG---QPVLEWTKRVKIALGAAKGLAYLHEDCHP 480
C +RL + E+V +L +H+ G +P V A A GL +LH
Sbjct: 69 CFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPH-----AVFYAAEIAIGLFFLHSK--- 120
Query: 481 KIIHRDIKSANILVDDEFEAQVADFGLAKLN----DTTQTHVSTRVMGTFGYLAPE---Y 533
II+RD+K N+++D E ++ADFG+ K N TT+T GT Y+APE Y
Sbjct: 121 GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFC-----GTPDYIAPEIIAY 175
Query: 534 ASSGKLTDRSDVFSFGVVLLELITGRKPVD 563
GK D ++FGV+L E++ G+ P D
Sbjct: 176 QPYGKSVDW---WAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 1e-11
Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 19/210 (9%)
Query: 368 IGEGGFGCVYKGNLPEG---KVVAVKQLKSGSG-QGEREFRAEVEIISRVHHRHLVSLVG 423
IG G FG V G + G V VK+L+ + Q + +F E + + H +L+ +G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 424 YCISEKNRLLIYEFVPNNNLEHHLHGKGQPVL---EWTKRVKIALGAAKGLAYLHEDCHP 480
C LL+ EF P +L+ +L + L + T ++A A GL +LH++
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN--- 119
Query: 481 KIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHV-STRVMGTFGYLAPEYASS--G 537
IH D+ N L+ + ++ D+GL+ +V ++ ++APE G
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG 179
Query: 538 KL-----TDRSDVFSFGVVLLELIT-GRKP 561
L T S+V+S GV + EL G +P
Sbjct: 180 NLLVVDQTKESNVWSLGVTIWELFELGSQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|237605 PRK14086, dnaA, chromosomal replication initiation protein; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 1e-11
Identities = 41/198 (20%), Positives = 56/198 (28%), Gaps = 19/198 (9%)
Query: 25 EEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPP 84
E PP A +T PE P P G GG + P P + PA P
Sbjct: 93 GEPAPPPPHARRTSEPEL---PRPGRRPYEGYGGPRADDRPPGLPRQDQLP-TARPAYPA 148
Query: 85 PAASPPPGS--PPPASPPPASGSASPPPASPPPT-----RSESQSSPPPGDGGASPPPEQ 137
P PG+ PP +P + + + P G +
Sbjct: 149 YQQRPEPGAWPRAADDYGWQQQRLGFPPRAPYASPASYAPEQERDREPYDAGRPEYDQRR 208
Query: 138 SKNSPPAP----PGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPSNPGSPPSP 193
P P P + T PPPG G+ RD P P +P
Sbjct: 209 RDYDHPRPDWDRPRRDRTDRPEPPPG----AGHVHRGGPGPPERDDAPVVPIRPSAPGPL 264
Query: 194 STSQSGTPSTPNENSSPN 211
+ + P + N
Sbjct: 265 AAQPAPAPGPGEPTARLN 282
|
Length = 617 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-11
Identities = 48/191 (25%), Positives = 65/191 (34%), Gaps = 4/191 (2%)
Query: 71 ASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGG 130
A A + PP P +P S S S S ++ P G
Sbjct: 52 AVTVVAGAAACDRFEPPTGPPPGPGTEAPANESRSTPTWSLSTLAPASPAREGSPTPPGP 111
Query: 131 ASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPSNPGSP 190
+SP P P +PP S PD P P+ + + A S+ S
Sbjct: 112 SSPDPPPPTPPPASPP--PSPAPDLSEMLRPVGSPGPPPAASPPAAGASPAAVASDAASS 169
Query: 191 PSPSTSQSGTPSTPNENSSPNELSPPSNSKSPTSKSSPEESSSSSHSNSKKTPTSSSGHS 250
+ S T SSP PPS + S P SS S S S +P + G S
Sbjct: 170 RQAALPLSSPEETARAPSSPPAEPPPSTPPAAASPRPPRRSSPISASAS--SPAPAPGRS 227
Query: 251 SDSTKGSSSND 261
+ G+SS+D
Sbjct: 228 AADDAGASSSD 238
|
Length = 1352 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-11
Identities = 30/95 (31%), Positives = 38/95 (40%), Gaps = 6/95 (6%)
Query: 61 STTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTR--- 117
P +P PA P A+P P P PA S P + A+ PP P P R
Sbjct: 359 LLVPVPAPQPAKPTAAAPSPVRPTPAPSTRPKAAAAANIPPKEPVRETATPPPVPPRPVA 418
Query: 118 ---SESQSSPPPGDGGASPPPEQSKNSPPAPPGQA 149
+ S P A P E+ K +PPAPP +
Sbjct: 419 PPVPHTPESAPKLTRAAIPVDEKPKYTPPAPPKEE 453
|
Length = 585 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 71/247 (28%), Positives = 114/247 (46%), Gaps = 29/247 (11%)
Query: 341 GVLGGSKSFFTYEELMEITNGFARENVIGEGGFGCVYK-GNLPEGKVVAVKQLKSGSGQG 399
G+ + S E L + T+ + IG+G +G VYK N +G + AVK L S
Sbjct: 3 GLFPYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD 62
Query: 400 EREFRAEVEIISRV-HHRHLVSLVGYCISEKNRL-----LIYEFVPNNNLEHHLHG---K 450
E E AE I+ + +H ++V G + L+ E ++ + G
Sbjct: 63 E-EIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLIC 121
Query: 451 GQ----PVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFG 506
GQ ++ + I GA GL +LH + +IIHRD+K NIL+ E ++ DFG
Sbjct: 122 GQRLDEAMISY-----ILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFG 173
Query: 507 LAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTD-----RSDVFSFGVVLLELITGRKP 561
++ +T+ +T V GT ++APE + + D R DV+S G+ +EL G P
Sbjct: 174 VSAQLTSTRLRRNTSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPP 232
Query: 562 VDPTQPL 568
+ P+
Sbjct: 233 LFDMHPV 239
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 61/214 (28%), Positives = 104/214 (48%), Gaps = 23/214 (10%)
Query: 362 FARENVIGEGGFGCVYKG-NLPEGKVVAVKQLK---SGSGQGEREFRAEVEIISRVHHRH 417
+ + IGEG +G VYK + + +A+K+++ G R E+ ++ + H +
Sbjct: 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIR-EISLLKEMQHGN 62
Query: 418 LVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKR-VKIAL-GAAKGLAYLH 475
+V L SEK L++E++ +L+ H P R +K L +G+AY H
Sbjct: 63 IVRLQDVVHSEKRLYLVFEYL---DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH 119
Query: 476 EDCHPKIIHRDIKSANILVDDEFEA-QVADFGLAK---LNDTTQTHVSTRVMGTFGYLAP 531
+++HRD+K N+L+D A ++ADFGLA+ + T TH T Y AP
Sbjct: 120 SH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV----TLWYRAP 172
Query: 532 E-YASSGKLTDRSDVFSFGVVLLELITGRKPVDP 564
E S + D++S G + E++ +KP+ P
Sbjct: 173 EILLGSRHYSTPVDIWSVGCIFAEMVN-QKPLFP 205
|
Length = 294 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 60/211 (28%), Positives = 96/211 (45%), Gaps = 20/211 (9%)
Query: 368 IGEGGFGCVYKGNLPEGKV---VAVKQLKSG-SGQGERE-FRAEVEIISRVHHRHLVSLV 422
+GEG FG V +G L + VAVK +K + E E F +E + H +++ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 423 GYCISEKNR------LLIYEFVPNNNLEHHL---HGKGQPVLEWTKR-VKIALGAAKGLA 472
G C+ ++I F+ + +L L P T+ VK A G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 473 YLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGT-FGYLAP 531
YL IHRD+ + N ++++ VADFGL+K + R+ ++A
Sbjct: 127 YLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 532 EYASSGKLTDRSDVFSFGVVLLELIT-GRKP 561
E + T +SDV+SFGV + E+ T G+ P
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 20/208 (9%)
Query: 367 VIGEGGFGCVY-----KGNLPEGKVVAVKQLKSGS----GQGEREFRAEVEIISRVHHRH 417
V+G G +G V+ G+ GK+ A+K LK + + R E +++ +
Sbjct: 7 VLGTGAYGKVFLVRKVSGH-DSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 65
Query: 418 LVSLVGYCISEKNRL-LIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGA-AKGLAYLH 475
+ + Y +L LI +++ L HL Q + V+I G L +LH
Sbjct: 66 FLVTLHYAFQTDTKLHLILDYINGGELFTHL---SQRERFKEQEVQIYSGEIVLALEHLH 122
Query: 476 EDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYAS 535
+ II+RDIK NIL+D + DFGL+K + + GT Y+AP+
Sbjct: 123 K---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVR 179
Query: 536 SGKLT-DRS-DVFSFGVVLLELITGRKP 561
G D++ D +S GV++ EL+TG P
Sbjct: 180 GGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 12/204 (5%)
Query: 368 IGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCI 426
IGEG G V + GK+VAVK++ Q EV I+ H ++V + +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 427 SEKNRLLIYEFVPNNNLEHHL-HGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHR 485
++ EF+ L + H + + + + L K L+ LH +IHR
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLKALSVLHAQ---GVIHR 140
Query: 486 DIKSANILVDDEFEAQVADFGL-AKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSD 544
DIKS +IL+ + +++DFG A+++ S ++GT ++APE S D
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPELISRLPYGPEVD 198
Query: 545 VFSFGVVLLELITGRKPVDPTQPL 568
++S G++++E++ G P PL
Sbjct: 199 IWSLGIMVIEMVDGEPPYFNEPPL 222
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 60/215 (27%), Positives = 100/215 (46%), Gaps = 25/215 (11%)
Query: 367 VIGEGGFGCVYKGNLPE----GKVVAVKQLKSG--SGQGEREFRAEVEIISRVHHRHLVS 420
++G+G FG V + L + VAVK LK+ S EF E + H +++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 421 LVGYCISE--KNRL----LIYEFVPNNNLEHHLH----GKGQPVLEWTKRVKIALGAAKG 470
L+G + K RL +I F+ + +L L G+ L V+ + A G
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125
Query: 471 LAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK---LNDTTQTHVSTRVMGTFG 527
+ YL IHRD+ + N ++++ VADFGL+K D + ++++
Sbjct: 126 MEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL--PVK 180
Query: 528 YLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKP 561
+LA E + T SDV++FGV + E++T G+ P
Sbjct: 181 WLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 66/276 (23%), Positives = 123/276 (44%), Gaps = 27/276 (9%)
Query: 362 FARENVIGEGGFGCVYKGN-LPEGKVVAVKQLKS---GSGQGEREFRAEVEIISRVHHRH 417
F E IG G F VY+ L +G VA+K+++ + + E++++ +++H +
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 418 LVSLVGYCISEKNRLLIYEFVPNNNLEHHL-HGKGQPVLEWTKRV-KIALGAAKGLAYLH 475
++ I + ++ E +L + H K Q L K V K + L ++H
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123
Query: 476 EDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYAS 535
+++HRDIK AN+ + ++ D GL + +++T + ++GT Y++PE
Sbjct: 124 SR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLVGTPYYMSPERIH 179
Query: 536 SGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVD 595
+SD++S G +L E+ + P GD+ + L + IE D
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPF-----YGDKMNLY----SLCKKIEQCDYP---- 226
Query: 596 PRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQV 631
P HY E E+ +++ C+ KRP + V
Sbjct: 227 PLPSDHYSE-ELRQLVN---MCINPDPEKRPDITYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 4e-11
Identities = 50/250 (20%), Positives = 78/250 (31%), Gaps = 10/250 (4%)
Query: 4 SAETPGPPVANNASSGLGERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTT 63
+A P P A S + + P + ++ G ++S++
Sbjct: 182 TARAPSSPPAEPPPSTPPAAASPRPPRRSSPISASASSPAPAPGRSAADDAGASSSDSSS 241
Query: 64 P-----AASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRS 118
P P P P P + P + P PAS S+SP SP P+ S
Sbjct: 242 SESSGCGWGPENECPLPRPAPITLPTRIWEASGWNGPSSRPGPASSSSSPRERSPSPSPS 301
Query: 119 ESQSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRD 178
S P P S P S +S +ST S + P PS + SR
Sbjct: 302 SPGSGPAP-----SSPRASSSSSSSRESSSSSTSSSSESSRGAAVSPGPSPSRSPSPSRP 356
Query: 179 TKWAPPSNPGSPPSPSTSQSGTPSTPNENSSPNELSPPSNSKSPTSKSSPEESSSSSHSN 238
A PS+P P PS + S ++ + + + + + S
Sbjct: 357 PPPADPSSPRKRPRPSRAPSSPAASAGRPTRRRARAAVAGRARRRDATGRFPAGRPRPSP 416
Query: 239 SKKTPTSSSG 248
S +
Sbjct: 417 LDAGAASGAF 426
|
Length = 1352 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 4e-11
Identities = 33/145 (22%), Positives = 50/145 (34%), Gaps = 19/145 (13%)
Query: 17 SSGLGERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPASPPPA 76
++ K PA E V A PAA+P A+ PA
Sbjct: 367 AAAAEAAAPAEKKTPARPEAAAPAAAPVAQAAAA-----------PAPAAAPAAAASAPA 415
Query: 77 SPPPASPP--PAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPP 134
+PP A+PP + P + P A+P A + + PA P E+ + P +P
Sbjct: 416 APPAAAPPAP--VAAPAAAAPAAAPAAAPAAVALAPAPPAQAAPETVAIPVR----VAPE 469
Query: 135 PEQSKNSPPAPPGQASTPPDSPPPG 159
P + +P A+ G
Sbjct: 470 PAVASAAPAPAAAPAAARLTPTEEG 494
|
Length = 618 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 4e-11
Identities = 44/175 (25%), Positives = 75/175 (42%), Gaps = 19/175 (10%)
Query: 469 KGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGY 528
+GL YLH +IIHRD+K+ NI ++D + + D G A+ + + GT
Sbjct: 168 EGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG--LAGTVET 222
Query: 529 LAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIET- 587
APE + K ++D++S G+VL E++ + P E V+ L++ I T
Sbjct: 223 NAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTL 282
Query: 588 ----GDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSE 638
+ RL + ++E A+ R + P +V +D E
Sbjct: 283 KVHPEEFPRDPGSRLVRGFIEY---------ASLERQPYTRYPCFQRVNLPIDGE 328
|
Length = 357 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 65/201 (32%), Positives = 90/201 (44%), Gaps = 13/201 (6%)
Query: 367 VIGEGGFGCVYKGNLP-EGKVVAVKQLKSGSGQGEREFR---AEVEIISR-VHHRHLVSL 421
VIG+G FG V +GK AVK L+ +E + AE ++ + V H LV L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 422 VGYCISEKNRL-LIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHP 480
Y +L + +FV L HL + + E R A A L YLH
Sbjct: 62 -HYSFQTTEKLYFVLDFVNGGELFFHLQ-RERSFPEPRARFYAA-EIASALGYLHS---I 115
Query: 481 KIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLT 540
I++RD+K NIL+D + + DFGL K Q+ +T GT YLAPE
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFCGTPEYLAPEVIRKQPYD 174
Query: 541 DRSDVFSFGVVLLELITGRKP 561
+ D + G VL E++ G P
Sbjct: 175 NTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 44/141 (31%), Positives = 74/141 (52%), Gaps = 9/141 (6%)
Query: 425 CISEKNRL-LIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKII 483
C +RL + E+V +L +H+ G+ + + V A + GL +LH II
Sbjct: 69 CFQTVDRLYFVMEYVNGGDLMYHIQQVGK--FKEPQAVFYAAEISVGLFFLHRR---GII 123
Query: 484 HRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVM-GTFGYLAPEYASSGKLTDR 542
+RD+K N+++D E ++ADFG+ K + V+TR GT Y+APE +
Sbjct: 124 YRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKS 181
Query: 543 SDVFSFGVVLLELITGRKPVD 563
D +++GV+L E++ G+ P D
Sbjct: 182 VDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 65.7 bits (161), Expect = 4e-11
Identities = 31/165 (18%), Positives = 50/165 (30%), Gaps = 11/165 (6%)
Query: 65 AASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSP 124
A P P P PP ++ P A++ +P A PP + + PPPAS P
Sbjct: 358 AFHPAAPLPEPEVPPQSAAPAASAQATAAPTAAVAPPQAPAVPPPPASAPQQAPAVPLPE 417
Query: 125 PPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPP 184
++ G P P N + + P
Sbjct: 418 TT------SQLLAARQQLQRAQGATKAKKSEPAA-----ASRARPVNSALERLASVRPAP 466
Query: 185 SNPGSPPSPSTSQSGTPSTPNENSSPNELSPPSNSKSPTSKSSPE 229
S P+ + + P E +P + K+ + +PE
Sbjct: 467 SALEKAPAKKEAYRWKATNPVEVKKEPVATPKALKKALEHEKTPE 511
|
Length = 647 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 64.0 bits (155), Expect = 5e-11
Identities = 47/208 (22%), Positives = 99/208 (47%), Gaps = 8/208 (3%)
Query: 362 FARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVS 420
+ R IG+G G V+ ++ G+ VA+KQ+ + E+ ++ + + ++V+
Sbjct: 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVN 80
Query: 421 LVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHP 480
+ + ++ E++ +L + + ++ + + + L +LH +
Sbjct: 81 FLDSFLVGDELFVVMEYLAGGSLTDVV---TETCMDEAQIAAVCRECLQALEFLHAN--- 134
Query: 481 KIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLT 540
++IHRDIKS N+L+ + ++ DFG Q+ ST V GT ++APE +
Sbjct: 135 QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYG 193
Query: 541 DRSDVFSFGVVLLELITGRKPVDPTQPL 568
+ D++S G++ +E++ G P PL
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPPYLNENPL 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 5e-11
Identities = 36/87 (41%), Positives = 51/87 (58%), Gaps = 2/87 (2%)
Query: 479 HPK-IIHRDIKSANILVDDEFEAQVADFGLAKL-NDTTQTHVSTRVMGTFGYLAPEYASS 536
H K +IHRDIKSANIL+ ++ DFG +K+ T V GT Y+APE
Sbjct: 160 HSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRR 219
Query: 537 GKLTDRSDVFSFGVVLLELITGRKPVD 563
+ ++D+FS GV+L EL+T ++P D
Sbjct: 220 KPYSKKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 5e-11
Identities = 53/203 (26%), Positives = 104/203 (51%), Gaps = 18/203 (8%)
Query: 367 VIGEGGFG-CVYKGNLPEGKVVAVKQLK-SGSGQGEREFRAEVEIISRVHHRHLVSLVGY 424
V+GEG FG + ++ + A+K+++ S + R E +++++ H ++V+
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66
Query: 425 CISEKNRLLIYEFVPNNNLEHHL---HGK---GQPVLEWTKRVKIALGAAKGLAYLHEDC 478
++ + ++ E+ +L + GK +L+W V++ LG + ++HE
Sbjct: 67 FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWF--VQMCLG----VQHIHEK- 119
Query: 479 HPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGK 538
+++HRDIKS NI + + ++ DFG A+L + + T V GT Y+ PE +
Sbjct: 120 --RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIWENMP 176
Query: 539 LTDRSDVFSFGVVLLELITGRKP 561
++SD++S G +L EL T + P
Sbjct: 177 YNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 55/196 (28%), Positives = 101/196 (51%), Gaps = 13/196 (6%)
Query: 368 IGEGGFGCVYKGNLP-EGKVVAVKQLKSGSGQGEREFRA--EVEIISRVHHRHLVSLVGY 424
+GEG + VYKG GK+VA+K ++ +G F A E ++ + H ++V L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT-PFTAIREASLLKGLKHANIVLLHDI 71
Query: 425 CISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIAL-GAAKGLAYLHEDCHPKII 483
+++ L++E+V + ++ P + VK+ L +GL+Y+H+ I+
Sbjct: 72 IHTKETLTLVFEYVHTDLCQYM---DKHPGGLHPENVKLFLFQLLRGLSYIHQR---YIL 125
Query: 484 HRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPE-YASSGKLTDR 542
HRD+K N+L+ D E ++ADFGLA+ + +H + + T Y P+ S + +
Sbjct: 126 HRDLKPQNLLISDTGELKLADFGLARAK-SVPSHTYSNEVVTLWYRPPDVLLGSTEYSTC 184
Query: 543 SDVFSFGVVLLELITG 558
D++ G + +E+I G
Sbjct: 185 LDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 6e-11
Identities = 28/153 (18%), Positives = 34/153 (22%), Gaps = 20/153 (13%)
Query: 60 NSTTPAASPPPASPPP--ASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTR 117
P PP S + P S S P PP
Sbjct: 144 EGEDPNPGPPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPED 203
Query: 118 SESQSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSR 177
S S PP S S PP S SPPP G P
Sbjct: 204 PSSPSDSSL------PPAPSSFQSDTPPPSPESPTNPSPPP------GPAAPPPPPVQQV 251
Query: 178 DTKWAPPSNPGSPPSPSTSQSGTPSTPNENSSP 210
P + P+P ++ +
Sbjct: 252 ------PPLSTAKPTPPSASATPAPIGGITLDD 278
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 6e-11
Identities = 26/143 (18%), Positives = 46/143 (32%), Gaps = 14/143 (9%)
Query: 65 AASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPA-SPPPTRSESQSS 123
A P A+ A +P + P + P A A A+ P A + P + +
Sbjct: 363 AFKPAAAAEAAAPAEKKTPARPEAAAPAAAPVAQAAAAPAPAAAPAAAASAPAAPPAAAP 422
Query: 124 PPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAP 183
P P P + + A+ PP + + +P
Sbjct: 423 PAP-----VAAPAAAAPAAAPAAAPAAVALAPAPPAQAAPETVAIPVRVA--------PE 469
Query: 184 PSNPGSPPSPSTSQSGTPSTPNE 206
P+ + P+P+ + + TP E
Sbjct: 470 PAVASAAPAPAAAPAAARLTPTE 492
|
Length = 618 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 7e-11
Identities = 44/223 (19%), Positives = 68/223 (30%), Gaps = 10/223 (4%)
Query: 2 ANSAETPGPPVANNASSGLGERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNS 61
+ SA +P P +A+ G + + PE + P +
Sbjct: 214 SASASSPAPAPGRSAADDAG-ASSSDSSSSESSGCGWGPENECPLPRPAPITLPTRIWEA 272
Query: 62 TTPAASPPPASPPPASPPPASPPPAASPP-PGSPPPASPPPASGSASPPPASPPPTRSES 120
+ P +S P P+ SP PGS P S P AS S+S S S S
Sbjct: 273 SGWNGPSSRPGPASSSSSPRERSPSPSPSSPGSGPAPSSPRASSSSSSSRESSSS--STS 330
Query: 121 QSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTK 180
SS SP P P+ S PP P + P + + + +
Sbjct: 331 SSSESSRGAAVSPGP------SPSRSPSPSRPPPPADPSSPRKRPRPSRAPSSPAASAGR 384
Query: 181 WAPPSNPGSPPSPSTSQSGTPSTPNENSSPNELSPPSNSKSPT 223
+ + + T P P+ L + S +
Sbjct: 385 PTRRRARAAVAGRARRRDATGRFPAGRPRPSPLDAGAASGAFY 427
|
Length = 1352 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 7e-11
Identities = 64/210 (30%), Positives = 91/210 (43%), Gaps = 25/210 (11%)
Query: 362 FARENVIGEGGFG----CVYKGNLPEGKVVAVKQLKSGS---GQGEREFRAEVEIISRVH 414
F +G G FG +KG G+ A+K LK + + E I+ +
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQHVAQEKSILMELS 76
Query: 415 HRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLA-- 472
H +V+++ E + EFV L HL G+ + V A LA
Sbjct: 77 HPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGR----FPNDVAKFYHAELVLAFE 132
Query: 473 YLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK-LNDTTQTHVSTRVMGTFGYLAP 531
YLH II+RD+K N+L+D++ +V DFG AK + D T T + GT YLAP
Sbjct: 133 YLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFT-----LCGTPEYLAP 184
Query: 532 EYASSGKLTDRSDVFSFGVVLLELITGRKP 561
E S D ++ GV+L E I G P
Sbjct: 185 EVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 9e-11
Identities = 53/203 (26%), Positives = 84/203 (41%), Gaps = 18/203 (8%)
Query: 367 VIGEGGFG----CVYKGNLPEGKVVAVKQLKSGSGQGEREFR---AEVEIISRVHHRHLV 419
++G+G FG K GK A+K LK + E E ++ H L
Sbjct: 2 LLGKGTFGKVILVREKAT---GKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLT 58
Query: 420 SLVGYCISEKNRL-LIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDC 478
+L Y +RL + E+ L HL + + + + +A L YLH
Sbjct: 59 AL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA--LGYLHSC- 114
Query: 479 HPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGK 538
+++RD+K N+++D + ++ DFGL K + GT YLAPE
Sbjct: 115 --DVVYRDLKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPEVLEDND 171
Query: 539 LTDRSDVFSFGVVLLELITGRKP 561
D + GVV+ E++ GR P
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 9e-11
Identities = 55/203 (27%), Positives = 92/203 (45%), Gaps = 10/203 (4%)
Query: 368 IGEGGFGCVYKGNLPE-GKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCI 426
IGEG G V GK VAVK++ Q EV I+ HH ++V + +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 427 SEKNRLLIYEFVPNNNLEHHL-HGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHR 485
++ EF+ L + H + + + + L + L+YLH +IHR
Sbjct: 90 VGDELWVVMEFLEGGALTDIVTHTR----MNEEQIATVCLSVLRALSYLHNQ---GVIHR 142
Query: 486 DIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDV 545
DIKS +IL+ + +++DFG + + ++GT ++APE S D+
Sbjct: 143 DIKSDSILLTSDGRIKLSDFGFCA-QVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDI 201
Query: 546 FSFGVVLLELITGRKPVDPTQPL 568
+S G++++E+I G P PL
Sbjct: 202 WSLGIMVIEMIDGEPPYFNEPPL 224
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-10
Identities = 59/206 (28%), Positives = 100/206 (48%), Gaps = 19/206 (9%)
Query: 364 RENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQG-EREFRAEVEIISRVHHRHLVSL 421
R N IG G G VYK + P G++ A+K + R+ E+EI+ V+H ++V
Sbjct: 78 RVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKC 137
Query: 422 VGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPK 481
++ EF+ +LE Q + + +++ G+AYLH
Sbjct: 138 HDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQI------LSGIAYLHRR---H 188
Query: 482 IIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTD 541
I+HRDIK +N+L++ ++ADFG++++ T ++ V GT Y++PE ++ L
Sbjct: 189 IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPERINT-DLNH 246
Query: 542 ------RSDVFSFGVVLLELITGRKP 561
D++S GV +LE GR P
Sbjct: 247 GAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 53/203 (26%), Positives = 93/203 (45%), Gaps = 10/203 (4%)
Query: 368 IGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCI 426
IGEG G V + G+ VAVK++ Q EV I+ H ++V + +
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86
Query: 427 SEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRD 486
++ EF+ L + + + + L K L++LH +IHRD
Sbjct: 87 VGDELWVVMEFLEGGALTDIV---THTRMNEEQIATVCLAVLKALSFLHAQ---GVIHRD 140
Query: 487 IKSANILVDDEFEAQVADFGL-AKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDV 545
IKS +IL+ + +++DFG A+++ S ++GT ++APE S D+
Sbjct: 141 IKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPEVISRLPYGTEVDI 198
Query: 546 FSFGVVLLELITGRKPVDPTQPL 568
+S G++++E++ G P PL
Sbjct: 199 WSLGIMVIEMVDGEPPYFNEPPL 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 64.1 bits (157), Expect = 2e-10
Identities = 20/85 (23%), Positives = 33/85 (38%), Gaps = 3/85 (3%)
Query: 49 ADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASP 108
AD + AA+ ++P A A PA +PP + P A P PA+ +A+
Sbjct: 34 ADYGPGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAA 93
Query: 109 PPASPPPTRSESQSSPPPGDGGASP 133
+ PP + ++ P
Sbjct: 94 AAPAAPP---AAAAAAAPAAAAVED 115
|
Length = 1228 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 33/97 (34%), Positives = 55/97 (56%), Gaps = 6/97 (6%)
Query: 469 KGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGY 528
+GL Y+H ++HRD+K +N+L++ + ++ DFGLA+ ++ V+ T Y
Sbjct: 119 RGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWY 174
Query: 529 LAPE-YASSGKLTDRSDVFSFGVVLLELITGRKPVDP 564
APE + + T DV+S G + EL+ GRKP+ P
Sbjct: 175 RAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPLFP 210
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|223065 PHA03378, PHA03378, EBNA-3B; Provisional | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-10
Identities = 39/144 (27%), Positives = 53/144 (36%), Gaps = 6/144 (4%)
Query: 31 PAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPAASPP 90
P E T + G N +P PPP +P P PPAA P
Sbjct: 654 PPQVEITPYKPTWTQIGHIPYQPSPTGANTMLPIQWAPGTMQPPPRAPTPM-RPPAAPPG 712
Query: 91 PGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAP---PG 147
P A+ A A+ P + PP + ++ PP G + PP + P PG
Sbjct: 713 RAQRPAAATGRARPPAAAPGRARPPAAAPGRARPPAAAPGRARPPAAAPGRARPPAAAPG 772
Query: 148 QAS--TPPDSPPPGIQSNQGNPVP 169
+ PP +PP Q +G P P
Sbjct: 773 APTPQPPPQAPPAPQQRPRGAPTP 796
|
Length = 991 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 49/208 (23%), Positives = 98/208 (47%), Gaps = 8/208 (3%)
Query: 362 FARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVS 420
+ R IG+G G VY ++ G+ VA+KQ+ + E+ ++ + ++V+
Sbjct: 21 YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVN 80
Query: 421 LVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHP 480
+ + ++ E++ +L + + ++ + + + L +LH +
Sbjct: 81 YLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALDFLHSN--- 134
Query: 481 KIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLT 540
++IHRDIKS NIL+ + ++ DFG Q+ ST V GT ++APE +
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYG 193
Query: 541 DRSDVFSFGVVLLELITGRKPVDPTQPL 568
+ D++S G++ +E++ G P PL
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPPYLNENPL 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 3e-10
Identities = 27/160 (16%), Positives = 47/160 (29%), Gaps = 15/160 (9%)
Query: 61 STTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSES 120
S A A + S A+P A A+ PA+ +
Sbjct: 368 SDDERGLLARLERLERRLGVAGGAGAPAAAAPSAAAAAPAAAPAPAAAAPAAAAAPAPAA 427
Query: 121 QSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTK 180
P P P P P P + P P + + P+ + +
Sbjct: 428 APQPAPA-----PAPA-----PAPPSPAGNAPAGGAPSPPPAAAPSAQPAPAPAAAPEPT 477
Query: 181 WAPPSNPGSPPSPST-----SQSGTPSTPNENSSPNELSP 215
AP P + P+P+ + P+ ++ ++ E P
Sbjct: 478 AAPAPAPPAAPAPAAAPAAPAAPAAPAGADDAATLRERWP 517
|
Length = 824 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 63.8 bits (156), Expect = 3e-10
Identities = 22/80 (27%), Positives = 31/80 (38%)
Query: 45 TPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASG 104
+ S AA A PA PPA+ PAA P P + A+ PA+
Sbjct: 40 STAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAPAAP 99
Query: 105 SASPPPASPPPTRSESQSSP 124
A+ A+P E + +P
Sbjct: 100 PAAAAAAAPAAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 35/93 (37%), Positives = 54/93 (58%), Gaps = 10/93 (10%)
Query: 469 KGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQT-HVSTRVMGTFG 527
KGL Y+H IIHRD+K N+ V+++ E ++ DFGLA+ D+ T +V TR
Sbjct: 129 KGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----W 180
Query: 528 YLAPEYASSG-KLTDRSDVFSFGVVLLELITGR 559
Y APE + T D++S G ++ E++TG+
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 3e-10
Identities = 53/210 (25%), Positives = 104/210 (49%), Gaps = 12/210 (5%)
Query: 362 FARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRA-EVEIISRVHHRHLV 419
+ R IG+G G VY ++ G+ VA+KQ+ Q ++E E+ ++ H ++V
Sbjct: 21 YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNL-QQQPKKELIINEILVMRENKHPNIV 79
Query: 420 SLV-GYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDC 478
+ + Y + ++ ++ E++ +L + + ++ + + + L +LH +
Sbjct: 80 NYLDSYLVGDE-LWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHSN- 134
Query: 479 HPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGK 538
++IHRDIKS NIL+ + ++ DFG Q+ ST V GT ++APE +
Sbjct: 135 --QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKA 191
Query: 539 LTDRSDVFSFGVVLLELITGRKPVDPTQPL 568
+ D++S G++ +E++ G P PL
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPPYLNENPL 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 44/141 (31%), Positives = 72/141 (51%), Gaps = 9/141 (6%)
Query: 425 CISEKNRL-LIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKII 483
C +RL + E+V +L + + G+ + V A A GL +LH II
Sbjct: 69 CFQTMDRLYFVMEYVNGGDLMYQIQQVGR--FKEPHAVFYAAEIAIGLFFLHSK---GII 123
Query: 484 HRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVM-GTFGYLAPEYASSGKLTDR 542
+RD+K N+++D E ++ADFG+ K N V+T+ GT Y+APE +
Sbjct: 124 YRDLKLDNVMLDSEGHIKIADFGMCKEN--MWDGVTTKTFCGTPDYIAPEIIAYQPYGKS 181
Query: 543 SDVFSFGVVLLELITGRKPVD 563
D ++FGV+L E++ G+ P +
Sbjct: 182 VDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 59/200 (29%), Positives = 86/200 (43%), Gaps = 12/200 (6%)
Query: 367 VIGEGGFG-CVYKGNLPEGKVVAVKQLKSGSGQGEREFR---AEVEIISRVHHRHLVSLV 422
++G+G FG + GK A+K LK + E E ++ H L SL
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL- 60
Query: 423 GYCISEKNRL-LIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPK 481
Y K+RL + E+V L HL + V + L YLH K
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHL--SRERVFSEDRTRFYGAEIVSALDYLHSG---K 115
Query: 482 IIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTD 541
I++RD+K N+++D + ++ DFGL K T + T GT YLAPE
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT-FCGTPEYLAPEVLEDNDYGR 174
Query: 542 RSDVFSFGVVLLELITGRKP 561
D + GVV+ E++ GR P
Sbjct: 175 AVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 4e-10
Identities = 50/202 (24%), Positives = 95/202 (47%), Gaps = 25/202 (12%)
Query: 368 IGEGGFGCVY----KGNLPEGKVVAVKQLKSGSGQGEREFRAEVE--IISRVHHRHLVSL 421
+G+G FG VY K + E ++ +K++ G +A E ++S++ H +V
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67
Query: 422 VGYCISEKNRLLIYEFVPNNNLEHHLH-----GKGQP---VLEWTKRVKIALGAAKGLAY 473
+ +I E+ +L+ L GK V EW ++ + G+ Y
Sbjct: 68 HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL------GVHY 121
Query: 474 LHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEY 533
+H+ +I+HRD+K+ NI + + ++ DFG+++L ++T GT Y++PE
Sbjct: 122 MHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLL-MGSCDLATTFTGTPYYMSPEA 176
Query: 534 ASSGKLTDRSDVFSFGVVLLEL 555
+SD++S G +L E+
Sbjct: 177 LKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|235906 PRK07003, PRK07003, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 5e-10
Identities = 37/197 (18%), Positives = 57/197 (28%), Gaps = 17/197 (8%)
Query: 10 PPVANNASSGLGERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAASPP 69
P V + G G A A PAP + + P T
Sbjct: 360 PAVTGGGAPGGGVPARVAGAVPAPGARAAAAVGASAVPAV-------------TAVTGAA 406
Query: 70 PASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDG 129
A+ P + A+ A +PP PPA+ +A P + + + +
Sbjct: 407 GAALAPKAAAAAAATRAEAPPAAPAPPATADRGDDAADGDAPVPAKANARASADSRCDER 466
Query: 130 GASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTD----SRDTKWAPPS 185
A PP + S PA + P + P SR+ A +
Sbjct: 467 DAQPPADSGSASAPASDAPPDAAFEPAPRAAAPSAATPAAVPDARAPAAASREDAPAAAA 526
Query: 186 NPGSPPSPSTSQSGTPS 202
P P T + P+
Sbjct: 527 PPAPEARPPTPAAAAPA 543
|
Length = 830 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 5e-10
Identities = 61/203 (30%), Positives = 102/203 (50%), Gaps = 19/203 (9%)
Query: 368 IGEGGFGCVYKGNLP-EGKVVAVKQLKS---GSGQGEREFRAEVEIISRVHHRHLVSLVG 423
IG G FG V+ P +GK VA+K++ + +R FR E++++ H +++S +
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFR-ELKMLCFFKHDNVLSALD 66
Query: 424 YCISEKNRLLIYE--FVPNNNLEHHLHG---KGQPVLEWTKRVKIAL-GAAKGLAYLHED 477
I + + +E +V ++ LH QP+ + VK+ L +GL YLH
Sbjct: 67 --ILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLS--SDHVKVFLYQILRGLKYLHS- 121
Query: 478 CHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPE-YASS 536
I+HRDIK N+LV+ ++ DFGLA++ + ++ T+ + T Y APE S
Sbjct: 122 --AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGS 179
Query: 537 GKLTDRSDVFSFGVVLLELITGR 559
T D++S G + EL+ R
Sbjct: 180 RHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 5e-10
Identities = 59/255 (23%), Positives = 115/255 (45%), Gaps = 14/255 (5%)
Query: 362 FARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVS 420
+ R IG+G G VY ++ G+ VA++Q+ + E+ ++ + ++V+
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 421 LVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHP 480
+ + ++ E++ +L + + ++ + + + L +LH +
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHSN--- 135
Query: 481 KIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLT 540
++IHRDIKS NIL+ + ++ DFG Q+ ST V GT ++APE +
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYG 194
Query: 541 DRSDVFSFGVVLLELITGRKPVDPTQPLGDESLV------EWARPVLVRAIETGDLSEIV 594
+ D++S G++ +E+I G P PL L+ E P + AI L+ +
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL 254
Query: 595 DPRLEKHYVESEMFR 609
D +EK E+ +
Sbjct: 255 DMDVEKRGSAKELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 6e-10
Identities = 35/125 (28%), Positives = 51/125 (40%), Gaps = 9/125 (7%)
Query: 23 RKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPAS 82
R +A ++ + TP G G + T A+P PAS P +P P
Sbjct: 372 RHHPKRASLPTRKRRSARHAA-TPFAR------GPGGDDQTRPAAPVPASVPTPAPTPV- 423
Query: 83 PPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSP 142
P +A PPP +P P++ P + +PPP PP + + P D + P
Sbjct: 424 -PASAPPPPATPLPSAEPGSDDGPAPPPERQPPAPATEPAPDDPDDATRKALDALRERRP 482
Query: 143 PAPPG 147
P PPG
Sbjct: 483 PEPPG 487
|
Length = 3151 |
| >gnl|CDD|235906 PRK07003, PRK07003, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 6e-10
Identities = 48/230 (20%), Positives = 79/230 (34%), Gaps = 25/230 (10%)
Query: 5 AETPGPPVANNASSGLGERKEEAKAPPAPAEKTESPEKKV--TPPPADNNNNGGGGNNST 62
A P A A +R ++A AP + D G+ S
Sbjct: 420 ATRAEAPPAAPAPPATADRGDDAADGDAPVPAKANARASADSRCDERDAQPPADSGSASA 479
Query: 63 TPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSES-- 120
+ +PP A+ PA P A+ P AA+P P +P AS +P A+PP +
Sbjct: 480 PASDAPPDAAFEPA--PRAAAPSAATPAA-VPDARAPAAASREDAPAAAAPPAPEARPPT 536
Query: 121 --QSSPPPGDGGASPPPEQSKNS-----------PPAPPGQASTPPDSPPPGIQSNQGNP 167
++P GGA+ + +N+ A A+ P +P P
Sbjct: 537 PAAAAPAARAGGAAAALDVLRNAGMRVSSDRGARAAAAAKPAAAPAAAPKPAA-PRVAVQ 595
Query: 168 VPSNGTTDSRDTKWAPPSNPGSPPSPSTSQSGTPSTPNENSSPNELSPPS 217
VP+ + + + ++S P E+ P++ P S
Sbjct: 596 VPTPRARAATGDAPPNG----AARAEQAAESRGAPPPWEDIPPDDYVPLS 641
|
Length = 830 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 6e-10
Identities = 54/191 (28%), Positives = 97/191 (50%), Gaps = 4/191 (2%)
Query: 378 KGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEF 437
+G+ P+ KVVA + + Q R+E+ ++ H +V S+ LLI E+
Sbjct: 88 RGSDPKEKVVAKFVMLNDERQAAYA-RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146
Query: 438 VPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDE 497
+L + + + L + + ++ L + + L E K++HRD+KSANI +
Sbjct: 147 GSGGDLNKQIKQRLKEHLPF-QEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPT 205
Query: 498 FEAQVADFGLAK-LNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELI 556
++ DFG +K +D+ V++ GT YLAPE + + ++D++S GV+L EL+
Sbjct: 206 GIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELL 265
Query: 557 TGRKPVD-PTQ 566
T +P P+Q
Sbjct: 266 TLHRPFKGPSQ 276
|
Length = 478 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 7e-10
Identities = 66/274 (24%), Positives = 123/274 (44%), Gaps = 33/274 (12%)
Query: 362 FARENVIGEGGFGCVYKGN-LPEGKVVAVKQLK---SGSGQGEREFRAEVEIISRVHHRH 417
F E IG G F VY+ L + K VA+K+++ + ++ E++++ +++H +
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 418 LVSLVGYCISEKNRLLIYEFVPNNNLEHHL-HGKGQPVLEWTKRV-KIALGAAKGLAYLH 475
++ + I + ++ E +L + + K Q L + V K + + ++H
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123
Query: 476 EDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKL--NDTTQTHVSTRVMGTFGYLAPEY 533
+++HRDIK AN+ + ++ D GL + + TT H ++GT Y++PE
Sbjct: 124 SR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH---SLVGTPYYMSPER 177
Query: 534 ASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDE-SLVEWARPVLVRAIETGDLSE 592
+SD++S G +L E+ + P GD+ +L L + IE D
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPF-----YGDKMNLFS-----LCQKIEQCDYP- 226
Query: 593 IVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRP 626
P +HY SE R E + C+ +RP
Sbjct: 227 ---PLPTEHY--SEKLR--ELVSMCIYPDPDQRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 9e-10
Identities = 58/208 (27%), Positives = 91/208 (43%), Gaps = 24/208 (11%)
Query: 367 VIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGERE----FRAEVEIISRVHHRHLVSLV 422
VIG G FG V + V +L S +R F E +I++ + +V L
Sbjct: 50 VIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109
Query: 423 GYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTK----RVKIALGAAKGLAYLHEDC 478
+K ++ E++P +L + + P +W K V +AL A +
Sbjct: 110 CAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE-KWAKFYTAEVVLALDAIHSMG------ 162
Query: 479 HPKIIHRDIKSANILVDDEFEAQVADFGLA-KLNDTTQTHVSTRVMGTFGYLAPEYASS- 536
+IHRD+K N+L+D ++ADFG K+++T T V GT Y++PE S
Sbjct: 163 ---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYISPEVLKSQ 218
Query: 537 ---GKLTDRSDVFSFGVVLLELITGRKP 561
G D +S GV L E++ G P
Sbjct: 219 GGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 9e-10
Identities = 48/152 (31%), Positives = 74/152 (48%), Gaps = 21/152 (13%)
Query: 421 LVGY--CISEKNRL-LIYEFVPNNNLEHHLHGKGQPVLEWTK--RVKIALGAAKGLAYLH 475
LVG C ++RL + EFV +L H+ + + E + +I+L L +LH
Sbjct: 58 LVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLA----LNFLH 113
Query: 476 EDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLN----DTTQTHVSTRVMGTFGYLAP 531
E II+RD+K N+L+D E ++ D+G+ K DTT T GT Y+AP
Sbjct: 114 ER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFC-----GTPNYIAP 165
Query: 532 EYASSGKLTDRSDVFSFGVVLLELITGRKPVD 563
E D ++ GV++ E++ GR P D
Sbjct: 166 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 9e-10
Identities = 36/100 (36%), Positives = 53/100 (53%), Gaps = 8/100 (8%)
Query: 469 KGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK--LNDTTQTHVSTRVMGTF 526
+ L Y+H + HRD+K NIL + + + ++ DFGLA+ NDT T + T
Sbjct: 114 RALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 527 GYLAPEYASS--GKLTDRSDVFSFGVVLLELITGRKPVDP 564
Y APE S K T D++S G + E++TG KP+ P
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFP 209
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 71/288 (24%), Positives = 119/288 (41%), Gaps = 44/288 (15%)
Query: 368 IGEGGFGCVYKGNLPEGKVVA---VKQLKSGSGQGER-EFRAEVEIISRVHHRHLVSLVG 423
IG G FG V + VA VK+LK+ + E+ EF + + + H +++ +G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 424 YCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKR-------VKIALGAAKGLAYLHE 476
C+ LL++E+ +L+ +L + +W +R ++A A G+ ++H+
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQE-----QWHRRNSQLLLLQRMACEIAAGVTHMHK 117
Query: 477 DCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVST--RVMGTFGYLAPEYA 534
+H D+ N + + +V D+G+ + ++ T +LAPE
Sbjct: 118 H---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSR-YKEDYIETEDDKCVPLRWLAPELV 173
Query: 535 SS--GKL-----TDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIET 587
G L T S+V++ GV L EL QP S R VL I+
Sbjct: 174 GEFHGGLITAEQTKPSNVWALGVTLWELFENAA-----QPYSHLS----DREVLNHVIKD 224
Query: 588 GDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRAL 635
+ ++ P+LE Y E R E C S KR +V R L
Sbjct: 225 QQV-KLFKPQLELPYSE----RWYEVLQFCWL-SPEKRATAEEVHRLL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 59/217 (27%), Positives = 103/217 (47%), Gaps = 26/217 (11%)
Query: 355 LMEITNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGE----REFRAEVEI 409
+ E+ + +G G +G V + G+ VA+K+L S Q E R +R E+ +
Sbjct: 10 VWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKL-SRPFQSEIFAKRAYR-ELTL 67
Query: 410 ISRVHHRHLVSLVGYCISEKNRLLIYEF---VP--NNNLEHHLHGKGQPVLEWTKRVKIA 464
+ + H +++ L+ S + +F +P +L+ + G P+ E K +
Sbjct: 68 LKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIM---GHPLSE-DKVQYLV 123
Query: 465 LGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQT-HVSTRVM 523
GL Y+H IIHRD+K N+ V+++ E ++ DFGLA+ D T +V TR
Sbjct: 124 YQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-- 178
Query: 524 GTFGYLAPEYASSG-KLTDRSDVFSFGVVLLELITGR 559
Y APE + D++S G ++ E++TG+
Sbjct: 179 ---WYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 65/227 (28%), Positives = 101/227 (44%), Gaps = 34/227 (14%)
Query: 368 IGEGGFGCVYKGNLPE-------GKVVAVKQLKSGSGQGER---EFRAEVEIISRVHHRH 417
+G+G F +YKG L G V + G R F ++S++ H+H
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 418 LVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPV-LEWTKRVKIALGAAKGLAYLHE 476
LV L G C+ ++N +++ E+V L+ LH + V L W ++ +A A L YL +
Sbjct: 63 LVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLED 119
Query: 477 DCHPKIIHRDIKSANILV--DDEFEAQVADFGLAKLND----TTQTHVSTRVMGTFGYLA 530
K++H ++ NILV E V KL+D T RV ++A
Sbjct: 120 K---KLVHGNVCGKNILVARYGLNEGYVPF---IKLSDPGIPITVLSREERVERI-PWIA 172
Query: 531 PEYASSG--KLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVE 575
PE +G LT +D +SFG LLE+ + + +PL S E
Sbjct: 173 PECIRNGQASLTIAADKWSFGTTLLEICSNGE-----EPLSTLSSSE 214
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 60.7 bits (148), Expect = 2e-09
Identities = 24/90 (26%), Positives = 35/90 (38%), Gaps = 8/90 (8%)
Query: 64 PAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSS 123
P ++ P + A+ AS P AA PA PPA A+ P A P P ++
Sbjct: 38 PGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPA---AAAPAAPPKP-----AAA 89
Query: 124 PPPGDGGASPPPEQSKNSPPAPPGQASTPP 153
A+PP + +P A + P
Sbjct: 90 AAAAAAPAAPPAAAAAAAPAAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|220392 pfam09770, PAT1, Topoisomerase II-associated protein PAT1 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 2e-09
Identities = 38/170 (22%), Positives = 47/170 (27%), Gaps = 20/170 (11%)
Query: 62 TTPAASPPPASPPPASPPPASPPPAASPPPGSPPPA----SPPPASGSASPPPASPPPTR 117
+P PP P PP A+ P PP PP P P
Sbjct: 164 QQRQQAPQLPQPPQQVLPQGMPPRQAAFPQQGPPEQPPGYPQPPQGHPEQVQPQQFLPAP 223
Query: 118 SESQSSPP--------PGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPV- 168
S++ + PP P P S+ PP PP P P Q P
Sbjct: 224 SQAPAQPPLPPQLPQQPPPLQQPQFPGLSQQMPPPPPQP---PQQQQQPPQPQAQPPPQN 280
Query: 169 ---PSNGTTDSRDTKWAPPSNPGSPPSPSTSQSGTPSTPNENSSPNELSP 215
P G ++ PP P P G P +LS
Sbjct: 281 QPTPHPGLPQGQNAPLPPPQQPQLLPLV-QQPQGQQRGPQFREQLVQLSQ 329
|
Members of this family are necessary for accurate chromosome transmission during cell division. Length = 804 |
| >gnl|CDD|219339 pfam07223, DUF1421, Protein of unknown function (DUF1421) | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 51/244 (20%), Positives = 70/244 (28%), Gaps = 30/244 (12%)
Query: 25 EEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPP 84
+ K PPAP + + N+ P A P + P +PP
Sbjct: 45 DSTKQPPAPEQVAKHELADAPLQQV----------NAALPPAPAPQSPQPDQQQQSQAPP 94
Query: 85 PAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPP----EQSKN 140
P P P + P PPP++ + + P PPP +Q
Sbjct: 95 SHQYPSQLPPQQVQSVPQQPTPQQEPYYPPPSQPQPPPAQQPQAQQPQPPPQVPQQQQYQ 154
Query: 141 SPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPSN--PGSPPSPSTS-- 196
SPP P PP Q + P S S PS+ P S +
Sbjct: 155 SPPQQPQYQQNPPPQAQSAPQVSGLYPEESPYQPQSYPPNEPLPSSMAMQPPYSGAPPSQ 214
Query: 197 ------------QSGTPSTPNENSSPNELSPPSNSKSPTSKSSPEESSSSSHSNSKKTPT 244
G PN + PPS + S P S + S + P
Sbjct: 215 QFYGPPQPSPYMYGGPGGRPNSGFPSGQQPPPSQGQEGYGYSGPPPSKGNHGSVASYAPQ 274
Query: 245 SSSG 248
SS
Sbjct: 275 GSSQ 278
|
This family represents a conserved region approximately 350 residues long within a number of plant proteins of unknown function. Length = 357 |
| >gnl|CDD|217392 pfam03153, TFIIA, Transcription factor IIA, alpha/beta subunit | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 31/199 (15%), Positives = 49/199 (24%), Gaps = 15/199 (7%)
Query: 61 STTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSES 120
S + A P P A PP A P PP + + P P P +
Sbjct: 40 SQSGVAEFPWDPSPQAPPPVAQLPQPLPQPPPTQALQALPAGDQQQHNTPTGSPAANPPA 99
Query: 121 QSSPPPGDGGASPPPEQSKNSPPA-PPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDT 179
+ P G G + E + P P P +SP Q Q +
Sbjct: 100 TFALPAGPAGPTIQTEPGQLYPVQVPVMVTQNPANSPLD--QPAQQRALQQL-------- 149
Query: 180 KWAPPSNPGSPPSPSTSQSGTPSTPNENSSPNELSPPSNSKSPTSKSSPEESSSSSHSNS 239
+ S + N+ S + T + +ES +
Sbjct: 150 --QQRYGAPA--SGQLPSQQQSAQKNDESQLQQQPNGETPPQQTDGAGDDESEALVRLRE 205
Query: 240 KKTPTSSSGHSSDSTKGSS 258
++
Sbjct: 206 ADGTLEQRIKGAEGGGAMK 224
|
Transcription initiation factor IIA (TFIIA) is a heterotrimer, the three subunits being known as alpha, beta, and gamma, in order of molecular weight. The N and C-terminal domains of the gamma subunit are represented in pfam02268 and pfam02751, respectively. This family represents the precursor that yields both the alpha and beta subunits. The TFIIA heterotrimer is an essential general transcription initiation factor for the expression of genes transcribed by RNA polymerase II. Together with TFIID, TFIIA binds to the promoter region; this is the first step in the formation of a pre-initiation complex (PIC). Binding of the rest of the transcription machinery follows this step. After initiation, the PIC does not completely dissociate from the promoter. Some components, including TFIIA, remain attached and re-initiate a subsequent round of transcription. Length = 332 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 50/190 (26%), Positives = 87/190 (45%), Gaps = 13/190 (6%)
Query: 373 FGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRL 432
F C G+ KV+ +K+ +G E++I+ + HR +++L+ + K+ +
Sbjct: 109 FVCTKHGDEQRKKVI----VKAVTGGKTPG--REIDILKTISHRAIINLI-HAYRWKSTV 161
Query: 433 LIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANI 492
+ +L ++ G LE + + I + LAYLH IIHRD+K+ NI
Sbjct: 162 CMVMPKYKCDLFTYVDRSGPLPLE--QAITIQRRLLEALAYLHGR---GIIHRDVKTENI 216
Query: 493 LVDDEFEAQVADFGLA-KLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVV 551
+D+ A + DFG A KL+ T GT +PE + ++D++S G+V
Sbjct: 217 FLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLV 276
Query: 552 LLELITGRKP 561
L E+
Sbjct: 277 LFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 3e-09
Identities = 40/192 (20%), Positives = 61/192 (31%), Gaps = 14/192 (7%)
Query: 7 TPGPPVANNASSGLGERKEEAKAPPAPAEKTESPEKKV-----TPPPADNNNNGGGGNNS 61
P + +G R A + +P E++ SP P +++ S
Sbjct: 265 LPTRIWEASGWNGPSSRPGPASSSSSPRERSPSPSPSSPGSGPAPSSPRASSSSSSSRES 324
Query: 62 TTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQ 121
++ + S S A+ P P P+ SP P PPP + P + P P+ P + + S
Sbjct: 325 SSSSTSSSSESSRGAAVSP-GPSPSRSPSPSRPPPPADPSSP-RKRPRPSRAPSSPAASA 382
Query: 122 SSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKW 181
P A+ + P G S T W
Sbjct: 383 GRPTRRRARAAVAGRARRRDATGRFPAGRPRPSPLDAGAASGAFYARYPLLTPSG--EPW 440
Query: 182 APPSNPGSPPSP 193
PGSPP P
Sbjct: 441 -----PGSPPPP 447
|
Length = 1352 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 31/147 (21%), Positives = 48/147 (32%), Gaps = 14/147 (9%)
Query: 10 PPVANNASSGLGERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAASPP 69
P + + + + P+D ++ G + +P P
Sbjct: 147 DPNPGPPLDE-EDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPS 205
Query: 70 PASPPPASPPPASPPPAASPP-PGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGD 128
S P P+S PP P SP SPPP + PPP P S ++ +PP
Sbjct: 206 SPSDSSLPPAPSSFQSDTPPPSPESPTNPSPPPGPAAPPPPPVQQVPPLSTAKPTPPSAS 265
Query: 129 GGASPPPEQSKNSPPAPPGQASTPPDS 155
+ PAP G + D+
Sbjct: 266 ------------ATPAPIGGITLDDDA 280
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 44/207 (21%), Positives = 90/207 (43%), Gaps = 20/207 (9%)
Query: 367 VIGEGGFGCVYKGNLPEGKVVAVKQLK---SGSGQGEREFRAEVEIISRVHHRHLVSLVG 423
+I E +YKG K V ++ K G E++ + R+ +++ + G
Sbjct: 27 LIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYG 85
Query: 424 YCISEKNRL----LIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHE-DC 478
+ I + L LI E+ L L + L + ++ +A+ KGL L++
Sbjct: 86 FIIDIVDDLPRLSLILEYCTRGYLREVLDKEKD--LSFKTKLDMAIDCCKGLYNLYKYTN 143
Query: 479 HPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASS-- 536
P ++++ S + LV + ++ ++ GL K + + + Y + + +
Sbjct: 144 KP---YKNLTSVSFLVTENYKLKIICHGLEK----ILSSPPFKNVNFMVYFSYKMLNDIF 196
Query: 537 GKLTDRSDVFSFGVVLLELITGRKPVD 563
+ T + D++S GVVL E+ TG+ P +
Sbjct: 197 SEYTIKDDIYSLGVVLWEIFTGKIPFE 223
|
Length = 283 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 59/208 (28%), Positives = 100/208 (48%), Gaps = 21/208 (10%)
Query: 368 IGEGGFGCVYKGNLPE--GKVVAVKQLK---SGSGQGEREFRAEVEIISRVH---HRHLV 419
IGEG +G V+K + G+ VA+K+++ G R EV ++ + H ++V
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR-EVAVLRHLETFEHPNVV 67
Query: 420 SLVGYC-ISEKNR----LLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYL 474
L C +S +R L++E V + +L +L +P + + +GL +L
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 126
Query: 475 HEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYA 534
H +++HRD+K NILV + ++ADFGLA++ + T V+ T Y APE
Sbjct: 127 HSH---RVVHRDLKPQNILVTSSGQIKLADFGLARI--YSFQMALTSVVVTLWYRAPEVL 181
Query: 535 SSGKLTDRSDVFSFGVVLLELITGRKPV 562
D++S G + E+ RKP+
Sbjct: 182 LQSSYATPVDLWSVGCIFAEMFR-RKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 53/204 (25%), Positives = 94/204 (46%), Gaps = 12/204 (5%)
Query: 368 IGEGGFG--CVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYC 425
IGEG G C+ + G+ VAVK + Q EV I+ H+++V +
Sbjct: 29 IGEGSTGIVCIAREK-HSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 426 ISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHR 485
+ + ++ EF+ L + Q L + + + L YLH +IHR
Sbjct: 88 LVGEELWVLMEFLQGGALTDIV---SQTRLNEEQIATVCESVLQALCYLHSQ---GVIHR 141
Query: 486 DIKSANILVDDEFEAQVADFGL-AKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSD 544
DIKS +IL+ + +++DFG A+++ S ++GT ++APE S D
Sbjct: 142 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRTPYGTEVD 199
Query: 545 VFSFGVVLLELITGRKPVDPTQPL 568
++S G++++E++ G P P+
Sbjct: 200 IWSLGIMVIEMVDGEPPYFSDSPV 223
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 4e-09
Identities = 63/219 (28%), Positives = 93/219 (42%), Gaps = 41/219 (18%)
Query: 368 IGEGGFGCV----YKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVH---HRHLVS 420
+G+G +G V E V A+K++ + + RA E+ H H+++
Sbjct: 8 LGQGAYGIVCSARNAETSEEETV-AIKKITNVFSKKILAKRALRELKLLRHFRGHKNITC 66
Query: 421 LVGYCI---SEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAK-------- 469
L I N L +YE + +L + GQP L A
Sbjct: 67 LYDMDIVFPGNFNELYLYEELMEADLHQIIR-SGQP-----------LTDAHFQSFIYQI 114
Query: 470 --GLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK---LNDTTQTHVSTRVMG 524
GL Y+H ++HRD+K N+LV+ + E ++ DFGLA+ N T +
Sbjct: 115 LCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVA 171
Query: 525 TFGYLAPEYA-SSGKLTDRSDVFSFGVVLLELITGRKPV 562
T Y APE S T DV+S G +L EL+ GRKPV
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 59/213 (27%), Positives = 104/213 (48%), Gaps = 33/213 (15%)
Query: 368 IGEGGFGCVYKGNLPEGKV---VAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGY 424
+G G +G VYK +GK A+KQ++ G+G R E+ ++ + H +++SL
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIE-GTGISMSACR-EIALLRELKHPNVISLQKV 66
Query: 425 CISEKNR--LLIYEFVPNN---NLEHHLHGKGQPVLEWTKRVKIALGAAK--------GL 471
+S +R L++++ ++ ++ H K K V++ G K G+
Sbjct: 67 FLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN-----KKPVQLPRGMVKSLLYQILDGI 121
Query: 472 AYLHEDCHPKIIHRDIKSANILVDDE----FEAQVADFGLAKLNDTTQTHVS--TRVMGT 525
YLH + ++HRD+K ANILV E ++AD G A+L ++ ++ V+ T
Sbjct: 122 HYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 178
Query: 526 FGYLAPEYASSGK-LTDRSDVFSFGVVLLELIT 557
F Y APE + T D+++ G + EL+T
Sbjct: 179 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-09
Identities = 35/93 (37%), Positives = 57/93 (61%), Gaps = 10/93 (10%)
Query: 469 KGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQT-HVSTRVMGTFG 527
+GL Y+H IIHRD+K +N+ V+++ E ++ DFGLA+ D T +V+TR
Sbjct: 131 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 182
Query: 528 YLAPEYASSGKLTDRS-DVFSFGVVLLELITGR 559
Y APE + +++ D++S G ++ EL+TGR
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 5e-09
Identities = 27/88 (30%), Positives = 34/88 (38%), Gaps = 6/88 (6%)
Query: 56 GGGNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPP 115
G+ S T PPP PP P P + P PP PP A+ ++S PA P
Sbjct: 513 QSGSASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPA 572
Query: 116 TRSESQSSPPPGDGGASPPPEQSKNSPP 143
S P P P +K+S P
Sbjct: 573 DSSPPPPIPEE------PTPSPTKDSSP 594
|
Length = 620 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 63/201 (31%), Positives = 92/201 (45%), Gaps = 13/201 (6%)
Query: 367 VIGEGGFGCVYKG-NLPEGKVVAVKQLKSGS---GQGEREFRAEVEIISR-VHHRHLVSL 421
VIG+G FG V + E K AVK L+ + + E+ +E ++ + V H LV L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 422 VGYCISEKNRL-LIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHP 480
+ ++L + +++ L +HL + + LE R A A L YLH
Sbjct: 62 -HFSFQTADKLYFVLDYINGGELFYHLQ-RERCFLEPRARF-YAAEIASALGYLHS---L 115
Query: 481 KIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLT 540
I++RD+K NIL+D + + DFGL K N ST GT YLAPE
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST-FCGTPEYLAPEVLHKQPYD 174
Query: 541 DRSDVFSFGVVLLELITGRKP 561
D + G VL E++ G P
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 5e-09
Identities = 65/233 (27%), Positives = 100/233 (42%), Gaps = 44/233 (18%)
Query: 362 FARENVIGEGGFGCV----YKGNLPEGKVVAVKQL-------KSGSGQGEREFRAEVEII 410
F VIG G FG V +K + +V A+K L +S S F E +I+
Sbjct: 45 FDVIKVIGRGAFGEVQLVRHKSS---KQVYAMKLLSKFEMIKRSDSAF----FWEERDIM 97
Query: 411 SRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEW----TKRVKIALG 466
+ + +V L +K ++ E++P +L + + P +W T V +AL
Sbjct: 98 AHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPE-KWARFYTAEVVLALD 156
Query: 467 AAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLA-KLNDTTQTHVSTRVMGT 525
A + + IHRD+K N+L+D ++ADFG K++ T V GT
Sbjct: 157 AIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GT 206
Query: 526 FGYLAPEYASS----GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLV 574
Y++PE S G D +S GV L E++ G D P +SLV
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG----DT--PFYADSLV 253
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 6e-09
Identities = 38/191 (19%), Positives = 59/191 (30%), Gaps = 9/191 (4%)
Query: 3 NSAETPGPPVANNASSGLGERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNST 62
+ PGP ++++ + PA + + ++++ + S+
Sbjct: 277 GPSSRPGPASSSSSPRERSPSPSPSSPGSGPAPSSPRASSSSSSSRESSSSSTSSSSESS 336
Query: 63 TPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRS---- 118
AA P SP + P PPPA P P S P+S +AS + R+
Sbjct: 337 RGAAVSPGPSPSRSPSPSRPPPPADPSSPRKRPRPSRAPSSPAASAGRPTRRRARAAVAG 396
Query: 119 -ESQSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPD----SPPPGIQSNQGNPVPSNGT 173
+ P P + A P P PG V G
Sbjct: 397 RARRRDATGRFPAGRPRPSPLDAGAASGAFYARYPLLTPSGEPWPGSPPPPPGRVRYGGL 456
Query: 174 TDSRDTKWAPP 184
DSR W P
Sbjct: 457 GDSRPGLWDAP 467
|
Length = 1352 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 6e-09
Identities = 35/142 (24%), Positives = 51/142 (35%), Gaps = 20/142 (14%)
Query: 17 SSGLGERKEEAKAPPAPAEKTESPEK--KVTPPPADNNNNGGGGNNSTTPAASPPPASPP 74
G +R+ PP+ E + K P + ++ A+P
Sbjct: 348 PLGFPKRRRPTWTPPSSLEDLSAGRHHPKRASLP------------TRKRRSARHAATPF 395
Query: 75 PASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPP 134
P A+P P S P +P P SA PPPA+P P S+ P D G +PP
Sbjct: 396 ARGPGGDDQTRPAAPVPASVPTPAPTPVPASAPPPPATPLP------SAEPGSDDGPAPP 449
Query: 135 PEQSKNSPPAPPGQASTPPDSP 156
PE+ +P P +
Sbjct: 450 PERQPPAPATEPAPDDPDDATR 471
|
Length = 3151 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 6e-09
Identities = 54/256 (21%), Positives = 75/256 (29%), Gaps = 56/256 (21%)
Query: 6 ETPGPPVANNASSGLGERKEEAKAPPA-PAEKTESPEKKVTPPPADNNNNGGGGNNSTTP 64
P + A G R+ +++P A PA P +++ P + ST
Sbjct: 2847 PPSLPLGGSVAPGGDVRRRPPSRSPAAKPAAPARPPVRRLARPAV---------SRSTES 2897
Query: 65 AASPPPASPPPASPPPASPP--PAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQS 122
A PP P P PP PPP P P PPP P + P E
Sbjct: 2898 FALPPDQPERPPQPQAPPPPQPQPQPPPPPQPQPPPPPPPRPQPPLAPTTDPAGAGEPSG 2957
Query: 123 SPPPGDGGASPPPE----QSKNSPPAPPGQASTPPDSPP--------------------- 157
+ P GA P + + PAP +A P
Sbjct: 2958 AVPQPWLGALVPGRVAVPRFRVPQPAPSREAPASSTPPLTGHSLSRVSSWASSLALHEET 3017
Query: 158 -PGIQSNQGNPVPSNGTTDSRDTKWA------------------PPSNPGSPPSPSTSQS 198
P S + P + T DS P P P+T ++
Sbjct: 3018 DPPPVSLKQTLWPPDDTEDSDADSLFDSDSERSDLEALDPLPPEPHDPFAHEPDPATPEA 3077
Query: 199 GTPSTPNENSSPNELS 214
G +P+ P LS
Sbjct: 3078 GARESPSSQFGPPPLS 3093
|
Length = 3151 |
| >gnl|CDD|235906 PRK07003, PRK07003, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 6e-09
Identities = 24/190 (12%), Positives = 56/190 (29%), Gaps = 7/190 (3%)
Query: 72 SPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGA 131
P P A P PG+ A+ ++ A +++ A
Sbjct: 366 GAPGGGVPAR--VAGAVPAPGARAAAAVGASAVPAVTAVTGAAGAALAPKAAAAAAATRA 423
Query: 132 SPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPSNPGSPP 191
PP P + + ++ D RD + S S P
Sbjct: 424 EAPPAA---PAPPATADRGDDAADGDAPVPAKANARASADSRCDERDAQPPADSGSASAP 480
Query: 192 SPSTSQSGT--PSTPNENSSPNELSPPSNSKSPTSKSSPEESSSSSHSNSKKTPTSSSGH 249
+ P+ S + ++++P + S + ++++ + P + +
Sbjct: 481 ASDAPPDAAFEPAPRAAAPSAATPAAVPDARAPAAASREDAPAAAAPPAPEARPPTPAAA 540
Query: 250 SSDSTKGSSS 259
+ + G ++
Sbjct: 541 APAARAGGAA 550
|
Length = 830 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 6e-09
Identities = 45/154 (29%), Positives = 71/154 (46%), Gaps = 14/154 (9%)
Query: 414 HHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAY 473
+H LV L +E + E+V +L H+ + + E + + A L Y
Sbjct: 54 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA--LNY 111
Query: 474 LHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKL----NDTTQTHVSTRVMGTFGYL 529
LHE II+RD+K N+L+D E ++ D+G+ K DTT + GT Y+
Sbjct: 112 LHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT-----STFCGTPNYI 163
Query: 530 APEYASSGKLTDRSDVFSFGVVLLELITGRKPVD 563
APE D ++ GV++ E++ GR P D
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 7e-09
Identities = 46/176 (26%), Positives = 90/176 (51%), Gaps = 15/176 (8%)
Query: 469 KGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQT-HVSTRVMGTFG 527
+GL Y+H IIHRD+K +N+ V+++ E ++ DFGLA+ D T +V+TR
Sbjct: 129 RGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----W 180
Query: 528 YLAPEYASSGKLTDRS-DVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIE 586
Y APE + +++ D++S G ++ EL+ G K + P G++ + + R + V
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKG-KALFP----GNDYIDQLKRIMEVVGTP 235
Query: 587 TGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEMS 642
+ ++ + + + Y++S + R + P +++ + LDS+ +S
Sbjct: 236 SPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRIS 291
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 8e-09
Identities = 32/113 (28%), Positives = 42/113 (37%), Gaps = 5/113 (4%)
Query: 1 MANSAETPGPPVANNASSGLGERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNN 60
A +A P A A + A PAPA P PP N GG +
Sbjct: 401 AAAAAPAAAPAPAAAAPAAAAAPAPAAAPQPAPA-----PAPAPAPPSPAGNAPAGGAPS 455
Query: 61 STTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASP 113
AA +P PA+ P + PA +PP P A+P + A+P A
Sbjct: 456 PPPAAAPSAQPAPAPAAAPEPTAAPAPAPPAAPAPAAAPAAPAAPAAPAGADD 508
|
Length = 824 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 58.3 bits (142), Expect = 8e-09
Identities = 20/98 (20%), Positives = 31/98 (31%)
Query: 61 STTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSES 120
S PAAS + P A+ P P PP +P A P + S A+ +
Sbjct: 374 SAAPAASAQATAAPTAAVAPPQAPAVPPPPASAPQQAPAVPLPETTSQLLAARQQLQRAQ 433
Query: 121 QSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPP 158
++ A+ + NS P +
Sbjct: 434 GATKAKKSEPAAASRARPVNSALERLASVRPAPSALEK 471
|
Length = 647 |
| >gnl|CDD|178748 PLN03209, PLN03209, translocon at the inner envelope of chloroplast subunit 62; Provisional | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 8e-09
Identities = 57/259 (22%), Positives = 86/259 (33%), Gaps = 36/259 (13%)
Query: 8 PGPPVANNASSGLGERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAAS 67
P A + + + +AP P E+ K V P P +P +
Sbjct: 330 PKESDAADGPKPVPTKPVTPEAPSPPIEEEPPQPKAVVPRP-------------LSPYTA 376
Query: 68 ----PPPASPPPASPPPASPPPAASPPPGSPPPASP--PPASGSASPPPASPPPTRSESQ 121
PP SP P PP+S P ++ PA P P+ GSAS P P +
Sbjct: 377 YEDLKPPTSPIPT--PPSSSPASSKSVDAVAKPAEPDVVPSPGSASNVPEVEPAQVEAKK 434
Query: 122 SSP-----------PPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPS 170
+ P PP SP + + PD+ P ++ P P+
Sbjct: 435 TRPLSPYARYEDLKPPTS--PSPTAPTGVSPSVSSTSSVPAVPDTAPATAATDAAAPPPA 492
Query: 171 NGTTDSRDTKWAPPSNPGSPPSPSTSQSGTPSTPNENSSPNELSPPSNSKSPTSKSSPEE 230
N S + P SP + PS+ NE +PP+ + P+
Sbjct: 493 NMRPLSPYAVYDDLKPPTSPSPAAPVGKVAPSSTNEVVKVGNSAPPTALADEQHHAQPKP 552
Query: 231 SSSSSHS--NSKKTPTSSS 247
S ++ K PTS +
Sbjct: 553 RPLSPYTMYEDLKPPTSPT 571
|
Length = 576 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 58.7 bits (143), Expect = 9e-09
Identities = 19/78 (24%), Positives = 30/78 (38%)
Query: 48 PADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSAS 107
P + A++P A A PA PPAA+ P P PA+ A+ + +
Sbjct: 38 PGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAPA 97
Query: 108 PPPASPPPTRSESQSSPP 125
PPA+ + +
Sbjct: 98 APPAAAAAAAPAAAAVED 115
|
Length = 1228 |
| >gnl|CDD|235906 PRK07003, PRK07003, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-08
Identities = 32/138 (23%), Positives = 50/138 (36%), Gaps = 15/138 (10%)
Query: 2 ANSAETPGPPVANNASSGLGERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGG---- 57
A + V + + R++ A PA + P P A GG
Sbjct: 497 AAPSAATPAAVPDARAPAAASREDAPAAAAPPAPEARPPTPAAAAPAA----RAGGAAAA 552
Query: 58 -------GNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPP 110
G ++ + A+ PA+ P A+P PAA P A+G A P
Sbjct: 553 LDVLRNAGMRVSSDRGARAAAAAKPAAAPAAAPKPAAPRVAVQVPTPRARAATGDAPPNG 612
Query: 111 ASPPPTRSESQSSPPPGD 128
A+ +ES+ +PPP +
Sbjct: 613 AARAEQAAESRGAPPPWE 630
|
Length = 830 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 58.4 bits (142), Expect = 1e-08
Identities = 23/94 (24%), Positives = 31/94 (32%), Gaps = 13/94 (13%)
Query: 21 GERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPP 80
AP A A + PA A + P +PP A+ P
Sbjct: 35 DYGPGSTAAPTAAAAAAAAAASAPAAAPA-------------AKAPAAPAPAPPAAAAPA 81
Query: 81 ASPPPAASPPPGSPPPASPPPASGSASPPPASPP 114
A P PAA+ + P A P A+ +A A
Sbjct: 82 APPKPAAAAAAAAAPAAPPAAAAAAAPAAAAVED 115
|
Length = 1228 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 56/213 (26%), Positives = 93/213 (43%), Gaps = 16/213 (7%)
Query: 360 NGFARENVIGEGGFGCVY-KGNLPEGKVVAVKQLKSGSGQGERE---FRAEVEIISRVHH 415
F ++++G G FG V G + A+K +K + F E +I+S +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 416 RHLVSLVGYCISEKNRL-LIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYL 474
+ L Y +K+ L L+ E+ P +L L+ E + +A + +
Sbjct: 61 PWIPQLQ-YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLA-ELVLAIHSV 118
Query: 475 HEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYA 534
H+ + +HRDIK N+L+D ++ADFG A + S +GT Y+APE
Sbjct: 119 HQMGY---VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVL 175
Query: 535 SS------GKLTDRSDVFSFGVVLLELITGRKP 561
++ G D +S GV+ E+I GR P
Sbjct: 176 TTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 60/202 (29%), Positives = 92/202 (45%), Gaps = 14/202 (6%)
Query: 368 IGEGGFGCVYKGNLPE-GKVVAVKQLKSGSGQGEREFR---AEVEIISRVHHRHLVSLVG 423
IG+G FG VY+ + ++ A+K L ++E E I+ R +VG
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 424 YCIS---EKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHP 480
S + + L+ +++ L HL +G+ E + IA L +LH+
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGR-FSEDRAKFYIA-ELVLALEHLHKY--- 115
Query: 481 KIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGK-L 539
I++RD+K NIL+D + DFGL+K N T +T GT YLAPE K
Sbjct: 116 DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT-FCGTTEYLAPEVLLDEKGY 174
Query: 540 TDRSDVFSFGVVLLELITGRKP 561
T D +S GV++ E+ G P
Sbjct: 175 TKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 56/212 (26%), Positives = 94/212 (44%), Gaps = 29/212 (13%)
Query: 367 VIGEGGFGCVY----KGNLPEGKVVAVKQLKSGS----GQGEREFRAEVEIISRVHHRHL 418
V+G G +G V+ GK+ A+K L+ + + R E ++ V
Sbjct: 7 VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPF 66
Query: 419 VSLVGYCISEKNRL-LIYEFVPNNNLEHHL----HGKGQPVLEWTKRVKIALGAAKGLAY 473
+ + Y + +L LI ++V + HL + V ++ + +AL +
Sbjct: 67 LVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILAL------EH 120
Query: 474 LHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEY 533
LH+ I++RDIK NIL+D E + DFGL+K + + + GT Y+APE
Sbjct: 121 LHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEI 177
Query: 534 ASS----GKLTDRSDVFSFGVVLLELITGRKP 561
GK D +S G+++ EL+TG P
Sbjct: 178 IRGKGGHGKAVDW---WSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 46/150 (30%), Positives = 73/150 (48%), Gaps = 17/150 (11%)
Query: 421 LVGY--CISEKNRL-LIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHED 477
LVG C +RL L+ E+V +L H+ + + E + + A L +LHE
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIA--LNFLHER 115
Query: 478 CHPKIIHRDIKSANILVDDEFEAQVADFGLAKL----NDTTQTHVSTRVMGTFGYLAPEY 533
II+RD+K N+L+D + ++ D+G+ K DTT T GT Y+APE
Sbjct: 116 ---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC-----GTPNYIAPEI 167
Query: 534 ASSGKLTDRSDVFSFGVVLLELITGRKPVD 563
+ D ++ GV++ E++ GR P D
Sbjct: 168 LRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 53/192 (27%), Positives = 82/192 (42%), Gaps = 20/192 (10%)
Query: 384 GKVVAVKQLKSGSGQGEREFRAEVEII----------SRV--HHRH-LVSLVGYCISEKN 430
GKV+ V++ +G + R EV I SRV + RH ++ + Y +
Sbjct: 9 GKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD 68
Query: 431 RL-LIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKS 489
RL + E+ L HL + V + L YLH +++RDIK
Sbjct: 69 RLCFVMEYANGGELFFHL--SRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKL 123
Query: 490 ANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFG 549
N+++D + ++ DFGL K + + T GT YLAPE D + G
Sbjct: 124 ENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLEDNDYGRAVDWWGLG 182
Query: 550 VVLLELITGRKP 561
VV+ E++ GR P
Sbjct: 183 VVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 59/223 (26%), Positives = 103/223 (46%), Gaps = 30/223 (13%)
Query: 368 IGEGGFGCVYKG-NLPEGKVVAVKQLKSGS---GQGEREFRAEVEIISRVHHR-HLVSLV 422
IGEG +G VYK + GK+VA+K+ + G R E+ ++ + ++V L+
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALR-EISLLQMLSESIYIVRLL 67
Query: 423 GYCISEKNR-----LLIYEFVPNNNLEHHL--HGKGQPVLEWTKRVK-IALGAAKGLAYL 474
E+ L++E++ +++L+ + +G+G K +K KG+A+
Sbjct: 68 DVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHC 126
Query: 475 HEDCHPKIIHRDIKSANILVDDEFEA-QVADFGLAKLNDTTQTHVSTRVMGTFGYLAPE- 532
H+ ++HRD+K N+LVD + ++AD GL + + T + T Y APE
Sbjct: 127 HKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGR-AFSIPVKSYTHEIVTLWYRAPEV 182
Query: 533 YASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPL--GDESL 573
S + D++S G + E+ QPL GD L
Sbjct: 183 LLGSTHYSTPVDIWSVGCIFAEMSRK-------QPLFPGDSEL 218
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 53/222 (23%), Positives = 99/222 (44%), Gaps = 30/222 (13%)
Query: 368 IGEGGFGCVYKGNLPE----GKV----VAVKQLKSGSGQGEREFRAEVEIISRVHHRHLV 419
+G+G F ++KG E G++ V +K L F ++S++ H+HLV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 420 SLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPV-LEWTKRVKIALGAAKGLAY-LHED 477
G C+ +++ E+V +L+ +L + + W V AK LA+ LH
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEV------AKQLAWALHFL 116
Query: 478 CHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGT------FGYLAP 531
+ H ++ + N+L+ E + + + KL+D +S V+ ++ P
Sbjct: 117 EDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG---ISITVLPKEILLERIPWVPP 173
Query: 532 EYASSGK-LTDRSDVFSFGVVLLELITG-RKPV---DPTQPL 568
E + + L+ +D +SFG L E+ +G KP+ D + L
Sbjct: 174 ECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL 215
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|223065 PHA03378, PHA03378, EBNA-3B; Provisional | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 2e-08
Identities = 40/146 (27%), Positives = 57/146 (39%), Gaps = 6/146 (4%)
Query: 8 PGPPVANNASSGLGERKEEAKAPPAPAEKTESPEKKVTPPPAD--NNNNGGGGNNSTTPA 65
P P A++ L + P P T P A G + P
Sbjct: 673 PYQPSPTGANTMLPIQWAPGTMQPPPRAPTPMRPPAAPPGRAQRPAAATGRARPPAAAPG 732
Query: 66 ASPPPASPPPASPPPASPPPAASPPPGSPPPASPP---PASGSASPPPASPPPTRSESQS 122
+ PPA+ P + PPA+ P A PP +P A PP P + + PPP +PP + +
Sbjct: 733 RARPPAAAPGRARPPAAAPGRARPPAAAPGRARPPAAAPGAPTPQPPPQAPPAPQQRPRG 792
Query: 123 SPPPGDGGASPPPEQSKNSPPAPPGQ 148
+P P + P + P A PGQ
Sbjct: 793 APTPQPPPQAGPTSM-QLMPRAAPGQ 817
|
Length = 991 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 2e-08
Identities = 19/96 (19%), Positives = 34/96 (35%), Gaps = 6/96 (6%)
Query: 65 AASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPP--PASPPPTRSESQS 122
A +PP A+ P A+ PP + PAA P +P P A R+ + +
Sbjct: 50 ALAPPAAAAPAAAQPPPAAAPAAVSRPAAPAAEPAPWLVEHAKRLTAQREQLVARAAAPA 109
Query: 123 SPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPP 158
+P +P + + + + + P
Sbjct: 110 APEA----QAPAAPAERAAAENAARRLARAAAAAPR 141
|
Length = 484 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 57/213 (26%), Positives = 99/213 (46%), Gaps = 15/213 (7%)
Query: 360 NGFARENVIGEGGFGCVYKGNLPEGK-VVAVKQLKSGSGQGEREFRA--EVEIISRVHHR 416
N F V+GEG +G V K E K +VA+K+ K E + E++++ +
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 417 HLVSLVGYCISEKNRLLIYEFVPNNNLEH-HLHGKGQPVLEWTKRVKIAL-GAAKGLAYL 474
++V L L++E+V N LE G P ++V+ + K + +
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVP----PEKVRSYIYQLIKAIHWC 116
Query: 475 HEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK-LNDTTQTHVSTRVMGTFGYLAPEY 533
H++ I+HRDIK N+L+ ++ DFG A+ L++ + + T + T Y +PE
Sbjct: 117 HKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY-TEYVATRWYRSPEL 172
Query: 534 ASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQ 566
D++S G +L EL G +P+ P +
Sbjct: 173 LLGAPYGKAVDMWSVGCILGELSDG-QPLFPGE 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 2e-08
Identities = 24/70 (34%), Positives = 29/70 (41%), Gaps = 5/70 (7%)
Query: 65 AASPPPASPPPASPPPASPPPAASPPPGSPPPASP---PPASGSASPPPASPPPTRSESQ 121
A P A P PA+PPPAA+PP PA P PA A PPA+ P +
Sbjct: 382 PAPPSAAWGAPTPAAPAAPPPAAAPPVPPAAPARPAAARPA--PAPAPPAAAAPPARSAD 439
Query: 122 SSPPPGDGGA 131
+ G
Sbjct: 440 PAAAASAGDR 449
|
Length = 576 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 56/212 (26%), Positives = 98/212 (46%), Gaps = 26/212 (12%)
Query: 368 IGEGGFGCV----YK-GNLPEGKVVAVKQLKSGSGQGEREFR---AEVEIISRVHHRHLV 419
+G G FG V YK + P VA+K+ + +++ +E +I++ ++H V
Sbjct: 38 LGTGSFGRVILATYKNEDFPP---VAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCV 94
Query: 420 SLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGA--AKGLAYLHED 477
+L G E L+ EFV + G+ L KR +G A + + E
Sbjct: 95 NLYGSFKDESYLYLVLEFV--------IGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEY 146
Query: 478 CHP-KIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASS 536
I++RD+K N+L+D + ++ DFG AK+ DT + + GT Y+APE +
Sbjct: 147 LQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR----TYTLCGTPEYIAPEILLN 202
Query: 537 GKLTDRSDVFSFGVVLLELITGRKPVDPTQPL 568
+D ++ G+ + E++ G P +PL
Sbjct: 203 VGHGKAADWWTLGIFIYEILVGCPPFYANEPL 234
|
Length = 340 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 62/246 (25%), Positives = 96/246 (39%), Gaps = 66/246 (26%)
Query: 367 VIGEGGFG----CVYKGNLPEGKVVAVKQLKSGSGQGERE----FRAEVEIISRVHHRHL 418
VIG G FG K G + A+K+L+ S E+E RAE +I++ + +
Sbjct: 8 VIGRGAFGEVRLVQKKDT---GHIYAMKKLRK-SEMLEKEQVAHVRAERDILAEADNPWV 63
Query: 419 VSLVGYCI--SEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTK----RVKIALGAAKGLA 472
V L Y E LI E++P ++ L K E T+ +A+ + L
Sbjct: 64 VKL--YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG 121
Query: 473 YLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGL----------------------AKL 510
Y IHRDIK N+L+D + +++DFGL L
Sbjct: 122 Y---------IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFL 172
Query: 511 NDTTQTHVSTR---------------VMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLEL 555
+ ++ S R +GT Y+APE D +S GV++ E+
Sbjct: 173 DFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM 232
Query: 556 ITGRKP 561
+ G P
Sbjct: 233 LVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 3e-08
Identities = 39/218 (17%), Positives = 59/218 (27%), Gaps = 40/218 (18%)
Query: 57 GGNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPP-------ASPPPASGSASPP 109
A P + A+ PP P AA +PP A P A + P
Sbjct: 256 APPPVVGEGADRAPETARGATGPPPPPEAAAPNGAAAPPDGVWGAALAGAPLALPAPPDP 315
Query: 110 PASPP-------------------------------PTRSESQSSPPPGDGGASPPPEQS 138
P P P R +PP S
Sbjct: 316 PPPAPAGDAEEEDDEDGAMEVVSPLPRPRQHYPLGFPKRRRPTWTPPSSLEDLSAGRHHP 375
Query: 139 KNSPPAPPGQASTPPDSPPPGIQSNQGN-PVPSNGTTDSRDTKWAPPSNPGSPPSPST-S 196
K + + S + P + P+ S T P +PP P+T
Sbjct: 376 KRASLPTRKRRSARHAATPFARGPGGDDQTRPAAPVPASVPTPAPTPVPASAPPPPATPL 435
Query: 197 QSGTPSTPNENSSPNELSPPSNSKSPTSKSSPEESSSS 234
S P + + + P E PP+ + P + + +
Sbjct: 436 PSAEPGSDDGPAPPPERQPPAPATEPAPDDPDDATRKA 473
|
Length = 3151 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 65/220 (29%), Positives = 100/220 (45%), Gaps = 29/220 (13%)
Query: 368 IGEGGFGCVYK-GNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVH-HRHLVSLVG-- 423
IG+G +G V+K N G AVK L E E AE I+ + H ++V G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDE-EIEAEYNILKALSDHPNVVKFYGMY 84
Query: 424 YCISEKN---RLLIYEFVPNNNLEHHLHG-------KGQPVLEWTKRVKIALGAAKGLAY 473
Y KN L+ E ++ + G +P++ + I A GL +
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAY-----ILHEALMGLQH 139
Query: 474 LHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEY 533
LH + K IHRD+K NIL+ E ++ DFG++ +T+ +T V GT ++APE
Sbjct: 140 LHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEV 195
Query: 534 ASSGKLTD-----RSDVFSFGVVLLELITGRKPVDPTQPL 568
+ + D R DV+S G+ +EL G P+ P+
Sbjct: 196 IACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM 235
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 4e-08
Identities = 51/232 (21%), Positives = 68/232 (29%), Gaps = 39/232 (16%)
Query: 8 PGPPVANNASSGLGERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAAS 67
P PP + P P + +P PP G + P A
Sbjct: 255 PAPPPVVGEGADRAPETARGATGPPPPPEAAAPNGAAAPPD-----GVWGAALAGAPLAL 309
Query: 68 PPPASPPPASPPPAS----------------PPPAASPPPGSP--------PPASPPPAS 103
P P PPP +P + P P P G P PP+S S
Sbjct: 310 PAPPDPPPPAPAGDAEEEDDEDGAMEVVSPLPRPRQHYPLGFPKRRRPTWTPPSSLEDLS 369
Query: 104 GSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSN 163
P + PTR + S + P + PA P AS P +P P
Sbjct: 370 AGRHHPKRASLPTR--KRRSARHAATPFARGPGGDDQTRPAAPVPASVPTPAPTPVP--- 424
Query: 164 QGNPVPSNGTTDSRDTKWAPPSNPGSPPSPSTSQSGTPSTPNENSSPNELSP 215
P P S A P + P P Q P+T P++ +
Sbjct: 425 ASAPPPPATPLPS-----AEPGSDDGPAPPPERQPPAPATEPAPDDPDDATR 471
|
Length = 3151 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 56.4 bits (137), Expect = 4e-08
Identities = 24/126 (19%), Positives = 34/126 (26%), Gaps = 7/126 (5%)
Query: 33 PAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPAASPPPG 92
PA PE + P A+ P P PPPAS P A P
Sbjct: 361 PAAPLPEPEVPPQSAAP-----AASAQATAAPTAAVAPPQAPAVPPPPASAPQQAPAVPL 415
Query: 93 SPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPPGQASTP 152
+ A + +SE ++ + E+ + PAP P
Sbjct: 416 PETTSQLLAARQQLQRAQGATKAKKSEPAAASRARP--VNSALERLASVRPAPSALEKAP 473
Query: 153 PDSPPP 158
Sbjct: 474 AKKEAY 479
|
Length = 647 |
| >gnl|CDD|219321 pfam07174, FAP, Fibronectin-attachment protein (FAP) | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 4e-08
Identities = 32/91 (35%), Positives = 36/91 (39%), Gaps = 8/91 (8%)
Query: 27 AKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPA 86
A A PA P PP + PAA PPP P P P A
Sbjct: 28 AVAIALPATANADPAPPPPPPSTAAA--------APAPAAPPPPPPPAAPPAPQPDDPNA 79
Query: 87 ASPPPGSPPPASPPPASGSASPPPASPPPTR 117
A PPP + P A PPP +PPP +P P R
Sbjct: 80 APPPPPADPNAPPPPPVDPNAPPPPAPEPGR 110
|
This family contains bacterial fibronectin-attachment proteins (FAP). Family members are rich in alanine and proline, are approximately 300 long, and seem to be restricted to mycobacteria. These proteins contain a fibronectin-binding motif that allows mycobacteria to bind to fibronectin in the extracellular matrix. Length = 297 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 5e-08
Identities = 29/114 (25%), Positives = 37/114 (32%), Gaps = 15/114 (13%)
Query: 26 EAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPP 85
EA P PA + P P + P A+PPP P P
Sbjct: 357 EALLVPVPAPQPAKPTAAAPSPVRPTPAPSTRPKAAAAANIPPKEPVRETATPPPVPPRP 416
Query: 86 AASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSK 139
A P P P S P + +A P P + +PP PP E+ K
Sbjct: 417 VAPPVP--HTPESAPKLTRAAIPVDEKP-------KYTPPA------PPKEEEK 455
|
Length = 585 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 56.4 bits (137), Expect = 5e-08
Identities = 16/79 (20%), Positives = 31/79 (39%)
Query: 49 ADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASP 108
+ + AAS P A+P +P +P P A+ P +PP + A+ +A
Sbjct: 38 PGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAPA 97
Query: 109 PPASPPPTRSESQSSPPPG 127
P + + + ++
Sbjct: 98 APPAAAAAAAPAAAAVEDE 116
|
Length = 1228 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 51/201 (25%), Positives = 97/201 (48%), Gaps = 12/201 (5%)
Query: 368 IGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRA--EVEIISRVHHRHLVSLVGY 424
+GEG + VYKG + G++VA+K + + +G F A E ++ + H ++V L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEG-VPFTAIREASLLKGLKHANIVLLHDI 71
Query: 425 CISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIH 484
+++ ++E++ + ++ + G L +GLAY+H I+H
Sbjct: 72 IHTKETLTFVFEYMHTDLAQYMIQHPGG--LHPYNVRLFMFQLLRGLAYIH---GQHILH 126
Query: 485 RDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPE-YASSGKLTDRS 543
RD+K N+L+ E ++ADFGLA+ S+ V+ T Y P+ + +
Sbjct: 127 RDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPDVLLGATDYSSAL 185
Query: 544 DVFSFGVVLLELITGRKPVDP 564
D++ G + +E++ G +P P
Sbjct: 186 DIWGAGCIFIEMLQG-QPAFP 205
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 5e-08
Identities = 52/226 (23%), Positives = 99/226 (43%), Gaps = 37/226 (16%)
Query: 368 IGEGGFGCVYKGNLPE-GKVVAVKQLK---SGSGQGEREFRAEVEIISRVHHRHLVSLVG 423
IG+GG G VY P + VA+K+++ S + ++ F E +I + + H +V +
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV-- 67
Query: 424 YCISEKNRLLIYE--FVPNNNLEHHLHGKGQ-PVLEWTKRVKIALGA--------AKGLA 472
Y I + Y ++ L+ L Q L K ++GA +
Sbjct: 68 YSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIE 127
Query: 473 YLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLA-------------KLNDTTQTH-- 517
Y+H ++HRD+K NIL+ E + D+G A +++ +
Sbjct: 128 YVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSS 184
Query: 518 --VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKP 561
+ +++GT Y+APE ++ +D+++ GV+L +++T P
Sbjct: 185 MTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|240420 PTZ00441, PTZ00441, sporozoite surface protein 2 (SSP2); Provisional | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 5e-08
Identities = 57/238 (23%), Positives = 83/238 (34%), Gaps = 27/238 (11%)
Query: 64 PAASPPPASPPPASPPPASPPPAASPP------PGSPPPASPPPASGSAS--------PP 109
P +P P +P +P P A P +P PPP G PP
Sbjct: 290 PVPAPVPPTPEDDNPRPTDDEFAVPNFNEGLDVPDNPQDPVPPPNEGKDGNPNEENLFPP 349
Query: 110 PASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNP-- 167
P S +PP GG++ +PP PP P P SN+ P
Sbjct: 350 GDDEVPDESNVPPNPPNVPGGSNSEFSSDVENPPNPP-NPDIPEQEPNIPEDSNKEVPED 408
Query: 168 VPSNGTTDSRDTKWAPPSNPGSPPSPSTSQSGTPSTPNEN--SSPNELSPPSNSKS---- 221
VP D RD + P P + NE S+ N+ P N +
Sbjct: 409 VPME-PEDDRDNNFNEPKKPENKGDGQNEPVIPKPLDNERDQSNKNKQVNPGNRHNSEDR 467
Query: 222 ---PTSKSSPEESSSSSHSNSKKTPTSSSGHSSDSTKGSSSNDDQAIIGATAAGVVLI 276
P +++ + ++ +S+ K P S + K SSN+ I G AG+ L+
Sbjct: 468 YTRPHGRNNENRNYNNKNSDIPKHPERSEHEQPEDKKKKSSNNGYKIAGGVIAGLALV 525
|
Length = 576 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 5e-08
Identities = 58/208 (27%), Positives = 104/208 (50%), Gaps = 23/208 (11%)
Query: 368 IGEGGFGCVYKGNLPEGK---VVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGY 424
+G G +G VYK +GK A+KQ++ G+G R E+ ++ + H ++++L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIE-GTGISMSACR-EIALLRELKHPNVIALQKV 66
Query: 425 CISEKNR--LLIYEFVPNN---NLEHHLHGKG--QPVLEWTKRVKIAL-GAAKGLAYLHE 476
+S +R L++++ ++ ++ H K +P+ VK L G+ YLH
Sbjct: 67 FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126
Query: 477 DCHPKIIHRDIKSANILVDDE----FEAQVADFGLAKLNDTTQTHVS--TRVMGTFGYLA 530
+ ++HRD+K ANILV E ++AD G A+L ++ ++ V+ TF Y A
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 531 PEYASSGK-LTDRSDVFSFGVVLLELIT 557
PE + T D+++ G + EL+T
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 5e-08
Identities = 59/204 (28%), Positives = 92/204 (45%), Gaps = 19/204 (9%)
Query: 367 VIGEGGFGCVYKGNLPEGK----VVAVKQLKSGSGQGEREFR---AEVEIIS-RVHHRHL 418
V+G+G FG V L E K V A+K LK + + E I++ H L
Sbjct: 2 VLGKGSFGKVM---LAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFL 58
Query: 419 VSLVGYCISEKNRLL-IYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHED 477
+L C K+RL + E+V +L + + + E R A L +LH
Sbjct: 59 TALHC-CFQTKDRLFFVMEYVNGGDLMFQIQ-RSRKFDEPRSRF-YAAEVTLALMFLHRH 115
Query: 478 CHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSG 537
+I+RD+K NIL+D E ++ADFG+ K +T GT Y+APE
Sbjct: 116 ---GVIYRDLKLDNILLDAEGHCKLADFGMCKEG-ILNGVTTTTFCGTPDYIAPEILQEL 171
Query: 538 KLTDRSDVFSFGVVLLELITGRKP 561
+ D ++ GV++ E++ G+ P
Sbjct: 172 EYGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 56.1 bits (136), Expect = 6e-08
Identities = 14/76 (18%), Positives = 25/76 (32%)
Query: 72 SPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGA 131
P + P A+ AA+ + + A PPA+ P ++
Sbjct: 37 GPGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAP 96
Query: 132 SPPPEQSKNSPPAPPG 147
+ PP + + PA
Sbjct: 97 AAPPAAAAAAAPAAAA 112
|
Length = 1228 |
| >gnl|CDD|217393 pfam03154, Atrophin-1, Atrophin-1 family | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 6e-08
Identities = 60/252 (23%), Positives = 80/252 (31%), Gaps = 15/252 (5%)
Query: 9 GPPVANNASSGLGERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAASP 68
P SS + PP P + P P+ N G S P P
Sbjct: 252 QSPQPPAPSSRHPQSSHHGPGPPMPHALQQGP--VFLQHPSSNPPQPFGLAQSQVPP-LP 308
Query: 69 PPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGD 128
P+ P S P S P P P P+ PPP +P P PP
Sbjct: 309 LPSQAQPHSHTPPSQSALQPQQPPREQPLPPAPSMPHIKPPPTTPIPQLPNQSHKHPPHL 368
Query: 129 GGASPPPEQSKNSPPAPPGQ------ASTPPDSPPPGI----QSNQGNPVPSN--GTTDS 176
G SP P+ N PP P + PP + PP + QS VP+ T S
Sbjct: 369 QGPSPFPQMPSNLPPPPALKPLSSLPTHHPPSAHPPPLQLMPQSQPLQSVPAQPPVLTQS 428
Query: 177 RDTKWAPPSNPGSPPSPSTSQSGTPSTPNENSSPNELSPPSNSKSPTSKSSPEESSSSSH 236
+ ++P S QS P + + PP + + T + P SS S
Sbjct: 429 QSLPPKASTHPHSGLHSGPPQSPFAQHPFTSGGLPAIGPPPSLPTSTPAAPPRASSGSQP 488
Query: 237 SNSKKTPTSSSG 248
S +
Sbjct: 489 PGSALPSSGGCA 500
|
Atrophin-1 is the protein product of the dentatorubral-pallidoluysian atrophy (DRPLA) gene. DRPLA OMIM:125370 is a progressive neurodegenerative disorder. It is caused by the expansion of a CAG repeat in the DRPLA gene on chromosome 12p. This results in an extended polyglutamine region in atrophin-1, that is thought to confer toxicity to the protein, possibly through altering its interactions with other proteins. The expansion of a CAG repeat is also the underlying defect in six other neurodegenerative disorders, including Huntington's disease. One interaction of expanded polyglutamine repeats that is thought to be pathogenic is that with the short glutamine repeat in the transcriptional coactivator CREB binding protein, CBP. This interaction draws CBP away from its usual nuclear location to the expanded polyglutamine repeat protein aggregates that are characteristic of the polyglutamine neurodegenerative disorders. This interferes with CBP-mediated transcription and causes cytotoxicity. Length = 979 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 6e-08
Identities = 40/148 (27%), Positives = 66/148 (44%), Gaps = 19/148 (12%)
Query: 417 HLVSLVGYCISEKNRLLIYEFVPNNNLEHH----LHGKGQPVLEWTKRVKIALGAAKGLA 472
++V L Y +SE + L+ + L H L+ + V W + +AL A
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA----- 100
Query: 473 YLHEDCHPKIIHRDIKSANILVDDEFEAQVADFG-LAKLNDTTQTHVSTRVMGTFGYLAP 531
LH + I+ RD+ NIL+DD Q+ F +++ D+ + Y AP
Sbjct: 101 -LHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----YCAP 151
Query: 532 EYASSGKLTDRSDVFSFGVVLLELITGR 559
E + T+ D +S G +L EL+TG+
Sbjct: 152 EVGGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 7e-08
Identities = 63/201 (31%), Positives = 89/201 (44%), Gaps = 13/201 (6%)
Query: 367 VIGEGGFGCVYKGNLP-EGKVVAVKQLKSGSGQGERE---FRAEVEIISR-VHHRHLVSL 421
VIG+G FG V +G AVK L+ + ++E AE ++ + + H LV L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 422 VGYCISEKNRL-LIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHP 480
Y +L + ++V L HL + + LE R A A + YLH
Sbjct: 62 -HYSFQTAEKLYFVLDYVNGGELFFHLQ-RERCFLEPRARF-YAAEVASAIGYLHS---L 115
Query: 481 KIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLT 540
II+RD+K NIL+D + + DFGL K + ST GT YLAPE
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST-FCGTPEYLAPEVLRKEPYD 174
Query: 541 DRSDVFSFGVVLLELITGRKP 561
D + G VL E++ G P
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 8e-08
Identities = 69/247 (27%), Positives = 110/247 (44%), Gaps = 34/247 (13%)
Query: 366 NVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGY 424
N+IG G FG VY+ + + VA+K++ RE I+ ++H +++ L Y
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELL----IMKNLNHINIIFLKDY 127
Query: 425 ----CI--SEKNRLL--IYEFVP---NNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAY 473
C +EKN L + EF+P + ++H+ L K L + LAY
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQL--CRALAY 185
Query: 474 LHEDCHPKIIHRDIKSANILVDDEFEA-QVADFGLAKLNDTTQTHVSTRVMGTFGYLAPE 532
+H I HRD+K N+L+D ++ DFG AK Q VS + F Y APE
Sbjct: 186 IHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSY-ICSRF-YRAPE 240
Query: 533 YA-SSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPL--GDESLVEWARPVLVRAIETGD 589
+ T D++S G ++ E+I G P+ G S+ + R + V T D
Sbjct: 241 LMLGATNYTTHIDLWSLGCIIAEMILG-------YPIFSGQSSVDQLVRIIQVLGTPTED 293
Query: 590 LSEIVDP 596
+ ++P
Sbjct: 294 QLKEMNP 300
|
Length = 440 |
| >gnl|CDD|218439 pfam05109, Herpes_BLLF1, Herpes virus major outer envelope glycoprotein (BLLF1) | Back alignment and domain information |
|---|
Score = 55.2 bits (132), Expect = 9e-08
Identities = 49/243 (20%), Positives = 75/243 (30%), Gaps = 15/243 (6%)
Query: 32 APAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPASPP-PASPPPASPPPAASPP 90
AP + S PA++ P S P S P + P
Sbjct: 425 APDTTKSVIFVYTLVHVEPHKTTAVPTTPSLPPASTGPTVSTADPTSGTPTGTTSSTLPE 484
Query: 91 PGSPPPASPPPASGSASPPPASPPPTRSESQS-SPPPGDGGASPPPEQSKNSP--PAPPG 147
SP + + SP PA P + + SP P + +PP
Sbjct: 485 DTSPTSRTTSATPNATSPTPAVTTPNATSPTTQKTSDTPNATSPTPIVIGVTTTATSPPT 544
Query: 148 QASTP--PDSPPPGIQSNQGNPVPSNGTTDSRDTKWAP-PSNPGSPPSPSTSQSGTPSTP 204
++ SP +S N T+ A G+ SP++ Q G PS+
Sbjct: 545 GTTSVPNATSPQVTEESPVNNTNTPVVTSAPSVLTSAVTTGQHGTGSSPTSQQPGIPSSS 604
Query: 205 NENSSPNELS--PPSNSKSPT-SKSSPEESSSSSHSNSKKT-----PTSSSGHSSDSTKG 256
+ N S P S PT ++ EE+ S + T ++ S
Sbjct: 605 HSTPRSNSTSTTPLLTSAHPTGGENITEETPSVPSTTHVSTLSPGPGPGTTSQVSGPGNS 664
Query: 257 SSS 259
S+S
Sbjct: 665 STS 667
|
This family consists of the BLLF1 viral late glycoprotein, also termed gp350/220. It is the most abundantly expressed glycoprotein in the viral envelope of the Herpesviruses and is the major antigen responsible for stimulating the production of neutralising antibodies in vivo. Length = 830 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 1e-07
Identities = 23/90 (25%), Positives = 35/90 (38%), Gaps = 6/90 (6%)
Query: 71 ASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGG 130
P P P + P+ P +P P++ P A+ +A+ PP P R + P P
Sbjct: 362 PVPAPQPAKPTAAAPSPVRP--TPAPSTRPKAAAAANIPPK--EPVRETATPPPVPPRPV 417
Query: 131 ASPPPEQSKNSPPAPPGQASTP--PDSPPP 158
A P P +++P P PP
Sbjct: 418 APPVPHTPESAPKLTRAAIPVDEKPKYTPP 447
|
Length = 585 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 54.9 bits (133), Expect = 1e-07
Identities = 32/133 (24%), Positives = 46/133 (34%), Gaps = 13/133 (9%)
Query: 26 EAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPP 85
++ AP A A+ T +P V PP A P AS P +P P S
Sbjct: 373 QSAAPAASAQATAAPTAAVAPPQAPAVP---------PPPASAPQQAPAVPLPETTSQLL 423
Query: 86 AASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAP 145
AA A+ S A+ A P + E +S P A E++ A
Sbjct: 424 AARQQLQRAQGATKAKKSEPAAASRARPVNSALERLASVRP----APSALEKAPAKKEAY 479
Query: 146 PGQASTPPDSPPP 158
+A+ P +
Sbjct: 480 RWKATNPVEVKKE 492
|
Length = 647 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 54.9 bits (133), Expect = 1e-07
Identities = 34/168 (20%), Positives = 46/168 (27%), Gaps = 28/168 (16%)
Query: 2 ANSAETPGPPVANNASSGLGERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNS 61
A P P + A + + A AP + P PPPA
Sbjct: 362 AAPLPEPEVPPQSAAPAASAQATAAPTAAVAPPQAPAVP-----PPPA------------ 404
Query: 62 TTPAASPPPASPPP------ASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPP 115
+ P +P P A A P AS SA AS P
Sbjct: 405 SAPQQAPAVPLPETTSQLLAARQQLQRAQGATKAKKSEPAAASRARPVNSALERLASVRP 464
Query: 116 TRSESQSSPPPGDG---GASPPPEQSKNSPPAP--PGQASTPPDSPPP 158
S + +P + A+ P E K P +A +P
Sbjct: 465 APSALEKAPAKKEAYRWKATNPVEVKKEPVATPKALKKALEHEKTPEL 512
|
Length = 647 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 1e-07
Identities = 17/93 (18%), Positives = 28/93 (30%), Gaps = 5/93 (5%)
Query: 64 PAASPPPASPPPASPPPASPPPAASPPPGSPP-----PASPPPASGSASPPPASPPPTRS 118
AA PPPA+ P A PA+P +P A +A P + P
Sbjct: 60 AAAQPPPAAAPAAVSRPAAPAAEPAPWLVEHAKRLTAQREQLVARAAAPAAPEAQAPAAP 119
Query: 119 ESQSSPPPGDGGASPPPEQSKNSPPAPPGQAST 151
+++ + + A+
Sbjct: 120 AERAAAENAARRLARAAAAAPRPRVPADAAAAV 152
|
Length = 484 |
| >gnl|CDD|219321 pfam07174, FAP, Fibronectin-attachment protein (FAP) | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 29/71 (40%), Positives = 33/71 (46%), Gaps = 2/71 (2%)
Query: 65 AASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSP 124
A+ PA PPP PP + A P PPP + PPA P A PPP + P
Sbjct: 36 TANADPAPPPP--PPSTAAAAPAPAAPPPPPPPAAPPAPQPDDPNAAPPPPPADPNAPPP 93
Query: 125 PPGDGGASPPP 135
PP D A PPP
Sbjct: 94 PPVDPNAPPPP 104
|
This family contains bacterial fibronectin-attachment proteins (FAP). Family members are rich in alanine and proline, are approximately 300 long, and seem to be restricted to mycobacteria. These proteins contain a fibronectin-binding motif that allows mycobacteria to bind to fibronectin in the extracellular matrix. Length = 297 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 26/97 (26%), Positives = 44/97 (45%), Gaps = 1/97 (1%)
Query: 49 ADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPP-PASPPPASGSAS 107
A+ + N G T + P +P PA+P +P + +P + P PA P + +
Sbjct: 152 AELSQNSGQSVPLDTSTTTDPATTPAPAAPVDTTPTNSQTPAVATAPAPAVDPQQNAVVA 211
Query: 108 PPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPA 144
P A+ + + ++P DG A P +Q+ S PA
Sbjct: 212 PSQANVDTAATPAPAAPATPDGAAPLPTDQAGVSTPA 248
|
Length = 331 |
| >gnl|CDD|184923 PRK14959, PRK14959, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 30/94 (31%), Positives = 37/94 (39%), Gaps = 1/94 (1%)
Query: 46 PPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPAASP-PPGSPPPASPPPASG 104
P P G TP+++ P P A+P P P A P PP S P P P
Sbjct: 398 PTPGTQGPQGTAPAAGMTPSSAAPATPAPSAAPSPRVPWDDAPPAPPRSGIPPRPAPRMP 457
Query: 105 SASPPPASPPPTRSESQSSPPPGDGGASPPPEQS 138
ASP P +P S S + P GD + S
Sbjct: 458 EASPVPGAPDSVASASDAPPTLGDPSDTAEHTPS 491
|
Length = 624 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 2e-07
Identities = 41/205 (20%), Positives = 59/205 (28%), Gaps = 17/205 (8%)
Query: 71 ASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASP-PPTRSESQSSPPPGDG 129
PP A GS A +A A R E + PPPG G
Sbjct: 17 GGEFFPRPPATPGDAADDLLSGSQGQLVSDSAELAAVTVVAGAAACDRFEPPTGPPPGPG 76
Query: 130 GASPPPEQSKNSPPAP-------------PGQASTPPDSPPPGIQSNQGNPVPSNGTTDS 176
+P E + P PPP +P PS S
Sbjct: 77 TEAPANESRSTPTWSLSTLAPASPAREGSPTPPGPSSPDPPPPT-PPPASPPPSPAPDLS 135
Query: 177 RDTKWAPPSNPGSPPSPSTSQSGTPSTPNENSSPNELSPPSNSKSPT--SKSSPEESSSS 234
+ P SP + + + ++ +S + + P +S T + SSP
Sbjct: 136 EMLRPVGSPGPPPAASPPAAGASPAAVASDAASSRQAALPLSSPEETARAPSSPPAEPPP 195
Query: 235 SHSNSKKTPTSSSGHSSDSTKGSSS 259
S + +P S S SS
Sbjct: 196 STPPAAASPRPPRRSSPISASASSP 220
|
Length = 1352 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 2e-07
Identities = 27/156 (17%), Positives = 47/156 (30%), Gaps = 7/156 (4%)
Query: 90 PPGSPPPASPPPASGSASPPP--ASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPPG 147
P PPA S+ PP A P + + + P G A+ P E S P
Sbjct: 590 PAPGAAGGEGPPAPASSGPPEEAARPAAPAAPAAPAAPAPAGAAAAPAEASAAPAPGVAA 649
Query: 148 QASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPSNPGSPPSPSTSQSGTPSTPNEN 207
P P + A P +P +P+ P+ P
Sbjct: 650 PEHHPKHVAVPDASDG-----GDGWPAKAGGAAPAAPPPAPAPAAPAAPAGAAPAQPAPA 704
Query: 208 SSPNELSPPSNSKSPTSKSSPEESSSSSHSNSKKTP 243
+ + ++ + + + +S+ S + P
Sbjct: 705 PAATPPAGQADDPAAQPPQAAQGASAPSPAADDPVP 740
|
Length = 824 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 54.5 bits (132), Expect = 2e-07
Identities = 21/83 (25%), Positives = 29/83 (34%), Gaps = 1/83 (1%)
Query: 75 PASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPP 134
P S + AA+ S P A P A A+P PA P + P A+ P
Sbjct: 38 PGSTAAPTAAAAAAAAAASAPAA-APAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAP 96
Query: 135 PEQSKNSPPAPPGQASTPPDSPP 157
+ A P A+ + P
Sbjct: 97 AAPPAAAAAAAPAAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 54.5 bits (132), Expect = 2e-07
Identities = 16/86 (18%), Positives = 26/86 (30%), Gaps = 5/86 (5%)
Query: 77 SPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPE 136
P + P AA+ + A + A PA PP + + P P A+
Sbjct: 37 GPGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAA- 95
Query: 137 QSKNSPPAPPGQASTPPDSPPPGIQS 162
P A+ P + +
Sbjct: 96 ----PAAPPAAAAAAAPAAAAVEDEV 117
|
Length = 1228 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 54.1 bits (131), Expect = 2e-07
Identities = 25/101 (24%), Positives = 35/101 (34%), Gaps = 19/101 (18%)
Query: 8 PGPPVANNASSGLGERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAAS 67
PG A A++ A A A + +P K PA PAA+
Sbjct: 38 PGSTAAPTAAA--------AAAAAAASAPAAAPAAKAPAAPA-----------PAPPAAA 78
Query: 68 PPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASP 108
P A P PA+ A+ PAA P + + +P
Sbjct: 79 APAAPPKPAAAAAAAAAPAAPPAAAAAAAPAAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 2e-07
Identities = 23/68 (33%), Positives = 29/68 (42%), Gaps = 8/68 (11%)
Query: 63 TPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQS 122
PA+PPPA+ PP PPAA P + PA P PP A+ PP RS +
Sbjct: 390 GAPTPAAPAAPPPAAAPP--VPPAAPARPAAARPAPAPA------PPAAAAPPARSADPA 441
Query: 123 SPPPGDGG 130
+
Sbjct: 442 AAASAGDR 449
|
Length = 576 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 19/94 (20%), Positives = 31/94 (32%), Gaps = 2/94 (2%)
Query: 42 KKVTPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPP 101
P D + +T A+P +P + P + PA + P +P
Sbjct: 157 NSGQSVPLDTST--TTDPATTPAPAAPVDTTPTNSQTPAVATAPAPAVDPQQNAVVAPSQ 214
Query: 102 ASGSASPPPASPPPTRSESQSSPPPGDGGASPPP 135
A+ + PA P + + P G S P
Sbjct: 215 ANVDTAATPAPAAPATPDGAAPLPTDQAGVSTPA 248
|
Length = 331 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 2e-07
Identities = 24/99 (24%), Positives = 35/99 (35%), Gaps = 4/99 (4%)
Query: 60 NSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSE 119
T P P PAA+P P + ASP P+ SA+ P++P
Sbjct: 361 QLTQKGDDASGGRGPKQHIKPVFTQPAAAPQPSAAAAASPSPSQSSAAAQPSAPQSATQP 420
Query: 120 SQSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPP 158
+ + P + PP +PP+ QA P
Sbjct: 421 AGTPPT----VSVDPPAAVPVNPPSTAPQAVRPAQFKEE 455
|
Length = 614 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 62/272 (22%), Positives = 99/272 (36%), Gaps = 81/272 (29%)
Query: 362 FARE-----NVIGEGGFGCVYK------GNLPEGKVVAVKQLKSGSGQGE-REFRAEVEI 409
F R+ +G G FG V + + VAVK LK G+ E + E++I
Sbjct: 4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKI 63
Query: 410 ISRV-HHRHLVSLVG--------------YC----ISEKNRLLIYEFVPNNN-------- 442
+ + HH ++V+L+G YC +S R F P N
Sbjct: 64 LIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREM 123
Query: 443 -----------------------------LEHH-----LHGKGQPVLEWTKRVKIALGAA 468
L + L + + A
Sbjct: 124 KQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVA 183
Query: 469 KGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHV---STRVMGT 525
+G+ +L K IHRD+ + NIL+ + ++ DFGLA+ +V R+
Sbjct: 184 RGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL--P 238
Query: 526 FGYLAPEYASSGKLTDRSDVFSFGVVLLELIT 557
++APE T +SDV+SFGV+L E+ +
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|184918 PRK14954, PRK14954, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-07
Identities = 28/83 (33%), Positives = 32/83 (38%), Gaps = 9/83 (10%)
Query: 63 TPAASPP---PASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSE 119
+PA SP A P P P PA PG+ P P PAS P PP R
Sbjct: 383 SPAGSPDVKKKAPEPDLPQPDRHPGPAKPEAPGARPAELPSPASAPT--PEQQPPVAR-- 438
Query: 120 SQSSPPPGDGGASPPPEQSKNSP 142
S+P P AS P + P
Sbjct: 439 --SAPLPPSPQASAPRNVASGKP 459
|
Length = 620 |
| >gnl|CDD|220392 pfam09770, PAT1, Topoisomerase II-associated protein PAT1 | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 3e-07
Identities = 28/147 (19%), Positives = 34/147 (23%), Gaps = 3/147 (2%)
Query: 25 EEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPP 84
+ P A + P + PP G P P+ P P P P
Sbjct: 181 PQGMPPRQAAFPQQGPPE---QPPGYPQPPQGHPEQVQPQQFLPAPSQAPAQPPLPPQLP 237
Query: 85 PAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPA 144
P P PP PP P Q +N+P
Sbjct: 238 QQPPPLQQPQFPGLSQQMPPPPPQPPQQQQQPPQPQAQPPPQNQPTPHPGLPQGQNAPLP 297
Query: 145 PPGQASTPPDSPPPGIQSNQGNPVPSN 171
PP Q P P Q
Sbjct: 298 PPQQPQLLPLVQQPQGQQRGPQFREQL 324
|
Members of this family are necessary for accurate chromosome transmission during cell division. Length = 804 |
| >gnl|CDD|218439 pfam05109, Herpes_BLLF1, Herpes virus major outer envelope glycoprotein (BLLF1) | Back alignment and domain information |
|---|
Score = 53.6 bits (128), Expect = 3e-07
Identities = 48/240 (20%), Positives = 74/240 (30%), Gaps = 13/240 (5%)
Query: 30 PPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPA-ASPPPASPPPASPPPASPPPAAS 88
PPA T S + P ++ + S T S P + P P A S
Sbjct: 456 PPASTGPTVSTADPTSGTPTGTTSSTLPEDTSPTSRTTSATPNATSPTPAVTT--PNATS 513
Query: 89 PPPGSPPP----ASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPA 144
P SP P + SPP + ++ P SP + +
Sbjct: 514 PTTQKTSDTPNATSPTPIVIGVTTTATSPPTGTTSVPNATSPQVTEESPVNNTNTPVVTS 573
Query: 145 PPGQASTPPDSPPPGIQSNQGN-----PVPSNGTTDSRDTKWAPPSNPGSPPSPSTSQSG 199
P ++ + G S+ + P S+ T S T P P
Sbjct: 574 APSVLTSAVTTGQHGTGSSPTSQQPGIPSSSHSTPRSNSTSTTPLLTSAHPTGGENITEE 633
Query: 200 TPSTPNENSSPNELSPPSNSKSPTSKSSPEESSSSSHSNSKKTPTSSSGHSSDSTKGSSS 259
TPS P+ + + LSP + + S P SS+S + ++ S S
Sbjct: 634 TPSVPS-TTHVSTLSPGPGPGTTSQVSGPGNSSTSRYPGEVHVTEGMPNPNATSPSAPSG 692
|
This family consists of the BLLF1 viral late glycoprotein, also termed gp350/220. It is the most abundantly expressed glycoprotein in the viral envelope of the Herpesviruses and is the major antigen responsible for stimulating the production of neutralising antibodies in vivo. Length = 830 |
| >gnl|CDD|215533 PLN02983, PLN02983, biotin carboxyl carrier protein of acetyl-CoA carboxylase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 28/62 (45%), Positives = 31/62 (50%)
Query: 67 SPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPP 126
PPP + PPASPP A P P+A P PASPPPA S P P SP P
Sbjct: 155 PPPPHAMPPASPPAAQPAPSAPASSPPPTPASPPPAKAPKSSHPPLKSPMAGTFYRSPAP 214
Query: 127 GD 128
G+
Sbjct: 215 GE 216
|
Length = 274 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 56/204 (27%), Positives = 95/204 (46%), Gaps = 27/204 (13%)
Query: 368 IGEGGFGCVYKG-NLPEGKVVAVKQLK---SGSGQGEREFRAEVEIISRVHHRHLVSLVG 423
IG G G V + G VAVK+L +R +R E+ ++ V+H++++SL+
Sbjct: 29 IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLN 87
Query: 424 YCISEK------NRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHED 477
+K + L+ E + + NL +H + L+ + + G+ +LH
Sbjct: 88 VFTPQKSLEEFQDVYLVMELM-DANLCQVIHME----LDHERMSYLLYQMLCGIKHLHS- 141
Query: 478 CHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTT---QTHVSTRVMGTFGYLAPEYA 534
IIHRD+K +NI+V + ++ DFGLA+ T +V TR Y APE
Sbjct: 142 --AGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRY-----YRAPEVI 194
Query: 535 SSGKLTDRSDVFSFGVVLLELITG 558
+ D++S G ++ EL+ G
Sbjct: 195 LGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 19/206 (9%)
Query: 379 GNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFV 438
E KV+ +K L F ++ +V H+H+V L G C+ + +++ EFV
Sbjct: 28 SYEKEIKVI-LKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFV 86
Query: 439 PNNNLEHHLHGKGQPV-LEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDE 497
L+ +H K + W + K+A A L+YL ED ++H ++ + NIL+ E
Sbjct: 87 EFGPLDLFMHRKSDVLTTPW--KFKVAKQLASALSYL-ED--KDLVHGNVCTKNILLARE 141
Query: 498 -FEAQVADFGLAKLNDT-TQTHVSTR--VMGTFGYLAPEYASSGK-LTDRSDVFSFGVVL 552
+ + F KL+D V +R + ++APE K L+ +D +SFG L
Sbjct: 142 GIDGECGPF--IKLSDPGIPITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTL 199
Query: 553 LELITGRKPVDPTQPLGDESLVEWAR 578
E+ + PL D++L E R
Sbjct: 200 WEIC-----YNGEIPLKDKTLAEKER 220
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 4e-07
Identities = 23/131 (17%), Positives = 32/131 (24%)
Query: 7 TPGPPVANNASSGLGERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAA 66
P A + A A PA + ++ P+
Sbjct: 674 GGAAPAAPPPAPAPAAPAAPAGAAPAQPAPAPAATPPAGQADDPAAQPPQAAQGASAPSP 733
Query: 67 SPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPP 126
+ P P P P A P PP +P A +A PP +P
Sbjct: 734 AADDPVPLPPEPDDPPDPAGAPAQPPPPPAPAPAAAPAAAPPPSPPSEEEEMAEDDAPSM 793
Query: 127 GDGGASPPPEQ 137
D E
Sbjct: 794 DDEDRRDAEEV 804
|
Length = 824 |
| >gnl|CDD|215533 PLN02983, PLN02983, biotin carboxyl carrier protein of acetyl-CoA carboxylase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 4e-07
Identities = 26/58 (44%), Positives = 30/58 (51%), Gaps = 2/58 (3%)
Query: 70 PASPPPASPPPASPPPAASPPPGSPPPASP--PPASGSASPPPASPPPTRSESQSSPP 125
P PPPA PPP + PP SPP A P + S P PASPPP ++ S PP
Sbjct: 142 PQPPPPAPVVMMQPPPPHAMPPASPPAAQPAPSAPASSPPPTPASPPPAKAPKSSHPP 199
|
Length = 274 |
| >gnl|CDD|236382 PRK09111, PRK09111, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 53.0 bits (128), Expect = 4e-07
Identities = 17/71 (23%), Positives = 25/71 (35%)
Query: 47 PPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSA 106
PP+ GG P A A+P A+ PA+ PAA+ A+ A
Sbjct: 391 PPSPGGGGGGPPGGGGAPGAPAAAAAPGAAAAAPAAGGPAAALAAVPDAAAAAAAPPAPA 450
Query: 107 SPPPASPPPTR 117
+ P +
Sbjct: 451 AAPQPAVRLNS 461
|
Length = 598 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 5e-07
Identities = 28/117 (23%), Positives = 36/117 (30%), Gaps = 7/117 (5%)
Query: 53 NNGGGGNNSTTPAASPPPASPPPASPPPASPPPAASPPPGS-----PPPASPPPASGSAS 107
G + P P PA+ P S AASP P P A + +
Sbjct: 364 QKGDDASGGRGPKQHIKPVFTQPAAAPQPSAAAAASPSPSQSSAAAQPSAPQSATQPAGT 423
Query: 108 PPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQ 164
PP S P + PP + P Q K P + S+ S IQ
Sbjct: 424 PPTVSVDPP--AAVPVNPPSTAPQAVRPAQFKEEKKIPVSKVSSLGPSTLRPIQEKA 478
|
Length = 614 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 5e-07
Identities = 57/208 (27%), Positives = 89/208 (42%), Gaps = 24/208 (11%)
Query: 367 VIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGERE----FRAEVEIISRVHHRHLVSLV 422
VIG G FG V + V +L S +R F E +I++ + +V L
Sbjct: 50 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109
Query: 423 GYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEW----TKRVKIALGAAKGLAYLHEDC 478
++ ++ E++P +L + + P +W T V +AL A + +
Sbjct: 110 YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE-KWARFYTAEVVLALDAIHSMGF----- 163
Query: 479 HPKIIHRDIKSANILVDDEFEAQVADFGLA-KLNDTTQTHVSTRVMGTFGYLAPEYASS- 536
IHRD+K N+L+D ++ADFG K+N T V GT Y++PE S
Sbjct: 164 ----IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQ 218
Query: 537 ---GKLTDRSDVFSFGVVLLELITGRKP 561
G D +S GV L E++ G P
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 6e-07
Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 11/93 (11%)
Query: 470 GLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKL--NDTTQT-HVSTRVMGTF 526
G+ +LH IIHRD+K +NI+V + ++ DFGLA+ T +V TR
Sbjct: 130 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---- 182
Query: 527 GYLAPEYASSGKLTDRSDVFSFGVVLLELITGR 559
Y APE + D++S G ++ E+I G
Sbjct: 183 -YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 7e-07
Identities = 29/143 (20%), Positives = 45/143 (31%), Gaps = 3/143 (2%)
Query: 18 SGLGERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNST-TPAASPPPASPPPA 76
S + + EA A PAE G S A+ AS +
Sbjct: 762 SLVPAKLAEALALLEPAEPQRGAGSSPPVRAEAAFRRPGRLRRSGPAADAASRTASKRKS 821
Query: 77 SPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPE 136
+S P P A+ PP + S+ + P ++ G PP
Sbjct: 822 RSHTPDGGSESSGPARPPGAAARPPPARSSESSKSKPAAAGGRARGK--NGRRRPRPPEP 879
Query: 137 QSKNSPPAPPGQASTPPDSPPPG 159
+++ APP A+ P + P
Sbjct: 880 RARPGAAAPPKAAAAAPPAGAPA 902
|
Length = 1352 |
| >gnl|CDD|217393 pfam03154, Atrophin-1, Atrophin-1 family | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 7e-07
Identities = 44/178 (24%), Positives = 61/178 (34%), Gaps = 12/178 (6%)
Query: 64 PAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSS 123
P+ PPP + P S P PP+A PPP P S P + PP ++SQS
Sbjct: 378 PSNLPPPPALKPLSSLPTHHPPSAHPPPLQLMPQSQP------LQSVPAQPPVLTQSQSL 431
Query: 124 PPPGDGGASPPPEQSKNSPPAPP---GQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTK 180
PP P P PPP + ++ P +
Sbjct: 432 PPKASTHPHSGLHSGPPQSPFAQHPFTSGGLPAIGPPPSLPTSTPAAPPRASSGSQPPGS 491
Query: 181 WAPPSNPGSPPSPSTSQSGTPSTPNENSSPNELSPP---SNSKSPTSKSSPEESSSSS 235
P S + P P P + + E PP S S PT ++P +S S+
Sbjct: 492 ALPSSGGCAGPGPPLPPIQIKEEPLDEAEEPESPPPPPRSPSPEPTVVNTPSHASQSA 549
|
Atrophin-1 is the protein product of the dentatorubral-pallidoluysian atrophy (DRPLA) gene. DRPLA OMIM:125370 is a progressive neurodegenerative disorder. It is caused by the expansion of a CAG repeat in the DRPLA gene on chromosome 12p. This results in an extended polyglutamine region in atrophin-1, that is thought to confer toxicity to the protein, possibly through altering its interactions with other proteins. The expansion of a CAG repeat is also the underlying defect in six other neurodegenerative disorders, including Huntington's disease. One interaction of expanded polyglutamine repeats that is thought to be pathogenic is that with the short glutamine repeat in the transcriptional coactivator CREB binding protein, CBP. This interaction draws CBP away from its usual nuclear location to the expanded polyglutamine repeat protein aggregates that are characteristic of the polyglutamine neurodegenerative disorders. This interferes with CBP-mediated transcription and causes cytotoxicity. Length = 979 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 8e-07
Identities = 41/199 (20%), Positives = 59/199 (29%), Gaps = 14/199 (7%)
Query: 65 AASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTR------S 118
A P A P P P A P P PA P P R S
Sbjct: 2486 ARFPFAAGAAPDPGGGGPPDPDAPPAPSRLAPAILPDEPVGEPVHPRMLTWIRGLEELAS 2545
Query: 119 ESQSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNP-VPSNGTTDS- 176
+ PPP A+PP ++ PP P P P + S P P
Sbjct: 2546 DDAGDPPPPLPPAAPPAAPDRSVPPPRPA-----PRPSEPAVTSRARRPDAPPQSARPRA 2600
Query: 177 -RDTKWAPPSNPGSPPSPSTSQSGTPSTPNENSSPNELSPPSNSKSPTSKSSPEESSSSS 235
D + P P P + + P P+ + + NE P P + ++ +
Sbjct: 2601 PVDDRGDPRGPAPPSPLPPDTHAPDPPPPSPSPAANEPDPHPPPTVPPPERPRDDPAPGR 2660
Query: 236 HSNSKKTPTSSSGHSSDST 254
S ++ + S
Sbjct: 2661 VSRPRRARRLGRAAQASSP 2679
|
Length = 3151 |
| >gnl|CDD|178748 PLN03209, PLN03209, translocon at the inner envelope of chloroplast subunit 62; Provisional | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 8e-07
Identities = 54/229 (23%), Positives = 86/229 (37%), Gaps = 26/229 (11%)
Query: 64 PAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASP-------------PP 110
P+ PP A P P +P SPP PP + P PP
Sbjct: 324 PSQRVPPKESDAADGPKPVPTKPVTPEAPSPPIEEEPPQPKAVVPRPLSPYTAYEDLKPP 383
Query: 111 ASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPS 170
SP PT S + + P E + P+ PG AS P+ P +++ + P+
Sbjct: 384 TSPIPTPPSSSPASSKSVDAVAKPAEP--DVVPS-PGSASNVPEVEPAQVEAKKTRPLSP 440
Query: 171 NGTTDSRDTKWAPPSNPGSPPSPSTSQSGTPSTPNENSSPNELSPPSNSKSPTSKSSPEE 230
+ D K PP++P SP +P+ ST + + P+ + P+ + + + P
Sbjct: 441 YARYE--DLK--PPTSP-SPTAPTGVSPSVSSTSSVPAVPD--TAPATAATDAAAPPPAN 493
Query: 231 SSSSSH---SNSKKTPTSSSGHSSDSTKGSSSNDDQAIIGATAAGVVLI 276
S + K PTS S + SS ++ +G +A L
Sbjct: 494 MRPLSPYAVYDDLKPPTSPSPAAPVGKVAPSSTNEVVKVGNSAPPTALA 542
|
Length = 576 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 9e-07
Identities = 33/98 (33%), Positives = 57/98 (58%), Gaps = 9/98 (9%)
Query: 468 AKGLAYL-HEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK--LNDTTQTHVSTRVMG 524
A+G+ +L ++C IHRD+ + N+L+ D A++ DFGLA+ +ND+ V
Sbjct: 222 AQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV-VKGNARL 276
Query: 525 TFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKP 561
++APE T +SDV+S+G++L E+ + G+ P
Sbjct: 277 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 9e-07
Identities = 28/95 (29%), Positives = 51/95 (53%), Gaps = 7/95 (7%)
Query: 469 KGLAYLHEDCHPKIIHRDIKSANILVD-DEFEAQVADFGLAKLNDTTQTHVSTRVMG--T 525
+GL Y+H ++HRD+K AN+ ++ ++ ++ DFGLA++ D +H G T
Sbjct: 125 RGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVT 181
Query: 526 FGYLAPEYA-SSGKLTDRSDVFSFGVVLLELITGR 559
Y +P S T D+++ G + E++TG+
Sbjct: 182 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|235899 PRK06975, PRK06975, bifunctional uroporphyrinogen-III synthetase/uroporphyrin-III C-methyltransferase; Reviewed | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 9e-07
Identities = 14/56 (25%), Positives = 22/56 (39%)
Query: 63 TPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRS 118
AA P A+P P+ + + + P + A PP + A+PP R
Sbjct: 267 DAAAQPATAAPAPSRMTDTNDSKSVTSQPAAAAAAPAPPPNPPATPPEPPARRGRG 322
|
Length = 656 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 1e-06
Identities = 18/62 (29%), Positives = 27/62 (43%), Gaps = 1/62 (1%)
Query: 73 PPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGAS 132
PP A+ +P A+PPP + PP P + A+ PA P P + + P A+
Sbjct: 384 PPSAAWGAPTPAAPAAPPPAAAPPVPPAAPARPAAARPA-PAPAPPAAAAPPARSADPAA 442
Query: 133 PP 134
Sbjct: 443 AA 444
|
Length = 576 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 1e-06
Identities = 28/135 (20%), Positives = 42/135 (31%), Gaps = 8/135 (5%)
Query: 21 GERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAAS-PPPASPPPASPP 79
G+ + P + + P A + +S S P A+ P +PP
Sbjct: 366 GDDASGGRGPKQHIKPVFTQPAAAPQPSAAAAASPSPSQSSAAAQPSAPQSATQPAGTPP 425
Query: 80 PASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSK 139
S P A+ P PP++ P A A P S+ S P EQ+
Sbjct: 426 TVSVDPPAAVP--VNPPSTAPQAVRPAQFKEEKKIPV-SKVSSLGPSTLRPIQEKAEQAT 482
Query: 140 NSPPAPPGQASTPPD 154
+ A T
Sbjct: 483 GNIKE----APTGTQ 493
|
Length = 614 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.7 bits (122), Expect = 1e-06
Identities = 57/240 (23%), Positives = 94/240 (39%), Gaps = 51/240 (21%)
Query: 362 FARENVIGEGGFGCVYKGNLPE-GKVVAVKQLKSGSGQGEREF---RAEVEIISRVHHRH 417
F + ++G+G G V+ L GK+ A+K L + E EI++ + H
Sbjct: 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPF 62
Query: 418 LVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAK-------- 469
L +L +E L+ ++ P L L + QP K + A+
Sbjct: 63 LPTLYASFQTETYLCLVMDYCPGGELFRLL--QRQP----GKCLSEE--VARFYAAEVLL 114
Query: 470 GLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRV------- 522
L YLH I++RD+K NIL+ + ++DF L+K +D VS +
Sbjct: 115 ALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRS 171
Query: 523 ---------------------MGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKP 561
+GT Y+APE S D ++ G++L E++ G P
Sbjct: 172 SVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|235124 PRK03427, PRK03427, cell division protein ZipA; Provisional | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 27/123 (21%), Positives = 39/123 (31%), Gaps = 1/123 (0%)
Query: 75 PASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPP 134
+ PA+ + P PP AS P PP + Q +P P P
Sbjct: 70 RVNHAPANAQEHEAARPSPQHQYQPPYASAQPRQPVQQPPEAQVPPQHAPRPAQPAPQPV 129
Query: 135 PEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPSNPGSPPSPS 194
+ + P P Q P P Q P P+ + AP P + P+P
Sbjct: 130 QQPAYQPQPEQPLQQPVSPQVAPAP-QPVHSAPQPAQQAFQPAEPVAAPQPEPVAEPAPV 188
Query: 195 TSQ 197
+
Sbjct: 189 MDK 191
|
Length = 333 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 2e-06
Identities = 28/103 (27%), Positives = 38/103 (36%), Gaps = 1/103 (0%)
Query: 5 AETPGPPVANNASSGLGERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTP 64
A P P A A++ + PAPA P P + S P
Sbjct: 407 AAAPAPAAAAPAAAAAPAPAAAPQPAPAPAPAPAPPSPAGNAPAGGAPSPPPAAAPSAQP 466
Query: 65 AASPPPASPPPASPPPASPP-PAASPPPGSPPPASPPPASGSA 106
A +P A P A+P PA P PA + P +P + P + A
Sbjct: 467 APAPAAAPEPTAAPAPAPPAAPAPAAAPAAPAAPAAPAGADDA 509
|
Length = 824 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 24/98 (24%), Positives = 32/98 (32%), Gaps = 9/98 (9%)
Query: 94 PPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPPGQASTPP 153
P PA P +A+P P P P S+ P A+ PP++ PP P
Sbjct: 362 PVPAPQPAKPTAAAPSPVRPTPA----PSTRPKAAAAANIPPKEPVRETATPPPVPPRPV 417
Query: 154 DSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPSNPGSPP 191
P P T + P P +PP
Sbjct: 418 APPVPHTP-----ESAPKLTRAAIPVDEKPKYTPPAPP 450
|
Length = 585 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 2e-06
Identities = 19/82 (23%), Positives = 25/82 (30%), Gaps = 2/82 (2%)
Query: 75 PASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPP 134
++ A PP P PPPA PP + P PP + + P
Sbjct: 515 GSASNTAKTPPPPQKSP--PPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPA 572
Query: 135 PEQSKNSPPAPPGQASTPPDSP 156
P P + T SP
Sbjct: 573 DSSPPPPIPEEPTPSPTKDSSP 594
|
Length = 620 |
| >gnl|CDD|178748 PLN03209, PLN03209, translocon at the inner envelope of chloroplast subunit 62; Provisional | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 2e-06
Identities = 50/249 (20%), Positives = 73/249 (29%), Gaps = 33/249 (13%)
Query: 23 RKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPAS 82
++ K A P K VTP +P P P P P S
Sbjct: 326 QRVPPKESDAADGPKPVPTKPVTPEA-------------PSPPIEEEPPQPKAVVPRPLS 372
Query: 83 PPPAAS--PPPGSPPPASPPPASGSASPPPASPPPTRSESQSSP--PPGDGGASPPPEQS 138
P A PP SP P P + S+ A P + SP P ++
Sbjct: 373 PYTAYEDLKPPTSPIPTPPSSSPASSKSVDAVAKPAEPDVVPSPGSASNVPEVEPAQVEA 432
Query: 139 KNSPPAPPGQAS---TPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPSNPGSPPSPST 195
K + P P PP SP P + V S + P+ P + P+ +
Sbjct: 433 KKTRPLSPYARYEDLKPPTSPSPTAPTGVSPSVSSTSSV---------PAVPDTAPATAA 483
Query: 196 SQSGTPSTPNENSSPNELSPPSNSKSPTSKSSPEESSSSSHSNSKKTPTSSSGHSSDSTK 255
+ + P N LSP + +SP ++ T +S
Sbjct: 484 TDAAAPPPAN----MRPLSPYAVYDDLKPPTSPSPAAPVGKVAPSSTNEVVKVGNSAPPT 539
Query: 256 GSSSNDDQA 264
+ A
Sbjct: 540 ALADEQHHA 548
|
Length = 576 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 2e-06
Identities = 30/87 (34%), Positives = 41/87 (47%), Gaps = 9/87 (10%)
Query: 29 APPAPA----EKTESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPP 84
AP AP ++ E+ E+ PP+ G + A+PPPA+ PP P + P
Sbjct: 362 APGAPVSELLDRLEALERGAPAPPS-----AAWGAPTPAAPAAPPPAAAPPVPPAAPARP 416
Query: 85 PAASPPPGSPPPASPPPASGSASPPPA 111
AA P P PPA+ P + SA P A
Sbjct: 417 AAARPAPAPAPPAAAAPPARSADPAAA 443
|
Length = 576 |
| >gnl|CDD|219321 pfam07174, FAP, Fibronectin-attachment protein (FAP) | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 34/89 (38%), Positives = 41/89 (46%), Gaps = 7/89 (7%)
Query: 61 STTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSES 120
S A P A+ PA PPP P AA+ P + PP PPPA P +P P +
Sbjct: 27 SAVAIALPATANADPA-PPPPPPSTAAAAPAPAAPPPPPPPA------APPAPQPDDPNA 79
Query: 121 QSSPPPGDGGASPPPEQSKNSPPAPPGQA 149
PPP D A PPP N+PP P +
Sbjct: 80 APPPPPADPNAPPPPPVDPNAPPPPAPEP 108
|
This family contains bacterial fibronectin-attachment proteins (FAP). Family members are rich in alanine and proline, are approximately 300 long, and seem to be restricted to mycobacteria. These proteins contain a fibronectin-binding motif that allows mycobacteria to bind to fibronectin in the extracellular matrix. Length = 297 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 49/193 (25%), Positives = 78/193 (40%), Gaps = 21/193 (10%)
Query: 384 GKVVAVKQLKSGSGQGEREFRAEV--------------EIISRVHHRHLVSLVGYCISEK 429
GKV+ VK+ +G + + EV ++ H L +L Y
Sbjct: 9 GKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL-KYSFQTH 67
Query: 430 NRL-LIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIK 488
+RL + E+ L HL + V + L YLH + +++RD+K
Sbjct: 68 DRLCFVMEYANGGELFFHL--SRERVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLK 123
Query: 489 SANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSF 548
N+++D + ++ DFGL K + T GT YLAPE D +
Sbjct: 124 LENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLEDNDYGRAVDWWGL 182
Query: 549 GVVLLELITGRKP 561
GVV+ E++ GR P
Sbjct: 183 GVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 36/101 (35%), Positives = 52/101 (51%), Gaps = 17/101 (16%)
Query: 483 IHRDIKSANILVDDEFEAQVADFG-LAKLND--TTQTHVSTRVMGTFGYLAPEYASS--- 536
+HRDIK N+L+D ++ADFG K+N T Q+ V+ +GT Y++PE +
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVA---VGTPDYISPEILQAMED 180
Query: 537 --GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVE 575
GK D +S GV + E++ G P ESLVE
Sbjct: 181 GMGKYGPECDWWSLGVCMYEMLYGET------PFYAESLVE 215
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|223079 PHA03419, PHA03419, E4 protein; Provisional | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 2e-06
Identities = 26/106 (24%), Positives = 33/106 (31%), Gaps = 8/106 (7%)
Query: 75 PASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTR-------SESQSSPPPG 127
PP +P P++ PPP P P PP + + A PP + P G
Sbjct: 49 YPFCPPTTPHPSSQPPPCPPSPGHPPQTNDTHEKDLALQPPPGGKKKEKKKKETEKPAQG 108
Query: 128 DGGASPPPEQSKNSPPAPPGQ-ASTPPDSPPPGIQSNQGNPVPSNG 172
PE P PP G +G P P G
Sbjct: 109 GEKPDQGPEAKGEGEGHEPEDPPPEDTPPPPGGEGEVEGGPSPGPG 154
|
Length = 200 |
| >gnl|CDD|177464 PHA02682, PHA02682, ORF080 virion core protein; Provisional | Back alignment and domain information |
|---|
Score = 49.5 bits (117), Expect = 2e-06
Identities = 34/109 (31%), Positives = 43/109 (39%), Gaps = 3/109 (2%)
Query: 65 AASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSP 124
A SP A+P PA P A PA + +P PA PP + + PP P P R P
Sbjct: 83 APSPACAAPAPACPACAPAAPAPAVTCPAPAPACPPATAPTCPPPAVCPAPARPAPACPP 142
Query: 125 PPGDGGASPPPEQSKNSPPAPPG---QASTPPDSPPPGIQSNQGNPVPS 170
+PP K +P A P PPD P + + P S
Sbjct: 143 STRQCPPAPPLPTPKPAPAAKPIFLHNQLPPPDYPAASCPTIETAPAAS 191
|
Length = 280 |
| >gnl|CDD|237605 PRK14086, dnaA, chromosomal replication initiation protein; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 3e-06
Identities = 36/194 (18%), Positives = 52/194 (26%), Gaps = 19/194 (9%)
Query: 60 NSTTPAASPPPASPPPASPPPASPPPAASPPPGSP-PPASPPPASGSASPPPASPPPTRS 118
+ + +PPP + P P P P G P A P + P
Sbjct: 89 DPSAGEPAPPPPH-ARRTSEPELPRPGRRPYEGYGGPRADDRPPGLPRQDQLPTARPAYP 147
Query: 119 ESQSSPPPGD--GGASPPPEQ---SKNSPPAPPGQASTP-----PDSPPPGIQSNQGNPV 168
Q P PG A Q P AP ++ D P + +
Sbjct: 148 AYQQRPEPGAWPRAADDYGWQQQRLGFPPRAPYASPASYAPEQERDREPYDAGRPEYDQR 207
Query: 169 PSNGTTDSRDTKWAPPSN-----PGSPPSPSTSQSGTPSTPNENSSPNELSPPSNSKSPT 223
+ D W P P PP G P P + +P PS
Sbjct: 208 RRDYDHPRPD--WDRPRRDRTDRPEPPPGAGHVHRGGPGPPERDDAPVVPIRPSAPGPLA 265
Query: 224 SKSSPEESSSSSHS 237
++ +P +
Sbjct: 266 AQPAPAPGPGEPTA 279
|
Length = 617 |
| >gnl|CDD|220392 pfam09770, PAT1, Topoisomerase II-associated protein PAT1 | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 3e-06
Identities = 32/168 (19%), Positives = 45/168 (26%), Gaps = 6/168 (3%)
Query: 66 ASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPP 125
+P P PP +P P + S +P PP + Q PP
Sbjct: 128 TAPKPEPQPPQAPESQPQPQTPAQKMLSLEEVEAQLQQRQQAPQLPQPPQ-QVLPQGMPP 186
Query: 126 PGDGGAS-PPPEQSKNSPPAPPG--QASTPPDSPPPGIQSNQGNPVPSNGTTDSRD--TK 180
PPEQ P P G + P P Q+ P+P
Sbjct: 187 RQAAFPQQGPPEQPPGYPQPPQGHPEQVQPQQFLPAPSQAPAQPPLPPQLPQQPPPLQQP 246
Query: 181 WAPPSNPGSPPSPSTSQSGTPSTPNENSSPNELSPPSNSKSPTSKSSP 228
P + PP P P + P + P+ +
Sbjct: 247 QFPGLSQQMPPPPPQPPQQQQQPPQPQAQPPPQNQPTPHPGLPQGQNA 294
|
Members of this family are necessary for accurate chromosome transmission during cell division. Length = 804 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 3e-06
Identities = 17/110 (15%), Positives = 31/110 (28%)
Query: 12 VANNASSGLGERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPA 71
+A A++ + A PA + +P + P ++ A+ P A
Sbjct: 51 LAPPAAAAPAAAQPPPAAAPAAVSRPAAPAAEPAPWLVEHAKRLTAQREQLVARAAAPAA 110
Query: 72 SPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQ 121
A PA A + A+ P + A+
Sbjct: 111 PEAQAPAAPAERAAAENAARRLARAAAAAPRPRVPADAAAAVADAVKARI 160
|
Length = 484 |
| >gnl|CDD|217393 pfam03154, Atrophin-1, Atrophin-1 family | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 3e-06
Identities = 50/213 (23%), Positives = 73/213 (34%), Gaps = 3/213 (1%)
Query: 40 PEKKVTPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASP 99
P++ +P P + +S P S PP P P ++P
Sbjct: 234 PQRLPSPHPPLQPQTASQQSPQPPAPSSRHPQSSHHGPGPPMPHALQQGPVFLQHPSSNP 293
Query: 100 P-PASGSASPPPASPPPTRSESQSSPPPGDGGASPP-PEQSKNSPPAPPGQASTPPDSPP 157
P P + S P P P++++ S PP P P + + PPAP PP + P
Sbjct: 294 PQPFGLAQSQVPPLPLPSQAQPHSHTPPSQSALQPQQPPREQPLPPAPSMPHIKPPPTTP 353
Query: 158 PGIQSNQGNPVPSNGTTDSRDTKWAPPSNPGSPPSPSTSQSGTPSTPNENSSPNELSPPS 217
NQ + P + S + P + P P S T P+ + P +L P S
Sbjct: 354 IPQLPNQSHKHPPHLQGPSPFPQ-MPSNLPPPPALKPLSSLPTHHPPSAHPPPLQLMPQS 412
Query: 218 NSKSPTSKSSPEESSSSSHSNSKKTPTSSSGHS 250
P + S S T S HS
Sbjct: 413 QPLQSVPAQPPVLTQSQSLPPKASTHPHSGLHS 445
|
Atrophin-1 is the protein product of the dentatorubral-pallidoluysian atrophy (DRPLA) gene. DRPLA OMIM:125370 is a progressive neurodegenerative disorder. It is caused by the expansion of a CAG repeat in the DRPLA gene on chromosome 12p. This results in an extended polyglutamine region in atrophin-1, that is thought to confer toxicity to the protein, possibly through altering its interactions with other proteins. The expansion of a CAG repeat is also the underlying defect in six other neurodegenerative disorders, including Huntington's disease. One interaction of expanded polyglutamine repeats that is thought to be pathogenic is that with the short glutamine repeat in the transcriptional coactivator CREB binding protein, CBP. This interaction draws CBP away from its usual nuclear location to the expanded polyglutamine repeat protein aggregates that are characteristic of the polyglutamine neurodegenerative disorders. This interferes with CBP-mediated transcription and causes cytotoxicity. Length = 979 |
| >gnl|CDD|218439 pfam05109, Herpes_BLLF1, Herpes virus major outer envelope glycoprotein (BLLF1) | Back alignment and domain information |
|---|
Score = 50.6 bits (120), Expect = 3e-06
Identities = 53/307 (17%), Positives = 96/307 (31%), Gaps = 42/307 (13%)
Query: 31 PAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPAASPP 90
+P T S +P + + T A S ++ S P + P
Sbjct: 540 TSPPTGTTSVPNATSPQVTEESPVNNTNTPVVTSAPSVLTSAVTTGQHGTGSSPTSQQPG 599
Query: 91 PGSPPPASPPPASGSASPPPASPPPTRSE-----SQSSP--------------------- 124
S ++P S S +P S PT E + S P
Sbjct: 600 IPSSSHSTPRSNSTSTTPLLTSAHPTGGENITEETPSVPSTTHVSTLSPGPGPGTTSQVS 659
Query: 125 PPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPP 184
PG+ S P + + P A++P + +++T
Sbjct: 660 GPGNSSTSRYPGEVHVTEGMPNPNATSPSAPSGQKTAVPTVTSTGGKANSTTKET---SG 716
Query: 185 SNPGSPPSPSTSQSGTPSTPNENSSPNELSPPSNSKSPTSKSSPEESSSSSHSNSKKTPT 244
S + SP T++ +TP ++ S S + + +SP T
Sbjct: 717 STLMASTSPHTNEGAFRTTPYNATTYLPPSTSSKLRPRWTFTSPP-----------VTTK 765
Query: 245 SSSGHSSDSTKGSSSNDDQAIIGATAAGVVLIVLIAIFFLARGRRRRRDAYATHYMPPPN 304
++ + SN ++ + V+ ++L+ + L RR +Y Y PP
Sbjct: 766 QATVPVPPTQHPDHSNLSMLVLQWASLSVLTLLLLLV--LVDCAFRRPSSYLHTYTYPPY 823
Query: 305 NFNEKTV 311
+ +E V
Sbjct: 824 DDSETEV 830
|
This family consists of the BLLF1 viral late glycoprotein, also termed gp350/220. It is the most abundantly expressed glycoprotein in the viral envelope of the Herpesviruses and is the major antigen responsible for stimulating the production of neutralising antibodies in vivo. Length = 830 |
| >gnl|CDD|236382 PRK09111, PRK09111, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 49.9 bits (120), Expect = 4e-06
Identities = 16/74 (21%), Positives = 24/74 (32%)
Query: 65 AASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSP 124
PP PP P A +P A+ PA+G + A+ P + + + P
Sbjct: 388 QEGPPSPGGGGGGPPGGGGAPGAPAAAAAPGAAAAAPAAGGPAAALAAVPDAAAAAAAPP 447
Query: 125 PPGDGGASPPPEQS 138
P S
Sbjct: 448 APAAAPQPAVRLNS 461
|
Length = 598 |
| >gnl|CDD|236382 PRK09111, PRK09111, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 49.9 bits (120), Expect = 4e-06
Identities = 27/120 (22%), Positives = 42/120 (35%), Gaps = 26/120 (21%)
Query: 25 EEAKAPPAPAEKTE-------------SPE---KKVTPPPADNNNNGGGGNNSTTPAASP 68
EE + P P E +P+ +++ P GGG P
Sbjct: 352 EEVQGAPRPLAAAEMVLIRLAYAADLPTPDEALRRLQEGPPSPGGGGGG----------P 401
Query: 69 PPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGD 128
P P +P A+ P AA+ P + PA+ A A+ A+PP + Q +
Sbjct: 402 PGGGGAPGAPAAAAAPGAAAAAPAAGGPAAALAAVPDAAAAAAAPPAPAAAPQPAVRLNS 461
|
Length = 598 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 4e-06
Identities = 67/250 (26%), Positives = 97/250 (38%), Gaps = 55/250 (22%)
Query: 362 FARENVIGEGGFGCVYKGNLPE-GKVVAVKQLKSGSGQGERE----FRAEVEIISRVHHR 416
F VIG G FG V + G V A+K L+ E+E RAE +I+
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKAD-MLEKEQVGHIRAERDILVEADSL 61
Query: 417 HLVSLVGYCISEK-NRLLIYEFVPNNNLEHHLHGKGQPVLEWTK----RVKIALGAAKGL 471
+V + Y +K N LI EF+P ++ L K E T+ +A+ + L
Sbjct: 62 WVVKMF-YSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL 120
Query: 472 AYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLA-------------KLND------ 512
+ IHRDIK N+L+D + +++DFGL LN
Sbjct: 121 GF---------IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDF 171
Query: 513 TTQTHVSTR---------------VMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT 557
T Q S R +GT Y+APE D +S GV++ E++
Sbjct: 172 TFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231
Query: 558 GRKPVDPTQP 567
G P P
Sbjct: 232 GYPPFCSETP 241
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|185616 PTZ00436, PTZ00436, 60S ribosomal protein L19-like protein; Provisional | Back alignment and domain information |
|---|
Score = 49.2 bits (116), Expect = 4e-06
Identities = 43/145 (29%), Positives = 65/145 (44%), Gaps = 16/145 (11%)
Query: 22 ERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPA 81
ER A A A K ++ KK P + AA+P A+ PPA A
Sbjct: 186 ERARREDAAAAAAAKQKAAAKKAAAPSGKKSAKAAA---PAKAAAAPAKAAAPPAKAAAA 242
Query: 82 SPPPAASPPPGSPPP--ASPPPASGSASPPPASPPPTRSE---SQSSPPPGDGGASP--- 133
AA+P + PP A+ PPA +A P A+ PP ++ ++++ PP A+P
Sbjct: 243 PAKAAAAPAKAAAPPAKAAAPPAKAAAPPAKAAAPPAKAAAPPAKAAAPPAKAAAAPAKA 302
Query: 134 --PPEQSKNSP---PAPPGQASTPP 153
P ++ +P APP +A+ PP
Sbjct: 303 AAAPAKAAAAPAKAAAPPAKAAAPP 327
|
Length = 357 |
| >gnl|CDD|218883 pfam06075, DUF936, Plant protein of unknown function (DUF936) | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 4e-06
Identities = 46/226 (20%), Positives = 68/226 (30%), Gaps = 19/226 (8%)
Query: 65 AASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSP 124
A+ A A A+S P +S AS +SP P P +
Sbjct: 116 VAADSLAFFSDAVIQVIKRKKASSAPRRGSWDSSSKSASIDSSPTVIGPRPRSFSELNLT 175
Query: 125 PPGDGGASPP--------PEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPV--PSNGTT 174
P + P + G+ S+ G S + +
Sbjct: 176 DRTPAKVRSSRSELGAPSPSGGTSCPSSSGGRRSSIGSRRLRGSASLRKKVAVLSAPRKP 235
Query: 175 DSR--DTKWAPPSNPGSPPSPSTSQ-----SGTPSTPNENSSPNELSPPSNSKSPTSKSS 227
SR D K +P + S SP S + S + +SP + S S S+ K S
Sbjct: 236 GSRSSDCKSSPRARSSSAKSPFKSSIQRKATKALSKLSLRASPKDTSKSSKSEVAPPKKS 295
Query: 228 PEESSSSSHSNSKKTPTSSS--GHSSDSTKGSSSNDDQAIIGATAA 271
+ SSS + + S S K + D A A A
Sbjct: 296 EAKVPSSSKKWTDGNVSWDSLPSSLSKLGKEALRQRDVAQKAALEA 341
|
This family consists of several hypothetical proteins from Arabidopsis thaliana and Oryza sativa. The function of this family is unknown. Length = 564 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 4e-06
Identities = 32/151 (21%), Positives = 58/151 (38%), Gaps = 22/151 (14%)
Query: 368 IGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVS--LVGYC 425
+ G VY + V +K + S + + EV I+ + + L ++
Sbjct: 6 LKGGLTNRVYLLGTKDEDYV-LKI--NPSREKGADREREVAILQLLARKGLPVPKVLASG 62
Query: 426 ISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALG--AAKGLAYLHEDCHPK-- 481
S+ L+ E++ G+ + E ++ K + A+ LA LH+ P
Sbjct: 63 ESDGWSYLLMEWIE-----------GETLDEVSEEEKEDIAEQLAELLAKLHQ--LPLLV 109
Query: 482 IIHRDIKSANILVDDEFEAQVADFGLAKLND 512
+ H D+ NILVDD + D+ A
Sbjct: 110 LCHGDLHPGNILVDDGKILGIIDWEYAGYGP 140
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 5e-06
Identities = 23/79 (29%), Positives = 29/79 (36%), Gaps = 1/79 (1%)
Query: 38 ESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPA 97
S + N N S PA P A + SPPPA + PP P PA
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPP-IPVPA 419
Query: 98 SPPPASGSASPPPASPPPT 116
P S + A+ PP+
Sbjct: 420 EPTEPSPTPPANAANAPPS 438
|
Length = 620 |
| >gnl|CDD|178748 PLN03209, PLN03209, translocon at the inner envelope of chloroplast subunit 62; Provisional | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 5e-06
Identities = 40/198 (20%), Positives = 62/198 (31%), Gaps = 13/198 (6%)
Query: 4 SAETPGPPVANNASSGLGE---RKEEAKAPPAPAEKTESPEKKVTPPPADNNN--NGGGG 58
++ P PP ++ ASS + + E P+P + PE + A +
Sbjct: 384 TSPIPTPPSSSPASSKSVDAVAKPAEPDVVPSPGSASNVPEVEPAQVEAKKTRPLSPYAR 443
Query: 59 NNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRS 118
P SP P + P P S + P + P + A+ P
Sbjct: 444 YEDLKPPTSPSP-TAPTGVSPSVSSTSSVPAVPDTAPATAATDAAAPPPANMRPLSPYAV 502
Query: 119 ESQSSPPPGDGGASP-PPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSR 177
PP A+P ++ S PP + Q P P + T
Sbjct: 503 YDDLKPPTSPSPAAPVGKVAPSSTNEVVKVGNSAPPTALADEQHHAQPKPRPLSPYTMYE 562
Query: 178 DTKWAPPSNPGSPPSPST 195
D K P + P+PS
Sbjct: 563 DLK------PPTSPTPSP 574
|
Length = 576 |
| >gnl|CDD|217393 pfam03154, Atrophin-1, Atrophin-1 family | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 5e-06
Identities = 39/206 (18%), Positives = 59/206 (28%), Gaps = 9/206 (4%)
Query: 25 EEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPP 84
EE + P ++ P P DN ++ PP+ P A
Sbjct: 134 EEGSSDPKDIDQDNRSSSPSIPSPQDNESDSDSSAQQQLLQPQGPPSIQVPPGAALAPSA 193
Query: 85 PAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPA 144
P +P + PP P A+ A P P + + S P SP P +
Sbjct: 194 PPPTPSAQAVPPQGSPIAAQPAPQPQQPSPLSLISAPSLHPQRL--PSPHPPLQPQTASQ 251
Query: 145 PPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPSNPGSPPSPSTSQSGTPSTP 204
Q P P G P+P P +P S
Sbjct: 252 QSPQPPAPSSRHPQSSHHGPGPPMPHALQQ-------GPVFLQHPSSNPPQPFGLAQSQV 304
Query: 205 NENSSPNELSPPSNSKSPTSKSSPEE 230
P++ P S++ S P++
Sbjct: 305 PPLPLPSQAQPHSHTPPSQSALQPQQ 330
|
Atrophin-1 is the protein product of the dentatorubral-pallidoluysian atrophy (DRPLA) gene. DRPLA OMIM:125370 is a progressive neurodegenerative disorder. It is caused by the expansion of a CAG repeat in the DRPLA gene on chromosome 12p. This results in an extended polyglutamine region in atrophin-1, that is thought to confer toxicity to the protein, possibly through altering its interactions with other proteins. The expansion of a CAG repeat is also the underlying defect in six other neurodegenerative disorders, including Huntington's disease. One interaction of expanded polyglutamine repeats that is thought to be pathogenic is that with the short glutamine repeat in the transcriptional coactivator CREB binding protein, CBP. This interaction draws CBP away from its usual nuclear location to the expanded polyglutamine repeat protein aggregates that are characteristic of the polyglutamine neurodegenerative disorders. This interferes with CBP-mediated transcription and causes cytotoxicity. Length = 979 |
| >gnl|CDD|237000 PRK11855, PRK11855, dihydrolipoamide acetyltransferase; Reviewed | Back alignment and domain information |
|---|
Score = 49.4 bits (119), Expect = 5e-06
Identities = 19/51 (37%), Positives = 27/51 (52%), Gaps = 1/51 (1%)
Query: 63 TPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASP 113
PAA+ PA+ PA+ A+P PA + +P A+P A+ P ASP
Sbjct: 198 APAAAAAPAAAAPAAAAAAAPAPAPAAAA-APAAAAPAAAAAPGKAPHASP 247
|
Length = 547 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 6e-06
Identities = 27/141 (19%), Positives = 39/141 (27%), Gaps = 2/141 (1%)
Query: 6 ETPGPPVANNASSGLGERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPA 65
P A+ +S R + P PPPA ++ + +
Sbjct: 805 SGPAADAASRTASKRKSRSHTPDGGSESSGPARPPGAAARPPPARSSESSKSKPAAAGGR 864
Query: 66 ASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPP 125
A P P P + P AA+PP + + P PA P
Sbjct: 865 ARGKNGRRRPRPPEPRARPGAAAPPKAAAAAPPAGAP--APRPRPAPRVKLGPMPPGGPD 922
Query: 126 PGDGGASPPPEQSKNSPPAPP 146
P G PP P+
Sbjct: 923 PRGGFRRVPPGDLHTPAPSAA 943
|
Length = 1352 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 6e-06
Identities = 22/131 (16%), Positives = 36/131 (27%), Gaps = 12/131 (9%)
Query: 89 PPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPPGQ 148
G + S +A+ P A+P P A+ +P P
Sbjct: 386 GVAGGAGAPAAAAPSAAAAAPAAAPAP----------AAAAPAAAAAPAPAAAPQPAPAP 435
Query: 149 ASTPPDSPPPGIQSNQGNPVPSNGT--TDSRDTKWAPPSNPGSPPSPSTSQSGTPSTPNE 206
A P P G G P P + A P + P+P+ + P+
Sbjct: 436 APAPAPPSPAGNAPAGGAPSPPPAAAPSAQPAPAPAAAPEPTAAPAPAPPAAPAPAAAPA 495
Query: 207 NSSPNELSPPS 217
+ +
Sbjct: 496 APAAPAAPAGA 506
|
Length = 824 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 49.5 bits (119), Expect = 6e-06
Identities = 19/101 (18%), Positives = 27/101 (26%), Gaps = 10/101 (9%)
Query: 6 ETPGPPVANNASSGLGERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPA 65
GP ++ A AP A PP A +
Sbjct: 34 ADYGPGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAA----------APAAP 83
Query: 66 ASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSA 106
P A+ A+P AA+ P + P G+A
Sbjct: 84 PKPAAAAAAAAAPAAPPAAAAAAAPAAAAVEDEVTPLRGAA 124
|
Length = 1228 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 6e-06
Identities = 18/79 (22%), Positives = 25/79 (31%), Gaps = 1/79 (1%)
Query: 69 PPASPPPA-SPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPG 127
AS PPP PP +P P P P + P PPP + + + P
Sbjct: 515 GSASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPADS 574
Query: 128 DGGASPPPEQSKNSPPAPP 146
P E + +
Sbjct: 575 SPPPPIPEEPTPSPTKDSS 593
|
Length = 620 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 6e-06
Identities = 24/117 (20%), Positives = 33/117 (28%), Gaps = 14/117 (11%)
Query: 89 PPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPPGQ 148
P P + A+ P P ASP P QS + Q
Sbjct: 370 SGGRGPKQHIKPVFTQPAAAPQ--------------PSAAAAASPSPSQSSAAAQPSAPQ 415
Query: 149 ASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPSNPGSPPSPSTSQSGTPSTPN 205
++T P PP + + VP N + + S S PST
Sbjct: 416 SATQPAGTPPTVSVDPPAAVPVNPPSTAPQAVRPAQFKEEKKIPVSKVSSLGPSTLR 472
|
Length = 614 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 6e-06
Identities = 29/91 (31%), Positives = 44/91 (48%), Gaps = 3/91 (3%)
Query: 469 KGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGY 528
+ + YLHE+ +IIHRDIK+ NI ++ + + DFG A + GT
Sbjct: 193 RAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIAT 249
Query: 529 LAPEYASSGKLTDRSDVFSFGVVLLELITGR 559
APE + D++S G+VL E+ T
Sbjct: 250 NAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 7e-06
Identities = 23/105 (21%), Positives = 35/105 (33%), Gaps = 1/105 (0%)
Query: 4 SAETPGPPVANNASSGLGERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTT 63
+ A A+ + A PAPA SP A + +
Sbjct: 409 APAPAAAAPAAAAAPAPAAAPQPA-PAPAPAPAPPSPAGNAPAGGAPSPPPAAAPSAQPA 467
Query: 64 PAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASP 108
PA + P +P P + P A+ P PA+P A +A+
Sbjct: 468 PAPAAAPEPTAAPAPAPPAAPAPAAAPAAPAAPAAPAGADDAATL 512
|
Length = 824 |
| >gnl|CDD|185616 PTZ00436, PTZ00436, 60S ribosomal protein L19-like protein; Provisional | Back alignment and domain information |
|---|
Score = 48.4 bits (114), Expect = 7e-06
Identities = 41/131 (31%), Positives = 60/131 (45%), Gaps = 23/131 (17%)
Query: 27 AKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPA 86
AKA APA+ P K P AA+P A+ PPA A+PP
Sbjct: 223 AKAAAAPAKAAAPPAKAAAAP--------------AKAAAAPAKAAAPPAK--AAAPPAK 266
Query: 87 ASPPPGSPPPASPPPASGSASPPPASPPPTRSES---QSSPPPGDGGASPPPEQSKNS-P 142
A+ PP A+ PPA +A P A+ PP ++ + +++ P A+P + +
Sbjct: 267 AAAPPAK---AAAPPAKAAAPPAKAAAPPAKAAAAPAKAAAAPAKAAAAPAKAAAPPAKA 323
Query: 143 PAPPGQASTPP 153
APP +A+TPP
Sbjct: 324 AAPPAKAATPP 334
|
Length = 357 |
| >gnl|CDD|223033 PHA03291, PHA03291, envelope glycoprotein I; Provisional | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 7e-06
Identities = 28/91 (30%), Positives = 34/91 (37%), Gaps = 19/91 (20%)
Query: 29 APPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPAAS 88
P T SPE TP P+ SPP + P S A+P +
Sbjct: 207 TPRPTPRTTASPET--TPTPS--------------TTTSPPSTTIPAPSTTIAAPQAGTT 250
Query: 89 P-PPGSPPPASPPPASGSASPPPASPPPTRS 118
P G+P P P P G A P A+P P S
Sbjct: 251 PEAEGTPAP--PTPGGGEAPPANATPAPEAS 279
|
Length = 401 |
| >gnl|CDD|166942 PRK00404, tatB, sec-independent translocase; Provisional | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 7e-06
Identities = 24/58 (41%), Positives = 28/58 (48%), Gaps = 3/58 (5%)
Query: 69 PPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPP 126
PPA P P +PP A P A P P + PPA +A P PA+ PP S PP
Sbjct: 84 PPAPPEPVTPPTAQSPAPAVPTPPPTSTPAVPPAPAAAVPAPAAAPPP---SDPPQPP 138
|
Length = 141 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 7e-06
Identities = 67/224 (29%), Positives = 100/224 (44%), Gaps = 31/224 (13%)
Query: 367 VIGEGGFGCVYKGNLPEG-KVVAVKQLKSGSGQGERE---FRAEVEIISRVHHRHLVSLV 422
VIG G FG V L KV A+K L E FR E +++ ++ + +L
Sbjct: 8 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTL- 66
Query: 423 GYCISEKNRL-LIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIA--LGAAKGLAYLHEDCH 479
Y ++N L L+ ++ +L L + E R +A + A + LH
Sbjct: 67 HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH---- 122
Query: 480 PKIIHRDIKSANILVDDEFEAQVADFG--LAKLND-TTQTHVSTRVMGTFGYLAPEYASS 536
+HRDIK NIL+D ++ADFG L + D T Q+ V+ +GT Y++PE +
Sbjct: 123 --YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA---VGTPDYISPEILQA 177
Query: 537 -----GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVE 575
GK D +S GV + E++ G P ESLVE
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGE------TPFYAESLVE 215
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 8e-06
Identities = 32/107 (29%), Positives = 43/107 (40%), Gaps = 21/107 (19%)
Query: 8 PGPPVANNASSGLGERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAAS 67
PG PV + L + A APP+ A +P PPPA A+
Sbjct: 363 PGAPV-SELLDRLEALERGAPAPPSAAWGAPTPAAPAAPPPA----------------AA 405
Query: 68 PPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPP 114
PP PP A PA+ PA +P P P A+PP S + ++
Sbjct: 406 PPV--PPAAPARPAAARPAPAPAP--PAAAAPPARSADPAAAASAGD 448
|
Length = 576 |
| >gnl|CDD|217393 pfam03154, Atrophin-1, Atrophin-1 family | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 8e-06
Identities = 48/199 (24%), Positives = 57/199 (28%), Gaps = 22/199 (11%)
Query: 47 PPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPAASPP---------------- 90
PP+ G S P A PP SP A P P P
Sbjct: 178 PPSIQVPPGAALAPSAPPPTPSAQAVPPQGSPIAAQPAPQPQQPSPLSLISAPSLHPQRL 237
Query: 91 PGSPPPASPPPASGSASPPPASPPPTRSESQSSP-PPGDGGASPPPEQSKNSPPAPPGQA 149
P PP P AS + PPA S P PP P ++ PP
Sbjct: 238 PSPHPPLQPQTASQQSPQPPAPSSRHPQSSHHGPGPPMPHALQQGPVFLQHPSSNPPQPF 297
Query: 150 STPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPSNPGSPPSPSTSQSGTPSTPNENSS 209
PP +Q P + S PP PP+PS P T +
Sbjct: 298 GLAQSQVPPLPLPSQAQPHSHTPPSQSALQPQQPPREQPLPPAPSMPHIKPPPT-----T 352
Query: 210 PNELSPPSNSKSPTSKSSP 228
P P + K P P
Sbjct: 353 PIPQLPNQSHKHPPHLQGP 371
|
Atrophin-1 is the protein product of the dentatorubral-pallidoluysian atrophy (DRPLA) gene. DRPLA OMIM:125370 is a progressive neurodegenerative disorder. It is caused by the expansion of a CAG repeat in the DRPLA gene on chromosome 12p. This results in an extended polyglutamine region in atrophin-1, that is thought to confer toxicity to the protein, possibly through altering its interactions with other proteins. The expansion of a CAG repeat is also the underlying defect in six other neurodegenerative disorders, including Huntington's disease. One interaction of expanded polyglutamine repeats that is thought to be pathogenic is that with the short glutamine repeat in the transcriptional coactivator CREB binding protein, CBP. This interaction draws CBP away from its usual nuclear location to the expanded polyglutamine repeat protein aggregates that are characteristic of the polyglutamine neurodegenerative disorders. This interferes with CBP-mediated transcription and causes cytotoxicity. Length = 979 |
| >gnl|CDD|236940 PRK11633, PRK11633, cell division protein DedD; Provisional | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 8e-06
Identities = 24/103 (23%), Positives = 30/103 (29%), Gaps = 17/103 (16%)
Query: 64 PAASPPPASPPPASPP-PASPPPAAS---------PPPGSPPPASPPPASGSASPPPASP 113
P P P A+ P PP A+ P P +PP P P P
Sbjct: 47 PGDRDEPDMMPAATQALPTQPPEGAAEAVRAGDAAAPSLDPATVAPPNTPVEPEPAPVEP 106
Query: 114 PPTRSESQSSPPPGDGGASPPPEQSK-------NSPPAPPGQA 149
P + + P P P K AP G+A
Sbjct: 107 PKPKPVEKPKPKPKPQQKVEAPPAPKPEPKPVVEEKAAPTGKA 149
|
Length = 226 |
| >gnl|CDD|235906 PRK07003, PRK07003, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 9e-06
Identities = 35/229 (15%), Positives = 82/229 (35%), Gaps = 14/229 (6%)
Query: 83 PPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSP 142
P PG PA A + A+ + + G GA+ P
Sbjct: 360 PAVTGGGAPGGGVPARVAGAVPAPGARAAAAVGASAVPAVTAVTGAAGAALAP------K 413
Query: 143 PAPPGQAS---TPPDSPPPGIQSNQGN-----PVPSNGTTDSRDTKWAPPSNPGSPPSPS 194
A A+ PP +P P +++G+ P ++R + + + P
Sbjct: 414 AAAAAAATRAEAPPAAPAPPATADRGDDAADGDAPVPAKANARASADSRCDERDAQPPAD 473
Query: 195 TSQSGTPSTPNENSSPNELSPPSNSKSPTSKSSPEESSSSSHSNSKKTPTSSSGHSSDST 254
+ + P++ + E +P + + S + ++ ++ + + ++ + P +++ + ++
Sbjct: 474 SGSASAPASDAPPDAAFEPAPRAAAPSAATPAAVPDARAPAAASREDAPAAAAPPAPEAR 533
Query: 255 KGSSSNDDQAIIGATAAGVVLIVLIAIFFLARGRRRRRDAYATHYMPPP 303
+ + A AA + ++ A ++ R R A A P
Sbjct: 534 PPTPAAAAPAARAGGAAAALDVLRNAGMRVSSDRGARAAAAAKPAAAPA 582
|
Length = 830 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 9e-06
Identities = 17/69 (24%), Positives = 29/69 (42%)
Query: 81 ASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKN 140
A PP+A+ +P + PP + + PPA+P + + P A+PP +
Sbjct: 381 APAPPSAAWGAPTPAAPAAPPPAAAPPVPPAAPARPAAARPAPAPAPPAAAAPPARSADP 440
Query: 141 SPPAPPGQA 149
+ A G
Sbjct: 441 AAAASAGDR 449
|
Length = 576 |
| >gnl|CDD|184918 PRK14954, PRK14954, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 9e-06
Identities = 26/85 (30%), Positives = 31/85 (36%), Gaps = 17/85 (20%)
Query: 31 PAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPASPP-PASPPPASPPPAASP 89
P+PA KK P P P P PA P P + P P PA++P
Sbjct: 382 PSPAGS--PDVKKKAPEPD-----------LPQPDRHPGPAKPEAPGARPAELPSPASAP 428
Query: 90 PPGSPPPASPP---PASGSASPPPA 111
P PP + P S AS P
Sbjct: 429 TPEQQPPVARSAPLPPSPQASAPRN 453
|
Length = 620 |
| >gnl|CDD|185616 PTZ00436, PTZ00436, 60S ribosomal protein L19-like protein; Provisional | Back alignment and domain information |
|---|
Score = 48.0 bits (113), Expect = 9e-06
Identities = 43/156 (27%), Positives = 64/156 (41%), Gaps = 16/156 (10%)
Query: 2 ANSAETPGPPVANNASSGLGERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNS 61
A A P + A++ AKA PA+ +P K P
Sbjct: 205 AKKAAAPSGKKSAKAAAPAKAAAAPAKAAAPPAKAAAAPAKAAAAPAKAAAPPAKAAAPP 264
Query: 62 TTPAASPPPASPPPASPPPASPPPAASPPPG----SPPPASPPPASGSASPPPASPPPTR 117
AA P A+ PPA A+PP A+ PP +P A+ PA +A+P A+ PP +
Sbjct: 265 AKAAAPPAKAAAPPAK--AAAPPAKAAAPPAKAAAAPAKAAAAPAKAAAAPAKAAAPPAK 322
Query: 118 SESQSSPPPGDGGASPPPEQSKNSPPAPPGQASTPP 153
+ + P A+PP + + APP +A+ P
Sbjct: 323 AAA-----PPAKAATPPAKAA-----APPAKAAAAP 348
|
Length = 357 |
| >gnl|CDD|166942 PRK00404, tatB, sec-independent translocase; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 9e-06
Identities = 19/56 (33%), Positives = 23/56 (41%)
Query: 60 NSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPP 115
TP A P P +PP A P + P + PPA A+ PP S PP
Sbjct: 80 APLTPPAPPEPVTPPTAQSPAPAVPTPPPTSTPAVPPAPAAAVPAPAAAPPPSDPP 135
|
Length = 141 |
| >gnl|CDD|222997 PHA03132, PHA03132, thymidine kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 9e-06
Identities = 31/157 (19%), Positives = 39/157 (24%), Gaps = 3/157 (1%)
Query: 68 PPPASPPPASPPPASPPPAASPPPGSPPPA---SPPPASGSASPPPASPPPTRSESQSSP 124
PP + ++ PP G PAS P P PP SSP
Sbjct: 56 PPRETGSGGGVATSTIYTVPRPPRGPEQTLDKPDSLPASRELPPGPTPVPPGGFRGASSP 115
Query: 125 PPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPP 184
G SP N P + S + P PS K P
Sbjct: 116 RLGADSTSPRFLYQVNFPVILAPIGESNSSSEELSEEEEHSRPPPSESLKVKNGGKVYPK 175
Query: 185 SNPGSPPSPSTSQSGTPSTPNENSSPNELSPPSNSKS 221
+ SG + + PS K
Sbjct: 176 GFSKHKTHKRSEFSGLTKKAARKRKGSFVFKPSQLKE 212
|
Length = 580 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 1e-05
Identities = 23/158 (14%), Positives = 36/158 (22%), Gaps = 2/158 (1%)
Query: 1 MANSAETPGPPVANNASSGLGERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNN 60
+A + P + + EA + P A + +
Sbjct: 768 LAEALALLEPAEPQRGAGSSPPVRAEAAFRRPGRLRRSGPAADAASRTA--SKRKSRSHT 825
Query: 61 STTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSES 120
+ S PA PP A+ P + S P P R +
Sbjct: 826 PDGGSESSGPARPPGAAARPPPARSSESSKSKPAAAGGRARGKNGRRRPRPPEPRARPGA 885
Query: 121 QSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPP 158
+ P + P PP P P
Sbjct: 886 AAPPKAAAAAPPAGAPAPRPRPAPRVKLGPMPPGGPDP 923
|
Length = 1352 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 48.3 bits (116), Expect = 1e-05
Identities = 24/112 (21%), Positives = 34/112 (30%), Gaps = 33/112 (29%)
Query: 2 ANSAETPGPPVANNASSGLGERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNS 61
+ A AS+ +A A PAPA
Sbjct: 41 TAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPA--------------------------- 73
Query: 62 TTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASP 113
PP A+ P A P PA+ AA+ P P A+ + +A +P
Sbjct: 74 ------PPAAAAPAAPPKPAAAAAAAAAPAAPPAAAAAAAPAAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|220392 pfam09770, PAT1, Topoisomerase II-associated protein PAT1 | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 1e-05
Identities = 36/190 (18%), Positives = 43/190 (22%), Gaps = 21/190 (11%)
Query: 48 PADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSAS 107
S ++ P AS P P P P+ +
Sbjct: 70 KLSAAVRYNQNAPGAPSVGPDSDLSQKTSTFSPCQSGYEASTDPEYIPDLQPDPSLWGTA 129
Query: 108 PPPASPPPTRSESQSSPPPGDG---------------GASPPPEQSKN---SPPAPPGQA 149
P P PP ESQ P +P Q PP QA
Sbjct: 130 PKPEPQPPQAPESQPQPQTPAQKMLSLEEVEAQLQQRQQAPQLPQPPQQVLPQGMPPRQA 189
Query: 150 STPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPSNPGSPPSPSTSQSGTP---STPNE 206
+ P PP P + AP P PP P P
Sbjct: 190 AFPQQGPPEQPPGYPQPPQGHPEQVQPQQFLPAPSQAPAQPPLPPQLPQQPPPLQQPQFP 249
Query: 207 NSSPNELSPP 216
S PP
Sbjct: 250 GLSQQMPPPP 259
|
Members of this family are necessary for accurate chromosome transmission during cell division. Length = 804 |
| >gnl|CDD|219339 pfam07223, DUF1421, Protein of unknown function (DUF1421) | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 1e-05
Identities = 35/167 (20%), Positives = 47/167 (28%), Gaps = 7/167 (4%)
Query: 33 PAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPAASPPPG 92
P ++ + + + +G S S PP P P+S P A P
Sbjct: 156 PPQQPQYQQNPPPQAQSAPQVSGLYPEESPYQPQSYPPNEPLPSSMAMQPPYSGAPPSQQ 215
Query: 93 SPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPPGQASTP 152
P P P P P + S PPP G + PP G +
Sbjct: 216 FYGPPQPSP---YMYGGPGGRPNSGFPSGQQPPPSQGQEGYGY----SGPPPSKGNHGSV 268
Query: 153 PDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPSNPGSPPSPSTSQSG 199
P G + PS S P S + QSG
Sbjct: 269 ASYAPQGSSQSYSTAYPSLPAATVLPQALPMSSAPMSGGGSGSPQSG 315
|
This family represents a conserved region approximately 350 residues long within a number of plant proteins of unknown function. Length = 357 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 48.0 bits (115), Expect = 1e-05
Identities = 20/84 (23%), Positives = 28/84 (33%), Gaps = 4/84 (4%)
Query: 71 ASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGG 130
S + AS P +P P PP +P S + A+ P S P P
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIP---- 416
Query: 131 ASPPPEQSKNSPPAPPGQASTPPD 154
P + +PPA A +
Sbjct: 417 VPAEPTEPSPTPPANAANAPPSLN 440
|
Length = 620 |
| >gnl|CDD|184918 PRK14954, PRK14954, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 1e-05
Identities = 25/86 (29%), Positives = 28/86 (32%), Gaps = 9/86 (10%)
Query: 83 PPPAASPPPGSPPPASPPPASGSASPPPASP--PPTRSESQSSPPPGDGGASPPPEQSKN 140
P PA SP P P P PA P P R SP P PEQ
Sbjct: 382 PSPAGSPDVKKKAPEPDLPQP-DRHPGPAKPEAPGARPAELPSPASA-----PTPEQQPP 435
Query: 141 SPPAPPGQASTPPDSPPPGIQSNQGN 166
+ P S P S P + S +
Sbjct: 436 VARSAPLPPS-PQASAPRNVASGKPG 460
|
Length = 620 |
| >gnl|CDD|218621 pfam05518, Totivirus_coat, Totivirus coat protein | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 1e-05
Identities = 16/75 (21%), Positives = 21/75 (28%), Gaps = 1/75 (1%)
Query: 57 GGNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPT 116
G T + A P P PPP P A+ P GS+ + PP
Sbjct: 680 GDPVRPTAHHAALRA-PQAPRPGGPPGGGGGLPPPPDLPAAAGPAPCGSSLIASPTAPPE 738
Query: 117 RSESQSSPPPGDGGA 131
+ G
Sbjct: 739 PEPPGAEQADGAENQ 753
|
Length = 753 |
| >gnl|CDD|218107 pfam04484, DUF566, Family of unknown function (DUF566) | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 25/123 (20%), Positives = 38/123 (30%), Gaps = 4/123 (3%)
Query: 55 GGGGNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPP 114
G ++++P +S AS P P SPP +SP + S+S S
Sbjct: 8 GSTSGDASSPRSSSRRRLSSSFLSTSASSRPRRLNAPASPPSSSPARNTSSSSSFGLSKQ 67
Query: 115 PTRSESQSSPPPGDGGASPPPEQSKNSPPAPP--GQASTPPDSPPPGIQSNQGNPVPSNG 172
S S+ SP + AST S P + + + S
Sbjct: 68 RPSSLSRGRLS--SRFVSPSRGSPSAAASLNGSLATASTSGSSSPSRSRRTTSSDLSSGN 125
Query: 173 TTD 175
Sbjct: 126 GPS 128
|
Family of related proteins that is plant specific. Length = 313 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 61/251 (24%), Positives = 97/251 (38%), Gaps = 57/251 (22%)
Query: 362 FARENVIGEGGFG---CVYKGNLPEGKVVAVKQLKSGSGQGERE----FRAEVEIISRVH 414
F VIG G FG V K + G + A+K L+ + E+E RAE +I+
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKD--TGHIYAMKILRK-ADMLEKEQVAHIRAERDILVEAD 59
Query: 415 HRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTK----RVKIALGAAKG 470
+V + ++N LI EF+P ++ L K E T+ +A+ A
Sbjct: 60 GAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQ 119
Query: 471 LAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGL----------------------- 507
L + IHRDIK N+L+D + +++DFGL
Sbjct: 120 LGF---------IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSD 170
Query: 508 -----------AKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELI 556
A+ + ++ +GT Y+APE D +S GV++ E++
Sbjct: 171 FSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
Query: 557 TGRKPVDPTQP 567
G P P
Sbjct: 231 IGYPPFCSETP 241
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 34/101 (33%), Positives = 52/101 (51%), Gaps = 17/101 (16%)
Query: 483 IHRDIKSANILVDDEFEAQVADFG-LAKLND--TTQTHVSTRVMGTFGYLAPEYASS--- 536
+HRDIK N+L+D ++ADFG +L T Q++V+ +GT Y++PE +
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVA---VGTPDYISPEILQAMED 180
Query: 537 --GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVE 575
G+ D +S GV + E++ G P ESLVE
Sbjct: 181 GKGRYGPECDWWSLGVCMYEMLYG------ETPFYAESLVE 215
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|233045 TIGR00601, rad23, UV excision repair protein Rad23 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 1e-05
Identities = 22/72 (30%), Positives = 31/72 (43%), Gaps = 2/72 (2%)
Query: 61 STTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSES 120
+ T +PP A+P A P SPP + + + P ++ S S A+ P S S
Sbjct: 79 TGTGKVAPPAATPTSAPTPTPSPPASPASGMSAAPASAVEEKSPSEESATATAP--ESPS 136
Query: 121 QSSPPPGDGGAS 132
S P G AS
Sbjct: 137 TSVPSSGSDAAS 148
|
All proteins in this family for which functions are known are components of a multiprotein complex used for targeting nucleotide excision repair to specific parts of the genome. In humans, Rad23 complexes with the XPC protein. This family is based on the phylogenomic analysis of JA Eisen (1999, Ph.D. Thesis, Stanford University) [DNA metabolism, DNA replication, recombination, and repair]. Length = 378 |
| >gnl|CDD|152960 pfam12526, DUF3729, Protein of unknown function (DUF3729) | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 1e-05
Identities = 22/80 (27%), Positives = 27/80 (33%), Gaps = 3/80 (3%)
Query: 77 SPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPE 136
SPP ++ P P PP P SA P + P P P
Sbjct: 30 SPPESAHPDDPPPVGDPRPPVVDTPPPVSAVWVLPPPS---EPAAPPPDPEPPVPGPAGP 86
Query: 137 QSKNSPPAPPGQASTPPDSP 156
S +PPAP + PP P
Sbjct: 87 PSPLAPPAPARKPPLPPPRP 106
|
This family of proteins is found in viruses. Proteins in this family are typically between 145 and 1707 amino acids in length. The family is found in association with pfam01443, pfam01661, pfam05417, pfam01660, pfam00978. There is a single completely conserved residue L that may be functionally important. Length = 115 |
| >gnl|CDD|227400 COG5068, ARG80, Regulator of arginine metabolism and related MADS box-containing transcription factors [Transcription] | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 39/226 (17%), Positives = 60/226 (26%), Gaps = 11/226 (4%)
Query: 35 EKTESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPAASPPPGS- 93
+ S + P DNN G +N + P +P S P S
Sbjct: 167 SEEPSSSASFSVDPNDNNPMGSFQHNGSPQTNFIPLQNPQTQQYQQHSSRKDHPTVPHSN 226
Query: 94 ----PPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPPGQA 149
PPA +S P P P S PP
Sbjct: 227 TNNGRPPAKFMIPELHSSHSTLDLPSDFISDSGFPNQSSTSIFPL--DSAIIQITPPHLP 284
Query: 150 STPPDSPPPGIQSNQGNPVPS--NGTTDSRDTKWAPPSNPGSPPSPSTSQSGTPSTPNEN 207
+ PP + SN + V + P N S +P++ S N
Sbjct: 285 NNPPQENRHELYSNDSSMVSETPPPKNLPNGSPNQSPLNNLSRGNPASPNSIIR--ENNQ 342
Query: 208 SSPNELSPPSNSKSPTSKSSPEESSSSSHSNSKKTPTSSSGHSSDS 253
+ S + S + +S H+ + P+S+
Sbjct: 343 VEDESFNGRQGSAIWNALISTTQPNSGLHTEASTAPSSTIPADPLK 388
|
Length = 412 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 2e-05
Identities = 30/142 (21%), Positives = 45/142 (31%), Gaps = 12/142 (8%)
Query: 139 KNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPSNPGSPPS------ 192
K PG D +N N P + + PPS+ PS
Sbjct: 143 KEGEDPNPGPPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPE 202
Query: 193 -----PSTSQSGTPSTPNENSSPNELSPPSNSKSPTSKSSPEESSSSSH-SNSKKTPTSS 246
+S PS+ ++ P P+N P ++P S PT
Sbjct: 203 DPSSPSDSSLPPAPSSFQSDTPPPSPESPTNPSPPPGPAAPPPPPVQQVPPLSTAKPTPP 262
Query: 247 SGHSSDSTKGSSSNDDQAIIGA 268
S ++ + G + DD AI A
Sbjct: 263 SASATPAPIGGITLDDDAIAKA 284
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 48.0 bits (115), Expect = 2e-05
Identities = 16/83 (19%), Positives = 32/83 (38%), Gaps = 2/83 (2%)
Query: 79 PPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQS 138
P ++ P A+ + ++P A A+ PA+P P + + P A+ +
Sbjct: 38 PGSTAAPTAAAAAAAAAASAPAAAP--AAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAA 95
Query: 139 KNSPPAPPGQASTPPDSPPPGIQ 161
+PPA A+ + +
Sbjct: 96 PAAPPAAAAAAAPAAAAVEDEVT 118
|
Length = 1228 |
| >gnl|CDD|220392 pfam09770, PAT1, Topoisomerase II-associated protein PAT1 | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 21/104 (20%), Positives = 27/104 (25%), Gaps = 10/104 (9%)
Query: 66 ASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPP-----ASPPPTRSES 120
P PP P PPP PP P A PPP P + ++
Sbjct: 234 PQLPQQPPPLQQPQFPGLSQQMPPPPPQPPQQQQQPPQPQAQPPPQNQPTPHPGLPQGQN 293
Query: 121 QSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQ 164
PPP P P + + Q +
Sbjct: 294 APLPPP-----QQPQLLPLVQQPQGQQRGPQFREQLVQLSQQQR 332
|
Members of this family are necessary for accurate chromosome transmission during cell division. Length = 804 |
| >gnl|CDD|217392 pfam03153, TFIIA, Transcription factor IIA, alpha/beta subunit | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 31/230 (13%), Positives = 48/230 (20%), Gaps = 28/230 (12%)
Query: 40 PEKKVTPPPADNNNNGGGGNNSTTPAASPPPASPP---PASPPPASPPPAASPPPGSPPP 96
P + PP A + A P P P A+PP + P G P
Sbjct: 51 PSPQAPPPVAQLPQPLPQPPPTQALQALPAGDQQQHNTPTGSPAANPPATFALPAGPAGP 110
Query: 97 ASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSP 156
+ P A +Q +P + GQ + S
Sbjct: 111 TIQTEPGQLYPVQVPVMVTQNPANSPLDQPAQQRALQQLQQRYGAPAS--GQLPSQQQSA 168
Query: 157 PPGIQSNQGNPVPSNGTTDSRDTKWAPPSNPGSPPSPSTSQSGTPSTPNENSSPNELSPP 216
+S P P + E
Sbjct: 169 QKNDESQL-------------------QQQPNGETPPQQTDGAGDDESEALVRLREADGT 209
Query: 217 ----SNSKSPTSKSSPEESSSSSHSNSKKTPTSSSGHSSDSTKGSSSNDD 262
+ +SK+ + +G S+DD
Sbjct: 210 LEQRIKGAEGGGAMKVLKQPKKQAKSSKRRTIAQIDGIDSDDEGDGSDDD 259
|
Transcription initiation factor IIA (TFIIA) is a heterotrimer, the three subunits being known as alpha, beta, and gamma, in order of molecular weight. The N and C-terminal domains of the gamma subunit are represented in pfam02268 and pfam02751, respectively. This family represents the precursor that yields both the alpha and beta subunits. The TFIIA heterotrimer is an essential general transcription initiation factor for the expression of genes transcribed by RNA polymerase II. Together with TFIID, TFIIA binds to the promoter region; this is the first step in the formation of a pre-initiation complex (PIC). Binding of the rest of the transcription machinery follows this step. After initiation, the PIC does not completely dissociate from the promoter. Some components, including TFIIA, remain attached and re-initiate a subsequent round of transcription. Length = 332 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 48.0 bits (115), Expect = 2e-05
Identities = 29/103 (28%), Positives = 38/103 (36%), Gaps = 13/103 (12%)
Query: 59 NNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRS 118
N + ++ A PP PP SPPP A PP P A+ PP + PP A+ + +
Sbjct: 509 NLESQSGSASNTAKTPP--PPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNA 566
Query: 119 ESQSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQ 161
+Q P P P S DS P I
Sbjct: 567 PAQIPAD-------SSPPPPIPEEPTP----SPTKDSSPEEID 598
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 2e-05
Identities = 28/95 (29%), Positives = 34/95 (35%), Gaps = 9/95 (9%)
Query: 37 TESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPP 96
+ S K PPP + PA +PP P +PPP PPP + S
Sbjct: 516 SASNTAKTPPPPQKSPPP---------PAPTPPLPQPTATAPPPTPPPPPPTATQASSNA 566
Query: 97 ASPPPASGSASPPPASPPPTRSESQSSPPPGDGGA 131
+ PA S PP P SSP D A
Sbjct: 567 PAQIPADSSPPPPIPEEPTPSPTKDSSPEEIDKAA 601
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 2e-05
Identities = 21/83 (25%), Positives = 29/83 (34%), Gaps = 8/83 (9%)
Query: 64 PAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSS 123
S + PA+P PA P P P + A+ + PP + PP +
Sbjct: 363 AFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPP---IPVPA 419
Query: 124 PPPGDGGASPPPEQSKNSPPAPP 146
P P P N+ APP
Sbjct: 420 EPT-----EPSPTPPANAANAPP 437
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 2e-05
Identities = 20/81 (24%), Positives = 30/81 (37%), Gaps = 4/81 (4%)
Query: 60 NSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSE 119
+ A + PA+P PA P P P P + A+ P + + PP P +E
Sbjct: 364 FISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAEPTE 423
Query: 120 SQSSPPPGDGGASPPPEQSKN 140
+PP + S N
Sbjct: 424 PSPTPPA----NAANAPPSLN 440
|
Length = 620 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 2e-05
Identities = 18/82 (21%), Positives = 25/82 (30%), Gaps = 16/82 (19%)
Query: 78 PPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQ 137
PP A+ P +PPPA+ PP +A PA+ P +P P
Sbjct: 384 PPSAAWGAPTPAAPAAPPPAAAPPVPPAAPARPAAARP----------------APAPAP 427
Query: 138 SKNSPPAPPGQASTPPDSPPPG 159
+ P S
Sbjct: 428 PAAAAPPARSADPAAAASAGDR 449
|
Length = 576 |
| >gnl|CDD|184923 PRK14959, PRK14959, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-05
Identities = 42/152 (27%), Positives = 56/152 (36%), Gaps = 30/152 (19%)
Query: 48 PADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASG--S 105
P ++ GGG AS P S A+ PAS A P PG+ P PA+G
Sbjct: 367 PVESLRPSGGG-------ASAPSGS---AAEGPASGGAATIPTPGTQGPQGTAPAAGMTP 416
Query: 106 ASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPPGQASTP-PDSPPPGIQSNQ 164
+S PA+P P+ + S P ++PPAPP P P P
Sbjct: 417 SSAAPATPAPSAAPSPRVP-------------WDDAPPAPPRSGIPPRPAPRMPEASPVP 463
Query: 165 GNPVPSNGTTDSRDTKWAP----PSNPGSPPS 192
G P +D+ T P P P +
Sbjct: 464 GAPDSVASASDAPPTLGDPSDTAEHTPSGPRT 495
|
Length = 624 |
| >gnl|CDD|215533 PLN02983, PLN02983, biotin carboxyl carrier protein of acetyl-CoA carboxylase | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 36/96 (37%), Positives = 44/96 (45%), Gaps = 17/96 (17%)
Query: 23 RKEEA---KAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPASPPPASPP 79
RK+EA PPAP + P PP + PAA P P++P + PP
Sbjct: 136 RKKEALPQPPPPAPVVMMQPPPPHAMPPAS-------------PPAAQPAPSAPASSPPP 182
Query: 80 -PASPPPAASPPPGSPPPASPPPASGSASPPPASPP 114
PASPPPA +P PP SP + SP P PP
Sbjct: 183 TPASPPPAKAPKSSHPPLKSPMAGTFYRSPAPGEPP 218
|
Length = 274 |
| >gnl|CDD|223033 PHA03291, PHA03291, envelope glycoprotein I; Provisional | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 30/126 (23%), Positives = 39/126 (30%), Gaps = 10/126 (7%)
Query: 13 ANNASS-GLGERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPA 71
A NAS LG A+ A E P + G + PA P
Sbjct: 153 ATNASLFPLGLAAFPAEGTLAAPPLGEGSADGSCDPALPLSAPRLGPADVFVPATPRPTP 212
Query: 72 SPPPASPPPASPPPAASPPPG--SPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDG 129
+ P P SPP + P S + + P A P + + P PG G
Sbjct: 213 RTT-------ASPETTPTPSTTTSPPSTTIPAPSTTIAAPQAGTTPEAEGTPAPPTPGGG 265
Query: 130 GASPPP 135
A P
Sbjct: 266 EAPPAN 271
|
Length = 401 |
| >gnl|CDD|222997 PHA03132, PHA03132, thymidine kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 2e-05
Identities = 30/146 (20%), Positives = 39/146 (26%), Gaps = 8/146 (5%)
Query: 30 PPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPAASP 89
P + S + PP + + GGG ST PP P P S P +
Sbjct: 39 PLGSTSEATSEDDDDLYPPRETGS-GGGVATSTIYTVPRPPRGPEQTLDKPDSLPASREL 97
Query: 90 PPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPP-----GDGGASPPPEQSKNSPPA 144
PPG P PP AS P T G ++ E+
Sbjct: 98 PPGPTPV--PPGGFRGASSPRLGADSTSPRFLYQVNFPVILAPIGESNSSSEELSEEEEH 155
Query: 145 PPGQASTPPDSPPPGIQSNQGNPVPS 170
S G +G
Sbjct: 156 SRPPPSESLKVKNGGKVYPKGFSKHK 181
|
Length = 580 |
| >gnl|CDD|152960 pfam12526, DUF3729, Protein of unknown function (DUF3729) | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 2e-05
Identities = 21/75 (28%), Positives = 26/75 (34%)
Query: 61 STTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSES 120
S+ + P PP +PPP S PPP+ +A PP PP
Sbjct: 26 SSCFSPPESAHPDDPPPVGDPRPPVVDTPPPVSAVWVLPPPSEPAAPPPDPEPPVPGPAG 85
Query: 121 QSSPPPGDGGASPPP 135
SP A PP
Sbjct: 86 PPSPLAPPAPARKPP 100
|
This family of proteins is found in viruses. Proteins in this family are typically between 145 and 1707 amino acids in length. The family is found in association with pfam01443, pfam01661, pfam05417, pfam01660, pfam00978. There is a single completely conserved residue L that may be functionally important. Length = 115 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 11/93 (11%)
Query: 470 GLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTT---QTHVSTRVMGTF 526
G+ +LH IIHRD+K +NI+V + ++ DFGLA+ T+ +V TR
Sbjct: 138 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---- 190
Query: 527 GYLAPEYASSGKLTDRSDVFSFGVVLLELITGR 559
Y APE + D++S G ++ E+I G
Sbjct: 191 -YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|227665 COG5373, COG5373, Predicted membrane protein [Function unknown] | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 21/91 (23%), Positives = 31/91 (34%), Gaps = 7/91 (7%)
Query: 64 PAASPPPASPPPASPP--PASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQ 121
+ A+ P A A+P A + P P A+ AS PP P E+
Sbjct: 36 RSLVAEGAAGPVAKAAEQMAAPEAAEAAP---LPAAAESIASPEVPPPVPPAPAQEGEAP 92
Query: 122 SSPPPGDGGASPPPEQSKNSPPAPPGQASTP 152
++ P P + P P A+ P
Sbjct: 93 AAEQP--SAVPAPSAAPAPAEPVEPSLAANP 121
|
Length = 931 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 34/98 (34%), Positives = 52/98 (53%), Gaps = 9/98 (9%)
Query: 468 AKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHV---STRVMG 524
AKG+ +L K IHRD+ + NIL+ + ++ DFGLA+ +V R+
Sbjct: 189 AKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL-- 243
Query: 525 TFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKP 561
++APE T +SDV+SFGV+L E+ + G P
Sbjct: 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 31/108 (28%), Positives = 57/108 (52%), Gaps = 8/108 (7%)
Query: 453 PVLEWTKRVKIALGAAKGLAYL-HEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK-- 509
P L + V + A G+ +L ++C +HRD+ + N+L+ + ++ DFGLA+
Sbjct: 234 PALSYMDLVGFSYQVANGMEFLASKNC----VHRDLAARNVLICEGKLVKICDFGLARDI 289
Query: 510 LNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT 557
+ D+ + + ++APE + T SDV+SFG++L E+ T
Sbjct: 290 MRDSNYISKGSTFL-PLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|236669 PRK10263, PRK10263, DNA translocase FtsK; Provisional | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 2e-05
Identities = 39/200 (19%), Positives = 56/200 (28%), Gaps = 13/200 (6%)
Query: 42 KKVTPPPADNNNNGGGGNNSTTPAASPPPAS------PPPASPPPASPP-PAASPPPGSP 94
+ T P D + G T P A A+ P P +PP + PP P
Sbjct: 297 NRATQPEYDEYDPLLNGAPITEPVAVAAAATTATQSWAAPVEPVTQTPPVASVDVPPAQP 356
Query: 95 -----PPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPPGQA 149
P P +P P P +Q + + P Q PA A
Sbjct: 357 TVAWQPVPGPQTGEPVIAPAPEGYPQQSQYAQPAVQYNEPLQQPVQPQQPYYAPAAEQPA 416
Query: 150 STPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPSNPGSPPSPSTSQSGTPSTPNENSS 209
P +P P + Q P+ + + A P T Q+
Sbjct: 417 QQPYYAPAPEQPAQQPYYAPAPEQPVAGNAWQAEEQQSTFAPQS-TYQTEQTYQQPAAQE 475
Query: 210 PNELSPPSNSKSPTSKSSPE 229
P P + P + P
Sbjct: 476 PLYQQPQPVEQQPVVEPEPV 495
|
Length = 1355 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 3e-05
Identities = 22/95 (23%), Positives = 29/95 (30%)
Query: 76 ASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPP 135
A P A+P A PP +P S P A + P R +Q A P
Sbjct: 52 APPAAAAPAAAQPPPAAAPAAVSRPAAPAAEPAPWLVEHAKRLTAQREQLVARAAAPAAP 111
Query: 136 EQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPS 170
E + PA A + VP+
Sbjct: 112 EAQAPAAPAERAAAENAARRLARAAAAAPRPRVPA 146
|
Length = 484 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 3e-05
Identities = 15/75 (20%), Positives = 25/75 (33%), Gaps = 1/75 (1%)
Query: 81 ASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKN 140
+ PA +P P +P +P + A +P + + P +
Sbjct: 168 TTTDPATTPAPAAPVDTTPTNSQTPAVATAPAPAVD-PQQNAVVAPSQANVDTAATPAPA 226
Query: 141 SPPAPPGQASTPPDS 155
+P P G A P D
Sbjct: 227 APATPDGAAPLPTDQ 241
|
Length = 331 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 24/110 (21%), Positives = 37/110 (33%), Gaps = 7/110 (6%)
Query: 49 ADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASP 108
AD ++ N+ + + P +P PA+P +P A+ P +
Sbjct: 147 ADQSSAELSQNSGQSVPLDTSTTTDPATTPAPAAPVDTTPTNSQTPAVATAPAPAVDPQQ 206
Query: 109 PPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPPGQA--STPPDSP 156
P SQ++ A P + P P QA STP P
Sbjct: 207 NAVVAP-----SQANVDTAATPAPAAPATPDGAAPLPTDQAGVSTPAADP 251
|
Length = 331 |
| >gnl|CDD|237011 PRK11892, PRK11892, pyruvate dehydrogenase subunit beta; Provisional | Back alignment and domain information |
|---|
Score = 46.8 bits (112), Expect = 3e-05
Identities = 15/55 (27%), Positives = 20/55 (36%)
Query: 57 GGNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPA 111
G + S AA A A+P A+ A P PA+P + PA
Sbjct: 81 GESASDAGAAPAAAAEAAAAAPAAAAAAAAKKAAPAPAAPAAPAAEVAADPDIPA 135
|
Length = 464 |
| >gnl|CDD|218056 pfam04388, Hamartin, Hamartin protein | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 3e-05
Identities = 49/196 (25%), Positives = 64/196 (32%), Gaps = 19/196 (9%)
Query: 62 TTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQ 121
T +S S +S P S P A PP S P SGS S P
Sbjct: 265 PTETSSEDGYSFSRSSAYPNSSPRQALPPSISLPQN--TSTSGSLHSAQTSRRPN----- 317
Query: 122 SSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSP-PPGIQSNQGNPVPSN--GTTDSRD 178
D AS + S SP + G A+ P P I S + + GTT S
Sbjct: 318 ---TTFDKAASSGTKDSLWSPSSLCGMATPPSSIGMSPLILSLSPSHLSGRAPGTTGSGK 374
Query: 179 TKWAPPSNPGSPPSPSTSQSGTPSTPNENSSPNELSPPSNSKSPTSKSSPEESSSSSHSN 238
+ A S P + P P SS S P + S P+ + N
Sbjct: 375 GEPASESTPSTSPPPPGLADDIVRAIFATSSR---SAPRKEELQNESSFPKLVRQENLQN 431
Query: 239 SKKTPTSSSGHSSDST 254
+K S+ G D+
Sbjct: 432 IEK---SAEGGILDAA 444
|
This family includes the hamartin protein which is thought to function as a tumour suppressor. The hamartin protein interacts with the tuberin protein pfam03542. Tuberous sclerosis complex (TSC) is an autosomal dominant disorder and is characterized by the presence of hamartomas in many organs, such as brain, skin, heart, lung, and kidney. It is caused by mutation either TSC1 or TSC2 tumour suppressor gene. TSC1 encodes a protein, hamartin, containing two coiled-coil regions, which have been shown to mediate binding to tuberin. The TSC2 gene codes for tuberin pfam03542. These two proteins function within the same pathway(s) regulating cell cycle, cell growth, adhesion, and vesicular trafficking. Length = 667 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 32/93 (34%), Positives = 51/93 (54%), Gaps = 8/93 (8%)
Query: 468 AKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHV---STRVMG 524
A+G+ +L K IHRD+ + NIL+ + ++ DFGLA+ +V S R+
Sbjct: 184 ARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL-- 238
Query: 525 TFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT 557
++APE T +SDV+SFGV+L E+ +
Sbjct: 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 46.9 bits (112), Expect = 4e-05
Identities = 24/139 (17%), Positives = 41/139 (29%), Gaps = 5/139 (3%)
Query: 79 PPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQS 138
P AS A G+ +P A+P ++P A+ P +
Sbjct: 365 PSASDDERGLLARLERLERRLGVAGGAGAPAAAAPSAA----AAAPAAAPAPAAAAPAAA 420
Query: 139 KNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPSNPGSPPSPSTSQS 198
PA Q + P P P + A P+ P +P + +
Sbjct: 421 AAPAPAAAPQPAPAPAPAPAPPSPAGNAPAGGAPSPPPAAAPSAQPA-PAPAAAPEPTAA 479
Query: 199 GTPSTPNENSSPNELSPPS 217
P+ P + + P+
Sbjct: 480 PAPAPPAAPAPAAAPAAPA 498
|
Length = 824 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 46.9 bits (112), Expect = 4e-05
Identities = 25/94 (26%), Positives = 35/94 (37%), Gaps = 10/94 (10%)
Query: 137 QSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPSNPGSPPSPSTS 196
QS ++ PPP P + PP+ P PP+ + +
Sbjct: 513 QSGSASNTAKTPPPPQKSPPPPAPTPPLPQPTATA----------PPPTPPPPPPTATQA 562
Query: 197 QSGTPSTPNENSSPNELSPPSNSKSPTSKSSPEE 230
S P+ +SSP P + SPT SSPEE
Sbjct: 563 SSNAPAQIPADSSPPPPIPEEPTPSPTKDSSPEE 596
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 4e-05
Identities = 19/77 (24%), Positives = 26/77 (33%)
Query: 46 PPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGS 105
++ N N + P SPPPA P++P SPPP P P PA +
Sbjct: 363 AFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAEPT 422
Query: 106 ASPPPASPPPTRSESQS 122
P +
Sbjct: 423 EPSPTPPANAANAPPSL 439
|
Length = 620 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 4e-05
Identities = 19/104 (18%), Positives = 30/104 (28%), Gaps = 8/104 (7%)
Query: 28 KAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPAA 87
P + + + + TP PA + + + A +P PA P + A
Sbjct: 158 SGQSVPLDTSTTTDPATTPAPAAPVDTTPTNSQTPAVATAPAPAVDPQQNAVVAPSQANV 217
Query: 88 SPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGA 131
P A P + P + S P D A
Sbjct: 218 DTAATPAPAAPATPDGAAPLPTDQAGV--------STPAADPNA 253
|
Length = 331 |
| >gnl|CDD|236382 PRK09111, PRK09111, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 46.8 bits (112), Expect = 4e-05
Identities = 15/70 (21%), Positives = 23/70 (32%)
Query: 90 PPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPPGQA 149
PP PP G A PA+ + + + G A + + APP A
Sbjct: 391 PPSPGGGGGGPPGGGGAPGAPAAAAAPGAAAAAPAAGGPAAALAAVPDAAAAAAAPPAPA 450
Query: 150 STPPDSPPPG 159
+ P +
Sbjct: 451 AAPQPAVRLN 460
|
Length = 598 |
| >gnl|CDD|166942 PRK00404, tatB, sec-independent translocase; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 4e-05
Identities = 17/52 (32%), Positives = 21/52 (40%)
Query: 63 TPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPP 114
P PP + PA P PP + P +P A P PA+ P PP
Sbjct: 87 PPEPVTPPTAQSPAPAVPTPPPTSTPAVPPAPAAAVPAPAAAPPPSDPPQPP 138
|
Length = 141 |
| >gnl|CDD|221188 pfam11725, AvrE, Pathogenicity factor | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 4e-05
Identities = 36/212 (16%), Positives = 64/212 (30%), Gaps = 21/212 (9%)
Query: 60 NSTTPAASPPPASPPPASPPP----ASPPPAASP---------PPGSPPP----ASPPPA 102
N+ T A P A+P +P + P + P +S P
Sbjct: 7 NTATKTAVQPEATPSAGAPTGLQQSSESPTQRASHSLASEGKKNRKKMPKVFQKSSAPRQ 66
Query: 103 SGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPPGQAS--TPPDSPPPGI 160
+A P +P +S P + A P + +P + P +
Sbjct: 67 IQAAPPQALNPTAAAPQSSRGPTLRELLALPEDDGETQAPESSPSARRLTRSEGVARHEM 126
Query: 161 QSNQGNPVPSNGTTDSRDTKWAPPSNPGSPPSPSTSQSGTPST-PNENSSPNELSPPSNS 219
+ G PV S+ S P + + GT S P + L
Sbjct: 127 EDLAGRPVVKPDADRQLRQDILNKSS-SSRRPPVSKEEGTSSKMPATALASAALFKDDEI 185
Query: 220 KSPTSKSSPEESSSSSHSNSKKTPTSSSGHSS 251
+ + +++S S S S+ P + ++
Sbjct: 186 RQEVDAARSDQASQSRLSRSRGNPPAIPPDAA 217
|
This family is secreted by gram-negative Gammaproteobacteria such as Pseudomonas syringae of tomato and the fire blight plant pathogen Erwinia amylovora, amongst others. It is an essential pathogenicity factor of approximately 198 kDa. Its injection into the host-plant is dependent upon the bacterial type III or Hrp secretion system. The family is long and carries a number of predicted functional regions, including an ERMS or endoplasmic reticulum membrane retention signal at both the C- and the N-termini, a leucine-zipper motif from residues 539-560, and a nuclear localisation signal at 1358-1361. this conserved AvrE-family of effectors is among the few that are required for full virulence of many phytopathogenic pseudomonads, erwinias and pantoeas. Length = 1771 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 46/179 (25%), Positives = 85/179 (47%), Gaps = 20/179 (11%)
Query: 387 VAVKQLK---SGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEK------NRLLIYEF 437
VA+K+L +R +R E+ ++ V+H++++SL+ +K + L+ E
Sbjct: 45 VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMEL 103
Query: 438 VPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDE 497
+ N L Q L+ + + G+ +LH IIHRD+K +NI+V +
Sbjct: 104 MDAN-----LCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSD 155
Query: 498 FEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELI 556
++ DFGLA+ T + + T + T Y APE + D++S G ++ E++
Sbjct: 156 CTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|237863 PRK14949, PRK14949, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 4e-05
Identities = 35/156 (22%), Positives = 46/156 (29%), Gaps = 13/156 (8%)
Query: 74 PPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASP 133
PP+ PPAS AS P S AS S P S S+P P P
Sbjct: 648 PPSRAPPASLSKPASSPDASQTSASFDLDPDFELATHQSVPEAALASGSAPAP------P 701
Query: 134 PPEQSKNSPP--APPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPSNPGSPP 191
P + PP P AS D P + N V ++ + P
Sbjct: 702 PVPDPYDRPPWEEAPEVASA-NDGPNNAAEGNLSESVEDASNSELQAV----EQQATHQP 756
Query: 192 SPSTSQSGTPSTPNENSSPNELSPPSNSKSPTSKSS 227
ST + +E+ + S S
Sbjct: 757 QVQAEAQSPASTTALTQTSSEVQDTELNLVLLSSGS 792
|
Length = 944 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 4e-05
Identities = 31/105 (29%), Positives = 50/105 (47%), Gaps = 17/105 (16%)
Query: 471 LAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK---LNDTT-----------QT 516
L YLH + I+HRD+K N+L+ ++ DFGL+K ++ TT +
Sbjct: 114 LEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 517 HVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKP 561
+ +V GT Y+APE D ++ G++L E + G P
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|221745 pfam12737, Mating_C, C-terminal domain of homeodomain 1 | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 4e-05
Identities = 48/191 (25%), Positives = 65/191 (34%), Gaps = 14/191 (7%)
Query: 69 PPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGD 128
P S A P P SP S SP P+ SP ASP + SSP +
Sbjct: 58 PRQSRRSKRAAHAYPSPERSPALSSERLLSPSPSVLDLSPVLASPQTGKRRRSSSPSDDE 117
Query: 129 GGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPSNPG 188
A P ++ ++ + +S+ P PP P P+ T D A P
Sbjct: 118 DEAERPSKRPRSDSIS----SSSSPAKPPEA-----CLPSPAASTQDELSEASAAPLPTP 168
Query: 189 SPPSPSTSQSGTPSTP-NENSSPNELSP----PSNSKSPTSKSSPEESSSSSHSNSKKTP 243
S P T PS S P P S P + S P +++ ++
Sbjct: 169 SLSPPHTPTDTAPSGKRKRRLSDGFQLPAPKRPQTSSRPQTVSDPLPLHATTDWDTWFQA 228
Query: 244 TSSSGHSSDST 254
T SS S T
Sbjct: 229 TVSSSPSLLLT 239
|
Mating in fungi is controlled by the loci that determine the mating type of an individual, and only individuals with differing mating types can mate. Basidiomycete fungi have evolved a unique mating system, termed tetrapolar or bifactorial incompatibility, in which mating type is determined by two unlinked loci; compatibility at both loci is required for mating to occur. The multi-allelic tetrapolar mating system is considered to be a novel innovation that could have only evolved once, and is thus unique to the mushroom fungi. This domain is C-terminal to the homeodomain transcription factor region. Length = 418 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 4e-05
Identities = 43/184 (23%), Positives = 94/184 (51%), Gaps = 18/184 (9%)
Query: 382 PEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSL--------VGYCISEKNRLL 433
P+ + + K++K+GS + + E+ + R++H +++ + Y I++K
Sbjct: 190 PKCERLIAKRVKAGS-RAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFD 248
Query: 434 IYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANIL 493
+Y F+ + + K +P+L+ T+ + L A + Y+H+ K+IHRDIK NI
Sbjct: 249 LYSFMYDEAFDW----KDRPLLKQTRAIMKQLLCA--VEYIHDK---KLIHRDIKLENIF 299
Query: 494 VDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLL 553
++ + + + DFG A + + +GT +PE + + +D++S G++LL
Sbjct: 300 LNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILL 359
Query: 554 ELIT 557
++++
Sbjct: 360 DMLS 363
|
Length = 501 |
| >gnl|CDD|200219 TIGR02927, SucB_Actino, 2-oxoglutarate dehydrogenase, E2 component, dihydrolipoamide succinyltransferase | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 4e-05
Identities = 20/70 (28%), Positives = 31/70 (44%), Gaps = 1/70 (1%)
Query: 58 GNNSTTPAASPPPASPPPASPPPA-SPPPAASPPPGSPPPASPPPASGSASPPPASPPPT 116
G+ + PA +P P+ +P PAA P +P P +P PA + P A+ P +
Sbjct: 201 GDANAAPAEPAEEEAPAPSEAGSEPAPDPAARAPHAAPDPPAPAPAPAKTAAPAAAAPVS 260
Query: 117 RSESQSSPPP 126
+S P
Sbjct: 261 SGDSGPYVTP 270
|
This model represents an Actinobacterial clade of E2 enzyme, a component of the 2-oxoglutarate dehydrogenase complex involved in the TCA cycle. These proteins have multiple domains including the catalytic domain (pfam00198), one or two biotin domains (pfam00364) and an E3-component binding domain (pfam02817). Length = 579 |
| >gnl|CDD|237605 PRK14086, dnaA, chromosomal replication initiation protein; Provisional | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 5e-05
Identities = 27/183 (14%), Positives = 38/183 (20%), Gaps = 14/183 (7%)
Query: 70 PASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDG 129
P P P P + P P P P G P PP P D
Sbjct: 87 TVDPSAGEPAPPPPHARRTSEPELPRPG-RRPYEGYGGPRADDRPPG-------LPRQDQ 138
Query: 130 GASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRD----TKWAPPS 185
+ P PG D Q G P + + + + P
Sbjct: 139 LPTARPAYPAYQQRPEPGAWPRAADDYGWQQQR-LGFPPRAPYASPASYAPEQERDREPY 197
Query: 186 NPGSPPSPSTSQSGTPSTPNENSSPNELSPPSNSKSPTSKSSPEESSSSSHSNSKKTPTS 245
+ G P + P + P P + +
Sbjct: 198 DAGRPEYDQRRRDYDHPRP-DWDRPRRDRTDRPEPPPGAGHVHRGGPGPPERDDAPVVPI 256
Query: 246 SSG 248
Sbjct: 257 RPS 259
|
Length = 617 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 5e-05
Identities = 19/68 (27%), Positives = 26/68 (38%)
Query: 59 NNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRS 118
+ +A P P SPPPA P+A + SPPPA S P + P S
Sbjct: 366 SEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAEPTEPS 425
Query: 119 ESQSSPPP 126
+ +
Sbjct: 426 PTPPANAA 433
|
Length = 620 |
| >gnl|CDD|218621 pfam05518, Totivirus_coat, Totivirus coat protein | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 5e-05
Identities = 26/122 (21%), Positives = 31/122 (25%), Gaps = 14/122 (11%)
Query: 39 SPEKKVTPPPADNNNNGGGGNNSTTPAASPPPA------SPPPASPPPASPPPAASPPPG 92
P T P + N GG P P A P P +
Sbjct: 635 FPPVFKTALPRPDYNRGGEAGGPGVPGPVPVGMPAHTARPSRVARGDPVRPTAHHAALRA 694
Query: 93 SPPP-ASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPPGQAST 151
P PP G PPP P + P G+S + P PPG
Sbjct: 695 PQAPRPGGPPGGGGGLPPPPDLPA-------AAGPAPCGSSLIASPTAPPEPEPPGAEQA 747
Query: 152 PP 153
Sbjct: 748 DG 749
|
Length = 753 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 5e-05
Identities = 31/97 (31%), Positives = 54/97 (55%), Gaps = 7/97 (7%)
Query: 468 AKGLAYL-HEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK-LNDTTQTHVSTRVMGT 525
AKG+++L ++C IHRD+ + NIL+ ++ DFGLA+ + + + V
Sbjct: 224 AKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279
Query: 526 FGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKP 561
++APE + T SDV+S+G++L E+ + G P
Sbjct: 280 VKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP 316
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|223064 PHA03375, PHA03375, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 5e-05
Identities = 27/114 (23%), Positives = 36/114 (31%), Gaps = 16/114 (14%)
Query: 69 PPASPPPASPPPASPPPAASPPPGS-PPPASPPPASGSASPPPASPPPT----------- 116
P + A PP AA P P S P+S +S SA PP P
Sbjct: 372 NVGGRPRTARLSAPPPSAAPPVPRSGSSPSSLSSSSSSAPPPATDPSSDPTRRYVRIISR 431
Query: 117 ----RSESQSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGN 166
R + D P++ + P A + S D P P + G
Sbjct: 432 LSFVRYRERLRRRAADPAFDFTPQRPRRRPLAHRREESLAVDGPAPDRRKVPGG 485
|
Length = 844 |
| >gnl|CDD|183756 PRK12799, motB, flagellar motor protein MotB; Reviewed | Back alignment and domain information |
|---|
Score = 45.9 bits (108), Expect = 5e-05
Identities = 33/142 (23%), Positives = 47/142 (33%), Gaps = 16/142 (11%)
Query: 58 GNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTR 117
+ T P A+ P+S S A P P + A+ + + A
Sbjct: 294 DTHGTVPVAAVTPSSAVTQSSAITPSSAAIPSPAVIPSSVTTQSATTTQASAVALSSAGV 353
Query: 118 SESQSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPS-NGTTDS 176
S + P + P A P P S QS+ GN + NG T S
Sbjct: 354 LPSDVTLPG-----------TVALPAAEPVNMQPQPMSTTETQQSSTGNITSTANGPTTS 402
Query: 177 RDTKWAPPSNPGSPPSPSTSQS 198
AP SN P SP++ +
Sbjct: 403 LPA--APASN--IPVSPTSRDA 420
|
Length = 421 |
| >gnl|CDD|165468 PHA03201, PHA03201, uracil DNA glycosylase; Provisional | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 5e-05
Identities = 27/94 (28%), Positives = 35/94 (37%), Gaps = 7/94 (7%)
Query: 65 AASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSP 124
A S P+ P SPP +PP + P PP+ P P + A P R + P
Sbjct: 4 ARSRSPSPPRRPSPPRPTPPRSPDASPEETPPSPPGPGAEPPPGRAAGPAAPRRRPRGCP 63
Query: 125 PPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPP 158
+S PP P G P +PPP
Sbjct: 64 AGVTFSSSAPPRP-------PLGLDDAPAATPPP 90
|
Length = 318 |
| >gnl|CDD|234938 PRK01297, PRK01297, ATP-dependent RNA helicase RhlB; Provisional | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 5e-05
Identities = 13/53 (24%), Positives = 16/53 (30%)
Query: 64 PAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPT 116
SP A PP A+P A+ P + P A P P
Sbjct: 20 APPSPAAAPAPPPPAKTAAPATKAAAPAAAAPRAEKPKKDKPRRERKPKPASL 72
|
Length = 475 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 6e-05
Identities = 19/75 (25%), Positives = 26/75 (34%)
Query: 29 APPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPAAS 88
+ A+ P+K PP PPP + +S PA P +S
Sbjct: 516 SASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPADSS 575
Query: 89 PPPGSPPPASPPPAS 103
PPP P +P P
Sbjct: 576 PPPPIPEEPTPSPTK 590
|
Length = 620 |
| >gnl|CDD|185628 PTZ00449, PTZ00449, 104 kDa microneme/rhoptry antigen; Provisional | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 6e-05
Identities = 59/295 (20%), Positives = 86/295 (29%), Gaps = 55/295 (18%)
Query: 10 PPVANNASSGLGERKEEAKAPPAPAE-----KTESPEKKVTPPPADNNNNGGGGNNSTTP 64
PP A G E++K P E +T+ E P PA + S P
Sbjct: 520 PPKAPGDKEGEEGEHEDSKESDEPKEGGKPGETKEGEVGKKPGPAKEHKPSKIPTLSKKP 579
Query: 65 AASPPPASPP-PASPPPASPPPAASPPPGSPPPASP-------------PPASGSASPPP 110
P P P P P +A P P P P S PPP
Sbjct: 580 EFPKDPKHPKDPEEPKKPKRPRSAQRPTRPKSPKLPELLDIPKSPKRPESPKSPKRPPPP 639
Query: 111 ASP-PPTRSESQSSPPPGDGGASPPP---------------------EQSKNSPPAPPGQ 148
P P R E SP P +++K +
Sbjct: 640 QRPSSPERPEGPKIIKSPKPPKSPKPPFDPKFKEKFYDDYLDAAAKSKETKTTVVLDESF 699
Query: 149 ASTPPDSPP--PGIQSNQGNPVPSNGTTDSRDTKWAPPSNPGSPPSPSTSQSGTP----- 201
S ++ P PG P+P D + P +P + P + TP
Sbjct: 700 ESILKETLPETPGTPFTTPRPLPPKLPRDEEFP-FEPIGDPDA-EQPDDIEFFTPPEEER 757
Query: 202 ----STPNENSSPNELSPPSNSKSPTSKS-SPEESSSSSHSNSKKTPTSSSGHSS 251
TP + P+ L+ + +++ P+E+ S S+ H S
Sbjct: 758 TFFHETPADTPLPDILAEEFKEEDIHAETGEPDEAMKRPDSPSEHEDKPPGDHPS 812
|
Length = 943 |
| >gnl|CDD|166942 PRK00404, tatB, sec-independent translocase; Provisional | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 7e-05
Identities = 18/50 (36%), Positives = 23/50 (46%)
Query: 62 TTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPA 111
TP + PA P PP ++P +P P PA+ PP S PP A
Sbjct: 91 VTPPTAQSPAPAVPTPPPTSTPAVPPAPAAAVPAPAAAPPPSDPPQPPRA 140
|
Length = 141 |
| >gnl|CDD|236333 PRK08691, PRK08691, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 45.9 bits (108), Expect = 7e-05
Identities = 40/205 (19%), Positives = 61/205 (29%), Gaps = 30/205 (14%)
Query: 4 SAETPGPPVANNASSGLGERKEEAKAPPAPAEKTESPEKKVTPPPADN-NNNGGGGNNST 62
SA+T A E + + E K P ++ NN+ ++
Sbjct: 381 SAQTAEKETAAKKPQPRPEAETAQTPVQTASAAAMPSEGKTAGPVSNQENNDVPPWEDAP 440
Query: 63 TPAASPPPASPPPA-----SPPPASPPP-------AASPPPGSPPPASPPPASGSASP-- 108
A + + A + +PP AA +P P A+P
Sbjct: 441 DEAQTAAGTAQTSAKSIQTASEAETPPENQVSKNKAADNETDAPLSEVPSENPIQATPND 500
Query: 109 -----------PPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPP 157
PA P + PP DG PPP+ ++ PA ++
Sbjct: 501 EAVETETFAHEAPAEPFYGYGFPDNDCPPEDGAEIPPPDWE-HAAPADTAGGGADEEAEA 559
Query: 158 PGIQSNQGNPVPSNGTTDSRDTKWA 182
GI GN PS + WA
Sbjct: 560 GGI---GGNNTPSAPPPEFSTENWA 581
|
Length = 709 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 45.7 bits (109), Expect = 8e-05
Identities = 18/83 (21%), Positives = 27/83 (32%), Gaps = 6/83 (7%)
Query: 76 ASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPP 135
S + A++P +P P PP + P A + + S PP + PP
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPA--PIQPSAPKTKQAATTPSPPPA----KASPP 414
Query: 136 EQSKNSPPAPPGQASTPPDSPPP 158
P P + PP
Sbjct: 415 IPVPAEPTEPSPTPPANAANAPP 437
|
Length = 620 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 8e-05
Identities = 14/64 (21%), Positives = 22/64 (34%)
Query: 96 PASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDS 155
PA P A G+ +P + PP + P A+ P + P A A + +
Sbjct: 382 PAPPSAAWGAPTPAAPAAPPPAAAPPVPPAAPARPAAARPAPAPAPPAAAAPPARSADPA 441
Query: 156 PPPG 159
Sbjct: 442 AAAS 445
|
Length = 576 |
| >gnl|CDD|185628 PTZ00449, PTZ00449, 104 kDa microneme/rhoptry antigen; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 8e-05
Identities = 52/266 (19%), Positives = 72/266 (27%), Gaps = 20/266 (7%)
Query: 22 ERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTT---------PAASPPPAS 72
E E + PP E E + + GG T PA P+
Sbjct: 512 EGPEASGLPPKAPGDKEGEEGEHEDSKESDEPKEGGKPGETKEGEVGKKPGPAKEHKPSK 571
Query: 73 PPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRS----ESQSSPPPGD 128
P S P P P P P S P SP +S P
Sbjct: 572 IPTLSKKPEFPKDPKHPKDPEEPKKPKRPRSAQRPTRPKSPKLPELLDIPKSPKRPESPK 631
Query: 129 GGASPPPEQSKNSPPAPPG----QASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPP 184
PPP Q +SP P G ++ PP SP P + + +K
Sbjct: 632 SPKRPPPPQRPSSPERPEGPKIIKSPKPPKSPKPPFDPKFKEKFYDDYLDAAAKSKETKT 691
Query: 185 SNPGSPPSPSTSQSGTPSTPNENSSPNELSPPSNSKSPTSKSSPEESSSSSHSNSKKTPT 244
+ S + P TP + PP K P + P E +
Sbjct: 692 TVVLDESFESILKETLPETPGTPFTTPRPLPP---KLPRDEEFPFEPIGDPDAEQPDDIE 748
Query: 245 SSSGHSSDSTKGSSSNDDQAIIGATA 270
+ + T + D + A
Sbjct: 749 FFTPPEEERTFFHETPADTPLPDILA 774
|
Length = 943 |
| >gnl|CDD|215130 PLN02217, PLN02217, probable pectinesterase/pectinesterase inhibitor | Back alignment and domain information |
|---|
Score = 45.9 bits (108), Expect = 8e-05
Identities = 41/159 (25%), Positives = 61/159 (38%), Gaps = 22/159 (13%)
Query: 8 PGPPVANNAS-SGLGERKEEAKAPPAPAEKTES----PEKKVTPPPADNNNNGGGGNNST 62
PG + + G+ + +E PA+ + P K V P N G N++
Sbjct: 514 PGAAITKRVTWPGIKKLSDEEILKFTPAQYIQGDAWIPGKGVPYIPGLFAGNPGSTNSTP 573
Query: 63 TPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQS 122
T +A+ + SP P+ SPP +G PPA+ P++ S S
Sbjct: 574 TGSAASSNTTFSSDSPS-TVVAPSTSPP------------AGHLGSPPAT--PSKIVSPS 618
Query: 123 SPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQ 161
+ PP SP S SP + AST SP I+
Sbjct: 619 TSPPASHLGSPSTTPS--SPESSIKVASTETASPESSIK 655
|
Length = 670 |
| >gnl|CDD|237011 PRK11892, PRK11892, pyruvate dehydrogenase subunit beta; Provisional | Back alignment and domain information |
|---|
Score = 45.3 bits (108), Expect = 9e-05
Identities = 13/61 (21%), Positives = 24/61 (39%)
Query: 62 TTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQ 121
+ A PA+ A+ + AA+ +P PA+P + + P P T +
Sbjct: 83 SASDAGAAPAAAAEAAAAAPAAAAAAAAKKAAPAPAAPAAPAAEVAADPDIPAGTEMVTM 142
Query: 122 S 122
+
Sbjct: 143 T 143
|
Length = 464 |
| >gnl|CDD|223065 PHA03378, PHA03378, EBNA-3B; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-04
Identities = 37/200 (18%), Positives = 52/200 (26%), Gaps = 22/200 (11%)
Query: 46 PPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASP------------------PPAA 87
P P + S P S P P P P P P PP
Sbjct: 598 PVPHPSQTPEPPTTQSHIPETSAPRQWPMPLRPIPMRPLRMQPITFNVLVFPTPHQPPQV 657
Query: 88 SPPPGSPPPASPP--PASGSASPPPASPPPTRSESQSSPPPGDGGASPPPE--QSKNSPP 143
P P P S + P + PPP PP + P
Sbjct: 658 EITPYKPTWTQIGHIPYQPSPTGANTMLPIQWAPGTMQPPPRAPTPMRPPAAPPGRAQRP 717
Query: 144 APPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPSNPGSPPSPSTSQSGTPST 203
A + PP + P + P + + P + PG P+ +
Sbjct: 718 AAATGRARPPAAAPGRARPPAAAPGRARPPAAAPGRARPPAAAPGRARPPAAAPGAPTPQ 777
Query: 204 PNENSSPNELSPPSNSKSPT 223
P + P P + +P
Sbjct: 778 PPPQAPPAPQQRPRGAPTPQ 797
|
Length = 991 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 1e-04
Identities = 14/77 (18%), Positives = 23/77 (29%)
Query: 27 AKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPA 86
A + +P P + T A+ P+ PP + PP P
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAE 420
Query: 87 ASPPPGSPPPASPPPAS 103
+ P +PP +
Sbjct: 421 PTEPSPTPPANAANAPP 437
|
Length = 620 |
| >gnl|CDD|218439 pfam05109, Herpes_BLLF1, Herpes virus major outer envelope glycoprotein (BLLF1) | Back alignment and domain information |
|---|
Score = 45.2 bits (106), Expect = 1e-04
Identities = 54/265 (20%), Positives = 92/265 (34%), Gaps = 33/265 (12%)
Query: 23 RKEEAKAPPAPAEKTESPEKKVTPPPA----DNNNNGGGGNNSTTPAASPP---PASPPP 75
P T S + T P + N TTP A+ P S P
Sbjct: 464 VSTADPTSGTPTGTTSSTLPEDTSPTSRTTSATPNATSPTPAVTTPNATSPTTQKTSDTP 523
Query: 76 ASPPPA-----SPPPAASPPPG-SPPPASPPPASGSASPPPASPPPTRSESQS----SPP 125
+ P A SPP G + P + P SP + P + + S +
Sbjct: 524 NATSPTPIVIGVTTTATSPPTGTTSVPNATSPQVTEESPVNNTNTPVVTSAPSVLTSAVT 583
Query: 126 PGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPS 185
G G + P P + + P S + P+ G + +T P +
Sbjct: 584 TGQHG---TGSSPTSQQPGIPSSSHSTPRSNSTSTTPLLTSAHPTGGENITEETPSVPST 640
Query: 186 N------PGSPPSPSTSQSGTPSTPNENSSPNELS-----PPSNSKSPTSKSSPEESSSS 234
PG P +TSQ P + + P E+ P N+ SP++ S ++++
Sbjct: 641 THVSTLSPGPGPG-TTSQVSGPGNSSTSRYPGEVHVTEGMPNPNATSPSAPSG-QKTAVP 698
Query: 235 SHSNSKKTPTSSSGHSSDSTKGSSS 259
+ +++ S++ +S ST +S+
Sbjct: 699 TVTSTGGKANSTTKETSGSTLMAST 723
|
This family consists of the BLLF1 viral late glycoprotein, also termed gp350/220. It is the most abundantly expressed glycoprotein in the viral envelope of the Herpesviruses and is the major antigen responsible for stimulating the production of neutralising antibodies in vivo. Length = 830 |
| >gnl|CDD|184923 PRK14959, PRK14959, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 1e-04
Identities = 32/125 (25%), Positives = 46/125 (36%), Gaps = 8/125 (6%)
Query: 126 PGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPS 185
P GGAS P + A + P PG Q QG P+ G T S P
Sbjct: 373 PSGGGASAP-----SGSAAEGPASGGAATIPTPGTQGPQGTA-PAAGMTPSSAAPATPA- 425
Query: 186 NPGSPPSPSTSQSGTPSTPNENSSPNELSPPSNSKSPTSKSSPEESSSSSHSNSKKTPTS 245
P + PSP P P + P +P SP + +S+S + P+
Sbjct: 426 -PSAAPSPRVPWDDAPPAPPRSGIPPRPAPRMPEASPVPGAPDSVASASDAPPTLGDPSD 484
Query: 246 SSGHS 250
++ H+
Sbjct: 485 TAEHT 489
|
Length = 624 |
| >gnl|CDD|237000 PRK11855, PRK11855, dihydrolipoamide acetyltransferase; Reviewed | Back alignment and domain information |
|---|
Score = 44.8 bits (107), Expect = 1e-04
Identities = 18/116 (15%), Positives = 31/116 (26%), Gaps = 25/116 (21%)
Query: 55 GGGGNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPP----- 109
+ A + + A+ P +P AA+P +P A+ P + ASP
Sbjct: 194 VAAAAPAAAAAPAAAAPAAAAAAAPAPAPAAAAAPAAAAPAAAAAPGKAPHASPAVRRLA 253
Query: 110 ----------PASPPPTR----------SESQSSPPPGDGGASPPPEQSKNSPPAP 145
+ R + S+ A+ P P
Sbjct: 254 RELGVDLSQVKGTGKKGRITKEDVQAFVKGAMSAAAAAAAAAAAAGGGGLGLLPWP 309
|
Length = 547 |
| >gnl|CDD|227665 COG5373, COG5373, Predicted membrane protein [Function unknown] | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 1e-04
Identities = 31/108 (28%), Positives = 37/108 (34%), Gaps = 22/108 (20%)
Query: 5 AETPGPPVANNASSGLGERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTP 64
AE PVA A E A+A P PA +V PP
Sbjct: 40 AEGAAGPVAKAAEQM--AAPEAAEAAPLPAAAESIASPEVPPPV---------------- 81
Query: 65 AASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPAS 112
PPA P A P A P +P PA P S +A+P A+
Sbjct: 82 ----PPAPAQEGEAPAAEQPSAVPAPSAAPAPAEPVEPSLAANPFAAA 125
|
Length = 931 |
| >gnl|CDD|171499 PRK12438, PRK12438, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 1e-04
Identities = 22/56 (39%), Positives = 25/56 (44%), Gaps = 2/56 (3%)
Query: 56 GGGNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPA 111
G G A AS PP P +PP A PP + PPA+PP G PP A
Sbjct: 896 GPGTGRVATAPGGDAASAPPPGAGPPAPPQAVPPPRTTQPPAAPP--RGPDVPPAA 949
|
Length = 991 |
| >gnl|CDD|185594 PTZ00395, PTZ00395, Sec24-related protein; Provisional | Back alignment and domain information |
|---|
Score = 45.5 bits (107), Expect = 1e-04
Identities = 51/234 (21%), Positives = 80/234 (34%), Gaps = 23/234 (9%)
Query: 2 ANSAETPGPPVANNASSG-LGERKEEAKA-----PPAPAEKTESPEKKVTPPPADNNNNG 55
A SA P + N A G + + +A+ P + A + A +N G
Sbjct: 349 AASAGAPFNGLGNQADGGHINQVHPDARGAWAGGPHSNASYNCAAYSNAAQSNAAQSNAG 408
Query: 56 GGGNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPP 115
+ P S P + P S P + PP ++ P +PP ++PP ++ S P S P
Sbjct: 409 FSNAGYSNPGNSNPGYNNAPNSNTPYNNPPNSNTPYSNPPNSNPPYSNLPYSNTPYSNAP 468
Query: 116 TRSESQSSPPPGDG---------GASPPP--EQSKNSPPAPP---GQAST---PPDSPPP 158
+ SS A+ P + N P A ++ P S P
Sbjct: 469 LSNAPPSSAKDHHSAYHAAYQHRAANQPAANLPTANQPAANNFHGAAGNSVGNPFASRPF 528
Query: 159 GIQSNQGNPVPSNGTTDSRDTKWAPPSNPGSPPSPSTSQSGTPSTPNENSSPNE 212
G GN + + P + + S+ +ENSS NE
Sbjct: 529 GSAPYGGNAATTADPNGIAKREDHPEGGTNRQKYEQSDEESVESSSSENSSENE 582
|
Length = 1560 |
| >gnl|CDD|227505 COG5178, PRP8, U5 snRNP spliceosome subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 1e-04
Identities = 25/53 (47%), Positives = 27/53 (50%), Gaps = 11/53 (20%)
Query: 71 ASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSS 123
AS PP +PPP PP PPPG PP+ PPP PPP RS Q S
Sbjct: 2 ASLPPGNPPP--PP----PPPGFEPPSQPPP-----PPPPGVNVKKRSRKQLS 43
|
Length = 2365 |
| >gnl|CDD|237015 PRK11901, PRK11901, hypothetical protein; Reviewed | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 35/161 (21%), Positives = 51/161 (31%), Gaps = 27/161 (16%)
Query: 45 TPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPAASPP-------PGSPPPA 97
+ P A NN + G + A P S PP SP P P +P PG+ A
Sbjct: 93 SSPSAANNTSDGHDASGVKNTAPPQDISAPPISPTPTQAAPPQTPNGQQRIELPGNISDA 152
Query: 98 ----------SPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPPG 147
+ A G+ S P +P P G P ++ +PP P
Sbjct: 153 LSQQQGQVNAASQNAQGNTSTLPTAPATV--------APSKGAKVPATAETHPTPPQKPA 204
Query: 148 QASTPPDSP--PPGIQSNQGNPVPSNGTTDSRDTKWAPPSN 186
+ + P +G +R AP S+
Sbjct: 205 TKKPAVNHHKTATVAVPPATSGKPKSGAASARALSSAPASH 245
|
Length = 327 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 49/159 (30%), Positives = 72/159 (45%), Gaps = 21/159 (13%)
Query: 360 NGFARENVIGEGGFGCV-YKGNLPEGKVVAVKQL-KSGSGQGER--EFRAEVEIISRVHH 415
F VIG+G FG V GK+ A+K L KS + ++ +AE ++++
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 416 RHLVSLVGYCISEKNRL-LIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIA-----LGAAK 469
+VSL Y + L LI EF+P +L L K E R +A + A
Sbjct: 61 PWVVSLY-YSFQDAQYLYLIMEFLPGGDLMTMLI-KYDTFSEDVTRFYMAECVLAIEAVH 118
Query: 470 GLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLA 508
L + IHRDIK NIL+D +++DFGL+
Sbjct: 119 KLGF---------IHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|240289 PTZ00144, PTZ00144, dihydrolipoamide succinyltransferase; Provisional | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 16/69 (23%), Positives = 23/69 (33%), Gaps = 1/69 (1%)
Query: 57 GGNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPT 116
GG A+ A +P PP + P P A P PA+ PP
Sbjct: 121 GGAPPAAAPAAAAAAKAEKTTPEKPKAAAPTPEPPAASKPTPPAAAK-PPEPAPAAKPPP 179
Query: 117 RSESQSSPP 125
+++ P
Sbjct: 180 TPVARADPR 188
|
Length = 418 |
| >gnl|CDD|237001 PRK11856, PRK11856, branched-chain alpha-keto acid dehydrogenase subunit E2; Reviewed | Back alignment and domain information |
|---|
Score = 44.4 bits (106), Expect = 1e-04
Identities = 16/54 (29%), Positives = 23/54 (42%)
Query: 56 GGGNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPP 109
+ AA+ P P PA+ AA+ P + PA+P A+ ASP
Sbjct: 77 EEEGEAEAAAAAEAAPEAPAPEPAPAAAAAAAAAPAAAAAPAAPAAAAAKASPA 130
|
Length = 411 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 2e-04
Identities = 25/143 (17%), Positives = 35/143 (24%), Gaps = 3/143 (2%)
Query: 62 TTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQ 121
S PP A P G A+ AS S + S
Sbjct: 776 EPAEPQRGAGSSPPVRAEAAFRRPGRLRRSGPAADAASRTASKRKSRSHTPDGGSESSGP 835
Query: 122 SSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKW 181
+ PP A PPP +S S A+ G + + + +
Sbjct: 836 ARPPGA--AARPPPARSSESSK-SKPAAAGGRARGKNGRRRPRPPEPRARPGAAAPPKAA 892
Query: 182 APPSNPGSPPSPSTSQSGTPSTP 204
A G+P P
Sbjct: 893 AAAPPAGAPAPRPRPAPRVKLGP 915
|
Length = 1352 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 2e-04
Identities = 18/150 (12%), Positives = 47/150 (31%)
Query: 115 PTRSESQSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTT 174
P + PP + PP E ++ + PA P + P + +
Sbjct: 590 PAPGAAGGEGPPAPASSGPPEEAARPAAPAAPAAPAAPAPAGAAAAPAEASAAPAPGVAA 649
Query: 175 DSRDTKWAPPSNPGSPPSPSTSQSGTPSTPNENSSPNELSPPSNSKSPTSKSSPEESSSS 234
K + +++G + +P +P + + + ++ +P +++
Sbjct: 650 PEHHPKHVAVPDASDGGDGWPAKAGGAAPAAPPPAPAPAAPAAPAGAAPAQPAPAPAATP 709
Query: 235 SHSNSKKTPTSSSGHSSDSTKGSSSNDDQA 264
+ + ++ S + DD
Sbjct: 710 PAGQADDPAAQPPQAAQGASAPSPAADDPV 739
|
Length = 824 |
| >gnl|CDD|219339 pfam07223, DUF1421, Protein of unknown function (DUF1421) | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 35/178 (19%), Positives = 47/178 (26%), Gaps = 5/178 (2%)
Query: 61 STTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSES 120
S + PPA A A +P P PA S P
Sbjct: 37 SEAHSFHVDSTKQPPAPEQVAKHELADAPLQQVNAALPPAPAPQSPQPDQQQQSQAPPSH 96
Query: 121 QSSPPPGDGGASPPPEQSKNSPP---APPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSR 177
Q P+Q PP Q PP P Q VP S
Sbjct: 97 QYPSQLPPQQVQSVPQQPTPQQEPYYPPPSQPQPPPAQQPQAQQPQPPPQVPQQQQYQSP 156
Query: 178 DTKWAPPSNPGSPPSPSTSQSGTPSTPNENSSPNELSPPSNSKSPTSKSSPEESSSSS 235
+ NP PP ++ + P E+ + PP+ + P S +
Sbjct: 157 PQQPQYQQNP--PPQAQSAPQVSGLYPEESPYQPQSYPPNEPLPSSMAMQPPYSGAPP 212
|
This family represents a conserved region approximately 350 residues long within a number of plant proteins of unknown function. Length = 357 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 2e-04
Identities = 17/78 (21%), Positives = 24/78 (30%), Gaps = 1/78 (1%)
Query: 27 AKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPA 86
P P +K+ P P P P A+ ++ P P +SPPP
Sbjct: 520 TAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPADSSPPPP 579
Query: 87 ASPPPGSPPPASPPPASG 104
P +P P
Sbjct: 580 IPEEP-TPSPTKDSSPEE 596
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 2e-04
Identities = 16/65 (24%), Positives = 25/65 (38%)
Query: 59 NNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRS 118
+ TPA +P P P P + A +P P + P P + P +PP +
Sbjct: 374 PANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAEPTEPSPTPPANAA 433
Query: 119 ESQSS 123
+ S
Sbjct: 434 NAPPS 438
|
Length = 620 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 15/66 (22%), Positives = 20/66 (30%), Gaps = 1/66 (1%)
Query: 92 GSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPPGQAST 151
G+P P PA+PPP + P A+ P A P S
Sbjct: 380 GAPAP-PSAAWGAPTPAAPAAPPPAAAPPVPPAAPARPAAARPAPAPAPPAAAAPPARSA 438
Query: 152 PPDSPP 157
P +
Sbjct: 439 DPAAAA 444
|
Length = 576 |
| >gnl|CDD|215533 PLN02983, PLN02983, biotin carboxyl carrier protein of acetyl-CoA carboxylase | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 31/87 (35%), Positives = 37/87 (42%), Gaps = 15/87 (17%)
Query: 75 PASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPP 134
P PPPA PPP + PPASPP A +P + P +P SPP
Sbjct: 142 PQPPPPAPVVMMQPPPPHAMPPASPPAAQ--PAPSAPASSPP-----PTPA------SPP 188
Query: 135 PEQSKNS--PPAPPGQASTPPDSPPPG 159
P ++ S PP A T SP PG
Sbjct: 189 PAKAPKSSHPPLKSPMAGTFYRSPAPG 215
|
Length = 274 |
| >gnl|CDD|235124 PRK03427, PRK03427, cell division protein ZipA; Provisional | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 2e-04
Identities = 21/95 (22%), Positives = 27/95 (28%), Gaps = 3/95 (3%)
Query: 64 PAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSS 123
PP + P P A P +P P P P P P P S+
Sbjct: 103 QPVQQPPEAQVP--PQHAPRPAQPAPQPVQQPAYQPQPEQPLQQPVSPQVAPAPQPVHSA 160
Query: 124 PPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPP 158
P P P + P P + + D P
Sbjct: 161 PQPAQQAFQPAEPVAA-PQPEPVAEPAPVMDKPKR 194
|
Length = 333 |
| >gnl|CDD|235124 PRK03427, PRK03427, cell division protein ZipA; Provisional | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 27/105 (25%), Positives = 32/105 (30%), Gaps = 10/105 (9%)
Query: 60 NSTTPAASPPPASP---PPASPPPA---SPPPAASPPPGSPPPASPPPASGSASPPPASP 113
S PP AS P PP P A P +P P P P P P
Sbjct: 86 PSPQHQYQPPYASAQPRQPVQQPPEAQVPPQHAPRPAQPAPQPVQQPA----YQPQPEQP 141
Query: 114 PPTRSESQSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPP 158
Q +P P ++P P Q P P P + P
Sbjct: 142 LQQPVSPQVAPAPQPVHSAPQPAQQAFQPAEPVAAPQPEPVAEPA 186
|
Length = 333 |
| >gnl|CDD|234938 PRK01297, PRK01297, ATP-dependent RNA helicase RhlB; Provisional | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 15/59 (25%), Positives = 21/59 (35%), Gaps = 3/59 (5%)
Query: 70 PASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGD 128
+P P SP A PP + A+ P A A+P P + + P P
Sbjct: 16 QPAPAPPSPAAAPAPPPPAKTAAPATKAAAPAA---AAPRAEKPKKDKPRRERKPKPAS 71
|
Length = 475 |
| >gnl|CDD|223041 PHA03321, PHA03321, tegument protein VP11/12; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 50/226 (22%), Positives = 62/226 (27%), Gaps = 16/226 (7%)
Query: 2 ANSAETPGPPVANNASSGLGERKEE----AKAPPAPAEKTESPEKKVTPPPADNNNNGGG 57
A TP A E PA PE P PA GG
Sbjct: 448 ARPGSTPACARRARAQRARDAGPEYVDPLGALRRLPAGAAPPPEPAAAPSPATYYTRMGG 507
Query: 58 GNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTR 117
G P P PP A+PP P P G+A+ + P
Sbjct: 508 GPPRLPPRNRATETLRPDWGPPAAAPPEQMEDPYLEPDDDRFDRRDGAAAAATSHPREAP 567
Query: 118 SESQSSPPPG--DGGAS-----PPPEQSKNSPPAPPGQASTPP-DSPPPGIQSNQGNPVP 169
+ G D P P +N P P A PP P + NP+
Sbjct: 568 APDDDPIYEGVSDSEEPVYEEIPTPRVYQNPLPRPMEGAGEPPDLDAPTSPWVEEENPIY 627
Query: 170 SNGTTDSRDTKWAPPSNPGSPPSPSTSQSGTPSTPNENSSPNELSP 215
G ++PP PP P+ P P L+P
Sbjct: 628 GWG----DSPLFSPPPAARFPPPDPALSPEPPALPAHRPRPGALAP 669
|
Length = 694 |
| >gnl|CDD|233365 TIGR01347, sucB, 2-oxoglutarate dehydrogenase complex dihydrolipoamide succinyltransferase (E2 component) | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 2e-04
Identities = 26/121 (21%), Positives = 35/121 (28%), Gaps = 6/121 (4%)
Query: 31 PAPA-----EKTESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPP 85
P+PA E V G + PA S PA+ A+P
Sbjct: 47 PSPADGVLQEILFKEGDTVESGQVLAILEEGNDATAAPPAKSGEEKEETPAASAAAAPTA 106
Query: 86 AASPPPGSPPPASPPPASG-SASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPA 144
AA+ P SP G S P + R + + AS + A
Sbjct: 107 AANRPSLSPAARRLAKEHGIDLSAVPGTGVTGRVTKEDIIKKTEAPASAQQPAPAAAAKA 166
Query: 145 P 145
P
Sbjct: 167 P 167
|
This model describes the TCA cycle 2-oxoglutarate system E2 component, dihydrolipoamide succinyltransferase. It is closely related to the pyruvate dehydrogenase E2 component, dihydrolipoamide acetyltransferase. The seed for this model includes mitochondrial and Gram-negative bacterial forms. Mycobacterial candidates are highly derived, differ in having and extra copy of the lipoyl-binding domain at the N-terminus. They score below the trusted cutoff, but above the noise cutoff and above all examples of dihydrolipoamide acetyltransferase [Energy metabolism, TCA cycle]. Length = 403 |
| >gnl|CDD|225689 COG3147, DedD, Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 26/106 (24%), Positives = 36/106 (33%), Gaps = 13/106 (12%)
Query: 23 RKEEAKAPPA-PAEKTESPEKKVTPPPADNNN-----------NGGGGNNSTTPAASPPP 70
R++E A P P + + E +V P ++ + P P
Sbjct: 34 RQDEVAAIPLPPKPQGDRDEPRVLPAVVQVVALPTQPPEGVAQEIQDAGDAAAASVDPQP 93
Query: 71 ASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPT 116
+ PP PA P AA P PP PPA + P P P
Sbjct: 94 VAQPPVESTPAGVPVAAQTPKPVKPP-KQPPAGAVPAKPTPKPEPK 138
|
Length = 226 |
| >gnl|CDD|219916 pfam08580, KAR9, Yeast cortical protein KAR9 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 2e-04
Identities = 34/226 (15%), Positives = 64/226 (28%), Gaps = 20/226 (8%)
Query: 14 NNASSGLGERK--EEAKAPPAPAEKTESP-EKKVTPPPADNNNNGGGGNNSTTPAASPPP 70
SG G P + +++ + +++ P + +N +
Sbjct: 408 TPPDSGPGSNVSSRRVGTPGSKSDRVGAVLLRRMNIKPTLASIPDEKPSNISVF--EDSE 465
Query: 71 ASP---PPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPG 127
SP PP S + P + + S+ PP P +S P
Sbjct: 466 TSPNSSTLLRDPPPKKCGEESGHLPNNPFFNKLKLTLSSIPP---LSPRQSIITLPTP-- 520
Query: 128 DGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPS--NGTTDSRDTKWAPPS 185
+ P S S S P P + S +G S +D + +
Sbjct: 521 ---SRPASRISSLSLRLGSYSGSIVSPPPYPTLVSRKGAAGLSFNRSVSDIEGERIGRYN 577
Query: 186 NPGSPPSPSTSQSGTPSTPNENSSPNELSPPSNSKSPTSKSSPEES 231
+ ++ + ++ +SS SP P S +
Sbjct: 578 LLPTRIPALPFKAESTTSSRRSSSLP--SPTGVIGFPGSVPRFDHE 621
|
The KAR9 protein in Saccharomyces cerevisiae is a cytoskeletal protein required for karyogamy, correct positioning of the mitotic spindle and for orientation of cytoplasmic microtubules. KAR9 localises at the shmoo tip in mating cells and at the tip of the growing bud in anaphase. Length = 626 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 32/129 (24%), Positives = 45/129 (34%), Gaps = 42/129 (32%)
Query: 483 IHRDIKSANILVDDEFEAQVADFGL----------------------------------- 507
IHRDIK NIL+D + ++ DFGL
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182
Query: 508 AKLNDTTQTHV--STRVM-----GTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRK 560
+L + R + GT Y+APE T D +S GV+L E++ G+
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQP 242
Query: 561 PVDPTQPLG 569
P P
Sbjct: 243 PFLADTPAE 251
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|220749 pfam10428, SOG2, RAM signalling pathway protein | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 29/134 (21%), Positives = 39/134 (29%), Gaps = 7/134 (5%)
Query: 84 PPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPP 143
+ P+S A P S +P G +S P S +
Sbjct: 147 SLGPPLQHRKRDAVTASPSSMIARNTPISD--RLRPRSVTPTRGRRPSSSPRSLSNPTTL 204
Query: 144 APPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPSNPGSPPS-PSTSQSGTPS 202
P D PPP + S+ S + A P S S ST SG+ S
Sbjct: 205 ESPSNLQVTTDVPPPYSNGTSRSSTMSSSANLSIISSLAT---PRSGESFRSTPTSGSSS 261
Query: 203 TPNENSSPNELSPP 216
N S +E
Sbjct: 262 -INPVSGLDEAEED 274
|
SOG2 proteins in Saccharomyces cerevisiae are involved in cell separation and cytokinesis. Length = 419 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 3e-04
Identities = 23/143 (16%), Positives = 36/143 (25%), Gaps = 6/143 (4%)
Query: 86 AASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNS---- 141
P +SPP + +A P + + ++ S S
Sbjct: 775 LEPAEPQRGAGSSPPVRAEAAFRRPGRLRRSGPAADAASRTASKRKSRSHTPDGGSESSG 834
Query: 142 PPAPPGQASTPP--DSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPSNPGSPPSPSTSQSG 199
P PPG A+ PP S + G R + P +P + +
Sbjct: 835 PARPPGAAARPPPARSSESSKSKPAAAGGRARGKNGRRRPRPPEPRARPGAAAPPKAAAA 894
Query: 200 TPSTPNENSSPNELSPPSNSKSP 222
P P P
Sbjct: 895 APPAGAPAPRPRPAPRVKLGPMP 917
|
Length = 1352 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 3e-04
Identities = 26/121 (21%), Positives = 40/121 (33%), Gaps = 5/121 (4%)
Query: 5 AETPGPPVANNASSGLGERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTP 64
++N+ G A P+ P P + ++ ++
Sbjct: 160 DADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPSSPSDSSLPPAPSSF 219
Query: 65 AASPPPASPPPASPPPASPPPAASPPP-----GSPPPASPPPASGSASPPPASPPPTRSE 119
+ PP SP + P P PAA PPP A P P S SA+P P +
Sbjct: 220 QSDTPPPSPESPTNPSPPPGPAAPPPPPVQQVPPLSTAKPTPPSASATPAPIGGITLDDD 279
Query: 120 S 120
+
Sbjct: 280 A 280
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 3e-04
Identities = 18/80 (22%), Positives = 25/80 (31%), Gaps = 1/80 (1%)
Query: 84 PPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPP 143
A++ PPP PP P P + PPP AS +
Sbjct: 515 GSASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPADS 574
Query: 144 APPGQASTPPDSPPPGIQSN 163
+PP +P P S+
Sbjct: 575 SPP-PPIPEEPTPSPTKDSS 593
|
Length = 620 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 3e-04
Identities = 20/124 (16%), Positives = 31/124 (25%), Gaps = 14/124 (11%)
Query: 27 AKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPA 86
A APPA A + P A + PAA +P
Sbjct: 50 ALAPPAAAAPAAAQPPPAAAPAAVSR-----------PAAPAAEPAPWLVEHAKRLTAQR 98
Query: 87 ASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPP 146
+ PA+P + +A A+ + P + A
Sbjct: 99 EQLVARAAAPAAPEAQAPAAPAERAAAENAARRLARAAAAAPRPRVPADAAAA---VADA 155
Query: 147 GQAS 150
+A
Sbjct: 156 VKAR 159
|
Length = 484 |
| >gnl|CDD|236382 PRK09111, PRK09111, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 43.7 bits (104), Expect = 3e-04
Identities = 13/75 (17%), Positives = 20/75 (26%), Gaps = 2/75 (2%)
Query: 76 ASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPP 135
PP P G P A A+ A+ + + + P A+ P
Sbjct: 389 EGPPSPGGGGGGPPGGGGAPGAPAAAAAPGAAAAAPAAGGPA--AALAAVPDAAAAAAAP 446
Query: 136 EQSKNSPPAPPGQAS 150
+P S
Sbjct: 447 PAPAAAPQPAVRLNS 461
|
Length = 598 |
| >gnl|CDD|236382 PRK09111, PRK09111, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 43.7 bits (104), Expect = 3e-04
Identities = 9/71 (12%), Positives = 15/71 (21%)
Query: 85 PAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPA 144
P + G PP A+ + + PA
Sbjct: 391 PPSPGGGGGGPPGGGGAPGAPAAAAAPGAAAAAPAAGGPAAALAAVPDAAAAAAAPPAPA 450
Query: 145 PPGQASTPPDS 155
Q + +S
Sbjct: 451 AAPQPAVRLNS 461
|
Length = 598 |
| >gnl|CDD|223033 PHA03291, PHA03291, envelope glycoprotein I; Provisional | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 3e-04
Identities = 31/122 (25%), Positives = 44/122 (36%), Gaps = 12/122 (9%)
Query: 63 TPAASPPPASPPPASPPPASPPPAASPPPGSP-PPASPPPASGSASPPPASPPPTRSESQ 121
T AA P S PA P A P PA+P P + + P +P P+ + S
Sbjct: 171 TLAAPPLGEGSADGSCDPALPLSAPRLGPADVFVPATPRPTPRTTASPETTPTPSTTTSP 230
Query: 122 SSPPPGDGGASPPPEQSKNSP-PAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTK 180
S P P + +P +A P P PG G P+N T ++
Sbjct: 231 PSTTI------PAPSTTIAAPQAGTTPEAEGTPAPPTPGG----GEAPPANATPAPEASR 280
Query: 181 WA 182
+
Sbjct: 281 YE 282
|
Length = 401 |
| >gnl|CDD|221188 pfam11725, AvrE, Pathogenicity factor | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 3e-04
Identities = 28/165 (16%), Positives = 48/165 (29%), Gaps = 8/165 (4%)
Query: 71 ASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGG 130
A+PP A P A+ P ++ P A P + +P + + S+ G
Sbjct: 69 AAPPQALNPTAAAPQSSRGPTLRELLALPEDDGETQAPESSPSARRLTRSE-------GV 121
Query: 131 ASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPSNPGSP 190
A E P P S++ PV T S+ A S
Sbjct: 122 ARHEMEDLAGRPVVKPDADRQLRQDILNKSSSSRRPPVSKEEGTSSKMPATALASAALFK 181
Query: 191 PSPSTSQSGTPSTPNENSSPNELSPPSNSKSPTSKSSPEESSSSS 235
Q + ++ S N + ++P + +
Sbjct: 182 DD-EIRQEVDAARSDQASQSRLSRSRGNPPAIPPDAAPRQPMLTR 225
|
This family is secreted by gram-negative Gammaproteobacteria such as Pseudomonas syringae of tomato and the fire blight plant pathogen Erwinia amylovora, amongst others. It is an essential pathogenicity factor of approximately 198 kDa. Its injection into the host-plant is dependent upon the bacterial type III or Hrp secretion system. The family is long and carries a number of predicted functional regions, including an ERMS or endoplasmic reticulum membrane retention signal at both the C- and the N-termini, a leucine-zipper motif from residues 539-560, and a nuclear localisation signal at 1358-1361. this conserved AvrE-family of effectors is among the few that are required for full virulence of many phytopathogenic pseudomonads, erwinias and pantoeas. Length = 1771 |
| >gnl|CDD|237863 PRK14949, PRK14949, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 3e-04
Identities = 32/172 (18%), Positives = 52/172 (30%), Gaps = 23/172 (13%)
Query: 22 ERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTT-PAASPPPASPP----PA 76
+RK K PP+ A + +P + + + + S P A+ PA
Sbjct: 642 DRKP--KTPPSRAPPASLSKPASSPDASQTSASFDLDPDFELATHQSVPEAALASGSAPA 699
Query: 77 SPPPASP---PPAASPPPGSP---PPASPPPASGSASPPPASPPPTRSESQSSPPPGDGG 130
PP P PP P + P + + S S AS ++ Q +
Sbjct: 700 PPPVPDPYDRPPWEEAPEVASANDGPNNAAEGNLSESVEDASNSELQAVEQQATHQPQVQ 759
Query: 131 ASPPPEQSKNSPPAPPGQAS-TPPDSPPPGIQSNQGNPVPSNGTTDSRDTKW 181
A S + + T + S G+P+ D W
Sbjct: 760 AEAQSPASTTALTQTSSEVQDTELNLVLLSSGSITGHPL---------DLHW 802
|
Length = 944 |
| >gnl|CDD|234938 PRK01297, PRK01297, ATP-dependent RNA helicase RhlB; Provisional | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 3e-04
Identities = 18/61 (29%), Positives = 24/61 (39%), Gaps = 3/61 (4%)
Query: 66 ASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPP 125
A P +PP + PA PPPA + P + A A + P P R E + P
Sbjct: 14 AEQPAPAPPSPAAAPAPPPPAKTAAPATKAAAPAAAAPRAEKPKKDKP---RRERKPKPA 70
Query: 126 P 126
Sbjct: 71 S 71
|
Length = 475 |
| >gnl|CDD|227505 COG5178, PRP8, U5 snRNP spliceosome subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 3e-04
Identities = 18/31 (58%), Positives = 20/31 (64%), Gaps = 2/31 (6%)
Query: 66 ASPPPASPPPASPPPASPPPAASPPPGSPPP 96
AS PP +PPP PPP PP+ PPP PPP
Sbjct: 2 ASLPPGNPPPPPPPPGFEPPSQPPPP--PPP 30
|
Length = 2365 |
| >gnl|CDD|237001 PRK11856, PRK11856, branched-chain alpha-keto acid dehydrogenase subunit E2; Reviewed | Back alignment and domain information |
|---|
Score = 43.6 bits (104), Expect = 3e-04
Identities = 15/50 (30%), Positives = 22/50 (44%)
Query: 65 AASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPP 114
A A+ P P PAA+ + P A+ PA+ +A+ ASP
Sbjct: 81 EAEAAAAAEAAPEAPAPEPAPAAAAAAAAAPAAAAAPAAPAAAAAKASPA 130
|
Length = 411 |
| >gnl|CDD|177614 PHA03377, PHA03377, EBNA-3C; Provisional | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 3e-04
Identities = 24/105 (22%), Positives = 32/105 (30%), Gaps = 4/105 (3%)
Query: 35 EKTESPEKKVTPPPADNNNNGGGGNNSTTPAASP----PPASPPPASPPPASPPPAASPP 90
E P K +G +T P SP PP + PP PP++ P + P
Sbjct: 524 ESVTQPAKPHRKVQDGFQRSGRRQKRATPPKVSPSDRGPPKASPPVMAPPSTGPRVMATP 583
Query: 91 PGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPP 135
P +PP PP + PP P
Sbjct: 584 STGPRDMAPPSTGPRQQAKCKDGPPASGPHEKQPPSSAPRDMAPS 628
|
Length = 1000 |
| >gnl|CDD|223044 PHA03325, PHA03325, nuclear-egress-membrane-like protein; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 32/180 (17%), Positives = 48/180 (26%), Gaps = 42/180 (23%)
Query: 17 SSGLGERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPASPPPA 76
S G + A A+ S P PA+ PPP P
Sbjct: 277 SRRAGAMRAAAGETADLADDDGSEHSDPEP----------------LPASLPPP---PVR 317
Query: 77 SPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPE 136
P P P G+ + PA + S +++ S PG A+
Sbjct: 318 RPRVKHPEAGKEEPDGARNAEAKEPAQPATSTSSKGSSSAQNKDSGSTGPGSSLAA---- 373
Query: 137 QSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPSNPGSPPSPSTS 196
AS+ + P + TT R ++ PPS +
Sbjct: 374 ------------ASSFLEDD-------DFGSPPLDLTTSLRHMPSPSVTSAPEPPSIPLT 414
|
Length = 418 |
| >gnl|CDD|234818 PRK00708, PRK00708, sec-independent translocase; Provisional | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 3e-04
Identities = 22/100 (22%), Positives = 29/100 (29%), Gaps = 2/100 (2%)
Query: 61 STTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSES 120
T + P + P P P PP P PA P + +A+ A+P
Sbjct: 98 KATSMSEPATENKPAEVTTPVEPMGLPETPPAVPVPAPAPAVAAAAAQAAAAPKAPAKPR 157
Query: 121 QSSPPPGDGGASPPPEQSKNSPP--APPGQASTPPDSPPP 158
SP P A P E T + P
Sbjct: 158 AKSPRPAAKAAPKPTETITAKKAKKTAAAPKPTADKTATP 197
|
Length = 209 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 4e-04
Identities = 17/71 (23%), Positives = 23/71 (32%)
Query: 59 NNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRS 118
N S +P P PP +P S P PP + P P PT
Sbjct: 370 NASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPAEPTEPSPTPP 429
Query: 119 ESQSSPPPGDG 129
+ ++ PP
Sbjct: 430 ANAANAPPSLN 440
|
Length = 620 |
| >gnl|CDD|166942 PRK00404, tatB, sec-independent translocase; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 4e-04
Identities = 20/61 (32%), Positives = 28/61 (45%), Gaps = 3/61 (4%)
Query: 85 PAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPA 144
P A P P +PP A P + PP ++P + + + P P A+PPP P A
Sbjct: 84 PPAPPEPVTPPTAQSPAPAVPTPPPTSTPAVPPAPAAAVPAP---AAAPPPSDPPQPPRA 140
Query: 145 P 145
P
Sbjct: 141 P 141
|
Length = 141 |
| >gnl|CDD|227665 COG5373, COG5373, Predicted membrane protein [Function unknown] | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 4e-04
Identities = 22/86 (25%), Positives = 26/86 (30%), Gaps = 6/86 (6%)
Query: 64 PAASP--PPASPPPASPPPASPP-PAASPPPGSPPPASPPPASGSASPPPASPPPTRSES 120
AA P A A + P PAA+ SP PP A A P S
Sbjct: 42 GAAGPVAKAAEQMAAPEAAEAAPLPAAAESIASPE-VPPPVPPAPAQEGEA--PAAEQPS 98
Query: 121 QSSPPPGDGGASPPPEQSKNSPPAPP 146
P + P E S + P
Sbjct: 99 AVPAPSAAPAPAEPVEPSLAANPFAA 124
|
Length = 931 |
| >gnl|CDD|237863 PRK14949, PRK14949, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 4e-04
Identities = 34/169 (20%), Positives = 56/169 (33%), Gaps = 13/169 (7%)
Query: 81 ASPPPAASPPPGSPPPASPP-PASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSK 139
+A P +PP +PP S AS P AS + + P +
Sbjct: 635 DGKKSSADRKPKTPPSRAPPASLSKPASSPDASQTSASFDLDPDFELATHQSVPEAALAS 694
Query: 140 NSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPSNPGSPPSPSTSQSG 199
S PAPP P D PP + P ++ + S S S
Sbjct: 695 GSAPAPP-PVPDPYDRPPW-----EEAPEVASANDGPNN----AAEGNLSESVEDASNSE 744
Query: 200 TPSTPNENSSPNELSPPSNSKSPTSKSSPEESSSSSHSNSKKTPTSSSG 248
+ + + ++ + ++SP S ++ ++SS SSG
Sbjct: 745 LQAVEQQATHQPQV--QAEAQSPASTTALTQTSSEVQDTELNLVLLSSG 791
|
Length = 944 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 4e-04
Identities = 49/217 (22%), Positives = 81/217 (37%), Gaps = 35/217 (16%)
Query: 365 ENVIGEGGFGCVYK------GNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHH--- 415
+ +IG GGFGCVY+ + V ++ L++ + E + I ++
Sbjct: 17 DKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKN 76
Query: 416 ----RHLVSLVGY-CISEKNRLLIYEFV-------PNNNLEHHLHGKGQPVLEWTKRVKI 463
HL Y C S K + Y F+ + + K + +++ I
Sbjct: 77 IHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIK-----NI 131
Query: 464 ALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRV- 522
L Y+HE I H DIK NI+VD + D+G+A H+
Sbjct: 132 MKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKE 188
Query: 523 -----MGTFGYLAPEYASSGKLTDRSDVFSFGVVLLE 554
GT Y + + +T R D+ S G +L+
Sbjct: 189 QKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225
|
Length = 294 |
| >gnl|CDD|237081 PRK12372, PRK12372, ribonuclease III; Reviewed | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 4e-04
Identities = 29/140 (20%), Positives = 44/140 (31%), Gaps = 10/140 (7%)
Query: 2 ANSAETPGPPVANNASSGLGERKEEAKAPPAPAEKT-------ESPEKKVTPPPADNNNN 54
A + E A A++ EE P A + + E+ P AD
Sbjct: 269 AAAREARAAAAAPAATAAAAAPAEEPAVAPMAAIRAAHVETAADKGERAAKPAAADK--- 325
Query: 55 GGGGNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPP 114
AA P A+P A P + P S P ++ +A+ PA
Sbjct: 326 AADKPADRPDAAEKAAEKPAEAAPRAADKPAGQAADPASSSADKPGASADAAARTPARAR 385
Query: 115 PTRSESQSSPPPGDGGASPP 134
+ +PP G A+
Sbjct: 386 DAAAPDADTPPGGASLAAAQ 405
|
Length = 413 |
| >gnl|CDD|223880 COG0810, TonB, Periplasmic protein TonB, links inner and outer membranes [Cell envelope biogenesis, outer membrane] | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 4e-04
Identities = 19/124 (15%), Positives = 28/124 (22%), Gaps = 13/124 (10%)
Query: 24 KEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASP 83
+ PP K + + P P P P P
Sbjct: 56 PQPEPEPPEEQPKPPTEPETPPEPTPP----------KPKEKPKPEKKPKKPKPKPKPKP 105
Query: 84 PPAASPPPGSPPPASPPPASG--SASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNS 141
P P P P PP + + + P P + S S G + +
Sbjct: 106 KPKPKVKP-QPKPKKPPSKTAAKAPAAPNQPARPPSAASASGAATGPSASYLSGLRRAIR 164
Query: 142 PPAP 145
Sbjct: 165 RAPR 168
|
Length = 244 |
| >gnl|CDD|217392 pfam03153, TFIIA, Transcription factor IIA, alpha/beta subunit | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 5e-04
Identities = 26/161 (16%), Positives = 45/161 (27%), Gaps = 8/161 (4%)
Query: 25 EEAKAPPAPAEKTESPEKKVTPPPA----DNNNNGGGGNNSTTPAASPPP-ASPPPASPP 79
+ + P P + P + P A + + +PAA+PP + P
Sbjct: 50 DPSPQAPPPVAQLPQPLPQPPPTQALQALPAGDQQQHNTPTGSPAANPPATFALPAGPAG 109
Query: 80 PASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSK 139
P P P + S PA + Q P G + ++
Sbjct: 110 PTIQTEPGQLYPVQVPVMVTQNPANSPLDQPAQQRALQQLQQRYGAPASGQLPSQQQSAQ 169
Query: 140 NSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTK 180
+ Q P+ P Q++ S R+
Sbjct: 170 KN---DESQLQQQPNGETPPQQTDGAGDDESEALVRLREAD 207
|
Transcription initiation factor IIA (TFIIA) is a heterotrimer, the three subunits being known as alpha, beta, and gamma, in order of molecular weight. The N and C-terminal domains of the gamma subunit are represented in pfam02268 and pfam02751, respectively. This family represents the precursor that yields both the alpha and beta subunits. The TFIIA heterotrimer is an essential general transcription initiation factor for the expression of genes transcribed by RNA polymerase II. Together with TFIID, TFIIA binds to the promoter region; this is the first step in the formation of a pre-initiation complex (PIC). Binding of the rest of the transcription machinery follows this step. After initiation, the PIC does not completely dissociate from the promoter. Some components, including TFIIA, remain attached and re-initiate a subsequent round of transcription. Length = 332 |
| >gnl|CDD|235899 PRK06975, PRK06975, bifunctional uroporphyrinogen-III synthetase/uroporphyrin-III C-methyltransferase; Reviewed | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 5e-04
Identities = 16/67 (23%), Positives = 23/67 (34%), Gaps = 6/67 (8%)
Query: 65 AASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSP 124
+ A P A+P P+ + PA+ A PPA+PP +
Sbjct: 264 TWADAAAQPATAAPAPSRMTDTNDSKSVTSQPAAAAAAPAPPPNPPATPP------EPPA 317
Query: 125 PPGDGGA 131
G G A
Sbjct: 318 RRGRGSA 324
|
Length = 656 |
| >gnl|CDD|221745 pfam12737, Mating_C, C-terminal domain of homeodomain 1 | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 5e-04
Identities = 45/203 (22%), Positives = 70/203 (34%), Gaps = 20/203 (9%)
Query: 63 TPAASPPPASPPPASPPPAS---PPPAASPPPGSPP-PASPPPASGSASPPPASP--PPT 116
+P SP +S SP P+ P ASP G +SP A P P
Sbjct: 73 SPERSPALSSERLLSPSPSVLDLSPVLASPQTGKRRRSSSPSDDEDEAERPSKRPRSDSI 132
Query: 117 RSESQSSPPPGDGGASPPP----EQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNG 172
S S + PP SP E S+ S P + +PP +P S + S+G
Sbjct: 133 SSSSSPAKPPEACLPSPAASTQDELSEASAAPLPTPSLSPPHTPTDTAPSGKRKRRLSDG 192
Query: 173 --TTDSRDTKWAPPSNPGSPPSPSTSQS-------GTPSTPNENSSPNELSPPSNSKSPT 223
+ + + S P P + + T S+ ++ PP + +P
Sbjct: 193 FQLPAPKRPQTSSRPQTVSDPLPLHATTDWDTWFQATVSSSPSLLLTGDIPPPVSVFAPD 252
Query: 224 SKSSPEESSSSSHSNSKKTPTSS 246
S+P + S + P +
Sbjct: 253 D-STPLDISLFNFPLIPLLPPEA 274
|
Mating in fungi is controlled by the loci that determine the mating type of an individual, and only individuals with differing mating types can mate. Basidiomycete fungi have evolved a unique mating system, termed tetrapolar or bifactorial incompatibility, in which mating type is determined by two unlinked loci; compatibility at both loci is required for mating to occur. The multi-allelic tetrapolar mating system is considered to be a novel innovation that could have only evolved once, and is thus unique to the mushroom fungi. This domain is C-terminal to the homeodomain transcription factor region. Length = 418 |
| >gnl|CDD|220603 pfam10152, DUF2360, Predicted coiled-coil domain-containing protein (DUF2360) | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 5e-04
Identities = 18/57 (31%), Positives = 20/57 (35%), Gaps = 2/57 (3%)
Query: 60 NSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPT 116
+ T PPPAS PP PP A PPP P + P A T
Sbjct: 52 DVTVQTTPPPPASAITNGGPPPPPPARAEAAS--PPPPEAPAEPPAEPEPEAPAENT 106
|
This is the conserved 140 amino acid region of a family of proteins conserved from nematodes to humans. One C. elegans member is annotated as a Daf-16-dependent longevity protein 1 but this could not be confirmed. The function is unknown. Length = 147 |
| >gnl|CDD|233366 TIGR01348, PDHac_trf_long, pyruvate dehydrogenase complex dihydrolipoamide acetyltransferase, long form | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 5e-04
Identities = 17/54 (31%), Positives = 24/54 (44%), Gaps = 1/54 (1%)
Query: 62 TTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPP 115
+TPA +P PAS PA+ PA+ P + P A P + + PA
Sbjct: 194 STPATAPAPASAQPAAQSPAATQPEPAAAPA-AAKAQAPAPQQAGTQNPAKVDH 246
|
This model describes a subset of pyruvate dehydrogenase complex dihydrolipoamide acetyltransferase specifically close by both phylogenetic and per cent identity (UPGMA) trees. Members of this set include two or three copies of the lipoyl-binding domain. E. coli AceF is a member of this model, while mitochondrial and some other bacterial forms belong to a separate model [Energy metabolism, Pyruvate dehydrogenase]. Length = 546 |
| >gnl|CDD|215641 PLN03237, PLN03237, DNA topoisomerase 2; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 5e-04
Identities = 41/251 (16%), Positives = 71/251 (28%), Gaps = 19/251 (7%)
Query: 14 NNASSGLGERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPASP 73
N + + + APA E E+ D + A
Sbjct: 1232 ENVAEVVKPKGRAGAKKKAPAAAKEKEEEDEILDLKDRLAAYNLDSAPAQSAKMEETVKA 1291
Query: 74 PPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASP 133
PA A P AS S + + + + P + A+
Sbjct: 1292 VPARRAAARKKPLASVSVISDSDDD----DDDFAVEVSLAERLKKKGGRKPAAANKKAAK 1347
Query: 134 PPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPSNPGSPPSP 193
PP +K G A+ + + P + G + + + S P + S
Sbjct: 1348 PPAAAK-----KRGPATVQ---SGQKLLTEMLKPAEAIGISPEKKVRKMRAS-PFNKKSG 1398
Query: 194 STSQSGTPSTPNENSSPNELSPPSNSKSPTSKSSPEESSSSSHSNSKKTPTSSSGHSSDS 253
S +T E S +S S+S K + S+ + + T+ S+S
Sbjct: 1399 SVLGRA--ATNKETESSENVSGSSSS----EKDEIDVSAKPRPQRANRKQTTYVLSDSES 1452
Query: 254 TKGSSSNDDQA 264
S+ D
Sbjct: 1453 ESADDSDFDDD 1463
|
Length = 1465 |
| >gnl|CDD|217469 pfam03276, Gag_spuma, Spumavirus gag protein | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 5e-04
Identities = 30/93 (32%), Positives = 34/93 (36%), Gaps = 10/93 (10%)
Query: 64 PAASPPPASPPPASPPPASPPPAAS--PPPGSPPPASPPPASGSASPPPASP--PPTRSE 119
P PPP S P PP ++S P S P P S + P SP P
Sbjct: 179 GGNIPGAIQPPPPSSLPGLPPGSSSLAPSASSTPGNRLPRVSFNPFLPGPSPAQPSAPPA 238
Query: 120 SQSSPPPGDGGASPPPEQSKNSPPAPPGQASTP 152
S +PP PP Q PP PP Q P
Sbjct: 239 SIPAPP------IPPVIQYVAPPPVPPPQPIIP 265
|
Length = 582 |
| >gnl|CDD|235124 PRK03427, PRK03427, cell division protein ZipA; Provisional | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 6e-04
Identities = 30/132 (22%), Positives = 37/132 (28%), Gaps = 12/132 (9%)
Query: 41 EKKVTPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPP 100
E +V N +P P P PP A PP +P
Sbjct: 65 EVRVHRVNHAPANAQEHEAARPSPQHQYQPPYASAQPRQPVQQPPEAQ----VPPQHAPR 120
Query: 101 PASGSASP---PPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPP 157
PA + P P P P + Q P P Q +S P P QA P +
Sbjct: 121 PAQPAPQPVQQPAYQPQPEQPLQQPVSP-----QVAPAPQPVHSAPQPAQQAFQPAEPVA 175
Query: 158 PGIQSNQGNPVP 169
P P
Sbjct: 176 APQPEPVAEPAP 187
|
Length = 333 |
| >gnl|CDD|171499 PRK12438, PRK12438, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 6e-04
Identities = 22/84 (26%), Positives = 35/84 (41%), Gaps = 2/84 (2%)
Query: 64 PAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSS 123
A++PPP + PPA P PP + P + PP P + + + RS +S
Sbjct: 910 AASAPPPGAGPPAPPQAV--PPPRTTQPPAAPPRGPDVPPAAVAELRETLADLRSAQRSG 967
Query: 124 PPPGDGGASPPPEQSKNSPPAPPG 147
G A E++ ++ P G
Sbjct: 968 DFTAYGAALDRLEKAIDAYETPGG 991
|
Length = 991 |
| >gnl|CDD|240289 PTZ00144, PTZ00144, dihydrolipoamide succinyltransferase; Provisional | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 6e-04
Identities = 18/69 (26%), Positives = 26/69 (37%)
Query: 66 ASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPP 125
P + PA+ A P + P PPA+ +PP A+ PP + + PP
Sbjct: 120 TGGAPPAAAPAAAAAAKAEKTTPEKPKAAAPTPEPPAASKPTPPAAAKPPEPAPAAKPPP 179
Query: 126 PGDGGASPP 134
A P
Sbjct: 180 TPVARADPR 188
|
Length = 418 |
| >gnl|CDD|240289 PTZ00144, PTZ00144, dihydrolipoamide succinyltransferase; Provisional | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 6e-04
Identities = 14/64 (21%), Positives = 19/64 (29%)
Query: 63 TPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQS 122
AA A+ P P AA P PPA+ P + P +
Sbjct: 125 PAAAPAAAAAAKAEKTTPEKPKAAAPTPEPPAASKPTPPAAAKPPEPAPAAKPPPTPVAR 184
Query: 123 SPPP 126
+ P
Sbjct: 185 ADPR 188
|
Length = 418 |
| >gnl|CDD|237081 PRK12372, PRK12372, ribonuclease III; Reviewed | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 6e-04
Identities = 34/142 (23%), Positives = 46/142 (32%), Gaps = 28/142 (19%)
Query: 22 ERKEEAKAPPAPAE--------KTESPEKKVTPPP------ADNNNNGGGGNNSTTPAAS 67
ERKE A A A A +P ++ P A G + PAA+
Sbjct: 264 ERKERAAAREARAAAAAPAATAAAAAPAEEPAVAPMAAIRAAHVETAADKGERAAKPAAA 323
Query: 68 PPPASPPPA----------SPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTR 117
A P P A+P A P + PAS AS A+ P R
Sbjct: 324 DKAADKPADRPDAAEKAAEKPAEAAPRAADKPAGQAADPASSSADKPGASADAAARTPAR 383
Query: 118 SESQSSP----PPGDGGASPPP 135
+ ++P PPG +
Sbjct: 384 ARDAAAPDADTPPGGASLAAAQ 405
|
Length = 413 |
| >gnl|CDD|217469 pfam03276, Gag_spuma, Spumavirus gag protein | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 6e-04
Identities = 26/80 (32%), Positives = 30/80 (37%), Gaps = 2/80 (2%)
Query: 79 PPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQS 138
P PPP S P PP S S +P +S P R S P G + P
Sbjct: 179 GGNIPGAIQPPPPSSLP--GLPPGSSSLAPSASSTPGNRLPRVSFNPFLPGPSPAQPSAP 236
Query: 139 KNSPPAPPGQASTPPDSPPP 158
S PAPP +PPP
Sbjct: 237 PASIPAPPIPPVIQYVAPPP 256
|
Length = 582 |
| >gnl|CDD|236712 PRK10547, PRK10547, chemotaxis protein CheA; Provisional | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 6e-04
Identities = 10/46 (21%), Positives = 12/46 (26%)
Query: 62 TTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSAS 107
+ P S PP A P G +S S S
Sbjct: 234 KAEETTEVVEVSPKISVPPVLKLAAEQAPAGRVEREKTARSSESTS 279
|
Length = 670 |
| >gnl|CDD|151322 pfam10873, DUF2668, Protein of unknown function (DUF2668) | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 6e-04
Identities = 19/44 (43%), Positives = 22/44 (50%), Gaps = 1/44 (2%)
Query: 75 PASPPPASPPPAASPPPGSPPPASP-PPASGSASPPPASPPPTR 117
P +PPP + P PPP SP P AS SPPP P +R
Sbjct: 110 PMAPPPYTYDHEMEYPTDLPPPYSPAPQASAQRSPPPPYPGNSR 153
|
Members in this family of proteins are annotated as Cysteine and tyrosine-rich protein 1, however currently no function is known. Length = 154 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 7e-04
Identities = 33/108 (30%), Positives = 53/108 (49%), Gaps = 13/108 (12%)
Query: 362 FAREN-----VIGEGGFGCVYK------GNLPEGKVVAVKQLKSGSGQGERE-FRAEVEI 409
F R+N +G G FG V + G VAVK LK+ + ERE +E++I
Sbjct: 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKI 94
Query: 410 ISRV-HHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLE 456
+S + H+++V+L+G C L+I E+ +L + L K + L
Sbjct: 95 LSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLN 142
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|184281 PRK13729, PRK13729, conjugal transfer pilus assembly protein TraB; Provisional | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 7e-04
Identities = 24/76 (31%), Positives = 28/76 (36%), Gaps = 7/76 (9%)
Query: 59 NNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPAS------ 112
A+P A+ P PASPP P P S PP A PPP +
Sbjct: 118 EQVKALGANPVTATGEPVPQMPASPPGPEGEPQPGNTPVSFPPQGSVAVPPPTAFYPGNG 177
Query: 113 -PPPTRSESQSSPPPG 127
PP + QS P P
Sbjct: 178 VTPPPQVTYQSVPVPN 193
|
Length = 475 |
| >gnl|CDD|236768 PRK10819, PRK10819, transport protein TonB; Provisional | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 7e-04
Identities = 27/105 (25%), Positives = 32/105 (30%), Gaps = 9/105 (8%)
Query: 64 PAASPPPASPPPASPPPASPPPAASPPPGSPPPA----SPPPASGSASPPPASPPPTRSE 119
PA PP + P P P P P P P A P P P P + E
Sbjct: 55 PADLEPPQAVQPPPEPVVEPEPEPEPIPEPPKEAPVVIPKPEPKPKPKPKPKPKPVKKVE 114
Query: 120 SQSSP---PPGDGGASP--PPEQSKNSPPAPPGQASTPPDSPPPG 159
Q P ASP ++ + AS P S G
Sbjct: 115 EQPKREVKPVEPRPASPFENTAPARPTSSTATAAASKPVTSVSSG 159
|
Length = 246 |
| >gnl|CDD|220708 pfam10349, WWbp, WW-domain ligand protein | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 7e-04
Identities = 22/48 (45%), Positives = 24/48 (50%)
Query: 68 PPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPP 115
P PA A+PPP PPP P P P PPP SG + P PPP
Sbjct: 58 PLPAYGQYAAPPPYGPPPPYYPAPPGVYPTPPPPNSGYMADPQEPPPP 105
|
The WWbp domain is characterized by several short PY and PT-like motifs of the PPPPY form. These appear to bind directly to the WW domains of WWP1 and WWP2 and other such diverse proteins as dystrophin and YAP (Yes-associated protein). This is the WW-domain binding protein WWbp via PY and PY_like motifs. The presence of a phosphotyrosine residue in the pWBP-1 peptide abolishes WW domain binding which suggests a potential regulatory role for tyrosine phosphorylation in modulating WW domain-ligand interactions. Given the likelihood that WWP1 and WWP2 function as E3 ubiquitin-protein ligases, it is possible that initial substrate-specific recognition occurs via WW domain-substrate protein interaction followed by ubiquitin transfer and subsequent proteolysis. This domain lies just downstream of the GRAM (pfam02893) in many members. Length = 111 |
| >gnl|CDD|235826 PRK06549, PRK06549, acetyl-CoA carboxylase biotin carboxyl carrier protein subunit; Validated | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 7e-04
Identities = 13/48 (27%), Positives = 16/48 (33%)
Query: 69 PPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPT 116
P + PA P P P A P A+ A P+ P T
Sbjct: 24 PAQAAAPAQPASTPVPVPTEASPQVEAQAPQPAAAAGADAMPSPMPGT 71
|
Length = 130 |
| >gnl|CDD|114270 pfam05539, Pneumo_att_G, Pneumovirinae attachment membrane glycoprotein G | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 7e-04
Identities = 34/187 (18%), Positives = 57/187 (30%), Gaps = 15/187 (8%)
Query: 27 AKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPA 86
+K P E + P + G + +S P + ++P P
Sbjct: 175 SKTTSWPTEVSHPTYPSQVTPQSQPATQGHQTATANQRLSSTEPVGTQ-GTTTSSNPEPQ 233
Query: 87 ASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPP 146
PPP P+ P S + S T + Q + S P
Sbjct: 234 TEPPPSQRGPSGSPQHPPSTTSQDQS---TTGDGQEHTQRRKTPPAT-------SNRRSP 283
Query: 147 GQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPSNPGSPPSPSTSQSGTPSTPNE 206
+TPP + + G P P T ++ P S+P + T+Q+ +
Sbjct: 284 HSTATPPPTTK---RQETGRPTPRP-TATTQSGSSPPHSSPPGVQANPTTQNLVDCKELD 339
Query: 207 NSSPNEL 213
PN +
Sbjct: 340 PPKPNSI 346
|
Length = 408 |
| >gnl|CDD|219339 pfam07223, DUF1421, Protein of unknown function (DUF1421) | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 8e-04
Identities = 42/224 (18%), Positives = 60/224 (26%), Gaps = 12/224 (5%)
Query: 31 PAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPAASPP 90
+ ++ ++ PPP+ + P P PP P +PP
Sbjct: 108 QSVPQQPTPQQEPYYPPPSQPQPPPAQQPQAQQPQPPPQVPQQQQYQSPPQQPQYQQNPP 167
Query: 91 PGSPPPASPPPA--SGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPPGQ 148
P A + P S PP S +PP +Q P P
Sbjct: 168 P-QAQSAPQVSGLYPEESPYQPQSYPPNEPLPSSMAMQPPYSGAPPSQQFYGPPQPSPYM 226
Query: 149 ASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPSNPGSPPSPSTSQSGTPSTPNENS 208
P P G S Q P G PPS S P +S
Sbjct: 227 YGGPGGRPNSGFPSGQQPPPSQGQ---------EGYGYSGPPPSKGNHGSVASYAPQGSS 277
Query: 209 SPNELSPPSNSKSPTSKSSPEESSSSSHSNSKKTPTSSSGHSSD 252
+ PS + + SS+ +P S + D
Sbjct: 278 QSYSTAYPSLPAATVLPQALPMSSAPMSGGGSGSPQSGNRVPID 321
|
This family represents a conserved region approximately 350 residues long within a number of plant proteins of unknown function. Length = 357 |
| >gnl|CDD|184923 PRK14959, PRK14959, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 8e-04
Identities = 30/124 (24%), Positives = 43/124 (34%), Gaps = 3/124 (2%)
Query: 95 PPASPPPASGSASPPPAS--PPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPPGQASTP 152
P S P+ G AS P S P + + P PG G + +P + P
Sbjct: 367 PVESLRPSGGGASAPSGSAAEGPASGGAATIPTPGTQGPQGTAPAAGMTPSSAAPATPAP 426
Query: 153 PDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPSNPGS-PPSPSTSQSGTPSTPNENSSPN 211
+P P + + P P R P ++P P S S P T + S
Sbjct: 427 SAAPSPRVPWDDAPPAPPRSGIPPRPAPRMPEASPVPGAPDSVASASDAPPTLGDPSDTA 486
Query: 212 ELSP 215
E +P
Sbjct: 487 EHTP 490
|
Length = 624 |
| >gnl|CDD|185616 PTZ00436, PTZ00436, 60S ribosomal protein L19-like protein; Provisional | Back alignment and domain information |
|---|
Score = 41.9 bits (97), Expect = 8e-04
Identities = 36/168 (21%), Positives = 69/168 (41%), Gaps = 20/168 (11%)
Query: 65 AASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSP 124
AA+ A A+ A+P S +P A+ PA +A P A+ P ++ ++
Sbjct: 193 AAAAAAAKQKAAAKKAAAPSGKKSAKAAAPAKAAAAPAKAAAPPAKAAAAPAKA---AAA 249
Query: 125 PPGDGGASPPPEQSKNSP---PAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKW 181
P A+ PP ++ P APP +A+ PP + P+
Sbjct: 250 P---AKAAAPPAKAAAPPAKAAAPPAKAAAPP---------AKAAAPPAKAAAPPAKAAA 297
Query: 182 APPSNPGSPPSPSTSQSGTPSTPNENSSP--NELSPPSNSKSPTSKSS 227
AP +P + + + + P + ++P +PP+ + +P +K++
Sbjct: 298 APAKAAAAPAKAAAAPAKAAAPPAKAAAPPAKAATPPAKAAAPPAKAA 345
|
Length = 357 |
| >gnl|CDD|234818 PRK00708, PRK00708, sec-independent translocase; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 8e-04
Identities = 25/120 (20%), Positives = 41/120 (34%), Gaps = 11/120 (9%)
Query: 25 EEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPP 84
++A + PA P + TP G T PA P +P A+ A+
Sbjct: 97 QKATSMSEPAT-ENKPAEVTTPVEP-------MGLPETPPAVPVPAPAPAVAA---AAAQ 145
Query: 85 PAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPA 144
AA+P + P A P + A+P P + +++ P K +
Sbjct: 146 AAAAPKAPAKPRAKSPRPAAKAAPKPTETITAKKAKKTAAAPKPTADKTATPAKKTTKKK 205
|
Length = 209 |
| >gnl|CDD|220708 pfam10349, WWbp, WW-domain ligand protein | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 8e-04
Identities = 25/69 (36%), Positives = 30/69 (43%), Gaps = 1/69 (1%)
Query: 61 STTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSES 120
S PPP + P PA AA PP G PPP P P +PPP + ++
Sbjct: 41 SRESGYYPPPGAYVHLEPLPAYGQYAAPPPYGPPPPYYPAPPGVYPTPPPPNSGY-MADP 99
Query: 121 QSSPPPGDG 129
Q PPP G
Sbjct: 100 QEPPPPYPG 108
|
The WWbp domain is characterized by several short PY and PT-like motifs of the PPPPY form. These appear to bind directly to the WW domains of WWP1 and WWP2 and other such diverse proteins as dystrophin and YAP (Yes-associated protein). This is the WW-domain binding protein WWbp via PY and PY_like motifs. The presence of a phosphotyrosine residue in the pWBP-1 peptide abolishes WW domain binding which suggests a potential regulatory role for tyrosine phosphorylation in modulating WW domain-ligand interactions. Given the likelihood that WWP1 and WWP2 function as E3 ubiquitin-protein ligases, it is possible that initial substrate-specific recognition occurs via WW domain-substrate protein interaction followed by ubiquitin transfer and subsequent proteolysis. This domain lies just downstream of the GRAM (pfam02893) in many members. Length = 111 |
| >gnl|CDD|114270 pfam05539, Pneumo_att_G, Pneumovirinae attachment membrane glycoprotein G | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 8e-04
Identities = 32/153 (20%), Positives = 51/153 (33%), Gaps = 18/153 (11%)
Query: 124 PPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGN----PVPSNGTTDSRDT 179
P + ++ S P P Q + G Q+ N GT + +
Sbjct: 168 PKTAVTTSKTTSWPTEVSHPTYPSQVTPQSQPATQGHQTATANQRLSSTEPVGTQGTTTS 227
Query: 180 KWAPPSN--PGSPPSPSTSQSGTPSTPNENSSPNELS-----------PPSNSKSPTSKS 226
P P S PS S PST +++ S SN +SP S +
Sbjct: 228 SNPEPQTEPPPSQRGPSGSPQHPPSTTSQDQSTTGDGQEHTQRRKTPPATSNRRSPHSTA 287
Query: 227 SPEESSSSSHSNSKKTPTSSSGHSSDSTKGSSS 259
+P ++ + TP ++ S S+ SS
Sbjct: 288 TPPP-TTKRQETGRPTPRPTATTQSGSSPPHSS 319
|
Length = 408 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 8e-04
Identities = 53/187 (28%), Positives = 86/187 (45%), Gaps = 28/187 (14%)
Query: 403 FRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLH-GKGQPVLEWTKRV 461
F ++S+V H HL + G C+ +++ EFV + L+ L KG+ + W ++
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KI 120
Query: 462 KIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLA-------KLND-- 512
+A A L+YL + ++H ++ + NIL +A GLA KL+D
Sbjct: 121 TVAQQLASALSYLEDK---NLVHGNVCAKNIL--------LARLGLAEGTSPFIKLSDPG 169
Query: 513 TTQTHVS--TRVMGTFGYLAPEYASSG-KLTDRSDVFSFGVVLLEL-ITGRKPVDPTQPL 568
+ T +S RV ++APE G L+ +D +SFG LLE+ G P+ P
Sbjct: 170 VSFTALSREERV-ERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPS 228
Query: 569 GDESLVE 575
E E
Sbjct: 229 EKERFYE 235
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|152960 pfam12526, DUF3729, Protein of unknown function (DUF3729) | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 9e-04
Identities = 18/57 (31%), Positives = 23/57 (40%)
Query: 61 STTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTR 117
T P S PPP+ P P P P + PP+ P + + PP P P R
Sbjct: 52 DTPPPVSAVWVLPPPSEPAAPPPDPEPPVPGPAGPPSPLAPPAPARKPPLPPPRPQR 108
|
This family of proteins is found in viruses. Proteins in this family are typically between 145 and 1707 amino acids in length. The family is found in association with pfam01443, pfam01661, pfam05417, pfam01660, pfam00978. There is a single completely conserved residue L that may be functionally important. Length = 115 |
| >gnl|CDD|223061 PHA03369, PHA03369, capsid maturational protease; Provisional | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 9e-04
Identities = 22/98 (22%), Positives = 26/98 (26%), Gaps = 4/98 (4%)
Query: 59 NNSTTPAASPPPASPPPASPPPASPPPAASP--PPGSPP--PASPPPASGSASPPPASPP 114
S T + A+ A + P P P S P S + PP
Sbjct: 350 TASLTAPSRVLAAAAKVAVIAAPQTHTGPADRQRPQRPDGIPYSVPARSPMTAYPPVPQF 409
Query: 115 PTRSESQSSPPPGDGGASPPPEQSKNSPPAPPGQASTP 152
S P G S PE PP P P
Sbjct: 410 CGDPGLVSPYNPQSPGTSYGPEPVGPVPPQPTNPYVMP 447
|
Length = 663 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 0.001
Identities = 19/108 (17%), Positives = 32/108 (29%), Gaps = 3/108 (2%)
Query: 2 ANSAETPGPPVANNASSGLGERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNS 61
A + P P A + +A + + + + V PP ++ G +
Sbjct: 697 APAQPAPAPAATPPAGQADDPAAQPPQAAQGASAPSPAADDPVPLPPEPDDPPDPAGAPA 756
Query: 62 TTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPP 109
P P + PA+ PP SPP +P
Sbjct: 757 QPPPPPAPAPAAAPAAAPPPSPPS---EEEEMAEDDAPSMDDEDRRDA 801
|
Length = 824 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 0.001
Identities = 27/115 (23%), Positives = 38/115 (33%), Gaps = 23/115 (20%)
Query: 4 SAETPGP-PVANNASSGLGERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNST 62
A P PVA A++ A A A +P V P A
Sbjct: 385 EAAAPAAAPVAQAAAAPAPAAAPAAAASAPAAPPAAAPPAPVAAPAAAAPAA-------- 436
Query: 63 TPAASPPPASPPPASPPPASP--------------PPAASPPPGSPPPASPPPAS 103
PAA+P + PA P A+P +A+P P + P A+ +
Sbjct: 437 APAAAPAAVALAPAPPAQAAPETVAIPVRVAPEPAVASAAPAPAAAPAAARLTPT 491
|
Length = 618 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 0.001
Identities = 21/79 (26%), Positives = 24/79 (30%), Gaps = 3/79 (3%)
Query: 36 KTESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPP 95
T P + T PP PP A +S PA P SPP
Sbjct: 519 NTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTA-TQASSNAPAQIPADSSPP 577
Query: 96 PASPPPASGSASPPPASPP 114
P P + SP S P
Sbjct: 578 PPIPEEP--TPSPTKDSSP 594
|
Length = 620 |
| >gnl|CDD|235124 PRK03427, PRK03427, cell division protein ZipA; Provisional | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 0.001
Identities = 30/138 (21%), Positives = 39/138 (28%), Gaps = 19/138 (13%)
Query: 13 ANNASSGLGERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPAS 72
A + + + P + P + V PP A PP +
Sbjct: 74 APANAQEHEAARPSPQHQYQPPYASAQPRQPVQQPPE---------------AQVPPQHA 118
Query: 73 PPPASP-PPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGA 131
P PA P P PA P P P P A P S P ++ P A
Sbjct: 119 PRPAQPAPQPVQQPAYQPQPEQPLQQPVSPQVAPAPQPVHSAPQPAQQAFQPAEP---VA 175
Query: 132 SPPPEQSKNSPPAPPGQA 149
+P PE P
Sbjct: 176 APQPEPVAEPAPVMDKPK 193
|
Length = 333 |
| >gnl|CDD|223033 PHA03291, PHA03291, envelope glycoprotein I; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 42/186 (22%), Positives = 65/186 (34%), Gaps = 25/186 (13%)
Query: 136 EQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPSNPGSPPSPST 195
E + N+ P G A+ P + +G ++G+ D AP P P+T
Sbjct: 151 EGATNASLFPLGLAAFPAEGTLAAPPLGEG---SADGSCDPALPLSAPRLGPADVFVPAT 207
Query: 196 SQSGTPSTPNENSSPNELSPPSNSKSPTSKS---------SPEESSSSSHSNSKKTPTSS 246
TP +SP PS + SP S + +P+ ++ + PT
Sbjct: 208 P----RPTPRTTASPETTPTPSTTTSPPSTTIPAPSTTIAAPQAGTTPEAEGTPAPPTPG 263
Query: 247 SGHSSDSTKGSSSNDD-------QAIIGATAAGVVLIVLIA--IFFLARGRRRRRDAYAT 297
G + + + Q I A A ++ V + L R RRRR A
Sbjct: 264 GGEAPPANATPAPEASRYELTVTQIIQIAIPASIIACVFLGSCACCLHRRCRRRRRRPAR 323
Query: 298 HYMPPP 303
Y PP
Sbjct: 324 IYRPPS 329
|
Length = 401 |
| >gnl|CDD|222997 PHA03132, PHA03132, thymidine kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 0.001
Identities = 34/192 (17%), Positives = 50/192 (26%), Gaps = 14/192 (7%)
Query: 73 PPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGAS 132
PP + S P P P + + PP G GAS
Sbjct: 56 PPRETGSGGGVAT--STIYTVPRPPRGPEQTLDKPDSLPASRELPPGPTPVPPGGFRGAS 113
Query: 133 PPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPSNPGSPPS 192
P + ++ P Q P I + G S+ + S P S
Sbjct: 114 SPRLGADSTSPRFLYQ------VNFPVILAPIGESNSSSEELSEEE----EHSRPPPSES 163
Query: 193 PSTSQSGTPSTPNENSSPNELSPPSNSKSPTSKSSPEESSSSSHSNSKKTPTSSSGHSSD 252
G P S + S T K++ + S S+ S S +
Sbjct: 164 LKVKNGGK-VYPKGFSKH-KTHKRSEFSGLTKKAARKRKGSFVFKPSQLKELSGSLKNLL 221
Query: 253 STKGSSSNDDQA 264
S+ D
Sbjct: 222 HLDDSAETDPAT 233
|
Length = 580 |
| >gnl|CDD|218107 pfam04484, DUF566, Family of unknown function (DUF566) | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 37/163 (22%), Positives = 52/163 (31%), Gaps = 26/163 (15%)
Query: 70 PASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDG 129
AS P +S S S P PAS PP+S P + S SS
Sbjct: 13 DASSPRSSSRRRLSSSFLSTSASSRPRRLNAPAS-----PPSSSPARNTSSSSSFGLSK- 66
Query: 130 GASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPSNPGS 189
+ G+ S+ SP G S + S T +
Sbjct: 67 ---------QRPSSLSRGRLSSRFVSPSRGSPSAAASLNGSLATASTS-----------G 106
Query: 190 PPSPSTSQSGTPSTPNENSSPNELSPPSNSKSPTSKSSPEESS 232
SPS S+ T S + + P+ LS ++ K S E +
Sbjct: 107 SSSPSRSRRTTSSDLSSGNGPSVLSFMADVKRGKKGPSKIEDA 149
|
Family of related proteins that is plant specific. Length = 313 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 30/92 (32%), Positives = 47/92 (51%), Gaps = 9/92 (9%)
Query: 368 IGEGGFGCVYKGN------LPEGKVVAVKQLKSGSGQGE-REFRAEVEIISRV-HHRHLV 419
+G G FG V + + + VAVK LK G+ E R +E++I+ + HH ++V
Sbjct: 15 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 74
Query: 420 SLVGYCISEKNRLL-IYEFVPNNNLEHHLHGK 450
+L+G C L+ I EF NL ++L K
Sbjct: 75 NLLGACTKPGGPLMVIVEFCKFGNLSNYLRSK 106
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|234938 PRK01297, PRK01297, ATP-dependent RNA helicase RhlB; Provisional | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.001
Identities = 11/65 (16%), Positives = 22/65 (33%), Gaps = 1/65 (1%)
Query: 91 PGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPP-PEQSKNSPPAPPGQA 149
P +PP + + +PPP + + ++P A P ++ + P
Sbjct: 13 EAEQPAPAPPSPAAAPAPPPPAKTAAPATKAAAPAAAAPRAEKPKKDKPRRERKPKPASL 72
Query: 150 STPPD 154
D
Sbjct: 73 WKLED 77
|
Length = 475 |
| >gnl|CDD|227505 COG5178, PRP8, U5 snRNP spliceosome subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 0.001
Identities = 16/32 (50%), Positives = 20/32 (62%), Gaps = 2/32 (6%)
Query: 61 STTPAASPPPASPPPASPPPASPPPAASPPPG 92
++ P +PPP PPP PP+ PPP PPPG
Sbjct: 2 ASLPPGNPPPPPPPPGFEPPSQPPP--PPPPG 31
|
Length = 2365 |
| >gnl|CDD|240289 PTZ00144, PTZ00144, dihydrolipoamide succinyltransferase; Provisional | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 0.001
Identities = 17/89 (19%), Positives = 24/89 (26%), Gaps = 15/89 (16%)
Query: 20 LGERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPASPPPASPP 79
L E P A + + + T P + P PPA+
Sbjct: 115 LSEIDTGGAPPAAAPAAAAAAKAEKTTPEK---------------PKAAAPTPEPPAASK 159
Query: 80 PASPPPAASPPPGSPPPASPPPASGSASP 108
P P A P P P P + +
Sbjct: 160 PTPPAAAKPPEPAPAAKPPPTPVARADPR 188
|
Length = 418 |
| >gnl|CDD|220749 pfam10428, SOG2, RAM signalling pathway protein | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 25/119 (21%), Positives = 44/119 (36%), Gaps = 11/119 (9%)
Query: 133 PPPEQSKNSPPAPPGQASTP-------PDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPS 185
PP Q + +S P + +G S+ + S T PS
Sbjct: 149 GPPLQHRKRDAVTASPSSMIARNTPISDRLRPRSVTPTRGRRPSSSPRSLSNPTTLESPS 208
Query: 186 NPGSP---PSPSTSQSGTPSTPNENSSPNELSPPSNSKSPTSK-SSPEESSSSSHSNSK 240
N P P ++ + ST + +++ + +S + +S S S+P SSS + S
Sbjct: 209 NLQVTTDVPPPYSNGTSRSSTMSSSANLSIISSLATPRSGESFRSTPTSGSSSINPVSG 267
|
SOG2 proteins in Saccharomyces cerevisiae are involved in cell separation and cytokinesis. Length = 419 |
| >gnl|CDD|220749 pfam10428, SOG2, RAM signalling pathway protein | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 21/127 (16%), Positives = 37/127 (29%), Gaps = 9/127 (7%)
Query: 98 SPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPP 157
S A S + P D ++ P +S S P
Sbjct: 146 SSLGPPLQHRKRDAVTASPSSMIARNTPISDRLRPRSVTPTRGRRP----SSSPRSLSNP 201
Query: 158 PGIQSNQGNPVPSNGTT-----DSRDTKWAPPSNPGSPPSPSTSQSGTPSTPNENSSPNE 212
++S V ++ SR + + +N S +T +SG S +
Sbjct: 202 TTLESPSNLQVTTDVPPPYSNGTSRSSTMSSSANLSIISSLATPRSGESFRSTPTSGSSS 261
Query: 213 LSPPSNS 219
++P S
Sbjct: 262 INPVSGL 268
|
SOG2 proteins in Saccharomyces cerevisiae are involved in cell separation and cytokinesis. Length = 419 |
| >gnl|CDD|220749 pfam10428, SOG2, RAM signalling pathway protein | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 30/122 (24%), Positives = 39/122 (31%), Gaps = 7/122 (5%)
Query: 141 SPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPSNPGSPPSPSTSQSGT 200
S PP Q N S+ T P SP + + T
Sbjct: 146 SSLGPPLQHRKRDAVTASPSSMIARNTPISDRLRPRSVT---PTRGRRPSSSPRSLSNPT 202
Query: 201 PSTPNEN--SSPNELSPPSNSKSPTSKSSPEESSSSSHSNSKKTPTSSSGHSSDSTKGSS 258
N + + P SN S +S S S++ S +S TP S S T GSS
Sbjct: 203 TLESPSNLQVTTDVPPPYSNGTSRSSTMSS--SANLSIISSLATPRSGESFRSTPTSGSS 260
Query: 259 SN 260
S
Sbjct: 261 SI 262
|
SOG2 proteins in Saccharomyces cerevisiae are involved in cell separation and cytokinesis. Length = 419 |
| >gnl|CDD|220603 pfam10152, DUF2360, Predicted coiled-coil domain-containing protein (DUF2360) | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.001
Identities = 15/55 (27%), Positives = 19/55 (34%)
Query: 64 PAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRS 118
P P P A PPP + A+ PP + + PPA P P
Sbjct: 48 PGLEDVTVQTTPPPPASAITNGGPPPPPPARAEAASPPPPEAPAEPPAEPEPEAP 102
|
This is the conserved 140 amino acid region of a family of proteins conserved from nematodes to humans. One C. elegans member is annotated as a Daf-16-dependent longevity protein 1 but this could not be confirmed. The function is unknown. Length = 147 |
| >gnl|CDD|236712 PRK10547, PRK10547, chemotaxis protein CheA; Provisional | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 0.001
Identities = 10/55 (18%), Positives = 12/55 (21%)
Query: 68 PPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQS 122
+ P + SP PP A SES S
Sbjct: 225 ETAVAAPQEKAEETTEVVEVSPKISVPPVLKLAAEQAPAGRVEREKTARSSESTS 279
|
Length = 670 |
| >gnl|CDD|237866 PRK14952, PRK14952, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 0.001
Identities = 18/53 (33%), Positives = 24/53 (45%), Gaps = 3/53 (5%)
Query: 70 PASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQS 122
PA+ +P A P AA+P P P P P +P PAS P + +S
Sbjct: 388 PANLLHNAPQAAPAPSAAAPEPKHQPAPEPRPV---LAPTPASGEPNAAAVRS 437
|
Length = 584 |
| >gnl|CDD|177328 PHA01929, PHA01929, putative scaffolding protein | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.001
Identities = 25/105 (23%), Positives = 29/105 (27%), Gaps = 3/105 (2%)
Query: 11 PVANNASSGLGERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAASPPP 70
GL A PPA A T P + P G P P P
Sbjct: 3 QNEQQLPPGLAGL--VANVPPAAA-PTPQPNPVIQPQAPVQPGQPGAPQQLAIPTQQPQP 59
Query: 71 ASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPP 115
+P PA P P + P + PPPA P
Sbjct: 60 VPTSAMTPHVVQQAPAQPAPAAPPAAGAALPEALEVPPPPAFTPN 104
|
Length = 306 |
| >gnl|CDD|227430 COG5099, COG5099, RNA-binding protein of the Puf family, translational repressor [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 0.001
Identities = 47/251 (18%), Positives = 74/251 (29%), Gaps = 28/251 (11%)
Query: 31 PAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPA---- 86
+ A + K P P +N+ + S+ +S P + +S
Sbjct: 137 SSTASSMFNSNKLPLPNPNHSNSATTNQSGSSFINTPASSSSQPLTNLVVSSIKRFPYLT 196
Query: 87 ASPPPGS--PPPASP-PPASGSASP---PPASPPPTRSESQSSPPPGDGGASPPPEQSKN 140
+ P + P+S AS SP PP + P S S P P + +N
Sbjct: 197 SLSPFFNYLIDPSSDSATASADTSPSFNPPPNLSPNNLFSTSDLSPL-----PDTQSVEN 251
Query: 141 SPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPSNPGSPPSPSTSQSGT 200
+ + S + S + N N S + + S +G+
Sbjct: 252 NIILNSSSSINELTSIYGSVPSIR-NLRGLNSALVSFLNVSSSSLAFSALNGKEVSPTGS 310
Query: 201 PST-----PNENSSPNELSPPSNSKSPTSKSSPEESSSSSHSNSKKTPTSSSG----HSS 251
PST SSPN L T + P+ S + T T S
Sbjct: 311 PSTRSFARVLPKSSPNNLLTE---ILTTGVNPPQSLPSLLNPVFLSTSTGFSLTNLSGYL 367
Query: 252 DSTKGSSSNDD 262
+ K N
Sbjct: 368 NPNKNLKKNTL 378
|
Length = 777 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.001
Identities = 44/208 (21%), Positives = 78/208 (37%), Gaps = 60/208 (28%)
Query: 483 IHRDIKSANILVDDEFEAQVADFGLA---------------------------KLNDTTQ 515
IHRDIK NIL+D + ++ DFGL + D
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 516 THVSTRV-------------------MGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELI 556
R+ +GT Y+APE T D +S GV+L E++
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
Query: 557 TGRKPVDPTQPLGDE-SLVEWARPVLV--RAIETGDLSEIV-------DPRLEKHYVES- 605
G+ P PL + ++ W + + +A + + S+++ + RL K+ +
Sbjct: 243 VGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNGADEI 302
Query: 606 ---EMFRMIEAAAACVRHSGPKRPRMVQ 630
F+ I+ ++ + S P P++
Sbjct: 303 KAHPFFKTIDFSSDLRQQSAPYIPKITH 330
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|237802 PRK14723, flhF, flagellar biosynthesis regulator FlhF; Provisional | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 0.001
Identities = 12/45 (26%), Positives = 16/45 (35%)
Query: 63 TPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSAS 107
AAS +PP +P PA+ A PA+ P
Sbjct: 50 AVAASAQAYAPPAPAPLPAALVAPAPAAASIAAPAAVPAPGAIGD 94
|
Length = 767 |
| >gnl|CDD|217835 pfam03999, MAP65_ASE1, Microtubule associated protein (MAP65/ASE1 family) | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.001
Identities = 24/162 (14%), Positives = 48/162 (29%), Gaps = 9/162 (5%)
Query: 99 PPPASGSASPPPASPPPTRSESQSSPP----PGDGGASPPPEQSKNSPPAPPGQASTPPD 154
PP S S P++P R++ + + + S + +T
Sbjct: 459 PPYGSTE-SSVPSTPSTRRNDRNITSNTPSLKRTPNLTKSSLSQEASLISKS-TGNTHKH 516
Query: 155 SPPPGIQSNQGNPVPSNGTTDSRDTKWAPPSNPGSPPSPSTSQSGTPSTPNENSSPNELS 214
S P + + P S + + A + SP + S +P
Sbjct: 517 STPRRLTTLPKLPAASRSSKGNLIRSGANGNASSDLSSPGSINSKSPEHSVPLVRV--FD 574
Query: 215 PPSNSKSPTSKSSPEESSSSSHSNSKKTPTSSSGHSSDSTKG 256
+ + + S ++ K++P S S +T
Sbjct: 575 IHLRASTTKGRHSTPSTNEKKKRLLKRSP-LSPPKESVATTP 615
|
Length = 619 |
| >gnl|CDD|165527 PHA03269, PHA03269, envelope glycoprotein C; Provisional | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 0.001
Identities = 31/141 (21%), Positives = 47/141 (33%), Gaps = 12/141 (8%)
Query: 59 NNSTTPAASPPPASPPPASPPPASPPPAASPPPGS---PPPASPPPASGSASPPPASPPP 115
N + P S P PA +P + P PA P ++ S P A P
Sbjct: 16 NLIIANLNTNIPIPELHTSAATQKPDPAPAPHQAASRAPDPAVAPTSAASRKPDLAQAPT 75
Query: 116 TRSESQSSPPPGDGGAS---PPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNG 172
+ + P P A+ P P + AP A+ S Q + P++
Sbjct: 76 PAASEKFDPAPAPHQAASRAPDPAVAPQLAAAPKPDAAEAFTSAA------QAHEAPADA 129
Query: 173 TTDSRDTKWAPPSNPGSPPSP 193
T + K P ++ P P
Sbjct: 130 GTSAASKKPDPAAHTQHSPPP 150
|
Length = 566 |
| >gnl|CDD|220950 pfam11029, DAZAP2, DAZ associated protein 2 (DAZAP2) | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.001
Identities = 29/103 (28%), Positives = 36/103 (34%), Gaps = 16/103 (15%)
Query: 64 PAASPPPASPPPAS---PPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSES 120
P A P + S PP A P A++P PG P P + P + PP
Sbjct: 2 PDAPPAYSELYQPSYVVPPQAQMPQASAPYPG-PSMYLPMAQVMAVGPQSSHPPMAYYPI 60
Query: 121 QSSPPPG------------DGGASPPPEQSKNSPPAPPGQAST 151
+ PP D GA P + PP PPG A
Sbjct: 61 GAPPPVYPPGSTVLVQGGFDAGARFGPGTGSSIPPPPPGCAPN 103
|
DAZ associated protein 2 has a highly conserved sequence throughout evolution including a conserved polyproline region and several SH2/SH3 binding sites. It occurs as a single copy gene with a four-exon organisation and is located on chromosome 12. It encodes a ubiquitously expressed protein and binds to DAZ and DAZL1 through DAZ repeats. Length = 136 |
| >gnl|CDD|213844 TIGR03657, IsdB, heme uptake protein IsdB | Back alignment and domain information |
|---|
Score = 41.8 bits (97), Expect = 0.001
Identities = 32/150 (21%), Positives = 62/150 (41%), Gaps = 7/150 (4%)
Query: 106 ASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPG-IQSNQ 164
A+P + PP ESQ D P + +N + G+ TP P G ++S+
Sbjct: 478 ATPSKPTTPPVEKESQKQDSQKDDNKQSPSVEKENDASSESGKDKTPATKPAKGEVESSS 537
Query: 165 GNPVPSNGTTDSRDTKWAPPSNPGSPPSPSTSQSGTPSTPNENSSPNELSPPSNSKSPTS 224
P TT + A P+ S + Q+ S+ ++S+P + + N+ +
Sbjct: 538 TTPTKVVSTTQNV----AKPTTASSETTKDVVQTSAGSSEAKDSAPLQKANIKNTNDGHT 593
Query: 225 KSSPEESSSSSHSNSKKTPTSSSGHSSDST 254
+S + + ++ + +K P + + D T
Sbjct: 594 QS--QNNKNTQENKAKSLPQTGEESNKDMT 621
|
Isd proteins are iron-regulated surface proteins found in Bacillus, Staphylococcus and Listeria species and are responsible for heme scavenging from hemoproteins. The IsdB protein is only observed in Staphylococcus and consists of an N-terminal hydrophobic signal sequence, a pair of tandem NEAT (NEAr Transporter, pfam05031) domains which confers the ability to bind heme and a C-terminal sortase processing signal which targets the protein to the cell wall. IsdB is believed to make a direct contact with methemoglobin facilitating transfer of heme to IsdB. The heme is then transferred to other cell wall-bound NEAT domain proteins such as IsdA and IsdC. Length = 644 |
| >gnl|CDD|236792 PRK10905, PRK10905, cell division protein DamX; Validated | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 26/104 (25%), Positives = 39/104 (37%), Gaps = 8/104 (7%)
Query: 29 APPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPAAS 88
A A KT++ E+ T PA T P P + P PA+P +
Sbjct: 138 ASRQTA-KTQTAERPATTRPARKQAVIEPKKPQATAKTEPKPVAQTPKRTEPAAPVASTK 196
Query: 89 PPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGAS 132
P + PA A+ +P T S +Q++ P GG +
Sbjct: 197 APAATSTPAPKETAT-------TAPVQTASPAQTTATPAAGGKT 233
|
Length = 328 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.002
Identities = 20/72 (27%), Positives = 29/72 (40%), Gaps = 3/72 (4%)
Query: 102 ASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPA-PPGQASTPPDSPPPGI 160
G+ +PP A+ + ++PPP A P P + P A P A PP + P
Sbjct: 378 ERGAPAPPSAAWGAPTPAAPAAPPP--AAAPPVPPAAPARPAAARPAPAPAPPAAAAPPA 435
Query: 161 QSNQGNPVPSNG 172
+S S G
Sbjct: 436 RSADPAAAASAG 447
|
Length = 576 |
| >gnl|CDD|219321 pfam07174, FAP, Fibronectin-attachment protein (FAP) | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.002
Identities = 29/95 (30%), Positives = 35/95 (36%), Gaps = 8/95 (8%)
Query: 81 ASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKN 140
AS A P + PA PPP +A+ PA P PPP A P P+
Sbjct: 26 ASAVAIALPATANADPAPPPPPPSTAAAAPAPAAP--------PPPPPPAAPPAPQPDDP 77
Query: 141 SPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTD 175
+ PP A PPP + P P G D
Sbjct: 78 NAAPPPPPADPNAPPPPPVDPNAPPPPAPEPGRID 112
|
This family contains bacterial fibronectin-attachment proteins (FAP). Family members are rich in alanine and proline, are approximately 300 long, and seem to be restricted to mycobacteria. These proteins contain a fibronectin-binding motif that allows mycobacteria to bind to fibronectin in the extracellular matrix. Length = 297 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.002
Identities = 15/105 (14%), Positives = 27/105 (25%), Gaps = 6/105 (5%)
Query: 2 ANSAETPGPPVANNASSGLGERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNS 61
+ ++ P + + A P P D N+
Sbjct: 155 SQNSGQSVPLDTSTTTDPATTPAPAAPVDTTPTNSQTPAVATAPAPAVDPQ------QNA 208
Query: 62 TTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSA 106
+ + +P + P A+P P S P A +A
Sbjct: 209 VVAPSQANVDTAATPAPAAPATPDGAAPLPTDQAGVSTPAADPNA 253
|
Length = 331 |
| >gnl|CDD|184918 PRK14954, PRK14954, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.002
Identities = 23/77 (29%), Positives = 29/77 (37%), Gaps = 6/77 (7%)
Query: 16 ASSGLGERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPASPPP 75
A S G + KAP P+ P PA G +PA++P P PP
Sbjct: 381 APSPAGSPDVKKKAPEPDL-----PQPDRHPGPAKPEAPGARPAELPSPASAPTPEQQPP 435
Query: 76 ASPPPASPP-PAASPPP 91
+ PP P AS P
Sbjct: 436 VARSAPLPPSPQASAPR 452
|
Length = 620 |
| >gnl|CDD|236382 PRK09111, PRK09111, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 0.002
Identities = 16/79 (20%), Positives = 22/79 (27%), Gaps = 8/79 (10%)
Query: 84 PPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPP 143
PP+ G PP P A A+P + + P A P +
Sbjct: 391 PPSPGGGGGGPPGGGGAP---GAPAAAAAPGAAAAAPAAGGPAAALAAVPDA-----AAA 442
Query: 144 APPGQASTPPDSPPPGIQS 162
A A P + S
Sbjct: 443 AAAPPAPAAAPQPAVRLNS 461
|
Length = 598 |
| >gnl|CDD|235899 PRK06975, PRK06975, bifunctional uroporphyrinogen-III synthetase/uroporphyrin-III C-methyltransferase; Reviewed | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 0.002
Identities = 15/62 (24%), Positives = 22/62 (35%), Gaps = 9/62 (14%)
Query: 97 ASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSP 156
A +A+P P+ T + P A+P P PP +TPP+ P
Sbjct: 266 ADAAAQPATAAPAPSRMTDTNDSKSVTSQPAAAAAAPAP---------PPNPPATPPEPP 316
Query: 157 PP 158
Sbjct: 317 AR 318
|
Length = 656 |
| >gnl|CDD|223079 PHA03419, PHA03419, E4 protein; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.002
Identities = 23/99 (23%), Positives = 28/99 (28%), Gaps = 3/99 (3%)
Query: 64 PAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSES--- 120
P P + PPP P P PP PP + P +
Sbjct: 54 PTTPHPSSQPPPCPPSPGHPPQTNDTHEKDLALQPPPGGKKKEKKKKETEKPAQGGEKPD 113
Query: 121 QSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPG 159
Q G+G P + P PPG P PG
Sbjct: 114 QGPEAKGEGEGHEPEDPPPEDTPPPPGGEGEVEGGPSPG 152
|
Length = 200 |
| >gnl|CDD|237000 PRK11855, PRK11855, dihydrolipoamide acetyltransferase; Reviewed | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 0.002
Identities = 13/45 (28%), Positives = 19/45 (42%)
Query: 64 PAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASP 108
A + A+ P A+ PA+ AA P + P A+ A G
Sbjct: 77 AAGAAAAAAAPAAAAAPAAAAAAAPAPAAAAPAAAAAAAGGGVVE 121
|
Length = 547 |
| >gnl|CDD|152960 pfam12526, DUF3729, Protein of unknown function (DUF3729) | Back alignment and domain information |
|---|
Score = 38.5 bits (90), Expect = 0.002
Identities = 18/66 (27%), Positives = 19/66 (28%)
Query: 61 STTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSES 120
PP PP PP + P P P P P P A P P R
Sbjct: 41 PPVGDPRPPVVDTPPPVSAVWVLPPPSEPAAPPPDPEPPVPGPAGPPSPLAPPAPARKPP 100
Query: 121 QSSPPP 126
P P
Sbjct: 101 LPPPRP 106
|
This family of proteins is found in viruses. Proteins in this family are typically between 145 and 1707 amino acids in length. The family is found in association with pfam01443, pfam01661, pfam05417, pfam01660, pfam00978. There is a single completely conserved residue L that may be functionally important. Length = 115 |
| >gnl|CDD|227665 COG5373, COG5373, Predicted membrane protein [Function unknown] | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.002
Identities = 24/97 (24%), Positives = 33/97 (34%), Gaps = 12/97 (12%)
Query: 20 LGERKEEAKAPP--APAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPASPPPAS 77
L E A P AE+ +PE P + +P PP P +
Sbjct: 35 LRSLVAEGAAGPVAKAAEQMAAPEAAEAAPLPA------AAESIASPEVPPPV----PPA 84
Query: 78 PPPASPPPAASPPPGSPPPASPPPASGSASPPPASPP 114
P PAA P P P++ P + P A+ P
Sbjct: 85 PAQEGEAPAAEQPSAVPAPSAAPAPAEPVEPSLAANP 121
|
Length = 931 |
| >gnl|CDD|227665 COG5373, COG5373, Predicted membrane protein [Function unknown] | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.002
Identities = 19/80 (23%), Positives = 26/80 (32%), Gaps = 3/80 (3%)
Query: 62 TTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQ 121
AA P A P S PPP P PA A A+ P++ P +
Sbjct: 52 EQMAA-PEAAEAAPLPAAAESIASPEVPPPVPPAPAQEGEA--PAAEQPSAVPAPSAAPA 108
Query: 122 SSPPPGDGGASPPPEQSKNS 141
+ P A+ P +
Sbjct: 109 PAEPVEPSLAANPFAAAIEW 128
|
Length = 931 |
| >gnl|CDD|237011 PRK11892, PRK11892, pyruvate dehydrogenase subunit beta; Provisional | Back alignment and domain information |
|---|
Score = 40.7 bits (96), Expect = 0.002
Identities = 16/61 (26%), Positives = 23/61 (37%), Gaps = 6/61 (9%)
Query: 71 ASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGG 130
AS A+P A+ AA+P + A P PA+P +E + P G
Sbjct: 84 ASDAGAAPAAAAEAAAAAPAAAAAAAAKKAA------PAPAAPAAPAAEVAADPDIPAGT 137
Query: 131 A 131
Sbjct: 138 E 138
|
Length = 464 |
| >gnl|CDD|200219 TIGR02927, SucB_Actino, 2-oxoglutarate dehydrogenase, E2 component, dihydrolipoamide succinyltransferase | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 35/190 (18%), Positives = 68/190 (35%), Gaps = 4/190 (2%)
Query: 58 GNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTR 117
G + P A P A+P P +P PA +P +P PA+P + P
Sbjct: 77 GEPGEAGSEPAPAAPEPEAAPEPEAPAPAPTPAAEAPAPAAPQAGGSGEATEVKMPELGE 136
Query: 118 SESQSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPG----IQSNQGNPVPSNGT 173
S ++ + E + + T SP G I++ + + V
Sbjct: 137 SVTEGTVTSWLKAVGDTVEVDEPLLEVSTDKVDTEIPSPVAGTLLEIRAPEDDTVEVGTV 196
Query: 174 TDSRDTKWAPPSNPGSPPSPSTSQSGTPSTPNENSSPNELSPPSNSKSPTSKSSPEESSS 233
A P+ P +P+ S++G+ P+ + +P + +P + +++
Sbjct: 197 LAIIGDANAAPAEPAEEEAPAPSEAGSEPAPDPAARAPHAAPDPPAPAPAPAKTAAPAAA 256
Query: 234 SSHSNSKKTP 243
+ S+ P
Sbjct: 257 APVSSGDSGP 266
|
This model represents an Actinobacterial clade of E2 enzyme, a component of the 2-oxoglutarate dehydrogenase complex involved in the TCA cycle. These proteins have multiple domains including the catalytic domain (pfam00198), one or two biotin domains (pfam00364) and an E3-component binding domain (pfam02817). Length = 579 |
| >gnl|CDD|165468 PHA03201, PHA03201, uracil DNA glycosylase; Provisional | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 28/109 (25%), Positives = 37/109 (33%), Gaps = 5/109 (4%)
Query: 84 PPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPP 143
+ SP P P P S P PP+ + PPPG P + P
Sbjct: 4 ARSRSPSPPRRPSPPRPTPPRSPDASPEETPPSPPGPGAEPPPGRAAGPAAPRRRPRGCP 63
Query: 144 APPGQASTPPDSPPPGI-QSNQGNPVPSNGTTDSR----DTKWAPPSNP 187
A +S+ P PP G+ + P P + T R W P P
Sbjct: 64 AGVTFSSSAPPRPPLGLDDAPAATPPPLDWTEFRRRFLVGDAWRPLLEP 112
|
Length = 318 |
| >gnl|CDD|215130 PLN02217, PLN02217, probable pectinesterase/pectinesterase inhibitor | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 28/122 (22%), Positives = 43/122 (35%), Gaps = 24/122 (19%)
Query: 91 PGSPPPASP-----PPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAP 145
PG P P P S +++P ++ + S SP ++ PP SPPA
Sbjct: 551 PGKGVPYIPGLFAGNPGSTNSTPTGSAASSNTTFSSDSPSTVVAPSTSPPAGHLGSPPAT 610
Query: 146 PGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPSNPGSPPSPSTSQSGTPSTPN 205
P + +P SPP +P + P SP S S ++P
Sbjct: 611 PSKIVSPSTSPP-------------------ASHLGSPSTTPSSPESSIKVASTETASPE 651
Query: 206 EN 207
+
Sbjct: 652 SS 653
|
Length = 670 |
| >gnl|CDD|240289 PTZ00144, PTZ00144, dihydrolipoamide succinyltransferase; Provisional | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 0.002
Identities = 15/63 (23%), Positives = 24/63 (38%)
Query: 63 TPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQS 122
AA+ + P A P + +PP A+ PP A+ PP +P ++
Sbjct: 131 AAAAAKAEKTTPEKPKAAAPTPEPPAASKPTPPAAAKPPEPAPAAKPPPTPVARADPRET 190
Query: 123 SPP 125
P
Sbjct: 191 RVP 193
|
Length = 418 |
| >gnl|CDD|220603 pfam10152, DUF2360, Predicted coiled-coil domain-containing protein (DUF2360) | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 0.002
Identities = 9/56 (16%), Positives = 15/56 (26%), Gaps = 3/56 (5%)
Query: 105 SASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGI 160
+ P P + PPP + P + P P++P
Sbjct: 54 TVQTTPPPPASAITNGGPPPPPPARAEAASPPPPEAPAEPPAEP---EPEAPAENT 106
|
This is the conserved 140 amino acid region of a family of proteins conserved from nematodes to humans. One C. elegans member is annotated as a Daf-16-dependent longevity protein 1 but this could not be confirmed. The function is unknown. Length = 147 |
| >gnl|CDD|233366 TIGR01348, PDHac_trf_long, pyruvate dehydrogenase complex dihydrolipoamide acetyltransferase, long form | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 17/59 (28%), Positives = 26/59 (44%), Gaps = 3/59 (5%)
Query: 58 GNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASP---PPASP 113
ST A P ++ P A P A+ P A+ P + A P +G+ +P A+P
Sbjct: 191 VAGSTPATAPAPASAQPAAQSPAATQPEPAAAPAAAKAQAPAPQQAGTQNPAKVDHAAP 249
|
This model describes a subset of pyruvate dehydrogenase complex dihydrolipoamide acetyltransferase specifically close by both phylogenetic and per cent identity (UPGMA) trees. Members of this set include two or three copies of the lipoyl-binding domain. E. coli AceF is a member of this model, while mitochondrial and some other bacterial forms belong to a separate model [Energy metabolism, Pyruvate dehydrogenase]. Length = 546 |
| >gnl|CDD|237866 PRK14952, PRK14952, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 15/41 (36%), Positives = 18/41 (43%)
Query: 64 PAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASG 104
PA A +P A+P P P P P +P PASG
Sbjct: 388 PANLLHNAPQAAPAPSAAAPEPKHQPAPEPRPVLAPTPASG 428
|
Length = 584 |
| >gnl|CDD|237802 PRK14723, flhF, flagellar biosynthesis regulator FlhF; Provisional | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.002
Identities = 14/47 (29%), Positives = 19/47 (40%), Gaps = 3/47 (6%)
Query: 70 PASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPT 116
AS +PP +P P +P PA+ S + P A P P
Sbjct: 47 DLGAVAASAQAYAPP---APAPLPAALVAPAPAAASIAAPAAVPAPG 90
|
Length = 767 |
| >gnl|CDD|165527 PHA03269, PHA03269, envelope glycoprotein C; Provisional | Back alignment and domain information |
|---|
Score = 41.3 bits (96), Expect = 0.002
Identities = 36/126 (28%), Positives = 47/126 (37%), Gaps = 14/126 (11%)
Query: 28 KAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPAA 87
K PAPA + P PA + + A +P PA+ P PA A+
Sbjct: 39 KPDPAPAPHQAASRA---PDPAVAPTSAA--SRKPDLAQAPTPAASEKFDPAPAPHQAAS 93
Query: 88 SPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPPG 147
+P PA P + + P A S +Q+ P D G S SK PA
Sbjct: 94 R----APDPAVAPQLAAAPKPDAAEAFT--SAAQAHEAPADAGTS---AASKKPDPAAHT 144
Query: 148 QASTPP 153
Q S PP
Sbjct: 145 QHSPPP 150
|
Length = 566 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.002
Identities = 45/241 (18%), Positives = 90/241 (37%), Gaps = 51/241 (21%)
Query: 355 LMEITNGFARENVIGEGGFGCVYKGNLPEGKVVAVKQ--LKSGSGQGEREFRAEVEIISR 412
L I F + + K P +VAVK+ L S S + + + E+ +
Sbjct: 3 LTLIGKCF------EDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQ 55
Query: 413 VHHRHLVSLVGYCISEKNRL-LIYEFVPNNNLEHHLHGKGQPVLEWT-----KRVKIAL- 465
+ H +++ V + L ++ + +G + +L+ + IA
Sbjct: 56 LQHPNILPYV-TSFIVDSELYVVSPLMA--------YGSCEDLLKTHFPEGLPELAIAFI 106
Query: 466 --GAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVA-----------DFGLAKLND 512
L Y+H IHR +K+++IL+ + + ++ ++D
Sbjct: 107 LKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD 163
Query: 513 TTQTHVSTRVMGTFGYLAPE--YASSGKLTDRSDVFSFGVVLLELITGRKP---VDPTQP 567
++ V +L+PE + ++SD++S G+ EL G P + TQ
Sbjct: 164 FPKSSVKN-----LPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM 218
Query: 568 L 568
L
Sbjct: 219 L 219
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|183854 PRK13042, PRK13042, superantigen-like protein; Reviewed | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 19/65 (29%), Positives = 31/65 (47%), Gaps = 3/65 (4%)
Query: 60 NSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSE 119
N+TTP+++ A P S PP++ A P + P S + +P +P T+ E
Sbjct: 29 NATTPSSTKVEA---PQSTPPSTKVEAPQSKPNATTPPSTKVEAPQQTPNATTPSSTKVE 85
Query: 120 SQSSP 124
+ SP
Sbjct: 86 TPQSP 90
|
Length = 291 |
| >gnl|CDD|113398 pfam04625, DEC-1_N, DEC-1 protein, N-terminal region | Back alignment and domain information |
|---|
Score = 40.9 bits (95), Expect = 0.002
Identities = 22/50 (44%), Positives = 27/50 (54%), Gaps = 1/50 (2%)
Query: 65 AASPPPA-SPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASP 113
AA+P PA +P PA+ PPA+P PAA P P A P G A+ A
Sbjct: 105 AAAPVPAPAPAPAAAPPAAPAPAADTPAAPIPDAVQPAILGQAALQNAFT 154
|
The defective chorion-1 gene (dec-1) in Drosophila encodes follicle cell proteins necessary for proper eggshell assembly. Multiple products of the dec-1 gene are formed by alternative RNA splicing and proteolytic processing. Cleavage products include S80 (80 kDa) which is incorporated into the eggshell, and further proteolysis of S80 gives S60 (60 kDa). Length = 407 |
| >gnl|CDD|218440 pfam05110, AF-4, AF-4 proto-oncoprotein | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.002
Identities = 47/218 (21%), Positives = 69/218 (31%), Gaps = 18/218 (8%)
Query: 45 TPPPADNNNNGGGGNNSTTPAASPPPASPPPASPP-PASPPPAASPPPGSPPPASPPPAS 103
+ PP G S+ P PPP S P A P S PA
Sbjct: 467 SNPPIKQPMEKEGKVKSSGSQYHPESKEPPPKSSSKEKRRPRTAQKGPESGRGKQKSPAQ 526
Query: 104 GSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSN 163
A P + + + GD PE S P S+ P +
Sbjct: 527 SEAPPQRRTVGKKQPKKPEKASAGDERTGLRPE----SEPGTLPYGSSVQTPPDRPKAAT 582
Query: 164 QGNPVPSNGTTDSRDTKWAPPSNP------GSPPSPSTSQSGTPSTPNENSSPNELSPPS 217
+G+ PS ++ K + P S+ + + + SP + S P
Sbjct: 583 KGSRKPSP----RKEPKSSVPPAAEKRKYKSPSKIVPKSREFIETDSSSSDSPEDESLPP 638
Query: 218 NSKSPTSKSSPEESSSSSHSNSKKTPTSSSGHSSDSTK 255
+S+SP + E S S S SS G +D +K
Sbjct: 639 SSQSP---GNTESSKESCASLRTPVCRSSVGSQNDLSK 673
|
This family consists of AF4 (Proto-oncogene AF4) and FMR2 (Fragile X E mental retardation syndrome) nuclear proteins. These proteins have been linked to human diseases such as acute lymphoblastic leukaemia and mental retardation. The family also contains a Drosophila AF4 protein homologue Lilliputian which contains an AT-hook domain. Lilliputian represents a novel pair-rule gene that acts in cytoskeleton regulation, segmentation and morphogenesis in Drosophila. Length = 1154 |
| >gnl|CDD|218440 pfam05110, AF-4, AF-4 proto-oncoprotein | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 36/143 (25%), Positives = 52/143 (36%), Gaps = 12/143 (8%)
Query: 125 PPGDGGASPPPEQSKNSPPAPPGQASTPP--DSPPPGIQ----SNQGNPVPSNGTTDSRD 178
P G PP K+S AP Q S S G + + + + S
Sbjct: 714 PYKKG--VPPKPAEKDSLSAPKKQTSKTASEKSSSKGKRKHKNDEEADKIESKKQRLEEK 771
Query: 179 TKWAPPSNPGSPPSPSTSQSGTPSTPNENSSPNELSPPSNSKSPTSKSSPEESSSSSHSN 238
+ PS+ S S+++ S + N L PS+ S S S E S
Sbjct: 772 SSSCSPSSSSSHHHSSSNKESRKS--SRNKEEEMLPSPSSPLS--SSSPKPEHPSRKRPR 827
Query: 239 SKKTPTSSSGHSSDSTKGSSSND 261
++ +SSSG S S+ SSS
Sbjct: 828 RQEDTSSSSGPFSASSTKSSSKS 850
|
This family consists of AF4 (Proto-oncogene AF4) and FMR2 (Fragile X E mental retardation syndrome) nuclear proteins. These proteins have been linked to human diseases such as acute lymphoblastic leukaemia and mental retardation. The family also contains a Drosophila AF4 protein homologue Lilliputian which contains an AT-hook domain. Lilliputian represents a novel pair-rule gene that acts in cytoskeleton regulation, segmentation and morphogenesis in Drosophila. Length = 1154 |
| >gnl|CDD|218440 pfam05110, AF-4, AF-4 proto-oncoprotein | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 46/202 (22%), Positives = 67/202 (33%), Gaps = 29/202 (14%)
Query: 74 PPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGG--- 130
A+ P S S P +P PA+ S S+S S + SES+SS +
Sbjct: 371 EQATEKPPSRNTPPSAPSSNPEPAASSSGSSSSSSGSESSSGSDSESESSSSDSEENEPP 430
Query: 131 --ASPPPEQ------------SKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDS 176
ASP PE +K +P + S PP Q P+ G S
Sbjct: 431 RTASPEPEPPSTNKWQLDNWLNKVNPHKVSP--AESVSSNPPIKQ-----PMEKEGKVKS 483
Query: 177 RDTKWAPPSNPGSPPSPSTSQSGTPSTPNENSSPNELSPPSNSKSPTSKSSPEESSSSSH 236
P + PP S+ + P T + KSP +P + +
Sbjct: 484 -SGSQYHPESKEPPPKSSSKEKRRPRTAQKGPESGRGK----QKSPAQSEAPPQRRTVGK 538
Query: 237 SNSKKTPTSSSGHSSDSTKGSS 258
KK +S+G + S
Sbjct: 539 KQPKKPEKASAGDERTGLRPES 560
|
This family consists of AF4 (Proto-oncogene AF4) and FMR2 (Fragile X E mental retardation syndrome) nuclear proteins. These proteins have been linked to human diseases such as acute lymphoblastic leukaemia and mental retardation. The family also contains a Drosophila AF4 protein homologue Lilliputian which contains an AT-hook domain. Lilliputian represents a novel pair-rule gene that acts in cytoskeleton regulation, segmentation and morphogenesis in Drosophila. Length = 1154 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.002
Identities = 34/109 (31%), Positives = 55/109 (50%), Gaps = 15/109 (13%)
Query: 463 IALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRV 522
I GA +GL YLH++ + IHR+IK+++IL+ + V+ GL+ L + +V
Sbjct: 106 ILFGALRGLNYLHQNGY---IHRNIKASHILISGD--GLVSLSGLSHLYSLVRNGQKAKV 160
Query: 523 MGTFG--------YLAPEYASSG--KLTDRSDVFSFGVVLLELITGRKP 561
+ F +L+PE +SD++S G+ EL TGR P
Sbjct: 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|237082 PRK12373, PRK12373, NADH dehydrogenase subunit E; Provisional | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 32/145 (22%), Positives = 47/145 (32%), Gaps = 9/145 (6%)
Query: 8 PGPPVANNAS---SGLGERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTP 64
PGP + AS GL EEA A K + + T D G
Sbjct: 179 PGPQIGRYASEPAGGLTSLTEEAGKARYNASKALAEDIGDTVKRID------GTEVPLLA 232
Query: 65 AASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSP 124
A PP+ A + P +P A+ +A P A P + ++ +P
Sbjct: 233 PWQGDAAPVPPSEAARPKSADAETNAALKTPATAPKAAAKNAKAPEAQPVSGTAAAEPAP 292
Query: 125 PPGDGGASPPPEQSKNSPPAPPGQA 149
A+ + + P P G A
Sbjct: 293 KEAAKAAAAAAKPALEDKPRPLGIA 317
|
Length = 400 |
| >gnl|CDD|218108 pfam04487, CITED, CITED | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.002
Identities = 23/109 (21%), Positives = 35/109 (32%), Gaps = 7/109 (6%)
Query: 55 GGGGNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPP---ASPPPASGSASPPPA 111
GGG +++ S P + P P P P P S
Sbjct: 49 PGGGMDASGRPRSAMSGPMGGGHPHQSMPAYMMFNPSSKPQPFMLVPGPQLMASMQLQKL 108
Query: 112 SPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGI 160
+ T+ + + P G G P+Q + PPG P + PP +
Sbjct: 109 N---TQYQGHAGAPAGHPG-GGGPQQFRPGAGQPPGMQHMPAPALPPNV 153
|
CITED, CBP/p300-interacting transactivator with ED-rich tail, are characterized by a conserved 32-amino acid sequence at the C-terminus. CITED proteins do not bind DNA directly and are thought to function as transcriptional co-activators. Length = 206 |
| >gnl|CDD|223003 PHA03169, PHA03169, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.002
Identities = 42/189 (22%), Positives = 63/189 (33%), Gaps = 15/189 (7%)
Query: 15 NASSGLGERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPASPP 74
S GE++E + P+ + +P + G +T+ ++ PAS
Sbjct: 76 AEESRHGEKEERGQGGPSGSGSESVGSPTPSPSGSAEELASGLSPENTSGSSPESPASHS 135
Query: 75 PASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPP 134
P PP+ P P PP S P+ S P + SP + S P
Sbjct: 136 PPPSPPSHPGPHEPAPPESHNPSPNQQPSSFLQP----------SHEDSPEEPEPPTSEP 185
Query: 135 PEQSKNSPPAPPGQASTPPDSP-----PPGIQSNQGNPVPSNGTTDSRDTKWAPPSNPGS 189
S P + +S PP SP P + Q P P+ + + P G
Sbjct: 186 EPDSPGPPQSETPTSSPPPQSPPDEPGEPQSPTPQQAPSPNTQQAVEHEDEPTEPEREGP 245
Query: 190 PPSPSTSQS 198
P S S
Sbjct: 246 PFPGHRSHS 254
|
Length = 413 |
| >gnl|CDD|227709 COG5422, ROM1, RhoGEF, Guanine nucleotide exchange factor for Rho/Rac/Cdc42-like GTPases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 42/208 (20%), Positives = 64/208 (30%), Gaps = 20/208 (9%)
Query: 58 GNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSAS------PPPA 111
G + A PP +P + + + G + +
Sbjct: 18 GAPRKSDAFVSKQLLPPRRLQRKLNPISIRNGADNDIINSESKESFGKYALGHQIFSSFS 77
Query: 112 SPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSN 171
S P S+ P SP S +S + G +P S NP +
Sbjct: 78 SSPKLFQRRNSAGPITH---SPSATSSTSSLNSNDGDQFSPAS------DSLSFNPSSTQ 128
Query: 172 GTTDSRDTKWAPPSNPGSPPSPSTSQSGTPSTPNENSSPNELSPPSNSKSPTSKSSPEES 231
DS +P +P PS+S GT P + N S++ +P ++S E
Sbjct: 129 SRKDSGPGDGSPVQKRKNPLLPSSSTHGTHP-PIVFTDNN----GSHAGAPNARSRKEIP 183
Query: 232 SSSSHSNSKKTPTSSSGHSSDSTKGSSS 259
S S S +P SS T S
Sbjct: 184 SLGSQSMQLPSPHFRQKFSSSDTSNGFS 211
|
Length = 1175 |
| >gnl|CDD|217310 pfam02993, MCPVI, Minor capsid protein VI | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.002
Identities = 25/106 (23%), Positives = 33/106 (31%), Gaps = 11/106 (10%)
Query: 22 ERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPA 81
E+ + P E P + + P P + PAA PP+ P PA
Sbjct: 107 EKVLGEEEPAPQEETVADPIQALQPRPRPD------VEEVLVPAAPEPPSYEETIKPGPA 160
Query: 82 -SPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPP 126
P S P +P + PPA PP Q S
Sbjct: 161 PVEEPVDSMAIAVPAIDTP----VTLELPPAPQPPPPVVPQPSTMV 202
|
This minor capsid protein may act as a link between the external capsid and the internal DNA-protein core. The C-terminal 11 residues may function as a protease cofactor leading to enzyme activation. Length = 238 |
| >gnl|CDD|218754 pfam05795, Plasmodium_Vir, Plasmodium vivax Vir protein | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 24/149 (16%), Positives = 46/149 (30%), Gaps = 14/149 (9%)
Query: 193 PSTSQSGTPSTPNENSSPNELSPPSNSKSPTSKSSPEESSSSSHSNSKKT-PTSSSGHSS 251
+ + + S + SS E SS S +SS ++
Sbjct: 205 NESKKEKSKEGGAAEGDEKLELLEEESSELETSSSAEGGPSSEPSLPGSPSSGASSLNTL 264
Query: 252 DSTKGSSSNDDQAIIGATAAGVVLIVLI------AIFFLARGRRRRRDAYATHYMPPPNN 305
+T +D + + AG+ LI + +L + R++ NN
Sbjct: 265 TTTPIEKISDIFTGVVISVAGISLIFYLLYKFTPLGSWLRKKLGRKKKIMN-------NN 317
Query: 306 FNEKTVDTYYGSQTPQMHSYGSQRGVGYH 334
E+ Y ++ S+ + YH
Sbjct: 318 NEEEYELELYAYESENPSLNSSRYNISYH 346
|
This family consists of several Vir proteins specific to Plasmodium vivax. The vir genes are present at about 600-1,000 copies per haploid genome and encode proteins that are immunovariant in natural infections, indicating that they may have a functional role in establishing chronic infection through antigenic variation. Length = 348 |
| >gnl|CDD|219404 pfam07415, Herpes_LMP2, Gammaherpesvirus latent membrane protein (LMP2) protein | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 22/108 (20%), Positives = 28/108 (25%), Gaps = 19/108 (17%)
Query: 46 PPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGS 105
P + G +N P++ P P P P P PP
Sbjct: 14 PRSHGGPDGDEGDSNPYYPSSF----GSSWDRPGP--PVPEDYDAPSHRPPPYGGSNGDR 67
Query: 106 ASPPPASPPPTRSESQS---SPPPGDGGASPPPEQSKNSPPAPPGQAS 150
P + S GG PPP P +P Q S
Sbjct: 68 HGG----YQPLGQQDPSLYAGLGQNGGGGLPPP------PYSPRDQGS 105
|
This family consists of several Gammaherpesvirus latent membrane protein (LMP2) proteins. Epstein-Barr virus is a human Gammaherpesvirus that infects and establishes latency in B lymphocytes in vivo. The latent membrane protein 2 (LMP2) gene is expressed in latently infected B cells and encodes two protein isoforms, LMP2A and LMP2B, that are identical except for an additional N-terminal 119 aa cytoplasmic domain which is present in the LMP2A isoform. LMP2A is thought to play a key role in either the establishment or the maintenance of latency and/or the reactivation of productive infection from the latent state. The significance of LMP2B and its role in pathogenesis remain unclear. Length = 489 |
| >gnl|CDD|218881 pfam06070, Herpes_UL32, Herpesvirus large structural phosphoprotein UL32 | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 41/249 (16%), Positives = 67/249 (26%), Gaps = 13/249 (5%)
Query: 10 PPVANNASSGLGERKEEAKAPPAPAE-KTESPEKKVTPPPADNNNNGGGGNNSTTPAASP 68
P + + E ++ + +E E + + + SP
Sbjct: 478 APASRLDDAKRPEVTATPESSGSDSEGGASGREDETSSDAESVVSIKELRPRIGFINKSP 537
Query: 69 PPASPPPASPPPASPPPAASP-PPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPG 127
PP SPP + ASP GSP P + P A R G
Sbjct: 538 PPKSPPKSRRTLIVALSLASPSTAGSPRPKPSLGKFVIGTDPFAFANTVRLTDNMRGGNG 597
Query: 128 DGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPSNP 187
G + P + + P PG P S+ V + + P
Sbjct: 598 VGSSVKPKGSASSKPLTGPGSDLKPATLNGKTPSSSL---VGAARNAGASSKVKIPSGLG 654
Query: 188 GSPPS-----PSTSQSGTPSTPNENSSPNELSPPSNSKSP---TSKSSPEESSSSSHSNS 239
G + T +T + +N + T +S + + +
Sbjct: 655 GFTSPISLLESALEDVLTSATSTPVKKNDPYLWDTNGEKAGGGTESASTTDVFQNFAGLN 714
Query: 240 KKTPTSSSG 248
KKTP
Sbjct: 715 KKTPVGGPF 723
|
The large phosphorylated protein (UL32-like) of herpes viruses is the polypeptide most frequently reactive in immuno-blotting analyses with antisera when compared with other viral proteins. Length = 777 |
| >gnl|CDD|184927 PRK14963, PRK14963, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 16/77 (20%), Positives = 19/77 (24%), Gaps = 3/77 (3%)
Query: 44 VTPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPP---PAASPPPGSPPPASPP 100
V PP + N S A A+ A P P PP P S
Sbjct: 353 VAPPAPAPADLTQRLNRLEKEVRSLRSAPTAAATAAGAPLPDFDPRPRGPPAPEPARSAE 412
Query: 101 PASGSASPPPASPPPTR 117
A + R
Sbjct: 413 APPLVAPAAAPAGLALR 429
|
Length = 504 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 0.003
Identities = 18/81 (22%), Positives = 29/81 (35%)
Query: 19 GLGERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPASPPPASP 78
GL ++ A A +P +PPPA + + T + PP + PP
Sbjct: 358 GLLPSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPV 417
Query: 79 PPASPPPAASPPPGSPPPASP 99
P P+ +PP +
Sbjct: 418 PAEPTEPSPTPPANAANAPPS 438
|
Length = 620 |
| >gnl|CDD|223033 PHA03291, PHA03291, envelope glycoprotein I; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.003
Identities = 26/121 (21%), Positives = 37/121 (30%), Gaps = 14/121 (11%)
Query: 75 PASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPP 134
PA A+PP GS PA P A P P + P P +
Sbjct: 167 PAEGTLAAPPLGEGSADGSCDPALPLSA------PRLGPADVFVPATPRPTPR---TTAS 217
Query: 135 PEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPSNPGSPPSPS 194
PE + P ++PP + P + P P +PP+ +
Sbjct: 218 PETT-----PTPSTTTSPPSTTIPAPSTTIAAPQAGTTPEAEGTPAPPTPGGGEAPPANA 272
Query: 195 T 195
T
Sbjct: 273 T 273
|
Length = 401 |
| >gnl|CDD|236940 PRK11633, PRK11633, cell division protein DedD; Provisional | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 0.003
Identities = 22/91 (24%), Positives = 29/91 (31%), Gaps = 5/91 (5%)
Query: 69 PPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGD 128
P P P A+ PP G A+ +G A+ P P + P
Sbjct: 47 PGDRDEPDMMPAATQALPTQPPEG----AAEAVRAGDAAAPSLDPATVAPPNTPVEPEPA 102
Query: 129 GGASPPPE-QSKNSPPAPPGQASTPPDSPPP 158
P P+ K P P Q P +P P
Sbjct: 103 PVEPPKPKPVEKPKPKPKPQQKVEAPPAPKP 133
|
Length = 226 |
| >gnl|CDD|152960 pfam12526, DUF3729, Protein of unknown function (DUF3729) | Back alignment and domain information |
|---|
Score = 37.7 bits (88), Expect = 0.003
Identities = 25/87 (28%), Positives = 28/87 (32%), Gaps = 9/87 (10%)
Query: 88 SPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPPG 147
SPP PP G PP PP S PPP + A PP P PP
Sbjct: 30 SPPE--SAHPDDPPPVGDPRPPVVDTPPPVSAVWVLPPPSEPAAPPPD-------PEPPV 80
Query: 148 QASTPPDSPPPGIQSNQGNPVPSNGTT 174
P SP + P+P
Sbjct: 81 PGPAGPPSPLAPPAPARKPPLPPPRPQ 107
|
This family of proteins is found in viruses. Proteins in this family are typically between 145 and 1707 amino acids in length. The family is found in association with pfam01443, pfam01661, pfam05417, pfam01660, pfam00978. There is a single completely conserved residue L that may be functionally important. Length = 115 |
| >gnl|CDD|233366 TIGR01348, PDHac_trf_long, pyruvate dehydrogenase complex dihydrolipoamide acetyltransferase, long form | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.003
Identities = 12/49 (24%), Positives = 21/49 (42%)
Query: 76 ASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSP 124
S P +P PA++ P P A+ P + + + A P + +P
Sbjct: 193 GSTPATAPAPASAQPAAQSPAATQPEPAAAPAAAKAQAPAPQQAGTQNP 241
|
This model describes a subset of pyruvate dehydrogenase complex dihydrolipoamide acetyltransferase specifically close by both phylogenetic and per cent identity (UPGMA) trees. Members of this set include two or three copies of the lipoyl-binding domain. E. coli AceF is a member of this model, while mitochondrial and some other bacterial forms belong to a separate model [Energy metabolism, Pyruvate dehydrogenase]. Length = 546 |
| >gnl|CDD|235826 PRK06549, PRK06549, acetyl-CoA carboxylase biotin carboxyl carrier protein subunit; Validated | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.003
Identities = 15/48 (31%), Positives = 17/48 (35%), Gaps = 3/48 (6%)
Query: 63 TPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPP 110
PA + PA P P P ASP + P A A P P
Sbjct: 23 APAQAAAPAQPAST---PVPVPTEASPQVEAQAPQPAAAAGADAMPSP 67
|
Length = 130 |
| >gnl|CDD|183854 PRK13042, PRK13042, superantigen-like protein; Reviewed | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 22/86 (25%), Positives = 34/86 (39%), Gaps = 3/86 (3%)
Query: 130 GASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPSNPGS 189
G Q+ N+ P P S PP + P+ T S TK P +
Sbjct: 19 GVITTTTQAANAT-TPSSTKVEAPQSTPPSTKVEAPQSKPNATTPPS--TKVEAPQQTPN 75
Query: 190 PPSPSTSQSGTPSTPNENSSPNELSP 215
+PS+++ TP +P P E++P
Sbjct: 76 ATTPSSTKVETPQSPTTKQVPTEINP 101
|
Length = 291 |
| >gnl|CDD|113398 pfam04625, DEC-1_N, DEC-1 protein, N-terminal region | Back alignment and domain information |
|---|
Score = 40.2 bits (93), Expect = 0.003
Identities = 19/49 (38%), Positives = 23/49 (46%), Gaps = 1/49 (2%)
Query: 64 PAASPPPASPPPASPPPA-SPPPAASPPPGSPPPASPPPASGSASPPPA 111
PA P A+P PA +P PAA+PP P A P A + PA
Sbjct: 94 PAMPSMPGLLGAAAPVPAPAPAPAAAPPAAPAPAADTPAAPIPDAVQPA 142
|
The defective chorion-1 gene (dec-1) in Drosophila encodes follicle cell proteins necessary for proper eggshell assembly. Multiple products of the dec-1 gene are formed by alternative RNA splicing and proteolytic processing. Cleavage products include S80 (80 kDa) which is incorporated into the eggshell, and further proteolysis of S80 gives S60 (60 kDa). Length = 407 |
| >gnl|CDD|184927 PRK14963, PRK14963, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.003
Identities = 18/79 (22%), Positives = 28/79 (35%), Gaps = 2/79 (2%)
Query: 45 TPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASG 104
PPA + N ++P A+ +P P P P PP +P PA
Sbjct: 353 VAPPAPAPADLTQRLNRLEKEVRSLRSAPTAAATAAGAPLPDFDPRPRGPP--APEPARS 410
Query: 105 SASPPPASPPPTRSESQSS 123
+ +PP +P +
Sbjct: 411 AEAPPLVAPAAAPAGLALR 429
|
Length = 504 |
| >gnl|CDD|183558 PRK12495, PRK12495, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.003
Identities = 18/90 (20%), Positives = 28/90 (31%), Gaps = 5/90 (5%)
Query: 48 PADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSAS 107
P+D + +++ A + P S A PP + +
Sbjct: 87 PSDAGSQASPDDDAQPAAEAEAADQSAPPEASSTSATDEA---ATDPPATAAARDGPTPD 143
Query: 108 PP--PASPPPTRSESQSSPPPGDGGASPPP 135
P PA+P RS Q P G+ P
Sbjct: 144 PTAQPATPDERRSPRQRPPVSGEPPTPSTP 173
|
Length = 226 |
| >gnl|CDD|152115 pfam11679, DUF3275, Protein of unknown function (DUF3275) | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.003
Identities = 22/60 (36%), Positives = 23/60 (38%)
Query: 56 GGGNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPP 115
G S P P P PAS P AS P +P P SP PAS AS P
Sbjct: 81 GIDKLSRDEPRRTEPQEPDPLDESPASAAPVASAPAPAPSPQSPKPASRRASRDMRRIAP 140
|
This family of proteins with unknown function appear to be restricted to Proteobacteria. Length = 211 |
| >gnl|CDD|219133 pfam06682, DUF1183, Protein of unknown function (DUF1183) | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.003
Identities = 26/131 (19%), Positives = 37/131 (28%), Gaps = 20/131 (15%)
Query: 37 TESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPP 96
+ P P GGGG PPP + PP P P
Sbjct: 178 LSCGGVRGGPRPERAGYGGGGGGGGGGGGGGGSGPGPPPPGFKSSFPP----PYGPGAGP 233
Query: 97 ASPPPASGSASPPPASPP----------------PTRSESQSSPPPGDGGASPPPEQSKN 140
+S + G+ S P +R + SS G SP S +
Sbjct: 234 SSGYGSGGTRSGQGGWGPGFWTGLGAGGALGYLFGSRRNNNSSYGRSYGSGSPSYSPSSS 293
Query: 141 SPPAPPGQAST 151
S + +S+
Sbjct: 294 SNSSSSSSSSS 304
|
This family consists of several eukaryotic proteins of around 360 residues in length. The function of this family is unknown. Length = 317 |
| >gnl|CDD|222095 pfam13388, DUF4106, Protein of unknown function (DUF4106) | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.003
Identities = 20/84 (23%), Positives = 29/84 (34%), Gaps = 2/84 (2%)
Query: 84 PPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPP 143
PP +P PG P + P + PT P + + P+Q P
Sbjct: 176 PPREAPAPGLPKTFTSSHGHRHRHAPKPTQQPTVQNPAQQPTVQN--PAQQPQQQPQQQP 233
Query: 144 APPGQASTPPDSPPPGIQSNQGNP 167
P Q TP + Q+ QG+
Sbjct: 234 VQPAQQPTPQNPAQQPPQTEQGHK 257
|
This family of proteins are found in large numbers in the Trichomonas vaginalis proteome. The function of this protein is unknown. Length = 422 |
| >gnl|CDD|216078 pfam00716, Peptidase_S21, Assemblin (Peptidase family S21) | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.003
Identities = 29/109 (26%), Positives = 37/109 (33%), Gaps = 5/109 (4%)
Query: 48 PADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSAS 107
A N G + T P+ P+ P P + PP S G+ ASP G
Sbjct: 223 VASKGGNDRGVSPGTAPSFDATPSVSPSGQPLSPAAPPGTSSVAGTALSASPAALFGDMV 282
Query: 108 PPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSP 156
P Q+ P D PP + APP A PP +P
Sbjct: 283 YVPLDAYNQLLAGQAFNQPPDPQGPAPP-----AELAPPAPAPPPPANP 326
|
Length = 326 |
| >gnl|CDD|219927 pfam08601, PAP1, Transcription factor PAP1 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.003
Identities = 31/167 (18%), Positives = 50/167 (29%), Gaps = 14/167 (8%)
Query: 99 PPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPP 158
P A S+ P +ES S P + P A S P
Sbjct: 45 PKLAKNSSVSSPVPGLLNSTESNVSSPNNNPNGYTSPS------SAAMNNKSNNRAVDPS 98
Query: 159 GIQSNQGNPVPSNGTTDSRDTKWAPPSNP-GSPPSPSTSQSGTPSTPNENSSPNELSPPS 217
S S S T++ N PS SG+ N+ S SP
Sbjct: 99 ANASAAS--TNSPNGLQSSATQYNSNDNSSSDSPS-----SGSDGFTNQLLSSLGTSPEP 151
Query: 218 NSKSPTSKSSPEESSSSSHSNSKKTPTSSSGHSSDSTKGSSSNDDQA 264
+++SP +S ++ ++ + S+ S+ + G
Sbjct: 152 STESPPQLASVNNFAAIRNNAESNSNVPSAASSTPNIPGIDFLLAFP 198
|
The transcription factor Pap1 regulates antioxidant-gene transcription in response to H2O2. This region is cysteine rich. Alkylation of cysteine residues following treatment with a cysteine alkylating agent can mask the accessibility of the nuclear exporter Crm1, triggering nuclear accumulation and Pap1 dependent transcriptional expression. Length = 344 |
| >gnl|CDD|223066 PHA03379, PHA03379, EBNA-3A; Provisional | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.003
Identities = 40/168 (23%), Positives = 54/168 (32%), Gaps = 4/168 (2%)
Query: 30 PPAPAEKTESPEKKVTPP---PADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPA 86
PP + E P+ T A + P +P P + P P
Sbjct: 418 PPVEKPRPEVPQSLETATSHGSAQVPEPPPVHDLEPGPLHDQHSMAPCPVAQLPPGPLQD 477
Query: 87 ASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPP 146
P P + + P PA P E+ S PG A P+ P P
Sbjct: 478 LEPGDQLPGVVQDGRPACAPVPAPAGPIVRPWEASLSQVPGVAFAPVMPQPMPVEPVPVP 537
Query: 147 GQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPSNPGSPPSPS 194
A P P P + + QG P ++G R+ P P P SPS
Sbjct: 538 TVALERPVCPAPPLIAMQG-PGETSGIVRVRERWRPAPWTPNPPRSPS 584
|
Length = 935 |
| >gnl|CDD|237191 PRK12757, PRK12757, cell division protein FtsN; Provisional | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 0.003
Identities = 17/88 (19%), Positives = 25/88 (28%), Gaps = 3/88 (3%)
Query: 33 PAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPAASPPPG 92
P + +E P + TP + P A+ P +P +P P
Sbjct: 99 PTQLSEVPYNEQTPQVPRSTVQIQQQAQQQQPPATTAQPQPVTPPRQTTAPVQPQTPAPV 158
Query: 93 SPPPASPPPASGSASPPPASPPPTRSES 120
PA+P A P E
Sbjct: 159 RTQPAAP---VTQAVEAPKVEAEKEKEQ 183
|
Length = 256 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 40.2 bits (95), Expect = 0.004
Identities = 21/118 (17%), Positives = 36/118 (30%), Gaps = 1/118 (0%)
Query: 5 AETPGPPVANNASSGLGERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTP 64
+ P P+ S L R++ +A A K P P N+ + P
Sbjct: 408 QQAPAVPLPETTSQLLAARQQLQRAQGATKAKKSEPAAASRARPV-NSALERLASVRPAP 466
Query: 65 AASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQS 122
+A + A A+ P P + P A +P A+ + +
Sbjct: 467 SALEKAPAKKEAYRWKATNPVEVKKEPVATPKALKKALEHEKTPELAAKLAAEAIERD 524
|
Length = 647 |
| >gnl|CDD|184918 PRK14954, PRK14954, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.004
Identities = 26/94 (27%), Positives = 31/94 (32%), Gaps = 18/94 (19%)
Query: 16 ASSGLGERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPASPP- 74
+ +G + K++A P P K P A PA P PAS P
Sbjct: 383 SPAGSPDVKKKAPEPDLPQPDRHPGPAKPEAPGA-------------RPAELPSPASAPT 429
Query: 75 PASPPPASPPPAASPPPGSPPPASPPPASGSASP 108
P PP A PP AS P S P
Sbjct: 430 PEQQPP-VARSAPLPPSPQ---ASAPRNVASGKP 459
|
Length = 620 |
| >gnl|CDD|233045 TIGR00601, rad23, UV excision repair protein Rad23 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.004
Identities = 25/85 (29%), Positives = 35/85 (41%), Gaps = 11/85 (12%)
Query: 67 SPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPP 126
S P +PP A+P ++P P PPASP S PAS +S S+ S
Sbjct: 75 SKPKTGTGKVAPPAATP--TSAPTPTPSPPASPASG---MSAAPASAVEEKSPSEESAT- 128
Query: 127 GDGGASPPPEQSKNSPPAPPGQAST 151
+ PE S P+ A++
Sbjct: 129 -----ATAPESPSTSVPSSGSDAAS 148
|
All proteins in this family for which functions are known are components of a multiprotein complex used for targeting nucleotide excision repair to specific parts of the genome. In humans, Rad23 complexes with the XPC protein. This family is based on the phylogenomic analysis of JA Eisen (1999, Ph.D. Thesis, Stanford University) [DNA metabolism, DNA replication, recombination, and repair]. Length = 378 |
| >gnl|CDD|223044 PHA03325, PHA03325, nuclear-egress-membrane-like protein; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.004
Identities = 24/160 (15%), Positives = 43/160 (26%), Gaps = 6/160 (3%)
Query: 59 NNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASP-PPASGSASPPPASPPPTR 117
S+ + + P + A+ + S P + PPP
Sbjct: 257 LTSSAFMLNSSLPTSAPKRRSRRAGAMRAAAGETADLADDDGSEHSDPEPLPASLPPPPV 316
Query: 118 SESQSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSR 177
+ P P+ ++N+ P Q +T S G S Q S G S
Sbjct: 317 RRPRVKHPEAGKE---EPDGARNAEAKEPAQPATSTSS--KGSSSAQNKDSGSTGPGSSL 371
Query: 178 DTKWAPPSNPGSPPSPSTSQSGTPSTPNENSSPNELSPPS 217
+ + P + P+ + + P
Sbjct: 372 AAASSFLEDDDFGSPPLDLTTSLRHMPSPSVTSAPEPPSI 411
|
Length = 418 |
| >gnl|CDD|237081 PRK12372, PRK12372, ribonuclease III; Reviewed | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.004
Identities = 23/104 (22%), Positives = 33/104 (31%), Gaps = 17/104 (16%)
Query: 21 GERKE----EAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPASPPPA 76
GER KA PA++ ++ EK P + A P + PA
Sbjct: 314 GERAAKPAAADKAADKPADRPDAAEKAAEKPA----------EAAPRAADKPAGQAADPA 363
Query: 77 SPP---PASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTR 117
S P + AA+ P A+ P A + R
Sbjct: 364 SSSADKPGASADAAARTPARARDAAAPDADTPPGGASLAAAQAR 407
|
Length = 413 |
| >gnl|CDD|220603 pfam10152, DUF2360, Predicted coiled-coil domain-containing protein (DUF2360) | Back alignment and domain information |
|---|
Score = 38.1 bits (89), Expect = 0.004
Identities = 17/65 (26%), Positives = 20/65 (30%), Gaps = 3/65 (4%)
Query: 66 ASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPP 125
AS P P P A PP PP + +ASPPP P
Sbjct: 45 ASIPGLEDVTVQTTPPPPASA---ITNGGPPPPPPARAEAASPPPPEAPAEPPAEPEPEA 101
Query: 126 PGDGG 130
P +
Sbjct: 102 PAENT 106
|
This is the conserved 140 amino acid region of a family of proteins conserved from nematodes to humans. One C. elegans member is annotated as a Daf-16-dependent longevity protein 1 but this could not be confirmed. The function is unknown. Length = 147 |
| >gnl|CDD|220708 pfam10349, WWbp, WW-domain ligand protein | Back alignment and domain information |
|---|
Score = 37.4 bits (87), Expect = 0.004
Identities = 21/60 (35%), Positives = 23/60 (38%)
Query: 56 GGGNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPP 115
G + A A+PPP PPP P P PPP S A PPP PP
Sbjct: 51 GAYVHLEPLPAYGQYAAPPPYGPPPPYYPAPPGVYPTPPPPNSGYMADPQEPPPPYPGPP 110
|
The WWbp domain is characterized by several short PY and PT-like motifs of the PPPPY form. These appear to bind directly to the WW domains of WWP1 and WWP2 and other such diverse proteins as dystrophin and YAP (Yes-associated protein). This is the WW-domain binding protein WWbp via PY and PY_like motifs. The presence of a phosphotyrosine residue in the pWBP-1 peptide abolishes WW domain binding which suggests a potential regulatory role for tyrosine phosphorylation in modulating WW domain-ligand interactions. Given the likelihood that WWP1 and WWP2 function as E3 ubiquitin-protein ligases, it is possible that initial substrate-specific recognition occurs via WW domain-substrate protein interaction followed by ubiquitin transfer and subsequent proteolysis. This domain lies just downstream of the GRAM (pfam02893) in many members. Length = 111 |
| >gnl|CDD|218881 pfam06070, Herpes_UL32, Herpesvirus large structural phosphoprotein UL32 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.004
Identities = 44/270 (16%), Positives = 71/270 (26%), Gaps = 15/270 (5%)
Query: 15 NASSGLGERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAASPP----- 69
G+ + + PE K NN+ T A
Sbjct: 381 KEMPGILTTENLDLPLASTDSTEMDPEDKRGGAVKINNSGILAWGLKTPGLAVNDERSIA 440
Query: 70 -PASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTR---SESQSSPP 125
+ P SP S + P SA + +SS
Sbjct: 441 VSSDGITDVLDPPSPLRLHSSDKVIDSVSPPSKRRVSAPASRLDDAKRPEVTATPESSGS 500
Query: 126 PGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPS 185
+GGAS +++ + + P +P S T A PS
Sbjct: 501 DSEGGASGREDETSSDAESVVSIKELRPRIGFINKSPPPKSPPKSRR-TLIVALSLASPS 559
Query: 186 NPGSPPSPSTSQSGTPSTPNENSSPNELSPPSNSKSPTSKSS---PEESSSSSHSNSKKT 242
GS P P S + + N + N + S P+ S+SS +
Sbjct: 560 TAGS-PRPKPSLGKFVIGTDPFAFANTVRLTDNMRGGNGVGSSVKPKGSASSKPLTGPGS 618
Query: 243 PTSSSGHSSDSTKGSSSNDDQAIIGATAAG 272
+ + + SS GA++
Sbjct: 619 DLKPATLNGKTPS-SSLVGAARNAGASSKV 647
|
The large phosphorylated protein (UL32-like) of herpes viruses is the polypeptide most frequently reactive in immuno-blotting analyses with antisera when compared with other viral proteins. Length = 777 |
| >gnl|CDD|183558 PRK12495, PRK12495, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.004
Identities = 27/129 (20%), Positives = 37/129 (28%), Gaps = 28/129 (21%)
Query: 49 ADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASP 108
++ G G +T P+ + ASP + P A A P S + +
Sbjct: 72 GAAGDDAGDGAEATAPSDAGSQASPDDDAQPAAEAEAADQSAPPEASSTSATDEAAT--- 128
Query: 109 PPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPV 168
PP A P P P Q +TP + P Q PV
Sbjct: 129 ---------------DPPATAAARDGPT------PDPTAQPATPDERRSPR----QRPPV 163
Query: 169 PSNGTTDSR 177
T S
Sbjct: 164 SGEPPTPST 172
|
Length = 226 |
| >gnl|CDD|216078 pfam00716, Peptidase_S21, Assemblin (Peptidase family S21) | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.004
Identities = 25/119 (21%), Positives = 35/119 (29%), Gaps = 22/119 (18%)
Query: 2 ANSAETPGPPVANNASSGLGERKEEAKAPP----APAEKTESPEKKVTPPPADNNNNGGG 57
+ T AS G +R P P+ PP ++ G
Sbjct: 210 ESPGLTAACHDEVVASKGGNDRGVSPGTAPSFDATPSVSPSGQPLSPAAPPGTSSVAGT- 268
Query: 58 GNNSTTPAASP----------------PPASPPPASPPPASPPPAASPPPGSPPPASPP 100
S +PAA A P P +PP +PP +PPP + P
Sbjct: 269 -ALSASPAALFGDMVYVPLDAYNQLLAGQAFNQPPDPQGPAPPAELAPPAPAPPPPANP 326
|
Length = 326 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.004
Identities = 26/93 (27%), Positives = 52/93 (55%), Gaps = 8/93 (8%)
Query: 468 AKGLAYL-HEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK--LNDTTQTHVSTRVMG 524
A+G+ +L ++C +HRD+ + N+L+ ++ DFGLA+ ++D+ + +
Sbjct: 247 ARGMEFLASKNC----VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFL- 301
Query: 525 TFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT 557
++APE T SDV+S+G++L E+ +
Sbjct: 302 PVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|215397 PLN02744, PLN02744, dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.004
Identities = 15/47 (31%), Positives = 21/47 (44%)
Query: 82 SPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGD 128
P +A+P P+ PPP P +SP P S+ + P GD
Sbjct: 201 KPSSSAAPAAPKAKPSPPPPKEEEVEKPASSPEPKASKPSAPPSSGD 247
|
Length = 539 |
| >gnl|CDD|130689 TIGR01628, PABP-1234, polyadenylate binding protein, human types 1, 2, 3, 4 family | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.004
Identities = 21/140 (15%), Positives = 33/140 (23%), Gaps = 15/140 (10%)
Query: 91 PGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPPGQAS 150
P P G+ PP + + P + P P P G A
Sbjct: 380 PRMRQLPMGSPMGGAMGQPPYYGQGPQQQFNGQPLGWPRMSMMPTPMGPGGPLRPNGLAP 439
Query: 151 TPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPSNPGSPPSPSTSQSGTPSTPNENSSP 210
P N PP P P S + P S+
Sbjct: 440 MNAVRAPSRNAQNAAQK---------------PPMQPVMYPPNYQSLPLSQDLPQPQSTA 484
Query: 211 NELSPPSNSKSPTSKSSPEE 230
++ + ++P+
Sbjct: 485 SQGGQNKKLAQVLASATPQM 504
|
These eukaryotic proteins recognize the poly-A of mRNA and consists of four tandem RNA recognition domains at the N-terminus (rrm: pfam00076) followed by a PABP-specific domain (pfam00658) at the C-terminus. The protein is involved in the transport of mRNA's from the nucleus to the cytoplasm. There are four paralogs in Homo sapiens which are expressed in testis (GP:11610605_PABP3 ), platelets (SP:Q13310_PABP4 ), broadly expressed (SP:P11940_PABP1) and of unknown tissue range (SP:Q15097_PABP2). Length = 562 |
| >gnl|CDD|217453 pfam03251, Tymo_45kd_70kd, Tymovirus 45/70Kd protein | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.004
Identities = 45/208 (21%), Positives = 62/208 (29%), Gaps = 23/208 (11%)
Query: 61 STTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSES 120
TT + P PA S P + P ++ P P P + G PPP S P R
Sbjct: 249 HTTRPSPPRPAFSRSPSSPLSPLPRPSTRRGLLPNPRLPRASRGHL-PPPTSSAPPRPNG 307
Query: 121 ---------QSSPPPGDGGASPPPEQSKNSPPAPPGQAST--------PPDSPPPGIQSN 163
S P + + S A G + + PPP +
Sbjct: 308 GLRRPLHLHSSRPNSPNLRPRRIRKNSLQQTRARLGHSKSLGQSPNLRSSQLPPPTKRRL 367
Query: 164 QGNPVPSNGTTDSRDTKWAP-----PSNPGSPPSPSTSQSGTPSTPNENSSPNELSPPSN 218
+ PVP T AP PS P P + S+ + P + P
Sbjct: 368 RLLPVPPPKVQALPLTALAPLVRHSPSIPLPHPPSALPSHVGASSSKHHRLPPSVLPGPR 427
Query: 219 SKSPTSKSSPEESSSSSHSNSKKTPTSS 246
SP+ S + PT S
Sbjct: 428 LSSPSPSPSLPTRRPGTPPPPASPPTPS 455
|
Tymoviruses are single stranded RNA viruses. This family includes a protein of unknown function that has been named based on its molecular weight. Tymoviruses such as the ononis yellow mosaic tymovirus encode only three proteins. Of these two are overlapping this protein overlaps a larger ORF that is thought to be the polymerase. Length = 458 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.004
Identities = 45/149 (30%), Positives = 69/149 (46%), Gaps = 13/149 (8%)
Query: 368 IGEGGFGCVY---KGNLPEGKVVAVKQLKSGSGQGE---REFRAEVEIISRVHHRHLVSL 421
I G FG VY K N K+ AVK +K + + +AE + ++ +V L
Sbjct: 12 ISRGAFGKVYLGRKKN--NSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHL 69
Query: 422 VGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPK 481
S N L+ E++ +++ LH G + VK A L YLH
Sbjct: 70 YYSLQSANNVYLVMEYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLHRH---G 124
Query: 482 IIHRDIKSANILVDDEFEAQVADFGLAKL 510
IIHRD+K N+L+ +E ++ DFGL+K+
Sbjct: 125 IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 723 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.98 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.98 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.98 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.91 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.9 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.87 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.87 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.85 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.84 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.84 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.83 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.83 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.82 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.81 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.8 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.79 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.77 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.76 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.75 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.75 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.75 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.74 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.73 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.7 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.69 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.65 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.6 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.59 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.51 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.47 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.45 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.43 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.36 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.34 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.31 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.3 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.25 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.22 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.13 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.12 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.12 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.05 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.01 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.0 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.87 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.79 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.78 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.75 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.73 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.64 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.62 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.55 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.53 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.43 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.39 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.34 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.27 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.26 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.25 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.25 | |
| PHA03247 | 3151 | large tegument protein UL36; Provisional | 98.24 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.23 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.19 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 98.17 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.16 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.12 | |
| PHA03247 | 3151 | large tegument protein UL36; Provisional | 98.12 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 98.11 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.02 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 98.01 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.95 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.92 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.87 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.76 | |
| KOG1924 | 1102 | consensus RhoA GTPase effector DIA/Diaphanous [Sig | 97.73 | |
| KOG1924 | 1102 | consensus RhoA GTPase effector DIA/Diaphanous [Sig | 97.61 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.59 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.54 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.52 | |
| PF04478 | 154 | Mid2: Mid2 like cell wall stress sensor; InterPro: | 97.51 | |
| PF01102 | 122 | Glycophorin_A: Glycophorin A; InterPro: IPR001195 | 97.49 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.41 | |
| KOG3671 | 569 | consensus Actin regulatory protein (Wiskott-Aldric | 97.39 | |
| PLN02236 | 344 | choline kinase | 97.39 | |
| PF01102 | 122 | Glycophorin_A: Glycophorin A; InterPro: IPR001195 | 97.34 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.29 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 97.22 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.14 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.13 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 97.07 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 97.02 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.98 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.97 | |
| PTZ00382 | 96 | Variant-specific surface protein (VSP); Provisiona | 96.92 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-57 Score=490.41 Aligned_cols=291 Identities=60% Similarity=1.016 Sum_probs=257.6
Q ss_pred CccccCHHHHHHHhcCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeee
Q 046750 346 SKSFFTYEELMEITNGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYC 425 (723)
Q Consensus 346 ~~~~~~~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~ 425 (723)
....|+|++|..++++|...++||+|+||.||+|.+.+|+.||||++.....+..++|..|+++|.+++|+|||+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 34679999999999999999999999999999999999999999988776443256799999999999999999999999
Q ss_pred eccc-ceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEee
Q 046750 426 ISEK-NRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVAD 504 (723)
Q Consensus 426 ~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~D 504 (723)
.+.+ +.+||||||.+|+|+++|+......|+|.+|++||.++|+||+|||+.+.+.|||||||++|||||+++++||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9998 499999999999999999976543789999999999999999999999988899999999999999999999999
Q ss_pred cccccccCCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhh
Q 046750 505 FGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRA 584 (723)
Q Consensus 505 FGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~ 584 (723)
||||+.......+......||++|+||||+..+.++.|+|||||||+|+||++|+.+++.........+++|+...
T Consensus 221 FGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~---- 296 (361)
T KOG1187|consen 221 FGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPL---- 296 (361)
T ss_pred ccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHH----
Confidence 9999766541222222117999999999999999999999999999999999999999887666677799998644
Q ss_pred hhcCCcccccchhhh-ccccH-HHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCC
Q 046750 585 IETGDLSEIVDPRLE-KHYVE-SEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGE 640 (723)
Q Consensus 585 i~~~~l~~~vd~~l~-~~~~~-~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~ 640 (723)
+..+++.+++|++|. ..+.. .++.++..++.+|++.++++||+|.||+++|+.+..
T Consensus 297 ~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 297 LEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred HHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 455699999999998 66665 789999999999999999999999999999965443
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-47 Score=409.03 Aligned_cols=257 Identities=34% Similarity=0.553 Sum_probs=210.2
Q ss_pred cccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchh--HHHHHHHHHHHHHccCCceeeEeeeeeccc-ceEEEEEec
Q 046750 362 FARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQG--EREFRAEVEIISRVHHRHLVSLVGYCISEK-NRLLIYEFV 438 (723)
Q Consensus 362 f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~-~~~lV~E~~ 438 (723)
+...+.||+|+||.||+|.+.....||||++....... .++|.+|+.+|.+|+|||||+|+|+|.+.. ..+|||||+
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 34456699999999999999555559999998653222 558999999999999999999999999887 789999999
Q ss_pred CCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCC-cEEEeecccccccCCCCcc
Q 046750 439 PNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEF-EAQVADFGLAKLNDTTQTH 517 (723)
Q Consensus 439 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~-~vkL~DFGla~~~~~~~~~ 517 (723)
.+|+|.++|+......+++..+++|+++||+||.|||+++. |||||||+.||||+.++ ++||+|||+++...... .
T Consensus 123 ~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~ 199 (362)
T KOG0192|consen 123 PGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-T 199 (362)
T ss_pred CCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc-c
Confidence 99999999988555579999999999999999999999931 99999999999999997 99999999998665432 2
Q ss_pred eeecccccccccChhhhc--cCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccc
Q 046750 518 VSTRVMGTFGYLAPEYAS--SGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVD 595 (723)
Q Consensus 518 ~~~~~~gt~~y~APE~~~--~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd 595 (723)
..+...||+.|||||++. ...|+.|+||||||||||||++|+.||....... ... ..+..+..
T Consensus 200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~---~~~-------~v~~~~~R----- 264 (362)
T KOG0192|consen 200 SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQ---VAS-------AVVVGGLR----- 264 (362)
T ss_pred cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHH---HHH-------HHHhcCCC-----
Confidence 233367999999999999 5689999999999999999999999998764311 111 11111111
Q ss_pred hhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCC
Q 046750 596 PRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGE 640 (723)
Q Consensus 596 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~ 640 (723)
..........|..|+.+||+.||.+||++.+|+..|+.+..
T Consensus 265 ----p~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 265 ----PPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred ----CCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 11112244578888999999999999999999999997665
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-47 Score=407.71 Aligned_cols=255 Identities=30% Similarity=0.469 Sum_probs=218.7
Q ss_pred cccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEecCCC
Q 046750 362 FARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPNN 441 (723)
Q Consensus 362 f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 441 (723)
+..++.||+|.||.||+|+++....||||.++... ...++|.+|+++|++|+|+|||+|+|+|..++.+|||||||..|
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 35678899999999999999888899999998863 44568999999999999999999999999988999999999999
Q ss_pred chhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcceeec
Q 046750 442 NLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTR 521 (723)
Q Consensus 442 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 521 (723)
+|.+||....+..+...+.+.|+.|||+|++||+++ ++|||||.++||||+++..|||+|||||+...++.......
T Consensus 287 sLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~ 363 (468)
T KOG0197|consen 287 SLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEG 363 (468)
T ss_pred cHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCceeecCC
Confidence 999999986667899999999999999999999999 69999999999999999999999999999766655555444
Q ss_pred ccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhhhc
Q 046750 522 VMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEK 600 (723)
Q Consensus 522 ~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~ 600 (723)
..-...|.|||.+..++|+.|+|||||||+||||+| |+.||..... ..+.+.++.|. +.
T Consensus 364 ~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn-----------~ev~~~le~Gy---------Rl 423 (468)
T KOG0197|consen 364 GKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN-----------EEVLELLERGY---------RL 423 (468)
T ss_pred CCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH-----------HHHHHHHhccC---------cC
Confidence 445679999999999999999999999999999999 8888865432 11344555553 12
Q ss_pred cccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCC
Q 046750 601 HYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGE 640 (723)
Q Consensus 601 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~ 640 (723)
.-+..+...+++||..||+.+|++||+++.+...|+....
T Consensus 424 p~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 424 PRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred CCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 2233455678899999999999999999999999987543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-46 Score=383.07 Aligned_cols=252 Identities=30% Similarity=0.466 Sum_probs=207.9
Q ss_pred cccceEEeccCcEEEEEEEc-CCCcEEEEEEcccC-CchhHHHHHHHHHHHHHccCCceeeEeeeeecccc-eEEEEEec
Q 046750 362 FARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSG-SGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKN-RLLIYEFV 438 (723)
Q Consensus 362 f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~-~~lV~E~~ 438 (723)
++..+.||+|..|.|||+++ .+++.+|+|.+... .....+++.+|++++++++|++||.++|.|.+... ++|+||||
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM 160 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM 160 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence 45678999999999999955 46889999999554 33445789999999999999999999999999884 99999999
Q ss_pred CCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcce
Q 046750 439 PNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHV 518 (723)
Q Consensus 439 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 518 (723)
++|+|++++...+ .+++..+-+|+.+|++||.|||+.- +||||||||+||||+..|+|||||||.+..+... .
T Consensus 161 DgGSLd~~~k~~g--~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---~ 233 (364)
T KOG0581|consen 161 DGGSLDDILKRVG--RIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---I 233 (364)
T ss_pred CCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh---h
Confidence 9999999998664 3889999999999999999999632 6999999999999999999999999999866544 3
Q ss_pred eecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhh
Q 046750 519 STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRL 598 (723)
Q Consensus 519 ~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l 598 (723)
...++||..|||||.+.+..|+.++||||||+.|+||..|+.||-... .....|+. ++..|-.+.-- ++
T Consensus 234 a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~----~~~~~~~~--Ll~~Iv~~ppP-----~l 302 (364)
T KOG0581|consen 234 ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPN----PPYLDIFE--LLCAIVDEPPP-----RL 302 (364)
T ss_pred cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcC----CCCCCHHH--HHHHHhcCCCC-----CC
Confidence 456789999999999999999999999999999999999999997652 22233433 33444333322 22
Q ss_pred hccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 599 EKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 599 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
... ....++..++..||++||.+|+++.|++++
T Consensus 303 P~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 303 PEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred Ccc---cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 222 123367888999999999999999999864
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-46 Score=419.31 Aligned_cols=259 Identities=26% Similarity=0.482 Sum_probs=218.0
Q ss_pred cCcccceEEeccCcEEEEEEEcC------CCcEEEEEEcccCCch-hHHHHHHHHHHHHHccCCceeeEeeeeecccceE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLP------EGKVVAVKQLKSGSGQ-GEREFRAEVEIISRVHHRHLVSLVGYCISEKNRL 432 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~------~g~~VAvK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 432 (723)
.+....+.||+|.||+||+|+.. +...||||.|+..... ..++|++|+++|..|+|+|||+|+|+|.+++..|
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 34566788999999999999653 3467999999988766 6779999999999999999999999999999999
Q ss_pred EEEEecCCCchhhccccCC------------CCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcE
Q 046750 433 LIYEFVPNNNLEHHLHGKG------------QPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEA 500 (723)
Q Consensus 433 lV~E~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~v 500 (723)
+|||||..|||.+||..+. ...|...+.+.||.|||.|++||-++ ++|||||..+|+||.++..|
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEE
Confidence 9999999999999996421 12388889999999999999999999 69999999999999999999
Q ss_pred EEeecccccccCCCCcce-eecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhh
Q 046750 501 QVADFGLAKLNDTTQTHV-STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWAR 578 (723)
Q Consensus 501 kL~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~ 578 (723)
||+||||++.+-..+.+. ..+.+-..+||+||.|+.++|+.++|||||||||||+++ |+.||.+.... .
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~---E------ 713 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ---E------ 713 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH---H------
Confidence 999999998654444433 234556789999999999999999999999999999999 88998765421 1
Q ss_pred hhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCCC
Q 046750 579 PVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEM 641 (723)
Q Consensus 579 ~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~~ 641 (723)
+.+.+..|++.. -......++++||..||+.+|++||+++||-.+|+.....
T Consensus 714 --VIe~i~~g~lL~---------~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 714 --VIECIRAGQLLS---------CPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred --HHHHHHcCCccc---------CCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 334556666532 3345566899999999999999999999999999876543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-46 Score=385.36 Aligned_cols=200 Identities=28% Similarity=0.491 Sum_probs=179.1
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccC--CchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSG--SGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYE 436 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 436 (723)
.+|...+.||+|.|+.||+|++ +++..||||.+... ..+..+.+..||.+|+.|+|+|||+|+++++..+.+|||||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 5677888899999999999955 45789999999766 44455668899999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCC------CcEEEeecccccc
Q 046750 437 FVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDE------FEAQVADFGLAKL 510 (723)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~------~~vkL~DFGla~~ 510 (723)
||.||+|.+||++++. +++.....++.||+.||++||++ +||||||||+||||+.. -.+||+|||+|+.
T Consensus 90 yC~gGDLs~yi~~~~~--l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 90 YCNGGDLSDYIRRRGR--LPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred eCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 9999999999998764 89999999999999999999999 69999999999999864 5689999999998
Q ss_pred cCCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCC
Q 046750 511 NDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQ 566 (723)
Q Consensus 511 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~ 566 (723)
+.... .....+|++.|||||+++..+|+.|+|+||+|+|||+|++|+.||+...
T Consensus 165 L~~~~--~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 165 LQPGS--MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred CCchh--HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 76433 2345789999999999999999999999999999999999999998654
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-47 Score=374.76 Aligned_cols=257 Identities=25% Similarity=0.440 Sum_probs=213.6
Q ss_pred cCcccceEEeccCcEEEEEE-EcCCCcEEEEEEcccC--CchhHHHHHHHHHHHHHccCCceeeEee-eeecccc-eEEE
Q 046750 360 NGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSG--SGQGEREFRAEVEIISRVHHRHLVSLVG-YCISEKN-RLLI 434 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~-~~~~g~~VAvK~l~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~g-~~~~~~~-~~lV 434 (723)
.+|++.++||+|.||.||++ ++.+|..||.|.++-. +.+..+++..|+.+|++|+|+|||++++ .|.+++. ++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 34778899999999999999 7789999999998754 3344567899999999999999999998 4544544 8899
Q ss_pred EEecCCCchhhcccc--CCCCcchHHHHHHHHHHHHhhhchhcccCCCc--eeecCCCCCcEEeCCCCcEEEeecccccc
Q 046750 435 YEFVPNNNLEHHLHG--KGQPVLEWTKRVKIALGAAKGLAYLHEDCHPK--IIHRDIKSANILVDDEFEAQVADFGLAKL 510 (723)
Q Consensus 435 ~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~--ivHrDIkp~NILl~~~~~vkL~DFGla~~ 510 (723)
||||..|+|.++++. .++..+++..+|+++.|++.||.++|.+. ++ |+||||||.||+|+.+|.|||+||||+++
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 999999999998864 45567999999999999999999999952 34 99999999999999999999999999998
Q ss_pred cCCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCc
Q 046750 511 NDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDL 590 (723)
Q Consensus 511 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l 590 (723)
+...... ....+||+.||+||++++..|+.|+||||+||+||||+.-+.||.+.. +.. |.++|+.|++
T Consensus 178 l~s~~tf-A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n------~~~-----L~~KI~qgd~ 245 (375)
T KOG0591|consen 178 LSSKTTF-AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN------LLS-----LCKKIEQGDY 245 (375)
T ss_pred hcchhHH-HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc------HHH-----HHHHHHcCCC
Confidence 8655443 345689999999999999999999999999999999999999997652 222 5567788876
Q ss_pred ccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhc
Q 046750 591 SEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDS 637 (723)
Q Consensus 591 ~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~ 637 (723)
..+-|. .....|.+|+..|+..|++.||+...++..+..
T Consensus 246 ~~~p~~--------~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 246 PPLPDE--------HYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred CCCcHH--------HhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 544332 234468889999999999999996655555544
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=382.12 Aligned_cols=256 Identities=23% Similarity=0.347 Sum_probs=209.3
Q ss_pred HhcCcccceEEeccCcEEEEEE-EcCCCcEEEEEEcccCCc-------hhHHHHHHHHHHHHHccCCceeeEeeeeeccc
Q 046750 358 ITNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSG-------QGEREFRAEVEIISRVHHRHLVSLVGYCISEK 429 (723)
Q Consensus 358 ~~~~f~~~~~LG~G~fG~Vy~~-~~~~g~~VAvK~l~~~~~-------~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 429 (723)
+.+.|.+.+.||+|+||.|.+| +.++|+.||||++..... ....+.++|++||++|+|||||+++++|...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 4567888999999999999999 667899999999975411 12334679999999999999999999999999
Q ss_pred ceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCC---CcEEEeecc
Q 046750 430 NRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDE---FEAQVADFG 506 (723)
Q Consensus 430 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~---~~vkL~DFG 506 (723)
..||||||++||+|.+++-.++. +.+..-..+++|++.||.|||++| |+||||||+||||..+ ..+||+|||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~--l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKY--LREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccc--cccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccc
Confidence 99999999999999999876653 666777889999999999999995 9999999999999766 889999999
Q ss_pred cccccCCCCcceeecccccccccChhhhccCCC---CCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhh
Q 046750 507 LAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKL---TDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVR 583 (723)
Q Consensus 507 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~---t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~ 583 (723)
+|+..+. ...+...+||+.|.|||++..+.+ ..|.|+||+|||||-+|+|..||...... .+ +.+
T Consensus 325 lAK~~g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~--~s--------l~e 392 (475)
T KOG0615|consen 325 LAKVSGE--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD--PS--------LKE 392 (475)
T ss_pred hhhcccc--ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC--cc--------HHH
Confidence 9998763 334566789999999999987653 44789999999999999999999765321 11 334
Q ss_pred hhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 046750 584 AIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALD 636 (723)
Q Consensus 584 ~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~ 636 (723)
.|..|.+.. ...+..+...+.++|+.+||..||++|+++.|+|+.=+
T Consensus 393 QI~~G~y~f------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW 439 (475)
T KOG0615|consen 393 QILKGRYAF------GPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPW 439 (475)
T ss_pred HHhcCcccc------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChh
Confidence 455555421 11223344557788999999999999999999987654
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=393.21 Aligned_cols=247 Identities=24% Similarity=0.409 Sum_probs=208.2
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccC---CchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSG---SGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 435 (723)
..|...++||+|||..||+++. ..|+.||+|++.+. .....+.+.+||+|.+.|+|+|||+|++||++.+++|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4689999999999999999965 88999999999764 2234457889999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ 515 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 515 (723)
|+|.+++|..+++++ ..+.+.++..+..||+.||.|||++ +|||||||..||||+++.+|||+|||||..+....
T Consensus 98 ELC~~~sL~el~Krr--k~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR--KPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred EecCCccHHHHHHhc--CCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCcc
Confidence 999999999999743 4689999999999999999999999 59999999999999999999999999998776443
Q ss_pred cceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccc
Q 046750 516 THVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVD 595 (723)
Q Consensus 516 ~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd 595 (723)
.. ....+||+.|.|||++....++..+||||+|||||-||.|+.||+... +.+ .++.|+..+..
T Consensus 173 Er-k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~------vke-----ty~~Ik~~~Y~---- 236 (592)
T KOG0575|consen 173 ER-KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT------VKE-----TYNKIKLNEYS---- 236 (592)
T ss_pred cc-cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch------HHH-----HHHHHHhcCcc----
Confidence 33 345789999999999999999999999999999999999999997543 111 12233332211
Q ss_pred hhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 046750 596 PRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVR 633 (723)
Q Consensus 596 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~ 633 (723)
.+........+|+..+|+.+|.+||++++|+.
T Consensus 237 ------~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 237 ------MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred ------cccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 11122335678889999999999999999985
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-44 Score=382.47 Aligned_cols=263 Identities=29% Similarity=0.432 Sum_probs=217.1
Q ss_pred cCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhH-HHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEec
Q 046750 360 NGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGE-REFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFV 438 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~-~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 438 (723)
....+.++||+|-||+|.++....+..||||+++....... ++|.+||++|.+|+|||||+|+|+|..++.+++|+|||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 45677899999999999999998889999999998866555 78999999999999999999999999999999999999
Q ss_pred CCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCC-Ccc
Q 046750 439 PNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTT-QTH 517 (723)
Q Consensus 439 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~-~~~ 517 (723)
++|+|.+||..+....+.....++|+.||+.|++||.+. ++|||||.++|||+|.++++||+|||+++.+-.. ..+
T Consensus 618 EnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~ 694 (807)
T KOG1094|consen 618 ENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYR 694 (807)
T ss_pred hcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCcee
Confidence 999999999887665567777889999999999999998 7999999999999999999999999999854433 334
Q ss_pred eeecccccccccChhhhccCCCCCccceechHHHHHHHHh--CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccc
Q 046750 518 VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT--GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVD 595 (723)
Q Consensus 518 ~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt--G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd 595 (723)
...+.+-..+|||+|.|.-++++.++|||+|||.|||++. ...||.... ++..++-...++ ..+....
T Consensus 695 vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt---~e~vven~~~~~----~~~~~~~--- 764 (807)
T KOG1094|consen 695 VQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLT---DEQVVENAGEFF----RDQGRQV--- 764 (807)
T ss_pred eecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhh---HHHHHHhhhhhc----CCCCcce---
Confidence 4566677899999999999999999999999999999865 677876433 233333322221 1111110
Q ss_pred hhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhcc
Q 046750 596 PRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSE 638 (723)
Q Consensus 596 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~ 638 (723)
....+.-....+++++++||+.+-++||++++|...|.+.
T Consensus 765 ---~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 765 ---VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ---eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 0112234455788999999999999999999999999764
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=398.28 Aligned_cols=256 Identities=29% Similarity=0.464 Sum_probs=218.6
Q ss_pred cccceEEeccCcEEEEEEEcCC----CcEEEEEEcccCC-chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEE
Q 046750 362 FARENVIGEGGFGCVYKGNLPE----GKVVAVKQLKSGS-GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYE 436 (723)
Q Consensus 362 f~~~~~LG~G~fG~Vy~~~~~~----g~~VAvK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 436 (723)
..+.++||.|.||+||+|+++. ...||||.||... ....++|+.|+.||.+++||||++|.|+....+..+||.|
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE 710 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE 710 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence 4577899999999999997754 3479999999874 4455689999999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCc
Q 046750 437 FVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQT 516 (723)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 516 (723)
||++|.|+.||+.+..+ +.+.++..++++|+.|++||.+. ++|||||.++||||+.+..+||+||||++.+.++..
T Consensus 711 yMENGsLDsFLR~~DGq-ftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~ 786 (996)
T KOG0196|consen 711 YMENGSLDSFLRQNDGQ-FTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 786 (996)
T ss_pred hhhCCcHHHHHhhcCCc-eEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecccCCC
Confidence 99999999999877654 89999999999999999999999 599999999999999999999999999997765543
Q ss_pred ceeecc--cccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccc
Q 046750 517 HVSTRV--MGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEI 593 (723)
Q Consensus 517 ~~~~~~--~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~ 593 (723)
...+.. .-..+|.|||.|..++++.++|||||||||||.|+ |++||-+.. .+.+.+.|++|-
T Consensus 787 ~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS-----------NQdVIkaIe~gy---- 851 (996)
T KOG0196|consen 787 AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS-----------NQDVIKAIEQGY---- 851 (996)
T ss_pred ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc-----------hHHHHHHHHhcc----
Confidence 322222 22579999999999999999999999999999988 888875433 333556666542
Q ss_pred cchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCCC
Q 046750 594 VDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEM 641 (723)
Q Consensus 594 vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~~ 641 (723)
+..-+.++...|.+||+.||++|-.+||.+.||+..|++++..
T Consensus 852 -----RLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 852 -----RLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred -----CCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 2334556778999999999999999999999999999988763
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-44 Score=368.27 Aligned_cols=241 Identities=27% Similarity=0.405 Sum_probs=200.4
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCc---hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSG---QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 435 (723)
++|++.++||+|+||+||+++. +.++.||+|++++... .+.+..++|..||.+++||+||+++..|++.+.+|||+
T Consensus 25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl 104 (357)
T KOG0598|consen 25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL 104 (357)
T ss_pred hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence 5799999999999999999954 4589999999987532 34456889999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ 515 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 515 (723)
||+.||.|..+|++.+. +.+.....++.+|+.||.|||+++ ||||||||+|||||++|+++|+||||++......
T Consensus 105 d~~~GGeLf~hL~~eg~--F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~ 179 (357)
T KOG0598|consen 105 DYLNGGELFYHLQREGR--FSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG 179 (357)
T ss_pred eccCCccHHHHHHhcCC--cchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcccCC
Confidence 99999999999987664 788888889999999999999994 9999999999999999999999999998544332
Q ss_pred cceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccc
Q 046750 516 THVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVD 595 (723)
Q Consensus 516 ~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd 595 (723)
. ....++||..|||||++.+..|+..+|.|||||+||||++|..||...+. ..|. +.+..+++.
T Consensus 180 ~-~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~------~~~~-----~~I~~~k~~---- 243 (357)
T KOG0598|consen 180 D-ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV------KKMY-----DKILKGKLP---- 243 (357)
T ss_pred C-ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH------HHHH-----HHHhcCcCC----
Confidence 2 23447899999999999999999999999999999999999999976542 2222 233333311
Q ss_pred hhhhccccHHHHHHHHHHHHHHhccCCCCCC
Q 046750 596 PRLEKHYVESEMFRMIEAAAACVRHSGPKRP 626 (723)
Q Consensus 596 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP 626 (723)
....+ ......+++.++|..||++|-
T Consensus 244 --~~p~~---ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 244 --LPPGY---LSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred --CCCcc---CCHHHHHHHHHHhccCHHHhc
Confidence 01111 123567888899999999996
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=354.35 Aligned_cols=267 Identities=21% Similarity=0.325 Sum_probs=207.5
Q ss_pred cCcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCCc--hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGSG--QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYE 436 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 436 (723)
+.|+...++|+|+||.||+++.+ .|+.||||+|..... ...+-.++||++|++|+|+|+|.|+++|.....++||||
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 45778889999999999999665 489999999876432 233557899999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCc
Q 046750 437 FVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQT 516 (723)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 516 (723)
||+..-|.++-+ ..+ .++.+.+.++++|+++|+.|+|++ +||||||||+||||..++.+||||||+|+.+.. ..
T Consensus 82 ~~dhTvL~eLe~-~p~-G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pg 155 (396)
T KOG0593|consen 82 YCDHTVLHELER-YPN-GVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PG 155 (396)
T ss_pred ecchHHHHHHHh-ccC-CCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC-Cc
Confidence 997765655443 222 478888999999999999999999 699999999999999999999999999998764 33
Q ss_pred ceeecccccccccChhhhcc-CCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhh-hhhhhhhh---h-cCCc
Q 046750 517 HVSTRVMGTFGYLAPEYASS-GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWA-RPVLVRAI---E-TGDL 590 (723)
Q Consensus 517 ~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~-~~~l~~~i---~-~~~l 590 (723)
...+..+.|.+|+|||++.+ -.|+...|||++|||+.||++|...|-+....+...++... ..++.+++ . ...|
T Consensus 156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F 235 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF 235 (396)
T ss_pred chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence 44567788999999999987 68999999999999999999999999776654333332221 12222221 1 2222
Q ss_pred ccccchh------hhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 046750 591 SEIVDPR------LEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVR 633 (723)
Q Consensus 591 ~~~vd~~------l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~ 633 (723)
..+.-+. |+..| .....-+++++..||+.||.+|.+-+|++.
T Consensus 236 ~Gv~lP~~~~~epLe~k~-p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 236 HGVRLPEPEHPEPLERKY-PKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eeeecCCCCCccchhhhc-ccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 2222111 11122 223346889999999999999999999874
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=367.97 Aligned_cols=268 Identities=24% Similarity=0.370 Sum_probs=206.7
Q ss_pred cCcccceEEeccCcEEEEEE-EcCCCcEEEEEEcccCCchh--HHHHHHHHHHHHHccCCceeeEeeeeecc--cceEEE
Q 046750 360 NGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQG--EREFRAEVEIISRVHHRHLVSLVGYCISE--KNRLLI 434 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~-~~~~g~~VAvK~l~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~~lV 434 (723)
+.|+.+++||+|.||.||+| ++.+|+.||+|+++....+. ..-..+||.||++|+|+||++|.+...+. ..+|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 55788899999999999999 66789999999998764332 34467899999999999999999998876 679999
Q ss_pred EEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCC
Q 046750 435 YEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTT 514 (723)
Q Consensus 435 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 514 (723)
|||| ..||.-++...+- .|.+.++..|+.||+.||+|||.+| |+|||||.+|||||++|.+||+|||||+++...
T Consensus 197 FeYM-dhDL~GLl~~p~v-kft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 197 FEYM-DHDLSGLLSSPGV-KFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred Eecc-cchhhhhhcCCCc-ccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 9999 5578887765433 4888999999999999999999995 999999999999999999999999999988877
Q ss_pred CcceeecccccccccChhhhccC-CCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhH----------Hhhhhhhhh
Q 046750 515 QTHVSTRVMGTFGYLAPEYASSG-KLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLV----------EWARPVLVR 583 (723)
Q Consensus 515 ~~~~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~----------~~~~~~l~~ 583 (723)
.....+..+.|++|++||++++. .|+.+.|+||+||||.||+.|+..|.+..+......+ .|....|..
T Consensus 272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~ 351 (560)
T KOG0600|consen 272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPH 351 (560)
T ss_pred CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCc
Confidence 77667778889999999999876 5999999999999999999999999876653221111 121101100
Q ss_pred hhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 584 AIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 584 ~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
. ..-.-..-...++... ........++|+..+|..||.+|.++.++|+.
T Consensus 352 ~-~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 352 A-TIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred c-cccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 0 0000000000111111 11112246788999999999999999998753
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-43 Score=405.47 Aligned_cols=258 Identities=29% Similarity=0.484 Sum_probs=212.7
Q ss_pred CcccceEEeccCcEEEEEEEcCC--Cc----EEEEEEcccCC-chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEE
Q 046750 361 GFARENVIGEGGFGCVYKGNLPE--GK----VVAVKQLKSGS-GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLL 433 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~~~~--g~----~VAvK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 433 (723)
+.+..+.||+|.||.||+|.+.+ |. .||||.++... .+...+|.+|..+|++++|+|||+++|+|.+....+|
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i 772 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI 772 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence 45677899999999999996543 43 49999998774 4556789999999999999999999999999999999
Q ss_pred EEEecCCCchhhccccC-----CCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccc
Q 046750 434 IYEFVPNNNLEHHLHGK-----GQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLA 508 (723)
Q Consensus 434 V~E~~~~gsL~~~l~~~-----~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla 508 (723)
|+|||++|+|..||++. +...|....++.|+.+||+|+.|||++ ++|||||.++|+||+....|||+|||||
T Consensus 773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGlA 849 (1025)
T KOG1095|consen 773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGLA 849 (1025)
T ss_pred EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccchh
Confidence 99999999999999764 234688999999999999999999999 6999999999999999999999999999
Q ss_pred cccCCCCcceeec-ccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhh
Q 046750 509 KLNDTTQTHVSTR-VMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIE 586 (723)
Q Consensus 509 ~~~~~~~~~~~~~-~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~ 586 (723)
+.+.+...+.... ..-...|||||.++.+.|+.|+|||||||+||||++ |..||...... +.+. ..++
T Consensus 850 rDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~--~v~~--------~~~~ 919 (1025)
T KOG1095|consen 850 RDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF--EVLL--------DVLE 919 (1025)
T ss_pred HhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH--HHHH--------HHHh
Confidence 9554444433222 244579999999999999999999999999999999 88998765431 1111 1223
Q ss_pred cCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCCC
Q 046750 587 TGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEM 641 (723)
Q Consensus 587 ~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~~ 641 (723)
.|++ +.+..+...+++||+.||+.+|++||++..|++++..+...
T Consensus 920 ggRL----------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 920 GGRL----------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred CCcc----------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence 3422 23344556788999999999999999999999988776653
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=369.14 Aligned_cols=258 Identities=27% Similarity=0.476 Sum_probs=205.5
Q ss_pred cCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCC--chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEe
Q 046750 360 NGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGS--GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEF 437 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 437 (723)
+.+.+.+.||+|.||+||+|+|.. .||||+|+... .+..+.|+.|+.+|++-+|.||+-|+|||..... .||.-|
T Consensus 392 ~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqw 468 (678)
T KOG0193|consen 392 EEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQW 468 (678)
T ss_pred HHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehh
Confidence 345678899999999999998843 69999998763 3455789999999999999999999999988776 899999
Q ss_pred cCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCC-Cc
Q 046750 438 VPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTT-QT 516 (723)
Q Consensus 438 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~-~~ 516 (723)
|+|.+|+.|||... ..|+..+.+.|+.||++|+.|||.+ +|||||||..||||+++++|||+||||+.....- ..
T Consensus 469 CeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~ 544 (678)
T KOG0193|consen 469 CEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGE 544 (678)
T ss_pred ccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceeeeeeeccc
Confidence 99999999999755 3589999999999999999999999 6999999999999999999999999999643221 11
Q ss_pred ceeecccccccccChhhhccC---CCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccc
Q 046750 517 HVSTRVMGTFGYLAPEYASSG---KLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEI 593 (723)
Q Consensus 517 ~~~~~~~gt~~y~APE~~~~~---~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~ 593 (723)
.....-.|...|||||+++.. .|+..+|||+||||+|||++|..||..... +..+ | ++..|.+ +
T Consensus 545 ~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~--dqIi--f-------mVGrG~l--~ 611 (678)
T KOG0193|consen 545 QQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR--DQII--F-------MVGRGYL--M 611 (678)
T ss_pred cccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh--hheE--E-------Eeccccc--C
Confidence 112223477889999999743 589999999999999999999999983322 2111 1 1222211 1
Q ss_pred cchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCC
Q 046750 594 VDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGE 640 (723)
Q Consensus 594 vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~ 640 (723)
.|... ...+..++|.+|+..||..++++||.+.+|+..|+.+..
T Consensus 612 pd~s~---~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 612 PDLSK---IRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred ccchh---hhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 11111 122345578889999999999999999999998887765
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=370.80 Aligned_cols=269 Identities=22% Similarity=0.324 Sum_probs=211.7
Q ss_pred HHhcCcccceEEeccCcEEEEEE-EcCCCcEEEEEEcccCCchhHH-HHHHHHHHHHHcc-CCceeeEeeeeeccc-ceE
Q 046750 357 EITNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGER-EFRAEVEIISRVH-HRHLVSLVGYCISEK-NRL 432 (723)
Q Consensus 357 ~~~~~f~~~~~LG~G~fG~Vy~~-~~~~g~~VAvK~l~~~~~~~~~-~~~~Ei~il~~l~-HpnIv~l~g~~~~~~-~~~ 432 (723)
.+.++|..+++||.|.||.||+| ....|..||||+++......++ .-++|++.|++|+ |+|||+|.+++.+.+ .+|
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 35578999999999999999999 5567899999999876433332 3468999999998 999999999999888 899
Q ss_pred EEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccC
Q 046750 433 LIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLND 512 (723)
Q Consensus 433 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 512 (723)
+||||| ..+|+++++++ +..+.+..+..|++||++||+|+|.+| +.||||||+|||+..+..+||+||||||.+.
T Consensus 87 fVfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 87 FVFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eeHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccc
Confidence 999999 67899999887 668999999999999999999999995 9999999999999988899999999999775
Q ss_pred CCCcceeecccccccccChhhhc-cCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchh----------hHHhhhhh-
Q 046750 513 TTQTHVSTRVMGTFGYLAPEYAS-SGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDES----------LVEWARPV- 580 (723)
Q Consensus 513 ~~~~~~~~~~~gt~~y~APE~~~-~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~----------l~~~~~~~- 580 (723)
.... .+..+-|.+|+|||++. .+-|+.+.|||++|||++||.+-+..|-+..+.+... ...|....
T Consensus 162 SkpP--YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~ 239 (538)
T KOG0661|consen 162 SKPP--YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN 239 (538)
T ss_pred cCCC--cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence 4433 46677899999999775 5679999999999999999999999997766532211 11222211
Q ss_pred hhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 581 LVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 581 l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
+...+. =.+-.+.--.|..-. .....+.++++.+||.+||.+||++.|.+++
T Consensus 240 La~~mn-f~~P~~~~~~l~~L~-p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 240 LASAMN-FRFPQVKPSPLKDLL-PNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHhc-cCCCcCCCCChHHhC-cccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 111111 011112111222112 2255678899999999999999999999874
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=365.86 Aligned_cols=249 Identities=24% Similarity=0.373 Sum_probs=206.3
Q ss_pred cCcccceEEeccCcEEEEEE-EcCCCcEEEEEEcccCC---chhHHHHHHHHHHHHHc-cCCceeeEeeeeecccceEEE
Q 046750 360 NGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGS---GQGEREFRAEVEIISRV-HHRHLVSLVGYCISEKNRLLI 434 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~-~~~~g~~VAvK~l~~~~---~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV 434 (723)
++|.+++.||+|+|++||+| +...++.||||++.+.- ....+-+..|-++|.+| .||.|++|+..|+|+..+|+|
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv 152 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV 152 (604)
T ss_pred hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence 57899999999999999999 55678999999996642 22233467899999999 899999999999999999999
Q ss_pred EEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCC
Q 046750 435 YEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTT 514 (723)
Q Consensus 435 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 514 (723)
+||+++|+|.++|++.+. |++.....++.+|+.||+|||++| ||||||||+|||||+|+++||+|||-|+.+...
T Consensus 153 Le~A~nGdll~~i~K~Gs--fde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 153 LEYAPNGDLLDLIKKYGS--FDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILSPS 227 (604)
T ss_pred EEecCCCcHHHHHHHhCc--chHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence 999999999999988764 888888999999999999999995 999999999999999999999999999876543
Q ss_pred Ccc----------e--eecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhh
Q 046750 515 QTH----------V--STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLV 582 (723)
Q Consensus 515 ~~~----------~--~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~ 582 (723)
... . ...++||-.|.+||++..+..+..+|+|+||||||.||.|..||....+.. ++
T Consensus 228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl-----------iF 296 (604)
T KOG0592|consen 228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL-----------IF 296 (604)
T ss_pred hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH-----------HH
Confidence 221 1 144799999999999999999999999999999999999999998765321 22
Q ss_pred hhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 583 RAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 583 ~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
+.|.. +.-.+...-.....+|+.+.|..||.+|.+..||.++
T Consensus 297 qkI~~----------l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 297 QKIQA----------LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred HHHHH----------hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 22211 1111122222467889999999999999999988654
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=369.47 Aligned_cols=250 Identities=22% Similarity=0.372 Sum_probs=210.0
Q ss_pred cCcccceEEeccCcEEEEEE-EcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEec
Q 046750 360 NGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFV 438 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~-~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 438 (723)
..|...++||+|.-|.||.+ +...++.||||++........+-+..|+.+|+.++|+|||++++.|...+++|+|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 34667789999999999999 56678999999998776666667889999999999999999999999999999999999
Q ss_pred CCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcce
Q 046750 439 PNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHV 518 (723)
Q Consensus 439 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 518 (723)
++|+|.+.+... .+++.++..|++++++||+|||.++ |||||||..||||+.++.+||+|||++..+..... .
T Consensus 353 ~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-K 425 (550)
T KOG0578|consen 353 EGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-K 425 (550)
T ss_pred CCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC-c
Confidence 999999998654 3899999999999999999999995 99999999999999999999999999987665443 4
Q ss_pred eecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhh
Q 046750 519 STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRL 598 (723)
Q Consensus 519 ~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l 598 (723)
....+||+.|||||++....|+.|.||||||++++||+-|+.||-...++....++ ...|.. .|
T Consensus 426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLI----------a~ng~P------~l 489 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI----------ATNGTP------KL 489 (550)
T ss_pred cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHH----------hhcCCC------Cc
Confidence 45678999999999999999999999999999999999999999765543221111 112221 11
Q ss_pred hccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 599 EKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 599 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
.........|.+++.+||..|+.+|+++.|+|+.
T Consensus 490 --k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 490 --KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred --CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 1122223467889999999999999999999863
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=408.23 Aligned_cols=263 Identities=31% Similarity=0.570 Sum_probs=215.2
Q ss_pred HhcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEE
Q 046750 358 ITNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYE 436 (723)
Q Consensus 358 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 436 (723)
+...|...++||+|+||.||+|.+ .+++.||||+++.... ....|++++++++|+|||+++|+|.+.+..|+|||
T Consensus 688 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 688 ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred HHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 345688889999999999999965 5789999999875432 22356889999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCc
Q 046750 437 FVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQT 516 (723)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 516 (723)
|+++|+|.++++. ++|..+.+|+.||++||+|||..+.++|+|||||++|||++.++..++. ||........
T Consensus 764 y~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-- 835 (968)
T PLN00113 764 YIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-- 835 (968)
T ss_pred CCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC--
Confidence 9999999999963 7899999999999999999997666689999999999999999888875 6655432211
Q ss_pred ceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccch
Q 046750 517 HVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDP 596 (723)
Q Consensus 517 ~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~ 596 (723)
....|+..|||||++.+..++.|+|||||||+||||++|+.||+.... ....+++|.+..+ .......++|+
T Consensus 836 ---~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~----~~~~~~~~~~~ 907 (968)
T PLN00113 836 ---TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCY----SDCHLDMWIDP 907 (968)
T ss_pred ---CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhc----CccchhheeCc
Confidence 223578999999999999999999999999999999999999965432 2445677765322 23344556666
Q ss_pred hhhc--cccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCC
Q 046750 597 RLEK--HYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGE 640 (723)
Q Consensus 597 ~l~~--~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~ 640 (723)
.+.. ....++..++++++.+||+.+|++||+|.||++.|+....
T Consensus 908 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 908 SIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred cccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 6643 3445677789999999999999999999999999998654
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=367.40 Aligned_cols=258 Identities=27% Similarity=0.430 Sum_probs=202.4
Q ss_pred cCcccceEEeccCcEEEEEEEc------CCCcEEEEEEcccCCc-hhHHHHHHHHHHHHHc-cCCceeeEeeeeeccc-c
Q 046750 360 NGFARENVIGEGGFGCVYKGNL------PEGKVVAVKQLKSGSG-QGEREFRAEVEIISRV-HHRHLVSLVGYCISEK-N 430 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~------~~g~~VAvK~l~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~-~ 430 (723)
++|++.++||+|+||.||+|.+ ..++.||||+++.... .....+.+|+++|.++ +|+||++++++|...+ .
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGP 86 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCc
Confidence 5788999999999999999953 2356899999976433 3345789999999999 8999999999887644 5
Q ss_pred eEEEEEecCCCchhhccccCC-----------------------------------------------------------
Q 046750 431 RLLIYEFVPNNNLEHHLHGKG----------------------------------------------------------- 451 (723)
Q Consensus 431 ~~lV~E~~~~gsL~~~l~~~~----------------------------------------------------------- 451 (723)
+++||||+.+|+|.++|....
T Consensus 87 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (338)
T cd05102 87 LMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDL 166 (338)
T ss_pred eEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccc
Confidence 789999999999999886432
Q ss_pred -CCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcce-eeccccccccc
Q 046750 452 -QPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHV-STRVMGTFGYL 529 (723)
Q Consensus 452 -~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~ 529 (723)
...+.+..++.++.||++||+|||++ +|+|||||++||||++++.+||+|||+++......... .....++..|+
T Consensus 167 ~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 243 (338)
T cd05102 167 WKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM 243 (338)
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcccc
Confidence 12367788899999999999999998 59999999999999999999999999997653322221 22334667899
Q ss_pred ChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhhhccccHHHHH
Q 046750 530 APEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMF 608 (723)
Q Consensus 530 APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~ 608 (723)
|||++.+..++.++|||||||+||||++ |..||...... .. +.+.+..+..... ......
T Consensus 244 aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~--~~--------~~~~~~~~~~~~~---------~~~~~~ 304 (338)
T cd05102 244 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN--EE--------FCQRLKDGTRMRA---------PENATP 304 (338)
T ss_pred CcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc--HH--------HHHHHhcCCCCCC---------CCCCCH
Confidence 9999999999999999999999999997 99999754321 11 1122222221111 111223
Q ss_pred HHHHHHHHHhccCCCCCCCHHHHHHHHhccC
Q 046750 609 RMIEAAAACVRHSGPKRPRMVQVVRALDSEG 639 (723)
Q Consensus 609 ~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~ 639 (723)
.+.+|+.+||+.||.+||++.+|++.|+.+.
T Consensus 305 ~l~~li~~cl~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 305 EIYRIMLACWQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 6789999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=351.74 Aligned_cols=260 Identities=25% Similarity=0.383 Sum_probs=209.2
Q ss_pred cCcccceEEeccCcEEEEEE-EcCCCcEEEEEEcccCCc-hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEe
Q 046750 360 NGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSG-QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEF 437 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~-~~~~g~~VAvK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 437 (723)
+.|+..+.||.|.-+.||+| +...++.||||++.-... .....+++|++.|+.++||||++++..|..+..+|+||.|
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf 105 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF 105 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence 56899999999999999999 556789999999975533 3357899999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcc
Q 046750 438 VPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTH 517 (723)
Q Consensus 438 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 517 (723)
|.+|++.+++...-...+++..+..|++++++||.|||++| .||||||+.||||+.+|.|||+|||.+..+.+....
T Consensus 106 Ma~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R 182 (516)
T KOG0582|consen 106 MAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDR 182 (516)
T ss_pred hcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccCce
Confidence 99999999998776667999999999999999999999995 999999999999999999999999988655443332
Q ss_pred ee---ecccccccccChhhhcc--CCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCccc
Q 046750 518 VS---TRVMGTFGYLAPEYASS--GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSE 592 (723)
Q Consensus 518 ~~---~~~~gt~~y~APE~~~~--~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~ 592 (723)
.. ..++|++.|||||+++. ..|+.|+||||||+...||.+|..||...-+.. . |+..+. +....
T Consensus 183 ~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk--v--------Ll~tLq-n~pp~ 251 (516)
T KOG0582|consen 183 QVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK--V--------LLLTLQ-NDPPT 251 (516)
T ss_pred eeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH--H--------HHHHhc-CCCCC
Confidence 22 44689999999999654 359999999999999999999999998765532 1 222222 11111
Q ss_pred ccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 046750 593 IVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVR 633 (723)
Q Consensus 593 ~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~ 633 (723)
++--.+..+-....-..+.+++..||++||.+||+++++++
T Consensus 252 ~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 252 LLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred cccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 11001111111112237889999999999999999999985
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=334.15 Aligned_cols=266 Identities=23% Similarity=0.391 Sum_probs=206.7
Q ss_pred cCcccceEEeccCcEEEEEE-EcCCCcEEEEEEcccCCch--hHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQ--GEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYE 436 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~-~~~~g~~VAvK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 436 (723)
++|...++||+|.||.||+| +.+.|+.||||+++..... ......+||++|+.++|+||+.|+++|-+.+.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 46778899999999999999 6678999999999875322 23467899999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCc
Q 046750 437 FVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQT 516 (723)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 516 (723)
|| ..+|+..++++.. .|.-.++..++.++++||+|||+++ |+||||||.|+|++.++.+||+||||++.+.....
T Consensus 82 fm-~tdLe~vIkd~~i-~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 82 FM-PTDLEVVIKDKNI-ILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred ec-cccHHHHhccccc-ccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 99 7789999977654 6778888999999999999999995 99999999999999999999999999998875544
Q ss_pred ceeecccccccccChhhhccC-CCCCccceechHHHHHHHHhCCCCCCCCCCCCchhh----------HHhhhhhhhhhh
Q 046750 517 HVSTRVMGTFGYLAPEYASSG-KLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESL----------VEWARPVLVRAI 585 (723)
Q Consensus 517 ~~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l----------~~~~~~~l~~~i 585 (723)
.... .+-|.+|+|||++.+. .|+...||||.|||+.||+.|..-|.+....+.... ..|-. +...-
T Consensus 157 ~~~~-~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~--~~~lp 233 (318)
T KOG0659|consen 157 IQTH-QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPE--MTSLP 233 (318)
T ss_pred cccc-ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcc--ccccc
Confidence 3333 3679999999988765 599999999999999999999888876654322111 11111 00000
Q ss_pred hcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 586 ETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 586 ~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
+..++..+-.+.+ ..+-.......++|+..+|..||.+|.++.|.+++
T Consensus 234 dY~~~~~~P~~~~-~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 234 DYVKIQQFPKPPL-NNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cHHHHhcCCCCcc-ccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 0001110101111 11333344567899999999999999999999865
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=356.43 Aligned_cols=259 Identities=27% Similarity=0.428 Sum_probs=204.9
Q ss_pred cCcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeeccc--ceEEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEK--NRLLIYE 436 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~--~~~lV~E 436 (723)
.+|...+.||+|.||.||++... +|+..|||.+........+.+.+|+.+|++|+|+|||+++|...... .++++||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 45788899999999999999654 48999999987654333667899999999999999999999855554 5889999
Q ss_pred ecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCC-CCcEEEeecccccccCC--
Q 046750 437 FVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDD-EFEAQVADFGLAKLNDT-- 513 (723)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~-~~~vkL~DFGla~~~~~-- 513 (723)
|+.+|+|.+++.+.+. .|.+..+.++..||++||+|||++| |||||||++||||+. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred ccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999988776 6899999999999999999999994 999999999999999 79999999999986653
Q ss_pred CCcceeecccccccccChhhhccCC-CCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCccc
Q 046750 514 TQTHVSTRVMGTFGYLAPEYASSGK-LTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSE 592 (723)
Q Consensus 514 ~~~~~~~~~~gt~~y~APE~~~~~~-~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~ 592 (723)
........+.||+.|||||++..+. ...++|||||||+++||+||+.||.... ....+. ......+..-
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~-----~~~~~~----~~ig~~~~~P- 242 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF-----EEAEAL----LLIGREDSLP- 242 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc-----chHHHH----HHHhccCCCC-
Confidence 1222234567999999999999643 3459999999999999999999997531 111111 1111111111
Q ss_pred ccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCC
Q 046750 593 IVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGE 640 (723)
Q Consensus 593 ~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~ 640 (723)
.+.........+++.+|+..+|.+||++.++|+..-....
T Consensus 243 --------~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 243 --------EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN 282 (313)
T ss_pred --------CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence 1222223356788889999999999999999987655443
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=362.48 Aligned_cols=251 Identities=23% Similarity=0.383 Sum_probs=206.2
Q ss_pred HhcCcccceEEeccCcEEEEEE-EcCCCcEEEEEEcccC----Cc-hhHHHHHHHHHHHHHcc-CCceeeEeeeeecccc
Q 046750 358 ITNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSG----SG-QGEREFRAEVEIISRVH-HRHLVSLVGYCISEKN 430 (723)
Q Consensus 358 ~~~~f~~~~~LG~G~fG~Vy~~-~~~~g~~VAvK~l~~~----~~-~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~ 430 (723)
..++|.+.+.||+|.||.||+| ...+++.||||++... .. ...+.+.+|+.++++++ |+||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 4568999999999999999999 5557899999977653 12 23456778999999998 9999999999999999
Q ss_pred eEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCC-CcEEEeeccccc
Q 046750 431 RLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDE-FEAQVADFGLAK 509 (723)
Q Consensus 431 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~-~~vkL~DFGla~ 509 (723)
+|+||||+.+|+|.+++.+.+ .+.+....+++.||+.||+|||++| |+|||||++||||+.+ +++||+|||++.
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~g--~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNKG--RLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred EEEEEEecCCccHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 999999999999999998744 3777889999999999999999995 9999999999999999 999999999998
Q ss_pred ccCCCCcceeecccccccccChhhhccCC-CC-CccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhc
Q 046750 510 LNDTTQTHVSTRVMGTFGYLAPEYASSGK-LT-DRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIET 587 (723)
Q Consensus 510 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~t-~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~ 587 (723)
... .........+|++.|+|||++.+.. |+ .++||||||||||.|++|+.||+.... . .+...+..
T Consensus 170 ~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~------~-----~l~~ki~~ 237 (370)
T KOG0583|consen 170 ISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV------P-----NLYRKIRK 237 (370)
T ss_pred ccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH------H-----HHHHHHhc
Confidence 774 2223345578999999999999877 75 789999999999999999999987331 1 12233444
Q ss_pred CCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 588 GDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 588 ~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
+.+. +..... ...+..|+.+||..+|.+|+++.+|++.
T Consensus 238 ~~~~------~p~~~~---S~~~~~Li~~mL~~~P~~R~t~~~i~~h 275 (370)
T KOG0583|consen 238 GEFK------IPSYLL---SPEARSLIEKMLVPDPSTRITLLEILEH 275 (370)
T ss_pred CCcc------CCCCcC---CHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence 4321 111110 3467889999999999999999999943
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=349.47 Aligned_cols=268 Identities=30% Similarity=0.484 Sum_probs=203.1
Q ss_pred CcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHc--cCCceeeEeeeeeccc----ceEEE
Q 046750 361 GFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRV--HHRHLVSLVGYCISEK----NRLLI 434 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l--~HpnIv~l~g~~~~~~----~~~lV 434 (723)
..+..++||+|.||.||+|.+ +++.||||+|.. +..+.|+.|-+|++.. +|+||++|+++-.... +++||
T Consensus 211 pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred chhhHHHhhcCccceeehhhc-cCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence 345667899999999999999 559999999975 5667899999998875 8999999999876554 78999
Q ss_pred EEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccC------CCceeecCCCCCcEEeCCCCcEEEeecccc
Q 046750 435 YEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDC------HPKIIHRDIKSANILVDDEFEAQVADFGLA 508 (723)
Q Consensus 435 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g------~~~ivHrDIkp~NILl~~~~~vkL~DFGla 508 (723)
+||++.|+|.+||..+ .++|....+|+..+++||+|||+.- ++.|+|||||.+||||.+|+.+.|+|||||
T Consensus 287 t~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA 363 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA 363 (534)
T ss_pred eeeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence 9999999999999765 5899999999999999999999742 568999999999999999999999999999
Q ss_pred cccCCCCcc-eeecccccccccChhhhccCC-CC-----CccceechHHHHHHHHhCCCCCCC-CCCC---------Cch
Q 046750 509 KLNDTTQTH-VSTRVMGTFGYLAPEYASSGK-LT-----DRSDVFSFGVVLLELITGRKPVDP-TQPL---------GDE 571 (723)
Q Consensus 509 ~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~-~t-----~ksDVwSlGviL~eLltG~~P~~~-~~~~---------~~~ 571 (723)
..+...... .....+||.+|||||++.+.. +. .+.||||+|.|||||++....++. ..+. +..
T Consensus 364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~h 443 (534)
T KOG3653|consen 364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNH 443 (534)
T ss_pred EEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCC
Confidence 876543322 223368999999999997643 22 268999999999999998766642 1110 000
Q ss_pred hhHHhhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCCCc
Q 046750 572 SLVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEMS 642 (723)
Q Consensus 572 ~l~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~~~ 642 (723)
--.+-.+.++.++ +.+..+...+.++ ..+..|.+.+..||++|++.|-++.-|.+.+..+....
T Consensus 444 Pt~e~mq~~VV~k----K~RP~~p~~W~~h---~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 444 PTLEEMQELVVRK----KQRPKIPDAWRKH---AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred CCHHHHHHHHHhh----ccCCCChhhhhcC---ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 0011111111111 1111111111111 34567888999999999999999999999998877664
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=349.30 Aligned_cols=277 Identities=27% Similarity=0.393 Sum_probs=214.4
Q ss_pred ccCHHHHHHHhcCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHc--cCCceeeEeeeee
Q 046750 349 FFTYEELMEITNGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRV--HHRHLVSLVGYCI 426 (723)
Q Consensus 349 ~~~~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l--~HpnIv~l~g~~~ 426 (723)
-..+.....+.+.....+.||+|.||+||+|+| .|+.||||+|.. .+++.+.+|.+|++.+ +|+||+.|++.-.
T Consensus 200 GlplLVQRTiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~ 275 (513)
T KOG2052|consen 200 GLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADN 275 (513)
T ss_pred CchhHhHHhhhheeEEEEEecCccccceeeccc-cCCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccc
Confidence 345666778888999999999999999999999 789999999976 4567788999999875 9999999998765
Q ss_pred ccc----ceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcc-----cCCCceeecCCCCCcEEeCCC
Q 046750 427 SEK----NRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHE-----DCHPKIIHRDIKSANILVDDE 497 (723)
Q Consensus 427 ~~~----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-----~g~~~ivHrDIkp~NILl~~~ 497 (723)
.++ .++||.||++.|+|.|||.+. .++.+..+++++.+|.||++||- +|++.|.|||||.+||||.++
T Consensus 276 ~~~gs~TQLwLvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn 352 (513)
T KOG2052|consen 276 KDNGSWTQLWLVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN 352 (513)
T ss_pred cCCCceEEEEEeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccC
Confidence 443 468999999999999999764 48889999999999999999995 578999999999999999999
Q ss_pred CcEEEeecccccccCCCCcc---eeecccccccccChhhhccCC----C--CCccceechHHHHHHHHhC----------
Q 046750 498 FEAQVADFGLAKLNDTTQTH---VSTRVMGTFGYLAPEYASSGK----L--TDRSDVFSFGVVLLELITG---------- 558 (723)
Q Consensus 498 ~~vkL~DFGla~~~~~~~~~---~~~~~~gt~~y~APE~~~~~~----~--t~ksDVwSlGviL~eLltG---------- 558 (723)
+.+.|+|||||......... .....+||.+|||||++.... + -..+||||||+||||+...
T Consensus 353 ~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey 432 (513)
T KOG2052|consen 353 GTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEY 432 (513)
T ss_pred CcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhh
Confidence 99999999999765544222 223457999999999985432 1 1258999999999999773
Q ss_pred CCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhcc
Q 046750 559 RKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSE 638 (723)
Q Consensus 559 ~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~ 638 (723)
+.||.+..+ .+.++.++.+.. -..++...++.++ .+.+.+..|.+||+.||..+|..|-++-.|-+.|.++
T Consensus 433 ~~Pyyd~Vp-~DPs~eeMrkVV-----Cv~~~RP~ipnrW---~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l 503 (513)
T KOG2052|consen 433 QLPYYDVVP-SDPSFEEMRKVV-----CVQKLRPNIPNRW---KSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKL 503 (513)
T ss_pred cCCcccCCC-CCCCHHHHhcce-----eecccCCCCCccc---ccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHH
Confidence 344443322 122222222111 1122222222222 2446788899999999999999999999999999887
Q ss_pred CCC
Q 046750 639 GEM 641 (723)
Q Consensus 639 ~~~ 641 (723)
...
T Consensus 504 ~~~ 506 (513)
T KOG2052|consen 504 SNS 506 (513)
T ss_pred hcC
Confidence 654
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=361.19 Aligned_cols=242 Identities=27% Similarity=0.448 Sum_probs=204.2
Q ss_pred cceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEecCCCch
Q 046750 364 RENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNL 443 (723)
Q Consensus 364 ~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 443 (723)
.++-||.|+-|.||+|++ .++.||||+++.. -..+|+-|++|+|+||+.|.|+|...-.+|||||||..|-|
T Consensus 128 ELeWlGSGaQGAVF~Grl-~netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRL-HNETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL 199 (904)
T ss_pred hhhhhccCcccceeeeec-cCceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence 457899999999999999 6789999988632 24589999999999999999999999999999999999999
Q ss_pred hhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcceeeccc
Q 046750 444 EHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVM 523 (723)
Q Consensus 444 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 523 (723)
+..|+... .+.......|..+||.|+.|||.+ +|||||||.-||||..+..|||+|||-++...+. .....++
T Consensus 200 ~~VLka~~--~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMSFa 272 (904)
T KOG4721|consen 200 YEVLKAGR--PITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMSFA 272 (904)
T ss_pred HHHHhccC--ccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhhhh
Confidence 99997654 466777889999999999999999 6999999999999999999999999999876554 2345578
Q ss_pred ccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhhhcccc
Q 046750 524 GTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEKHYV 603 (723)
Q Consensus 524 gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~ 603 (723)
||..|||||+|+....++|.|||||||||||||||..||..-+. ..+-|- +.. ..|.....
T Consensus 273 GTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds----sAIIwG-------VGs--------NsL~LpvP 333 (904)
T KOG4721|consen 273 GTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS----SAIIWG-------VGS--------NSLHLPVP 333 (904)
T ss_pred hhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch----heeEEe-------ccC--------CcccccCc
Confidence 99999999999999999999999999999999999999975432 112221 111 12333445
Q ss_pred HHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccC
Q 046750 604 ESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEG 639 (723)
Q Consensus 604 ~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~ 639 (723)
..+...|.-|++.||+..|..||++.+|+..|+-..
T Consensus 334 stcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~ 369 (904)
T KOG4721|consen 334 STCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIAS 369 (904)
T ss_pred ccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence 556667888999999999999999999999997654
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=369.16 Aligned_cols=258 Identities=26% Similarity=0.424 Sum_probs=207.8
Q ss_pred cCcccceEEeccCcEEEEEEEcCCC----cE-EEEEEcccC---CchhHHHHHHHHHHHHHccCCceeeEeeeeecccce
Q 046750 360 NGFARENVIGEGGFGCVYKGNLPEG----KV-VAVKQLKSG---SGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNR 431 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~~g----~~-VAvK~l~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 431 (723)
++....++||+|.||+||+|+++.+ .. ||||..+.. ......+|++|+++|+.++|+|||+|+|++.+...+
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 3445568999999999999966442 23 899999852 355667899999999999999999999999999999
Q ss_pred EEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeeccccccc
Q 046750 432 LLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLN 511 (723)
Q Consensus 432 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 511 (723)
|||||+|.||+|++||..... .++..+++++++++|+||+|||++ ++|||||.++|+|++.++.+||+||||++..
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~~ 312 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRAG 312 (474)
T ss_pred EEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccCC
Confidence 999999999999999987765 588999999999999999999999 6999999999999999999999999999755
Q ss_pred CCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCc
Q 046750 512 DTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDL 590 (723)
Q Consensus 512 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l 590 (723)
........ ...-...|+|||.+..+.|+.++|||||||++||+++ |..||.+.... . +...+....+
T Consensus 313 ~~~~~~~~-~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~---~--------v~~kI~~~~~ 380 (474)
T KOG0194|consen 313 SQYVMKKF-LKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY---E--------VKAKIVKNGY 380 (474)
T ss_pred cceeeccc-cccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH---H--------HHHHHHhcCc
Confidence 41111110 1124679999999999999999999999999999999 88888765421 1 2223322221
Q ss_pred ccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCCC
Q 046750 591 SEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEM 641 (723)
Q Consensus 591 ~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~~ 641 (723)
.. .........+..++..||..+|++|++|.+|.+.|+.....
T Consensus 381 r~--------~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~ 423 (474)
T KOG0194|consen 381 RM--------PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKK 423 (474)
T ss_pred cC--------CCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhc
Confidence 11 11223344677788899999999999999999999887654
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=361.80 Aligned_cols=246 Identities=27% Similarity=0.425 Sum_probs=208.7
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCC--chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS--GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYE 436 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 436 (723)
++|.+.+.||+|.||.||||+. .+.+.||||.+.+.. .++.+.+++|++|+++|+|+|||.++++|+...++++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 5688889999999999999954 467899999986643 3445678999999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCc
Q 046750 437 FVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQT 516 (723)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 516 (723)
|+.| +|..+|...+ .+.++.+..|+.+++.||.|||++ +|+|||+||+||||+..+.+||||||+|+.... ..
T Consensus 82 ~a~g-~L~~il~~d~--~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDG--KLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMST-NT 154 (808)
T ss_pred hhhh-hHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhccc-Cc
Confidence 9966 9999997655 489999999999999999999999 699999999999999999999999999997765 44
Q ss_pred ceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccch
Q 046750 517 HVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDP 596 (723)
Q Consensus 517 ~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~ 596 (723)
...+.+.||+-|||||++.+..|+..+|+||||||||||+.|+.||.... +.. +.+.|..+..
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s------i~~-----Lv~~I~~d~v------ 217 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS------ITQ-----LVKSILKDPV------ 217 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH------HHH-----HHHHHhcCCC------
Confidence 56677889999999999999999999999999999999999999996432 222 2222222221
Q ss_pred hhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 046750 597 RLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVR 633 (723)
Q Consensus 597 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~ 633 (723)
.+.......+.+++...|.+||.+|-+-.+++.
T Consensus 218 ----~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 218 ----KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred ----CCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 233345557889999999999999999988764
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=349.50 Aligned_cols=262 Identities=26% Similarity=0.428 Sum_probs=202.1
Q ss_pred cCcccceEEeccCcEEEEEEEcCC-----------------CcEEEEEEcccCCc-hhHHHHHHHHHHHHHccCCceeeE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLPE-----------------GKVVAVKQLKSGSG-QGEREFRAEVEIISRVHHRHLVSL 421 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~~-----------------g~~VAvK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l 421 (723)
++|.+.++||+|+||.||+|.+.+ +..||||+++.... ....+|.+|+++|.+++|+||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 568899999999999999996532 33699999876533 334579999999999999999999
Q ss_pred eeeeecccceEEEEEecCCCchhhccccCC-----------------CCcchHHHHHHHHHHHHhhhchhcccCCCceee
Q 046750 422 VGYCISEKNRLLIYEFVPNNNLEHHLHGKG-----------------QPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIH 484 (723)
Q Consensus 422 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~-----------------~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivH 484 (723)
+++|.+.+..++||||+.+|+|.+++.... ...+.+..+++|+.||+.||+|||++ +|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cccc
Confidence 999999999999999999999999885421 12467888999999999999999999 4999
Q ss_pred cCCCCCcEEeCCCCcEEEeecccccccCCCCcc-eeecccccccccChhhhccCCCCCccceechHHHHHHHHh--CCCC
Q 046750 485 RDIKSANILVDDEFEAQVADFGLAKLNDTTQTH-VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT--GRKP 561 (723)
Q Consensus 485 rDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt--G~~P 561 (723)
||||++||||++++.+||+|||+++........ ......++..|+|||++.++.++.++|||||||+||||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 999999999999999999999999765433221 2233456789999999999999999999999999999987 4566
Q ss_pred CCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhc
Q 046750 562 VDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDS 637 (723)
Q Consensus 562 ~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~ 637 (723)
|.... ......+....+.. ... .+. ..........+.+|+.+||+.+|.+||+|.+|++.|++
T Consensus 242 ~~~~~---~~~~~~~~~~~~~~----~~~-~~~-----~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 242 YGELT---DEQVIENAGEFFRD----QGR-QVY-----LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCcCC---HHHHHHHHHHHhhh----ccc-ccc-----ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 65432 22222222211110 000 000 00011223468899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=346.30 Aligned_cols=252 Identities=26% Similarity=0.389 Sum_probs=201.2
Q ss_pred CcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCC---chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEE
Q 046750 361 GFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS---GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYE 436 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 436 (723)
.|+..++||+|+||.||+|.. .+|+.||||++.... ......+.+|+++|++++|+||++++++|.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 377889999999999999954 578999999986532 2233457889999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCc
Q 046750 437 FVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQT 516 (723)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 516 (723)
|+.+|+|.+++.......+++..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||++........
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET 157 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence 99999999888655444688999999999999999999999 599999999999999999999999999976543221
Q ss_pred ceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccch
Q 046750 517 HVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDP 596 (723)
Q Consensus 517 ~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~ 596 (723)
.....|+..|+|||++.+..++.++|||||||+||||++|+.||......... .. +...+....
T Consensus 158 --~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~--~~-----~~~~~~~~~------- 221 (285)
T cd05631 158 --VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR--EE-----VDRRVKEDQ------- 221 (285)
T ss_pred --ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH--HH-----HHHHhhccc-------
Confidence 23456899999999999999999999999999999999999999765432110 00 111111111
Q ss_pred hhhccccHHHHHHHHHHHHHHhccCCCCCCC-----HHHHHHH
Q 046750 597 RLEKHYVESEMFRMIEAAAACVRHSGPKRPR-----MVQVVRA 634 (723)
Q Consensus 597 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~eVl~~ 634 (723)
..+.......+.+|+.+||+.||.+|++ +++|++.
T Consensus 222 ---~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 222 ---EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred ---ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 0111112336788999999999999997 7777763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=332.86 Aligned_cols=236 Identities=26% Similarity=0.369 Sum_probs=199.8
Q ss_pred cCcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCCc---hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGSG---QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 435 (723)
++|++.+.||.|+||.|.+++.+ +|..+|+|+|..... .+.+....|..+|+.+.||+++++++.|.+...+||||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 46888999999999999999654 578999999976532 33345678999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ 515 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 515 (723)
||+.||.|..+|++.++ +++.....++.+|+.||+|||++ .||+|||||+|||||.+|.+||+|||+|+.....
T Consensus 124 eyv~GGElFS~Lrk~~r--F~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r- 197 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSGR--FSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR- 197 (355)
T ss_pred eccCCccHHHHHHhcCC--CCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecCc-
Confidence 99999999999988765 88899999999999999999999 5999999999999999999999999999876532
Q ss_pred cceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccc
Q 046750 516 THVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVD 595 (723)
Q Consensus 516 ~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd 595 (723)
....+||+.|+|||++....|..++|.|+|||++|||+.|..||...... .+.++|..+++.
T Consensus 198 ---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~-----------~iY~KI~~~~v~---- 259 (355)
T KOG0616|consen 198 ---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI-----------QIYEKILEGKVK---- 259 (355)
T ss_pred ---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH-----------HHHHHHHhCccc----
Confidence 34578999999999999999999999999999999999999999876542 134445555431
Q ss_pred hhhhccccHHHHHHHHHHHHHHhccCCCCC
Q 046750 596 PRLEKHYVESEMFRMIEAAAACVRHSGPKR 625 (723)
Q Consensus 596 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~R 625 (723)
++..-...+.+|+..+|+.|-.+|
T Consensus 260 ------fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 260 ------FPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred ------CCcccCHHHHHHHHHHHhhhhHhh
Confidence 111222356778888888888887
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=348.33 Aligned_cols=248 Identities=20% Similarity=0.326 Sum_probs=199.1
Q ss_pred cceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchh---HHHHHHHHHHHHHccCCceeeEeeeeec----ccceEEEEE
Q 046750 364 RENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQG---EREFRAEVEIISRVHHRHLVSLVGYCIS----EKNRLLIYE 436 (723)
Q Consensus 364 ~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~g~~~~----~~~~~lV~E 436 (723)
....||+|+||.||+|.+ +|+.||||+++...... .+.|.+|+++|++++|+||++++|+|.+ ....++|||
T Consensus 24 ~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~E 102 (283)
T PHA02988 24 TSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE 102 (283)
T ss_pred CCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEE
Confidence 346899999999999988 78999999997653322 3578899999999999999999999877 346789999
Q ss_pred ecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCc
Q 046750 437 FVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQT 516 (723)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 516 (723)
|+.+|+|.++++... .+.+...++++.+++.||.|||+.. +++|||||++|||+++++.+||+|||+++......
T Consensus 103 y~~~g~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 103 YCTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred eCCCCcHHHHHhhCC--CCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 999999999997654 4889999999999999999999852 48899999999999999999999999997654322
Q ss_pred ceeecccccccccChhhhcc--CCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCccccc
Q 046750 517 HVSTRVMGTFGYLAPEYASS--GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIV 594 (723)
Q Consensus 517 ~~~~~~~gt~~y~APE~~~~--~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~v 594 (723)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||..... ..+. ..+..+....
T Consensus 178 ---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~---~~~~--------~~i~~~~~~~-- 241 (283)
T PHA02988 178 ---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT---KEIY--------DLIINKNNSL-- 241 (283)
T ss_pred ---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH---HHHH--------HHHHhcCCCC--
Confidence 22457889999999976 6899999999999999999999999975431 1111 1111111110
Q ss_pred chhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccC
Q 046750 595 DPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEG 639 (723)
Q Consensus 595 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~ 639 (723)
.........+.+++.+||+.||.+||++.+|++.|+...
T Consensus 242 ------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 242 ------KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred ------CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 011122346788999999999999999999999998754
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=375.22 Aligned_cols=260 Identities=23% Similarity=0.345 Sum_probs=213.0
Q ss_pred hcCcccceEEeccCcEEEEEEEcCCC-cEEEEEEcccCCchhHHHHHHHHHHHHHcc-CCceeeEee-eeec------cc
Q 046750 359 TNGFARENVIGEGGFGCVYKGNLPEG-KVVAVKQLKSGSGQGEREFRAEVEIISRVH-HRHLVSLVG-YCIS------EK 429 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~~~g-~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g-~~~~------~~ 429 (723)
..++++.+.|.+|||+.||++....+ ..||+|++...+....+.+++||++|++|. |+|||.|++ .... ..
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 35688999999999999999977665 999999998888888889999999999996 999999999 3221 24
Q ss_pred ceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeeccccc
Q 046750 430 NRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK 509 (723)
Q Consensus 430 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 509 (723)
+++|+||||.||.|-+++..+....|.+.++++|+.++++|+++||.. .+.|||||||.+||||..++.+||||||-+.
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 578999999999999999876555699999999999999999999997 5779999999999999999999999999985
Q ss_pred ccCCCC-cce-------eecccccccccChhhh---ccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhh
Q 046750 510 LNDTTQ-THV-------STRVMGTFGYLAPEYA---SSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWAR 578 (723)
Q Consensus 510 ~~~~~~-~~~-------~~~~~gt~~y~APE~~---~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~ 578 (723)
-..... ... .-...-|+.|++||+| .+..+++|+|||+|||+||-||....||+....+
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l---------- 264 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL---------- 264 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce----------
Confidence 332211 110 0112358899999977 4677999999999999999999999999876432
Q ss_pred hhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCCCc
Q 046750 579 PVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEMS 642 (723)
Q Consensus 579 ~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~~~ 642 (723)
+|..++ +.-........+|.+||..||+.+|.+||++-||+..+-.+....
T Consensus 265 -----aIlng~--------Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 265 -----AILNGN--------YSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred -----eEEecc--------ccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 122222 222223456678999999999999999999999999988777653
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=347.94 Aligned_cols=262 Identities=24% Similarity=0.321 Sum_probs=206.3
Q ss_pred HHHhcCcccceEEeccCcEEEEEE-EcCCCcEEEEEEcccCC--------------chhHHHHHHHHHHHHHccCCceee
Q 046750 356 MEITNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGS--------------GQGEREFRAEVEIISRVHHRHLVS 420 (723)
Q Consensus 356 ~~~~~~f~~~~~LG~G~fG~Vy~~-~~~~g~~VAvK~l~~~~--------------~~~~~~~~~Ei~il~~l~HpnIv~ 420 (723)
.+..++|.+++.||+|.||.|.+| ...+++.||||++.+.. ....+..++||.||++|+|+|||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 344578999999999999999999 44578999999986431 112347889999999999999999
Q ss_pred Eeeeeecc--cceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCC
Q 046750 421 LVGYCISE--KNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEF 498 (723)
Q Consensus 421 l~g~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~ 498 (723)
|+++..+. +.+|||+|||..|.+...-... ..|.+.+..+|+.+++.||+|||.++ ||||||||+|+||++++
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~--~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPPDK--PELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDG 247 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCCCCc--ccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCC
Confidence 99998764 5789999999988876544322 22889999999999999999999995 99999999999999999
Q ss_pred cEEEeecccccccCCCC----cceeecccccccccChhhhccCC----CCCccceechHHHHHHHHhCCCCCCCCCCCCc
Q 046750 499 EAQVADFGLAKLNDTTQ----THVSTRVMGTFGYLAPEYASSGK----LTDRSDVFSFGVVLLELITGRKPVDPTQPLGD 570 (723)
Q Consensus 499 ~vkL~DFGla~~~~~~~----~~~~~~~~gt~~y~APE~~~~~~----~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~ 570 (723)
+|||+|||.+..+.... .....+.+||+.|+|||.+.++. .+.+.|||++||.||.|+.|+.||.....+
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~-- 325 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL-- 325 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH--
Confidence 99999999997662211 11223468999999999987743 456899999999999999999999754321
Q ss_pred hhhHHhhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCCC
Q 046750 571 ESLVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEM 641 (723)
Q Consensus 571 ~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~~ 641 (723)
+ +.++| +...|.-....++-..+.+|++++|.+||++|.++.+|....+-....
T Consensus 326 ----~-----l~~KI--------vn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g 379 (576)
T KOG0585|consen 326 ----E-----LFDKI--------VNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDG 379 (576)
T ss_pred ----H-----HHHHH--------hcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCC
Confidence 1 22222 222333222334455788999999999999999999999988776653
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=363.05 Aligned_cols=261 Identities=27% Similarity=0.397 Sum_probs=217.5
Q ss_pred CcccceEEeccCcEEEEEEEcCC-CcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEecC
Q 046750 361 GFARENVIGEGGFGCVYKGNLPE-GKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVP 439 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~~~~-g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 439 (723)
++...++||-|.||.||.|.|+. .-.||||.|+.+. ...++|++|..+|+.|+|+|+|+|+|+|..+-.+|||.|||.
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~ 346 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMC 346 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEeccc
Confidence 34556789999999999997765 5689999998765 445799999999999999999999999999999999999999
Q ss_pred CCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCccee
Q 046750 440 NNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVS 519 (723)
Q Consensus 440 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 519 (723)
.|+|.+||.+..+..+....++.++.||..|++||..+ ++|||||.++|+|+.++..|||+||||++++..+.....
T Consensus 347 yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAH 423 (1157)
T KOG4278|consen 347 YGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAH 423 (1157)
T ss_pred CccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcCCceecc
Confidence 99999999998887888888999999999999999998 799999999999999999999999999998765544322
Q ss_pred ecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhh
Q 046750 520 TRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRL 598 (723)
Q Consensus 520 ~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l 598 (723)
....-...|.|||-+....++.|+|||+|||+|||+.| |..||-+.+. +. ++ +++.+.+
T Consensus 424 AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl----Sq-------VY---------~LLEkgy 483 (1157)
T KOG4278|consen 424 AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL----SQ-------VY---------GLLEKGY 483 (1157)
T ss_pred cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH----HH-------HH---------HHHhccc
Confidence 22234678999999999999999999999999999999 7788765421 11 11 1122223
Q ss_pred hccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCCCcccc
Q 046750 599 EKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEMSDLS 645 (723)
Q Consensus 599 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~~~~~~ 645 (723)
+.+....+...+++||+.||+++|.+||++.||.+.|+.+.....++
T Consensus 484 RM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sSis 530 (1157)
T KOG4278|consen 484 RMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSSIS 530 (1157)
T ss_pred cccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcccccc
Confidence 33444556668999999999999999999999999999876643333
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=361.40 Aligned_cols=249 Identities=25% Similarity=0.380 Sum_probs=209.7
Q ss_pred cCcccceEEeccCcEEEEEE-EcCCCcEEEEEEcccCC---chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGS---GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~-~~~~g~~VAvK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 435 (723)
+-|+.++.||+|+-|.|-+| +...|+.+|||++.... ......+.+||-||+.|.|+||++||+++++..++|||+
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 34888999999999999999 55779999999997652 222346889999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ 515 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 515 (723)
||+.+|.|.++|-+++. |.+.+..+++.||+.||.|+|.. +|+|||||++|+|||..+++||+|||+|.+...+.
T Consensus 92 Eyv~gGELFdylv~kG~--l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk 166 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKGP--LPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK 166 (786)
T ss_pred EecCCchhHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCCc
Confidence 99999999999987764 78888999999999999999999 69999999999999999999999999997654332
Q ss_pred cceeecccccccccChhhhccCCCC-CccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCccccc
Q 046750 516 THVSTRVMGTFGYLAPEYASSGKLT-DRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIV 594 (723)
Q Consensus 516 ~~~~~~~~gt~~y~APE~~~~~~~t-~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~v 594 (723)
.....+|.++|.+||+++|..|. .++||||+|||||.||+|++||++.+- + .|+.++..|.|+.-
T Consensus 167 --lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi----------r-~LLlKV~~G~f~MP- 232 (786)
T KOG0588|consen 167 --LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI----------R-VLLLKVQRGVFEMP- 232 (786)
T ss_pred --cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH----------H-HHHHHHHcCcccCC-
Confidence 23446799999999999999875 589999999999999999999985431 1 24456667765322
Q ss_pred chhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 046750 595 DPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALD 636 (723)
Q Consensus 595 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~ 636 (723)
.....+..+|+.+|+..||.+|.+++||+++-.
T Consensus 233 ---------s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~ 265 (786)
T KOG0588|consen 233 ---------SNISSEAQDLLRRMLDVDPSTRITTEEILKHPF 265 (786)
T ss_pred ---------CcCCHHHHHHHHHHhccCccccccHHHHhhCch
Confidence 122335678889999999999999999998643
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=338.11 Aligned_cols=254 Identities=26% Similarity=0.448 Sum_probs=207.9
Q ss_pred cCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEecC
Q 046750 360 NGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVP 439 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 439 (723)
++|++.++||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++|+||+++++++.+.+..++||||+.
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 5688999999999999999988888899999987543 335678999999999999999999999999999999999999
Q ss_pred CCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCccee
Q 046750 440 NNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVS 519 (723)
Q Consensus 440 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 519 (723)
+++|.++++......+.+..++.++.+|++||+|||+. +++|||||++|||+++++.+||+|||++...........
T Consensus 85 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (261)
T cd05072 85 KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAR 161 (261)
T ss_pred CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCceecc
Confidence 99999999765555688889999999999999999998 599999999999999999999999999986654332222
Q ss_pred ecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhh
Q 046750 520 TRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRL 598 (723)
Q Consensus 520 ~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l 598 (723)
....++..|+|||++.++.++.++|||||||+||||++ |+.||..... .....+ +..+.... ..
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~---~~~~~~--------~~~~~~~~----~~ 226 (261)
T cd05072 162 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN---SDVMSA--------LQRGYRMP----RM 226 (261)
T ss_pred CCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH---HHHHHH--------HHcCCCCC----CC
Confidence 33346778999999998999999999999999999998 9999865321 111111 11111100 00
Q ss_pred hccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhc
Q 046750 599 EKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDS 637 (723)
Q Consensus 599 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~ 637 (723)
. .....+.+++.+||+.+|++||++.+|++.|+.
T Consensus 227 -~----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 227 -E----NCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred -C----CCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1 112357889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=341.45 Aligned_cols=255 Identities=22% Similarity=0.378 Sum_probs=204.1
Q ss_pred cCcccceEEeccCcEEEEEEEcC----CCcEEEEEEcccCCc-hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLP----EGKVVAVKQLKSGSG-QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLI 434 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~----~g~~VAvK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 434 (723)
++|++.++||+|+||.||+|.++ .+..||+|+++.... .....|.+|+.++++++|+||+++++++...+..+||
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46889999999999999999653 356899999987533 3345789999999999999999999999999999999
Q ss_pred EEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCC
Q 046750 435 YEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTT 514 (723)
Q Consensus 435 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 514 (723)
|||+.+|+|.+++.... ..+.+..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||++......
T Consensus 85 ~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 85 TEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred EEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 99999999999987643 2578999999999999999999998 5999999999999999999999999987654322
Q ss_pred CcceeecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccc
Q 046750 515 QTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEI 593 (723)
Q Consensus 515 ~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~ 593 (723)
.........++..|+|||++.+..++.++|||||||+||||++ |+.||..... .. +.+.+..+....
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~---~~--------~~~~~~~~~~~~- 228 (266)
T cd05064 161 AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG---QD--------VIKAVEDGFRLP- 228 (266)
T ss_pred chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH---HH--------HHHHHHCCCCCC-
Confidence 2111122335678999999999999999999999999999875 9999965432 11 112222221111
Q ss_pred cchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhcc
Q 046750 594 VDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSE 638 (723)
Q Consensus 594 vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~ 638 (723)
........+.+++.+||+.+|.+||++.+|++.|...
T Consensus 229 --------~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 229 --------APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred --------CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 1112234688899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=361.53 Aligned_cols=257 Identities=26% Similarity=0.409 Sum_probs=202.4
Q ss_pred cCcccceEEeccCcEEEEEEEc------CCCcEEEEEEcccCC-chhHHHHHHHHHHHHHc-cCCceeeEeeeeecccce
Q 046750 360 NGFARENVIGEGGFGCVYKGNL------PEGKVVAVKQLKSGS-GQGEREFRAEVEIISRV-HHRHLVSLVGYCISEKNR 431 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~------~~g~~VAvK~l~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~ 431 (723)
++|++.++||+|+||.||+|.+ ..+..||||+++... ....+.+.+|+++|..+ +|+||++++++|.+....
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~ 114 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT 114 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence 4688899999999999999953 235689999997543 23445788999999999 899999999999999999
Q ss_pred EEEEEecCCCchhhccccCC------------------------------------------------------------
Q 046750 432 LLIYEFVPNNNLEHHLHGKG------------------------------------------------------------ 451 (723)
Q Consensus 432 ~lV~E~~~~gsL~~~l~~~~------------------------------------------------------------ 451 (723)
++||||+.+|+|.++++...
T Consensus 115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (375)
T cd05104 115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY 194 (375)
T ss_pred eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence 99999999999998886422
Q ss_pred -------------CCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcce
Q 046750 452 -------------QPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHV 518 (723)
Q Consensus 452 -------------~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 518 (723)
...+++..+++|+.||++||+|||++ +|+|||||++||||++++.+||+|||+++.........
T Consensus 195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 12467888999999999999999998 59999999999999999999999999997654332211
Q ss_pred -eecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccch
Q 046750 519 -STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDP 596 (723)
Q Consensus 519 -~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~ 596 (723)
.....++..|+|||++.+..++.++|||||||+||||++ |..||..... +..+.. .+..+.... .+
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~--~~~~~~--------~~~~~~~~~--~~ 339 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV--DSKFYK--------MIKEGYRML--SP 339 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc--hHHHHH--------HHHhCccCC--CC
Confidence 122335678999999999999999999999999999998 8888865432 111111 122221100 00
Q ss_pred hhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhcc
Q 046750 597 RLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSE 638 (723)
Q Consensus 597 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~ 638 (723)
. .....+.+|+.+||+.||++||+|.||++.|++.
T Consensus 340 ----~---~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 340 ----E---CAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ----C---CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 1 1123678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=337.75 Aligned_cols=252 Identities=26% Similarity=0.443 Sum_probs=203.9
Q ss_pred cCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEecC
Q 046750 360 NGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVP 439 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 439 (723)
+.|++.+.||+|+||.||+++++++..||+|.++... ....+|.+|+++|++++|+||++++++|.+....++||||+.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 3578889999999999999998888899999987543 334678899999999999999999999999999999999999
Q ss_pred CCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCccee
Q 046750 440 NNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVS 519 (723)
Q Consensus 440 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 519 (723)
+|+|.++++.... .+++..++.++.+|+.||+|||++ +|+|||||++||||++++.+||+|||+++..........
T Consensus 83 ~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05114 83 NGCLLNYLRQRQG-KLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS 158 (256)
T ss_pred CCcHHHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCceecc
Confidence 9999999875432 478999999999999999999998 599999999999999999999999999976543322222
Q ss_pred ecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhh
Q 046750 520 TRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRL 598 (723)
Q Consensus 520 ~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l 598 (723)
....++..|+|||++.+..++.++|||||||+||||++ |+.||..... .... ..+..+.. +..+.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~---~~~~--------~~i~~~~~--~~~~~- 224 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN---YEVV--------EMISRGFR--LYRPK- 224 (256)
T ss_pred CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHH--------HHHHCCCC--CCCCC-
Confidence 22335678999999998899999999999999999999 8999865432 1111 11222211 00111
Q ss_pred hccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 046750 599 EKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALD 636 (723)
Q Consensus 599 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~ 636 (723)
.....+.+++.+||+.+|.+||++.+|++.|.
T Consensus 225 ------~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 225 ------LASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred ------CCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11236789999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=359.26 Aligned_cols=242 Identities=28% Similarity=0.399 Sum_probs=202.4
Q ss_pred hcCcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCCc---hhHHHHHHHHHHHHHcc-CCceeeEeeeeecccceEE
Q 046750 359 TNGFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGSG---QGEREFRAEVEIISRVH-HRHLVSLVGYCISEKNRLL 433 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~~---~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~l 433 (723)
.++|...++||+|.||+|+++.++ +++.+|||++++... ++.+..+.|.+|+.... ||.|++|+.+|+..+++|+
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 367999999999999999999664 478999999998743 34456788999998885 9999999999999999999
Q ss_pred EEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCC
Q 046750 434 IYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDT 513 (723)
Q Consensus 434 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 513 (723)
||||+.||+|..+.+. ..+++.....++..|+.||.|||+++ |||||||..|||||.+|++||+||||++....
T Consensus 447 vmey~~Ggdm~~~~~~---~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHIHT---DVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG 520 (694)
T ss_pred EEEecCCCcEEEEEec---ccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccccCC
Confidence 9999999996555543 34889999999999999999999994 99999999999999999999999999985543
Q ss_pred CCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccc
Q 046750 514 TQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEI 593 (723)
Q Consensus 514 ~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~ 593 (723)
... ....++||+.|||||++.+..|+...|.|+|||+|||||.|..||.+.++.+ +...|...+
T Consensus 521 ~g~-~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee-----------~FdsI~~d~---- 584 (694)
T KOG0694|consen 521 QGD-RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE-----------VFDSIVNDE---- 584 (694)
T ss_pred CCC-ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH-----------HHHHHhcCC----
Confidence 332 3456899999999999999999999999999999999999999998765311 222222211
Q ss_pred cchhhhccccHHHHHHHHHHHHHHhccCCCCCCCH
Q 046750 594 VDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRM 628 (723)
Q Consensus 594 vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 628 (723)
..|+.-...+.++|+.++|..+|++|--+
T Consensus 585 ------~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 585 ------VRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ------CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 23444445678899999999999999977
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=339.26 Aligned_cols=254 Identities=27% Similarity=0.442 Sum_probs=207.1
Q ss_pred cCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEecC
Q 046750 360 NGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVP 439 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 439 (723)
++|++.+.||+|+||.||+|.+.+++.||||.++... ...++|.+|++++++++|+||+++++++...+..++||||+.
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMK 84 (261)
T ss_pred hheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeeccc
Confidence 5688999999999999999988788899999987643 345678999999999999999999999999999999999999
Q ss_pred CCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCccee
Q 046750 440 NNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVS 519 (723)
Q Consensus 440 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 519 (723)
+++|.+++.......+.+..++.++.+++.||.|||++ +|+|||||++|||+++++.+||+|||+++..........
T Consensus 85 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (261)
T cd05068 85 YGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAR 161 (261)
T ss_pred CCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCccccc
Confidence 99999999765545689999999999999999999998 499999999999999999999999999987653322212
Q ss_pred ecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhh
Q 046750 520 TRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRL 598 (723)
Q Consensus 520 ~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l 598 (723)
........|+|||++.+..++.++|||||||+||||++ |+.||..... .. +...+..+...
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~--------~~~~~~~~~~~------- 223 (261)
T cd05068 162 EGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN---AE--------VLQQVDQGYRM------- 223 (261)
T ss_pred CCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH---HH--------HHHHHHcCCCC-------
Confidence 22223457999999999999999999999999999999 9999865431 11 11112111100
Q ss_pred hccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhc
Q 046750 599 EKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDS 637 (723)
Q Consensus 599 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~ 637 (723)
.........+.+++.+||+.+|.+||++.+|++.|+.
T Consensus 224 --~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 224 --PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred --CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 0111223468899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=343.90 Aligned_cols=269 Identities=21% Similarity=0.280 Sum_probs=201.7
Q ss_pred cCcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCC--chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGS--GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYE 436 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 436 (723)
++|++.+.||+|+||.||+|+.+ +++.||||+++... ....+.+.+|++++++++|+||++++++|...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46899999999999999999664 57899999987542 2234568899999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCc
Q 046750 437 FVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQT 516 (723)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 516 (723)
|+.++.|..+.... ..+.+..++.++.||+.||.|||+. +|+|||||++||||+.++.+||+|||+++.......
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 81 YVEKNMLELLEEMP--NGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred cCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 99888776554332 2478888999999999999999998 599999999999999999999999999986644333
Q ss_pred ceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhh-hhh----hhhhhhcCCcc
Q 046750 517 HVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWA-RPV----LVRAIETGDLS 591 (723)
Q Consensus 517 ~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~-~~~----l~~~i~~~~l~ 591 (723)
.......|+..|+|||++.+..++.++|||||||+||||++|+.||............... ..+ +........+.
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH 235 (287)
T ss_pred ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence 3333456899999999999999999999999999999999999999764321111111100 000 00000011111
Q ss_pred cccchh------hhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 046750 592 EIVDPR------LEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVR 633 (723)
Q Consensus 592 ~~vd~~------l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~ 633 (723)
.+..+. +...+.......+.+|+.+||+.||++|++++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 110000 001111112346889999999999999999999886
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=341.17 Aligned_cols=250 Identities=32% Similarity=0.580 Sum_probs=194.9
Q ss_pred ccceEEeccCcEEEEEEEcC-----CCcEEEEEEcccCCc-hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEE
Q 046750 363 ARENVIGEGGFGCVYKGNLP-----EGKVVAVKQLKSGSG-QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYE 436 (723)
Q Consensus 363 ~~~~~LG~G~fG~Vy~~~~~-----~g~~VAvK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 436 (723)
...+.||.|.||.||+|.+. .+..|+||+++.... ...++|.+|+++|++++|+||++++|+|...+..++|||
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 35689999999999999776 256799999976433 346789999999999999999999999998888999999
Q ss_pred ecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCc
Q 046750 437 FVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQT 516 (723)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 516 (723)
|+.+|+|.++|+......+++..++.|+.||++||+|||++ +|+|+||+++||||++++.+||+|||++........
T Consensus 82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 99999999999887555689999999999999999999998 599999999999999999999999999987632222
Q ss_pred -ceeecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCccccc
Q 046750 517 -HVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIV 594 (723)
Q Consensus 517 -~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~v 594 (723)
.......+...|+|||++....++.++||||||++||||++ |+.||.... ...+ ...+..+.....
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~---~~~~--------~~~~~~~~~~~~- 226 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD---NEEI--------IEKLKQGQRLPI- 226 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC---HHHH--------HHHHHTTEETTS-
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc---cccc--------ccccccccccee-
Confidence 22233456789999999999999999999999999999999 678875442 1111 122222211111
Q ss_pred chhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 046750 595 DPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRAL 635 (723)
Q Consensus 595 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L 635 (723)
.......+.+++.+||+.+|++||+|.+|++.|
T Consensus 227 --------~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 227 --------PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp --------BTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred --------ccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 111233678999999999999999999999987
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=352.46 Aligned_cols=245 Identities=26% Similarity=0.365 Sum_probs=199.3
Q ss_pred cCcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCC---chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGS---GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 435 (723)
++|.+.+.||+|+||.||+|++. +++.||||+++... ....+.+.+|+++|++++|+||+++++++.+++..|+||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56899999999999999999654 58899999987532 223456889999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ 515 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 515 (723)
||+.+|+|.+++.... .+.+..+..++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++......
T Consensus 98 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 172 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT 172 (329)
T ss_pred cCCCCChHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc
Confidence 9999999999997654 367888889999999999999999 59999999999999999999999999998654322
Q ss_pred cceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccc
Q 046750 516 THVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVD 595 (723)
Q Consensus 516 ~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd 595 (723)
....|+..|+|||++.+..++.++|||||||+||||++|+.||..... .. +.+.+..+.+.
T Consensus 173 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~------~~-----~~~~i~~~~~~---- 233 (329)
T PTZ00263 173 ----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP------FR-----IYEKILAGRLK---- 233 (329)
T ss_pred ----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH------HH-----HHHHHhcCCcC----
Confidence 234689999999999999999999999999999999999999965431 01 11222222211
Q ss_pred hhhhccccHHHHHHHHHHHHHHhccCCCCCCC-----HHHHHHH
Q 046750 596 PRLEKHYVESEMFRMIEAAAACVRHSGPKRPR-----MVQVVRA 634 (723)
Q Consensus 596 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~eVl~~ 634 (723)
+...+ ...+.+|+.+||+.||.+|++ +.+|++.
T Consensus 234 --~p~~~----~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 234 --FPNWF----DGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred --CCCCC----CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 01111 235678999999999999996 5666644
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=349.59 Aligned_cols=200 Identities=27% Similarity=0.426 Sum_probs=175.0
Q ss_pred hcCcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCCc-hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEE
Q 046750 359 TNGFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGSG-QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYE 436 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 436 (723)
.++|++.+.||+|+||.||++... ++..||+|+++.... .....+.+|+++|++++|+||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 367999999999999999999554 688999999876432 334578999999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCc
Q 046750 437 FVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQT 516 (723)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 516 (723)
|+.+++|.+++.... .+.+..+..++.||+.||.|||+.+ +|+|||||++||||++++.+||+|||++.......
T Consensus 84 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 158 (331)
T cd06649 84 HMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 158 (331)
T ss_pred cCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccc-
Confidence 999999999997644 4788899999999999999999863 59999999999999999999999999997553322
Q ss_pred ceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCC
Q 046750 517 HVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPT 565 (723)
Q Consensus 517 ~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~ 565 (723)
.....|+..|+|||++.+..++.++|||||||+||||++|+.||...
T Consensus 159 --~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 205 (331)
T cd06649 159 --ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP 205 (331)
T ss_pred --cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 23346899999999999999999999999999999999999999653
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=324.44 Aligned_cols=250 Identities=26% Similarity=0.377 Sum_probs=210.2
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccC---CchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSG---SGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 435 (723)
++|++++.||+|.||.||+|+. +++-.||+|++.+. ..+..+++++|++|-..|+||||++++++|.+....||++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 5688999999999999999955 45778999998764 2234568999999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ 515 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 515 (723)
||..+|.|...|.......+++.....++.|+|.||.|+|.. +||||||||+|+||+.++.+||+|||.+.....
T Consensus 102 Eya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~-- 176 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-- 176 (281)
T ss_pred EecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecCC--
Confidence 999999999999876666788899999999999999999998 699999999999999999999999999976542
Q ss_pred cceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccc
Q 046750 516 THVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVD 595 (723)
Q Consensus 516 ~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd 595 (723)
......+||+.|++||...+..++.+.|+|++||+.||++.|..||..... ++ ..+.|..-+
T Consensus 177 -~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~--~e---------tYkrI~k~~------ 238 (281)
T KOG0580|consen 177 -NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH--SE---------TYKRIRKVD------ 238 (281)
T ss_pred -CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh--HH---------HHHHHHHcc------
Confidence 234557899999999999999999999999999999999999999976541 11 112222111
Q ss_pred hhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 046750 596 PRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALD 636 (723)
Q Consensus 596 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~ 636 (723)
-.+.........+++.+|+.++|.+|....||+..-+
T Consensus 239 ----~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpw 275 (281)
T KOG0580|consen 239 ----LKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPW 275 (281)
T ss_pred ----ccCCcccChhHHHHHHHHhccCccccccHHHHhhhHH
Confidence 1122333446788999999999999999999987644
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=349.55 Aligned_cols=248 Identities=27% Similarity=0.442 Sum_probs=207.5
Q ss_pred cCcccceEEeccCcEEEEEE-EcCCCcEEEEEEcccC-CchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEe
Q 046750 360 NGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSG-SGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEF 437 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~-~~~~g~~VAvK~l~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 437 (723)
..|...++||+|.||.|||| +.+.++.||||++... .....+++++|+.+|..++|+||.++++.|..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 34777899999999999999 5566899999999765 334557899999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcc
Q 046750 438 VPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTH 517 (723)
Q Consensus 438 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 517 (723)
|.||++.+.|.... .+++..+.-|+.+++.||.|||.+ +.+|||||+.||||..+|.|||+|||++.........
T Consensus 93 ~~gGsv~~lL~~~~--~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r 167 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGN--ILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR 167 (467)
T ss_pred hcCcchhhhhccCC--CCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence 99999999997544 357777888899999999999999 5999999999999999999999999999766554443
Q ss_pred eeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchh
Q 046750 518 VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPR 597 (723)
Q Consensus 518 ~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~ 597 (723)
. ..++||+.|||||++++..|+.|+||||||++.+||++|..|+....+..-..++ .+-.-+.
T Consensus 168 r-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI----------------pk~~PP~ 230 (467)
T KOG0201|consen 168 R-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI----------------PKSAPPR 230 (467)
T ss_pred c-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec----------------cCCCCCc
Confidence 3 5678999999999999889999999999999999999999999876653211111 1111233
Q ss_pred hhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 046750 598 LEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVR 633 (723)
Q Consensus 598 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~ 633 (723)
|.+++ ...|.+++..||+++|+.||++.++++
T Consensus 231 L~~~~----S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 231 LDGDF----SPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred ccccc----CHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 43433 336889999999999999999999875
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=350.69 Aligned_cols=252 Identities=24% Similarity=0.349 Sum_probs=202.0
Q ss_pred cCcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCC---chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGS---GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 435 (723)
++|++.+.||+|+||.||+|+.. +++.||||+++... ....+.+..|++++.+++|+||+++++++.+.+..||||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46899999999999999999664 58899999987542 223456889999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ 515 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 515 (723)
||+.+|+|.++++... .+.+..+..++.||+.||.|||++ +|+|||||++||||+.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 9999999999997544 478888999999999999999999 599999999999999999999999999975543
Q ss_pred cceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCc-hhhHHhhhhhhhhhhhcCCccccc
Q 046750 516 THVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGD-ESLVEWARPVLVRAIETGDLSEIV 594 (723)
Q Consensus 516 ~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~-~~l~~~~~~~l~~~i~~~~l~~~v 594 (723)
......|+..|+|||++.+..++.++|||||||+||||++|+.||........ ..+..|.. .+..
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~----------~~~~-- 219 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKE----------TLQR-- 219 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccc----------cccC--
Confidence 22345689999999999999999999999999999999999999975432110 00111100 0000
Q ss_pred chhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 595 DPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 595 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
+.. ..........+.+++.+||..++.+|+++.+|++.
T Consensus 220 -~~~-~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 220 -PVY-DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred -CCC-CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 000 00001123467889999999999999999999976
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=350.92 Aligned_cols=242 Identities=23% Similarity=0.322 Sum_probs=195.0
Q ss_pred eEEeccCcEEEEEEEc-CCCcEEEEEEcccCC---chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEecCCC
Q 046750 366 NVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS---GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPNN 441 (723)
Q Consensus 366 ~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 441 (723)
++||+|+||.||+++. .+|+.||||+++... ......+.+|+++|++++|+||++++++|...+..||||||+.+|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4799999999999954 568999999987532 223356788999999999999999999999999999999999999
Q ss_pred chhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcceeec
Q 046750 442 NLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTR 521 (723)
Q Consensus 442 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 521 (723)
+|.+++.... .+.+..+..|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++....... ....
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~~ 154 (323)
T cd05571 81 ELFFHLSRER--VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKT 154 (323)
T ss_pred cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC-cccc
Confidence 9999987544 478889999999999999999999 599999999999999999999999999875322221 2233
Q ss_pred ccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhhhcc
Q 046750 522 VMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEKH 601 (723)
Q Consensus 522 ~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~~ 601 (723)
.+|+..|+|||++.+..++.++|||||||+||||++|+.||..... .. +.+.+..+.+ .+
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~---~~--------~~~~~~~~~~------~~--- 214 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EK--------LFELILMEEI------RF--- 214 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH---HH--------HHHHHHcCCC------CC---
Confidence 5699999999999999999999999999999999999999965321 11 1111111211 11
Q ss_pred ccHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 046750 602 YVESEMFRMIEAAAACVRHSGPKRP-----RMVQVVRA 634 (723)
Q Consensus 602 ~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~eVl~~ 634 (723)
.......+.+++.+||+.||++|+ ++.+|++.
T Consensus 215 -p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 215 -PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred -CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 111233578899999999999999 78888754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=338.39 Aligned_cols=255 Identities=27% Similarity=0.405 Sum_probs=206.3
Q ss_pred cCcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEec
Q 046750 360 NGFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFV 438 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 438 (723)
.+|.+.+.||+|+||.||+|.+. .++.||+|+++.. .....++.+|++++++++|+||++++++|..+...++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 35788899999999999999654 5889999998754 334567899999999999999999999999999999999999
Q ss_pred CCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcce
Q 046750 439 PNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHV 518 (723)
Q Consensus 439 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 518 (723)
.+++|.+++.......+++..++.++.|+++||+|||++ +|+|||||++|||+++++.+||+|||++..........
T Consensus 85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~ 161 (263)
T cd05052 85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 161 (263)
T ss_pred CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceeec
Confidence 999999999766555689999999999999999999998 49999999999999999999999999998665433222
Q ss_pred eecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchh
Q 046750 519 STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPR 597 (723)
Q Consensus 519 ~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~ 597 (723)
.....++..|+|||++.+..++.++|||||||+||||++ |..||..... .++ .+.+..+.-
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~------~~~-----~~~~~~~~~------- 223 (263)
T cd05052 162 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------SQV-----YELLEKGYR------- 223 (263)
T ss_pred cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH------HHH-----HHHHHCCCC-------
Confidence 222334668999999999999999999999999999998 8898865321 111 111111110
Q ss_pred hhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhcc
Q 046750 598 LEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSE 638 (723)
Q Consensus 598 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~ 638 (723)
..........+.+++.+||+.+|.+||++.+|++.|+.+
T Consensus 224 --~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 224 --MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred --CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 011111234688899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=359.21 Aligned_cols=258 Identities=24% Similarity=0.384 Sum_probs=201.7
Q ss_pred cCcccceEEeccCcEEEEEEEc------CCCcEEEEEEcccCCch-hHHHHHHHHHHHHHc-cCCceeeEeeeeecccce
Q 046750 360 NGFARENVIGEGGFGCVYKGNL------PEGKVVAVKQLKSGSGQ-GEREFRAEVEIISRV-HHRHLVSLVGYCISEKNR 431 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~------~~g~~VAvK~l~~~~~~-~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~ 431 (723)
++|++.+.||+|+||.||+|.+ .++..||||+++..... ....+.+|+++|+.+ +|+|||+++++|......
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 4688999999999999999853 22357999999765333 345688999999999 899999999999999999
Q ss_pred EEEEEecCCCchhhccccCC------------------------------------------------------------
Q 046750 432 LLIYEFVPNNNLEHHLHGKG------------------------------------------------------------ 451 (723)
Q Consensus 432 ~lV~E~~~~gsL~~~l~~~~------------------------------------------------------------ 451 (723)
++||||+.+|+|.++++...
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 99999999999998875321
Q ss_pred --------CCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcce-eecc
Q 046750 452 --------QPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHV-STRV 522 (723)
Q Consensus 452 --------~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~-~~~~ 522 (723)
...+++..+++|+.||++||+|||++ +|+|||||++|||+++++.+||+|||+++......... ....
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 12367888999999999999999998 59999999999999999999999999997654332211 1223
Q ss_pred cccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhhhcc
Q 046750 523 MGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEKH 601 (723)
Q Consensus 523 ~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~~ 601 (723)
.++..|||||++.+..++.++|||||||+||||++ |+.||...... .. +.+.+..+. .. ..+ .
T Consensus 275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~--~~--------~~~~~~~~~-~~-~~~---~- 338 (374)
T cd05106 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN--SK--------FYKMVKRGY-QM-SRP---D- 338 (374)
T ss_pred CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc--HH--------HHHHHHccc-Cc-cCC---C-
Confidence 35678999999999999999999999999999997 99999654321 11 111111111 00 000 0
Q ss_pred ccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccC
Q 046750 602 YVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEG 639 (723)
Q Consensus 602 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~ 639 (723)
.....+.+++.+||+.||.+||++.+|++.|+++.
T Consensus 339 ---~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 339 ---FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred ---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 11246788999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=339.21 Aligned_cols=251 Identities=23% Similarity=0.388 Sum_probs=214.0
Q ss_pred HHhcCcccceEEeccCcEEEEEE-EcCCCcEEEEEEcccCCchhH---HHHHHHHHHHHHccCCceeeEeeeeecccceE
Q 046750 357 EITNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGE---REFRAEVEIISRVHHRHLVSLVGYCISEKNRL 432 (723)
Q Consensus 357 ~~~~~f~~~~~LG~G~fG~Vy~~-~~~~g~~VAvK~l~~~~~~~~---~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 432 (723)
....+|++.+.||+|.||+|-++ ..+.|+.||||.+++.....+ -.+++||+||..|+||||+.++.+|+..+.++
T Consensus 50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIv 129 (668)
T KOG0611|consen 50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIV 129 (668)
T ss_pred chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEE
Confidence 34567899999999999999999 457899999999987644444 35789999999999999999999999999999
Q ss_pred EEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccC
Q 046750 433 LIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLND 512 (723)
Q Consensus 433 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 512 (723)
|||||..+|.|++|+.+++. |.+.....|+.||..|+.|+|.+ +++|||||.+|||||.|+++||+||||+-++.
T Consensus 130 ivMEYaS~GeLYDYiSer~~--LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 130 IVMEYASGGELYDYISERGS--LSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EEEEecCCccHHHHHHHhcc--ccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhc
Confidence 99999999999999987664 88899999999999999999999 69999999999999999999999999998776
Q ss_pred CCCcceeecccccccccChhhhccCCCC-CccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcc
Q 046750 513 TTQTHVSTRVMGTFGYLAPEYASSGKLT-DRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLS 591 (723)
Q Consensus 513 ~~~~~~~~~~~gt~~y~APE~~~~~~~t-~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~ 591 (723)
.... ...++|++-|.+||++.+..|. ...|-|||||+||-|+.|..||++.+- ..+.+.|..|.+.
T Consensus 205 ~~kf--LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh-----------k~lvrQIs~GaYr 271 (668)
T KOG0611|consen 205 DKKF--LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH-----------KRLVRQISRGAYR 271 (668)
T ss_pred cccH--HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH-----------HHHHHHhhccccc
Confidence 5443 3567899999999999998874 579999999999999999999987642 1244566666654
Q ss_pred cccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 046750 592 EIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALD 636 (723)
Q Consensus 592 ~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~ 636 (723)
+--.+ ....-|+.+||..+|++|-++.+|...-+
T Consensus 272 EP~~P-----------SdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 272 EPETP-----------SDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred CCCCC-----------chHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 43221 23456788999999999999999987664
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=356.11 Aligned_cols=263 Identities=22% Similarity=0.273 Sum_probs=197.0
Q ss_pred cCcccceEEeccCcEEEEEEE-cCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEec
Q 046750 360 NGFARENVIGEGGFGCVYKGN-LPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFV 438 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~-~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 438 (723)
++|.+.++||+|+||.||++. ...++.||||+... ..+.+|+++|++|+|+|||+++++|......++|||++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 579999999999999999994 45688999997542 35788999999999999999999999999999999999
Q ss_pred CCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcce
Q 046750 439 PNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHV 518 (723)
Q Consensus 439 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 518 (723)
+++|..++.... .+.+..++.|+.||+.||+|||++ +||||||||+||||+.++.+||+|||+++.........
T Consensus 166 -~~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~ 239 (391)
T PHA03212 166 -KTDLYCYLAAKR--NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK 239 (391)
T ss_pred -CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccccccc
Confidence 578888876543 478889999999999999999999 59999999999999999999999999997543333233
Q ss_pred eecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhc----------C
Q 046750 519 STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIET----------G 588 (723)
Q Consensus 519 ~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~----------~ 588 (723)
.....||..|+|||++.+..++.++|||||||+||||++|+.||..................+.+.... .
T Consensus 240 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~ 319 (391)
T PHA03212 240 YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQA 319 (391)
T ss_pred cccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhH
Confidence 344679999999999999999999999999999999999998875432211110000000000000000 0
Q ss_pred Cccccc---------ch--hhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 589 DLSEIV---------DP--RLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 589 ~l~~~v---------d~--~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
.+..+. .+ +............+.+|+.+||+.||.+||++.|+++.
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 320 NLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000 00 00000001223468889999999999999999999864
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=332.11 Aligned_cols=269 Identities=22% Similarity=0.308 Sum_probs=202.0
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCchhH--HHHHHHHHHHHHccCCceeeEeeeee--cccceEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQGE--REFRAEVEIISRVHHRHLVSLVGYCI--SEKNRLLI 434 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~~~--~~~~~Ei~il~~l~HpnIv~l~g~~~--~~~~~~lV 434 (723)
+.|++.++|++|.||.||+|+. ++++.||+|+++......- -.-.+||.+|.+++|+|||.+-.+.. +-+.+|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 4477889999999999999954 5688999999986532111 13578999999999999999987765 34568999
Q ss_pred EEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCC
Q 046750 435 YEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTT 514 (723)
Q Consensus 435 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 514 (723)
|||| ..+|..+++.... .+...+...+..|+++||+|||.++ |+|||||++|+|+.+.|.+||+|||||+.++..
T Consensus 156 Me~~-EhDLksl~d~m~q-~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 156 MEYV-EHDLKSLMETMKQ-PFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred HHHH-HhhHHHHHHhccC-CCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 9999 5689998887664 4666777889999999999999996 999999999999999999999999999988755
Q ss_pred CcceeecccccccccChhhhccC-CCCCccceechHHHHHHHHhCCCCCCCCCCCCchhh----------HHhhhhhhhh
Q 046750 515 QTHVSTRVMGTFGYLAPEYASSG-KLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESL----------VEWARPVLVR 583 (723)
Q Consensus 515 ~~~~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l----------~~~~~~~l~~ 583 (723)
. ...+..+.|++|+|||++.+. .|+...||||+|||+.||+.++..|.+..+.+.... ..|.....+.
T Consensus 231 ~-k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp 309 (419)
T KOG0663|consen 231 L-KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELP 309 (419)
T ss_pred c-ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccc
Confidence 3 345667789999999999876 499999999999999999999999987765332211 1121111111
Q ss_pred hhhcCCcccccchhhhccccHH-HHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 584 AIETGDLSEIVDPRLEKHYVES-EMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 584 ~i~~~~l~~~vd~~l~~~~~~~-~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
.+..-.+.+---..|+..+... ....-++|+..+|..||.+|-+++|.|+.
T Consensus 310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 1111111111112222222221 22345678889999999999999998764
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=353.21 Aligned_cols=247 Identities=26% Similarity=0.411 Sum_probs=192.2
Q ss_pred cccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCc-hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEecC
Q 046750 362 FARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSG-QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVP 439 (723)
Q Consensus 362 f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 439 (723)
|+..++||+|+||.||+|+. .+++.||||++..... .....|.+|+++|++++|+||+++++++.+.+..++||||+.
T Consensus 76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 155 (353)
T PLN00034 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMD 155 (353)
T ss_pred HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCC
Confidence 45668899999999999965 4689999999865432 334578999999999999999999999999999999999999
Q ss_pred CCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCccee
Q 046750 440 NNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVS 519 (723)
Q Consensus 440 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 519 (723)
+++|.++. .+.+..++.|+.||+.||+|||++ +|+|||||++||||++++.+||+|||+++.+..... ..
T Consensus 156 ~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~ 225 (353)
T PLN00034 156 GGSLEGTH------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-PC 225 (353)
T ss_pred CCcccccc------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccccc-cc
Confidence 99987643 245667788999999999999999 599999999999999999999999999986543221 12
Q ss_pred ecccccccccChhhhcc-----CCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCccccc
Q 046750 520 TRVMGTFGYLAPEYASS-----GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIV 594 (723)
Q Consensus 520 ~~~~gt~~y~APE~~~~-----~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~v 594 (723)
....|+..|+|||++.. ...+.++|||||||+||||++|+.||...... +|... ...+..+...
T Consensus 226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~------~~~~~--~~~~~~~~~~--- 294 (353)
T PLN00034 226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG------DWASL--MCAICMSQPP--- 294 (353)
T ss_pred cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc------cHHHH--HHHHhccCCC---
Confidence 33568999999998743 23456899999999999999999999743221 22211 1111111110
Q ss_pred chhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 046750 595 DPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRAL 635 (723)
Q Consensus 595 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L 635 (723)
.........+.+|+.+||+.||.+||++.||++.-
T Consensus 295 ------~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp 329 (353)
T PLN00034 295 ------EAPATASREFRHFISCCLQREPAKRWSAMQLLQHP 329 (353)
T ss_pred ------CCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 01112233678999999999999999999999864
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=346.15 Aligned_cols=246 Identities=24% Similarity=0.327 Sum_probs=199.8
Q ss_pred cCcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCC---chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGS---GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 435 (723)
++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+++|++++|+||+++++++.+....|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36889999999999999999654 68999999986432 233456889999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ 515 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 515 (723)
||+.+|+|.+++...+ .+.+..++.++.||+.||+|||++ +|+|||||++|||+++++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~- 154 (291)
T cd05612 81 EYVPGGELFSYLRNSG--RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR- 154 (291)
T ss_pred eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC-
Confidence 9999999999997654 478888999999999999999999 5999999999999999999999999999765432
Q ss_pred cceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccc
Q 046750 516 THVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVD 595 (723)
Q Consensus 516 ~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd 595 (723)
.....|+..|+|||++.+..++.++|||||||+||||++|+.||..... . . +.+.+..+.+.
T Consensus 155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~---~---~-----~~~~i~~~~~~---- 216 (291)
T cd05612 155 ---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP---F---G-----IYEKILAGKLE---- 216 (291)
T ss_pred ---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---H---H-----HHHHHHhCCcC----
Confidence 1234689999999999999999999999999999999999999975432 1 1 11222222210
Q ss_pred hhhhccccHHHHHHHHHHHHHHhccCCCCCCC-----HHHHHHHH
Q 046750 596 PRLEKHYVESEMFRMIEAAAACVRHSGPKRPR-----MVQVVRAL 635 (723)
Q Consensus 596 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~eVl~~L 635 (723)
+...+ ...+.+|+.+||+.||.+|++ +.++++.-
T Consensus 217 --~~~~~----~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 255 (291)
T cd05612 217 --FPRHL----DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHR 255 (291)
T ss_pred --CCccC----CHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCc
Confidence 11111 235788999999999999995 77776543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=338.65 Aligned_cols=255 Identities=31% Similarity=0.468 Sum_probs=210.8
Q ss_pred hcCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEec
Q 046750 359 TNGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFV 438 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 438 (723)
..+|++.++||+|+||.||+|...+++.|++|+++........++.+|+++++.++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 35688899999999999999988889999999998776556678999999999999999999999999999999999999
Q ss_pred CCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcce
Q 046750 439 PNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHV 518 (723)
Q Consensus 439 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 518 (723)
.+++|.++++......+.+..+++++.+|+.||+|||+++ |+|||||++||||++++.+||+|||++.........
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~- 160 (261)
T cd05148 85 EKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL- 160 (261)
T ss_pred ccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcccc-
Confidence 9999999998765556899999999999999999999984 999999999999999999999999999765432221
Q ss_pred eecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchh
Q 046750 519 STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPR 597 (723)
Q Consensus 519 ~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~ 597 (723)
.....++..|++||++.+..++.++|||||||+||+|++ |+.||..... .....+ +..+..
T Consensus 161 ~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~---~~~~~~--------~~~~~~------- 222 (261)
T cd05148 161 SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN---HEVYDQ--------ITAGYR------- 222 (261)
T ss_pred ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH---HHHHHH--------HHhCCc-------
Confidence 223345678999999998899999999999999999998 8999965431 111111 111110
Q ss_pred hhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhc
Q 046750 598 LEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDS 637 (723)
Q Consensus 598 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~ 637 (723)
..........+.+++.+||+.+|.+||++.+|++.|+.
T Consensus 223 --~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 223 --MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred --CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 00111223467899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=349.26 Aligned_cols=250 Identities=23% Similarity=0.307 Sum_probs=200.1
Q ss_pred hcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCch---hHHHHHHHHHHHHHccCCceeeEeeeeecccceEEE
Q 046750 359 TNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQ---GEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLI 434 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 434 (723)
.++|+.++.||+|+||.||+|+. ..|..+|+|+|++.... +...+++|-+||...++++||+|+..|++.+.+|||
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi 219 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI 219 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence 46799999999999999999954 45999999999876433 345678899999999999999999999999999999
Q ss_pred EEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCC-
Q 046750 435 YEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDT- 513 (723)
Q Consensus 435 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~- 513 (723)
|||++||++..+|.+.+ .|.++....++.+++.||+.||++| ||||||||+|+|||..|++||+||||+.-+..
T Consensus 220 MEylPGGD~mTLL~~~~--~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 220 MEYLPGGDMMTLLMRKD--TLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred EEecCCccHHHHHHhcC--cCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhhhh
Confidence 99999999999997665 5888888999999999999999995 99999999999999999999999999842110
Q ss_pred --------------C-------Ccc------------------------eeecccccccccChhhhccCCCCCccceech
Q 046750 514 --------------T-------QTH------------------------VSTRVMGTFGYLAPEYASSGKLTDRSDVFSF 548 (723)
Q Consensus 514 --------------~-------~~~------------------------~~~~~~gt~~y~APE~~~~~~~t~ksDVwSl 548 (723)
. ... .....+||+.|||||++.+..|+..+|.|||
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL 374 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL 374 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence 0 000 0112479999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCC-chhhHHhhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCC
Q 046750 549 GVVLLELITGRKPVDPTQPLG-DESLVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPR 627 (723)
Q Consensus 549 GviL~eLltG~~P~~~~~~~~-~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs 627 (723)
|||+||||.|..||....... -..++.|-..+. .-.+ .....+..+||.+||. |+.+|--
T Consensus 375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~----------fP~~--------~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSETPQETYRKIVNWRETLK----------FPEE--------VDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhcc----------CCCc--------CcccHHHHHHHHHHhc-CHHHhcC
Confidence 999999999999998766521 112334432111 0000 0111356788889999 9999986
Q ss_pred ---HHHHH
Q 046750 628 ---MVQVV 632 (723)
Q Consensus 628 ---~~eVl 632 (723)
+.||.
T Consensus 436 ~~G~~EIK 443 (550)
T KOG0605|consen 436 SKGAEEIK 443 (550)
T ss_pred cccHHHHh
Confidence 55553
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=341.21 Aligned_cols=255 Identities=29% Similarity=0.522 Sum_probs=205.1
Q ss_pred cCcccceEEeccCcEEEEEEEcCC------CcEEEEEEcccCCc-hhHHHHHHHHHHHHHccCCceeeEeeeeecccceE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLPE------GKVVAVKQLKSGSG-QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRL 432 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~~------g~~VAvK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 432 (723)
++|++.+.||+|+||.||+|.+.. ...|++|.++.... ....+|.+|++++.+++|+||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 467889999999999999996533 25799999875433 33457899999999999999999999999999999
Q ss_pred EEEEecCCCchhhccccCCC--------------CcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCC
Q 046750 433 LIYEFVPNNNLEHHLHGKGQ--------------PVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEF 498 (723)
Q Consensus 433 lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~ 498 (723)
++|||+.+++|.+++..... ..+++..++.++.||+.||+|||++ +|+|||||++||||++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence 99999999999999865321 3578889999999999999999999 599999999999999999
Q ss_pred cEEEeecccccccCCCCc-ceeecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHh
Q 046750 499 EAQVADFGLAKLNDTTQT-HVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEW 576 (723)
Q Consensus 499 ~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~ 576 (723)
.+||+|||+++....... .......++..|+|||++.++.++.++|||||||+||||++ |..||..... ..+
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~---~~~--- 235 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN---QEV--- 235 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH---HHH---
Confidence 999999999976543222 12233456788999999999999999999999999999998 9999875432 111
Q ss_pred hhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhc
Q 046750 577 ARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDS 637 (723)
Q Consensus 577 ~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~ 637 (723)
.+.+..+....+ .......+.+|+.+||+.+|.+||++.+|++.|+.
T Consensus 236 -----~~~i~~~~~~~~---------~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 236 -----IEMIRSRQLLPC---------PEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred -----HHHHHcCCcCCC---------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 122222222111 12233578899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=351.98 Aligned_cols=251 Identities=21% Similarity=0.377 Sum_probs=210.9
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccC--CchhHHHHHHHHHHHHHccCCceeeEeeeeecccc-eEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSG--SGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKN-RLLIY 435 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~-~~lV~ 435 (723)
++|..+++||+|+||.+|+.+. .++..|++|.+... .....+....|+.++++++|||||.+.+.|++++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 5788899999999999999944 45788999998654 33344567889999999999999999999998888 89999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ 515 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 515 (723)
+|++||+|.+.+.+.....++++.+++|+.||+.||.|||++ +|+|||||..|||++.+..|||+|||+|+......
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 999999999999887777899999999999999999999987 79999999999999999999999999999887655
Q ss_pred cceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccc
Q 046750 516 THVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVD 595 (723)
Q Consensus 516 ~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd 595 (723)
.. ...++||+.||.||++.+..|..|+|||||||++|||++-+.+|...+- ..++ ..+..+.+
T Consensus 161 ~~-a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m---~~Li--------~ki~~~~~----- 223 (426)
T KOG0589|consen 161 SL-ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM---SELI--------LKINRGLY----- 223 (426)
T ss_pred hh-hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch---HHHH--------HHHhhccC-----
Confidence 33 3446799999999999999999999999999999999999999976542 1111 11222211
Q ss_pred hhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 596 PRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 596 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
..........|..++..|++.+|+.||++.++|.+
T Consensus 224 ----~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 224 ----SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ----CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 11223344578889999999999999999999875
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=332.58 Aligned_cols=252 Identities=25% Similarity=0.427 Sum_probs=203.9
Q ss_pred cCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEecC
Q 046750 360 NGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVP 439 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 439 (723)
++|.+.+.||+|+||.||+|++.++..||||.++... ....+|.+|+.++++++|+||++++++|.+....++||||+.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4578889999999999999988777789999987543 334678999999999999999999999998888999999999
Q ss_pred CCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCccee
Q 046750 440 NNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVS 519 (723)
Q Consensus 440 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 519 (723)
+++|.+++..... .+.+..++.++.||+.||+|||+. +|+|+|||+.|||+++++.+||+|||+++..........
T Consensus 83 ~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05113 83 NGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS 158 (256)
T ss_pred CCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCceeec
Confidence 9999999876443 578999999999999999999999 599999999999999999999999999876544332222
Q ss_pred ecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhh
Q 046750 520 TRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRL 598 (723)
Q Consensus 520 ~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l 598 (723)
....++..|++||++.+..++.++|||||||+||||++ |..||..... .... ..+..+......
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---~~~~--------~~~~~~~~~~~~---- 223 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN---SETV--------EKVSQGLRLYRP---- 223 (256)
T ss_pred CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH---HHHH--------HHHhcCCCCCCC----
Confidence 22345678999999998889999999999999999998 9999865431 1111 111121111000
Q ss_pred hccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 046750 599 EKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALD 636 (723)
Q Consensus 599 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~ 636 (723)
......+.+++.+||+.+|.+||++.+|++.|+
T Consensus 224 -----~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 224 -----HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred -----CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 011346789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=346.29 Aligned_cols=253 Identities=25% Similarity=0.308 Sum_probs=198.5
Q ss_pred CcccceEEeccCcEEEEEEEc----CCCcEEEEEEcccC----CchhHHHHHHHHHHHHHc-cCCceeeEeeeeecccce
Q 046750 361 GFARENVIGEGGFGCVYKGNL----PEGKVVAVKQLKSG----SGQGEREFRAEVEIISRV-HHRHLVSLVGYCISEKNR 431 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~~----~~g~~VAvK~l~~~----~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~ 431 (723)
+|++.++||+|+||.||+++. .+++.||||+++.. .....+.+..|+++|+++ +|+||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478899999999999999854 35789999998643 122334678899999999 599999999999999999
Q ss_pred EEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeeccccccc
Q 046750 432 LLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLN 511 (723)
Q Consensus 432 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 511 (723)
++||||+.+|+|.+++..+. .+.+..+..++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++.+
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD--NFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 99999999999999987543 478889999999999999999998 4999999999999999999999999999765
Q ss_pred CCCCcceeecccccccccChhhhccC-CCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCc
Q 046750 512 DTTQTHVSTRVMGTFGYLAPEYASSG-KLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDL 590 (723)
Q Consensus 512 ~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l 590 (723)
............|+..|+|||++.+. .++.++||||||||||||++|+.||........... +...+....
T Consensus 156 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~-------~~~~~~~~~- 227 (332)
T cd05614 156 LSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSE-------VSRRILKCD- 227 (332)
T ss_pred cccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHH-------HHHHHhcCC-
Confidence 44333333345799999999999865 478899999999999999999999975432211111 111111110
Q ss_pred ccccchhhhccccHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHHH
Q 046750 591 SEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRP-----RMVQVVRAL 635 (723)
Q Consensus 591 ~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~eVl~~L 635 (723)
+.+... ....+.+++.+||+.||++|+ ++.++++.-
T Consensus 228 -----~~~~~~----~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 268 (332)
T cd05614 228 -----PPFPSF----IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHP 268 (332)
T ss_pred -----CCCCCC----CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCC
Confidence 111111 223577899999999999999 677777653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=335.66 Aligned_cols=255 Identities=27% Similarity=0.495 Sum_probs=206.0
Q ss_pred cCcccceEEeccCcEEEEEEEcCC------CcEEEEEEcccCCch-hHHHHHHHHHHHHHccCCceeeEeeeeecccceE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLPE------GKVVAVKQLKSGSGQ-GEREFRAEVEIISRVHHRHLVSLVGYCISEKNRL 432 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~~------g~~VAvK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 432 (723)
++|.+.+.||+|+||.||+|.+.+ ++.||||.++..... ..+.|.+|+++|++++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 457888999999999999996533 478999999876444 4568999999999999999999999999999999
Q ss_pred EEEEecCCCchhhccccCC------------CCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcE
Q 046750 433 LIYEFVPNNNLEHHLHGKG------------QPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEA 500 (723)
Q Consensus 433 lV~E~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~v 500 (723)
+||||+.+++|.++++..+ ...+.+..++.++.+|+.||.|||++ +|+|||||++|||++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence 9999999999999986542 23478889999999999999999999 49999999999999999999
Q ss_pred EEeecccccccCCCCc-ceeecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhh
Q 046750 501 QVADFGLAKLNDTTQT-HVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWAR 578 (723)
Q Consensus 501 kL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~ 578 (723)
||+|||+++....... .......++..|+|||++.+..++.++|||||||+||||++ |..||..... ....
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~---~~~~---- 234 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN---EEVI---- 234 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHH----
Confidence 9999999975433222 11233346788999999999999999999999999999998 9999865432 1111
Q ss_pred hhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhc
Q 046750 579 PVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDS 637 (723)
Q Consensus 579 ~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~ 637 (723)
..+..+.+.... ......+.+++.+||+.+|.+||++.||++.|++
T Consensus 235 ----~~~~~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 235 ----ECITQGRLLQRP---------RTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred ----HHHHcCCcCCCC---------CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 122223222111 1123467899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=333.35 Aligned_cols=253 Identities=30% Similarity=0.466 Sum_probs=204.7
Q ss_pred cCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEecC
Q 046750 360 NGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVP 439 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 439 (723)
++|++.++||+|+||.||+|.+.++..||+|.++.... ..+.|.+|++++++++|+||+++++++. ....++||||+.
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 56888999999999999999888888999999976433 3457899999999999999999999885 456899999999
Q ss_pred CCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCccee
Q 046750 440 NNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVS 519 (723)
Q Consensus 440 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 519 (723)
+++|.++++......+++..++.++.+++.||+|||+. +|+|||||+.|||+++++.++|+|||++...........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05070 84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcccccc
Confidence 99999999765545688999999999999999999999 499999999999999999999999999976544332222
Q ss_pred ecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhh
Q 046750 520 TRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRL 598 (723)
Q Consensus 520 ~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l 598 (723)
....++..|+|||++.+..++.++|||||||+||||++ |..||..... ....+ .+..+...
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---~~~~~--------~~~~~~~~------- 222 (260)
T cd05070 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN---REVLE--------QVERGYRM------- 222 (260)
T ss_pred cCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH---HHHHH--------HHHcCCCC-------
Confidence 23345678999999998899999999999999999999 8888865321 11111 11111100
Q ss_pred hccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhc
Q 046750 599 EKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDS 637 (723)
Q Consensus 599 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~ 637 (723)
.........+.+++.+||..+|.+||++.+|++.|++
T Consensus 223 --~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 --PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred --CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0111223468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=332.52 Aligned_cols=273 Identities=20% Similarity=0.333 Sum_probs=205.8
Q ss_pred HHHHhcCcccceEEeccCcEEEEEE-EcCCCcEEEEEEccc--CCchhHHHHHHHHHHHHHccCCceeeEeeeeec----
Q 046750 355 LMEITNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKS--GSGQGEREFRAEVEIISRVHHRHLVSLVGYCIS---- 427 (723)
Q Consensus 355 l~~~~~~f~~~~~LG~G~fG~Vy~~-~~~~g~~VAvK~l~~--~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~---- 427 (723)
..++...|...+.||+|+||.|+.+ +..+|+.||||++.. ......+...+|+.+|++++|+||+.+++++..
T Consensus 17 ~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~ 96 (359)
T KOG0660|consen 17 LFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRD 96 (359)
T ss_pred EEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccc
Confidence 3445566777899999999999999 556789999999873 334455677899999999999999999998865
Q ss_pred -ccceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecc
Q 046750 428 -EKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFG 506 (723)
Q Consensus 428 -~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFG 506 (723)
-+.+|+|+|+| +.+|.+.++.+. .|...++..+++||++||+|+|+. +|+||||||.|+|++.++.+||||||
T Consensus 97 ~f~DvYiV~elM-etDL~~iik~~~--~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFG 170 (359)
T KOG0660|consen 97 KFNDVYLVFELM-ETDLHQIIKSQQ--DLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFG 170 (359)
T ss_pred ccceeEEehhHH-hhHHHHHHHcCc--cccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEecccc
Confidence 35689999999 889999997654 388899999999999999999999 69999999999999999999999999
Q ss_pred cccccCCC-CcceeecccccccccChhhhcc-CCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhh----hh
Q 046750 507 LAKLNDTT-QTHVSTRVMGTFGYLAPEYASS-GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWAR----PV 580 (723)
Q Consensus 507 la~~~~~~-~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~----~~ 580 (723)
||+..... .....+..+.|.+|+|||++.. ..|+...||||+||||.|||+|+..|-+.+......++.... ..
T Consensus 171 LAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e 250 (359)
T KOG0660|consen 171 LARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEE 250 (359)
T ss_pred ceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHH
Confidence 99977532 1223456678999999998864 569999999999999999999999998776543322221110 00
Q ss_pred hhhhhhcCCcccccc-------hhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 581 LVRAIETGDLSEIVD-------PRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 581 l~~~i~~~~l~~~vd-------~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
....+...+....+. .-+...+. ..--..++|+.+||..||.+|.+++|.|+.
T Consensus 251 ~l~~i~s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 251 DLQKIRSEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHhccHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 011111111111110 00000010 111246789999999999999999998864
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=344.77 Aligned_cols=200 Identities=27% Similarity=0.447 Sum_probs=174.1
Q ss_pred hcCcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCCc-hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEE
Q 046750 359 TNGFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGSG-QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYE 436 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 436 (723)
.++|++.++||+|+||.||++... ++..||+|+++.... .....+.+|+++|++++|+||++++++|.+.+..+||||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 367999999999999999999654 678899998876432 334578999999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCc
Q 046750 437 FVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQT 516 (723)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 516 (723)
|+.+++|.+++.... .+.+..+..++.+|++||.|||+.+ +|+|||||++||||++++.+||+|||++.......
T Consensus 84 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~- 158 (333)
T cd06650 84 HMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 158 (333)
T ss_pred cCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc-
Confidence 999999999997644 4788888999999999999999753 59999999999999999999999999987553221
Q ss_pred ceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCC
Q 046750 517 HVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPT 565 (723)
Q Consensus 517 ~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~ 565 (723)
.....|+..|+|||++.+..++.++|||||||+||||++|+.||...
T Consensus 159 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 159 --ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred --cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 22346899999999999989999999999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=334.30 Aligned_cols=255 Identities=28% Similarity=0.455 Sum_probs=205.2
Q ss_pred cCcccceEEeccCcEEEEEEEcCC----CcEEEEEEcccCCc-hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLPE----GKVVAVKQLKSGSG-QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLI 434 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~~----g~~VAvK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 434 (723)
++|++.+.||+|+||.||+|.++. ...||||+++.... ....+|.+|+.++++++|+||+++++++.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 568899999999999999997643 35799999876533 3345789999999999999999999999999999999
Q ss_pred EEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCC
Q 046750 435 YEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTT 514 (723)
Q Consensus 435 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 514 (723)
|||+.+++|.+++..... .+.+..+++++.|++.||+|||++ +|+|||||++||||++++.+||+|||+++.....
T Consensus 84 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 84 TEYMENGSLDKFLRENDG-KFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEcCCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 999999999999976443 578999999999999999999998 5999999999999999999999999999876522
Q ss_pred Cc-ceeecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCccc
Q 046750 515 QT-HVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSE 592 (723)
Q Consensus 515 ~~-~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~ 592 (723)
.. .......++..|++||++.+..++.++|||||||++|||++ |..||..... ..+ ...+..+....
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~---~~~--------~~~~~~~~~~~ 228 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN---QDV--------IKAVEDGYRLP 228 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH---HHH--------HHHHHcCCCCC
Confidence 22 12222335678999999999999999999999999999998 9999854321 111 12222221110
Q ss_pred ccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhcc
Q 046750 593 IVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSE 638 (723)
Q Consensus 593 ~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~ 638 (723)
........+.+++.+||+.+|++||++.+|+++|+..
T Consensus 229 ---------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 229 ---------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0111234678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=355.42 Aligned_cols=258 Identities=23% Similarity=0.364 Sum_probs=203.6
Q ss_pred cCcccceEEeccCcEEEEEEEcCC------CcEEEEEEcccCCch-hHHHHHHHHHHHHHcc-CCceeeEeeeeecccce
Q 046750 360 NGFARENVIGEGGFGCVYKGNLPE------GKVVAVKQLKSGSGQ-GEREFRAEVEIISRVH-HRHLVSLVGYCISEKNR 431 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~~------g~~VAvK~l~~~~~~-~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~ 431 (723)
++|.+.++||+|+||.||+|.+.. +..||||+++..... ..+.|.+|+++|++|. |+||++++++|.+....
T Consensus 37 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (400)
T cd05105 37 DGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPI 116 (400)
T ss_pred cceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCce
Confidence 578889999999999999996421 347999999754333 3457899999999996 99999999999999999
Q ss_pred EEEEEecCCCchhhccccCC------------------------------------------------------------
Q 046750 432 LLIYEFVPNNNLEHHLHGKG------------------------------------------------------------ 451 (723)
Q Consensus 432 ~lV~E~~~~gsL~~~l~~~~------------------------------------------------------------ 451 (723)
||||||+.+|+|.++|+...
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (400)
T cd05105 117 YIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKE 196 (400)
T ss_pred EEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhh
Confidence 99999999999998876421
Q ss_pred ----------------------------------CCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCC
Q 046750 452 ----------------------------------QPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDE 497 (723)
Q Consensus 452 ----------------------------------~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~ 497 (723)
...+.+..+++++.||++||+|||+. +|+|||||++||||+++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~~ 273 (400)
T cd05105 197 ASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQG 273 (400)
T ss_pred hhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeCC
Confidence 12367788899999999999999998 59999999999999999
Q ss_pred CcEEEeecccccccCCCCcc-eeecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHH
Q 046750 498 FEAQVADFGLAKLNDTTQTH-VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVE 575 (723)
Q Consensus 498 ~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~ 575 (723)
+.+||+|||+++........ ......++..|+|||++.+..++.++|||||||+||||++ |..||...... ..
T Consensus 274 ~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~--~~--- 348 (400)
T cd05105 274 KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD--ST--- 348 (400)
T ss_pred CEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh--HH---
Confidence 99999999999765433222 1223456788999999999999999999999999999997 88998654221 11
Q ss_pred hhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccC
Q 046750 576 WARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEG 639 (723)
Q Consensus 576 ~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~ 639 (723)
+...+..+... .........+.+++.+||+.+|++||++.+|+++|+.+.
T Consensus 349 -----~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 349 -----FYNKIKSGYRM---------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred -----HHHHHhcCCCC---------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 11122222110 011122346889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=346.55 Aligned_cols=242 Identities=22% Similarity=0.321 Sum_probs=194.1
Q ss_pred eEEeccCcEEEEEEEc-CCCcEEEEEEcccCC---chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEecCCC
Q 046750 366 NVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS---GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPNN 441 (723)
Q Consensus 366 ~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 441 (723)
++||+|+||.||+++. .+|+.||+|+++... ......+.+|++++++++|+||++++++|...+..||||||+.+|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4799999999999954 568999999987532 233456778999999999999999999999999999999999999
Q ss_pred chhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcceeec
Q 046750 442 NLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTR 521 (723)
Q Consensus 442 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 521 (723)
+|..++.... .+.+..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++...... .....
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~ 154 (323)
T cd05595 81 ELFFHLSRER--VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKT 154 (323)
T ss_pred cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Ccccc
Confidence 9998886543 478899999999999999999999 59999999999999999999999999987532221 12233
Q ss_pred ccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhhhcc
Q 046750 522 VMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEKH 601 (723)
Q Consensus 522 ~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~~ 601 (723)
..|+..|+|||++.+..++.++|||||||+||||++|+.||...... . +.+.+..+.+ .+...
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~---~--------~~~~~~~~~~------~~p~~ 217 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---R--------LFELILMEEI------RFPRT 217 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH---H--------HHHHHhcCCC------CCCCC
Confidence 56899999999999999999999999999999999999999654321 1 1111111111 11111
Q ss_pred ccHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 046750 602 YVESEMFRMIEAAAACVRHSGPKRP-----RMVQVVRA 634 (723)
Q Consensus 602 ~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~eVl~~ 634 (723)
+ ...+.+++.+||+.||++|+ ++.++++.
T Consensus 218 ~----~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 218 L----SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred C----CHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 2 23577899999999999998 78888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=345.84 Aligned_cols=242 Identities=25% Similarity=0.341 Sum_probs=195.0
Q ss_pred eEEeccCcEEEEEEEc-CCCcEEEEEEcccCC---chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEecCCC
Q 046750 366 NVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS---GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPNN 441 (723)
Q Consensus 366 ~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 441 (723)
++||+|+||.||+++. .+++.||||+++... ......+.+|+++|+.++|+||+++++++...+..||||||+.+|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4799999999999954 568999999997542 233456788999999999999999999999999999999999999
Q ss_pred chhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcceeec
Q 046750 442 NLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTR 521 (723)
Q Consensus 442 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 521 (723)
+|.+++.... .+.+..++.|+.||+.||+|||++ +|+|||||++||||++++.+||+|||+++...... .....
T Consensus 81 ~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~ 154 (328)
T cd05593 81 ELFFHLSRER--VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMKT 154 (328)
T ss_pred CHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-ccccc
Confidence 9998886543 478899999999999999999999 59999999999999999999999999987533221 12234
Q ss_pred ccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhhhcc
Q 046750 522 VMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEKH 601 (723)
Q Consensus 522 ~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~~ 601 (723)
..|+..|+|||++.+..++.++|||||||+||||++|+.||..... . .. .+.+..+.+ .+...
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~---~---~~-----~~~~~~~~~------~~p~~ 217 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---E---KL-----FELILMEDI------KFPRT 217 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH---H---HH-----HHHhccCCc------cCCCC
Confidence 5699999999999999999999999999999999999999965421 1 11 111111111 11111
Q ss_pred ccHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 046750 602 YVESEMFRMIEAAAACVRHSGPKRP-----RMVQVVRA 634 (723)
Q Consensus 602 ~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~eVl~~ 634 (723)
+ ...+.+++.+||+.||.+|+ ++.+|++.
T Consensus 218 ~----~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 218 L----SADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred C----CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 1 23577899999999999997 88998865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=333.21 Aligned_cols=254 Identities=29% Similarity=0.446 Sum_probs=204.7
Q ss_pred cCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEecC
Q 046750 360 NGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVP 439 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 439 (723)
++|.+.++||+|+||.||+|.+.+...||||+++... ...++|.+|++++++++|+||+++++++. ....++||||+.
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence 5689999999999999999987777789999998643 23457899999999999999999999875 456799999999
Q ss_pred CCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCccee
Q 046750 440 NNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVS 519 (723)
Q Consensus 440 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 519 (723)
+|+|.+++.......+++..++.++.++++||+|||+. +|+|||||++|||+++++.+||+|||+++..........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~ 160 (262)
T cd05071 84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 160 (262)
T ss_pred CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccccccc
Confidence 99999999765444678999999999999999999998 499999999999999999999999999976654332222
Q ss_pred ecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhh
Q 046750 520 TRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRL 598 (723)
Q Consensus 520 ~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l 598 (723)
....++..|++||++.+..++.++|||||||++|||++ |..||..... .. +...+..+...
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~---~~--------~~~~~~~~~~~------- 222 (262)
T cd05071 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---RE--------VLDQVERGYRM------- 222 (262)
T ss_pred cCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh---HH--------HHHHHhcCCCC-------
Confidence 23346778999999998999999999999999999999 7888864421 11 11111111100
Q ss_pred hccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhcc
Q 046750 599 EKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSE 638 (723)
Q Consensus 599 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~ 638 (723)
.........+.+++.+||+.+|.+||++.++++.|+..
T Consensus 223 --~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 223 --PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred --CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 01122344688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=351.05 Aligned_cols=253 Identities=25% Similarity=0.316 Sum_probs=202.3
Q ss_pred cCcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCC---chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGS---GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 435 (723)
++|.+.++||+|+||.||+|+.. +++.||||+++... ......+.+|+++|..++|+||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46899999999999999999654 68999999987532 234457889999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ 515 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 515 (723)
||+.+++|.+++... ..+.+..++.|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++......
T Consensus 81 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 81 EYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 999999999999765 3588899999999999999999998 59999999999999999999999999997654433
Q ss_pred ----------------------------cceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCC
Q 046750 516 ----------------------------THVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQP 567 (723)
Q Consensus 516 ----------------------------~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~ 567 (723)
........|+..|+|||++.+..++.++||||||||||||++|+.||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 235 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence 1122335689999999999999999999999999999999999999976542
Q ss_pred CCchhhHHhhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCC-HHHHHHHH
Q 046750 568 LGDESLVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPR-MVQVVRAL 635 (723)
Q Consensus 568 ~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~eVl~~L 635 (723)
. ..+.+ +.... ..+.. +.. .. ....+.+++.+||+ +|.+|++ +.+|++..
T Consensus 236 ~-----~~~~~--i~~~~--~~~~~---p~~-~~----~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp 286 (350)
T cd05573 236 Q-----ETYNK--IINWK--ESLRF---PPD-PP----VSPEAIDLICRLLC-DPEDRLGSFEEIKSHP 286 (350)
T ss_pred H-----HHHHH--HhccC--CcccC---CCC-CC----CCHHHHHHHHHHcc-ChhhcCCCHHHHhcCC
Confidence 1 11100 00000 01000 000 00 23467788899997 9999999 99998763
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=332.93 Aligned_cols=250 Identities=24% Similarity=0.405 Sum_probs=201.7
Q ss_pred CcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEecCC
Q 046750 361 GFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPN 440 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 440 (723)
+|++.+.||+|+||.||+|.++.++.+|||++.... ....+|.+|++++++++|+||+++++++...+..++||||+.+
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 477889999999999999988777889999987543 2345788999999999999999999999999999999999999
Q ss_pred CchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcceee
Q 046750 441 NNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVST 520 (723)
Q Consensus 441 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 520 (723)
++|.+++..... .+.+..++.++.||+.||+|||++ +|+|||||++|||+++++.+||+|||+++...........
T Consensus 84 ~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~ 159 (256)
T cd05059 84 GCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ 159 (256)
T ss_pred CCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccccccC
Confidence 999999875443 578999999999999999999999 4999999999999999999999999999765433222222
Q ss_pred cccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhhh
Q 046750 521 RVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLE 599 (723)
Q Consensus 521 ~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~ 599 (723)
...++..|+|||++.+..++.++|||||||+||||++ |+.||+..... ... ..+..+.. +
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~--------~~~~~~~~--~------ 220 (256)
T cd05059 160 GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS---EVV--------ESVSAGYR--L------ 220 (256)
T ss_pred CCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH---HHH--------HHHHcCCc--C------
Confidence 2234567999999999999999999999999999999 78988654321 111 11111110 0
Q ss_pred ccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 046750 600 KHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRAL 635 (723)
Q Consensus 600 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L 635 (723)
.........+.+++.+||+.+|++||+|.+|++.|
T Consensus 221 -~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 221 -YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred -CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 00111234688999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=334.87 Aligned_cols=264 Identities=23% Similarity=0.350 Sum_probs=195.4
Q ss_pred cCcccceEEeccCcEEEEEEEc-C-CCcEEEEEEcccCCch--hHHHHHHHHHHHHHc---cCCceeeEeeeeec-----
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-P-EGKVVAVKQLKSGSGQ--GEREFRAEVEIISRV---HHRHLVSLVGYCIS----- 427 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~-~g~~VAvK~l~~~~~~--~~~~~~~Ei~il~~l---~HpnIv~l~g~~~~----- 427 (723)
++|++.+.||+|+||.||+|+. . +++.||||+++..... ....+.+|+++++++ +|+||++++++|..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 3688999999999999999965 3 4688999998754322 234566788888776 69999999998852
Q ss_pred ccceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeeccc
Q 046750 428 EKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGL 507 (723)
Q Consensus 428 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGl 507 (723)
....++||||+. ++|.+++.......+++..++.|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 345789999995 6899988765555688999999999999999999999 599999999999999999999999999
Q ss_pred ccccCCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhh----h
Q 046750 508 AKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLV----R 583 (723)
Q Consensus 508 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~----~ 583 (723)
++..... .......|+..|+|||++.+..++.++|||||||+||||++|+.||...... .........+. .
T Consensus 157 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~---~~~~~i~~~~~~~~~~ 231 (290)
T cd07862 157 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV---DQLGKILDVIGLPGEE 231 (290)
T ss_pred eEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH---HHHHHHHHHhCCCChh
Confidence 9765433 2223456899999999999899999999999999999999999999765421 11111000000 0
Q ss_pred hh------hcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 046750 584 AI------ETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVR 633 (723)
Q Consensus 584 ~i------~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~ 633 (723)
.+ ....+.......+. .........+.+++.+||+.||++||++.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 232 DWPRDVALPRQAFHSKSAQPIE-KFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hchhhhcccchhccCCCCCCHH-HHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00 00000000000000 011112235678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=339.47 Aligned_cols=266 Identities=21% Similarity=0.332 Sum_probs=196.5
Q ss_pred cCcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCCc-hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEe
Q 046750 360 NGFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGSG-QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEF 437 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 437 (723)
++|++.+.||+|+||.||+|+.. +++.||||+++.... .....+.+|++++++++|+||+++++++.+....++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY 84 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence 67999999999999999999654 688999999875432 2234678899999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcc
Q 046750 438 VPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTH 517 (723)
Q Consensus 438 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 517 (723)
+ .++|.+++.... ..+.+..+..++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++...... .
T Consensus 85 ~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~ 158 (303)
T cd07869 85 V-HTDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-H 158 (303)
T ss_pred C-CcCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-c
Confidence 9 567877776543 2477888899999999999999999 49999999999999999999999999987543222 1
Q ss_pred eeecccccccccChhhhcc-CCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhh-------------h
Q 046750 518 VSTRVMGTFGYLAPEYASS-GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLV-------------R 583 (723)
Q Consensus 518 ~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~-------------~ 583 (723)
......|+..|+|||++.+ ..++.++|||||||+||||++|+.||....... .........+. .
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ--DQLERIFLVLGTPNEDTWPGVHSLP 236 (303)
T ss_pred cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhCCCChhhccchhhcc
Confidence 2233458999999999875 458899999999999999999999997643211 11111000000 0
Q ss_pred hhhcCCcccccchhhhccccH-HHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 046750 584 AIETGDLSEIVDPRLEKHYVE-SEMFRMIEAAAACVRHSGPKRPRMVQVVR 633 (723)
Q Consensus 584 ~i~~~~l~~~vd~~l~~~~~~-~~~~~l~~l~~~cl~~dP~~RPs~~eVl~ 633 (723)
......+.......+...+.. .....+.+|+.+||+.||++|+++.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000000000000111100000 01235678999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=331.42 Aligned_cols=254 Identities=28% Similarity=0.444 Sum_probs=206.3
Q ss_pred hcCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEec
Q 046750 359 TNGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFV 438 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 438 (723)
.+.|++.++||+|+||.||+|..++++.||||.+.... ....+|.+|++++++++|+||+++++++. .+..++||||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 46788999999999999999998889999999987644 33467899999999999999999999875 45689999999
Q ss_pred CCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcce
Q 046750 439 PNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHV 518 (723)
Q Consensus 439 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 518 (723)
.+++|.+++.......+.+..++.++.|++.||+|||+. +|+|||||++||++++++.++|+|||++..........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05067 83 ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCCccc
Confidence 999999998765555688999999999999999999998 59999999999999999999999999997665332222
Q ss_pred eecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchh
Q 046750 519 STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPR 597 (723)
Q Consensus 519 ~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~ 597 (723)
.....++..|++||++....++.++|||||||++|||++ |+.||..... ..+. +.+..+.....
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~--------~~~~~~~~~~~---- 224 (260)
T cd05067 160 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN---PEVI--------QNLERGYRMPR---- 224 (260)
T ss_pred ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh---HHHH--------HHHHcCCCCCC----
Confidence 223346678999999998999999999999999999999 9999965431 1111 11111111010
Q ss_pred hhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhc
Q 046750 598 LEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDS 637 (723)
Q Consensus 598 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~ 637 (723)
.......+.+++.+||+.+|++||++++|++.|+.
T Consensus 225 -----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 225 -----PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred -----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 11122368899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=343.63 Aligned_cols=256 Identities=26% Similarity=0.441 Sum_probs=202.1
Q ss_pred cCcccceEEeccCcEEEEEEEcC-CCc----EEEEEEcccCC-chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLP-EGK----VVAVKQLKSGS-GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLL 433 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~----~VAvK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 433 (723)
.+|+..++||+|+||.||+|.+. +++ .||||+++... ....++|..|+.+++.++|+||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46899999999999999999653 333 48999987543 34456788999999999999999999999864 5789
Q ss_pred EEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCC
Q 046750 434 IYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDT 513 (723)
Q Consensus 434 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 513 (723)
|+||+.+|+|.++++... ..+.+..+++++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++....
T Consensus 86 v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccccC
Confidence 999999999999997643 2478889999999999999999998 599999999999999999999999999987654
Q ss_pred CCccee-ecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcc
Q 046750 514 TQTHVS-TRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLS 591 (723)
Q Consensus 514 ~~~~~~-~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~ 591 (723)
...... ....++..|++||++.+..++.++|||||||+||||++ |+.||+.... ..+. +.+..+...
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~---~~~~--------~~~~~~~~~ 230 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA---SEIS--------SILEKGERL 230 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHH--------HHHhCCCCC
Confidence 333221 22234678999999999999999999999999999998 9999865321 1111 111111110
Q ss_pred cccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCC
Q 046750 592 EIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGE 640 (723)
Q Consensus 592 ~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~ 640 (723)
.. .......+.+++.+||+.+|.+||++.+|+..|..+..
T Consensus 231 ~~---------~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 231 PQ---------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred CC---------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 00 01112357889999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=336.68 Aligned_cols=258 Identities=26% Similarity=0.475 Sum_probs=208.8
Q ss_pred cCcccceEEeccCcEEEEEEEc------CCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNL------PEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLL 433 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~------~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 433 (723)
.+|.+.+.||+|+||.||+|+. .++..|++|.++.......+.|.+|++++++++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 3578889999999999999964 2356799999987666666789999999999999999999999999999999
Q ss_pred EEEecCCCchhhccccCC--------------CCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCc
Q 046750 434 IYEFVPNNNLEHHLHGKG--------------QPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFE 499 (723)
Q Consensus 434 V~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~ 499 (723)
||||+.+++|.+++.... ...+++..++.++.||+.||+|||++ +|+|||||++|||+++++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence 999999999999986432 23478999999999999999999999 4999999999999999999
Q ss_pred EEEeecccccccCCCCc-ceeecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhh
Q 046750 500 AQVADFGLAKLNDTTQT-HVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWA 577 (723)
Q Consensus 500 vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~ 577 (723)
+||+|||++........ .......++..|+|||++.+..++.++|||||||+||||++ |+.||..... ...
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---~~~---- 234 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN---TEV---- 234 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHH----
Confidence 99999999975543222 12233456788999999999999999999999999999998 9999865432 111
Q ss_pred hhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCC
Q 046750 578 RPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGE 640 (723)
Q Consensus 578 ~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~ 640 (723)
.+.+..+...... ......+.+++.+||+.+|.+||++.+|++.|+.+..
T Consensus 235 ----~~~~~~~~~~~~~---------~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 235 ----IECITQGRVLERP---------RVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred ----HHHHhCCCCCCCC---------ccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 1222223222111 1123468899999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=360.84 Aligned_cols=250 Identities=20% Similarity=0.291 Sum_probs=201.9
Q ss_pred CcccceEEeccCcEEEEEEEc-CC-CcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEec
Q 046750 361 GFARENVIGEGGFGCVYKGNL-PE-GKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFV 438 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~~-~~-g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 438 (723)
.|.+.++||+|+||.||+|.. .+ ++.||+|.+..........+++|+++|++++|+|||+++++|...+..||||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 388999999999999999943 34 6788899876655555567888999999999999999999999999999999999
Q ss_pred CCCchhhccccC--CCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCc
Q 046750 439 PNNNLEHHLHGK--GQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQT 516 (723)
Q Consensus 439 ~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 516 (723)
.+|+|.++|+.. ....+.+..+..++.||+.||.|||++ +|||||||++||||+.++.+||+|||+++.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999888542 233578888999999999999999998 599999999999999999999999999986644322
Q ss_pred -ceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccc
Q 046750 517 -HVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVD 595 (723)
Q Consensus 517 -~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd 595 (723)
......+|+..|+|||++.+..++.++|||||||+||||++|+.||..... .+ +.+.+..+....+
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~------~~-----~~~~~~~~~~~~~-- 291 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ------RE-----IMQQVLYGKYDPF-- 291 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH------HH-----HHHHHHhCCCCCC--
Confidence 123445699999999999999999999999999999999999999965321 11 1112222222111
Q ss_pred hhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 046750 596 PRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVR 633 (723)
Q Consensus 596 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~ 633 (723)
.......+.+++.+||+.+|++||++.++++
T Consensus 292 -------~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 292 -------PCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred -------CccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 1112236788999999999999999999875
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=351.52 Aligned_cols=260 Identities=24% Similarity=0.433 Sum_probs=213.1
Q ss_pred CCCccccCHHHHHHHhcCcccceEEeccCcEEEEEEEcCC--Cc--EEEEEEcccCCch-hHHHHHHHHHHHHHccCCce
Q 046750 344 GGSKSFFTYEELMEITNGFARENVIGEGGFGCVYKGNLPE--GK--VVAVKQLKSGSGQ-GEREFRAEVEIISRVHHRHL 418 (723)
Q Consensus 344 ~~~~~~~~~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~--g~--~VAvK~l~~~~~~-~~~~~~~Ei~il~~l~HpnI 418 (723)
++....+..++| ...++||+|.||.||+|.|.. |+ .||||.++.+... ...+|++|+.+|.+|+|+||
T Consensus 101 ~~lkclIpee~i-------~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hl 173 (1039)
T KOG0199|consen 101 IDLKCLIPEEQI-------KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHL 173 (1039)
T ss_pred CCcceeccHHHH-------HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcce
Confidence 334455555555 456899999999999997743 44 6999999987554 56789999999999999999
Q ss_pred eeEeeeeecccceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCC
Q 046750 419 VSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEF 498 (723)
Q Consensus 419 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~ 498 (723)
|+|||+..+ ....||||++.+|+|.+.|++..+..|-...+..++.|||.|+.||..+ ++|||||..+||||-...
T Consensus 174 iRLyGvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllaspr 249 (1039)
T KOG0199|consen 174 IRLYGVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPR 249 (1039)
T ss_pred eEEeeeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccc
Confidence 999999887 6788999999999999999986666788899999999999999999999 699999999999999999
Q ss_pred cEEEeecccccccCCCCccee-e-cccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHH
Q 046750 499 EAQVADFGLAKLNDTTQTHVS-T-RVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVE 575 (723)
Q Consensus 499 ~vkL~DFGla~~~~~~~~~~~-~-~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~ 575 (723)
.|||+||||.+-++..+.+.. . .....+.|+|||.|..+.|+.++|||+|||.||||++ |+.||-+-...
T Consensus 250 tVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~------- 322 (1039)
T KOG0199|consen 250 TVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI------- 322 (1039)
T ss_pred eeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH-------
Confidence 999999999997765554432 1 1234678999999999999999999999999999999 77888654321
Q ss_pred hhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 576 WARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 576 ~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
.+++.|+.|. +......+.+++++++++||.++|.+||++..|.+.
T Consensus 323 ----qIL~~iD~~e---------rLpRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 323 ----QILKNIDAGE---------RLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred ----HHHHhccccc---------cCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 1334444332 223344567789999999999999999999999743
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=334.53 Aligned_cols=252 Identities=27% Similarity=0.374 Sum_probs=201.0
Q ss_pred CcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCc---hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEE
Q 046750 361 GFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSG---QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYE 436 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 436 (723)
+|++.++||+|+||.||++.. .+++.||||++..... .....+.+|++++++|+|+||++++++|...+..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 478889999999999999965 4689999999865321 223457789999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCc
Q 046750 437 FVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQT 516 (723)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 516 (723)
|+.+|+|.+++.......+++..++.++.||+.||+|||+. +|+|||||++|||+++++.++|+|||+++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 99999999888665445689999999999999999999999 499999999999999999999999999976543222
Q ss_pred ceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccch
Q 046750 517 HVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDP 596 (723)
Q Consensus 517 ~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~ 596 (723)
.....|+..|+|||++.+..++.++|||||||+||||++|+.||...... ...+. +...+..+.
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~---~~~~~----~~~~~~~~~------- 221 (285)
T cd05605 158 --IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK---VKREE----VERRVKEDQ------- 221 (285)
T ss_pred --cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh---hHHHH----HHHHhhhcc-------
Confidence 12346899999999999999999999999999999999999999754321 11111 111111111
Q ss_pred hhhccccHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 046750 597 RLEKHYVESEMFRMIEAAAACVRHSGPKRP-----RMVQVVRA 634 (723)
Q Consensus 597 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~eVl~~ 634 (723)
..+.......+.+|+.+||+.||.+|+ ++.+|++.
T Consensus 222 ---~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 222 ---EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ---cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 111122234678899999999999999 77787654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=342.66 Aligned_cols=239 Identities=26% Similarity=0.338 Sum_probs=191.1
Q ss_pred EeccCcEEEEEEEcC-CCcEEEEEEcccC---CchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEecCCCch
Q 046750 368 IGEGGFGCVYKGNLP-EGKVVAVKQLKSG---SGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNL 443 (723)
Q Consensus 368 LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 443 (723)
||+|+||.||+|+.. +++.||||+++.. .......+.+|+++|++++|+||++++++|.+.+..|+||||+.+|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999654 5789999998653 223345678899999999999999999999999999999999999999
Q ss_pred hhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcceeeccc
Q 046750 444 EHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVM 523 (723)
Q Consensus 444 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 523 (723)
.+++.... .+.+..+..++.||++||.|||++ +|+|||||++||||+.++.+||+|||+++...... .......
T Consensus 81 ~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 154 (312)
T cd05585 81 FHHLQREG--RFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFC 154 (312)
T ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccccccc
Confidence 99997644 478889999999999999999998 59999999999999999999999999997543222 2223456
Q ss_pred ccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhhhcccc
Q 046750 524 GTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEKHYV 603 (723)
Q Consensus 524 gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~ 603 (723)
|+..|+|||++.+..++.++|||||||+||||++|+.||..... ..+. +.+..+.+ .+..
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~------~~~~-----~~~~~~~~------~~~~--- 214 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV------NEMY-----RKILQEPL------RFPD--- 214 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH------HHHH-----HHHHcCCC------CCCC---
Confidence 89999999999999999999999999999999999999965321 1111 11111111 0111
Q ss_pred HHHHHHHHHHHHHHhccCCCCCCC---HHHHHH
Q 046750 604 ESEMFRMIEAAAACVRHSGPKRPR---MVQVVR 633 (723)
Q Consensus 604 ~~~~~~l~~l~~~cl~~dP~~RPs---~~eVl~ 633 (723)
.....+.+++.+||+.||.+|++ +.++++
T Consensus 215 -~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 215 -GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred -cCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 12235778999999999999986 455544
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=342.28 Aligned_cols=264 Identities=19% Similarity=0.336 Sum_probs=195.2
Q ss_pred CcccceEEeccCcEEEEEEE-cCCCcEEEEEEcccCC--chhHHHHHHHHHHHHHccCCceeeEeeeeecc-----cceE
Q 046750 361 GFARENVIGEGGFGCVYKGN-LPEGKVVAVKQLKSGS--GQGEREFRAEVEIISRVHHRHLVSLVGYCISE-----KNRL 432 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~-~~~g~~VAvK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-----~~~~ 432 (723)
+|++.++||+|+||.||+|. ..+++.||||+++... ......+.+|+++|++|+|+||+++++++... ...|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 48889999999999999995 4568999999987532 23345688999999999999999999988643 2479
Q ss_pred EEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccC
Q 046750 433 LIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLND 512 (723)
Q Consensus 433 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 512 (723)
+||||+ +++|.+++.... .+.+..+..|+.||++||.|||++ +|+|||||++|||++.++.+||+|||+++...
T Consensus 81 lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 81 VVFELM-ESDLHQVIKAND--DLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEecC-CCCHHHHHHhcc--cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 999999 578988886544 478899999999999999999999 59999999999999999999999999997543
Q ss_pred CCCc--ceeecccccccccChhhhcc--CCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhh-------h
Q 046750 513 TTQT--HVSTRVMGTFGYLAPEYASS--GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPV-------L 581 (723)
Q Consensus 513 ~~~~--~~~~~~~gt~~y~APE~~~~--~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~-------l 581 (723)
.... .......|+..|+|||++.+ ..++.++|||||||+||||++|+.||....... ...+.... .
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~---~~~~~~~~~~~~~~~~ 231 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH---QLDLITDLLGTPSPET 231 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHH---HHHHHHHHhCCCCHHH
Confidence 2211 12234568999999999876 678999999999999999999999996543211 11100000 0
Q ss_pred hhhhhcCCcccccc-------hhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 582 VRAIETGDLSEIVD-------PRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 582 ~~~i~~~~l~~~vd-------~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
...+.......+++ ..+...+ ......+.+++.+||+.+|.+||++.||++.
T Consensus 232 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 232 ISRVRNEKARRYLSSMRKKQPVPFSQKF-PNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHHhhhhhHHHHHHhhcccCCCchHHhc-CCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00011110000000 0000000 0112356789999999999999999999964
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=348.20 Aligned_cols=252 Identities=22% Similarity=0.312 Sum_probs=196.8
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCC---chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS---GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 435 (723)
++|++.++||+|+||.||+|+. .+++.||||+++... ......+.+|+++|..++|+||++++++|.+.+..||||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 4689999999999999999955 468999999997532 233456788999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ 515 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 515 (723)
||+.+|+|.+++.... .+.+..+..|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||++..+....
T Consensus 81 E~~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 81 EYLPGGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred CCCCCcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 9999999999997654 488889999999999999999999 59999999999999999999999999986543211
Q ss_pred cc-------------------------------------eeecccccccccChhhhccCCCCCccceechHHHHHHHHhC
Q 046750 516 TH-------------------------------------VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITG 558 (723)
Q Consensus 516 ~~-------------------------------------~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG 558 (723)
.. .....+||+.|+|||++.+..++.++|||||||+||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 10 01124699999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCC---HHHHHHH
Q 046750 559 RKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPR---MVQVVRA 634 (723)
Q Consensus 559 ~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs---~~eVl~~ 634 (723)
+.||...... .... ..+.......+.+ . .. ....+.+++.+|+. +|.+|++ +.++++.
T Consensus 236 ~~Pf~~~~~~---~~~~-------~i~~~~~~~~~~~-~--~~----~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 236 YPPFCSDNPQ---ETYR-------KIINWKETLQFPD-E--VP----LSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCCHH---HHHH-------HHHcCCCccCCCC-C--CC----CCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 9999754321 0100 0000000000000 0 01 12256677888886 8999998 8888764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=346.68 Aligned_cols=245 Identities=24% Similarity=0.306 Sum_probs=199.0
Q ss_pred cCcccceEEeccCcEEEEEEEcCC--CcEEEEEEcccC---CchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLPE--GKVVAVKQLKSG---SGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLI 434 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~~--g~~VAvK~l~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 434 (723)
++|.+.+.||+|+||.||+|.+.. +..||||++... .......+.+|+++++.++|+||+++++++.+.+..|+|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 468999999999999999996533 368999998643 223345688999999999999999999999999999999
Q ss_pred EEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCC
Q 046750 435 YEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTT 514 (723)
Q Consensus 435 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 514 (723)
|||+.+|+|.+++.... .+.+..+..++.||+.||.|||++ +|+|||||++||||+.++.+||+|||+++.....
T Consensus 110 ~Ey~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~ 184 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR 184 (340)
T ss_pred EeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence 99999999999997654 478888999999999999999999 5999999999999999999999999999865432
Q ss_pred CcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCccccc
Q 046750 515 QTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIV 594 (723)
Q Consensus 515 ~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~v 594 (723)
.....|+..|+|||++.+..++.++|||||||+||||++|+.||...... . +.+.+..+.+.
T Consensus 185 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~---~--------~~~~i~~~~~~--- 246 (340)
T PTZ00426 185 ----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL---L--------IYQKILEGIIY--- 246 (340)
T ss_pred ----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH---H--------HHHHHhcCCCC---
Confidence 12356899999999999988999999999999999999999999754321 0 11222222210
Q ss_pred chhhhccccHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 046750 595 DPRLEKHYVESEMFRMIEAAAACVRHSGPKRP-----RMVQVVRA 634 (723)
Q Consensus 595 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~eVl~~ 634 (723)
+...+ ...+.+++.+||+.+|.+|+ ++.+|++.
T Consensus 247 ---~p~~~----~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 247 ---FPKFL----DNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ---CCCCC----CHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 11111 12467899999999999995 78888765
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=336.89 Aligned_cols=269 Identities=20% Similarity=0.329 Sum_probs=197.8
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCc-hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEe
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSG-QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEF 437 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 437 (723)
++|.+.++||+|+||.||+|.. .+++.||||+++.... .....+.+|++++++++|+||+++++++.+....++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 4688999999999999999954 4688999999875432 2345678999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcc
Q 046750 438 VPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTH 517 (723)
Q Consensus 438 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 517 (723)
+. ++|.+++..... .+.+..+..++.||+.||+|||++ +|+|||||++|||+++++.+||+|||+++.......
T Consensus 85 ~~-~~l~~~l~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~- 158 (288)
T cd07871 85 LD-SDLKQYLDNCGN-LMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK- 158 (288)
T ss_pred CC-cCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-
Confidence 96 589888865432 467888999999999999999998 599999999999999999999999999975432221
Q ss_pred eeecccccccccChhhhcc-CCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHH-hhhh---hhhhh-hhcCCcc
Q 046750 518 VSTRVMGTFGYLAPEYASS-GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVE-WARP---VLVRA-IETGDLS 591 (723)
Q Consensus 518 ~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~-~~~~---~l~~~-i~~~~l~ 591 (723)
......++..|+|||++.+ ..++.++|||||||+||||++|+.||............. .... ..... .....+.
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR 238 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence 1233457899999999875 568999999999999999999999997543211100000 0000 00000 0000111
Q ss_pred cccchhhhccc----cHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 592 EIVDPRLEKHY----VESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 592 ~~vd~~l~~~~----~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
.++.+...... .......+++++.+||+.||.+|+++.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 11111110000 00112357799999999999999999999863
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=353.38 Aligned_cols=268 Identities=21% Similarity=0.270 Sum_probs=193.6
Q ss_pred HHhcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCchhHHHHHHHHHHHHHccC------CceeeEeeeeecc-
Q 046750 357 EITNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHH------RHLVSLVGYCISE- 428 (723)
Q Consensus 357 ~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~H------pnIv~l~g~~~~~- 428 (723)
...++|++.++||+|+||.||+|.. ..++.||||+++... ...+++..|++++++++| .+|++++++|...
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~ 204 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNET 204 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCC
Confidence 3457899999999999999999954 457889999997532 234456778888888765 4588899988765
Q ss_pred cceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCC----------
Q 046750 429 KNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEF---------- 498 (723)
Q Consensus 429 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~---------- 498 (723)
.+.|||||++ +++|.+++.+.+ .+.+..+..|+.||+.||+|||++. +|||||||++||||+.++
T Consensus 205 ~~~~iv~~~~-g~~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~--gIiHrDlKP~NILl~~~~~~~~~~~~~~ 279 (467)
T PTZ00284 205 GHMCIVMPKY-GPCLLDWIMKHG--PFSHRHLAQIIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTVVDPVTNRA 279 (467)
T ss_pred ceEEEEEecc-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCHHHEEEecCCcccccccccc
Confidence 4678889888 778888886543 4888999999999999999999742 599999999999998665
Q ss_pred ------cEEEeecccccccCCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchh
Q 046750 499 ------EAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDES 572 (723)
Q Consensus 499 ------~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~ 572 (723)
.+||+|||++.... ......+||..|+|||++.+..|+.++|||||||+||||++|+.||+.........
T Consensus 280 ~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~ 355 (467)
T PTZ00284 280 LPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLH 355 (467)
T ss_pred cCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 49999999886432 22344679999999999999999999999999999999999999998654321111
Q ss_pred hHHhhhhhhhhhh--------------hcCCcccccchhhhccc-------cHHHHHHHHHHHHHHhccCCCCCCCHHHH
Q 046750 573 LVEWARPVLVRAI--------------ETGDLSEIVDPRLEKHY-------VESEMFRMIEAAAACVRHSGPKRPRMVQV 631 (723)
Q Consensus 573 l~~~~~~~l~~~i--------------~~~~l~~~vd~~l~~~~-------~~~~~~~l~~l~~~cl~~dP~~RPs~~eV 631 (723)
++......+...+ ..+.+....++.....+ .......+.+|+.+||+.||++|+++.||
T Consensus 356 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~ 435 (467)
T PTZ00284 356 LMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQM 435 (467)
T ss_pred HHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHH
Confidence 1111000000000 00111111111100000 00112357799999999999999999999
Q ss_pred HHH
Q 046750 632 VRA 634 (723)
Q Consensus 632 l~~ 634 (723)
++.
T Consensus 436 L~H 438 (467)
T PTZ00284 436 TTH 438 (467)
T ss_pred hcC
Confidence 974
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=315.64 Aligned_cols=263 Identities=23% Similarity=0.330 Sum_probs=210.3
Q ss_pred hcCcccceEEeccCcEEEEEE-EcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccc-----eE
Q 046750 359 TNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKN-----RL 432 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~-~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~-----~~ 432 (723)
.++|.+.++||+|||..||++ .+.+++.||+|++.....++.+..++|++..++++|+||+++++++..+.. .|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 467999999999999999999 467789999999988777778889999999999999999999998876544 89
Q ss_pred EEEEecCCCchhhccccC--CCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccc
Q 046750 433 LIYEFVPNNNLEHHLHGK--GQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKL 510 (723)
Q Consensus 433 lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 510 (723)
|++.|+..|+|.+++... +...+++.+++.|+.+|++||++||+.. +.++||||||.|||+.+.+.++|.|||.+..
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCccc
Confidence 999999999999988653 3346899999999999999999999983 4699999999999999999999999999864
Q ss_pred cCCCCc----c----eeecccccccccChhhhc---cCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhh
Q 046750 511 NDTTQT----H----VSTRVMGTFGYLAPEYAS---SGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARP 579 (723)
Q Consensus 511 ~~~~~~----~----~~~~~~gt~~y~APE~~~---~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~ 579 (723)
..-... + .......|.-|+|||++. +..+++++|||||||+||+||.|..||+.....++.
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgS-------- 250 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGS-------- 250 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCe--------
Confidence 332111 0 011234788999999885 345889999999999999999999999764432211
Q ss_pred hhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccC
Q 046750 580 VLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEG 639 (723)
Q Consensus 580 ~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~ 639 (723)
+.-++..+.+. ..-.......|.+++++||+.||.+||++.+++..++...
T Consensus 251 -laLAv~n~q~s--------~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 251 -LALAVQNAQIS--------IPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred -EEEeeeccccc--------cCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 11112222221 1111124557899999999999999999999999998653
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=335.58 Aligned_cols=255 Identities=26% Similarity=0.483 Sum_probs=202.3
Q ss_pred cCcccceEEeccCcEEEEEEEc-----CCCcEEEEEEcccCCc-hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-----PEGKVVAVKQLKSGSG-QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLL 433 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-----~~g~~VAvK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 433 (723)
+.|++.++||+|+||.||+|.+ ..++.|+||.++.... +...+|.+|++++++++|+||+++++++......|+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4578889999999999999964 3467899999975433 334678899999999999999999999999999999
Q ss_pred EEEecCCCchhhccccCC---------------CCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCC
Q 046750 434 IYEFVPNNNLEHHLHGKG---------------QPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEF 498 (723)
Q Consensus 434 V~E~~~~gsL~~~l~~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~ 498 (723)
||||+.+++|.+++.... ...+++..++.++.+|+.||+|||++ +|+|||||++||||++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence 999999999999885321 23478889999999999999999999 499999999999999999
Q ss_pred cEEEeecccccccCCCCc-ceeecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHh
Q 046750 499 EAQVADFGLAKLNDTTQT-HVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEW 576 (723)
Q Consensus 499 ~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~ 576 (723)
.+||+|||+++....... .......++..|+|||++.+..++.++|||||||+||||++ |..||..... ..+.
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~---~~~~-- 236 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN---QEVI-- 236 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHH--
Confidence 999999999976543222 11223345678999999998899999999999999999998 8888865321 1111
Q ss_pred hhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhc
Q 046750 577 ARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDS 637 (723)
Q Consensus 577 ~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~ 637 (723)
+.+..+....+ .. .....+.+++.+||+.+|.+||++.+|++.|..
T Consensus 237 ------~~~~~~~~~~~-----~~----~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 237 ------EMVRKRQLLPC-----SE----DCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred ------HHHHcCCcCCC-----CC----CCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 22222221110 01 112367889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=347.69 Aligned_cols=251 Identities=22% Similarity=0.331 Sum_probs=193.5
Q ss_pred CcccceEEeccCcEEEEEEE-cCCCcEEEEEEcccCC---chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEE
Q 046750 361 GFARENVIGEGGFGCVYKGN-LPEGKVVAVKQLKSGS---GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYE 436 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~-~~~g~~VAvK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 436 (723)
.|.++++||+|+||.||+|+ ..+++.||||+++... ......+++|+++|++++|+||++++++|.+.+..|||||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 58899999999999999994 4568899999997532 2334568899999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCc
Q 046750 437 FVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQT 516 (723)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 516 (723)
|+.+|+|.+++.... .+.+..+..++.||+.||+|||+. +|+|||||++||||+.++++||+|||+++.+.....
T Consensus 82 ~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 82 YIPGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred cCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 999999999987644 477888888999999999999998 599999999999999999999999999754321000
Q ss_pred ----------------------------------------------ceeecccccccccChhhhccCCCCCccceechHH
Q 046750 517 ----------------------------------------------HVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGV 550 (723)
Q Consensus 517 ----------------------------------------------~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGv 550 (723)
......+||..|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 0012346999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhh-cCCcccccchhhhccccHHHHHHHHHHHHH--HhccCCCCCCC
Q 046750 551 VLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIE-TGDLSEIVDPRLEKHYVESEMFRMIEAAAA--CVRHSGPKRPR 627 (723)
Q Consensus 551 iL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~-~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~--cl~~dP~~RPs 627 (723)
|||||++|+.||....... ... ..+. ...+. +. . ...+ ...+.+++.+ |+..++..|++
T Consensus 237 il~elltG~~Pf~~~~~~~--~~~--------~i~~~~~~~~-~~-~--~~~~----s~~~~dli~~ll~~~~~~~~R~~ 298 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTE--TQL--------KVINWENTLH-IP-P--QVKL----SPEAVDLITKLCCSAEERLGRNG 298 (381)
T ss_pred HHHHHHhCCCCCcCCCHHH--HHH--------HHHccccccC-CC-C--CCCC----CHHHHHHHHHHccCcccccCCCC
Confidence 9999999999997643211 000 0010 00000 00 0 0011 1245566666 55666667999
Q ss_pred HHHHHHH
Q 046750 628 MVQVVRA 634 (723)
Q Consensus 628 ~~eVl~~ 634 (723)
+.+|++.
T Consensus 299 ~~~~l~h 305 (381)
T cd05626 299 ADDIKAH 305 (381)
T ss_pred HHHHhcC
Confidence 9999875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=342.46 Aligned_cols=242 Identities=26% Similarity=0.384 Sum_probs=193.5
Q ss_pred eEEeccCcEEEEEEEc----CCCcEEEEEEcccCC----chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEe
Q 046750 366 NVIGEGGFGCVYKGNL----PEGKVVAVKQLKSGS----GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEF 437 (723)
Q Consensus 366 ~~LG~G~fG~Vy~~~~----~~g~~VAvK~l~~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 437 (723)
++||+|+||.||+++. ..++.||||+++... ......+.+|+++|++++|+||++++++|..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6899999999999964 357899999987531 22334678899999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcc
Q 046750 438 VPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTH 517 (723)
Q Consensus 438 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 517 (723)
+.+++|.+++...+ .+.+..+..++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 155 (323)
T cd05584 82 LSGGELFMHLEREG--IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT- 155 (323)
T ss_pred CCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-
Confidence 99999999987554 367778888999999999999999 599999999999999999999999999875432222
Q ss_pred eeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchh
Q 046750 518 VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPR 597 (723)
Q Consensus 518 ~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~ 597 (723)
......|+..|+|||++.+..++.++|||||||+||||++|+.||...... . ....+..+.+.
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~------~-----~~~~~~~~~~~------ 218 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK------K-----TIDKILKGKLN------ 218 (323)
T ss_pred cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH------H-----HHHHHHcCCCC------
Confidence 223356899999999999989999999999999999999999999754321 1 11122222211
Q ss_pred hhccccHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 046750 598 LEKHYVESEMFRMIEAAAACVRHSGPKRP-----RMVQVVRA 634 (723)
Q Consensus 598 l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~eVl~~ 634 (723)
+ .......+.+++.+||+.+|.+|+ ++.++++.
T Consensus 219 ~----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 219 L----PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred C----CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 0 111123578999999999999999 78887764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=334.10 Aligned_cols=258 Identities=25% Similarity=0.475 Sum_probs=207.8
Q ss_pred cCcccceEEeccCcEEEEEEEc------CCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNL------PEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLL 433 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~------~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 433 (723)
++|.+.+.||+|+||.||++.. .++..||||.++.........+.+|++++++++|+||++++++|...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 5688999999999999999964 2345699999987665666789999999999999999999999999999999
Q ss_pred EEEecCCCchhhccccCC-----------CCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEE
Q 046750 434 IYEFVPNNNLEHHLHGKG-----------QPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQV 502 (723)
Q Consensus 434 V~E~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL 502 (723)
||||+.+++|.+++.... ...+.+..++.++.||+.+|+|||++ +|+||||||+|||+++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEe
Confidence 999999999999886432 23489999999999999999999998 4999999999999999999999
Q ss_pred eecccccccCCCCcc-eeecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhh
Q 046750 503 ADFGLAKLNDTTQTH-VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPV 580 (723)
Q Consensus 503 ~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~ 580 (723)
+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |..||..... ..
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~---~~-------- 230 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---NE-------- 230 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HH--------
Confidence 999999755432221 1122345778999999998999999999999999999998 8888865432 11
Q ss_pred hhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCC
Q 046750 581 LVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGE 640 (723)
Q Consensus 581 l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~ 640 (723)
+...+..+.+.... .. ....+.+|+.+||+.+|.+||++.+|++.|+.+..
T Consensus 231 ~~~~i~~~~~~~~~-----~~----~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 231 VIECITQGRVLQRP-----RT----CPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred HHHHHHcCCcCCCC-----CC----CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 11222233221111 11 12368899999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=350.56 Aligned_cols=198 Identities=27% Similarity=0.389 Sum_probs=173.9
Q ss_pred CcccceEEeccCcEEEEEE-EcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHcc-C-----CceeeEeeeeecccceEE
Q 046750 361 GFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVH-H-----RHLVSLVGYCISEKNRLL 433 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~-~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~-H-----pnIv~l~g~~~~~~~~~l 433 (723)
+|.+.++||+|.||.|.+| +.+.++.||||+++.... -.++-..|+.||.+|+ | -|||++++||...++.||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 7899999999999999999 666799999999987532 2345567999999996 3 589999999999999999
Q ss_pred EEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCC--CCcEEEeeccccccc
Q 046750 434 IYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDD--EFEAQVADFGLAKLN 511 (723)
Q Consensus 434 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~--~~~vkL~DFGla~~~ 511 (723)
|+|.+ .-+|+++|+.+.-..|....+..|+.||+.||.+||+. +|||+||||+||||.+ ...|||+|||.+.+.
T Consensus 266 VfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 99999 78999999988877899999999999999999999999 5999999999999975 347999999999865
Q ss_pred CCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCC
Q 046750 512 DTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQP 567 (723)
Q Consensus 512 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~ 567 (723)
.... . ..+.+..|+|||+|.+..|+.+.|||||||||+||++|...|-+..+
T Consensus 342 ~q~v---y-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne 393 (586)
T KOG0667|consen 342 SQRV---Y-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE 393 (586)
T ss_pred CCcc---e-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH
Confidence 4322 2 45678899999999999999999999999999999999888876654
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=347.32 Aligned_cols=256 Identities=27% Similarity=0.453 Sum_probs=214.5
Q ss_pred cccceEEeccCcEEEEEEEcC---CCc--EEEEEEcccC-CchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEE
Q 046750 362 FARENVIGEGGFGCVYKGNLP---EGK--VVAVKQLKSG-SGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 362 f~~~~~LG~G~fG~Vy~~~~~---~g~--~VAvK~l~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 435 (723)
....++||+|-||.||+|.+. .|. .||||..+.+ ..+..+.|+.|.-+|+.++|+|||+|+|+|.+. ..+|||
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wivm 469 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVM 469 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEE
Confidence 455689999999999999542 233 5899999875 344567899999999999999999999999754 589999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ 515 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 515 (723)
|++..|.|..||+.+.. .|+...+..+++||+.+|+|||+. ++|||||..+|||+...-.|||+||||++.+.+..
T Consensus 470 EL~~~GELr~yLq~nk~-sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~ 545 (974)
T KOG4257|consen 470 ELAPLGELREYLQQNKD-SLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA 545 (974)
T ss_pred ecccchhHHHHHHhccc-cchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhccccc
Confidence 99999999999987654 588999999999999999999998 79999999999999999999999999999998877
Q ss_pred cceeecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCccccc
Q 046750 516 THVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIV 594 (723)
Q Consensus 516 ~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~v 594 (723)
.+...+..-...|||||-+.-.+++.++|||.|||++||++. |..||.+-...+ +.-.+++|+-.
T Consensus 546 yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD-----------VI~~iEnGeRl--- 611 (974)
T KOG4257|consen 546 YYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD-----------VIGHIENGERL--- 611 (974)
T ss_pred hhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc-----------eEEEecCCCCC---
Confidence 766665556779999999999999999999999999999877 999997643211 12234444421
Q ss_pred chhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCCCc
Q 046750 595 DPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEMS 642 (723)
Q Consensus 595 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~~~ 642 (723)
..++.+.-.|+.|+.+||..+|.+||++.+|...|.....++
T Consensus 612 ------P~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qee 653 (974)
T KOG4257|consen 612 ------PCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEE 653 (974)
T ss_pred ------CCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHh
Confidence 223445567889999999999999999999999998876653
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=345.90 Aligned_cols=202 Identities=27% Similarity=0.384 Sum_probs=174.0
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCC---chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS---GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 435 (723)
++|++.+.||+|+||.||++.. .+++.||||+++... ......+++|+.++.+++|+||+++++++.+....||||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 4688999999999999999954 468899999997532 223356788999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ 515 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 515 (723)
||+.+|+|.+++...+ .+.+..+..++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 81 EFLPGGDMMTLLMKKD--TLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred cCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 9999999999997654 478899999999999999999999 59999999999999999999999999987543211
Q ss_pred c----------------------------------ceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCC
Q 046750 516 T----------------------------------HVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKP 561 (723)
Q Consensus 516 ~----------------------------------~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P 561 (723)
. ......+||..|+|||++.+..++.++|||||||+||||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 0 001235799999999999999999999999999999999999999
Q ss_pred CCCCC
Q 046750 562 VDPTQ 566 (723)
Q Consensus 562 ~~~~~ 566 (723)
|....
T Consensus 236 f~~~~ 240 (363)
T cd05628 236 FCSET 240 (363)
T ss_pred CCCCC
Confidence 97543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=346.35 Aligned_cols=258 Identities=27% Similarity=0.415 Sum_probs=201.7
Q ss_pred cCcccceEEeccCcEEEEEEEcC------CCcEEEEEEcccCCc-hhHHHHHHHHHHHHHc-cCCceeeEeeeeec-ccc
Q 046750 360 NGFARENVIGEGGFGCVYKGNLP------EGKVVAVKQLKSGSG-QGEREFRAEVEIISRV-HHRHLVSLVGYCIS-EKN 430 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~------~g~~VAvK~l~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~-~~~ 430 (723)
++|++.++||+|+||.||+|.+. .++.||||+++.... ...+.+..|++++.++ +|+||++++++|.. +..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 46889999999999999999532 247899999975432 2345678899999999 89999999998865 456
Q ss_pred eEEEEEecCCCchhhccccCC-----------------------------------------------------------
Q 046750 431 RLLIYEFVPNNNLEHHLHGKG----------------------------------------------------------- 451 (723)
Q Consensus 431 ~~lV~E~~~~gsL~~~l~~~~----------------------------------------------------------- 451 (723)
.++||||+.+++|.++|....
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 789999999999998885321
Q ss_pred CCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcce-eecccccccccC
Q 046750 452 QPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHV-STRVMGTFGYLA 530 (723)
Q Consensus 452 ~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~A 530 (723)
...+.+..+.+++.||+.||+|||++ +|+|||||+.||||++++.+||+|||+++.+....... .....++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 12578899999999999999999998 59999999999999999999999999998654332222 222345678999
Q ss_pred hhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhhhccccHHHHHH
Q 046750 531 PEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFR 609 (723)
Q Consensus 531 PE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~ 609 (723)
||++.+..++.++|||||||+||||++ |..||...... +. +...+..+..... .......
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~--~~--------~~~~~~~~~~~~~---------~~~~~~~ 304 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID--EE--------FCRRLKEGTRMRA---------PEYATPE 304 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc--HH--------HHHHHhccCCCCC---------CccCCHH
Confidence 999999999999999999999999998 99998653221 11 1112222211110 1112346
Q ss_pred HHHHHHHHhccCCCCCCCHHHHHHHHhccC
Q 046750 610 MIEAAAACVRHSGPKRPRMVQVVRALDSEG 639 (723)
Q Consensus 610 l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~ 639 (723)
+.+++.+||+.+|++||++.||+++|+.+.
T Consensus 305 ~~~l~~~cl~~~p~~RPs~~ell~~l~~~~ 334 (337)
T cd05054 305 IYSIMLDCWHNNPEDRPTFSELVEILGDLL 334 (337)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=331.04 Aligned_cols=257 Identities=25% Similarity=0.440 Sum_probs=202.5
Q ss_pred HhcCcccceEEeccCcEEEEEEEcC------CCcEEEEEEcccCCc-hhHHHHHHHHHHHHHccCCceeeEeeeeecccc
Q 046750 358 ITNGFARENVIGEGGFGCVYKGNLP------EGKVVAVKQLKSGSG-QGEREFRAEVEIISRVHHRHLVSLVGYCISEKN 430 (723)
Q Consensus 358 ~~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~VAvK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 430 (723)
..++|++.+.||+|+||.||+|.+. .+..||||+++.... ....+|.+|+.++++++|+||+++++++.+...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567999999999999999998642 246799999865432 334568899999999999999999999999999
Q ss_pred eEEEEEecCCCchhhccccCC--------CCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEE
Q 046750 431 RLLIYEFVPNNNLEHHLHGKG--------QPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQV 502 (723)
Q Consensus 431 ~~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL 502 (723)
.++||||+.+++|.++++... ...+.+..++.++.|+++||+|||+. +++|||||++||||++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEE
Confidence 999999999999999986532 12357788999999999999999998 5999999999999999999999
Q ss_pred eecccccccCCCCcce-eecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhh
Q 046750 503 ADFGLAKLNDTTQTHV-STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPV 580 (723)
Q Consensus 503 ~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~ 580 (723)
+|||+++......... .....++..|+|||++.++.++.++|||||||+||||++ |..||..... ....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~---~~~~------ 231 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN---EQVL------ 231 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHH------
Confidence 9999987554322211 122345778999999999999999999999999999999 6888865432 1111
Q ss_pred hhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhc
Q 046750 581 LVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDS 637 (723)
Q Consensus 581 l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~ 637 (723)
+.+..+.+..+. ......+.+++.+||+.+|.+||++.||++.|+.
T Consensus 232 --~~~~~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 232 --RFVMEGGLLDKP---------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred --HHHHcCCcCCCC---------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 111122211111 1122367889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=347.88 Aligned_cols=253 Identities=22% Similarity=0.279 Sum_probs=194.4
Q ss_pred cCcccceEEeccCcEEEEEEE-cCCCcEEEEEEcccCC---chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGN-LPEGKVVAVKQLKSGS---GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~-~~~g~~VAvK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 435 (723)
++|.+.++||+|+||.||++. ..+++.||||++.... ......+++|+++|++++|+||++++++|.+....||||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 468899999999999999995 4578999999986431 233456888999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ 515 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 515 (723)
||+.+|+|.+++.... .+.+..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++.+....
T Consensus 81 E~~~gg~L~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 81 EFLPGGDLMTMLIKYD--TFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 9999999999987543 477888889999999999999999 49999999999999999999999999986332110
Q ss_pred cc----------------------------------------------eeecccccccccChhhhccCCCCCccceechH
Q 046750 516 TH----------------------------------------------VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFG 549 (723)
Q Consensus 516 ~~----------------------------------------------~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlG 549 (723)
.. .....+||..|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 00 00124699999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCC---C
Q 046750 550 VVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKR---P 626 (723)
Q Consensus 550 viL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~R---P 626 (723)
||||||++|+.||...... ..+ . ..+.......+- .. ......+.+++.+||. ++.+| +
T Consensus 236 vil~elltG~~Pf~~~~~~--~~~----~----~i~~~~~~~~~p-----~~--~~~s~~~~dli~~lL~-~~~~r~~r~ 297 (377)
T cd05629 236 AIMFECLIGWPPFCSENSH--ETY----R----KIINWRETLYFP-----DD--IHLSVEAEDLIRRLIT-NAENRLGRG 297 (377)
T ss_pred hhhhhhhcCCCCCCCCCHH--HHH----H----HHHccCCccCCC-----CC--CCCCHHHHHHHHHHhc-CHhhcCCCC
Confidence 9999999999999754321 000 0 000000000000 00 0112356788889997 66665 5
Q ss_pred CHHHHHHHH
Q 046750 627 RMVQVVRAL 635 (723)
Q Consensus 627 s~~eVl~~L 635 (723)
++.++++.-
T Consensus 298 ~~~~~l~hp 306 (377)
T cd05629 298 GAHEIKSHP 306 (377)
T ss_pred CHHHHhcCC
Confidence 999988754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=346.32 Aligned_cols=254 Identities=21% Similarity=0.251 Sum_probs=199.1
Q ss_pred hcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccC---CchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEE
Q 046750 359 TNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSG---SGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLI 434 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 434 (723)
.++|++.++||+|+||.||+++. .+++.||||++... .......+..|+.++++++|+||+++++++.+.+..|||
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 45799999999999999999955 46889999998643 122334578899999999999999999999999999999
Q ss_pred EEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCC
Q 046750 435 YEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTT 514 (723)
Q Consensus 435 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 514 (723)
|||+.+|+|.+++... .+.+..+..++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++.....
T Consensus 122 ~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 122 MEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred EcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence 9999999999998654 367778888999999999999998 5999999999999999999999999999765433
Q ss_pred CcceeecccccccccChhhhccC----CCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCc
Q 046750 515 QTHVSTRVMGTFGYLAPEYASSG----KLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDL 590 (723)
Q Consensus 515 ~~~~~~~~~gt~~y~APE~~~~~----~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l 590 (723)
........+|+..|+|||++.+. .++.++|||||||+||||++|+.||...... . +...+..+..
T Consensus 196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~-----~~~~i~~~~~ 264 (370)
T cd05596 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------G-----TYSKIMDHKN 264 (370)
T ss_pred CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH------H-----HHHHHHcCCC
Confidence 32223345699999999998753 4789999999999999999999999754321 1 1111111110
Q ss_pred ccccchhhhccccHHHHHHHHHHHHHHhccCCCC--CCCHHHHHHHH
Q 046750 591 SEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPK--RPRMVQVVRAL 635 (723)
Q Consensus 591 ~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~eVl~~L 635 (723)
. + .+.. .......+.+++.+||+.+|.+ |+++.+|++.-
T Consensus 265 ~-~---~~~~--~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~ 305 (370)
T cd05596 265 S-L---TFPD--DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHP 305 (370)
T ss_pred c-C---CCCC--cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCc
Confidence 0 0 0000 0012236778899999999988 99999998764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=328.63 Aligned_cols=253 Identities=30% Similarity=0.453 Sum_probs=203.7
Q ss_pred cCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEecC
Q 046750 360 NGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVP 439 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 439 (723)
++|.+.+.||+|+||.||+|.+..+..||+|+++... ...+.+.+|++++++++|+||+++++++. .+..++||||+.
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 5688899999999999999988777789999987543 33467889999999999999999999875 456899999999
Q ss_pred CCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCccee
Q 046750 440 NNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVS 519 (723)
Q Consensus 440 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 519 (723)
+++|.++++......+.+..++.++.+|+.||+|||+. +|+|||||++||||++++.++|+|||++...........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05069 84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCccccc
Confidence 99999999765555588999999999999999999998 499999999999999999999999999976543322222
Q ss_pred ecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhh
Q 046750 520 TRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRL 598 (723)
Q Consensus 520 ~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l 598 (723)
....++..|++||++.+..++.++|||||||+||||++ |+.||..... .....+ +..+...
T Consensus 161 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~--------~~~~~~~------- 222 (260)
T cd05069 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN---REVLEQ--------VERGYRM------- 222 (260)
T ss_pred CCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH--------HHcCCCC-------
Confidence 23346778999999998999999999999999999999 8899865431 111111 1111100
Q ss_pred hccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhc
Q 046750 599 EKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDS 637 (723)
Q Consensus 599 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~ 637 (723)
.........+.+++.+||+.+|.+||++.+|++.|+.
T Consensus 223 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 --PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred --CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0011223468889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=343.81 Aligned_cols=243 Identities=22% Similarity=0.324 Sum_probs=194.4
Q ss_pred eEEeccCcEEEEEEE-cCCCcEEEEEEcccCC---chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEecCCC
Q 046750 366 NVIGEGGFGCVYKGN-LPEGKVVAVKQLKSGS---GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPNN 441 (723)
Q Consensus 366 ~~LG~G~fG~Vy~~~-~~~g~~VAvK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 441 (723)
++||+|+||.||++. ..+++.||||+++... ......+..|++++..++|+||++++++|.+.+..||||||+.+|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 479999999999995 4578999999987532 223456778999999999999999999999999999999999999
Q ss_pred chhhccccCCCCcchHHHHHHHHHHHHhhhchhcc-cCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcceee
Q 046750 442 NLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHE-DCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVST 520 (723)
Q Consensus 442 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 520 (723)
+|.+++.... .+.+..++.|+.||+.||+|||+ + +|+|||||++||||++++.+||+|||+++....... ...
T Consensus 81 ~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~ 154 (325)
T cd05594 81 ELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMK 154 (325)
T ss_pred cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-ccc
Confidence 9998886543 47889999999999999999997 5 599999999999999999999999999875332221 123
Q ss_pred cccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhhhc
Q 046750 521 RVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEK 600 (723)
Q Consensus 521 ~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~ 600 (723)
...|+..|+|||++.+..++.++|||||||+||||++|+.||..... ..+ .+.+..+.+ .+..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~---~~~--------~~~i~~~~~------~~p~ 217 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKL--------FELILMEEI------RFPR 217 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH---HHH--------HHHHhcCCC------CCCC
Confidence 35699999999999999999999999999999999999999965431 111 111111111 1111
Q ss_pred cccHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHHH
Q 046750 601 HYVESEMFRMIEAAAACVRHSGPKRP-----RMVQVVRAL 635 (723)
Q Consensus 601 ~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~eVl~~L 635 (723)
.+ ...+.+++.+||+.||++|+ ++.+|++.-
T Consensus 218 ~~----~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~ 253 (325)
T cd05594 218 TL----SPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHK 253 (325)
T ss_pred CC----CHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCC
Confidence 12 23577899999999999997 899988653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=332.83 Aligned_cols=267 Identities=27% Similarity=0.380 Sum_probs=201.8
Q ss_pred cccceEEeccCcEEEEEEEc-----CCCcEEEEEEcccCCc-hhHHHHHHHHHHHHHccCCceeeEeeeeecc--cceEE
Q 046750 362 FARENVIGEGGFGCVYKGNL-----PEGKVVAVKQLKSGSG-QGEREFRAEVEIISRVHHRHLVSLVGYCISE--KNRLL 433 (723)
Q Consensus 362 f~~~~~LG~G~fG~Vy~~~~-----~~g~~VAvK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~~l 433 (723)
|++.+.||+|+||.||++.. .+++.||||.++.... .....|.+|+++|++++|+||++++++|... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 38889999999999988642 3577899999976533 3456788999999999999999999988754 35789
Q ss_pred EEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCC
Q 046750 434 IYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDT 513 (723)
Q Consensus 434 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 513 (723)
||||+.+++|.+++... .+++..++.|+.|+++||+|||++ +|+|||||++||||++++.+||+|||+++....
T Consensus 86 v~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred EecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 99999999999998654 389999999999999999999999 599999999999999999999999999986543
Q ss_pred CCcce--eecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcc
Q 046750 514 TQTHV--STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLS 591 (723)
Q Consensus 514 ~~~~~--~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~ 591 (723)
..... .....++..|++||++.+..++.++|||||||+||||++|+.||....... .....+... ......+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~----~~~~~~~~ 234 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQG----QMTVVRLI 234 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhccccc----ccchhhhh
Confidence 32211 112235667999999998999999999999999999999999986532210 011111000 00000111
Q ss_pred cccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccC
Q 046750 592 EIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEG 639 (723)
Q Consensus 592 ~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~ 639 (723)
++++..............+.+++.+||+.+|.+||++.+|++.|+.+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 235 ELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 111111111112223357889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=345.08 Aligned_cols=253 Identities=21% Similarity=0.263 Sum_probs=200.6
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCC---chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS---GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 435 (723)
++|.+.++||+|+||.||++.. .+++.||||+++... ....+.+.+|+.+++.++|+||+++++++.+.+..||||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 4689999999999999999954 468999999997542 233456889999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ 515 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 515 (723)
||+.+|+|.+++.+.. ..+.+..+..++.||+.||+|||++ +|+|||||++||||+.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 81 EYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred CCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 9999999999997652 2488889999999999999999999 59999999999999999999999999998765444
Q ss_pred cceeecccccccccChhhhc------cCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCC
Q 046750 516 THVSTRVMGTFGYLAPEYAS------SGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGD 589 (723)
Q Consensus 516 ~~~~~~~~gt~~y~APE~~~------~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~ 589 (723)
........|+..|+|||++. ...++.++|||||||+||||++|+.||...... .... +.+....
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~~~~----~i~~~~~ 226 (330)
T cd05601 157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA------KTYN----NIMNFQR 226 (330)
T ss_pred ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH------HHHH----HHHcCCC
Confidence 33334456899999999987 456789999999999999999999999754321 1111 1111111
Q ss_pred cccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 590 LSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 590 l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
+..+.+ .......+.+|+..||+ +|.+|+++.++++.
T Consensus 227 ~~~~~~-------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 227 FLKFPE-------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred ccCCCC-------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 111100 01122357788889997 99999999998754
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=348.30 Aligned_cols=254 Identities=21% Similarity=0.249 Sum_probs=196.5
Q ss_pred hcCcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccC---CchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEE
Q 046750 359 TNGFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSG---SGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLI 434 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 434 (723)
.++|++.++||+|+||.||+++.. +++.||+|++... .......+.+|+.+++.++|+||+++++++.++...|+|
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV 121 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 467999999999999999999654 5789999998642 222344678999999999999999999999999999999
Q ss_pred EEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCC
Q 046750 435 YEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTT 514 (723)
Q Consensus 435 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 514 (723)
|||+.+|+|.+++... .+.+..+..++.||+.||+|||++ +|+|||||++||||++++.+||+|||++......
T Consensus 122 ~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~ 195 (370)
T cd05621 122 MEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET 195 (370)
T ss_pred EcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecccC
Confidence 9999999999998654 367888899999999999999999 5999999999999999999999999999866443
Q ss_pred CcceeecccccccccChhhhccC----CCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCc
Q 046750 515 QTHVSTRVMGTFGYLAPEYASSG----KLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDL 590 (723)
Q Consensus 515 ~~~~~~~~~gt~~y~APE~~~~~----~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l 590 (723)
.........||..|+|||++.+. .++.++|||||||+||||++|+.||...... .. +.+.+.....
T Consensus 196 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~------~~----~~~i~~~~~~ 265 (370)
T cd05621 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV------GT----YSKIMDHKNS 265 (370)
T ss_pred CceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH------HH----HHHHHhCCcc
Confidence 33233446799999999999754 3788999999999999999999999754321 11 1111111100
Q ss_pred ccccchhhhccccHHHHHHHHHHHHHHhccCCCC--CCCHHHHHHHH
Q 046750 591 SEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPK--RPRMVQVVRAL 635 (723)
Q Consensus 591 ~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~eVl~~L 635 (723)
..+ .........+.+++.+||..++.+ |+++.|+++.-
T Consensus 266 ~~~-------p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp 305 (370)
T cd05621 266 LNF-------PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHP 305 (370)
T ss_pred cCC-------CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCc
Confidence 000 000111234667778888755543 88999998863
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=340.97 Aligned_cols=244 Identities=28% Similarity=0.419 Sum_probs=192.1
Q ss_pred cccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCC---chhHHHHHHHHHHH---HHccCCceeeEeeeeecccceEEE
Q 046750 362 FARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS---GQGEREFRAEVEII---SRVHHRHLVSLVGYCISEKNRLLI 434 (723)
Q Consensus 362 f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~---~~~~~~~~~Ei~il---~~l~HpnIv~l~g~~~~~~~~~lV 434 (723)
|.+.++||+|+||.||+|.. .+++.||||+++... ....+.+.+|++++ ++++|+||+++++++.+.+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 67789999999999999955 468999999997532 22334566776665 456799999999999999999999
Q ss_pred EEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCC
Q 046750 435 YEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTT 514 (723)
Q Consensus 435 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 514 (723)
|||+.+++|..+++.. .+.+..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++.....
T Consensus 81 ~E~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 81 MEYAAGGDLMMHIHTD---VFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EcCCCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 9999999999888643 488999999999999999999999 5999999999999999999999999998743322
Q ss_pred CcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCccccc
Q 046750 515 QTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIV 594 (723)
Q Consensus 515 ~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~v 594 (723)
.. ......|+..|+|||++.+..++.++|||||||+||||++|+.||..... . + +...+..+...
T Consensus 155 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~---~---~-----~~~~i~~~~~~--- 219 (324)
T cd05589 155 GD-RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE---E---E-----VFDSIVNDEVR--- 219 (324)
T ss_pred CC-cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH---H---H-----HHHHHHhCCCC---
Confidence 21 12345689999999999999999999999999999999999999975432 1 1 11112121110
Q ss_pred chhhhccccHHHHHHHHHHHHHHhccCCCCCCC-----HHHHHH
Q 046750 595 DPRLEKHYVESEMFRMIEAAAACVRHSGPKRPR-----MVQVVR 633 (723)
Q Consensus 595 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~eVl~ 633 (723)
+.......+.+++.+||+.||.+||+ +.++++
T Consensus 220 -------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 220 -------YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred -------CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 11111235778999999999999994 555554
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=333.02 Aligned_cols=266 Identities=26% Similarity=0.382 Sum_probs=201.7
Q ss_pred cCcccceEEeccCcEEEEEEEc-----CCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeec--ccceE
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-----PEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCIS--EKNRL 432 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-----~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~~~ 432 (723)
++|++.+.||+|+||.||++.+ .+++.||||+++.......+.|.+|+++|++++|+||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4788999999999999999964 3578999999987665666789999999999999999999998754 34678
Q ss_pred EEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccC
Q 046750 433 LIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLND 512 (723)
Q Consensus 433 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 512 (723)
+||||+.+++|.+++.+.. ..+++..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++...
T Consensus 84 lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred EEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 9999999999999997543 2478999999999999999999999 59999999999999999999999999998664
Q ss_pred CCCccee--ecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHH-----hhhhhhhhhh
Q 046750 513 TTQTHVS--TRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVE-----WARPVLVRAI 585 (723)
Q Consensus 513 ~~~~~~~--~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~-----~~~~~l~~~i 585 (723)
....... ....+...|+|||++.+..++.++|||||||+||||++|..++..........+.. .....+.+.+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL 239 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence 3322211 11223456999999999899999999999999999999877653321100000000 0000000111
Q ss_pred hcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhcc
Q 046750 586 ETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSE 638 (723)
Q Consensus 586 ~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~ 638 (723)
..+. ...........+.+|+.+||+.+|++||++.+|++.|+.+
T Consensus 240 ~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 240 KNNG---------RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred hcCC---------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 1110 0001112234688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=324.35 Aligned_cols=254 Identities=28% Similarity=0.451 Sum_probs=206.3
Q ss_pred hcCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEec
Q 046750 359 TNGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFV 438 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 438 (723)
.++|++.++||+|+||.||++.+.++..|+||.++... ...+.|.+|++++++++|+||+++++++.+ ...++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 46789999999999999999988788889999987542 334678899999999999999999999887 7789999999
Q ss_pred CCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcce
Q 046750 439 PNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHV 518 (723)
Q Consensus 439 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 518 (723)
.+++|.+++.......+++..++.++.+|+.||+|||+. +++|||||++||+++.++.+||+|||++..........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 159 (260)
T cd05073 83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 159 (260)
T ss_pred CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCccc
Confidence 999999999765555688899999999999999999998 59999999999999999999999999997654333222
Q ss_pred eecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchh
Q 046750 519 STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPR 597 (723)
Q Consensus 519 ~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~ 597 (723)
.....++..|++||++..+.++.++|||||||++|||++ |+.||..... ..+. +.+..+.....
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~---~~~~--------~~~~~~~~~~~---- 224 (260)
T cd05073 160 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN---PEVI--------RALERGYRMPR---- 224 (260)
T ss_pred ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH---HHHH--------HHHhCCCCCCC----
Confidence 222345678999999998899999999999999999999 8899864321 1111 11222211111
Q ss_pred hhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhc
Q 046750 598 LEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDS 637 (723)
Q Consensus 598 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~ 637 (723)
.......+.+++.+||+.+|++||++.+|++.|+.
T Consensus 225 -----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 225 -----PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred -----cccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11223468899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=328.42 Aligned_cols=266 Identities=22% Similarity=0.325 Sum_probs=201.4
Q ss_pred cCcccceEEeccCcEEEEEE-EcCCCcEEEEEEcccCCch--hHHHHHHHHHHHHHccCCc-eeeEeeeeeccc------
Q 046750 360 NGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQ--GEREFRAEVEIISRVHHRH-LVSLVGYCISEK------ 429 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~-~~~~g~~VAvK~l~~~~~~--~~~~~~~Ei~il~~l~Hpn-Iv~l~g~~~~~~------ 429 (723)
..|...++||+|.||.||+| ...+|+.||+|+++-...+ .-....+|+.+|++|+|.| ||+|++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 44667788999999999999 4557899999999865432 2345689999999999999 999999999877
Q ss_pred ceEEEEEecCCCchhhccccCCC--CcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeeccc
Q 046750 430 NRLLIYEFVPNNNLEHHLHGKGQ--PVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGL 507 (723)
Q Consensus 430 ~~~lV~E~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGl 507 (723)
..+|||||+ .-+|.+++..... ..++...+..+.+||++||+|||++ +|+||||||+||||++++.+||+|||+
T Consensus 91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccch
Confidence 788999999 7799999976553 3567788999999999999999999 599999999999999999999999999
Q ss_pred ccccCCCCcceeecccccccccChhhhccC-CCCCccceechHHHHHHHHhCCCCCCCCCCCCch----------hhHHh
Q 046750 508 AKLNDTTQTHVSTRVMGTFGYLAPEYASSG-KLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDE----------SLVEW 576 (723)
Q Consensus 508 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~----------~l~~~ 576 (723)
|+.+..... ..+..++|.+|+|||++.+. .|+...||||+|||++||++++..|.+....... +...|
T Consensus 167 Ara~~ip~~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 167 ARAFSIPMR-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred HHHhcCCcc-cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 986653222 23456789999999999887 6999999999999999999999999876541110 11111
Q ss_pred hhhhhhhhhhcCCcccccchhhhccccHHH---HHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 577 ARPVLVRAIETGDLSEIVDPRLEKHYVESE---MFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 577 ~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~---~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
-.......++. .+...-++ ..+.... .....+++.+||+.+|.+|.++...+.+
T Consensus 246 p~v~~~~~~k~-~f~~~~~~---~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 246 PGVSSLPDYKA-PFPKWPGP---KDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCccccccccc-cCcCCCCc---cchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 11000000000 00000000 0011111 1367889999999999999999999875
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=334.28 Aligned_cols=257 Identities=28% Similarity=0.437 Sum_probs=203.8
Q ss_pred cCcccceEEeccCcEEEEEEEcCC------CcEEEEEEcccCC-chhHHHHHHHHHHHHHc-cCCceeeEeeeeecccce
Q 046750 360 NGFARENVIGEGGFGCVYKGNLPE------GKVVAVKQLKSGS-GQGEREFRAEVEIISRV-HHRHLVSLVGYCISEKNR 431 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~~------g~~VAvK~l~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~ 431 (723)
++|++.+.||+|+||.||++.+.. ...||+|+++... .....++.+|+++++++ +|+||++++++|......
T Consensus 12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (293)
T cd05053 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPL 91 (293)
T ss_pred hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCe
Confidence 568899999999999999996532 3679999987642 23345688999999999 899999999999999999
Q ss_pred EEEEEecCCCchhhccccC--------------CCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCC
Q 046750 432 LLIYEFVPNNNLEHHLHGK--------------GQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDE 497 (723)
Q Consensus 432 ~lV~E~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~ 497 (723)
++||||+.+|+|.++++.. ....+++..+++++.||+.||+|||++ +|+|||||+.|||++++
T Consensus 92 ~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~~ 168 (293)
T cd05053 92 YVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTED 168 (293)
T ss_pred EEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcCC
Confidence 9999999999999998642 234588999999999999999999998 59999999999999999
Q ss_pred CcEEEeecccccccCCCCcce-eecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHH
Q 046750 498 FEAQVADFGLAKLNDTTQTHV-STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVE 575 (723)
Q Consensus 498 ~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~ 575 (723)
+.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||..... ..
T Consensus 169 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~--- 242 (293)
T cd05053 169 HVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV---EE--- 242 (293)
T ss_pred CeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH---HH---
Confidence 999999999998654332211 122234678999999998999999999999999999997 8888864321 11
Q ss_pred hhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccC
Q 046750 576 WARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEG 639 (723)
Q Consensus 576 ~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~ 639 (723)
+.+.+..+... .........+.+|+.+||+.+|.+||++.+|++.|+...
T Consensus 243 -----~~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 243 -----LFKLLKEGYRM---------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred -----HHHHHHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 11111111110 111122346889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=325.68 Aligned_cols=258 Identities=21% Similarity=0.359 Sum_probs=205.9
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccC---CchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSG---SGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 435 (723)
++|++.+.||+|+||.||+|+. .+++.||||.++.. .......+.+|++++++++|+||+++++++.+.+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 5789999999999999999965 46899999987643 2233456889999999999999999999999999999999
Q ss_pred EecCCCchhhcccc--CCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCC
Q 046750 436 EFVPNNNLEHHLHG--KGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDT 513 (723)
Q Consensus 436 E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 513 (723)
||+.+++|.+++.. .....+.+..++.++.||++||+|||++ +|+|||||++||||+.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999988753 2234578888999999999999999998 599999999999999999999999999876543
Q ss_pred CCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccc
Q 046750 514 TQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEI 593 (723)
Q Consensus 514 ~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~ 593 (723)
.... .....|+..|+|||++.+..++.++|||||||++|||++|+.||..... ....+. +.+.......+
T Consensus 159 ~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~----~~~~~~-----~~~~~~~~~~~ 228 (267)
T cd08228 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLFSLC-----QKIEQCDYPPL 228 (267)
T ss_pred hhHH-HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc----cHHHHH-----HHHhcCCCCCC
Confidence 2221 1234578899999999988899999999999999999999999864321 111111 11222111111
Q ss_pred cchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhcc
Q 046750 594 VDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSE 638 (723)
Q Consensus 594 vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~ 638 (723)
. .......+.+++.+||+.+|.+||++.+|++.|+++
T Consensus 229 ~--------~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 229 P--------TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred C--------hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 0 112234688999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=327.81 Aligned_cols=255 Identities=29% Similarity=0.462 Sum_probs=207.8
Q ss_pred hcCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEec
Q 046750 359 TNGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFV 438 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 438 (723)
.++|.+.++||+|+||.||+|.+++++.||||.+.... ....++.+|++++++++|+||+++++++......++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 46789999999999999999988888899999987543 34467999999999999999999999999888999999999
Q ss_pred CCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcce
Q 046750 439 PNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHV 518 (723)
Q Consensus 439 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 518 (723)
.+++|.+++.......+.+..++.++.+|+.||+|||++ +|+|+|||++||||++++.+||+|||+++.........
T Consensus 84 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 160 (261)
T cd05034 84 SKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTA 160 (261)
T ss_pred CCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhhhh
Confidence 999999999876555689999999999999999999999 59999999999999999999999999997665422222
Q ss_pred eecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchh
Q 046750 519 STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPR 597 (723)
Q Consensus 519 ~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~ 597 (723)
.....++..|++||++.+..++.++|||||||++|||++ |+.||..... .... +.+..+. ....
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~---~~~~--------~~~~~~~-~~~~--- 225 (261)
T cd05034 161 REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN---REVL--------EQVERGY-RMPR--- 225 (261)
T ss_pred hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHH--------HHHHcCC-CCCC---
Confidence 222334568999999999899999999999999999998 9999864321 1111 1111111 0000
Q ss_pred hhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhc
Q 046750 598 LEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDS 637 (723)
Q Consensus 598 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~ 637 (723)
.......+.+++.+||+.+|.+||++.+|++.|+.
T Consensus 226 -----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 226 -----PPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -----CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 01113468899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=339.25 Aligned_cols=248 Identities=22% Similarity=0.335 Sum_probs=194.2
Q ss_pred eEEeccCcEEEEEEEc-CCCcEEEEEEcccCC---chhHHHHHHHHHHHHHc-cCCceeeEeeeeecccceEEEEEecCC
Q 046750 366 NVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS---GQGEREFRAEVEIISRV-HHRHLVSLVGYCISEKNRLLIYEFVPN 440 (723)
Q Consensus 366 ~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~---~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 440 (723)
++||+|+||.||+++. .+++.||||+++... ......+++|+.++.++ +|+||++++++|.+.+..||||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4799999999999955 468899999997542 22334678899999998 799999999999999999999999999
Q ss_pred CchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcceee
Q 046750 441 NNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVST 520 (723)
Q Consensus 441 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 520 (723)
|+|.+++...+ .+.+..++.|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++...... ....
T Consensus 81 g~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~~ 154 (329)
T cd05588 81 GDLMFHMQRQR--KLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTTS 154 (329)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCC-Cccc
Confidence 99998886543 488999999999999999999999 59999999999999999999999999987432211 1223
Q ss_pred cccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCC--chhhHHhhhhhhhhhhhcCCcccccchhh
Q 046750 521 RVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLG--DESLVEWARPVLVRAIETGDLSEIVDPRL 598 (723)
Q Consensus 521 ~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~--~~~l~~~~~~~l~~~i~~~~l~~~vd~~l 598 (723)
...|+..|+|||++.+..++.++|||||||+||||++|+.||+...... .....+|.. +.+..+.+. +
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~----~~~~~~~~~------~ 224 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLF----QVILEKQIR------I 224 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHH----HHHHcCCCC------C
Confidence 4568999999999999999999999999999999999999997432211 111222221 222222111 1
Q ss_pred hccccHHHHHHHHHHHHHHhccCCCCCCC------HHHHHH
Q 046750 599 EKHYVESEMFRMIEAAAACVRHSGPKRPR------MVQVVR 633 (723)
Q Consensus 599 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs------~~eVl~ 633 (723)
... ....+.+++.+||+.||.+|++ +.+|++
T Consensus 225 p~~----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 225 PRS----LSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred CCC----CCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 111 1235788999999999999997 566654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=334.49 Aligned_cols=256 Identities=28% Similarity=0.436 Sum_probs=202.6
Q ss_pred CcccceEEeccCcEEEEEEEcC------CCcEEEEEEcccCCc-hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEE
Q 046750 361 GFARENVIGEGGFGCVYKGNLP------EGKVVAVKQLKSGSG-QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLL 433 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~~~------~g~~VAvK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 433 (723)
+|++.++||+|+||.||+|... ....|++|.+..... ....++.+|+++++.++|+||++++++|...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778899999999999999642 235789998876543 334578899999999999999999999999999999
Q ss_pred EEEecCCCchhhccccCC----------------------CCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCc
Q 046750 434 IYEFVPNNNLEHHLHGKG----------------------QPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSAN 491 (723)
Q Consensus 434 V~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~N 491 (723)
||||+.+++|.+++.... ...+.+..++.++.||+.||+|||++ +|+|||||++|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence 999999999999875321 12478889999999999999999998 59999999999
Q ss_pred EEeCCCCcEEEeecccccccCCCCcce-eecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCC
Q 046750 492 ILVDDEFEAQVADFGLAKLNDTTQTHV-STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLG 569 (723)
Q Consensus 492 ILl~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~ 569 (723)
|||++++.+||+|||+++......... .....++..|++||++.+..++.++|||||||+||||++ |+.||.....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-- 235 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP-- 235 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH--
Confidence 999999999999999997554332221 122345678999999998899999999999999999998 9999865431
Q ss_pred chhhHHhhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccC
Q 046750 570 DESLVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEG 639 (723)
Q Consensus 570 ~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~ 639 (723)
..+..+ +..+.. ..........+.+++.+||+.+|.+||++.+|++.|+++.
T Consensus 236 -~~~~~~--------~~~~~~---------~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 236 -ERLFNL--------LKTGYR---------MERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred -HHHHHH--------HhCCCC---------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 112111 111110 0011112346889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=332.47 Aligned_cols=255 Identities=27% Similarity=0.423 Sum_probs=201.0
Q ss_pred hcCcccceEEeccCcEEEEEEEcCC------CcEEEEEEcccCCc-hhHHHHHHHHHHHHHccCCceeeEeeeeecccce
Q 046750 359 TNGFARENVIGEGGFGCVYKGNLPE------GKVVAVKQLKSGSG-QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNR 431 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~~~------g~~VAvK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 431 (723)
.++|.+.+.||+|+||.||+|.+.+ +..|++|.+..... ....+|.+|+.++++++|+||+++++++.+....
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 3568999999999999999996643 56799998875433 3345789999999999999999999999999899
Q ss_pred EEEEEecCCCchhhccccCCC-----CcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCC---cEEEe
Q 046750 432 LLIYEFVPNNNLEHHLHGKGQ-----PVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEF---EAQVA 503 (723)
Q Consensus 432 ~lV~E~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~---~vkL~ 503 (723)
++||||+.+++|.++++.... ..+.+..+++++.||++||+|||++ +|+|||||++|||++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEec
Confidence 999999999999999865431 2588999999999999999999999 599999999999998654 59999
Q ss_pred ecccccccCCCCcce-eecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhh
Q 046750 504 DFGLAKLNDTTQTHV-STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVL 581 (723)
Q Consensus 504 DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l 581 (723)
|||+++......... ......+..|+|||++.+..++.++|||||||+||||++ |+.||..... ..+.
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~---~~~~------- 231 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN---QEVM------- 231 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHH-------
Confidence 999998653222111 112234568999999999999999999999999999997 9999875432 1111
Q ss_pred hhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 046750 582 VRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALD 636 (723)
Q Consensus 582 ~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~ 636 (723)
..+..+.. ..+.......+.+++.+||+.+|++||++.+|++.|+
T Consensus 232 -~~~~~~~~---------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 232 -EFVTGGGR---------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred -HHHHcCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 11111110 0111122346788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=347.09 Aligned_cols=251 Identities=22% Similarity=0.293 Sum_probs=193.5
Q ss_pred CcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCC---chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEE
Q 046750 361 GFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS---GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYE 436 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 436 (723)
+|++.+.||+|+||.||+++. .+++.||||++.... ......+.+|+++|++++|+||++++++|.+++..|||||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 689999999999999999954 568999999986532 2234568899999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCC-
Q 046750 437 FVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ- 515 (723)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~- 515 (723)
|+.+|+|.+++...+ .+.+..+..++.||+.||+|||++ +|+|||||++||||+.++.+||+|||++..+....
T Consensus 82 ~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 82 YIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred CCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence 999999999997654 477888888999999999999999 59999999999999999999999999975321100
Q ss_pred -----------------------------------------cceeecccccccccChhhhccCCCCCccceechHHHHHH
Q 046750 516 -----------------------------------------THVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLE 554 (723)
Q Consensus 516 -----------------------------------------~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~e 554 (723)
.......+|+..|||||++.+..++.++|||||||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 000123469999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCC---CHHHH
Q 046750 555 LITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRP---RMVQV 631 (723)
Q Consensus 555 LltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP---s~~eV 631 (723)
|++|+.||....... +.. .+..... .+..+. ...+ ...+.+++.+|+ .+|.+|+ ++.++
T Consensus 237 ll~G~~Pf~~~~~~~------~~~-----~i~~~~~-~~~~~~-~~~~----s~~~~~li~~l~-~~p~~R~~~~t~~el 298 (376)
T cd05598 237 MLVGQPPFLADTPAE------TQL-----KVINWET-TLHIPS-QAKL----SREASDLILRLC-CGAEDRLGKNGADEI 298 (376)
T ss_pred hhhCCCCCCCCCHHH------HHH-----HHhccCc-cccCCC-CCCC----CHHHHHHHHHHh-cCHhhcCCCCCHHHH
Confidence 999999997654211 100 0000000 000000 0111 224556666766 4999999 88888
Q ss_pred HHH
Q 046750 632 VRA 634 (723)
Q Consensus 632 l~~ 634 (723)
++.
T Consensus 299 l~h 301 (376)
T cd05598 299 KAH 301 (376)
T ss_pred hCC
Confidence 765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=324.58 Aligned_cols=247 Identities=28% Similarity=0.447 Sum_probs=198.8
Q ss_pred eEEeccCcEEEEEEEcCCCcEEEEEEcccCCch-hHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEecCCCchh
Q 046750 366 NVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQ-GEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNLE 444 (723)
Q Consensus 366 ~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~ 444 (723)
++||+|+||.||+|...+++.||+|+++..... ....|.+|++++++++|+||++++++|......++||||+.+++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 478999999999998888999999998765433 3346889999999999999999999999999999999999999999
Q ss_pred hccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcceeecccc
Q 046750 445 HHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMG 524 (723)
Q Consensus 445 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~g 524 (723)
+++.... ..+++..++.++.+++.+|.|||++ +++|||||++||++++++.+||+|||++...............+
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05085 81 SFLRKKK-DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI 156 (250)
T ss_pred HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence 9986543 3478999999999999999999998 59999999999999999999999999997543322222222234
Q ss_pred cccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhhhcccc
Q 046750 525 TFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEKHYV 603 (723)
Q Consensus 525 t~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~ 603 (723)
...|+|||++.++.++.++|||||||+||||++ |..||..... ... ...+..+.... ..
T Consensus 157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~---~~~--------~~~~~~~~~~~---------~~ 216 (250)
T cd05085 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN---QQA--------REQVEKGYRMS---------CP 216 (250)
T ss_pred cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH---HHH--------HHHHHcCCCCC---------CC
Confidence 678999999999999999999999999999998 9999865421 111 11111111111 11
Q ss_pred HHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 046750 604 ESEMFRMIEAAAACVRHSGPKRPRMVQVVRALD 636 (723)
Q Consensus 604 ~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~ 636 (723)
......+.+++.+||+.+|++||++.+|++.|.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 217 QKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 112347889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=338.06 Aligned_cols=243 Identities=23% Similarity=0.346 Sum_probs=190.3
Q ss_pred eEEeccCcEEEEEEEc-CCCcEEEEEEcccC---CchhHHHHHHHHHHHHHc-cCCceeeEeeeeecccceEEEEEecCC
Q 046750 366 NVIGEGGFGCVYKGNL-PEGKVVAVKQLKSG---SGQGEREFRAEVEIISRV-HHRHLVSLVGYCISEKNRLLIYEFVPN 440 (723)
Q Consensus 366 ~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~---~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 440 (723)
++||+|+||.||++.. .+++.||||+++.. .......+..|+.++.++ +|+||+++++++.+.+..|+||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4799999999999965 45789999999754 223344577899998887 799999999999999999999999999
Q ss_pred CchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcceee
Q 046750 441 NNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVST 520 (723)
Q Consensus 441 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 520 (723)
|+|..++.... .+.+..++.|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++....... ...
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~~~ 154 (329)
T cd05618 81 GDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TTS 154 (329)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-ccc
Confidence 99998886543 478899999999999999999999 599999999999999999999999999875322221 223
Q ss_pred cccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCC--chhhHHhhhhhhhhhhhcCCcccccchhh
Q 046750 521 RVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLG--DESLVEWARPVLVRAIETGDLSEIVDPRL 598 (723)
Q Consensus 521 ~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~--~~~l~~~~~~~l~~~i~~~~l~~~vd~~l 598 (723)
...|+..|+|||++.+..++.++|||||||+||||++|+.||....... ......|. .+.+..+.+.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~----~~~i~~~~~~------- 223 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL----FQVILEKQIR------- 223 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHH----HHHHhcCCCC-------
Confidence 4568999999999999999999999999999999999999996432211 11112221 1222222110
Q ss_pred hccccHHHHHHHHHHHHHHhccCCCCCCCH
Q 046750 599 EKHYVESEMFRMIEAAAACVRHSGPKRPRM 628 (723)
Q Consensus 599 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 628 (723)
+.......+.+++.+||+.||.+|++.
T Consensus 224 ---~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 224 ---IPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred ---CCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 111123357789999999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=350.96 Aligned_cols=262 Identities=21% Similarity=0.305 Sum_probs=195.2
Q ss_pred hcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEe
Q 046750 359 TNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEF 437 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 437 (723)
..+|.+.++||+|+||.||++.. ..++.||||.... ..+.+|+++|++|+|+|||++++++......+||||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 35788999999999999999955 4578999996432 3467899999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcc
Q 046750 438 VPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTH 517 (723)
Q Consensus 438 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 517 (723)
+ .++|.+++..... .+++..++.|+.||++||+|||++ +|||||||++||||+.++.+||+|||+++........
T Consensus 242 ~-~~~L~~~l~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 242 Y-RSDLYTYLGARLR-PLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred c-CCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 9 5788888765432 589999999999999999999999 4999999999999999999999999999865433221
Q ss_pred -eeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCC-C----chhhHHhhhhhhhhhhhcCCcc
Q 046750 518 -VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPL-G----DESLVEWARPVLVRAIETGDLS 591 (723)
Q Consensus 518 -~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~-~----~~~l~~~~~~~l~~~i~~~~l~ 591 (723)
......||..|+|||++.+..++.++||||||||||||++|..++...... . ...+....+.. .+....+.
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~---~~~~~~~~ 393 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQA---QVHVDEFP 393 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhh---ccccccCC
Confidence 223456999999999999999999999999999999999988665322111 0 11111111100 00000111
Q ss_pred cccchhhhccc------------c-------HHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 592 EIVDPRLEKHY------------V-------ESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 592 ~~vd~~l~~~~------------~-------~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
.....++...+ . ......+.+|+.+||+.||.+||++.|||+.
T Consensus 394 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 394 QHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 10000010000 0 0111257789999999999999999999975
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=322.39 Aligned_cols=250 Identities=26% Similarity=0.431 Sum_probs=204.8
Q ss_pred CcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccC--CchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEe
Q 046750 361 GFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSG--SGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEF 437 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 437 (723)
+|.+.+.||+|+||.||+|.. .+++.|++|.+... ......++.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 478889999999999999965 46889999998643 334456788999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcc
Q 046750 438 VPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTH 517 (723)
Q Consensus 438 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 517 (723)
+.+++|.++++......+.+..++.++.+|+.||.|||+. +|+|||||++|||++.++.+||+|||+++........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~ 157 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF 157 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence 9999999999875445688999999999999999999998 5999999999999999999999999998866543322
Q ss_pred eeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchh
Q 046750 518 VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPR 597 (723)
Q Consensus 518 ~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~ 597 (723)
.....|+..|+|||++.+..++.++|||||||+||||++|+.||..... .... +.+..+.+..+.
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~--------~~~~~~~~~~~~--- 222 (256)
T cd08529 158 -ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ---GALI--------LKIIRGVFPPVS--- 222 (256)
T ss_pred -hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH---HHHH--------HHHHcCCCCCCc---
Confidence 2234578899999999999999999999999999999999999975431 1111 112222222111
Q ss_pred hhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 598 LEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 598 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
......+.+++.+||+.+|++||++.+|++.
T Consensus 223 ------~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 223 ------QMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ------cccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 1223468899999999999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=325.36 Aligned_cols=249 Identities=30% Similarity=0.495 Sum_probs=205.5
Q ss_pred cCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEecC
Q 046750 360 NGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVP 439 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 439 (723)
++|++.+.||+|+||.||+|.. .|+.||||.++.... ..+.+.+|+.++++++|+||+++++++.+....++||||+.
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 4688899999999999999987 478999999987644 45678999999999999999999999999899999999999
Q ss_pred CCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCccee
Q 046750 440 NNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVS 519 (723)
Q Consensus 440 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 519 (723)
+++|.+++.......+.+..++.++.|++.||.|||++ +|+|||||++|||+++++.+||+|||+++.......
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~--- 157 (256)
T cd05039 84 KGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD--- 157 (256)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc---
Confidence 99999999776555689999999999999999999999 599999999999999999999999999976532221
Q ss_pred ecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhh
Q 046750 520 TRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRL 598 (723)
Q Consensus 520 ~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l 598 (723)
...++..|++||++..+.++.++|||||||++|||++ |+.||..... .. +...+..+.....
T Consensus 158 -~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~--------~~~~~~~~~~~~~----- 220 (256)
T cd05039 158 -SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KD--------VVPHVEKGYRMEA----- 220 (256)
T ss_pred -cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH---HH--------HHHHHhcCCCCCC-----
Confidence 2235678999999998999999999999999999997 9999864421 11 1112222111111
Q ss_pred hccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhc
Q 046750 599 EKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDS 637 (723)
Q Consensus 599 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~ 637 (723)
.......+.+++.+||+.+|.+||++.+|+++|+.
T Consensus 221 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 221 ----PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred ----ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 11123468899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=335.57 Aligned_cols=257 Identities=26% Similarity=0.398 Sum_probs=204.8
Q ss_pred cCcccceEEeccCcEEEEEEEc------CCCcEEEEEEcccCCc-hhHHHHHHHHHHHHHc-cCCceeeEeeeeecccce
Q 046750 360 NGFARENVIGEGGFGCVYKGNL------PEGKVVAVKQLKSGSG-QGEREFRAEVEIISRV-HHRHLVSLVGYCISEKNR 431 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~------~~g~~VAvK~l~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~ 431 (723)
++|.+.+.||+|+||.||++.. ..+..||||+++.... ...+.+.+|+++++++ +|+||++++++|...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 5689999999999999999953 2345799999876532 3345789999999999 799999999999999999
Q ss_pred EEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeeccccccc
Q 046750 432 LLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLN 511 (723)
Q Consensus 432 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 511 (723)
++||||+.+|+|.++++......+++..++.|+.+|+.||+|||++ +|+|+|||++|||+++++.+||+|||+++..
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~ 191 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARDI 191 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcccccc
Confidence 9999999999999999765544589999999999999999999998 5999999999999999999999999999765
Q ss_pred CCCCcc-eeecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCC
Q 046750 512 DTTQTH-VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGD 589 (723)
Q Consensus 512 ~~~~~~-~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~ 589 (723)
...... ......++..|+|||++.+..++.++|||||||+||||++ |..||..... ...+. +.+..+.
T Consensus 192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~--~~~~~--------~~~~~~~ 261 (302)
T cd05055 192 MNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV--DSKFY--------KLIKEGY 261 (302)
T ss_pred cCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc--hHHHH--------HHHHcCC
Confidence 433221 1122345678999999999999999999999999999998 9999865432 11111 1111111
Q ss_pred cccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhcc
Q 046750 590 LSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSE 638 (723)
Q Consensus 590 l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~ 638 (723)
... ........+.+++.+||+.+|++||++.||++.|++.
T Consensus 262 ~~~---------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 262 RMA---------QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred cCC---------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 000 0011123688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=338.33 Aligned_cols=242 Identities=24% Similarity=0.335 Sum_probs=192.2
Q ss_pred eEEeccCcEEEEEEEcC-CCcEEEEEEcccCC---chhHHHHHHHHHHHHHc-cCCceeeEeeeeecccceEEEEEecCC
Q 046750 366 NVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGS---GQGEREFRAEVEIISRV-HHRHLVSLVGYCISEKNRLLIYEFVPN 440 (723)
Q Consensus 366 ~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~---~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 440 (723)
++||+|+||.||+|+.. +++.||||+++... ....+.+..|++++..+ +|+||+++++++.+.+..||||||+.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999654 57899999987532 23334577899999876 799999999999999999999999999
Q ss_pred CchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcceee
Q 046750 441 NNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVST 520 (723)
Q Consensus 441 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 520 (723)
++|..++.... .+.+..+..++.||+.||.|||++ +|+|||||++||||++++.+||+|||+++....... ...
T Consensus 81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~~ 154 (321)
T cd05591 81 GDLMFQIQRSR--KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TTT 154 (321)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCc-ccc
Confidence 99998886544 478888999999999999999999 499999999999999999999999999875432222 223
Q ss_pred cccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhhhc
Q 046750 521 RVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEK 600 (723)
Q Consensus 521 ~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~ 600 (723)
...|+..|+|||++.+..++.++|||||||+||||++|+.||..... ..+ .+.+..+... +
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~---~~~--------~~~i~~~~~~------~-- 215 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE---DDL--------FESILHDDVL------Y-- 215 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH---HHH--------HHHHHcCCCC------C--
Confidence 45689999999999999999999999999999999999999975432 111 1122222110 0
Q ss_pred cccHHHHHHHHHHHHHHhccCCCCCC-------CHHHHHHH
Q 046750 601 HYVESEMFRMIEAAAACVRHSGPKRP-------RMVQVVRA 634 (723)
Q Consensus 601 ~~~~~~~~~l~~l~~~cl~~dP~~RP-------s~~eVl~~ 634 (723)
.......+.+++.+||+.||++|+ ++.++++.
T Consensus 216 --p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 216 --PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred --CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 001123577899999999999999 66666644
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=338.17 Aligned_cols=241 Identities=25% Similarity=0.348 Sum_probs=192.0
Q ss_pred CcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccC---CchhHHHHHHHHHHHHHccC-CceeeEeeeeecccceEEEE
Q 046750 361 GFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSG---SGQGEREFRAEVEIISRVHH-RHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~---~~~~~~~~~~Ei~il~~l~H-pnIv~l~g~~~~~~~~~lV~ 435 (723)
+|++.+.||+|+||.||+|+.. .++.||||+++.. .....+.+..|++++..++| ++|+++++++.+.+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788999999999999999654 5789999998753 22334567889999999976 46888999999999999999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ 515 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 515 (723)
||+.+|+|.+++.... .+.+..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 81 EYVNGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 9999999999987554 378889999999999999999998 59999999999999999999999999987432222
Q ss_pred cceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccc
Q 046750 516 THVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVD 595 (723)
Q Consensus 516 ~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd 595 (723)
. ......|+..|+|||++.+..++.++|||||||+||||++|+.||..... ..+ .+.+.....
T Consensus 156 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~~--------~~~i~~~~~----- 218 (324)
T cd05587 156 K-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE---DEL--------FQSIMEHNV----- 218 (324)
T ss_pred C-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHH--------HHHHHcCCC-----
Confidence 1 22345689999999999999999999999999999999999999975431 111 111111111
Q ss_pred hhhhccccHHHHHHHHHHHHHHhccCCCCCCCH
Q 046750 596 PRLEKHYVESEMFRMIEAAAACVRHSGPKRPRM 628 (723)
Q Consensus 596 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 628 (723)
.+... ....+.+++.+||+.+|.+|++.
T Consensus 219 -~~~~~----~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 219 -SYPKS----LSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred -CCCCC----CCHHHHHHHHHHhhcCHHHcCCC
Confidence 01111 22357889999999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=338.18 Aligned_cols=238 Identities=25% Similarity=0.388 Sum_probs=187.7
Q ss_pred eEEeccCcEEEEEEEc-CCCcEEEEEEcccCC---chhHHHHHHHHHHHHHc-cCCceeeEeeeeecccceEEEEEecCC
Q 046750 366 NVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS---GQGEREFRAEVEIISRV-HHRHLVSLVGYCISEKNRLLIYEFVPN 440 (723)
Q Consensus 366 ~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~---~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 440 (723)
++||+|+||.||+|+. .+++.||||+++... ....+.+..|..++..+ +|+||+++++++......|+||||+.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999965 457899999987532 22334456677777654 899999999999999999999999999
Q ss_pred CchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcceee
Q 046750 441 NNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVST 520 (723)
Q Consensus 441 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 520 (723)
|+|.+++.... .+.+..+..|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++...... ....
T Consensus 81 g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~ 154 (316)
T cd05592 81 GDLMFHIQSSG--RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKAS 154 (316)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cccc
Confidence 99999887554 478888999999999999999998 59999999999999999999999999997543322 2223
Q ss_pred cccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhhhc
Q 046750 521 RVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEK 600 (723)
Q Consensus 521 ~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~ 600 (723)
...|+..|+|||++.+..++.++|||||||+||||++|+.||..... ..+ ...+.....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~---~~~--------~~~i~~~~~---------- 213 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE---DEL--------FDSILNDRP---------- 213 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH---HHH--------HHHHHcCCC----------
Confidence 45689999999999999999999999999999999999999975431 111 111111110
Q ss_pred cccHHHHHHHHHHHHHHhccCCCCCCCHHH
Q 046750 601 HYVESEMFRMIEAAAACVRHSGPKRPRMVQ 630 (723)
Q Consensus 601 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~e 630 (723)
.+.......+.+++.+||+.+|.+|+++.+
T Consensus 214 ~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~ 243 (316)
T cd05592 214 HFPRWISKEAKDCLSKLFERDPTKRLGVDG 243 (316)
T ss_pred CCCCCCCHHHHHHHHHHccCCHHHcCCChH
Confidence 011112235678899999999999998764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=344.72 Aligned_cols=267 Identities=21% Similarity=0.297 Sum_probs=197.8
Q ss_pred CcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCC--chhHHHHHHHHHHHHHccCCceeeEeeeeeccc-----ceE
Q 046750 361 GFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS--GQGEREFRAEVEIISRVHHRHLVSLVGYCISEK-----NRL 432 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~-----~~~ 432 (723)
+|++.++||+|+||.||++.. .+++.||||++.... ....+.+.+|+++|+.++|+||+++++++.... ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478899999999999999964 578999999986532 233457889999999999999999999998776 789
Q ss_pred EEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccC
Q 046750 433 LIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLND 512 (723)
Q Consensus 433 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 512 (723)
+||||+. ++|.+++.... .+.+..+..++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++...
T Consensus 81 lv~e~~~-~~l~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQ--PLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred EEeeccc-cCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 9999995 67877775443 488899999999999999999999 59999999999999999999999999998654
Q ss_pred CCCcceeecccccccccChhhhccC-CCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHH----------hhh--h
Q 046750 513 TTQTHVSTRVMGTFGYLAPEYASSG-KLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVE----------WAR--P 579 (723)
Q Consensus 513 ~~~~~~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~----------~~~--~ 579 (723)
...........++..|+|||++.+. .++.++||||||||||||++|+.||...........+. +.. .
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 234 (372)
T cd07853 155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE 234 (372)
T ss_pred cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence 4333333345678999999999874 47999999999999999999999997654321110000 000 0
Q ss_pred hhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 580 VLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 580 ~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
.....+.......-....+ ..........+.+|+.+||+.||.+||++.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 235 GARAHILRGPHKPPSLPVL-YTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHHhCCCCCCchHHh-cccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0000000000000000000 00111123467889999999999999999999875
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=323.91 Aligned_cols=254 Identities=24% Similarity=0.399 Sum_probs=199.7
Q ss_pred cccceEEeccCcEEEEEEEcCC----CcEEEEEEcccCC--chhHHHHHHHHHHHHHccCCceeeEeeeeecccc-----
Q 046750 362 FARENVIGEGGFGCVYKGNLPE----GKVVAVKQLKSGS--GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKN----- 430 (723)
Q Consensus 362 f~~~~~LG~G~fG~Vy~~~~~~----g~~VAvK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~----- 430 (723)
|.+.++||+|+||.||+|.+.. +..||||+++... ......+.+|+++++.++|+||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678899999999999996542 3679999987542 2334578999999999999999999998876554
Q ss_pred -eEEEEEecCCCchhhccccC----CCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeec
Q 046750 431 -RLLIYEFVPNNNLEHHLHGK----GQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADF 505 (723)
Q Consensus 431 -~~lV~E~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DF 505 (723)
.++||||+.+++|..++... ....+++..++.++.||+.||+|||+. +|+|||||++|||+++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 68999999999999888542 234588899999999999999999998 5999999999999999999999999
Q ss_pred ccccccCCCCccee-ecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhh
Q 046750 506 GLAKLNDTTQTHVS-TRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVR 583 (723)
Q Consensus 506 Gla~~~~~~~~~~~-~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~ 583 (723)
|+++.......... ....++..|++||++.+..++.++|||||||+||||++ |..||..... ..+. +
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~---~~~~--------~ 226 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN---HEIY--------D 226 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH---HHHH--------H
Confidence 99986543332211 11234678999999998899999999999999999999 8888865331 1111 2
Q ss_pred hhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhcc
Q 046750 584 AIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSE 638 (723)
Q Consensus 584 ~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~ 638 (723)
.+..+....+ .......+.+++.+||+.||.+||++.||++.|+.+
T Consensus 227 ~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 227 YLRHGNRLKQ---------PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred HHHcCCCCCC---------CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 2222221111 112234688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=345.67 Aligned_cols=201 Identities=24% Similarity=0.364 Sum_probs=171.7
Q ss_pred CcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCC---chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEE
Q 046750 361 GFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS---GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYE 436 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 436 (723)
.|.++++||+|+||.||+|+. .+++.||||++.... ......+.+|+++|++++|+||++++++|.+.+..|||||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 588999999999999999954 568899999987532 2334568899999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCc
Q 046750 437 FVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQT 516 (723)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 516 (723)
|+.+|+|.+++.+.+ .+.+..+..++.||+.||+|||++ +|||||||++||||+.++.+||+|||++..+.....
T Consensus 82 ~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 82 YIPGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred CCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 999999999987653 477888889999999999999999 599999999999999999999999999753211000
Q ss_pred ----------------------------------------------ceeecccccccccChhhhccCCCCCccceechHH
Q 046750 517 ----------------------------------------------HVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGV 550 (723)
Q Consensus 517 ----------------------------------------------~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGv 550 (723)
......+||..|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 0012246899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCC
Q 046750 551 VLLELITGRKPVDPTQ 566 (723)
Q Consensus 551 iL~eLltG~~P~~~~~ 566 (723)
+||||++|+.||....
T Consensus 237 il~elltG~~Pf~~~~ 252 (382)
T cd05625 237 ILYEMLVGQPPFLAQT 252 (382)
T ss_pred HHHHHHhCCCCCCCCC
Confidence 9999999999997643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=326.52 Aligned_cols=256 Identities=25% Similarity=0.439 Sum_probs=204.3
Q ss_pred hcCcccceEEeccCcEEEEEEEcCC------CcEEEEEEcccCCc-hhHHHHHHHHHHHHHccCCceeeEeeeeecccce
Q 046750 359 TNGFARENVIGEGGFGCVYKGNLPE------GKVVAVKQLKSGSG-QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNR 431 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~~~------g~~VAvK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 431 (723)
.++|.+.+.||+|+||.||+|.+.. +..||||.+..... .....+.+|+++|+.++|+||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 3578899999999999999996532 36899999876532 3345788999999999999999999999999999
Q ss_pred EEEEEecCCCchhhccccCC--------CCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEe
Q 046750 432 LLIYEFVPNNNLEHHLHGKG--------QPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVA 503 (723)
Q Consensus 432 ~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~ 503 (723)
++||||+.+++|.+++.... ...+.+..++.++.||+.||.|||+. +|+|||||++||||++++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEEC
Confidence 99999999999999986432 22468889999999999999999998 59999999999999999999999
Q ss_pred ecccccccCCCCcc-eeecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhh
Q 046750 504 DFGLAKLNDTTQTH-VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVL 581 (723)
Q Consensus 504 DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l 581 (723)
|||+++........ ......++..|+|||++.++.++.++|||||||++|||++ |..||..... ..+..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---~~~~~------ 232 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN---EEVLK------ 232 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH---HHHHH------
Confidence 99999765433221 2223456789999999998899999999999999999998 8888864332 11111
Q ss_pred hhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhc
Q 046750 582 VRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDS 637 (723)
Q Consensus 582 ~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~ 637 (723)
.+..+....+.+ .....+.+++.+||+.+|.+||++.+|+..|+.
T Consensus 233 --~~~~~~~~~~~~---------~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 233 --FVIDGGHLDLPE---------NCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred --HHhcCCCCCCCC---------CCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 122222111111 113468899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=337.04 Aligned_cols=241 Identities=24% Similarity=0.348 Sum_probs=192.5
Q ss_pred CcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCC---chhHHHHHHHHHHHHHc-cCCceeeEeeeeecccceEEEE
Q 046750 361 GFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGS---GQGEREFRAEVEIISRV-HHRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~---~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~ 435 (723)
+|.+.++||+|+||.||+|+.. +++.||||+++... ....+.+..|..++..+ +|++|+++++++.+.+..|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4788999999999999999554 57899999987542 22234567788888887 5889999999999999999999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ 515 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 515 (723)
||+.+|+|.+++.... .+.+..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 81 EYVNGGDLMYQIQQVG--RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred cCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 9999999999886554 378889999999999999999998 59999999999999999999999999997543222
Q ss_pred cceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccc
Q 046750 516 THVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVD 595 (723)
Q Consensus 516 ~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd 595 (723)
. ......|+..|+|||++.+..++.++|||||||+||||++|+.||..... ..+ .+.+....+
T Consensus 156 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~---~~~--------~~~i~~~~~----- 218 (323)
T cd05616 156 V-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DEL--------FQSIMEHNV----- 218 (323)
T ss_pred C-ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH---HHH--------HHHHHhCCC-----
Confidence 1 22345689999999999999999999999999999999999999975432 111 111212111
Q ss_pred hhhhccccHHHHHHHHHHHHHHhccCCCCCCCH
Q 046750 596 PRLEKHYVESEMFRMIEAAAACVRHSGPKRPRM 628 (723)
Q Consensus 596 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 628 (723)
.+.......+.+++.+||+.+|.+|++.
T Consensus 219 -----~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 219 -----AYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred -----CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 0111123467889999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=329.26 Aligned_cols=254 Identities=25% Similarity=0.410 Sum_probs=201.3
Q ss_pred CcccceEEeccCcEEEEEEEcC------CCcEEEEEEcccCCchh-HHHHHHHHHHHHHccCCceeeEeeeeecccceEE
Q 046750 361 GFARENVIGEGGFGCVYKGNLP------EGKVVAVKQLKSGSGQG-EREFRAEVEIISRVHHRHLVSLVGYCISEKNRLL 433 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~~~------~g~~VAvK~l~~~~~~~-~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 433 (723)
.|.+.+.||+|+||.||+|.+. .++.||||+++...... .+.|.+|+.++..++|+||+++++++.+....++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 4677889999999999999653 24789999998654332 3568899999999999999999999999999999
Q ss_pred EEEecCCCchhhccccC--------------CCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCc
Q 046750 434 IYEFVPNNNLEHHLHGK--------------GQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFE 499 (723)
Q Consensus 434 V~E~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~ 499 (723)
++||+.+++|.+++... ....+.+..+++++.|++.||+|||++ +|+|||||+.|||+++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCc
Confidence 99999999999987421 123478888999999999999999998 4999999999999999999
Q ss_pred EEEeecccccccCCCCcc-eeecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhh
Q 046750 500 AQVADFGLAKLNDTTQTH-VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWA 577 (723)
Q Consensus 500 vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~ 577 (723)
+||+|||+++........ ......++..|+|||++.++.++.++|||||||+||||++ |..||..... . ++
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~---~~- 235 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---Q---DV- 235 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH---H---HH-
Confidence 999999998765433221 1223346778999999998999999999999999999998 7788865321 1 11
Q ss_pred hhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhc
Q 046750 578 RPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDS 637 (723)
Q Consensus 578 ~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~ 637 (723)
.+.+..+....+ .......+.+|+.+||+.+|.+||++.+|+..|+.
T Consensus 236 ----~~~i~~~~~~~~---------~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 236 ----IEMIRNRQVLPC---------PDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred ----HHHHHcCCcCCC---------CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 122222222111 11223457899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=332.75 Aligned_cols=262 Identities=24% Similarity=0.387 Sum_probs=200.1
Q ss_pred cCcccceEEeccCcEEEEEEEcCC---------------CcEEEEEEcccCCc-hhHHHHHHHHHHHHHccCCceeeEee
Q 046750 360 NGFARENVIGEGGFGCVYKGNLPE---------------GKVVAVKQLKSGSG-QGEREFRAEVEIISRVHHRHLVSLVG 423 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~~---------------g~~VAvK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g 423 (723)
++|++.++||+|+||.||++.... ...||||+++.... .....|.+|+++|++++|+||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 578899999999999999986532 23589999976532 33457899999999999999999999
Q ss_pred eeecccceEEEEEecCCCchhhccccCC----------CCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEE
Q 046750 424 YCISEKNRLLIYEFVPNNNLEHHLHGKG----------QPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANIL 493 (723)
Q Consensus 424 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~----------~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NIL 493 (723)
++...+..++||||+.+++|.+++.... ...+.+..+++++.+|++||+|||++ +|+|||||++|||
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEE
Confidence 9999999999999999999999885432 12367889999999999999999999 5999999999999
Q ss_pred eCCCCcEEEeecccccccCCCCcc-eeecccccccccChhhhccCCCCCccceechHHHHHHHHh--CCCCCCCCCCCCc
Q 046750 494 VDDEFEAQVADFGLAKLNDTTQTH-VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT--GRKPVDPTQPLGD 570 (723)
Q Consensus 494 l~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt--G~~P~~~~~~~~~ 570 (723)
|++++.+||+|||++......... ......++..|+|||++.++.++.++|||||||+||||++ |..||.....
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~--- 238 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD--- 238 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh---
Confidence 999999999999999755432221 1222345778999999999999999999999999999998 5566654321
Q ss_pred hhhHHhhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhc
Q 046750 571 ESLVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDS 637 (723)
Q Consensus 571 ~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~ 637 (723)
.......... ......... ..........+.+|+.+||+.+|.+||+|.+|++.|++
T Consensus 239 ~~~~~~~~~~----~~~~~~~~~------~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 239 EQVIENTGEF----FRNQGRQIY------LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHHHHHHHh----hhhcccccc------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 1111111100 000000000 00011122478999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=328.33 Aligned_cols=255 Identities=25% Similarity=0.436 Sum_probs=199.6
Q ss_pred cCcccceEEeccCcEEEEEEEcC-CCc----EEEEEEcccCCc-hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLP-EGK----VVAVKQLKSGSG-QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLL 433 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~----~VAvK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 433 (723)
++|++.+.||+|+||.||+|.+. +++ .|++|.+..... ....++..|+.++++++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 45778899999999999999653 344 478888765432 234578889999999999999999998864 45789
Q ss_pred EEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCC
Q 046750 434 IYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDT 513 (723)
Q Consensus 434 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 513 (723)
|+||+.+|+|.++++.... .+++..++.|+.||+.||+|||++ +|+|||||++|||+++++.+||+|||+++....
T Consensus 86 i~e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRD-SLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEEeCCCCcHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 9999999999999975433 478999999999999999999998 499999999999999999999999999986543
Q ss_pred CCcc-eeecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcc
Q 046750 514 TQTH-VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLS 591 (723)
Q Consensus 514 ~~~~-~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~ 591 (723)
.... ......++..|++||++.++.++.++|||||||+||||++ |+.||..... ..+. +.+..+...
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~---~~~~--------~~~~~~~~~ 230 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP---HEVP--------DLLEKGERL 230 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHH--------HHHHCCCcC
Confidence 3222 2233456788999999999999999999999999999998 9999875432 1111 112222211
Q ss_pred cccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccC
Q 046750 592 EIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEG 639 (723)
Q Consensus 592 ~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~ 639 (723)
.. +.+ ....+.+++.+||..+|.+||++.||++.|..+.
T Consensus 231 ~~--~~~-------~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 231 AQ--PQI-------CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred CC--CCC-------CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 11 111 1225677899999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=321.24 Aligned_cols=258 Identities=21% Similarity=0.380 Sum_probs=207.6
Q ss_pred cCcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccC---CchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSG---SGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 435 (723)
++|++.++||+|+||.||+|... +|+.||+|.++.. .....+.+.+|++++++++|+||+++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57899999999999999999665 7899999988642 2233557889999999999999999999999999999999
Q ss_pred EecCCCchhhccccC--CCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCC
Q 046750 436 EFVPNNNLEHHLHGK--GQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDT 513 (723)
Q Consensus 436 E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 513 (723)
||+.+++|.+++... ....+.+..++.++.+|++||+|||+. +|+||||+++|||++.++.++|+|||+++....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999988542 234578899999999999999999999 599999999999999999999999999876543
Q ss_pred CCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccc
Q 046750 514 TQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEI 593 (723)
Q Consensus 514 ~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~ 593 (723)
.... .....++..|+|||++.+..++.++|||||||++|||++|+.||..... .+.++ .+.+..+.+..+
T Consensus 159 ~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~-----~~~~~~~~~~~~ 228 (267)
T cd08224 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSL-----CKKIEKCDYPPL 228 (267)
T ss_pred CCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc----cHHHH-----HhhhhcCCCCCC
Confidence 3221 2234578899999999998999999999999999999999999864321 11111 112222222111
Q ss_pred cchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhcc
Q 046750 594 VDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSE 638 (723)
Q Consensus 594 vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~ 638 (723)
.. ......+.+++.+||..+|.+||++.+|+++|+++
T Consensus 229 ~~--------~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 229 PA--------DHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred Ch--------hhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 11 12234678899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=325.12 Aligned_cols=247 Identities=26% Similarity=0.425 Sum_probs=195.3
Q ss_pred eEEeccCcEEEEEEEc-CCCcEEEEEEcccCC-chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEecCCCch
Q 046750 366 NVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS-GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNL 443 (723)
Q Consensus 366 ~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 443 (723)
+.||+|+||.||+|.+ .+++.||||.++... ......|.+|++++++++|+||++++++|......++||||+.+++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 4689999999999965 468899999886543 33456789999999999999999999999999999999999999999
Q ss_pred hhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCccee-ecc
Q 046750 444 EHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVS-TRV 522 (723)
Q Consensus 444 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~-~~~ 522 (723)
.+++.... ..+++..++.++.||+.||+|||++ +|+|||||+.|||++.++.+||+|||++........... ...
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 81 LTFLRTEG-PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred HHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence 99986543 3478999999999999999999999 499999999999999999999999999875432211111 111
Q ss_pred cccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhhhcc
Q 046750 523 MGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEKH 601 (723)
Q Consensus 523 ~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~~ 601 (723)
.++..|+|||++.++.++.++|||||||+||||++ |..||..... ... ...+..+... .
T Consensus 157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~---~~~--------~~~~~~~~~~---------~ 216 (252)
T cd05084 157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN---QQT--------REAIEQGVRL---------P 216 (252)
T ss_pred CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH---HHH--------HHHHHcCCCC---------C
Confidence 23457999999999999999999999999999998 8888864321 111 1111111100 1
Q ss_pred ccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 046750 602 YVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALD 636 (723)
Q Consensus 602 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~ 636 (723)
........+.+++.+||+.+|.+||++.+|+++|+
T Consensus 217 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 217 CPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 11112346888999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=348.04 Aligned_cols=258 Identities=26% Similarity=0.384 Sum_probs=202.6
Q ss_pred cCcccceEEeccCcEEEEEEEcC------CCcEEEEEEcccCCch-hHHHHHHHHHHHHHcc-CCceeeEeeeeecccce
Q 046750 360 NGFARENVIGEGGFGCVYKGNLP------EGKVVAVKQLKSGSGQ-GEREFRAEVEIISRVH-HRHLVSLVGYCISEKNR 431 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~------~g~~VAvK~l~~~~~~-~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~ 431 (723)
++|.+.++||+|+||.||+|++. .++.||||+++..... ..+.+.+|+++|.++. |+|||+++++|......
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~ 116 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI 116 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence 45778899999999999999753 3468999999865333 2346889999999997 99999999999999999
Q ss_pred EEEEEecCCCchhhccccCCC-----------------------------------------------------------
Q 046750 432 LLIYEFVPNNNLEHHLHGKGQ----------------------------------------------------------- 452 (723)
Q Consensus 432 ~lV~E~~~~gsL~~~l~~~~~----------------------------------------------------------- 452 (723)
++||||+.+|+|.++|+....
T Consensus 117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (401)
T cd05107 117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK 196 (401)
T ss_pred EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence 999999999999999865321
Q ss_pred -------------------------------------CcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeC
Q 046750 453 -------------------------------------PVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVD 495 (723)
Q Consensus 453 -------------------------------------~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~ 495 (723)
..+.+..+++|+.||++||+|||+. +|+|||||++||||+
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiLl~ 273 (401)
T cd05107 197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLIC 273 (401)
T ss_pred hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEEEe
Confidence 2366778899999999999999998 599999999999999
Q ss_pred CCCcEEEeecccccccCCCCc-ceeecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhh
Q 046750 496 DEFEAQVADFGLAKLNDTTQT-HVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESL 573 (723)
Q Consensus 496 ~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l 573 (723)
+++.+||+|||+++....... .......++..|++||++.+..++.++|||||||+||||++ |+.||...... ..
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~--~~- 350 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN--EQ- 350 (401)
T ss_pred CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch--HH-
Confidence 999999999999976533222 11223456788999999998899999999999999999998 88888654311 10
Q ss_pred HHhhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccC
Q 046750 574 VEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEG 639 (723)
Q Consensus 574 ~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~ 639 (723)
+...+..+.. + .........+.+|+.+||+.+|.+||++.+|++.|+.++
T Consensus 351 -------~~~~~~~~~~--~-------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 351 -------FYNAIKRGYR--M-------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred -------HHHHHHcCCC--C-------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1111111110 0 001112246888999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=321.36 Aligned_cols=248 Identities=28% Similarity=0.478 Sum_probs=200.6
Q ss_pred cCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeee-cccceEEEEEec
Q 046750 360 NGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCI-SEKNRLLIYEFV 438 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~-~~~~~~lV~E~~ 438 (723)
++|++.+.||+|+||.||++.. .|..|++|.++... ..+.|.+|+.++++++|+||+++++++. .....++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 4688899999999999999976 47889999987542 3457899999999999999999999764 456789999999
Q ss_pred CCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcce
Q 046750 439 PNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHV 518 (723)
Q Consensus 439 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 518 (723)
.+++|.++++......+.+..+++++.+|+.||+|||++ +|+|||||++|||+++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--- 156 (256)
T cd05082 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 156 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence 999999999876655688999999999999999999998 59999999999999999999999999987543322
Q ss_pred eecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchh
Q 046750 519 STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPR 597 (723)
Q Consensus 519 ~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~ 597 (723)
....++..|+|||++.+..++.++|||||||++|||++ |+.||..... ..+. ..+..+....+
T Consensus 157 -~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~---~~~~--------~~~~~~~~~~~---- 220 (256)
T cd05082 157 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVV--------PRVEKGYKMDA---- 220 (256)
T ss_pred -CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH---HHHH--------HHHhcCCCCCC----
Confidence 12234668999999998899999999999999999998 8888864321 1111 11222211111
Q ss_pred hhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhc
Q 046750 598 LEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDS 637 (723)
Q Consensus 598 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~ 637 (723)
.......+.+++.+||+.+|++||++.+|++.|+.
T Consensus 221 -----~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 221 -----PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred -----CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 11123467889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=326.78 Aligned_cols=255 Identities=29% Similarity=0.479 Sum_probs=203.1
Q ss_pred cCcccceEEeccCcEEEEEEEcCC-C---cEEEEEEcccCC-chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLPE-G---KVVAVKQLKSGS-GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLI 434 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~~-g---~~VAvK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 434 (723)
++|+..++||+|+||.||+|.+.. + ..|+||.++... ....+++..|++++++++|+||+++++++.+.+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 468889999999999999997642 3 379999987653 33446789999999999999999999999999999999
Q ss_pred EEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCC
Q 046750 435 YEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTT 514 (723)
Q Consensus 435 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 514 (723)
|||+.+++|.+++.... ..+.+..++.++.+++.||+|||+. +|+|||||++|||+++++.+||+|||++......
T Consensus 85 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 85 TEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred EEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 99999999999987543 3478899999999999999999998 5999999999999999999999999999765433
Q ss_pred Ccceee--cccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcc
Q 046750 515 QTHVST--RVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLS 591 (723)
Q Consensus 515 ~~~~~~--~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~ 591 (723)
...... ....+..|++||++.+..++.++|||||||+||||++ |+.||..... . ++ .+.+..+...
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~---~---~~-----~~~i~~~~~~ 229 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN---H---EV-----MKAINDGFRL 229 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH---H---HH-----HHHHhcCCCC
Confidence 222211 1223457999999998899999999999999999997 9999864321 1 11 1112211110
Q ss_pred cccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhcc
Q 046750 592 EIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSE 638 (723)
Q Consensus 592 ~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~ 638 (723)
. ........+.+++.+||+.+|.+||+|.+|++.|+++
T Consensus 230 ~---------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 230 P---------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred C---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 0111234678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=329.22 Aligned_cols=262 Identities=26% Similarity=0.403 Sum_probs=203.2
Q ss_pred cCcccceEEeccCcEEEEEEEcCC-----------------CcEEEEEEcccCCc-hhHHHHHHHHHHHHHccCCceeeE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLPE-----------------GKVVAVKQLKSGSG-QGEREFRAEVEIISRVHHRHLVSL 421 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~~-----------------g~~VAvK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l 421 (723)
++|++.+.||+|+||.||++...+ +..||+|++..... ....++.+|+++|++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 568899999999999999986532 24689999876533 345678999999999999999999
Q ss_pred eeeeecccceEEEEEecCCCchhhccccCC---------CCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcE
Q 046750 422 VGYCISEKNRLLIYEFVPNNNLEHHLHGKG---------QPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANI 492 (723)
Q Consensus 422 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NI 492 (723)
+++|..+...++||||+.+++|.+++.... ...+++..++.++.||+.||+|||++ +|+|||||++||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~Ni 161 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhce
Confidence 999999999999999999999999986543 12578999999999999999999998 599999999999
Q ss_pred EeCCCCcEEEeecccccccCCCCc-ceeecccccccccChhhhccCCCCCccceechHHHHHHHHh--CCCCCCCCCCCC
Q 046750 493 LVDDEFEAQVADFGLAKLNDTTQT-HVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT--GRKPVDPTQPLG 569 (723)
Q Consensus 493 Ll~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt--G~~P~~~~~~~~ 569 (723)
|+++++.++|+|||+++....... .......++..|+|||++.+..++.++|||||||+||||++ |..||....
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~--- 238 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT--- 238 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC---
Confidence 999999999999999975433222 12233456788999999998899999999999999999998 667775432
Q ss_pred chhhHHhhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhc
Q 046750 570 DESLVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDS 637 (723)
Q Consensus 570 ~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~ 637 (723)
......+.. ............ .........+.+++.+||+.+|.+||++.+|++.|+.
T Consensus 239 ~~~~~~~~~----~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 239 DQQVIENAG----HFFRDDGRQIYL------PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred hHHHHHHHH----hccccccccccC------CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 111222111 111111111111 1111122468999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=340.59 Aligned_cols=238 Identities=26% Similarity=0.340 Sum_probs=191.1
Q ss_pred eEEeccCcEEEEEEEc----CCCcEEEEEEcccCCc--hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEecC
Q 046750 366 NVIGEGGFGCVYKGNL----PEGKVVAVKQLKSGSG--QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVP 439 (723)
Q Consensus 366 ~~LG~G~fG~Vy~~~~----~~g~~VAvK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 439 (723)
+.||+|+||.||+++. ..|+.||||+++.... .....+..|+++|++++|+||++++++|.+....|+||||+.
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6799999999999854 3578999999975321 233457789999999999999999999999999999999999
Q ss_pred CCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCccee
Q 046750 440 NNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVS 519 (723)
Q Consensus 440 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 519 (723)
+|+|.+++.+.. .+++..++.|+.||++||+|||++ +|+|||||++||||++++.+||+|||+++....... ..
T Consensus 82 ~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-~~ 155 (318)
T cd05582 82 GGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-KA 155 (318)
T ss_pred CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-ce
Confidence 999999986543 488999999999999999999999 599999999999999999999999999976543322 22
Q ss_pred ecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhhh
Q 046750 520 TRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLE 599 (723)
Q Consensus 520 ~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~ 599 (723)
....|+..|+|||++.+..++.++|||||||+||||++|+.||..... ... ...+..+.+. +
T Consensus 156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~---~~~--------~~~i~~~~~~------~- 217 (318)
T cd05582 156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR---KET--------MTMILKAKLG------M- 217 (318)
T ss_pred ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH---HHH--------HHHHHcCCCC------C-
Confidence 345689999999999988899999999999999999999999975431 111 1111111110 0
Q ss_pred ccccHHHHHHHHHHHHHHhccCCCCCCCHHH
Q 046750 600 KHYVESEMFRMIEAAAACVRHSGPKRPRMVQ 630 (723)
Q Consensus 600 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~e 630 (723)
.......+.+|+.+||+.||.+|+++.+
T Consensus 218 ---p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 218 ---PQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred ---CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 1111235678999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=327.80 Aligned_cols=255 Identities=27% Similarity=0.457 Sum_probs=203.6
Q ss_pred cCcccceEEeccCcEEEEEEEc------CCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNL------PEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLL 433 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~------~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 433 (723)
.+|...++||+|+||.||++.. .++..|++|.++........+|.+|++++++++|+||+++++++.+....++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 4577889999999999999953 2356899999887666667789999999999999999999999999999999
Q ss_pred EEEecCCCchhhccccCCC-------------CcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcE
Q 046750 434 IYEFVPNNNLEHHLHGKGQ-------------PVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEA 500 (723)
Q Consensus 434 V~E~~~~gsL~~~l~~~~~-------------~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~v 500 (723)
||||+.+++|.++++.... ..+.+..++.++.||+.||+|||++ +|+|||||++|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCE
Confidence 9999999999999865431 3478899999999999999999998 59999999999999999999
Q ss_pred EEeecccccccCCCCcc-eeecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhh
Q 046750 501 QVADFGLAKLNDTTQTH-VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWAR 578 (723)
Q Consensus 501 kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~ 578 (723)
||+|||+++........ ......++..|+|||++.+..++.++|||||||+||||++ |..||..... ...
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~----- 233 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN---TEA----- 233 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH---HHH-----
Confidence 99999999755432221 1222345678999999999999999999999999999998 8898864322 111
Q ss_pred hhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhc
Q 046750 579 PVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDS 637 (723)
Q Consensus 579 ~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~ 637 (723)
.+.+..+..... .......+.+++.+||+.||.+||++.+|++.|+.
T Consensus 234 ---~~~~~~~~~~~~---------~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 234 ---IECITQGRELER---------PRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred ---HHHHHcCccCCC---------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 111112111110 01112357899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=337.34 Aligned_cols=237 Identities=25% Similarity=0.367 Sum_probs=189.7
Q ss_pred eEEeccCcEEEEEEEcC-CCcEEEEEEcccCC---chhHHHHHHHHHHHHHc-cCCceeeEeeeeecccceEEEEEecCC
Q 046750 366 NVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGS---GQGEREFRAEVEIISRV-HHRHLVSLVGYCISEKNRLLIYEFVPN 440 (723)
Q Consensus 366 ~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~---~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 440 (723)
++||+|+||.||+|+.+ +++.||||+++... ....+.+..|+.++..+ +|+||+++++++.+.+..|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999654 58899999987531 23345677889999877 699999999999999999999999999
Q ss_pred CchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcceee
Q 046750 441 NNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVST 520 (723)
Q Consensus 441 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 520 (723)
|+|.+++.... .+++..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++....... ...
T Consensus 81 g~L~~~i~~~~--~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~-~~~ 154 (320)
T cd05590 81 GDLMFHIQKSR--RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-TTS 154 (320)
T ss_pred chHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-ccc
Confidence 99999887554 478889999999999999999999 599999999999999999999999999875432221 223
Q ss_pred cccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhhhc
Q 046750 521 RVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEK 600 (723)
Q Consensus 521 ~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~ 600 (723)
...|+..|+|||++.+..++.++|||||||+||||++|+.||..... ..+ .+.+..+.+. +
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~---~~~--------~~~i~~~~~~------~-- 215 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE---DDL--------FEAILNDEVV------Y-- 215 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH---HHH--------HHHHhcCCCC------C--
Confidence 45689999999999999999999999999999999999999975432 111 1122222110 0
Q ss_pred cccHHHHHHHHHHHHHHhccCCCCCCCHH
Q 046750 601 HYVESEMFRMIEAAAACVRHSGPKRPRMV 629 (723)
Q Consensus 601 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 629 (723)
.......+.+++.+||+.||.+|+++.
T Consensus 216 --~~~~~~~~~~li~~~L~~dP~~R~~~~ 242 (320)
T cd05590 216 --PTWLSQDAVDILKAFMTKNPTMRLGSL 242 (320)
T ss_pred --CCCCCHHHHHHHHHHcccCHHHCCCCC
Confidence 011123578899999999999999983
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=355.04 Aligned_cols=257 Identities=23% Similarity=0.320 Sum_probs=203.3
Q ss_pred HHHHhcCcccceEEeccCcEEEEEEE-cCCCcEEEEEEcccCC--chhHHHHHHHHHHHHHccCCceeeEeeeeeccc--
Q 046750 355 LMEITNGFARENVIGEGGFGCVYKGN-LPEGKVVAVKQLKSGS--GQGEREFRAEVEIISRVHHRHLVSLVGYCISEK-- 429 (723)
Q Consensus 355 l~~~~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~VAvK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~-- 429 (723)
+....++|.+.++||+|+||.||+|+ ..+|+.||||++.... ......+++|+.+|..++|+||+++++.+....
T Consensus 27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 33445789999999999999999995 4578999999986542 334456889999999999999999988765432
Q ss_pred ------ceEEEEEecCCCchhhccccC--CCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEE
Q 046750 430 ------NRLLIYEFVPNNNLEHHLHGK--GQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQ 501 (723)
Q Consensus 430 ------~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vk 501 (723)
.+++||||+.+|+|.++|+.. ....+.+..++.|+.||+.||.|||++ +|+||||||+||||+.++.+|
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vk 183 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVK 183 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEE
Confidence 257999999999999998643 234578889999999999999999999 599999999999999999999
Q ss_pred EeecccccccCCCCc-ceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhh
Q 046750 502 VADFGLAKLNDTTQT-HVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPV 580 (723)
Q Consensus 502 L~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~ 580 (723)
|+|||+++.+..... .......|+..|+|||++.+..++.++|||||||+||||++|+.||..... .++
T Consensus 184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~------~~~---- 253 (496)
T PTZ00283 184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM------EEV---- 253 (496)
T ss_pred EEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH------HHH----
Confidence 999999976543222 222345799999999999999999999999999999999999999975321 111
Q ss_pred hhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 581 LVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 581 l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
.+.+..+.+..+ .......+.+++.+||+.+|.+||++.+|++.
T Consensus 254 -~~~~~~~~~~~~---------~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 254 -MHKTLAGRYDPL---------PPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred -HHHHhcCCCCCC---------CCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 112222222111 11123467889999999999999999999864
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=333.48 Aligned_cols=257 Identities=28% Similarity=0.443 Sum_probs=200.6
Q ss_pred cCcccceEEeccCcEEEEEEEcCC-C--cEEEEEEcccCC-chhHHHHHHHHHHHHHc-cCCceeeEeeeeecccceEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLPE-G--KVVAVKQLKSGS-GQGEREFRAEVEIISRV-HHRHLVSLVGYCISEKNRLLI 434 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~~-g--~~VAvK~l~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV 434 (723)
++|++.++||+|+||.||+|.+++ + ..+++|.++... ....+.|.+|++++.++ +|+||+++++++.+....++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 468899999999999999997644 3 347888887532 33446789999999999 799999999999999999999
Q ss_pred EEecCCCchhhccccCC--------------CCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcE
Q 046750 435 YEFVPNNNLEHHLHGKG--------------QPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEA 500 (723)
Q Consensus 435 ~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~v 500 (723)
|||+.+++|.++++... ...+.+..++.|+.||+.||+|||++ +|+|||||++||||++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence 99999999999986532 12478889999999999999999998 59999999999999999999
Q ss_pred EEeecccccccCCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhh
Q 046750 501 QVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARP 579 (723)
Q Consensus 501 kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~ 579 (723)
||+|||++........ ......+..|++||++.+..++.++|||||||+||||++ |..||..... ..+
T Consensus 159 kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~---~~~------ 227 (297)
T cd05089 159 KIADFGLSRGEEVYVK--KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC---AEL------ 227 (297)
T ss_pred EECCcCCCccccceec--cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHH------
Confidence 9999999864322111 111123567999999998899999999999999999997 9999965432 111
Q ss_pred hhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCCC
Q 046750 580 VLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEM 641 (723)
Q Consensus 580 ~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~~ 641 (723)
.+.+..+.... ........+.+|+.+||+.+|.+||++.+|++.|+.+...
T Consensus 228 --~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~ 278 (297)
T cd05089 228 --YEKLPQGYRME---------KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA 278 (297)
T ss_pred --HHHHhcCCCCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 11111111000 0111223678999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=329.94 Aligned_cols=262 Identities=24% Similarity=0.410 Sum_probs=200.6
Q ss_pred cCcccceEEeccCcEEEEEEEcC-----------------CCcEEEEEEcccCC-chhHHHHHHHHHHHHHccCCceeeE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLP-----------------EGKVVAVKQLKSGS-GQGEREFRAEVEIISRVHHRHLVSL 421 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~-----------------~g~~VAvK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l 421 (723)
++|++.++||+|+||.||++... ++..||||+++... .....+|.+|+++|++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 56899999999999999998532 23469999997653 2344679999999999999999999
Q ss_pred eeeeecccceEEEEEecCCCchhhccccCCC---------CcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcE
Q 046750 422 VGYCISEKNRLLIYEFVPNNNLEHHLHGKGQ---------PVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANI 492 (723)
Q Consensus 422 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---------~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NI 492 (723)
++++.+.+..++||||+.+++|.+++..... ..+.+..+++++.||+.||+|||++ +|+|||||++||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheE
Confidence 9999999999999999999999999865321 2367788999999999999999999 499999999999
Q ss_pred EeCCCCcEEEeecccccccCCCCcc-eeecccccccccChhhhccCCCCCccceechHHHHHHHHh--CCCCCCCCCCCC
Q 046750 493 LVDDEFEAQVADFGLAKLNDTTQTH-VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT--GRKPVDPTQPLG 569 (723)
Q Consensus 493 Ll~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt--G~~P~~~~~~~~ 569 (723)
||++++.++|+|||+++.+...... ......++..|++||++.++.++.++|||||||+||||++ |..||.....
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~-- 239 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD-- 239 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh--
Confidence 9999999999999999755332221 1222344678999999988999999999999999999998 6677754322
Q ss_pred chhhHHhhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhc
Q 046750 570 DESLVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDS 637 (723)
Q Consensus 570 ~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~ 637 (723)
..........+ . .......+ + ........+.+++.+||+.||.+||+|.+|++.|++
T Consensus 240 -~~~~~~~~~~~-~---~~~~~~~~-~-----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 240 -EQVIENTGEFF-R---DQGRQVYL-P-----KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred -HHHHHHHHHHH-h---hccccccC-C-----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11111111000 0 00000000 0 011122468899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=326.05 Aligned_cols=249 Identities=24% Similarity=0.336 Sum_probs=196.2
Q ss_pred EeccCcEEEEEEEc-CCCcEEEEEEcccCC---chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEecCCCch
Q 046750 368 IGEGGFGCVYKGNL-PEGKVVAVKQLKSGS---GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNL 443 (723)
Q Consensus 368 LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 443 (723)
||+|+||.||+++. .+|+.||+|.+.... ......+..|++++++++|+||+++++++.++...++||||+.+++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999965 458999999986432 12234566799999999999999999999999999999999999999
Q ss_pred hhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcceeeccc
Q 046750 444 EHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVM 523 (723)
Q Consensus 444 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 523 (723)
.+++.......+++..++.++.||+.||+|||+. +|+|||||++|||+++++.++|+|||++....... ......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~ 155 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRA 155 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeeccC
Confidence 9988766555688999999999999999999998 59999999999999999999999999997654322 223346
Q ss_pred ccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhhhcccc
Q 046750 524 GTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEKHYV 603 (723)
Q Consensus 524 gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~ 603 (723)
|+..|+|||++.+..++.++|||||||+||||++|+.||....... ....+. +....+.+.. ....+
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~--~~~~~~-----~~~~~~~~~~-----~~~~~- 222 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV--AKEELK-----RRTLEDEVKF-----EHQNF- 222 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh--hHHHHH-----HHhhcccccc-----ccccC-
Confidence 8999999999999999999999999999999999999997543211 111111 1111111110 00111
Q ss_pred HHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhc
Q 046750 604 ESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDS 637 (723)
Q Consensus 604 ~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~ 637 (723)
...+.+|+.+||+.||.+|+++.|+++.+..
T Consensus 223 ---~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~ 253 (277)
T cd05607 223 ---TEESKDICRLFLAKKPEDRLGSREKNDDPRK 253 (277)
T ss_pred ---CHHHHHHHHHHhccCHhhCCCCccchhhhhc
Confidence 2357889999999999999999887655443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=324.63 Aligned_cols=252 Identities=24% Similarity=0.387 Sum_probs=200.6
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCc-----hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSG-----QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLL 433 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~-----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 433 (723)
++|...++||+|+||.||++.. .+++.|+||.++.... .....+.+|++++++++|+||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5789999999999999999954 5689999999864321 123468899999999999999999999999999999
Q ss_pred EEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCC
Q 046750 434 IYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDT 513 (723)
Q Consensus 434 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 513 (723)
|+||+.+++|.+++.... .+.+..+..++.+++.||.|||+. +|+||||+++|||+++++.++|+|||+++....
T Consensus 82 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EEEECCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 999999999999887543 477888899999999999999998 599999999999999999999999999975543
Q ss_pred CCccee--ecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcc
Q 046750 514 TQTHVS--TRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLS 591 (723)
Q Consensus 514 ~~~~~~--~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~ 591 (723)
...... ....++..|+|||++.+..++.++|||||||+||||++|+.||...... .... +.......
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~-------~~~~~~~~- 225 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM---AAIF-------KIATQPTN- 225 (263)
T ss_pred cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH---HHHH-------HHhccCCC-
Confidence 222111 2345788999999999999999999999999999999999998653221 0000 10011110
Q ss_pred cccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 046750 592 EIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRAL 635 (723)
Q Consensus 592 ~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L 635 (723)
..+.......+.+++.+||+.+|.+||++.+|++..
T Consensus 226 --------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~ 261 (263)
T cd06625 226 --------PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHF 261 (263)
T ss_pred --------CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCC
Confidence 011112223578899999999999999999998754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=322.91 Aligned_cols=254 Identities=24% Similarity=0.388 Sum_probs=196.7
Q ss_pred cccceEEeccCcEEEEEEEcCCC-c--EEEEEEcccC--CchhHHHHHHHHHHHHHccCCceeeEeeeeecc------cc
Q 046750 362 FARENVIGEGGFGCVYKGNLPEG-K--VVAVKQLKSG--SGQGEREFRAEVEIISRVHHRHLVSLVGYCISE------KN 430 (723)
Q Consensus 362 f~~~~~LG~G~fG~Vy~~~~~~g-~--~VAvK~l~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~------~~ 430 (723)
|.+.++||+|+||.||+|.+.+. . .||||.++.. .....+.|.+|++++++++|+||++++++|... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 35678999999999999976543 2 6899988754 233456788999999999999999999987532 24
Q ss_pred eEEEEEecCCCchhhcccc----CCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecc
Q 046750 431 RLLIYEFVPNNNLEHHLHG----KGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFG 506 (723)
Q Consensus 431 ~~lV~E~~~~gsL~~~l~~----~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFG 506 (723)
.++||||+.+|+|.+++.. .....+++..++.++.||+.||+|||++ +|+|||||++|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence 6899999999999887732 1223478999999999999999999998 59999999999999999999999999
Q ss_pred cccccCCCCccee-ecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhh
Q 046750 507 LAKLNDTTQTHVS-TRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRA 584 (723)
Q Consensus 507 la~~~~~~~~~~~-~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~ 584 (723)
+++.......... ....++..|++||++.+..++.++|||||||+||||++ |+.||..... .. +.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~--------~~~~ 226 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN---SE--------IYDY 226 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH---HH--------HHHH
Confidence 9986643322111 12245678999999999999999999999999999999 7888864321 11 1122
Q ss_pred hhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhcc
Q 046750 585 IETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSE 638 (723)
Q Consensus 585 i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~ 638 (723)
+..+..... .......+.+++.+||+.+|++||++.+|++.|+.+
T Consensus 227 ~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 227 LRQGNRLKQ---------PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred HHcCCCCCC---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 222221111 111233578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=326.82 Aligned_cols=246 Identities=25% Similarity=0.349 Sum_probs=195.5
Q ss_pred CcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCc---hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEE
Q 046750 361 GFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSG---QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYE 436 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 436 (723)
.|+..++||+|+||.||+|.. .+++.||||.+..... .....+.+|+++|++++|+||+.+++++..++..++|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 367789999999999999955 5688999999865422 223457789999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCc
Q 046750 437 FVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQT 516 (723)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 516 (723)
|+.+++|.+++.......+++..++.++.|++.||.|||+. +|+|||||++|||+++++.+||+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES 157 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence 99999999988765555689999999999999999999998 499999999999999999999999999975533221
Q ss_pred ceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccch
Q 046750 517 HVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDP 596 (723)
Q Consensus 517 ~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~ 596 (723)
.....|+..|+|||++.+..++.++|||||||+||||++|..||....... ....+ ...+..+..
T Consensus 158 --~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~--~~~~~-----~~~~~~~~~------ 222 (285)
T cd05632 158 --IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV--KREEV-----DRRVLETEE------ 222 (285)
T ss_pred --ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH--HHHHH-----HHhhhcccc------
Confidence 123468999999999999999999999999999999999999997543211 11111 111111110
Q ss_pred hhhccccHHHHHHHHHHHHHHhccCCCCCCCH
Q 046750 597 RLEKHYVESEMFRMIEAAAACVRHSGPKRPRM 628 (723)
Q Consensus 597 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 628 (723)
.+.......+.+|+.+||+.+|.+|+++
T Consensus 223 ----~~~~~~~~~~~~li~~~l~~~P~~R~~~ 250 (285)
T cd05632 223 ----VYSAKFSEEAKSICKMLLTKDPKQRLGC 250 (285)
T ss_pred ----ccCccCCHHHHHHHHHHccCCHhHcCCC
Confidence 0111122356789999999999999994
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=326.93 Aligned_cols=251 Identities=28% Similarity=0.398 Sum_probs=198.9
Q ss_pred cccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCc---hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEe
Q 046750 362 FARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSG---QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEF 437 (723)
Q Consensus 362 f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 437 (723)
|+..++||+|+||.||++.. .+++.||||.+..... .....+..|+.++++++|+||+.+++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 67789999999999999954 5688999999865422 2234577899999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcc
Q 046750 438 VPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTH 517 (723)
Q Consensus 438 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 517 (723)
+.+++|.+++.......+.+..++.++.|++.||.|||+. +|+|||||++|||+++++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 157 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT- 157 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc-
Confidence 9999999998665545688999999999999999999998 599999999999999999999999999875543222
Q ss_pred eeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchh
Q 046750 518 VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPR 597 (723)
Q Consensus 518 ~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~ 597 (723)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||........ ...+.. +...+.
T Consensus 158 -~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~--~~~~~~--~~~~~~----------- 221 (285)
T cd05630 158 -IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK--REEVER--LVKEVQ----------- 221 (285)
T ss_pred -ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch--HHHHHh--hhhhhh-----------
Confidence 1234689999999999999999999999999999999999999975432110 001100 000000
Q ss_pred hhccccHHHHHHHHHHHHHHhccCCCCCCC-----HHHHHHH
Q 046750 598 LEKHYVESEMFRMIEAAAACVRHSGPKRPR-----MVQVVRA 634 (723)
Q Consensus 598 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~eVl~~ 634 (723)
..+.......+.+|+.+||+.||.+|++ +.|+++.
T Consensus 222 --~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 222 --EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred --hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 0011112235778999999999999999 7888763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=324.45 Aligned_cols=245 Identities=26% Similarity=0.417 Sum_probs=195.2
Q ss_pred EEeccCcEEEEEEEc---CCCcEEEEEEcccCCc--hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEecCCC
Q 046750 367 VIGEGGFGCVYKGNL---PEGKVVAVKQLKSGSG--QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPNN 441 (723)
Q Consensus 367 ~LG~G~fG~Vy~~~~---~~g~~VAvK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 441 (723)
.||+|+||.||+|.+ .+++.||||+++.... ...++|.+|+.++++++|+||+++++++. .+..++||||+.++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999954 3578899999875432 23467899999999999999999999886 45678999999999
Q ss_pred chhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCccee--
Q 046750 442 NLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVS-- 519 (723)
Q Consensus 442 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~-- 519 (723)
+|.+++.... .+++..+++++.||+.||+|||++ +|+|||||+.|||+++++.+||+|||+++..........
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 81 PLNKFLQKNK--HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 9999996543 478899999999999999999998 599999999999999999999999999986654333211
Q ss_pred ecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhh
Q 046750 520 TRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRL 598 (723)
Q Consensus 520 ~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l 598 (723)
....++..|+|||++....++.++|||||||+||||++ |+.||..... ..+ .+.++.+....+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~--------~~~i~~~~~~~~----- 219 (257)
T cd05116 156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG---NEV--------TQMIESGERMEC----- 219 (257)
T ss_pred CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHH--------HHHHHCCCCCCC-----
Confidence 12234578999999988889999999999999999998 9999975432 111 122222221111
Q ss_pred hccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhc
Q 046750 599 EKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDS 637 (723)
Q Consensus 599 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~ 637 (723)
.......+.+++.+||+.||.+||+|.+|++.|+.
T Consensus 220 ----~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 220 ----PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred ----CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 11122367889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=334.27 Aligned_cols=243 Identities=21% Similarity=0.308 Sum_probs=190.9
Q ss_pred eEEeccCcEEEEEEEc-CCCcEEEEEEcccCC---chhHHHHHHHHHHHHHc-cCCceeeEeeeeecccceEEEEEecCC
Q 046750 366 NVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS---GQGEREFRAEVEIISRV-HHRHLVSLVGYCISEKNRLLIYEFVPN 440 (723)
Q Consensus 366 ~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~---~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 440 (723)
++||+|+||.||+|+. .+++.||||+++... ....+.+..|+.++.++ +|+||+++++++.+.+..||||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999965 457899999997642 22334678899999998 699999999999999999999999999
Q ss_pred CchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcceee
Q 046750 441 NNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVST 520 (723)
Q Consensus 441 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 520 (723)
|+|.+++.... .+.+..++.|+.||+.||+|||++ +|+|||||++||||++++.+||+|||+++...... ....
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (327)
T cd05617 81 GDLMFHMQRQR--KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTTS 154 (327)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Ccee
Confidence 99998886543 488999999999999999999999 49999999999999999999999999987432211 1223
Q ss_pred cccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhhhc
Q 046750 521 RVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEK 600 (723)
Q Consensus 521 ~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~ 600 (723)
..+|+..|+|||++.+..++.++|||||||+||||++|+.||+...........++.. +.+....+. +
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~----~~~~~~~~~------~-- 222 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLF----QVILEKPIR------I-- 222 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHH----HHHHhCCCC------C--
Confidence 4569999999999999999999999999999999999999997543222222222211 112111110 1
Q ss_pred cccHHHHHHHHHHHHHHhccCCCCCCCH
Q 046750 601 HYVESEMFRMIEAAAACVRHSGPKRPRM 628 (723)
Q Consensus 601 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 628 (723)
.......+.+++.+||+.||.+|+++
T Consensus 223 --p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 223 --PRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred --CCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 11112356789999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=327.49 Aligned_cols=252 Identities=23% Similarity=0.282 Sum_probs=205.9
Q ss_pred cCcccceEEeccCcEEEEEEEcCC-CcEEEEEEcccCCc---hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLPE-GKVVAVKQLKSGSG---QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~VAvK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 435 (723)
++|+.+++||+|.-|.||++++.+ +..+|+|++.+... +.....+.|-+||+.++||.+..|+..|+.++..||||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 457788999999999999998865 48899999977533 33345677999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCC--
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDT-- 513 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~-- 513 (723)
|||.||+|..+++++....+.+..+..++.+|+.||+|||-.| ||+|||||+||||.++|++.|+||+|+.....
T Consensus 157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 9999999999999988889999999999999999999999996 99999999999999999999999998743211
Q ss_pred -------------------------------CCc----------------------ceeecccccccccChhhhccCCCC
Q 046750 514 -------------------------------TQT----------------------HVSTRVMGTFGYLAPEYASSGKLT 540 (723)
Q Consensus 514 -------------------------------~~~----------------------~~~~~~~gt~~y~APE~~~~~~~t 540 (723)
... .....++||-.|+|||+|.+...+
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 000 011235799999999999999999
Q ss_pred CccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhcc
Q 046750 541 DRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRH 620 (723)
Q Consensus 541 ~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~ 620 (723)
.+.|.|.|||+|||||.|..||.+.... +.+...+ -+.+.-.........+.+||.+.|.+
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~~~--~Tl~NIv-----------------~~~l~Fp~~~~vs~~akDLIr~LLvK 374 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSNNK--ETLRNIV-----------------GQPLKFPEEPEVSSAAKDLIRKLLVK 374 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCCch--hhHHHHh-----------------cCCCcCCCCCcchhHHHHHHHHHhcc
Confidence 9999999999999999999999876542 2222211 11111111124456788999999999
Q ss_pred CCCCCCC----HHHHHH
Q 046750 621 SGPKRPR----MVQVVR 633 (723)
Q Consensus 621 dP~~RPs----~~eVl~ 633 (723)
||.+|-- +.||-+
T Consensus 375 dP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 375 DPSKRLGSKRGAAEIKR 391 (459)
T ss_pred ChhhhhccccchHHhhc
Confidence 9999998 666644
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=327.10 Aligned_cols=246 Identities=26% Similarity=0.353 Sum_probs=192.4
Q ss_pred EeccCcEEEEEEEc-CCCcEEEEEEcccCCc---hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEecCCCch
Q 046750 368 IGEGGFGCVYKGNL-PEGKVVAVKQLKSGSG---QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNL 443 (723)
Q Consensus 368 LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 443 (723)
||+|+||.||++.. .+++.||||++..... ...+.+..|++++++++|+||+++++++......|+||||+.+|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999954 4688999999865322 2234577899999999999999999999999999999999999999
Q ss_pred hhccccC--CCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcceeec
Q 046750 444 EHHLHGK--GQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTR 521 (723)
Q Consensus 444 ~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 521 (723)
.+++... ....+++..++.++.||+.||+|||++ +|+|||||++|||+++++.+||+|||++......... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-ccc
Confidence 8877432 234588999999999999999999998 5999999999999999999999999999765433222 233
Q ss_pred ccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhhhcc
Q 046750 522 VMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEKH 601 (723)
Q Consensus 522 ~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~~ 601 (723)
..|+..|+|||++.+..++.++|||||||+||||++|+.||........ ... +.+.+..+.+ .
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~~-----~~~~~~~~~~----------~ 219 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKE-----LKQRILNDSV----------T 219 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh--HHH-----HHHhhcccCC----------C
Confidence 5689999999999999999999999999999999999999975432111 001 1111111110 1
Q ss_pred ccHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 046750 602 YVESEMFRMIEAAAACVRHSGPKRP-----RMVQVVRA 634 (723)
Q Consensus 602 ~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~eVl~~ 634 (723)
+.......+.+++.+||+.||.+|+ +++++++.
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 220 YPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred CcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 1112234678899999999999999 56666653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=322.93 Aligned_cols=252 Identities=28% Similarity=0.495 Sum_probs=203.0
Q ss_pred cCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEecC
Q 046750 360 NGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVP 439 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 439 (723)
.+|++.+.||+|+||.||++.+.+++.+|||+++... ....+|.+|++++++++|+||+++++++......++||||+.
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 3578889999999999999988778899999987543 234578999999999999999999999999999999999999
Q ss_pred CCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCccee
Q 046750 440 NNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVS 519 (723)
Q Consensus 440 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 519 (723)
+++|.+++..... .+.+..++.++.+++.+|+|||+. +|+|||||++|||++.++.+||+|||+++..........
T Consensus 83 ~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 83 HGCLSDYLRAQRG-KFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred CCcHHHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence 9999999875432 478889999999999999999998 499999999999999999999999999876543322212
Q ss_pred ecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhh
Q 046750 520 TRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRL 598 (723)
Q Consensus 520 ~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l 598 (723)
....++.+|+|||++.++.++.++|||||||+||||++ |+.||..... ..+ .+.+..+. ...++.+
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~--------~~~~~~~~--~~~~~~~ 225 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN---SEV--------VETINAGF--RLYKPRL 225 (256)
T ss_pred CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH---HHH--------HHHHhCCC--CCCCCCC
Confidence 22335678999999998999999999999999999998 9999865431 111 11122211 1111111
Q ss_pred hccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 046750 599 EKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALD 636 (723)
Q Consensus 599 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~ 636 (723)
....+.+|+.+||+.+|++||++.+|++.|.
T Consensus 226 -------~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 226 -------ASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred -------CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 1246889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=323.98 Aligned_cols=254 Identities=25% Similarity=0.402 Sum_probs=200.9
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEec
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFV 438 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 438 (723)
++|++.+.||+|+||.||+|.. .+++.||||+++.........+++|+.++++++|+||+++++++...+..++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 5689999999999999999964 568899999997655455567889999999999999999999999999999999999
Q ss_pred CCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcce
Q 046750 439 PNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHV 518 (723)
Q Consensus 439 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 518 (723)
.+++|.++++... .+++..+..++.|+++||.|||+. +|+|||||++||||++++.+||+|||++........ .
T Consensus 89 ~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-~ 162 (267)
T cd06646 89 GGGSLQDIYHVTG--PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-K 162 (267)
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccccc-c
Confidence 9999999987543 478889999999999999999998 599999999999999999999999999976532211 1
Q ss_pred eecccccccccChhhhc---cCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccc
Q 046750 519 STRVMGTFGYLAPEYAS---SGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVD 595 (723)
Q Consensus 519 ~~~~~gt~~y~APE~~~---~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd 595 (723)
.....|+..|+|||++. ...++.++|||||||+||||++|+.||........ ...+ ....+. .
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~--~~~~---------~~~~~~---~ 228 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--LFLM---------SKSNFQ---P 228 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh--heee---------ecCCCC---C
Confidence 12345888999999884 34578899999999999999999999864332110 0000 011110 0
Q ss_pred hhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 046750 596 PRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRAL 635 (723)
Q Consensus 596 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L 635 (723)
+.+.. .......+.+++.+||+.+|.+||++++|++.|
T Consensus 229 ~~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 229 PKLKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCCcc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 11100 011224678999999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=342.17 Aligned_cols=260 Identities=21% Similarity=0.243 Sum_probs=199.5
Q ss_pred HHHHHhcCcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccC---CchhHHHHHHHHHHHHHccCCceeeEeeeeeccc
Q 046750 354 ELMEITNGFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSG---SGQGEREFRAEVEIISRVHHRHLVSLVGYCISEK 429 (723)
Q Consensus 354 ~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 429 (723)
++....++|++.+.||+|+||.||+++.+ +++.||+|++... .......+.+|+.+++.++|+||+++++++.+..
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 33444578999999999999999999654 5789999998642 1223345788999999999999999999999999
Q ss_pred ceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeeccccc
Q 046750 430 NRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK 509 (723)
Q Consensus 430 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 509 (723)
..|+||||+.+|+|.+++... .+....+..++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~ 190 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence 999999999999999998654 367788888999999999999999 59999999999999999999999999998
Q ss_pred ccCCCCcceeecccccccccChhhhccC----CCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhh
Q 046750 510 LNDTTQTHVSTRVMGTFGYLAPEYASSG----KLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAI 585 (723)
Q Consensus 510 ~~~~~~~~~~~~~~gt~~y~APE~~~~~----~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i 585 (723)
.............+||..|+|||++.+. .++.++|||||||+||||++|+.||...... .... +.+
T Consensus 191 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~----~i~ 260 (371)
T cd05622 191 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYS----KIM 260 (371)
T ss_pred EcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH------HHHH----HHH
Confidence 6654333333456799999999999754 3789999999999999999999999754321 1111 111
Q ss_pred hcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCC--CCCHHHHHHHHh
Q 046750 586 ETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPK--RPRMVQVVRALD 636 (723)
Q Consensus 586 ~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~eVl~~L~ 636 (723)
.......+.+ .......+.+++.+||..++.+ |+++.+|++...
T Consensus 261 ~~~~~~~~~~-------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~ 306 (371)
T cd05622 261 NHKNSLTFPD-------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 306 (371)
T ss_pred cCCCcccCCC-------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcc
Confidence 1111111111 0112335677888999844433 779999988754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=324.68 Aligned_cols=254 Identities=24% Similarity=0.429 Sum_probs=199.5
Q ss_pred HHhcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCchhHHHHHHHHHHHHHc-cCCceeeEeeeeecc------
Q 046750 357 EITNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQGEREFRAEVEIISRV-HHRHLVSLVGYCISE------ 428 (723)
Q Consensus 357 ~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~------ 428 (723)
.+.+.|.+.+.||+|+||.||+|.+ .+++.||||++.... ....++..|+.++.++ +|+||++++++|...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 3456788899999999999999965 457899999987543 3446788999999999 799999999998753
Q ss_pred cceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccc
Q 046750 429 KNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLA 508 (723)
Q Consensus 429 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla 508 (723)
...|+||||+.+++|.+++.......+.+..++.++.||+.||+|||++ +|+|||||++|||+++++.+||+|||++
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCc
Confidence 3578999999999999999865555688999999999999999999998 5999999999999999999999999999
Q ss_pred cccCCCCcceeecccccccccChhhhc-----cCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhh
Q 046750 509 KLNDTTQTHVSTRVMGTFGYLAPEYAS-----SGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVR 583 (723)
Q Consensus 509 ~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~ 583 (723)
+....... ......|+..|+|||++. +..++.++|||||||+||||++|+.||+...... .+.
T Consensus 159 ~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~-----~~~------ 226 (272)
T cd06637 159 AQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-----ALF------ 226 (272)
T ss_pred eecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH-----HHH------
Confidence 76543222 223356899999999986 3458889999999999999999999996543211 110
Q ss_pred hhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 584 AIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 584 ~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
.+.......+.+. .....+.+++.+||..+|.+||++.+|++.
T Consensus 227 ~~~~~~~~~~~~~--------~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 227 LIPRNPAPRLKSK--------KWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred HHhcCCCCCCCCC--------CcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 0001111111111 112357889999999999999999999863
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=327.14 Aligned_cols=255 Identities=27% Similarity=0.470 Sum_probs=202.9
Q ss_pred cCcccceEEeccCcEEEEEEEcC------CCcEEEEEEcccCCc-hhHHHHHHHHHHHHHccCCceeeEeeeeecccceE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLP------EGKVVAVKQLKSGSG-QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRL 432 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~------~g~~VAvK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 432 (723)
++|++.+.||+|+||.||++... ++..||||+++.... ....+|.+|++++++++|+||++++++|.++...+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMC 84 (288)
T ss_pred HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccE
Confidence 56889999999999999999653 467899999876532 34467899999999999999999999999999999
Q ss_pred EEEEecCCCchhhccccCC--------------------CCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcE
Q 046750 433 LIYEFVPNNNLEHHLHGKG--------------------QPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANI 492 (723)
Q Consensus 433 lV~E~~~~gsL~~~l~~~~--------------------~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NI 492 (723)
+||||+.+++|.+++.... ...+.+..++.++.||+.||+|||++ +|+|||||++||
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~ni 161 (288)
T cd05050 85 LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNC 161 (288)
T ss_pred EEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhhe
Confidence 9999999999999986421 12467888999999999999999998 599999999999
Q ss_pred EeCCCCcEEEeecccccccCCCCcc-eeecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCc
Q 046750 493 LVDDEFEAQVADFGLAKLNDTTQTH-VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGD 570 (723)
Q Consensus 493 Ll~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~ 570 (723)
|+++++.+||+|||++......... ......++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 162 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~--- 238 (288)
T cd05050 162 LVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH--- 238 (288)
T ss_pred EecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH---
Confidence 9999999999999998754322211 1122234667999999999999999999999999999997 8888854321
Q ss_pred hhhHHhhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhc
Q 046750 571 ESLVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDS 637 (723)
Q Consensus 571 ~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~ 637 (723)
. + +...+..+++.... ......+.+++.+||+.+|.+||++.||++.|++
T Consensus 239 ~---~-----~~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 239 E---E-----VIYYVRDGNVLSCP---------DNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred H---H-----HHHHHhcCCCCCCC---------CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1 1 11222333322111 1123468899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=324.29 Aligned_cols=258 Identities=21% Similarity=0.365 Sum_probs=205.5
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCC---chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS---GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 435 (723)
++|++.+.||+|+||.||++.. .+++.|+||.+.... .....++..|+++++.++|+||++++++|.+.+..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688889999999999999964 578999999876532 233457889999999999999999999999999999999
Q ss_pred EecCCCchhhcccc--CCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCC
Q 046750 436 EFVPNNNLEHHLHG--KGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDT 513 (723)
Q Consensus 436 E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 513 (723)
||+.+++|.+++.. .....+.+..++.++.+|++||+|||++ +|+|+|||++|||++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999998863 2234588999999999999999999998 599999999999999999999999999876543
Q ss_pred CCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccc
Q 046750 514 TQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEI 593 (723)
Q Consensus 514 ~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~ 593 (723)
.... .....|+..|+|||++.+..++.++||||||++||||++|..||..... ....+. +.+......
T Consensus 159 ~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~-----~~~~~~~~~-- 226 (267)
T cd08229 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLC-----KKIEQCDYP-- 226 (267)
T ss_pred CCcc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc----hHHHHh-----hhhhcCCCC--
Confidence 3221 2234588899999999998999999999999999999999999864321 111111 111111111
Q ss_pred cchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhcc
Q 046750 594 VDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSE 638 (723)
Q Consensus 594 vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~ 638 (723)
.+.. ......+.+++.+||+.+|.+||+|.+|++.|+++
T Consensus 227 ---~~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 227 ---PLPS---DHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred ---CCCc---ccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 1111 11233678899999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=333.88 Aligned_cols=258 Identities=28% Similarity=0.420 Sum_probs=203.3
Q ss_pred cCcccceEEeccCcEEEEEEEcC--------CCcEEEEEEcccCC-chhHHHHHHHHHHHHHc-cCCceeeEeeeeeccc
Q 046750 360 NGFARENVIGEGGFGCVYKGNLP--------EGKVVAVKQLKSGS-GQGEREFRAEVEIISRV-HHRHLVSLVGYCISEK 429 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~--------~g~~VAvK~l~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~ 429 (723)
++|.+.+.||+|+||.||+++.. +...||+|.++... .....++..|+++++++ +|+||++++++|...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 56899999999999999999642 23579999998642 33445788999999999 7999999999999999
Q ss_pred ceEEEEEecCCCchhhccccCC--------------CCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeC
Q 046750 430 NRLLIYEFVPNNNLEHHLHGKG--------------QPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVD 495 (723)
Q Consensus 430 ~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~ 495 (723)
..|+||||+.+|+|.+++.... ...+.+..+++++.||+.||+|||++ +|+|||||++||||+
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEEc
Confidence 9999999999999999996532 13478899999999999999999998 599999999999999
Q ss_pred CCCcEEEeecccccccCCCCcce-eecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhh
Q 046750 496 DEFEAQVADFGLAKLNDTTQTHV-STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESL 573 (723)
Q Consensus 496 ~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l 573 (723)
+++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||+||||++ |..||.....
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~------ 248 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV------ 248 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH------
Confidence 99999999999997554322111 111224568999999999999999999999999999998 8888854321
Q ss_pred HHhhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCC
Q 046750 574 VEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGE 640 (723)
Q Consensus 574 ~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~ 640 (723)
.+ +.+.+..+...+ ........+.+|+.+||+.+|.+||+|.+|++.|+.+..
T Consensus 249 ~~-----~~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~ 301 (307)
T cd05098 249 EE-----LFKLLKEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301 (307)
T ss_pred HH-----HHHHHHcCCCCC---------CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence 11 111122221111 111223467789999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=334.06 Aligned_cols=202 Identities=26% Similarity=0.334 Sum_probs=172.8
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccC---CchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSG---SGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 435 (723)
++|++.+.||+|+||.||+++. .+++.||||++... .....+.|++|+.++..++|+||++++++|.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 4689999999999999999965 45899999998642 2223456889999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ 515 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 515 (723)
||+.+|+|.+++.+.. ..+.+..+..++.||+.||+|||++ +|+|||||++||||+.++.+||+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred ecCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 9999999999996533 2478888899999999999999999 59999999999999999999999999997654433
Q ss_pred cceeecccccccccChhhhcc-----CCCCCccceechHHHHHHHHhCCCCCCCC
Q 046750 516 THVSTRVMGTFGYLAPEYASS-----GKLTDRSDVFSFGVVLLELITGRKPVDPT 565 (723)
Q Consensus 516 ~~~~~~~~gt~~y~APE~~~~-----~~~t~ksDVwSlGviL~eLltG~~P~~~~ 565 (723)
........|+..|+|||++.. ..++.++|||||||+||||++|+.||...
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~ 211 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC
Confidence 333333568999999999873 45788999999999999999999999653
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=328.22 Aligned_cols=258 Identities=23% Similarity=0.383 Sum_probs=205.6
Q ss_pred hcCcccceEEeccCcEEEEEEEcCC-----CcEEEEEEcccCC-chhHHHHHHHHHHHHHccCCceeeEeeeeec-ccce
Q 046750 359 TNGFARENVIGEGGFGCVYKGNLPE-----GKVVAVKQLKSGS-GQGEREFRAEVEIISRVHHRHLVSLVGYCIS-EKNR 431 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~~~-----g~~VAvK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~~~ 431 (723)
.++|++.++||+|+||.||+|.+.+ +..|++|+++... ....+.+.+|++++++|+|+||+++++++.. ....
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 3678899999999999999997655 6889999987543 3344678899999999999999999998776 4678
Q ss_pred EEEEEecCCCchhhccccCCC------CcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeec
Q 046750 432 LLIYEFVPNNNLEHHLHGKGQ------PVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADF 505 (723)
Q Consensus 432 ~lV~E~~~~gsL~~~l~~~~~------~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DF 505 (723)
++++||+.+++|.+++..... ..+.+..++.++.+|+.||+|||++ +|+|||||++|||+++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCC
Confidence 899999999999999865321 4588999999999999999999998 5999999999999999999999999
Q ss_pred ccccccCCCCcce-eecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhh
Q 046750 506 GLAKLNDTTQTHV-STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVR 583 (723)
Q Consensus 506 Gla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~ 583 (723)
|+++.+.....+. .....++..|+|||++.+..++.++|||||||+||||++ |+.||..... ..+..+
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~------- 231 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP---FEMAAY------- 231 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH---HHHHHH-------
Confidence 9998654333222 222346778999999998899999999999999999999 9999975432 122222
Q ss_pred hhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccC
Q 046750 584 AIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEG 639 (723)
Q Consensus 584 ~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~ 639 (723)
+..+.. +. ........+.+++.+||+.+|++||++.+|++.|+.+.
T Consensus 232 -~~~~~~--~~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 232 -LKDGYR--LA-------QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred -HHcCCC--CC-------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 111110 00 00111236789999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=325.65 Aligned_cols=255 Identities=29% Similarity=0.458 Sum_probs=201.5
Q ss_pred cCcccceEEeccCcEEEEEEEcCC-C---cEEEEEEcccCC-chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLPE-G---KVVAVKQLKSGS-GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLI 434 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~~-g---~~VAvK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 434 (723)
..|++.+.||+|+||.||+|.+.. + ..||||+++... .....+|..|+.++++++|+||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 347889999999999999996543 3 369999987653 33456899999999999999999999999999999999
Q ss_pred EEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCC
Q 046750 435 YEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTT 514 (723)
Q Consensus 435 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 514 (723)
|||+.+++|.+++..... .+.+..++.++.|++.||+|||++ +|+|||||++||||+.++.+||+|||++......
T Consensus 84 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 84 TEFMENGALDSFLRQNDG-QFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred EecCCCCcHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccC
Confidence 999999999999875433 478899999999999999999998 5999999999999999999999999998765432
Q ss_pred Ccce-eec-c--cccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCC
Q 046750 515 QTHV-STR-V--MGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGD 589 (723)
Q Consensus 515 ~~~~-~~~-~--~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~ 589 (723)
.... ... . ..+..|++||++.+..++.++|||||||+||||++ |..||..... .....+. ....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~---~~~~~~i--------~~~~ 228 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN---QDVINAI--------EQDY 228 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH---HHHHHHH--------HcCC
Confidence 2211 111 1 12457999999999999999999999999999886 9999865431 1222221 1110
Q ss_pred cccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhcc
Q 046750 590 LSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSE 638 (723)
Q Consensus 590 l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~ 638 (723)
. .....+....+.+++.+||+.+|.+||+|.+|+..|+..
T Consensus 229 -~--------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 229 -R--------LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred -c--------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 000111234578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=334.57 Aligned_cols=254 Identities=24% Similarity=0.332 Sum_probs=212.8
Q ss_pred HhcCcccceEEeccCcEEEEEEEcCC-CcEEEEEEcccCCch---hHHHHHHHHHHHHHcc-CCceeeEeeeeecccceE
Q 046750 358 ITNGFARENVIGEGGFGCVYKGNLPE-GKVVAVKQLKSGSGQ---GEREFRAEVEIISRVH-HRHLVSLVGYCISEKNRL 432 (723)
Q Consensus 358 ~~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~VAvK~l~~~~~~---~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~ 432 (723)
+...|.+.+.||+|.||.||++..+. |+.||+|++.+.... ....+.+|+.+|++|. |+|||.|+++|++...++
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 44678888999999999999995544 999999999765433 3458899999999998 999999999999999999
Q ss_pred EEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCC----CcEEEeecccc
Q 046750 433 LIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDE----FEAQVADFGLA 508 (723)
Q Consensus 433 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~----~~vkL~DFGla 508 (723)
+|||++.||.|.+.+... .+.+.....++.||+.+++|||+. +|+||||||+|||+... +.+||+|||++
T Consensus 113 lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred EEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 999999999999998766 288889999999999999999998 49999999999999643 57999999999
Q ss_pred cccCCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcC
Q 046750 509 KLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETG 588 (723)
Q Consensus 509 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~ 588 (723)
..... ......++||+.|+|||++....|+..+||||+||++|.|++|..||....... ....+..+
T Consensus 187 ~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~-----------~~~~i~~~ 253 (382)
T KOG0032|consen 187 KFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFE-----------IFLAILRG 253 (382)
T ss_pred eEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhH-----------HHHHHHcC
Confidence 88766 344566889999999999999999999999999999999999999998765321 11234444
Q ss_pred CcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 046750 589 DLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALD 636 (723)
Q Consensus 589 ~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~ 636 (723)
++ .+...+.......+.+++..|+..||.+|.++.++++.-+
T Consensus 254 ~~------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpW 295 (382)
T KOG0032|consen 254 DF------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPW 295 (382)
T ss_pred CC------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence 44 1222233333456788999999999999999999999754
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=319.63 Aligned_cols=250 Identities=20% Similarity=0.346 Sum_probs=202.9
Q ss_pred CcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccC-CchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEec
Q 046750 361 GFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSG-SGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFV 438 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 438 (723)
+|++.++||+|+||.||++.. .+++.||+|.++.. .....+.+.+|+.++++++|+||+++++++.+....|+||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 478899999999999999954 46889999998643 2334567889999999999999999999999999999999999
Q ss_pred CCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcce
Q 046750 439 PNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHV 518 (723)
Q Consensus 439 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 518 (723)
.+++|.+++.......+.+..++.++.+|+.||.|||++ +|+|+|||++|||+++++.++|+|||++........ .
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~ 156 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-Y 156 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc-c
Confidence 999999988765445678899999999999999999998 599999999999999999999999999976543222 2
Q ss_pred eecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhh
Q 046750 519 STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRL 598 (723)
Q Consensus 519 ~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l 598 (723)
.....|+..|+|||++.+..++.++||||||+++|+|++|+.||..... .. +...+..+.+..+-
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~------~~-----~~~~~~~~~~~~~~---- 221 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW------KN-----LILKVCQGSYKPLP---- 221 (255)
T ss_pred cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH------HH-----HHHHHhcCCCCCCC----
Confidence 2335688899999999998999999999999999999999999975321 11 11122223222111
Q ss_pred hccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 599 EKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 599 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
. .....+.+++.+||+.+|.+||++.+|+..
T Consensus 222 -~----~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 222 -S----HYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -c----ccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 1 112357789999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=321.43 Aligned_cols=252 Identities=25% Similarity=0.380 Sum_probs=191.2
Q ss_pred eEEeccCcEEEEEEEcCC---CcEEEEEEcccCCc-hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEecCCC
Q 046750 366 NVIGEGGFGCVYKGNLPE---GKVVAVKQLKSGSG-QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPNN 441 (723)
Q Consensus 366 ~~LG~G~fG~Vy~~~~~~---g~~VAvK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 441 (723)
+.||+|+||.||+|.+.+ +..||+|.++.... .....|.+|+.++++++|+||++++++|.+....++||||+.+|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999997644 35799999876543 33457889999999999999999999999999999999999999
Q ss_pred chhhccccCC---CCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcce
Q 046750 442 NLEHHLHGKG---QPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHV 518 (723)
Q Consensus 442 sL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 518 (723)
+|.++++... ...+++..++.++.|+++||+|||+. +|+|||||++|||++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999986532 22456778889999999999999998 59999999999999999999999999997543322221
Q ss_pred -eecccccccccChhhhccC-------CCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCC
Q 046750 519 -STRVMGTFGYLAPEYASSG-------KLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGD 589 (723)
Q Consensus 519 -~~~~~gt~~y~APE~~~~~-------~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~ 589 (723)
.....++..|+|||++.+. .++.++|||||||++|||++ |+.||...... ....+ ...+.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~---~~~~~--------~~~~~ 226 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE---QVLTY--------TVREQ 226 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH---HHHHH--------Hhhcc
Confidence 1234577889999998642 35789999999999999996 99999654321 11111 00111
Q ss_pred cccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 046750 590 LSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALD 636 (723)
Q Consensus 590 l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~ 636 (723)
...+.++.+.... ...+.+++..|| .+|.+||++.+|++.|.
T Consensus 227 ~~~~~~~~~~~~~----~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 227 QLKLPKPRLKLPL----SDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred cCCCCCCccCCCC----ChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1122222222111 224667888898 68999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=334.06 Aligned_cols=240 Identities=24% Similarity=0.374 Sum_probs=189.8
Q ss_pred eEEeccCcEEEEEEEcC-CCcEEEEEEcccCC---chhHHHHHHHHHHHHHc-cCCceeeEeeeeecccceEEEEEecCC
Q 046750 366 NVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGS---GQGEREFRAEVEIISRV-HHRHLVSLVGYCISEKNRLLIYEFVPN 440 (723)
Q Consensus 366 ~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~---~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 440 (723)
++||+|+||.||+|... +++.||||+++... ......+..|..++..+ +|+||+++++++.+.+..++||||+.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999654 57899999987542 22334566788888765 899999999999999999999999999
Q ss_pred CchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcceee
Q 046750 441 NNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVST 520 (723)
Q Consensus 441 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 520 (723)
|+|.+++.... .+.+..+..++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++....... ...
T Consensus 81 g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~ 154 (316)
T cd05619 81 GDLMFHIQSCH--KFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KTC 154 (316)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-cee
Confidence 99999987543 478888999999999999999999 599999999999999999999999999875322221 223
Q ss_pred cccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhhhc
Q 046750 521 RVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEK 600 (723)
Q Consensus 521 ~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~ 600 (723)
...|+..|+|||++.+..++.++|||||||+||||++|+.||..... ..+ .+.+..+.. .+..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~---~~~--------~~~i~~~~~------~~~~ 217 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE---EEL--------FQSIRMDNP------CYPR 217 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH---HHH--------HHHHHhCCC------CCCc
Confidence 45689999999999999999999999999999999999999975431 111 111211110 0111
Q ss_pred cccHHHHHHHHHHHHHHhccCCCCCCCHH-HHH
Q 046750 601 HYVESEMFRMIEAAAACVRHSGPKRPRMV-QVV 632 (723)
Q Consensus 601 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-eVl 632 (723)
. ....+.+++.+||+.+|.+|+++. +|+
T Consensus 218 ~----~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 218 W----LTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred c----CCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 1 123567889999999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=331.54 Aligned_cols=268 Identities=20% Similarity=0.354 Sum_probs=197.1
Q ss_pred cCcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCCc-hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEe
Q 046750 360 NGFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGSG-QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEF 437 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 437 (723)
++|.+.++||+|+||.||+|..+ +++.||||+++.... .....+.+|++++++++|+||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56889999999999999999654 578899999875432 2334678899999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcc
Q 046750 438 VPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTH 517 (723)
Q Consensus 438 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 517 (723)
+. ++|.+++.... ..+.+..+..++.||++||+|||++ +|+|||||++||||++++.+||+|||+++.......
T Consensus 86 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 159 (309)
T cd07872 86 LD-KDLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK- 159 (309)
T ss_pred CC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCcc-
Confidence 96 47888776543 2478888999999999999999998 599999999999999999999999999975433222
Q ss_pred eeecccccccccChhhhcc-CCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhH----------Hhhhhhhhhhhh
Q 046750 518 VSTRVMGTFGYLAPEYASS-GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLV----------EWARPVLVRAIE 586 (723)
Q Consensus 518 ~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~----------~~~~~~l~~~i~ 586 (723)
......++..|+|||++.+ ..++.++|||||||+||||++|+.||............ .|..........
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK 239 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence 1223457899999998865 46899999999999999999999999765432111111 010000000000
Q ss_pred cCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 587 TGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 587 ~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
.-++.......+.. ........+.+++.+||+.||.+|+++.|+++.
T Consensus 240 ~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 240 NYNFPKYKPQPLIN-HAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhhcCccCCCchhh-hccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 00000000000000 001122356789999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=323.56 Aligned_cols=265 Identities=28% Similarity=0.413 Sum_probs=202.1
Q ss_pred CcccceEEeccCcEEEEEEEc-----CCCcEEEEEEcccCC-chhHHHHHHHHHHHHHccCCceeeEeeeeecc--cceE
Q 046750 361 GFARENVIGEGGFGCVYKGNL-----PEGKVVAVKQLKSGS-GQGEREFRAEVEIISRVHHRHLVSLVGYCISE--KNRL 432 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~~-----~~g~~VAvK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~~ 432 (723)
.|++.+.||+|+||.||++++ .+++.||||.++... ......+.+|++++++++|+||+++++++.+. ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 478889999999999999963 357889999987553 33446789999999999999999999998875 5678
Q ss_pred EEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccC
Q 046750 433 LIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLND 512 (723)
Q Consensus 433 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 512 (723)
+||||+.+++|.+++.+... .+++..++.++.+|+.||+|||++ +|+|||||++|||+++++.+||+|||+++...
T Consensus 85 lv~e~~~g~~L~~~l~~~~~-~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNKN-KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred EEEEccCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccccccc
Confidence 99999999999999865432 478999999999999999999999 49999999999999999999999999998664
Q ss_pred CCCcc--eeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCch----hhHHhhhhhhhhhhh
Q 046750 513 TTQTH--VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDE----SLVEWARPVLVRAIE 586 (723)
Q Consensus 513 ~~~~~--~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~----~l~~~~~~~l~~~i~ 586 (723)
..... ......++..|+|||++.+..++.++|||||||+||||++++.++......... ....+........+.
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLE 240 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHH
Confidence 43321 112344677899999999889999999999999999999987654321110000 000000001111122
Q ss_pred cCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhcc
Q 046750 587 TGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSE 638 (723)
Q Consensus 587 ~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~ 638 (723)
.+....+ .......+.+|+.+||+.+|.+||++.+|++.|+.+
T Consensus 241 ~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 241 EGKRLPR---------PPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred cCccCCC---------CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 2211111 112234788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=336.60 Aligned_cols=238 Identities=27% Similarity=0.365 Sum_probs=187.2
Q ss_pred eEEeccCcEEEEEEEc-CCCcEEEEEEcccCC---chhHHHHHHHHH-HHHHccCCceeeEeeeeecccceEEEEEecCC
Q 046750 366 NVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS---GQGEREFRAEVE-IISRVHHRHLVSLVGYCISEKNRLLIYEFVPN 440 (723)
Q Consensus 366 ~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~---~~~~~~~~~Ei~-il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 440 (723)
++||+|+||.||+|.. .+|+.||||++.... .....++..|.. +++.++|+||+++++++.+.+..|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4799999999999965 468999999986531 122334555544 56789999999999999999999999999999
Q ss_pred CchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcceee
Q 046750 441 NNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVST 520 (723)
Q Consensus 441 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 520 (723)
|+|.+++.... .+.+..+..++.||++||+|||++ +|+|||||++||||++++.+||+|||+++...... ....
T Consensus 81 g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (323)
T cd05575 81 GELFFHLQRER--SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KTTS 154 (323)
T ss_pred CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Cccc
Confidence 99999887543 478888899999999999999999 49999999999999999999999999987532221 1223
Q ss_pred cccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhhhc
Q 046750 521 RVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEK 600 (723)
Q Consensus 521 ~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~ 600 (723)
...|+..|+|||++.+..++.++|||||||+||||++|+.||..... .+. .+.+..+.+. +..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~------~~~-----~~~i~~~~~~------~~~ 217 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT------AEM-----YDNILNKPLR------LKP 217 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH------HHH-----HHHHHcCCCC------CCC
Confidence 45689999999999999999999999999999999999999975421 111 1111112111 111
Q ss_pred cccHHHHHHHHHHHHHHhccCCCCCCCHHH
Q 046750 601 HYVESEMFRMIEAAAACVRHSGPKRPRMVQ 630 (723)
Q Consensus 601 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~e 630 (723)
.+ ...+.+++.+||+.||.+|+++.+
T Consensus 218 ~~----~~~~~~li~~~l~~~p~~R~~~~~ 243 (323)
T cd05575 218 NI----SVSARHLLEGLLQKDRTKRLGAKD 243 (323)
T ss_pred CC----CHHHHHHHHHHhhcCHHhCCCCCC
Confidence 11 336788999999999999998853
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=319.46 Aligned_cols=253 Identities=28% Similarity=0.473 Sum_probs=199.3
Q ss_pred cccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCCchhHH--HHHHHHHHHHHccCCceeeEeeeeecccceEEEEEec
Q 046750 362 FARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGSGQGER--EFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFV 438 (723)
Q Consensus 362 f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~~~~~~--~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 438 (723)
|++++.||+|+||.||+++.. +++.||+|++......... ...+|+.++++++|+||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 678899999999999999554 5678999999876544332 3456999999999999999999999999999999999
Q ss_pred CCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcce
Q 046750 439 PNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHV 518 (723)
Q Consensus 439 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 518 (723)
.+++|.++|... ..+++..++.++.||++||+|||+. +|+|||||+.|||+++++.++|+|||++.... .....
T Consensus 81 ~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~~ 154 (260)
T PF00069_consen 81 PGGSLQDYLQKN--KPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNEN 154 (260)
T ss_dssp TTEBHHHHHHHH--SSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEEST-STTSE
T ss_pred cccccccccccc--ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc-ccccc
Confidence 999999999732 3479999999999999999999999 59999999999999999999999999997542 12223
Q ss_pred eecccccccccChhhhc-cCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchh
Q 046750 519 STRVMGTFGYLAPEYAS-SGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPR 597 (723)
Q Consensus 519 ~~~~~gt~~y~APE~~~-~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~ 597 (723)
.....++..|+|||++. +..++.++||||||++||+|++|..||..... ..........+...... .
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~---~~~~~~~~~~~~~~~~~---------~ 222 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS---DDQLEIIEKILKRPLPS---------S 222 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH---HHHHHHHHHHHHTHHHH---------H
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccc---hhhhhhhhhcccccccc---------c
Confidence 34456899999999998 88899999999999999999999999976511 11111111111000000 0
Q ss_pred hhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 598 LEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 598 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
. .........+.+++.+||+.||++||++.+|++.
T Consensus 223 ~--~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 223 S--QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp T--TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred c--cccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 0000012578999999999999999999999863
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=333.42 Aligned_cols=269 Identities=22% Similarity=0.296 Sum_probs=196.6
Q ss_pred HHhcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccC--CchhHHHHHHHHHHHHHccCCceeeEeeeeeccc----
Q 046750 357 EITNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSG--SGQGEREFRAEVEIISRVHHRHLVSLVGYCISEK---- 429 (723)
Q Consensus 357 ~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~---- 429 (723)
.+.++|.+.+.||+|+||.||++.. ..|+.||||++... .......+.+|+.+++.++|+||+++++++....
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 4568899999999999999999954 56899999998653 2233456889999999999999999999986543
Q ss_pred --ceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeeccc
Q 046750 430 --NRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGL 507 (723)
Q Consensus 430 --~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGl 507 (723)
..|+||||+.+ +|.++++. .+++..+..++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCC
Confidence 46899999964 56666543 267788889999999999999999 599999999999999999999999999
Q ss_pred ccccCCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCch------------hhHH
Q 046750 508 AKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDE------------SLVE 575 (723)
Q Consensus 508 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~------------~l~~ 575 (723)
++...... ......|+..|+|||++.+..++.++|||||||+||||++|+.||...+..... .+..
T Consensus 170 a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (359)
T cd07876 170 ARTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMN 247 (359)
T ss_pred ccccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHH
Confidence 97543221 223356899999999999999999999999999999999999999754321000 0000
Q ss_pred hhhhhhhhhhhc-CC-----cccccchhhh---ccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 046750 576 WARPVLVRAIET-GD-----LSEIVDPRLE---KHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRAL 635 (723)
Q Consensus 576 ~~~~~l~~~i~~-~~-----l~~~vd~~l~---~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L 635 (723)
.....+...+.. .. +.++....+. ..........+.+|+.+||+.||++||++.|+++.-
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 316 (359)
T cd07876 248 RLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP 316 (359)
T ss_pred HHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 000000000000 00 0000000000 000111123578999999999999999999999854
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=332.49 Aligned_cols=260 Identities=26% Similarity=0.418 Sum_probs=205.0
Q ss_pred hcCcccceEEeccCcEEEEEEEc--------CCCcEEEEEEcccCC-chhHHHHHHHHHHHHHc-cCCceeeEeeeeecc
Q 046750 359 TNGFARENVIGEGGFGCVYKGNL--------PEGKVVAVKQLKSGS-GQGEREFRAEVEIISRV-HHRHLVSLVGYCISE 428 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~--------~~g~~VAvK~l~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~ 428 (723)
.++|.+.+.||+|+||.||+|+. .++..||||.++... ....+++.+|+++++.+ +|+||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 35688899999999999999953 134579999987543 34456789999999999 899999999999999
Q ss_pred cceEEEEEecCCCchhhccccCC--------------CCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEe
Q 046750 429 KNRLLIYEFVPNNNLEHHLHGKG--------------QPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILV 494 (723)
Q Consensus 429 ~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl 494 (723)
...++||||+.+|+|.+++.... ...+.+..++.++.||++||.|||++ +|+|||||++||||
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEEE
Confidence 99999999999999999986532 23478888999999999999999999 59999999999999
Q ss_pred CCCCcEEEeecccccccCCCCcce-eecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchh
Q 046750 495 DDEFEAQVADFGLAKLNDTTQTHV-STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDES 572 (723)
Q Consensus 495 ~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~ 572 (723)
++++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||+||||++ |..||....
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~------ 244 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------ 244 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC------
Confidence 999999999999998664433222 122345678999999998899999999999999999998 777775432
Q ss_pred hHHhhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCCC
Q 046750 573 LVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEM 641 (723)
Q Consensus 573 l~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~~ 641 (723)
..++. +.+..+.... ........+.+++.+||+.+|.+||+|.+|++.|+++...
T Consensus 245 ~~~~~-----~~~~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 245 VEELF-----KLLKEGHRMD---------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred HHHHH-----HHHHcCCcCC---------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 11111 1122221110 0112234688899999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=337.95 Aligned_cols=244 Identities=26% Similarity=0.351 Sum_probs=190.1
Q ss_pred eEEeccCcEEEEEEEc-CCCcEEEEEEcccC---CchhHHHHHHHHH-HHHHccCCceeeEeeeeecccceEEEEEecCC
Q 046750 366 NVIGEGGFGCVYKGNL-PEGKVVAVKQLKSG---SGQGEREFRAEVE-IISRVHHRHLVSLVGYCISEKNRLLIYEFVPN 440 (723)
Q Consensus 366 ~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~---~~~~~~~~~~Ei~-il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 440 (723)
++||+|+||.||+|+. .+|+.||||++... .......+..|.. +++.++|+||+++++++...+..|+||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999954 56899999998653 1223345555554 56778999999999999999999999999999
Q ss_pred CchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcceee
Q 046750 441 NNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVST 520 (723)
Q Consensus 441 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 520 (723)
|+|..++.... .+.+..+..++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++....... ...
T Consensus 81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~ 154 (325)
T cd05604 81 GELFFHLQRER--SFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD-TTT 154 (325)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC-Ccc
Confidence 99998886543 478889999999999999999999 499999999999999999999999999875322211 223
Q ss_pred cccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhhhc
Q 046750 521 RVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEK 600 (723)
Q Consensus 521 ~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~ 600 (723)
...|+..|+|||++.+..++.++|||||||+||||++|+.||..... .+ +.+.+..+.+. + ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~------~~-----~~~~~~~~~~~--~----~~ 217 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV------AE-----MYDNILHKPLV--L----RP 217 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH------HH-----HHHHHHcCCcc--C----CC
Confidence 45689999999999999999999999999999999999999975431 11 11111111110 0 11
Q ss_pred cccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 046750 601 HYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALD 636 (723)
Q Consensus 601 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~ 636 (723)
.....+.+++.+||+.+|.+|+++.+.++.+.
T Consensus 218 ----~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~ 249 (325)
T cd05604 218 ----GASLTAWSILEELLEKDRQRRLGAKEDFLEIQ 249 (325)
T ss_pred ----CCCHHHHHHHHHHhccCHHhcCCCCCCHHHHh
Confidence 12235778999999999999998875444443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=332.51 Aligned_cols=256 Identities=29% Similarity=0.461 Sum_probs=199.6
Q ss_pred cCcccceEEeccCcEEEEEEEcC-CCc--EEEEEEcccCC-chhHHHHHHHHHHHHHc-cCCceeeEeeeeecccceEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLP-EGK--VVAVKQLKSGS-GQGEREFRAEVEIISRV-HHRHLVSLVGYCISEKNRLLI 434 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~--~VAvK~l~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV 434 (723)
++|++.+.||+|+||.||+|.+. ++. .+++|.++... ......|.+|++++.++ +|+||+++++++.+++..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 46888999999999999999654 444 46788776543 33446788999999999 899999999999999999999
Q ss_pred EEecCCCchhhccccCC--------------CCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcE
Q 046750 435 YEFVPNNNLEHHLHGKG--------------QPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEA 500 (723)
Q Consensus 435 ~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~v 500 (723)
|||+.+++|.++++... ...+++..++.++.||+.||+|||++ +|+|||||++||||++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcE
Confidence 99999999999986532 23578899999999999999999998 59999999999999999999
Q ss_pred EEeecccccccCCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhh
Q 046750 501 QVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARP 579 (723)
Q Consensus 501 kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~ 579 (723)
||+|||++........ .....++..|+|||++.+..++.++|||||||+||||++ |..||..... ....
T Consensus 164 kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~----- 233 (303)
T cd05088 164 KIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AELY----- 233 (303)
T ss_pred EeCccccCcccchhhh--cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh---HHHH-----
Confidence 9999999863321111 111224567999999988889999999999999999998 9999864432 1111
Q ss_pred hhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCC
Q 046750 580 VLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGE 640 (723)
Q Consensus 580 ~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~ 640 (723)
+.+..+.... ........+.+|+.+||+.+|++||++.+|+..|+.+..
T Consensus 234 ---~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~ 282 (303)
T cd05088 234 ---EKLPQGYRLE---------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 282 (303)
T ss_pred ---HHHhcCCcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1111111000 001112357889999999999999999999999987544
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=333.53 Aligned_cols=240 Identities=25% Similarity=0.390 Sum_probs=189.8
Q ss_pred eEEeccCcEEEEEEEcC-CCcEEEEEEcccCC---chhHHHHHHHHHHHHHc-cCCceeeEeeeeecccceEEEEEecCC
Q 046750 366 NVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGS---GQGEREFRAEVEIISRV-HHRHLVSLVGYCISEKNRLLIYEFVPN 440 (723)
Q Consensus 366 ~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~---~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 440 (723)
++||+|+||.||+|+.+ +|+.||||+++... ......+..|+.++..+ +|+||+++++++.+.+..|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999654 58899999987532 22334567788888765 899999999999999999999999999
Q ss_pred CchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcceee
Q 046750 441 NNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVST 520 (723)
Q Consensus 441 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 520 (723)
|+|.+++.... .+++..+..++.||++||+|||++ +|+|||||++||||++++.+||+|||+++...... ....
T Consensus 81 g~L~~~i~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (316)
T cd05620 81 GDLMFHIQDKG--RFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRAS 154 (316)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Ccee
Confidence 99999887643 378888999999999999999999 59999999999999999999999999987432211 1223
Q ss_pred cccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhhhc
Q 046750 521 RVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEK 600 (723)
Q Consensus 521 ~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~ 600 (723)
...|+..|+|||++.+..++.++|||||||+||||++|+.||..... ..+ .+.+..+.. .+..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~---~~~--------~~~~~~~~~------~~~~ 217 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE---DEL--------FESIRVDTP------HYPR 217 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHH--------HHHHHhCCC------CCCC
Confidence 45689999999999999999999999999999999999999975431 111 111111110 1111
Q ss_pred cccHHHHHHHHHHHHHHhccCCCCCCCHH-HHH
Q 046750 601 HYVESEMFRMIEAAAACVRHSGPKRPRMV-QVV 632 (723)
Q Consensus 601 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-eVl 632 (723)
. ....+.+++.+||+.||.+|+++. +|+
T Consensus 218 ~----~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 218 W----ITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred C----CCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 1 123577899999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=324.41 Aligned_cols=255 Identities=28% Similarity=0.461 Sum_probs=203.1
Q ss_pred cCcccceEEeccCcEEEEEEEcC----CCcEEEEEEcccCC-chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLP----EGKVVAVKQLKSGS-GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLI 434 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~----~g~~VAvK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 434 (723)
.+|++.+.||+|+||.||+|.+. .+..||||.++... ....+.|.+|+.++++++|+||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46888999999999999999653 23479999987643 23345789999999999999999999999999999999
Q ss_pred EEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCC
Q 046750 435 YEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTT 514 (723)
Q Consensus 435 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 514 (723)
|||+.+++|.+++..... .+.+..++.|+.||+.||+|||++ +|+|||||++|||++.++.++|+|||++......
T Consensus 84 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 84 TEYMENGSLDAFLRKHDG-QFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEcCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 999999999999976543 478899999999999999999998 5999999999999999999999999999866543
Q ss_pred Ccceee--cccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcc
Q 046750 515 QTHVST--RVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLS 591 (723)
Q Consensus 515 ~~~~~~--~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~ 591 (723)
...... ...++..|++||++.+..++.++|||+|||++|||++ |..||..... ..... .+..+..
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~---~~~~~--------~~~~~~~- 227 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN---QDVIK--------AIEEGYR- 227 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH---HHHHH--------HHhCCCc-
Confidence 332221 1223568999999999999999999999999999887 9999865432 11111 1111110
Q ss_pred cccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhcc
Q 046750 592 EIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSE 638 (723)
Q Consensus 592 ~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~ 638 (723)
. .........+.+++.+||+.+|.+||+|.+|++.|+..
T Consensus 228 -~-------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 228 -L-------PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -C-------CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0 00111234678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=328.93 Aligned_cols=266 Identities=23% Similarity=0.357 Sum_probs=201.7
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCc-hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEe
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSG-QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEF 437 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 437 (723)
++|++.+.||+|+||.||++.. .++..||+|.++.... ....++.+|++++++++|+||++++++|.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 4689999999999999999954 4578899999875432 2345688999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcc
Q 046750 438 VPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTH 517 (723)
Q Consensus 438 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 517 (723)
+.+++|.++++... .+.+..+..++.||++||.|||+.. +|+|||||+.|||+++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 154 (308)
T cd06615 81 MDGGSLDQVLKKAG--RIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 154 (308)
T ss_pred cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccccc--
Confidence 99999999997653 4788889999999999999999742 59999999999999999999999999987543221
Q ss_pred eeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCC--------
Q 046750 518 VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGD-------- 589 (723)
Q Consensus 518 ~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~-------- 589 (723)
.....|+..|++||++.+..++.++|||||||+||||++|+.||....... +..+..... .......
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~-~~~~~~~~~~~~~~~ 229 (308)
T cd06615 155 -ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE---LEAMFGRPV-SEGEAKESHRPVSGH 229 (308)
T ss_pred -cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh---HHHhhcCcc-ccccccCCcccccCC
Confidence 123468899999999988889999999999999999999999986543211 111110000 0000000
Q ss_pred ---------cccccchhhhc---cc-cHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 046750 590 ---------LSEIVDPRLEK---HY-VESEMFRMIEAAAACVRHSGPKRPRMVQVVRALD 636 (723)
Q Consensus 590 ---------l~~~vd~~l~~---~~-~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~ 636 (723)
..++.+..+.. .. .......+.+++.+||+.+|++||++.+|++...
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~ 289 (308)
T cd06615 230 PPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF 289 (308)
T ss_pred CCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 00000000000 00 0011235789999999999999999999998754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=334.39 Aligned_cols=242 Identities=24% Similarity=0.359 Sum_probs=193.3
Q ss_pred eEEeccCcEEEEEEEcC-CCcEEEEEEcccCC---chhHHHHHHHHHHHHHc-cCCceeeEeeeeecccceEEEEEecCC
Q 046750 366 NVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGS---GQGEREFRAEVEIISRV-HHRHLVSLVGYCISEKNRLLIYEFVPN 440 (723)
Q Consensus 366 ~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~---~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 440 (723)
++||+|+||.||+|+.. +++.||||+++... ......+..|++++..+ +|+||+++++++.+.+..|+||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999654 57899999997542 23345677899999888 699999999999999999999999999
Q ss_pred CchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcceee
Q 046750 441 NNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVST 520 (723)
Q Consensus 441 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 520 (723)
|+|..++.... .+++..+..++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++....... ...
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~ 154 (318)
T cd05570 81 GDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-TTS 154 (318)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-ccc
Confidence 99999887654 488999999999999999999998 599999999999999999999999999875322221 123
Q ss_pred cccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhhhc
Q 046750 521 RVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEK 600 (723)
Q Consensus 521 ~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~ 600 (723)
..+|+..|+|||++.+..++.++|||||||+||||++|+.||..... ..+ .+.+..+... +
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~---~~~--------~~~i~~~~~~------~-- 215 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE---DEL--------FQSILEDEVR------Y-- 215 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH---HHH--------HHHHHcCCCC------C--
Confidence 34689999999999999999999999999999999999999975431 111 1112111110 1
Q ss_pred cccHHHHHHHHHHHHHHhccCCCCCCCH-----HHHHHH
Q 046750 601 HYVESEMFRMIEAAAACVRHSGPKRPRM-----VQVVRA 634 (723)
Q Consensus 601 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~-----~eVl~~ 634 (723)
.......+.+|+.+||+.||.+|+++ .++++.
T Consensus 216 --~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 216 --PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred --CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 11122367889999999999999999 777653
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=333.43 Aligned_cols=202 Identities=24% Similarity=0.320 Sum_probs=173.5
Q ss_pred cCcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccC---CchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSG---SGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 435 (723)
++|.+.+.||+|+||.||+++.. +++.||||++... .......+..|+.++..++|+||+++++++.+.+..||||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999654 5789999998642 1223345788999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ 515 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 515 (723)
||+.+|+|.++++.... .+.+..+..++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++......
T Consensus 81 Ey~~gg~L~~~l~~~~~-~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 81 DYYVGGDLLTLLSKFED-RLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred eCCCCCcHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 99999999999976432 478888889999999999999998 59999999999999999999999999997665443
Q ss_pred cceeecccccccccChhhhcc-----CCCCCccceechHHHHHHHHhCCCCCCCC
Q 046750 516 THVSTRVMGTFGYLAPEYASS-----GKLTDRSDVFSFGVVLLELITGRKPVDPT 565 (723)
Q Consensus 516 ~~~~~~~~gt~~y~APE~~~~-----~~~t~ksDVwSlGviL~eLltG~~P~~~~ 565 (723)
........|+..|+|||++.+ +.++.++|||||||+||||++|+.||...
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~ 211 (331)
T cd05624 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCC
Confidence 333334569999999999876 56888999999999999999999999754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=326.77 Aligned_cols=258 Identities=25% Similarity=0.441 Sum_probs=202.5
Q ss_pred hcCcccceEEeccCcEEEEEEEcC------CCcEEEEEEcccCCc-hhHHHHHHHHHHHHHccCCceeeEeeeeecccce
Q 046750 359 TNGFARENVIGEGGFGCVYKGNLP------EGKVVAVKQLKSGSG-QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNR 431 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~VAvK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 431 (723)
.++|++.++||+|+||.||+|..+ .+..||||.++.... .....+.+|+.++++++|+||+++++++.+....
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPT 84 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 467999999999999999999543 245799999875432 2334688899999999999999999999999999
Q ss_pred EEEEEecCCCchhhccccCC--------CCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEe
Q 046750 432 LLIYEFVPNNNLEHHLHGKG--------QPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVA 503 (723)
Q Consensus 432 ~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~ 503 (723)
|+||||+.+|+|.+++.... ...+.+..+++++.||+.||.|||++ +|+|||||++|||+++++.+||+
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEEC
Confidence 99999999999999996432 23356677889999999999999998 59999999999999999999999
Q ss_pred ecccccccCCCCcc-eeecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhh
Q 046750 504 DFGLAKLNDTTQTH-VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVL 581 (723)
Q Consensus 504 DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l 581 (723)
|||+++........ ......++..|++||++.++.++.++|||||||+||||++ |..||..... ..+.
T Consensus 162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~---~~~~------- 231 (288)
T cd05061 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN---EQVL------- 231 (288)
T ss_pred cCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHH-------
Confidence 99999754332221 1222345778999999999999999999999999999998 7888864321 1111
Q ss_pred hhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccC
Q 046750 582 VRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEG 639 (723)
Q Consensus 582 ~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~ 639 (723)
+.+..+....+ .......+.+++.+||+.+|++||++.+|++.|+...
T Consensus 232 -~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 232 -KFVMDGGYLDQ---------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred -HHHHcCCCCCC---------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 11112221111 1111247889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=338.87 Aligned_cols=202 Identities=26% Similarity=0.392 Sum_probs=173.8
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCC---chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS---GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 435 (723)
++|+..++||+|+||.||++.. .+++.||||+++... ......+++|++++..++|+||+++++++.+.+..||||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4688999999999999999955 468999999987432 233456888999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ 515 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 515 (723)
||+.+|+|.+++.... .+.+..+..++.||+.||+|||++ +|+|||||++||||+.++.+||+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 81 EFLPGGDMMTLLMKKD--TLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred eCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 9999999999987654 478889999999999999999999 59999999999999999999999999986442211
Q ss_pred c----------------------------------ceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCC
Q 046750 516 T----------------------------------HVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKP 561 (723)
Q Consensus 516 ~----------------------------------~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P 561 (723)
. ......+||..|+|||++.+..++.++|||||||+||||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 0 001234699999999999999999999999999999999999999
Q ss_pred CCCCC
Q 046750 562 VDPTQ 566 (723)
Q Consensus 562 ~~~~~ 566 (723)
|....
T Consensus 236 f~~~~ 240 (360)
T cd05627 236 FCSET 240 (360)
T ss_pred CCCCC
Confidence 97643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=316.82 Aligned_cols=248 Identities=29% Similarity=0.492 Sum_probs=202.1
Q ss_pred eEEeccCcEEEEEEEcCC----CcEEEEEEcccCCchh-HHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEecCC
Q 046750 366 NVIGEGGFGCVYKGNLPE----GKVVAVKQLKSGSGQG-EREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPN 440 (723)
Q Consensus 366 ~~LG~G~fG~Vy~~~~~~----g~~VAvK~l~~~~~~~-~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 440 (723)
++||+|+||.||+|.... +..|+||+++...... .+.+.+|++++++++|+||+++++++.+....++||||+.+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 479999999999996644 7889999998764443 56889999999999999999999999999999999999999
Q ss_pred CchhhccccCC-------CCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCC
Q 046750 441 NNLEHHLHGKG-------QPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDT 513 (723)
Q Consensus 441 gsL~~~l~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 513 (723)
++|.+++.... ...+++..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||++.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 99999997652 24589999999999999999999998 599999999999999999999999999987654
Q ss_pred CCc-ceeecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcc
Q 046750 514 TQT-HVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLS 591 (723)
Q Consensus 514 ~~~-~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~ 591 (723)
... .......++..|+|||++....++.++|||||||+||||++ |+.||..... ..+ .+.+..+...
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~--------~~~~~~~~~~ 226 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN---EEV--------LEYLRKGYRL 226 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH---HHH--------HHHHHcCCCC
Confidence 332 11233457889999999998899999999999999999999 6899876521 111 1222222111
Q ss_pred cccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 046750 592 EIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALD 636 (723)
Q Consensus 592 ~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~ 636 (723)
. ........+.+++.+||+.+|.+||++.||++.|+
T Consensus 227 ~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 227 P---------KPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred C---------CCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1 11111346889999999999999999999999884
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=317.37 Aligned_cols=247 Identities=26% Similarity=0.449 Sum_probs=196.7
Q ss_pred eEEeccCcEEEEEEEcCC----CcEEEEEEcccCCc-hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEecCC
Q 046750 366 NVIGEGGFGCVYKGNLPE----GKVVAVKQLKSGSG-QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPN 440 (723)
Q Consensus 366 ~~LG~G~fG~Vy~~~~~~----g~~VAvK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 440 (723)
++||+|+||.||+|.+.. +..||+|.++.... ...+++.+|++++++++|+||+++++++. .+..++||||+.+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999995422 26899999986544 24567899999999999999999999876 4568999999999
Q ss_pred CchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcceee
Q 046750 441 NNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVST 520 (723)
Q Consensus 441 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 520 (723)
++|.+++.... .+.+..++.++.|++.+|+|||.. +|+|||||++||||++++.+||+|||+++...........
T Consensus 80 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~ 154 (257)
T cd05060 80 GPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA 154 (257)
T ss_pred CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence 99999997654 578999999999999999999998 5999999999999999999999999999866443322211
Q ss_pred c--ccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchh
Q 046750 521 R--VMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPR 597 (723)
Q Consensus 521 ~--~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~ 597 (723)
. ..++..|+|||++.+..++.++|||||||+||||++ |..||+.... ..+..+ +..+.....
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~~--------~~~~~~~~~---- 219 (257)
T cd05060 155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIAM--------LESGERLPR---- 219 (257)
T ss_pred ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHHH--------HHcCCcCCC----
Confidence 1 123467999999999999999999999999999998 9999975432 222222 112211111
Q ss_pred hhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhcc
Q 046750 598 LEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSE 638 (723)
Q Consensus 598 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~ 638 (723)
.......+.+++.+||..+|++||++.+|++.|+..
T Consensus 220 -----~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 220 -----PEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred -----CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 111224678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=318.54 Aligned_cols=248 Identities=29% Similarity=0.452 Sum_probs=198.5
Q ss_pred eEEeccCcEEEEEEEcCCCcEEEEEEcccCCch-hHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEecCCCchh
Q 046750 366 NVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQ-GEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNLE 444 (723)
Q Consensus 366 ~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~ 444 (723)
++||+|+||.||++.+.+++.|++|+++..... ....|.+|++++++++|+||+++++++.+....++||||+.+++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999998767999999998765443 4567899999999999999999999999999999999999999999
Q ss_pred hccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCccee-eccc
Q 046750 445 HHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVS-TRVM 523 (723)
Q Consensus 445 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~-~~~~ 523 (723)
+++..... .+.+..++.++.+++.+|+|||++ +|+|||||++||||++++.+||+|||++........... ....
T Consensus 81 ~~l~~~~~-~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (251)
T cd05041 81 TFLRKKKN-RLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156 (251)
T ss_pred HHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence 99865433 478889999999999999999999 599999999999999999999999999976542222111 1122
Q ss_pred ccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhhhccc
Q 046750 524 GTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEKHY 602 (723)
Q Consensus 524 gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~~~ 602 (723)
++..|++||++.++.++.++|||||||++|||++ |..||...... .. .+.+..+. .+ ..
T Consensus 157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~---~~--------~~~~~~~~--~~-------~~ 216 (251)
T cd05041 157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ---QT--------RERIESGY--RM-------PA 216 (251)
T ss_pred ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH---HH--------HHHHhcCC--CC-------CC
Confidence 3567999999998999999999999999999999 78888654321 11 11111111 00 01
Q ss_pred cHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhc
Q 046750 603 VESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDS 637 (723)
Q Consensus 603 ~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~ 637 (723)
.......+.+++.+||+.+|.+||++.||++.|+.
T Consensus 217 ~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 217 PQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred CccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 11123468899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=327.60 Aligned_cols=250 Identities=22% Similarity=0.375 Sum_probs=202.6
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEec
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFV 438 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 438 (723)
.+|.+.+.||+|+||.||+|.. .+++.|+||.+..........+.+|+.+++.++|+||++++++|.+....|+||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 5788999999999999999964 568899999998765555677899999999999999999999999999999999999
Q ss_pred CCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcce
Q 046750 439 PNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHV 518 (723)
Q Consensus 439 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 518 (723)
.+++|.+++... .+.+..++.++.|++.||+|||+. +|+|||||++||||++++.+||+|||++.........
T Consensus 100 ~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~- 172 (296)
T cd06654 100 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK- 172 (296)
T ss_pred CCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccccc-
Confidence 999999998643 378889999999999999999999 4999999999999999999999999998754332211
Q ss_pred eecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhh
Q 046750 519 STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRL 598 (723)
Q Consensus 519 ~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l 598 (723)
.....++..|+|||++.+..++.++|||||||+||||++|+.||....... .+..+. ..+ ...+
T Consensus 173 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~--~~~~~~--------~~~-~~~~----- 236 (296)
T cd06654 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--ALYLIA--------TNG-TPEL----- 236 (296)
T ss_pred cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH--hHHHHh--------cCC-CCCC-----
Confidence 223458889999999998889999999999999999999999997543211 111110 011 0000
Q ss_pred hccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 599 EKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 599 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
.........+.+++.+||..+|.+||++.+|++.
T Consensus 237 --~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 237 --QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred --CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 0111223457889999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=321.96 Aligned_cols=247 Identities=26% Similarity=0.432 Sum_probs=194.3
Q ss_pred EEeccCcEEEEEEEcC---CCcEEEEEEcccCCc-hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEecCCCc
Q 046750 367 VIGEGGFGCVYKGNLP---EGKVVAVKQLKSGSG-QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNN 442 (723)
Q Consensus 367 ~LG~G~fG~Vy~~~~~---~g~~VAvK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gs 442 (723)
.||+|+||.||+|.+. .+..||||++..... ...+.|.+|++++++++|+||++++++|. ....++||||+.+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999653 355799999976533 33456899999999999999999999886 456899999999999
Q ss_pred hhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcceeec-
Q 046750 443 LEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTR- 521 (723)
Q Consensus 443 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~- 521 (723)
|.+++.... ..+++..+++++.||+.||+|||++ +|+|||||++|||++.++.+||+|||++.............
T Consensus 81 L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 81 LNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred HHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence 999986533 3578999999999999999999998 59999999999999999999999999997654333222111
Q ss_pred -ccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhhh
Q 046750 522 -VMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLE 599 (723)
Q Consensus 522 -~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~ 599 (723)
..++..|+|||++.+..++.++|||||||+||||++ |..||..... ..+ ...+..+...
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~--------~~~~~~~~~~-------- 217 (257)
T cd05115 157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG---PEV--------MSFIEQGKRL-------- 217 (257)
T ss_pred CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH---HHH--------HHHHHCCCCC--------
Confidence 223578999999998889999999999999999996 9999965431 111 1122222111
Q ss_pred ccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhcc
Q 046750 600 KHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSE 638 (723)
Q Consensus 600 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~ 638 (723)
.........+.+++.+||..++++||++.+|++.|+..
T Consensus 218 -~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 218 -DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred -CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 11112234677899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=314.28 Aligned_cols=256 Identities=21% Similarity=0.309 Sum_probs=207.7
Q ss_pred HhcCcccceEEeccCcEEEEEE-EcCCCcEEEEEEcccC--CchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEE
Q 046750 358 ITNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSG--SGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLI 434 (723)
Q Consensus 358 ~~~~f~~~~~LG~G~fG~Vy~~-~~~~g~~VAvK~l~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 434 (723)
+.+.|++.+.||+|.|+.||++ +...|+.+|+|++... .....+++.+|+.|-+.|+|||||+|.+.+.++...|||
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 3466888899999999999999 5667899998887432 344667899999999999999999999999999999999
Q ss_pred EEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCC---CCcEEEeeccccccc
Q 046750 435 YEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDD---EFEAQVADFGLAKLN 511 (723)
Q Consensus 435 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~---~~~vkL~DFGla~~~ 511 (723)
||+|.|++|..-+-.+ ...++...-..+.||+++|.|+|.+ +|||||+||.|+||.. .--+||+|||+|...
T Consensus 89 Fe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred EecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 9999999997655332 3567777888999999999999999 5999999999999953 346999999999877
Q ss_pred CCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcc
Q 046750 512 DTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLS 591 (723)
Q Consensus 512 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~ 591 (723)
. ........+||++|||||+++...|+..+|||+.|||||-||.|+.||.+... ..|.+.|..|++.
T Consensus 164 ~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~-----------~rlye~I~~g~yd 230 (355)
T KOG0033|consen 164 N--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-----------HRLYEQIKAGAYD 230 (355)
T ss_pred C--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH-----------HHHHHHHhccccC
Confidence 6 33344567799999999999999999999999999999999999999976432 1245556566542
Q ss_pred cccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhc
Q 046750 592 EIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDS 637 (723)
Q Consensus 592 ~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~ 637 (723)
++.. +-........+|+.+||..||.+|.++.|.|+.-+-
T Consensus 231 --~~~~----~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi 270 (355)
T KOG0033|consen 231 --YPSP----EWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWI 270 (355)
T ss_pred --CCCc----ccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchh
Confidence 1111 112223356788889999999999999998876554
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=334.18 Aligned_cols=245 Identities=25% Similarity=0.317 Sum_probs=189.1
Q ss_pred eEEeccCcEEEEEEEcC-CCcEEEEEEcccCC---chhHHHHHHHH-HHHHHccCCceeeEeeeeecccceEEEEEecCC
Q 046750 366 NVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGS---GQGEREFRAEV-EIISRVHHRHLVSLVGYCISEKNRLLIYEFVPN 440 (723)
Q Consensus 366 ~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~---~~~~~~~~~Ei-~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 440 (723)
+.||+|+||.||+|+.. +++.||||++.... ......+..|. .+++.++|+||+++++++...+..|+||||+.+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 47999999999999654 57889999986532 12223444444 456788999999999999999999999999999
Q ss_pred CchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcceee
Q 046750 441 NNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVST 520 (723)
Q Consensus 441 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 520 (723)
|+|.+++.... .+.+..+..++.||++||+|||++ +|+|||||++||||+.++.+||+|||+++....... ...
T Consensus 81 ~~L~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-~~~ 154 (325)
T cd05602 81 GELFYHLQRER--CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-TTS 154 (325)
T ss_pred CcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-Ccc
Confidence 99999987643 366777888999999999999999 499999999999999999999999999975432221 223
Q ss_pred cccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhhhc
Q 046750 521 RVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEK 600 (723)
Q Consensus 521 ~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~ 600 (723)
...|+..|+|||++.+..++.++|||||||+||||++|+.||..... . ++. +.+....+.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~---~~~-----~~i~~~~~~--------- 214 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT---A---EMY-----DNILNKPLQ--------- 214 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH---H---HHH-----HHHHhCCcC---------
Confidence 45699999999999999999999999999999999999999975431 1 111 111111110
Q ss_pred cccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhc
Q 046750 601 HYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDS 637 (723)
Q Consensus 601 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~ 637 (723)
+.......+.+++.+||+.+|.+|+++.+.+..+..
T Consensus 215 -~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~ 250 (325)
T cd05602 215 -LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKN 250 (325)
T ss_pred -CCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhc
Confidence 111122357789999999999999998765554444
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=320.76 Aligned_cols=255 Identities=25% Similarity=0.438 Sum_probs=204.0
Q ss_pred cCcccceEEeccCcEEEEEEEcC------CCcEEEEEEcccCCch-hHHHHHHHHHHHHHccCCceeeEeeeeecccceE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLP------EGKVVAVKQLKSGSGQ-GEREFRAEVEIISRVHHRHLVSLVGYCISEKNRL 432 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~------~g~~VAvK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 432 (723)
++|++.+.||+|+||.||+|+.+ +.+.|++|.+...... ...++.+|++++++++|+||++++++|.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 56889999999999999999753 3467999998765433 4567999999999999999999999999989999
Q ss_pred EEEEecCCCchhhccccCCC-------CcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeec
Q 046750 433 LIYEFVPNNNLEHHLHGKGQ-------PVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADF 505 (723)
Q Consensus 433 lV~E~~~~gsL~~~l~~~~~-------~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DF 505 (723)
+||||+.+|+|.++++.... ..+.+..++.++.||+.+|+|||+. +|+|||||++||||++++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence 99999999999999875441 2589999999999999999999998 5999999999999999999999999
Q ss_pred ccccccCCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhh
Q 046750 506 GLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRA 584 (723)
Q Consensus 506 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~ 584 (723)
|+++..............++..|++||++.+..++.++|||||||++|||++ |..||..... ..++ ..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~---~~~~--------~~ 230 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD---EEVL--------NR 230 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch---HHHH--------HH
Confidence 9987543322222233456778999999998889999999999999999999 7788854321 1111 12
Q ss_pred hhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 046750 585 IETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALD 636 (723)
Q Consensus 585 i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~ 636 (723)
+..+.+.... .......+.+++.+||+.+|.+||++.+|+..|+
T Consensus 231 ~~~~~~~~~~--------~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 231 LQAGKLELPV--------PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HHcCCcCCCC--------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 2222221111 1112236889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=321.32 Aligned_cols=251 Identities=24% Similarity=0.387 Sum_probs=197.4
Q ss_pred cCcccceEEeccCcEEEEEEE-cCCCcEEEEEEcccC-CchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEe
Q 046750 360 NGFARENVIGEGGFGCVYKGN-LPEGKVVAVKQLKSG-SGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEF 437 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~-~~~g~~VAvK~l~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 437 (723)
++|++.++||+|+||.||+|. ..+++.||||++... ......+|.+|++++++++|+||++++++|...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 357888999999999999995 457889999998654 233446788999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcc
Q 046750 438 VPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTH 517 (723)
Q Consensus 438 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 517 (723)
+.+++|..+. .+++..+..++.||+.||.|||+. +|+|+|||++|||++.++.+||+|||++.......
T Consensus 81 ~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~-- 149 (279)
T cd06619 81 MDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-- 149 (279)
T ss_pred CCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc--
Confidence 9999997653 256778889999999999999999 49999999999999999999999999997554322
Q ss_pred eeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCch-hhHHhhhhhhhhhhhcCCcccccch
Q 046750 518 VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDE-SLVEWARPVLVRAIETGDLSEIVDP 596 (723)
Q Consensus 518 ~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~-~l~~~~~~~l~~~i~~~~l~~~vd~ 596 (723)
.....|+..|+|||++.+..++.++|||||||+||||++|+.||......... ....+ .+.+.......+.
T Consensus 150 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~-- 221 (279)
T cd06619 150 -AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQL-----LQCIVDEDPPVLP-- 221 (279)
T ss_pred -ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHH-----HHHHhccCCCCCC--
Confidence 22346899999999999999999999999999999999999999653321110 00111 1111111111100
Q ss_pred hhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 046750 597 RLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRAL 635 (723)
Q Consensus 597 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L 635 (723)
...+ ...+.+++.+||+.+|.+||++.+|++..
T Consensus 222 --~~~~----~~~~~~li~~~l~~~P~~Rp~~~eil~~~ 254 (279)
T cd06619 222 --VGQF----SEKFVHFITQCMRKQPKERPAPENLMDHP 254 (279)
T ss_pred --CCcC----CHHHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence 0111 23578899999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=317.18 Aligned_cols=251 Identities=24% Similarity=0.392 Sum_probs=205.2
Q ss_pred CcccceEEeccCcEEEEEEE-cCCCcEEEEEEcccC--CchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEe
Q 046750 361 GFARENVIGEGGFGCVYKGN-LPEGKVVAVKQLKSG--SGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEF 437 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~-~~~g~~VAvK~l~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 437 (723)
+|+..++||+|+||.||.++ ..+++.|++|.+... .....+++.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 58889999999999999984 456889999987654 234456788999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcc
Q 046750 438 VPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTH 517 (723)
Q Consensus 438 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 517 (723)
+.+++|.+++.......+++..++.++.|++++|+|||+. +|+||||+++||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 9999999999765445688999999999999999999998 599999999999999999999999999976644332
Q ss_pred eeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchh
Q 046750 518 VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPR 597 (723)
Q Consensus 518 ~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~ 597 (723)
......++..|+|||++.+..++.++|||||||++|||++|+.+|..... .+ +...+..+.+....
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~-----~~~~~~~~~~~~~~--- 222 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP------LN-----LVVKIVQGNYTPVV--- 222 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH------HH-----HHHHHHcCCCCCCc---
Confidence 22335689999999999988899999999999999999999999965432 11 11122223322211
Q ss_pred hhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 046750 598 LEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRAL 635 (723)
Q Consensus 598 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L 635 (723)
......+.+++.+||+.+|.+||++.++++.+
T Consensus 223 ------~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 223 ------SVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred ------cccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 11233678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=320.52 Aligned_cols=255 Identities=25% Similarity=0.397 Sum_probs=203.1
Q ss_pred cCcccceEEeccCcEEEEEEEcCC----CcEEEEEEcccCC-chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLPE----GKVVAVKQLKSGS-GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLI 434 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~~----g~~VAvK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 434 (723)
++|.+.++||+|+||.||+|.+.+ ...|+||...... ....+.|.+|+.++++++|+||++++++|.+ ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 458888999999999999996543 2469999987654 3445679999999999999999999999875 457899
Q ss_pred EEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCC
Q 046750 435 YEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTT 514 (723)
Q Consensus 435 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 514 (723)
|||+.+++|.+++..... .+++..++.++.+|+.||+|||+. +++|||||++|||++.++.+||+|||+++.....
T Consensus 85 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 85 MELAPLGELRSYLQVNKY-SLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred EEcCCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 999999999999976433 489999999999999999999998 5999999999999999999999999999866544
Q ss_pred CcceeecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccc
Q 046750 515 QTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEI 593 (723)
Q Consensus 515 ~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~ 593 (723)
.........+...|+|||++....++.++|||||||+||||++ |..||..... .....+ +..+....+
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~---~~~~~~--------~~~~~~~~~ 229 (270)
T cd05056 161 SYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN---NDVIGR--------IENGERLPM 229 (270)
T ss_pred cceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHH--------HHcCCcCCC
Confidence 3332233334568999999988889999999999999999986 9999975432 111111 112211111
Q ss_pred cchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccC
Q 046750 594 VDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEG 639 (723)
Q Consensus 594 vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~ 639 (723)
.......+.+++.+||..+|.+||++.+|++.|+...
T Consensus 230 ---------~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~ 266 (270)
T cd05056 230 ---------PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266 (270)
T ss_pred ---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1112236888999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=332.53 Aligned_cols=241 Identities=24% Similarity=0.358 Sum_probs=191.9
Q ss_pred CcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCC---chhHHHHHHHHHHHHHcc-CCceeeEeeeeecccceEEEE
Q 046750 361 GFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS---GQGEREFRAEVEIISRVH-HRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~---~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~ 435 (723)
+|+..++||+|+||.||+|.. .+++.||||+++... ....+.+..|++++..+. |++|+++++++.+.+..|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 477889999999999999954 468899999987532 233356778999998885 577888999999999999999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ 515 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 515 (723)
||+.+|+|.+++.... .+.+..++.|+.||+.||+|||++ +|+|||||++||||++++.+||+|||+++......
T Consensus 81 Ey~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 81 EYVNGGDLMYHIQQVG--KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 9999999999986544 488899999999999999999998 49999999999999999999999999987543222
Q ss_pred cceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccc
Q 046750 516 THVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVD 595 (723)
Q Consensus 516 ~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd 595 (723)
. ......|+..|+|||++.+..++.++|||||||+||||++|+.||..... ..+ .+.+..+.+.
T Consensus 156 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~~--------~~~i~~~~~~---- 219 (323)
T cd05615 156 V-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE---DEL--------FQSIMEHNVS---- 219 (323)
T ss_pred c-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH---HHH--------HHHHHhCCCC----
Confidence 1 22335689999999999999999999999999999999999999975432 111 1111111110
Q ss_pred hhhhccccHHHHHHHHHHHHHHhccCCCCCCCH
Q 046750 596 PRLEKHYVESEMFRMIEAAAACVRHSGPKRPRM 628 (723)
Q Consensus 596 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 628 (723)
+.......+.+++.+||+.+|.+|++.
T Consensus 220 ------~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 220 ------YPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ------CCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 111122357789999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=338.04 Aligned_cols=259 Identities=27% Similarity=0.422 Sum_probs=199.9
Q ss_pred cCcccceEEeccCcEEEEEEEc------CCCcEEEEEEcccCCc-hhHHHHHHHHHHHHHc-cCCceeeEeeeeecc-cc
Q 046750 360 NGFARENVIGEGGFGCVYKGNL------PEGKVVAVKQLKSGSG-QGEREFRAEVEIISRV-HHRHLVSLVGYCISE-KN 430 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~------~~g~~VAvK~l~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~-~~ 430 (723)
++|++.++||+|+||.||+|.+ .+++.||||+++.... .....+.+|+++|.++ +|+||++++++|... ..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 5689999999999999999953 3467899999976432 3345688999999999 689999999988654 45
Q ss_pred eEEEEEecCCCchhhccccCC-----------------------------------------------------------
Q 046750 431 RLLIYEFVPNNNLEHHLHGKG----------------------------------------------------------- 451 (723)
Q Consensus 431 ~~lV~E~~~~gsL~~~l~~~~----------------------------------------------------------- 451 (723)
.++||||+.+|+|.++++...
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 789999999999999886421
Q ss_pred ------CCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcc-eeecccc
Q 046750 452 ------QPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTH-VSTRVMG 524 (723)
Q Consensus 452 ------~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~g 524 (723)
...+++..+++++.||++||+|||++ +|+|||||++|||+++++.+||+|||++......... ......+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 12367788899999999999999998 5999999999999999999999999999765332221 1122335
Q ss_pred cccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhhhcccc
Q 046750 525 TFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEKHYV 603 (723)
Q Consensus 525 t~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~ 603 (723)
+..|+|||++.+..++.++|||||||+||||++ |..||...... .. +...+..+....+ ....
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~--------~~~~~~~~~~~~~-----~~~~- 307 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EE--------FCRRLKEGTRMRA-----PDYT- 307 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc--HH--------HHHHHhccCCCCC-----CCCC-
Confidence 678999999999999999999999999999997 88888653211 11 1111222211111 0011
Q ss_pred HHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCC
Q 046750 604 ESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGE 640 (723)
Q Consensus 604 ~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~ 640 (723)
...+.+++.+||+.+|.+||++.+|++.|+.+..
T Consensus 308 ---~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 308 ---TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred ---CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1257889999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=324.20 Aligned_cols=262 Identities=24% Similarity=0.361 Sum_probs=194.9
Q ss_pred cCcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeeccc-----ceEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEK-----NRLL 433 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~-----~~~l 433 (723)
-.|...+++|.|.||.||+|.+. .++.||||++..+.. .-.+|+++|++++|+|||+|+.+|.... ...|
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 34777899999999999999654 468999999876432 2246899999999999999998886432 2348
Q ss_pred EEEecCCCchhhcccc--CCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCC-CcEEEeecccccc
Q 046750 434 IYEFVPNNNLEHHLHG--KGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDE-FEAQVADFGLAKL 510 (723)
Q Consensus 434 V~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~-~~vkL~DFGla~~ 510 (723)
||||| ..+|.++++. ..+..++...+.-+.+||++||+|||+. +|+||||||+|||+|.+ +.+||||||.|+.
T Consensus 100 Vleym-P~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 100 VLEYM-PETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHhc-hHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCccee
Confidence 99999 6688888763 1233466667778899999999999998 59999999999999966 9999999999997
Q ss_pred cCCCCcceeecccccccccChhhhccC-CCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhh---hhhhhh
Q 046750 511 NDTTQTHVSTRVMGTFGYLAPEYASSG-KLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPV---LVRAIE 586 (723)
Q Consensus 511 ~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~---l~~~i~ 586 (723)
+........ ...+..|+|||++.+. .|+.+.||||.|||+.||+.|+..|.+... ...+++..+-+ -.+.|.
T Consensus 176 L~~~epniS--YicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~--~dQL~eIik~lG~Pt~e~I~ 251 (364)
T KOG0658|consen 176 LVKGEPNIS--YICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS--VDQLVEIIKVLGTPTREDIK 251 (364)
T ss_pred eccCCCcee--EEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH--HHHHHHHHHHhCCCCHHHHh
Confidence 765555433 4578999999998875 699999999999999999999999987543 22333332210 011111
Q ss_pred cC--Ccccccchhhhc-----cccHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 046750 587 TG--DLSEIVDPRLEK-----HYVESEMFRMIEAAAACVRHSGPKRPRMVQVVR 633 (723)
Q Consensus 587 ~~--~l~~~vd~~l~~-----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~ 633 (723)
.- +..+...+.+.. -+.......+++++.++|..+|.+|-++.|++.
T Consensus 252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 11 111222222221 123344457889999999999999999999874
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=333.45 Aligned_cols=237 Identities=24% Similarity=0.346 Sum_probs=185.5
Q ss_pred eEEeccCcEEEEEEEc-CCCcEEEEEEcccCC---chhHHHHHHHHH-HHHHccCCceeeEeeeeecccceEEEEEecCC
Q 046750 366 NVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS---GQGEREFRAEVE-IISRVHHRHLVSLVGYCISEKNRLLIYEFVPN 440 (723)
Q Consensus 366 ~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~---~~~~~~~~~Ei~-il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 440 (723)
++||+|+||.||+|+. .+++.||||++.... ......+.+|+. +++.++|+||++++++|.+.+..|+||||+.+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999965 468899999986532 122334555554 67889999999999999999999999999999
Q ss_pred CchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcceee
Q 046750 441 NNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVST 520 (723)
Q Consensus 441 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 520 (723)
++|..++.... .+.+..+..++.||++||+|||++ +|+|||||++||||+.++.+||+|||+++...... ....
T Consensus 81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (321)
T cd05603 81 GELFFHLQRER--CFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTS 154 (321)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Cccc
Confidence 99988886543 467788888999999999999998 59999999999999999999999999987532221 1223
Q ss_pred cccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhhhc
Q 046750 521 RVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEK 600 (723)
Q Consensus 521 ~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~ 600 (723)
...|+..|+|||++.+..++.++|||||||+||||++|+.||..... ..+ .+.+..+.+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~-----~~~i~~~~~---------- 213 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV------SQM-----YDNILHKPL---------- 213 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH------HHH-----HHHHhcCCC----------
Confidence 45689999999999999999999999999999999999999965421 111 111111111
Q ss_pred cccHHHHHHHHHHHHHHhccCCCCCCCHH
Q 046750 601 HYVESEMFRMIEAAAACVRHSGPKRPRMV 629 (723)
Q Consensus 601 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 629 (723)
.+.......+.+++.+||+.+|.+|++..
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 214 QLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 01111233678999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=316.52 Aligned_cols=251 Identities=29% Similarity=0.476 Sum_probs=202.6
Q ss_pred cccceEEeccCcEEEEEEEcCC-----CcEEEEEEcccCCch-hHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEE
Q 046750 362 FARENVIGEGGFGCVYKGNLPE-----GKVVAVKQLKSGSGQ-GEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 362 f~~~~~LG~G~fG~Vy~~~~~~-----g~~VAvK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 435 (723)
|.+.+.||+|+||.||++.+.+ +..||+|+++..... ..+.+..|++++++++|+||+++++++.+.+..++||
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 4567899999999999996644 378999999766443 5668999999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ 515 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 515 (723)
||+.+++|.+++.......+.+..++.++.||+.+|+|||+. +|+|||||++|||+++++.++|+|||+++......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 999999999999765443389999999999999999999999 59999999999999999999999999998665443
Q ss_pred cceeecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCccccc
Q 046750 516 THVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIV 594 (723)
Q Consensus 516 ~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~v 594 (723)
........++..|++||.+.+..++.++|||+|||++|||++ |+.||..... ..+ .+.+..+......
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~---~~~--------~~~~~~~~~~~~~ 226 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN---EEV--------LEYLKKGYRLPKP 226 (258)
T ss_pred ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH---HHH--------HHHHhcCCCCCCC
Confidence 322222336789999999988889999999999999999998 7788765321 111 1222222211110
Q ss_pred chhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 046750 595 DPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRAL 635 (723)
Q Consensus 595 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L 635 (723)
......+.+++.+||+.+|.+||++.||++.|
T Consensus 227 ---------~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 227 ---------ENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ---------CcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 11234688899999999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=327.67 Aligned_cols=258 Identities=27% Similarity=0.439 Sum_probs=202.2
Q ss_pred cCcccceEEeccCcEEEEEEEcC--------CCcEEEEEEcccCC-chhHHHHHHHHHHHHHc-cCCceeeEeeeeeccc
Q 046750 360 NGFARENVIGEGGFGCVYKGNLP--------EGKVVAVKQLKSGS-GQGEREFRAEVEIISRV-HHRHLVSLVGYCISEK 429 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~--------~g~~VAvK~l~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~ 429 (723)
++|.+.++||+|+||.||++... ....||+|+++... .....++..|+++++++ +|+||++++++|.+..
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 56888999999999999999532 24579999987543 23445788999999999 6999999999999988
Q ss_pred ceEEEEEecCCCchhhccccCC--------------CCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeC
Q 046750 430 NRLLIYEFVPNNNLEHHLHGKG--------------QPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVD 495 (723)
Q Consensus 430 ~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~ 495 (723)
..++||||+.+|+|.+++.... ...+.+..+++++.||+.||.|||++ +|+|||||++||||+
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEEc
Confidence 9999999999999999986532 23488899999999999999999998 599999999999999
Q ss_pred CCCcEEEeecccccccCCCCcce-eecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhh
Q 046750 496 DEFEAQVADFGLAKLNDTTQTHV-STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESL 573 (723)
Q Consensus 496 ~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l 573 (723)
+++.+||+|||+++......... .....++..|+|||++.++.++.++|||||||+||||++ |..||..... ..+
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~---~~~ 245 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV---EEL 245 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH---HHH
Confidence 99999999999998654322211 111224467999999999999999999999999999999 8888854321 111
Q ss_pred HHhhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCC
Q 046750 574 VEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGE 640 (723)
Q Consensus 574 ~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~ 640 (723)
. ..+..+....+ .......+.+++.+||+.+|.+||++.+|++.|++...
T Consensus 246 ~--------~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 246 F--------KLLREGHRMDK---------PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred H--------HHHHcCCCCCC---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 1 11222211111 11123367789999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=335.57 Aligned_cols=191 Identities=24% Similarity=0.379 Sum_probs=163.6
Q ss_pred hcCcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEe
Q 046750 359 TNGFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEF 437 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 437 (723)
..+|.+.+.||+|+||.||+|... .++.||+|+.... .+..|+.+|++++|+||++++++|......++||||
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 138 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH 138 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence 457999999999999999999654 5678999986432 235699999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcc
Q 046750 438 VPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTH 517 (723)
Q Consensus 438 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 517 (723)
+ .++|.+++.... ..+.+..++.|+.||+.||.|||++ +|||||||++||||+.++.+||+|||+++......
T Consensus 139 ~-~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-- 211 (357)
T PHA03209 139 Y-SSDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP-- 211 (357)
T ss_pred c-CCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccCc--
Confidence 9 568888876543 3588999999999999999999999 59999999999999999999999999997533221
Q ss_pred eeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCC
Q 046750 518 VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPV 562 (723)
Q Consensus 518 ~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~ 562 (723)
......|+..|+|||++.+..++.++|||||||+||||+++..++
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 123356899999999999999999999999999999999966554
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=331.82 Aligned_cols=202 Identities=27% Similarity=0.328 Sum_probs=172.3
Q ss_pred cCcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccC---CchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSG---SGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 435 (723)
++|++.++||+|+||.||+++++ .++.||||++... .......|..|+.++..++|+||+++++++.+.+..||||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46889999999999999999664 4788999998642 1222345788999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ 515 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 515 (723)
||+.+|+|.+++++... .+.+..+..++.||+.||+|||++ +|+|||||++||||+.++.+||+|||++.......
T Consensus 81 ey~~~g~L~~~l~~~~~-~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 81 DYYVGGDLLTLLSKFED-RLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred eccCCCcHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 99999999999976332 478888899999999999999998 59999999999999999999999999997654333
Q ss_pred cceeecccccccccChhhhc-----cCCCCCccceechHHHHHHHHhCCCCCCCC
Q 046750 516 THVSTRVMGTFGYLAPEYAS-----SGKLTDRSDVFSFGVVLLELITGRKPVDPT 565 (723)
Q Consensus 516 ~~~~~~~~gt~~y~APE~~~-----~~~~t~ksDVwSlGviL~eLltG~~P~~~~ 565 (723)
.......+|+..|+|||++. ...++.++|||||||+||||++|+.||...
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~ 211 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (332)
T ss_pred cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC
Confidence 33333457999999999986 346889999999999999999999999754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=346.03 Aligned_cols=264 Identities=22% Similarity=0.336 Sum_probs=190.8
Q ss_pred hcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecc--------c
Q 046750 359 TNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISE--------K 429 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--------~ 429 (723)
.++|.+.++||+|+||.||+|.. ..++.||||++.... ....+|+.+|++++|+|||++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 45799999999999999999965 468899999886432 2345799999999999999998876432 2
Q ss_pred ceEEEEEecCCCchhhcccc--CCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCC-cEEEeecc
Q 046750 430 NRLLIYEFVPNNNLEHHLHG--KGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEF-EAQVADFG 506 (723)
Q Consensus 430 ~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~-~vkL~DFG 506 (723)
.+++||||+.+ +|.+++.. .....+.+..++.++.||+.||+|||++ +|||||||++||||+.++ .+||+|||
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccc
Confidence 35689999964 66665542 2234588889999999999999999999 499999999999999654 79999999
Q ss_pred cccccCCCCcceeecccccccccChhhhccC-CCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhh---hhh
Q 046750 507 LAKLNDTTQTHVSTRVMGTFGYLAPEYASSG-KLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARP---VLV 582 (723)
Q Consensus 507 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~---~l~ 582 (723)
+++.+..... .....|+..|+|||++.+. .++.++|||||||+||||++|..||...... ..+...... ...
T Consensus 217 la~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~--~~~~~i~~~~~~p~~ 292 (440)
T PTZ00036 217 SAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV--DQLVRIIQVLGTPTE 292 (440)
T ss_pred cchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCCH
Confidence 9986543222 2234689999999998764 6999999999999999999999999765321 111111100 000
Q ss_pred hhhh--cCC-----cccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 583 RAIE--TGD-----LSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 583 ~~i~--~~~-----l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
+.+. ... +..+....+...+.......+++|+.+||+.||.+|+++.|+++.
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 0000 000 111111111111222223468899999999999999999999854
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=338.69 Aligned_cols=245 Identities=26% Similarity=0.427 Sum_probs=196.5
Q ss_pred CcccceEEeccCcEEEEEEE-cCCCcEEEEEEcccCCchh---HHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEE
Q 046750 361 GFARENVIGEGGFGCVYKGN-LPEGKVVAVKQLKSGSGQG---EREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYE 436 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~-~~~g~~VAvK~l~~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 436 (723)
.|...+.||+|+||.||.++ ..+.+.||||++.....+. -.++.+|+.+|++|+|||+|.+-|||..+...|||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 36777889999999999994 4567899999987554333 3578899999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCc
Q 046750 437 FVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQT 516 (723)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 516 (723)
|| -|+-.++|.-... .|.+..+..|+.+.+.||+|||++ +.||||||+.||||.+.+.|||+|||.|.+....
T Consensus 107 YC-lGSAsDlleVhkK-plqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA-- 179 (948)
T KOG0577|consen 107 YC-LGSASDLLEVHKK-PLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA-- 179 (948)
T ss_pred HH-hccHHHHHHHHhc-cchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCch--
Confidence 99 6677777654332 478888999999999999999999 5999999999999999999999999999765443
Q ss_pred ceeecccccccccChhhhc---cCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccc
Q 046750 517 HVSTRVMGTFGYLAPEYAS---SGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEI 593 (723)
Q Consensus 517 ~~~~~~~gt~~y~APE~~~---~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~ 593 (723)
..++||+.|||||+|. .|.|+.|+|||||||.+.||.-.+.|+...+.. ..++ +|..++--
T Consensus 180 ---nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM--SALY---------HIAQNesP-- 243 (948)
T KOG0577|consen 180 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALY---------HIAQNESP-- 243 (948)
T ss_pred ---hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH--HHHH---------HHHhcCCC--
Confidence 3467999999999986 478999999999999999999999887544321 1111 12222211
Q ss_pred cchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 594 VDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 594 vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
-|. ..+....+.+++..||++-|.+||+.+++++.
T Consensus 244 ---tLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 244 ---TLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred ---CCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 111 11223357888999999999999999998865
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=323.31 Aligned_cols=265 Identities=23% Similarity=0.332 Sum_probs=194.3
Q ss_pred CcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCch--hHHHHHHHHHHHHHc---cCCceeeEeeeeecc-----c
Q 046750 361 GFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQ--GEREFRAEVEIISRV---HHRHLVSLVGYCISE-----K 429 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~--~~~~~~~Ei~il~~l---~HpnIv~l~g~~~~~-----~ 429 (723)
+|++.+.||+|+||.||+|.. .+++.||||.++..... ....+.+|++++++| +|+||++++++|... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 488899999999999999955 46889999998754222 234566788887776 699999999988642 3
Q ss_pred ceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeeccccc
Q 046750 430 NRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK 509 (723)
Q Consensus 430 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 509 (723)
..++||||+. ++|.+++.......+.+..+..++.||+.||+|||+++ |+|||||++|||+++++.+||+|||+++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCccc
Confidence 4789999996 58888887655556889999999999999999999994 9999999999999999999999999997
Q ss_pred ccCCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhh---hhhhh-
Q 046750 510 LNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPV---LVRAI- 585 (723)
Q Consensus 510 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~---l~~~i- 585 (723)
...... ......|+..|+|||++.+..++.++|||||||+||||++|+.+|...... ..+....... ....+
T Consensus 157 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07863 157 IYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA--DQLGKIFDLIGLPPEDDWP 232 (288)
T ss_pred cccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH--HHHHHHHHHhCCCChhhCc
Confidence 654322 123356889999999999999999999999999999999999998654321 1111110000 00000
Q ss_pred -----hcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 586 -----ETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 586 -----~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
....+.......+ ..........+.+++.+||+.||++||++.|++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 233 RDVTLPRGAFSPRGPRPV-QSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred ccccccccccCCCCCCch-HHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000000000000 00111223457899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=324.71 Aligned_cols=255 Identities=26% Similarity=0.454 Sum_probs=200.8
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCc----EEEEEEcccCC-chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGK----VVAVKQLKSGS-GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLL 433 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~----~VAvK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 433 (723)
++|++.++||+|+||.||+|.+ .+++ .||||+++... ....+++.+|+.+++.++|+||++++++|.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 5688899999999999999964 3444 48999987543 3345678899999999999999999999975 45789
Q ss_pred EEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCC
Q 046750 434 IYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDT 513 (723)
Q Consensus 434 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 513 (723)
++||+.+|+|.++++... ..+.+..++.++.||+.||+|||++ +|+|||||++|||+++++.+||+|||+++....
T Consensus 86 ~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 86 VTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred EEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 999999999999987543 2478899999999999999999998 599999999999999999999999999986643
Q ss_pred CCcce-eecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcc
Q 046750 514 TQTHV-STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLS 591 (723)
Q Consensus 514 ~~~~~-~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~ 591 (723)
..... .....++..|++||++.+..++.++|||||||+||||++ |..||+.... ..+..+ +..+...
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~--------~~~~~~~ 230 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA---REIPDL--------LEKGERL 230 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH--------HHCCCcC
Confidence 32221 112234678999999999999999999999999999998 8899865431 122222 1121111
Q ss_pred cccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccC
Q 046750 592 EIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEG 639 (723)
Q Consensus 592 ~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~ 639 (723)
.. .......+.+++.+||+.||.+||++.+|++.|+.+.
T Consensus 231 ~~---------~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 231 PQ---------PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred CC---------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 11 0112236788999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=322.74 Aligned_cols=249 Identities=29% Similarity=0.463 Sum_probs=194.2
Q ss_pred eEEeccCcEEEEEEEcCC-Cc--EEEEEEcccCC-chhHHHHHHHHHHHHHc-cCCceeeEeeeeecccceEEEEEecCC
Q 046750 366 NVIGEGGFGCVYKGNLPE-GK--VVAVKQLKSGS-GQGEREFRAEVEIISRV-HHRHLVSLVGYCISEKNRLLIYEFVPN 440 (723)
Q Consensus 366 ~~LG~G~fG~Vy~~~~~~-g~--~VAvK~l~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 440 (723)
++||+|+||.||+|.+++ +. .+++|.++... ......+.+|++++.++ +|+||++++++|......++||||+.+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 468999999999997644 43 47889887543 34456788999999999 899999999999999999999999999
Q ss_pred CchhhccccCC--------------CCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecc
Q 046750 441 NNLEHHLHGKG--------------QPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFG 506 (723)
Q Consensus 441 gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFG 506 (723)
|+|.++++... ...+.+..++.++.||+.||+|||+. +|+|||||++|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 99999986432 12478899999999999999999998 59999999999999999999999999
Q ss_pred cccccCCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhh
Q 046750 507 LAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAI 585 (723)
Q Consensus 507 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i 585 (723)
++........ ......+..|+|||++....++.++|||||||+||||++ |..||..... .. +.+.+
T Consensus 158 l~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~---~~--------~~~~~ 224 (270)
T cd05047 158 LSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AE--------LYEKL 224 (270)
T ss_pred Cccccchhhh--ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH---HH--------HHHHH
Confidence 9863321111 111223567999999998899999999999999999997 9999864321 11 11112
Q ss_pred hcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccC
Q 046750 586 ETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEG 639 (723)
Q Consensus 586 ~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~ 639 (723)
..+...+. .......+.+++.+||+.+|.+||++.+|+..|+.+.
T Consensus 225 ~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 225 PQGYRLEK---------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred hCCCCCCC---------CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 11111010 0112235789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=333.30 Aligned_cols=268 Identities=20% Similarity=0.283 Sum_probs=197.3
Q ss_pred HHhcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCC--chhHHHHHHHHHHHHHccCCceeeEeeeeecc-----
Q 046750 357 EITNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS--GQGEREFRAEVEIISRVHHRHLVSLVGYCISE----- 428 (723)
Q Consensus 357 ~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~----- 428 (723)
.+.++|++.+.||+|+||.||++.. ..++.||||++.... ......+.+|+.+++.++|+||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 4568899999999999999999954 468899999987542 23345678899999999999999999988643
Q ss_pred -cceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeeccc
Q 046750 429 -KNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGL 507 (723)
Q Consensus 429 -~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGl 507 (723)
...|+||||+.+ +|.+++.. .+++..++.++.||++||+|||++ +|+|||||++||||+.++.+||+|||+
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCcc
Confidence 246899999954 66666643 367888899999999999999999 599999999999999999999999999
Q ss_pred ccccCCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchh------------hHH
Q 046750 508 AKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDES------------LVE 575 (723)
Q Consensus 508 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~------------l~~ 575 (723)
++...... ......|+..|+|||++.+..++.++|||||||+||||++|+.||.......... +..
T Consensus 166 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (355)
T cd07874 166 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243 (355)
T ss_pred cccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 97654322 2233568999999999999999999999999999999999999997543211000 000
Q ss_pred hhhhhhhhhhhc-CCcccccchhh--------hccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 576 WARPVLVRAIET-GDLSEIVDPRL--------EKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 576 ~~~~~l~~~i~~-~~l~~~vd~~l--------~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
.....+...++. ..+..+..+.+ ...........+.+|+.+||+.||.+||++.||++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred hhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000000000000 00000000000 000111123467899999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=319.12 Aligned_cols=248 Identities=26% Similarity=0.430 Sum_probs=198.9
Q ss_pred eEEeccCcEEEEEEEcCC--C--cEEEEEEcccCCc-hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEecCC
Q 046750 366 NVIGEGGFGCVYKGNLPE--G--KVVAVKQLKSGSG-QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPN 440 (723)
Q Consensus 366 ~~LG~G~fG~Vy~~~~~~--g--~~VAvK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 440 (723)
++||+|+||.||+|.+.+ + ..||||.+..... ...+.|.+|++++++++|+||+++++++.+ ...++||||+.+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999996643 3 3699999987765 556789999999999999999999999988 888999999999
Q ss_pred CchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcce--
Q 046750 441 NNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHV-- 518 (723)
Q Consensus 441 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~-- 518 (723)
++|.+++.......+.+..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 9999999765434689999999999999999999999 59999999999999999999999999998664432221
Q ss_pred eecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchh
Q 046750 519 STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPR 597 (723)
Q Consensus 519 ~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~ 597 (723)
.....++..|++||++.+..++.++|||||||+||||++ |+.||+.... ....... ...+.. +
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~-------~~~~~~--~---- 220 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG---SQILKKI-------DKEGER--L---- 220 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH-------HhcCCc--C----
Confidence 112356789999999999999999999999999999998 9999864322 1111110 001110 0
Q ss_pred hhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 046750 598 LEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALD 636 (723)
Q Consensus 598 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~ 636 (723)
.........+.+++.+||+.+|.+||++.+|++.|.
T Consensus 221 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 ---ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ---CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 001112346889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=338.45 Aligned_cols=260 Identities=21% Similarity=0.266 Sum_probs=197.4
Q ss_pred hcCcccceEEeccCcEEEEEEEcC---CCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEE
Q 046750 359 TNGFARENVIGEGGFGCVYKGNLP---EGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~~---~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 435 (723)
..+|.+.+.||+|+||.||++... .++.||||.+... +.+.+|+++|++|+|+|||++++++......|+||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 457999999999999999999543 3578999988653 34568999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ 515 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 515 (723)
||+ +++|.+++... ..+.+..++.|+.||+.||.|||++ +|||||||++||||+.++.+||+|||+++......
T Consensus 166 e~~-~~~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 166 PKY-KCDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred hhc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 999 46888888433 3588999999999999999999999 59999999999999999999999999997654432
Q ss_pred cc-eeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCc-hhhHHhhhhhhhhhhhcCCcc--
Q 046750 516 TH-VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGD-ESLVEWARPVLVRAIETGDLS-- 591 (723)
Q Consensus 516 ~~-~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~-~~l~~~~~~~l~~~i~~~~l~-- 591 (723)
.. ......|+..|+|||++.+..++.++|||||||+||||++|+.||........ ..+.... +.+....+.
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~-----~~~~~~~~~~~ 314 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSII-----RCMQVHPLEFP 314 (392)
T ss_pred ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHH-----HHhccCccccC
Confidence 22 22345799999999999999999999999999999999999999966443211 1111100 000000000
Q ss_pred -----cc------cchhhhcccc-------HHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 592 -----EI------VDPRLEKHYV-------ESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 592 -----~~------vd~~l~~~~~-------~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
.+ .....+..+. ......+.+++.+||..||++||++.||+..
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 315 QNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred CccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 0000000000 0112356788999999999999999999876
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=319.44 Aligned_cols=240 Identities=23% Similarity=0.383 Sum_probs=188.8
Q ss_pred eEEeccCcEEEEEEEcCC-------------CcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceE
Q 046750 366 NVIGEGGFGCVYKGNLPE-------------GKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRL 432 (723)
Q Consensus 366 ~~LG~G~fG~Vy~~~~~~-------------g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 432 (723)
+.||+|+||.||+|.+.. ...|+||.+..........|..|+.+++.++|+||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999996532 2358999887655555567889999999999999999999999999999
Q ss_pred EEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCc-------EEEeec
Q 046750 433 LIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFE-------AQVADF 505 (723)
Q Consensus 433 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~-------vkL~DF 505 (723)
+||||+.+++|..+++.... .+++..+++|+.||++||+|||++ +|+|||||++||||+.++. +||+||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSD-VLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred EEEecccCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 99999999999988865432 478889999999999999999998 5999999999999987654 899999
Q ss_pred ccccccCCCCcceeecccccccccChhhhc-cCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhh
Q 046750 506 GLAKLNDTTQTHVSTRVMGTFGYLAPEYAS-SGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVR 583 (723)
Q Consensus 506 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~-~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~ 583 (723)
|++...... ....++..|+|||++. +..++.++|||||||+||||++ |+.||....... ..
T Consensus 157 g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~~------ 219 (262)
T cd05077 157 GIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE------KE------ 219 (262)
T ss_pred CCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH------HH------
Confidence 998654322 2235788899999887 4668999999999999999984 778775432110 00
Q ss_pred hhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 046750 584 AIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALD 636 (723)
Q Consensus 584 ~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~ 636 (723)
.+..+.+. +.. .....+.+|+.+||+.||.+||++.+|++.|+
T Consensus 220 ~~~~~~~~-~~~---------~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 220 RFYEGQCM-LVT---------PSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred HHHhcCcc-CCC---------CChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 00111110 111 11235788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=348.07 Aligned_cols=254 Identities=28% Similarity=0.451 Sum_probs=206.9
Q ss_pred cccceEEeccCcEEEEEEEc-CCCc----EEEEEEcccCCc-hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEE
Q 046750 362 FARENVIGEGGFGCVYKGNL-PEGK----VVAVKQLKSGSG-QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 362 f~~~~~LG~G~fG~Vy~~~~-~~g~----~VAvK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 435 (723)
+...++||.|+||.||+|.| .+|+ .||||++..... +...+|+.|+-+|.+|+|+||++|+|+|.... ..||.
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 35678999999999999954 4443 589999876643 44578999999999999999999999998765 78999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ 515 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 515 (723)
+||+.|+|.+|++.++. .+..+..+.|++||++||.|||++ ++|||||..+||||..-..+||.|||+++....+.
T Consensus 777 q~mP~G~LlDyvr~hr~-~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHRD-NIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred HhcccchHHHHHHHhhc-cccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 99999999999987543 578888999999999999999998 69999999999999999999999999999876554
Q ss_pred cceee-cccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccc
Q 046750 516 THVST-RVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEI 593 (723)
Q Consensus 516 ~~~~~-~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~ 593 (723)
..... ...-...|||-|.+....|+.++|||||||.+||||| |..|++.....+ +.+.++.|+
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e-----------I~dlle~ge---- 917 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE-----------IPDLLEKGE---- 917 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH-----------hhHHHhccc----
Confidence 43322 2234568999999999999999999999999999999 999997654321 222223332
Q ss_pred cchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCC
Q 046750 594 VDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGE 640 (723)
Q Consensus 594 vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~ 640 (723)
|| .-.+.....++.++.+||..|+..||.++++...+..+..
T Consensus 918 ---RL--sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 918 ---RL--SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred ---cC--CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 12 2234455678899999999999999999999988866543
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=322.27 Aligned_cols=257 Identities=26% Similarity=0.388 Sum_probs=203.4
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCC-chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEe
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS-GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEF 437 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 437 (723)
++|++.+.||+|+||.||++.. .+++.||+|++.... ....+.+.+|+++++.++|+||+++++++......+|||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 4678889999999999999955 468899999886543 33456789999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcc
Q 046750 438 VPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTH 517 (723)
Q Consensus 438 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 517 (723)
+.+++|.+++...+ .+.+..+..++.+++.+|.|||+.. +|+|||||++|||+++++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-- 158 (284)
T cd06620 85 MDCGSLDRIYKKGG--PIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-- 158 (284)
T ss_pred CCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhc--
Confidence 99999999887643 4788999999999999999999742 59999999999999999999999999986542221
Q ss_pred eeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCc-----hhhHHhhhhhhhhhhhcCCccc
Q 046750 518 VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGD-----ESLVEWARPVLVRAIETGDLSE 592 (723)
Q Consensus 518 ~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~-----~~l~~~~~~~l~~~i~~~~l~~ 592 (723)
.....|+..|++||++.++.++.++|||||||++|||++|+.||.......+ ..+.++.. .+......
T Consensus 159 -~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~- 231 (284)
T cd06620 159 -ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQ-----QIVQEPPP- 231 (284)
T ss_pred -cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHH-----HHhhccCC-
Confidence 1234689999999999988999999999999999999999999976543211 11112211 11111110
Q ss_pred ccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 046750 593 IVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALD 636 (723)
Q Consensus 593 ~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~ 636 (723)
.+.. ......+.+++.+||+.||.+||++.||++++.
T Consensus 232 ----~~~~---~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~ 268 (284)
T cd06620 232 ----RLPS---SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP 268 (284)
T ss_pred ----CCCc---hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 1100 112346788999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=319.42 Aligned_cols=247 Identities=29% Similarity=0.513 Sum_probs=199.8
Q ss_pred cCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEecC
Q 046750 360 NGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVP 439 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 439 (723)
++|.+.++||+|+||.||++.. .++.||+|+++... ....+.+|+.++++++|+||+++++++... ..++||||+.
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4588999999999999999975 67889999987542 345788999999999999999999998754 4799999999
Q ss_pred CCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCccee
Q 046750 440 NNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVS 519 (723)
Q Consensus 440 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 519 (723)
+++|.+++.......+.+..++.++.|++.||.|||+. +++|||||++|||++.++.+||+|||++.......
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---- 154 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---- 154 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC----
Confidence 99999999766555688999999999999999999998 59999999999999999999999999987543221
Q ss_pred ecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhh
Q 046750 520 TRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRL 598 (723)
Q Consensus 520 ~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l 598 (723)
........|++||++.++.++.++|||||||++|||++ |+.||..... .++ ...+..+.....
T Consensus 155 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------~~~-----~~~~~~~~~~~~----- 218 (254)
T cd05083 155 DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL------KEV-----KECVEKGYRMEP----- 218 (254)
T ss_pred CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH------HHH-----HHHHhCCCCCCC-----
Confidence 12234567999999998999999999999999999998 8999865431 111 112222211111
Q ss_pred hccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhc
Q 046750 599 EKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDS 637 (723)
Q Consensus 599 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~ 637 (723)
.......+.+++.+||+.+|.+||++.+|+..|+.
T Consensus 219 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 219 ----PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred ----CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 11123467899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=317.72 Aligned_cols=257 Identities=23% Similarity=0.332 Sum_probs=200.7
Q ss_pred HHHhcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEE
Q 046750 356 MEITNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLI 434 (723)
Q Consensus 356 ~~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 434 (723)
+..++++....+||+|+||.||+|.+ .+++.|+||.+........+.+.+|++++++++|+||+++++++..++..++|
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 34456677778999999999999964 45788999998876666677899999999999999999999999999999999
Q ss_pred EEecCCCchhhccccCCCC-cchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCC-CCcEEEeecccccccC
Q 046750 435 YEFVPNNNLEHHLHGKGQP-VLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDD-EFEAQVADFGLAKLND 512 (723)
Q Consensus 435 ~E~~~~gsL~~~l~~~~~~-~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~-~~~vkL~DFGla~~~~ 512 (723)
|||+.+++|.++++..... ..++..+..++.||+.||+|||+. +|+|||||++||||+. ++.+||+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 9999999999998754221 227788889999999999999998 5999999999999986 6799999999987554
Q ss_pred CCCcceeecccccccccChhhhccCC--CCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCc
Q 046750 513 TTQTHVSTRVMGTFGYLAPEYASSGK--LTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDL 590 (723)
Q Consensus 513 ~~~~~~~~~~~gt~~y~APE~~~~~~--~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l 590 (723)
.... ......|+..|+|||++.+.. ++.++|||||||+||||++|+.||..... .....|..... +.
T Consensus 161 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~---~~~~~~~~~~~------~~- 229 (268)
T cd06624 161 GINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGE---PQAAMFKVGMF------KI- 229 (268)
T ss_pred cCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccC---hhhhHhhhhhh------cc-
Confidence 3222 122335788999999987654 78899999999999999999999865321 11111111000 00
Q ss_pred ccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 591 SEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 591 ~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
...+.......+.+++.+||+.+|.+||++.||++.
T Consensus 230 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 230 --------HPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred --------CCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 011111223457889999999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=319.07 Aligned_cols=253 Identities=25% Similarity=0.404 Sum_probs=199.8
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEec
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFV 438 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 438 (723)
++|.+.+.||+|+||.||+|.. .+++.||||+++.........+.+|+.+++.++|+||+++++++.+.+..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 4688889999999999999954 568899999988765555567889999999999999999999999999999999999
Q ss_pred CCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcce
Q 046750 439 PNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHV 518 (723)
Q Consensus 439 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 518 (723)
.+++|.+++...+ .+++..++.++.||+.||.|||++ +|+|+|||++|||++.++.+||+|||++....... ..
T Consensus 89 ~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~~ 162 (267)
T cd06645 89 GGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-AK 162 (267)
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-cc
Confidence 9999999987554 478899999999999999999999 59999999999999999999999999987554321 11
Q ss_pred eecccccccccChhhhc---cCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccc
Q 046750 519 STRVMGTFGYLAPEYAS---SGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVD 595 (723)
Q Consensus 519 ~~~~~gt~~y~APE~~~---~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd 595 (723)
.....|+..|+|||++. ...++.++|||||||+||||++|+.||........ +.. +....+..
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~--~~~---------~~~~~~~~--- 228 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--LFL---------MTKSNFQP--- 228 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh--HHh---------hhccCCCC---
Confidence 23346899999999984 45688999999999999999999999864432111 000 00011100
Q ss_pred hhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 596 PRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 596 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
+.+.... .....+.+++.+||..+|++||++.+|++.
T Consensus 229 ~~~~~~~--~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 229 PKLKDKM--KWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred CcccccC--CCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 0000000 012357789999999999999999998763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=325.07 Aligned_cols=196 Identities=26% Similarity=0.414 Sum_probs=159.3
Q ss_pred ceEEeccCcEEEEEEEcC---CCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeec--ccceEEEEEecC
Q 046750 365 ENVIGEGGFGCVYKGNLP---EGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCIS--EKNRLLIYEFVP 439 (723)
Q Consensus 365 ~~~LG~G~fG~Vy~~~~~---~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~~~lV~E~~~ 439 (723)
.++||+|+||.||+|+.+ +++.||||+++... ....+.+|+++|++++|+||+++++++.. ....|+||||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~- 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA- 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc-
Confidence 468999999999999754 46789999987542 23457889999999999999999998864 45578999998
Q ss_pred CCchhhccccC-------CCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEe----CCCCcEEEeecccc
Q 046750 440 NNNLEHHLHGK-------GQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILV----DDEFEAQVADFGLA 508 (723)
Q Consensus 440 ~gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl----~~~~~vkL~DFGla 508 (723)
+++|.+++... ....+.+..+..|+.||+.||+|||++ +|+|||||++|||| +.++.+||+|||++
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 83 EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 45777766421 122478888999999999999999999 49999999999999 45678999999999
Q ss_pred cccCCCCcc--eeecccccccccChhhhccC-CCCCccceechHHHHHHHHhCCCCCCCCC
Q 046750 509 KLNDTTQTH--VSTRVMGTFGYLAPEYASSG-KLTDRSDVFSFGVVLLELITGRKPVDPTQ 566 (723)
Q Consensus 509 ~~~~~~~~~--~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSlGviL~eLltG~~P~~~~~ 566 (723)
+........ ......|+..|+|||++.+. .++.++|||||||+||||++|+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 866433221 12345789999999999774 58999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=324.08 Aligned_cols=251 Identities=21% Similarity=0.366 Sum_probs=203.1
Q ss_pred hcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEe
Q 046750 359 TNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEF 437 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 437 (723)
.++|.+.+.||+|+||.||+|.. .+++.||||.+........+.+.+|+.+++.++|+||++++++|...+..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 36789999999999999999964 57899999999766555566788999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcc
Q 046750 438 VPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTH 517 (723)
Q Consensus 438 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 517 (723)
+.+++|.+++.+. .+.+..++.++.+++.+|.|||+. +|+|||||++|||++.++.++|+|||++.........
T Consensus 98 ~~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 171 (297)
T cd06656 98 LAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (297)
T ss_pred cCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCccC
Confidence 9999999998643 378889999999999999999998 5999999999999999999999999998765433221
Q ss_pred eeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchh
Q 046750 518 VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPR 597 (723)
Q Consensus 518 ~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~ 597 (723)
.....++..|++||++.+..++.++|||||||+||+|++|+.||........ +. . +..+....+.
T Consensus 172 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~--~~--------~-~~~~~~~~~~--- 236 (297)
T cd06656 172 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LY--------L-IATNGTPELQ--- 236 (297)
T ss_pred -cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh--ee--------e-eccCCCCCCC---
Confidence 2234578899999999998999999999999999999999999965433110 00 0 0000000000
Q ss_pred hhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 598 LEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 598 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
........+.+++.+||+.+|.+||++.+|++.
T Consensus 237 ----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 237 ----NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred ----CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011122356789999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=317.60 Aligned_cols=251 Identities=26% Similarity=0.406 Sum_probs=187.7
Q ss_pred EEeccCcEEEEEEEcCC---CcEEEEEEcccCC-chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEecCCCc
Q 046750 367 VIGEGGFGCVYKGNLPE---GKVVAVKQLKSGS-GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNN 442 (723)
Q Consensus 367 ~LG~G~fG~Vy~~~~~~---g~~VAvK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gs 442 (723)
.||+|+||.||+|...+ ...|+||.+.... ......|.+|+++++.++|+||++++++|.+....++||||+.+|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999996543 3468888876543 2334578899999999999999999999999999999999999999
Q ss_pred hhhccccCCC---CcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcc-e
Q 046750 443 LEHHLHGKGQ---PVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTH-V 518 (723)
Q Consensus 443 L~~~l~~~~~---~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~-~ 518 (723)
|.+++..... ..+.+...+.++.||++||+|||++ +|+|||||+.||||++++.+||+|||+++........ .
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 9999865432 2346778889999999999999999 5999999999999999999999999998654322211 1
Q ss_pred eecccccccccChhhhcc-------CCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCc
Q 046750 519 STRVMGTFGYLAPEYASS-------GKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDL 590 (723)
Q Consensus 519 ~~~~~gt~~y~APE~~~~-------~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l 590 (723)
.....++..|+|||++.. ..++.++|||||||+||||++ |..||..... ... +...+..+.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~---~~~-------~~~~~~~~~- 227 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD---EQV-------LKQVVREQD- 227 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH---HHH-------HHHHhhccC-
Confidence 222345678999998753 356889999999999999999 7788864321 111 111111111
Q ss_pred ccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 046750 591 SEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALD 636 (723)
Q Consensus 591 ~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~ 636 (723)
..+.++.+...+ ...+.+++..|| .||++||++.+|++.|.
T Consensus 228 ~~~~~~~~~~~~----~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 228 IKLPKPQLDLKY----SDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred ccCCCCcccccC----CHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 122222222222 234566777888 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=321.30 Aligned_cols=266 Identities=26% Similarity=0.378 Sum_probs=204.6
Q ss_pred cCcccceEEeccCcEEEEEEEcC-----CCcEEEEEEcccCCch-hHHHHHHHHHHHHHccCCceeeEeeeeec--ccce
Q 046750 360 NGFARENVIGEGGFGCVYKGNLP-----EGKVVAVKQLKSGSGQ-GEREFRAEVEIISRVHHRHLVSLVGYCIS--EKNR 431 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~-----~g~~VAvK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~~ 431 (723)
+.|++.+.||+|+||.||++.+. .++.||||+++..... ...+|.+|++++++++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 35777899999999999999753 3678999999866443 45689999999999999999999999887 5578
Q ss_pred EEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeeccccccc
Q 046750 432 LLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLN 511 (723)
Q Consensus 432 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 511 (723)
++||||+.+++|.+++..... .+++..++.++.||+.||+|||++ +|+|||||+.|||++.++.++|+|||++...
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRD-QINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred EEEEecCCCCCHHHHHHhCcc-ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 999999999999999976543 489999999999999999999998 4999999999999999999999999999876
Q ss_pred CCCCcce--eecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchh----hHHhhhhhhhhhh
Q 046750 512 DTTQTHV--STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDES----LVEWARPVLVRAI 585 (723)
Q Consensus 512 ~~~~~~~--~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~----l~~~~~~~l~~~i 585 (723)
....... .....+...|++||++.+..++.++|||||||++|||++|+.|+.......... ...+....+.+.+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL 239 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH
Confidence 5322211 112235567999999998899999999999999999999999885432111000 0000011111111
Q ss_pred hcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhcc
Q 046750 586 ETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSE 638 (723)
Q Consensus 586 ~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~ 638 (723)
..+. ...........+.+++.+||+.+|.+||+|.||+++|+.+
T Consensus 240 ~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 240 KEGE---------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HcCC---------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1111 0001111224688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=315.84 Aligned_cols=238 Identities=25% Similarity=0.416 Sum_probs=189.6
Q ss_pred eEEeccCcEEEEEEEcCCCc-----------EEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEE
Q 046750 366 NVIGEGGFGCVYKGNLPEGK-----------VVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLI 434 (723)
Q Consensus 366 ~~LG~G~fG~Vy~~~~~~g~-----------~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 434 (723)
++||+|+||.||+|.+.+.. .|++|.++..... ...|.+|+++|++++|+||++++++|.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46899999999999765432 5788887654333 6788999999999999999999999988 778999
Q ss_pred EEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCC-------cEEEeeccc
Q 046750 435 YEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEF-------EAQVADFGL 507 (723)
Q Consensus 435 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~-------~vkL~DFGl 507 (723)
|||+.+|+|.+++..... .+++..++.++.||+.||+|||++ +|+|||||++||||+.++ .+||+|||+
T Consensus 79 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 999999999999976543 578889999999999999999998 599999999999999887 799999999
Q ss_pred ccccCCCCcceeecccccccccChhhhccC--CCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhh
Q 046750 508 AKLNDTTQTHVSTRVMGTFGYLAPEYASSG--KLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRA 584 (723)
Q Consensus 508 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~--~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~ 584 (723)
+..... .....+...|+|||++.+. .++.++|||||||++|||++ |..||....... ...+.
T Consensus 155 a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~---~~~~~------- 219 (259)
T cd05037 155 PITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE---KERFY------- 219 (259)
T ss_pred cccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh---HHHHH-------
Confidence 976543 1123467789999999877 78999999999999999999 567775543211 11111
Q ss_pred hhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 046750 585 IETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALD 636 (723)
Q Consensus 585 i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~ 636 (723)
......... ....+.+++.+||..+|.+||++.+|++.|+
T Consensus 220 -~~~~~~~~~-----------~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 220 -QDQHRLPMP-----------DCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred -hcCCCCCCC-----------CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 011100000 0157889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=329.51 Aligned_cols=259 Identities=27% Similarity=0.422 Sum_probs=203.6
Q ss_pred cCcccceEEeccCcEEEEEEEcC--------CCcEEEEEEcccCC-chhHHHHHHHHHHHHHc-cCCceeeEeeeeeccc
Q 046750 360 NGFARENVIGEGGFGCVYKGNLP--------EGKVVAVKQLKSGS-GQGEREFRAEVEIISRV-HHRHLVSLVGYCISEK 429 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~--------~g~~VAvK~l~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~ 429 (723)
.+|.+.+.||+|+||.||++... .+..||+|.++... ....+++.+|+++++++ +|+||++++++|.+.+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 45889999999999999999532 12368999987543 23446789999999999 7999999999999999
Q ss_pred ceEEEEEecCCCchhhccccCC--------------CCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeC
Q 046750 430 NRLLIYEFVPNNNLEHHLHGKG--------------QPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVD 495 (723)
Q Consensus 430 ~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~ 495 (723)
..++||||+.+|+|.++|.... ...+.+..++.++.||+.||+|||++ +|+|||||++||||+
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEc
Confidence 9999999999999999986432 23478889999999999999999998 599999999999999
Q ss_pred CCCcEEEeecccccccCCCCcce-eecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhh
Q 046750 496 DEFEAQVADFGLAKLNDTTQTHV-STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESL 573 (723)
Q Consensus 496 ~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l 573 (723)
+++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||+||||++ |..||.... .
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~------~ 242 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP------V 242 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC------H
Confidence 99999999999997654332211 111234567999999999999999999999999999998 888886432 1
Q ss_pred HHhhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCCC
Q 046750 574 VEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEM 641 (723)
Q Consensus 574 ~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~~ 641 (723)
.++. +.+..+....+ .......+.+++.+||+.+|.+||++.+|++.|+.+...
T Consensus 243 ~~~~-----~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~ 296 (334)
T cd05100 243 EELF-----KLLKEGHRMDK---------PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV 296 (334)
T ss_pred HHHH-----HHHHcCCCCCC---------CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence 1111 11222211111 112234688999999999999999999999999887644
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=317.72 Aligned_cols=249 Identities=25% Similarity=0.465 Sum_probs=199.1
Q ss_pred CcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCc------hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEE
Q 046750 361 GFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSG------QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLI 434 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~------~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 434 (723)
+|.+.+.||+|+||.||+|...+++.||||+++.... .....+.+|+++|++++|+||++++++|.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4788899999999999999887899999999864321 1234688999999999999999999999999999999
Q ss_pred EEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCC
Q 046750 435 YEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTT 514 (723)
Q Consensus 435 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 514 (723)
|||+.+++|.+++.+.. .+.+..+..++.||+.||+|||+. +|+|+||+++|||+++++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 81 MEFVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred EecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 99999999999997543 378888999999999999999998 4999999999999999999999999998754321
Q ss_pred C-----cceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhc-C
Q 046750 515 Q-----THVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIET-G 588 (723)
Q Consensus 515 ~-----~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~-~ 588 (723)
. ........|+..|++||++.+..++.++|||||||++|||++|+.||....... .. ...... +
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-----~~-----~~~~~~~~ 225 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA-----AM-----FYIGAHRG 225 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH-----HH-----HHhhhccC
Confidence 1 111223458899999999999899999999999999999999999997543211 00 000000 1
Q ss_pred CcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 046750 589 DLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVR 633 (723)
Q Consensus 589 ~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~ 633 (723)
.+.. +... ....+.+++.+||+.+|.+||++.+|++
T Consensus 226 ~~~~-----~~~~----~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 226 LMPR-----LPDS----FSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCCC-----CCCC----CCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1111 1111 2335788999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=321.49 Aligned_cols=252 Identities=23% Similarity=0.385 Sum_probs=200.1
Q ss_pred cCcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEec
Q 046750 360 NGFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFV 438 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 438 (723)
++|++.++||+|+||.||+|+.. +++.|++|++........+.+.+|++++++++|+||++++++|..+...++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56889999999999999999664 48899999998766666778999999999999999999999999999999999999
Q ss_pred CCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcce
Q 046750 439 PNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHV 518 (723)
Q Consensus 439 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 518 (723)
.+++|..++.+.. ..+.+..++.++.||+++|+|||++ +|+|||||++|||++.++.+||+|||++........ .
T Consensus 92 ~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~-~ 166 (292)
T cd06644 92 PGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ-R 166 (292)
T ss_pred CCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccccc-c
Confidence 9999988876543 2478899999999999999999998 599999999999999999999999999865432211 1
Q ss_pred eecccccccccChhhhc-----cCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccc
Q 046750 519 STRVMGTFGYLAPEYAS-----SGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEI 593 (723)
Q Consensus 519 ~~~~~gt~~y~APE~~~-----~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~ 593 (723)
.....++..|+|||++. ...++.++|||||||++|||++|+.||...... ..+. + +.......+
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--~~~~--------~-~~~~~~~~~ 235 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM--RVLL--------K-IAKSEPPTL 235 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH--HHHH--------H-HhcCCCccC
Confidence 22345788999999885 345788999999999999999999998654321 1111 1 111111111
Q ss_pred cchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 594 VDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 594 vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
.. .......+.+++.+||+.+|++||++.+|++.
T Consensus 236 ~~-------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 236 SQ-------PSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred CC-------CcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00 11122357889999999999999999999764
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=328.62 Aligned_cols=199 Identities=18% Similarity=0.276 Sum_probs=165.4
Q ss_pred cceEEecc--CcEEEEEEEc-CCCcEEEEEEcccCC--chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEec
Q 046750 364 RENVIGEG--GFGCVYKGNL-PEGKVVAVKQLKSGS--GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFV 438 (723)
Q Consensus 364 ~~~~LG~G--~fG~Vy~~~~-~~g~~VAvK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 438 (723)
++++||+| +|+.||++.. .+|+.||||+++... ....+.+++|+++++.++|+||++++++|..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 7889999954 568999999997542 233456788999999999999999999999999999999999
Q ss_pred CCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcc-
Q 046750 439 PNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTH- 517 (723)
Q Consensus 439 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~- 517 (723)
.+|+|.+++.......+++..++.++.||+.||+|||++ +|+|||||++||||+.++.++|+||+...........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 999999999665444588999999999999999999998 5999999999999999999999999875432211110
Q ss_pred -----eeecccccccccChhhhcc--CCCCCccceechHHHHHHHHhCCCCCCCC
Q 046750 518 -----VSTRVMGTFGYLAPEYASS--GKLTDRSDVFSFGVVLLELITGRKPVDPT 565 (723)
Q Consensus 518 -----~~~~~~gt~~y~APE~~~~--~~~t~ksDVwSlGviL~eLltG~~P~~~~ 565 (723)
......++..|+|||++.+ ..++.++|||||||+||||++|+.||...
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 213 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 213 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 0112346778999999976 35899999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=315.23 Aligned_cols=250 Identities=26% Similarity=0.423 Sum_probs=202.4
Q ss_pred cCcccceEEeccCcEEEEEEEcCC-CcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEec
Q 046750 360 NGFARENVIGEGGFGCVYKGNLPE-GKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFV 438 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 438 (723)
++|+..+.||+|+||.||+|.+.+ ++.|++|.++.... ..++.+|++++++++|+||+++++++.+....|+|+||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 578899999999999999997655 78999999876432 678999999999999999999999999999999999999
Q ss_pred CCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcce
Q 046750 439 PNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHV 518 (723)
Q Consensus 439 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 518 (723)
.+++|.+++.... ..+++..++.++.||++||.|||+. +|+||||++.||++++++.+||+|||++........ .
T Consensus 81 ~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~ 155 (256)
T cd06612 81 GAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-K 155 (256)
T ss_pred CCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc-c
Confidence 9999999986543 3578999999999999999999998 599999999999999999999999999976543321 2
Q ss_pred eecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhh
Q 046750 519 STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRL 598 (723)
Q Consensus 519 ~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l 598 (723)
.....++..|++||++.+..++.++|||||||++|||++|+.||........ ... +...... .+
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~--~~~---------~~~~~~~-----~~ 219 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA--IFM---------IPNKPPP-----TL 219 (256)
T ss_pred cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh--hhh---------hccCCCC-----CC
Confidence 2234578899999999999999999999999999999999999975432110 000 0000000 00
Q ss_pred hccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 599 EKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 599 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
.........+.+++.+||+.+|.+||++.||++.
T Consensus 220 --~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 220 --SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred --CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 0111122367889999999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=318.85 Aligned_cols=251 Identities=23% Similarity=0.371 Sum_probs=188.5
Q ss_pred EEeccCcEEEEEEEcCCC---cEEEEEEcccCC-chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEecCCCc
Q 046750 367 VIGEGGFGCVYKGNLPEG---KVVAVKQLKSGS-GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNN 442 (723)
Q Consensus 367 ~LG~G~fG~Vy~~~~~~g---~~VAvK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gs 442 (723)
.||+|+||.||+|++.++ ..+++|.++... ....+.|.+|+++++.++|+||++++++|.+....|+||||+.+|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 589999999999965443 346677766543 2345689999999999999999999999999999999999999999
Q ss_pred hhhccccCC--CCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCC-ccee
Q 046750 443 LEHHLHGKG--QPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ-THVS 519 (723)
Q Consensus 443 L~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~ 519 (723)
|.+++++.. ...+.+..++.++.||++||+|||+. +|+|||||++|||++.++.+||+|||++....... ....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 999987542 23456677889999999999999998 59999999999999999999999999986432111 1122
Q ss_pred ecccccccccChhhhcc-------CCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcc
Q 046750 520 TRVMGTFGYLAPEYASS-------GKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLS 591 (723)
Q Consensus 520 ~~~~gt~~y~APE~~~~-------~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~ 591 (723)
....++..|+|||++.. ..++.++|||||||++|||++ |..||..... . ++.. .+..+...
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~---~---~~~~-----~~~~~~~~ 227 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD---R---EVLN-----HVIKDQQV 227 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH---H---HHHH-----HHHhhccc
Confidence 33567889999998853 245789999999999999997 4667754321 1 1111 11112223
Q ss_pred cccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 046750 592 EIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALD 636 (723)
Q Consensus 592 ~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~ 636 (723)
.+.++.+...+. ..+.+++..|| .+|++||++.+|++.|-
T Consensus 228 ~~~~~~~~~~~~----~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 228 KLFKPQLELPYS----ERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred ccCCCccCCCCc----HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 333444433333 35677888899 67999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=331.15 Aligned_cols=251 Identities=22% Similarity=0.390 Sum_probs=202.4
Q ss_pred cCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccC--CchhHHHHHHHHHHHHHcc-CCceeeEeeeeecccceEEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSG--SGQGEREFRAEVEIISRVH-HRHLVSLVGYCISEKNRLLIYE 436 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~--~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~E 436 (723)
..|+++++||.||-+.||++...+.+.||+|++... +.+....|..|+.+|.+|+ |.+||+|++|-..++.+|||||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 458889999999999999998888899999886543 4455567999999999994 9999999999999999999999
Q ss_pred ecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCc
Q 046750 437 FVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQT 516 (723)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 516 (723)
|- ..+|.++|........+| .+..+..||+.++.++|.+| |||.||||.|+||.+. .+||+|||+|..+..+..
T Consensus 441 ~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVkG-~LKLIDFGIA~aI~~DTT 514 (677)
T KOG0596|consen 441 CG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVKG-RLKLIDFGIANAIQPDTT 514 (677)
T ss_pred cc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEee-eEEeeeechhcccCcccc
Confidence 76 779999998877666667 67788999999999999995 9999999999999875 899999999987776555
Q ss_pred ce-eecccccccccChhhhccCC-----------CCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhh
Q 046750 517 HV-STRVMGTFGYLAPEYASSGK-----------LTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRA 584 (723)
Q Consensus 517 ~~-~~~~~gt~~y~APE~~~~~~-----------~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~ 584 (723)
.. ....+||+.||+||.+.... .+.++||||||||||+|+.|+.||.... --|++
T Consensus 515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-------n~~aK------ 581 (677)
T KOG0596|consen 515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-------NQIAK------ 581 (677)
T ss_pred ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-------HHHHH------
Confidence 43 45578999999999886543 4568999999999999999999996432 12332
Q ss_pred hhcCCcccccchhhhccccHH-HHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 585 IETGDLSEIVDPRLEKHYVES-EMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 585 i~~~~l~~~vd~~l~~~~~~~-~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
+..|.|+.-+-+|... .-..++++|+.||.+||++|+++.+||+.
T Consensus 582 -----l~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 582 -----LHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred -----HHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 2333333222222111 11138999999999999999999999864
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=319.55 Aligned_cols=252 Identities=24% Similarity=0.389 Sum_probs=198.8
Q ss_pred cccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEecCC
Q 046750 362 FARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPN 440 (723)
Q Consensus 362 f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 440 (723)
|++.+.||+|+||.||+|... .+..|++|.+..........+.+|++++++++|+||++++++|...+..++||||+.+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 567789999999999999654 4778899998766555667789999999999999999999999999999999999999
Q ss_pred CchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcceee
Q 046750 441 NNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVST 520 (723)
Q Consensus 441 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 520 (723)
++|..++.+.. ..+.+..++.++.||++||+|||+. +|+|||||++|||++.++.+||+|||++........ ...
T Consensus 87 ~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~~~ 161 (282)
T cd06643 87 GAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RRD 161 (282)
T ss_pred CcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccccc-ccc
Confidence 99998876533 2588999999999999999999998 599999999999999999999999999875433221 223
Q ss_pred cccccccccChhhhc-----cCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccc
Q 046750 521 RVMGTFGYLAPEYAS-----SGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVD 595 (723)
Q Consensus 521 ~~~gt~~y~APE~~~-----~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd 595 (723)
...++..|++||++. +..++.++|||||||+||||++|+.||...... ..... +.......+..
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~~---------~~~~~~~~~~~ 230 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM--RVLLK---------IAKSEPPTLAQ 230 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH--HHHHH---------HhhcCCCCCCC
Confidence 346889999999984 445788999999999999999999998654321 11111 11111111111
Q ss_pred hhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 046750 596 PRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALD 636 (723)
Q Consensus 596 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~ 636 (723)
+ .. ....+.+++.+||+.+|.+||++.+|++.-.
T Consensus 231 ~---~~----~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 264 (282)
T cd06643 231 P---SR----WSSEFKDFLKKCLEKNVDARWTTTQLLQHPF 264 (282)
T ss_pred c---cc----cCHHHHHHHHHHccCChhhCcCHHHHhcCCC
Confidence 1 11 1236788999999999999999999886543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=313.96 Aligned_cols=250 Identities=22% Similarity=0.364 Sum_probs=200.0
Q ss_pred CcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCC--chhHHHHHHHHHHHHHccCCceeeEeeeeec-ccceEEEEE
Q 046750 361 GFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS--GQGEREFRAEVEIISRVHHRHLVSLVGYCIS-EKNRLLIYE 436 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~~~~lV~E 436 (723)
+|++.+.||+|+||.||++.. .+++.||||++.... ....+.+..|++++++++|+||+++++.+.. +...|+|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 488999999999999999954 457889999986542 2344568899999999999999999998764 445789999
Q ss_pred ecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCc
Q 046750 437 FVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQT 516 (723)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 516 (723)
|+.+++|.+++.......+.+.+++.++.+|+.||+|||+. +|+|||||++|||+++++.++|+|||++........
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 99999999999765445689999999999999999999999 499999999999999999999999999976543222
Q ss_pred ceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccch
Q 046750 517 HVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDP 596 (723)
Q Consensus 517 ~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~ 596 (723)
......++..|+|||++.+..++.++|||||||++|||++|+.||+.... ..+. ..+..+.+..
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~------~~~~-----~~~~~~~~~~---- 221 (257)
T cd08223 158 -MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM------NSLV-----YRIIEGKLPP---- 221 (257)
T ss_pred -ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHH-----HHHHhcCCCC----
Confidence 22334588899999999999999999999999999999999999874321 1111 1111222211
Q ss_pred hhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 597 RLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 597 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
........+.+++.+||+.+|.+||++.+|++.
T Consensus 222 -----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 222 -----MPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred -----CccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 111223468899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=330.81 Aligned_cols=266 Identities=20% Similarity=0.281 Sum_probs=196.6
Q ss_pred HHhcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCC--chhHHHHHHHHHHHHHccCCceeeEeeeeecc-----
Q 046750 357 EITNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS--GQGEREFRAEVEIISRVHHRHLVSLVGYCISE----- 428 (723)
Q Consensus 357 ~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~----- 428 (723)
.+.++|.+.+.||+|+||.||++.. ..++.||||++.... ......+.+|+.+++.++|+||+++++++...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 3457899999999999999999954 568899999987542 23345788999999999999999999987643
Q ss_pred -cceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeeccc
Q 046750 429 -KNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGL 507 (723)
Q Consensus 429 -~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGl 507 (723)
...|+||||+. ++|.+++.. .+++..++.++.||++||+|||++ +|+|||||++||||+.++.+||+|||+
T Consensus 101 ~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 101 FQDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred cCeEEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCC
Confidence 34699999995 467666643 367888899999999999999998 599999999999999999999999999
Q ss_pred ccccCCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhh----------
Q 046750 508 AKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWA---------- 577 (723)
Q Consensus 508 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~---------- 577 (723)
++...... ......|+..|+|||++.+..++.++|||||||+||||++|+.||....... .+....
T Consensus 173 a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~ 248 (364)
T cd07875 173 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID--QWNKVIEQLGTPCPEF 248 (364)
T ss_pred ccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCCHHH
Confidence 97654322 1233468999999999999999999999999999999999999997543211 000000
Q ss_pred ----hhhhhhhhhc-CCccc-----ccchhh---hccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 578 ----RPVLVRAIET-GDLSE-----IVDPRL---EKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 578 ----~~~l~~~i~~-~~l~~-----~vd~~l---~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
...+...+.. ..+.. +....+ ...........+.+|+.+||+.||.+||++.|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 249 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000000000 00000 000000 000111122367899999999999999999999875
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=320.99 Aligned_cols=261 Identities=25% Similarity=0.375 Sum_probs=201.4
Q ss_pred HHHHHHHhcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCchhHHHHHHHHHHHHHc-cCCceeeEeeeee---
Q 046750 352 YEELMEITNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQGEREFRAEVEIISRV-HHRHLVSLVGYCI--- 426 (723)
Q Consensus 352 ~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~--- 426 (723)
++.+..+.++|++.+.||+|+||.||++.. ..++.||||+++... ....++.+|+.+++++ +|+||++++++|.
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 455666788999999999999999999955 457899999886532 2345788999999999 6999999999884
Q ss_pred --cccceEEEEEecCCCchhhccccC--CCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEE
Q 046750 427 --SEKNRLLIYEFVPNNNLEHHLHGK--GQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQV 502 (723)
Q Consensus 427 --~~~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL 502 (723)
.++..++||||+++++|.++++.. ....+++..++.++.||++||.|||++ +|+|||||++||++++++.+||
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl 165 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKL 165 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEE
Confidence 345689999999999999887532 233578888999999999999999998 5999999999999999999999
Q ss_pred eecccccccCCCCcceeecccccccccChhhhcc-----CCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhh
Q 046750 503 ADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASS-----GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWA 577 (723)
Q Consensus 503 ~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~ 577 (723)
+|||+++....... ......|+..|+|||++.. ..++.++|||||||++|||++|+.||....... .+..
T Consensus 166 ~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~--~~~~-- 240 (286)
T cd06638 166 VDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR--ALFK-- 240 (286)
T ss_pred ccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH--HHhh--
Confidence 99999976543222 1223458999999998853 447889999999999999999999987543211 0100
Q ss_pred hhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 046750 578 RPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRAL 635 (723)
Q Consensus 578 ~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L 635 (723)
+..+....+.++. . ....+.+++.+||+.+|.+||++.||++.+
T Consensus 241 -------~~~~~~~~~~~~~---~----~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 241 -------IPRNPPPTLHQPE---L----WSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred -------ccccCCCcccCCC---C----cCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 1111111111111 1 123578899999999999999999999865
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=326.82 Aligned_cols=252 Identities=23% Similarity=0.305 Sum_probs=200.7
Q ss_pred cCcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCCch---hHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGSGQ---GEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 435 (723)
++|+..+.||+|+||.||+|... +++.||||.+...... ..+.+..|++++++++|+||+++++++.+....|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 46889999999999999999654 4899999998764322 4456889999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ 515 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 515 (723)
||+.+++|.+++.......+++..++.++.||++||+|||+. +|+|||||++||||+.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 999999999998765555688999999999999999999998 59999999999999999999999999987543221
Q ss_pred cc----------------------------eeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCC
Q 046750 516 TH----------------------------VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQP 567 (723)
Q Consensus 516 ~~----------------------------~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~ 567 (723)
.. ......|+..|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 11 01124678899999999999999999999999999999999999975432
Q ss_pred CCchhhHHhhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCC----HHHHHH
Q 046750 568 LGDESLVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPR----MVQVVR 633 (723)
Q Consensus 568 ~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs----~~eVl~ 633 (723)
. ..+. +.+ ..... ..........+.+++.+||..+|++||+ +.+|++
T Consensus 238 ~--~~~~--------~~~-~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 238 D--ETFS--------NIL-KKEVT--------FPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred H--HHHH--------HHh-cCCcc--------CCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 1 1111 111 11110 0001113447889999999999999999 555554
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=321.74 Aligned_cols=239 Identities=23% Similarity=0.377 Sum_probs=186.7
Q ss_pred EEeccCcEEEEEEEcCC-------------------------CcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeE
Q 046750 367 VIGEGGFGCVYKGNLPE-------------------------GKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSL 421 (723)
Q Consensus 367 ~LG~G~fG~Vy~~~~~~-------------------------g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l 421 (723)
+||+|+||.||+|.+.. ...|+||++..........|.+|++++++++|+||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999996421 13588999876544455678899999999999999999
Q ss_pred eeeeecccceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCC---
Q 046750 422 VGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEF--- 498 (723)
Q Consensus 422 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~--- 498 (723)
+++|.+....+|||||+.+|+|..++.... ..+++..+++|+.||++||+|||++ +|+|||||++||||++++
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCccc
Confidence 999999999999999999999999886533 2578888999999999999999998 599999999999997643
Q ss_pred ----cEEEeecccccccCCCCcceeecccccccccChhhhcc-CCCCCccceechHHHHHHHH-hCCCCCCCCCCCCchh
Q 046750 499 ----EAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASS-GKLTDRSDVFSFGVVLLELI-TGRKPVDPTQPLGDES 572 (723)
Q Consensus 499 ----~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSlGviL~eLl-tG~~P~~~~~~~~~~~ 572 (723)
.+||+|||++...... ....++..|+|||++.+ ..++.++|||||||+||||+ +|+.||.......
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--- 229 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE--- 229 (274)
T ss_pred CccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH---
Confidence 4899999998643221 12346788999998875 56899999999999999995 6888886543211
Q ss_pred hHHhhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 046750 573 LVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALD 636 (723)
Q Consensus 573 l~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~ 636 (723)
...+. .... .+.... ...+.+++.+||+.+|.+||+|.+|++.|.
T Consensus 230 ~~~~~--------~~~~-------~~~~~~----~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 230 KERFY--------EKKH-------RLPEPS----CKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHHHH--------Hhcc-------CCCCCC----ChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 11110 0000 000111 135788999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=315.94 Aligned_cols=253 Identities=23% Similarity=0.423 Sum_probs=199.8
Q ss_pred CcccceEEeccCcEEEEEEEcCC--CcEEEEEEcccC----------CchhHHHHHHHHHHHHH-ccCCceeeEeeeeec
Q 046750 361 GFARENVIGEGGFGCVYKGNLPE--GKVVAVKQLKSG----------SGQGEREFRAEVEIISR-VHHRHLVSLVGYCIS 427 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~~~~--g~~VAvK~l~~~----------~~~~~~~~~~Ei~il~~-l~HpnIv~l~g~~~~ 427 (723)
+|++.+.||+|+||.||+|.++. ++.||||.+... ......++..|+.++.+ ++|+||++++++|.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999997655 688999987532 12233457788988875 799999999999999
Q ss_pred ccceEEEEEecCCCchhhcccc--CCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeec
Q 046750 428 EKNRLLIYEFVPNNNLEHHLHG--KGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADF 505 (723)
Q Consensus 428 ~~~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DF 505 (723)
++..++||||+.+++|.+++.. .....+.+..+++++.|++.+|.|||... +|+|+||++.|||+++++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 9999999999999999988743 22345888999999999999999999632 5999999999999999999999999
Q ss_pred ccccccCCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhh
Q 046750 506 GLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAI 585 (723)
Q Consensus 506 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i 585 (723)
|++....... ......|+..|++||++.++.++.++|||||||++|||++|+.||..... ..+ ...+
T Consensus 159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~------~~~-----~~~~ 225 (269)
T cd08528 159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM------LSL-----ATKI 225 (269)
T ss_pred cceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH------HHH-----HHHH
Confidence 9997654433 22345688999999999998899999999999999999999999864421 111 1111
Q ss_pred hcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 046750 586 ETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALD 636 (723)
Q Consensus 586 ~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~ 636 (723)
..+....+.+ . .....+.+++.+||+.||++||++.||..+|+
T Consensus 226 ~~~~~~~~~~----~----~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 226 VEAVYEPLPE----G----MYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred hhccCCcCCc----c----cCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 1222111111 0 11236788999999999999999999999886
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=312.32 Aligned_cols=256 Identities=25% Similarity=0.393 Sum_probs=204.1
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCC-chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEe
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS-GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEF 437 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 437 (723)
++|++.+.||.|+||.||+|.. .++..|+||++.... ......+.+|+++|+.++|+||+++++.+...+..++||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 4688999999999999999964 467899999986542 23456789999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCC-CcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCc
Q 046750 438 VPNNNLEHHLHGKGQ-PVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQT 516 (723)
Q Consensus 438 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 516 (723)
+.+++|.++++.... ..+++..+..++.||+.||+|||++ +|+||||+++||++++++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999975432 4588999999999999999999998 599999999999999999999999999976554332
Q ss_pred c---eeecccccccccChhhhccC-CCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCccc
Q 046750 517 H---VSTRVMGTFGYLAPEYASSG-KLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSE 592 (723)
Q Consensus 517 ~---~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~ 592 (723)
. ......|+..|++||++... .++.++|||||||++|||++|+.||+..... ..+..+ +. +...
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~--~~~~~~--------~~-~~~~- 225 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM--KVLMLT--------LQ-NDPP- 225 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh--hhHHHH--------hc-CCCC-
Confidence 2 22334688999999999877 7899999999999999999999999754331 111111 11 1100
Q ss_pred ccchhhhccc-cHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 593 IVDPRLEKHY-VESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 593 ~vd~~l~~~~-~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
.+.... .......+.+++.+||+.+|.+||++.+|++.
T Consensus 226 ----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 226 ----SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred ----CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 111100 01223467899999999999999999999863
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=323.18 Aligned_cols=250 Identities=21% Similarity=0.384 Sum_probs=202.6
Q ss_pred cCcccceEEeccCcEEEEEEE-cCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEec
Q 046750 360 NGFARENVIGEGGFGCVYKGN-LPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFV 438 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~-~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 438 (723)
.+|++.+.||.|+||.||+|. ..+++.|+||.+........+.+.+|+.+++.++|+||++++++|.+.+..|+|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 468999999999999999995 4678999999987665555677899999999999999999999999999999999999
Q ss_pred CCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcce
Q 046750 439 PNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHV 518 (723)
Q Consensus 439 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 518 (723)
.+++|.+++... .+++..++.++.+++.||+|||++ +|+|||||++|||+++++.+||+|||++.........
T Consensus 99 ~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~- 171 (296)
T cd06655 99 AGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK- 171 (296)
T ss_pred CCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccccc-
Confidence 999999988643 378999999999999999999999 5999999999999999999999999998755433221
Q ss_pred eecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhh
Q 046750 519 STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRL 598 (723)
Q Consensus 519 ~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l 598 (723)
.....++..|++||++.+..++.++|||||||+||||++|+.||........ +.. +.......+.
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~--~~~---------~~~~~~~~~~---- 236 (296)
T cd06655 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LYL---------IATNGTPELQ---- 236 (296)
T ss_pred CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH---------HHhcCCcccC----
Confidence 2234588899999999988899999999999999999999999976543111 000 0001110000
Q ss_pred hccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 599 EKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 599 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
........+.+++.+||..+|.+||++.+|+..
T Consensus 237 ---~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 237 ---NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred ---CcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 011122357789999999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=315.41 Aligned_cols=249 Identities=27% Similarity=0.471 Sum_probs=198.2
Q ss_pred CcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCch---------hHHHHHHHHHHHHHccCCceeeEeeeeecccc
Q 046750 361 GFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQ---------GEREFRAEVEIISRVHHRHLVSLVGYCISEKN 430 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~---------~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 430 (723)
+|.+.+.||+|+||.||+|.. .+++.||||.+...... ..+.+.+|++++++++|+||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 477889999999999999954 46789999988654221 12468889999999999999999999999999
Q ss_pred eEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccc
Q 046750 431 RLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKL 510 (723)
Q Consensus 431 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 510 (723)
.++||||+.+++|.+++.... .+++..+..++.|++.||+|||+. +|+||||+++||||++++.+||+|||+++.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG--AFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 999999999999999997643 478888999999999999999998 599999999999999999999999999976
Q ss_pred cCCCCcc-----eeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhh
Q 046750 511 NDTTQTH-----VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAI 585 (723)
Q Consensus 511 ~~~~~~~-----~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i 585 (723)
....... ......|+..|++||++.+..++.++|||+|||+||||++|+.||...... .. +. .+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~--------~~-~~ 224 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL--QA--------IF-KI 224 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH--HH--------HH-HH
Confidence 6422111 112245788999999999989999999999999999999999999754221 00 00 01
Q ss_pred hcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 586 ETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 586 ~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
..... +. ........+.+++.+||+.+|.+||++.+|++.
T Consensus 225 ~~~~~-----~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 225 GENAS-----PE----IPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred hccCC-----Cc----CCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 11111 01 111223467889999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=312.56 Aligned_cols=250 Identities=21% Similarity=0.373 Sum_probs=202.5
Q ss_pred CcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccC--CchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEe
Q 046750 361 GFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSG--SGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEF 437 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 437 (723)
+|++.++||+|+||.||++.. .+++.||||.+... ......++.+|++++++++|+||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 488899999999999999944 56899999998643 223445789999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcc
Q 046750 438 VPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTH 517 (723)
Q Consensus 438 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 517 (723)
+.+++|.+++.......+.+..+++++.||+.||.|||++ +++|+||+++||||+.++.++|+|||++.........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 157 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL 157 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh
Confidence 9999999998765444578899999999999999999998 5999999999999999999999999999765433221
Q ss_pred eeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchh
Q 046750 518 VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPR 597 (723)
Q Consensus 518 ~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~ 597 (723)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||..... .++. ..+..+....+
T Consensus 158 -~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~-----~~~~~~~~~~~---- 221 (256)
T cd08218 158 -ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM------KNLV-----LKIIRGSYPPV---- 221 (256)
T ss_pred -hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH------HHHH-----HHHhcCCCCCC----
Confidence 2234578899999999999999999999999999999999999864321 1111 11112222111
Q ss_pred hhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 598 LEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 598 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
.......+.+++.+||+.+|.+||+|.+|++.
T Consensus 222 -----~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 222 -----SSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred -----cccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 11123368899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=316.41 Aligned_cols=249 Identities=24% Similarity=0.388 Sum_probs=202.4
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCC-chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEe
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS-GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEF 437 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 437 (723)
++|++.+.||.|+||.||+|.. .+++.||||++.... ......+.+|+++++.++|+||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 3678889999999999999965 468899999987543 33446788999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcc
Q 046750 438 VPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTH 517 (723)
Q Consensus 438 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 517 (723)
+.+++|.++++.. .+++..++.++.||+.||.|||++ +|+||||+++|||+++++.++|+|||+++.......
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~- 153 (274)
T cd06609 81 CGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS- 153 (274)
T ss_pred eCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccccc-
Confidence 9999999998754 578999999999999999999998 599999999999999999999999999986654322
Q ss_pred eeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchh
Q 046750 518 VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPR 597 (723)
Q Consensus 518 ~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~ 597 (723)
......++..|++||++.+..++.++|||||||+||||++|+.||....... . ...+..+....+.+
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~------~-----~~~~~~~~~~~~~~-- 220 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR------V-----LFLIPKNNPPSLEG-- 220 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH------H-----HHHhhhcCCCCCcc--
Confidence 2233457889999999999899999999999999999999999997543211 0 01111111111111
Q ss_pred hhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 598 LEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 598 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
. .....+.+++.+||..+|++||++.+|++.
T Consensus 221 ---~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 221 ---N---KFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred ---c---ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1 022357789999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=331.34 Aligned_cols=267 Identities=21% Similarity=0.346 Sum_probs=197.2
Q ss_pred HHHHHhcCcccceEEeccCcEEEEEEE-cCCCcEEEEEEcccCC--chhHHHHHHHHHHHHHccCCceeeEeeeeecc--
Q 046750 354 ELMEITNGFARENVIGEGGFGCVYKGN-LPEGKVVAVKQLKSGS--GQGEREFRAEVEIISRVHHRHLVSLVGYCISE-- 428 (723)
Q Consensus 354 ~l~~~~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~VAvK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-- 428 (723)
.+.++.++|.+.+.||+|+||.||+|. ..+++.||||++.... ....+.+.+|+++|++++|+||++++++|...
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07878 9 TVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATS 88 (343)
T ss_pred HHhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccc
Confidence 445677899999999999999999995 4568899999987542 22345677899999999999999999987643
Q ss_pred ----cceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEee
Q 046750 429 ----KNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVAD 504 (723)
Q Consensus 429 ----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~D 504 (723)
...|+++|++ +++|.+++... .+.+..+..|+.||+.||+|||++ +|+|||||++||||++++.+||+|
T Consensus 89 ~~~~~~~~~~~~~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~D 161 (343)
T cd07878 89 IENFNEVYLVTNLM-GADLNNIVKCQ---KLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILD 161 (343)
T ss_pred ccccCcEEEEeecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcC
Confidence 3468999988 88898887543 378899999999999999999999 499999999999999999999999
Q ss_pred cccccccCCCCcceeecccccccccChhhhcc-CCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhh-----
Q 046750 505 FGLAKLNDTTQTHVSTRVMGTFGYLAPEYASS-GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWAR----- 578 (723)
Q Consensus 505 FGla~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~----- 578 (723)
||+++..... .....|+..|+|||++.+ ..++.++|||||||+||||++|+.||...... ..+..+..
T Consensus 162 fg~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~ 235 (343)
T cd07878 162 FGLARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI--DQLKRIMEVVGTP 235 (343)
T ss_pred CccceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHhCCC
Confidence 9999865432 223468999999999877 56899999999999999999999999654321 11111100
Q ss_pred -hhhhhhhhcCC-------cccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 579 -PVLVRAIETGD-------LSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 579 -~~l~~~i~~~~-------l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
..+...+.... +..+-...+...+ ......+.+|+.+||+.||.+||++.||++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 236 SPEVLKKISSEHARKYIQSLPHMPQQDLKKIF-RGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred CHHHHHhcchhhHHHHhhccccccchhHHHhc-cCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000000 0000000000000 0011246789999999999999999999965
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=319.46 Aligned_cols=249 Identities=29% Similarity=0.519 Sum_probs=196.1
Q ss_pred eEEeccCcEEEEEEEcCC-------CcEEEEEEcccCC-chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEe
Q 046750 366 NVIGEGGFGCVYKGNLPE-------GKVVAVKQLKSGS-GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEF 437 (723)
Q Consensus 366 ~~LG~G~fG~Vy~~~~~~-------g~~VAvK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 437 (723)
+.||+|+||.||+|.+.+ ++.|+||.+.... .....+|.+|++++++++|+||++++++|......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 468999999999996543 2579999886543 23456788999999999999999999999999999999999
Q ss_pred cCCCchhhccccC-----CCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCC-----cEEEeeccc
Q 046750 438 VPNNNLEHHLHGK-----GQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEF-----EAQVADFGL 507 (723)
Q Consensus 438 ~~~gsL~~~l~~~-----~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~-----~vkL~DFGl 507 (723)
+.+++|.++++.. ....+.+..++.++.||+.||+|||+. +|+|+|||++|||++.+. .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999998653 223478899999999999999999998 599999999999999877 899999999
Q ss_pred ccccCCCCcc-eeecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhh
Q 046750 508 AKLNDTTQTH-VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAI 585 (723)
Q Consensus 508 a~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i 585 (723)
++........ ......++..|++||++.++.++.++|||||||+||||++ |+.||..... .... ..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~---~~~~--------~~~ 226 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN---QEVL--------QHV 226 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH---HHHH--------HHH
Confidence 9755332211 1122345678999999999999999999999999999998 9999864321 1111 111
Q ss_pred hcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhc
Q 046750 586 ETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDS 637 (723)
Q Consensus 586 ~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~ 637 (723)
..+... .........+.+++.+||+.+|.+||++.+|++.|+.
T Consensus 227 ~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 227 TAGGRL---------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred hcCCcc---------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 111111 0111223467899999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=316.78 Aligned_cols=265 Identities=22% Similarity=0.353 Sum_probs=196.3
Q ss_pred CcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCC--chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEe
Q 046750 361 GFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS--GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEF 437 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 437 (723)
+|++.+.||+|+||.||+|.. .+++.||||+++... ......+.+|+.++++++|+||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 478889999999999999965 468899999986542 22345788999999999999999999999999999999999
Q ss_pred cCCCchhhccccCC-CCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCc
Q 046750 438 VPNNNLEHHLHGKG-QPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQT 516 (723)
Q Consensus 438 ~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 516 (723)
+. ++|.+++.... ...+++..++.++.||++||+|||++ +|+|||||++|||+++++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 96 68888876432 24588999999999999999999998 59999999999999999999999999997554322
Q ss_pred ceeecccccccccChhhhccC-CCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHH------------hhhhhhhh
Q 046750 517 HVSTRVMGTFGYLAPEYASSG-KLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVE------------WARPVLVR 583 (723)
Q Consensus 517 ~~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~------------~~~~~l~~ 583 (723)
.......++..|+|||++.+. .++.++|||||||+||||++|+.||....... .+.. |.......
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID--QLFRIFRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhcchhhH
Confidence 122233578899999988754 47899999999999999999999997543211 0100 00000000
Q ss_pred hhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 584 AIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 584 ~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
... ..+.......+. .........+.+++.+||+.||.+||++.+|++.
T Consensus 234 ~~~-~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 234 DYK-NTFPKWKKGSLR-SAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHH-hhccccCcchhH-HhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000 000000000000 0001122356789999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=358.89 Aligned_cols=255 Identities=21% Similarity=0.348 Sum_probs=196.8
Q ss_pred HHhcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccC--CchhHHHHHHHHHHHHHccCCceeeEeeeeecc--cce
Q 046750 357 EITNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSG--SGQGEREFRAEVEIISRVHHRHLVSLVGYCISE--KNR 431 (723)
Q Consensus 357 ~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~ 431 (723)
...++|.++++||+|+||.||++.. ..+..||+|++... .......|..|+.+|++|+|+|||+++++|.+. ..+
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 3457899999999999999999955 45778999998653 223445788999999999999999999988643 458
Q ss_pred EEEEEecCCCchhhccccC--CCCcchHHHHHHHHHHHHhhhchhcccCC----CceeecCCCCCcEEeCC---------
Q 046750 432 LLIYEFVPNNNLEHHLHGK--GQPVLEWTKRVKIALGAAKGLAYLHEDCH----PKIIHRDIKSANILVDD--------- 496 (723)
Q Consensus 432 ~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~g~----~~ivHrDIkp~NILl~~--------- 496 (723)
||||||+.+|+|.++|... ....+++..++.|+.||+.||+|||+.+. .+||||||||.||||+.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 9999999999999998652 12358999999999999999999998541 35999999999999964
Q ss_pred --------CCcEEEeecccccccCCCCcceeecccccccccChhhhcc--CCCCCccceechHHHHHHHHhCCCCCCCCC
Q 046750 497 --------EFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASS--GKLTDRSDVFSFGVVLLELITGRKPVDPTQ 566 (723)
Q Consensus 497 --------~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~t~ksDVwSlGviL~eLltG~~P~~~~~ 566 (723)
...+||+|||++..+..... .....|+..|+|||++.+ ..++.++||||||||||||++|+.||....
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s~--~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIESM--AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred ccccccCCCCceEEccCCcccccccccc--ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 23589999999976543221 234568999999999864 458899999999999999999999996533
Q ss_pred CCCchhhHHhhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 046750 567 PLGDESLVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVR 633 (723)
Q Consensus 567 ~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~ 633 (723)
. +..+ ...+..+.... + . .....|.+|+..||+.+|.+||++.|++.
T Consensus 248 ~-----~~ql-----i~~lk~~p~lp-----i-~----~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 248 N-----FSQL-----ISELKRGPDLP-----I-K----GKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred c-----HHHH-----HHHHhcCCCCC-----c-C----CCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 2 1111 11111111000 0 0 11236788999999999999999999984
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=339.33 Aligned_cols=253 Identities=23% Similarity=0.398 Sum_probs=205.4
Q ss_pred cCcccceEEeccCcEEEEEEEcCC-CcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEec
Q 046750 360 NGFARENVIGEGGFGCVYKGNLPE-GKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFV 438 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 438 (723)
+.|.++..||.|+||+||++..++ +-..|.|++.-......++|+-||+||..++||+||+|++.|..++.++|+.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 457788899999999999996655 4456688888878888899999999999999999999999999999999999999
Q ss_pred CCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcce
Q 046750 439 PNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHV 518 (723)
Q Consensus 439 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 518 (723)
.||-++.++..-++ .|.+.++..++++++.||.|||++ +|||||||+.|||++-+|.++|+|||.+..... ....
T Consensus 112 ~GGAVDaimlEL~r-~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~qk 186 (1187)
T KOG0579|consen 112 GGGAVDAIMLELGR-VLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TRQK 186 (1187)
T ss_pred CCchHhHHHHHhcc-ccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchh-HHhh
Confidence 99999887765544 688999999999999999999999 799999999999999999999999999853321 1223
Q ss_pred eecccccccccChhhhcc-----CCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccc
Q 046750 519 STRVMGTFGYLAPEYASS-----GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEI 593 (723)
Q Consensus 519 ~~~~~gt~~y~APE~~~~-----~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~ 593 (723)
...++||++|||||++++ ..|++++||||||+.|.||..+..|-....... ++-.|....--.+
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR-----------VllKiaKSePPTL 255 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-----------VLLKIAKSEPPTL 255 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH-----------HHHHHhhcCCCcc
Confidence 455789999999998864 469999999999999999999999876544321 1112222222222
Q ss_pred cchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 046750 594 VDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRAL 635 (723)
Q Consensus 594 vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L 635 (723)
+.+ ......+.+++.+||.+||..||.+.+|++.-
T Consensus 256 lqP-------S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hp 290 (1187)
T KOG0579|consen 256 LQP-------SHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHP 290 (1187)
T ss_pred cCc-------chhhhHHHHHHHHHHhcCCccCCCHHHHhhCc
Confidence 222 12234688999999999999999999998753
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=315.60 Aligned_cols=250 Identities=28% Similarity=0.427 Sum_probs=191.5
Q ss_pred eEEeccCcEEEEEEEcCC----CcEEEEEEcccCC-chhHHHHHHHHHHHHHccCCceeeEeeeee-cccceEEEEEecC
Q 046750 366 NVIGEGGFGCVYKGNLPE----GKVVAVKQLKSGS-GQGEREFRAEVEIISRVHHRHLVSLVGYCI-SEKNRLLIYEFVP 439 (723)
Q Consensus 366 ~~LG~G~fG~Vy~~~~~~----g~~VAvK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~-~~~~~~lV~E~~~ 439 (723)
++||+|+||.||+|.+.+ +..||||++.... ....+.+.+|+.+++.++|+||++++++|. .+...++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999996532 3579999986532 334567889999999999999999999876 4556789999999
Q ss_pred CCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcc--
Q 046750 440 NNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTH-- 517 (723)
Q Consensus 440 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~-- 517 (723)
+++|.++++.... .+.+..++.++.+|++||+|||+. +|+|||||++||||++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 156 (262)
T cd05058 81 HGDLRNFIRSETH-NPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156 (262)
T ss_pred CCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence 9999999975432 356777889999999999999998 5999999999999999999999999999754332211
Q ss_pred -eeecccccccccChhhhccCCCCCccceechHHHHHHHHhCC-CCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccc
Q 046750 518 -VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGR-KPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVD 595 (723)
Q Consensus 518 -~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~-~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd 595 (723)
......++..|+|||++.+..++.++|||||||+||||++|. .+|..... ..+. ..+..+.....
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~--------~~~~~~~~~~~-- 223 (262)
T cd05058 157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS---FDIT--------VYLLQGRRLLQ-- 223 (262)
T ss_pred cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHH--------HHHhcCCCCCC--
Confidence 112234577899999999899999999999999999999964 55543221 1111 11112211000
Q ss_pred hhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccC
Q 046750 596 PRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEG 639 (723)
Q Consensus 596 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~ 639 (723)
.......+.+++.+||+.+|++||++.+|++.|+...
T Consensus 224 -------~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 224 -------PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred -------CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 0011236889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=319.50 Aligned_cols=270 Identities=24% Similarity=0.347 Sum_probs=203.2
Q ss_pred cCcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCC--chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGS--GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYE 436 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 436 (723)
++|++.+.||+|+||.||+|... +++.|+||+++... ......+.+|++++++++|+||++++++|.+.+..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36889999999999999999654 57899999987542 2334678999999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCc
Q 046750 437 FVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQT 516 (723)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 516 (723)
|+.++.|..++.... .+.+..++.++.+|++||+|||++ +|+||||+++||++++++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 81 YVERTLLELLEASPG--GLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred cCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 998877776654432 378899999999999999999999 599999999999999999999999999987655443
Q ss_pred ceeecccccccccChhhhccC-CCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhh-----hhhcCC-
Q 046750 517 HVSTRVMGTFGYLAPEYASSG-KLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVR-----AIETGD- 589 (723)
Q Consensus 517 ~~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~-----~i~~~~- 589 (723)
.......++..|+|||++.+. .++.++||||||++||||++|+.+|.............+....+.. ......
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF 235 (288)
T ss_pred ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence 333445688899999999888 8899999999999999999999999754321110000000000000 000000
Q ss_pred ----cccccch-hhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 590 ----LSEIVDP-RLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 590 ----l~~~vd~-~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
+....+. .+...+.......+.+++.+||..+|++||++.+|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 0011110 01111222224578999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=354.51 Aligned_cols=260 Identities=19% Similarity=0.285 Sum_probs=201.6
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCc---hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSG---QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 435 (723)
++|.+.++||+|+||.||+|.. ..++.||||+++.... ...+.|.+|++++++++|+||+++++++.+.+..|+||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 5799999999999999999955 4589999999875422 23457899999999999999999999999999999999
Q ss_pred EecCCCchhhccccCC---------CCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecc
Q 046750 436 EFVPNNNLEHHLHGKG---------QPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFG 506 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFG 506 (723)
||+.+++|.++++... ...+.+..++.++.||++||+|||++ +|+||||||+||||+.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999886321 12355677889999999999999999 59999999999999999999999999
Q ss_pred cccccCCCCc-----------------ceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCC
Q 046750 507 LAKLNDTTQT-----------------HVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLG 569 (723)
Q Consensus 507 la~~~~~~~~-----------------~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~ 569 (723)
+++....... ......+||..|||||++.+..++.++|||||||+||||++|+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9976521110 01123569999999999999999999999999999999999999996532110
Q ss_pred chhhHHhhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCC-CHHHHHHHHhccCC
Q 046750 570 DESLVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRP-RMVQVVRALDSEGE 640 (723)
Q Consensus 570 ~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~eVl~~L~~~~~ 640 (723)
.. +. ..+... ..+. ........+.+++.+||+.||++|+ ++.++++.|+....
T Consensus 239 ---i~-~~-----~~i~~P--~~~~-------p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 239 ---IS-YR-----DVILSP--IEVA-------PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred ---hh-hh-----hhccCh--hhcc-------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 00 00 000000 0000 0011223577899999999999996 67778787776544
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=322.65 Aligned_cols=195 Identities=25% Similarity=0.412 Sum_probs=158.4
Q ss_pred ceEEeccCcEEEEEEEcC---CCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeec--ccceEEEEEecC
Q 046750 365 ENVIGEGGFGCVYKGNLP---EGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCIS--EKNRLLIYEFVP 439 (723)
Q Consensus 365 ~~~LG~G~fG~Vy~~~~~---~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~~~lV~E~~~ 439 (723)
.++||+|+||.||+|+.. +++.||+|.++... ....+.+|+++|++++|+||++++++|.. +...++||||+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 368999999999999764 35789999987542 23467889999999999999999998854 456789999985
Q ss_pred CCchhhccccC-------CCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEe----CCCCcEEEeecccc
Q 046750 440 NNNLEHHLHGK-------GQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILV----DDEFEAQVADFGLA 508 (723)
Q Consensus 440 ~gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl----~~~~~vkL~DFGla 508 (723)
++|.+++... ....+.+..++.++.||+.||.|||++ +|+|||||++|||+ ++++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5676665321 123478888999999999999999999 49999999999999 56678999999999
Q ss_pred cccCCCCcc--eeecccccccccChhhhccC-CCCCccceechHHHHHHHHhCCCCCCCC
Q 046750 509 KLNDTTQTH--VSTRVMGTFGYLAPEYASSG-KLTDRSDVFSFGVVLLELITGRKPVDPT 565 (723)
Q Consensus 509 ~~~~~~~~~--~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSlGviL~eLltG~~P~~~~ 565 (723)
+........ ......|+..|+|||++.+. .++.++|||||||+||||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 866433221 12335689999999998764 5899999999999999999999999654
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=324.09 Aligned_cols=251 Identities=21% Similarity=0.274 Sum_probs=207.3
Q ss_pred hcCcccceEEeccCcEEEEEE-EcCCCcEEEEEEcccCCc--hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEE
Q 046750 359 TNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSG--QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~-~~~~g~~VAvK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 435 (723)
..-|...+.||+|.|..|.++ +...|..||||++.+... .....+.+|++.|+.++|+|||+||+++.....+|||+
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 345777789999999999999 556899999999976533 33457889999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeC-CCCcEEEeecccccccCCC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVD-DEFEAQVADFGLAKLNDTT 514 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~-~~~~vkL~DFGla~~~~~~ 514 (723)
|+-++|+|.+||-++.. .+.+....+++.||+.|+.|+|+. .+|||||||+||++- +-|-|||.|||++-.+...
T Consensus 97 ELGD~GDl~DyImKHe~-Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEE-GLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred EecCCchHHHHHHhhhc-cccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 99999999999965543 478888899999999999999999 699999999999875 5688999999999766554
Q ss_pred CcceeecccccccccChhhhccCCCCC-ccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccc
Q 046750 515 QTHVSTRVMGTFGYLAPEYASSGKLTD-RSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEI 593 (723)
Q Consensus 515 ~~~~~~~~~gt~~y~APE~~~~~~~t~-ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~ 593 (723)
.. ....+|.+.|-|||++.+..|+. +.||||||||||.|++|+.||...+..+ .+..|
T Consensus 173 ~k--L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE-------------------TLTmI 231 (864)
T KOG4717|consen 173 KK--LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE-------------------TLTMI 231 (864)
T ss_pred ch--hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh-------------------hhhhh
Confidence 33 34568999999999999999876 7899999999999999999997654311 12223
Q ss_pred cchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 046750 594 VDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALD 636 (723)
Q Consensus 594 vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~ 636 (723)
+|-++ ..+.....++.+||..||..||++|-+.+||+..-|
T Consensus 232 mDCKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~W 272 (864)
T KOG4717|consen 232 MDCKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSW 272 (864)
T ss_pred hcccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcccc
Confidence 33222 233445567889999999999999999999986443
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=319.86 Aligned_cols=240 Identities=20% Similarity=0.377 Sum_probs=188.8
Q ss_pred eEEeccCcEEEEEEEcCC--------CcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEe
Q 046750 366 NVIGEGGFGCVYKGNLPE--------GKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEF 437 (723)
Q Consensus 366 ~~LG~G~fG~Vy~~~~~~--------g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 437 (723)
+.||+|+||.||+|.... ...|++|.+........+.+..|+.+++.++|+||+++++++......++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 468999999999995532 234888888765545556788999999999999999999999998999999999
Q ss_pred cCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCc--------EEEeeccccc
Q 046750 438 VPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFE--------AQVADFGLAK 509 (723)
Q Consensus 438 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~--------vkL~DFGla~ 509 (723)
+.+|+|.++++..+. .+++..+++++.||+.||+|||++ +|+|||||++|||++.++. ++|+|||++.
T Consensus 81 ~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 81 VKFGSLDTYLKKNKN-LINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred CCCCcHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 999999999976543 578899999999999999999998 5999999999999987765 6999999986
Q ss_pred ccCCCCcceeecccccccccChhhhccC-CCCCccceechHHHHHHHHhCC-CCCCCCCCCCchhhHHhhhhhhhhhhhc
Q 046750 510 LNDTTQTHVSTRVMGTFGYLAPEYASSG-KLTDRSDVFSFGVVLLELITGR-KPVDPTQPLGDESLVEWARPVLVRAIET 587 (723)
Q Consensus 510 ~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSlGviL~eLltG~-~P~~~~~~~~~~~l~~~~~~~l~~~i~~ 587 (723)
..... ....++..|+|||++.+. .++.++|||||||+||||++|. .||...... .... ....
T Consensus 157 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~---~~~~--------~~~~ 220 (258)
T cd05078 157 TVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ---KKLQ--------FYED 220 (258)
T ss_pred ccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH---HHHH--------HHHc
Confidence 54321 224578899999999874 5899999999999999999985 555432211 0000 0000
Q ss_pred CCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 046750 588 GDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALD 636 (723)
Q Consensus 588 ~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~ 636 (723)
. ..+.......+.+++.+||+.+|++||++.+|++.|+
T Consensus 221 -~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 221 -R----------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -c----------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 0111112236789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=320.43 Aligned_cols=249 Identities=27% Similarity=0.399 Sum_probs=200.3
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCC-chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEe
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS-GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEF 437 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 437 (723)
+.|+..+.||+|+||.||+|.+ .+++.||||.+.... ....+.+.+|++++++++|+||++++++|......|+||||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 3467778899999999999954 457899999987543 33445789999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcc
Q 046750 438 VPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTH 517 (723)
Q Consensus 438 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 517 (723)
+.+++|.+++... .+.+..++.++.+|++||.|||++ +|+|+||+++||++++++.++|+|||++........
T Consensus 84 ~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06642 84 LGGGSALDLLKPG---PLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred cCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch-
Confidence 9999999988643 478889999999999999999998 599999999999999999999999999976543322
Q ss_pred eeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchh
Q 046750 518 VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPR 597 (723)
Q Consensus 518 ~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~ 597 (723)
......++..|++||++.+..++.++|||||||+||||++|+.||....... .. ..+..+.. +
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~--------~~~~~~~~-----~- 219 (277)
T cd06642 157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR---VL--------FLIPKNSP-----P- 219 (277)
T ss_pred hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh---HH--------hhhhcCCC-----C-
Confidence 1222457889999999999899999999999999999999999986443211 00 01111111 0
Q ss_pred hhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 046750 598 LEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRAL 635 (723)
Q Consensus 598 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L 635 (723)
.........+.+++.+||+.+|.+||+|.+|++.-
T Consensus 220 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 254 (277)
T cd06642 220 ---TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHK 254 (277)
T ss_pred ---CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhH
Confidence 11112234678999999999999999999999853
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=312.23 Aligned_cols=253 Identities=25% Similarity=0.425 Sum_probs=203.5
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEec
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFV 438 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 438 (723)
++|++.+.||+|+||.||+|.. .+++.|++|++........+.+.+|++++++++|+||+++++++.+....+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 5789999999999999999965 457889999998765556678999999999999999999999999999999999999
Q ss_pred CCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcce
Q 046750 439 PNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHV 518 (723)
Q Consensus 439 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 518 (723)
.+++|.+++.... ..+++..++.++.|++.||+|||++ +|+|+||+++||++++++.+||+|||++........ .
T Consensus 83 ~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~ 157 (262)
T cd06613 83 GGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-K 157 (262)
T ss_pred CCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhhh-c
Confidence 9999999887542 2478899999999999999999998 599999999999999999999999999876543221 1
Q ss_pred eecccccccccChhhhccC---CCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccc
Q 046750 519 STRVMGTFGYLAPEYASSG---KLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVD 595 (723)
Q Consensus 519 ~~~~~gt~~y~APE~~~~~---~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd 595 (723)
.....++..|++||++.+. .++.++|||||||+||||++|+.||...... ..... +....+..
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~--~~~~~---------~~~~~~~~--- 223 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM--RALFL---------ISKSNFPP--- 223 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHH---------HHhccCCC---
Confidence 2334678899999999877 8899999999999999999999999754321 11110 11111100
Q ss_pred hhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 046750 596 PRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVR 633 (723)
Q Consensus 596 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~ 633 (723)
..+ .........+.+++.+||..+|.+||++.+|+.
T Consensus 224 ~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 224 PKL--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred ccc--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 001 111223346889999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=315.10 Aligned_cols=249 Identities=24% Similarity=0.425 Sum_probs=192.1
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCC-----chhHHHHHHHHHHHHHccCCceeeEeeeeecc--cce
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS-----GQGEREFRAEVEIISRVHHRHLVSLVGYCISE--KNR 431 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~-----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~ 431 (723)
.+|+..++||+|+||.||+|.. ..++.|++|++.... .+....+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4688999999999999999955 468899999886432 12335688999999999999999999988753 567
Q ss_pred EEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeeccccccc
Q 046750 432 LLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLN 511 (723)
Q Consensus 432 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 511 (723)
+++|||+.+++|.+++.... .+++..++.++.||+.||+|||+. +|+|||||++|||++.++.+||+|||+++..
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~ 156 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL 156 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence 89999999999999987544 378888899999999999999998 5999999999999999999999999998754
Q ss_pred CCCCc--ceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCC
Q 046750 512 DTTQT--HVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGD 589 (723)
Q Consensus 512 ~~~~~--~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~ 589 (723)
..... .......++..|+|||++.+..++.++|||||||++|||++|+.||...... .. +.+......
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~-----~~-----~~~~~~~~~ 226 (266)
T cd06651 157 QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM-----AA-----IFKIATQPT 226 (266)
T ss_pred ccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH-----HH-----HHHHhcCCC
Confidence 32111 1112345888999999999988999999999999999999999999754221 00 011111110
Q ss_pred cccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 046750 590 LSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVR 633 (723)
Q Consensus 590 l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~ 633 (723)
++.+ .......+.+++ +||..+|++||+|+||++
T Consensus 227 -----~~~~----~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 227 -----NPQL----PSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred -----CCCC----chhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 0111 111122344454 689999999999999976
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=320.74 Aligned_cols=269 Identities=23% Similarity=0.376 Sum_probs=199.0
Q ss_pred cCcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCCch--hHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGSGQ--GEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYE 436 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 436 (723)
++|++.++||+|+||.||+|.++ .++.||||++...... ..+.+.+|++++++++|+||++++++|..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46889999999999999999765 5889999998654222 34568899999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCc
Q 046750 437 FVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQT 516 (723)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 516 (723)
|+.++.|..++.... .+++..++.++.||++||+|||+. +|+||||+++||++++++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~- 154 (286)
T cd07846 81 FVDHTVLDDLEKYPN--GLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG- 154 (286)
T ss_pred cCCccHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-
Confidence 999999988775433 378999999999999999999998 49999999999999999999999999997654332
Q ss_pred ceeecccccccccChhhhcc-CCCCCccceechHHHHHHHHhCCCCCCCCCCCCchh-hHHhhhhhhh---hhhhcCCc-
Q 046750 517 HVSTRVMGTFGYLAPEYASS-GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDES-LVEWARPVLV---RAIETGDL- 590 (723)
Q Consensus 517 ~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~-l~~~~~~~l~---~~i~~~~l- 590 (723)
.......++..|+|||++.+ ..++.++|||||||+||||++|+.+|.......... +..+...... ..+....+
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07846 155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF 234 (286)
T ss_pred cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHh
Confidence 22233457889999999875 457889999999999999999999886543211000 0000000000 00000000
Q ss_pred ccccchhhhc-----cccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 591 SEIVDPRLEK-----HYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 591 ~~~vd~~l~~-----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
..+..+.... .........+.+++.+||+.+|.+||++.+|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 0000000000 0011223468899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=319.37 Aligned_cols=256 Identities=27% Similarity=0.445 Sum_probs=202.8
Q ss_pred cCcccceEEeccCcEEEEEEEcCC-Cc----EEEEEEcccCCc-hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLPE-GK----VVAVKQLKSGSG-QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLL 433 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~----~VAvK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 433 (723)
.+|++.++||+|+||.||+|.+++ |+ .||+|.+..... ....++.+|+.++++++|+||++++++|.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 467888999999999999996533 33 589998876543 344678899999999999999999999987 78899
Q ss_pred EEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCC
Q 046750 434 IYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDT 513 (723)
Q Consensus 434 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 513 (723)
||||+.+|+|.++++.... .+.+..++.++.||+.||+|||+. +|+|||||++|||+++++.+||+|||+++....
T Consensus 86 v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKD-NIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EEecCCCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 9999999999999976543 388999999999999999999998 599999999999999999999999999986653
Q ss_pred CCccee-ecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcc
Q 046750 514 TQTHVS-TRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLS 591 (723)
Q Consensus 514 ~~~~~~-~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~ 591 (723)
...... ....++..|++||++....++.++|||||||++|||++ |+.||+.... ..+ .+.+..+...
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~--------~~~~~~~~~~ 230 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA---VEI--------PDLLEKGERL 230 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH---HHH--------HHHHhCCCCC
Confidence 332221 11223568999999988899999999999999999998 9999975432 111 1122222111
Q ss_pred cccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCC
Q 046750 592 EIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGE 640 (723)
Q Consensus 592 ~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~ 640 (723)
.. .......+.+++.+||..+|.+||++.+|++.|+.+..
T Consensus 231 ~~---------~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 231 PQ---------PPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred CC---------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 00 01112357888999999999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=319.59 Aligned_cols=266 Identities=21% Similarity=0.360 Sum_probs=196.7
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCC-chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEe
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS-GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEF 437 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 437 (723)
++|.+.+.||+|+||.||+|+. .+++.||+|.++... ......+.+|++++++|+|+||+++++++......++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 5688999999999999999965 457899999987542 22334678899999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcc
Q 046750 438 VPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTH 517 (723)
Q Consensus 438 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 517 (723)
+. ++|.+++..... .+.+..++.++.||++||+|||+. +|+|||||++||||++++.+||+|||++........
T Consensus 86 ~~-~~l~~~l~~~~~-~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~- 159 (301)
T cd07873 86 LD-KDLKQYLDDCGN-SINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK- 159 (301)
T ss_pred cc-cCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-
Confidence 96 688888865433 478888999999999999999999 599999999999999999999999999975432221
Q ss_pred eeecccccccccChhhhccC-CCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhh--------hhhhhcC
Q 046750 518 VSTRVMGTFGYLAPEYASSG-KLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVL--------VRAIETG 588 (723)
Q Consensus 518 ~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l--------~~~i~~~ 588 (723)
......++..|++||++.+. .++.++|||||||+||||++|+.||...... .........+ ...+...
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE---EQLHFIFRILGTPTEETWPGILSNE 236 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHcCCCChhhchhhhccc
Confidence 12223568899999988754 5888999999999999999999999754321 1111000000 0000000
Q ss_pred Ccccccchhhhc----cccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 589 DLSEIVDPRLEK----HYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 589 ~l~~~vd~~l~~----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
.+.....+.... .........+.+|+.+||+.||.+|+++.||++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000000000000 0001112357789999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=317.61 Aligned_cols=252 Identities=23% Similarity=0.391 Sum_probs=201.6
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEec
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFV 438 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 438 (723)
++|++.+.||+|+||.||+|.+ .++..||+|+++.......+.|.+|++++++|+|+||+++++++......|+||||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 5688899999999999999965 468899999998766566678999999999999999999999999999999999999
Q ss_pred CCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcce
Q 046750 439 PNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHV 518 (723)
Q Consensus 439 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 518 (723)
.+++|.+++..... .+++..++.++.|++.||.|||+. +|+|+|||++|||++.++.++|+|||++.........
T Consensus 85 ~~~~L~~~~~~~~~-~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~- 159 (280)
T cd06611 85 DGGALDSIMLELER-GLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK- 159 (280)
T ss_pred CCCcHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcccccc-
Confidence 99999999875433 488899999999999999999999 4999999999999999999999999998755432221
Q ss_pred eecccccccccChhhhc-----cCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccc
Q 046750 519 STRVMGTFGYLAPEYAS-----SGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEI 593 (723)
Q Consensus 519 ~~~~~gt~~y~APE~~~-----~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~ 593 (723)
.....++..|++||++. ...++.++|||||||++|||++|+.||...... ..+. .+..+....+
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~--~~~~---------~~~~~~~~~~ 228 (280)
T cd06611 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM--RVLL---------KILKSEPPTL 228 (280)
T ss_pred cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH--HHHH---------HHhcCCCCCc
Confidence 22345889999999985 344778999999999999999999999754321 1111 1111111111
Q ss_pred cchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 594 VDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 594 vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
.. .......+.+++.+||+.+|.+||++.+|++.
T Consensus 229 ~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 229 DQ-------PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CC-------cccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 00 01112357789999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=313.64 Aligned_cols=254 Identities=25% Similarity=0.447 Sum_probs=198.4
Q ss_pred CcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCc----------hhHHHHHHHHHHHHHccCCceeeEeeeeeccc
Q 046750 361 GFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSG----------QGEREFRAEVEIISRVHHRHLVSLVGYCISEK 429 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~----------~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 429 (723)
+|...+.||+|+||.||+|.. .+++.||||.++.... ...+.+.+|++++++++|+||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 477889999999999999954 4689999998864211 11245788999999999999999999999999
Q ss_pred ceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeeccccc
Q 046750 430 NRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK 509 (723)
Q Consensus 430 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 509 (723)
..++||||+.+++|.+++.+.. .+++..+..++.||+.||.|||++ +++||||+++||+++.++.++|+|||+++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG--RFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccccc
Confidence 9999999999999999997653 478889999999999999999998 59999999999999999999999999997
Q ss_pred ccCCCCcc-eeecccccccccChhhhccCC--CCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhh
Q 046750 510 LNDTTQTH-VSTRVMGTFGYLAPEYASSGK--LTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIE 586 (723)
Q Consensus 510 ~~~~~~~~-~~~~~~gt~~y~APE~~~~~~--~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~ 586 (723)
........ ......|+..|++||++.... ++.++||||||+++|||++|..||...... ..+. + +.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~~~-----~-~~ 225 (272)
T cd06629 157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI-----AAMF-----K-LG 225 (272)
T ss_pred cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH-----HHHH-----H-hh
Confidence 55432211 123345888999999987655 889999999999999999999999643221 1110 0 01
Q ss_pred cCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 587 TGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 587 ~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
.......++..+.. .....+.+++.+||+.+|.+||++.+|++.
T Consensus 226 ~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 226 NKRSAPPIPPDVSM----NLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ccccCCcCCccccc----cCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 11111111111111 223468889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=316.64 Aligned_cols=267 Identities=21% Similarity=0.322 Sum_probs=199.9
Q ss_pred cCcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCC--chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGS--GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYE 436 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 436 (723)
++|+..+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|++++++++|+||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46889999999999999999665 58999999986532 2233567899999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCc
Q 046750 437 FVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQT 516 (723)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 516 (723)
|++++.|..++.... .+++..++.++.||+++|+|||++ +|+|||||++||||++++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 81 YCDHTVLNELEKNPR--GVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred ccCccHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 999998888775433 478999999999999999999998 599999999999999999999999999986644322
Q ss_pred ceeecccccccccChhhhcc-CCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhh---hhhhhh---hhcCC
Q 046750 517 HVSTRVMGTFGYLAPEYASS-GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWAR---PVLVRA---IETGD 589 (723)
Q Consensus 517 ~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~---~~l~~~---i~~~~ 589 (723)
......++..|++||++.+ ..++.++|||||||++|||++|+.||....... .+..+.. ..+... .....
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07847 156 -DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVD--QLYLIRKTLGDLIPRHQQIFSTNQ 232 (286)
T ss_pred -cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCChHHhhhccccc
Confidence 1223457889999999876 458899999999999999999999997554321 1111100 000000 00000
Q ss_pred c-ccccchhhhccc-----cHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 590 L-SEIVDPRLEKHY-----VESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 590 l-~~~vd~~l~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
+ ..+..+...... .......+.+++.+||+.+|++||++.||+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0 000000000000 01123468899999999999999999998863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=318.77 Aligned_cols=259 Identities=26% Similarity=0.434 Sum_probs=201.4
Q ss_pred CHHHHHHHhcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCchhHHHHHHHHHHHHHc-cCCceeeEeeeeec-
Q 046750 351 TYEELMEITNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQGEREFRAEVEIISRV-HHRHLVSLVGYCIS- 427 (723)
Q Consensus 351 ~~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~- 427 (723)
++.++....+.|++.+.||+|+||.||+|.. .+++.||+|++.... ....++..|+.+++++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 3455556678899999999999999999955 568899999986543 3345688999999999 79999999999853
Q ss_pred -----ccceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEE
Q 046750 428 -----EKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQV 502 (723)
Q Consensus 428 -----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL 502 (723)
....|+||||+.+|+|.+++.......+.+..++.++.||++||+|||+. +|+|||||++||||++++.++|
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l 162 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKL 162 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEE
Confidence 45679999999999999998765555578888899999999999999998 5999999999999999999999
Q ss_pred eecccccccCCCCcceeecccccccccChhhhc-----cCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhh
Q 046750 503 ADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYAS-----SGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWA 577 (723)
Q Consensus 503 ~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~ 577 (723)
+|||++........ ......|+..|+|||++. ...++.++|||||||++|||++|+.||..........
T Consensus 163 ~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~----- 236 (282)
T cd06636 163 VDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF----- 236 (282)
T ss_pred eeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh-----
Confidence 99999875532221 122345889999999886 3468889999999999999999999996543211100
Q ss_pred hhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 046750 578 RPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVR 633 (723)
Q Consensus 578 ~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~ 633 (723)
. +.......+. ... ....+.+++.+||+.||.+||++.||++
T Consensus 237 -----~-~~~~~~~~~~----~~~----~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 237 -----L-IPRNPPPKLK----SKK----WSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred -----h-HhhCCCCCCc----ccc----cCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0 0000000000 011 2236889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=312.11 Aligned_cols=248 Identities=25% Similarity=0.425 Sum_probs=199.5
Q ss_pred CcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCC-----chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEE
Q 046750 361 GFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGS-----GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLI 434 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~-----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 434 (723)
+|+..+.||+|+||.||+|... +++.|+||.+.... .+..+.+.+|++++++++|+||+++++++.+....++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4778899999999999999665 78999999986543 23446788999999999999999999999999999999
Q ss_pred EEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCC
Q 046750 435 YEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTT 514 (723)
Q Consensus 435 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 514 (723)
|||+.+++|.+++.... .+++..++.++.||++||+|||+. +|+|+||+++||+++.++.+||+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 81 LELVPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EEecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 99999999999997653 378889999999999999999999 4999999999999999999999999998765433
Q ss_pred CcceeecccccccccChhhhccCC-CCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccc
Q 046750 515 QTHVSTRVMGTFGYLAPEYASSGK-LTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEI 593 (723)
Q Consensus 515 ~~~~~~~~~gt~~y~APE~~~~~~-~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~ 593 (723)
. ......|+..|++||.+.... ++.++|||+|||+||||++|+.||...... .....+ ........+
T Consensus 156 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~--~~~~~~--------~~~~~~~~~ 223 (258)
T cd06632 156 S--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV--AAVFKI--------GRSKELPPI 223 (258)
T ss_pred c--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH--HHHHHH--------HhcccCCCc
Confidence 2 123355888999999998776 899999999999999999999999754311 111111 010111111
Q ss_pred cchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 594 VDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 594 vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
.......+.+++.+||+.+|.+||++.++++.
T Consensus 224 ---------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 224 ---------PDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred ---------CCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 11112356789999999999999999999863
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=317.79 Aligned_cols=263 Identities=26% Similarity=0.404 Sum_probs=204.4
Q ss_pred ccCHHHHHHHhcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCchhHHHHHHHHHHHHHc-cCCceeeEeeeee
Q 046750 349 FFTYEELMEITNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQGEREFRAEVEIISRV-HHRHLVSLVGYCI 426 (723)
Q Consensus 349 ~~~~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~ 426 (723)
.++.+++..+.++|.+.+.||+|+||.||++.. .+++.||+|++.... .....+.+|+.++.++ +|+||++++++|.
T Consensus 11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 355566777789999999999999999999955 568899999986542 2345678899999999 8999999999987
Q ss_pred cc-----cceEEEEEecCCCchhhccccC--CCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCc
Q 046750 427 SE-----KNRLLIYEFVPNNNLEHHLHGK--GQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFE 499 (723)
Q Consensus 427 ~~-----~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~ 499 (723)
.. ...++||||+.+++|.++++.. ....+.+..++.++.||+.||+|||+. +|+|||||++|||+++++.
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGG 166 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCC
Confidence 53 3579999999999999988632 223578899999999999999999998 5999999999999999999
Q ss_pred EEEeecccccccCCCCcceeecccccccccChhhhccCC-----CCCccceechHHHHHHHHhCCCCCCCCCCCCchhhH
Q 046750 500 AQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGK-----LTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLV 574 (723)
Q Consensus 500 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-----~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~ 574 (723)
+||+|||++......... .....|+..|++||++.... ++.++|||||||++|||++|+.||...... ..+.
T Consensus 167 ~kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~--~~~~ 243 (291)
T cd06639 167 VKLVDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV--KTLF 243 (291)
T ss_pred EEEeecccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH--HHHH
Confidence 999999998765432221 12345788999999986543 688999999999999999999999754321 1111
Q ss_pred HhhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 575 EWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 575 ~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
.+ ..+....+.++ ......+.+++.+||+.+|.+||++.+|++.
T Consensus 244 ~~---------~~~~~~~~~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 244 KI---------PRNPPPTLLHP-------EKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred HH---------hcCCCCCCCcc-------cccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 11 11111111111 1122368899999999999999999999864
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=318.30 Aligned_cols=264 Identities=20% Similarity=0.321 Sum_probs=195.3
Q ss_pred CcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCc--hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEe
Q 046750 361 GFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSG--QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEF 437 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 437 (723)
+|++.++||+|+||.||+|.. .+|+.||+|+++.... .....+.+|++++++++|+||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 478889999999999999965 4689999999865422 2235678899999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcc
Q 046750 438 VPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTH 517 (723)
Q Consensus 438 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 517 (723)
+. ++|.+++.... ..+++..++.++.||++||.|||++ +|+|||||++|||++.++.+||+|||+++........
T Consensus 81 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 155 (284)
T cd07839 81 CD-QDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC 155 (284)
T ss_pred CC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC
Confidence 96 57877775433 2488999999999999999999999 5999999999999999999999999999765432221
Q ss_pred eeecccccccccChhhhccCC-CCCccceechHHHHHHHHhCCCCCCCCCCCCchhhH------------Hhhhhhhhhh
Q 046750 518 VSTRVMGTFGYLAPEYASSGK-LTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLV------------EWARPVLVRA 584 (723)
Q Consensus 518 ~~~~~~gt~~y~APE~~~~~~-~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~------------~~~~~~l~~~ 584 (723)
.....++..|+|||++.+.. ++.++|||||||++|||++|+.|+...... ...+. .|.. +.+.
T Consensus 156 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~--~~~~ 231 (284)
T cd07839 156 -YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-DDQLKRIFRLLGTPTEESWPG--VSKL 231 (284)
T ss_pred -cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH-HHHHHHHHHHhCCCChHHhHH--hhhc
Confidence 22345788999999987654 789999999999999999999986443221 11100 0100 0000
Q ss_pred hhcCCcccccchhhh-ccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 585 IETGDLSEIVDPRLE-KHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 585 i~~~~l~~~vd~~l~-~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
.....+.. +..... ..........+.+++.+||+.||.+||++.+|++.
T Consensus 232 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 232 PDYKPYPM-YPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred ccccccCC-CCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 00000000 000000 01111223467789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=316.34 Aligned_cols=265 Identities=23% Similarity=0.310 Sum_probs=201.1
Q ss_pred CcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCC--chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEe
Q 046750 361 GFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS--GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEF 437 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 437 (723)
+|++.+.||+|+||.||+|.+ .+|+.|+||++.... ......+.+|+.++++++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 478899999999999999965 468999999987653 23346789999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcc
Q 046750 438 VPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTH 517 (723)
Q Consensus 438 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 517 (723)
+ +++|.+++.... ..+++..++.++.||+++|+|||++ +|+|+|||++||+++.++.++|+|||++.........
T Consensus 81 ~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (286)
T cd07832 81 M-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR 155 (286)
T ss_pred c-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence 9 999999986544 3588999999999999999999998 5999999999999999999999999999866543322
Q ss_pred eeecccccccccChhhhccC-CCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhh----h---h-hcC
Q 046750 518 VSTRVMGTFGYLAPEYASSG-KLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVR----A---I-ETG 588 (723)
Q Consensus 518 ~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~----~---i-~~~ 588 (723)
......|+..|+|||++.+. .++.++|||||||+||||++|..+|..... .....+....+.. . + +..
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND---IEQLAIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH---HHHHHHHHHHcCCCChHHHhhccCcc
Confidence 23334688999999988654 468999999999999999999877754432 1111111000000 0 0 000
Q ss_pred Ccccccc-----hhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 589 DLSEIVD-----PRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 589 ~l~~~vd-----~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
+...+.. ..+. ....+....+.+++.+||+.+|.+||++++|++.
T Consensus 233 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 233 DYNKITFPESKPIPLE-EIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hhhcccCCCCCcchHH-HhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000 0010 0111223578899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=309.38 Aligned_cols=249 Identities=22% Similarity=0.420 Sum_probs=201.4
Q ss_pred CcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccC--CchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEe
Q 046750 361 GFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSG--SGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEF 437 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 437 (723)
+|...+.||+|+||.||++.. .+++.||||.+... .......+..|+++|++++|+||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 588899999999999999954 46789999998654 233456789999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCC-CcEEEeecccccccCCCCc
Q 046750 438 VPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDE-FEAQVADFGLAKLNDTTQT 516 (723)
Q Consensus 438 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~-~~vkL~DFGla~~~~~~~~ 516 (723)
+.+++|.+++.......+++..+++++.+++++|+|||++ +|+||||+++|||++++ +.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 9999999999876555688999999999999999999998 59999999999999854 4689999999986643322
Q ss_pred ceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccch
Q 046750 517 HVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDP 596 (723)
Q Consensus 517 ~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~ 596 (723)
.....++..|+|||++.+..++.++|||||||++|+|++|+.+|+.... ..... .+..+....+.+
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~---~~~~~--------~~~~~~~~~~~~- 223 (256)
T cd08220 158 --AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL---PALVL--------KIMSGTFAPISD- 223 (256)
T ss_pred --ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch---HHHHH--------HHHhcCCCCCCC-
Confidence 2234588899999999988899999999999999999999999965432 11111 111122222211
Q ss_pred hhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 597 RLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 597 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
.....+.+++.+||+.+|.+||++.||++.
T Consensus 224 --------~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 224 --------RYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred --------CcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 123357899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=315.16 Aligned_cols=250 Identities=24% Similarity=0.384 Sum_probs=202.7
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCC-chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEe
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS-GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEF 437 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 437 (723)
..|+..++||+|+||.||+|.. ..++.||||++.... ......+.+|++++++++|+||++++++|.+....++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 3577888999999999999965 458899999987543 34456788999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcc
Q 046750 438 VPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTH 517 (723)
Q Consensus 438 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 517 (723)
+.+++|.+++... .+.+..+..++.++++||+|||+. +++|+||+++|||+++++.++|+|||++........
T Consensus 84 ~~~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06640 84 LGGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-
Confidence 9999999998643 377888899999999999999998 599999999999999999999999999976543322
Q ss_pred eeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchh
Q 046750 518 VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPR 597 (723)
Q Consensus 518 ~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~ 597 (723)
......++..|+|||++.+..++.++|||||||+||||++|..||....... . ...+..+..
T Consensus 157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~--------~~~~~~~~~------- 218 (277)
T cd06640 157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR---V--------LFLIPKNNP------- 218 (277)
T ss_pred ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh---H--------hhhhhcCCC-------
Confidence 2223457889999999998899999999999999999999999987543211 0 001111111
Q ss_pred hhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 046750 598 LEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALD 636 (723)
Q Consensus 598 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~ 636 (723)
..........+.+++.+||+.+|.+||++.+|++.-.
T Consensus 219 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06640 219 --PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKF 255 (277)
T ss_pred --CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChH
Confidence 1122234457889999999999999999999987643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=346.03 Aligned_cols=270 Identities=18% Similarity=0.268 Sum_probs=188.7
Q ss_pred HHhcCcccceEEeccCcEEEEEEEcCC--CcEEEEE------------------EcccCCchhHHHHHHHHHHHHHccCC
Q 046750 357 EITNGFARENVIGEGGFGCVYKGNLPE--GKVVAVK------------------QLKSGSGQGEREFRAEVEIISRVHHR 416 (723)
Q Consensus 357 ~~~~~f~~~~~LG~G~fG~Vy~~~~~~--g~~VAvK------------------~l~~~~~~~~~~~~~Ei~il~~l~Hp 416 (723)
.+.++|+++++||+|+||.||++.++. +..+++| .++. .......|++|+++|++|+|+
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCCCC
Confidence 345789999999999999999985432 2222222 1111 122345688999999999999
Q ss_pred ceeeEeeeeecccceEEEEEecCCCchhhccccCC---CCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEE
Q 046750 417 HLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKG---QPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANIL 493 (723)
Q Consensus 417 nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NIL 493 (723)
|||++++++.+.+..|+|+|++ +++|.+++.... ........+..|+.||+.||+|||++ +|||||||++|||
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NIL 299 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIF 299 (501)
T ss_pred CcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEE
Confidence 9999999999999999999998 556766664321 11123455678999999999999998 5999999999999
Q ss_pred eCCCCcEEEeecccccccCCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCC-CCCCCCCCchh
Q 046750 494 VDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKP-VDPTQPLGDES 572 (723)
Q Consensus 494 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P-~~~~~~~~~~~ 572 (723)
|+.++.+||+|||+++.+............|+..|+|||++.+..++.++||||||||||||++|..+ |..........
T Consensus 300 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~ 379 (501)
T PHA03210 300 LNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379 (501)
T ss_pred ECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence 99999999999999987654443334456799999999999999999999999999999999998754 43322111111
Q ss_pred hHHhhhhh-------------hhhhhhcCCcc---cccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 573 LVEWARPV-------------LVRAIETGDLS---EIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 573 l~~~~~~~-------------l~~~i~~~~l~---~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
+.+....+ +.+.+....+. ..+...+... .....+.+++.+||+.||.+||++.|++..
T Consensus 380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNL---GLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhc---CCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 21111100 00000000000 0000011100 011246678899999999999999999874
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=329.03 Aligned_cols=240 Identities=25% Similarity=0.330 Sum_probs=185.2
Q ss_pred EeccCcEEEEEEEc-CCCcEEEEEEcccCCc---hhHHHHHHHHHHHHHc---cCCceeeEeeeeecccceEEEEEecCC
Q 046750 368 IGEGGFGCVYKGNL-PEGKVVAVKQLKSGSG---QGEREFRAEVEIISRV---HHRHLVSLVGYCISEKNRLLIYEFVPN 440 (723)
Q Consensus 368 LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~---~~~~~~~~Ei~il~~l---~HpnIv~l~g~~~~~~~~~lV~E~~~~ 440 (723)
||+|+||.||+|+. .+++.||||++..... .....+..|..++.++ +|+||+++++++.+....|+||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 69999999999955 4689999999864321 2223455677777766 699999999999999999999999999
Q ss_pred CchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcceee
Q 046750 441 NNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVST 520 (723)
Q Consensus 441 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 520 (723)
|+|.+++.... .+.+..+..|+.||++||+|||++ +|+|||||++||||++++.+||+|||+++....... ...
T Consensus 81 g~L~~~l~~~~--~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~~~ 154 (330)
T cd05586 81 GELFWHLQKEG--RFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TTN 154 (330)
T ss_pred ChHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-Ccc
Confidence 99999887544 478899999999999999999999 599999999999999999999999999875432222 123
Q ss_pred cccccccccChhhhccC-CCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhhh
Q 046750 521 RVMGTFGYLAPEYASSG-KLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLE 599 (723)
Q Consensus 521 ~~~gt~~y~APE~~~~~-~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~ 599 (723)
...|+..|+|||++.+. .++.++|||||||+||||++|+.||..... .. +.+.+..+.+. +.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~------~~-----~~~~i~~~~~~------~~ 217 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT------QQ-----MYRNIAFGKVR------FP 217 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH------HH-----HHHHHHcCCCC------CC
Confidence 45689999999998765 489999999999999999999999965431 11 11222222211 11
Q ss_pred ccccHHHHHHHHHHHHHHhccCCCCCCC----HHHHHH
Q 046750 600 KHYVESEMFRMIEAAAACVRHSGPKRPR----MVQVVR 633 (723)
Q Consensus 600 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs----~~eVl~ 633 (723)
... ....+.+++.+||+.||.+|++ +.++++
T Consensus 218 ~~~---~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 218 KNV---LSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred Ccc---CCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 110 1235678899999999999994 555554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=305.43 Aligned_cols=255 Identities=23% Similarity=0.361 Sum_probs=207.7
Q ss_pred HHHHhcCcccceEEeccCcEEEEEE-EcCCCcEEEEEEcccCCc-----h---hHHHHHHHHHHHHHc-cCCceeeEeee
Q 046750 355 LMEITNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSG-----Q---GEREFRAEVEIISRV-HHRHLVSLVGY 424 (723)
Q Consensus 355 l~~~~~~f~~~~~LG~G~fG~Vy~~-~~~~g~~VAvK~l~~~~~-----~---~~~~~~~Ei~il~~l-~HpnIv~l~g~ 424 (723)
-+...++|...+.||.|..+.|.++ ..+.|..+|+|++..... . -.+...+|+.||+++ .||+|+.|.++
T Consensus 12 a~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ 91 (411)
T KOG0599|consen 12 AKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV 91 (411)
T ss_pred HhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee
Confidence 3445567888899999999999998 455688999999854321 1 123456799999998 69999999999
Q ss_pred eecccceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEee
Q 046750 425 CISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVAD 504 (723)
Q Consensus 425 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~D 504 (723)
|+.....++|+|.|..|.|.++|...- .+++....+|+.|+++|++|||.+ +|||||||++|||+|++.++||+|
T Consensus 92 yes~sF~FlVFdl~prGELFDyLts~V--tlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isD 166 (411)
T KOG0599|consen 92 YESDAFVFLVFDLMPRGELFDYLTSKV--TLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISD 166 (411)
T ss_pred ccCcchhhhhhhhcccchHHHHhhhhe--eecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEec
Confidence 999999999999999999999997654 488888899999999999999999 799999999999999999999999
Q ss_pred cccccccCCCCcceeecccccccccChhhhccC------CCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhh
Q 046750 505 FGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSG------KLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWAR 578 (723)
Q Consensus 505 FGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~------~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~ 578 (723)
||++..+..... ....+||++|+|||.+... .|+...|+|++|||+|-||.|..||....+
T Consensus 167 FGFa~~l~~Gek--LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ----------- 233 (411)
T KOG0599|consen 167 FGFACQLEPGEK--LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ----------- 233 (411)
T ss_pred cceeeccCCchh--HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH-----------
Confidence 999987765443 3457899999999988653 477889999999999999999999964322
Q ss_pred hhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 046750 579 PVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVR 633 (723)
Q Consensus 579 ~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~ 633 (723)
-++++.|..|++. +...--.+......+|+.+||+.||.+|-+++|+|+
T Consensus 234 mlMLR~ImeGkyq------F~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 234 MLMLRMIMEGKYQ------FRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HHHHHHHHhcccc------cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 1244556666542 222222334456789999999999999999999875
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=323.43 Aligned_cols=256 Identities=29% Similarity=0.495 Sum_probs=199.6
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCc----EEEEEEcccCCc-hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGK----VVAVKQLKSGSG-QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLL 433 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~----~VAvK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 433 (723)
++|+..+.||+|+||.||+|.+ .+++ .||+|.+..... ....++.+|+.++++++|+||++++++|... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 4578889999999999999965 3443 578998876533 2234688999999999999999999998754 4679
Q ss_pred EEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCC
Q 046750 434 IYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDT 513 (723)
Q Consensus 434 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 513 (723)
|+||+.+|+|.+++..... .+.+..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++....
T Consensus 86 v~e~~~~g~l~~~~~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHKD-NIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred eehhcCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccccC
Confidence 9999999999999875432 478889999999999999999998 599999999999999999999999999986543
Q ss_pred CCcce-eecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcc
Q 046750 514 TQTHV-STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLS 591 (723)
Q Consensus 514 ~~~~~-~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~ 591 (723)
..... .....++..|++||++.+..++.++|||||||+||||++ |+.||..... ..+..+ +..+...
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~---~~~~~~--------~~~~~~~ 230 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT---REIPDL--------LEKGERL 230 (303)
T ss_pred cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH--------HHCCCCC
Confidence 32221 122345678999999999999999999999999999997 8899865321 112111 1111110
Q ss_pred cccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCC
Q 046750 592 EIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGE 640 (723)
Q Consensus 592 ~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~ 640 (723)
.. .......+.+++.+||..+|.+||+|.+|++.|+.+..
T Consensus 231 ~~---------~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~ 270 (303)
T cd05110 231 PQ---------PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR 270 (303)
T ss_pred CC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 00 01112367889999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=317.13 Aligned_cols=266 Identities=23% Similarity=0.321 Sum_probs=199.0
Q ss_pred CcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCch-----hHHHHHHHHHHHHHccCCceeeEeeeeecccceEEE
Q 046750 361 GFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQ-----GEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLI 434 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~-----~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 434 (723)
+|++.++||+|+||.||+|.. .+++.|+||+++..... ....+..|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 478889999999999999965 46899999999765322 334577899999999999999999999999999999
Q ss_pred EEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCC
Q 046750 435 YEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTT 514 (723)
Q Consensus 435 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 514 (723)
|||+ +++|.+++.... ..+++..++.++.||++||.|||++ +|+|||||++||||+.++.+||+|||+++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 9999 999999997654 3588999999999999999999999 4999999999999999999999999999866543
Q ss_pred CcceeecccccccccChhhhcc-CCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhh---hhhhh-hcCC
Q 046750 515 QTHVSTRVMGTFGYLAPEYASS-GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPV---LVRAI-ETGD 589 (723)
Q Consensus 515 ~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~---l~~~i-~~~~ 589 (723)
... .....++..|+|||++.+ ..++.++|||||||+||||++|..+|....... .+....... ..... ....
T Consensus 156 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 232 (298)
T cd07841 156 NRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID--QLGKIFEALGTPTEENWPGVTS 232 (298)
T ss_pred Ccc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH--HHHHHHHHcCCCchhhhhhccc
Confidence 222 122346788999998865 457899999999999999999977776543211 110000000 00000 0000
Q ss_pred cccccchhhhc-----cccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 590 LSEIVDPRLEK-----HYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 590 l~~~vd~~l~~-----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
+...+...... .........+.+++.+||+.+|++||++.||++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000000000 0111223568899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=316.45 Aligned_cols=254 Identities=25% Similarity=0.388 Sum_probs=199.1
Q ss_pred cCcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCC-chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEe
Q 046750 360 NGFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGS-GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEF 437 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 437 (723)
++|++.+.||+|+||.||++... .++.||+|.++... ......+.+|++++++++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 35788899999999999999664 68999999887542 23345788999999999999999999999999999999999
Q ss_pred cCCCchhhccccCC-CCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCc
Q 046750 438 VPNNNLEHHLHGKG-QPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQT 516 (723)
Q Consensus 438 ~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 516 (723)
+.+++|..+++... ...+++..+..++.+|+.||.|||+.. +|+|||||++|||++.++.+||+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL- 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence 99999999887532 235889999999999999999999742 59999999999999999999999999987553222
Q ss_pred ceeecccccccccChhhhccCC------CCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCc
Q 046750 517 HVSTRVMGTFGYLAPEYASSGK------LTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDL 590 (723)
Q Consensus 517 ~~~~~~~gt~~y~APE~~~~~~------~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l 590 (723)
.....++..|++||++.+.. ++.++|||||||+||||++|+.||...... ....- ...+..+..
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~-----~~~~~~~~~ 227 (286)
T cd06622 158 --AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA---NIFAQ-----LSAIVDGDP 227 (286)
T ss_pred --cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh---hHHHH-----HHHHhhcCC
Confidence 12235788999999986543 588999999999999999999999653211 11100 011111111
Q ss_pred ccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 046750 591 SEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRAL 635 (723)
Q Consensus 591 ~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L 635 (723)
.. ........+.+++.+||+.+|.+||++.+|+..-
T Consensus 228 ~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~ 263 (286)
T cd06622 228 PT---------LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHP 263 (286)
T ss_pred CC---------CCcccCHHHHHHHHHHcccCcccCCCHHHHhcCh
Confidence 11 1112334678899999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=316.53 Aligned_cols=269 Identities=20% Similarity=0.333 Sum_probs=196.2
Q ss_pred cCcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCCch-hHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEe
Q 046750 360 NGFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGSGQ-GEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEF 437 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 437 (723)
++|++.++||+|+||.||+|..+ +++.||||.+...... ....+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57899999999999999999654 6889999998754322 234567899999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcc
Q 046750 438 VPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTH 517 (723)
Q Consensus 438 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 517 (723)
+. ++|.+++..... .+.+..+..++.||++||.|||+. +|+|||||++|||+++++.+||+|||+++.......
T Consensus 85 ~~-~~L~~~~~~~~~-~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~- 158 (291)
T cd07844 85 LD-TDLKQYMDDCGG-GLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK- 158 (291)
T ss_pred CC-CCHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCCc-
Confidence 97 589988875443 578899999999999999999998 599999999999999999999999999875432211
Q ss_pred eeecccccccccChhhhcc-CCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhh-----hhhhhhh------
Q 046750 518 VSTRVMGTFGYLAPEYASS-GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWAR-----PVLVRAI------ 585 (723)
Q Consensus 518 ~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~-----~~l~~~i------ 585 (723)
......++..|+|||++.+ ..++.++|||||||+||||++|+.+|.......+.....|.. ......+
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF 238 (291)
T ss_pred cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccc
Confidence 1122346788999999875 458999999999999999999999996543110000000000 0000000
Q ss_pred hcCCcccccchhhhcccc-HHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 586 ETGDLSEIVDPRLEKHYV-ESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 586 ~~~~l~~~vd~~l~~~~~-~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
....+.......+..... ......+.+++.+||+.+|++||++.++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 000000000011110000 0112467789999999999999999998763
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=311.30 Aligned_cols=250 Identities=22% Similarity=0.355 Sum_probs=194.2
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCC-----chhHHHHHHHHHHHHHccCCceeeEeeeeecc--cce
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS-----GQGEREFRAEVEIISRVHHRHLVSLVGYCISE--KNR 431 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~-----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~ 431 (723)
.+|++.++||+|+||.||+|.. .+++.||||.+.... ....+.+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4688999999999999999965 458999999885321 12345788899999999999999999988764 457
Q ss_pred EEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeeccccccc
Q 046750 432 LLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLN 511 (723)
Q Consensus 432 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 511 (723)
++||||+.+++|.+++.... .+++..+++++.+++.+|+|||++ +|+|+|||++|||++.++.+||+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRL 156 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence 89999999999999987543 367888899999999999999998 5999999999999999999999999998754
Q ss_pred CCCCc--ceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCC
Q 046750 512 DTTQT--HVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGD 589 (723)
Q Consensus 512 ~~~~~--~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~ 589 (723)
..... .......|+..|+|||++.+..++.++|||||||++|||++|+.||...... .. +.+.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-----~~-----~~~~~~~~- 225 (265)
T cd06652 157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM-----AA-----IFKIATQP- 225 (265)
T ss_pred ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH-----HH-----HHHHhcCC-
Confidence 32211 1122345889999999998888999999999999999999999999643211 00 00111010
Q ss_pred cccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 590 LSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 590 l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
. . ..........+.+++.+||. +|.+||++++|++.
T Consensus 226 ~----~----~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 226 T----N----PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred C----C----CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 0 0 11122233467778888884 89999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=321.03 Aligned_cols=248 Identities=24% Similarity=0.377 Sum_probs=197.6
Q ss_pred cccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEecCC
Q 046750 362 FARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPN 440 (723)
Q Consensus 362 f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 440 (723)
|.....||+|+||.||++.. .++..||||++........+.+.+|+.++++++|+||++++++|...+..++||||+.+
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 34456799999999999955 46889999998765555566789999999999999999999999999999999999999
Q ss_pred CchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcceee
Q 046750 441 NNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVST 520 (723)
Q Consensus 441 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 520 (723)
++|.+++... .+.+..++.++.+|+.||+|||++ +|+|||||++||||++++.+||+|||++......... ..
T Consensus 104 ~~L~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~-~~ 176 (292)
T cd06658 104 GALTDIVTHT---RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK-RK 176 (292)
T ss_pred CcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc-Cc
Confidence 9999988543 378889999999999999999999 5999999999999999999999999998755332221 22
Q ss_pred cccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhhhc
Q 046750 521 RVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEK 600 (723)
Q Consensus 521 ~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~ 600 (723)
...|+..|+|||++.+..++.++|||||||+||||++|+.||....... .+ ..+... + ...+..
T Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--~~---------~~~~~~-~----~~~~~~ 240 (292)
T cd06658 177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ--AM---------RRIRDN-L----PPRVKD 240 (292)
T ss_pred eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HH---------HHHHhc-C----CCcccc
Confidence 3458899999999998899999999999999999999999997543210 00 011100 0 011111
Q ss_pred cccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 601 HYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 601 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
. ......+.+++.+||..+|.+||++.+|++.
T Consensus 241 ~--~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 241 S--HKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred c--cccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 0 0112356788899999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=312.20 Aligned_cols=254 Identities=24% Similarity=0.375 Sum_probs=196.3
Q ss_pred cccceEEeccCcEEEEEEEcC----CCcEEEEEEcccCC--chhHHHHHHHHHHHHHccCCceeeEeeeeeccc------
Q 046750 362 FARENVIGEGGFGCVYKGNLP----EGKVVAVKQLKSGS--GQGEREFRAEVEIISRVHHRHLVSLVGYCISEK------ 429 (723)
Q Consensus 362 f~~~~~LG~G~fG~Vy~~~~~----~g~~VAvK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~------ 429 (723)
|.+.++||+|+||.||+|.+. .++.||||+++... ....+++.+|++++++++|+||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999653 36789999987642 234557889999999999999999999886542
Q ss_pred ceEEEEEecCCCchhhccccC----CCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeec
Q 046750 430 NRLLIYEFVPNNNLEHHLHGK----GQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADF 505 (723)
Q Consensus 430 ~~~lV~E~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DF 505 (723)
..++++||+.+|+|.+++... ....+++..+++++.||+.||+|||+. +|+|||||++|||+++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 236889999999998876432 122478888999999999999999998 5999999999999999999999999
Q ss_pred ccccccCCCCcc-eeecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhh
Q 046750 506 GLAKLNDTTQTH-VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVR 583 (723)
Q Consensus 506 Gla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~ 583 (723)
|+++........ ......+...|++||.+....++.++|||||||+||||++ |+.||..... ..+..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---~~~~~-------- 226 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SEIYN-------- 226 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---HHHHH--------
Confidence 999865432221 1122335678999999998899999999999999999999 8888864432 11111
Q ss_pred hhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhcc
Q 046750 584 AIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSE 638 (723)
Q Consensus 584 ~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~ 638 (723)
.+..+..... .......+.+++.+||+.+|.+||++.+|++.|+++
T Consensus 227 ~~~~~~~~~~---------~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 227 YLIKGNRLKQ---------PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred HHHcCCcCCC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1111111100 011234788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=310.01 Aligned_cols=252 Identities=24% Similarity=0.447 Sum_probs=198.8
Q ss_pred CcccceEEeccCcEEEEEEE-cCCCcEEEEEEcccCCc------hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEE
Q 046750 361 GFARENVIGEGGFGCVYKGN-LPEGKVVAVKQLKSGSG------QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLL 433 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~-~~~g~~VAvK~l~~~~~------~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 433 (723)
+|+..++||+|+||.||+|. ..+++.||||++..... ...+.+++|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 47888999999999999995 46789999999865321 134578899999999999999999999999999999
Q ss_pred EEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCC-cEEEeecccccccC
Q 046750 434 IYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEF-EAQVADFGLAKLND 512 (723)
Q Consensus 434 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~-~vkL~DFGla~~~~ 512 (723)
||||+.+++|.+++.+.. .+++..++.++.||+.||+|||++ +|+|+||++.|||++.++ .+||+|||++....
T Consensus 81 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred EEeccCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 999999999999987543 478889999999999999999999 599999999999998765 59999999987654
Q ss_pred CCCcc---eeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCC
Q 046750 513 TTQTH---VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGD 589 (723)
Q Consensus 513 ~~~~~---~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~ 589 (723)
..... ......++..|++||++.+..++.++|||+|||++|||++|+.||........ ...+. + +....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~~~~~-----~-~~~~~ 227 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH--LALIF-----K-IASAT 227 (268)
T ss_pred cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch--HHHHH-----H-HhccC
Confidence 33211 12234688899999999888899999999999999999999999964432111 11110 0 00000
Q ss_pred cccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 046750 590 LSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVR 633 (723)
Q Consensus 590 l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~ 633 (723)
.. ..........+.+++.+||+.+|.+||++.++++
T Consensus 228 ~~--------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 228 TA--------PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred CC--------CCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 00 1111223346788999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=307.30 Aligned_cols=251 Identities=28% Similarity=0.448 Sum_probs=200.6
Q ss_pred CcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCch--hHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEe
Q 046750 361 GFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQ--GEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEF 437 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 437 (723)
+|+..+.||+|+||.||+|.. .+++.|+||.++..... ..+.+..|++++++++|+||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 578889999999999999965 46899999998766443 556889999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcc
Q 046750 438 VPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTH 517 (723)
Q Consensus 438 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 517 (723)
+.+++|.++++... .+.+..++.|+.+|+.||.|||+.+ |+|+||++.|||+++++.+||+|||++.........
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 81 CSGGTLEELLEHGR--ILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred CCCCcHHHHHhhcC--CCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 99999999997643 3788889999999999999999984 999999999999999999999999999766543332
Q ss_pred eee---cccccccccChhhhccCC---CCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcc
Q 046750 518 VST---RVMGTFGYLAPEYASSGK---LTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLS 591 (723)
Q Consensus 518 ~~~---~~~gt~~y~APE~~~~~~---~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~ 591 (723)
... ...++..|++||++.+.. ++.++|||+||++||||++|+.||..... .|.. . ..+..+...
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~-------~~~~--~-~~~~~~~~~ 225 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN-------EFQI--M-FHVGAGHKP 225 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc-------hHHH--H-HHHhcCCCC
Confidence 221 245788999999998776 88999999999999999999999965421 1110 0 001111111
Q ss_pred cccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 046750 592 EIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVR 633 (723)
Q Consensus 592 ~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~ 633 (723)
.+ ... ......+.+++.+||+.+|.+||++.+|+.
T Consensus 226 ~~-----~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 226 PI-----PDS--LQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CC-----Ccc--cccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11 000 011335678999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=319.73 Aligned_cols=247 Identities=27% Similarity=0.369 Sum_probs=202.2
Q ss_pred cCcccceEEeccCcEEEEEEE-cCCCcEEEEEEcccCC---chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGN-LPEGKVVAVKQLKSGS---GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~-~~~g~~VAvK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 435 (723)
+.|..-++||+||||.||-+. ...|+.||.|.+.+.. .+.+...+.|-+||.+++.+.||.|-..|+..+.+||||
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 458888999999999999994 4569999999986543 233445678999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ 515 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 515 (723)
..|.||+|..||.+.+...+++...+.++.+|+.||++||+. +||.|||||+|||||+.|+|+|+|+|||..+....
T Consensus 265 tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~ 341 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK 341 (591)
T ss_pred EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCCCC
Confidence 999999999999998888999999999999999999999999 69999999999999999999999999999877655
Q ss_pred cceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccc
Q 046750 516 THVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVD 595 (723)
Q Consensus 516 ~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd 595 (723)
.+. ..+||.+|||||++..+.|+...|.|+|||+||||+.|+.||..... -+.|.. +.+.+....
T Consensus 342 ~~~--~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke-----Kvk~eE--vdrr~~~~~------ 406 (591)
T KOG0986|consen 342 PIR--GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE-----KVKREE--VDRRTLEDP------ 406 (591)
T ss_pred ccc--cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh-----hhhHHH--HHHHHhcch------
Confidence 543 23799999999999999999999999999999999999999965432 122211 111111110
Q ss_pred hhhhccccHHHHHHHHHHHHHHhccCCCCCCCH
Q 046750 596 PRLEKHYVESEMFRMIEAAAACVRHSGPKRPRM 628 (723)
Q Consensus 596 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 628 (723)
.+|...-......|....|.+||.+|---
T Consensus 407 ----~ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 407 ----EEYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred ----hhcccccCHHHHHHHHHHHccCHHHhccC
Confidence 12333333456677778899999998743
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=317.86 Aligned_cols=255 Identities=21% Similarity=0.307 Sum_probs=199.5
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCc---hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSG---QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 435 (723)
++|++.+.||+|+||.||++.. ..++.|+||.+..... .....+.+|++++++++|+||+++++++..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 4688999999999999999955 4578999999876432 23456789999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ 515 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 515 (723)
||+.+++|.+++.... .+.+..+..++.+++.||+|||++ +|+|||||++||||++++.+||+|||+++......
T Consensus 81 e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 81 EYVEGGDCATLLKNIG--ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred ecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 9999999999996554 478888899999999999999998 59999999999999999999999999986421110
Q ss_pred c--------------ceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhh
Q 046750 516 T--------------HVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVL 581 (723)
Q Consensus 516 ~--------------~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l 581 (723)
. .......++..|+|||++.+..++.++|||||||+||||++|+.||..... .++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~------~~~----- 224 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP------EEL----- 224 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHH-----
Confidence 0 011124578899999999988999999999999999999999999964321 111
Q ss_pred hhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhc
Q 046750 582 VRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDS 637 (723)
Q Consensus 582 ~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~ 637 (723)
.+.+..+.+.. +.... .....+.+++.+||+.+|.+||++.++.+.|+.
T Consensus 225 ~~~~~~~~~~~---~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 225 FGQVISDDIEW---PEGDE----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HHHHHhcccCC---CCccc----cCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 11111111110 00001 122357899999999999999997777776665
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=316.09 Aligned_cols=244 Identities=25% Similarity=0.347 Sum_probs=198.3
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCC---chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS---GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 435 (723)
++|++.+.||+|+||.||++.. .+++.||||+++... ......+.+|+++|++++|+||+++++++.+....++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 4688999999999999999955 468999999986532 233456889999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ 515 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 515 (723)
||+.+++|.+++.... .+.+..++.++.||++||+|||+. +|+||||++.||||++++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 81 EYVPGGELFSHLRKSG--RFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred ecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 9999999999987653 478889999999999999999998 5999999999999999999999999999866443
Q ss_pred cceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccc
Q 046750 516 THVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVD 595 (723)
Q Consensus 516 ~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd 595 (723)
.....++..|++||++.+..++.++||||||++||||++|+.||..... .. +.+.+..+.+.
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~--------~~~~~~~~~~~---- 216 (290)
T cd05580 155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP---IQ--------IYEKILEGKVR---- 216 (290)
T ss_pred ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH---HH--------HHHHHhcCCcc----
Confidence 2334688999999999888899999999999999999999999975431 00 11111122211
Q ss_pred hhhhccccHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHH
Q 046750 596 PRLEKHYVESEMFRMIEAAAACVRHSGPKRP-----RMVQVVR 633 (723)
Q Consensus 596 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~eVl~ 633 (723)
+... ....+.+++.+||..+|.+|+ ++.++++
T Consensus 217 --~~~~----~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 217 --FPSF----FSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred --CCcc----CCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 1111 123677899999999999999 6666654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=316.22 Aligned_cols=269 Identities=20% Similarity=0.320 Sum_probs=200.0
Q ss_pred cCcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCCch--hHHHHHHHHHHHHHccCCceeeEeeeeecc--cceEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGSGQ--GEREFRAEVEIISRVHHRHLVSLVGYCISE--KNRLLI 434 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~~lV 434 (723)
++|++.+.||+|+||.||+|... +++.|+||.++..... ....+.+|++++++++|+||+++++++... ...|+|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888999999999999999664 5889999999754322 223567899999999999999999998877 789999
Q ss_pred EEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCC
Q 046750 435 YEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTT 514 (723)
Q Consensus 435 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 514 (723)
|||+. ++|.+++..... .+.+..++.++.||+.||+|||++ +|+|||||++|||+++++.+||+|||+++.....
T Consensus 85 ~e~~~-~~L~~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQ-PFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred ehhcC-cCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 99996 589888865433 588999999999999999999998 4999999999999999999999999999866543
Q ss_pred CcceeecccccccccChhhhccC-CCCCccceechHHHHHHHHhCCCCCCCCCCCCchh-h---------HHhhhhhhhh
Q 046750 515 QTHVSTRVMGTFGYLAPEYASSG-KLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDES-L---------VEWARPVLVR 583 (723)
Q Consensus 515 ~~~~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~-l---------~~~~~~~l~~ 583 (723)
... .....++..|+|||++.+. .++.++|||||||++|||++|+.+|.......... + ..|.......
T Consensus 160 ~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (293)
T cd07843 160 LKP-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP 238 (293)
T ss_pred ccc-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence 221 2234578899999998764 46899999999999999999999997543211000 0 0111100001
Q ss_pred hhhcCCcccccchhhhccccHH-HHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 584 AIETGDLSEIVDPRLEKHYVES-EMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 584 ~i~~~~l~~~vd~~l~~~~~~~-~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
......+.......+...+... ....+.+++.+||+.+|++||++.||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 1111111111112222222222 24467889999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=309.06 Aligned_cols=253 Identities=22% Similarity=0.368 Sum_probs=200.8
Q ss_pred CcccceEEeccCcEEEEEEE-cCCCcEEEEEEcccC--CchhHHHHHHHHHHHHHccCCceeeEeeeeec--ccceEEEE
Q 046750 361 GFARENVIGEGGFGCVYKGN-LPEGKVVAVKQLKSG--SGQGEREFRAEVEIISRVHHRHLVSLVGYCIS--EKNRLLIY 435 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~-~~~g~~VAvK~l~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~~~lV~ 435 (723)
+|++.+.||.|+||.||++. ..+++.||+|++... .....+.+..|++++++++|+||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 47888999999999999994 456889999998653 23334568899999999999999999998764 34578999
Q ss_pred EecCCCchhhccccC--CCCcchHHHHHHHHHHHHhhhchhcccC--CCceeecCCCCCcEEeCCCCcEEEeeccccccc
Q 046750 436 EFVPNNNLEHHLHGK--GQPVLEWTKRVKIALGAAKGLAYLHEDC--HPKIIHRDIKSANILVDDEFEAQVADFGLAKLN 511 (723)
Q Consensus 436 E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~g--~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 511 (723)
||+.+++|.+++... ....+++..++.++.+|++||.|||..| ..+|+|+|||++|||+++++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999998653 2345889999999999999999999332 236999999999999999999999999999876
Q ss_pred CCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcc
Q 046750 512 DTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLS 591 (723)
Q Consensus 512 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~ 591 (723)
...... .....++..|++||++....++.++|||+||++||+|++|+.||..... .. +.+.+..+.+.
T Consensus 161 ~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~--------~~~~~~~~~~~ 228 (265)
T cd08217 161 GHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ---LQ--------LASKIKEGKFR 228 (265)
T ss_pred cCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH---HH--------HHHHHhcCCCC
Confidence 543321 2234588999999999998899999999999999999999999975431 11 11222233221
Q ss_pred cccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 592 EIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 592 ~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
. ........+.+++.+||+.+|.+||++.+|++.
T Consensus 229 ~---------~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 229 R---------IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred C---------CccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 1 111223468899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=315.69 Aligned_cols=266 Identities=22% Similarity=0.336 Sum_probs=197.6
Q ss_pred CcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCC--chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEe
Q 046750 361 GFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS--GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEF 437 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 437 (723)
+|+..+.||+|+||.||+|+. .+++.||||+++... ......+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 488899999999999999965 468999999987542 22335788999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcc
Q 046750 438 VPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTH 517 (723)
Q Consensus 438 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 517 (723)
+. ++|.+++.......+.+..++.++.||++||+|||+. +|+||||+++|||+++++.+||+|||++.........
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 156 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 156 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc
Confidence 95 6898888765555689999999999999999999998 5999999999999999999999999998755432211
Q ss_pred eeecccccccccChhhhccCC-CCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhh---hh-------hhhhh-
Q 046750 518 VSTRVMGTFGYLAPEYASSGK-LTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWAR---PV-------LVRAI- 585 (723)
Q Consensus 518 ~~~~~~gt~~y~APE~~~~~~-~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~---~~-------l~~~i- 585 (723)
.....++..|+|||++.+.. ++.++|||||||+||||++|+.||...... ..+....+ .. +....
T Consensus 157 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07860 157 -YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--DQLFRIFRTLGTPDEVVWPGVTSLPD 233 (284)
T ss_pred -cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHhCCCChhhhhhhhHHHH
Confidence 22234688999999887644 688999999999999999999999654321 11111000 00 00000
Q ss_pred hcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 586 ETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 586 ~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
....+.......+.. ........+.+++.+||+.||.+||++.+|++.
T Consensus 234 ~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 234 YKPSFPKWARQDFSK-VVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHhhcccccccCHHH-HcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 000011111101100 001112356789999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=309.84 Aligned_cols=254 Identities=29% Similarity=0.452 Sum_probs=199.1
Q ss_pred HhcCcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCCchhHHHHHHHHHHHHHc-cCCceeeEeeeeeccc------
Q 046750 358 ITNGFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGSGQGEREFRAEVEIISRV-HHRHLVSLVGYCISEK------ 429 (723)
Q Consensus 358 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~------ 429 (723)
..++|++.+.||+|+||.||+|..+ +++.|++|++..... ...++.+|+++++++ +|+||++++++|....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 3578999999999999999999664 578999999876533 346789999999999 7999999999997644
Q ss_pred ceEEEEEecCCCchhhccccCC--CCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeeccc
Q 046750 430 NRLLIYEFVPNNNLEHHLHGKG--QPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGL 507 (723)
Q Consensus 430 ~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGl 507 (723)
..++||||+.+++|.++++... ...+.+..++.++.|++.||.|||++ +|+||||+++||+|++++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCcc
Confidence 4799999999999999886533 34688999999999999999999998 599999999999999999999999999
Q ss_pred ccccCCCCcceeecccccccccChhhhcc-----CCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhh
Q 046750 508 AKLNDTTQTHVSTRVMGTFGYLAPEYASS-----GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLV 582 (723)
Q Consensus 508 a~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~ 582 (723)
+........ ......|+..|+|||++.. ..++.++|||||||+||||++|+.||...... ..+ .
T Consensus 160 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~--------~ 228 (275)
T cd06608 160 SAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM--RAL--------F 228 (275)
T ss_pred ceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH--HHH--------H
Confidence 875543222 1233458899999998854 34678999999999999999999999643221 111 1
Q ss_pred hhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 583 RAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 583 ~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
+ +..+....+. ........+.+++.+||..||.+||++.+|++.
T Consensus 229 ~-~~~~~~~~~~-------~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 229 K-IPRNPPPTLK-------SPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred H-hhccCCCCCC-------chhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1 1111111111 111123467899999999999999999999863
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=306.78 Aligned_cols=252 Identities=26% Similarity=0.417 Sum_probs=206.0
Q ss_pred cCcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCCc-hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEe
Q 046750 360 NGFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGSG-QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEF 437 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 437 (723)
++|++.++||+|+||.||++... +++.|+||++..... .....+.+|++++.+++|+||+++++++......++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36888999999999999999665 589999999877644 4456899999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcc-cCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCc
Q 046750 438 VPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHE-DCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQT 516 (723)
Q Consensus 438 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 516 (723)
+.+++|.+++... ..+++..++.++.||+++|+|||+ . +++||||+++||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 81 MDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred cCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence 9999999999755 348899999999999999999999 8 599999999999999999999999999976643332
Q ss_pred ceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccch
Q 046750 517 HVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDP 596 (723)
Q Consensus 517 ~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~ 596 (723)
.. ....++..|++||++....++.++|||+||+++|||++|+.||..........+. +.+..+....+
T Consensus 156 ~~-~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~--------~~~~~~~~~~~--- 223 (264)
T cd06623 156 QC-NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELM--------QAICDGPPPSL--- 223 (264)
T ss_pred cc-cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHH--------HHHhcCCCCCC---
Confidence 21 2345788999999999999999999999999999999999999765431111111 11111111111
Q ss_pred hhhccccHH-HHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 597 RLEKHYVES-EMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 597 ~l~~~~~~~-~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
... ....+.+++.+||+.+|.+||++.+|++.
T Consensus 224 ------~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 224 ------PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred ------CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 111 23478899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=310.12 Aligned_cols=248 Identities=25% Similarity=0.456 Sum_probs=198.8
Q ss_pred CcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccC-CchhHHHHHHHHHHHHHcc---CCceeeEeeeeecccceEEEE
Q 046750 361 GFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSG-SGQGEREFRAEVEIISRVH---HRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~-~~~~~~~~~~Ei~il~~l~---HpnIv~l~g~~~~~~~~~lV~ 435 (723)
.|+..+.||+|+||.||+|.+ .+++.|+||.++.. ......++.+|++++++++ |+||++++++|.++...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477889999999999999964 57899999998754 2344567889999999997 999999999999999999999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ 515 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 515 (723)
||+.+++|.+++... .+.+..++.++.+|+.||.|||+. +|+||||+++||++++++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 82 EYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred ecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 999999999998653 478999999999999999999999 49999999999999999999999999997665433
Q ss_pred cceeecccccccccChhhhccC-CCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCccccc
Q 046750 516 THVSTRVMGTFGYLAPEYASSG-KLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIV 594 (723)
Q Consensus 516 ~~~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~v 594 (723)
.. .....|+..|+|||++.++ .++.++|||||||+||||++|+.||....... ...+ +.....
T Consensus 156 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~---~~~~--------~~~~~~---- 219 (277)
T cd06917 156 SK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR---AMML--------IPKSKP---- 219 (277)
T ss_pred cc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh---hhhc--------cccCCC----
Confidence 22 2334688899999998754 46889999999999999999999997543211 1100 011111
Q ss_pred chhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 595 DPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 595 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
+.+... .....+.+++.+||+.+|.+||++.+|++.
T Consensus 220 -~~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 220 -PRLEDN---GYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred -CCCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 111111 023467889999999999999999999864
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=320.67 Aligned_cols=268 Identities=21% Similarity=0.303 Sum_probs=198.3
Q ss_pred HHhcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccC--CchhHHHHHHHHHHHHHccCCceeeEeeeeecc-----
Q 046750 357 EITNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSG--SGQGEREFRAEVEIISRVHHRHLVSLVGYCISE----- 428 (723)
Q Consensus 357 ~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~----- 428 (723)
.+.++|+..+.||+|+||.||+|.. .+++.||||++... .......+.+|+.++++++|+||++++++|...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 4668899999999999999999954 57899999998643 223345677899999999999999999988643
Q ss_pred -cceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeeccc
Q 046750 429 -KNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGL 507 (723)
Q Consensus 429 -~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGl 507 (723)
...|+||||+. ++|.+++... +++..+..++.||++||+|||++ +|+|||||++|||++.++.+||+|||+
T Consensus 93 ~~~~~lv~e~~~-~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 93 FQDVYLVMELMD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred cCcEEEEEeccC-CCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCcc
Confidence 34699999994 5788877543 77888999999999999999999 599999999999999999999999999
Q ss_pred ccccCCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCc------------hhhHH
Q 046750 508 AKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGD------------ESLVE 575 (723)
Q Consensus 508 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~------------~~l~~ 575 (723)
++....... .....++..|+|||++.+..++.++|||||||+||+|++|+.||...+.... ..+..
T Consensus 165 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (353)
T cd07850 165 ARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMS 242 (353)
T ss_pred ceeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 986543221 2234578899999999999999999999999999999999999965432100 00000
Q ss_pred hhhhhhhhhhhcC------Ccccccchhhh----ccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 576 WARPVLVRAIETG------DLSEIVDPRLE----KHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 576 ~~~~~l~~~i~~~------~l~~~vd~~l~----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
.....+...+... .+.+++...+. ..........+.+++.+||+.||.+||++.||++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000000000 01111111110 00011234467899999999999999999999865
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=310.74 Aligned_cols=260 Identities=26% Similarity=0.334 Sum_probs=201.0
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCc-hhHHHHHHHHHHHHHccCCceeeEeeeeecc--cceEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSG-QGEREFRAEVEIISRVHHRHLVSLVGYCISE--KNRLLIY 435 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~~lV~ 435 (723)
++|...+.||.|+||.||++.. .+++.||+|.+..... ....++.+|++++++++|+||++++++|.+. ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 4688999999999999999966 4578999999875433 3456789999999999999999999998654 3679999
Q ss_pred EecCCCchhhcccc--CCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCC
Q 046750 436 EFVPNNNLEHHLHG--KGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDT 513 (723)
Q Consensus 436 E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 513 (723)
||+.+++|.+++.. .....+.+..++.|+.||+.||+|||+. +++|+||++.||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999988753 2233478888999999999999999998 599999999999999999999999999865432
Q ss_pred CCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCC--CCchhhHHhhhhhhhhhhhcCCcc
Q 046750 514 TQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQP--LGDESLVEWARPVLVRAIETGDLS 591 (723)
Q Consensus 514 ~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~--~~~~~l~~~~~~~l~~~i~~~~l~ 591 (723)
... ....++..|++||++.+..++.++|||+|||++|||++|+.||+.... .....+..|.. .....
T Consensus 158 ~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------~~~~~ 226 (287)
T cd06621 158 SLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV--------NMPNP 226 (287)
T ss_pred ccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHh--------cCCch
Confidence 221 234578899999999999999999999999999999999999976532 11112222211 11111
Q ss_pred cccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 046750 592 EIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALD 636 (723)
Q Consensus 592 ~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~ 636 (723)
.+.+ .... .......+.+++.+||+.+|.+||++.||++.-.
T Consensus 227 ~~~~-~~~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~ 268 (287)
T cd06621 227 ELKD-EPGN--GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPW 268 (287)
T ss_pred hhcc-CCCC--CCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcc
Confidence 1111 0000 0112346789999999999999999999998544
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=315.27 Aligned_cols=250 Identities=22% Similarity=0.370 Sum_probs=201.9
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEec
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFV 438 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 438 (723)
++|.+.+.||+|+||.||++.. .+++.|++|.+........+.+.+|+.++++++|+||++++++|...+..|+|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 6788999999999999999954 467899999987655555667889999999999999999999999999999999999
Q ss_pred CCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcce
Q 046750 439 PNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHV 518 (723)
Q Consensus 439 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 518 (723)
.+++|.+++.+. .+.+..++.++.+|+.||.|||++ +|+|||||++||++++++.+||+|||++.........
T Consensus 99 ~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~- 171 (293)
T cd06647 99 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK- 171 (293)
T ss_pred CCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccccccc-
Confidence 999999998653 367888999999999999999999 4999999999999999999999999998755433222
Q ss_pred eecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhh
Q 046750 519 STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRL 598 (723)
Q Consensus 519 ~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l 598 (723)
.....++..|++||++.+..++.++|||||||++|||++|+.||........ +..+ ...+. ..
T Consensus 172 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~--~~~~--------~~~~~-~~------ 234 (293)
T cd06647 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LYLI--------ATNGT-PE------ 234 (293)
T ss_pred cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh--eeeh--------hcCCC-CC------
Confidence 2234588899999999988899999999999999999999999975433111 0000 00000 00
Q ss_pred hccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 599 EKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 599 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
..........+.+++.+||+.+|.+||++.+|+.+
T Consensus 235 -~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 235 -LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred -CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00111122357789999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=318.77 Aligned_cols=248 Identities=21% Similarity=0.323 Sum_probs=198.0
Q ss_pred cccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEecCC
Q 046750 362 FARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPN 440 (723)
Q Consensus 362 f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 440 (723)
|.....||+|+||.||++.. .+++.||||++........+.+.+|+.+++.++|+||++++++|..++..++||||+.+
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 34456799999999999955 46899999998765555556788999999999999999999999999999999999999
Q ss_pred CchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcceee
Q 046750 441 NNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVST 520 (723)
Q Consensus 441 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 520 (723)
++|..++... .+.+..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||++........ ...
T Consensus 103 ~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~ 175 (297)
T cd06659 103 GALTDIVSQT---RLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRK 175 (297)
T ss_pred CCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-ccc
Confidence 9999887542 378899999999999999999998 599999999999999999999999999875443222 123
Q ss_pred cccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhhhc
Q 046750 521 RVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEK 600 (723)
Q Consensus 521 ~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~ 600 (723)
...|+..|+|||++.+..++.++|||||||+||||++|+.||...... .... .+........ ....
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---~~~~--------~~~~~~~~~~---~~~~ 241 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV---QAMK--------RLRDSPPPKL---KNAH 241 (297)
T ss_pred ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHH--------HHhccCCCCc---cccC
Confidence 356889999999999889999999999999999999999999754321 1111 1111110000 0001
Q ss_pred cccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 601 HYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 601 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
. ....+.+++.+||+.+|.+||++.+|++.
T Consensus 242 ~----~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 242 K----ISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred C----CCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 1 12357789999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=312.82 Aligned_cols=252 Identities=23% Similarity=0.382 Sum_probs=192.7
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCC-chhHHHHHHHHHH-HHHccCCceeeEeeeeecccceEEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS-GQGEREFRAEVEI-ISRVHHRHLVSLVGYCISEKNRLLIYE 436 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~-~~~~~~~~~Ei~i-l~~l~HpnIv~l~g~~~~~~~~~lV~E 436 (723)
++|++.+.||+|+||.||++.. .+|+.||||+++... .....++..|+.+ ++.++|+||+++++++..+...|+|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 4688999999999999999965 468999999987643 2334456667765 556689999999999999999999999
Q ss_pred ecCCCchhhccccC--CCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCC
Q 046750 437 FVPNNNLEHHLHGK--GQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTT 514 (723)
Q Consensus 437 ~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 514 (723)
|+. |+|.+++... ....+++..++.++.||+.||+|||+++ +|+|||||++|||++.++.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 995 6787776532 2346899999999999999999999863 5999999999999999999999999999765432
Q ss_pred CcceeecccccccccChhhhcc----CCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCc
Q 046750 515 QTHVSTRVMGTFGYLAPEYASS----GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDL 590 (723)
Q Consensus 515 ~~~~~~~~~gt~~y~APE~~~~----~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l 590 (723)
. ......++..|++||++.+ ..++.++|||+|||+||||++|+.||...... ... +...+ .+..
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~--------~~~~~-~~~~ 225 (283)
T cd06617 158 V--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-FQQ--------LKQVV-EEPS 225 (283)
T ss_pred c--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-HHH--------HHHHH-hcCC
Confidence 1 1223457889999998865 45688999999999999999999999643211 011 11111 1111
Q ss_pred ccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 591 SEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 591 ~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
..+... . ....+.+++.+||..+|.+||++.+|++.
T Consensus 226 ~~~~~~----~----~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 226 PQLPAE----K----FSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred CCCCcc----c----cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111111 1 12357889999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=312.88 Aligned_cols=269 Identities=18% Similarity=0.266 Sum_probs=194.6
Q ss_pred hcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCch-hHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEE
Q 046750 359 TNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQ-GEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYE 436 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 436 (723)
.++|.+.+.||+|+||.||+|.. .+++.|+||+++..... ....+.+|++++++++|+||+++++++.+++..|+|||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 46799999999999999999954 56889999998754322 23467889999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCc
Q 046750 437 FVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQT 516 (723)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 516 (723)
|+. ++|.+++.... ..+.+..+..++.||+.||+|||+. +|+|||||++|||++.++.+||+|||+++.......
T Consensus 84 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 158 (291)
T cd07870 84 YMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ 158 (291)
T ss_pred ccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence 995 67766664432 2467778888999999999999998 599999999999999999999999999975433221
Q ss_pred ceeecccccccccChhhhccC-CCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhh-----hhhhhh-----
Q 046750 517 HVSTRVMGTFGYLAPEYASSG-KLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARP-----VLVRAI----- 585 (723)
Q Consensus 517 ~~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~-----~l~~~i----- 585 (723)
. .....++..|+|||++.+. .++.++|||||||+||||++|+.||+......+.....|... .....+
T Consensus 159 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07870 159 T-YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPN 237 (291)
T ss_pred C-CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccc
Confidence 1 2233578899999998754 588899999999999999999999975442111111111000 000000
Q ss_pred -hcCCcccccchhhhccc-cHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 046750 586 -ETGDLSEIVDPRLEKHY-VESEMFRMIEAAAACVRHSGPKRPRMVQVVR 633 (723)
Q Consensus 586 -~~~~l~~~vd~~l~~~~-~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~ 633 (723)
....+.......+.... .......+.+++.+|++.||.+||++.|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred ccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00000000000000000 0011346778999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=311.95 Aligned_cols=265 Identities=23% Similarity=0.312 Sum_probs=198.9
Q ss_pred cccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCC--chhHHHHHHHHHHHHHccCCceeeEeeeeecc--cceEEEEE
Q 046750 362 FARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGS--GQGEREFRAEVEIISRVHHRHLVSLVGYCISE--KNRLLIYE 436 (723)
Q Consensus 362 f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~~lV~E 436 (723)
|++.+.||+|+||.||+|... +++.||||+++... ......+.+|++++++++|+||+++++++.+. ...++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 677899999999999999665 58899999998653 23345788999999999999999999999988 78999999
Q ss_pred ecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCc
Q 046750 437 FVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQT 516 (723)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 516 (723)
|+. ++|.+++.... ..+++..++.++.||++||+|||+. +++|+||+++|||+++++.+||+|||++........
T Consensus 81 ~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 81 YMD-HDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred ccc-ccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 996 58888876543 3588999999999999999999998 599999999999999999999999999986654432
Q ss_pred ceeecccccccccChhhhcc-CCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhh----h--------
Q 046750 517 HVSTRVMGTFGYLAPEYASS-GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLV----R-------- 583 (723)
Q Consensus 517 ~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~----~-------- 583 (723)
.......++..|++||.+.+ ..++.++|||+|||++|||++|+.||...... .........+. .
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL---EQLEKIFELCGSPTDENWPGVSKL 232 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCchhhccccccc
Confidence 22233456888999998765 45789999999999999999999999754421 11111000000 0
Q ss_pred -hhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 584 -AIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 584 -~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
..............+...+...+...+.+++.+||+.+|.+||++.+|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 000000000111111111111124578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=308.51 Aligned_cols=254 Identities=26% Similarity=0.390 Sum_probs=202.1
Q ss_pred cCcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCCc-hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEe
Q 046750 360 NGFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGSG-QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEF 437 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 437 (723)
++|+..+.||+|+||.||++... +++.|++|++..... ...+++.+|++++++++|+||+++++++......++|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35778899999999999999664 688999999876533 4456789999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcc-cCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCc
Q 046750 438 VPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHE-DCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQT 516 (723)
Q Consensus 438 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 516 (723)
+.+++|.+++.... ..+.+..+..++.||+.+|+|||+ . +|+|||||++||++++++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 81 MDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred cCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence 99999999997643 357888899999999999999999 7 599999999999999999999999999875532222
Q ss_pred ceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccch
Q 046750 517 HVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDP 596 (723)
Q Consensus 517 ~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~ 596 (723)
. ...++..|++||++.+..++.++|||||||+||+|++|+.||....... ....+... .+..+....
T Consensus 157 ~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~-----~~~~~~~~~---- 223 (265)
T cd06605 157 K---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQ-----YIVNEPPPR---- 223 (265)
T ss_pred h---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHH-----HHhcCCCCC----
Confidence 1 1568889999999999999999999999999999999999997543211 11222211 111111100
Q ss_pred hhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 597 RLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 597 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
+... .....+.+++.+||..+|.+||++.+|++.
T Consensus 224 -~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 224 -LPSG---KFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred -CChh---hcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 1011 023357889999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=310.84 Aligned_cols=247 Identities=27% Similarity=0.413 Sum_probs=199.3
Q ss_pred CcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCC-chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEec
Q 046750 361 GFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS-GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFV 438 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 438 (723)
-|+..+.||+|+||.||+|.. .+++.||||++.... ......|.+|++++++++|+||+++++++..+...++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 377889999999999999954 568899999986442 233457889999999999999999999999999999999999
Q ss_pred CCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcce
Q 046750 439 PNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHV 518 (723)
Q Consensus 439 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 518 (723)
.+++|.+++... .+.+..++.++.+++.+|.|||+. +|+|+||++.|||+++++.++|+|||++........ .
T Consensus 85 ~~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-~ 157 (277)
T cd06641 85 GGGSALDLLEPG---PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-K 157 (277)
T ss_pred CCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh-h
Confidence 999999998643 478899999999999999999998 599999999999999999999999999876543221 1
Q ss_pred eecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhh
Q 046750 519 STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRL 598 (723)
Q Consensus 519 ~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l 598 (723)
.....++..|++||++.+..++.++|||||||+||||++|..||...... .+. ..+..+... .+
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~-----~~~~~~~~~-----~~ 221 (277)
T cd06641 158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM------KVL-----FLIPKNNPP-----TL 221 (277)
T ss_pred hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH------HHH-----HHHhcCCCC-----CC
Confidence 22345788999999999888999999999999999999999998643211 111 111111111 11
Q ss_pred hccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 599 EKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 599 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
.......+.+++.+||+.+|.+||++.+|++.
T Consensus 222 ----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 222 ----EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ----CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 11223467889999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=306.64 Aligned_cols=250 Identities=22% Similarity=0.383 Sum_probs=201.2
Q ss_pred CcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCC--chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEe
Q 046750 361 GFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGS--GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEF 437 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 437 (723)
+|.+.+.||+|+||.||+|..+ +|..||+|.+.... ....+.+.+|++++++++|+||+++++++.+....++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 5788999999999999999654 57899999986532 23445788999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCC-cEEEeecccccccCCCCc
Q 046750 438 VPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEF-EAQVADFGLAKLNDTTQT 516 (723)
Q Consensus 438 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~-~vkL~DFGla~~~~~~~~ 516 (723)
+.+++|.+++.......+++..++.++.+|+.||.|||+. +|+|+|||+.|||+++++ .+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 9999999999765555678999999999999999999998 599999999999999875 569999999976643322
Q ss_pred ceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccch
Q 046750 517 HVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDP 596 (723)
Q Consensus 517 ~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~ 596 (723)
. .....|+..|+|||++.+..++.++|||||||++|||++|..||.... ..++.. + +..+.+..+.
T Consensus 158 ~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~----~-~~~~~~~~~~-- 223 (257)
T cd08225 158 L-AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN------LHQLVL----K-ICQGYFAPIS-- 223 (257)
T ss_pred c-ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHH----H-HhcccCCCCC--
Confidence 2 223458889999999998889999999999999999999999986432 111211 1 1112221111
Q ss_pred hhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 597 RLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 597 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
......+.+++.+||+.+|++||++.+|++.
T Consensus 224 -------~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 224 -------PNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred -------CCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1112368889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=300.66 Aligned_cols=250 Identities=29% Similarity=0.474 Sum_probs=203.9
Q ss_pred CcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEecC
Q 046750 361 GFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVP 439 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 439 (723)
.|...+.||+|+||.||++... +++.|++|++..........+.+|++++++++|+||+++++++......++++||+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3778899999999999999664 688999999987655566789999999999999999999999999999999999999
Q ss_pred CCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCccee
Q 046750 440 NNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVS 519 (723)
Q Consensus 440 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 519 (723)
+++|.+++.... ..+++..++.++.+++++|.|||++ +++||||+++||++++++.++|+|||++........ .
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~ 154 (253)
T cd05122 81 GGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--R 154 (253)
T ss_pred CCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc--c
Confidence 999999987653 3588999999999999999999998 599999999999999999999999999976654332 2
Q ss_pred ecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhhh
Q 046750 520 TRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLE 599 (723)
Q Consensus 520 ~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~ 599 (723)
....++..|++||++.+..++.++|||+||++||+|++|+.||...... ..... +.......+.+.
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~--------~~~~~~~~~~~~--- 220 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM---KALFK--------IATNGPPGLRNP--- 220 (253)
T ss_pred cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH---HHHHH--------HHhcCCCCcCcc---
Confidence 3456889999999999888999999999999999999999998754311 00000 111111111110
Q ss_pred ccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 600 KHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 600 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
......+.+++.+||+.+|.+||++.+|++.
T Consensus 221 ----~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 221 ----EKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred ----cccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0012468889999999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=308.35 Aligned_cols=247 Identities=27% Similarity=0.335 Sum_probs=200.1
Q ss_pred CcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCC---chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEE
Q 046750 361 GFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGS---GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYE 436 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 436 (723)
+|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++|+||+++++++.+....++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5889999999999999999664 58999999987542 2345678999999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCc
Q 046750 437 FVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQT 516 (723)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 516 (723)
|+.+++|.+++... ..+.+..++.|+.+|++||.|||++ +|+|+||+++|||+++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence 99999999999765 3578899999999999999999998 59999999999999999999999999987654432
Q ss_pred ceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccch
Q 046750 517 HVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDP 596 (723)
Q Consensus 517 ~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~ 596 (723)
......|+..|++||++....++.++||||||+++|+|++|+.||...... ..++.. +..... .
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~----~~~~~~--~----- 218 (258)
T cd05578 155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT----IRDQIR----AKQETA--D----- 218 (258)
T ss_pred -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc----HHHHHH----HHhccc--c-----
Confidence 123345888999999999888999999999999999999999999765431 111111 111110 0
Q ss_pred hhhccccHHHHHHHHHHHHHHhccCCCCCCCH--HHHH
Q 046750 597 RLEKHYVESEMFRMIEAAAACVRHSGPKRPRM--VQVV 632 (723)
Q Consensus 597 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~--~eVl 632 (723)
..........+.+++.+||+.+|.+|+++ .|++
T Consensus 219 ---~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 219 ---VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ---ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 01111122567889999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=311.57 Aligned_cols=248 Identities=21% Similarity=0.338 Sum_probs=199.2
Q ss_pred cccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEecCC
Q 046750 362 FARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPN 440 (723)
Q Consensus 362 f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 440 (723)
|...++||+|+||.||++.. .+++.|+||+++.......+.+.+|+.++++++|+||+++++++...+..++|+||+.+
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 55568999999999999964 56889999998765545556788999999999999999999999999999999999999
Q ss_pred CchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcceee
Q 046750 441 NNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVST 520 (723)
Q Consensus 441 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 520 (723)
++|.+++... .+++..++.++.+|+.+|+|||++ +|+||||+++|||++.++.++|+|||++........ ...
T Consensus 101 ~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~~ 173 (285)
T cd06648 101 GALTDIVTHT---RMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RRK 173 (285)
T ss_pred CCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-ccc
Confidence 9999998762 378889999999999999999999 499999999999999999999999998875443221 222
Q ss_pred cccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhhhc
Q 046750 521 RVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEK 600 (723)
Q Consensus 521 ~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~ 600 (723)
...|+..|++||++.+..++.++|||||||+||||++|+.||..... ..+. +.+..+....+ ..
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~------~~~~-----~~~~~~~~~~~-----~~ 237 (285)
T cd06648 174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP------LQAM-----KRIRDNLPPKL-----KN 237 (285)
T ss_pred cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH------HHHH-----HHHHhcCCCCC-----cc
Confidence 34588999999999988899999999999999999999999865432 1111 11111111111 00
Q ss_pred cccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 601 HYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 601 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
.......+.+++.+||+.+|++||++.+|++.
T Consensus 238 --~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 238 --LHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred --cccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 01122368899999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=314.38 Aligned_cols=269 Identities=22% Similarity=0.307 Sum_probs=195.8
Q ss_pred CcccceEEeccCcEEEEEEEcC---CCcEEEEEEcccCC---chhHHHHHHHHHHHHHccCCceeeEeeeeecc--cceE
Q 046750 361 GFARENVIGEGGFGCVYKGNLP---EGKVVAVKQLKSGS---GQGEREFRAEVEIISRVHHRHLVSLVGYCISE--KNRL 432 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~~~---~g~~VAvK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~~ 432 (723)
+|.+.++||+|+||.||+|... +++.||||.+.... ......+.+|+.++++++|+||++++++|.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4788899999999999999664 47899999998743 33345678899999999999999999999988 7899
Q ss_pred EEEEecCCCchhhccccC---CCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCC----CCcEEEeec
Q 046750 433 LIYEFVPNNNLEHHLHGK---GQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDD----EFEAQVADF 505 (723)
Q Consensus 433 lV~E~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~----~~~vkL~DF 505 (723)
+||||+.+ +|.+++... ....+.+..++.|+.||+.||+|||++ +|+|||||++||||+. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999964 666655322 223578889999999999999999999 4999999999999999 999999999
Q ss_pred ccccccCCCCc--ceeecccccccccChhhhccC-CCCCccceechHHHHHHHHhCCCCCCCCCCCCc-------hhhHH
Q 046750 506 GLAKLNDTTQT--HVSTRVMGTFGYLAPEYASSG-KLTDRSDVFSFGVVLLELITGRKPVDPTQPLGD-------ESLVE 575 (723)
Q Consensus 506 Gla~~~~~~~~--~~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~-------~~l~~ 575 (723)
|+++....... .......++..|+|||++.+. .++.++|||||||+||||++|+.+|........ ..+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99986543322 112334678899999988764 588999999999999999999999976543210 00100
Q ss_pred hhhhhhh--------hhhhcCCcccccc---------hhhhccccH--HHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 576 WARPVLV--------RAIETGDLSEIVD---------PRLEKHYVE--SEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 576 ~~~~~l~--------~~i~~~~l~~~vd---------~~l~~~~~~--~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
+.. .+. ...+...+..+.+ ..+...+.. .....+.+++.+||+.||++||++.||++.
T Consensus 237 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFE-VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHH-HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000 000 0000000000000 011110111 223468899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=311.26 Aligned_cols=265 Identities=22% Similarity=0.345 Sum_probs=197.7
Q ss_pred cccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCC--chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEec
Q 046750 362 FARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS--GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFV 438 (723)
Q Consensus 362 f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 438 (723)
|++.+.||+|+||.||+|.. .+|+.||||++.... ......+.+|++++++++|+||+++++++.+....|+||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 67789999999999999954 578999999987543 223356889999999999999999999999999999999999
Q ss_pred CCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcce
Q 046750 439 PNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHV 518 (723)
Q Consensus 439 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 518 (723)
+++|.+++.......+++..++.++.||++||+|||++ +++||||+++|||+++++.++|+|||+++........
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~- 155 (283)
T cd07835 81 -DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT- 155 (283)
T ss_pred -CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc-
Confidence 57899988766545689999999999999999999998 5999999999999999999999999999755432221
Q ss_pred eecccccccccChhhhccC-CCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhh----------hhhhhh-
Q 046750 519 STRVMGTFGYLAPEYASSG-KLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPV----------LVRAIE- 586 (723)
Q Consensus 519 ~~~~~gt~~y~APE~~~~~-~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~----------l~~~i~- 586 (723)
.....++..|+|||++.+. .++.++|||||||+||||++|+.||...... ..+....+.. +....+
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI--DQLFRIFRTLGTPDEDVWPGVTSLPDY 233 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCChHHhhhhhhchhh
Confidence 1223468899999988764 4788999999999999999999999754321 1111111000 000000
Q ss_pred cCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 587 TGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 587 ~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
...+.......+ ..........+.+++.+||+.+|.+||++.||++.
T Consensus 234 ~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 234 KPTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000000000000 00111122468899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=312.74 Aligned_cols=254 Identities=27% Similarity=0.415 Sum_probs=193.3
Q ss_pred CcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCC-chhHHHHHHHHHHHHHcc-CCceeeEeeeeecccceEEEEEe
Q 046750 361 GFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS-GQGEREFRAEVEIISRVH-HRHLVSLVGYCISEKNRLLIYEF 437 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~-~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~E~ 437 (723)
+|...+.||+|+||.||++.. .+++.||||++.... ......+.+|+.++.++. |+||+++++++......+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 455678899999999999954 468999999987543 234557889999999996 99999999999998899999999
Q ss_pred cCCCchhh---ccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCC
Q 046750 438 VPNNNLEH---HLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTT 514 (723)
Q Consensus 438 ~~~gsL~~---~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 514 (723)
+. ++|.+ ++.......+.+..+.+++.++++||+|||+.. +|+|||||++|||++.++.+||+|||+++.....
T Consensus 85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 85 44443 333333345888999999999999999999742 5999999999999999999999999999755432
Q ss_pred CcceeecccccccccChhhhccC---CCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcc
Q 046750 515 QTHVSTRVMGTFGYLAPEYASSG---KLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLS 591 (723)
Q Consensus 515 ~~~~~~~~~gt~~y~APE~~~~~---~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~ 591 (723)
.. .....|+..|+|||++.+. .++.++|||||||++|||++|+.||..... ...- +.+ +..+..
T Consensus 162 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~----~~~-~~~~~~- 228 (288)
T cd06616 162 IA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQ----LTQ-VVKGDP- 228 (288)
T ss_pred Cc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHH----Hhh-hcCCCC-
Confidence 21 1233578899999999876 689999999999999999999999965421 1100 111 111111
Q ss_pred cccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 592 EIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 592 ~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
+.+...........+.+|+.+||+.+|.+||++.+|++.
T Consensus 229 ----~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 229 ----PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred ----CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111111112234468899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=309.37 Aligned_cols=253 Identities=24% Similarity=0.380 Sum_probs=203.9
Q ss_pred HhcCcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEE
Q 046750 358 ITNGFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYE 436 (723)
Q Consensus 358 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 436 (723)
..++|...+.||+|+||.||+|.+. +++.|++|+++.... ....+.+|++++++++|+||+++++++......++|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4566888899999999999999665 688999999976544 45678899999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCc
Q 046750 437 FVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQT 516 (723)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 516 (723)
|+.+++|.+++.... ..+++..++.++.+|+.||+|||+. +|+|+||+++||+++.++.++|+|||++........
T Consensus 96 ~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 171 (286)
T cd06614 96 YMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS 171 (286)
T ss_pred ccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence 999999999998654 3588999999999999999999998 599999999999999999999999999865443221
Q ss_pred ceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccch
Q 046750 517 HVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDP 596 (723)
Q Consensus 517 ~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~ 596 (723)
......++..|++||++.+..++.++|||||||+||||++|+.||...... ..... +.......+.+
T Consensus 172 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~--~~~~~---------~~~~~~~~~~~- 238 (286)
T cd06614 172 -KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL--RALFL---------ITTKGIPPLKN- 238 (286)
T ss_pred -hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH--HHHHH---------HHhcCCCCCcc-
Confidence 122345788999999999888999999999999999999999998654321 00110 11111111111
Q ss_pred hhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 597 RLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 597 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
.......+.+++.+||+.+|.+||++.+|++.
T Consensus 239 ------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 239 ------PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred ------hhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 01122367889999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=302.22 Aligned_cols=251 Identities=28% Similarity=0.413 Sum_probs=204.3
Q ss_pred CcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCCc--hhHHHHHHHHHHHHHccCCceeeEeeeeecc--cceEEEE
Q 046750 361 GFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGSG--QGEREFRAEVEIISRVHHRHLVSLVGYCISE--KNRLLIY 435 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~~lV~ 435 (723)
+|+..+.||+|+||.||+|... +++.|+||+++.... ...+.+.+|++++++++|+||+++++++.+. ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4788899999999999999665 689999999876543 4456789999999999999999999999988 8899999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ 515 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 515 (723)
||+.+++|.+++.... .+.+..++.++.+++++|+|||+. +++|+||+++||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 81 EYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 9999999999987654 588999999999999999999998 59999999999999999999999999998765543
Q ss_pred cc-eeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCccccc
Q 046750 516 TH-VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIV 594 (723)
Q Consensus 516 ~~-~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~v 594 (723)
.. ......++..|++||++.+..++.++|||+||++||+|++|+.||..... .....| .....+...
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~------~~~~~~~~~--- 223 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN---PMAALY------KIGSSGEPP--- 223 (260)
T ss_pred ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---hHHHHH------hccccCCCc---
Confidence 21 12334688899999999988899999999999999999999999976541 111111 100001111
Q ss_pred chhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 595 DPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 595 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
.+.......+.+++.+||..+|.+||++.++++.
T Consensus 224 ------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 224 ------EIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred ------CCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 1112224578899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=324.58 Aligned_cols=253 Identities=23% Similarity=0.337 Sum_probs=206.9
Q ss_pred hcCcccceEEeccCcEEEEEEE-cCCCcEEEEEEcccCCch--hHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEE
Q 046750 359 TNGFARENVIGEGGFGCVYKGN-LPEGKVVAVKQLKSGSGQ--GEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~VAvK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 435 (723)
...|.+.+.||+|.|+.|.+|. ...+..||||.+.+...+ ..+.+.+|+++|+.|+|||||+|+.+.+....+|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 4678999999999999999994 456899999999875333 2345889999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ 515 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 515 (723)
||+.+|.|.+||.++++ +.......++.|+..+++|||++ .|||||||.+||||+.+.++||+|||++.++...
T Consensus 135 eya~~ge~~~yl~~~gr--~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~- 208 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGR--MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDYG- 208 (596)
T ss_pred EeccCchhHHHHHhccc--chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeeccc-
Confidence 99999999999988775 44477778899999999999999 4999999999999999999999999999877632
Q ss_pred cceeecccccccccChhhhccCCC-CCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCccccc
Q 046750 516 THVSTRVMGTFGYLAPEYASSGKL-TDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIV 594 (723)
Q Consensus 516 ~~~~~~~~gt~~y~APE~~~~~~~-t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~v 594 (723)
......+|++-|.|||++.+..| +..+|+|++|+|||-|+.|.+||++..- .++-
T Consensus 209 -~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l-----------------------k~Lr 264 (596)
T KOG0586|consen 209 -LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL-----------------------KELR 264 (596)
T ss_pred -ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc-----------------------cccc
Confidence 33455789999999999998876 5689999999999999999999986532 1111
Q ss_pred chhhhccc--cHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCCC
Q 046750 595 DPRLEKHY--VESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEM 641 (723)
Q Consensus 595 d~~l~~~~--~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~~ 641 (723)
++.+.+.| +.-....+-+|++++|-.+|.+|.++++|.+.-+.....
T Consensus 265 ~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~ 313 (596)
T KOG0586|consen 265 PRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLL 313 (596)
T ss_pred chheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhh
Confidence 11111111 111122466788899999999999999998876655444
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=304.22 Aligned_cols=248 Identities=25% Similarity=0.330 Sum_probs=199.5
Q ss_pred hcCcccceEEeccCcEEEEEE-EcCCCcEEEEEEcccCCchhH---HHHHHHHHHHHHccCCceeeEeeeeecccceEEE
Q 046750 359 TNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGE---REFRAEVEIISRVHHRHLVSLVGYCISEKNRLLI 434 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~-~~~~g~~VAvK~l~~~~~~~~---~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 434 (723)
.++|...++||+|.||+|.++ ....++.||||++++...... ..-+.|-++|+..+||.+..|-..|+..+.+|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 467999999999999999999 455689999999988643333 3456799999999999999999999999999999
Q ss_pred EEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCC
Q 046750 435 YEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTT 514 (723)
Q Consensus 435 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 514 (723)
|||..||.|..+|.+.. .+.+.....+...|+.||.|||++ +||.||||.+|+|||++|++||+||||++.....
T Consensus 247 MeyanGGeLf~HLsrer--~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~ 321 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRER--VFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY 321 (516)
T ss_pred EEEccCceEeeehhhhh--cccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcccc
Confidence 99999999999997644 577777888999999999999998 6999999999999999999999999999743322
Q ss_pred CcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCccccc
Q 046750 515 QTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIV 594 (723)
Q Consensus 515 ~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~v 594 (723)
......++||+.|+|||++....|+...|.|.+|||+|||++|+.||...+... |+..|-.+++
T Consensus 322 -g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k-----------LFeLIl~ed~---- 385 (516)
T KOG0690|consen 322 -GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK-----------LFELILMEDL---- 385 (516)
T ss_pred -cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH-----------HHHHHHhhhc----
Confidence 233456889999999999999999999999999999999999999997654211 1122212211
Q ss_pred chhhhccccHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHH
Q 046750 595 DPRLEKHYVESEMFRMIEAAAACVRHSGPKRP-----RMVQVVR 633 (723)
Q Consensus 595 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~eVl~ 633 (723)
++ +.....+...|+..+|.+||++|- ++.||.+
T Consensus 386 --kF----Pr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 386 --KF----PRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred --cC----CccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence 11 112222455677789999999997 3555543
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=319.71 Aligned_cols=275 Identities=18% Similarity=0.300 Sum_probs=200.2
Q ss_pred HhcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccC--CchhHHHHHHHHHHHHHccCCceeeEeeeeecc-----c
Q 046750 358 ITNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSG--SGQGEREFRAEVEIISRVHHRHLVSLVGYCISE-----K 429 (723)
Q Consensus 358 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-----~ 429 (723)
+.++|.+.+.||+|+||.||+|.. .+++.||||.++.. .......+.+|+.++++++|+||+++++++... .
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 456899999999999999999954 56899999998753 223345677899999999999999999988654 3
Q ss_pred ceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeeccccc
Q 046750 430 NRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK 509 (723)
Q Consensus 430 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 509 (723)
..|+||||+. ++|.+++.... .+.+..++.++.||+.||.|||++ +|+|||||++|||++.++.+||+|||+++
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRSSQ--TLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 4799999995 78888886543 488899999999999999999998 59999999999999999999999999998
Q ss_pred ccCCCCcceeecccccccccChhhhcc-CCCCCccceechHHHHHHHHhCCCCCCCCCCCCchh-hHHhhhhhh---hhh
Q 046750 510 LNDTTQTHVSTRVMGTFGYLAPEYASS-GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDES-LVEWARPVL---VRA 584 (723)
Q Consensus 510 ~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~-l~~~~~~~l---~~~ 584 (723)
....... ......++..|+|||++.. ..++.++|||||||+||||++|+.||.......... +........ ...
T Consensus 157 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07858 157 TTSEKGD-FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF 235 (337)
T ss_pred ccCCCcc-cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence 6543321 1223457889999998865 468999999999999999999999996543210000 000000000 000
Q ss_pred hhcCCcccc-------cchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH--HhccCC
Q 046750 585 IETGDLSEI-------VDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA--LDSEGE 640 (723)
Q Consensus 585 i~~~~l~~~-------vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~--L~~~~~ 640 (723)
+..+..... .+..+.. ........+.+++.+||+.+|.+||++.+|++. |+...+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~ 299 (337)
T cd07858 236 IRNEKARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD 299 (337)
T ss_pred cCchhhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcC
Confidence 000000000 0000000 011233467899999999999999999999977 555433
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=315.20 Aligned_cols=251 Identities=25% Similarity=0.405 Sum_probs=196.5
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCC---chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS---GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 435 (723)
+.|...+.||+|+||.||+++. .++..||||++.... .....++.+|++++++++|+|+++++++|.+....++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 3477889999999999999965 468899999986432 223356889999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ 515 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 515 (723)
||+. |+|.+++.... ..+++..+..++.+|+.||.|||+. +|+||||+++||++++++.+||+|||++......
T Consensus 105 e~~~-g~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 105 EYCL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred eCCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence 9996 57777765433 2478999999999999999999999 5999999999999999999999999998754322
Q ss_pred cceeecccccccccChhhhc---cCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCccc
Q 046750 516 THVSTRVMGTFGYLAPEYAS---SGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSE 592 (723)
Q Consensus 516 ~~~~~~~~gt~~y~APE~~~---~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~ 592 (723)
....|+..|+|||++. .+.++.++|||||||++|||++|+.||...... ..+..+ ..+....
T Consensus 179 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~~~---------~~~~~~~ 243 (317)
T cd06635 179 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALYHI---------AQNESPT 243 (317)
T ss_pred ----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH--HHHHHH---------HhccCCC
Confidence 2245788999999974 456899999999999999999999998653211 111111 1111111
Q ss_pred ccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccC
Q 046750 593 IVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEG 639 (723)
Q Consensus 593 ~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~ 639 (723)
.. .......+.+++.+||+.+|.+||++.+|++.+....
T Consensus 244 ~~--------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 244 LQ--------SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred CC--------CccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 00 1112235788999999999999999999998776544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=326.97 Aligned_cols=239 Identities=27% Similarity=0.465 Sum_probs=192.2
Q ss_pred ceEEeccCcEEEEEEE-cCCCcEEEEEE--cccC--CchhHHHHHHHHHHHHHccCCceeeEeeeeecccc--eEEEEEe
Q 046750 365 ENVIGEGGFGCVYKGN-LPEGKVVAVKQ--LKSG--SGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKN--RLLIYEF 437 (723)
Q Consensus 365 ~~~LG~G~fG~Vy~~~-~~~g~~VAvK~--l~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~--~~lV~E~ 437 (723)
..+||+|.|-+||||. -.+|..||=-. ++.. .....+.|..|+.+|+.|+|+|||+|+.++.+... +.+|.|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 4679999999999994 44577776222 2221 23444789999999999999999999999987766 6789999
Q ss_pred cCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCC-CcEEEeecccccccCCCCc
Q 046750 438 VPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDE-FEAQVADFGLAKLNDTTQT 516 (723)
Q Consensus 438 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~-~~vkL~DFGla~~~~~~~~ 516 (723)
+..|+|..|+.+.++ ++...+..|+.||++||.|||++ ++.|||||||..||||+.+ |.|||+|+|||.+.....
T Consensus 125 ~TSGtLr~Y~kk~~~--vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~- 200 (632)
T KOG0584|consen 125 FTSGTLREYRKKHRR--VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH- 200 (632)
T ss_pred ccCCcHHHHHHHhcc--CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhccc-
Confidence 999999999987765 67789999999999999999998 7899999999999999865 899999999998765332
Q ss_pred ceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcC----Cccc
Q 046750 517 HVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETG----DLSE 592 (723)
Q Consensus 517 ~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~----~l~~ 592 (723)
...++||+.|||||+.. ..|++..||||||++++||+|+..||..=.. -. -+++++-.| .|..
T Consensus 201 --aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n-----~A-----QIYKKV~SGiKP~sl~k 267 (632)
T KOG0584|consen 201 --AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN-----PA-----QIYKKVTSGIKPAALSK 267 (632)
T ss_pred --cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC-----HH-----HHHHHHHcCCCHHHhhc
Confidence 23378999999999886 8899999999999999999999999964221 11 133344343 2333
Q ss_pred ccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 046750 593 IVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVR 633 (723)
Q Consensus 593 ~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~ 633 (723)
+-|+ .+.++|.+||.. ..+|+++.|+|.
T Consensus 268 V~dP------------evr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 268 VKDP------------EVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred cCCH------------HHHHHHHHHhcC-chhccCHHHHhh
Confidence 3333 467888899999 999999999985
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=310.50 Aligned_cols=269 Identities=20% Similarity=0.294 Sum_probs=195.6
Q ss_pred cCcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCCc--hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGSG--QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYE 436 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 436 (723)
++|++.+.||+|+||.||+|... +++.||||+++.... .....+.+|++++++++|+||+++++++.+....|+|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57899999999999999999654 688999999865422 233568899999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCC-CCcEEEeecccccccCCCC
Q 046750 437 FVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDD-EFEAQVADFGLAKLNDTTQ 515 (723)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~-~~~vkL~DFGla~~~~~~~ 515 (723)
|+. ++|.+++.......+++..++.++.||+.||+|||++ +|+||||+++||||++ ++.+||+|||++.......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 995 5787777654444467888889999999999999998 5999999999999985 5679999999997654321
Q ss_pred cceeecccccccccChhhhccC-CCCCccceechHHHHHHHHhCCCCCCCCCCCCchhh-HHhhhhhhhhhhhc-CCccc
Q 046750 516 THVSTRVMGTFGYLAPEYASSG-KLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESL-VEWARPVLVRAIET-GDLSE 592 (723)
Q Consensus 516 ~~~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l-~~~~~~~l~~~i~~-~~l~~ 592 (723)
. ......++..|++||++.+. .++.++|||||||++|||++|+.||......+.... ..+........+.. ..+..
T Consensus 158 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (294)
T PLN00009 158 R-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236 (294)
T ss_pred c-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence 1 12234578899999998764 578999999999999999999999975432111000 00000000000000 00000
Q ss_pred -------ccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 593 -------IVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 593 -------~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
.....+. .........+.+++.+||+.+|++||++.++++.
T Consensus 237 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 237 YKSAFPKWPPKDLA-TVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hhhhcccCCCCCHH-HhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000 0011123357889999999999999999999863
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=306.46 Aligned_cols=247 Identities=25% Similarity=0.400 Sum_probs=203.9
Q ss_pred cccceEEeccCcEEEEEE-EcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEecCC
Q 046750 362 FARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPN 440 (723)
Q Consensus 362 f~~~~~LG~G~fG~Vy~~-~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 440 (723)
|.++.+||+|.||.||++ +...|..||||++... .+.+++.+||.||++++.++||+++|.|.....+++|||||..
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 678899999999999999 5567999999998765 4567889999999999999999999999888999999999999
Q ss_pred CchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcceee
Q 046750 441 NNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVST 520 (723)
Q Consensus 441 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 520 (723)
|++.++++.+. ..|.++.+..|+...++||+|||.. +-||||||+.||||+-+|.+||+|||.+-.+.+.. ....
T Consensus 113 GSiSDI~R~R~-K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM-AKRN 187 (502)
T KOG0574|consen 113 GSISDIMRARR-KPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM-AKRN 187 (502)
T ss_pred CcHHHHHHHhc-CCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhH-HhhC
Confidence 99999987554 4688999999999999999999998 69999999999999999999999999996554322 2345
Q ss_pred cccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhhhc
Q 046750 521 RVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEK 600 (723)
Q Consensus 521 ~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~ 600 (723)
.+.||+.|||||++..-.|+.++||||||+...||..|+.||.+..+...... |-..-- +-+
T Consensus 188 TVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM-----------IPT~PP-----PTF-- 249 (502)
T KOG0574|consen 188 TVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM-----------IPTKPP-----PTF-- 249 (502)
T ss_pred ccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEe-----------ccCCCC-----CCC--
Confidence 57899999999999999999999999999999999999999987655321110 000000 001
Q ss_pred cccHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 046750 601 HYVESEMFRMIEAAAACVRHSGPKRPRMVQVVR 633 (723)
Q Consensus 601 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~ 633 (723)
.....-...+-++++.||-++|++|-++.++++
T Consensus 250 ~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 250 KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 111122336788999999999999999988764
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=318.57 Aligned_cols=266 Identities=21% Similarity=0.351 Sum_probs=195.6
Q ss_pred HhcCcccceEEeccCcEEEEEEE-cCCCcEEEEEEcccCC-chhHHHHHHHHHHHHHccCCceeeEeeeeecc-----cc
Q 046750 358 ITNGFARENVIGEGGFGCVYKGN-LPEGKVVAVKQLKSGS-GQGEREFRAEVEIISRVHHRHLVSLVGYCISE-----KN 430 (723)
Q Consensus 358 ~~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~VAvK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-----~~ 430 (723)
+.++|++.++||+|+||.||+|. ..+|+.||||+++... ......+.+|+.++++++|+||+++++++... ..
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 35789999999999999999995 4568999999986432 23345678899999999999999999987654 34
Q ss_pred eEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccc
Q 046750 431 RLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKL 510 (723)
Q Consensus 431 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 510 (723)
.|+|+||+. ++|.+++... .+.+..++.++.||++||+|||+. +|+|||||++|||++.++.+||+|||+++.
T Consensus 83 ~~lv~e~~~-~~l~~~~~~~---~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 83 VYIVQELME-TDLYKLIKTQ---HLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEEehhcc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceee
Confidence 789999995 5787777543 478889999999999999999999 599999999999999999999999999976
Q ss_pred cCCCCcc--eeecccccccccChhhhcc-CCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhc
Q 046750 511 NDTTQTH--VSTRVMGTFGYLAPEYASS-GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIET 587 (723)
Q Consensus 511 ~~~~~~~--~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~ 587 (723)
....... ......|+..|+|||++.+ ..++.++|||||||+||||++|+.||...... ....+....+. ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~---~~~~~~~~~~~-~~~~ 231 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL---HQLNLILGVLG-TPSQ 231 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHcC-CCCH
Confidence 5432221 1223468899999998765 46899999999999999999999999654321 11111100000 0000
Q ss_pred CCcccccchhhh---------c-----cccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 588 GDLSEIVDPRLE---------K-----HYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 588 ~~l~~~vd~~l~---------~-----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
..+..+++.... . .........+.+++.+||+.+|.+||++.||++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 232 EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 001111110000 0 0001123458899999999999999999999987
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=307.19 Aligned_cols=241 Identities=27% Similarity=0.374 Sum_probs=189.7
Q ss_pred EeccCcEEEEEEEc-CCCcEEEEEEcccCC---chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEecCCCch
Q 046750 368 IGEGGFGCVYKGNL-PEGKVVAVKQLKSGS---GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNL 443 (723)
Q Consensus 368 LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 443 (723)
||+|+||.||++.. .+|+.||||.+.... ......+..|+++|++++|+||+++++++...+..|+||||+.+++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999954 468999999986532 22344567899999999999999999999999999999999999999
Q ss_pred hhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcceeeccc
Q 046750 444 EHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVM 523 (723)
Q Consensus 444 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 523 (723)
.+++.......+.+..++.++.|++.||.|||+. +|+||||+++|||+++++.+||+|||++....... ......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~ 155 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGRA 155 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--cccccc
Confidence 9999766555688999999999999999999998 59999999999999999999999999987654321 122345
Q ss_pred ccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhhhcccc
Q 046750 524 GTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEKHYV 603 (723)
Q Consensus 524 gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~ 603 (723)
++..|++||++.++.++.++|||||||+||||++|+.||......... .. +.+.+.... ..+.
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~-----~~~~~~~~~----------~~~~ 218 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK--EE-----LKRRTLEMA----------VEYP 218 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccH--HH-----HHhcccccc----------ccCC
Confidence 788999999999888999999999999999999999999654321110 00 111110000 0111
Q ss_pred HHHHHHHHHHHHHHhccCCCCCCCHHH
Q 046750 604 ESEMFRMIEAAAACVRHSGPKRPRMVQ 630 (723)
Q Consensus 604 ~~~~~~l~~l~~~cl~~dP~~RPs~~e 630 (723)
......+.+++.+||+.+|.+||+..+
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 219 DKFSPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred ccCCHHHHHHHHHHccCChhHccCCCc
Confidence 112336789999999999999994444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=309.11 Aligned_cols=258 Identities=20% Similarity=0.276 Sum_probs=183.0
Q ss_pred cCcccceEEeccCcEEEEEEEcCC----CcEEEEEEcccCCchhH-----------HHHHHHHHHHHHccCCceeeEeee
Q 046750 360 NGFARENVIGEGGFGCVYKGNLPE----GKVVAVKQLKSGSGQGE-----------REFRAEVEIISRVHHRHLVSLVGY 424 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~~----g~~VAvK~l~~~~~~~~-----------~~~~~Ei~il~~l~HpnIv~l~g~ 424 (723)
++|++.++||+|+||.||+|.+.+ +..+++|+......... .....++..+..++|.||++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 679999999999999999997644 34666775433221111 111223344555689999999997
Q ss_pred eeccc----ceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcE
Q 046750 425 CISEK----NRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEA 500 (723)
Q Consensus 425 ~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~v 500 (723)
+.... ..++++|++ ..++.+++.... ...+..++.|+.||++||+|||++ +|+||||||+||||+.++.+
T Consensus 92 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKL-VENTKEIFKRIK--CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred eeEecCCceEEEEEEehh-ccCHHHHHHhhc--cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCcE
Confidence 76543 236777776 345555554322 245777889999999999999998 59999999999999999999
Q ss_pred EEeecccccccCCCCcce------eecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhH
Q 046750 501 QVADFGLAKLNDTTQTHV------STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLV 574 (723)
Q Consensus 501 kL~DFGla~~~~~~~~~~------~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~ 574 (723)
+|+|||+++.+....... .....||..|+|||++.+..++.++|||||||+||||++|+.||....... .+.
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~--~~~ 243 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG--NLI 243 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch--HHH
Confidence 999999998654322111 122469999999999999999999999999999999999999997653211 111
Q ss_pred HhhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 046750 575 EWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALD 636 (723)
Q Consensus 575 ~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~ 636 (723)
......+...+..+.+ . .......+.+++..|+..++++||++.+|++.|+
T Consensus 244 ~~~~~~~~~~~~~~~~--------~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 244 HAAKCDFIKRLHEGKI--------K---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHhHHHHHHHhhhhhh--------c---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 1111111122222211 0 0112346889999999999999999999999874
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=306.80 Aligned_cols=242 Identities=26% Similarity=0.338 Sum_probs=185.1
Q ss_pred EEeccCcEEEEEEEc-CCCcEEEEEEcccCCc---hhHHHHHHHHHHHHH---ccCCceeeEeeeeecccceEEEEEecC
Q 046750 367 VIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSG---QGEREFRAEVEIISR---VHHRHLVSLVGYCISEKNRLLIYEFVP 439 (723)
Q Consensus 367 ~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~---~~~~~~~~Ei~il~~---l~HpnIv~l~g~~~~~~~~~lV~E~~~ 439 (723)
+||+|+||.||++.. .+++.||||.+..... .....+.+|..+++. .+|+||+.+++++...+..++||||+.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999965 4588999999865421 222334455544444 479999999999999999999999999
Q ss_pred CCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCccee
Q 046750 440 NNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVS 519 (723)
Q Consensus 440 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 519 (723)
+++|.+++.... .+.+..+..|+.||+.||+|||++ +|+|||||++|||+++++.++|+|||++........
T Consensus 81 ~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~--- 152 (279)
T cd05633 81 GGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--- 152 (279)
T ss_pred CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc---
Confidence 999999887544 489999999999999999999999 499999999999999999999999999875543222
Q ss_pred ecccccccccChhhhcc-CCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhh
Q 046750 520 TRVMGTFGYLAPEYASS-GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRL 598 (723)
Q Consensus 520 ~~~~gt~~y~APE~~~~-~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l 598 (723)
....|+..|+|||++.. ..++.++|||||||+||||++|+.||..........+..+ ... .+
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~--------~~~------~~--- 215 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM--------TLT------VN--- 215 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH--------hhc------CC---
Confidence 22458999999999864 5589999999999999999999999975432111111000 000 00
Q ss_pred hccccHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 046750 599 EKHYVESEMFRMIEAAAACVRHSGPKRP-----RMVQVVRA 634 (723)
Q Consensus 599 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~eVl~~ 634 (723)
..........+.+++.+||+.||.+|+ ++.+|++.
T Consensus 216 -~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 216 -VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred -cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 011112234678889999999999999 58888775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=315.02 Aligned_cols=265 Identities=19% Similarity=0.265 Sum_probs=193.3
Q ss_pred eEEecc--CcEEEEEEEc-CCCcEEEEEEcccCC--chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEecCC
Q 046750 366 NVIGEG--GFGCVYKGNL-PEGKVVAVKQLKSGS--GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPN 440 (723)
Q Consensus 366 ~~LG~G--~fG~Vy~~~~-~~g~~VAvK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 440 (723)
..||+| +||.||++.. ..|+.||||++.... ....+.+++|+.+++.++|+||++++++|..++..++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 345666 9999999965 578999999987542 22345788999999999999999999999999999999999999
Q ss_pred CchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcce--
Q 046750 441 NNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHV-- 518 (723)
Q Consensus 441 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~-- 518 (723)
++|.+++.......+++..+..++.||+.||+|||+. +|+|||||++||||+.++.++|+||+.+..........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 9999998765545588889999999999999999998 59999999999999999999999998654322111100
Q ss_pred ----eecccccccccChhhhccC--CCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhh-----------
Q 046750 519 ----STRVMGTFGYLAPEYASSG--KLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVL----------- 581 (723)
Q Consensus 519 ----~~~~~gt~~y~APE~~~~~--~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l----------- 581 (723)
.....++..|++||++.+. .++.++|||||||+||||++|+.||...... ..+........
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT--QMLLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH--HHHHHHhcCCCCCCccccccch
Confidence 0112345679999999764 4789999999999999999999999754321 11111000000
Q ss_pred -----------------hhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 046750 582 -----------------VRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRAL 635 (723)
Q Consensus 582 -----------------~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L 635 (723)
...+..+....+.+..+...........+.+|+.+||+.||++||++.||++.-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~ 309 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHA 309 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCH
Confidence 000000000011111222222233455789999999999999999999998643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=310.71 Aligned_cols=248 Identities=26% Similarity=0.400 Sum_probs=194.7
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCc---hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSG---QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 435 (723)
+.|...+.||+|+||.||+|.. .+++.||||++..... ....++.+|++++++++|+||++++++|.+.+..|+||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 5588889999999999999965 4688999999864322 23356889999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ 515 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 515 (723)
||+. |+|.+++..... .+.+..+..++.||+.||.|||+. +|+||||+++|||+++++.+||+|||++......
T Consensus 95 e~~~-g~l~~~~~~~~~-~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~- 168 (307)
T cd06607 95 EYCL-GSASDILEVHKK-PLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA- 168 (307)
T ss_pred HhhC-CCHHHHHHHccc-CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence 9996 567666654332 478999999999999999999998 5999999999999999999999999998755332
Q ss_pred cceeecccccccccChhhhc---cCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCccc
Q 046750 516 THVSTRVMGTFGYLAPEYAS---SGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSE 592 (723)
Q Consensus 516 ~~~~~~~~gt~~y~APE~~~---~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~ 592 (723)
....++..|+|||++. .+.++.++|||||||++|||++|+.||...... ... ..+..+....
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~---~~~--------~~~~~~~~~~ 233 (307)
T cd06607 169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SAL--------YHIAQNDSPT 233 (307)
T ss_pred ----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH---HHH--------HHHhcCCCCC
Confidence 2245788999999874 456889999999999999999999998644211 100 0011111111
Q ss_pred ccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 046750 593 IVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALD 636 (723)
Q Consensus 593 ~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~ 636 (723)
+. .......+.+++.+||+.+|.+||++.+|+....
T Consensus 234 ~~--------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 269 (307)
T cd06607 234 LS--------SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRF 269 (307)
T ss_pred CC--------chhhCHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence 10 0112346789999999999999999999987543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=309.55 Aligned_cols=269 Identities=23% Similarity=0.326 Sum_probs=197.4
Q ss_pred HHhcCcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCCc--hhHHHHHHHHHHHHHccCCceeeEeeeeeccc----
Q 046750 357 EITNGFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGSG--QGEREFRAEVEIISRVHHRHLVSLVGYCISEK---- 429 (723)
Q Consensus 357 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~---- 429 (723)
...++|++.+.||+|+||.||+|..+ +++.||||+++.... .....+.+|++++++++|+||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34578999999999999999999664 588999999975432 23346788999999999999999999987655
Q ss_pred ------ceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEe
Q 046750 430 ------NRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVA 503 (723)
Q Consensus 430 ------~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~ 503 (723)
..++|+||+.+ +|..++... ...+++..++.|+.||+.||+|||+. +|+|||||++|||+++++.+||+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeC
Confidence 78999999965 676766544 23588999999999999999999999 59999999999999999999999
Q ss_pred ecccccccCCCCcceeecccccccccChhhhccC-CCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhh
Q 046750 504 DFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSG-KLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLV 582 (723)
Q Consensus 504 DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~ 582 (723)
|||++...............++..|++||++.+. .++.++|||+|||++|||++|+.+|...... ..+..... ...
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~--~~~~~~~~-~~~ 235 (302)
T cd07864 159 DFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL--AQLELISR-LCG 235 (302)
T ss_pred cccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHH-HhC
Confidence 9999986654332222333467889999988653 5788999999999999999999999754321 11111100 000
Q ss_pred -------hhhhcCCcccccc------hhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 583 -------RAIETGDLSEIVD------PRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 583 -------~~i~~~~l~~~vd------~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
..+.........+ ..+...+. .....+.+++.+||+.+|.+||++.+|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 236 SPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFS-FIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred CCChhhcccccccccccccccccccccchhhhcC-CCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000000000000 01101000 113468899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=327.00 Aligned_cols=271 Identities=25% Similarity=0.377 Sum_probs=203.4
Q ss_pred CcccceEEeccCcEEEEEEE-cCCCcEEEEEEcccCCc-hhHHHHHHHHHHHHHccCCceeeEeeeeeccc------ceE
Q 046750 361 GFARENVIGEGGFGCVYKGN-LPEGKVVAVKQLKSGSG-QGEREFRAEVEIISRVHHRHLVSLVGYCISEK------NRL 432 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~-~~~g~~VAvK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~------~~~ 432 (723)
.|...+.||+|+||.||+|+ .+.|+.||||.++.... ...+...+|+++|++|+|+|||+++++-+... ..+
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 35667899999999999997 66799999999987543 33456779999999999999999999766543 468
Q ss_pred EEEEecCCCchhhccccC-CCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeC----CCCcEEEeeccc
Q 046750 433 LIYEFVPNNNLEHHLHGK-GQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVD----DEFEAQVADFGL 507 (723)
Q Consensus 433 lV~E~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~----~~~~vkL~DFGl 507 (723)
+|||||.+|+|+.+|++- ....|.+...+.++.+++.||.|||++ +||||||||.||++- .....||+|||+
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 999999999999999763 335699999999999999999999998 599999999999984 233589999999
Q ss_pred ccccCCCCcceeecccccccccChhhhc-cCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhh
Q 046750 508 AKLNDTTQTHVSTRVMGTFGYLAPEYAS-SGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIE 586 (723)
Q Consensus 508 a~~~~~~~~~~~~~~~gt~~y~APE~~~-~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~ 586 (723)
|+...++. ....++||..|++||++. .+.|+.-+|.|||||++||++||..||...........+.|.. +.+.-
T Consensus 171 Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~--~tkkp- 245 (732)
T KOG4250|consen 171 ARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHI--ITKKP- 245 (732)
T ss_pred cccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhh--hccCC-
Confidence 99877655 567788999999999998 4889999999999999999999999997654432212222221 11110
Q ss_pred cCCcccccchhh------------hccccHHHHHHHHHHHHHHhccCCCCCC--CHHHHHHHHhccCC
Q 046750 587 TGDLSEIVDPRL------------EKHYVESEMFRMIEAAAACVRHSGPKRP--RMVQVVRALDSEGE 640 (723)
Q Consensus 587 ~~~l~~~vd~~l------------~~~~~~~~~~~l~~l~~~cl~~dP~~RP--s~~eVl~~L~~~~~ 640 (723)
.+ +.-.+++.. ..........++-..+..+|..++++|- ...+....+..++.
T Consensus 246 ~~-v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 246 SG-VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred Cc-eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 00 000011111 1122333444566677778888888888 66565555555444
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=299.46 Aligned_cols=250 Identities=24% Similarity=0.401 Sum_probs=203.8
Q ss_pred CcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCCc--hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEe
Q 046750 361 GFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGSG--QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEF 437 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 437 (723)
+|.+.+.||+|+||.||++... +++.|+||++..... .....+.+|+++++.++|+|++++++.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4788899999999999999654 588999999876533 4556788999999999999999999999999999999999
Q ss_pred cCCCchhhccccCC--CCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 046750 438 VPNNNLEHHLHGKG--QPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ 515 (723)
Q Consensus 438 ~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 515 (723)
+.+++|.+++.... ...+++..++.++.+|+.||.|||+. +++|+||+++|||+++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999987642 34689999999999999999999999 59999999999999999999999999997665433
Q ss_pred cceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccc
Q 046750 516 THVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVD 595 (723)
Q Consensus 516 ~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd 595 (723)
.......|+..|++||++.+..++.++|||+||+++|+|++|+.||+.... .. +...+..+.+..+
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~------~~-----~~~~~~~~~~~~~-- 223 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL------LE-----LALKILKGQYPPI-- 223 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH------HH-----HHHHHhcCCCCCC--
Confidence 122334688899999999988999999999999999999999999865431 11 1111112222111
Q ss_pred hhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 596 PRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 596 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
.......+.+++.+||..+|.+||++.+|++.
T Consensus 224 -------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 224 -------PSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred -------CCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11122467889999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=305.29 Aligned_cols=267 Identities=21% Similarity=0.351 Sum_probs=197.9
Q ss_pred CcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCCch-hHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEec
Q 046750 361 GFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGSGQ-GEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFV 438 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 438 (723)
+|++.++||+|+||.||+|... +|+.||||+++..... ....+.+|++++++++|+||++++++|.+.+..+|||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5888999999999999999664 5889999998765332 3456778999999999999999999999999999999999
Q ss_pred CCCchhhccccCC-CCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcc
Q 046750 439 PNNNLEHHLHGKG-QPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTH 517 (723)
Q Consensus 439 ~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 517 (723)
. ++|.+++.... ...+++..++.++.||++||+|||+. +|+|||||++|||+++++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 D-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred C-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 7 48888776543 23589999999999999999999998 599999999999999999999999999975543222
Q ss_pred eeecccccccccChhhhccC-CCCCccceechHHHHHHHHhCCCCCCCCCCCCch-hhHHhhhhhh---hhhhh-----c
Q 046750 518 VSTRVMGTFGYLAPEYASSG-KLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDE-SLVEWARPVL---VRAIE-----T 587 (723)
Q Consensus 518 ~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~-~l~~~~~~~l---~~~i~-----~ 587 (723)
......++..|++||++.+. .++.++|||+|||++|||++|+.||......... ....+..... .+.+. .
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK 235 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence 11233578899999988664 5788999999999999999999999755421100 0000000000 00000 0
Q ss_pred CCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 046750 588 GDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVR 633 (723)
Q Consensus 588 ~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~ 633 (723)
..+....+..+ ..+.......+.+++.+||+.+|.+||++.+|++
T Consensus 236 ~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 236 PTFPRYPPQDL-QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred ccccCCChHHH-HHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 01111111111 1111122346789999999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=305.75 Aligned_cols=262 Identities=22% Similarity=0.275 Sum_probs=193.5
Q ss_pred cccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCC-chhHHHHHHHHHHHHHcc-CCceeeEeeeeecc--cceEEEEE
Q 046750 362 FARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS-GQGEREFRAEVEIISRVH-HRHLVSLVGYCISE--KNRLLIYE 436 (723)
Q Consensus 362 f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~-~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~--~~~~lV~E 436 (723)
|++.+.||+|+||.||+|.. .+++.||||+++... ........+|+.++.++. |+||+++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 56789999999999999954 568899999987642 222334567999999995 99999999999987 88999999
Q ss_pred ecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCc
Q 046750 437 FVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQT 516 (723)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 516 (723)
|+. ++|.+++.... ..+++..++.++.||+.||+|||+. +|+||||++.||||++ +.+||+|||+++.......
T Consensus 81 ~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~ 154 (282)
T cd07831 81 LMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP 154 (282)
T ss_pred cCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence 996 57777776533 3589999999999999999999998 5999999999999999 9999999999976543322
Q ss_pred ceeecccccccccChhhhcc-CCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhh-------hhhhhcC
Q 046750 517 HVSTRVMGTFGYLAPEYASS-GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVL-------VRAIETG 588 (723)
Q Consensus 517 ~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l-------~~~i~~~ 588 (723)
. ....++..|+|||++.. +.++.++|||||||+||||++|..||..... ...+.+....+ .+.....
T Consensus 155 ~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07831 155 Y--TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE---LDQIAKIHDVLGTPDAEVLKKFRKS 229 (282)
T ss_pred c--CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH---HHHHHHHHHHcCCCCHHHHHhhccc
Confidence 1 23457889999997654 5578899999999999999999999965432 11122211110 0011000
Q ss_pred Ccccccchhhh----ccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 589 DLSEIVDPRLE----KHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 589 ~l~~~vd~~l~----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
....+..+... ..........+.+++.+||+.+|.+||++.+|++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 230 RHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred ccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00000000000 00011234578999999999999999999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=315.94 Aligned_cols=270 Identities=23% Similarity=0.347 Sum_probs=197.3
Q ss_pred HHhcCcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccC--CchhHHHHHHHHHHHHHc-cCCceeeEeeeeecc--cc
Q 046750 357 EITNGFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSG--SGQGEREFRAEVEIISRV-HHRHLVSLVGYCISE--KN 430 (723)
Q Consensus 357 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~--~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~--~~ 430 (723)
.+.++|++.+.||+|+||.||+|... +++.||||++... .......+.+|+.+++++ +|+||++++++|... ..
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 35678999999999999999999654 5789999988543 223345677899999999 999999999998654 35
Q ss_pred eEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccc
Q 046750 431 RLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKL 510 (723)
Q Consensus 431 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 510 (723)
.|+||||+. ++|..++... .+++..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||+++.
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 84 IYLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 799999996 6898888654 578889999999999999999998 599999999999999999999999999976
Q ss_pred cCCCCcc----eeecccccccccChhhhcc-CCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhh----h
Q 046750 511 NDTTQTH----VSTRVMGTFGYLAPEYASS-GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPV----L 581 (723)
Q Consensus 511 ~~~~~~~----~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~----l 581 (723)
....... ......|+..|++||++.+ ..++.++|||||||+||||++|+.+|.............+.... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 5433221 2233568899999998765 45888999999999999999999999654321110000000000 0
Q ss_pred hhhhhcCCcccccc-------hhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 582 VRAIETGDLSEIVD-------PRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 582 ~~~i~~~~l~~~vd-------~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
...+.......+++ ..+. .........+.+++.+||+.+|.+||++.+|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 237 IESIKSPFAATMLDSLPSRPRKPLD-ELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHhhhHHHhhhhcccccccchh-hhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00000000000000 0000 0011123468899999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=307.80 Aligned_cols=262 Identities=21% Similarity=0.298 Sum_probs=193.6
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCc--hhHHHHHHHHHHHHHcc-CCceeeEeeeeecccc-----
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSG--QGEREFRAEVEIISRVH-HRHLVSLVGYCISEKN----- 430 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~--~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~----- 430 (723)
++|++.+.||+|+||.||+|.. .+++.||||+++.... .....+.+|+.+++++. |+||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4688999999999999999965 4689999999765422 23357888999999995 6999999999987665
Q ss_pred eEEEEEecCCCchhhccccCC---CCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCC-CCcEEEeecc
Q 046750 431 RLLIYEFVPNNNLEHHLHGKG---QPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDD-EFEAQVADFG 506 (723)
Q Consensus 431 ~~lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~-~~~vkL~DFG 506 (723)
.|+||||+.+ +|.+++.... ...+.+..++.++.||++||.|||++ +|+|||||++||||+. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999975 7888875432 23578999999999999999999999 5999999999999998 8899999999
Q ss_pred cccccCCCCcceeecccccccccChhhhcc-CCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhh
Q 046750 507 LAKLNDTTQTHVSTRVMGTFGYLAPEYASS-GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAI 585 (723)
Q Consensus 507 la~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i 585 (723)
+++.+..... ......++..|+|||++.+ ..++.++|||||||+||||++|..||....... .+.. +.+.+
T Consensus 157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~--~~~~-----~~~~~ 228 (295)
T cd07837 157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ--QLLH-----IFKLL 228 (295)
T ss_pred cceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH--HHHH-----HHHHh
Confidence 9875532211 1122346788999998865 457999999999999999999999997543211 1110 00111
Q ss_pred hcCC---ccc---c---------cchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 586 ETGD---LSE---I---------VDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 586 ~~~~---l~~---~---------vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
.... +.. + ....+ ..........+.+++.+||+.+|.+||++.||+..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 229 GTPTEQVWPGVSKLRDWHEFPQWKPQDL-SRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred CCCChhhCcchhhccchhhcCcccchhH-HHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000 000 0 00000 00011223467899999999999999999998863
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=307.60 Aligned_cols=251 Identities=25% Similarity=0.329 Sum_probs=195.2
Q ss_pred CcccceEEeccCcEEEEEEEc----CCCcEEEEEEcccCCc----hhHHHHHHHHHHHHHc-cCCceeeEeeeeecccce
Q 046750 361 GFARENVIGEGGFGCVYKGNL----PEGKVVAVKQLKSGSG----QGEREFRAEVEIISRV-HHRHLVSLVGYCISEKNR 431 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~~----~~g~~VAvK~l~~~~~----~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~ 431 (723)
+|++.+.||+|+||.||+++. .+|+.||+|+++.... ...+.+.+|+++|+++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478889999999999999965 3688999999875321 2335678899999999 599999999999998889
Q ss_pred EEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeeccccccc
Q 046750 432 LLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLN 511 (723)
Q Consensus 432 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 511 (723)
|+||||+.+++|.+++.... .+.+..+..++.||++||.|||+. +|+||||+++||||++++.+||+|||++...
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE--RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 99999999999999987543 477888899999999999999998 5999999999999999999999999999866
Q ss_pred CCCCcceeecccccccccChhhhccC--CCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCC
Q 046750 512 DTTQTHVSTRVMGTFGYLAPEYASSG--KLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGD 589 (723)
Q Consensus 512 ~~~~~~~~~~~~gt~~y~APE~~~~~--~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~ 589 (723)
............|+..|++||++.+. .++.++|||||||+||||++|+.||...... ....++.. .+....
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--~~~~~~~~-----~~~~~~ 228 (290)
T cd05613 156 HEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK--NSQAEISR-----RILKSE 228 (290)
T ss_pred ccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc--ccHHHHHH-----HhhccC
Confidence 44333223345688999999998754 4788999999999999999999999653321 11122211 111110
Q ss_pred cccccchhhhccccHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHH
Q 046750 590 LSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRP-----RMVQVVR 633 (723)
Q Consensus 590 l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~eVl~ 633 (723)
..+.......+.+++.+||+.+|.+|+ ++.+++.
T Consensus 229 ----------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 229 ----------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ----------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 011112234678899999999999997 5555543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=304.29 Aligned_cols=246 Identities=25% Similarity=0.376 Sum_probs=196.6
Q ss_pred EeccCcEEEEEEEcCC-CcEEEEEEcccCCc---hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEecCCCch
Q 046750 368 IGEGGFGCVYKGNLPE-GKVVAVKQLKSGSG---QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNL 443 (723)
Q Consensus 368 LG~G~fG~Vy~~~~~~-g~~VAvK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 443 (723)
||+|+||.||++.... |+.|+||++..... ...+.+.+|++++++++|+||+++++++......|+||||+.+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999997654 89999999876533 3445788999999999999999999999999999999999999999
Q ss_pred hhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCc-------
Q 046750 444 EHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQT------- 516 (723)
Q Consensus 444 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~------- 516 (723)
.+++++.. .+++..++.++.||++||+|||+. +|+||||+++|||+++++.++|+|||++........
T Consensus 81 ~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 81 ASLLENVG--SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 99997654 488999999999999999999998 599999999999999999999999999875433211
Q ss_pred ceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccch
Q 046750 517 HVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDP 596 (723)
Q Consensus 517 ~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~ 596 (723)
.......++..|++||++....++.++|||+||+++|||++|+.||..... ..+ .+.+..+.+....
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~---~~~--------~~~~~~~~~~~~~-- 222 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP---EEI--------FQNILNGKIEWPE-- 222 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH---HHH--------HHHHhcCCcCCCc--
Confidence 122334578899999999988899999999999999999999999975431 111 1111112111000
Q ss_pred hhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhc
Q 046750 597 RLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDS 637 (723)
Q Consensus 597 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~ 637 (723)
. ......+.+++.+||+.+|.+||++.+|.+.|+-
T Consensus 223 ----~--~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 223 ----D--VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred ----c--ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 0 0013467899999999999999999777766653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=316.51 Aligned_cols=274 Identities=19% Similarity=0.301 Sum_probs=200.1
Q ss_pred HhcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCC--chhHHHHHHHHHHHHHccCCceeeEeeeeec----ccc
Q 046750 358 ITNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS--GQGEREFRAEVEIISRVHHRHLVSLVGYCIS----EKN 430 (723)
Q Consensus 358 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~----~~~ 430 (723)
+.++|++.+.||+|+||.||+|.. .+|+.||||++.... ......+.+|+.+|++++|+||++++++|.. ...
T Consensus 3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 82 (334)
T cd07855 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD 82 (334)
T ss_pred hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence 347899999999999999999954 468999999987542 2334567889999999999999999998763 346
Q ss_pred eEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccc
Q 046750 431 RLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKL 510 (723)
Q Consensus 431 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 510 (723)
.++||||+. ++|.+++.... .+.+..++.++.||+.||+|||++ +|+|||||++|||+++++.+||+|||++..
T Consensus 83 ~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 83 VYVVMDLME-SDLHHIIHSDQ--PLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEEehhh-hhHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEeccccccee
Confidence 799999994 68988887544 388999999999999999999998 599999999999999999999999999975
Q ss_pred cCCCCcc---eeecccccccccChhhhcc-CCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhh-h---hhhh
Q 046750 511 NDTTQTH---VSTRVMGTFGYLAPEYASS-GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWA-R---PVLV 582 (723)
Q Consensus 511 ~~~~~~~---~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~-~---~~l~ 582 (723)
....... ......|+..|++||++.+ ..++.++|||||||++|||++|+.||.............-. . ..+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence 5432221 1223468899999999865 46899999999999999999999999764321100000000 0 0000
Q ss_pred hhhhcCCcccccchhh-h-----ccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhc
Q 046750 583 RAIETGDLSEIVDPRL-E-----KHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDS 637 (723)
Q Consensus 583 ~~i~~~~l~~~vd~~l-~-----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~ 637 (723)
+.+....+.+.++..- . ..........+.+++.+||+.+|.+||++.+|+..-.-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~ 297 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFL 297 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhh
Confidence 0011111111111000 0 00111224578899999999999999999999885543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=337.94 Aligned_cols=257 Identities=26% Similarity=0.421 Sum_probs=207.9
Q ss_pred cCcccceEEeccCcEEEEEEEcCC--------CcEEEEEEcccCCc-hhHHHHHHHHHHHHHc-cCCceeeEeeeeeccc
Q 046750 360 NGFARENVIGEGGFGCVYKGNLPE--------GKVVAVKQLKSGSG-QGEREFRAEVEIISRV-HHRHLVSLVGYCISEK 429 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~~--------g~~VAvK~l~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~ 429 (723)
+++.+.+.||+|.||.||+|.+.. ...||||+++.... .+.+.+..|+++|+.+ +|+||+.++|+|....
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~ 375 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG 375 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence 445666799999999999995431 35799999987643 4556899999999999 6999999999999988
Q ss_pred ceEEEEEecCCCchhhccccCC------------C--CcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeC
Q 046750 430 NRLLIYEFVPNNNLEHHLHGKG------------Q--PVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVD 495 (723)
Q Consensus 430 ~~~lV~E~~~~gsL~~~l~~~~------------~--~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~ 495 (723)
..++|+||+..|+|.++|+.++ . ..|....++.+++|||.|++||++. ++|||||..+||||.
T Consensus 376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLIT 452 (609)
T ss_pred ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEec
Confidence 9999999999999999997655 0 2388889999999999999999999 699999999999999
Q ss_pred CCCcEEEeecccccccCCCCcceeeccc--ccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchh
Q 046750 496 DEFEAQVADFGLAKLNDTTQTHVSTRVM--GTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDES 572 (723)
Q Consensus 496 ~~~~vkL~DFGla~~~~~~~~~~~~~~~--gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~ 572 (723)
++..+||+||||++.............. -...|||||.+....|+.|+|||||||+||||++ |..||..... ...
T Consensus 453 ~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~--~~~ 530 (609)
T KOG0200|consen 453 KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP--TEE 530 (609)
T ss_pred CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc--HHH
Confidence 9999999999999976555544433222 2457999999999999999999999999999999 7788865211 111
Q ss_pred hHHhhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhcc
Q 046750 573 LVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSE 638 (723)
Q Consensus 573 l~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~ 638 (723)
+ .+.++.|... ..+.....+++++|+.||+.+|++||++.++++.|+.+
T Consensus 531 l--------~~~l~~G~r~---------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 531 L--------LEFLKEGNRM---------EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred H--------HHHHhcCCCC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 2 2334444421 11222345788999999999999999999999999884
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=300.72 Aligned_cols=248 Identities=24% Similarity=0.406 Sum_probs=202.2
Q ss_pred CcccceEEeccCcEEEEEEE-cCCCcEEEEEEcccCC--chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEe
Q 046750 361 GFARENVIGEGGFGCVYKGN-LPEGKVVAVKQLKSGS--GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEF 437 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~-~~~g~~VAvK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 437 (723)
+|++.++||+|+||.||++. ..+++.|+||.+.... .....++.+|++++++++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 47889999999999999994 4568899999987542 23345678899999999999999999999999999999999
Q ss_pred cCCCchhhccccC--CCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 046750 438 VPNNNLEHHLHGK--GQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ 515 (723)
Q Consensus 438 ~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 515 (723)
+.+++|.+++.+. ....+++..++.++.+++.||+|||+. +++|+||++.||++++++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 9999999988652 224578899999999999999999998 5999999999999999999999999999766543
Q ss_pred cceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccc
Q 046750 516 THVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVD 595 (723)
Q Consensus 516 ~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd 595 (723)
......++..|++||++.+..++.++||||||+++|||++|+.||..... .. +...+..+.+..+.
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~--------~~~~~~~~~~~~~~- 222 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM---QD--------LRYKVQRGKYPPIP- 222 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HH--------HHHHHhcCCCCCCc-
Confidence 12224578899999999999999999999999999999999999975432 11 11122222222221
Q ss_pred hhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 596 PRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 596 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
......+.+++.+||+.+|.+||++.+|++.
T Consensus 223 --------~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 223 --------PIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred --------hhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1233468899999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=306.00 Aligned_cols=266 Identities=22% Similarity=0.319 Sum_probs=197.7
Q ss_pred cccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCCc-hhHHHHHHHHHHHHHcc-CCceeeEeeeeecccceEEEEEec
Q 046750 362 FARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGSG-QGEREFRAEVEIISRVH-HRHLVSLVGYCISEKNRLLIYEFV 438 (723)
Q Consensus 362 f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~~-~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~E~~ 438 (723)
|++.+.||+|+||.||+|... +++.|+||++..... .....+.+|+..+++++ |+||+++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 677899999999999999765 478899999876432 22334567999999999 999999999999999999999999
Q ss_pred CCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcce
Q 046750 439 PNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHV 518 (723)
Q Consensus 439 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 518 (723)
+|+|.+++.......+.+..++.++.||+.+|.|||++ +|+|+||++.|||+++++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 154 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-- 154 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--
Confidence 88999988766545689999999999999999999998 599999999999999999999999999976543322
Q ss_pred eecccccccccChhhhcc-CCCCCccceechHHHHHHHHhCCCCCCCCCCCCchh----------hHHhhhhhhhhhhhc
Q 046750 519 STRVMGTFGYLAPEYASS-GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDES----------LVEWARPVLVRAIET 587 (723)
Q Consensus 519 ~~~~~gt~~y~APE~~~~-~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~----------l~~~~~~~l~~~i~~ 587 (723)
.....++..|+|||++.. ..++.++||||||++||||++|+.+|.......... ...|...........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 123457889999998754 458999999999999999999999986543211000 001111000000000
Q ss_pred CCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 588 GDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 588 ~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
..+.......+. .+.......+.+++.+||+.+|.+||++.||+..
T Consensus 235 ~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 235 FRFPQFAPTSLH-QLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccHH-HHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 000000000110 1111113468899999999999999999999764
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=302.23 Aligned_cols=263 Identities=23% Similarity=0.355 Sum_probs=196.3
Q ss_pred cccceEEeccCcEEEEEEEcCC-CcEEEEEEcccCCch--hHHHHHHHHHHHHHc---cCCceeeEeeeeecccc-----
Q 046750 362 FARENVIGEGGFGCVYKGNLPE-GKVVAVKQLKSGSGQ--GEREFRAEVEIISRV---HHRHLVSLVGYCISEKN----- 430 (723)
Q Consensus 362 f~~~~~LG~G~fG~Vy~~~~~~-g~~VAvK~l~~~~~~--~~~~~~~Ei~il~~l---~HpnIv~l~g~~~~~~~----- 430 (723)
|++.+.||+|+||.||+|+++. ++.||||+++..... ....+.+|+.+++++ +|+||++++++|.+.+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 6778999999999999997654 899999999754222 234567788888777 59999999999988776
Q ss_pred eEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccc
Q 046750 431 RLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKL 510 (723)
Q Consensus 431 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 510 (723)
.+++|||+. ++|.+++.......+++..++.++.||++||+|||+. +|+|+||+++|||+++++.+||+|||++..
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCccee
Confidence 899999996 5788888765444589999999999999999999998 599999999999999999999999999976
Q ss_pred cCCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhh-hh--h-
Q 046750 511 NDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVR-AI--E- 586 (723)
Q Consensus 511 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~-~i--~- 586 (723)
...... .....++..|++||++.+..++.++|||||||++|||++|+.+|..... .+.+..+....... .. .
T Consensus 157 ~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07838 157 YSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE--ADQLDKIFDVIGLPSEEEWPR 232 (287)
T ss_pred ccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh--HHHHHHHHHHcCCCChHhcCC
Confidence 543322 1233478899999999999999999999999999999999998875432 11111111100000 00 0
Q ss_pred -----cCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 046750 587 -----TGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVR 633 (723)
Q Consensus 587 -----~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~ 633 (723)
...+.......+ ..........+.+++.+||+.||.+||++.+|++
T Consensus 233 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 233 NVSLPRSSFPSYTPRSF-KSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred Ccccchhhcccccccch-hhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 000000000000 1111123356778999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=308.83 Aligned_cols=268 Identities=22% Similarity=0.311 Sum_probs=193.7
Q ss_pred hcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCc--hhHHHHHHHHHHHHHccCCceeeEeeeeecccc-----
Q 046750 359 TNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSG--QGEREFRAEVEIISRVHHRHLVSLVGYCISEKN----- 430 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~----- 430 (723)
.++|++.++||+|+||.||+|.. .+++.||||++..... .....+.+|++++++++|+||++++++|.....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 35799999999999999999955 4689999999865422 223356789999999999999999999876543
Q ss_pred ---eEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeeccc
Q 046750 431 ---RLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGL 507 (723)
Q Consensus 431 ---~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGl 507 (723)
.++||||+. ++|.+++.... ..+.+..++.++.||+.||+|||++ +|+|+|||++||||+.++.+||+|||+
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCC
Confidence 499999995 57877776543 2478999999999999999999999 599999999999999999999999999
Q ss_pred ccccCCCCcc---eeecccccccccChhhhccCC-CCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhh
Q 046750 508 AKLNDTTQTH---VSTRVMGTFGYLAPEYASSGK-LTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVR 583 (723)
Q Consensus 508 a~~~~~~~~~---~~~~~~gt~~y~APE~~~~~~-~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~ 583 (723)
+......... ......++..|+|||++.+.. ++.++|||||||+||||++|+.+|..................+..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP 245 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 9765432221 112345788999999887654 788999999999999999999998765432111111110000000
Q ss_pred ----hhh----------cCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 584 ----AIE----------TGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 584 ----~i~----------~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
... .......+..++.... +...+.+++.+||+.||.+||++.++++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~---~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYV---KDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hhcccccchhhhhhccCCCccchhhHHhccccc---CCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 000 0000000001110000 12356789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=305.89 Aligned_cols=256 Identities=25% Similarity=0.300 Sum_probs=199.4
Q ss_pred CcccceEEeccCcEEEEEEEc----CCCcEEEEEEcccCC----chhHHHHHHHHHHHHHc-cCCceeeEeeeeecccce
Q 046750 361 GFARENVIGEGGFGCVYKGNL----PEGKVVAVKQLKSGS----GQGEREFRAEVEIISRV-HHRHLVSLVGYCISEKNR 431 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~~----~~g~~VAvK~l~~~~----~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~ 431 (723)
+|++.+.||+|+||.||+++. .+++.||||+++... ......+..|++++.++ +|+||+++++++..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 478889999999999999854 356889999987532 12335678899999999 599999999999999999
Q ss_pred EEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeeccccccc
Q 046750 432 LLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLN 511 (723)
Q Consensus 432 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 511 (723)
++||||+.+++|.+++.... .+.+..+..++.|++++|.|||+. +++|||||+.|||++.++.++|+|||+++..
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE--HFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC--CcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 99999999999999986543 478888999999999999999998 5999999999999999999999999998765
Q ss_pred CCCCcceeecccccccccChhhhccCC--CCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCC
Q 046750 512 DTTQTHVSTRVMGTFGYLAPEYASSGK--LTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGD 589 (723)
Q Consensus 512 ~~~~~~~~~~~~gt~~y~APE~~~~~~--~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~ 589 (723)
............|+..|++||++.+.. ++.++||||||++||||++|..||....... ...++. +.+....
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~-----~~~~~~~ 228 (288)
T cd05583 156 LAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQSEIS-----RRILKSK 228 (288)
T ss_pred ccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hHHHHH-----HHHHccC
Confidence 443332233346889999999987765 7889999999999999999999996432211 111111 1111110
Q ss_pred cccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhcc
Q 046750 590 LSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSE 638 (723)
Q Consensus 590 l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~ 638 (723)
. .+ .......+.+++.+||+.+|++||++.+|...|+..
T Consensus 229 ~------~~----~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 229 P------PF----PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred C------CC----CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 0 01 111123577899999999999999999888877653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=301.81 Aligned_cols=250 Identities=22% Similarity=0.357 Sum_probs=195.2
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccC-----CchhHHHHHHHHHHHHHccCCceeeEeeeeecc--cce
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSG-----SGQGEREFRAEVEIISRVHHRHLVSLVGYCISE--KNR 431 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~-----~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~ 431 (723)
.+|.+.++||+|+||.||+|.. .+++.|++|.+... .......|++|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4688999999999999999954 56899999987532 223345788999999999999999999998764 457
Q ss_pred EEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeeccccccc
Q 046750 432 LLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLN 511 (723)
Q Consensus 432 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 511 (723)
++|+||+.+++|.+++.... .+.+..+++++.+|+.||.|||+.+ |+|+|||++|||++.++.++|+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 89999999999999987544 3778888999999999999999984 999999999999999999999999999755
Q ss_pred CCCCc--ceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCC
Q 046750 512 DTTQT--HVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGD 589 (723)
Q Consensus 512 ~~~~~--~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~ 589 (723)
..... .......++..|+|||++.+..++.++|||||||+||||++|+.||....... . +.+....+
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~--------~~~~~~~~- 225 (264)
T cd06653 157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA--A--------IFKIATQP- 225 (264)
T ss_pred ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH--H--------HHHHHcCC-
Confidence 32111 11123458899999999998889999999999999999999999996432210 0 11111111
Q ss_pred cccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 590 LSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 590 l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
... .+.......+.+++.+||+. +.+||+..++++.
T Consensus 226 ~~~--------~~p~~~~~~~~~~i~~~l~~-~~~r~~~~~~~~~ 261 (264)
T cd06653 226 TKP--------MLPDGVSDACRDFLKQIFVE-EKRRPTAEFLLRH 261 (264)
T ss_pred CCC--------CCCcccCHHHHHHHHHHhcC-cccCccHHHHhcC
Confidence 111 11222234678899999995 6999999988764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=308.77 Aligned_cols=267 Identities=16% Similarity=0.237 Sum_probs=195.2
Q ss_pred ccceEEeccCcEEEEEEEcCCCcEEEEEEcccC--CchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEecCC
Q 046750 363 ARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSG--SGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPN 440 (723)
Q Consensus 363 ~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 440 (723)
.+.+.+|.|+++.||++.. +++.||||+++.. .......+.+|++++++++|+||+++++++.+.+..+++|||+.+
T Consensus 5 ~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 3445566667777777655 7899999998754 334456799999999999999999999999999999999999999
Q ss_pred CchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcc---
Q 046750 441 NNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTH--- 517 (723)
Q Consensus 441 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~--- 517 (723)
++|.++++......+++..+..++.||++||+|||++ +|+|||||++|||+++++.+||+|||++.........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 9999999865444578888999999999999999999 5999999999999999999999999988644322110
Q ss_pred ---eeecccccccccChhhhccC--CCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhh------
Q 046750 518 ---VSTRVMGTFGYLAPEYASSG--KLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIE------ 586 (723)
Q Consensus 518 ---~~~~~~gt~~y~APE~~~~~--~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~------ 586 (723)
......++..|+|||++.+. .++.++|||||||++|||++|+.||...... ..+.+.....+...+.
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 238 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT--QMLLEKVRGTVPCLLDKSTYPL 238 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhccCccccccCchhh
Confidence 11223467789999998763 5889999999999999999999999754321 1111110000000000
Q ss_pred -cCCccc----ccchhh----hccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 046750 587 -TGDLSE----IVDPRL----EKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRAL 635 (723)
Q Consensus 587 -~~~l~~----~vd~~l----~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L 635 (723)
...... ..+... ...+.......+.+++.+||+.+|.+||++.+|++.-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p 296 (314)
T cd08216 239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHS 296 (314)
T ss_pred hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCc
Confidence 000000 001110 1111222334678899999999999999999998753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=296.19 Aligned_cols=247 Identities=28% Similarity=0.457 Sum_probs=201.3
Q ss_pred CcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCc--hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEe
Q 046750 361 GFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSG--QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEF 437 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 437 (723)
+|++.+.||+|+||.||++.. .+++.|+||.+..... .....+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 478889999999999999955 4678999999987643 3456789999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcc
Q 046750 438 VPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTH 517 (723)
Q Consensus 438 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 517 (723)
+.+++|.+++.... .+++..++.++.|++.+|.|||+. +|+||||+++||+++.++.++|+|||++.........
T Consensus 81 ~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 81 AENGSLRQIIKKFG--PFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred CCCCcHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 99999999987653 488999999999999999999998 5999999999999999999999999999866543332
Q ss_pred eeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchh
Q 046750 518 VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPR 597 (723)
Q Consensus 518 ~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~ 597 (723)
.....++..|++||++.+..++.++|||+||+++|+|++|+.||..... ....|. +.......
T Consensus 156 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~----~~~~~~-------~~~~~~~~----- 218 (254)
T cd06627 156 -DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP----MAALFR-------IVQDDHPP----- 218 (254)
T ss_pred -ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH----HHHHHH-------HhccCCCC-----
Confidence 2334578899999999888899999999999999999999999865431 111111 01111111
Q ss_pred hhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 046750 598 LEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVR 633 (723)
Q Consensus 598 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~ 633 (723)
+ .......+.+++.+||..+|++||++.+++.
T Consensus 219 ~----~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 219 L----PEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred C----CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1 1111346778999999999999999999985
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=313.52 Aligned_cols=268 Identities=21% Similarity=0.301 Sum_probs=200.4
Q ss_pred CcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCC--chhHHHHHHHHHHHHHccCCceeeEeeeeeccc-----ceE
Q 046750 361 GFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGS--GQGEREFRAEVEIISRVHHRHLVSLVGYCISEK-----NRL 432 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~-----~~~ 432 (723)
+|.+.+.||+|+||.||+|... .++.||||++.... ....+.+.+|++++++++|+||+++++++.... ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5888999999999999999664 48999999987653 344567899999999999999999999998775 789
Q ss_pred EEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccC
Q 046750 433 LIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLND 512 (723)
Q Consensus 433 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 512 (723)
+||||+. ++|.++++... .+.+..++.++.+|++||+|||++ +|+|||||+.||||+.++.++|+|||++....
T Consensus 81 lv~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred EEecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 9999996 58888887544 588999999999999999999999 49999999999999999999999999998665
Q ss_pred CCCc--ceeecccccccccChhhhccC-CCCCccceechHHHHHHHHhCCCCCCCCCCCCchh-hHHhhhhhhhhh---h
Q 046750 513 TTQT--HVSTRVMGTFGYLAPEYASSG-KLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDES-LVEWARPVLVRA---I 585 (723)
Q Consensus 513 ~~~~--~~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~-l~~~~~~~l~~~---i 585 (723)
.... .......++..|+|||++.+. .++.++|||||||++|+|++|+.||.......... +..+......+. +
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 234 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI 234 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence 4321 112334578899999999888 79999999999999999999999997654211000 000000000000 0
Q ss_pred hcCCcccccch---hh---hccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 586 ETGDLSEIVDP---RL---EKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 586 ~~~~l~~~vd~---~l---~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
........+.. .. ...........+.+++.+||+++|.+||++.+|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00000000000 00 000011123467899999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=320.51 Aligned_cols=245 Identities=25% Similarity=0.395 Sum_probs=199.7
Q ss_pred EEeccCcEEEEEEEcCC-CcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEecCCCchhh
Q 046750 367 VIGEGGFGCVYKGNLPE-GKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNLEH 445 (723)
Q Consensus 367 ~LG~G~fG~Vy~~~~~~-g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~ 445 (723)
+||+|.||.||-|+..+ ...+|||.+.....+..+-+..||.+.++|+|.|||+++|.|.+++.+.|.||.++||+|..
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 79999999999996655 56799999988777777789999999999999999999999999999999999999999999
Q ss_pred ccccCCCC-cchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeC-CCCcEEEeecccccccCCCCcceeeccc
Q 046750 446 HLHGKGQP-VLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVD-DEFEAQVADFGLAKLNDTTQTHVSTRVM 523 (723)
Q Consensus 446 ~l~~~~~~-~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~-~~~~vkL~DFGla~~~~~~~~~~~~~~~ 523 (723)
+|..+=.. .-.+.++-.+..||++||.|||++ .|||||||-.||||+ -.|.+||.|||-++.+..-. .....+-
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin-P~TETFT 737 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN-PCTETFT 737 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCC-ccccccc
Confidence 99754221 125677888999999999999999 699999999999997 57899999999997654322 2234467
Q ss_pred ccccccChhhhccCC--CCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhhhcc
Q 046750 524 GTFGYLAPEYASSGK--LTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEKH 601 (723)
Q Consensus 524 gt~~y~APE~~~~~~--~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~~ 601 (723)
||+.|||||+|..+. |+.++|||||||.+.||.||+.||.....- ....+ +-|-+ +....
T Consensus 738 GTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp---qAAMF---------kVGmy------KvHP~ 799 (1226)
T KOG4279|consen 738 GTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP---QAAMF---------KVGMY------KVHPP 799 (1226)
T ss_pred cchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh---hHhhh---------hhcce------ecCCC
Confidence 999999999998764 888999999999999999999999764321 11111 11111 12234
Q ss_pred ccHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 046750 602 YVESEMFRMIEAAAACVRHSGPKRPRMVQVVR 633 (723)
Q Consensus 602 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~ 633 (723)
.+.+...+..+++++|+..||.+||++.+++.
T Consensus 800 iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 800 IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 45566678889999999999999999999875
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=309.08 Aligned_cols=270 Identities=22% Similarity=0.332 Sum_probs=194.7
Q ss_pred hcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCch--hHHHHHHHHHHHHHccCCceeeEeeeeecc--cceEE
Q 046750 359 TNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQ--GEREFRAEVEIISRVHHRHLVSLVGYCISE--KNRLL 433 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~~l 433 (723)
.++|++.++||+|+||.||+|.. .+|+.||+|+++..... ....+.+|++++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 36799999999999999999965 46899999998754222 223567899999999999999999998765 45799
Q ss_pred EEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCC
Q 046750 434 IYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDT 513 (723)
Q Consensus 434 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 513 (723)
||||+. ++|.+++.... ..+.+..++.++.||++||+|||+.+ |+|||||++|||+++++.+||+|||++.....
T Consensus 86 v~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 86 VMEYCE-QDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred EEecCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 999995 57888776533 35889999999999999999999994 99999999999999999999999999986653
Q ss_pred CCcceeecccccccccChhhhcc-CCCCCccceechHHHHHHHHhCCCCCCCCCCCCchh-hHHhhhh---hhhhhhh--
Q 046750 514 TQTHVSTRVMGTFGYLAPEYASS-GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDES-LVEWARP---VLVRAIE-- 586 (723)
Q Consensus 514 ~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~-l~~~~~~---~l~~~i~-- 586 (723)
... ......++..|+|||++.+ ..++.++|||||||+||||++|+.||.......... +..+... .+...+.
T Consensus 161 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07845 161 PAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL 239 (309)
T ss_pred ccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcc
Confidence 321 1222345788999999875 458999999999999999999999997543211000 0000000 0000000
Q ss_pred --cCCcccccchhhhc--cccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 046750 587 --TGDLSEIVDPRLEK--HYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRAL 635 (723)
Q Consensus 587 --~~~l~~~vd~~l~~--~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L 635 (723)
.+.+ .+-...+.. .........+.+++.+||+.||++||++.+|++.-
T Consensus 240 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~ 291 (309)
T cd07845 240 PLVGKF-TLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESS 291 (309)
T ss_pred cccccc-cccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 0000 000000000 00001133567899999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=298.55 Aligned_cols=242 Identities=24% Similarity=0.316 Sum_probs=193.4
Q ss_pred EeccCcEEEEEEEcC-CCcEEEEEEcccCCc---hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEecCCCch
Q 046750 368 IGEGGFGCVYKGNLP-EGKVVAVKQLKSGSG---QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNL 443 (723)
Q Consensus 368 LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 443 (723)
||.|+||.||++... .++.|+||++..... ...+.+.+|++++++++|+||+++++++.++...++||||+.+++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999664 488999999865422 3346789999999999999999999999999999999999999999
Q ss_pred hhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcceeeccc
Q 046750 444 EHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVM 523 (723)
Q Consensus 444 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 523 (723)
.+++.+.. .+.+..+..++.||+.||+|||+. +++|+||+++|||++.++.++|+|||++....... ......
T Consensus 81 ~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~ 153 (262)
T cd05572 81 WTILRDRG--LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFC 153 (262)
T ss_pred HHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccccc
Confidence 99997653 378889999999999999999998 59999999999999999999999999998664432 122345
Q ss_pred ccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhhhcccc
Q 046750 524 GTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEKHYV 603 (723)
Q Consensus 524 gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~ 603 (723)
++..|++||++.+..++.++|||+||++||||++|..||...... ..++ .+.+..+.. ...+.
T Consensus 154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~-----~~~~~~~~~--------~~~~~ 216 (262)
T cd05572 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED----PMEI-----YNDILKGNG--------KLEFP 216 (262)
T ss_pred CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC----HHHH-----HHHHhccCC--------CCCCC
Confidence 788999999998888999999999999999999999999765421 1111 111111100 01111
Q ss_pred HHHHHHHHHHHHHHhccCCCCCCC-----HHHHHH
Q 046750 604 ESEMFRMIEAAAACVRHSGPKRPR-----MVQVVR 633 (723)
Q Consensus 604 ~~~~~~l~~l~~~cl~~dP~~RPs-----~~eVl~ 633 (723)
......+.+++.+||+.+|.+|++ +.|+++
T Consensus 217 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 217 NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 112346889999999999999999 666655
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=306.80 Aligned_cols=245 Identities=22% Similarity=0.344 Sum_probs=195.3
Q ss_pred ceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEecCCCch
Q 046750 365 ENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNL 443 (723)
Q Consensus 365 ~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 443 (723)
..+||+|+||.||++.. .+++.||||++..........+.+|+.++++++|+||++++++|...+..++||||+.+++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 36799999999999965 56899999998765555566789999999999999999999999999999999999999999
Q ss_pred hhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcceeeccc
Q 046750 444 EHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVM 523 (723)
Q Consensus 444 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 523 (723)
.+++... .+.+..++.++.|++.+|+|||+. +|+||||+++|||+++++.++|+|||++........ ......
T Consensus 105 ~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~ 177 (292)
T cd06657 105 TDIVTHT---RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLV 177 (292)
T ss_pred HHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc-cccccc
Confidence 9987543 378889999999999999999999 499999999999999999999999999875543221 123345
Q ss_pred ccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhhhcccc
Q 046750 524 GTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEKHYV 603 (723)
Q Consensus 524 gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~ 603 (723)
|+..|++||++.+..++.++|||||||++|||++|..||..... ....... ..+ +.. .+.. .
T Consensus 178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~---~~~~~~~--------~~~-~~~----~~~~--~ 239 (292)
T cd06657 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP---LKAMKMI--------RDN-LPP----KLKN--L 239 (292)
T ss_pred cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHH--------Hhh-CCc----ccCC--c
Confidence 78999999999888899999999999999999999999865322 1111111 000 000 0000 0
Q ss_pred HHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 604 ESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 604 ~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
......+.+++.+||+.+|.+||++.+|++.
T Consensus 240 ~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 240 HKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred ccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 0112356788999999999999999998873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=347.75 Aligned_cols=257 Identities=28% Similarity=0.420 Sum_probs=207.2
Q ss_pred HHHHHhcCcccceEEeccCcEEEEEE-EcCCCcEEEEEEcccCCch--hHHHHHHHHHHHHHccCCceeeEeeeeecccc
Q 046750 354 ELMEITNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQ--GEREFRAEVEIISRVHHRHLVSLVGYCISEKN 430 (723)
Q Consensus 354 ~l~~~~~~f~~~~~LG~G~fG~Vy~~-~~~~g~~VAvK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 430 (723)
.+..++-+|....+||.|.||.||-| ...+|...|||.++-.... ....+.+|+.+|..|+|+|||+++|+-.+.+.
T Consensus 1229 ~lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRek 1308 (1509)
T KOG4645|consen 1229 SLSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREK 1308 (1509)
T ss_pred HhccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHH
Confidence 34456778999999999999999999 6677999999988754333 33467889999999999999999999999999
Q ss_pred eEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccc
Q 046750 431 RLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKL 510 (723)
Q Consensus 431 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 510 (723)
.+|.||||.+|+|.+++...+ .+++.....+..|++.||+|||++| |||||||+.||||+.+|.+|++|||.|+.
T Consensus 1309 v~IFMEyC~~GsLa~ll~~gr--i~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~k 1383 (1509)
T KOG4645|consen 1309 VYIFMEYCEGGSLASLLEHGR--IEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVK 1383 (1509)
T ss_pred HHHHHHHhccCcHHHHHHhcc--hhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeE
Confidence 999999999999999997544 3666666778899999999999995 99999999999999999999999999987
Q ss_pred cCCCCcc---eeecccccccccChhhhccC---CCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhh
Q 046750 511 NDTTQTH---VSTRVMGTFGYLAPEYASSG---KLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRA 584 (723)
Q Consensus 511 ~~~~~~~---~~~~~~gt~~y~APE~~~~~---~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~ 584 (723)
+...... .....+||..|||||+|.+. ...-+.||||||||++||+||++||...+. +|+ ++-+
T Consensus 1384 i~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-------e~a---IMy~ 1453 (1509)
T KOG4645|consen 1384 IKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-------EWA---IMYH 1453 (1509)
T ss_pred ecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-------hhH---HHhH
Confidence 6544211 12345799999999999753 366689999999999999999999976542 344 3344
Q ss_pred hhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 585 IETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 585 i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
+..|..-.+ +......-.+++.+||..||++|-++.||++.
T Consensus 1454 V~~gh~Pq~---------P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1454 VAAGHKPQI---------PERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred HhccCCCCC---------chhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 555554322 22233455678889999999999888877765
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=303.14 Aligned_cols=266 Identities=21% Similarity=0.304 Sum_probs=198.5
Q ss_pred cccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCch--hHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEec
Q 046750 362 FARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQ--GEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFV 438 (723)
Q Consensus 362 f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 438 (723)
|.+.+.||+|+||.||+|.. .+++.|++|+++..... ....+..|++++++++|+||+++++++.+....++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 56778999999999999965 46889999998765322 3467888999999999999999999999999999999999
Q ss_pred CCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcce
Q 046750 439 PNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHV 518 (723)
Q Consensus 439 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 518 (723)
. ++|.+++.... ..+++..++.++.+|++||.|||++ +|+|+|||++|||+++++.+||+|||++....... ..
T Consensus 81 ~-~~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~ 154 (283)
T cd05118 81 D-TDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RP 154 (283)
T ss_pred C-CCHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-cc
Confidence 6 48888876543 3588999999999999999999999 59999999999999999999999999997665433 12
Q ss_pred eecccccccccChhhhccC-CCCCccceechHHHHHHHHhCCCCCCCCCCCCchhh-HHh-------hhhhhhhhhhcC-
Q 046750 519 STRVMGTFGYLAPEYASSG-KLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESL-VEW-------ARPVLVRAIETG- 588 (723)
Q Consensus 519 ~~~~~gt~~y~APE~~~~~-~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l-~~~-------~~~~l~~~i~~~- 588 (723)
.....++..|++||.+.+. .++.++|||||||+||+|++|+.+|........... .+. ....+.+.....
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK 234 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence 2334578899999998876 789999999999999999999999865432111000 000 000000000000
Q ss_pred -CcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 589 -DLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 589 -~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
.+....+..+ ..........+.+++.+||+.||.+||++.+|+..
T Consensus 235 ~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 235 FSFPKKAGMPL-PKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhccccccCH-HHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0000000000 01112234578899999999999999999999864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=313.77 Aligned_cols=265 Identities=22% Similarity=0.359 Sum_probs=196.4
Q ss_pred HHHHhcCcccceEEeccCcEEEEEEE-cCCCcEEEEEEcccCC--chhHHHHHHHHHHHHHccCCceeeEeeeeeccc--
Q 046750 355 LMEITNGFARENVIGEGGFGCVYKGN-LPEGKVVAVKQLKSGS--GQGEREFRAEVEIISRVHHRHLVSLVGYCISEK-- 429 (723)
Q Consensus 355 l~~~~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~VAvK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~-- 429 (723)
+..+.++|++.+.||+|+||.||++. ..+++.||||++.... ......+.+|+++|++++|+||++++++|....
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 44567889999999999999999995 5578999999986432 223356889999999999999999999987653
Q ss_pred ----ceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeec
Q 046750 430 ----NRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADF 505 (723)
Q Consensus 430 ----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DF 505 (723)
.+++||||+ +++|.+++... .+++..++.++.||++||+|||+. +|+|||||++|||+++++.+||+||
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKHE---KLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeec
Confidence 358999998 77898887542 478899999999999999999998 4999999999999999999999999
Q ss_pred ccccccCCCCcceeecccccccccChhhhcc-CCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhh------
Q 046750 506 GLAKLNDTTQTHVSTRVMGTFGYLAPEYASS-GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWAR------ 578 (723)
Q Consensus 506 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~------ 578 (723)
|++....... ....++..|++||++.+ ..++.++|||||||+||+|++|+.||...... ..+.....
T Consensus 163 g~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~ 236 (343)
T cd07880 163 GLARQTDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL--DQLMEIMKVTGTPS 236 (343)
T ss_pred ccccccccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcCCCC
Confidence 9997654321 23357889999999876 45889999999999999999999999754321 00000000
Q ss_pred hhhhhhhhcCCcccccc-------hhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 046750 579 PVLVRAIETGDLSEIVD-------PRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVR 633 (723)
Q Consensus 579 ~~l~~~i~~~~l~~~vd-------~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~ 633 (723)
..+...+........+. ..+. .........+.+++.+||+.||.+||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 237 KEFVQKLQSEDAKNYVKKLPRFRKKDFR-SLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHHHhhcchhHHHHHHhccccCcchHH-HhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00001111110000000 0000 000112235789999999999999999999984
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=294.98 Aligned_cols=267 Identities=21% Similarity=0.362 Sum_probs=208.5
Q ss_pred CHHHHHHHhcCcccceEEeccCcEEEEEE-EcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHcc-CCceeeEeeeeecc
Q 046750 351 TYEELMEITNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVH-HRHLVSLVGYCISE 428 (723)
Q Consensus 351 ~~~~l~~~~~~f~~~~~LG~G~fG~Vy~~-~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~ 428 (723)
+++++.++++ ++||+|+|+.|--+ .+..|..||||++.+........+.+|++++.+.+ |+||++|++||+++
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 4667766654 68999999999888 67889999999999887777788999999999995 99999999999999
Q ss_pred cceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCC---CcEEEeec
Q 046750 429 KNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDE---FEAQVADF 505 (723)
Q Consensus 429 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~---~~vkL~DF 505 (723)
..+|||||.|.||.|..+|+++. .+.+.+..++..+|+.||.|||.+| |.||||||+|||-.+- .-||||||
T Consensus 149 ~~FYLVfEKm~GGplLshI~~~~--~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDf 223 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQKRK--HFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDF 223 (463)
T ss_pred ceEEEEEecccCchHHHHHHHhh--hccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeecc
Confidence 99999999999999999998654 4888899999999999999999995 9999999999998654 35899999
Q ss_pred ccccccCCCCc------ceeecccccccccChhhhc-----cCCCCCccceechHHHHHHHHhCCCCCCCCCCCC----c
Q 046750 506 GLAKLNDTTQT------HVSTRVMGTFGYLAPEYAS-----SGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLG----D 570 (723)
Q Consensus 506 Gla~~~~~~~~------~~~~~~~gt~~y~APE~~~-----~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~----~ 570 (723)
+|..-+..... .....-+|+-.|||||+.. .-.|+.++|.||||||||-||.|..||-+....+ .
T Consensus 224 DLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdr 303 (463)
T KOG0607|consen 224 DLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDR 303 (463)
T ss_pred ccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccC
Confidence 99853322111 1122346889999999763 2358999999999999999999999997654321 1
Q ss_pred hhhHHhhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 046750 571 ESLVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVR 633 (723)
Q Consensus 571 ~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~ 633 (723)
-....-....|++.|..|.+ ++-|+.+. .......+++...+..++..|-++.++++
T Consensus 304 Ge~Cr~CQ~~LFesIQEGkY-eFPdkdWa-----hIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 304 GEVCRVCQNKLFESIQEGKY-EFPDKDWA-----HISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CCccHHHHHHHHHHHhccCC-cCChhhhH-----HhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 11222334456666776654 23332221 11223456677788899999999999987
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=309.76 Aligned_cols=272 Identities=21% Similarity=0.331 Sum_probs=196.5
Q ss_pred HHhcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCC--chhHHHHHHHHHHHHHccCCceeeEeeeeeccc----
Q 046750 357 EITNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS--GQGEREFRAEVEIISRVHHRHLVSLVGYCISEK---- 429 (723)
Q Consensus 357 ~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~---- 429 (723)
.+.++|...+.||+|+||.||+|.. .+|+.||||+++... ......+.+|++++++++|+||++++++|....
T Consensus 12 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 91 (342)
T cd07879 12 ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDE 91 (342)
T ss_pred ccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCC
Confidence 4468899999999999999999964 568999999987532 223356889999999999999999999987543
Q ss_pred --ceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeeccc
Q 046750 430 --NRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGL 507 (723)
Q Consensus 430 --~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGl 507 (723)
..++|+||+. .+|..++. ..+.+..+..++.||++||+|||++ +|+|||||++|||++.++.+||+|||+
T Consensus 92 ~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 92 FQDFYLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred CceEEEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCC
Confidence 4589999995 46766552 2378888999999999999999999 499999999999999999999999999
Q ss_pred ccccCCCCcceeecccccccccChhhhcc-CCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhh----hhhhh
Q 046750 508 AKLNDTTQTHVSTRVMGTFGYLAPEYASS-GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWA----RPVLV 582 (723)
Q Consensus 508 a~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~----~~~l~ 582 (723)
++..... .....++..|+|||++.+ ..++.++|||||||+||||++|+.||.............+. ...+.
T Consensus 164 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (342)
T cd07879 164 ARHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFV 239 (342)
T ss_pred CcCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 8754322 123457889999999876 46899999999999999999999999764321110000000 00000
Q ss_pred hhhhcCCccccc-------chhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH--HhccCCC
Q 046750 583 RAIETGDLSEIV-------DPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA--LDSEGEM 641 (723)
Q Consensus 583 ~~i~~~~l~~~v-------d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~--L~~~~~~ 641 (723)
+.+........+ ...+...+ ......+.+++.+||+.||.+||++.+|+.. |+...+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~ 306 (342)
T cd07879 240 QKLEDKAAKSYIKSLPKYPRKDFSTLF-PKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA 306 (342)
T ss_pred HHhcccchHHHHhhcCCcccchHHHHh-cCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence 000000000000 00000000 0122357899999999999999999999954 6665443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=299.87 Aligned_cols=244 Identities=23% Similarity=0.298 Sum_probs=188.0
Q ss_pred eEEeccCcEEEEEEEc-CCCcEEEEEEcccCCc---hhHHHHHHHHHHHH-HccCCceeeEeeeeecccceEEEEEecCC
Q 046750 366 NVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSG---QGEREFRAEVEIIS-RVHHRHLVSLVGYCISEKNRLLIYEFVPN 440 (723)
Q Consensus 366 ~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~---~~~~~~~~Ei~il~-~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 440 (723)
+.||+|+||.||+|.. .+++.||||+++.... .....+..|..++. .++|+||+++++++..++..|+|+||+.+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5789999999999955 4688999999875432 22234455555544 45899999999999999999999999999
Q ss_pred CchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcceee
Q 046750 441 NNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVST 520 (723)
Q Consensus 441 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 520 (723)
++|.+++.... .+++..+..++.||+.||.|||+. +|+||||++.||||++++.+||+|||+++.... ..
T Consensus 82 ~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~ 151 (260)
T cd05611 82 GDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NK 151 (260)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----cc
Confidence 99999997544 478888999999999999999998 599999999999999999999999999875432 22
Q ss_pred cccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhhhc
Q 046750 521 RVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEK 600 (723)
Q Consensus 521 ~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~ 600 (723)
...++..|++||++.+..++.++||||||++||||++|..||..... ... + ..+..+.+.. ..
T Consensus 152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~--~------~~~~~~~~~~------~~ 214 (260)
T cd05611 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP---DAV--F------DNILSRRINW------PE 214 (260)
T ss_pred cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH---HHH--H------HHHHhcccCC------CC
Confidence 34578899999999988899999999999999999999999965432 111 1 1111111110 00
Q ss_pred cccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 046750 601 HYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALD 636 (723)
Q Consensus 601 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~ 636 (723)
.........+.+++.+||+.+|++||++.++.+.|.
T Consensus 215 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 215 EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred cccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 011112346889999999999999997766655543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=307.35 Aligned_cols=270 Identities=23% Similarity=0.319 Sum_probs=193.6
Q ss_pred hcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCch--hHHHHHHHHHHHHHccCCceeeEeeeeeccc------
Q 046750 359 TNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQ--GEREFRAEVEIISRVHHRHLVSLVGYCISEK------ 429 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~------ 429 (723)
.++|.+.++||+|+||.||+|.. .+++.||||++...... ....+.+|++++++++|+||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 47899999999999999999965 46889999998654322 2346788999999999999999999875543
Q ss_pred --ceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeeccc
Q 046750 430 --NRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGL 507 (723)
Q Consensus 430 --~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGl 507 (723)
..++|+||+. ++|..++.... ..+++..++.++.||++||+|||++ +|+|||||++|||+++++.+||+|||+
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLENPS-VKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCcc
Confidence 3589999995 46776665432 3588999999999999999999999 499999999999999999999999999
Q ss_pred ccccCCCCcc----------eeecccccccccChhhhccC-CCCCccceechHHHHHHHHhCCCCCCCCCCCCchhh-HH
Q 046750 508 AKLNDTTQTH----------VSTRVMGTFGYLAPEYASSG-KLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESL-VE 575 (723)
Q Consensus 508 a~~~~~~~~~----------~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l-~~ 575 (723)
++........ ......++..|+|||++.+. .++.++|||||||+||||++|+.+|........... ..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~ 241 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK 241 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9755432211 11234578889999988654 589999999999999999999999975443211000 00
Q ss_pred hhhhhhh---------hhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 576 WARPVLV---------RAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 576 ~~~~~l~---------~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
....... ...............+...+ ......+.+++.+||+.+|.+||++.+|+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERF-GKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HhCCCChhhchhhhhcccccccccCCCCCccHHHHc-ccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 0000000 00000000000111111111 1112468899999999999999999998753
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=312.15 Aligned_cols=247 Identities=23% Similarity=0.328 Sum_probs=198.7
Q ss_pred ceEEeccCcEEEEEE-EcCCCcEEEEEEcccC--CchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEecCCC
Q 046750 365 ENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSG--SGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPNN 441 (723)
Q Consensus 365 ~~~LG~G~fG~Vy~~-~~~~g~~VAvK~l~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 441 (723)
.++||.|.||.||-| +.+.|+.||||++.+. ..+.+..+++|+.||+.++||.||.|.-.|+..+.+++|||.+ +|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 578999999999999 5567999999999764 3355578999999999999999999999999999999999999 45
Q ss_pred chhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCC---CcEEEeecccccccCCCCcce
Q 046750 442 NLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDE---FEAQVADFGLAKLNDTTQTHV 518 (723)
Q Consensus 442 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~---~~vkL~DFGla~~~~~~~~~~ 518 (723)
++.+++.......|.+..-..++.||+.||.|||.+ +|+|+||||+||||... -.+||||||+|+++++...
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF-- 722 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF-- 722 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhhh--
Confidence 544444333444588888888999999999999999 69999999999999754 4699999999999876544
Q ss_pred eecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhh
Q 046750 519 STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRL 598 (723)
Q Consensus 519 ~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l 598 (723)
...++||+.|+|||+++.+.|...-||||+|||+|.-|.|..||+..... .+.|.+..|..--
T Consensus 723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdI-------------ndQIQNAaFMyPp---- 785 (888)
T KOG4236|consen 723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDI-------------NDQIQNAAFMYPP---- 785 (888)
T ss_pred hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccch-------------hHHhhccccccCC----
Confidence 45578999999999999999999999999999999999999999875432 2223333221111
Q ss_pred hccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 046750 599 EKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALD 636 (723)
Q Consensus 599 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~ 636 (723)
+...+.....++|+...|+..-++|.++.+.+..-+
T Consensus 786 --~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~W 821 (888)
T KOG4236|consen 786 --NPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPW 821 (888)
T ss_pred --CchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchh
Confidence 111222335678889999999999999988765443
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=305.61 Aligned_cols=254 Identities=26% Similarity=0.410 Sum_probs=193.6
Q ss_pred cCcccceEEeccCcEEEEEEEcCC-CcEEEEEEcccCCc-hhHHHHHHHHHHHHHcc-CCceeeEeeeeecccceEEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLPE-GKVVAVKQLKSGSG-QGEREFRAEVEIISRVH-HRHLVSLVGYCISEKNRLLIYE 436 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~VAvK~l~~~~~-~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~E 436 (723)
++|++.+.||+|+||.||+|.+.+ ++.||||+++.... ....++..|+.++.++. |+||++++++|.+....|+|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 567889999999999999997754 88999999975432 33456677888777775 9999999999999999999999
Q ss_pred ecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCc
Q 046750 437 FVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQT 516 (723)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 516 (723)
|+ +++|.+++..... .+++..+..++.+|++||+|||+.. +|+||||+++|||+++++.+||+|||++........
T Consensus 95 ~~-~~~l~~l~~~~~~-~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~ 170 (296)
T cd06618 95 LM-STCLDKLLKRIQG-PIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA 170 (296)
T ss_pred cc-CcCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccCCCc
Confidence 98 4567666644322 5888999999999999999999742 599999999999999999999999999876543222
Q ss_pred ceeecccccccccChhhhccCC----CCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCccc
Q 046750 517 HVSTRVMGTFGYLAPEYASSGK----LTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSE 592 (723)
Q Consensus 517 ~~~~~~~gt~~y~APE~~~~~~----~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~ 592 (723)
.....++..|+|||++.+.. ++.++|||||||+||||++|+.||...... . +. +.+.+. +....
T Consensus 171 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~---~~----~~~~~~-~~~~~ 238 (296)
T cd06618 171 --KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE--F---EV----LTKILQ-EEPPS 238 (296)
T ss_pred --ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH--H---HH----HHHHhc-CCCCC
Confidence 12335788999999987554 888999999999999999999999643211 0 11 111111 11111
Q ss_pred ccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 046750 593 IVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALD 636 (723)
Q Consensus 593 ~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~ 636 (723)
+-. .......+.+++.+||+.+|.+||++.+|++...
T Consensus 239 ~~~-------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~ 275 (296)
T cd06618 239 LPP-------NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF 275 (296)
T ss_pred CCC-------CCCCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence 100 0012336789999999999999999999987643
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=297.59 Aligned_cols=263 Identities=25% Similarity=0.344 Sum_probs=209.6
Q ss_pred HHHHHHHhcCcccceEEeccCcEEEEEEEcCC------CcEEEEEEcccCCch-hHHHHHHHHHHHHHccCCceeeEeee
Q 046750 352 YEELMEITNGFARENVIGEGGFGCVYKGNLPE------GKVVAVKQLKSGSGQ-GEREFRAEVEIISRVHHRHLVSLVGY 424 (723)
Q Consensus 352 ~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~------g~~VAvK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~ 424 (723)
..+|..-..+|+...++-+|.||.||+|.|.+ .+.|.||.++....+ +...|..|.-+|..+.|+|+..+.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 34555556778888999999999999996543 346788888876443 34567889999999999999999998
Q ss_pred eecc-cceEEEEEecCCCchhhcccc------CCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCC
Q 046750 425 CISE-KNRLLIYEFVPNNNLEHHLHG------KGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDE 497 (723)
Q Consensus 425 ~~~~-~~~~lV~E~~~~gsL~~~l~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~ 497 (723)
+.++ ...+++|.++.-|+|..||.. ...+.+...++..++.|++.|++|||++ +|||.||..+|++||+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhh
Confidence 8754 556899999999999999972 2334577788899999999999999999 49999999999999999
Q ss_pred CcEEEeecccccccCCCCcceee-cccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHH
Q 046750 498 FEAQVADFGLAKLNDTTQTHVST-RVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVE 575 (723)
Q Consensus 498 ~~vkL~DFGla~~~~~~~~~~~~-~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~ 575 (723)
.+|||+|-.|++.+-..+.+..+ .......||++|.+....|+.++|||||||+||||++ |+.|+.+.++.+..
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~---- 508 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME---- 508 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH----
Confidence 99999999999866555544322 2235678999999999999999999999999999999 99999876653221
Q ss_pred hhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhc
Q 046750 576 WARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDS 637 (723)
Q Consensus 576 ~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~ 637 (723)
..+.+|. ||... -++..+|+.+|.-||..+|++||+++|++.-|..
T Consensus 509 -------~ylkdGy-------RlaQP--~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 509 -------HYLKDGY-------RLAQP--FNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred -------HHHhccc-------eecCC--CCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 1222332 23222 2345578899999999999999999999998865
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=301.67 Aligned_cols=248 Identities=23% Similarity=0.356 Sum_probs=200.6
Q ss_pred cCcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccC---CchhHHHHHHHHHHHHHcc-CCceeeEeeeeecccceEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSG---SGQGEREFRAEVEIISRVH-HRHLVSLVGYCISEKNRLLI 434 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~---~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV 434 (723)
++|.+.+.||+|+||.||+|... +++.|+||++... .....+.+..|++++++++ |+||+++++++.+.+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46889999999999999999654 6899999998653 2233467889999999998 99999999999999999999
Q ss_pred EEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCC
Q 046750 435 YEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTT 514 (723)
Q Consensus 435 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 514 (723)
|||+.+++|.+++.... .+.+..++.|+.||+.||.|||+. +++|+||+++||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 81 LEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred EcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 99999999999997654 489999999999999999999998 5999999999999999999999999999765433
Q ss_pred Cc-------------------ceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHH
Q 046750 515 QT-------------------HVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVE 575 (723)
Q Consensus 515 ~~-------------------~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~ 575 (723)
.. .......++..|++||++....++.++|||+||+++|+|++|+.||..... ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~-- 230 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE---YLT-- 230 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH---HHH--
Confidence 22 112234578899999999988899999999999999999999999975531 111
Q ss_pred hhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCH----HHHHH
Q 046750 576 WARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRM----VQVVR 633 (723)
Q Consensus 576 ~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~----~eVl~ 633 (723)
.+.+.... ..+.......+.+++.+||+.+|.+||++ .+|++
T Consensus 231 ------~~~~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 231 ------FQKILKLE----------YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred ------HHHHHhcC----------CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 01111110 11111223468899999999999999999 66654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=299.48 Aligned_cols=242 Identities=26% Similarity=0.353 Sum_probs=185.4
Q ss_pred EEeccCcEEEEEEEc-CCCcEEEEEEcccCCc---hhHHHHHHHHH---HHHHccCCceeeEeeeeecccceEEEEEecC
Q 046750 367 VIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSG---QGEREFRAEVE---IISRVHHRHLVSLVGYCISEKNRLLIYEFVP 439 (723)
Q Consensus 367 ~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~---~~~~~~~~Ei~---il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 439 (723)
+||+|+||.||++.. ..++.||||.+..... .....+..|.. +++..+|+||+++++++.+.+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999955 4588999999865422 11223344444 4444579999999999999999999999999
Q ss_pred CCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCccee
Q 046750 440 NNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVS 519 (723)
Q Consensus 440 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 519 (723)
+++|.+++.... .+.+..++.|+.|+++||+|||+. +|+|||||++|||+++++.+||+|||++..+.....
T Consensus 81 g~~L~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~--- 152 (278)
T cd05606 81 GGDLHYHLSQHG--VFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--- 152 (278)
T ss_pred CCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC---
Confidence 999999886543 589999999999999999999998 499999999999999999999999999875533222
Q ss_pred ecccccccccChhhhccC-CCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhh
Q 046750 520 TRVMGTFGYLAPEYASSG-KLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRL 598 (723)
Q Consensus 520 ~~~~gt~~y~APE~~~~~-~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l 598 (723)
....|+..|+|||++.++ .++.++|||||||+||||++|+.||........... . +..... +..+
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~-~-------~~~~~~------~~~~ 218 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-D-------RMTLTM------AVEL 218 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH-H-------HHhhcc------CCCC
Confidence 234689999999999754 689999999999999999999999976532111110 0 000000 0011
Q ss_pred hccccHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 046750 599 EKHYVESEMFRMIEAAAACVRHSGPKRP-----RMVQVVRA 634 (723)
Q Consensus 599 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~eVl~~ 634 (723)
.. .....+.+++.+||..+|.+|+ ++.++++.
T Consensus 219 ~~----~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 219 PD----SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred CC----cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 11 1234678899999999999999 88888753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=310.85 Aligned_cols=273 Identities=21% Similarity=0.325 Sum_probs=199.5
Q ss_pred CHHHHHHHhcCcccceEEeccCcEEEEEEE-cCCCcEEEEEEcccCC--chhHHHHHHHHHHHHHccCCceeeEeeeeec
Q 046750 351 TYEELMEITNGFARENVIGEGGFGCVYKGN-LPEGKVVAVKQLKSGS--GQGEREFRAEVEIISRVHHRHLVSLVGYCIS 427 (723)
Q Consensus 351 ~~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~VAvK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~ 427 (723)
..+++..+.++|.+.+.||+|+||.||+|. ..+++.||||+++... ....+.+.+|++++++++|+||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 346777888999999999999999999995 4578999999987532 2234567889999999999999999998864
Q ss_pred c------cceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEE
Q 046750 428 E------KNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQ 501 (723)
Q Consensus 428 ~------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vk 501 (723)
. ...|++++++ +++|.+++... .+.+..++.++.||++||+|||++ +|+|||||++||++++++.+|
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEE
Confidence 3 3357777776 88998887543 378899999999999999999999 599999999999999999999
Q ss_pred EeecccccccCCCCcceeecccccccccChhhhcc-CCCCCccceechHHHHHHHHhCCCCCCCCCCCCchh-hHHhh--
Q 046750 502 VADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASS-GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDES-LVEWA-- 577 (723)
Q Consensus 502 L~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~-l~~~~-- 577 (723)
|+|||+++..... .....++..|+|||++.+ ..++.++|||||||+||||++|+.||.......... +..+.
T Consensus 161 l~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (345)
T cd07877 161 ILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 236 (345)
T ss_pred Eeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 9999998754322 223457889999999876 468889999999999999999999996543211000 00000
Q ss_pred -hhhhhhhhhcCCc-------ccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 046750 578 -RPVLVRAIETGDL-------SEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRAL 635 (723)
Q Consensus 578 -~~~l~~~i~~~~l-------~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L 635 (723)
...+...+..... ..+.+..+... .......+.+++.+||+.+|.+|+++.++++.=
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 301 (345)
T cd07877 237 PGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 301 (345)
T ss_pred CCHHHHhhcccHhHHHHHHHhcccCCcchhhh-cCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh
Confidence 0000000000000 00000000000 001123578999999999999999999998653
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=295.84 Aligned_cols=249 Identities=22% Similarity=0.292 Sum_probs=191.5
Q ss_pred HHHHHHhcCcccceEE--eccCcEEEEEEEc-CCCcEEEEEEcccCCchhHHHHHHHHHHHHHc-cCCceeeEeeeeecc
Q 046750 353 EELMEITNGFARENVI--GEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQGEREFRAEVEIISRV-HHRHLVSLVGYCISE 428 (723)
Q Consensus 353 ~~l~~~~~~f~~~~~L--G~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~ 428 (723)
.++....++|.+.+.+ |+|+||.||++.. .+++.+|+|.+....... .|+.+...+ +|+||++++++|...
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~ 81 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTL 81 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecC
Confidence 3444556777777776 9999999999954 567889999986532111 133333323 799999999999999
Q ss_pred cceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCC-cEEEeeccc
Q 046750 429 KNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEF-EAQVADFGL 507 (723)
Q Consensus 429 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~-~vkL~DFGl 507 (723)
+..|+||||+.+++|.+++.... .+.+..++.++.||++||.|||+.+ |+|||||++|||++.++ .++|+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~ 156 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGL 156 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCcc
Confidence 99999999999999999997654 5899999999999999999999994 99999999999999998 999999999
Q ss_pred ccccCCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhc
Q 046750 508 AKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIET 587 (723)
Q Consensus 508 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~ 587 (723)
+....... ...++..|+|||++.+..++.++|||||||++|||++|+.||...... ...+..|.. .. .
T Consensus 157 ~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~-~~~~~~~~~-----~~-~ 224 (267)
T PHA03390 157 CKIIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE-ELDLESLLK-----RQ-Q 224 (267)
T ss_pred ceecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc-hhhHHHHHH-----hh-c
Confidence 87654322 235788999999999999999999999999999999999999744321 111222211 11 1
Q ss_pred CCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCC-HHHHHH
Q 046750 588 GDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPR-MVQVVR 633 (723)
Q Consensus 588 ~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~eVl~ 633 (723)
..+ .. .......+.+++.+||+.+|.+|++ ++++++
T Consensus 225 ~~~-~~---------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 225 KKL-PF---------IKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ccC-Cc---------ccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 110 00 0122336788999999999999995 688874
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=303.27 Aligned_cols=303 Identities=20% Similarity=0.253 Sum_probs=204.0
Q ss_pred CcccceEEeccCcEEEEEEEcC-C--CcEEEEEEcccCC--chhHHHHHHHHHHHHHc-cCCceeeEeeeeecc----cc
Q 046750 361 GFARENVIGEGGFGCVYKGNLP-E--GKVVAVKQLKSGS--GQGEREFRAEVEIISRV-HHRHLVSLVGYCISE----KN 430 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~~~-~--g~~VAvK~l~~~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~----~~ 430 (723)
+|.+.++||+|+||.||+++.. . +..||||++.... ....+.+.+|+++++++ +|+||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788999999999999999654 3 6789999987532 22345678899999999 599999999875432 44
Q ss_pred eEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccc
Q 046750 431 RLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKL 510 (723)
Q Consensus 431 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 510 (723)
.|+++||+ +++|.+++.... .+++..++.++.||+.||+|||++ +|+|||||++|||+++++.+||+|||+++.
T Consensus 81 ~~~~~e~~-~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 81 LYLYEELM-EADLHQIIRSGQ--PLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred EEEEEecc-cCCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 67888888 468988886443 478899999999999999999999 499999999999999999999999999976
Q ss_pred cCCCCcc---eeecccccccccChhhhcc-CCCCCccceechHHHHHHHHhCCCCCCCCCCCCc-------------hhh
Q 046750 511 NDTTQTH---VSTRVMGTFGYLAPEYASS-GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGD-------------ESL 573 (723)
Q Consensus 511 ~~~~~~~---~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~-------------~~l 573 (723)
....... ......|+..|+|||++.+ ..++.++|||||||+||+|++|+.||........ ..+
T Consensus 155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 234 (332)
T cd07857 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETL 234 (332)
T ss_pred cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 5432221 1233568999999998876 4689999999999999999999999875432100 000
Q ss_pred HHhhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCCCccccCCccCCCc
Q 046750 574 VEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEMSDLSNGVKYGQS 653 (723)
Q Consensus 574 ~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~~~~~~~~~~~~~s 653 (723)
..+........+.. +...-...+.. ........+.+++.+||+.+|.+||++.+++..=.- ...++..+... ++.
T Consensus 235 ~~~~~~~~~~~~~~--~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~-~~~~~~~~~~~-~~~ 309 (332)
T cd07857 235 SRIGSPKAQNYIRS--LPNIPKKPFES-IFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYL-AIWHDPDDEPV-CQK 309 (332)
T ss_pred HhhhhhhHHHHHHh--ccccCCcchHh-hCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhh-hhhcCcccccc-ccc
Confidence 01100000000000 00000000000 001113468899999999999999999998743211 11111111111 222
Q ss_pred cccCCCcchHHHHHHHHHhhc
Q 046750 654 TVYDSGQYNQDIMMFRKMALG 674 (723)
Q Consensus 654 ~~~~~~~~~~d~~~~r~l~~~ 674 (723)
.........+.|+.+|.|+.+
T Consensus 310 ~~~~~~~~~~~~~~~~~~~~~ 330 (332)
T cd07857 310 PFDFSFESEDSMEELRDMIIE 330 (332)
T ss_pred cccCCccccccHHHHHHHHhh
Confidence 222223335667788877653
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=333.26 Aligned_cols=256 Identities=24% Similarity=0.403 Sum_probs=195.2
Q ss_pred HHHhcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCC-chhHHHHHHHHHHHHHccCCceeeEeeeeecc-----
Q 046750 356 MEITNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS-GQGEREFRAEVEIISRVHHRHLVSLVGYCISE----- 428 (723)
Q Consensus 356 ~~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~----- 428 (723)
.+...+|+..++||+||||.||+++. -||+.||||++.... ......+.+|+.+|++|+|+|||+++..+.+.
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 35567788899999999999999944 489999999987653 33445788999999999999999987422000
Q ss_pred --------------------------------------------------------------------------------
Q 046750 429 -------------------------------------------------------------------------------- 428 (723)
Q Consensus 429 -------------------------------------------------------------------------------- 428 (723)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred ----------------------------------cceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchh
Q 046750 429 ----------------------------------KNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYL 474 (723)
Q Consensus 429 ----------------------------------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yL 474 (723)
..+||-||||+...|.++++++... -.....|+++.+|++||+|+
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~-~~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN-SQRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc-hhhHHHHHHHHHHHHHHHHH
Confidence 0136788999888888888665321 14677899999999999999
Q ss_pred cccCCCceeecCCCCCcEEeCCCCcEEEeecccccccC------C-----------CCcceeecccccccccChhhhccC
Q 046750 475 HEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLND------T-----------TQTHVSTRVMGTFGYLAPEYASSG 537 (723)
Q Consensus 475 H~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~------~-----------~~~~~~~~~~gt~~y~APE~~~~~ 537 (723)
|++| ||||||||.|||||.+..|||+|||+|.... + ......+..+||.-|+|||++.+.
T Consensus 714 H~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 714 HDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred HhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 9996 9999999999999999999999999997611 0 001123456899999999999765
Q ss_pred C---CCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHH
Q 046750 538 K---LTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAA 614 (723)
Q Consensus 538 ~---~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~ 614 (723)
. |+.|+|||||||||+||+. ||... +.+..++..++.|.+..- ..+...++..-..++
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts----------MERa~iL~~LR~g~iP~~------~~f~~~~~~~e~slI 851 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTS----------MERASILTNLRKGSIPEP------ADFFDPEHPEEASLI 851 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhc---cCCch----------HHHHHHHHhcccCCCCCC------cccccccchHHHHHH
Confidence 4 9999999999999999986 46443 223334555666665443 122233344556889
Q ss_pred HHHhccCCCCCCCHHHHHHH
Q 046750 615 AACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 615 ~~cl~~dP~~RPs~~eVl~~ 634 (723)
.+++++||.+||++.|+|+.
T Consensus 852 ~~Ll~hdP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 852 RWLLSHDPSKRPTATELLNS 871 (1351)
T ss_pred HHHhcCCCccCCCHHHHhhc
Confidence 99999999999999999863
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=302.63 Aligned_cols=251 Identities=24% Similarity=0.384 Sum_probs=195.3
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccC---CchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSG---SGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 435 (723)
+.|...+.||+|+||.||+|.. .+++.|+||.+... ......++.+|+++++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 3477778999999999999965 45788999998642 2233456888999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ 515 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 515 (723)
||+. |+|.+++.... ..+++..++.++.+++.||.|||+. +++||||+++|||++.++.+||+|||++......
T Consensus 95 e~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~- 168 (308)
T cd06634 95 EYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (308)
T ss_pred EccC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence 9995 67777765433 2478889999999999999999998 5999999999999999999999999998765432
Q ss_pred cceeecccccccccChhhhc---cCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCccc
Q 046750 516 THVSTRVMGTFGYLAPEYAS---SGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSE 592 (723)
Q Consensus 516 ~~~~~~~~gt~~y~APE~~~---~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~ 592 (723)
....++..|+|||++. .+.++.++|||||||++|||++|+.||...... ..+. .+..+....
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~---------~~~~~~~~~ 233 (308)
T cd06634 169 ----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALY---------HIAQNESPA 233 (308)
T ss_pred ----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH--HHHH---------HHhhcCCCC
Confidence 2345788999999985 356888999999999999999999998643211 1111 111111111
Q ss_pred ccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccC
Q 046750 593 IVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEG 639 (723)
Q Consensus 593 ~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~ 639 (723)
.. .......+.+++.+||+.+|.+||++.+|++......
T Consensus 234 ~~--------~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 234 LQ--------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred cC--------cccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 11 1112235788999999999999999999998765543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=302.68 Aligned_cols=244 Identities=27% Similarity=0.440 Sum_probs=191.5
Q ss_pred cccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCc---hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEe
Q 046750 362 FARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSG---QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEF 437 (723)
Q Consensus 362 f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 437 (723)
|...+.||+|+||.||+|.. .+++.|+||++..... .....+.+|++++++++|+||+++++++.+....|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 66678899999999999965 4688999999865322 2335688899999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcc
Q 046750 438 VPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTH 517 (723)
Q Consensus 438 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 517 (723)
+. ++|.+++.... ..+.+..++.++.||+.+|.|||++ +|+||||+++|||+++++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---- 173 (313)
T cd06633 103 CL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---- 173 (313)
T ss_pred CC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC----
Confidence 95 67777765433 2478999999999999999999998 499999999999999999999999999864322
Q ss_pred eeecccccccccChhhhc---cCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCccccc
Q 046750 518 VSTRVMGTFGYLAPEYAS---SGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIV 594 (723)
Q Consensus 518 ~~~~~~gt~~y~APE~~~---~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~v 594 (723)
.....|+..|+|||++. .+.++.++|||||||+||||++|..||...... ....+ +.........
T Consensus 174 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~---~~~~~--------~~~~~~~~~~ 241 (313)
T cd06633 174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SALYH--------IAQNDSPTLQ 241 (313)
T ss_pred -CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH---HHHHH--------HHhcCCCCCC
Confidence 12346888999999984 456888999999999999999999998654321 11111 1111111111
Q ss_pred chhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 595 DPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 595 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
. ..+ ...+.+++.+||+.+|.+||++.+|++.
T Consensus 242 ~----~~~----~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 242 S----NEW----TDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred c----ccc----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1 111 2357789999999999999999999865
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=311.55 Aligned_cols=268 Identities=20% Similarity=0.316 Sum_probs=193.6
Q ss_pred hcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecc---------
Q 046750 359 TNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISE--------- 428 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--------- 428 (723)
..+|.+.+.||+|+||.||+|.. .+++.||||++........+.+.+|++++++++|+||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 46799999999999999999954 56889999998776556667788999999999999999999876543
Q ss_pred -----cceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeC-CCCcEEE
Q 046750 429 -----KNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVD-DEFEAQV 502 (723)
Q Consensus 429 -----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~-~~~~vkL 502 (723)
...|+||||+. ++|.+++... .+.+..++.++.||++||.|||+. +|+|||||++|||++ +++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQG---PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEE
Confidence 34689999996 6888887543 378889999999999999999998 599999999999997 4567899
Q ss_pred eecccccccCCCCcce--eecccccccccChhhhcc-CCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhh
Q 046750 503 ADFGLAKLNDTTQTHV--STRVMGTFGYLAPEYASS-GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARP 579 (723)
Q Consensus 503 ~DFGla~~~~~~~~~~--~~~~~gt~~y~APE~~~~-~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~ 579 (723)
+|||+++.......+. .....++..|+|||++.+ ..++.++|||||||+||||++|+.||.............+..+
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~ 236 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP 236 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 9999997653322211 122357889999998754 5688899999999999999999999975543211111000000
Q ss_pred hhhhhhhcCCcccccchhhh----------ccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 580 VLVRAIETGDLSEIVDPRLE----------KHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 580 ~l~~~i~~~~l~~~vd~~l~----------~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
..... +...+...+...+. ..........+.+++.+||+.||.+||++.+|++.
T Consensus 237 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 237 VVREE-DRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred CCChH-HhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 00000 00000000000000 00001122467889999999999999999999853
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=306.37 Aligned_cols=270 Identities=21% Similarity=0.347 Sum_probs=198.0
Q ss_pred HHHHHhcCcccceEEeccCcEEEEEEE-cCCCcEEEEEEcccC--CchhHHHHHHHHHHHHHccCCceeeEeeeeec-cc
Q 046750 354 ELMEITNGFARENVIGEGGFGCVYKGN-LPEGKVVAVKQLKSG--SGQGEREFRAEVEIISRVHHRHLVSLVGYCIS-EK 429 (723)
Q Consensus 354 ~l~~~~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~VAvK~l~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~ 429 (723)
++..+.++|++.+.||+|+||.||++. ..+++.||||++... .....+.+.+|++++++++|+||++++++|.. ..
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 345578899999999999999999995 457899999987643 22334678899999999999999999998875 55
Q ss_pred ceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeeccccc
Q 046750 430 NRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK 509 (723)
Q Consensus 430 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 509 (723)
..++|+||+ +++|.++++.. .+.+..+..++.||++||+|||++ +|+||||++.|||+++++.+||+|||++.
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred cEEEEeehh-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccccc
Confidence 788999998 67898888643 367778888999999999999999 59999999999999999999999999987
Q ss_pred ccCCCCcceeecccccccccChhhhcc-CCCCCccceechHHHHHHHHhCCCCCCCCCCCCch-hhHHhhhhh---hhhh
Q 046750 510 LNDTTQTHVSTRVMGTFGYLAPEYASS-GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDE-SLVEWARPV---LVRA 584 (723)
Q Consensus 510 ~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~-~l~~~~~~~---l~~~ 584 (723)
..... .....++..|++||++.+ ..++.++|||||||+||||++|+.+|......... .+.++.... +.+.
T Consensus 157 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 157 IQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred ccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 54321 122457888999998866 56899999999999999999999999654321100 011110000 0000
Q ss_pred hhcCCcccccch-hhhcccc-----HHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 585 IETGDLSEIVDP-RLEKHYV-----ESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 585 i~~~~l~~~vd~-~l~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
+..++..+++.. ....... ......+.+++.+||+.+|.+||++.+|+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000100000000 0000011 1123468899999999999999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=289.97 Aligned_cols=204 Identities=27% Similarity=0.404 Sum_probs=168.9
Q ss_pred HhcCcccceEEeccCcEEEEEEEcCC-----CcEEEEEEcccCCc-hh-HHHHHHHHHHHHHccCCceeeEeeeeec-cc
Q 046750 358 ITNGFARENVIGEGGFGCVYKGNLPE-----GKVVAVKQLKSGSG-QG-EREFRAEVEIISRVHHRHLVSLVGYCIS-EK 429 (723)
Q Consensus 358 ~~~~f~~~~~LG~G~fG~Vy~~~~~~-----g~~VAvK~l~~~~~-~~-~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~ 429 (723)
....|+.+..||+|.||.||++.-++ .+.+|||+++.... .+ .....+|+.+++.|+|+||+.|+.+|.. +.
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 34568999999999999999993322 23799999976421 11 2356789999999999999999999887 77
Q ss_pred ceEEEEEecCCCchhhccccC---CCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCC----CcEEE
Q 046750 430 NRLLIYEFVPNNNLEHHLHGK---GQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDE----FEAQV 502 (723)
Q Consensus 430 ~~~lV~E~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~----~~vkL 502 (723)
.++|+|||. ..+|.++++.+ ....+....+..|++||+.|+.|||+++ |+||||||.||||..+ |.|||
T Consensus 102 ~v~l~fdYA-EhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 102 KVWLLFDYA-EHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred eEEEEehhh-hhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEe
Confidence 889999999 55787777532 2246788888999999999999999997 9999999999999877 99999
Q ss_pred eecccccccCCCCcc--eeecccccccccChhhhccC-CCCCccceechHHHHHHHHhCCCCCCCC
Q 046750 503 ADFGLAKLNDTTQTH--VSTRVMGTFGYLAPEYASSG-KLTDRSDVFSFGVVLLELITGRKPVDPT 565 (723)
Q Consensus 503 ~DFGla~~~~~~~~~--~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSlGviL~eLltG~~P~~~~ 565 (723)
+||||++++...... ....++.|++|+|||++.+. .|+.+.|||++|||+.|||+-+..|...
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 999999988654332 23457789999999999876 5999999999999999999988888654
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=331.72 Aligned_cols=145 Identities=31% Similarity=0.431 Sum_probs=129.8
Q ss_pred cCcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCCc---hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGSG---QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 435 (723)
++|.+.++||+|+||.||+|.+. +++.||||+++.... .....+.+|+++++.++|+||+++++++.....+||||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 67999999999999999999654 689999999975422 23357889999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeeccccc
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK 509 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 509 (723)
||+.+++|.++++..+ .+.+..+++|+.||+.||+|||.+ +|||||||++||||+.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999997544 477888999999999999999998 59999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=302.95 Aligned_cols=256 Identities=26% Similarity=0.424 Sum_probs=194.6
Q ss_pred hcCcccceEEeccCcEEEEEE-EcCCCcEEEEEEcccCCc--hh-----HHHHHHHHHHHHHccCCceeeEeeeeec-cc
Q 046750 359 TNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSG--QG-----EREFRAEVEIISRVHHRHLVSLVGYCIS-EK 429 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~-~~~~g~~VAvK~l~~~~~--~~-----~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~ 429 (723)
.++|..+++||+|||++||++ ++...+.||||+...... +. .+...+|.+|.+.|+|+.||++++||.. .+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 455778899999999999999 777889999998643311 11 1235689999999999999999999974 45
Q ss_pred ceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCC---CCcEEEeecc
Q 046750 430 NRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDD---EFEAQVADFG 506 (723)
Q Consensus 430 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~---~~~vkL~DFG 506 (723)
.+|-|+|||+|.+|+.||+.+. .+.+.....|+.||+.||.||.+. .+.|||-||||.||||.+ .|.+||.|||
T Consensus 542 sFCTVLEYceGNDLDFYLKQhk--lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQHK--LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred cceeeeeecCCCchhHHHHhhh--hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 6789999999999999997554 588899999999999999999997 578999999999999964 4789999999
Q ss_pred cccccCCCCcc------eeecccccccccChhhhccC----CCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHh
Q 046750 507 LAKLNDTTQTH------VSTRVMGTFGYLAPEYASSG----KLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEW 576 (723)
Q Consensus 507 la~~~~~~~~~------~~~~~~gt~~y~APE~~~~~----~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~ 576 (723)
|++++.++... ......||++|++||.+.-+ +++.|.||||+|||+|.+|.|+.||...... ..++..
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ--QdILqe 696 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ--QDILQE 696 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH--HHHHhh
Confidence 99987654332 23346799999999988654 4788999999999999999999999765432 111111
Q ss_pred hhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHH
Q 046750 577 ARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVV 632 (723)
Q Consensus 577 ~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl 632 (723)
.- ++++ ..+ .+ ...+-...+...++.+||...-++|-+..++.
T Consensus 697 NT--IlkA---tEV------qF--P~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 697 NT--ILKA---TEV------QF--PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred hc--hhcc---eec------cC--CCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 00 1110 000 00 00111122456778899999999998877664
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=298.26 Aligned_cols=263 Identities=23% Similarity=0.348 Sum_probs=198.3
Q ss_pred cccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCC--chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEec
Q 046750 362 FARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGS--GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFV 438 (723)
Q Consensus 362 f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 438 (723)
|+..+.||+|+||.||+|... +++.|++|+++... ......+..|++++++++|+||+++++++.+....++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 566788999999999999665 48999999987653 233457888999999999999999999999999999999999
Q ss_pred CCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcce
Q 046750 439 PNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHV 518 (723)
Q Consensus 439 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 518 (723)
. ++|.+++.... ..+++..++.++.++++||+|||++ +|+||||+++||++++++.+||+|||+++........
T Consensus 81 ~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~- 154 (282)
T cd07829 81 D-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT- 154 (282)
T ss_pred C-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCccc-
Confidence 6 58999987653 2488999999999999999999999 4999999999999999999999999999765443221
Q ss_pred eecccccccccChhhhccC-CCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhh-------hhh---h--
Q 046750 519 STRVMGTFGYLAPEYASSG-KLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVL-------VRA---I-- 585 (723)
Q Consensus 519 ~~~~~gt~~y~APE~~~~~-~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l-------~~~---i-- 585 (723)
.....++..|+|||++.+. .++.++|||+|||++|||++|+.+|....... ...+....+ ... +
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEID---QLFKIFQILGTPTEESWPGVTKLPD 231 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHH---HHHHHHHHhCCCcHHHHHhhccccc
Confidence 2223467789999998877 78999999999999999999999996644211 111000000 000 0
Q ss_pred hcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 586 ETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 586 ~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
....+.......+.. ........+.+++.+||+.+|.+||++.+|+..
T Consensus 232 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 232 YKPTFPKFPPKDLEK-VLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred ccccccccCccchHH-hcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 000111111000100 011113468999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=306.26 Aligned_cols=268 Identities=22% Similarity=0.271 Sum_probs=195.5
Q ss_pred hcCccc-ceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCchh--------------HHHHHHHHHHHHHccCCceeeEe
Q 046750 359 TNGFAR-ENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQG--------------EREFRAEVEIISRVHHRHLVSLV 422 (723)
Q Consensus 359 ~~~f~~-~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~~--------------~~~~~~Ei~il~~l~HpnIv~l~ 422 (723)
.++|.. .+.||+|+||.||+|.. .+++.||||+++...... ...+.+|++++++++|+||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 355653 57799999999999964 468999999986542221 12577899999999999999999
Q ss_pred eeeecccceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEE
Q 046750 423 GYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQV 502 (723)
Q Consensus 423 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL 502 (723)
+++...+..++||||+. |+|.+++.... .+.+..++.++.||+.||+|||+. +|+||||+++||||+.++.+||
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDRKI--RLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEE
Confidence 99999999999999995 68988886543 478889999999999999999998 4999999999999999999999
Q ss_pred eecccccccCCCC-------------cceeecccccccccChhhhccC-CCCCccceechHHHHHHHHhCCCCCCCCCCC
Q 046750 503 ADFGLAKLNDTTQ-------------THVSTRVMGTFGYLAPEYASSG-KLTDRSDVFSFGVVLLELITGRKPVDPTQPL 568 (723)
Q Consensus 503 ~DFGla~~~~~~~-------------~~~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSlGviL~eLltG~~P~~~~~~~ 568 (723)
+|||++....... ........++..|++||++.+. .++.++|||||||++|||++|+.||......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999997654111 1111223467889999998764 4789999999999999999999999765431
Q ss_pred CchhhHHhhhhhhh--------hhhhcC---CcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 046750 569 GDESLVEWARPVLV--------RAIETG---DLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALD 636 (723)
Q Consensus 569 ~~~~l~~~~~~~l~--------~~i~~~---~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~ 636 (723)
. ........+. +..... .+.......+... .......+.+++.+||+.+|.+||++.||+..-.
T Consensus 241 ~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~ 315 (335)
T PTZ00024 241 D---QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTI-FPNASDDAIDLLQSLLKLNPLERISAKEALKHEY 315 (335)
T ss_pred H---HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHh-CcCCChHHHHHHHHHcCCCchhccCHHHHhcCcc
Confidence 1 1111000000 000000 0000001111110 1112346789999999999999999999997543
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=298.96 Aligned_cols=267 Identities=22% Similarity=0.326 Sum_probs=205.1
Q ss_pred HHhcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCchhHHHHHHHHHHHHHcc-C-C----ceeeEeeeeeccc
Q 046750 357 EITNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQGEREFRAEVEIISRVH-H-R----HLVSLVGYCISEK 429 (723)
Q Consensus 357 ~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~-H-p----nIv~l~g~~~~~~ 429 (723)
.+.++|.+..+||+|.||.|..+.. +.+..||||+++..... .+..+-|+++|.+|. + | -+|++.++|...+
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg 164 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG 164 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence 3478999999999999999999943 44789999999865322 234567999999993 2 1 3688888999999
Q ss_pred ceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCC-------------
Q 046750 430 NRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDD------------- 496 (723)
Q Consensus 430 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~------------- 496 (723)
+.|||+|.+ |-++.++|..+.-..+...++..|++|++++++|||+. +++|-||||+|||+.+
T Consensus 165 hiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~~ 240 (415)
T KOG0671|consen 165 HICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKKV 240 (415)
T ss_pred ceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCcc
Confidence 999999998 77999999988888899999999999999999999999 5999999999999841
Q ss_pred -------CCcEEEeecccccccCCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCC
Q 046750 497 -------EFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLG 569 (723)
Q Consensus 497 -------~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~ 569 (723)
+..++|+|||.|.+..... ..++.|..|+|||++++-.|+..+||||+||||+||++|...|......
T Consensus 241 ~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~- 315 (415)
T KOG0671|consen 241 CFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL- 315 (415)
T ss_pred ceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH-
Confidence 3569999999998655433 4466899999999999999999999999999999999999999776532
Q ss_pred chhhHHhhh---hhhhhhhhc---------CCc-----------ccccchh--h--hccccHHHHHHHHHHHHHHhccCC
Q 046750 570 DESLVEWAR---PVLVRAIET---------GDL-----------SEIVDPR--L--EKHYVESEMFRMIEAAAACVRHSG 622 (723)
Q Consensus 570 ~~~l~~~~~---~~l~~~i~~---------~~l-----------~~~vd~~--l--~~~~~~~~~~~l~~l~~~cl~~dP 622 (723)
+.+..+.+ ++-..++.. |.+ ....+.. | .......+...|++|+.+||..||
T Consensus 316 -EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP 394 (415)
T KOG0671|consen 316 -EHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDP 394 (415)
T ss_pred -HHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCc
Confidence 22221111 000111111 110 0011100 0 112234566679999999999999
Q ss_pred CCCCCHHHHHHH
Q 046750 623 PKRPRMVQVVRA 634 (723)
Q Consensus 623 ~~RPs~~eVl~~ 634 (723)
.+|.++.|++..
T Consensus 395 ~~RiTl~EAL~H 406 (415)
T KOG0671|consen 395 ARRITLREALSH 406 (415)
T ss_pred cccccHHHHhcC
Confidence 999999998753
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=294.69 Aligned_cols=249 Identities=20% Similarity=0.331 Sum_probs=193.4
Q ss_pred CcccceEEeccCcEEEEEEEcCC-CcEEEEEEcccC-----CchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEE
Q 046750 361 GFARENVIGEGGFGCVYKGNLPE-GKVVAVKQLKSG-----SGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLI 434 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~~~~-g~~VAvK~l~~~-----~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 434 (723)
+|.+.+.||+|+||.||++.... +..+++|+++.. ......++..|++++++++|+||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47888999999999999996543 445666665432 122334577899999999999999999999999999999
Q ss_pred EEecCCCchhhcccc--CCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccC
Q 046750 435 YEFVPNNNLEHHLHG--KGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLND 512 (723)
Q Consensus 435 ~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 512 (723)
|||+.+++|.+++.. .....+++..++.++.|+++||.|||+. +|+|+||+++|||++++ .+||+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~~-~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKNN-LLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeecC-CEeecccCceeecC
Confidence 999999999988864 2234589999999999999999999998 59999999999999864 69999999987654
Q ss_pred CCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCccc
Q 046750 513 TTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSE 592 (723)
Q Consensus 513 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~ 592 (723)
.... ......|+..|++||++.+..++.++||||||+++|+|++|..+|..... .... ..+..+....
T Consensus 157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~------~~~~-----~~~~~~~~~~ 224 (260)
T cd08222 157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF------LSVV-----LRIVEGPTPS 224 (260)
T ss_pred CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHH-----HHHHcCCCCC
Confidence 3322 12234578899999999888899999999999999999999999864321 1111 1111111111
Q ss_pred ccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 593 IVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 593 ~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
........+.+++.+||+.+|.+||++.+|++.
T Consensus 225 ---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 225 ---------LPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred ---------CcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 112233467889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=287.34 Aligned_cols=258 Identities=24% Similarity=0.320 Sum_probs=203.3
Q ss_pred HHhcCcccc-eEEeccCcEEEEEE-EcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHc-cCCceeeEeeeeec----cc
Q 046750 357 EITNGFARE-NVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRV-HHRHLVSLVGYCIS----EK 429 (723)
Q Consensus 357 ~~~~~f~~~-~~LG~G~fG~Vy~~-~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~----~~ 429 (723)
.++++|.+. ++||-|-.|+|..+ +...++.+|+|+|... ...++|+++.-+. .|+|||+++++|.. ..
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 355666654 57999999999999 5557899999999643 4567888887666 69999999998864 34
Q ss_pred ceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeC---CCCcEEEeecc
Q 046750 430 NRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVD---DEFEAQVADFG 506 (723)
Q Consensus 430 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~---~~~~vkL~DFG 506 (723)
.+++|||+|+||.|...++.++...+.+.+.-.|..||+.|+.|||+. +|.|||||++|+|.. .|..+||+|||
T Consensus 133 cLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccc
Confidence 467899999999999999999988899999999999999999999999 799999999999996 45679999999
Q ss_pred cccccCCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhh
Q 046750 507 LAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIE 586 (723)
Q Consensus 507 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~ 586 (723)
+|+...... ....-+.|+.|.|||++...+|+..+|+||+|||+|-||+|..||.....+. +. +-....|.
T Consensus 210 FAK~t~~~~--~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a---is----pgMk~rI~ 280 (400)
T KOG0604|consen 210 FAKETQEPG--DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA---IS----PGMKRRIR 280 (400)
T ss_pred cccccCCCc--cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc---CC----hhHHhHhh
Confidence 998654322 2234567999999999999999999999999999999999999997654321 11 11223344
Q ss_pred cCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhc
Q 046750 587 TGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDS 637 (723)
Q Consensus 587 ~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~ 637 (723)
.|.+ ++-++. .....+...++++.+|+.+|.+|.++.+++..=+-
T Consensus 281 ~gqy-~FP~pE-----Ws~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi 325 (400)
T KOG0604|consen 281 TGQY-EFPEPE-----WSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWI 325 (400)
T ss_pred ccCc-cCCChh-----HhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchh
Confidence 4432 222211 12334456788999999999999999999876443
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=310.47 Aligned_cols=267 Identities=20% Similarity=0.337 Sum_probs=197.6
Q ss_pred HHHhcCcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCC--chhHHHHHHHHHHHHHccCCceeeEeeeeecccc--
Q 046750 356 MEITNGFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGS--GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKN-- 430 (723)
Q Consensus 356 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~-- 430 (723)
.++.++|.+.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++++++|+||+++++++...+.
T Consensus 11 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07851 11 WEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLE 90 (343)
T ss_pred ecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccc
Confidence 356788999999999999999999664 57899999986532 2233567789999999999999999998876554
Q ss_pred ----eEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecc
Q 046750 431 ----RLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFG 506 (723)
Q Consensus 431 ----~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFG 506 (723)
.++|+||+ +++|.+++... .+++..++.++.||++||+|||+. +|+|||||++|||+++++.+||+|||
T Consensus 91 ~~~~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 91 DFQDVYLVTHLM-GADLNNIVKCQ---KLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred ccccEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccc
Confidence 89999998 67998888652 488899999999999999999998 59999999999999999999999999
Q ss_pred cccccCCCCcceeecccccccccChhhhcc-CCCCCccceechHHHHHHHHhCCCCCCCCCCCCch-hhHHhh---hhhh
Q 046750 507 LAKLNDTTQTHVSTRVMGTFGYLAPEYASS-GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDE-SLVEWA---RPVL 581 (723)
Q Consensus 507 la~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~-~l~~~~---~~~l 581 (723)
++...... .....++..|+|||++.+ ..++.++|||||||+||||++|+.||......... .+.... ...+
T Consensus 164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 239 (343)
T cd07851 164 LARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEEL 239 (343)
T ss_pred cccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Confidence 99765432 223457889999999865 36789999999999999999999999654321100 000000 0000
Q ss_pred hhhhhcCCcccccc-------hhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 582 VRAIETGDLSEIVD-------PRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 582 ~~~i~~~~l~~~vd-------~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
...+.......+++ ..+... .......+.+++.+||+.+|.+||++.+|++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 240 LQKISSESARNYIQSLPQMPKKDFKEV-FSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HhhccchhHHHHHHhccccCCCCHHHH-hccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 01111000000000 000000 01123478899999999999999999999864
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=315.22 Aligned_cols=261 Identities=25% Similarity=0.414 Sum_probs=211.6
Q ss_pred CHHHHHHHhcCcccceEEeccCcEEEEEE-EcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHc-cCCceeeEeeeeec-
Q 046750 351 TYEELMEITNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRV-HHRHLVSLVGYCIS- 427 (723)
Q Consensus 351 ~~~~l~~~~~~f~~~~~LG~G~fG~Vy~~-~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~- 427 (723)
.++.+-.-++.|++.+.||+|.+|.||++ ..++|+.+|||++.... ..+++++.|++||+.+ +|+|++.++|+|..
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 34444445677999999999999999999 55678999999887643 4456788999999998 69999999998863
Q ss_pred ----ccceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEe
Q 046750 428 ----EKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVA 503 (723)
Q Consensus 428 ----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~ 503 (723)
++.+|||||||.+|+.-+++++.....+.|..+..|++.++.||.+||.+ ++||||||-.||||+.++.|||+
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEe
Confidence 46789999999999999999876666799999999999999999999999 69999999999999999999999
Q ss_pred ecccccccCCCCcceeecccccccccChhhhccCC-----CCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhh
Q 046750 504 DFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGK-----LTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWAR 578 (723)
Q Consensus 504 DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-----~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~ 578 (723)
|||++..... ..+.....+||+.|||||++...+ |+.++|+||||++..||.-|..|+.+..+...
T Consensus 166 DFGvSaQlds-T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra-------- 236 (953)
T KOG0587|consen 166 DFGVSAQLDS-TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA-------- 236 (953)
T ss_pred eeeeeeeeec-ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh--------
Confidence 9999976543 333445567999999999997653 77899999999999999999999977654211
Q ss_pred hhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 579 PVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 579 ~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
|+... -.+.........-.+++.+++..||.+|-.+||.+.+++++
T Consensus 237 --LF~Ip--------RNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 237 --LFLIP--------RNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred --hccCC--------CCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 11111 11222222334456689999999999999999999998764
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=281.45 Aligned_cols=249 Identities=25% Similarity=0.421 Sum_probs=193.4
Q ss_pred ccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCC-chhHHHHHHHHHHHHHcc-CCceeeEeeeeecccceEEEEEecC
Q 046750 363 ARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS-GQGEREFRAEVEIISRVH-HRHLVSLVGYCISEKNRLLIYEFVP 439 (723)
Q Consensus 363 ~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~-~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~E~~~ 439 (723)
+.+..||.|..|.||+++. ..|...|||.+.... .++.+.++..++++.+.+ ++.||+.+|||..+..+++-||.|
T Consensus 95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM- 173 (391)
T KOG0983|consen 95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM- 173 (391)
T ss_pred hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-
Confidence 4567899999999999955 458899999997653 344567788888887765 899999999999999999999988
Q ss_pred CCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCccee
Q 046750 440 NNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVS 519 (723)
Q Consensus 440 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 519 (723)
.-.++++|.+... .+.+..+-++...+++||.||.++. .|||||+||+|||||+.|++||||||++-.+-+...+
T Consensus 174 s~C~ekLlkrik~-piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh-- 248 (391)
T KOG0983|consen 174 STCAEKLLKRIKG-PIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH-- 248 (391)
T ss_pred HHHHHHHHHHhcC-CchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccccc--
Confidence 6667777765444 4777778889999999999999875 7999999999999999999999999999766554433
Q ss_pred ecccccccccChhhhcc---CCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccch
Q 046750 520 TRVMGTFGYLAPEYASS---GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDP 596 (723)
Q Consensus 520 ~~~~gt~~y~APE~~~~---~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~ 596 (723)
++..|-..|||||.+.- ..|+.++||||||+.|+||.||+.||..-.-. .. .+..+.+ +.- +
T Consensus 249 trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td--Fe--------~ltkvln-~eP----P 313 (391)
T KOG0983|consen 249 TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD--FE--------VLTKVLN-EEP----P 313 (391)
T ss_pred ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc--HH--------HHHHHHh-cCC----C
Confidence 45568899999999864 36999999999999999999999999764321 11 1111111 111 2
Q ss_pred hhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 597 RLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 597 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
+|.... .-...+.+++..||++|+.+||...+++++
T Consensus 314 ~L~~~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 314 LLPGHM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred CCCccc--CcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 222111 012367889999999999999999988764
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=285.21 Aligned_cols=236 Identities=28% Similarity=0.365 Sum_probs=191.0
Q ss_pred EeccCcEEEEEEEcC-CCcEEEEEEcccCCc---hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEecCCCch
Q 046750 368 IGEGGFGCVYKGNLP-EGKVVAVKQLKSGSG---QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNL 443 (723)
Q Consensus 368 LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 443 (723)
||+|+||.||++... +++.|++|+++.... .....+..|++++++++|+||+++++.+..+...++||||+.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999654 588999999876432 2345788999999999999999999999999999999999999999
Q ss_pred hhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcceeeccc
Q 046750 444 EHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVM 523 (723)
Q Consensus 444 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 523 (723)
.+++.... .+++..++.++.||+.||.|||+. +++|+||++.||++++++.++|+|||++........ ......
T Consensus 81 ~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~ 154 (250)
T cd05123 81 FSHLSKEG--RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-RTNTFC 154 (250)
T ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCC-cccCCc
Confidence 99997654 478999999999999999999998 599999999999999999999999999976543321 123345
Q ss_pred ccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhhhcccc
Q 046750 524 GTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEKHYV 603 (723)
Q Consensus 524 gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~ 603 (723)
++..|++||.+.+..++.++|+|+||+++|||++|+.||..... ..+. +.+..+.+ .+.
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~--------~~~~~~~~----------~~~ 213 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIY--------EKILKDPL----------RFP 213 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHH--------HHHhcCCC----------CCC
Confidence 78899999999988899999999999999999999999965432 1111 11111111 011
Q ss_pred HHHHHHHHHHHHHHhccCCCCCCCHHH
Q 046750 604 ESEMFRMIEAAAACVRHSGPKRPRMVQ 630 (723)
Q Consensus 604 ~~~~~~l~~l~~~cl~~dP~~RPs~~e 630 (723)
......+.+++.+||..||++||++.+
T Consensus 214 ~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 214 EFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 111346788999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=261.33 Aligned_cols=200 Identities=25% Similarity=0.416 Sum_probs=169.1
Q ss_pred CcccceEEeccCcEEEEEEE-cCCCcEEEEEEcccCCch--hHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEe
Q 046750 361 GFARENVIGEGGFGCVYKGN-LPEGKVVAVKQLKSGSGQ--GEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEF 437 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~-~~~g~~VAvK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 437 (723)
+|...++||+|.||+||+|+ +..++.||+|+++-.+.+ .-....+||.+|+.|+|.|||+++++...++..-||+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 46677899999999999995 455889999998765322 235678999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcc
Q 046750 438 VPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTH 517 (723)
Q Consensus 438 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 517 (723)
| .-+|.+|+..... .++.+....+++|+++||.++|++ +++||||||+|+||+.+|++||+|||+++.++.....
T Consensus 83 c-dqdlkkyfdslng-~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvrc 157 (292)
T KOG0662|consen 83 C-DQDLKKYFDSLNG-DLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC 157 (292)
T ss_pred h-hHHHHHHHHhcCC-cCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceEe
Confidence 9 6788888765433 478888899999999999999999 7999999999999999999999999999987654433
Q ss_pred eeecccccccccChhhhccCC-CCCccceechHHHHHHHHh-CCCCCCCCC
Q 046750 518 VSTRVMGTFGYLAPEYASSGK-LTDRSDVFSFGVVLLELIT-GRKPVDPTQ 566 (723)
Q Consensus 518 ~~~~~~gt~~y~APE~~~~~~-~t~ksDVwSlGviL~eLlt-G~~P~~~~~ 566 (723)
.. ..+.|++|++|.++.+.+ |+...|+||.|||+.||.. |+..|-+.+
T Consensus 158 ys-aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~d 207 (292)
T KOG0662|consen 158 YS-AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND 207 (292)
T ss_pred ee-ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCc
Confidence 33 345699999999998765 8889999999999999998 555565544
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=323.01 Aligned_cols=206 Identities=28% Similarity=0.332 Sum_probs=182.0
Q ss_pred HHHHHhcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCc---hhHHHHHHHHHHHHHccCCceeeEeeeeeccc
Q 046750 354 ELMEITNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSG---QGEREFRAEVEIISRVHHRHLVSLVGYCISEK 429 (723)
Q Consensus 354 ~l~~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 429 (723)
++..-.++|.++++||+|+||.|.+++. ..++.||+|++.+... ....-|+.|-++|..-+.+-|++|+..|+++.
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~ 148 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER 148 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence 3333457899999999999999999965 4588999999987422 23456889999999999999999999999999
Q ss_pred ceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeeccccc
Q 046750 430 NRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK 509 (723)
Q Consensus 430 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 509 (723)
++|||||||.||+|..+|.+.. .+++....+++..|+.||.-||+.| +|||||||.|||||..|++||+|||.+.
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsCl 223 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSCL 223 (1317)
T ss_pred ceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhHH
Confidence 9999999999999999998766 4888888899999999999999995 9999999999999999999999999998
Q ss_pred ccCCCCcceeecccccccccChhhhc----c-CCCCCccceechHHHHHHHHhCCCCCCC
Q 046750 510 LNDTTQTHVSTRVMGTFGYLAPEYAS----S-GKLTDRSDVFSFGVVLLELITGRKPVDP 564 (723)
Q Consensus 510 ~~~~~~~~~~~~~~gt~~y~APE~~~----~-~~~t~ksDVwSlGviL~eLltG~~P~~~ 564 (723)
.+..++.-.....+||+.|.+||+++ + +.|+..+|.||+||++||||.|..||..
T Consensus 224 km~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa 283 (1317)
T KOG0612|consen 224 KMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA 283 (1317)
T ss_pred hcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence 88766666666778999999999996 2 5799999999999999999999999973
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=293.23 Aligned_cols=241 Identities=26% Similarity=0.341 Sum_probs=196.2
Q ss_pred cCcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCCchhHH---HHHHHHHHHHHc-cCCceeeEeeeeecccceEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGSGQGER---EFRAEVEIISRV-HHRHLVSLVGYCISEKNRLLI 434 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~~~~~~---~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV 434 (723)
.+|..+.+||+|+||+|.+++.+ ..+.||||+|++....+.. --+.|-++|... +-+.+++|+.+|+..+.+|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 46888999999999999999554 4578999999986433322 345677788776 467899999999999999999
Q ss_pred EEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCC
Q 046750 435 YEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTT 514 (723)
Q Consensus 435 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 514 (723)
|||+.||+|..+++..++ +.+.....++..|+-||-+||++| ||.||||..|||||.+|++||+|||+++.--..
T Consensus 429 MEyvnGGDLMyhiQQ~Gk--FKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~ 503 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVGK--FKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD 503 (683)
T ss_pred EEEecCchhhhHHHHhcc--cCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccccC
Confidence 999999999999987664 677888999999999999999995 999999999999999999999999999743222
Q ss_pred CcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCccccc
Q 046750 515 QTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIV 594 (723)
Q Consensus 515 ~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~v 594 (723)
. .....++||+.|+|||++....|+...|.|+|||+|||||.|+.||++.++.. +.+.|..-+
T Consensus 504 ~-~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e-----------lF~aI~ehn----- 566 (683)
T KOG0696|consen 504 G-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE-----------LFQAIMEHN----- 566 (683)
T ss_pred C-cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH-----------HHHHHHHcc-----
Confidence 2 22345789999999999999999999999999999999999999999876421 233332221
Q ss_pred chhhhccccHHHHHHHHHHHHHHhccCCCCCCC
Q 046750 595 DPRLEKHYVESEMFRMIEAAAACVRHSGPKRPR 627 (723)
Q Consensus 595 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs 627 (723)
..|......+.+.|....|.+.|.+|.-
T Consensus 567 -----vsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 567 -----VSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred -----CcCcccccHHHHHHHHHHhhcCCccccC
Confidence 2344445557788888999999999863
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=288.38 Aligned_cols=252 Identities=26% Similarity=0.392 Sum_probs=196.2
Q ss_pred cceEEeccCcEEEEEE-EcCCCcEEEEEEcccCCc-hhHHHHHHHHHHHHHc-cCCceeeEeeeeecccceEEEEEecCC
Q 046750 364 RENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSG-QGEREFRAEVEIISRV-HHRHLVSLVGYCISEKNRLLIYEFVPN 440 (723)
Q Consensus 364 ~~~~LG~G~fG~Vy~~-~~~~g~~VAvK~l~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 440 (723)
....||.|.||.|+|- +...|+..|||+++.... .+.++|+.|.+...+- +.+|||+|+|.+..++..|+-||+| .
T Consensus 68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d 146 (361)
T KOG1006|consen 68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-D 146 (361)
T ss_pred HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-h
Confidence 4567999999999998 556799999999988754 4556788888877665 7899999999999999999999999 4
Q ss_pred Cchhh---ccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcc
Q 046750 441 NNLEH---HLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTH 517 (723)
Q Consensus 441 gsL~~---~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 517 (723)
-+|+. +++...+..+.+..+-+|....++||.||.+.- +||||||||+||||+..|.+||||||++-.+.+. .
T Consensus 147 ~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S--i 222 (361)
T KOG1006|consen 147 ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS--I 222 (361)
T ss_pred hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHH--H
Confidence 45544 344445556888888889999999999999865 7999999999999999999999999998654322 2
Q ss_pred eeecccccccccChhhhcc--CCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccc
Q 046750 518 VSTRVMGTFGYLAPEYASS--GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVD 595 (723)
Q Consensus 518 ~~~~~~gt~~y~APE~~~~--~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd 595 (723)
..+.-.|-.-|||||.+.. ..|+.++||||||+.|||+.||+.||..+... .+ .+..+..|+...++.
T Consensus 223 AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv-----fe-----ql~~Vv~gdpp~l~~ 292 (361)
T KOG1006|consen 223 AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV-----FE-----QLCQVVIGDPPILLF 292 (361)
T ss_pred HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH-----HH-----HHHHHHcCCCCeecC
Confidence 2344568889999999853 35999999999999999999999999765421 11 112334555544433
Q ss_pred hhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 596 PRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 596 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
..-. .+....|..++.-|+.+|-.+||...++++.
T Consensus 293 ~~~~----~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 293 DKEC----VHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred cccc----cccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 2221 2234578899999999999999999988653
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=312.87 Aligned_cols=260 Identities=22% Similarity=0.288 Sum_probs=170.7
Q ss_pred HhcCcccceEEeccCcEEEEEEEcC-C----CcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeee------ee
Q 046750 358 ITNGFARENVIGEGGFGCVYKGNLP-E----GKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGY------CI 426 (723)
Q Consensus 358 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~----g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~------~~ 426 (723)
..++|.+.++||+|+||.||+|.+. + +..||||+++..... +.+..| .+.+..+.+++.++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 3568999999999999999999664 4 689999998653211 111111 1222222333322221 24
Q ss_pred cccceEEEEEecCCCchhhccccCCCC------------------cchHHHHHHHHHHHHhhhchhcccCCCceeecCCC
Q 046750 427 SEKNRLLIYEFVPNNNLEHHLHGKGQP------------------VLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIK 488 (723)
Q Consensus 427 ~~~~~~lV~E~~~~gsL~~~l~~~~~~------------------~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIk 488 (723)
.+...+|||||+.+++|.++++..... ......+..|+.||+.||+|||++ +|||||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence 566789999999999999988654211 112234567999999999999998 59999999
Q ss_pred CCcEEeCC-CCcEEEeecccccccCCCCcceeecccccccccChhhhccC----------------------CCCCccce
Q 046750 489 SANILVDD-EFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSG----------------------KLTDRSDV 545 (723)
Q Consensus 489 p~NILl~~-~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~----------------------~~t~ksDV 545 (723)
|+||||++ ++.+||+|||+++.+............++..|||||.+... .+..++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999985 57999999999986654444444556789999999965422 24557799
Q ss_pred echHHHHHHHHhCCCCCCCCCC-------CCchhhHHhhhhhhhhhhhcCCcccccchhhhccc--cHHHHHHHHHHHHH
Q 046750 546 FSFGVVLLELITGRKPVDPTQP-------LGDESLVEWARPVLVRAIETGDLSEIVDPRLEKHY--VESEMFRMIEAAAA 616 (723)
Q Consensus 546 wSlGviL~eLltG~~P~~~~~~-------~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~~~--~~~~~~~l~~l~~~ 616 (723)
||||||||||+++..+++.... ..+..+..|.... ... ....+...+ ........++|+.+
T Consensus 363 wSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~-----~~~-----~~~~~~~~~~~~d~~~~~~~dLi~~ 432 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLV-----EPR-----ASPDLRRGFEVLDLDGGAGWELLKS 432 (566)
T ss_pred HHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhh-----ccc-----cchhhhhhhhhccccchHHHHHHHH
Confidence 9999999999998766542110 0001111221100 000 000000000 00111235689999
Q ss_pred HhccCCCCCCCHHHHHHH
Q 046750 617 CVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 617 cl~~dP~~RPs~~eVl~~ 634 (723)
||+.||++||++.|+++.
T Consensus 433 mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 433 MMRFKGRQRISAKAALAH 450 (566)
T ss_pred HccCCcccCCCHHHHhCC
Confidence 999999999999999975
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.6e-32 Score=304.99 Aligned_cols=259 Identities=20% Similarity=0.283 Sum_probs=180.7
Q ss_pred hcCcccceEEeccCcEEEEEEEc-----------------CCCcEEEEEEcccCCchhHHH--------------HHHHH
Q 046750 359 TNGFARENVIGEGGFGCVYKGNL-----------------PEGKVVAVKQLKSGSGQGERE--------------FRAEV 407 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~-----------------~~g~~VAvK~l~~~~~~~~~~--------------~~~Ei 407 (723)
.++|.+.++||+|+||.||+|.+ .+++.||||+++.......++ +..|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 46899999999999999999953 235689999987543322223 33477
Q ss_pred HHHHHccCCce-----eeEeeeeec--------ccceEEEEEecCCCchhhccccCCC----------------------
Q 046750 408 EIISRVHHRHL-----VSLVGYCIS--------EKNRLLIYEFVPNNNLEHHLHGKGQ---------------------- 452 (723)
Q Consensus 408 ~il~~l~HpnI-----v~l~g~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~~---------------------- 452 (723)
.++.+++|.++ ++++++|.. ....+|||||+.+++|.++|+....
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77888877655 677787753 3467999999999999999874311
Q ss_pred CcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcceeecccccccccChh
Q 046750 453 PVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPE 532 (723)
Q Consensus 453 ~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE 532 (723)
..+++..+..|+.||+++|.|||++ +|+|||||++||||+.++.+||+|||+++..............++..|++||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 1245677889999999999999998 5999999999999999999999999999755432222222223578999999
Q ss_pred hhccCCC----------------------CCccceechHHHHHHHHhCCC-CCCCCCCCC------chhhHHhhhhhhhh
Q 046750 533 YASSGKL----------------------TDRSDVFSFGVVLLELITGRK-PVDPTQPLG------DESLVEWARPVLVR 583 (723)
Q Consensus 533 ~~~~~~~----------------------t~ksDVwSlGviL~eLltG~~-P~~~~~~~~------~~~l~~~~~~~l~~ 583 (723)
.+..... ..+.||||||||||||++|.. +|....... +..+..|.
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r------ 454 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWR------ 454 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHH------
Confidence 8764321 235799999999999999875 664322111 11111121
Q ss_pred hhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCC---CCCCCHHHHHHH
Q 046750 584 AIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSG---PKRPRMVQVVRA 634 (723)
Q Consensus 584 ~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP---~~RPs~~eVl~~ 634 (723)
.+....+. ............+|+.+||..++ .+|+++.|++++
T Consensus 455 ~~~~~~~~--------~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 455 MYKGQKYD--------FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred hhcccCCC--------cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 11111110 00111122356788889998765 689999999875
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.8e-32 Score=287.74 Aligned_cols=269 Identities=23% Similarity=0.329 Sum_probs=205.6
Q ss_pred cCcccceEEeccCcEEEEEE-EcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHcc-----C---CceeeEeeeeec---
Q 046750 360 NGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVH-----H---RHLVSLVGYCIS--- 427 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~-~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~-----H---pnIv~l~g~~~~--- 427 (723)
.+|.++++||.|.|++||++ +....+.||+|+.+... .-.+..+.||++|++++ | .+||+|+++|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 57999999999999999999 55667899999998752 22345678999999983 2 579999999974
Q ss_pred -ccceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeC-----------
Q 046750 428 -EKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVD----------- 495 (723)
Q Consensus 428 -~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~----------- 495 (723)
+.++|||||++ |.+|..+|.....+.+....+.+|++||+.||.|||+.| +|||-||||+||||.
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~e~~~~~~~~ 233 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCSTEIDPAKDAR 233 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeeccccchhhhhh
Confidence 56889999999 888999998877778999999999999999999999999 999999999999981
Q ss_pred --------------------------------------------------------------------------------
Q 046750 496 -------------------------------------------------------------------------------- 495 (723)
Q Consensus 496 -------------------------------------------------------------------------------- 495 (723)
T Consensus 234 ~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~ 313 (590)
T KOG1290|consen 234 EAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNE 313 (590)
T ss_pred hhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccc
Confidence
Q ss_pred -----------------------C----------------------------------------------------CCcE
Q 046750 496 -----------------------D----------------------------------------------------EFEA 500 (723)
Q Consensus 496 -----------------------~----------------------------------------------------~~~v 500 (723)
. +.+|
T Consensus 314 ~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~v 393 (590)
T KOG1290|consen 314 STVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRV 393 (590)
T ss_pred cchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeE
Confidence 0 0126
Q ss_pred EEeecccccccCCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCC---CchhhHHhh
Q 046750 501 QVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPL---GDESLVEWA 577 (723)
Q Consensus 501 kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~---~~~~l~~~~ 577 (723)
||+|||.|.++. +..+.-+.|..|+|||++.+..|+..+|||||+|++|||+||...|+..... .++..+...
T Consensus 394 KIaDlGNACW~~----khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i 469 (590)
T KOG1290|consen 394 KIADLGNACWVH----KHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALI 469 (590)
T ss_pred EEeeccchhhhh----hhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHH
Confidence 778888776543 2234445789999999999999999999999999999999999999764321 122221111
Q ss_pred hhhh---hhh-hh-----------cCCcccccc-------hhhhc--cccHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 046750 578 RPVL---VRA-IE-----------TGDLSEIVD-------PRLEK--HYVESEMFRMIEAAAACVRHSGPKRPRMVQVVR 633 (723)
Q Consensus 578 ~~~l---~~~-i~-----------~~~l~~~vd-------~~l~~--~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~ 633 (723)
..+| .+. +. .|++..|-. ..|.. .+..++...|.+++.-||+.+|++|+++.+.++
T Consensus 470 ~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~ 549 (590)
T KOG1290|consen 470 MELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLK 549 (590)
T ss_pred HHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhc
Confidence 1111 111 11 222222211 11211 456788889999999999999999999999997
Q ss_pred HHh
Q 046750 634 ALD 636 (723)
Q Consensus 634 ~L~ 636 (723)
.=+
T Consensus 550 hPw 552 (590)
T KOG1290|consen 550 HPW 552 (590)
T ss_pred Ccc
Confidence 544
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=297.62 Aligned_cols=206 Identities=25% Similarity=0.382 Sum_probs=175.2
Q ss_pred cCcccceEEeccCcEEEEEEEcCC-CcEEEEEEcccCCc---hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLPE-GKVVAVKQLKSGSG---QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~VAvK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 435 (723)
..|-.++.||-|+||+|.+++..| ...||+|.|++.+. +.....++|-+||..-+.+-||+|+..|++.+.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 458889999999999999995544 56899999987632 23345788999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccC---
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLND--- 512 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~--- 512 (723)
||+.||+|..+|.+.+ .+.+.....++.++.+|+++.|..| +|||||||.|||||.+|++||.||||+.-+.
T Consensus 709 dYIPGGDmMSLLIrmg--IFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMG--IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred eccCCccHHHHHHHhc--cCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceecc
Confidence 9999999999998765 5888888888999999999999995 9999999999999999999999999984221
Q ss_pred CCC-----cce---------------------------------eecccccccccChhhhccCCCCCccceechHHHHHH
Q 046750 513 TTQ-----THV---------------------------------STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLE 554 (723)
Q Consensus 513 ~~~-----~~~---------------------------------~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~e 554 (723)
+.. .|. ....+||..|+|||+|....|+.-+|.|+.||||||
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE 863 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence 110 000 012479999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCCc
Q 046750 555 LITGRKPVDPTQPLGD 570 (723)
Q Consensus 555 LltG~~P~~~~~~~~~ 570 (723)
|+.|+.||....+.+.
T Consensus 864 m~~g~~pf~~~tp~~t 879 (1034)
T KOG0608|consen 864 MLVGQPPFLADTPGET 879 (1034)
T ss_pred HhhCCCCccCCCCCcc
Confidence 9999999987766543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.5e-33 Score=302.70 Aligned_cols=244 Identities=22% Similarity=0.278 Sum_probs=198.2
Q ss_pred HhcCcccceEEeccCcEEEEEE-EcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHc-cCCceeeEeeeeecccceEEEE
Q 046750 358 ITNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRV-HHRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 358 ~~~~f~~~~~LG~G~fG~Vy~~-~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~ 435 (723)
+.+.|.....||.|+|+.|.++ ...+++..+||++.+. ..+..+|+.++.+. +|+||+++++.|.+..+.|+||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 3566778888999999999998 4556889999999764 33456688777776 7999999999999999999999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEe-CCCCcEEEeecccccccCCC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILV-DDEFEAQVADFGLAKLNDTT 514 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl-~~~~~vkL~DFGla~~~~~~ 514 (723)
|++.++-|.+.+..... +. ..+..|+.+|+.+|.|||++| ||||||||+|||+ ++.++++|+|||.++.....
T Consensus 396 e~l~g~ell~ri~~~~~--~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKPE--FC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred hhccccHHHHHHHhcch--hH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 99999988887765443 22 667789999999999999995 9999999999999 58899999999999876544
Q ss_pred CcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCccccc
Q 046750 515 QTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIV 594 (723)
Q Consensus 515 ~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~v 594 (723)
...-+-|..|.|||++....|++++|+||||++||+||+|+.||...... ..+...+..+.+.+.|
T Consensus 470 ----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~----------~ei~~~i~~~~~s~~v 535 (612)
T KOG0603|consen 470 ----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG----------IEIHTRIQMPKFSECV 535 (612)
T ss_pred ----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch----------HHHHHhhcCCcccccc
Confidence 22234688999999999999999999999999999999999999765432 1234445555544222
Q ss_pred chhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhc
Q 046750 595 DPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDS 637 (723)
Q Consensus 595 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~ 637 (723)
.....+|+.+||+.||.+|++|.+|...=+-
T Consensus 536 ------------S~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 536 ------------SDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred ------------CHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 2356788889999999999999999865443
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=272.11 Aligned_cols=238 Identities=28% Similarity=0.361 Sum_probs=193.2
Q ss_pred CcEEEEEEEcCC-CcEEEEEEcccCCchh-HHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEecCCCchhhcccc
Q 046750 372 GFGCVYKGNLPE-GKVVAVKQLKSGSGQG-EREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHG 449 (723)
Q Consensus 372 ~fG~Vy~~~~~~-g~~VAvK~l~~~~~~~-~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~ 449 (723)
+||.||+|...+ ++.|++|++....... .+.+.+|++++++++|+||+++++++......++|+||+.+++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999997754 8999999998765444 67899999999999999999999999999999999999999999999876
Q ss_pred CCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcceeeccccccccc
Q 046750 450 KGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYL 529 (723)
Q Consensus 450 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~ 529 (723)
... +++..++.++.+++++|.|||+. +|+|+||++.||++++++.++|+|||++....... ......++..|+
T Consensus 81 ~~~--~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~ 153 (244)
T smart00220 81 RGR--LSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYM 153 (244)
T ss_pred ccC--CCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCC
Confidence 543 78899999999999999999998 59999999999999999999999999998665432 223455788999
Q ss_pred ChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhhhccccHHHHHH
Q 046750 530 APEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFR 609 (723)
Q Consensus 530 APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~ 609 (723)
+||.+.+..++.++|||+||+++|+|++|..||..... ...+.++ +..+...... ........
T Consensus 154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~--~~~~~~~--------~~~~~~~~~~-------~~~~~~~~ 216 (244)
T smart00220 154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ--LLELFKK--------IGKPKPPFPP-------PEWKISPE 216 (244)
T ss_pred CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHH--------HhccCCCCcc-------ccccCCHH
Confidence 99999988899999999999999999999999865321 1112211 1111111100 00002246
Q ss_pred HHHHHHHHhccCCCCCCCHHHHHH
Q 046750 610 MIEAAAACVRHSGPKRPRMVQVVR 633 (723)
Q Consensus 610 l~~l~~~cl~~dP~~RPs~~eVl~ 633 (723)
+.+++.+||..+|++||++.+|++
T Consensus 217 ~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 217 AKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHHccCCchhccCHHHHhh
Confidence 889999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-32 Score=277.75 Aligned_cols=220 Identities=21% Similarity=0.203 Sum_probs=173.9
Q ss_pred cCcEEEEEEE-cCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEecCCCchhhcccc
Q 046750 371 GGFGCVYKGN-LPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHG 449 (723)
Q Consensus 371 G~fG~Vy~~~-~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~ 449 (723)
|.||.||+++ ..+++.||+|+++... .+..|...+....|+||+++++++.+.+..++||||+.+|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 8999999994 4568899999997642 334455556666799999999999999999999999999999999865
Q ss_pred CCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcceeeccccccccc
Q 046750 450 KGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYL 529 (723)
Q Consensus 450 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~ 529 (723)
.. .+.+..++.++.|+++||.|||++ +|+|||||++|||++.++.++|+|||++...... .....++..|+
T Consensus 79 ~~--~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~ 149 (237)
T cd05576 79 FL--NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYC 149 (237)
T ss_pred hc--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCcccc
Confidence 43 378899999999999999999998 5999999999999999999999999987654332 12234567899
Q ss_pred ChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhhhccccHHHHHH
Q 046750 530 APEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFR 609 (723)
Q Consensus 530 APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~ 609 (723)
+||++.+..++.++|||||||++|||++|+.++...... + .. ...+ .+... ....
T Consensus 150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-------~---------~~--~~~~---~~~~~----~~~~ 204 (237)
T cd05576 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-------I---------NT--HTTL---NIPEW----VSEE 204 (237)
T ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-------c---------cc--cccc---CCccc----CCHH
Confidence 999998888999999999999999999999876532110 0 00 0000 01111 1235
Q ss_pred HHHHHHHHhccCCCCCCCHH
Q 046750 610 MIEAAAACVRHSGPKRPRMV 629 (723)
Q Consensus 610 l~~l~~~cl~~dP~~RPs~~ 629 (723)
+.+++.+||+.||.+|+++.
T Consensus 205 ~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 205 ARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHHHHccCCHHHhcCCC
Confidence 77899999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-33 Score=274.18 Aligned_cols=267 Identities=24% Similarity=0.392 Sum_probs=192.8
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCch-h-HHHHHHHHHHHHHccCCceeeEeeeeecc--------
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQ-G-EREFRAEVEIISRVHHRHLVSLVGYCISE-------- 428 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~-~-~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-------- 428 (723)
..|....+||+|.||+||+++. +.|+.||+|++...... + -....+|+++|..|+|+|++.|++.|...
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 3466778999999999999955 45788898876432111 1 13457899999999999999999988642
Q ss_pred cceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccc
Q 046750 429 KNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLA 508 (723)
Q Consensus 429 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla 508 (723)
..+||||++| ..+|.-+|.+.. ..+...++.++..++..||.|+|+. .|+|||+|+.|+||+.++.+||+|||++
T Consensus 97 ~t~ylVf~~c-ehDLaGlLsn~~-vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 97 ATFYLVFDFC-EHDLAGLLSNRK-VRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred ceeeeeHHHh-hhhHHHHhcCcc-ccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccc
Confidence 3479999999 557877776542 2478888999999999999999999 6999999999999999999999999999
Q ss_pred cccCCCCcc---eeecccccccccChhhhccC-CCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHH---------
Q 046750 509 KLNDTTQTH---VSTRVMGTFGYLAPEYASSG-KLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVE--------- 575 (723)
Q Consensus 509 ~~~~~~~~~---~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~--------- 575 (723)
+.+...... ..+..+.|++|+.||.+.+. .|+.+.|||..|||+.||++|..-+.....+....++.
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke 251 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE 251 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence 765433222 23445679999999988764 69999999999999999999998887665432221111
Q ss_pred -hh---hhhhhhhhhcCC----cccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 576 -WA---RPVLVRAIETGD----LSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 576 -~~---~~~l~~~i~~~~----l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
|- .-.|.+.++..- -...+..++......+ ..++|+..+|..||.+|+.+.+++..
T Consensus 252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~---~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDD---EALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCCh---hHHHHHHHHhccCcccCcchHhhhch
Confidence 11 111222221110 0111111221111111 45677889999999999999998865
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-33 Score=293.37 Aligned_cols=250 Identities=22% Similarity=0.311 Sum_probs=204.4
Q ss_pred CcccceEEeccCcEEEEEEEcCCCc-EEEEEEcccC---CchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEE
Q 046750 361 GFARENVIGEGGFGCVYKGNLPEGK-VVAVKQLKSG---SGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYE 436 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~~~~g~-~VAvK~l~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 436 (723)
+++++..||-|+||.|=+++.+..+ .+|+|++++. ...+++.+..|-+||..++.+.||+||.-|.+.+.+|++||
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE 500 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME 500 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence 3556677999999999999775544 3888888765 33445567889999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCc
Q 046750 437 FVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQT 516 (723)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 516 (723)
-|-||.|...|.+++. ++......++..+++|++|||++ +||.|||||+|.|||.+|-+||.|||+|+.+.....
T Consensus 501 aClGGElWTiLrdRg~--Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K 575 (732)
T KOG0614|consen 501 ACLGGELWTILRDRGS--FDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK 575 (732)
T ss_pred hhcCchhhhhhhhcCC--cccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccCCc
Confidence 9999999999987664 78888888999999999999999 599999999999999999999999999998765443
Q ss_pred ceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccch
Q 046750 517 HVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDP 596 (723)
Q Consensus 517 ~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~ 596 (723)
.-.++||+.|.|||++..+.++...|.|+||+++||||+|..||...++..--++ +++.++.
T Consensus 576 --TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~-------ILkGid~--------- 637 (732)
T KOG0614|consen 576 --TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNL-------ILKGIDK--------- 637 (732)
T ss_pred --eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHH-------HHhhhhh---------
Confidence 3447899999999999999999999999999999999999999987765321111 2222211
Q ss_pred hhhccccHHHHHHHHHHHHHHhccCCCCCCC-----HHHHHHHHh
Q 046750 597 RLEKHYVESEMFRMIEAAAACVRHSGPKRPR-----MVQVVRALD 636 (723)
Q Consensus 597 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~eVl~~L~ 636 (723)
.+++....+...+|+++.|+.+|.+|-- +.+|.++.+
T Consensus 638 ---i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~W 679 (732)
T KOG0614|consen 638 ---IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRW 679 (732)
T ss_pred ---hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhh
Confidence 2333444556788999999999999875 566655543
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-32 Score=301.21 Aligned_cols=244 Identities=25% Similarity=0.375 Sum_probs=187.0
Q ss_pred cccceEEeccCcE-EEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHc-cCCceeeEeeeeecccceEEEEEecC
Q 046750 362 FARENVIGEGGFG-CVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRV-HHRHLVSLVGYCISEKNRLLIYEFVP 439 (723)
Q Consensus 362 f~~~~~LG~G~fG-~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~ 439 (723)
|...+++|+|.-| .||+|.. +|+.||||++-.. ...-..+||.+|+.- +|+|||++++.-.+....||.+|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 4555778999999 6799988 7899999998642 233457899999988 6999999999988999999999999
Q ss_pred CCchhhccccC--CCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCC-----CCcEEEeecccccccC
Q 046750 440 NNNLEHHLHGK--GQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDD-----EFEAQVADFGLAKLND 512 (723)
Q Consensus 440 ~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~-----~~~vkL~DFGla~~~~ 512 (723)
..+|++++... ..........+.+..|+++||++||+. +||||||||+||||+. ..+++|+|||+++.+.
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 77999999763 111112134567889999999999997 6999999999999975 3679999999998776
Q ss_pred CCCcce--eecccccccccChhhhccCCCCCccceechHHHHHHHHhC-CCCCCCCCCCCchhhHHhhhhhhhhhhhcCC
Q 046750 513 TTQTHV--STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITG-RKPVDPTQPLGDESLVEWARPVLVRAIETGD 589 (723)
Q Consensus 513 ~~~~~~--~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG-~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~ 589 (723)
.+.... .....||.+|+|||++....-+...||||||||+|+.++| .+||...-..+ .+ |..|+
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~-~N------------Il~~~ 729 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ-AN------------ILTGN 729 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh-hh------------hhcCc
Confidence 554432 2346799999999999998888899999999999999996 89997543211 11 11111
Q ss_pred cccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 046750 590 LSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVR 633 (723)
Q Consensus 590 l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~ 633 (723)
. .++ .|.... ++ ...+||.+|++.+|..||++.+|+.
T Consensus 730 ~-~L~--~L~~~~--d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 730 Y-TLV--HLEPLP--DC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred c-cee--eeccCc--hH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 1 000 111111 11 5678899999999999999999973
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-32 Score=272.53 Aligned_cols=270 Identities=21% Similarity=0.333 Sum_probs=199.2
Q ss_pred cccceEEeccCcEEEEEE-EcCCCcEEEEEEcccCC--chhHHHHHHHHHHHHHccCCceeeEeeeeecc-----cceEE
Q 046750 362 FARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGS--GQGEREFRAEVEIISRVHHRHLVSLVGYCISE-----KNRLL 433 (723)
Q Consensus 362 f~~~~~LG~G~fG~Vy~~-~~~~g~~VAvK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-----~~~~l 433 (723)
.+..+-||.|.||.||.+ +-.+|+.||+|++.... ....+.+.+|+++|..++|.|++.++++..-. .++|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 455688999999999988 55679999999986542 22346788999999999999999988766432 34678
Q ss_pred EEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCC
Q 046750 434 IYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDT 513 (723)
Q Consensus 434 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 513 (723)
|.|+| ..+|.+++-.-. .|.-+.+.-+++||++||+|||+. +|+||||||.|+|++.|+.+|||||||++....
T Consensus 135 ~TELm-QSDLHKIIVSPQ--~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 135 LTELM-QSDLHKIIVSPQ--ALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHH-HhhhhheeccCC--CCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccch
Confidence 88888 778888875433 477778888999999999999999 599999999999999999999999999998776
Q ss_pred CCcceeecccccccccChhhhccC-CCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHH-hhhhhhhhhh---hcC
Q 046750 514 TQTHVSTRVMGTFGYLAPEYASSG-KLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVE-WARPVLVRAI---ETG 588 (723)
Q Consensus 514 ~~~~~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~-~~~~~l~~~i---~~~ 588 (723)
.....++..+.|..|+|||++++. .|+.+.||||+|||+.||+-.+..|....+.....++. ....--++++ .+|
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG 288 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG 288 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence 666667777789999999999875 59999999999999999999999887766533222221 1110001111 111
Q ss_pred Ccccccc-----hhhhccc----cHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhc
Q 046750 589 DLSEIVD-----PRLEKHY----VESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDS 637 (723)
Q Consensus 589 ~l~~~vd-----~~l~~~~----~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~ 637 (723)
.-..++. +.+...| ....-..-+.+...++..||++|-+..+.+..+..
T Consensus 289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~ 346 (449)
T KOG0664|consen 289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL 346 (449)
T ss_pred hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence 1111111 1111111 11222345567788999999999999988876643
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-31 Score=265.87 Aligned_cols=247 Identities=22% Similarity=0.327 Sum_probs=193.3
Q ss_pred cCcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCCchhH---HHHHHHHHHHHHc-cCCceeeEeeeeecccceEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGSGQGE---REFRAEVEIISRV-HHRHLVSLVGYCISEKNRLLI 434 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~~~~~---~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV 434 (723)
++|...++||+|.|.+|.+++++ ..+.||+|++++.-..+. .=.+.|-.++..- +||.+|-|+.+|+.+..+++|
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv 329 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV 329 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence 56899999999999999999765 467899999987532222 2345677777776 799999999999999999999
Q ss_pred EEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCC
Q 046750 435 YEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTT 514 (723)
Q Consensus 435 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 514 (723)
.||+.||+|..+++++.+ |.++....+...|+.+|.|||++| ||.||||..|||||..+++||.|||+++.....
T Consensus 330 ieyv~ggdlmfhmqrqrk--lpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l~~ 404 (593)
T KOG0695|consen 330 IEYVNGGDLMFHMQRQRK--LPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP 404 (593)
T ss_pred EEEecCcceeeehhhhhc--CcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCCCC
Confidence 999999999888876553 888888889999999999999995 999999999999999999999999999754322
Q ss_pred CcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCC-CchhhHHhhhhhhhhhhhcCCcccc
Q 046750 515 QTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPL-GDESLVEWARPVLVRAIETGDLSEI 593 (723)
Q Consensus 515 ~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~-~~~~l~~~~~~~l~~~i~~~~l~~~ 593 (723)
. .....++||+.|.|||++++..|....|.|+|||+++||+.|+.||+.-.-. .+.+-.++.. +.|-...+
T Consensus 405 g-d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylf----qvilekqi--- 476 (593)
T KOG0695|consen 405 G-DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLF----QVILEKQI--- 476 (593)
T ss_pred C-cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHH----HHHhhhcc---
Confidence 2 2345578999999999999999999999999999999999999999753211 1233333332 22222111
Q ss_pred cchhhhccccHHHHHHHHHHHHHHhccCCCCCC
Q 046750 594 VDPRLEKHYVESEMFRMIEAAAACVRHSGPKRP 626 (723)
Q Consensus 594 vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP 626 (723)
++ .....-+...+++..|++||++|-
T Consensus 477 ---ri----prslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 477 ---RI----PRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ---cc----cceeehhhHHHHHHhhcCCcHHhc
Confidence 11 111112445677788999999886
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=283.51 Aligned_cols=279 Identities=20% Similarity=0.236 Sum_probs=209.4
Q ss_pred cccCHHHHHHHhcCcccceEEeccCcEEEEEEE-cCCCcEEEEEEcccCCchhHHHHHHHHHHHHHcc------CCceee
Q 046750 348 SFFTYEELMEITNGFARENVIGEGGFGCVYKGN-LPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVH------HRHLVS 420 (723)
Q Consensus 348 ~~~~~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~------HpnIv~ 420 (723)
.||.+.--+.+..+|.+....|+|-|+.|.+|. ...|..||||+++... .-.+.=++|++||++|+ .-|+++
T Consensus 420 GYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclr 498 (752)
T KOG0670|consen 420 GYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLR 498 (752)
T ss_pred ceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHH
Confidence 456665556677899999999999999999994 4558899999998753 22344568999999994 357999
Q ss_pred EeeeeecccceEEEEEecCCCchhhccccCC-CCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCC-C
Q 046750 421 LVGYCISEKNRLLIYEFVPNNNLEHHLHGKG-QPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDE-F 498 (723)
Q Consensus 421 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~-~ 498 (723)
|+..|...+++|||||-+ .-+|.+.|...+ +..|....+..++.|++.||.+|... +|+|+||||.|||+++. .
T Consensus 499 l~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~ 574 (752)
T KOG0670|consen 499 LFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKN 574 (752)
T ss_pred HHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcc
Confidence 999999999999999988 678999997654 34588888899999999999999987 59999999999999865 5
Q ss_pred cEEEeecccccccCCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhh
Q 046750 499 EAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWAR 578 (723)
Q Consensus 499 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~ 578 (723)
.+||||||.|....+... +....+..|.|||+|.+..|+...|+||+||+||||.||+..|-+...-...-+..-..
T Consensus 575 iLKLCDfGSA~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~K 651 (752)
T KOG0670|consen 575 ILKLCDFGSASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELK 651 (752)
T ss_pred eeeeccCccccccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhc
Confidence 689999999987665443 33345678999999999999999999999999999999999997654322222211111
Q ss_pred hhh-hhhhhcCCccc------------ccc---------------h------hhhc--ccc---HHHHHHHHHHHHHHhc
Q 046750 579 PVL-VRAIETGDLSE------------IVD---------------P------RLEK--HYV---ESEMFRMIEAAAACVR 619 (723)
Q Consensus 579 ~~l-~~~i~~~~l~~------------~vd---------------~------~l~~--~~~---~~~~~~l~~l~~~cl~ 619 (723)
..+ .+.+..|.|.. -+| + .|.. .+. ...+..|.+|+..||.
T Consensus 652 Gk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~ 731 (752)
T KOG0670|consen 652 GKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLI 731 (752)
T ss_pred CCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhc
Confidence 111 11222221110 011 1 1100 122 2345578899999999
Q ss_pred cCCCCCCCHHHHHHH
Q 046750 620 HSGPKRPRMVQVVRA 634 (723)
Q Consensus 620 ~dP~~RPs~~eVl~~ 634 (723)
.||.+|-+..+.|..
T Consensus 732 LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 732 LDPEKRITVNQALKH 746 (752)
T ss_pred cChhhcCCHHHHhcC
Confidence 999999999987753
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-30 Score=249.93 Aligned_cols=201 Identities=25% Similarity=0.427 Sum_probs=164.3
Q ss_pred CcccceEEeccCcEEEEEE-EcCCCcEEEEEEcccC-CchhHHHHHHHHHHHHHc-cCCceeeEeeeeecccceEEEEEe
Q 046750 361 GFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSG-SGQGEREFRAEVEIISRV-HHRHLVSLVGYCISEKNRLLIYEF 437 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~-~~~~g~~VAvK~l~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~E~ 437 (723)
....+..||+|+||.|-+- ...+|+..|||.++.. ..+..+.+++|+++..+. .+|.+|+|+|........++.||.
T Consensus 47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~ 126 (282)
T KOG0984|consen 47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMEL 126 (282)
T ss_pred hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHH
Confidence 3445678999999998777 4457999999999765 345556788899988776 799999999999889999999999
Q ss_pred cCCCchhhcccc--CCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 046750 438 VPNNNLEHHLHG--KGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ 515 (723)
Q Consensus 438 ~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 515 (723)
| .-+|+.+... .....+.+..+-+|+..+++||.|||++- .|||||+||+||||+.+|+|||||||++-.+.+..
T Consensus 127 M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi 203 (282)
T KOG0984|consen 127 M-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI 203 (282)
T ss_pred h-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhhh
Confidence 9 5567665432 12335788888899999999999999986 89999999999999999999999999997654332
Q ss_pred cceeecccccccccChhhhcc----CCCCCccceechHHHHHHHHhCCCCCCCCC
Q 046750 516 THVSTRVMGTFGYLAPEYASS----GKLTDRSDVFSFGVVLLELITGRKPVDPTQ 566 (723)
Q Consensus 516 ~~~~~~~~gt~~y~APE~~~~----~~~t~ksDVwSlGviL~eLltG~~P~~~~~ 566 (723)
.. +-..|-.-|||||.+.. ..|+.|+||||||+.+.||.+++.||+.+.
T Consensus 204 Ak--t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 204 AK--TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred HH--HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 21 22347778999998853 369999999999999999999999998654
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.7e-29 Score=245.24 Aligned_cols=211 Identities=33% Similarity=0.555 Sum_probs=183.2
Q ss_pred EeccCcEEEEEEEcCC-CcEEEEEEcccCCch-hHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEecCCCchhh
Q 046750 368 IGEGGFGCVYKGNLPE-GKVVAVKQLKSGSGQ-GEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNLEH 445 (723)
Q Consensus 368 LG~G~fG~Vy~~~~~~-g~~VAvK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~ 445 (723)
||+|.||.||++.... ++.++||++...... ....+.+|+++++++.|++|+++++++......+++|||+.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999997754 899999999875432 34678999999999999999999999999889999999999999999
Q ss_pred ccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCC-CCcEEEeecccccccCCCCcceeecccc
Q 046750 446 HLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDD-EFEAQVADFGLAKLNDTTQTHVSTRVMG 524 (723)
Q Consensus 446 ~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~-~~~vkL~DFGla~~~~~~~~~~~~~~~g 524 (723)
++.... ..+++..++.++.+++++|.|||+. +++|+||++.||+++. ++.++|+|||++........ ......+
T Consensus 81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~ 155 (215)
T cd00180 81 LLKENE-GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVG 155 (215)
T ss_pred HHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccC
Confidence 987542 2478899999999999999999999 5999999999999999 89999999999976654321 1223457
Q ss_pred cccccChhhhccC-CCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhhhcccc
Q 046750 525 TFGYLAPEYASSG-KLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEKHYV 603 (723)
Q Consensus 525 t~~y~APE~~~~~-~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~ 603 (723)
...|++||.+... .++.+.|+|+||++|++|
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------ 187 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------ 187 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------
Confidence 8899999999887 888999999999999999
Q ss_pred HHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 046750 604 ESEMFRMIEAAAACVRHSGPKRPRMVQVVRAL 635 (723)
Q Consensus 604 ~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L 635 (723)
..+.+++..|++.+|.+||++.++++.|
T Consensus 188 ----~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ----PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ----HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 3577899999999999999999998754
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=244.28 Aligned_cols=261 Identities=19% Similarity=0.316 Sum_probs=193.5
Q ss_pred hcCcccceEEeccCcEEEEEE-EcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHcc-CCceeeEeeeeeccc--ceEEE
Q 046750 359 TNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVH-HRHLVSLVGYCISEK--NRLLI 434 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~-~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~--~~~lV 434 (723)
.++|++.+++|+|.|++||.| ...+.+.++||+++. ...+.+.+|+.||..|. |+||++|+++..+.. ...||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 467889999999999999999 556788999999986 45568899999999997 999999999988754 45799
Q ss_pred EEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCC-CCcEEEeecccccccCC
Q 046750 435 YEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDD-EFEAQVADFGLAKLNDT 513 (723)
Q Consensus 435 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~-~~~vkL~DFGla~~~~~ 513 (723)
+||+.+.+...+.. .|..-.+..++.++++||.|+|++| |+|||+||.|++||. ...++|+|+|||.++..
T Consensus 114 FE~v~n~Dfk~ly~-----tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 114 FEYVNNTDFKQLYP-----TLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred hhhhccccHHHHhh-----hhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 99999988777654 2455567788999999999999995 999999999999995 46799999999988775
Q ss_pred CCcceeecccccccccChhhhcc-CCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhh----hhh--
Q 046750 514 TQTHVSTRVMGTFGYLAPEYASS-GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVR----AIE-- 586 (723)
Q Consensus 514 ~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~----~i~-- 586 (723)
..... . .+.+..|.-||++.. ..|+..-|+|||||+|..|+..+.||-.... .-..++..++.+-.. -+.
T Consensus 186 ~~eYn-V-RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~d-N~DQLVkIakVLGt~el~~Yl~KY 262 (338)
T KOG0668|consen 186 GKEYN-V-RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD-NYDQLVKIAKVLGTDELYAYLNKY 262 (338)
T ss_pred Cceee-e-eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCC-CHHHHHHHHHHhChHHHHHHHHHH
Confidence 54432 1 235778899998875 4588899999999999999999999854332 233444443321111 011
Q ss_pred ----cCCcccccchhhhcc---ccHH----H-HHHHHHHHHHHhccCCCCCCCHHHHHH
Q 046750 587 ----TGDLSEIVDPRLEKH---YVES----E-MFRMIEAAAACVRHSGPKRPRMVQVVR 633 (723)
Q Consensus 587 ----~~~l~~~vd~~l~~~---~~~~----~-~~~l~~l~~~cl~~dP~~RPs~~eVl~ 633 (723)
...+..+++...+.. +... . ..+.++++.+.|+.|-.+|+++.|.+.
T Consensus 263 ~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 263 QIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred ccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 111222222111111 1000 0 135678889999999999999998764
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=247.25 Aligned_cols=199 Identities=32% Similarity=0.475 Sum_probs=173.0
Q ss_pred cccceEEeccCcEEEEEEEcCC-CcEEEEEEcccCCch-hHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEecC
Q 046750 362 FARENVIGEGGFGCVYKGNLPE-GKVVAVKQLKSGSGQ-GEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVP 439 (723)
Q Consensus 362 f~~~~~LG~G~fG~Vy~~~~~~-g~~VAvK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 439 (723)
|.+.+.||.|+||.||++...+ ++.|+||.+...... ..+.+.+|++.+++++|+|++++++++......++++||+.
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5677899999999999997765 889999999876544 56789999999999999999999999999899999999999
Q ss_pred CCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCccee
Q 046750 440 NNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVS 519 (723)
Q Consensus 440 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 519 (723)
+++|.+++...... +++..++.++.+++.+|.|||+. +++|+||++.||+++.++.++|+|||++...........
T Consensus 81 ~~~L~~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (225)
T smart00221 81 GGDLFDYLRKKGGK-LSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALL 156 (225)
T ss_pred CCCHHHHHHhcccC-CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccc
Confidence 99999998764422 78889999999999999999998 599999999999999999999999999987654421122
Q ss_pred ecccccccccChhhh-ccCCCCCccceechHHHHHHHHhCCCCCCC
Q 046750 520 TRVMGTFGYLAPEYA-SSGKLTDRSDVFSFGVVLLELITGRKPVDP 564 (723)
Q Consensus 520 ~~~~gt~~y~APE~~-~~~~~t~ksDVwSlGviL~eLltG~~P~~~ 564 (723)
....+...|++||++ ....++.++|||+||++||||++|+.||+.
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 334578889999998 667788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=269.39 Aligned_cols=195 Identities=22% Similarity=0.347 Sum_probs=165.4
Q ss_pred CcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCCchh--------HHHHHHHHHHHHHcc---CCceeeEeeeeecc
Q 046750 361 GFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGSGQG--------EREFRAEVEIISRVH---HRHLVSLVGYCISE 428 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~~~~--------~~~~~~Ei~il~~l~---HpnIv~l~g~~~~~ 428 (723)
.|...+.||+|+||.|++|..+ +...|+||++++..... .-.+-.||+||..|+ |+||++++++|+++
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd 641 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD 641 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence 4888899999999999999554 45689999987642111 112346999999997 99999999999999
Q ss_pred cceEEEEEecCCC-chhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeeccc
Q 046750 429 KNRLLIYEFVPNN-NLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGL 507 (723)
Q Consensus 429 ~~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGl 507 (723)
+.+||++|....| +|.+++..+.+ +++.....|+.||+.|+++||+++ |||||||-+||.|+.+|-+||+|||.
T Consensus 642 d~yyl~te~hg~gIDLFd~IE~kp~--m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 642 DYYYLETEVHGEGIDLFDFIEFKPR--MDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred CeeEEEecCCCCCcchhhhhhccCc--cchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeeccc
Confidence 9999999976544 78888876654 888889999999999999999995 99999999999999999999999999
Q ss_pred ccccCCCCcceeecccccccccChhhhccCCCCC-ccceechHHHHHHHHhCCCCCC
Q 046750 508 AKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTD-RSDVFSFGVVLLELITGRKPVD 563 (723)
Q Consensus 508 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~-ksDVwSlGviL~eLltG~~P~~ 563 (723)
+.+...... ..++||.+|.|||++.+..|-- .-|||+||++||-++....||.
T Consensus 717 aa~~ksgpf---d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 717 AAYTKSGPF---DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhhhcCCCc---ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 976654433 3467999999999999988754 5799999999999999998885
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.6e-29 Score=251.00 Aligned_cols=265 Identities=23% Similarity=0.313 Sum_probs=195.3
Q ss_pred hcCcccceEEeccCcEEEEEE-EcCCCcEEEEEEcccC--CchhHHHHHHHHHHHHHccCCceeeEeeeeecc------c
Q 046750 359 TNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSG--SGQGEREFRAEVEIISRVHHRHLVSLVGYCISE------K 429 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~-~~~~g~~VAvK~l~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~------~ 429 (723)
..+|...+.+|.|.- .|..+ +.-.++.||||++... .....+...+|+.++..++|+||++++.+|.-. .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 456777788888888 55555 4556899999987543 223345677899999999999999999998633 4
Q ss_pred ceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeeccccc
Q 046750 430 NRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK 509 (723)
Q Consensus 430 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 509 (723)
+.|+||||| ..+|...++. .++..++.+|.+|+++|++|||+.+ |+||||||+||+|..++.+||.|||+++
T Consensus 95 e~y~v~e~m-~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 95 EVYLVMELM-DANLCQVILM----ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred hHHHHHHhh-hhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence 579999999 7788888762 3788889999999999999999995 9999999999999999999999999998
Q ss_pred ccCCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCc------------hhhHHhh
Q 046750 510 LNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGD------------ESLVEWA 577 (723)
Q Consensus 510 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~------------~~l~~~~ 577 (723)
..... ...+..+.+..|+|||++.+..|.++.||||+||++.||++|...|.+.+..+. ..+.+-.
T Consensus 167 ~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL 244 (369)
T KOG0665|consen 167 TEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQL 244 (369)
T ss_pred ccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHh
Confidence 65443 455667889999999999998899999999999999999999998875443211 0111110
Q ss_pred hhhhhhhhh------cCCcccccchhh-hc--cccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 578 RPVLVRAIE------TGDLSEIVDPRL-EK--HYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 578 ~~~l~~~i~------~~~l~~~vd~~l-~~--~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
.+.....++ .-.+.+++...+ .. +........+.+++.+||-.+|++|-++.++|+.
T Consensus 245 ~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 245 QPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred hHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 000000000 011111111111 10 1112233456788999999999999999999874
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-29 Score=271.98 Aligned_cols=252 Identities=25% Similarity=0.399 Sum_probs=201.9
Q ss_pred hcCcccceEEeccCcEEEEEEE-cCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEe
Q 046750 359 TNGFARENVIGEGGFGCVYKGN-LPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEF 437 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 437 (723)
.++|....+||.|.||.|||++ ...++..|||+++-.......-++.|+-+++..+|+|||.++|.+...+..++.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 4678889999999999999995 456889999999988777778889999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcc
Q 046750 438 VPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTH 517 (723)
Q Consensus 438 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 517 (723)
|.+|+|++..|..+ .+.+.++..++...++||+|||++| -+|||||-.||||++.+.+||+|||.+-.+.... .
T Consensus 94 cgggslQdiy~~Tg--plselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati-~ 167 (829)
T KOG0576|consen 94 CGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATI-A 167 (829)
T ss_pred cCCCcccceeeecc--cchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhh-h
Confidence 99999999987655 5889999999999999999999995 8999999999999999999999999986554322 2
Q ss_pred eeecccccccccChhhh---ccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCccccc
Q 046750 518 VSTRVMGTFGYLAPEYA---SSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIV 594 (723)
Q Consensus 518 ~~~~~~gt~~y~APE~~---~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~v 594 (723)
....+.||+.|||||+. +.+.|..++|||++|+...||---+.|.....++. .+.. +....+..
T Consensus 168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr--~l~L---------mTkS~~qp-- 234 (829)
T KOG0576|consen 168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR--ALFL---------MTKSGFQP-- 234 (829)
T ss_pred hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH--HHHH---------hhccCCCC--
Confidence 34557899999999976 45679999999999999999987776654333321 1111 11111111
Q ss_pred chhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHH
Q 046750 595 DPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVV 632 (723)
Q Consensus 595 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl 632 (723)
+.++.. ......+-++++.|+-++|++||+++.+|
T Consensus 235 -p~lkDk--~kws~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 235 -PTLKDK--TKWSEFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred -CcccCC--ccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence 111111 11123577899999999999999998765
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-27 Score=237.66 Aligned_cols=252 Identities=19% Similarity=0.363 Sum_probs=186.4
Q ss_pred HHhcCcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCCchhHHHHHHHHHHHHHc-cCCceeeEee-eeecccceEE
Q 046750 357 EITNGFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGSGQGEREFRAEVEIISRV-HHRHLVSLVG-YCISEKNRLL 433 (723)
Q Consensus 357 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g-~~~~~~~~~l 433 (723)
.+.+.|.+.+.||+|.||.+.+++.+ ..+.+++|.+... ....++|.+|+.---.| .|.||+.-++ .|+..+.+++
T Consensus 21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF 99 (378)
T KOG1345|consen 21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF 99 (378)
T ss_pred chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence 44577999999999999999999664 4678889988653 24457899998766666 5899988765 4666777889
Q ss_pred EEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeC--CCCcEEEeeccccccc
Q 046750 434 IYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVD--DEFEAQVADFGLAKLN 511 (723)
Q Consensus 434 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~--~~~~vkL~DFGla~~~ 511 (723)
++||++.|+|..-+...+ +.+....+++.|++.||.|||++ ++||||||.+||||- +..+|||||||+.+..
T Consensus 100 ~qE~aP~gdL~snv~~~G---igE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 100 VQEFAPRGDLRSNVEAAG---IGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred eeccCccchhhhhcCccc---ccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeeccccccc
Confidence 999999999999886644 66777888999999999999999 799999999999994 4468999999999765
Q ss_pred CCCCcceeecccccccccChhhhccC-----CCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhh
Q 046750 512 DTTQTHVSTRVMGTFGYLAPEYASSG-----KLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIE 586 (723)
Q Consensus 512 ~~~~~~~~~~~~gt~~y~APE~~~~~-----~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~ 586 (723)
+..-. .......|.+||+.... .....+|||.||+|||.+|+|+.||. .....+..+.+|.. +.
T Consensus 174 g~tV~----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQ-ka~~~d~~Y~~~~~------w~ 242 (378)
T KOG1345|consen 174 GTTVK----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQ-KASIMDKPYWEWEQ------WL 242 (378)
T ss_pred Cceeh----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcch-hhhccCchHHHHHH------Hh
Confidence 43222 22245679999977532 24567999999999999999999997 33345667777753 12
Q ss_pred cCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHH
Q 046750 587 TGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVV 632 (723)
Q Consensus 587 ~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl 632 (723)
.+....+ +++-+.+.. +++.+.++-|..++++|-.+.++.
T Consensus 243 ~rk~~~~--P~~F~~fs~----~a~r~Fkk~lt~~~~drcki~~~k 282 (378)
T KOG1345|consen 243 KRKNPAL--PKKFNPFSE----KALRLFKKSLTPRFKDRCKIWTAK 282 (378)
T ss_pred cccCccC--chhhcccCH----HHHHHHHHhcCCcccccchhHHHH
Confidence 2221111 122222222 456777788899999994444433
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-26 Score=242.97 Aligned_cols=199 Identities=28% Similarity=0.403 Sum_probs=163.9
Q ss_pred HHHhcCcccceEEeccCcEEEEEEEcC----CCcEEEEEEcccCCchhHHHHHHHHHHHHHc-cCCceeeEeeeeecccc
Q 046750 356 MEITNGFARENVIGEGGFGCVYKGNLP----EGKVVAVKQLKSGSGQGEREFRAEVEIISRV-HHRHLVSLVGYCISEKN 430 (723)
Q Consensus 356 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~----~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~ 430 (723)
-.+.+.|..+++||+|.|+.||++.+. ..+.||+|.+... ..-..+.+|+++|.++ .+.||+.+.+++..++.
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 345677999999999999999999543 3678999998654 2334688999999999 59999999999999999
Q ss_pred eEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCC-CCcEEEeeccccc
Q 046750 431 RLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDD-EFEAQVADFGLAK 509 (723)
Q Consensus 431 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~-~~~vkL~DFGla~ 509 (723)
.++||||++.....+++.. ++...+..+++.+++||+++|.+| ||||||||+|+|.+. .++-.|+|||||.
T Consensus 110 v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred eEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHH
Confidence 9999999999988888753 556778888999999999999995 999999999999984 5788999999997
Q ss_pred ccCCCC------------------c-------------------------ceeecccccccccChhhhcc-CCCCCccce
Q 046750 510 LNDTTQ------------------T-------------------------HVSTRVMGTFGYLAPEYASS-GKLTDRSDV 545 (723)
Q Consensus 510 ~~~~~~------------------~-------------------------~~~~~~~gt~~y~APE~~~~-~~~t~ksDV 545 (723)
...... . .......||.||+|||++.. ...+.+.||
T Consensus 182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi 261 (418)
T KOG1167|consen 182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI 261 (418)
T ss_pred HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence 211000 0 00112469999999998864 567889999
Q ss_pred echHHHHHHHHhCCCCCCC
Q 046750 546 FSFGVVLLELITGRKPVDP 564 (723)
Q Consensus 546 wSlGviL~eLltG~~P~~~ 564 (723)
||.||||+-+++++.||-.
T Consensus 262 ws~GVI~Lslls~~~PFf~ 280 (418)
T KOG1167|consen 262 WSAGVILLSLLSRRYPFFK 280 (418)
T ss_pred eeccceeehhhcccccccc
Confidence 9999999999999999854
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-26 Score=278.04 Aligned_cols=196 Identities=13% Similarity=0.204 Sum_probs=138.1
Q ss_pred HccC-CceeeEeeee-------ecccceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCcee
Q 046750 412 RVHH-RHLVSLVGYC-------ISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKII 483 (723)
Q Consensus 412 ~l~H-pnIv~l~g~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~iv 483 (723)
+++| .||++++++| .+...++++|||+ +++|.++|+... ..+++..++.|+.||++||+|||++ +||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---gIv 102 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD-RSVDAFECFHVFRQIVEIVNAAHSQ---GIV 102 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc-ccccHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 4455 5788888877 2334567788987 779999997543 3588999999999999999999998 499
Q ss_pred ecCCCCCcEEeCCC-------------------CcEEEeecccccccCCCCc---------------ceeeccccccccc
Q 046750 484 HRDIKSANILVDDE-------------------FEAQVADFGLAKLNDTTQT---------------HVSTRVMGTFGYL 529 (723)
Q Consensus 484 HrDIkp~NILl~~~-------------------~~vkL~DFGla~~~~~~~~---------------~~~~~~~gt~~y~ 529 (723)
||||||+||||+.. +.+||+|||+++....... ......+||..||
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 99999999999653 4556666666653211000 0011235788999
Q ss_pred ChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhhhccccHHHHHH
Q 046750 530 APEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFR 609 (723)
Q Consensus 530 APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~ 609 (723)
|||++.+..|+.++||||||||||||++|..++.... ..+.. +... ++.+.. ......
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~----~~~~~---------~~~~----~~~~~~-----~~~~~~ 240 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS----RTMSS---------LRHR----VLPPQI-----LLNWPK 240 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH----HHHHH---------HHHh----hcChhh-----hhcCHH
Confidence 9999999999999999999999999999888764221 00101 1000 011111 011224
Q ss_pred HHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 610 MIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 610 l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
+..++.+||+.+|.+||+|.||++.
T Consensus 241 ~~~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 241 EASFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHHHHhCCCChhhCcChHHHhhc
Confidence 5678889999999999999999864
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.8e-24 Score=231.78 Aligned_cols=261 Identities=21% Similarity=0.256 Sum_probs=195.1
Q ss_pred CcccceEEeccCcEEEEEEEcCCC--cEEEEEEcccCCchhHHHHHHHHHHHHHccC----CceeeEeeee-ecccceEE
Q 046750 361 GFARENVIGEGGFGCVYKGNLPEG--KVVAVKQLKSGSGQGEREFRAEVEIISRVHH----RHLVSLVGYC-ISEKNRLL 433 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~~~~g--~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~H----pnIv~l~g~~-~~~~~~~l 433 (723)
+|.+.++||+|+||.||++..... ..+|+|............+..|+.+|..+.+ .++..+++.. ......|+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999965443 5788888776533333378889999999973 5888999888 47778899
Q ss_pred EEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCC-----CcEEEeecccc
Q 046750 434 IYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDE-----FEAQVADFGLA 508 (723)
Q Consensus 434 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~-----~~vkL~DFGla 508 (723)
||+.+ |.+|.++........+...+.++|+.|++.+|++||+.| +|||||||.|+++... ..+.|+|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99988 899999886655567899999999999999999999995 9999999999999854 46999999999
Q ss_pred cccC--CCCc----ce---eecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhh
Q 046750 509 KLND--TTQT----HV---STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARP 579 (723)
Q Consensus 509 ~~~~--~~~~----~~---~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~ 579 (723)
+.+. .... .. .....||..|.+++...+.+.+.+.|+||++.++.||+.|..||.......... .
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~--~---- 248 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKS--K---- 248 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHH--H----
Confidence 8322 2211 11 123459999999999999999999999999999999999999995543211110 0
Q ss_pred hhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCCC
Q 046750 580 VLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEM 641 (723)
Q Consensus 580 ~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~~ 641 (723)
+.+... ...... ........+.+++..+-..+-..+|....+...|++....
T Consensus 249 -~~~~~~----~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 249 -FEKDPR----KLLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred -HHHHhh----hhcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 000000 000000 1111122455555556668999999999999998776543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-24 Score=233.88 Aligned_cols=166 Identities=21% Similarity=0.235 Sum_probs=129.4
Q ss_pred HHHhcCcccceEEeccCcEEEEEEEcC--CCcEEEEEEcccC-----CchhHHHHHHHHHHHHHccCCceee-Eeeeeec
Q 046750 356 MEITNGFARENVIGEGGFGCVYKGNLP--EGKVVAVKQLKSG-----SGQGEREFRAEVEIISRVHHRHLVS-LVGYCIS 427 (723)
Q Consensus 356 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~--~g~~VAvK~l~~~-----~~~~~~~~~~Ei~il~~l~HpnIv~-l~g~~~~ 427 (723)
..+.++|.+.++||+|+||.||+|.+. +++.||||++... .....+.|.+|+++|++|+|+||+. ++++
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 345678999999999999999999654 5778899987533 1123456899999999999999985 4432
Q ss_pred ccceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCC-CCCcEEeCCCCcEEEeecc
Q 046750 428 EKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDI-KSANILVDDEFEAQVADFG 506 (723)
Q Consensus 428 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDI-kp~NILl~~~~~vkL~DFG 506 (723)
+..||||||+.+++|... .... ...++.+++++|.|||++ +|+|||| ||+||||+.++.+||+|||
T Consensus 91 -~~~~LVmE~~~G~~L~~~-~~~~--------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLHLA-RPHG--------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred -CCcEEEEEccCCCCHHHh-Cccc--------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECc
Confidence 457999999999999632 1111 145788999999999999 4999999 9999999999999999999
Q ss_pred cccccCCCCccee-------ecccccccccChhhhccC
Q 046750 507 LAKLNDTTQTHVS-------TRVMGTFGYLAPEYASSG 537 (723)
Q Consensus 507 la~~~~~~~~~~~-------~~~~gt~~y~APE~~~~~ 537 (723)
+++.+........ ..+++++.|++||++.-.
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 9986654332111 346788899999998644
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-25 Score=223.10 Aligned_cols=248 Identities=22% Similarity=0.353 Sum_probs=194.4
Q ss_pred ccceEEeccCcEEEEEEEcCCCcEEEEEEcccC--CchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEecCC
Q 046750 363 ARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSG--SGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPN 440 (723)
Q Consensus 363 ~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 440 (723)
....+|.+...|+.|+|+|. |..+++|++... .....++|..|.-.|+.+.||||+.++|.|....+..+|..||+.
T Consensus 193 nl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~ 271 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF 271 (448)
T ss_pred hhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence 34467889999999999994 455666776543 334457899999999999999999999999999999999999999
Q ss_pred CchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEe--ecccccccCCCCcce
Q 046750 441 NNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVA--DFGLAKLNDTTQTHV 518 (723)
Q Consensus 441 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~--DFGla~~~~~~~~~~ 518 (723)
|+|+..||+....+.+..+..+++++|++|++|||+.- +-|..--|....|+||++.+++|. |--++. .
T Consensus 272 gslynvlhe~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsf--------q 342 (448)
T KOG0195|consen 272 GSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSF--------Q 342 (448)
T ss_pred hHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeee--------e
Confidence 99999999988888999999999999999999999973 344455689999999999887774 322221 1
Q ss_pred eecccccccccChhhhccCCC---CCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccc
Q 046750 519 STRVMGTFGYLAPEYASSGKL---TDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVD 595 (723)
Q Consensus 519 ~~~~~gt~~y~APE~~~~~~~---t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd 595 (723)
.......+.||+||.++...- -..+|+|||+++||||.|...||.+..+.+. -. ++. -
T Consensus 343 e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec--gm---------kia--------l 403 (448)
T KOG0195|consen 343 EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC--GM---------KIA--------L 403 (448)
T ss_pred ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh--hh---------hhh--------h
Confidence 112234678999999987653 3368999999999999999999987655321 11 111 1
Q ss_pred hhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccC
Q 046750 596 PRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEG 639 (723)
Q Consensus 596 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~ 639 (723)
..|+....+.....|.+|+.-|+++||.+||.+..|+-+||.+.
T Consensus 404 eglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 404 EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 12334445555667889999999999999999999999998754
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-24 Score=212.06 Aligned_cols=167 Identities=20% Similarity=0.241 Sum_probs=125.5
Q ss_pred CchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcceee
Q 046750 441 NNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVST 520 (723)
Q Consensus 441 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 520 (723)
|+|.++++.++ ..+++..++.|+.||++||+|||+++ |++|||+++++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~----- 63 (176)
T smart00750 1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ----- 63 (176)
T ss_pred CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc-----
Confidence 68889887543 35899999999999999999999983 999999999999999 99997654322
Q ss_pred cccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhhhc
Q 046750 521 RVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEK 600 (723)
Q Consensus 521 ~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~ 600 (723)
..|+..|||||++.+..++.++|||||||+||||++|+.||....... ..+..+. ..+...... + +
T Consensus 64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-~~~~~~~-----~~~~~~~~~---~-~--- 129 (176)
T smart00750 64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS-AILEILL-----NGMPADDPR---D-R--- 129 (176)
T ss_pred -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc-HHHHHHH-----HHhccCCcc---c-c---
Confidence 248899999999999999999999999999999999999996543211 1111111 111100000 0 0
Q ss_pred cccHHHH--HHHHHHHHHHhccCCCCCCCHHHHHHHHhcc
Q 046750 601 HYVESEM--FRMIEAAAACVRHSGPKRPRMVQVVRALDSE 638 (723)
Q Consensus 601 ~~~~~~~--~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~ 638 (723)
....... ..+.+++.+||+.+|.+||++.||++.+...
T Consensus 130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 0011111 2588999999999999999999999988654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-22 Score=212.96 Aligned_cols=259 Identities=27% Similarity=0.375 Sum_probs=196.7
Q ss_pred cccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCch---hHHHHHHHHHHHHHccCC-ceeeEeeeeecccceEEEEEe
Q 046750 362 FARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQ---GEREFRAEVEIISRVHHR-HLVSLVGYCISEKNRLLIYEF 437 (723)
Q Consensus 362 f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~---~~~~~~~Ei~il~~l~Hp-nIv~l~g~~~~~~~~~lV~E~ 437 (723)
|...+.||.|.||.||++... ..+++|.+...... ....|.+|+.+++.+.|+ +|+++++++......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 677889999999999999775 88999998765333 366799999999999988 799999999777778999999
Q ss_pred cCCCchhhccccCCC-CcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCC-cEEEeecccccccCCCC
Q 046750 438 VPNNNLEHHLHGKGQ-PVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEF-EAQVADFGLAKLNDTTQ 515 (723)
Q Consensus 438 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~-~vkL~DFGla~~~~~~~ 515 (723)
+.+++|.+++..... ..+.......++.+++.+|.|+|+.+ ++|||||++|||++... .++|+|||+++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999977654432 25778888999999999999999995 99999999999999988 79999999997554433
Q ss_pred cc-----eeecccccccccChhhhcc---CCCCCccceechHHHHHHHHhCCCCCCCCCCC-CchhhHHhhhhhhhhhhh
Q 046750 516 TH-----VSTRVMGTFGYLAPEYASS---GKLTDRSDVFSFGVVLLELITGRKPVDPTQPL-GDESLVEWARPVLVRAIE 586 (723)
Q Consensus 516 ~~-----~~~~~~gt~~y~APE~~~~---~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~-~~~~l~~~~~~~l~~~i~ 586 (723)
.. ......|+..|++||.+.+ ..+....|+|++|+++++++.|..||...... ........ +.
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~--------~~ 228 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKI--------IL 228 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHH--------HH
Confidence 22 2355679999999999987 57889999999999999999999997654321 00111111 11
Q ss_pred cCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 587 TGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 587 ~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
..... .....+...........+.+++..|+..++..|..+.+....
T Consensus 229 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 229 ELPTP-SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred hcCCc-ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 11100 000000000002223467788999999999999999987764
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1e-23 Score=206.21 Aligned_cols=261 Identities=21% Similarity=0.269 Sum_probs=196.2
Q ss_pred HhcCcccceEEeccCcEEEEEE-EcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccC-CceeeEeeeeecccceEEEE
Q 046750 358 ITNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHH-RHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 358 ~~~~f~~~~~LG~G~fG~Vy~~-~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~g~~~~~~~~~lV~ 435 (723)
+.++|..+++||.|+||.+|+| .+.+|..||||+-..... .-++..|..+++.|+| ..|..+..|+.+.....|||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 4567999999999999999999 667899999998776532 3467889999999976 46777777888888899999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCC---CCcEEEeecccccccC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDD---EFEAQVADFGLAKLND 512 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~---~~~vkL~DFGla~~~~ 512 (723)
|.+ |-+|++++.-..+ .+...+.+.++-|++.-|+|+|.+| +|||||||.|+|..- ...+.|+||||++.+.
T Consensus 91 dLL-GPsLEdLfnfC~R-~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFCSR-RFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred ecc-CccHHHHHHHHhh-hhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence 999 8899998876544 4788899999999999999999995 999999999999863 3469999999998765
Q ss_pred CCCc--ce----eecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhh
Q 046750 513 TTQT--HV----STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIE 586 (723)
Q Consensus 513 ~~~~--~~----~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~ 586 (723)
+... |. .....||.+|.+=....+.+.+.+.|+-|+|.||.++..|..||.+........-.+. |.
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEk--------I~ 237 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEK--------IS 237 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHH--------HH
Confidence 4433 22 2346799999998888888889999999999999999999999987543221111111 11
Q ss_pred cCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhcc
Q 046750 587 TGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSE 638 (723)
Q Consensus 587 ~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~ 638 (723)
+.++...+. .|-.-+ ..++...+.-|-...-++-|+..-|-+.+.-+
T Consensus 238 EkK~s~~ie-~LC~G~----P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriL 284 (341)
T KOG1163|consen 238 EKKMSTPIE-VLCKGF----PAEFAMYLNYCRGLGFEEKPDYMYLRQLFRIL 284 (341)
T ss_pred HhhcCCCHH-HHhCCC----cHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHH
Confidence 111111111 111111 23456666778778888888877666555443
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.5e-23 Score=210.82 Aligned_cols=203 Identities=23% Similarity=0.352 Sum_probs=173.2
Q ss_pred HhcCcccceEEeccCcEEEEEE-EcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHcc-CCceeeEeeeeecccceEEEE
Q 046750 358 ITNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVH-HRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 358 ~~~~f~~~~~LG~G~fG~Vy~~-~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~ 435 (723)
+.-+|.++++||+|.||.+|.| .+-+++.||||.-... ...-+++.|.+.++.|. .++|..++.|..++.+..||+
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 3457999999999999999999 6678999999986543 23346888999999995 688999998888899999999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCC-----CCcEEEeecccccc
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDD-----EFEAQVADFGLAKL 510 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~-----~~~vkL~DFGla~~ 510 (723)
|++ |-+|++++.-+++ .+...+++.||.|++.-++|+|++ .+|.|||||+|+||.. ...+.|+|||+|+.
T Consensus 104 dLL-GPSLEDLFD~CgR-~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 104 DLL-GPSLEDLFDLCGR-RFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hhh-CcCHHHHHHHhcC-cccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 999 8899998876554 488999999999999999999999 6999999999999964 34699999999997
Q ss_pred cCCCCcc--e----eecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCC
Q 046750 511 NDTTQTH--V----STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQP 567 (723)
Q Consensus 511 ~~~~~~~--~----~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~ 567 (723)
+.+.... + ....-||-+||+=.-..+.+.+.+.|+-+||-|+.++|.|.+||.+...
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA 241 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 241 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence 7665442 2 2335699999999999999999999999999999999999999987554
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.3e-23 Score=238.21 Aligned_cols=255 Identities=21% Similarity=0.264 Sum_probs=188.4
Q ss_pred ccceEEeccCcEEEEEE-EcCCCcEEEEEEcccC--CchhHH----HHHHHHHHHHHccCCceeeEeeeeecccceEEEE
Q 046750 363 ARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSG--SGQGER----EFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 363 ~~~~~LG~G~fG~Vy~~-~~~~g~~VAvK~l~~~--~~~~~~----~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 435 (723)
...+++|.|.||.|+.. +......++.|.++.. ....++ .+..|+.+-..|+|+|++..+..+.+....+.+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 45678999999987777 3334444444443310 111222 2556888888899999999888888777777779
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ 515 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 515 (723)
|||++ +|..++.... .+....+..++.|++.||.|||..| |.|||||++|+|+..++.+||+|||.+..+....
T Consensus 401 E~~~~-Dlf~~~~~~~--~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNG--KLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred hcccH-HHHHHHhccc--ccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 99999 9999987652 3666777889999999999999996 9999999999999999999999999997665433
Q ss_pred c---ceeecccccccccChhhhccCCCCCc-cceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcc
Q 046750 516 T---HVSTRVMGTFGYLAPEYASSGKLTDR-SDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLS 591 (723)
Q Consensus 516 ~---~~~~~~~gt~~y~APE~~~~~~~t~k-sDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~ 591 (723)
. +....++|.-.|+|||++.+..|... .||||.|+|+..|++|+.||......+... ......+.+.
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~---------~~~~~~~~~~ 545 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF---------KTNNYSDQRN 545 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch---------hhhccccccc
Confidence 3 55677889999999999999998874 899999999999999999997655432221 0000001111
Q ss_pred cccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 046750 592 EIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRAL 635 (723)
Q Consensus 592 ~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L 635 (723)
.. .-..........+...++.++|+.+|.+|-+|++|++.=
T Consensus 546 ~~---~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~ 586 (601)
T KOG0590|consen 546 IF---EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDE 586 (601)
T ss_pred cc---cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhCh
Confidence 00 001122233445677899999999999999999998643
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.2e-22 Score=203.50 Aligned_cols=172 Identities=12% Similarity=0.145 Sum_probs=135.0
Q ss_pred HhcCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHH---------HHHHHHHHHHccCCceeeEeeeeecc
Q 046750 358 ITNGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGERE---------FRAEVEIISRVHHRHLVSLVGYCISE 428 (723)
Q Consensus 358 ~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~---------~~~Ei~il~~l~HpnIv~l~g~~~~~ 428 (723)
+.++|...++||.|+||.||+.+. +++.+|||+++.......+. +.+|++.+.+|+|++|..+.+++.+.
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 468899999999999999999866 57789999997653332222 68999999999999999998886643
Q ss_pred --------cceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcE
Q 046750 429 --------KNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEA 500 (723)
Q Consensus 429 --------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~v 500 (723)
...+|||||++|.+|.++.. +.. .+..+|+.+|..||+.| |+||||||+|||++.++ +
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i 173 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-L 173 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-E
Confidence 34789999999999988742 221 24558899999999994 99999999999999988 9
Q ss_pred EEeecccccccCCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHh
Q 046750 501 QVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT 557 (723)
Q Consensus 501 kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt 557 (723)
+|+|||........... -.+++...|..++|+|+|||.|..+..
T Consensus 174 ~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 174 RIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred EEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHHH
Confidence 99999988654221110 014555667789999999998876643
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.8e-22 Score=229.74 Aligned_cols=252 Identities=24% Similarity=0.251 Sum_probs=180.8
Q ss_pred CcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCC-chhHHHHHHHHHH--HHHccCCceeeEeeeeecccceEEEEEe
Q 046750 361 GFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGS-GQGEREFRAEVEI--ISRVHHRHLVSLVGYCISEKNRLLIYEF 437 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~-~~~~~~~~~Ei~i--l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 437 (723)
+|...+.||.+.|=+|.+|+..+|. |+||++-+.. ....+.|.++++- +..++|||++.+.-+...+..-|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5777899999999999999987887 8888875443 4444555443333 4556899999998887777778899999
Q ss_pred cCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeeccccc--ccCCCC
Q 046750 438 VPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK--LNDTTQ 515 (723)
Q Consensus 438 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~--~~~~~~ 515 (723)
+ ..+|+++|.. +..|...++.-|+.||++||..+|+.| |+|||||.+||||+.=.-+.|+||.--+ ++.+++
T Consensus 103 v-khnLyDRlST--RPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 103 V-KHNLYDRLST--RPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred H-hhhhhhhhcc--chHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 8 6689998864 446788888889999999999999995 9999999999999988889999998664 222222
Q ss_pred cceeecc----cccccccChhhhccCC-----------CCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhh
Q 046750 516 THVSTRV----MGTFGYLAPEYASSGK-----------LTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARP 579 (723)
Q Consensus 516 ~~~~~~~----~gt~~y~APE~~~~~~-----------~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~ 579 (723)
.....-+ ..-..|+|||.+.... ++.+.||||+|||++||++ |+.+|+... +..
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ------L~a---- 246 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ------LLA---- 246 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH------HHh----
Confidence 2111111 2234799999875421 6678999999999999998 677775321 111
Q ss_pred hhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccC
Q 046750 580 VLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEG 639 (723)
Q Consensus 580 ~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~ 639 (723)
++.|. .......|++-- -..+.++++.|++.||.+|-+++++|+.-.+..
T Consensus 247 -----Yr~~~-~~~~e~~Le~Ie----d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~ 296 (1431)
T KOG1240|consen 247 -----YRSGN-ADDPEQLLEKIE----DVSLRNLILSMIQRDPSKRLSAEDYLQKYRGLV 296 (1431)
T ss_pred -----HhccC-ccCHHHHHHhCc----CccHHHHHHHHHccCchhccCHHHHHHhhhccc
Confidence 11111 000001111000 015678999999999999999999998855544
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.1e-21 Score=191.07 Aligned_cols=139 Identities=18% Similarity=0.216 Sum_probs=107.4
Q ss_pred ceEEeccCcEEEEEEEcCCCcEEEEEEcccCCch--h-------H-----------------HHHHHHHHHHHHccCCce
Q 046750 365 ENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQ--G-------E-----------------REFRAEVEIISRVHHRHL 418 (723)
Q Consensus 365 ~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~--~-------~-----------------~~~~~Ei~il~~l~HpnI 418 (723)
..+||+|+||.||+|...+|+.||||+++..... . . .....|+++|.+|.|.++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999998778999999999754211 0 0 112359999999988776
Q ss_pred eeEeeeeecccceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchh-cccCCCceeecCCCCCcEEeCCC
Q 046750 419 VSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYL-HEDCHPKIIHRDIKSANILVDDE 497 (723)
Q Consensus 419 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~g~~~ivHrDIkp~NILl~~~ 497 (723)
.....+.. ...+|||||+.+++|...+... ..+++.....++.||+.+|.|| |+. +|+||||||+|||+++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~~- 153 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYHD- 153 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEEC-
Confidence 44332222 2348999999888776543222 2478888999999999999999 687 5999999999999984
Q ss_pred CcEEEeeccccccc
Q 046750 498 FEAQVADFGLAKLN 511 (723)
Q Consensus 498 ~~vkL~DFGla~~~ 511 (723)
+.++|+|||++...
T Consensus 154 ~~v~LiDFG~a~~~ 167 (190)
T cd05147 154 GKLYIIDVSQSVEH 167 (190)
T ss_pred CcEEEEEccccccC
Confidence 68999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=7.7e-21 Score=222.74 Aligned_cols=194 Identities=22% Similarity=0.266 Sum_probs=156.8
Q ss_pred hcCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHcc---CCceeeEeeeeecccceEEEE
Q 046750 359 TNGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVH---HRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~g~~~~~~~~~lV~ 435 (723)
.+.|.+.+.||+|+||.||+|...+|+.||||+-+..... +|.--.+++.||+ -+-|+.+..++.-.+..+||+
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ 773 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVS 773 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcceeee
Confidence 4678999999999999999997777999999998765432 2222334455554 234555555556667789999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCC-------CCcEEEeecccc
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDD-------EFEAQVADFGLA 508 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~-------~~~vkL~DFGla 508 (723)
||.+.|+|.+++. ....++|...+.|+.|+++.|++||.. +|||+||||.|+||.. +.-++|+|||.+
T Consensus 774 ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~s 848 (974)
T KOG1166|consen 774 EYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRS 848 (974)
T ss_pred eccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEecccc
Confidence 9999999999998 444699999999999999999999999 5999999999999953 356999999999
Q ss_pred cccCCCC-cceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCC
Q 046750 509 KLNDTTQ-THVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRK 560 (723)
Q Consensus 509 ~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~ 560 (723)
..+.-.. ......+++|-.|-..|+..++.|++..|.|.|+.+++.||.|+.
T Consensus 849 iDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 849 IDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 6433221 224456778999999999999999999999999999999999975
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.3e-20 Score=183.86 Aligned_cols=139 Identities=19% Similarity=0.185 Sum_probs=109.3
Q ss_pred ceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchh--------------------------HHHHHHHHHHHHHccCCce
Q 046750 365 ENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQG--------------------------EREFRAEVEIISRVHHRHL 418 (723)
Q Consensus 365 ~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~--------------------------~~~~~~Ei~il~~l~HpnI 418 (723)
...||+|+||.||+|...+|+.||||+++...... ...++.|++.+.++.|++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46899999999999987789999999987642110 1124579999999999987
Q ss_pred eeEeeeeecccceEEEEEecCCCchhhc-cccCCCCcchHHHHHHHHHHHHhhhchhcc-cCCCceeecCCCCCcEEeCC
Q 046750 419 VSLVGYCISEKNRLLIYEFVPNNNLEHH-LHGKGQPVLEWTKRVKIALGAAKGLAYLHE-DCHPKIIHRDIKSANILVDD 496 (723)
Q Consensus 419 v~l~g~~~~~~~~~lV~E~~~~gsL~~~-l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~g~~~ivHrDIkp~NILl~~ 496 (723)
.....+... ..+|||||+.++.+... +.. ..++...+..++.+++.+|.|||. + +|+||||||+||||+
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-
Confidence 544433332 34899999988855433 332 235677888999999999999999 7 599999999999999
Q ss_pred CCcEEEeecccccccC
Q 046750 497 EFEAQVADFGLAKLND 512 (723)
Q Consensus 497 ~~~vkL~DFGla~~~~ 512 (723)
++.++|+|||++....
T Consensus 153 ~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 DGKPYIIDVSQAVELD 168 (190)
T ss_pred CCCEEEEEcccceecC
Confidence 7899999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=4e-20 Score=183.36 Aligned_cols=188 Identities=18% Similarity=0.119 Sum_probs=140.4
Q ss_pred cccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchh----HHHHHHHHHHHHHcc-CCceeeEeeeeecccceEEEEE
Q 046750 362 FARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQG----EREFRAEVEIISRVH-HRHLVSLVGYCISEKNRLLIYE 436 (723)
Q Consensus 362 f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~----~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~E 436 (723)
+.+...|+.|+||.||++.. .+..++.+.+....... ...|++|+++|++|+ |++|.+++++ +..+++||
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred cccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 34568999999999998866 77888877776543211 125789999999995 5789999886 45699999
Q ss_pred ecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCC-CCCcEEeCCCCcEEEeecccccccCCCC
Q 046750 437 FVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDI-KSANILVDDEFEAQVADFGLAKLNDTTQ 515 (723)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDI-kp~NILl~~~~~vkL~DFGla~~~~~~~ 515 (723)
|+.|.+|.+.+.. ....++.+++.+|++||++| |+|||| |+.|||++.++.++|+|||++.......
T Consensus 79 yI~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 79 YLAGAAMYQRPPR---------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred eecCccHHhhhhh---------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 9999988765421 11346788999999999995 999999 7999999999999999999998554333
Q ss_pred cc----e--------eecccccccccChhhhccC-CCC-CccceechHHHHHHHHhCCCCCCCCC
Q 046750 516 TH----V--------STRVMGTFGYLAPEYASSG-KLT-DRSDVFSFGVVLLELITGRKPVDPTQ 566 (723)
Q Consensus 516 ~~----~--------~~~~~gt~~y~APE~~~~~-~~t-~ksDVwSlGviL~eLltG~~P~~~~~ 566 (723)
.. . ......+..|+.|+...-- ..+ ...+.++.|+.+|.++|++.+.....
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 10 0 1112357788888744321 222 45688999999999999998765443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.3e-21 Score=210.62 Aligned_cols=186 Identities=29% Similarity=0.356 Sum_probs=156.2
Q ss_pred EEeccCcEEEEEEEc----CCCcEEEEEEcccCCchhH--HHHHHHHHHHHHcc-CCceeeEeeeeecccceEEEEEecC
Q 046750 367 VIGEGGFGCVYKGNL----PEGKVVAVKQLKSGSGQGE--REFRAEVEIISRVH-HRHLVSLVGYCISEKNRLLIYEFVP 439 (723)
Q Consensus 367 ~LG~G~fG~Vy~~~~----~~g~~VAvK~l~~~~~~~~--~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~E~~~ 439 (723)
.+|+|.||.|++++. +.|..+|+|++++...... .....|-.++..++ |+.+|++...++.+...+++++|+.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 379999999998843 3467799999876532211 14566888999997 9999999999999999999999999
Q ss_pred CCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCccee
Q 046750 440 NNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVS 519 (723)
Q Consensus 440 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 519 (723)
+|+|..++..... ++......+...++-+|++||+.+ |+|||+|.+||+|+.+|++++.|||+++..-.....
T Consensus 81 gg~lft~l~~~~~--f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~-- 153 (612)
T KOG0603|consen 81 GGDLFTRLSKEVM--FDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA-- 153 (612)
T ss_pred cchhhhccccCCc--hHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhhc--
Confidence 9999998876543 566666677788999999999995 999999999999999999999999999865433322
Q ss_pred ecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCC
Q 046750 520 TRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDP 564 (723)
Q Consensus 520 ~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~ 564 (723)
+|+..|||||++. .+....|.|+||++++||++|..||..
T Consensus 154 ---cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 154 ---CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred ---ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 7999999999998 567789999999999999999999975
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1e-19 Score=200.69 Aligned_cols=218 Identities=23% Similarity=0.381 Sum_probs=164.1
Q ss_pred HHHccCCceeeEeeeeecccceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCC
Q 046750 410 ISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKS 489 (723)
Q Consensus 410 l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp 489 (723)
|+.+.|.|+.+|+|.+.++...++|.+||..|+|.+.+... ...++|.....++.+|++||+|||.-- -.+|+.|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeecc
Confidence 35688999999999999999999999999999999999763 346899999999999999999999872 239999999
Q ss_pred CcEEeCCCCcEEEeecccccccCCC-CcceeecccccccccChhhhccCC-------CCCccceechHHHHHHHHhCCCC
Q 046750 490 ANILVDDEFEAQVADFGLAKLNDTT-QTHVSTRVMGTFGYLAPEYASSGK-------LTDRSDVFSFGVVLLELITGRKP 561 (723)
Q Consensus 490 ~NILl~~~~~vkL~DFGla~~~~~~-~~~~~~~~~gt~~y~APE~~~~~~-------~t~ksDVwSlGviL~eLltG~~P 561 (723)
.|+++|..+.+||.|||+....... .........-..-|.|||.+.... .+.+.||||||+|++|+++...|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 9999999999999999998765321 111111122356799999997642 46679999999999999999999
Q ss_pred CCCCCCCCch-hhHHhhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCC
Q 046750 562 VDPTQPLGDE-SLVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGE 640 (723)
Q Consensus 562 ~~~~~~~~~~-~l~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~ 640 (723)
|+......+. .++.+ ++. .....+.+.+.... +....+..++..||..+|.+||++.+|-..++.+..
T Consensus 158 ~~~~~~~~~~~eii~~--------~~~-~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILR--------VKK-GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred cccccccCChHHHHHH--------HHh-cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 9875432221 11111 222 11122222222111 222268899999999999999999999998877654
Q ss_pred C
Q 046750 641 M 641 (723)
Q Consensus 641 ~ 641 (723)
.
T Consensus 227 ~ 227 (484)
T KOG1023|consen 227 G 227 (484)
T ss_pred c
Confidence 3
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.80 E-value=1e-19 Score=189.39 Aligned_cols=232 Identities=22% Similarity=0.323 Sum_probs=147.9
Q ss_pred CcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCC---chhHHHHHHHHHHHHHcc----------CCceeeEeeee-
Q 046750 361 GFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS---GQGEREFRAEVEIISRVH----------HRHLVSLVGYC- 425 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~---~~~~~~~~~Ei~il~~l~----------HpnIv~l~g~~- 425 (723)
.+...+.||.|+|+.||.+.. ..++.+|||++.... ....+++++|.-.+..+. |-.++--++..
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 456778999999999999955 458999999975432 223456666665444422 21122111111
Q ss_pred --------ecc---c-----ceEEEEEecCCCchhhcccc-----CCCCcchHHHHHHHHHHHHhhhchhcccCCCceee
Q 046750 426 --------ISE---K-----NRLLIYEFVPNNNLEHHLHG-----KGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIH 484 (723)
Q Consensus 426 --------~~~---~-----~~~lV~E~~~~gsL~~~l~~-----~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivH 484 (723)
... . +.+++|.-+ -++|.+++.. .....+....++.+..|+++.+++||.+| |||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence 111 1 336777777 7788777532 12234666777888899999999999995 999
Q ss_pred cCCCCCcEEeCCCCcEEEeecccccccCCCCcceeecccccccccChhhhccC--------CCCCccceechHHHHHHHH
Q 046750 485 RDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSG--------KLTDRSDVFSFGVVLLELI 556 (723)
Q Consensus 485 rDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~--------~~t~ksDVwSlGviL~eLl 556 (723)
+||+++|+|++.+|.++|+||+.....+.... . ...+..|.+||..... .++.+.|.|+||++||.|+
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~---~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYR---C-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEEE---G-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCceee---c-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 99999999999999999999998765443211 1 2346789999977543 4788999999999999999
Q ss_pred hCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCC
Q 046750 557 TGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKR 625 (723)
Q Consensus 557 tG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~R 625 (723)
+|+.||+....... .+| +|. .-. +....+..|+..+|+.++.+|
T Consensus 245 C~~lPf~~~~~~~~---~~~------------~f~---------~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 245 CGRLPFGLSSPEAD---PEW------------DFS---------RCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSS-STCCCGGGST---SGG------------GGT---------TSS----HHHHHHHHHHT-SSGGGS
T ss_pred HccCCCCCCCcccc---ccc------------cch---------hcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999986543211 111 111 111 345567889999999999987
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.2e-19 Score=178.71 Aligned_cols=137 Identities=20% Similarity=0.268 Sum_probs=107.0
Q ss_pred cccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHc-----cCCceeeEeeeeeccc---ceE-
Q 046750 362 FARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRV-----HHRHLVSLVGYCISEK---NRL- 432 (723)
Q Consensus 362 f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l-----~HpnIv~l~g~~~~~~---~~~- 432 (723)
+...++||+|+||.||+ +..++.. +||++........+++.+|+++|+.| .|+||++++|++.++. ..+
T Consensus 4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 34568999999999996 4444444 69988765445567899999999999 5799999999998864 323
Q ss_pred EEEEe--cCCCchhhccccCCCCcchHHHHHHHHHHHHhhh-chhcccCCCceeecCCCCCcEEeCC----CCcEEEeec
Q 046750 433 LIYEF--VPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGL-AYLHEDCHPKIIHRDIKSANILVDD----EFEAQVADF 505 (723)
Q Consensus 433 lV~E~--~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~g~~~ivHrDIkp~NILl~~----~~~vkL~DF 505 (723)
+|+|| +.+++|.+++.+.. +++. ..++.+++.+| +|||++ +||||||||+|||++. ++.++|+||
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~~---~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQCR---YEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EEecCCCCcchhHHHHHHccc---ccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 78999 44799999996532 4444 35677888887 899999 5999999999999974 347999995
Q ss_pred ccc
Q 046750 506 GLA 508 (723)
Q Consensus 506 Gla 508 (723)
+.+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 544
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.7e-18 Score=175.69 Aligned_cols=142 Identities=18% Similarity=0.171 Sum_probs=110.9
Q ss_pred CcccceEEeccCcEEEEEEE--cCCCcEEEEEEcccCCch------------------------hHHHHHHHHHHHHHcc
Q 046750 361 GFARENVIGEGGFGCVYKGN--LPEGKVVAVKQLKSGSGQ------------------------GEREFRAEVEIISRVH 414 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~--~~~g~~VAvK~l~~~~~~------------------------~~~~~~~Ei~il~~l~ 414 (723)
.|.+.+.||+|+||.||+|. ..+|+.||||+++..... ....+..|++++.+|.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48889999999999999997 678999999998754210 1123568999999997
Q ss_pred CCc--eeeEeeeeecccceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcE
Q 046750 415 HRH--LVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANI 492 (723)
Q Consensus 415 Hpn--Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NI 492 (723)
+.+ +.+++++ ...+|||||+.+++|..++.... .+.......++.||+.+|.|||.++ .|+||||||+||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~NI 180 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV--EPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYNI 180 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccC--CcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhhE
Confidence 633 3344443 23589999999988877653322 2455567789999999999999993 399999999999
Q ss_pred EeCCCCcEEEeeccccccc
Q 046750 493 LVDDEFEAQVADFGLAKLN 511 (723)
Q Consensus 493 Ll~~~~~vkL~DFGla~~~ 511 (723)
|++ +++++|+|||++...
T Consensus 181 li~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 181 LVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred EEE-CCCEEEEEChhhhcc
Confidence 999 789999999998754
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.9e-18 Score=173.12 Aligned_cols=134 Identities=21% Similarity=0.373 Sum_probs=113.1
Q ss_pred eEEeccCcEEEEEEEcCCCcEEEEEEcccCCch--------hHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEe
Q 046750 366 NVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQ--------GEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEF 437 (723)
Q Consensus 366 ~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~--------~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 437 (723)
++||+|+||.||+|.+ .|..|+||+....... ....+.+|++++.+++|.+|.....++.+....++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 7788999986643211 123577899999999999988777777777888999999
Q ss_pred cCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccc
Q 046750 438 VPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKL 510 (723)
Q Consensus 438 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 510 (723)
++|++|.+++.... + .+..++.+|+.+|.+||+. +|+||||++.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999886432 2 7788999999999999999 499999999999999 78999999999864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.9e-18 Score=168.63 Aligned_cols=144 Identities=19% Similarity=0.199 Sum_probs=112.0
Q ss_pred HHHHHhcCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCc----------------------hhHHHHHHHHHHHH
Q 046750 354 ELMEITNGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSG----------------------QGEREFRAEVEIIS 411 (723)
Q Consensus 354 ~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~----------------------~~~~~~~~Ei~il~ 411 (723)
++......|.+.+.||+|+||.||++...+|+.||||+++.... .....+..|+.++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 33333344888899999999999999888899999998754320 01123677999999
Q ss_pred HccCCc--eeeEeeeeecccceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCC
Q 046750 412 RVHHRH--LVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKS 489 (723)
Q Consensus 412 ~l~Hpn--Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp 489 (723)
.+.|.+ +..+++. ...++||||+.+++|.+++.. .....++.+|+.+|.+||+. +|+||||||
T Consensus 89 ~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p 153 (198)
T cd05144 89 ALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKH---GIIHGDLSE 153 (198)
T ss_pred HHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCc
Confidence 998874 4444432 345899999999999776531 23457888999999999998 599999999
Q ss_pred CcEEeCCCCcEEEeecccccccC
Q 046750 490 ANILVDDEFEAQVADFGLAKLND 512 (723)
Q Consensus 490 ~NILl~~~~~vkL~DFGla~~~~ 512 (723)
.||||++++.++|+|||++....
T Consensus 154 ~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 154 FNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred ccEEEcCCCcEEEEECCccccCC
Confidence 99999999999999999996443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.4e-18 Score=180.98 Aligned_cols=196 Identities=21% Similarity=0.267 Sum_probs=133.9
Q ss_pred cCCceeeEeeeeecc---------------------------cceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHH
Q 046750 414 HHRHLVSLVGYCISE---------------------------KNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALG 466 (723)
Q Consensus 414 ~HpnIv~l~g~~~~~---------------------------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ 466 (723)
+|||||+++++|.+. ...||||..+ ..+|..||..+. .......-|+.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~---~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH---RSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC---CchHHHHHHHHH
Confidence 599999999987652 2358888887 568888886543 344556678899
Q ss_pred HHhhhchhcccCCCceeecCCCCCcEEeC--CC--CcEEEeecccccccCCCCc---ce--eecccccccccChhhhccC
Q 046750 467 AAKGLAYLHEDCHPKIIHRDIKSANILVD--DE--FEAQVADFGLAKLNDTTQT---HV--STRVMGTFGYLAPEYASSG 537 (723)
Q Consensus 467 ia~gL~yLH~~g~~~ivHrDIkp~NILl~--~~--~~vkL~DFGla~~~~~~~~---~~--~~~~~gt~~y~APE~~~~~ 537 (723)
+++|+.|||++| |.|||+|..||||. +| -.+.|+|||++.......- +. ....-|.-..||||+....
T Consensus 350 lLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~ 426 (598)
T KOG4158|consen 350 LLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV 426 (598)
T ss_pred HHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence 999999999995 99999999999984 33 3478999998853322111 11 1223467789999988543
Q ss_pred C------CCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhhhccccHHHHHHHH
Q 046750 538 K------LTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMI 611 (723)
Q Consensus 538 ~------~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~ 611 (723)
. --.|+|.|+.|.+.||++....||....+. +.+- +.+.+..+- .+ .......+.
T Consensus 427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem----~L~~------r~Yqe~qLP-----al----p~~vpp~~r 487 (598)
T KOG4158|consen 427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM----LLDT------RTYQESQLP-----AL----PSRVPPVAR 487 (598)
T ss_pred CCCceeeccchhhhhhhhhhHHHHhccCCcccccchh----eech------hhhhhhhCC-----CC----cccCChHHH
Confidence 2 234899999999999999999999764321 1000 111111111 11 112233567
Q ss_pred HHHHHHhccCCCCCCCHHHHHHHH
Q 046750 612 EAAAACVRHSGPKRPRMVQVVRAL 635 (723)
Q Consensus 612 ~l~~~cl~~dP~~RPs~~eVl~~L 635 (723)
+++...|+.||.+|++..-..+.|
T Consensus 488 qlV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 488 QLVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHHHHhcCCccccCCccHHHhHH
Confidence 888899999999999865444433
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.8e-18 Score=170.67 Aligned_cols=130 Identities=22% Similarity=0.386 Sum_probs=106.1
Q ss_pred EEeccCcEEEEEEEcCCCcEEEEEEcccCCc--------hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEec
Q 046750 367 VIGEGGFGCVYKGNLPEGKVVAVKQLKSGSG--------QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFV 438 (723)
Q Consensus 367 ~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~--------~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 438 (723)
+||+|+||.||+|.+ ++..|+||++..... .....+.+|++++.+++|.++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999986 678899998654321 11245778999999999887655555555666789999999
Q ss_pred CCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccc
Q 046750 439 PNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKL 510 (723)
Q Consensus 439 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 510 (723)
.|++|.+++..... .++.+++++|.+||+.+ |+||||++.|||++ ++.++|+|||++..
T Consensus 80 ~g~~l~~~~~~~~~---------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGND---------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHH---------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999988754211 78899999999999994 99999999999999 78999999999864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.74 E-value=8.5e-19 Score=189.96 Aligned_cols=172 Identities=23% Similarity=0.407 Sum_probs=130.7
Q ss_pred ceEEEEEecCCCchhhcccc-CCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccc
Q 046750 430 NRLLIYEFVPNNNLEHHLHG-KGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLA 508 (723)
Q Consensus 430 ~~~lV~E~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla 508 (723)
..|+.|++|...+|+++|.+ ......++...+.++.|++.+++| + +.+|||+|+.||++..+..+||.||||.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence 46899999999999999964 334457788889999999999999 5 4999999999999999999999999998
Q ss_pred cccCCCC-----cceeecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhh
Q 046750 509 KLNDTTQ-----THVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLV 582 (723)
Q Consensus 509 ~~~~~~~-----~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~ 582 (723)
....... ....+..+||..||+||.|.+..|+.|+|||+||+||+||+. -...++ +...+
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e--------------r~~t~ 469 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE--------------RIATL 469 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH--------------HHHhh
Confidence 7655444 223355679999999999999999999999999999999998 222221 11122
Q ss_pred hhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHH
Q 046750 583 RAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQ 630 (723)
Q Consensus 583 ~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~e 630 (723)
..++.|.+. +.+..+|.. -+.|+.+++...|.+||.+.+
T Consensus 470 ~d~r~g~ip----~~~~~d~p~-----e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 470 TDIRDGIIP----PEFLQDYPE-----EYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred hhhhcCCCC----hHHhhcCcH-----HHHHHHHhcCCCcccCchHHH
Confidence 334444432 223333332 246788999999999994433
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.73 E-value=7e-18 Score=194.25 Aligned_cols=139 Identities=22% Similarity=0.375 Sum_probs=111.9
Q ss_pred HHhcCcccceEEeccCcEEEEEEEcCCCcEEEEEE-cccC-Cc------hhHHHHHHHHHHHHHccCCceeeEeeeeecc
Q 046750 357 EITNGFARENVIGEGGFGCVYKGNLPEGKVVAVKQ-LKSG-SG------QGEREFRAEVEIISRVHHRHLVSLVGYCISE 428 (723)
Q Consensus 357 ~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~-l~~~-~~------~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 428 (723)
.....|...++||+|+||.||+|.+.... +++|+ +... .. ...+.+.+|++++++++|++|+..+.++.+.
T Consensus 330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~ 408 (535)
T PRK09605 330 EVKRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP 408 (535)
T ss_pred ccccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC
Confidence 33445667899999999999999875444 33333 2211 11 1224688999999999999999888888777
Q ss_pred cceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccc
Q 046750 429 KNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLA 508 (723)
Q Consensus 429 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla 508 (723)
...++||||+++++|.+++. ....++.+|+++|.|||+. +|+||||||+|||| +++.++|+|||++
T Consensus 409 ~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla 474 (535)
T PRK09605 409 EEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLG 474 (535)
T ss_pred CCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccc
Confidence 78899999999999998874 3567899999999999999 49999999999999 5779999999999
Q ss_pred cc
Q 046750 509 KL 510 (723)
Q Consensus 509 ~~ 510 (723)
+.
T Consensus 475 ~~ 476 (535)
T PRK09605 475 KY 476 (535)
T ss_pred cc
Confidence 75
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.1e-17 Score=192.61 Aligned_cols=209 Identities=24% Similarity=0.346 Sum_probs=139.5
Q ss_pred hcCcccceEEeccCcEEEEEEEcCC-CcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEe
Q 046750 359 TNGFARENVIGEGGFGCVYKGNLPE-GKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEF 437 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 437 (723)
..+|..+++|-.|+||.||+.+.+. .+.+|+|+=+.. .+ | +||..+. +..++|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~------li------l-----Rnilt~a------~npfvv--- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN------LI------L-----RNILTFA------GNPFVV--- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccccc------hh------h-----hcccccc------CCccee---
Confidence 4679999999999999999996654 566777543321 11 1 1122222 122222
Q ss_pred cCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCc-
Q 046750 438 VPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQT- 516 (723)
Q Consensus 438 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~- 516 (723)
|+-..++...+. +.. +++.+++|||+.+ |+|||+|+.|.||+..|++||.||||.+.......
T Consensus 136 ---gDc~tllk~~g~--lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 ---GDCATLLKNIGP--LPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred ---chhhhhcccCCC--Ccc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 333444443332 221 2277899999995 99999999999999999999999999864322111
Q ss_pred -------------ceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhh
Q 046750 517 -------------HVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVR 583 (723)
Q Consensus 517 -------------~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~ 583 (723)
.....++||+.|.|||++....|..-.|.|++|+||||++-|+.||..+.+.+ |..- ++..
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee---lfg~---visd 273 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE---LFGQ---VISD 273 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH---HHhh---hhhh
Confidence 12344689999999999999999999999999999999999999998775421 1110 0100
Q ss_pred hhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCC
Q 046750 584 AIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPR 627 (723)
Q Consensus 584 ~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs 627 (723)
.++ + .+-+.....+..+++.++|+++|..|--
T Consensus 274 ~i~---w---------pE~dea~p~Ea~dli~~LL~qnp~~Rlg 305 (1205)
T KOG0606|consen 274 DIE---W---------PEEDEALPPEAQDLIEQLLRQNPLCRLG 305 (1205)
T ss_pred hcc---c---------cccCcCCCHHHHHHHHHHHHhChHhhcc
Confidence 000 0 0111122235677788899999998874
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.3e-16 Score=148.65 Aligned_cols=135 Identities=21% Similarity=0.187 Sum_probs=114.5
Q ss_pred cceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccC--CceeeEeeeeecccceEEEEEecCCC
Q 046750 364 RENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHH--RHLVSLVGYCISEKNRLLIYEFVPNN 441 (723)
Q Consensus 364 ~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~g~~~~~~~~~lV~E~~~~g 441 (723)
+.+.||+|.++.||++...+ ..++||.+..... ...+.+|+.++++|+| .++.++++++...+..+++|||+.++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 45789999999999998744 7899999876543 5678999999999977 48999999888878899999999888
Q ss_pred chhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccc
Q 046750 442 NLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKL 510 (723)
Q Consensus 442 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 510 (723)
.+..+ .......++.+++++|++||......++|+||++.|||+++.+.++|+|||+++.
T Consensus 79 ~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77655 3456677889999999999986444699999999999999989999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.65 E-value=7e-16 Score=152.62 Aligned_cols=136 Identities=21% Similarity=0.246 Sum_probs=99.2
Q ss_pred ceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchh--HHH----------------------HHHHHHHHHHccCCc--e
Q 046750 365 ENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQG--ERE----------------------FRAEVEIISRVHHRH--L 418 (723)
Q Consensus 365 ~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~--~~~----------------------~~~Ei~il~~l~Hpn--I 418 (723)
.+.||+|+||.||+|...+++.||||+++...... ... ...|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46899999999999988789999999987532111 111 135666777775443 4
Q ss_pred eeEeeeeecccceEEEEEecCCCchhhc-cccCCCCcchHHHHHHHHHHHHhhhchhcc-cCCCceeecCCCCCcEEeCC
Q 046750 419 VSLVGYCISEKNRLLIYEFVPNNNLEHH-LHGKGQPVLEWTKRVKIALGAAKGLAYLHE-DCHPKIIHRDIKSANILVDD 496 (723)
Q Consensus 419 v~l~g~~~~~~~~~lV~E~~~~gsL~~~-l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~g~~~ivHrDIkp~NILl~~ 496 (723)
.+++++ ...++||||+.++.+... +.... . ......++.+++.+|.+||. . +|+|||||++||||+
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~-~~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---L-LEDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---h-cccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-
Confidence 444443 246899999998654322 21111 1 15577899999999999999 7 599999999999999
Q ss_pred CCcEEEeecccccccC
Q 046750 497 EFEAQVADFGLAKLND 512 (723)
Q Consensus 497 ~~~vkL~DFGla~~~~ 512 (723)
++.++|+|||++....
T Consensus 150 ~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 DGKVYIIDVPQAVEID 165 (187)
T ss_pred CCcEEEEECccccccc
Confidence 8899999999996443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.60 E-value=3.3e-15 Score=154.06 Aligned_cols=136 Identities=18% Similarity=0.252 Sum_probs=104.6
Q ss_pred ceEEe-ccCcEEEEEEEcCCCcEEEEEEcccCC-------------chhHHHHHHHHHHHHHccCCce--eeEeeeeecc
Q 046750 365 ENVIG-EGGFGCVYKGNLPEGKVVAVKQLKSGS-------------GQGEREFRAEVEIISRVHHRHL--VSLVGYCISE 428 (723)
Q Consensus 365 ~~~LG-~G~fG~Vy~~~~~~g~~VAvK~l~~~~-------------~~~~~~~~~Ei~il~~l~HpnI--v~l~g~~~~~ 428 (723)
...|| .|+.|.||+++. .+..++||.++... ......+.+|++++.+|+|.+| ++.++++...
T Consensus 36 ~~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 45788 899999999977 47788888875321 1223467889999999998875 6777765443
Q ss_pred cc----eEEEEEecCC-CchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEe
Q 046750 429 KN----RLLIYEFVPN-NNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVA 503 (723)
Q Consensus 429 ~~----~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~ 503 (723)
.. .+|||||+++ .+|.+++.... +... .+.+|+.+|.+||++| |+|||||+.|||++.++.++|+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~~---l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEAP---LSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcCC---CCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence 22 2599999997 68888875432 3322 3568899999999995 9999999999999998899999
Q ss_pred eccccccc
Q 046750 504 DFGLAKLN 511 (723)
Q Consensus 504 DFGla~~~ 511 (723)
|||.+...
T Consensus 185 Dfg~~~~~ 192 (239)
T PRK01723 185 DFDRGELR 192 (239)
T ss_pred ECCCcccC
Confidence 99998754
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.59 E-value=2.4e-16 Score=181.63 Aligned_cols=253 Identities=22% Similarity=0.295 Sum_probs=186.3
Q ss_pred CcccceEEeccCcEEEEEEEcCC--CcEEEEEEcccCC--chhHHHHHHHHHHHHHcc-CCceeeEeeeeecccceEEEE
Q 046750 361 GFARENVIGEGGFGCVYKGNLPE--GKVVAVKQLKSGS--GQGEREFRAEVEIISRVH-HRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~~~~--g~~VAvK~l~~~~--~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~ 435 (723)
.|...+.||+|.|+.|-+..... ...+|+|.+.... .........|+.+-+.+. |.|++++++...+.+..++++
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 46667789999999998885533 3456777665443 233344556888888886 999999999999999999999
Q ss_pred EecCCCchhhcc-ccCCCCcchHHHHHHHHHHHHhhhchhc-ccCCCceeecCCCCCcEEeCCCC-cEEEeecccccccC
Q 046750 436 EFVPNNNLEHHL-HGKGQPVLEWTKRVKIALGAAKGLAYLH-EDCHPKIIHRDIKSANILVDDEF-EAQVADFGLAKLND 512 (723)
Q Consensus 436 E~~~~gsL~~~l-~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~g~~~ivHrDIkp~NILl~~~~-~vkL~DFGla~~~~ 512 (723)
+|..++++.+.+ +... ........-.++.|+..+|.|+| .. .+.||||||+|.+++..+ .+++.|||+|..+.
T Consensus 101 ~~s~g~~~f~~i~~~~~-~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHPDS-TGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred CcccccccccccccCCc-cCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 999999999888 4332 13455566778899999999999 77 599999999999999999 99999999998766
Q ss_pred C--CCcceeecccc-cccccChhhhccC-CCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcC
Q 046750 513 T--TQTHVSTRVMG-TFGYLAPEYASSG-KLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETG 588 (723)
Q Consensus 513 ~--~~~~~~~~~~g-t~~y~APE~~~~~-~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~ 588 (723)
. .........+| ++.|+|||...+. ......|+||+|+++.-+++|..|++...... ..+..|.... +
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~-~~~~~~~~~~-------~ 248 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD-GRYSSWKSNK-------G 248 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc-ccceeecccc-------c
Confidence 5 22233344578 9999999998874 45678999999999999999999998655422 2223332110 0
Q ss_pred CcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 046750 589 DLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVR 633 (723)
Q Consensus 589 ~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~ 633 (723)
.+. ............++..+++..++..|.+.+++..
T Consensus 249 ~~~--------~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 249 RFT--------QLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ccc--------cCccccCChhhhhcccccccCCchhccccccccc
Confidence 100 0111111224566777888899999999887754
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.51 E-value=5.8e-14 Score=157.04 Aligned_cols=140 Identities=24% Similarity=0.260 Sum_probs=100.2
Q ss_pred eEEeccCcEEEEEEEcCCCcEEEEEEcccCCchh----------------------------------------HHHHHH
Q 046750 366 NVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQG----------------------------------------EREFRA 405 (723)
Q Consensus 366 ~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~----------------------------------------~~~~~~ 405 (723)
+.||.|++|.||+|++++|+.||||+.+...... +-+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 6799999999999999999999999986542110 013555
Q ss_pred HHHHHHHcc----CCceeeEeeeeec-ccceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHh-hhchhcccCC
Q 046750 406 EVEIISRVH----HRHLVSLVGYCIS-EKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAK-GLAYLHEDCH 479 (723)
Q Consensus 406 Ei~il~~l~----HpnIv~l~g~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~-gL~yLH~~g~ 479 (723)
|++.+.+++ |.+-+.+-.+|.+ ....+|||||++|++|.+++..... .+ .+.+++..+++ .+..+|..
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~---~~~~ia~~~~~~~l~ql~~~-- 276 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GL---DRKALAENLARSFLNQVLRD-- 276 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CC---CHHHHHHHHHHHHHHHHHhC--
Confidence 666666652 3333443333332 3457999999999999887643211 11 23455666655 46788888
Q ss_pred CceeecCCCCCcEEeCCCCcEEEeecccccccC
Q 046750 480 PKIIHRDIKSANILVDDEFEAQVADFGLAKLND 512 (723)
Q Consensus 480 ~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 512 (723)
+++|+|+||.||+++++++++|+|||++..+.
T Consensus 277 -g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 -GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred -CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 49999999999999999999999999987554
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.47 E-value=7.5e-14 Score=154.54 Aligned_cols=247 Identities=22% Similarity=0.240 Sum_probs=180.1
Q ss_pred cCcccceEEec--cCcEEEEEEEc---CCCcEEEEEEcccCCc--hhHHHHHHHHHHHHHc-cCCceeeEeeeeecccce
Q 046750 360 NGFARENVIGE--GGFGCVYKGNL---PEGKVVAVKQLKSGSG--QGEREFRAEVEIISRV-HHRHLVSLVGYCISEKNR 431 (723)
Q Consensus 360 ~~f~~~~~LG~--G~fG~Vy~~~~---~~g~~VAvK~l~~~~~--~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~ 431 (723)
..|.+...+|. |.||.||.+.. .++..+|+|.-+.... .....=.+|+.-.+++ .|.|.++.+..+...+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 34677788999 99999999955 5678899988443222 2222334577777777 499999988888888888
Q ss_pred EEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHh----hhchhcccCCCceeecCCCCCcEEeCCC-CcEEEeecc
Q 046750 432 LLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAK----GLAYLHEDCHPKIIHRDIKSANILVDDE-FEAQVADFG 506 (723)
Q Consensus 432 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~g~~~ivHrDIkp~NILl~~~-~~vkL~DFG 506 (723)
++-.|++ +.+|..+.+.... .+....++.+..++.. ||.++|.. .|+|-|+|+.||++..+ ..++++|||
T Consensus 194 fiqtE~~-~~sl~~~~~~~~~-~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 194 FIQTELC-GESLQSYCHTPCN-FLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred eeeeccc-cchhHHhhhcccc-cCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCcc
Confidence 8888988 6889988876543 3566677778888888 99999998 69999999999999999 889999999
Q ss_pred cccccCCCCcce----eecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhh
Q 046750 507 LAKLNDTTQTHV----STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLV 582 (723)
Q Consensus 507 la~~~~~~~~~~----~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~ 582 (723)
+...+.+..... ..+..|...|++||.+. +-++.+.|+|+||.+++|.++|........ ...|.. +
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~------~~~W~~--~- 338 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGK------NSSWSQ--L- 338 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCC------CCCccc--c-
Confidence 998877665332 22336888999999875 568899999999999999999876553321 112321 0
Q ss_pred hhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHH
Q 046750 583 RAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVV 632 (723)
Q Consensus 583 ~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl 632 (723)
+.+. +..+|......++..++..+++.++..|++...++
T Consensus 339 ---r~~~--------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 339 ---RQGY--------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred ---cccc--------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence 0100 11112212222445578889999999998877654
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.45 E-value=6.8e-13 Score=148.14 Aligned_cols=167 Identities=19% Similarity=0.268 Sum_probs=128.0
Q ss_pred EcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEecCCCchhhccccCCCCcchHHH
Q 046750 380 NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTK 459 (723)
Q Consensus 380 ~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~ 459 (723)
+..++..|.|+..+..........++.++.|+.|+||||++|+..++.+...|||.|.+. .|..+|.+.+ ...
T Consensus 33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~-----~~~ 105 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG-----KEE 105 (690)
T ss_pred eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH-----HHH
Confidence 556788888888877655444567889999999999999999999999999999999883 4666665433 334
Q ss_pred HHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcceeecccccccccChhhhccCCC
Q 046750 460 RVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKL 539 (723)
Q Consensus 460 ~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~ 539 (723)
....++||++||.|||+.| +++|++|.-.-|+|+..|+.||++|.++........ ......---.|..|+.+....
T Consensus 106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~- 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE- 181 (690)
T ss_pred HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc-
Confidence 4556789999999999888 899999999999999999999999998864432221 001111223467777654333
Q ss_pred CCccceechHHHHHHHHhC
Q 046750 540 TDRSDVFSFGVVLLELITG 558 (723)
Q Consensus 540 t~ksDVwSlGviL~eLltG 558 (723)
...|.|-|||+++|++.|
T Consensus 182 -~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 -WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred -cchhhhhHHHHHHHHhCc
Confidence 345999999999999999
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.43 E-value=5.6e-13 Score=129.43 Aligned_cols=130 Identities=19% Similarity=0.126 Sum_probs=97.7
Q ss_pred ceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCcee-eEeeeeecccceEEEEEecCCCch
Q 046750 365 ENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLV-SLVGYCISEKNRLLIYEFVPNNNL 443 (723)
Q Consensus 365 ~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv-~l~g~~~~~~~~~lV~E~~~~gsL 443 (723)
.+.|+.|.++.||++.. .++.|+||+...... ....+.+|+++++.+.+.+++ +++.++ ....++||||+++..+
T Consensus 3 ~~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEE-CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 36789999999999987 477899999865432 233578899999999765544 455443 3346899999999888
Q ss_pred hhccccCCCCcchHHHHHHHHHHHHhhhchhcccC--CCceeecCCCCCcEEeCCCCcEEEeeccccc
Q 046750 444 EHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDC--HPKIIHRDIKSANILVDDEFEAQVADFGLAK 509 (723)
Q Consensus 444 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g--~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 509 (723)
.... . ....++.+++++|+.||..+ ...++|+|+++.||+++ ++.++|+|||.+.
T Consensus 79 ~~~~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 79 LTED-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cccc-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 6541 0 11235678899999999984 22369999999999999 5689999999975
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.36 E-value=8.9e-13 Score=149.46 Aligned_cols=144 Identities=17% Similarity=0.183 Sum_probs=95.5
Q ss_pred hcCcccceEEeccCcEEEEEEEcCC-CcEEEEEEcccCCch----------------------------------hH---
Q 046750 359 TNGFARENVIGEGGFGCVYKGNLPE-GKVVAVKQLKSGSGQ----------------------------------GE--- 400 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~VAvK~l~~~~~~----------------------------------~~--- 400 (723)
...|+. +.||.|++|.||+|++++ |+.||||+++..... ..
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 445666 789999999999999887 999999999754210 01
Q ss_pred ---HHHHHHHHHHHHcc----CCceeeEeeeeec-ccceEEEEEecCCCchhhc--cccCCC--CcchHHHHHHHHHHHH
Q 046750 401 ---REFRAEVEIISRVH----HRHLVSLVGYCIS-EKNRLLIYEFVPNNNLEHH--LHGKGQ--PVLEWTKRVKIALGAA 468 (723)
Q Consensus 401 ---~~~~~Ei~il~~l~----HpnIv~l~g~~~~-~~~~~lV~E~~~~gsL~~~--l~~~~~--~~l~~~~~~~i~~~ia 468 (723)
-+|.+|+..+.+++ +.+.+.+-.++++ ....+|||||+.|+.|.++ +...+. ..+.......++.||
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi- 276 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV- 276 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-
Confidence 12444555555552 3444444444433 3456899999999999774 322221 112222233333333
Q ss_pred hhhchhcccCCCceeecCCCCCcEEeCCCC----cEEEeecccccccCC
Q 046750 469 KGLAYLHEDCHPKIIHRDIKSANILVDDEF----EAQVADFGLAKLNDT 513 (723)
Q Consensus 469 ~gL~yLH~~g~~~ivHrDIkp~NILl~~~~----~vkL~DFGla~~~~~ 513 (723)
+.. +++|+|+||.|||++.++ +++++|||+...+..
T Consensus 277 ------f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 ------FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ------HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 345 599999999999999888 999999999876543
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.3e-12 Score=133.96 Aligned_cols=154 Identities=21% Similarity=0.327 Sum_probs=115.1
Q ss_pred HHHHHHHccCCceeeEeeeeeccc-----ceEEEEEecCCCchhhccccC--CCCcchHHHHHHHHHHHHhhhchhcccC
Q 046750 406 EVEIISRVHHRHLVSLVGYCISEK-----NRLLIYEFVPNNNLEHHLHGK--GQPVLEWTKRVKIALGAAKGLAYLHEDC 478 (723)
Q Consensus 406 Ei~il~~l~HpnIv~l~g~~~~~~-----~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~g 478 (723)
-++-|-.+.|-|||+++.|+.+.+ ...++.|||.-|+|..+|++. ....+....+.+|+.||+.||.|||+.
T Consensus 117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~- 195 (458)
T KOG1266|consen 117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC- 195 (458)
T ss_pred HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-
Confidence 344555667999999999886543 367899999999999999763 234577778889999999999999995
Q ss_pred CCceeecCCCCCcEEeCCCCcEEEeecccccccC---CCCcceeecccccccccChhhhccCCCCCccceechHHHHHHH
Q 046750 479 HPKIIHRDIKSANILVDDEFEAQVADFGLAKLND---TTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLEL 555 (723)
Q Consensus 479 ~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~---~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eL 555 (723)
.+.|+|+++..+-|++..++-+||.---...... .........-.+-.+|.+||+=..-..+..+|||+||.+.+||
T Consensus 196 ~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 196 DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred CCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 7899999999999999999888874221111000 0000111112356789999987766778899999999999999
Q ss_pred HhCCC
Q 046750 556 ITGRK 560 (723)
Q Consensus 556 ltG~~ 560 (723)
.-|..
T Consensus 276 ailEi 280 (458)
T KOG1266|consen 276 AILEI 280 (458)
T ss_pred HHhee
Confidence 88764
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.31 E-value=1.2e-12 Score=145.03 Aligned_cols=250 Identities=19% Similarity=0.228 Sum_probs=178.5
Q ss_pred HHHHhcCcccceEEeccCcEEEEEEEc--CCCcEEEEEEcccCCchhHHHH--HHHHHHHHHc-cCCceeeEeeeeeccc
Q 046750 355 LMEITNGFARENVIGEGGFGCVYKGNL--PEGKVVAVKQLKSGSGQGEREF--RAEVEIISRV-HHRHLVSLVGYCISEK 429 (723)
Q Consensus 355 l~~~~~~f~~~~~LG~G~fG~Vy~~~~--~~g~~VAvK~l~~~~~~~~~~~--~~Ei~il~~l-~HpnIv~l~g~~~~~~ 429 (723)
.......|..+..||.|.|+.||+... .++..|++|.+.+.......++ ..|+.+...+ .|.|+++++..+....
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence 334456788899999999999999843 4578899999887644433333 3577777777 4889999888777777
Q ss_pred ceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCC-CcEEEeecccc
Q 046750 430 NRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDE-FEAQVADFGLA 508 (723)
Q Consensus 430 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~-~~vkL~DFGla 508 (723)
..|+-.|||+++++...+. -...++...++++..+++.+|.++|+. .++|+|+|++||++.++ +..++.|||++
T Consensus 340 ~~~ip~e~~~~~s~~l~~~--~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~ 414 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSV--TSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCW 414 (524)
T ss_pred cccCchhhhcCcchhhhhH--HHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccc
Confidence 8889999999998877662 233477888999999999999999998 59999999999999886 88999999998
Q ss_pred cccCCCCcceeecccccccc-cChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhc
Q 046750 509 KLNDTTQTHVSTRVMGTFGY-LAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIET 587 (723)
Q Consensus 509 ~~~~~~~~~~~~~~~gt~~y-~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~ 587 (723)
..+. .........+..| .+++.+....+..+.|+|+||+-+.|.++|...-. +.+.|.. +..
T Consensus 415 t~~~---~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~--------~~~~~~~------i~~ 477 (524)
T KOG0601|consen 415 TRLA---FSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSE--------SGVQSLT------IRS 477 (524)
T ss_pred cccc---eecccccccccccccchhhccccccccccccccccccccccccCcccCc--------cccccee------eec
Confidence 6321 1111111123334 35566666778999999999999999999865321 2222321 222
Q ss_pred CCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 046750 588 GDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALD 636 (723)
Q Consensus 588 ~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~ 636 (723)
|.+..+ . .....+..++..++..++..|+.+.++....+
T Consensus 478 ~~~p~~-----~-----~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 478 GDTPNL-----P-----GLKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred ccccCC-----C-----chHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 222111 1 11135667778899999999998887765543
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.30 E-value=2e-11 Score=123.53 Aligned_cols=142 Identities=20% Similarity=0.284 Sum_probs=109.5
Q ss_pred eEEeccCcEEEEEEEcCCCcEEEEEEcccCCc-hhHHHHHHHHHHHHHccCC--ceeeEeeeeeccc---ceEEEEEecC
Q 046750 366 NVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSG-QGEREFRAEVEIISRVHHR--HLVSLVGYCISEK---NRLLIYEFVP 439 (723)
Q Consensus 366 ~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~-~~~~~~~~Ei~il~~l~Hp--nIv~l~g~~~~~~---~~~lV~E~~~ 439 (723)
+.|+.|.++.||++...+|+.++||+...... ....++..|+++++.|++. ++.+++.++.... ..++||||+.
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 67899999999999887778999999865432 2345789999999999764 4567777766542 5689999999
Q ss_pred CCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccC-----------------------------------------
Q 046750 440 NNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDC----------------------------------------- 478 (723)
Q Consensus 440 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g----------------------------------------- 478 (723)
|.+|.+.+.. ..++...+..++.++++.|.+||+..
T Consensus 84 G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 84 GRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 9988876642 13566667777888888888887521
Q ss_pred ------------CCceeecCCCCCcEEeCC--CCcEEEeecccccc
Q 046750 479 ------------HPKIIHRDIKSANILVDD--EFEAQVADFGLAKL 510 (723)
Q Consensus 479 ------------~~~ivHrDIkp~NILl~~--~~~vkL~DFGla~~ 510 (723)
...++|+|+++.|||++. ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 235799999999999998 66789999998863
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.25 E-value=5.5e-11 Score=118.05 Aligned_cols=136 Identities=18% Similarity=0.185 Sum_probs=97.2
Q ss_pred eEEeccCcEEEEEEEcCC-------CcEEEEEEcccCC----------------------chhHHHHH----HHHHHHHH
Q 046750 366 NVIGEGGFGCVYKGNLPE-------GKVVAVKQLKSGS----------------------GQGEREFR----AEVEIISR 412 (723)
Q Consensus 366 ~~LG~G~fG~Vy~~~~~~-------g~~VAvK~l~~~~----------------------~~~~~~~~----~Ei~il~~ 412 (723)
..||.|--+.||.|...+ +..||||+.+-.. ....+.+. +|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 568999999999996543 4799999974310 00122333 79999999
Q ss_pred ccC--CceeeEeeeeecccceEEEEEecCCCchhh-ccccCCCCcchHHHHHHHHHHHHhhhchh-cccCCCceeecCCC
Q 046750 413 VHH--RHLVSLVGYCISEKNRLLIYEFVPNNNLEH-HLHGKGQPVLEWTKRVKIALGAAKGLAYL-HEDCHPKIIHRDIK 488 (723)
Q Consensus 413 l~H--pnIv~l~g~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~g~~~ivHrDIk 488 (723)
|.. -++.+++++ ...+|||||+.++.+.. .|.+. .+.......+..+++.+|.+| |+. +||||||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~---~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDLs 152 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA---KLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADLS 152 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc---ccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCCC
Confidence 954 355566654 46789999997654422 22221 234445667788999999999 777 59999999
Q ss_pred CCcEEeCCCCcEEEeecccccccC
Q 046750 489 SANILVDDEFEAQVADFGLAKLND 512 (723)
Q Consensus 489 p~NILl~~~~~vkL~DFGla~~~~ 512 (723)
+.|||+++ +.++|+|||.+....
T Consensus 153 ~~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 153 EYNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred HHHEEEEC-CcEEEEECCCceeCC
Confidence 99999974 589999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.22 E-value=6.6e-11 Score=113.27 Aligned_cols=143 Identities=18% Similarity=0.287 Sum_probs=106.4
Q ss_pred cceEEeccCcEEEEEEEcCCCcEEEEEEcccCC--------chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEE
Q 046750 364 RENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGS--------GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 364 ~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~--------~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 435 (723)
...+|-||+-+.|+++.+ .|+.++||.-.... ....+..++|+++|.+++--.|.--.-++.+.....|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 568999999999999988 67777777643221 112346778999999997555554444566777789999
Q ss_pred EecCC-CchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCC---CcEEEeecccccc
Q 046750 436 EFVPN-NNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDE---FEAQVADFGLAKL 510 (723)
Q Consensus 436 E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~---~~vkL~DFGla~~ 510 (723)
||+++ .++.+++...............++..|=+.|.-||.. .|||+||..+||||..+ ..+.|+||||+..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99966 3778887654333333334467888888899999998 59999999999999654 3468999999853
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.13 E-value=3.1e-10 Score=109.29 Aligned_cols=131 Identities=21% Similarity=0.356 Sum_probs=98.5
Q ss_pred eEEeccCcEEEEEEEcCCCcEEEEEEcccCCc---h-----hHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEe
Q 046750 366 NVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSG---Q-----GEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEF 437 (723)
Q Consensus 366 ~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~---~-----~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 437 (723)
.+|++|+-..+|.+.+. |..+++|.-..+.. + ..+...+|+.+|.+++--.|.--+-|+.+.....|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 46789999999999774 44466775432211 1 112456799999999765555555566677788999999
Q ss_pred cCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccc
Q 046750 438 VPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKL 510 (723)
Q Consensus 438 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 510 (723)
++|..|.++|... ...++..|=.-+.-||..| |||+||..+||+|.... +.++||||+.+
T Consensus 81 I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA---------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888654 2455666666778899995 99999999999999874 99999999874
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.12 E-value=2.1e-11 Score=141.46 Aligned_cols=248 Identities=19% Similarity=0.246 Sum_probs=169.4
Q ss_pred hcCcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCC---chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEE
Q 046750 359 TNGFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGS---GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLI 434 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 434 (723)
.+.|.+.+-+-.|.|+.++.+.-. .|...++|.+.... ....+..+.+-.++-..+||.+++.+.-+.-....+||
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~ 882 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV 882 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence 356777788889999999987432 34444555443321 12223344454555455677777776665667778999
Q ss_pred EEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCC
Q 046750 435 YEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTT 514 (723)
Q Consensus 435 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 514 (723)
++|+.+++|...||..+ .++.......+..+...++|||.. .++|||+++.|+|+..++..++.|||+.......
T Consensus 883 ~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~ 957 (1205)
T KOG0606|consen 883 GHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI 957 (1205)
T ss_pred hHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccccc
Confidence 99999999999998765 234334444556678899999997 5899999999999999999999999843211100
Q ss_pred ---------------------C---------cceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCC
Q 046750 515 ---------------------Q---------THVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDP 564 (723)
Q Consensus 515 ---------------------~---------~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~ 564 (723)
. ......+.||..|++||.+.+......+|.|++|++|+|.++|..||+.
T Consensus 958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen 958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence 0 0112345789999999999999999999999999999999999999987
Q ss_pred CCCCCchhhHHhhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHH
Q 046750 565 TQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMV 629 (723)
Q Consensus 565 ~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 629 (723)
..... +++.+..+++.- ..........+.+++.+.+..++.+|-.|.
T Consensus 1038 ~tpq~-----------~f~ni~~~~~~~-------p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1038 ETPQQ-----------IFENILNRDIPW-------PEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred cchhh-----------hhhccccCCCCC-------CCCccccChhhhhhhhhhhccCchhccCcc
Confidence 65421 112222221100 011111222456677788889999888766
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.12 E-value=8.7e-10 Score=119.92 Aligned_cols=167 Identities=18% Similarity=0.276 Sum_probs=126.2
Q ss_pred EEEEEE-EcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeee----cccceEEEEEecCCC-chhhcc
Q 046750 374 GCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCI----SEKNRLLIYEFVPNN-NLEHHL 447 (723)
Q Consensus 374 G~Vy~~-~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~----~~~~~~lV~E~~~~g-sL~~~l 447 (723)
.+.||+ ...||..|++|+++....+.......-+++++++.|.|||.|.++|. .+..++|||+|+++. +|.++.
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 377888 55689999999996544343334455689999999999999999887 344578999999875 565543
Q ss_pred ccC-------------CCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCC
Q 046750 448 HGK-------------GQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTT 514 (723)
Q Consensus 448 ~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 514 (723)
... ....+.+..+|.++.|+..||.++|+.| +.-+-|.+.+||++.+.+++|...|+......+
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 211 1234677899999999999999999995 888999999999999999999988887655443
Q ss_pred CcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCC
Q 046750 515 QTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKP 561 (723)
Q Consensus 515 ~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P 561 (723)
.. |-+.. ..+-|.-.||++|+.|.+|..-
T Consensus 447 ~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 447 PT---------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CC---------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 31 11111 1256888999999999999653
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.7e-09 Score=113.15 Aligned_cols=140 Identities=18% Similarity=0.101 Sum_probs=101.2
Q ss_pred eEEeccCcEEEEEEEcCCCcEEEEEEcccCCch-----------hHHHHHHHHHHHHHccCCc--eeeEeeeeec-----
Q 046750 366 NVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQ-----------GEREFRAEVEIISRVHHRH--LVSLVGYCIS----- 427 (723)
Q Consensus 366 ~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~-----------~~~~~~~Ei~il~~l~Hpn--Iv~l~g~~~~----- 427 (723)
+++-+.....|++..+ +|+.|.||+....... ....+.+|++.+.+|...+ +..++++++.
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 4555555556778766 6788999977443211 1124789999999995433 3445555543
Q ss_pred ccceEEEEEecCCC-chhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCC-------CCc
Q 046750 428 EKNRLLIYEFVPNN-NLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDD-------EFE 499 (723)
Q Consensus 428 ~~~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~-------~~~ 499 (723)
....+||+|++++. +|.+++........+...+..++.+|+..+.-||..| |+|+||+++||||+. +..
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCce
Confidence 23468999999876 7888875322223445667789999999999999995 999999999999985 578
Q ss_pred EEEeeccccc
Q 046750 500 AQVADFGLAK 509 (723)
Q Consensus 500 vkL~DFGla~ 509 (723)
+.|+||+.++
T Consensus 184 ~~LIDl~r~~ 193 (268)
T PRK15123 184 LSVIDLHRAQ 193 (268)
T ss_pred EEEEECCccc
Confidence 9999999885
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.01 E-value=2.7e-09 Score=105.59 Aligned_cols=126 Identities=24% Similarity=0.314 Sum_probs=82.5
Q ss_pred EEEEEEcCCCcEEEEEEcccCC-------------ch-------------hHHHHHHHHHHHHHccCC--ceeeEeeeee
Q 046750 375 CVYKGNLPEGKVVAVKQLKSGS-------------GQ-------------GEREFRAEVEIISRVHHR--HLVSLVGYCI 426 (723)
Q Consensus 375 ~Vy~~~~~~g~~VAvK~l~~~~-------------~~-------------~~~~~~~Ei~il~~l~Hp--nIv~l~g~~~ 426 (723)
.||.|...+|..||||+.+... .. .....++|++.|.++..- ++.+++++
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 4899988899999999975320 00 112456799999999765 45566644
Q ss_pred cccceEEEEEecC--CCchhhccccCCCCcchHHHHHHHHHHHHhhhch-hcccCCCceeecCCCCCcEEeCCCCcEEEe
Q 046750 427 SEKNRLLIYEFVP--NNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAY-LHEDCHPKIIHRDIKSANILVDDEFEAQVA 503 (723)
Q Consensus 427 ~~~~~~lV~E~~~--~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~y-LH~~g~~~ivHrDIkp~NILl~~~~~vkL~ 503 (723)
...+|||||+. |..|..+.... +.......++.+++..+.. ||.. +|||+||...|||++++ .+.|+
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE-
T ss_pred --eCCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEEE
Confidence 24589999998 55554433221 1234455677777775555 5677 59999999999999988 99999
Q ss_pred ecccccccC
Q 046750 504 DFGLAKLND 512 (723)
Q Consensus 504 DFGla~~~~ 512 (723)
|||.+....
T Consensus 149 Df~qav~~~ 157 (188)
T PF01163_consen 149 DFGQAVDSS 157 (188)
T ss_dssp -GTTEEETT
T ss_pred ecCcceecC
Confidence 999987543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.00 E-value=3.4e-09 Score=112.59 Aligned_cols=262 Identities=19% Similarity=0.198 Sum_probs=160.2
Q ss_pred ccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHc-cCCceeeEeeee------ecc-cceEEE
Q 046750 363 ARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRV-HHRHLVSLVGYC------ISE-KNRLLI 434 (723)
Q Consensus 363 ~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~------~~~-~~~~lV 434 (723)
.....||+|+.+.+|-.-. -+..+.|+.+.-..-...+. +..|... .|+-+..-+.+= -+. ....++
T Consensus 14 ~~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCCccccCCccceeeecch--hhchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 4557899999999997521 12233465554332222222 2333333 455443311111 111 225677
Q ss_pred EEecCCCc-hhhccc----cCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeeccccc
Q 046750 435 YEFVPNNN-LEHHLH----GKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK 509 (723)
Q Consensus 435 ~E~~~~gs-L~~~l~----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 509 (723)
|..+.+.. +..++. ++.-...+|.-.++++..|+.+.+-||+.| .+-+|++.+|||+.+++.|.|+|-+...
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEccccee
Confidence 77776542 222221 223355899999999999999999999996 8899999999999999999999977655
Q ss_pred ccCCCCcceeecccccccccChhhhc-----cCCCCCccceechHHHHHHHHhC-CCCCCCCCCCCchhhHHhhhhhhhh
Q 046750 510 LNDTTQTHVSTRVMGTFGYLAPEYAS-----SGKLTDRSDVFSFGVVLLELITG-RKPVDPTQPLGDESLVEWARPVLVR 583 (723)
Q Consensus 510 ~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~t~ksDVwSlGviL~eLltG-~~P~~~~~~~~~~~l~~~~~~~l~~ 583 (723)
+...+.. ..--+|...|.+||.-. +..-+...|.|.|||+|++||.| ++||.+.....+. -.-+.-
T Consensus 166 i~~ng~~--~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~a------p~p~E~ 237 (637)
T COG4248 166 INANGTL--HLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDA------PNPLET 237 (637)
T ss_pred eccCCce--EecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCC------CCcchh
Confidence 4432222 22346889999999654 44567789999999999999996 9999764332111 011112
Q ss_pred hhhcCCcccccchhhhc-----cccHHH-HHHHHHHHHHHhccC--CCCCCCHHHHHHHHhccCC
Q 046750 584 AIETGDLSEIVDPRLEK-----HYVESE-MFRMIEAAAACVRHS--GPKRPRMVQVVRALDSEGE 640 (723)
Q Consensus 584 ~i~~~~l~~~vd~~l~~-----~~~~~~-~~~l~~l~~~cl~~d--P~~RPs~~eVl~~L~~~~~ 640 (723)
.|..|.|..--|.+-.. .+.... .-.+..|..+|+... +.-||+.+.++..|..+.+
T Consensus 238 ~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~ 302 (637)
T COG4248 238 DIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQ 302 (637)
T ss_pred hhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHH
Confidence 33344433333322111 111111 123445666787764 5689999999988866543
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.87 E-value=5.1e-10 Score=125.91 Aligned_cols=149 Identities=21% Similarity=0.305 Sum_probs=104.0
Q ss_pred HHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcce--------eecccccccccChhhhcc
Q 046750 465 LGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHV--------STRVMGTFGYLAPEYASS 536 (723)
Q Consensus 465 ~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~--------~~~~~gt~~y~APE~~~~ 536 (723)
.+++.||.|||+.. ++||++|.|++|.++.++.+||+.|+++........+. .--..-...|.|||++.+
T Consensus 106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 45569999999986 89999999999999999999999999986544311111 111234678999999999
Q ss_pred CCCCCccceechHHHHHHHHhC-CCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHH
Q 046750 537 GKLTDRSDVFSFGVVLLELITG-RKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAA 615 (723)
Q Consensus 537 ~~~t~ksDVwSlGviL~eLltG-~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~ 615 (723)
...+.++|+|||||++|-+..| +.-++....... .. .+ ...+..-...+......++.+-+.
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~---~~---------~~-----~~~~~~~~~~~s~~~p~el~~~l~ 246 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS---YS---------FS-----RNLLNAGAFGYSNNLPSELRESLK 246 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcch---hh---------hh-----hcccccccccccccCcHHHHHHHH
Confidence 8899999999999999999954 444443322110 00 00 000101111223344557888888
Q ss_pred HHhccCCCCCCCHHHHH
Q 046750 616 ACVRHSGPKRPRMVQVV 632 (723)
Q Consensus 616 ~cl~~dP~~RPs~~eVl 632 (723)
+++..+...||++.++.
T Consensus 247 k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 247 KLLNGDSAVRPTLDLLL 263 (700)
T ss_pred HHhcCCcccCcchhhhh
Confidence 99999999999888774
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.79 E-value=5.1e-08 Score=97.24 Aligned_cols=137 Identities=17% Similarity=0.126 Sum_probs=102.0
Q ss_pred EeccCcEEEEEEEcCCCcEEEEEEcccCC------chhHHHHHHHHHHHHHccCCc--eeeEeeeeecc-----cceEEE
Q 046750 368 IGEGGFGCVYKGNLPEGKVVAVKQLKSGS------GQGEREFRAEVEIISRVHHRH--LVSLVGYCISE-----KNRLLI 434 (723)
Q Consensus 368 LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~------~~~~~~~~~Ei~il~~l~Hpn--Iv~l~g~~~~~-----~~~~lV 434 (723)
-|+||-+.|++..+ +|+.+-||+-.... ......|.+|+..|.+|..-+ +.+++ ++... ..-+||
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 36789999999877 44478888865221 235668999999999996432 44444 33211 124789
Q ss_pred EEecCC-CchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCc--EEEeeccccc
Q 046750 435 YEFVPN-NNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFE--AQVADFGLAK 509 (723)
Q Consensus 435 ~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~--vkL~DFGla~ 509 (723)
.|.+.+ -+|.+++.+......+...+..++.+|+..|+-||..| +.|+|+.+.|||++.++. ++++||.-++
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 998754 47888886654434567778899999999999999995 999999999999986556 9999998765
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.78 E-value=3.6e-08 Score=100.54 Aligned_cols=135 Identities=21% Similarity=0.200 Sum_probs=96.4
Q ss_pred cccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCc----------------------hhHHHHHHHHHHHHHccCC--c
Q 046750 362 FARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSG----------------------QGEREFRAEVEIISRVHHR--H 417 (723)
Q Consensus 362 f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~----------------------~~~~~~~~Ei~il~~l~Hp--n 417 (723)
..+.+.||-|--+.||.|...+|..+|||.-+.... ......++|+++|.+|.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 456789999999999999999999999998643210 0112456799999999654 5
Q ss_pred eeeEeeeeecccceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCC
Q 046750 418 LVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDE 497 (723)
Q Consensus 418 Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~ 497 (723)
|.+.++ .+...+||||++|-.|...-. +....-.|+..|++-+..+-.. +|||+|+..-|||+++|
T Consensus 173 VP~P~~----~nRHaVvMe~ieG~eL~~~r~-------~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~d 238 (304)
T COG0478 173 VPKPIA----WNRHAVVMEYIEGVELYRLRL-------DVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTED 238 (304)
T ss_pred CCCccc----cccceeeeehcccceeecccC-------cccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEecC
Confidence 666554 355689999998877765431 1112223334444444444444 49999999999999999
Q ss_pred CcEEEeecccccc
Q 046750 498 FEAQVADFGLAKL 510 (723)
Q Consensus 498 ~~vkL~DFGla~~ 510 (723)
|.++|+||=.+..
T Consensus 239 g~~~vIDwPQ~v~ 251 (304)
T COG0478 239 GDIVVIDWPQAVP 251 (304)
T ss_pred CCEEEEeCccccc
Confidence 9999999987753
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.75 E-value=3.7e-08 Score=99.37 Aligned_cols=106 Identities=25% Similarity=0.318 Sum_probs=83.3
Q ss_pred HHHHHHHHHHHHHccCC--ceeeEeeeeeccc----ceEEEEEecCCC-chhhccccCCCCcchHHHHHHHHHHHHhhhc
Q 046750 400 EREFRAEVEIISRVHHR--HLVSLVGYCISEK----NRLLIYEFVPNN-NLEHHLHGKGQPVLEWTKRVKIALGAAKGLA 472 (723)
Q Consensus 400 ~~~~~~Ei~il~~l~Hp--nIv~l~g~~~~~~----~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~ 472 (723)
.....+|+..+.+|... .+.+.+++..... ..+||+|++++. +|.+++..... ++......++.+++..++
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIA 132 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHH
Confidence 34678899999988543 3455666655432 347999999885 79988875332 455667889999999999
Q ss_pred hhcccCCCceeecCCCCCcEEeCCCC---cEEEeecccccc
Q 046750 473 YLHEDCHPKIIHRDIKSANILVDDEF---EAQVADFGLAKL 510 (723)
Q Consensus 473 yLH~~g~~~ivHrDIkp~NILl~~~~---~vkL~DFGla~~ 510 (723)
-||..| |+|+|+++.||||+.+. .+.|+||+.++.
T Consensus 133 ~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 133 KLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999995 99999999999999886 899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.73 E-value=2.4e-08 Score=112.88 Aligned_cols=140 Identities=22% Similarity=0.252 Sum_probs=92.7
Q ss_pred eEEeccCcEEEEEEEcCCCcEEEEEEcccCCch----------------------------------------hHHHHHH
Q 046750 366 NVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQ----------------------------------------GEREFRA 405 (723)
Q Consensus 366 ~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~----------------------------------------~~~~~~~ 405 (723)
+-|+.++-|.||+|++++|+.||||+.+.+-.. .+-+|.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 578999999999999999999999997643110 1123555
Q ss_pred HHHHHHHcc----CCceeeEeeeeec-ccceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhh-hchhcccCC
Q 046750 406 EVEIISRVH----HRHLVSLVGYCIS-EKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKG-LAYLHEDCH 479 (723)
Q Consensus 406 Ei~il~~l~----HpnIv~l~g~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~g-L~yLH~~g~ 479 (723)
|...+.+++ +..-+++=.+|++ ....+|+|||++|-.+.++..-.. ..++...+. ..++++ +..+-..
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia---~~~~~~f~~q~~~d-- 284 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELA---ELLVRAFLRQLLRD-- 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHH---HHHHHHHHHHHHhc--
Confidence 666666552 2222333333443 356789999999999988742221 123433332 222222 2223234
Q ss_pred CceeecCCCCCcEEeCCCCcEEEeecccccccC
Q 046750 480 PKIIHRDIKSANILVDDEFEAQVADFGLAKLND 512 (723)
Q Consensus 480 ~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 512 (723)
+++|+|.+|.||+++.++++.+.|||+...+.
T Consensus 285 -gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 285 -GFFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred -CccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 49999999999999999999999999986554
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.64 E-value=2.9e-07 Score=94.23 Aligned_cols=138 Identities=17% Similarity=0.187 Sum_probs=86.1
Q ss_pred eEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCc--eeeEeeeeecccceEEEEEecCCCc-
Q 046750 366 NVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRH--LVSLVGYCISEKNRLLIYEFVPNNN- 442 (723)
Q Consensus 366 ~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~g~~~~~~~~~lV~E~~~~gs- 442 (723)
..||+|..+.||+. .+..+++|...... ....+.+|+++++.+..-. +.+.++++.+.+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 67899999999984 25567889887533 3345789999999996543 4677777777777889999998863
Q ss_pred hhhc---------------------cccCCCCcchHHHHHH-HHHH----------HHh-hhchhccc-CCCceeecCCC
Q 046750 443 LEHH---------------------LHGKGQPVLEWTKRVK-IALG----------AAK-GLAYLHED-CHPKIIHRDIK 488 (723)
Q Consensus 443 L~~~---------------------l~~~~~~~l~~~~~~~-i~~~----------ia~-gL~yLH~~-g~~~ivHrDIk 488 (723)
+... ||...........+.. +..+ +.. ...+|... ....++|+|++
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 2111 1211000001011000 0000 000 11112111 12357999999
Q ss_pred CCcEEeCCCCcEEEeeccccc
Q 046750 489 SANILVDDEFEAQVADFGLAK 509 (723)
Q Consensus 489 p~NILl~~~~~vkL~DFGla~ 509 (723)
+.||++++++ +.|+||+.+.
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCcEEEcCCC-cEEEechhcC
Confidence 9999999887 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.62 E-value=4.8e-07 Score=91.59 Aligned_cols=153 Identities=23% Similarity=0.317 Sum_probs=101.1
Q ss_pred cCHHHHHHHhcCcccceEEe---ccCcEEEEEEEcCCCcEEEEEEcccCCch-------------------hHHH-----
Q 046750 350 FTYEELMEITNGFARENVIG---EGGFGCVYKGNLPEGKVVAVKQLKSGSGQ-------------------GERE----- 402 (723)
Q Consensus 350 ~~~~~l~~~~~~f~~~~~LG---~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~-------------------~~~~----- 402 (723)
.+++.|..+..+..+..+.| .|--..||+|...++..||||+++..... ..++
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 45667777777777766655 45566999998888999999998643111 1111
Q ss_pred HHHHHHHHHHcc--CCceeeEeeeeecccceEEEEEecCCCch-hhccccCCCCcchHHHHHHHHHHHHhhhchhcccCC
Q 046750 403 FRAEVEIISRVH--HRHLVSLVGYCISEKNRLLIYEFVPNNNL-EHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCH 479 (723)
Q Consensus 403 ~~~Ei~il~~l~--HpnIv~l~g~~~~~~~~~lV~E~~~~gsL-~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~ 479 (723)
.++|+..|.++. +=.+.+-+++. +..|||||+...-+ .=.|.+-. +.......+..++++.+.-|-..+
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv~---~e~~e~~~~~~~~v~~~~~l~~~a- 186 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKDVP---LELEEAEGLYEDVVEYMRRLYKEA- 186 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcccCC---cCchhHHHHHHHHHHHHHHHHHhc-
Confidence 235777777764 22333444433 45799999955411 11222221 222245566677778888777644
Q ss_pred CceeecCCCCCcEEeCCCCcEEEeecccccccC
Q 046750 480 PKIIHRDIKSANILVDDEFEAQVADFGLAKLND 512 (723)
Q Consensus 480 ~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 512 (723)
++||+||..-|||+. ++.+.|+||+.+....
T Consensus 187 -~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 187 -GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred -CcccccchhhheEEE-CCeEEEEECccccccC
Confidence 699999999999999 7799999999997543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.55 E-value=5e-07 Score=90.58 Aligned_cols=137 Identities=15% Similarity=0.206 Sum_probs=95.4
Q ss_pred HhcCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHH---------HHHHHHHHHccC---CceeeEeeee
Q 046750 358 ITNGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREF---------RAEVEIISRVHH---RHLVSLVGYC 425 (723)
Q Consensus 358 ~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~---------~~Ei~il~~l~H---pnIv~l~g~~ 425 (723)
+.++|...+++-......|.+-+. +|+.+++|..+......++.| .+++..+.+++. -.++.++.++
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 356788888888888888888877 778999999877544433333 234555555532 2223322222
Q ss_pred e-----cccceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcE
Q 046750 426 I-----SEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEA 500 (723)
Q Consensus 426 ~-----~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~v 500 (723)
. .....+|||||++|..|.++.. ++. .++..|+++|.-||..| ++|+|+++.|+++.++ .+
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-~i 173 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-GI 173 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-cE
Confidence 2 1234568999999998877653 121 24455677889999995 9999999999999966 59
Q ss_pred EEeeccccc
Q 046750 501 QVADFGLAK 509 (723)
Q Consensus 501 kL~DFGla~ 509 (723)
+++||+..+
T Consensus 174 ~iID~~~k~ 182 (229)
T PF06176_consen 174 RIIDTQGKR 182 (229)
T ss_pred EEEECcccc
Confidence 999998765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.53 E-value=6.6e-07 Score=90.88 Aligned_cols=142 Identities=20% Similarity=0.311 Sum_probs=84.9
Q ss_pred ceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCC--ceeeEeeeeecc---cceEEEEEecC
Q 046750 365 ENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHR--HLVSLVGYCISE---KNRLLIYEFVP 439 (723)
Q Consensus 365 ~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~g~~~~~---~~~~lV~E~~~ 439 (723)
++.|+.|..+.||+....+ +.++||+.... .....+.+|+.+++.|... .+.+++.++... ...+++|+|+.
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 4689999999999998866 69999997654 4556788999999999543 345666644332 33689999999
Q ss_pred CCchhh----------------cc---ccC--C-CCcchHHH--------HHHH------------HHHHHh-hhchhcc
Q 046750 440 NNNLEH----------------HL---HGK--G-QPVLEWTK--------RVKI------------ALGAAK-GLAYLHE 476 (723)
Q Consensus 440 ~gsL~~----------------~l---~~~--~-~~~l~~~~--------~~~i------------~~~ia~-gL~yLH~ 476 (723)
+..+.. +| |.. . .....+.. .... ...+.+ .+..|+.
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 988777 11 111 0 00011000 0000 011111 2333332
Q ss_pred c----CCCceeecCCCCCcEEeC-CCCcEEEeeccccc
Q 046750 477 D----CHPKIIHRDIKSANILVD-DEFEAQVADFGLAK 509 (723)
Q Consensus 477 ~----g~~~ivHrDIkp~NILl~-~~~~vkL~DFGla~ 509 (723)
. ....++|+|+.+.|||++ +++.+-|+||+.+.
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 1 223599999999999999 66667899999875
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.43 E-value=5e-08 Score=108.81 Aligned_cols=181 Identities=19% Similarity=0.197 Sum_probs=131.0
Q ss_pred eEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCc-eeeEeeeeecccceEEEEEecCCC-ch
Q 046750 366 NVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRH-LVSLVGYCISEKNRLLIYEFVPNN-NL 443 (723)
Q Consensus 366 ~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~g~~~~~~~~~lV~E~~~~g-sL 443 (723)
+-+++|.++++||.+-...+.+.++++... ....-++++|.+++||| .+..++-+..+...+++++++.++ +.
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~ 322 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSS 322 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccc
Confidence 446889999999875433344445555432 45567899999999999 778888787788889999999887 22
Q ss_pred hhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcceeeccc
Q 046750 444 EHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVM 523 (723)
Q Consensus 444 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 523 (723)
..... .....+..-+...++..-+++|+|||+. .-+||| |||..+ ...|+.||+....+.... ......
T Consensus 323 ~~~~~-~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~t~~ 391 (829)
T KOG0576|consen 323 ALEMT-VSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPRTAI 391 (829)
T ss_pred cccCC-hhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc--ccccCC
Confidence 11111 1111233344456677778899999986 358999 887776 589999999887554433 234456
Q ss_pred ccccccChhhhccCCCCCccceechHHHHHHHHhCCCCC
Q 046750 524 GTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPV 562 (723)
Q Consensus 524 gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~ 562 (723)
++..|++||++..+.+..+-|+|++++--.+|--|..|-
T Consensus 392 ~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 392 GTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred CCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 899999999999999999999999998767776666553
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.39 E-value=2.4e-06 Score=88.30 Aligned_cols=139 Identities=20% Similarity=0.192 Sum_probs=85.7
Q ss_pred EEeccCc-EEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHcc-CCceeeEeeeeecccceEEEEEecCCCchh
Q 046750 367 VIGEGGF-GCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVH-HRHLVSLVGYCISEKNRLLIYEFVPNNNLE 444 (723)
Q Consensus 367 ~LG~G~f-G~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~ 444 (723)
.|-.|.+ ..||+.... +..++||+..... ..++.+|+++++.|. +--+.++++++...+..++||||++|..|.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 3455555 689999764 4788899886543 346788999999984 434557787777666679999999988775
Q ss_pred hcc-------------------ccCCCC--cch--HHHHHHHHHH--------------------HHhhhchhcc----c
Q 046750 445 HHL-------------------HGKGQP--VLE--WTKRVKIALG--------------------AAKGLAYLHE----D 477 (723)
Q Consensus 445 ~~l-------------------~~~~~~--~l~--~~~~~~i~~~--------------------ia~gL~yLH~----~ 477 (723)
... |..... .+. ...++..... +...+..|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 432 111000 000 0000000000 0011111111 1
Q ss_pred CCCceeecCCCCCcEEeCCCCcEEEeeccccc
Q 046750 478 CHPKIIHRDIKSANILVDDEFEAQVADFGLAK 509 (723)
Q Consensus 478 g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 509 (723)
..+.++|+|+.+.|||++++..+.|+||+.+.
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 12359999999999999998778899999875
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.34 E-value=1.8e-06 Score=97.43 Aligned_cols=141 Identities=23% Similarity=0.288 Sum_probs=90.4
Q ss_pred eEEeccCcEEEEEEEcCCCcEEEEEEcccCCch-------------------------------------hHHHHHHHHH
Q 046750 366 NVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQ-------------------------------------GEREFRAEVE 408 (723)
Q Consensus 366 ~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~-------------------------------------~~~~~~~Ei~ 408 (723)
+-||.-..|.||+|++++|+.||||+-+..-.. .+-+|..|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 578999999999999999999999996543110 1124555655
Q ss_pred HHHHc----cCCce---eeEeeeeec-ccceEEEEEecCCCchhhcc--ccCCCCcchHHHHHHHHHHHHhhhchhcccC
Q 046750 409 IISRV----HHRHL---VSLVGYCIS-EKNRLLIYEFVPNNNLEHHL--HGKGQPVLEWTKRVKIALGAAKGLAYLHEDC 478 (723)
Q Consensus 409 il~~l----~HpnI---v~l~g~~~~-~~~~~lV~E~~~~gsL~~~l--~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g 478 (723)
-.+++ +|-++ |.+=.++++ ....+|+||||+|.-+.+.. .+.+ ++... |+..+.++ |++..-
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~g---i~~~~---i~~~l~~~--~~~qIf 318 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRG---ISPHD---ILNKLVEA--YLEQIF 318 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcC---CCHHH---HHHHHHHH--HHHHHH
Confidence 55554 34451 222223333 24578999999999777653 3332 33333 33333332 222111
Q ss_pred CCceeecCCCCCcEEeC----CCCcEEEeecccccccCCC
Q 046750 479 HPKIIHRDIKSANILVD----DEFEAQVADFGLAKLNDTT 514 (723)
Q Consensus 479 ~~~ivHrDIkp~NILl~----~~~~vkL~DFGla~~~~~~ 514 (723)
..+++|+|-+|.|||++ .++++.|.|||+...+...
T Consensus 319 ~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 319 KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred hcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 12599999999999998 4788999999998765443
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.27 E-value=3.2e-06 Score=81.27 Aligned_cols=128 Identities=20% Similarity=0.296 Sum_probs=86.7
Q ss_pred ccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCcee-eEeeeeecccceEEEEEecCCC
Q 046750 363 ARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLV-SLVGYCISEKNRLLIYEFVPNN 441 (723)
Q Consensus 363 ~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv-~l~g~~~~~~~~~lV~E~~~~g 441 (723)
...+.|++|.+|.||+|.+ .|..+|+|+-+.+ .....|..|+++|..++--++- +++.|. ..++.|||+.|-
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~ 97 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEW-RGGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGR 97 (201)
T ss_pred hhhhhhhcccccEEEEeec-cCceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCc
Confidence 3457899999999999999 4558888887765 3346789999999999866654 344332 234559999888
Q ss_pred chhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCC-C-CcEEeCCCCcEEEeecccccc
Q 046750 442 NLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIK-S-ANILVDDEFEAQVADFGLAKL 510 (723)
Q Consensus 442 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIk-p-~NILl~~~~~vkL~DFGla~~ 510 (723)
.|.+..... +-++++ .+++.---|... +|-|+.|. + .||++.+ .++.|+||.-|..
T Consensus 98 ~L~~~~~~~-----~rk~l~----~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~-~~~~iIDFd~At~ 155 (201)
T COG2112 98 PLGKLEIGG-----DRKHLL----RVLEKAYKLDRL---GIEHGELSRPWKNVLVND-RDVYIIDFDSATF 155 (201)
T ss_pred chhhhhhcc-----cHHHHH----HHHHHHHHHHHh---ccchhhhcCCceeEEecC-CcEEEEEccchhh
Confidence 887765422 222333 333443334444 48888876 3 4555554 4999999999874
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.26 E-value=8.8e-06 Score=98.76 Aligned_cols=79 Identities=14% Similarity=0.268 Sum_probs=58.4
Q ss_pred ceEEeccCcEEEEEEEcCCC---cEEEEEEcccCC-chhHHHHHHHHHHHHHcc-CCce--eeEeeeeecc---cceEEE
Q 046750 365 ENVIGEGGFGCVYKGNLPEG---KVVAVKQLKSGS-GQGEREFRAEVEIISRVH-HRHL--VSLVGYCISE---KNRLLI 434 (723)
Q Consensus 365 ~~~LG~G~fG~Vy~~~~~~g---~~VAvK~l~~~~-~~~~~~~~~Ei~il~~l~-HpnI--v~l~g~~~~~---~~~~lV 434 (723)
.+.|+.|.+..+|+..+.++ ..+++|+..... ......+.+|+++|+.|. |.+| .+++.+|.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 57789999999999876554 367777764432 123457889999999995 6665 7888888764 457899
Q ss_pred EEecCCCch
Q 046750 435 YEFVPNNNL 443 (723)
Q Consensus 435 ~E~~~~gsL 443 (723)
|||++|..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999987654
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.25 E-value=6.4e-06 Score=84.79 Aligned_cols=73 Identities=12% Similarity=0.212 Sum_probs=47.9
Q ss_pred eEEeccCcE-EEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCC---ceeeEeeeeeccc---ceEEEEEec
Q 046750 366 NVIGEGGFG-CVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHR---HLVSLVGYCISEK---NRLLIYEFV 438 (723)
Q Consensus 366 ~~LG~G~fG-~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~Hp---nIv~l~g~~~~~~---~~~lV~E~~ 438 (723)
+.|+.|+.. .||+. +..+++|..+.. ....++.+|+++|..|... .+.++++.+...+ ..++||+++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 567777777 48975 245778876542 2345789999999998532 3444454443322 348899999
Q ss_pred CCCchh
Q 046750 439 PNNNLE 444 (723)
Q Consensus 439 ~~gsL~ 444 (723)
+|.+|.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 987764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.25 E-value=3.1e-06 Score=83.98 Aligned_cols=104 Identities=20% Similarity=0.237 Sum_probs=82.4
Q ss_pred HHHHHHHHHccC-CceeeEeeeeecccceEEEEEecCCCchhhcccc-CCCCcchHHHHHHHHHHHHhhhchhcccCCCc
Q 046750 404 RAEVEIISRVHH-RHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHG-KGQPVLEWTKRVKIALGAAKGLAYLHEDCHPK 481 (723)
Q Consensus 404 ~~Ei~il~~l~H-pnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ 481 (723)
..|.-+|+.+++ +++.+++|+| ..++|.||+..+.+...... ..-....|..|.+|+.++++.+.+|+..-...
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 458889999976 6999999999 45789999987765421000 01113689999999999999999998853335
Q ss_pred eeecCCCCCcEEeCCCCcEEEeeccccccc
Q 046750 482 IIHRDIKSANILVDDEFEAQVADFGLAKLN 511 (723)
Q Consensus 482 ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 511 (723)
+..+|++++|+.+++++++|++|.+.+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 889999999999999999999999987544
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PHA03247 large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Probab=98.24 E-value=0.00033 Score=88.41 Aligned_cols=12 Identities=25% Similarity=0.332 Sum_probs=6.9
Q ss_pred HHHHHHHHHhcc
Q 046750 609 RMIEAAAACVRH 620 (723)
Q Consensus 609 ~l~~l~~~cl~~ 620 (723)
.|.-|+..|.+.
T Consensus 3110 alAlLi~ACr~i 3121 (3151)
T PHA03247 3110 ALAVLIEACRRI 3121 (3151)
T ss_pred HHHHHHHHHHHH
Confidence 455566666554
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.23 E-value=1e-05 Score=80.88 Aligned_cols=133 Identities=21% Similarity=0.329 Sum_probs=95.0
Q ss_pred cceEEeccCcEEEEEEEcCCCcEEEEEEcccCC----------------chhHHHHHHHHHHHHHcc------CCceeeE
Q 046750 364 RENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGS----------------GQGEREFRAEVEIISRVH------HRHLVSL 421 (723)
Q Consensus 364 ~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~----------------~~~~~~~~~Ei~il~~l~------HpnIv~l 421 (723)
...+||+|+.-.||. ..+....+||+++... ....+++++|+.-+..+. +.+|.++
T Consensus 5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 456899999999997 4556678889887654 223466777888777776 7889999
Q ss_pred eeeeecccceEEEEEecCCC------chhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeC
Q 046750 422 VGYCISEKNRLLIYEFVPNN------NLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVD 495 (723)
Q Consensus 422 ~g~~~~~~~~~lV~E~~~~g------sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~ 495 (723)
+|+.+.+....+|+|.+.+. +|.+++.... ++. ...+.+. +-..||-++ +|+.+||++.||++.
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~---~~~-~~~~~L~---~f~~~l~~~---~Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG---LTE-ELRQALD---EFKRYLLDH---HIVIRDLNPHNIVVQ 152 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC---ccH-HHHHHHH---HHHHHHHHc---CCeecCCCcccEEEE
Confidence 99999999999999987653 5677774432 333 3333333 334566666 599999999999996
Q ss_pred CC---C-cEEEee-cccc
Q 046750 496 DE---F-EAQVAD-FGLA 508 (723)
Q Consensus 496 ~~---~-~vkL~D-FGla 508 (723)
.+ . .+.|+| ||..
T Consensus 153 ~~~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 153 RRDSGEFRLVLIDGLGEK 170 (199)
T ss_pred ecCCCceEEEEEeCCCCc
Confidence 43 2 577777 4543
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.19 E-value=2.5e-05 Score=83.36 Aligned_cols=80 Identities=14% Similarity=0.107 Sum_probs=59.0
Q ss_pred CcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccC---CceeeEeeeeecc---cceEEE
Q 046750 361 GFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHH---RHLVSLVGYCISE---KNRLLI 434 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~H---pnIv~l~g~~~~~---~~~~lV 434 (723)
.....+.||.|..+.||+....++ .++||..+.. .....|.+|.+.|+.|.. -.+.+++++|.+. +..+||
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV 91 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYDSQG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL 91 (297)
T ss_pred hhheeeecCCccceeEEEEEcCCC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence 344567899999999999876555 4667775431 123578999999999953 3577888877543 557999
Q ss_pred EEecCCCch
Q 046750 435 YEFVPNNNL 443 (723)
Q Consensus 435 ~E~~~~gsL 443 (723)
||++++..+
T Consensus 92 mE~i~G~~~ 100 (297)
T PRK10593 92 LERLRGVSV 100 (297)
T ss_pred EeccCCEec
Confidence 999998755
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.17 E-value=6.7e-05 Score=82.74 Aligned_cols=76 Identities=22% Similarity=0.242 Sum_probs=54.6
Q ss_pred ceEEeccCcEEEEEEEcCCC-cEEEEEEcccCC-------chhHHHHHHHHHHHHHcc---CCceeeEeeeeecccceEE
Q 046750 365 ENVIGEGGFGCVYKGNLPEG-KVVAVKQLKSGS-------GQGEREFRAEVEIISRVH---HRHLVSLVGYCISEKNRLL 433 (723)
Q Consensus 365 ~~~LG~G~fG~Vy~~~~~~g-~~VAvK~l~~~~-------~~~~~~~~~Ei~il~~l~---HpnIv~l~g~~~~~~~~~l 433 (723)
.+.||.|.+..||++...+| +.|+||+-.... ......+..|.+.|..+. -.++.+++.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 36789999999999988777 589999854221 123456677888888873 2456677765 4456789
Q ss_pred EEEecCCCc
Q 046750 434 IYEFVPNNN 442 (723)
Q Consensus 434 V~E~~~~gs 442 (723)
||||+.+..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998743
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.16 E-value=1.4e-05 Score=79.35 Aligned_cols=125 Identities=24% Similarity=0.438 Sum_probs=89.1
Q ss_pred cCcccceEEeccCc-EEEEEEEcCCCcEEEEEEcccCC------------c---------hhHHHHHHHHHHHHHcc---
Q 046750 360 NGFARENVIGEGGF-GCVYKGNLPEGKVVAVKQLKSGS------------G---------QGEREFRAEVEIISRVH--- 414 (723)
Q Consensus 360 ~~f~~~~~LG~G~f-G~Vy~~~~~~g~~VAvK~l~~~~------------~---------~~~~~~~~Ei~il~~l~--- 414 (723)
..|+.++.||+|.. |.||++++ +|+.||||+++... . ....-|..|.+.+.+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 67889999999999 99999998 77899999943210 0 11124778999888884
Q ss_pred CCce--eeEeeeeeccc------------------ceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchh
Q 046750 415 HRHL--VSLVGYCISEK------------------NRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYL 474 (723)
Q Consensus 415 HpnI--v~l~g~~~~~~------------------~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yL 474 (723)
+.++ |+.+||..-.. ..-||.||+.... ....+-+.+|.+-|..|
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------------~~~~~~~~~~~~dl~~~ 180 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------------PLQIRDIPQMLRDLKIL 180 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------------ccchhHHHHHHHHHHHH
Confidence 4456 89999874321 1245667664432 11223345677778889
Q ss_pred cccCCCceeecCCCCCcEEeCCCCcEEEeecccc
Q 046750 475 HEDCHPKIIHRDIKSANILVDDEFEAQVADFGLA 508 (723)
Q Consensus 475 H~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla 508 (723)
|..| |+-+|++..|.. .-||+|||.+
T Consensus 181 ~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHCC---eeeccCcccccc-----CCEEEecccC
Confidence 9985 999999999984 4589999864
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.12 E-value=1.9e-05 Score=81.04 Aligned_cols=74 Identities=20% Similarity=0.135 Sum_probs=50.5
Q ss_pred ceEEeccCcEEEEEEEcCC--CcEEEEEEcccCCchhHHHHHHHHHHHHHccCCc-eeeEeeeeecccceEEEEEecCCC
Q 046750 365 ENVIGEGGFGCVYKGNLPE--GKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRH-LVSLVGYCISEKNRLLIYEFVPNN 441 (723)
Q Consensus 365 ~~~LG~G~fG~Vy~~~~~~--g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~g~~~~~~~~~lV~E~~~~g 441 (723)
.+.|..|-...||+....+ ++.|++|+...... ..-+..+|+.+++.+...+ ..++++++. ..+||||++|.
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~ 77 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGR 77 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCC
Confidence 3567888888999997764 67899998764322 1223457999999985433 344544332 24899999887
Q ss_pred ch
Q 046750 442 NL 443 (723)
Q Consensus 442 sL 443 (723)
.|
T Consensus 78 ~l 79 (235)
T cd05157 78 TL 79 (235)
T ss_pred cC
Confidence 66
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PHA03247 large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Probab=98.12 E-value=0.00072 Score=85.56 Aligned_cols=11 Identities=36% Similarity=0.513 Sum_probs=5.9
Q ss_pred CCCCCcccccc
Q 046750 6 ETPGPPVANNA 16 (723)
Q Consensus 6 ~~~~~~~~~~~ 16 (723)
+..|++|.+-+
T Consensus 2523 ~~~~~~~~p~~ 2533 (3151)
T PHA03247 2523 EPVGEPVHPRM 2533 (3151)
T ss_pred CCCCCCCCchh
Confidence 44555665554
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=98.11 E-value=1.2e-05 Score=85.68 Aligned_cols=152 Identities=18% Similarity=0.172 Sum_probs=90.5
Q ss_pred HHHHHhcCccc-----ceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCc--eeeEeee--
Q 046750 354 ELMEITNGFAR-----ENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRH--LVSLVGY-- 424 (723)
Q Consensus 354 ~l~~~~~~f~~-----~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~g~-- 424 (723)
++..+.++|.+ .+.|..|....+|+....+ ..+++|+... .....+..|++++..|.+.+ +.+++..
T Consensus 3 ~l~~~l~~y~~~~~~~i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~ 78 (296)
T cd05153 3 ELASFLADYDLGELLSFEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRD 78 (296)
T ss_pred HHHHHHHHcCCCchhheecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCC
Confidence 44455455543 4567777778999987644 4688898765 23456778999999985433 4444432
Q ss_pred ----eecccceEEEEEecCCCchhhc--------------cccC----C-----CCcchHHHHHH----------HHHHH
Q 046750 425 ----CISEKNRLLIYEFVPNNNLEHH--------------LHGK----G-----QPVLEWTKRVK----------IALGA 467 (723)
Q Consensus 425 ----~~~~~~~~lV~E~~~~gsL~~~--------------l~~~----~-----~~~l~~~~~~~----------i~~~i 467 (723)
....+..++|++|++|..+... ||.. . .....|..... ....+
T Consensus 79 g~~~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 158 (296)
T cd05153 79 GEYLSELAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALL 158 (296)
T ss_pred CcEeeeeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHH
Confidence 1223456899999988765320 1110 0 01112221110 01112
Q ss_pred Hhhhchhcc----cCCCceeecCCCCCcEEeCCCCcEEEeeccccc
Q 046750 468 AKGLAYLHE----DCHPKIIHRDIKSANILVDDEFEAQVADFGLAK 509 (723)
Q Consensus 468 a~gL~yLH~----~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 509 (723)
...+.+|.. .....+||+|+.+.|||++++..+.|+||+.+.
T Consensus 159 ~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 159 ADELARQDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred HHHHHHHHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 223333332 112359999999999999998777899999875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.02 E-value=2.6e-05 Score=81.31 Aligned_cols=136 Identities=13% Similarity=0.108 Sum_probs=78.4
Q ss_pred EeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCce-eeEeeeeecccceEEEEEecCCCchhhc
Q 046750 368 IGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHL-VSLVGYCISEKNRLLIYEFVPNNNLEHH 446 (723)
Q Consensus 368 LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~g~~~~~~~~~lV~E~~~~gsL~~~ 446 (723)
+..|-...+|+... +++.+++|+.........-+..+|+++++.+....+ .++++++. .++||||++|..+...
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence 45677788998874 567888887654322211246789999999964433 34444332 3689999988766421
Q ss_pred -----------------cccCCC--CcchHHHH-HHHHHHH---------Hhhhchhccc-----CCCceeecCCCCCcE
Q 046750 447 -----------------LHGKGQ--PVLEWTKR-VKIALGA---------AKGLAYLHED-----CHPKIIHRDIKSANI 492 (723)
Q Consensus 447 -----------------l~~~~~--~~l~~~~~-~~i~~~i---------a~gL~yLH~~-----g~~~ivHrDIkp~NI 492 (723)
||.... ..++...+ ..+..++ ...+..+-.. ....++|+|+.+.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 122111 11111111 1111111 1111111111 123589999999999
Q ss_pred EeCCCCcEEEeeccccc
Q 046750 493 LVDDEFEAQVADFGLAK 509 (723)
Q Consensus 493 Ll~~~~~vkL~DFGla~ 509 (723)
|+++++ +.|+||..+.
T Consensus 159 l~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYAS 174 (256)
T ss_pred EEeCCC-CEEEeccccC
Confidence 999876 7899999885
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=98.01 E-value=6.1e-05 Score=80.77 Aligned_cols=158 Identities=20% Similarity=0.225 Sum_probs=92.8
Q ss_pred ccCHHHHHHHhcCccc-----ceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCc--eeeE
Q 046750 349 FFTYEELMEITNGFAR-----ENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRH--LVSL 421 (723)
Q Consensus 349 ~~~~~~l~~~~~~f~~-----~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l 421 (723)
..+.++|..+.++|.+ .+.|+.|....+|+.+..+| .+++|+.+... ...++..|++++..|.... +.++
T Consensus 6 ~~~~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~ 82 (307)
T TIGR00938 6 SVSDEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKP 82 (307)
T ss_pred cCCHHHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCcc
Confidence 3455777777666755 34566777789999876545 57788875532 2345667888888885322 3444
Q ss_pred eeee------ecccceEEEEEecCCCchhhc--------------cccCCC----------CcchHHHHHH---------
Q 046750 422 VGYC------ISEKNRLLIYEFVPNNNLEHH--------------LHGKGQ----------PVLEWTKRVK--------- 462 (723)
Q Consensus 422 ~g~~------~~~~~~~lV~E~~~~gsL~~~--------------l~~~~~----------~~l~~~~~~~--------- 462 (723)
+... ...+..++||||++|..+... ||.... ....|.....
T Consensus 83 i~t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l 162 (307)
T TIGR00938 83 VKSRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQL 162 (307)
T ss_pred ccCCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhccccc
Confidence 4321 123456899999988654211 121100 0111211110
Q ss_pred ---HHHHHHhhhchhcc----cCCCceeecCCCCCcEEeCCCCcEEEeeccccc
Q 046750 463 ---IALGAAKGLAYLHE----DCHPKIIHRDIKSANILVDDEFEAQVADFGLAK 509 (723)
Q Consensus 463 ---i~~~ia~gL~yLH~----~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 509 (723)
....+.+.+++|.. .....+||+|++..||++++++.+.|+||+.+.
T Consensus 163 ~~~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 163 EAHMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CHHHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 01112233444432 123469999999999999998777899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.95 E-value=1.4e-05 Score=83.41 Aligned_cols=145 Identities=19% Similarity=0.201 Sum_probs=100.3
Q ss_pred cCHHHHHHHhcC---cccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCc--------------------h--hHHHHH
Q 046750 350 FTYEELMEITNG---FARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSG--------------------Q--GEREFR 404 (723)
Q Consensus 350 ~~~~~l~~~~~~---f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~--------------------~--~~~~~~ 404 (723)
+.|..|..+.++ +.+++.||-|--+.||++-..+|+..++|+.+.... . ..-...
T Consensus 79 yDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~ 158 (465)
T KOG2268|consen 79 YDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAAT 158 (465)
T ss_pred chHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHH
Confidence 455566666544 678899999999999999998999999998542210 0 011234
Q ss_pred HHHHHHHHcc-CC-ceeeEeeeeecccceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCce
Q 046750 405 AEVEIISRVH-HR-HLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKI 482 (723)
Q Consensus 405 ~Ei~il~~l~-Hp-nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~i 482 (723)
+|+..|+.|. |- -|.+.+++ +..++|||++.+..|.+.-+-. +..+++.- +..-+--|..+ ++
T Consensus 159 kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v~-----d~~~ly~~---lm~~Iv~la~~---Gl 223 (465)
T KOG2268|consen 159 KEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRHVE-----DPPTLYDD---LMGLIVRLANH---GL 223 (465)
T ss_pred HHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeeecC-----ChHHHHHH---HHHHHHHHHHc---Cc
Confidence 6888888884 32 24444543 4578999999998887765422 22333322 22334445566 49
Q ss_pred eecCCCCCcEEeCCCCcEEEeeccccc
Q 046750 483 IHRDIKSANILVDDEFEAQVADFGLAK 509 (723)
Q Consensus 483 vHrDIkp~NILl~~~~~vkL~DFGla~ 509 (723)
||||+.--||+|++++.++++||=...
T Consensus 224 IHgDFNEFNimv~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 224 IHGDFNEFNIMVKDDDKIVVIDFPQMV 250 (465)
T ss_pred eecccchheeEEecCCCEEEeechHhh
Confidence 999999999999999999999997654
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.92 E-value=0.00017 Score=77.14 Aligned_cols=74 Identities=26% Similarity=0.341 Sum_probs=49.8
Q ss_pred eEEeccCcEEEEEEEcCC-------CcEEEEEEcccCCchhHHHHHHHHHHHHHccCCce-eeEeeeeecccceEEEEEe
Q 046750 366 NVIGEGGFGCVYKGNLPE-------GKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHL-VSLVGYCISEKNRLLIYEF 437 (723)
Q Consensus 366 ~~LG~G~fG~Vy~~~~~~-------g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~g~~~~~~~~~lV~E~ 437 (723)
+.|..|--..||+....+ ++.|++|+..... ....+..+|++++..|....+ .++++++. ..+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhhe
Confidence 456666667899987655 5789999976543 222456789999999854333 35555553 2368999
Q ss_pred cCCCchh
Q 046750 438 VPNNNLE 444 (723)
Q Consensus 438 ~~~gsL~ 444 (723)
++|..|.
T Consensus 79 i~G~~l~ 85 (302)
T cd05156 79 IPSRTLT 85 (302)
T ss_pred eCCCcCC
Confidence 9887664
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00014 Score=78.30 Aligned_cols=156 Identities=17% Similarity=0.184 Sum_probs=87.8
Q ss_pred cCHHHHHHHhcCccc-----ceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCc--eeeEe
Q 046750 350 FTYEELMEITNGFAR-----ENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRH--LVSLV 422 (723)
Q Consensus 350 ~~~~~l~~~~~~f~~-----~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~ 422 (723)
.+.+++..+...|.+ .+.|+.|....+|+.+..+| .+++|++.. .....+..|+++++.|...+ +.+++
T Consensus 7 ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~i 82 (319)
T PRK05231 7 VSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAPV 82 (319)
T ss_pred CCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCcce
Confidence 455666666666654 34566777779999877555 688898762 22345556777777774322 23333
Q ss_pred e------eeecccceEEEEEecCCCchhh-----------c---cccCCC---------CcchH-HHHHH----------
Q 046750 423 G------YCISEKNRLLIYEFVPNNNLEH-----------H---LHGKGQ---------PVLEW-TKRVK---------- 462 (723)
Q Consensus 423 g------~~~~~~~~~lV~E~~~~gsL~~-----------~---l~~~~~---------~~l~~-~~~~~---------- 462 (723)
. +....+..++|++|++|..+.. . ||.... ..+.| ...+.
T Consensus 83 ~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (319)
T PRK05231 83 ARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQ 162 (319)
T ss_pred eCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhH
Confidence 2 1122455789999998875421 0 111100 01111 11111
Q ss_pred --HHHH-HHhhhchhccc----CCCceeecCCCCCcEEeCCCCcEEEeeccccc
Q 046750 463 --IALG-AAKGLAYLHED----CHPKIIHRDIKSANILVDDEFEAQVADFGLAK 509 (723)
Q Consensus 463 --i~~~-ia~gL~yLH~~----g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 509 (723)
.+.+ +...++++... -...+||+|+++.|||++++...-|+||+.+.
T Consensus 163 ~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 163 AALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred HHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 1111 11112222211 13369999999999999977656899999875
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.76 E-value=7e-05 Score=89.50 Aligned_cols=197 Identities=19% Similarity=0.243 Sum_probs=133.5
Q ss_pred HHHHHHHHHHHccCCceeeEeeeeecccce----EEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhccc
Q 046750 402 EFRAEVEIISRVHHRHLVSLVGYCISEKNR----LLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHED 477 (723)
Q Consensus 402 ~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~----~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~ 477 (723)
....|++.+.++.|.|++.++.|-...... .+..|++...++...+...+ .+.......+..++.+||+|+|+.
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~--~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG--SIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc--ccCHHHHHHHHHHHhhhHHHHHHh
Confidence 455678888888999999999887654332 34557777777877776554 366777778889999999999998
Q ss_pred CCCceeecCCCCC---cEEeCCCCcEEEe--ecccccccCCCCcceeecccccccccChhhhccCCCCCc--cceechHH
Q 046750 478 CHPKIIHRDIKSA---NILVDDEFEAQVA--DFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDR--SDVFSFGV 550 (723)
Q Consensus 478 g~~~ivHrDIkp~---NILl~~~~~vkL~--DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~k--sDVwSlGv 550 (723)
.+.|.-|... +...+.++.+.+. ||+..+...+...... ......|.++|......+..+ .|+|++|.
T Consensus 306 ---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~--~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl 380 (1351)
T KOG1035|consen 306 ---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS--DLLAEIRNADEDLKENTAKKSRLTDLWCLGL 380 (1351)
T ss_pred ---ccceeEEecccccccccCccceeecchhhhcccccCCCcccchh--hcCccccccccccccccchhhhhhHHHHHHH
Confidence 4666666555 5555667777777 9988876654433221 224556788887776655554 79999999
Q ss_pred HHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHH
Q 046750 551 VLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQ 630 (723)
Q Consensus 551 iL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~e 630 (723)
++..+..|...-..... ...+++ ... . ..+.+....|+..+.++|....+
T Consensus 381 l~~~~~~~~~i~~~~~~----------------------~~~~l~----~~~-~---~~~~d~~~~~~~~~~~~Rl~~~~ 430 (1351)
T KOG1035|consen 381 LLLQLSQGEDISEKSAV----------------------PVSLLD----VLS-T---SELLDALPKCLDEDSEERLSALE 430 (1351)
T ss_pred HHhhhhhcCcccccccc----------------------hhhhhc----ccc-c---hhhhhhhhhhcchhhhhccchhh
Confidence 99999987654321110 000000 000 0 03556677899999999999999
Q ss_pred HHHHH
Q 046750 631 VVRAL 635 (723)
Q Consensus 631 Vl~~L 635 (723)
++...
T Consensus 431 ll~~~ 435 (1351)
T KOG1035|consen 431 LLTHP 435 (1351)
T ss_pred hhhch
Confidence 98654
|
|
| >KOG1924 consensus RhoA GTPase effector DIA/Diaphanous [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00015 Score=82.19 Aligned_cols=11 Identities=36% Similarity=0.434 Sum_probs=5.0
Q ss_pred HHHHHHHHhcc
Q 046750 628 MVQVVRALDSE 638 (723)
Q Consensus 628 ~~eVl~~L~~~ 638 (723)
|.++|+.|..-
T Consensus 1043 mDslLeaLqsg 1053 (1102)
T KOG1924|consen 1043 MDSLLEALQSG 1053 (1102)
T ss_pred HHHHHHHHHhh
Confidence 44444444443
|
|
| >KOG1924 consensus RhoA GTPase effector DIA/Diaphanous [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00024 Score=80.47 Aligned_cols=7 Identities=43% Similarity=0.861 Sum_probs=3.0
Q ss_pred cCHHHHH
Q 046750 350 FTYEELM 356 (723)
Q Consensus 350 ~~~~~l~ 356 (723)
+.|++|.
T Consensus 713 mpyeeik 719 (1102)
T KOG1924|consen 713 MPYEEIK 719 (1102)
T ss_pred CCHHHHH
Confidence 3444443
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00051 Score=72.56 Aligned_cols=71 Identities=13% Similarity=0.017 Sum_probs=42.0
Q ss_pred EEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccC--Cc-eeeEeeeeecccceEEEEEecCCCch
Q 046750 367 VIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHH--RH-LVSLVGYCISEKNRLLIYEFVPNNNL 443 (723)
Q Consensus 367 ~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~H--pn-Iv~l~g~~~~~~~~~lV~E~~~~gsL 443 (723)
.++.|-...||.....+|+.+++|+-+.. .....+.+|+++|+.|.. +- +.+++..+ ..+++|+++.|..+
T Consensus 18 ~~~~g~~~~v~~i~~~~g~~~VlR~p~~~--~~~~~l~rE~~vL~~L~~~l~vpvP~~~~~~----~~~~~y~~i~G~p~ 91 (276)
T cd05152 18 LNESGLDFQVVFAKDTDGVPWVLRIPRRP--DVSERAAAEKRVLALVRKHLPVQVPDWRVHT----PELIAYPKLPGVPA 91 (276)
T ss_pred ecCCcceeEEEEEEcCCCCeEEEEecCCH--HHHHHHHHHHHHHHHHHhcCCCCCCceeeec----CceEEEeccCCCcc
Confidence 33445555677665557889999987532 334568899999999953 11 12222211 22566766666544
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.0009 Score=71.50 Aligned_cols=128 Identities=18% Similarity=0.330 Sum_probs=77.0
Q ss_pred CcEEEEEEcc--cCCchhHHHHHHHHHHHHHccC--CceeeEeeeeeccc--ceEEEEEecCCCchhhccccCC------
Q 046750 384 GKVVAVKQLK--SGSGQGEREFRAEVEIISRVHH--RHLVSLVGYCISEK--NRLLIYEFVPNNNLEHHLHGKG------ 451 (723)
Q Consensus 384 g~~VAvK~l~--~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~g~~~~~~--~~~lV~E~~~~gsL~~~l~~~~------ 451 (723)
++.++|+ .- .......++..+|+++|+.+.- --+-+.+++|.++. ..|.||+|++|..+...+....
T Consensus 48 ~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~~~~~ 126 (321)
T COG3173 48 GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLGRQFA 126 (321)
T ss_pred CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccchHHHH
Confidence 6777777 22 1233445677889999998853 23445677777666 5699999998855443332211
Q ss_pred ------------------------------CCcchHHHHHHHHHH--------HHhhhchhccc-----CCCceeecCCC
Q 046750 452 ------------------------------QPVLEWTKRVKIALG--------AAKGLAYLHED-----CHPKIIHRDIK 488 (723)
Q Consensus 452 ------------------------------~~~l~~~~~~~i~~~--------ia~gL~yLH~~-----g~~~ivHrDIk 488 (723)
++...|...++.+.. +..-..||+.+ +...++|+|++
T Consensus 127 ~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~ 206 (321)
T COG3173 127 LDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYR 206 (321)
T ss_pred HHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcc
Confidence 111111111210000 11112223222 23569999999
Q ss_pred CCcEEeCCCCcEEEeecccccccC
Q 046750 489 SANILVDDEFEAQVADFGLAKLND 512 (723)
Q Consensus 489 p~NILl~~~~~vkL~DFGla~~~~ 512 (723)
+.||+|+.+..+=|+||+++.+.+
T Consensus 207 ~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 207 PGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred cCCEEEeCCCeeEEEeccccccCC
Confidence 999999999889999999987543
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.00056 Score=72.98 Aligned_cols=140 Identities=19% Similarity=0.297 Sum_probs=94.1
Q ss_pred cceEEeccCcEEEEEEEcCCCcEEEEEEcccC---------------------CchhHHH-----HHHHHHHHHHccCCc
Q 046750 364 RENVIGEGGFGCVYKGNLPEGKVVAVKQLKSG---------------------SGQGERE-----FRAEVEIISRVHHRH 417 (723)
Q Consensus 364 ~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~---------------------~~~~~~~-----~~~Ei~il~~l~Hpn 417 (723)
+..+|..|--..||.+...+|..+|||+++-. +...-+. ...|++-|.+|+.-.
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 34567888899999999999999999997421 0000011 235788888886443
Q ss_pred eeeEeeeeecccceEEEEEecCCCchhh-ccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCC
Q 046750 418 LVSLVGYCISEKNRLLIYEFVPNNNLEH-HLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDD 496 (723)
Q Consensus 418 Iv~l~g~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~ 496 (723)
|..---+. -...+|||+|+....... .|.. ..+....+..+-++++.-+.-|.+.| ++||.||.--|+|+.+
T Consensus 228 IP~PePIl--Lk~hVLVM~FlGrdgw~aPkLKd---~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyhd 300 (520)
T KOG2270|consen 228 IPCPEPIL--LKNHVLVMEFLGRDGWAAPKLKD---ASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYHD 300 (520)
T ss_pred CCCCCcee--eecceEeeeeccCCCCcCccccc---ccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEEC
Confidence 32111001 124579999995432221 2222 22455566667778888888898888 8999999999999876
Q ss_pred CCcEEEeeccccccc
Q 046750 497 EFEAQVADFGLAKLN 511 (723)
Q Consensus 497 ~~~vkL~DFGla~~~ 511 (723)
. .+.|+|.+.+...
T Consensus 301 G-~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 301 G-KLYIIDVSQSVEH 314 (520)
T ss_pred C-EEEEEEccccccC
Confidence 5 8999999988644
|
|
| >PF04478 Mid2: Mid2 like cell wall stress sensor; InterPro: IPR007567 This family represents a region near the C terminus of Mid2, which contains a transmembrane region | Back alignment and domain information |
|---|
Probab=97.51 E-value=4.3e-05 Score=71.02 Aligned_cols=37 Identities=27% Similarity=0.481 Sum_probs=19.5
Q ss_pred CCCCCCCCceeehhhhHHH--HHHHHHHHHHHhhhcccc
Q 046750 255 KGSSSNDDQAIIGATAAGV--VLIVLIAIFFLARGRRRR 291 (723)
Q Consensus 255 ~~~~~~~~~~ii~~~~~~~--~~l~~l~~~~~~~~rr~r 291 (723)
++.+.....+|||+|||+. ++|++++++||||+||||
T Consensus 41 sGlS~knknIVIGvVVGVGg~ill~il~lvf~~c~r~kk 79 (154)
T PF04478_consen 41 SGLSSKNKNIVIGVVVGVGGPILLGILALVFIFCIRRKK 79 (154)
T ss_pred CCCCcCCccEEEEEEecccHHHHHHHHHhheeEEEeccc
Confidence 3566666677788776643 333333334444444444
|
The remainder of the protein sequence is serine-rich and of low complexity, and is therefore impossible to align accurately. Mid2 is thought to act as a mechanosensor of cell wall stress. The C-terminal cytoplasmic region of Mid2 is known to interact with Rom2, a guanine nucleotide exchange factor (GEF) for Rho1, which is part of the cell wall integrity signalling pathway []. |
| >PF01102 Glycophorin_A: Glycophorin A; InterPro: IPR001195 Proteins in this group are responsible for the molecular basis of the blood group antigens, surface markers on the outside of the red blood cell membrane | Back alignment and domain information |
|---|
Probab=97.49 E-value=6.9e-05 Score=67.97 Aligned_cols=19 Identities=21% Similarity=0.242 Sum_probs=9.3
Q ss_pred CCCCceeehhhhHHHHHHH
Q 046750 259 SNDDQAIIGATAAGVVLIV 277 (723)
Q Consensus 259 ~~~~~~ii~~~~~~~~~l~ 277 (723)
+.+.++|++|++|+++.++
T Consensus 60 ~fs~~~i~~Ii~gv~aGvI 78 (122)
T PF01102_consen 60 RFSEPAIIGIIFGVMAGVI 78 (122)
T ss_dssp SSS-TCHHHHHHHHHHHHH
T ss_pred CccccceeehhHHHHHHHH
Confidence 4455566666655443333
|
Most of these markers are proteins, but some are carbohydrates attached to lipids or proteins [Reid M.E., Lomas-Francis C. The Blood Group Antigen FactsBook Academic Press, London / San Diego, (1997)]. Glycophorin A (PAS-2) and glycophorin B (PAS-3) belong to the MNS blood group system and are associated with antigens that include M/N, S/s, U, He, Mi(a), M(c), Vw, Mur, M(g), Vr, M(e), Mt(a), St(a), Ri(a), Cl(a), Ny(a), Hut, Hil, M(v), Far, Mit, Dantu, Hop, Nob, En(a), ENKT, amongst others. Glycophorin A is the major sialoglycoprotein of the erythrocyte membrane []. Structurally, glycophorin A consists of an N-terminal extracellular domain, heavily glycosylated on serine and threonine residues, followed by a transmembrane region and a C-terminal cytoplasmic domain. Other glycophorins in this entry such as Glycophorin B and Glycophorin E represent minor sialoglycoproteins in the erythrocyte membrane.; GO: 0016021 integral to membrane; PDB: 2KPF_B 1AFO_B 2KPE_A. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.0053 Score=67.43 Aligned_cols=75 Identities=15% Similarity=0.169 Sum_probs=49.7
Q ss_pred ceEEeccCcEEEEEEEcCC-CcEEEEEEcccCC------chhHHHHHHHHHHHHHcc--CC-ceeeEeeeeecccceEEE
Q 046750 365 ENVIGEGGFGCVYKGNLPE-GKVVAVKQLKSGS------GQGEREFRAEVEIISRVH--HR-HLVSLVGYCISEKNRLLI 434 (723)
Q Consensus 365 ~~~LG~G~fG~Vy~~~~~~-g~~VAvK~l~~~~------~~~~~~~~~Ei~il~~l~--Hp-nIv~l~g~~~~~~~~~lV 434 (723)
.+.||.|.-..||++.+.. ++.|+||+-.... .-.......|.++|+.+. .| ++.+++.| +.+...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 4678999999999998743 6789999854221 122345566888888763 34 35555533 45556788
Q ss_pred EEecCCC
Q 046750 435 YEFVPNN 441 (723)
Q Consensus 435 ~E~~~~g 441 (723)
||++...
T Consensus 112 MEdL~~~ 118 (409)
T PRK12396 112 MEDLSDH 118 (409)
T ss_pred HHhCccc
Confidence 8888543
|
|
| >KOG3671 consensus Actin regulatory protein (Wiskott-Aldrich syndrome protein) [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.006 Score=66.55 Aligned_cols=18 Identities=28% Similarity=0.296 Sum_probs=11.1
Q ss_pred CCccccccccCcCcCCCC
Q 046750 9 GPPVANNASSGLGERKEE 26 (723)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~ 26 (723)
-.++.||+.+-+|..-..
T Consensus 265 ~dp~~nn~~s~agise~~ 282 (569)
T KOG3671|consen 265 NDPPLNNLFSSAGISEAQ 282 (569)
T ss_pred CChhhhcccccCCCCccc
Confidence 346677777776655433
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.0013 Score=71.67 Aligned_cols=139 Identities=19% Similarity=0.249 Sum_probs=81.5
Q ss_pred eEEeccCcEEEEEEEcCC-----CcEEEEEEcccCCchhHHHHHHHHHHHHHccCCce-eeEeeeeecccceEEEEEecC
Q 046750 366 NVIGEGGFGCVYKGNLPE-----GKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHL-VSLVGYCISEKNRLLIYEFVP 439 (723)
Q Consensus 366 ~~LG~G~fG~Vy~~~~~~-----g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~g~~~~~~~~~lV~E~~~ 439 (723)
+.|-.|-.-.+|+..+.+ ++.|++|+........ -+...|+.+++.+...++ .++++++..+ .|+||+.
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~-idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELF-FDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCee-echHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 445557777899986533 3678899876543222 234779999999965444 3566665332 5899997
Q ss_pred CCchhhc-----------------cccCC----CCcchHHHHHHHHHHH-----------------Hhhhch----hcc-
Q 046750 440 NNNLEHH-----------------LHGKG----QPVLEWTKRVKIALGA-----------------AKGLAY----LHE- 476 (723)
Q Consensus 440 ~gsL~~~-----------------l~~~~----~~~l~~~~~~~i~~~i-----------------a~gL~y----LH~- 476 (723)
+..|... ||... ....-+.++.++..++ ...+.. +..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 7666421 12211 1111223222222111 111111 121
Q ss_pred cCCCceeecCCCCCcEEeCC-CCcEEEeeccccc
Q 046750 477 DCHPKIIHRDIKSANILVDD-EFEAQVADFGLAK 509 (723)
Q Consensus 477 ~g~~~ivHrDIkp~NILl~~-~~~vkL~DFGla~ 509 (723)
.....++|+||++.|||+++ ++.++|+||.++.
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 11235899999999999986 4689999999875
|
|
| >PF01102 Glycophorin_A: Glycophorin A; InterPro: IPR001195 Proteins in this group are responsible for the molecular basis of the blood group antigens, surface markers on the outside of the red blood cell membrane | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.00011 Score=66.68 Aligned_cols=35 Identities=29% Similarity=0.326 Sum_probs=21.7
Q ss_pred CCCCCCCceeehhhhHHHHHHHHHHHHHHhhhccc
Q 046750 256 GSSSNDDQAIIGATAAGVVLIVLIAIFFLARGRRR 290 (723)
Q Consensus 256 ~~~~~~~~~ii~~~~~~~~~l~~l~~~~~~~~rr~ 290 (723)
+.+.....+||+.|++|+++++||++||++|+|||
T Consensus 60 ~fs~~~i~~Ii~gv~aGvIg~Illi~y~irR~~Kk 94 (122)
T PF01102_consen 60 RFSEPAIIGIIFGVMAGVIGIILLISYCIRRLRKK 94 (122)
T ss_dssp SSS-TCHHHHHHHHHHHHHHHHHHHHHHHHHHS--
T ss_pred CccccceeehhHHHHHHHHHHHHHHHHHHHHHhcc
Confidence 55556677777777777787887666555444444
|
Most of these markers are proteins, but some are carbohydrates attached to lipids or proteins [Reid M.E., Lomas-Francis C. The Blood Group Antigen FactsBook Academic Press, London / San Diego, (1997)]. Glycophorin A (PAS-2) and glycophorin B (PAS-3) belong to the MNS blood group system and are associated with antigens that include M/N, S/s, U, He, Mi(a), M(c), Vw, Mur, M(g), Vr, M(e), Mt(a), St(a), Ri(a), Cl(a), Ny(a), Hut, Hil, M(v), Far, Mit, Dantu, Hop, Nob, En(a), ENKT, amongst others. Glycophorin A is the major sialoglycoprotein of the erythrocyte membrane []. Structurally, glycophorin A consists of an N-terminal extracellular domain, heavily glycosylated on serine and threonine residues, followed by a transmembrane region and a C-terminal cytoplasmic domain. Other glycophorins in this entry such as Glycophorin B and Glycophorin E represent minor sialoglycoproteins in the erythrocyte membrane.; GO: 0016021 integral to membrane; PDB: 2KPF_B 1AFO_B 2KPE_A. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0014 Score=69.54 Aligned_cols=76 Identities=16% Similarity=0.278 Sum_probs=50.0
Q ss_pred cccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHcc---CCceeeEeeeeecccceEEEEEec
Q 046750 362 FARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVH---HRHLVSLVGYCISEKNRLLIYEFV 438 (723)
Q Consensus 362 f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~g~~~~~~~~~lV~E~~ 438 (723)
.+..+.|+.|....+|+.+ .+++.+.||+-.. .....|..|++-|+.|. --.+.+++++....+..+|||||+
T Consensus 19 i~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp --EEEEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred eeeeEecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 3455678999999999988 5778899998762 33456889999999993 345778888887777789999999
Q ss_pred CCC
Q 046750 439 PNN 441 (723)
Q Consensus 439 ~~g 441 (723)
+.+
T Consensus 95 ~~~ 97 (288)
T PF03881_consen 95 EMG 97 (288)
T ss_dssp ---
T ss_pred cCC
Confidence 877
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.0026 Score=68.57 Aligned_cols=135 Identities=23% Similarity=0.343 Sum_probs=81.6
Q ss_pred CcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCce------eeEee----eeecccceEEEEEecCCC
Q 046750 372 GFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHL------VSLVG----YCISEKNRLLIYEFVPNN 441 (723)
Q Consensus 372 ~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnI------v~l~g----~~~~~~~~~lV~E~~~~g 441 (723)
.-..||+....+|+. ++|+.+.. ....++..|+.+|..|.-..| ..+=| ........+.|++|++|.
T Consensus 37 ~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~ 113 (331)
T COG2334 37 EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGR 113 (331)
T ss_pred ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCc
Confidence 455799998877777 88988875 455677888999999843222 22211 111112667899999988
Q ss_pred chhh-cc--------------cc----C------CCCcchHHH---H----------HHHHHHHHhhhchhcccC----C
Q 046750 442 NLEH-HL--------------HG----K------GQPVLEWTK---R----------VKIALGAAKGLAYLHEDC----H 479 (723)
Q Consensus 442 sL~~-~l--------------~~----~------~~~~l~~~~---~----------~~i~~~ia~gL~yLH~~g----~ 479 (723)
.+.. .. |. . ....+.|.. + .....++...+..+++.- .
T Consensus 114 ~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp 193 (331)
T COG2334 114 PLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLP 193 (331)
T ss_pred CcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCC
Confidence 7773 11 11 0 011233431 0 112222333333333321 1
Q ss_pred ---CceeecCCCCCcEEeCCCCc-EEEeeccccc
Q 046750 480 ---PKIIHRDIKSANILVDDEFE-AQVADFGLAK 509 (723)
Q Consensus 480 ---~~ivHrDIkp~NILl~~~~~-vkL~DFGla~ 509 (723)
..+||+|+.+.|||++.+.. +.++|||.+.
T Consensus 194 ~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 194 ALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred cccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 12999999999999999875 8999999875
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.0003 Score=85.86 Aligned_cols=176 Identities=11% Similarity=0.007 Sum_probs=115.5
Q ss_pred EEEEEEcccCCchhHHH-----HHHHHHHHHHccCCceeeEeeeeec--ccceEEEEEecCCCchhhccccCC--CCcch
Q 046750 386 VVAVKQLKSGSGQGERE-----FRAEVEIISRVHHRHLVSLVGYCIS--EKNRLLIYEFVPNNNLEHHLHGKG--QPVLE 456 (723)
Q Consensus 386 ~VAvK~l~~~~~~~~~~-----~~~Ei~il~~l~HpnIv~l~g~~~~--~~~~~lV~E~~~~gsL~~~l~~~~--~~~l~ 456 (723)
.+.+|+.+..+.+...+ +..|.+.++...|.++.....-... ....+.+++|+.+|.+.+.|-+.. ...++
T Consensus 1254 ~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld 1333 (2724)
T KOG1826|consen 1254 WFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLD 1333 (2724)
T ss_pred eeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcch
Confidence 34566655443332222 2334444555678888776654432 344688999999999998875432 12233
Q ss_pred HHHHHHHHHHHHhhhchhcccC--CCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcceeecccccccccChhhh
Q 046750 457 WTKRVKIALGAAKGLAYLHEDC--HPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYA 534 (723)
Q Consensus 457 ~~~~~~i~~~ia~gL~yLH~~g--~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~ 534 (723)
...+...-.+.+....-+|+.. ..-.+|++||.-|.+|+.+..+|+.++|+.+..... ....+..+++..|+.++..
T Consensus 1334 ~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~-~sf~Gl~l~sp~~v~qli~ 1412 (2724)
T KOG1826|consen 1334 RSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV-LSFFGLELCSPIYVLQLIK 1412 (2724)
T ss_pred hchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCch-HhhhhhhhCCHHHHHHHHH
Confidence 3322222222244444444331 123789999999999999999999999999833322 2223445678899999999
Q ss_pred ccCCCCCccceechHHHHHHHHhCCCCC
Q 046750 535 SSGKLTDRSDVFSFGVVLLELITGRKPV 562 (723)
Q Consensus 535 ~~~~~t~ksDVwSlGviL~eLltG~~P~ 562 (723)
..-.++.++|+|..++.+|++..|..+|
T Consensus 1413 N~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1413 NEIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred HHHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence 9889999999999999999998775543
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.027 Score=61.19 Aligned_cols=73 Identities=16% Similarity=0.162 Sum_probs=47.8
Q ss_pred EEeccCcEEEEEEEcCCC-cEEEEEEcccCC-------chhHHHHHHHHHHHHHcc--CC-ceeeEeeeeecccceEEEE
Q 046750 367 VIGEGGFGCVYKGNLPEG-KVVAVKQLKSGS-------GQGEREFRAEVEIISRVH--HR-HLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 367 ~LG~G~fG~Vy~~~~~~g-~~VAvK~l~~~~-------~~~~~~~~~Ei~il~~l~--Hp-nIv~l~g~~~~~~~~~lV~ 435 (723)
.||.|....||++...+| +.|+||+-.... .........|.+.|+.+. -| .+.+++. .+.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence 479999999999987655 689999854221 122334556778887763 24 3444543 3455667999
Q ss_pred EecCCC
Q 046750 436 EFVPNN 441 (723)
Q Consensus 436 E~~~~g 441 (723)
|++...
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 998654
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.0023 Score=64.54 Aligned_cols=121 Identities=17% Similarity=0.215 Sum_probs=59.4
Q ss_pred CcEEEEEEcccCCchhHHHHHHHHHHHHHccCCc-eeeEeeeeecccceEEEEEecCCCchhhc-c--------------
Q 046750 384 GKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRH-LVSLVGYCISEKNRLLIYEFVPNNNLEHH-L-------------- 447 (723)
Q Consensus 384 g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~-l-------------- 447 (723)
.+.|+||+..... ...-+...|+.+++.+..-+ -.++++++.+ .+|++|+.+..|..- +
T Consensus 2 ~~~~~~Ri~g~~t-~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~----g~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~ 76 (211)
T PF01633_consen 2 PEKYLVRIPGEGT-ENFIDRENENEALKLLSEAGLGPKIIYFFEN----GRVEEFIEGRTLSPEDFRNPEILKRIAKLLA 76 (211)
T ss_dssp TSEEEEEEEESCG-CSHHHHHHHHHHHHHHHHTTSSS-EEEEETT----EEEEE--SSEE--CGGGGSHHHHHHHHHHHH
T ss_pred CCEEEEEeCCCCc-ccccCHHHHHHHHHHHHHcCCCCeEEEEcCC----CcEEEEecccccChhhccChHHHHHHHHHHH
Confidence 4678888887653 22346678999999986444 4566665533 367799966655221 1
Q ss_pred --cc-----CCCCcchHHHHHHH----------------------HHHHHhhhchhcc----c-CCCceeecCCCCCcEE
Q 046750 448 --HG-----KGQPVLEWTKRVKI----------------------ALGAAKGLAYLHE----D-CHPKIIHRDIKSANIL 493 (723)
Q Consensus 448 --~~-----~~~~~l~~~~~~~i----------------------~~~ia~gL~yLH~----~-g~~~ivHrDIkp~NIL 493 (723)
|. ......-|..+.++ ...+.+-+..|.+ . ...-++|+||.+.|||
T Consensus 77 ~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil 156 (211)
T PF01633_consen 77 KLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNIL 156 (211)
T ss_dssp HHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEE
T ss_pred HHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEE
Confidence 11 00111111222111 0111111111111 0 0124899999999999
Q ss_pred e-CCCCcEEEeeccccc
Q 046750 494 V-DDEFEAQVADFGLAK 509 (723)
Q Consensus 494 l-~~~~~vkL~DFGla~ 509 (723)
+ +.++.++|+||.++.
T Consensus 157 ~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 157 INNKDGEVKLIDFEYAG 173 (211)
T ss_dssp ETSSSSCEEE--GTT-E
T ss_pred eccCCCeEEEecHHHHh
Confidence 9 888999999999885
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.02 E-value=0.0038 Score=66.76 Aligned_cols=136 Identities=16% Similarity=0.180 Sum_probs=81.6
Q ss_pred ceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeeccccc
Q 046750 430 NRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK 509 (723)
Q Consensus 430 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 509 (723)
..|++|++. |+.|...- ...|.+.+.|+++.+..|.-|..+- .+-|||+.-.||||+ +|+|.|+||-+++
T Consensus 300 y~yl~~kdh-gt~is~ik------~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfklsR 369 (488)
T COG5072 300 YLYLHFKDH-GTPISIIK------ADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKLSR 369 (488)
T ss_pred EEEEEEecC-Cceeeeee------cccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeeeee
Confidence 345666665 55553321 2467888999999988888887765 789999999999999 8999999999998
Q ss_pred ccCCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCC
Q 046750 510 LNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGD 589 (723)
Q Consensus 510 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~ 589 (723)
+-..... .. ...+--|-++.| .-+..=|||-+- --|+.|+- ....-...+-|..-+..+.+..++
T Consensus 370 l~~~q~~-is-----y~rldhp~lF~G-~dd~QFeIYrlM---r~l~~g~w-----a~F~P~TNvlWL~yLs~~llkk~~ 434 (488)
T COG5072 370 LSYSQGI-IS-----YNRLDHPDLFNG-VDDYQFEIYRLM---RRLLKGRW-----AQFEPITNVLWLYYLSHQLLKKKN 434 (488)
T ss_pred cccCCce-ee-----ccccCchhhhcC-ccceeeeHHHHH---HHHhcCcH-----HhcccchhhHHHHHHHHHHHhhcc
Confidence 4332222 11 112334444443 224444554332 22333331 111223445676666655555554
Q ss_pred c
Q 046750 590 L 590 (723)
Q Consensus 590 l 590 (723)
+
T Consensus 435 ~ 435 (488)
T COG5072 435 L 435 (488)
T ss_pred c
Confidence 3
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.0041 Score=66.58 Aligned_cols=64 Identities=9% Similarity=0.148 Sum_probs=40.3
Q ss_pred EEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCC--ceeeEeee------eecccceEEEEEecCCCch
Q 046750 375 CVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHR--HLVSLVGY------CISEKNRLLIYEFVPNNNL 443 (723)
Q Consensus 375 ~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~g~------~~~~~~~~lV~E~~~~gsL 443 (723)
.||+....+| .+++|++... ...+..|+.++..|... .+.+++.. ...++..++|+||++|..+
T Consensus 11 ~v~~v~t~~g-~~~LK~~~~~----~~~~~~~~~~~~~L~~~g~~vp~~i~t~~g~~~~~~~~~~~~l~~~i~G~~~ 82 (313)
T TIGR02906 11 NVYKVETDSG-NKCLKKINYP----PERLLFILGAQEHLRKNGFNIPKILKTKDGELYVKYNGDLYVLTEWIEGREC 82 (313)
T ss_pred cEEEEEeCCC-CeEEEEcCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEehhccCcCC
Confidence 4899876555 5888987531 23456678888887533 33344321 1234567899999988654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.015 Score=62.96 Aligned_cols=93 Identities=11% Similarity=0.101 Sum_probs=55.7
Q ss_pred cCHHHHHHHhcCcccc---e-EEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCC--ceeeEe-
Q 046750 350 FTYEELMEITNGFARE---N-VIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHR--HLVSLV- 422 (723)
Q Consensus 350 ~~~~~l~~~~~~f~~~---~-~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~- 422 (723)
++-+.+..+...+-+. + .+=.+.-..||+....+|..+++|+.+... ....++..|++++..|... .++..+
T Consensus 11 l~p~~~~~a~~~~g~~~~~~~~~l~s~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~~ 89 (325)
T PRK11768 11 LTPDLILDALESLGLRVDGRLLALNSYENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPLA 89 (325)
T ss_pred CChHHHHHHHHHcCCCCccceEeeccccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCcc
Confidence 4445555554444221 1 222345568999988888899999886432 3456677899998888421 122211
Q ss_pred --e--eeecccceEEEEEecCCCch
Q 046750 423 --G--YCISEKNRLLIYEFVPNNNL 443 (723)
Q Consensus 423 --g--~~~~~~~~~lV~E~~~~gsL 443 (723)
| +...++..+.|++|+.|..+
T Consensus 90 ~~G~~~~~~~g~~~~l~~~~~G~~~ 114 (325)
T PRK11768 90 FNGQTLHEHQGFRFALFPRRGGRAP 114 (325)
T ss_pred CCCCEEEEECCEEEEEEeeeCCCCC
Confidence 1 12224557789999987643
|
|
| >PTZ00382 Variant-specific surface protein (VSP); Provisional | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.00051 Score=60.08 Aligned_cols=23 Identities=26% Similarity=0.212 Sum_probs=16.1
Q ss_pred CCCCCCceeehhhhHHHHHHHHH
Q 046750 257 SSSNDDQAIIGATAAGVVLIVLI 279 (723)
Q Consensus 257 ~~~~~~~~ii~~~~~~~~~l~~l 279 (723)
.++++.++|+||++++++++.+|
T Consensus 60 ~~~ls~gaiagi~vg~~~~v~~l 82 (96)
T PTZ00382 60 RSGLSTGAIAGISVAVVAVVGGL 82 (96)
T ss_pred CCCcccccEEEEEeehhhHHHHH
Confidence 45677789999888766555444
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 723 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-70 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 6e-70 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-52 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-52 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-43 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-42 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-42 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-40 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 7e-28 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-27 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-27 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-27 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 7e-27 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-24 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-23 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-23 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-23 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-23 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 7e-23 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 7e-23 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 7e-23 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 8e-23 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 8e-23 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 9e-23 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 9e-23 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-22 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-22 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-22 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-22 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-22 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-22 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-22 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-22 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-22 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-22 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-22 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-22 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-22 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-22 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-22 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-22 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-22 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-22 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-22 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-22 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-22 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-22 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-22 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-22 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-22 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-22 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-22 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-22 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-22 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-22 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-22 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-22 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 6e-22 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 8e-22 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 8e-22 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-21 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-21 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-21 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-21 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-21 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-21 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-21 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-21 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-21 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 7e-21 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 8e-21 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 8e-21 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 9e-21 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 9e-21 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 9e-21 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 9e-21 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 9e-21 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 9e-21 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 9e-21 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 9e-21 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-20 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-20 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-20 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-20 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-20 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-20 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-20 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-20 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-20 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-20 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-20 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-20 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-20 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-20 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-20 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-20 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-20 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-20 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-20 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-20 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-20 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-20 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-20 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-20 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-20 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-20 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-20 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-20 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-20 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-20 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-20 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-20 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-20 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 5e-20 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 5e-20 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 5e-20 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-20 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 5e-20 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 5e-20 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 5e-20 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 6e-20 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 7e-20 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 7e-20 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-20 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-20 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 7e-20 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 7e-20 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 8e-20 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 9e-20 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-19 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-19 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-19 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-19 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-19 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-19 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-19 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-19 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-19 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-19 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-19 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-19 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-19 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-19 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-19 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 5e-19 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 6e-19 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-19 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 7e-19 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 7e-19 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 8e-19 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 9e-19 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-19 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-18 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-18 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-18 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-18 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-18 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-18 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-18 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-18 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-18 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-18 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-18 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-18 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-18 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-18 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-18 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-18 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-18 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-18 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-18 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-18 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-18 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-18 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-18 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-18 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-18 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-18 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-18 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-18 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-18 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-18 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-18 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-18 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-18 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 5e-18 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-18 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-18 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 5e-18 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-18 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 5e-18 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-18 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 5e-18 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 5e-18 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-18 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-18 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-18 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-18 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 6e-18 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-18 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-18 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 7e-18 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 7e-18 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 7e-18 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 8e-18 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-17 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-17 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-17 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-17 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-17 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-17 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-17 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-17 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-17 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-17 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-17 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-17 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-17 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-17 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-17 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-17 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-17 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-17 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-17 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-17 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-17 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-17 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-17 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-17 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-17 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-17 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-17 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-17 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-17 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-17 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 6e-17 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 6e-17 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 7e-17 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 7e-17 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 7e-17 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-17 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 9e-17 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 9e-17 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 9e-17 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-16 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-16 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-16 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-16 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-16 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-16 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-16 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-16 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-16 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-16 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-16 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-16 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-16 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-16 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-16 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-16 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-16 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-16 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-16 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-16 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-16 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-16 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-16 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-16 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-16 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-16 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-16 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-16 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-16 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-16 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 6e-16 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 6e-16 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-16 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 8e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-16 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 9e-16 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-15 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-15 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-15 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-15 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-15 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-15 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-15 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-15 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-15 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-15 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-15 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-15 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-15 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-15 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 5e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-15 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 6e-15 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 6e-15 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 6e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 6e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 7e-15 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 7e-15 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 7e-15 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-15 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 8e-15 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 8e-15 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-15 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 8e-15 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-15 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 9e-15 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 9e-15 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-14 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-14 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-14 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-14 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-14 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-14 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-14 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-14 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-14 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-14 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-14 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-14 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-14 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-14 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-14 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-14 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-14 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-14 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-14 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-14 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-14 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-14 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-14 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-14 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-14 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-14 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-14 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-14 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-14 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 4e-14 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-14 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 6e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 6e-14 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-14 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 7e-14 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 8e-14 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 8e-14 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 8e-14 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 9e-14 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-14 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 9e-14 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 9e-14 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-14 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 9e-14 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-14 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 9e-14 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 9e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-13 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-13 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-13 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-13 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-13 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-13 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-13 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-13 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-13 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-13 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-13 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-13 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-13 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-13 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-13 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-13 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-13 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-13 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-13 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-13 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-13 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-13 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-13 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-13 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-13 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-13 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-13 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-13 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-13 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-13 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-13 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-13 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-13 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-13 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-13 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-13 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-13 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-13 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-13 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-13 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-13 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-13 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-13 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-13 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-13 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 5e-13 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-13 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-13 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 5e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-13 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 5e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-13 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-13 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-13 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-13 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 7e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-13 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 8e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 8e-13 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 9e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-12 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-12 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-12 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-12 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-12 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-12 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-12 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-12 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-12 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-12 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-12 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-12 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-12 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-12 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-12 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-12 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-12 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-12 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-12 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 7e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 8e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-11 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-11 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-11 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-11 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-11 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-11 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-11 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-11 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-11 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-11 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-11 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-11 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-11 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-11 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-11 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-11 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-11 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-11 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-11 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-11 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-11 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-11 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-11 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 4e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-11 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-11 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 5e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-11 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 5e-11 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 6e-11 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 6e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 7e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 7e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 7e-11 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 8e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 9e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-10 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-10 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-10 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-10 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-10 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-10 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-10 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-10 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-10 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-10 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-10 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-10 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-10 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-10 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-10 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-10 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-10 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-10 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-10 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-10 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-10 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-10 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-10 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-10 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-10 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-10 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-10 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-10 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-10 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-10 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-10 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-10 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-10 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-10 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-10 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-10 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-10 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-10 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-10 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-10 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 5e-10 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-10 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 5e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-10 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 6e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 6e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-10 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 6e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-10 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 6e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-10 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 6e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 7e-10 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 7e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-10 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 7e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 8e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 8e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 8e-10 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 8e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 9e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 9e-10 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 9e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 9e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-09 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-09 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-09 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-09 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-09 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-09 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-09 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-09 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-09 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 7e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 7e-09 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 7e-09 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 7e-09 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 7e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 8e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 9e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 9e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 9e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 9e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 9e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 9e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-08 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-08 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-08 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-08 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-08 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-08 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-08 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-08 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-08 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-08 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-08 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-08 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-08 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-08 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-08 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-08 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-08 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-08 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-08 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-08 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-08 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-08 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-08 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-08 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-08 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 5e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 5e-08 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 6e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 6e-08 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 6e-08 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 6e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-08 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 7e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 7e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 7e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 7e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 7e-08 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 8e-08 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 8e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 9e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-07 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-07 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-07 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-07 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-07 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-07 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-07 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 3e-07 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 3e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 5e-07 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 7e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 8e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 8e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 8e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 9e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 9e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 9e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 9e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 9e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-06 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-06 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-06 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-06 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-06 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 5e-06 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 5e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 5e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 6e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 6e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 7e-06 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 7e-06 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 7e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 7e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 7e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 7e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 7e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 8e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 8e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 8e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 8e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 8e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 8e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 8e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 8e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 8e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 8e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 8e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 8e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 9e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 9e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 9e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 9e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 9e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 9e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 9e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-05 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-05 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-05 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-05 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-05 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-05 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-05 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-05 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-05 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-05 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-05 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-05 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-05 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 3e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 723 | |||
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 0.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 0.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 1e-173 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 4e-96 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 2e-70 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 1e-65 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 8e-65 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 5e-64 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 2e-63 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 4e-63 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 4e-61 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 2e-60 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 1e-59 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 1e-59 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 1e-58 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 1e-58 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 2e-56 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 9e-56 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 2e-45 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 6e-44 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 1e-43 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 2e-43 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 4e-43 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 8e-43 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 2e-42 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 2e-04 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 2e-42 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 6e-42 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 6e-42 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 8e-42 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 1e-41 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 1e-41 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 2e-41 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 2e-41 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 2e-41 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 3e-41 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 3e-41 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 3e-41 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 4e-41 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 7e-41 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 1e-40 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 1e-40 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 2e-40 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 2e-40 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 3e-40 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 3e-40 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 4e-40 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 4e-40 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 5e-40 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 6e-40 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 9e-40 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 1e-39 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 2e-39 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 3e-39 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 6e-39 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 6e-39 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 1e-38 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 1e-38 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 1e-38 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 2e-38 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 2e-38 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 4e-38 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 8e-38 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 1e-37 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 2e-37 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 2e-37 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 4e-37 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 8e-37 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 2e-36 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 2e-36 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 2e-36 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 2e-36 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 3e-36 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 4e-36 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 6e-36 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 8e-36 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 1e-35 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 1e-35 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 2e-35 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 2e-35 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 2e-35 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 2e-35 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 4e-35 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 7e-35 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 8e-35 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 1e-34 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 1e-34 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 2e-33 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 2e-33 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 1e-32 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 3e-32 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 3e-07 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 9e-06 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 3e-32 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 4e-31 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 8e-31 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 1e-30 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 2e-30 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 2e-30 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 3e-30 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 1e-29 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-29 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 3e-29 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 5e-29 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 6e-29 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 7e-29 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 1e-28 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 2e-28 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 2e-28 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 3e-28 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 5e-28 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 1e-27 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 2e-27 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 2e-27 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 3e-27 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 3e-27 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 5e-27 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 5e-27 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 8e-27 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 2e-26 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 4e-26 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 4e-26 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 7e-26 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 9e-26 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 9e-26 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 1e-25 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 1e-25 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 4e-25 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 5e-25 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 2e-24 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 4e-24 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 5e-24 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 7e-24 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 8e-24 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 9e-24 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 2e-23 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 3e-23 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 3e-23 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 4e-23 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 6e-23 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 8e-23 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 9e-23 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 1e-22 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 2e-22 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 3e-22 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 5e-22 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 8e-22 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 8e-22 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 1e-21 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 1e-21 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 1e-21 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 2e-21 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 2e-21 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 2e-21 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 2e-21 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 2e-21 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 4e-21 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 5e-21 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 6e-21 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 6e-21 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 6e-21 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 9e-21 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 9e-21 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 1e-20 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 1e-20 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 1e-20 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 1e-20 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 2e-20 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 2e-20 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 2e-20 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 3e-20 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 3e-20 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 3e-20 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 4e-20 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 5e-20 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 7e-20 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 7e-20 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 9e-20 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 1e-19 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 1e-19 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 1e-19 | |
| 1twf_A | 1733 | B220, DNA-directed RNA polymerase II largest subun | 1e-19 | |
| 1twf_A | 1733 | B220, DNA-directed RNA polymerase II largest subun | 1e-18 | |
| 1twf_A | 1733 | B220, DNA-directed RNA polymerase II largest subun | 2e-18 | |
| 1twf_A | 1733 | B220, DNA-directed RNA polymerase II largest subun | 3e-18 | |
| 1twf_A | 1733 | B220, DNA-directed RNA polymerase II largest subun | 4e-14 | |
| 1twf_A | 1733 | B220, DNA-directed RNA polymerase II largest subun | 2e-09 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 2e-19 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 2e-19 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 2e-19 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 3e-19 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 3e-19 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 4e-19 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 4e-19 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 4e-19 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 6e-19 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 8e-19 | |
| 1m2v_B | 926 | SEC24, protein transport protein SEC24, SEC24P, SE | 1e-18 | |
| 1m2v_B | 926 | SEC24, protein transport protein SEC24, SEC24P, SE | 2e-16 | |
| 1m2v_B | 926 | SEC24, protein transport protein SEC24, SEC24P, SE | 6e-16 | |
| 1m2v_B | 926 | SEC24, protein transport protein SEC24, SEC24P, SE | 3e-14 | |
| 1m2v_B | 926 | SEC24, protein transport protein SEC24, SEC24P, SE | 9e-13 | |
| 1m2v_B | 926 | SEC24, protein transport protein SEC24, SEC24P, SE | 2e-11 | |
| 1m2v_B | 926 | SEC24, protein transport protein SEC24, SEC24P, SE | 2e-08 | |
| 1m2v_B | 926 | SEC24, protein transport protein SEC24, SEC24P, SE | 3e-04 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 1e-18 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 1e-18 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 2e-18 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 2e-18 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 2e-18 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 3e-18 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 3e-18 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 3e-18 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 4e-18 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 5e-18 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 6e-18 | |
| 3h0g_A | 1752 | DNA-directed RNA polymerase II subunit RPB1; trans | 6e-18 | |
| 3h0g_A | 1752 | DNA-directed RNA polymerase II subunit RPB1; trans | 7e-17 | |
| 3h0g_A | 1752 | DNA-directed RNA polymerase II subunit RPB1; trans | 2e-16 | |
| 3h0g_A | 1752 | DNA-directed RNA polymerase II subunit RPB1; trans | 2e-15 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 6e-18 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 7e-18 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 7e-18 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 1e-17 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 1e-17 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 2e-17 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 2e-17 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 2e-17 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 3e-17 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 5e-17 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 9e-17 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 1e-16 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 2e-16 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 7e-16 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 3e-15 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 3e-15 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 3e-15 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 4e-15 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 6e-15 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 7e-15 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 5e-14 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 6e-14 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 1e-13 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 2e-13 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 5e-13 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 6e-13 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 1e-12 | |
| 3v1v_A | 433 | 2-MIB synthase, 2-methylisoborneol synthase; class | 2e-12 | |
| 3v1v_A | 433 | 2-MIB synthase, 2-methylisoborneol synthase; class | 2e-11 | |
| 3v1v_A | 433 | 2-MIB synthase, 2-methylisoborneol synthase; class | 3e-10 | |
| 3v1v_A | 433 | 2-MIB synthase, 2-methylisoborneol synthase; class | 3e-09 | |
| 3v1v_A | 433 | 2-MIB synthase, 2-methylisoborneol synthase; class | 2e-08 | |
| 3v1v_A | 433 | 2-MIB synthase, 2-methylisoborneol synthase; class | 2e-08 | |
| 3v1v_A | 433 | 2-MIB synthase, 2-methylisoborneol synthase; class | 2e-06 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 3e-12 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 3e-12 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 8e-12 | |
| 3gdb_A | 937 | Endo-D, putative uncharacterized protein SPR0440; | 8e-12 | |
| 3gdb_A | 937 | Endo-D, putative uncharacterized protein SPR0440; | 4e-11 | |
| 3gdb_A | 937 | Endo-D, putative uncharacterized protein SPR0440; | 1e-09 | |
| 3gdb_A | 937 | Endo-D, putative uncharacterized protein SPR0440; | 2e-06 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 1e-11 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 1e-11 | |
| 1deq_A | 390 | Fibrinogen (alpha chain); coiled-coil, blood clott | 2e-11 | |
| 1deq_A | 390 | Fibrinogen (alpha chain); coiled-coil, blood clott | 1e-10 | |
| 1deq_A | 390 | Fibrinogen (alpha chain); coiled-coil, blood clott | 9e-10 | |
| 1deq_A | 390 | Fibrinogen (alpha chain); coiled-coil, blood clott | 2e-09 | |
| 1deq_A | 390 | Fibrinogen (alpha chain); coiled-coil, blood clott | 3e-09 | |
| 1deq_A | 390 | Fibrinogen (alpha chain); coiled-coil, blood clott | 1e-07 | |
| 1deq_A | 390 | Fibrinogen (alpha chain); coiled-coil, blood clott | 2e-05 | |
| 1deq_A | 390 | Fibrinogen (alpha chain); coiled-coil, blood clott | 6e-04 | |
| 2wvr_C | 546 | DNA replication factor CDT1; DNA replication licen | 7e-11 | |
| 2wvr_C | 546 | DNA replication factor CDT1; DNA replication licen | 3e-10 | |
| 2wvr_C | 546 | DNA replication factor CDT1; DNA replication licen | 9e-09 | |
| 2wvr_C | 546 | DNA replication factor CDT1; DNA replication licen | 3e-08 | |
| 2wvr_C | 546 | DNA replication factor CDT1; DNA replication licen | 5e-08 | |
| 2wvr_C | 546 | DNA replication factor CDT1; DNA replication licen | 2e-05 | |
| 2wvr_C | 546 | DNA replication factor CDT1; DNA replication licen | 2e-05 | |
| 2wvr_C | 546 | DNA replication factor CDT1; DNA replication licen | 1e-04 | |
| 3dzy_A | 467 | Retinoic acid receptor RXR-alpha; DNA-binding, HOS | 1e-10 | |
| 3dzy_A | 467 | Retinoic acid receptor RXR-alpha; DNA-binding, HOS | 2e-09 | |
| 3dzy_A | 467 | Retinoic acid receptor RXR-alpha; DNA-binding, HOS | 3e-09 | |
| 3dzy_A | 467 | Retinoic acid receptor RXR-alpha; DNA-binding, HOS | 1e-07 | |
| 3dzy_A | 467 | Retinoic acid receptor RXR-alpha; DNA-binding, HOS | 2e-06 | |
| 3dzy_A | 467 | Retinoic acid receptor RXR-alpha; DNA-binding, HOS | 4e-06 | |
| 3dzy_A | 467 | Retinoic acid receptor RXR-alpha; DNA-binding, HOS | 6e-06 | |
| 3dzy_A | 467 | Retinoic acid receptor RXR-alpha; DNA-binding, HOS | 4e-05 | |
| 3pgw_B | 231 | SM B; protein-RNA complex, U1 snRNA, SM fold, SM c | 2e-10 | |
| 3pgw_B | 231 | SM B; protein-RNA complex, U1 snRNA, SM fold, SM c | 6e-09 | |
| 3pgw_B | 231 | SM B; protein-RNA complex, U1 snRNA, SM fold, SM c | 6e-09 | |
| 3pgw_B | 231 | SM B; protein-RNA complex, U1 snRNA, SM fold, SM c | 2e-08 | |
| 3pgw_B | 231 | SM B; protein-RNA complex, U1 snRNA, SM fold, SM c | 6e-05 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 2e-10 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 3e-10 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 3e-10 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 2e-09 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 1e-08 | |
| 2z73_A | 448 | Rhodopsin; visual pigment, GQ-type, G-protein coup | 2e-08 | |
| 2z73_A | 448 | Rhodopsin; visual pigment, GQ-type, G-protein coup | 1e-07 | |
| 2z73_A | 448 | Rhodopsin; visual pigment, GQ-type, G-protein coup | 1e-06 | |
| 2z73_A | 448 | Rhodopsin; visual pigment, GQ-type, G-protein coup | 4e-06 | |
| 2z73_A | 448 | Rhodopsin; visual pigment, GQ-type, G-protein coup | 6e-06 | |
| 2z73_A | 448 | Rhodopsin; visual pigment, GQ-type, G-protein coup | 5e-05 | |
| 3ghg_A | 562 | Fibrinogen alpha chain; triple-stranded coiled coi | 4e-08 | |
| 3ghg_A | 562 | Fibrinogen alpha chain; triple-stranded coiled coi | 2e-05 | |
| 3ghg_A | 562 | Fibrinogen alpha chain; triple-stranded coiled coi | 1e-04 | |
| 3tx7_B | 352 | Nuclear receptor subfamily 5 group A member 2; LRH | 5e-08 | |
| 3tx7_B | 352 | Nuclear receptor subfamily 5 group A member 2; LRH | 2e-06 | |
| 3tx7_B | 352 | Nuclear receptor subfamily 5 group A member 2; LRH | 2e-05 | |
| 3tx7_B | 352 | Nuclear receptor subfamily 5 group A member 2; LRH | 3e-05 | |
| 2grx_C | 229 | Protein TONB; beta barrel, outer membrane, heteroc | 5e-08 | |
| 2grx_C | 229 | Protein TONB; beta barrel, outer membrane, heteroc | 2e-06 | |
| 2grx_C | 229 | Protein TONB; beta barrel, outer membrane, heteroc | 2e-05 | |
| 2grx_C | 229 | Protein TONB; beta barrel, outer membrane, heteroc | 2e-05 | |
| 2grx_C | 229 | Protein TONB; beta barrel, outer membrane, heteroc | 3e-05 | |
| 3nwa_A | 703 | GB, GB-1, GB1, envelope glycoprotein B; coiled-coi | 5e-08 | |
| 3nwa_A | 703 | GB, GB-1, GB1, envelope glycoprotein B; coiled-coi | 8e-08 | |
| 3nwa_A | 703 | GB, GB-1, GB1, envelope glycoprotein B; coiled-coi | 1e-07 | |
| 3nwa_A | 703 | GB, GB-1, GB1, envelope glycoprotein B; coiled-coi | 3e-06 | |
| 3nwa_A | 703 | GB, GB-1, GB1, envelope glycoprotein B; coiled-coi | 5e-05 | |
| 3nwa_A | 703 | GB, GB-1, GB1, envelope glycoprotein B; coiled-coi | 7e-05 | |
| 3nwa_A | 703 | GB, GB-1, GB1, envelope glycoprotein B; coiled-coi | 1e-04 | |
| 1pk8_A | 422 | RAT synapsin I; ATP binding, ATP grAsp, calcium (I | 6e-08 | |
| 1pk8_A | 422 | RAT synapsin I; ATP binding, ATP grAsp, calcium (I | 7e-08 | |
| 1pk8_A | 422 | RAT synapsin I; ATP binding, ATP grAsp, calcium (I | 9e-08 | |
| 1pk8_A | 422 | RAT synapsin I; ATP binding, ATP grAsp, calcium (I | 2e-07 | |
| 1pk8_A | 422 | RAT synapsin I; ATP binding, ATP grAsp, calcium (I | 2e-05 | |
| 1pk8_A | 422 | RAT synapsin I; ATP binding, ATP grAsp, calcium (I | 3e-05 | |
| 1pk8_A | 422 | RAT synapsin I; ATP binding, ATP grAsp, calcium (I | 2e-04 | |
| 1pk8_A | 422 | RAT synapsin I; ATP binding, ATP grAsp, calcium (I | 2e-04 | |
| 1pk8_A | 422 | RAT synapsin I; ATP binding, ATP grAsp, calcium (I | 3e-04 | |
| 1pk8_A | 422 | RAT synapsin I; ATP binding, ATP grAsp, calcium (I | 4e-04 | |
| 3dva_I | 428 | Dihydrolipoyllysine-residue acetyltransferase comp | 4e-07 | |
| 3dva_I | 428 | Dihydrolipoyllysine-residue acetyltransferase comp | 1e-05 | |
| 3dva_I | 428 | Dihydrolipoyllysine-residue acetyltransferase comp | 3e-05 | |
| 3dva_I | 428 | Dihydrolipoyllysine-residue acetyltransferase comp | 3e-04 | |
| 3dva_I | 428 | Dihydrolipoyllysine-residue acetyltransferase comp | 7e-04 | |
| 1mv3_A | 213 | MYC box dependent interacting protein 1; tumor sup | 9e-07 | |
| 1mv3_A | 213 | MYC box dependent interacting protein 1; tumor sup | 2e-06 | |
| 1mv3_A | 213 | MYC box dependent interacting protein 1; tumor sup | 9e-06 | |
| 1mv3_A | 213 | MYC box dependent interacting protein 1; tumor sup | 5e-04 | |
| 3odw_A | 536 | RHO guanine nucleotide exchange factor 1; regulati | 8e-06 | |
| 3odw_A | 536 | RHO guanine nucleotide exchange factor 1; regulati | 2e-05 | |
| 3odw_A | 536 | RHO guanine nucleotide exchange factor 1; regulati | 4e-05 | |
| 3u3p_A | 313 | Tumor necrosis factor receptor superfamily member; | 2e-05 | |
| 3i2d_A | 371 | E3 SUMO-protein ligase SIZ1; signal transduction, | 3e-05 | |
| 3i2d_A | 371 | E3 SUMO-protein ligase SIZ1; signal transduction, | 2e-04 | |
| 3i2d_A | 371 | E3 SUMO-protein ligase SIZ1; signal transduction, | 4e-04 | |
| 3i2d_A | 371 | E3 SUMO-protein ligase SIZ1; signal transduction, | 5e-04 | |
| 3oun_A | 157 | Putative uncharacterized protein TB39.8; peptidogl | 3e-05 | |
| 3oun_A | 157 | Putative uncharacterized protein TB39.8; peptidogl | 8e-05 | |
| 3oun_A | 157 | Putative uncharacterized protein TB39.8; peptidogl | 3e-04 | |
| 3oun_A | 157 | Putative uncharacterized protein TB39.8; peptidogl | 3e-04 | |
| 3oun_A | 157 | Putative uncharacterized protein TB39.8; peptidogl | 4e-04 | |
| 3oun_A | 157 | Putative uncharacterized protein TB39.8; peptidogl | 5e-04 | |
| 2uv9_A | 1878 | Fatty acid synthase alpha subunits; fungal, dehydr | 3e-05 | |
| 2uv9_A | 1878 | Fatty acid synthase alpha subunits; fungal, dehydr | 3e-04 | |
| 2uv9_A | 1878 | Fatty acid synthase alpha subunits; fungal, dehydr | 4e-04 | |
| 2uv9_A | 1878 | Fatty acid synthase alpha subunits; fungal, dehydr | 6e-04 | |
| 1dx0_A | 219 | Prion protein; brain, repeat; NMR {Bos taurus} SCO | 4e-05 | |
| 1dx0_A | 219 | Prion protein; brain, repeat; NMR {Bos taurus} SCO | 4e-05 | |
| 1dx0_A | 219 | Prion protein; brain, repeat; NMR {Bos taurus} SCO | 5e-05 | |
| 1dx0_A | 219 | Prion protein; brain, repeat; NMR {Bos taurus} SCO | 6e-04 | |
| 2uv8_A | 1887 | Fatty acid synthase subunit alpha (FAS2); fatty ac | 4e-05 | |
| 2uv8_A | 1887 | Fatty acid synthase subunit alpha (FAS2); fatty ac | 2e-04 | |
| 2uv8_A | 1887 | Fatty acid synthase subunit alpha (FAS2); fatty ac | 2e-04 | |
| 2uv8_A | 1887 | Fatty acid synthase subunit alpha (FAS2); fatty ac | 3e-04 | |
| 2uv8_A | 1887 | Fatty acid synthase subunit alpha (FAS2); fatty ac | 4e-04 | |
| 2uv8_A | 1887 | Fatty acid synthase subunit alpha (FAS2); fatty ac | 5e-04 | |
| 2uv8_A | 1887 | Fatty acid synthase subunit alpha (FAS2); fatty ac | 6e-04 | |
| 2uv8_A | 1887 | Fatty acid synthase subunit alpha (FAS2); fatty ac | 8e-04 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 4e-05 | |
| 2yew_A | 253 | Capsid protein, coat protein; alphavirus, molecula | 5e-05 | |
| 2yew_A | 253 | Capsid protein, coat protein; alphavirus, molecula | 1e-04 | |
| 2yew_A | 253 | Capsid protein, coat protein; alphavirus, molecula | 2e-04 | |
| 3a58_A | 320 | Exocyst complex component SEC3; protein complex, P | 6e-05 | |
| 3a58_A | 320 | Exocyst complex component SEC3; protein complex, P | 1e-04 | |
| 3a58_A | 320 | Exocyst complex component SEC3; protein complex, P | 2e-04 | |
| 3a58_A | 320 | Exocyst complex component SEC3; protein complex, P | 7e-04 | |
| 3ttv_A | 753 | Catalase HPII; heme orientation, oxidoreductase; H | 7e-05 | |
| 3iz6_A | 305 | 40S ribosomal protein SA (S2P); eukaryotic ribosom | 2e-04 | |
| 1w7p_D | 566 | VPS36P, YLR417W; ESCRT-II complex, endosomal prote | 8e-04 | |
| 1pcx_A | 810 | Protein transport protein SEC24; 2.50A {Saccharomy | 8e-04 | |
| 2kpy_A | 108 | Major pollen allergen ART V 1; defensin-like, poly | 8e-04 |
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 560 bits (1445), Expect = 0.0
Identities = 140/312 (44%), Positives = 206/312 (66%), Gaps = 9/312 (2%)
Query: 338 PDSGVLGGSKSFFTYEELMEITNGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSG 397
D V G F+ EL ++ F+ +N++G GGFG VYKG L +G +VAVK+LK
Sbjct: 8 EDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERT 67
Query: 398 QG-EREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGK--GQPV 454
QG E +F+ EVE+IS HR+L+ L G+C++ RLL+Y ++ N ++ L + QP
Sbjct: 68 QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPP 127
Query: 455 LEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTT 514
L+W KR +IALG+A+GLAYLH+ C PKIIHRD+K+ANIL+D+EFEA V DFGLAKL D
Sbjct: 128 LDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 187
Query: 515 QTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDES-- 572
THV+T V GT G++APEY S+GK ++++DVF +GV+LLELITG++ D + D+
Sbjct: 188 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 247
Query: 573 LVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVV 632
L++W + +L + L +VD L+ +Y + E+ ++I+ A C + S +RP+M +VV
Sbjct: 248 LLDWVKGLL----KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVV 303
Query: 633 RALDSEGEMSDL 644
R L+ +G
Sbjct: 304 RMLEGDGLAERW 315
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 533 bits (1376), Expect = 0.0
Identities = 123/317 (38%), Positives = 174/317 (54%), Gaps = 10/317 (3%)
Query: 322 MHSYGSQRGVGYHGGGPDSGVLGGSKSFFTYEELMEITNGFARENVIGEGGFGCVYKGNL 381
M S S+ + S ++ +L E TN F + +IG G FG VYKG L
Sbjct: 1 MGSKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVL 60
Query: 382 PEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPNN 441
+G VA+K+ S QG EF E+E +S H HLVSL+G+C +LIY+++ N
Sbjct: 61 RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENG 120
Query: 442 NLEHHLHGKGQPV--LEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFE 499
NL+ HL+G P + W +R++I +GAA+GL YLH IIHRD+KS NIL+D+ F
Sbjct: 121 NLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFV 177
Query: 500 AQVADFGLAKLN-DTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITG 558
++ DFG++K + QTH+ST V GT GY+ PEY G+LT++SDV+SFGVVL E++
Sbjct: 178 PKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCA 237
Query: 559 RKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACV 618
R + + P +L EWA G L +IVDP L + + + A C+
Sbjct: 238 RSAIVQSLPREMVNLAEWAVESH----NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCL 293
Query: 619 RHSGPKRPRMVQVVRAL 635
S RP M V+ L
Sbjct: 294 ALSSEDRPSMGDVLWKL 310
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 495 bits (1278), Expect = e-173
Identities = 107/308 (34%), Positives = 173/308 (56%), Gaps = 23/308 (7%)
Query: 342 VLGGSKSFFTYEELMEITNGFARE------NVIGEGGFGCVYKGNLPEGKVVAVKQLKSG 395
V F++ EL +TN F N +GEGGFG VYKG + VAVK+L +
Sbjct: 7 VSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAM 65
Query: 396 ----SGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHG-K 450
+ + +++F E++++++ H +LV L+G+ + L+Y ++PN +L L
Sbjct: 66 VDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD 125
Query: 451 GQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKL 510
G P L W R KIA GAA G+ +LHE+ IHRDIKSANIL+D+ F A+++DFGLA+
Sbjct: 126 GTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARA 182
Query: 511 NDT-TQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLG 569
++ QT +++R++GT Y+APE G++T +SD++SFGVVLLE+ITG VD +
Sbjct: 183 SEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHRE-- 239
Query: 570 DESLVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMV 629
+ L++ + E + + +D ++ + + M A+ C+ KRP +
Sbjct: 240 PQLLLDIKEEIE---DEEKTIEDYIDKKMND-ADSTSVEAMYSVASQCLHEKKNKRPDIK 295
Query: 630 QVVRALDS 637
+V + L
Sbjct: 296 KVQQLLQE 303
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 299 bits (768), Expect = 4e-96
Identities = 79/322 (24%), Positives = 123/322 (38%), Gaps = 32/322 (9%)
Query: 346 SKSFFTYEELMEITNGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRA 405
S E L + V G FGCV+K + VAVK Q +
Sbjct: 10 SGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQSW-QNEY 67
Query: 406 EVEIISRVHHRHLVSLVGYCI----SEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRV 461
EV + + H +++ +G + + LI F +L L V+ W +
Sbjct: 68 EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN---VVSWNELC 124
Query: 462 KIALGAAKGLAYLHED-------CHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTT 514
IA A+GLAYLHED P I HRDIKS N+L+ + A +ADFGLA +
Sbjct: 125 HIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAG 184
Query: 515 QTHV-STRVMGTFGYLAPEYASSG-----KLTDRSDVFSFGVVLLELITGRKPVDPTQPL 568
++ + +GT Y+APE R D+++ G+VL EL + D
Sbjct: 185 KSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE 244
Query: 569 GDESLVEWARPVLVRAIETGDLSEIV-----DPRLEKHYVESEMFR-MIEAAAACVRHSG 622
E + + D+ E+V P L ++ + + E C H
Sbjct: 245 YMLPFEEE----IGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDA 300
Query: 623 PKRPRMVQVVRALDSEGEMSDL 644
R V + ++++
Sbjct: 301 EARLSAGCVGERITQMQRLTNI 322
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 2e-70
Identities = 64/328 (19%), Positives = 121/328 (36%), Gaps = 43/328 (13%)
Query: 350 FTYEELMEITNGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEI 409
E + +IG G +G VYKG+L + + VAVK + + F E I
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNI 58
Query: 410 --ISRVHHRHLVSLVGYCI-----SEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVK 462
+ + H ++ + LL+ E+ PN +L +L +W +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS---LHTSDWVSSCR 115
Query: 463 IALGAAKGLAYLHED------CHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTT-- 514
+A +GLAYLH + P I HRD+ S N+LV ++ ++DFGL+
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175
Query: 515 -----QTHVSTRVMGTFGYLAPEYASS-------GKLTDRSDVFSFGVVLLELITGRKPV 562
+ + + +GT Y+APE + D+++ G++ E+ +
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235
Query: 563 DPTQPLGDESLVEWARPVLVRAIETGDLSEIVD-----PRLEKHYVESE--MFRMIEAAA 615
P + + + + E D+ +V P+ + + E+ + + E
Sbjct: 236 FPGESVPEYQMAFQTEVGNHPTFE--DMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293
Query: 616 ACVRHSGPKRPRMVQVVRALDSEGEMSD 643
C R + + +
Sbjct: 294 DCWDQDAEARLTAQXAEERMAELMMIWE 321
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 1e-65
Identities = 78/237 (32%), Positives = 132/237 (55%), Gaps = 26/237 (10%)
Query: 341 GVLGGSKSFFTYEELMEITNG-FARENVIGEGGFGCVYKGN-LPEGKVVAVKQLKSGSGQ 398
G +GGS+ F L + + E IG+GGFG V+KG + + VVA+K L G +
Sbjct: 1 GAMGGSE--FPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSE 58
Query: 399 GE-------REFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKG 451
GE +EF+ EV I+S ++H ++V L G + ++ EFVP +L H L K
Sbjct: 59 GETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKA 116
Query: 452 QPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFE-----AQVADFG 506
P ++W+ ++++ L A G+ Y+ + +P I+HRD++S NI + E A+VADFG
Sbjct: 117 HP-IKWSVKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174
Query: 507 LAKLNDTTQTHVSTRVMGTFGYLAPE--YASSGKLTDRSDVFSFGVVLLELITGRKP 561
L++ + + + ++G F ++APE A T+++D +SF ++L ++TG P
Sbjct: 175 LSQQSVHS----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP 227
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 216 bits (553), Expect = 8e-65
Identities = 73/208 (35%), Positives = 113/208 (54%), Gaps = 9/208 (4%)
Query: 365 ENVIGEGGFGCVYKGNLPEGKVVAVKQLKSG--SGQGEREFRAEVEIISRVHHRHLVSLV 422
+ IG G FG V++ G VAVK L + EF EV I+ R+ H ++V +
Sbjct: 42 KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 423 GYCISEKNRLLIYEFVPNNNLEHHLHGKGQ-PVLEWTKRVKIALGAAKGLAYLHEDCHPK 481
G N ++ E++ +L LH G L+ +R+ +A AKG+ YLH +P
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPP 159
Query: 482 IIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTD 541
I+HR++KS N+LVD ++ +V DFGL++L +T S GT ++APE +
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS-SKSAAGTPEWMAPEVLRDEPSNE 218
Query: 542 RSDVFSFGVVLLELITGRKP---VDPTQ 566
+SDV+SFGV+L EL T ++P ++P Q
Sbjct: 219 KSDVYSFGVILWELATLQQPWGNLNPAQ 246
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 5e-64
Identities = 67/199 (33%), Positives = 102/199 (51%), Gaps = 11/199 (5%)
Query: 365 ENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGY 424
E V+G G FG V K K VA+KQ++S S + F E+ +SRV+H ++V L G
Sbjct: 13 EEVVGRGAFGVVCKAKW-RAKDVAIKQIESESE--RKAFIVELRQLSRVNHPNIVKLYGA 69
Query: 425 CISEKNRLLIYEFVPNNNLEHHLHGKGQ-PVLEWTKRVKIALGAAKGLAYLHEDCHPKII 483
C+ L+ E+ +L + LHG P + L ++G+AYLH +I
Sbjct: 70 CL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
Query: 484 HRDIKSANILVDDEFE-AQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDR 542
HRD+K N+L+ ++ DFG A T T G+ ++APE +++
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTACDIQTH----MTNNKGSAAWMAPEVFEGSNYSEK 183
Query: 543 SDVFSFGVVLLELITGRKP 561
DVFS+G++L E+IT RKP
Sbjct: 184 CDVFSWGIILWEVITRRKP 202
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 2e-63
Identities = 71/217 (32%), Positives = 106/217 (48%), Gaps = 22/217 (10%)
Query: 365 ENVIGEGGFGCVYKGNLPEGKVVAVKQLKSG----SGQGEREFRAEVEIISRVHHRHLVS 420
E +IG GGFG VY+ G VAVK + Q R E ++ + + H ++++
Sbjct: 12 EEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 421 LVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHP 480
L G C+ E N L+ EF L L GK + V A+ A+G+ YLH++
Sbjct: 71 LRGVCLKEPNLCLVMEFARGGPLNRVLSGK---RIPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 481 KIIHRDIKSANILVDDEFEAQ--------VADFGLAKLNDTTQTHVSTRVMGTFGYLAPE 532
IIHRD+KS+NIL+ + E + DFGLA+ T G + ++APE
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK---MSAAGAYAWMAPE 184
Query: 533 YASSGKLTDRSDVFSFGVVLLELITGRKP---VDPTQ 566
+ + SDV+S+GV+L EL+TG P +D
Sbjct: 185 VIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA 221
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 4e-63
Identities = 64/283 (22%), Positives = 123/283 (43%), Gaps = 40/283 (14%)
Query: 365 ENVIGEGGFGCVYKGNLPEGKVVAVKQLKSG--SGQGEREFRAEVEIISRVHHRHLVSLV 422
+ E G ++KG +G + VK LK S + R+F E + H +++ ++
Sbjct: 15 LTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL 73
Query: 423 GYCIS--EKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHP 480
G C S + LI ++P +L + LH V++ ++ VK AL A+G+A+LH P
Sbjct: 74 GACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLEP 132
Query: 481 KIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPE---YASSG 537
I + S ++++D++ A+++ + + S M ++APE
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVKF------SFQSPGRMYAPAWVAPEALQKKPED 186
Query: 538 KLTDRSDVFSFGVVLLELITGRKP---VDPTQPLGDESLVEWARPVLVRAIETGDLSEIV 594
+D++SF V+L EL+T P + + +G + +E RP + +
Sbjct: 187 TNRRSADMWSFAVLLWELVTREVPFADLSNME-IGMKVALEGLRP---------TIPPGI 236
Query: 595 DPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDS 637
P + K +++ C+ KRP+ +V L+
Sbjct: 237 SPHVSK---------LMK---ICMNEDPAKRPKFDMIVPILEK 267
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 4e-61
Identities = 64/232 (27%), Positives = 102/232 (43%), Gaps = 21/232 (9%)
Query: 365 ENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVG 423
V+G+G FG K G+V+ +K+L + +R F EV+++ + H +++ +G
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 424 YCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKII 483
+K I E++ L + W++RV A A G+AYLH II
Sbjct: 75 VLYKDKRLNFITEYIKGGTLRGIIKSMDSQ-YPWSQRVSFAKDIASGMAYLHS---MNII 130
Query: 484 HRDIKSANILVDDEFEAQVADFGLAKLNDTTQTH-------------VSTRVMGTFGYLA 530
HRD+ S N LV + VADFGLA+L +T V+G ++A
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 531 PEYASSGKLTDRSDVFSFGVVLLELITGRKP---VDPTQPLGDESLVEWARP 579
PE + ++ DVFSFG+VL E+I P ++ +
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR 242
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 2e-60
Identities = 63/297 (21%), Positives = 124/297 (41%), Gaps = 34/297 (11%)
Query: 365 ENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEI--ISRVHHRHLVSLV 422
+G+G +G V++G+ +G+ VAVK S + E+ + E E+ + H +++ +
Sbjct: 13 LECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFI 68
Query: 423 GYCISEKNR----LLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHED- 477
++ ++ LI + +L +L L+ ++I L A GLA+LH +
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYLQ---LTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 478 ----CHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHV---STRVMGTFGYLA 530
P I HRD+KS NILV + +AD GLA ++ + + + +GT Y+A
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 531 PE------YASSGKLTDRSDVFSFGVVLLELITGRKPVDPT----QPLGDESLVEWARPV 580
PE R D+++FG+VL E+ P D + +
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFED 245
Query: 581 LVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDS 637
+ + + + R + + ++++ C + R +++ + L
Sbjct: 246 MRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMK---ECWYQNPSARLTALRIKKTLTK 299
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 1e-59
Identities = 68/203 (33%), Positives = 109/203 (53%), Gaps = 13/203 (6%)
Query: 365 ENVIGEGGFGCVYKGNLPEGKVVAVKQLKSG--SGQGEREFRAEVEIISRVHHRHLVSLV 422
IG G FG VYKG G V AVK L + Q + F+ EV ++ + H +++ +
Sbjct: 29 GQRIGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86
Query: 423 GYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKI 482
GY + ++ ++ ++L HHLH E K + IA A+G+ YLH I
Sbjct: 87 GYS-TAPQLAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHA---KSI 141
Query: 483 IHRDIKSANILVDDEFEAQVADFGLAKL-NDTTQTHVSTRVMGTFGYLAPE---YASSGK 538
IHRD+KS NI + ++ ++ DFGLA + + +H ++ G+ ++APE S
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 539 LTDRSDVFSFGVVLLELITGRKP 561
+ +SDV++FG+VL EL+TG+ P
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQLP 224
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 201 bits (512), Expect = 1e-58
Identities = 69/304 (22%), Positives = 116/304 (38%), Gaps = 34/304 (11%)
Query: 365 ENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEI--ISRVHHRHLVSLV 422
IG+G +G V+ G G+ VAVK + E + E EI + H +++ +
Sbjct: 42 VKQIGKGRYGEVWMGKW-RGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFI 97
Query: 423 GYCISEKNR----LLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHED- 477
I LI ++ N +L +L L+ +K+A + GL +LH +
Sbjct: 98 AADIKGTGSWTQLYLITDYHENGSLYDYLK---STTLDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 478 ----CHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHV---STRVMGTFGYLA 530
P I HRD+KS NILV +AD GLA + V +GT Y+
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214
Query: 531 PE------YASSGKLTDRSDVFSFGVVLLELITGRKPVDPT----QPLGDESLVEWARPV 580
PE + + +D++SFG++L E+ P D + +
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYED 274
Query: 581 LVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGE 640
+ + L R +M +++ C H+ R ++V + L E
Sbjct: 275 MREIVCIKKLRPSFPNRWSSDECLRQMGKLMT---ECWAHNPASRLTALRVKKTLAKMSE 331
Query: 641 MSDL 644
D+
Sbjct: 332 SQDI 335
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 2e-56
Identities = 55/212 (25%), Positives = 89/212 (41%), Gaps = 22/212 (10%)
Query: 365 ENVIGEGGFGCVYKGNLPEGKVVAVKQLKSG--SGQGEREFRAEVEIISRVHHRHLVSLV 422
+IG+G FG VY G G+V A++ + + + F+ EV + H ++V +
Sbjct: 38 GELIGKGRFGQVYHGRW-HGEV-AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 423 GYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKI 482
G C+S + +I L + L+ K +IA KG+ YLH I
Sbjct: 96 GACMSPPHLAIITSLCKGRTLYSVVRDAKIV-LDVNKTRQIAQEIVKGMGYLHA---KGI 151
Query: 483 IHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVM----GTFGYLAPEYASSGK 538
+H+D+KS N+ D+ + + DFGL ++ Q + G +LAPE
Sbjct: 152 LHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 539 L---------TDRSDVFSFGVVLLELITGRKP 561
+ SDVF+ G + EL P
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 9e-56
Identities = 69/297 (23%), Positives = 125/297 (42%), Gaps = 34/297 (11%)
Query: 365 ENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEI--ISRVHHRHLVSLV 422
+ IG+G FG V++G G+ VAVK S + ER + E EI + H +++ +
Sbjct: 47 QESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFI 102
Query: 423 GYCISEKNR----LLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHED- 477
+ L+ ++ + +L +L+ + + +K+AL A GLA+LH +
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHMEI 159
Query: 478 ----CHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHV---STRVMGTFGYLA 530
P I HRD+KS NILV +AD GLA +D+ + +GT Y+A
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 219
Query: 531 PE------YASSGKLTDRSDVFSFGVVLLELITGRKP---VDPTQ-PLGDESLVEWARPV 580
PE + R+D+++ G+V E+ + Q P D + +
Sbjct: 220 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 279
Query: 581 LVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDS 637
+ + + L + R + M +++ C +G R +++ + L
Sbjct: 280 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR---ECWYANGAARLTALRIKKTLSQ 333
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 2e-45
Identities = 54/202 (26%), Positives = 94/202 (46%), Gaps = 10/202 (4%)
Query: 365 ENVIGEGGFGCVYKGNLPEGKV-VAVKQLKSGSGQGER-EFRAEVEIISRVHHRHLVSLV 422
IG G FG V+ G L VAVK + + +F E I+ + H ++V L+
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 423 GYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKI 482
G C ++ ++ E V + L +G L +++ AA G+ YL
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGAR-LRVKTLLQMVGDAAAGMEYLESK---CC 234
Query: 483 IHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGY--LAPEYASSGKLT 540
IHRD+ + N LV ++ +++DFG+++ + ++ + APE + G+ +
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADG-VYAASGGLRQVPVKWTAPEALNYGRYS 293
Query: 541 DRSDVFSFGVVLLELIT-GRKP 561
SDV+SFG++L E + G P
Sbjct: 294 SESDVWSFGILLWETFSLGASP 315
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 6e-44
Identities = 64/203 (31%), Positives = 109/203 (53%), Gaps = 20/203 (9%)
Query: 365 ENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGY 424
IG+G FG V G+ G VAVK +K+ + + F AE +++++ H +LV L+G
Sbjct: 26 LQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGV 82
Query: 425 CISEKNRLLI-YEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKII 483
+ EK L I E++ +L +L +G+ VL +K +L + + YL + +
Sbjct: 83 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFV 139
Query: 484 HRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRV----MGTFGYLAPEYASSGKL 539
HRD+ + N+LV ++ A+V+DFGL K + + T + ++ APE K
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLPVKWT------APEALREKKF 191
Query: 540 TDRSDVFSFGVVLLELIT-GRKP 561
+ +SDV+SFG++L E+ + GR P
Sbjct: 192 STKSDVWSFGILLWEIYSFGRVP 214
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 1e-43
Identities = 70/232 (30%), Positives = 111/232 (47%), Gaps = 14/232 (6%)
Query: 365 ENVIGEGGFGCVYKG-----NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLV 419
+ +G+G FG V G +VAVKQL+ +R+F+ E++I+ +H +V
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87
Query: 420 SLVGYCISEKNR--LLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHED 477
G + L+ E++P+ L L + + L+ ++ + + KG+ YL
Sbjct: 88 KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQ-RHRARLDASRLLLYSSQICKGMEYLGSR 146
Query: 478 CHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTF--GYLAPEYAS 535
+ +HRD+ + NILV+ E ++ADFGLAKL + + R G + APE S
Sbjct: 147 ---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLS 203
Query: 536 SGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIE 586
+ +SDV+SFGVVL EL T K P+ E P L R +E
Sbjct: 204 DNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE 255
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 2e-43
Identities = 72/263 (27%), Positives = 118/263 (44%), Gaps = 19/263 (7%)
Query: 341 GVLGGSKSFFTYEELMEITNGFAR-ENVIGEGGFGCVYKGNLP-----EGKVVAVKQLKS 394
G + K T + F + +GEG FG V G+ VAVK LK
Sbjct: 1 GDIVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKP 60
Query: 395 GSGQGER-EFRAEVEIISRVHHRHLVSLVGYCISEKNR--LLIYEFVPNNNLEHHLHGKG 451
SG + + E+EI+ ++H ++V G C + LI EF+P+ +L+ +L K
Sbjct: 61 ESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLP-KN 119
Query: 452 QPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLN 511
+ + +++K A+ KG+ YL + +HRD+ + N+LV+ E + ++ DFGL K
Sbjct: 120 KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAI 176
Query: 512 DTTQTHVSTRVMGTF--GYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPL 568
+T + + + + + APE K SDV+SFGV L EL+T P
Sbjct: 177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALF 236
Query: 569 GDESLV---EWARPVLVRAIETG 588
+ LV ++ G
Sbjct: 237 LKMIGPTHGQMTVTRLVNTLKEG 259
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 4e-43
Identities = 69/238 (28%), Positives = 115/238 (48%), Gaps = 18/238 (7%)
Query: 365 ENVIGEGGFGCVYKGNLP-----EGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLV 419
+G+G FG V G+VVAVK+L+ + + R+F E+EI+ + H ++V
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74
Query: 420 SLVGYCISEKNR--LLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHED 477
G C S R LI E++P +L +L K + ++ K ++ KG+ YL
Sbjct: 75 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGTK 133
Query: 478 CHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTF--GYLAPEYAS 535
+ IHRD+ + NILV++E ++ DFGL K+ + + G + APE +
Sbjct: 134 ---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLT 190
Query: 536 SGKLTDRSDVFSFGVVLLELIT-----GRKPVDPTQPLGDESLVEWARPVLVRAIETG 588
K + SDV+SFGVVL EL T P + + +G++ + L+ ++
Sbjct: 191 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 248
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 8e-43
Identities = 63/203 (31%), Positives = 110/203 (54%), Gaps = 20/203 (9%)
Query: 365 ENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGY 424
IG+G FG V G+ G VAVK +K+ + + F AE +++++ H +LV L+G
Sbjct: 198 LQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGV 254
Query: 425 CISEKNRL-LIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKII 483
+ EK L ++ E++ +L +L +G+ VL +K +L + + YL + +
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFV 311
Query: 484 HRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRV----MGTFGYLAPEYASSGKL 539
HRD+ + N+LV ++ A+V+DFGL K + + T + ++ APE K
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLPVKWT------APEALREKKF 363
Query: 540 TDRSDVFSFGVVLLELIT-GRKP 561
+ +SDV+SFG++L E+ + GR P
Sbjct: 364 STKSDVWSFGILLWEIYSFGRVP 386
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 2e-42
Identities = 109/483 (22%), Positives = 183/483 (37%), Gaps = 45/483 (9%)
Query: 104 GSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSN 163
+ S P + RS + G GG + P Q+ + P + G P
Sbjct: 2 SNKSKPKDASQRRRSLEPAENVHGAGGGAFPASQTPSKPASADGHRGPSAAFAPA----- 56
Query: 164 QGNPVPSNGTTDSRDTKWAPPSNPGSPPSPSTSQSGTPST-----PNENSSPNELSPPSN 218
P G S+ + P + +G +T E+ + +LS
Sbjct: 57 AAEPKLFGG---------FNSSDTVTSPQRAGPLAGGVTTFVALYDYESRTETDLSFKKG 107
Query: 219 SKSPTSKSSPEESSSSSHSNSKKTPTSSSGHSSDSTKGSSSNDDQAIIGATAAGVVLIVL 278
+ ++ + + ++ +T S + + S + I + +L+
Sbjct: 108 ERLQIVNNTEGDWWLAHSLSTGQTGYIPSNYVAPSDSIQAEEWYFGKITRRESERLLLNA 167
Query: 279 IAI--FFLARGRRRRRDAYATHYMPPPNNFNEKTVDTYYGSQTPQMHSYGSQRG------ 330
FL R + AY + +N V Y + Y + R
Sbjct: 168 ENPRGTFLVRESETTKGAYCLS-VSDFDNAKGLNVKHYKIRKLDSGGFYITSRTQFNSLQ 226
Query: 331 --VGYHGGGPDSGVLGGSKSFFTYEELMEITNGFARE---------NVIGEGGFGCVYKG 379
V Y+ D + T + + A E +G+G FG V+ G
Sbjct: 227 QLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMG 286
Query: 380 NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVP 439
VA+K LK G+ E F E +++ ++ H LV L SE+ ++ E++
Sbjct: 287 TWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMS 344
Query: 440 NNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFE 499
+L L G+ L + V +A A G+AY+ +HRD+++ANILV +
Sbjct: 345 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLV 401
Query: 500 AQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-G 558
+VADFGLA+L + + + APE A G+ T +SDV+SFG++L EL T G
Sbjct: 402 CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG 461
Query: 559 RKP 561
R P
Sbjct: 462 RVP 464
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 16/84 (19%), Positives = 22/84 (26%), Gaps = 2/84 (2%)
Query: 42 KKVTPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPP 101
K + + N PAS P PAS P P A+ P
Sbjct: 4 KSKPKDASQRRRSLEPAENVHGAGGGAFPASQTP--SKPASADGHRGPSAAFAPAAAEPK 61
Query: 102 ASGSASPPPASPPPTRSESQSSPP 125
G + P R+ +
Sbjct: 62 LFGGFNSSDTVTSPQRAGPLAGGV 85
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 2e-42
Identities = 69/238 (28%), Positives = 116/238 (48%), Gaps = 18/238 (7%)
Query: 365 ENVIGEGGFGCVYKGNLP-----EGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLV 419
+G+G FG V G+VVAVK+L+ + + R+F E+EI+ + H ++V
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105
Query: 420 SLVGYCISEKNR--LLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHED 477
G C S R LI E++P +L +L K + ++ K ++ KG+ YL
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGTK 164
Query: 478 CHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTF--GYLAPEYAS 535
+ IHRD+ + NILV++E ++ DFGL K+ + + + G + APE +
Sbjct: 165 ---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLT 221
Query: 536 SGKLTDRSDVFSFGVVLLELIT-----GRKPVDPTQPLGDESLVEWARPVLVRAIETG 588
K + SDV+SFGVVL EL T P + + +G++ + L+ ++
Sbjct: 222 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 279
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 6e-42
Identities = 58/204 (28%), Positives = 102/204 (50%), Gaps = 18/204 (8%)
Query: 365 ENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGY 424
IG G FG V+ G VA+K ++ G+ E +F E E++ ++ H LV L G
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 425 CISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIH 484
C+ + L+ EF+ + L +L + + + + L +G+AYL E+ +IH
Sbjct: 72 CLEQAPICLVTEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAYL-EEAC--VIH 127
Query: 485 RDIKSANILVDDEFEAQVADFGLAKL--NDTTQTHVSTRV----MGTFGYLAPEYASSGK 538
RD+ + N LV + +V+DFG+ + +D + T+ +PE S +
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA------SPEVFSFSR 181
Query: 539 LTDRSDVFSFGVVLLELIT-GRKP 561
+ +SDV+SFGV++ E+ + G+ P
Sbjct: 182 YSSKSDVWSFGVLMWEVFSEGKIP 205
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 6e-42
Identities = 68/198 (34%), Positives = 104/198 (52%), Gaps = 6/198 (3%)
Query: 365 ENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGY 424
E +G+G FG V+ G VA+K LK G+ E F E +++ ++ H LV L
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAV 247
Query: 425 CISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIH 484
SE+ ++ E++ +L L G+ L + V +A A G+AY+ +H
Sbjct: 248 V-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVH 303
Query: 485 RDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSD 544
RD+++ANILV + +VADFGLA+L + + + APE A G+ T +SD
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 545 VFSFGVVLLELIT-GRKP 561
V+SFG++L EL T GR P
Sbjct: 364 VWSFGILLTELTTKGRVP 381
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 8e-42
Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 18/204 (8%)
Query: 365 ENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGY 424
+G G FG V G VAVK +K GS E EF E + + ++ H LV G
Sbjct: 13 LKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGV 71
Query: 425 CISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIH 484
C E ++ E++ N L ++L G LE ++ +++ +G+A+L + IH
Sbjct: 72 CSKEYPIYIVTEYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESH---QFIH 127
Query: 485 RDIKSANILVDDEFEAQVADFGLAKL--NDTTQTHVSTRV----MGTFGYLAPEYASSGK 538
RD+ + N LVD + +V+DFG+ + +D + V T+ APE K
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWS------APEVFHYFK 181
Query: 539 LTDRSDVFSFGVVLLELIT-GRKP 561
+ +SDV++FG+++ E+ + G+ P
Sbjct: 182 YSSKSDVWAFGILMWEVFSLGKMP 205
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 1e-41
Identities = 64/205 (31%), Positives = 102/205 (49%), Gaps = 18/205 (8%)
Query: 365 ENVIGEGGFGCVYKGNLPEGKV-VAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVG 423
++ +G G +G VY+G + + VAVK LK + + E EF E ++ + H +LV L+G
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLG 76
Query: 424 YCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKII 483
C E +I EF+ NL +L + + + +A + + YL + I
Sbjct: 77 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFI 133
Query: 484 HRDIKSANILVDDEFEAQVADFGLAKL--NDTTQTHVSTRV----MGTFGYLAPEYASSG 537
HRD+ + N LV + +VADFGL++L DT H + APE +
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT------APESLAYN 187
Query: 538 KLTDRSDVFSFGVVLLELIT-GRKP 561
K + +SDV++FGV+L E+ T G P
Sbjct: 188 KFSIKSDVWAFGVLLWEIATYGMSP 212
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 1e-41
Identities = 58/204 (28%), Positives = 111/204 (54%), Gaps = 12/204 (5%)
Query: 365 ENVIGEGGFGCVYKG--NLPEGKV-VAVKQLKSGSGQGER-EFRAEVEIISRVHHRHLVS 420
+ +G G FG V +G + + ++ VA+K LK G+ + + E E +I+ ++ + ++V
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 421 LVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHP 480
L+G C +E +L+ E L L GK + + ++ + G+ YL E+ +
Sbjct: 75 LIGVCQAEAL-MLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYL-EEKN- 130
Query: 481 KIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTF--GYLAPEYASSGK 538
+HRD+ + N+L+ + A+++DFGL+K ++ + R G + + APE + K
Sbjct: 131 -FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 189
Query: 539 LTDRSDVFSFGVVLLELIT-GRKP 561
+ RSDV+S+GV + E ++ G+KP
Sbjct: 190 FSSRSDVWSYGVTMWEALSYGQKP 213
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-41
Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 25/211 (11%)
Query: 365 ENVIGEGGFGCVYKGNL-PEGK----VVAVKQLKSGSGQGER-EFRAEVEIISRVHHRHL 418
V+G G FG VYKG PEG+ VA+K+L+ + E E +++ V + H+
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 419 VSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDC 478
L+G C LI + +P L ++ + + + + + AKG+ YL +
Sbjct: 80 CRLLGIC-LTSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYLEDR- 136
Query: 479 HPKIIHRDIKSANILVDDEFEAQVADFGLAKL---NDTTQTHVSTRV----MGTFGYLAP 531
+++HRD+ + N+LV ++ DFGLAKL + +V M A
Sbjct: 137 --RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM------AL 188
Query: 532 EYASSGKLTDRSDVFSFGVVLLELIT-GRKP 561
E T +SDV+S+GV + EL+T G KP
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 2e-41
Identities = 60/203 (29%), Positives = 102/203 (50%), Gaps = 11/203 (5%)
Query: 365 ENVIGEGGFGCVYKG--NLPEGKV--VAVKQLKSGSGQGER-EFRAEVEIISRVHHRHLV 419
++GEG FG VY+G +G+ VAVK K + +F +E I+ + H H+V
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 420 SLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCH 479
L+G E+ +I E P L H+L + + L+ V +L K +AYL E +
Sbjct: 77 KLIGII-EEEPTWIIMELYPYGELGHYLE-RNKNSLKVLTLVLYSLQICKAMAYL-ESIN 133
Query: 480 PKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKL 539
+HRDI NILV ++ DFGL++ + + ++ +++PE + +
Sbjct: 134 --CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRF 191
Query: 540 TDRSDVFSFGVVLLELIT-GRKP 561
T SDV+ F V + E+++ G++P
Sbjct: 192 TTASDVWMFAVCMWEILSFGKQP 214
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-41
Identities = 67/233 (28%), Positives = 107/233 (45%), Gaps = 17/233 (7%)
Query: 365 ENVIGEGGFGCVYKG-----NLPEGKVVAVKQLKSGSGQGER-EFRAEVEIISRVHHRHL 418
+GEG FG V N G++VAVK LK+ +G R ++ E++I+ ++H H+
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 419 VSLVGYCISEKNR--LLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHE 476
+ G C L+ E+VP +L +L + + + A +G+AYLH
Sbjct: 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLHA 152
Query: 477 DCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTF--GYLAPEYA 534
IHRD+ + N+L+D++ ++ DFGLAK + R G + APE
Sbjct: 153 Q---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 209
Query: 535 SSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIE 586
K SDV+SFGV L EL+T P + + + ++R E
Sbjct: 210 KEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE 262
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 3e-41
Identities = 56/207 (27%), Positives = 98/207 (47%), Gaps = 14/207 (6%)
Query: 365 ENVIGEGGFGCVYKGNLPEGK----VVAVKQLKSGSGQGER-EFRAEVEIISRVHHRHLV 419
+ VIG+G FG VY G + A+K L + + F E ++ ++H +++
Sbjct: 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 420 SLVGYCISEKNRLLI-YEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDC 478
+L+G + + + ++ + +L + + L A+G+ YL E
Sbjct: 86 ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLAEQ- 143
Query: 479 HPKIIHRDIKSANILVDDEFEAQVADFGLAK-LNDTTQTHVSTRVMGTF--GYLAPEYAS 535
K +HRD+ + N ++D+ F +VADFGLA+ + D V + A E
Sbjct: 144 --KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQ 201
Query: 536 SGKLTDRSDVFSFGVVLLELIT-GRKP 561
+ + T +SDV+SFGV+L EL+T G P
Sbjct: 202 TYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 3e-41
Identities = 78/287 (27%), Positives = 127/287 (44%), Gaps = 44/287 (15%)
Query: 365 ENVIGEGGFGCVYKGNLPEGK----VVAVKQLKSGSGQGER-EFRAEVEIISRVHHRHLV 419
VIG G FGCVY G L + AVK L + GE +F E I+ H +++
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 420 SLVGYCI-SEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDC 478
SL+G C+ SE + L++ ++ + +L + + + + L AKG+ YL
Sbjct: 90 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLASK- 147
Query: 479 HPKIIHRDIKSANILVDDEFEAQVADFGLAKL---NDTTQTHVSTRVMGTFGYLAPEYAS 535
K +HRD+ + N ++D++F +VADFGLA+ + H T ++A E
Sbjct: 148 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 205
Query: 536 SGKLTDRSDVFSFGVVLLELIT-GRKP---VDPTQPLGDESLVEWARPVLVRAIETGDLS 591
+ K T +SDV+SFGV+L EL+T G P V+ + + G
Sbjct: 206 TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--------------ITVYLLQGR-- 249
Query: 592 EIVDPRLEK-HYVESEMFR-MIEAAAACVRHSGPKRPRMVQVVRALD 636
RL + Y ++ M++ C RP ++V +
Sbjct: 250 -----RLLQPEYCPDPLYEVMLK----CWHPKAEMRPSFSELVSRIS 287
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 3e-41
Identities = 78/292 (26%), Positives = 130/292 (44%), Gaps = 21/292 (7%)
Query: 285 ARGRRRRRDAYATHYMPPPNNFNEKTVDTYYGSQTPQMHSYGSQRGVGYHGGGPDSGVLG 344
RRR + A + P + + + T GS+ Y G +
Sbjct: 11 HHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENL--YFQGANTVHIDL 68
Query: 345 GSKSFFTYEELMEITNGFARENV-----IGEGGFGCVYKGNLPEGK----VVAVKQLKSG 395
+ + + + + G + V IG G FGCVY G L + AVK L
Sbjct: 69 SALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI 128
Query: 396 SGQGER-EFRAEVEIISRVHHRHLVSLVGYCI-SEKNRLLIYEFVPNNNLEHHLHGKGQP 453
+ GE +F E I+ H +++SL+G C+ SE + L++ ++ + +L + + +
Sbjct: 129 TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET-H 187
Query: 454 VLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKL--- 510
+ L AKG+ +L K +HRD+ + N ++D++F +VADFGLA+
Sbjct: 188 NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244
Query: 511 NDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKP 561
+ H T ++A E + K T +SDV+SFGV+L EL+T G P
Sbjct: 245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 4e-41
Identities = 57/206 (27%), Positives = 106/206 (51%), Gaps = 14/206 (6%)
Query: 364 RENVIGEGGFGCVYKGNLPEGKV---VAVKQLKSG--SGQGEREFRAEVEIISRVHHRHL 418
+ +G G FG V KG KV VAVK LK+ + E AE ++ ++ + ++
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 419 VSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDC 478
V ++G C +E +L+ E L +L ++ +++ + G+ YL E+
Sbjct: 81 VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYL-EES 136
Query: 479 HPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTF--GYLAPEYASS 536
+ +HRD+ + N+L+ + A+++DFGL+K + + + G + + APE +
Sbjct: 137 N--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 194
Query: 537 GKLTDRSDVFSFGVVLLELIT-GRKP 561
K + +SDV+SFGV++ E + G+KP
Sbjct: 195 YKFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 7e-41
Identities = 59/210 (28%), Positives = 91/210 (43%), Gaps = 15/210 (7%)
Query: 362 FARENVIGEGGFGCVYKG--NLPEGKV--VAVKQLKSG---SGQGEREFRAEVEIISRVH 414
+G+G FG V +G + P GK VAVK LK + +F EV + +
Sbjct: 20 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 79
Query: 415 HRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYL 474
HR+L+ L G ++ E P +L L K Q + A+ A+G+ YL
Sbjct: 80 HRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLR-KHQGHFLLGTLSRYAVQVAEGMGYL 137
Query: 475 HEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGY--LAPE 532
E IHRD+ + N+L+ ++ DFGL + H + + APE
Sbjct: 138 -ESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 194
Query: 533 YASSGKLTDRSDVFSFGVVLLELIT-GRKP 561
+ + SD + FGV L E+ T G++P
Sbjct: 195 SLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 1e-40
Identities = 55/204 (26%), Positives = 101/204 (49%), Gaps = 18/204 (8%)
Query: 365 ENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGY 424
+G G FG V G VA+K +K GS E EF E +++ + H LV L G
Sbjct: 29 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 425 CISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIH 484
C ++ +I E++ N L ++L + + + + +++ + + YL E +H
Sbjct: 88 CTKQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYL-ESKQ--FLH 143
Query: 485 RDIKSANILVDDEFEAQVADFGLAKL--NDTTQTHVSTRV----MGTFGYLAPEYASSGK 538
RD+ + N LV+D+ +V+DFGL++ +D + V ++ PE K
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS------PPEVLMYSK 197
Query: 539 LTDRSDVFSFGVVLLELIT-GRKP 561
+ +SD+++FGV++ E+ + G+ P
Sbjct: 198 FSSKSDIWAFGVLMWEIYSLGKMP 221
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-40
Identities = 67/200 (33%), Positives = 105/200 (52%), Gaps = 10/200 (5%)
Query: 365 ENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGY 424
+G G FG V+ G VAVK LK GS + F AE ++ ++ H+ LV L
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAV 76
Query: 425 CISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIH 484
+++ +I E++ N +L L L K + +A A+G+A++ E IH
Sbjct: 77 V-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIH 132
Query: 485 RDIKSANILVDDEFEAQVADFGLAKL--NDTTQTHVSTRVMGTFGYLAPEYASSGKLTDR 542
RD+++ANILV D ++ADFGLA+L ++ + + APE + G T +
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP--IKWTAPEAINYGTFTIK 190
Query: 543 SDVFSFGVVLLELIT-GRKP 561
SDV+SFG++L E++T GR P
Sbjct: 191 SDVWSFGILLTEIVTHGRIP 210
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-40
Identities = 66/229 (28%), Positives = 107/229 (46%), Gaps = 21/229 (9%)
Query: 350 FTYEELMEITNGFARE---------NVIGEGGFGCVYKGNL---PEGKV-VAVKQLKSGS 396
TYEE F RE +IG G G V G L + V VA+K LK+G
Sbjct: 30 HTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY 89
Query: 397 GQGER-EFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVL 455
+ +R +F +E I+ + H +++ L G + +++ E++ N +L+ L
Sbjct: 90 TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR-THDGQF 148
Query: 456 EWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ 515
+ V + G G+ YL D +HRD+ + N+LVD +V+DFGL+++ +
Sbjct: 149 TIMQLVGMLRGVGAGMRYL-SDLG--YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP 205
Query: 516 THVSTRVMGTFGYL--APEYASSGKLTDRSDVFSFGVVLLELIT-GRKP 561
T G APE + + SDV+SFGVV+ E++ G +P
Sbjct: 206 DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-40
Identities = 61/200 (30%), Positives = 100/200 (50%), Gaps = 10/200 (5%)
Query: 365 ENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGY 424
E +G G FG V+ + VAVK +K GS F AE ++ + H LV L
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 425 CISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIH 484
+++ +I EF+ +L L K + + A+G+A++ + IH
Sbjct: 252 V-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIH 307
Query: 485 RDIKSANILVDDEFEAQVADFGLAKL--NDTTQTHVSTRVMGTFGYLAPEYASSGKLTDR 542
RD+++ANILV ++ADFGLA++ ++ + + APE + G T +
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP--IKWTAPEAINFGSFTIK 365
Query: 543 SDVFSFGVVLLELIT-GRKP 561
SDV+SFG++L+E++T GR P
Sbjct: 366 SDVWSFGILLMEIVTYGRIP 385
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 3e-40
Identities = 60/199 (30%), Positives = 99/199 (49%), Gaps = 6/199 (3%)
Query: 365 ENVIGEGGFGCVYKGNLPEGKV-VAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVG 423
++ +G G +G VY+G + + VAVK LK + + E EF E ++ + H +LV L+G
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLG 283
Query: 424 YCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKII 483
C E +I EF+ NL +L + + + +A + + YL + I
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFI 340
Query: 484 HRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRS 543
HR++ + N LV + +VADFGL++L + APE + K + +S
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 400
Query: 544 DVFSFGVVLLELIT-GRKP 561
DV++FGV+L E+ T G P
Sbjct: 401 DVWAFGVLLWEIATYGMSP 419
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 3e-40
Identities = 58/203 (28%), Positives = 96/203 (47%), Gaps = 11/203 (5%)
Query: 365 ENVIGEGGFGCVYKGNL--PEGKV--VAVKQLKSGSGQGER-EFRAEVEIISRVHHRHLV 419
IGEG FG V++G PE VA+K K+ + R +F E + + H H+V
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 420 SLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCH 479
L+G +E +I E L L + L+ + A + LAYL
Sbjct: 80 KLIGVI-TENPVWIIMELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTALAYLESK-- 135
Query: 480 PKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKL 539
+ +HRDI + N+LV ++ DFGL++ + + + +++ ++APE + +
Sbjct: 136 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 194
Query: 540 TDRSDVFSFGVVLLELIT-GRKP 561
T SDV+ FGV + E++ G KP
Sbjct: 195 TSASDVWMFGVCMWEILMHGVKP 217
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 4e-40
Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 25/211 (11%)
Query: 364 RENVIGEGGFGCVYKG-NLPEGKVVAVKQ--LKSGSGQGEREFRAEVEIISRVHHRHLVS 420
+ IG G F VYKG + VA + + + + F+ E E++ + H ++V
Sbjct: 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89
Query: 421 LVGYCIS---EKNRLLIY-EFVPNNNLEHHLHGKGQPVLE-----WTKRVKIALGAAKGL 471
S K +++ E + + L+ +L + + + W +++ KGL
Sbjct: 90 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLK-RFKVMKIKVLRSWCRQI------LKGL 142
Query: 472 AYLHEDCHPKIIHRDIKSANILVDDEF-EAQVADFGLAKLNDTTQTHVSTRVMGTFGYLA 530
+LH P IIHRD+K NI + ++ D GLA L + V+GT ++A
Sbjct: 143 QFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMA 198
Query: 531 PEYASSGKLTDRSDVFSFGVVLLELITGRKP 561
PE + DV++FG+ +LE+ T P
Sbjct: 199 PEMYEEK-YDESVDVYAFGMCMLEMATSEYP 228
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 4e-40
Identities = 70/229 (30%), Positives = 109/229 (47%), Gaps = 22/229 (9%)
Query: 351 TYEELMEITNGFARE---------NVIGEGGFGCVYKG--NLPEGKV---VAVKQLKSGS 396
+ + F E VIG G FG VYKG GK VA+K LK+G
Sbjct: 26 MGSDPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY 85
Query: 397 GQGER-EFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVL 455
+ +R +F E I+ + H +++ L G K ++I E++ N L+ L +
Sbjct: 86 TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR-EKDGEF 144
Query: 456 EWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ 515
+ V + G A G+ YL + + +HRD+ + NILV+ +V+DFGL+++ +
Sbjct: 145 SVLQLVGMLRGIAAGMKYL-ANMN--YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 201
Query: 516 THVSTRVMGTFGY--LAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKP 561
T G APE S K T SDV+SFG+V+ E++T G +P
Sbjct: 202 EATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 5e-40
Identities = 68/229 (29%), Positives = 112/229 (48%), Gaps = 21/229 (9%)
Query: 350 FTYEELMEITNGFARE---------NVIGEGGFGCVYKG--NLPEGK--VVAVKQLKSGS 396
T+E+ + + FA+E V+G G FG V G LP K VA+K LK G
Sbjct: 26 HTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY 85
Query: 397 GQGER-EFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVL 455
+ +R +F E I+ + H +++ L G K +++ E++ N +L+ L K
Sbjct: 86 TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQF 144
Query: 456 EWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ 515
+ V + G A G+ YL D +HRD+ + NIL++ +V+DFGL ++ +
Sbjct: 145 TVIQLVGMLRGIASGMKYL-SDMG--YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP 201
Query: 516 THVSTRVMGTFGYL--APEYASSGKLTDRSDVFSFGVVLLELIT-GRKP 561
T G +PE + K T SDV+S+G+VL E+++ G +P
Sbjct: 202 EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 6e-40
Identities = 62/233 (26%), Positives = 102/233 (43%), Gaps = 42/233 (18%)
Query: 362 FARENV-----IGEGGFGCVYKG---NLPEGK---VVAVKQLKSGSGQGEREFRAEVEII 410
R ++ +GEG FG V+ NL K +VAVK LK + ++F+ E E++
Sbjct: 12 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELL 71
Query: 411 SRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKR---------- 460
+ + H H+V G C ++++E++ + +L L G +
Sbjct: 72 TNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 131
Query: 461 ----VKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKL---NDT 513
+ IA A G+ YL +HRD+ + N LV ++ DFG+++ D
Sbjct: 132 LSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY 188
Query: 514 TQTHVSTRV----MGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKP 561
+ T + M PE K T SDV+SFGV+L E+ T G++P
Sbjct: 189 YRVGGHTMLPIRWM------PPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 9e-40
Identities = 63/211 (29%), Positives = 103/211 (48%), Gaps = 25/211 (11%)
Query: 365 ENVIGEGGFGCVYKGNL-PEGK----VVAVKQLKSGSGQGER-EFRAEVEIISRVHHRHL 418
V+G G FG V+KG PEG+ V +K ++ SG+ + I + H H+
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 419 VSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDC 478
V L+G C L+ +++P +L H+ + + L + + AKG+ YL E
Sbjct: 78 VRLLGLCPGSS-LQLVTQYLPLGSLLDHVR-QHRGALGPQLLLNWGVQIAKGMYYLEEH- 134
Query: 479 HPKIIHRDIKSANILVDDEFEAQVADFGLAKL---NDTTQTHVSTRV----MGTFGYLAP 531
++HR++ + N+L+ + QVADFG+A L +D + + M A
Sbjct: 135 --GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM------AL 186
Query: 532 EYASSGKLTDRSDVFSFGVVLLELIT-GRKP 561
E GK T +SDV+S+GV + EL+T G +P
Sbjct: 187 ESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 146 bits (372), Expect = 1e-39
Identities = 57/201 (28%), Positives = 99/201 (49%), Gaps = 15/201 (7%)
Query: 368 IGEGGFGCVYKGN-LPEGKVVAVKQLKSGSGQGE---REFRAEVEIISRVHHRHLVSLVG 423
+G GG VY VA+K + + E + F EV S++ H+++VS+
Sbjct: 19 LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM-- 76
Query: 424 YCISEKNRL--LIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPK 481
+ E++ L+ E++ L ++ G L + G+ + H+ +
Sbjct: 77 IDVDEEDDCYYLVMEYIEGPTLSEYIESHGP--LSVDTAINFTNQILDGIKHAHDM---R 131
Query: 482 IIHRDIKSANILVDDEFEAQVADFGLAK-LNDTTQTHVSTRVMGTFGYLAPEYASSGKLT 540
I+HRDIK NIL+D ++ DFG+AK L++T+ T + V+GT Y +PE A
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNH-VLGTVQYFSPEQAKGEATD 190
Query: 541 DRSDVFSFGVVLLELITGRKP 561
+ +D++S G+VL E++ G P
Sbjct: 191 ECTDIYSIGIVLYEMLVGEPP 211
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-39
Identities = 62/222 (27%), Positives = 101/222 (45%), Gaps = 16/222 (7%)
Query: 351 TYEELMEITNGFARENV-----IGEGGFGCVYKGNL--PEGKV--VAVKQLKSGSGQGER 401
TY RE + IGEG FG V++G PE VA+K K+ + R
Sbjct: 376 TYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVR 435
Query: 402 -EFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKR 460
+F E + + H H+V L+G +E +I E L L + L+
Sbjct: 436 EKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQ-VRKFSLDLASL 493
Query: 461 VKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVST 520
+ A + LAYL + +HRDI + N+LV ++ DFGL++ + + + ++
Sbjct: 494 ILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS 550
Query: 521 RVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKP 561
+ ++APE + + T SDV+ FGV + E++ G KP
Sbjct: 551 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 592
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 3e-39
Identities = 60/221 (27%), Positives = 107/221 (48%), Gaps = 33/221 (14%)
Query: 365 ENVIGEGGFGCVYKGNL--PEGKV-VAVKQLKSGSGQGER-EFRAEVEIISRV-HHRHLV 419
++VIGEG FG V K + ++ A+K++K + + + +F E+E++ ++ HH +++
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 420 SLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKR--------------VKIAL 465
+L+G C L E+ P+ NL L + + A
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 466 GAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRV--- 522
A+G+ YL + + IHRD+ + NILV + + A++ADFGL++ + R+
Sbjct: 150 DVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR 206
Query: 523 -MGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKP 561
M A E + T SDV+S+GV+L E+++ G P
Sbjct: 207 WM------AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 6e-39
Identities = 60/228 (26%), Positives = 99/228 (43%), Gaps = 37/228 (16%)
Query: 362 FARENV-----IGEGGFGCVYKGNL----PEGKVVAVKQLKSG--SGQGEREFRAEVEII 410
R + +GEG FG V +GNL VAVK +K S + EF +E +
Sbjct: 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACM 90
Query: 411 SRVHHRHLVSLVGYCISEKNR-----LLIYEFVPNNNLEHHL----HGKGQPVLEWTKRV 461
H +++ L+G CI ++ ++I F+ +L +L G + +
Sbjct: 91 KDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLL 150
Query: 462 KIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKL---NDTTQTHV 518
K + A G+ YL +HRD+ + N ++ D+ VADFGL+K D +
Sbjct: 151 KFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGR 207
Query: 519 STRV----MGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKP 561
++ + A E + T +SDV++FGV + E+ T G P
Sbjct: 208 IAKMPVKWI------AIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 6e-39
Identities = 60/206 (29%), Positives = 104/206 (50%), Gaps = 13/206 (6%)
Query: 364 RENVIGEGGFGCVYKGNL-PEGK----VVAVKQLKSGSGQGER-EFRAEVEIISRVHHRH 417
+ V+G G FG VYKG PEG+ VA+K+L+ + E E +++ V + H
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78
Query: 418 LVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHED 477
+ L+G C++ LI + +P L ++ + + + + + AKG+ YL +
Sbjct: 79 VCRLLGICLTST-VQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 478 CHPKIIHRDIKSANILVDDEFEAQVADFGLAK-LNDTTQTHVSTRVMGTFGYLAPEYASS 536
+++HRD+ + N+LV ++ DFGLAK L + + + ++A E
Sbjct: 137 ---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 537 GKLTDRSDVFSFGVVLLELIT-GRKP 561
T +SDV+S+GV + EL+T G KP
Sbjct: 194 RIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-38
Identities = 62/228 (27%), Positives = 104/228 (45%), Gaps = 37/228 (16%)
Query: 362 FARENV-----IGEGGFGCVYKGNL------PEGKVVAVKQLKSGSGQGER-EFRAEVEI 409
ARE + +G+G FG VY+G VA+K + + ER EF E +
Sbjct: 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 81
Query: 410 ISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHL--------HGKGQPVLEWTKRV 461
+ + H+V L+G + L+I E + +L+ +L + +K +
Sbjct: 82 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 141
Query: 462 KIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKL---NDTTQTHV 518
++A A G+AYL+ + K +HRD+ + N +V ++F ++ DFG+ + D +
Sbjct: 142 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 198
Query: 519 STRV----MGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKP 561
+ M +PE G T SDV+SFGVVL E+ T +P
Sbjct: 199 KGLLPVRWM------SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-38
Identities = 57/205 (27%), Positives = 107/205 (52%), Gaps = 12/205 (5%)
Query: 364 RENVIGEGGFGCVYKGNLPEGKV---VAVKQLKSGSGQGER-EFRAEVEIISRVHHRHLV 419
+ +G G FG V +G K VA+K LK G+ + + E E +I+ ++ + ++V
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 399
Query: 420 SLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCH 479
L+G C + +L+ E L L GK + + + ++ + G+ YL E+ +
Sbjct: 400 RLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYL-EEKN 456
Query: 480 PKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGY--LAPEYASSG 537
+HR++ + N+L+ + A+++DFGL+K ++ + R G + APE +
Sbjct: 457 --FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 514
Query: 538 KLTDRSDVFSFGVVLLELIT-GRKP 561
K + RSDV+S+GV + E ++ G+KP
Sbjct: 515 KFSSRSDVWSYGVTMWEALSYGQKP 539
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-38
Identities = 63/232 (27%), Positives = 103/232 (44%), Gaps = 41/232 (17%)
Query: 362 FARENV-----IGEGGFGCVYKG---NLPEGK---VVAVKQLKSGSGQGEREFRAEVEII 410
R ++ +GEG FG V+ NL + +VAVK LK S ++F+ E E++
Sbjct: 38 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELL 97
Query: 411 SRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKR---------- 460
+ + H+H+V G C + L+++E++ + +L L G
Sbjct: 98 TMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGL 157
Query: 461 ---VKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKL---NDTT 514
+ +A A G+ YL +HRD+ + N LV ++ DFG+++ D
Sbjct: 158 GQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYY 214
Query: 515 QTHVSTRV----MGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKP 561
+ T + M PE K T SDV+SFGVVL E+ T G++P
Sbjct: 215 RVGGRTMLPIRWM------PPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-38
Identities = 67/329 (20%), Positives = 126/329 (38%), Gaps = 71/329 (21%)
Query: 362 FARENV-----IGEGGFGCVYKGNL----PEGKVVAVKQLKSG--SGQGEREFRAEVEII 410
+ +G+G FG V + L VAVK LK+ + EF E +
Sbjct: 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACM 79
Query: 411 SRVHHRHLVSLVGYCISEKNR------LLIYEFVPNNNLEHHL----HGKGQPVLEWTKR 460
H H+ LVG + + + ++I F+ + +L L G+ L
Sbjct: 80 KEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTL 139
Query: 461 VKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKL---NDTTQTH 517
V+ + A G+ YL IHRD+ + N ++ ++ VADFGL++ D +
Sbjct: 140 VRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQG 196
Query: 518 VSTRV----MGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKP---VDPTQPLG 569
++++ + A E + T SDV++FGV + E++T G+ P ++ +
Sbjct: 197 CASKLPVKWL------ALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE--- 247
Query: 570 DESLVEWARPVLVRAIETGDLSEIVDPRLEK-HYVESEMFR-MIEAAAACVRHSGPKRPR 627
+ + G+ RL++ E++ M + C +RP
Sbjct: 248 -----------IYNYLIGGN-------RLKQPPECMEEVYDLMYQ----CWSADPKQRPS 285
Query: 628 MVQVVRALDSEGEMSDLSNGVKYGQSTVY 656
+ L+ + + + Q +Y
Sbjct: 286 FTCLRMELE---NILGHLSVLSTSQDPLY 311
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-38
Identities = 47/216 (21%), Positives = 90/216 (41%), Gaps = 29/216 (13%)
Query: 365 ENVIGEGGFGCVYKGNL--------PEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHR 416
+G+G F ++KG V +K L F ++S++ H+
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 417 HLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHE 476
HLV G C+ +L+ EFV +L+ +L K + + ++++A A + +L E
Sbjct: 73 HLVLNYGVCVCGDENILVQEFVKFGSLDTYLK-KNKNCINILWKLEVAKQLAAAMHFL-E 130
Query: 477 DCHPKIIHRDIKSANILVDDEFEAQ--------VADFGLAK-LNDTTQTHVSTRVMGTFG 527
+ +IH ++ + NIL+ E + + ++D G++ + +
Sbjct: 131 ENT--LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWV---- 184
Query: 528 YLAPEYASSGKL-TDRSDVFSFGVVLLELIT-GRKP 561
PE + K +D +SFG L E+ + G KP
Sbjct: 185 --PPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 4e-38
Identities = 59/234 (25%), Positives = 103/234 (44%), Gaps = 43/234 (18%)
Query: 362 FARENV-----IGEGGFGCVYKG---NLPEGK---VVAVKQLKSGSGQGER-EFRAEVEI 409
+ V +GE FG VYKG G+ VA+K LK + R EFR E +
Sbjct: 6 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAML 65
Query: 410 ISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKR--------- 460
+R+ H ++V L+G ++ +I+ + + +L L + +
Sbjct: 66 RARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSAL 125
Query: 461 -----VKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKL---ND 512
V + A G+ YL ++H+D+ + N+LV D+ +++D GL + D
Sbjct: 126 EPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAAD 182
Query: 513 TTQTHVSTRV----MGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKP 561
+ ++ + M APE GK + SD++S+GVVL E+ + G +P
Sbjct: 183 YYKLLGNSLLPIRWM------APEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 8e-38
Identities = 49/213 (23%), Positives = 93/213 (43%), Gaps = 24/213 (11%)
Query: 362 FARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGERE---FRAEVEIISRVHHRH 417
F E IG G F VY+ L +G VA+K+++ + E++++ +++H +
Sbjct: 34 FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93
Query: 418 LVSLVGYCISEKNRLLIY-EFVPNNNLEHHLHGKGQP--------VLEWTKRVKIALGAA 468
++ E N L I E +L + + V ++ V++
Sbjct: 94 VIKYYA-SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYF--VQLCSA-- 148
Query: 469 KGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGY 528
L ++H +++HRDIK AN+ + ++ D GL + + T + V GT Y
Sbjct: 149 --LEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYY 202
Query: 529 LAPEYASSGKLTDRSDVFSFGVVLLELITGRKP 561
++PE +SD++S G +L E+ + P
Sbjct: 203 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-37
Identities = 59/228 (25%), Positives = 92/228 (40%), Gaps = 23/228 (10%)
Query: 362 FARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVS 420
+ +GEGGF V L +G A+K++ Q E + E ++ +H +++
Sbjct: 31 YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILR 90
Query: 421 LVGYCISEKNR----LLIYEFVPNNNLEHHL---HGKGQPVLEWTKRVKIALGAAKGLAY 473
LV YC+ E+ L+ F L + + KG + E + LG +GL
Sbjct: 91 LVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQIL-WLLLGICRGLEA 149
Query: 474 LHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVM--------GT 525
+H HRD+K NIL+ DE + + D G + T
Sbjct: 150 IHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 526 FGYLAPE---YASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGD 570
Y APE S + +R+DV+S G VL ++ G P D GD
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD 254
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-37
Identities = 56/217 (25%), Positives = 96/217 (44%), Gaps = 26/217 (11%)
Query: 362 FARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVS 420
F +IG GGFG V+K + +GK +K++K + EV+ ++++ H ++V
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK----YNNEKAEREVKALAKLDHVNIVH 68
Query: 421 LVGY---------------CISEKNRLLIY-EFVPNNNLEHHLHGKGQPVLEWTKRVKIA 464
G S+ L I EF LE + + L+ +++
Sbjct: 69 YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128
Query: 465 LGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMG 524
KG+ Y+H K+I+RD+K +NI + D + ++ DFGL TR G
Sbjct: 129 EQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR--TRSKG 183
Query: 525 TFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKP 561
T Y++PE SS D+++ G++L EL+
Sbjct: 184 TLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT 220
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-37
Identities = 61/212 (28%), Positives = 103/212 (48%), Gaps = 21/212 (9%)
Query: 360 NGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLK-SGSGQGEREF-RAEVEIISRVHHR 416
+ R IGEG FG + +G+ +K++ S ERE R EV +++ + H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 417 HLVSLVGYCISEKNRLLIY-EFVPNNNLEHHLHG-KGQP-----VLEWTKRVKIALGAAK 469
++V E L I ++ +L ++ KG +L+W V+I L
Sbjct: 84 NIVQYRE-SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWF--VQICLA--- 137
Query: 470 GLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYL 529
L ++H+ KI+HRDIKS NI + + Q+ DFG+A++ ++T + GT YL
Sbjct: 138 -LKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYL 192
Query: 530 APEYASSGKLTDRSDVFSFGVVLLELITGRKP 561
+PE + ++SD+++ G VL EL T +
Sbjct: 193 SPEICENKPYNNKSDIWALGCVLYELCTLKHA 224
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 4e-37
Identities = 60/228 (26%), Positives = 96/228 (42%), Gaps = 37/228 (16%)
Query: 362 FARENV-----IGEGGFGCVYKG---NLPEGK---VVAVKQLKSGSGQGER-EFRAEVEI 409
R+N+ +G G FG VY+G +P VAVK L + + +F E I
Sbjct: 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 86
Query: 410 ISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNL-----EHHLHGKGQPVLEWTKRVKIA 464
IS+ +H+++V +G + R ++ E + +L E L + +A
Sbjct: 87 ISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 146
Query: 465 LGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFE---AQVADFGLAKL---NDTTQTHV 518
A G YL E+ IHRDI + N L+ A++ DFG+A+ +
Sbjct: 147 RDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGG 203
Query: 519 STRV----MGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKP 561
+ M PE G T ++D +SFGV+L E+ + G P
Sbjct: 204 CAMLPVKWM------PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 8e-37
Identities = 52/213 (24%), Positives = 95/213 (44%), Gaps = 18/213 (8%)
Query: 362 FARENVIGEGGFGCVYKG-NLPEGKVVAVKQL-KSGSGQGEREF-RAEVEIISRVHHRHL 418
+ IG G +G K +GK++ K+L + E++ +EV ++ + H ++
Sbjct: 8 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67
Query: 419 VSLVGYCISEKNRLL--IYEFVPNNNLEHHL---HGKGQPVLE---WTKRVKIALGAAKG 470
V I N L + E+ +L + + Q + E ++ L
Sbjct: 68 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA---- 123
Query: 471 LAYLHE--DCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGY 528
L H D ++HRD+K AN+ +D + ++ DFGLA++ + + T V GT Y
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYY 182
Query: 529 LAPEYASSGKLTDRSDVFSFGVVLLELITGRKP 561
++PE + ++SD++S G +L EL P
Sbjct: 183 MSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-36
Identities = 61/233 (26%), Positives = 102/233 (43%), Gaps = 42/233 (18%)
Query: 362 FARENV-----IGEGGFGCVYKGNL------PEGKVVAVKQLKSGSGQGER-EFRAEVEI 409
F R N+ +G G FG V + VAVK LKS + E+ +E++I
Sbjct: 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 410 ISRV-HHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGK------------GQPVLE 456
+S + H ++V+L+G C L+I E+ +L + L K
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAS 162
Query: 457 WTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKL---NDT 513
+ + A+G+A+L IHRD+ + N+L+ + A++ DFGLA+ +
Sbjct: 163 TRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 219
Query: 514 TQTHVSTRV----MGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKP 561
+ R+ M APE T +SDV+S+G++L E+ + G P
Sbjct: 220 YIVKGNARLPVKWM------APESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 65/240 (27%), Positives = 106/240 (44%), Gaps = 47/240 (19%)
Query: 362 FARENV-----IGEGGFGCVYKGNLP-----EGKV-VAVKQLKSGSGQGER-EFRAEVEI 409
F R+N+ +GEG FG V K G VAVK LK + E + +E +
Sbjct: 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNV 79
Query: 410 ISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKR--------- 460
+ +V+H H++ L G C + LLI E+ +L L + +
Sbjct: 80 LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139
Query: 461 -------------VKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGL 507
+ A ++G+ YL E K++HRD+ + NILV + + +++DFGL
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGL 196
Query: 508 AKLNDTTQTHVSTRVMGTFGYL-----APEYASSGKLTDRSDVFSFGVVLLELIT-GRKP 561
++ D + + + G + A E T +SDV+SFGV+L E++T G P
Sbjct: 197 SR--DVYEEDSYVK--RSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-36
Identities = 49/222 (22%), Positives = 94/222 (42%), Gaps = 29/222 (13%)
Query: 362 FARENVIGEGGFGCVYKG-NLPEGKVVAVKQLK-SGSGQGEREFRAEVEIISRVHHRHLV 419
F +G GGFG V++ N + A+K+++ + EV+ ++++ H +V
Sbjct: 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 420 SLVGYCISEKN---------RLLIY---EFVPNNNLEHHLHG-KGQPVLEWTKRVKIALG 466
+ + ++ +Y + NL+ ++G E + + I L
Sbjct: 67 RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQ 126
Query: 467 AAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ----------- 515
A+ + +LH ++HRD+K +NI + +V DFGL D +
Sbjct: 127 IAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 516 THVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT 557
T +GT Y++PE + + D+FS G++L EL+
Sbjct: 184 YARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-36
Identities = 66/234 (28%), Positives = 104/234 (44%), Gaps = 41/234 (17%)
Query: 362 FARENV-----IGEGGFGCVYKGNL------PEGKVVAVKQLKSGSGQGER-EFRAEVEI 409
F R+ + +G G FG V + + + VAVK LK G+ E +E++I
Sbjct: 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI 83
Query: 410 ISRV-HHRHLVSLVGYC-ISEKNRLLIYEFVPNNNLEHHLHGK--------------GQP 453
+ + HH ++V+L+G C ++I EF NL +L K +
Sbjct: 84 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 143
Query: 454 VLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDT 513
L + + AKG+ +L K IHRD+ + NIL+ ++ ++ DFGLA+ D
Sbjct: 144 FLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLAR--DI 198
Query: 514 TQTHVSTRVMGTFGYL-----APEYASSGKLTDRSDVFSFGVVLLELIT-GRKP 561
+ R L APE T +SDV+SFGV+L E+ + G P
Sbjct: 199 YKDPDYVR--KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-36
Identities = 63/237 (26%), Positives = 106/237 (44%), Gaps = 46/237 (19%)
Query: 362 FARENV-----IGEGGFGCVYKGNLP--------EGKVVAVKQLKSGSGQGER-EFRAEV 407
F R+ + +GEG FG V E VAVK LK + + + + +E+
Sbjct: 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 91
Query: 408 EIISRV-HHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHL--------------HGKGQ 452
E++ + H+++++L+G C + +I E+ NL +L + +
Sbjct: 92 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 453 PVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKL-- 510
+ + V A+G+ YL K IHRD+ + N+LV + ++ADFGLA+
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 511 -NDTTQTHVSTRV----MGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKP 561
D + + R+ M APE T +SDV+SFGV++ E+ T G P
Sbjct: 209 NIDYYKKTTNGRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 4e-36
Identities = 56/205 (27%), Positives = 99/205 (48%), Gaps = 13/205 (6%)
Query: 364 RENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLV 422
V+G+G +G VY G +L +A+K++ + + E+ + + H+++V +
Sbjct: 26 DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYL 85
Query: 423 GYCISEKNRLLIY-EFVPNNNLEHHLHGKGQPVLEWTKRV--KIALGAAKGLAYLHEDCH 479
G SE + I+ E VP +L L K P L+ ++ +GL YLH++
Sbjct: 86 G-SFSENGFIKIFMEQVPGGSLSALLRSKWGP-LKDNEQTIGFYTKQILEGLKYLHDN-- 141
Query: 480 PKIIHRDIKSANILVDDEF-EAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPE--YASS 536
+I+HRDIK N+L++ +++DFG +K T GT Y+APE
Sbjct: 142 -QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGP 199
Query: 537 GKLTDRSDVFSFGVVLLELITGRKP 561
+D++S G ++E+ TG+ P
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGKPP 224
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 6e-36
Identities = 62/235 (26%), Positives = 99/235 (42%), Gaps = 42/235 (17%)
Query: 362 FARENV-----IGEGGFGCVYKG---NLPEGK---VVAVKQLKSGSGQGER-EFRAEVEI 409
F R + +G G FG V + L + VAVK LK + ER +E+++
Sbjct: 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKV 79
Query: 410 ISRV-HHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHL----------------HGKGQ 452
+S + +H ++V+L+G C L+I E+ +L + L +
Sbjct: 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 453 PVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLND 512
L+ + + AKG+A+L IHRD+ + NIL+ ++ DFGLA+ D
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLAR--D 194
Query: 513 TTQTHVSTRVMGTFGYL-----APEYASSGKLTDRSDVFSFGVVLLELIT-GRKP 561
L APE + T SDV+S+G+ L EL + G P
Sbjct: 195 IKNDSNYVV--KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 8e-36
Identities = 63/240 (26%), Positives = 103/240 (42%), Gaps = 47/240 (19%)
Query: 362 FARENV-----IGEGGFGCVYKG---NLPEGKV---VAVKQLKSGSGQGER-EFRAEVEI 409
F REN+ +G G FG V + + V VAVK LK + ER +E+++
Sbjct: 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKM 101
Query: 410 ISRV-HHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKR-------- 460
++++ H ++V+L+G C LI+E+ +L ++L K + E
Sbjct: 102 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 161
Query: 461 -------------VKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGL 507
+ A AKG+ +L +HRD+ + N+LV ++ DFGL
Sbjct: 162 EEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGL 218
Query: 508 AKLNDTTQTHVSTRVMGTFGYL-----APEYASSGKLTDRSDVFSFGVVLLELIT-GRKP 561
A+ D L APE G T +SDV+S+G++L E+ + G P
Sbjct: 219 AR--DIMSDSNYVV--RGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-35
Identities = 67/237 (28%), Positives = 109/237 (45%), Gaps = 46/237 (19%)
Query: 362 FARENV-----IGEGGFGCVYKGNLP--------EGKVVAVKQLKSGSGQGER-EFRAEV 407
R+ + +GEG FG V VAVK LKS + + + + +E+
Sbjct: 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEM 125
Query: 408 EIISRV-HHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKR------ 460
E++ + H+++++L+G C + +I E+ NL +L + P LE++
Sbjct: 126 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 185
Query: 461 --------VKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKL-- 510
V A A+G+ YL K IHRD+ + N+LV ++ ++ADFGLA+
Sbjct: 186 EQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 242
Query: 511 -NDTTQTHVSTRV----MGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKP 561
D + + R+ M APE T +SDV+SFGV+L E+ T G P
Sbjct: 243 HIDYYKKTTNGRLPVKWM------APEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-35
Identities = 61/204 (29%), Positives = 105/204 (51%), Gaps = 15/204 (7%)
Query: 368 IGEGGFGCVYKGN-LPEGKVVAVKQLKSGSGQGE---REFRAEVEIISRVHHRHLVSL-- 421
+G GG V+ L + + VAVK L++ + FR E + + ++H +V++
Sbjct: 20 LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 422 VGYCISEKNRL--LIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCH 479
G + L ++ E+V L +H +G + + +++ A + L + H++
Sbjct: 80 TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQN-- 135
Query: 480 PKIIHRDIKSANILVDDEFEAQVADFGLAK-LNDTTQTHVST-RVMGTFGYLAPEYASSG 537
IIHRD+K ANI++ +V DFG+A+ + D+ + T V+GT YL+PE A
Sbjct: 136 -GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD 194
Query: 538 KLTDRSDVFSFGVVLLELITGRKP 561
+ RSDV+S G VL E++TG P
Sbjct: 195 SVDARSDVYSLGCVLYEVLTGEPP 218
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-35
Identities = 56/207 (27%), Positives = 85/207 (41%), Gaps = 18/207 (8%)
Query: 362 FARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSG--SGQGEREFRAEVEIISRV-HHRH 417
F R + +G G +G V+K + +G++ AVK+ S + AEV +V H
Sbjct: 59 FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPC 118
Query: 418 LVSLVGYCISEKNRLLIY-EFVPNNNLEHHLHGKGQPVLEWTKRVK-IALGAAKGLAYLH 475
V L E L + E +L+ H G + E +V LA+LH
Sbjct: 119 CVRLEQ-AWEEGGILYLQTELC-GPSLQQHCEAWGASLPE--AQVWGYLRDTLLALAHLH 174
Query: 476 EDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK-LNDTTQTHVSTRVMGTFGYLAPEYA 534
++H D+K ANI + ++ DFGL L V G Y+APE
Sbjct: 175 SQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV---QEGDPRYMAPE-L 227
Query: 535 SSGKLTDRSDVFSFGVVLLELITGRKP 561
G +DVFS G+ +LE+ +
Sbjct: 228 LQGSYGTAADVFSLGLTILEVACNMEL 254
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-35
Identities = 56/211 (26%), Positives = 85/211 (40%), Gaps = 20/211 (9%)
Query: 362 FAR---ENVIGEGGFGCVYKGNLPE-GKVVAVKQLKSGSGQGE---REFRAEVEIISRVH 414
F ++G GG G VY+ ++VA+K + + E R+
Sbjct: 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQ 92
Query: 415 HRHLVSLVGYCISEKNRLLIY---EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGL 471
H+V + + E + L Y + +L L +G L + V I L
Sbjct: 93 EPHVVPI--HDFGEIDGQL-YVDMRLINGVDLAAMLRRQGP--LAPPRAVAIVRQIGSAL 147
Query: 472 AYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK-LNDTTQTHVSTRVMGTFGYLA 530
H HRD+K NILV + A + DFG+A D T + +GT Y+A
Sbjct: 148 DAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGTLYYMA 203
Query: 531 PEYASSGKLTDRSDVFSFGVVLLELITGRKP 561
PE S T R+D+++ VL E +TG P
Sbjct: 204 PERFSESHATYRADIYALTCVLYECLTGSPP 234
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-35
Identities = 60/228 (26%), Positives = 96/228 (42%), Gaps = 37/228 (16%)
Query: 362 FARENV-----IGEGGFGCVYKG---NLPEGK---VVAVKQLKSGSGQGER-EFRAEVEI 409
R+N+ +G G FG VY+G +P VAVK L + + +F E I
Sbjct: 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 127
Query: 410 ISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNL-----EHHLHGKGQPVLEWTKRVKIA 464
IS+ +H+++V +G + R ++ E + +L E L + +A
Sbjct: 128 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 187
Query: 465 LGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFE---AQVADFGLAKL---NDTTQTHV 518
A G YL E+ IHRDI + N L+ A++ DFG+A+ +
Sbjct: 188 RDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGG 244
Query: 519 STRV----MGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKP 561
+ M PE G T ++D +SFGV+L E+ + G P
Sbjct: 245 CAMLPVKWM------PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-35
Identities = 63/237 (26%), Positives = 106/237 (44%), Gaps = 46/237 (19%)
Query: 362 FARENV-----IGEGGFGCVYKGNL--------PEGKVVAVKQLKSGSGQGER-EFRAEV 407
F R+ + +GEG FG V E VAVK LK + + + + +E+
Sbjct: 78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 137
Query: 408 EIISRV-HHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHL--------------HGKGQ 452
E++ + H+++++L+G C + +I E+ NL +L + +
Sbjct: 138 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 197
Query: 453 PVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKL-- 510
+ + V A+G+ YL K IHRD+ + N+LV + ++ADFGLA+
Sbjct: 198 EQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDIN 254
Query: 511 -NDTTQTHVSTRV----MGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKP 561
D + + R+ M APE T +SDV+SFGV++ E+ T G P
Sbjct: 255 NIDYYKKTTNGRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-35
Identities = 63/240 (26%), Positives = 107/240 (44%), Gaps = 47/240 (19%)
Query: 362 FARENV-----IGEGGFGCVYKG---NLPEGK---VVAVKQLKSGSGQGER-EFRAEVEI 409
+ R N+ IGEG FG V++ L + +VAVK LK + + +F+ E +
Sbjct: 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAAL 103
Query: 410 ISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHL---------------------- 447
++ + ++V L+G C K L++E++ +L L
Sbjct: 104 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 163
Query: 448 HGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGL 507
G P L +++ IA A G+AYL E K +HRD+ + N LV + ++ADFGL
Sbjct: 164 SSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGL 220
Query: 508 AKLNDTTQTHVSTRVMGTFGYL-----APEYASSGKLTDRSDVFSFGVVLLELIT-GRKP 561
++ + + + PE + T SDV+++GVVL E+ + G +P
Sbjct: 221 SRNIYSADYY----KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 7e-35
Identities = 53/217 (24%), Positives = 99/217 (45%), Gaps = 25/217 (11%)
Query: 362 FARENVIGEGGFGCVYKGNLPEGKVVAVKQ--LKSGSGQGEREFRAEVEIISRV--HHRH 417
++ IG GG V++ + ++ A+K L+ Q +R E+ ++++ H
Sbjct: 11 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 70
Query: 418 LVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHED 477
++ L Y I+++ ++ E N +L L K + W ++ + + +H+
Sbjct: 71 IIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKK-SIDPWERK-SYWKNMLEAVHTIHQH 127
Query: 478 CHPKIIHRDIKSANILVDDEFEAQVADFGLAKL--NDTTQTHVSTRVMGTFGYLAPE--- 532
I+H D+K AN L+ D ++ DFG+A DTT ++V GT Y+ PE
Sbjct: 128 ---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPPEAIK 182
Query: 533 --------YASSGKLTDRSDVFSFGVVLLELITGRKP 561
S K++ +SDV+S G +L + G+ P
Sbjct: 183 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 8e-35
Identities = 57/246 (23%), Positives = 107/246 (43%), Gaps = 27/246 (10%)
Query: 333 YHGGGPDSGVLGGSKSFFTYEELMEITNGFARENVIGEGGFGCVYKGNLPEGKVVAVKQ- 391
+H LG +F + + ++ IG GG V++ + ++ A+K
Sbjct: 3 HHHHHSSGVDLGTENLYF--QSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYV 60
Query: 392 -LKSGSGQGEREFRAEVEIISRV--HHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLH 448
L+ Q +R E+ ++++ H ++ L Y I+++ ++ E N +L L
Sbjct: 61 NLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLK 119
Query: 449 GKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLA 508
K + W ++ + + +H+ I+H D+K AN L+ D ++ DFG+A
Sbjct: 120 KKK-SIDPWERK-SYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIA 173
Query: 509 KL--NDTTQTHVSTRVMGTFGYLAPE-----------YASSGKLTDRSDVFSFGVVLLEL 555
DTT ++V GT Y+ PE S K++ +SDV+S G +L +
Sbjct: 174 NQMQPDTTSVVKDSQV-GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYM 232
Query: 556 ITGRKP 561
G+ P
Sbjct: 233 TYGKTP 238
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-34
Identities = 60/231 (25%), Positives = 97/231 (41%), Gaps = 25/231 (10%)
Query: 366 NVIGEGGFGCVYKG-NLPEGKVVAVKQLK----SGSGQGEREFRAEVEIISRVHHRHLVS 420
+G+G FG VY ++A+K L +G + R EVEI S + H +++
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ-LRREVEIQSHLRHPNILR 73
Query: 421 LVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHP 480
L GY LI E+ P + L K E I A L+Y H
Sbjct: 74 LYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKFDEQRTATYITE-LANALSYCHSK--- 128
Query: 481 KIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLT 540
++IHRDIK N+L+ E ++ADFG + +++ + GT YL PE
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--D-LCGTLDYLPPEMIEGRMHD 185
Query: 541 DRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLS 591
++ D++S GV+ E + G+ P + + E + I + +
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPPFE------ANTYQE-----TYKRISRVEFT 225
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 1e-34
Identities = 60/236 (25%), Positives = 102/236 (43%), Gaps = 24/236 (10%)
Query: 362 FARENVIGEGGFGCVYKG-NLPEGKVVAVK-----QLKSGSGQGEREFRAEVEIISRVHH 415
F N++G+G F VY+ ++ G VA+K + +G +R + EV+I ++ H
Sbjct: 13 FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYK-AGMVQR-VQNEVKIHCQLKH 70
Query: 416 RHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLH 475
++ L Y L+ E N + +L + +P E R + G+ YLH
Sbjct: 71 PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMH-QIITGMLYLH 129
Query: 476 EDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYAS 535
I+HRD+ +N+L+ ++ADFGLA T + GT Y++PE A+
Sbjct: 130 SH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIAT 185
Query: 536 SGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLS 591
SDV+S G + L+ GR P D +++ + + D
Sbjct: 186 RSAHGLESDVWSLGCMFYTLLIGRPPFD------TDTV-----KNTLNKVVLADYE 230
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 48/221 (21%), Positives = 98/221 (44%), Gaps = 35/221 (15%)
Query: 367 VIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYC 425
V+G+G FG V K N + + A+K+++ + +EV +++ ++H+++V
Sbjct: 13 VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQYVVRYYAAW 71
Query: 426 ISEKNRLL----------IY---EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLA 472
+ +N + ++ E+ N L +H + ++ + L+
Sbjct: 72 LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW-RLFRQILEALS 130
Query: 473 YLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHV-------------- 518
Y+H IIHRD+K NI +D+ ++ DFGLAK + +
Sbjct: 131 YIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 519 STRVMGTFGYLAPE-YASSGKLTDRSDVFSFGVVLLELITG 558
++ + GT Y+A E +G ++ D++S G++ E+I
Sbjct: 188 TSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 51/279 (18%), Positives = 90/279 (32%), Gaps = 65/279 (23%)
Query: 362 FARENVIGEGGFGCVYKG-NLPEGKVVAVKQ--LKSGSGQGEREFRAEVEIISRV-HHRH 417
F IG G FG V+K +G + A+K+ E+ EV + + H H
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72
Query: 418 LVSLVGYCISEKNRLLIY-EFVPNNNLEHHL--HGKGQPVLEWTKRVKIALGAAKGLAYL 474
+V +E + +LI E+ +L + + + + + + L +GL Y+
Sbjct: 73 VVRYFS-AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131
Query: 475 HEDCHPKIIHRDIKSANILVDDE-------------------FEAQVADFGLAKLNDTTQ 515
H ++H DIK +NI + ++ D G + Q
Sbjct: 132 HSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ 188
Query: 516 THVSTRVMGTFGYLAPE-----YASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGD 570
G +LA E Y K +D+F+ + ++
Sbjct: 189 VEE-----GDSRFLANEVLQENYTHLPK----ADIFALALTVVCAAGAEPL--------- 230
Query: 571 ESLVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFR 609
I G L PR+ + S+ F
Sbjct: 231 -----PRNGDQWHEIRQGRL-----PRIPQVL--SQEFT 257
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 64/230 (27%), Positives = 93/230 (40%), Gaps = 25/230 (10%)
Query: 367 VIGEGGFGCVYKG-NLPEGKVVAVKQLK----SGSGQGEREFRAEVEIISRVHHRHLVSL 421
+G+G FG VY ++A+K L G + R E+EI S + H +++ +
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ-LRREIEIQSHLRHPNILRM 79
Query: 422 VGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPK 481
Y K L+ EF P L L K E + A L Y HE K
Sbjct: 80 YNYFHDRKRIYLMLEFAPRGELYKELQ-KHGRFDEQRSATFMEE-LADALHYCHER---K 134
Query: 482 IIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTD 541
+IHRDIK N+L+ + E ++ADFG + + + GT YL PE +
Sbjct: 135 VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC---GTLDYLPPEMIEGKTHDE 191
Query: 542 RSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLS 591
+ D++ GV+ E + G P D S E R I DL
Sbjct: 192 KVDLWCAGVLCYEFLVGMPPFD------SPSHTE-----THRRIVNVDLK 230
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-32
Identities = 44/204 (21%), Positives = 77/204 (37%), Gaps = 24/204 (11%)
Query: 367 VIGEGGFGCVYKG---NLPEGKVVAVKQLKSGSGQGERE-FRAEVEIISRVHHRHLVSL- 421
I GG G +Y N+ G+ V +K L + AE + ++ V H +V +
Sbjct: 87 CIAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 422 -VGYCISEKNRLLIY---EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHED 477
+ Y E+V +L+ K L + + L L+YLH
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK----LPVAEAIAYLLEILPALSYLHSI 201
Query: 478 CHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSG 537
+++ D+K NI++ +E + ++ D G + GT G+ APE
Sbjct: 202 ---GLVYNDLKPENIMLTEE-QLKLIDLGAVSR--INSFGY---LYGTPGFQAPEIVR-T 251
Query: 538 KLTDRSDVFSFGVVLLELITGRKP 561
T +D+++ G L L
Sbjct: 252 GPTVATDIYTVGRTLAALTLDLPT 275
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 3e-07
Identities = 12/106 (11%), Positives = 21/106 (19%), Gaps = 8/106 (7%)
Query: 64 PAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSS 123
+ P P SP + + + + S
Sbjct: 329 EVVAQDTGVPRPGLSTIFSPSRSTFGVDLLVAHTDVYLDGQVHAEKLTANEIVTALSVPL 388
Query: 124 PPPGDGGA--------SPPPEQSKNSPPAPPGQASTPPDSPPPGIQ 161
P D A S P + + A G ++
Sbjct: 389 VDPTDVAASVLQATVLSQPVQTLDSLRAARHGALDADGVDFSESVE 434
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 9e-06
Identities = 10/105 (9%), Positives = 16/105 (15%)
Query: 65 AASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSP 124
A P S + S A +
Sbjct: 326 VLREVVAQDTGVPRPGLSTIFSPSRSTFGVDLLVAHTDVYLDGQVHAEKLTANEIVTALS 385
Query: 125 PPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVP 169
P + + + P Q + G G
Sbjct: 386 VPLVDPTDVAASVLQATVLSQPVQTLDSLRAARHGALDADGVDFS 430
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-32
Identities = 51/217 (23%), Positives = 97/217 (44%), Gaps = 25/217 (11%)
Query: 362 FARENVIGEGGFGCVYKGNLPEGKVVAVKQ--LKSGSGQGEREFRAEVEIISRVHH--RH 417
++ IG GG V++ + ++ A+K L+ Q +R E+ ++++
Sbjct: 58 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 117
Query: 418 LVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHED 477
++ L Y I+++ ++ E N +L L K + W ++ + + +H+
Sbjct: 118 IIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKK-SIDPWERK-SYWKNMLEAVHTIHQH 174
Query: 478 CHPKIIHRDIKSANILVDDEFEAQVADFGLAKL--NDTTQTHVSTRVMGTFGYLAPE--- 532
I+H D+K AN L+ D ++ DFG+A DTT ++V G Y+ PE
Sbjct: 175 ---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV-GAVNYMPPEAIK 229
Query: 533 --------YASSGKLTDRSDVFSFGVVLLELITGRKP 561
S K++ +SDV+S G +L + G+ P
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 4e-31
Identities = 55/223 (24%), Positives = 91/223 (40%), Gaps = 26/223 (11%)
Query: 362 FARENVIGEGGFGCVYKGNLPEGKVVAVKQ-LKSGSGQGEREFRAEVEIISRV-HHRHLV 419
F ++V+G G G + + + + VAVK+ L +R EV+++ H +++
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADR----EVQLLRESDEHPNVI 81
Query: 420 SLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCH 479
+ + + E L+ ++ K L + + + GLA+LH
Sbjct: 82 RYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLG-LEPITLLQQTTSGLAHLHSL-- 137
Query: 480 PKIIHRDIKSANILVDDEFE-----AQVADFGLAKLNDTTQTHVSTR--VMGTFGYLAPE 532
I+HRD+K NIL+ A ++DFGL K + S R V GT G++APE
Sbjct: 138 -NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196
Query: 533 Y---ASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDES 572
T D+FS G V +I+ P G
Sbjct: 197 MLSEDCKENPTYTVDIFSAGCVFYYVISEGSH-----PFGKSL 234
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 8e-31
Identities = 49/217 (22%), Positives = 92/217 (42%), Gaps = 26/217 (11%)
Query: 367 VIGEGGFGCVYKG-NLPEGKVVAVKQL-KSGSGQGEREFRAEVEIISRVHHRHLVSL--V 422
++G+G V++G + G + A+K + E E++ +++H+++V L +
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 423 GYCISEKNRLLIYEFVPNNNLEHHL--HGKGQPVLEWTKRVKIA-LGAAKGLAYLHEDCH 479
+ ++++LI EF P +L L + E + + + G+ +L E+
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV--VGGMNHLREN-- 131
Query: 480 PKIIHRDIKSANILVDDEFEAQ----VADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYAS 535
I+HR+IK NI+ + Q + DFG A+ + + + GT YL P+
Sbjct: 132 -GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVSLY-GTEEYLHPDMYE 188
Query: 536 SGKLTDRS--------DVFSFGVVLLELITGRKPVDP 564
L D++S GV TG P P
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 1e-30
Identities = 67/269 (24%), Positives = 114/269 (42%), Gaps = 14/269 (5%)
Query: 362 FARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREF-RAEVEIISRVHHRHLV 419
F + + +G G G V+K + P G V+A K + R E++++ + ++V
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94
Query: 420 SLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCH 479
G S+ + E + +L+ L K + E K+++ KGL YL E
Sbjct: 95 GFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIPE-QILGKVSIAVIKGLTYLREKH- 151
Query: 480 PKIIHRDIKSANILVDDEFEAQVADFGLA-KLNDT-TQTHVSTRVMGTFGYLAPEYASSG 537
KI+HRD+K +NILV+ E ++ DFG++ +L D+ + V GT Y++PE
Sbjct: 152 -KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----GTRSYMSPERLQGT 205
Query: 538 KLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPR 597
+ +SD++S G+ L+E+ GR P+ P E + +
Sbjct: 206 HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLN 265
Query: 598 LEKHYVESEMFRMIEAAAACVRHSGPKRP 626
M + E V PK P
Sbjct: 266 KFGMDSRPPM-AIFELLDYIVNEPPPKLP 293
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 52/209 (24%), Positives = 90/209 (43%), Gaps = 16/209 (7%)
Query: 362 FARENVIGEGGFGCVYKG-NLPEGKVVAVK-----QLKSGSGQGEREFRAEVEIISRVHH 415
+ R +G+GGF ++ + +V A K L Q E+ E+ I + H
Sbjct: 17 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK-PHQREK-MSMEISIHRSLAH 74
Query: 416 RHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLH 475
+H+V G+ ++ E +L + + E R G YLH
Sbjct: 75 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK-ALTEPEAR-YYLRQIVLGCQYLH 132
Query: 476 EDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYAS 535
+ ++IHRD+K N+ ++++ E ++ DFGLA + + GT Y+APE
Sbjct: 133 RN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVL- 187
Query: 536 SGKLTD-RSDVFSFGVVLLELITGRKPVD 563
S K DV+S G ++ L+ G+ P +
Sbjct: 188 SKKGHSFEVDVWSIGCIMYTLLVGKPPFE 216
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-30
Identities = 63/215 (29%), Positives = 99/215 (46%), Gaps = 21/215 (9%)
Query: 367 VIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGERE-FRAEVEIISRVHHRHLVSLV-- 422
+G GGFG V + + G+ VA+KQ + RE + E++I+ +++H ++VS
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 423 ----GYCISEKNRLLIYEFVPNNNLEHHL--HGKGQPVLEWTKRVKIA-LGAAKGLAYLH 475
LL E+ +L +L + E R ++ + +A L YLH
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA--LRYLH 138
Query: 476 EDCHPKIIHRDIKSANILVDDEFEAQ---VADFGLAKLNDTTQTHVSTRVMGTFGYLAPE 532
E+ +IIHRD+K NI++ + + D G A + Q + T +GT YLAPE
Sbjct: 139 EN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYA--KELDQGELCTEFVGTLQYLAPE 193
Query: 533 YASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQP 567
K T D +SFG + E ITG +P P
Sbjct: 194 LLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ 228
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-30
Identities = 54/230 (23%), Positives = 95/230 (41%), Gaps = 18/230 (7%)
Query: 339 DSGVLGGSKSFFTYEELMEITNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSG 397
+ GVL K E E + + +G G FG V++ + G AVK+++
Sbjct: 37 NEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF 96
Query: 398 QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIY-EFVPNNNLEHHLHGKGQPVLE 456
+ E E+ + + +V L G + E + I+ E + +L L + + E
Sbjct: 97 RVE-----ELVACAGLSSPRIVPLYG-AVREGPWVNIFMELLEGGSL-GQLIKQMGCLPE 149
Query: 457 WTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDE-FEAQVADFGLAKLNDTTQ 515
A +GL YLH +I+H D+K+ N+L+ + A + DFG A
Sbjct: 150 DRALY-YLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205
Query: 516 THVSTR----VMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKP 561
S + GT ++APE + D++S ++L ++ G P
Sbjct: 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 64/206 (31%), Positives = 105/206 (50%), Gaps = 17/206 (8%)
Query: 362 FARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGERE-FRAEVEIISRVHHRHLV 419
F + IG+G FG V+KG + KVVA+K + + E E + E+ ++S+ ++
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 420 SLVGYCISEKNRL-LIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIAL---GAAKGLAYLH 475
G + +L +I E++ + L + P+ E +IA KGL YLH
Sbjct: 84 KYYG-SYLKDTKLWIIMEYLGGGSALDLL--EPGPLDE----TQIATILREILKGLDYLH 136
Query: 476 EDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYAS 535
+ K IHRDIK+AN+L+ + E ++ADFG+A TQ +T +GT ++APE
Sbjct: 137 SE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVIK 192
Query: 536 SGKLTDRSDVFSFGVVLLELITGRKP 561
++D++S G+ +EL G P
Sbjct: 193 QSAYDSKADIWSLGITAIELARGEPP 218
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-29
Identities = 51/219 (23%), Positives = 92/219 (42%), Gaps = 30/219 (13%)
Query: 367 VIGEGGFGCVYKG-NLPEGKVVAVKQL-KSGSGQGEREFRAEVEIISRVHHRHLVSLVGY 424
++G+G V++G + G + A+K + E E++ +++H+++V L +
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKL--F 73
Query: 425 CISE----KNRLLIYEFVPNNNLEHHL--HGKGQPVLEWTKRVKIA-LGAAKGLAYLHED 477
I E ++++LI EF P +L L + E + + + G+ +L E+
Sbjct: 74 AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV--VGGMNHLREN 131
Query: 478 CHPKIIHRDIKSANILVDDEFEAQ----VADFGLAKLNDTTQTHVSTRVMGTFGYLAPEY 533
I+HR+IK NI+ + Q + DFG A+ + + GT YL P+
Sbjct: 132 ---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLY-GTEEYLHPDM 186
Query: 534 ASSGKLTDRS--------DVFSFGVVLLELITGRKPVDP 564
L D++S GV TG P P
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 52/207 (25%), Positives = 89/207 (42%), Gaps = 16/207 (7%)
Query: 362 FARENVIGEGGFGCVYKG-NLPEGKVVAVK-----QLKSGSGQGEREFRAEVEIISRVHH 415
+ R +G+GGF ++ + +V A K L Q E+ E+ I + H
Sbjct: 43 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK-PHQREK-MSMEISIHRSLAH 100
Query: 416 RHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLH 475
+H+V G+ ++ E +L + + E R G YLH
Sbjct: 101 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK-ALTEPEAR-YYLRQIVLGCQYLH 158
Query: 476 EDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYAS 535
+ ++IHRD+K N+ ++++ E ++ DFGLA + + GT Y+APE
Sbjct: 159 RN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVL- 213
Query: 536 SGKLTD-RSDVFSFGVVLLELITGRKP 561
S K DV+S G ++ L+ G+ P
Sbjct: 214 SKKGHSFEVDVWSIGCIMYTLLVGKPP 240
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-29
Identities = 49/221 (22%), Positives = 88/221 (39%), Gaps = 25/221 (11%)
Query: 365 ENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRV-HHRHLVSLV 422
V+ EGGF VY+ ++ G+ A+K+L S + R EV + ++ H ++V
Sbjct: 33 RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92
Query: 423 GYCISEKNR-------LLIYEFVPNNNLEHHLHGKGQPVLEWTKRV-KIALGAAKGLAYL 474
K L+ + L L V KI + + ++
Sbjct: 93 SAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHM 152
Query: 475 HEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKL----NDTTQTHVSTRVM------- 523
H P IIHRD+K N+L+ ++ ++ DFG A D + + ++
Sbjct: 153 H-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN 211
Query: 524 GTFGYLAPE---YASSGKLTDRSDVFSFGVVLLELITGRKP 561
T Y PE S+ + ++ D+++ G +L L + P
Sbjct: 212 TTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 6e-29
Identities = 49/250 (19%), Positives = 99/250 (39%), Gaps = 41/250 (16%)
Query: 367 VIGEGGFGCVYKGNLPEGKVVAVKQL-----------------KSGSGQGEREFRAEVEI 409
+ +G F + + K A+K+ K +F+ E++I
Sbjct: 38 TLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96
Query: 410 ISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGA-- 467
I+ + + + ++ G + +IYE++ N+++ +T + I +
Sbjct: 97 ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156
Query: 468 ----AKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVM 523
+Y+H I HRD+K +NIL+D +++DFG ++ + S
Sbjct: 157 IKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGS---R 211
Query: 524 GTFGYLAPEYASSGKLTD--RSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVL 581
GT+ ++ PE+ S+ + + D++S G+ L + P SLVE L
Sbjct: 212 GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFS-----LKISLVE-----L 261
Query: 582 VRAIETGDLS 591
I T ++
Sbjct: 262 FNNIRTKNIE 271
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 7e-29
Identities = 54/212 (25%), Positives = 99/212 (46%), Gaps = 20/212 (9%)
Query: 362 FARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGERE-FRAEVEIISR-VHHRHL 418
+G G +G V K ++P G+++AVK++++ E++ +++I R V
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFT 68
Query: 419 VSLVGYCISEKNRLLIYEFVP--NNNLEHHLHGKGQPVLEWTKRV--KIALGAAKGLAYL 474
V+ G E + + E + + + KGQ + E + KIA+ K L +L
Sbjct: 69 VTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPE---DILGKIAVSIVKALEHL 125
Query: 475 HEDCHPKIIHRDIKSANILVDDEFEAQVADFGL-AKLNDTTQTHVSTRVMGTFGYLAPE- 532
H +IHRD+K +N+L++ + ++ DFG+ L D G Y+APE
Sbjct: 126 HSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA---KDIDAGCKPYMAPER 180
Query: 533 ---YASSGKLTDRSDVFSFGVVLLELITGRKP 561
+ + +SD++S G+ ++EL R P
Sbjct: 181 INPELNQKGYSVKSDIWSLGITMIELAILRFP 212
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 57/210 (27%), Positives = 105/210 (50%), Gaps = 19/210 (9%)
Query: 362 FARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVS 420
+ +G+G FG VYK N G + A K +++ S + ++ E+EI++ H ++V
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 421 LVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIAL---GAAKGLAYLHED 477
L+G + ++ EF P ++ + + + E +I + + L +LH
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTE----PQIQVVCRQMLEALNFLHSK 136
Query: 478 CHPKIIHRDIKSANILVDDEFEAQVADFGL-AKLNDTTQTHVSTRVMGTFGYLAPEYASS 536
+IIHRD+K+ N+L+ E + ++ADFG+ AK T Q S +GT ++APE
Sbjct: 137 ---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVMC 191
Query: 537 GKLTD-----RSDVFSFGVVLLELITGRKP 561
+ D ++D++S G+ L+E+ P
Sbjct: 192 ETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-28
Identities = 60/248 (24%), Positives = 101/248 (40%), Gaps = 41/248 (16%)
Query: 357 EITNGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRV-HH 415
+ N E ++G G G V +G+ VAVK++ E+++++ H
Sbjct: 12 SLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDH 68
Query: 416 RHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKR-----VKIALGAAKG 470
+++ +++ + E N NL+ + K + + + A G
Sbjct: 69 PNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127
Query: 471 LAYLHEDCHPKIIHRDIKSANILVD-------------DEFEAQVADFGLAKLNDTTQTH 517
+A+LH KIIHRD+K NILV + ++DFGL K D+ Q+
Sbjct: 128 VAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSS 184
Query: 518 VSTRVM---GTFGYLAPE-------YASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQP 567
T + GT G+ APE + +LT D+FS G V +++ K P
Sbjct: 185 FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH-----P 239
Query: 568 LGDESLVE 575
GD+ E
Sbjct: 240 FGDKYSRE 247
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 22/247 (8%), Positives = 50/247 (20%), Gaps = 43/247 (17%)
Query: 362 FARENVIGEGGFGCVYKG-NLPEGKVVAVKQL---KSGSGQGEREFRAEVEIISRVHHRH 417
+ G V+ ++ + A+K S +R+
Sbjct: 64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGES 123
Query: 418 LVSLVGYC--------------------------ISEKNRLLIYEFVPNNNLEH----HL 447
+ N LL+ +
Sbjct: 124 PEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDF 183
Query: 448 HGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGL 507
+ + + A L ++H N+ + + + D
Sbjct: 184 VYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSA 240
Query: 508 AKLNDTTQTHVSTRVMGTFGYLAPEYASSGKL--TDRSDVFSFGVVLLELITGRKPVDPT 565
T Y E+ ++ T + + G+ + + P
Sbjct: 241 LWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV 296
Query: 566 QPLGDES 572
P S
Sbjct: 297 TPGIKGS 303
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 43/322 (13%), Positives = 93/322 (28%), Gaps = 46/322 (14%)
Query: 301 PPPNNFNEKTVDTYYGSQTPQMHSYGSQRGVGYHGGGPDSGVLGGSKSFFTYEELMEITN 360
N +++K + + + SY + E
Sbjct: 17 IVGNPWDDKLIFKLLSGLSKPVSSY--------------PNTFEWQCKLPAIKPKTEFQL 62
Query: 361 G---FARENVIGEGGFGCVYKG------NLPEGKVVAVKQLKSGSGQGEREFRAEVEIIS 411
G +++GEG F VY+ + + +K K + +E +
Sbjct: 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLK 122
Query: 412 RVHHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQP---VLEWTKRVKIALGAA 468
+ + + +L+ E L + ++ V+ + A+
Sbjct: 123 PSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRML 182
Query: 469 KGLAYLHEDCHPKIIHRDIKSANILVDDEFEA-----------QVADFGLAK-LNDTTQT 516
+ +H+ +IIH DIK N ++ + F + D G + + +
Sbjct: 183 YMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKG 239
Query: 517 HVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEW 576
+ T T G+ E S+ + D F + ++ G + +E
Sbjct: 240 TIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM-----KVKNEGGECK 294
Query: 577 ARPVLVRAIETGDLSEIVDPRL 598
+ R +E L
Sbjct: 295 PEGLFRRLPHLDMWNEFFHVML 316
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-28
Identities = 66/222 (29%), Positives = 105/222 (47%), Gaps = 21/222 (9%)
Query: 362 FARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGERE-FRAEVEIISR-VHHRHL 418
IG G +G V K + P G+++AVK+++S + E++ +++++ R ++
Sbjct: 24 LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYI 83
Query: 419 VSLVGYCISEKNRLLIYEFVP---NNNLEHHLHGKGQPVLEWTKRV--KIALGAAKGLAY 473
V G E + + E + + ++ + E + KI L K L +
Sbjct: 84 VQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPE---EILGKITLATVKALNH 140
Query: 474 LHEDCHPKIIHRDIKSANILVDDEFEAQVADFGL-AKLNDTTQTHVSTRVMGTFGYLAPE 532
L E+ KIIHRDIK +NIL+D ++ DFG+ +L D+ TR G Y+APE
Sbjct: 141 LKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK---TRDAGCRPYMAPE 195
Query: 533 ----YASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGD 570
AS RSDV+S G+ L EL TGR P + D
Sbjct: 196 RIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD 237
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 59/214 (27%), Positives = 102/214 (47%), Gaps = 18/214 (8%)
Query: 362 FARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGERE-FRAEVEIISRVHHRHLV 419
+ + VIG G V P+ + VA+K++ Q + E++ +S+ HH ++V
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76
Query: 420 SLVGYCISEKNRL-LIYEFVPNNNLEH---HLHGKGQPVLEWTKRVKIAL---GAAKGLA 472
S K+ L L+ + + ++ H+ KG+ IA +GL
Sbjct: 77 SYYT-SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLE 135
Query: 473 YLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGL-AKLNDTTQTHVSTR---VMGTFGY 528
YLH++ IHRD+K+ NIL+ ++ Q+ADFG+ A L + +GT +
Sbjct: 136 YLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCW 192
Query: 529 LAPEYASSGKLTD-RSDVFSFGVVLLELITGRKP 561
+APE + D ++D++SFG+ +EL TG P
Sbjct: 193 MAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 60/217 (27%), Positives = 110/217 (50%), Gaps = 26/217 (11%)
Query: 362 FARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRV-HHRHLV 419
F ++G G +G VYKG ++ G++ A+K + +G E E + E+ ++ + HHR++
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQEINMLKKYSHHRNIA 84
Query: 420 S-----LVGYCISEKNRL-LIYEFVPNNNLEHHLHG-KGQPVLEWTKRVKIAL---GAAK 469
+ + ++L L+ EF ++ + KG + E IA +
Sbjct: 85 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKE----EWIAYICREILR 140
Query: 470 GLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYL 529
GL++LH+ K+IHRDIK N+L+ + E ++ DFG++ D T +T +GT ++
Sbjct: 141 GLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWM 196
Query: 530 APEYASSGKLTD-----RSDVFSFGVVLLELITGRKP 561
APE + + D +SD++S G+ +E+ G P
Sbjct: 197 APEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 58/204 (28%), Positives = 99/204 (48%), Gaps = 14/204 (6%)
Query: 362 FARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVS 420
F +GEG +G VYK + G++VA+KQ+ +E E+ I+ + H+V
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVK 88
Query: 421 LVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIAL---GAAKGLAYLHED 477
G + ++ E+ ++ + + + + E +IA KGL YLH
Sbjct: 89 YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTE----DEIATILQSTLKGLEYLHFM 144
Query: 478 CHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSG 537
+ IHRDIK+ NIL++ E A++ADFG+A T +T + GT ++APE
Sbjct: 145 ---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQEI 200
Query: 538 KLTDRSDVFSFGVVLLELITGRKP 561
+D++S G+ +E+ G+ P
Sbjct: 201 GYNCVADIWSLGITAIEMAEGKPP 224
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-27
Identities = 54/257 (21%), Positives = 108/257 (42%), Gaps = 35/257 (13%)
Query: 346 SKSFFTYEELMEITNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQL-KSGSGQGERE- 402
+ F + ++ + R +G G +G V + A+K + K+
Sbjct: 23 TPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSK 82
Query: 403 FRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKR-- 460
EV ++ + H +++ L + ++N L+ E L + + + + +
Sbjct: 83 LLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMK----FNEVDA 138
Query: 461 ---VKIALGAAKGLAYLHEDCHPKIIHRDIKSANILV---DDEFEAQVADFGLAKLNDTT 514
+K L + YLH+ I+HRD+K N+L+ + + ++ DFGL+ + +
Sbjct: 139 AVIIKQVLSG---VTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192
Query: 515 QTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLV 574
+ +GT Y+APE K ++ DV+S GV+L L+ G P G ++
Sbjct: 193 KKM--KERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGY------PPFGGQTDQ 243
Query: 575 EWARPVLVRAIETGDLS 591
E ++R +E G +
Sbjct: 244 E-----ILRKVEKGKYT 255
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 3e-27
Identities = 63/209 (30%), Positives = 98/209 (46%), Gaps = 26/209 (12%)
Query: 367 VIGEGGFGCVY----KGNLPEGKVVAVKQLKSG---SGQGEREFRAEVEIISRVHHRHLV 419
V+G GGFG V+ K GK+ A K+L +G + E +I+++VH R +V
Sbjct: 192 VLGRGGFGEVFACQMKAT---GKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIV 248
Query: 420 SLVGYCISEKNRL-LIYEFVPNNNLEHHLHGKGQPVLEWT-KRVK-----IALGAAKGLA 472
SL Y K L L+ + ++ +H++ + + R I G L
Sbjct: 249 SLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG----LE 303
Query: 473 YLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPE 532
+LH+ II+RD+K N+L+DD+ +++D GLA QT GT G++APE
Sbjct: 304 HLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPE 359
Query: 533 YASSGKLTDRSDVFSFGVVLLELITGRKP 561
+ D F+ GV L E+I R P
Sbjct: 360 LLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-27
Identities = 54/269 (20%), Positives = 115/269 (42%), Gaps = 36/269 (13%)
Query: 335 GGGPDSGVLGGSKSFFTYEELMEITNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQL- 392
G G L + F ++ + + V+G+G FG V + G+ AVK +
Sbjct: 1 GPGSMMDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVIS 60
Query: 393 --KSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGK 450
+ + EV+++ ++ H +++ L + + L+ E L + +
Sbjct: 61 KRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR 120
Query: 451 GQPVLEWTKR-----VKIALGAAKGLAYLHEDCHPKIIHRDIKSANILV---DDEFEAQV 502
+ +++ ++ L + Y+H++ KI+HRD+K N+L+ + ++
Sbjct: 121 KR----FSEVDAARIIRQVLSG---ITYMHKN---KIVHRDLKPENLLLESKSKDANIRI 170
Query: 503 ADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPV 562
DFGL+ + ++ +GT Y+APE G ++ DV+S GV+L L++G
Sbjct: 171 IDFGLSTHFEASKKM--KDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGC--- 224
Query: 563 DPTQPLGDESLVEWARPVLVRAIETGDLS 591
P + + +++ +E G +
Sbjct: 225 ---PPFNGANEYD-----ILKKVEKGKYT 245
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 72/306 (23%), Positives = 124/306 (40%), Gaps = 50/306 (16%)
Query: 336 GGPDSGVL--GGSKSFFTYEELMEITNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQL 392
G +G L GG + +L + +G G G V+K G V+AVKQ+
Sbjct: 6 SGKQTGYLTIGGQRYQAEINDLENL-------GEMGSGTCGQVWKMRFRKTGHVIAVKQM 58
Query: 393 KSGSGQGERE-FRAEVEIISR-VHHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGK 450
+ + E + +++++ + ++V G I+ + + E + E
Sbjct: 59 RRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRM 117
Query: 451 GQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGL-AK 509
P+ E K+ + K L YL E +IHRD+K +NIL+D+ + ++ DFG+ +
Sbjct: 118 QGPIPERILG-KMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGR 174
Query: 510 LNDTTQTHVSTRVMGTFGYLAPE-----YASSGKLTDRSDVFSFGVVLLELITGRKPVDP 564
L D R G Y+APE + R+DV+S G+ L+EL TG+ P
Sbjct: 175 LVDDKA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKN 231
Query: 565 TQPLGDESLVEWARPVLVRAIETGDLSEIVD---PRLEKHYVESEMFR-MIEAAAACVRH 620
+ + L++++ P L H S F+ + C+
Sbjct: 232 CKTDFEV------------------LTKVLQEEPPLLPGHMGFSGDFQSFV---KDCLTK 270
Query: 621 SGPKRP 626
KRP
Sbjct: 271 DHRKRP 276
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 8e-27
Identities = 44/202 (21%), Positives = 96/202 (47%), Gaps = 10/202 (4%)
Query: 362 FARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVS 420
+ R IG+G G VY ++ G+ VA++Q+ + E+ ++ + ++V+
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 421 LVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHP 480
+ + ++ E++ +L + ++ + + + L +LH +
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN--- 135
Query: 481 KIIHRDIKSANILVDDEFEAQVADFGL-AKLNDTTQTHVSTRVMGTFGYLAPEYASSGKL 539
++IHRDIKS NIL+ + ++ DFG A++ + ++GT ++APE +
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAY 193
Query: 540 TDRSDVFSFGVVLLELITGRKP 561
+ D++S G++ +E+I G P
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPP 215
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-26
Identities = 52/210 (24%), Positives = 91/210 (43%), Gaps = 26/210 (12%)
Query: 362 FARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVS 420
IGEG G V G+ VAVK + Q EV I+ H ++V
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 421 LVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVK--------IALGAAKGLA 472
+ + + ++ EF+ G + + +V+ + + LA
Sbjct: 107 MYKSYLVGEELWVLMEFLQ-----------GGALTDIVSQVRLNEEQIATVCEAVLQALA 155
Query: 473 YLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGL-AKLNDTTQTHVSTRVMGTFGYLAP 531
YLH +IHRDIKS +IL+ + +++DFG A+++ S ++GT ++AP
Sbjct: 156 YLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAP 210
Query: 532 EYASSGKLTDRSDVFSFGVVLLELITGRKP 561
E S D++S G++++E++ G P
Sbjct: 211 EVISRSLYATEVDIWSLGIMVIEMVDGEPP 240
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 4e-26
Identities = 65/211 (30%), Positives = 102/211 (48%), Gaps = 33/211 (15%)
Query: 367 VIGEGGFG----CVYKGNLPEGKVVAVKQLKSG---SGQGEREFRAEVEIISRVHHRHLV 419
V+G+GGFG C + GK+ A K+L+ +GE E +I+ +V+ R +V
Sbjct: 191 VLGKGGFGEVCACQVRAT---GKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVV 247
Query: 420 SLVGYCISEKNRL-LIYEFVPNNNLEHHLHGKGQPVLEWTKRVK-----IALGAAKGLAY 473
SL Y K+ L L+ + +L+ H++ GQ R I G L
Sbjct: 248 SLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP-EARAVFYAAEICCG----LED 301
Query: 474 LHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK---LNDTTQTHVSTRVMGTFGYLA 530
LH + +I++RD+K NIL+DD +++D GLA T + V GT GY+A
Sbjct: 302 LHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV-----GTVGYMA 353
Query: 531 PEYASSGKLTDRSDVFSFGVVLLELITGRKP 561
PE + + T D ++ G +L E+I G+ P
Sbjct: 354 PEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 7e-26
Identities = 42/224 (18%), Positives = 83/224 (37%), Gaps = 21/224 (9%)
Query: 362 FARENVIGEG--GFGCVYKG-NLPEGKVVAVKQ--LKSGSGQGEREFRAEVEIISRVHHR 416
+ VIG+G V P G+ V V++ L++ S + + E+ + +H
Sbjct: 27 YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86
Query: 417 HLVSLVGYCISEKNRL-LIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLH 475
++V N L ++ F+ + + + + I G K L Y+H
Sbjct: 87 NIVPYRA-TFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH 145
Query: 476 EDCHPKIIHRDIKSANILVDDEFEAQVADFG-LAKLNDT-----TQTHVSTRVMGTFGYL 529
+HR +K+++IL+ + + ++ + + +L
Sbjct: 146 HM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWL 202
Query: 530 APEYASSGKL--TDRSDVFSFGVVLLELITGRKP---VDPTQPL 568
+PE +SD++S G+ EL G P + TQ L
Sbjct: 203 SPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML 246
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 9e-26
Identities = 50/241 (20%), Positives = 94/241 (39%), Gaps = 35/241 (14%)
Query: 343 LGGSKSFFTYEELMEITNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLK-------- 393
+ + + ++ +I + + +G G +G V A+K +K
Sbjct: 19 IAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGR 78
Query: 394 -----SGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLH 448
+ E E+ ++ + H +++ L +K L+ EF L +
Sbjct: 79 YSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQII 138
Query: 449 GKGQPVLEWTKR-----VKIALGAAKGLAYLHEDCHPKIIHRDIKSANILV---DDEFEA 500
+ + + + +K L + YLH+ I+HRDIK NIL+ +
Sbjct: 139 NRHK----FDECDAANIMKQILSG---ICYLHKH---NIVHRDIKPENILLENKNSLLNI 188
Query: 501 QVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRK 560
++ DFGL+ +GT Y+APE K ++ DV+S GV++ L+ G
Sbjct: 189 KIVDFGLSSFFSKDY--KLRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYP 245
Query: 561 P 561
P
Sbjct: 246 P 246
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 9e-26
Identities = 30/246 (12%), Positives = 69/246 (28%), Gaps = 54/246 (21%)
Query: 362 FARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGERE------------------ 402
R V+G+ + + G+ V
Sbjct: 75 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 134
Query: 403 ----------FRAEVEIISRVHHRHLVSLVGYC--ISEKNRLLIYEFVPNNNLEH----H 446
F +++ + ++ + + +R +Y + +N
Sbjct: 135 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 194
Query: 447 LHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFG 506
H L R+++ L + LA LH H ++H ++ +I++D + F
Sbjct: 195 SHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFE 251
Query: 507 LAKLNDTTQTHVSTRVMGTFGYLAPEYASS-----------GKLTDRSDVFSFGVVLLEL 555
+ + G+ PE + +T D ++ G+V+ +
Sbjct: 252 HLVRDGARVV-----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI 306
Query: 556 ITGRKP 561
P
Sbjct: 307 WCADLP 312
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-25
Identities = 65/217 (29%), Positives = 97/217 (44%), Gaps = 34/217 (15%)
Query: 362 FARENVIGEGGFGCVY----KGNLPEGKVVAVKQLKSG---SGQGEREFRAEVEIISRVH 414
F+ +IG GGFG VY GK+ A+K L QGE E ++S V
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADT---GKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 247
Query: 415 ---HRHLVSLVGYCISEKNRL-LIYEFVPNNNLEHHLHGKGQPVLEWTKRVK-----IAL 465
+V + Y ++L I + + +L +HL G ++ I L
Sbjct: 248 TGDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA---DMRFYAAEIIL 303
Query: 466 GAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGT 525
G L ++H +++RD+K ANIL+D+ +++D GLA + H V GT
Sbjct: 304 G----LEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--ASV-GT 353
Query: 526 FGYLAPEYASSGKLTDRS-DVFSFGVVLLELITGRKP 561
GY+APE G D S D FS G +L +L+ G P
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-25
Identities = 52/259 (20%), Positives = 110/259 (42%), Gaps = 38/259 (14%)
Query: 344 GGSKSFFTYEELMEITNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQL-KSGSGQGER 401
G ++ + + ++G+G FG V K + + AVK + K+ + +
Sbjct: 9 SGRENLYFQGT---FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDT 65
Query: 402 E-FRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKR 460
EVE++ ++ H +++ L + ++ E L + + + +++
Sbjct: 66 STILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR----FSEH 121
Query: 461 -----VKIALGAAKGLAYLHEDCHPKIIHRDIKSANILV---DDEFEAQVADFGLAKLND 512
+K + Y+H+ I+HRD+K NIL+ + + + ++ DFGL+
Sbjct: 122 DAARIIKQVFSG---ITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175
Query: 513 TTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDES 572
+GT Y+APE G ++ DV+S GV+L L++G P ++
Sbjct: 176 QNTKM--KDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGT------PPFYGKN 226
Query: 573 LVEWARPVLVRAIETGDLS 591
+ +++ +ETG +
Sbjct: 227 EYD-----ILKRVETGKYA 240
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-25
Identities = 33/240 (13%), Positives = 69/240 (28%), Gaps = 43/240 (17%)
Query: 362 FARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGE---REFRAEVEIISRV---- 413
R V+G+ + + G+ V ++ + EV + +
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
Query: 414 -------HHRHL----------------VSLVGYCISEKNRLLIYEFVPNNNLEH----H 446
H R + V L + +R +Y + +N
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199
Query: 447 LHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFG 506
H L R+++ L + LA LH H ++H ++ +I++D + F
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFE 256
Query: 507 LAKLNDTTQTHVSTRVMGTFGYLAPE-----YASSGKLTDRSDVFSFGVVLLELITGRKP 561
+ + R A +T D ++ G+ + + P
Sbjct: 257 HLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 53/218 (24%), Positives = 100/218 (45%), Gaps = 38/218 (17%)
Query: 362 FARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGERE------FRAEVEIISRVH 414
+ + IGEG +G V+K N ++VA+K+++ + E R E+ ++ +
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD---DDEGVPSSALR-EICLLKELK 59
Query: 415 HRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVK-IALGAAKGLAY 473
H+++V L S+K L++EF + L+ + + + VK KGL +
Sbjct: 60 HKNIVRLHDVLHSDKKLTLVFEFCDQD-LKKYFDSCNGDLDP--EIVKSFLFQLLKGLGF 116
Query: 474 LHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK---LNDTTQTHVSTRVMGTFGYLA 530
H ++HRD+K N+L++ E ++A+FGLA+ + + V+ T Y
Sbjct: 117 CHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA---EVV-TLWYRP 169
Query: 531 PE-------YASSGKLTDRSDVFSFGVVLLELITGRKP 561
P+ Y++S D++S G + EL +P
Sbjct: 170 PDVLFGAKLYSTS------IDMWSAGCIFAELANAGRP 201
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 58/214 (27%), Positives = 98/214 (45%), Gaps = 31/214 (14%)
Query: 362 FARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREF---RAEVEIISRVHHRH 417
F+ IG G FG VY ++ +VVA+K++ Q ++ EV + ++ H +
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 418 LVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRV----KIAL---GAAKG 470
+ G + E L+ E+ G +LE K+ +IA GA +G
Sbjct: 116 TIQYRGCYLREHTAWLVMEY---------CLGSASDLLEVHKKPLQEVEIAAVTHGALQG 166
Query: 471 LAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLA 530
LAYLH +IHRD+K+ NIL+ + ++ DFG A + ++ +GT ++A
Sbjct: 167 LAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA----SIMAPANS-FVGTPYWMA 218
Query: 531 PEYASSGKLTD---RSDVFSFGVVLLELITGRKP 561
PE + + DV+S G+ +EL + P
Sbjct: 219 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 52/269 (19%), Positives = 93/269 (34%), Gaps = 54/269 (20%)
Query: 344 GGSKSFFTYEELMEITNGFARENVIGEGGFGCVYKG-NLPEGKVVAVK-----QLKSGSG 397
G +F L+E+ + + IG+G +G V + A+K +++ +
Sbjct: 10 GRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINP 69
Query: 398 QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEW 457
+ + EV ++ ++HH ++ L E+ L+ E +L L+
Sbjct: 70 KDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGK 129
Query: 458 TKRVKIALG-------------------------------AAK-------GLAYLHEDCH 479
+ + L YLH
Sbjct: 130 CAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ-- 187
Query: 480 PKIIHRDIKSANILVDDEFEAQV--ADFGLAKL---NDTTQTHVSTRVMGTFGYLAPE-- 532
I HRDIK N L ++ DFGL+K + + + T GT ++APE
Sbjct: 188 -GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVL 246
Query: 533 YASSGKLTDRSDVFSFGVVLLELITGRKP 561
++ + D +S GV+L L+ G P
Sbjct: 247 NTTNESYGPKCDAWSAGVLLHLLLMGAVP 275
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 51/197 (25%), Positives = 91/197 (46%), Gaps = 22/197 (11%)
Query: 365 ENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVG 423
V+G G F V+ GK+ A+K +K + E+ ++ ++ H ++V+L
Sbjct: 14 MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLED 73
Query: 424 YCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKR-----VKIALGAAKGLAYLHEDC 478
S + L+ + V L + +G +T++ ++ L A + YLHE+
Sbjct: 74 IYESTTHYYLVMQLVSGGELFDRILERGV----YTEKDASLVIQQVLSA---VKYLHEN- 125
Query: 479 HPKIIHRDIKSANILV---DDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYAS 535
I+HRD+K N+L ++ + + DFGL+K+ ST GT GY+APE +
Sbjct: 126 --GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM--STAC-GTPGYVAPEVLA 180
Query: 536 SGKLTDRSDVFSFGVVL 552
+ D +S GV+
Sbjct: 181 QKPYSKAVDCWSIGVIT 197
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 7e-24
Identities = 58/221 (26%), Positives = 98/221 (44%), Gaps = 40/221 (18%)
Query: 358 ITNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGERE---FRA--EVEIIS 411
+ + + IGEG +G V+K N G++VA+K+ + A E+ ++
Sbjct: 1 MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE---DDPVIKKIALREIRMLK 57
Query: 412 RVHHRHLVSLVGYCISEKNRL-LIYEFVPNNNLEHHLHGKGQPVLEWTKRVK-IALGAAK 469
++ H +LV+L+ K RL L++E+ ++ + H L + V E VK I +
Sbjct: 58 QLKHPNLVNLLE-VFRRKRRLHLVFEYC-DHTVLHELDRYQRGVPE--HLVKSITWQTLQ 113
Query: 470 GLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK---LNDTTQTH-VSTRVMGT 525
+ + H+ H IHRD+K NIL+ ++ DFG A+ V+TR
Sbjct: 114 AVNFCHK--H-NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR---- 166
Query: 526 FGYLAPE-------YASSGKLTDRSDVFSFGVVLLELITGR 559
Y +PE Y DV++ G V EL++G
Sbjct: 167 -WYRSPELLVGDTQYGPP------VDVWAIGCVFAELLSGV 200
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 8e-24
Identities = 61/228 (26%), Positives = 117/228 (51%), Gaps = 34/228 (14%)
Query: 346 SKSFFTYEELMEITNGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGERE--- 402
+ ++ LME + + +GEG +G VYK +G++VA+K+++ + E E
Sbjct: 10 GRENLYFQGLME---KYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDA---EDEGIP 63
Query: 403 ---FRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTK 459
R E+ ++ +HH ++VSL+ SE+ L++EF+ + L+ L + +
Sbjct: 64 STAIR-EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKD-LKKVLDENKTGLQD--S 119
Query: 460 RVK-IALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHV 518
++K +G+A+ H+ +I+HRD+K N+L++ + ++ADFGLA+
Sbjct: 120 QIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY 176
Query: 519 STRVMGTFGYLAPE-------YASSGKLTDRSDVFSFGVVLLELITGR 559
+ V+ T Y AP+ Y++S D++S G + E+ITG+
Sbjct: 177 THEVV-TLWYRAPDVLMGSKKYSTS------VDIWSIGCIFAEMITGK 217
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 47/243 (19%), Positives = 91/243 (37%), Gaps = 41/243 (16%)
Query: 367 VIGEGGFGCVYKG-NLPEGKVVAVK-----QLKSGSGQGEREFRAEVEIISRVHHRHLVS 420
++GEG +G V + + AVK +L+ + E++++ R+ H++++
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKK-EIQLLRRLRHKNVIQ 70
Query: 421 L--VGYCISEKNRLLIYEFVPNNNLE---HHLHGKGQPVLEWTKRVK----IALGAAKGL 471
L V Y ++ ++ E+ E + I GL
Sbjct: 71 LVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKR---FPVCQAHGYFCQLID-----GL 122
Query: 472 AYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDT-TQTHVSTRVMGTFGYLA 530
YLH I+H+DIK N+L+ +++ G+A+ G+ +
Sbjct: 123 EYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQP 179
Query: 531 PEYASSGKLTD--RSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETG 588
PE A+ + D++S GV L + TG P + +++ L I G
Sbjct: 180 PEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE------GDNI-----YKLFENIGKG 228
Query: 589 DLS 591
+
Sbjct: 229 SYA 231
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 99.5 bits (249), Expect = 3e-23
Identities = 55/212 (25%), Positives = 100/212 (47%), Gaps = 31/212 (14%)
Query: 362 FARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGERE------FRAEVEIISRVHH 415
+ IGEG +G VYK G+ A+K+++ E E R E+ I+ + H
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEK---EDEGIPSTTIR-EISILKELKH 59
Query: 416 RHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVK-IALGAAKGLAYL 474
++V L ++K +L++E + + L+ L + T K L G+AY
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQD-LKKLLDVCEGGLESVT--AKSFLLQLLNGIAYC 116
Query: 475 HEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPE-- 532
H+ +++HRD+K N+L++ E E ++ADFGLA+ + ++ T Y AP+
Sbjct: 117 HDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPDVL 172
Query: 533 -----YASSGKLTDRSDVFSFGVVLLELITGR 559
Y+++ D++S G + E++ G
Sbjct: 173 MGSKKYSTT------IDIWSVGCIFAEMVNGT 198
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 50/268 (18%), Positives = 89/268 (33%), Gaps = 74/268 (27%)
Query: 362 FARENVIGEGGFGCVYKG-NLPEG-----KVVAVKQLKSGSGQGEREFRAEVEI----IS 411
F +G GGFG V++ N + K + + + + RE +A ++ I
Sbjct: 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67
Query: 412 RVHHRHLVS----------------------------------------------LVGYC 425
R + L + VG
Sbjct: 68 RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127
Query: 426 ISEKNRLLIY---EFVPNNNLEHHL-HGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPK 481
++ +Y + NL+ + E + I + A+ + +LH
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK---G 184
Query: 482 IIHRDIKSANILVDDEFEAQVADFGLAK-----------LNDTTQTHVSTRVMGTFGYLA 530
++HRD+K +NI + +V DFGL L T +GT Y++
Sbjct: 185 LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244
Query: 531 PEYASSGKLTDRSDVFSFGVVLLELITG 558
PE + + D+FS G++L EL+
Sbjct: 245 PEQIHGNNYSHKVDIFSLGLILFELLYS 272
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 57/216 (26%), Positives = 104/216 (48%), Gaps = 35/216 (16%)
Query: 362 FARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGERE------FRAEVEIISRVH 414
+ + + +GEG F VYK + ++VA+K++K G ++ R E++++ +
Sbjct: 12 YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR-EIKLLQELS 70
Query: 415 HRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVK-IALGAAKGLAY 473
H +++ L+ + N L+++F+ + LE + + +K L +GL Y
Sbjct: 71 HPNIIGLLDAFGHKSNISLVFDFMETD-LEVIIKDNSLVLTP--SHIKAYMLMTLQGLEY 127
Query: 474 LHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK---LNDTTQTHVSTRVMGTFGYLA 530
LH+ I+HRD+K N+L+D+ ++ADFGLAK + TH +V+ T Y A
Sbjct: 128 LHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH---QVV-TRWYRA 180
Query: 531 PE-------YASSGKLTDRSDVFSFGVVLLELITGR 559
PE Y D+++ G +L EL+
Sbjct: 181 PELLFGARMYGVG------VDMWAVGCILAELLLRV 210
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 6e-23
Identities = 56/217 (25%), Positives = 96/217 (44%), Gaps = 40/217 (18%)
Query: 362 FARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGERE------FRAEVEIISRVH 414
+ ++GEG +G V K N G++VA+K+ + + R E++++ ++
Sbjct: 27 YENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD---DDKMVKKIAMR-EIKLLKQLR 82
Query: 415 HRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVK-IALGAAKGLAY 473
H +LV+L+ C +K L++EFV ++ + L + + V+ G+ +
Sbjct: 83 HENLVNLLEVCKKKKRWYLVFEFV-DHTILDDLELFPNGLDY--QVVQKYLFQIINGIGF 139
Query: 474 LHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK---LNDTTQTH-VSTRVMGTFGYL 529
H H IIHRDIK NILV ++ DFG A+ V+TR Y
Sbjct: 140 CHS--H-NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATR-----WYR 191
Query: 530 APE-------YASSGKLTDRSDVFSFGVVLLELITGR 559
APE Y + DV++ G ++ E+ G
Sbjct: 192 APELLVGDVKYGKA------VDVWAIGCLVTEMFMGE 222
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 8e-23
Identities = 57/240 (23%), Positives = 100/240 (41%), Gaps = 22/240 (9%)
Query: 336 GGPDSGVLGGSKSFFTYEELMEITNGFARENVIGEGGFGCVYKG-NLPEGKVVAVK---- 390
G P GG ++ + + + VIG+G F V + N G+ AVK
Sbjct: 1 GSPGISGGGGGILDMADDD-VLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDV 59
Query: 391 -QLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHG 449
+ S G + + E I + H H+V L+ S+ +++EF+ +L +
Sbjct: 60 AKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVK 119
Query: 450 KGQPVLEWTKR-----VKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQ--- 501
+ +++ ++ L A L Y H++ IIHRD+K +L+ + +
Sbjct: 120 RADAGFVYSEAVASHYMRQILEA---LRYCHDN---NIIHRDVKPHCVLLASKENSAPVK 173
Query: 502 VADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKP 561
+ FG+A + RV GT ++APE DV+ GV+L L++G P
Sbjct: 174 LGGFGVAIQLGESGLVAGGRV-GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 9e-23
Identities = 53/209 (25%), Positives = 87/209 (41%), Gaps = 18/209 (8%)
Query: 362 FARENVIGEGGFGCVY----KGNLPEGKVVAVKQLKSGSGQGEREF---RAEVEIISRVH 414
F ++GEG F V + A+K L+ E + E +++SR+
Sbjct: 32 FKFGKILGEGSFSTVVLARELAT---SREYAIKILEKRHIIKENKVPYVTRERDVMSRLD 88
Query: 415 HRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIA-LGAAKGLAY 473
H V L ++ + N L ++ K E R A + +A L Y
Sbjct: 89 HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSA--LEY 145
Query: 474 LHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVM-GTFGYLAPE 532
LH IIHRD+K NIL++++ Q+ DFG AK+ GT Y++PE
Sbjct: 146 LHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 202
Query: 533 YASSGKLTDRSDVFSFGVVLLELITGRKP 561
+ SD+++ G ++ +L+ G P
Sbjct: 203 LLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 65/233 (27%), Positives = 104/233 (44%), Gaps = 36/233 (15%)
Query: 368 IGEGGFGCVYKG-NLPEGKVVAVKQL---KSGSGQGEREFRAEVEIISRVHHRHLVSLVG 423
IG+G F V ++ G+ VA+K + + ++ FR EV I+ ++H ++V L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVKL-- 79
Query: 424 Y-CISEKNRL-LIYEFVPNNNLEHHLHGKGQPVLEWTKRVK---IALGAAKGLAYLHEDC 478
+ I + L LI E+ + +L G + E R K I + Y H+
Sbjct: 80 FEVIETEKTLYLIMEYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSA----VQYCHQKR 134
Query: 479 HPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGK 538
I+HRD+K+ N+L+D + ++ADFG + N+ T G Y APE GK
Sbjct: 135 ---IVHRDLKAENLLLDADMNIKIADFGFS--NEFTVGGKLDAFCGAPPYAAPELF-QGK 188
Query: 539 LTD--RSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGD 589
D DV+S GV+L L++G P D ++L L + G
Sbjct: 189 KYDGPEVDVWSLGVILYTLVSGSLPFD------GQNL-----KELRERVLRGK 230
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 54/228 (23%), Positives = 95/228 (41%), Gaps = 22/228 (9%)
Query: 344 GGSKSFFTYEELMEITNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQL-KSGSGQGER 401
G ++ + I + F + +G G FG V+ G +K + K S
Sbjct: 9 SGRENLYFQGT---IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPME 65
Query: 402 EFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKR- 460
+ AE+E++ + H +++ + N ++ E L + ++
Sbjct: 66 QIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGY 125
Query: 461 ----VKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQ---VADFGLAKLNDT 513
+K + A LAY H ++H+D+K NIL D + DFGLA+L +
Sbjct: 126 VAELMKQMMNA---LAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS 179
Query: 514 TQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKP 561
+ + GT Y+APE +T + D++S GVV+ L+TG P
Sbjct: 180 DEHS-TNAA-GTALYMAPEVF-KRDVTFKCDIWSAGVVMYFLLTGCLP 224
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 3e-22
Identities = 55/224 (24%), Positives = 94/224 (41%), Gaps = 44/224 (19%)
Query: 362 FARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRAEV------EI----- 409
+ IG G +G VYK + G VA+K ++ + + E+
Sbjct: 11 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPN---GGGGGGGLPISTVREVALLRR 67
Query: 410 ISRVHHRHLVSL----VGYCISEKNRL-LIYEFVPNNNLEHHLHGKGQPVLEWTKRVK-I 463
+ H ++V L + ++ L++E V + +L +L P L + +K +
Sbjct: 68 LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLP-AETIKDL 125
Query: 464 ALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKL--NDTTQTHVSTR 521
+GL +LH + I+HRD+K NILV ++ADFGLA++ T
Sbjct: 126 MRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTP---V 179
Query: 522 VMGTFGYLAPE------YASSGKLTDRSDVFSFGVVLLELITGR 559
V+ T Y APE YA+ D++S G + E+ +
Sbjct: 180 VV-TLWYRAPEVLLQSTYATP------VDMWSVGCIFAEMFRRK 216
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 5e-22
Identities = 61/232 (26%), Positives = 107/232 (46%), Gaps = 58/232 (25%)
Query: 362 FARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGERE------FRAEVEIISRVH 414
+ + IG+G FG V+K + G+ VA+K++ + E+E R E++I+ +
Sbjct: 19 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN---EKEGFPITALR-EIKILQLLK 74
Query: 415 HRHLVSLVGYCISEKNRL--------LIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALG 466
H ++V+L+ C ++ + L+++F EH L G +L VK L
Sbjct: 75 HENVVNLIEICRTKASPYNRCKGSIYLVFDF-----CEHDLAG----LLS-NVLVKFTLS 124
Query: 467 AAK--------GLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKL----NDTT 514
K GL Y+H + KI+HRD+K+AN+L+ + ++ADFGLA+ ++
Sbjct: 125 EIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ 181
Query: 515 QTHVSTRVMGTFGYLAPE-------YASSGKLTDRSDVFSFGVVLLELITGR 559
+ RV+ T Y PE Y D++ G ++ E+ T
Sbjct: 182 PNRYTNRVV-TLWYRPPELLLGERDYGPP------IDLWGAGCIMAEMWTRS 226
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 8e-22
Identities = 48/210 (22%), Positives = 89/210 (42%), Gaps = 23/210 (10%)
Query: 367 VIGEGGFGCVYKG-NLPEGKVVAVKQLK--------SGSGQGEREFRAEVEIISRVHHRH 417
+G G G V K VA++ + + E+EI+ +++H
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201
Query: 418 LVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHED 477
++ + + ++ ++ E + L + G + + E T + + YLHE+
Sbjct: 202 IIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKR-LKEATCK-LYFYQMLLAVQYLHEN 258
Query: 478 CHPKIIHRDIKSANILV---DDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPE-- 532
IIHRD+K N+L+ +++ ++ DFG +K+ T + T GT YLAPE
Sbjct: 259 ---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLC-GTPTYLAPEVL 313
Query: 533 -YASSGKLTDRSDVFSFGVVLLELITGRKP 561
+ D +S GV+L ++G P
Sbjct: 314 VSVGTAGYNRAVDCWSLGVILFICLSGYPP 343
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 8e-22
Identities = 58/230 (25%), Positives = 98/230 (42%), Gaps = 54/230 (23%)
Query: 357 EITNGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHR 416
+ + VIG G FG V++ L E VA+K++ + R E++I+ V H
Sbjct: 37 QREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK---RFKNR-ELQIMRIVKHP 92
Query: 417 HLVSLVGYCISEKNRL------LIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAA-- 468
++V L + S ++ L+ E+VP ++ ++K +
Sbjct: 93 NVVDLKAFFYSNGDKKDEVFLNLVLEYVPET-----VY----RASRHYAKLKQTMPMLLI 143
Query: 469 --------KGLAYLHEDCHPKIIHRDIKSANILVD-DEFEAQVADFGLAKLNDTTQTHVS 519
+ LAY+H I HRDIK N+L+D ++ DFG AK+ + +VS
Sbjct: 144 KLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVS 200
Query: 520 ---TRVMGTFGYLAPE-------YASSGKLTDRSDVFSFGVVLLELITGR 559
+R Y APE Y ++ D++S G V+ EL+ G+
Sbjct: 201 YICSRY-----YRAPELIFGATNYTTN------IDIWSTGCVMAELMQGQ 239
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-21
Identities = 55/226 (24%), Positives = 98/226 (43%), Gaps = 39/226 (17%)
Query: 357 EITNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHH 415
+ + F E + G+G FG V G G VA+K++ RE + ++ ++ +HH
Sbjct: 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQDLAVLHH 78
Query: 416 RHLVSL--VGYCISEKNR-----LLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAA 468
++V L Y + E++R ++ E+VP+ LH R ++A
Sbjct: 79 PNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDT-----LH----RCCRNYYRRQVAPPPI 129
Query: 469 ----------KGLAYLHEDCHPKIIHRDIKSANILVDDE-FEAQVADFGLAKLNDTTQTH 517
+ + LH + HRDIK N+LV++ ++ DFG AK ++ +
Sbjct: 130 LIKVFLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN 188
Query: 518 VS---TRVMGTFGYLAPEY-ASSGKLTDRSDVFSFGVVLLELITGR 559
V+ +R Y APE + T D++S G + E++ G
Sbjct: 189 VAYICSRY-----YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 1e-21
Identities = 54/218 (24%), Positives = 89/218 (40%), Gaps = 31/218 (14%)
Query: 362 FARENVIGEGGFGCVY----KGNLPEGKVVAVKQLKSGS--GQGERE-FRAEVEIISRVH 414
F VIG G FG V K KV A+K L + E FR E +++
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNA---DKVFAMKILNKWEMLKRAETACFREERDVLVNGD 132
Query: 415 HRHLVSLVGYCISEKNRL-LIYEFVPNNNLEHHLHGKGQPVLEWTKRVK-----IALGAA 468
+ + +L Y + N L L+ ++ +L L + E + + + +
Sbjct: 133 SKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPE--EMARFYLAEMVIA-- 187
Query: 469 KGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGY 528
+ +H+ +HRDIK NIL+D ++ADFG T S+ +GT Y
Sbjct: 188 --IDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDY 242
Query: 529 LAPEYASSGKLTDRS-----DVFSFGVVLLELITGRKP 561
++PE + + D +S GV + E++ G P
Sbjct: 243 ISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 1e-21
Identities = 62/212 (29%), Positives = 101/212 (47%), Gaps = 34/212 (16%)
Query: 367 VIGEGGFGCVY----KGNLPEGKVVAVKQLKSGS--GQGEREFRAEVEIISRVHHRHLVS 420
V+G+G FG V+ ++ A+K LK + + + E +I+ V+H +V
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90
Query: 421 LVGYCISEKNRL-LIYEFVPNNNLEHHLHGKGQPVLEWTKRVK-----IALGAAKGLAYL 474
L Y + +L LI +F+ +L L + E VK +AL L +L
Sbjct: 91 LH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE---DVKFYLAELALA----LDHL 142
Query: 475 HEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLN----DTTQTHVSTRVMGTFGYLA 530
H II+RD+K NIL+D+E ++ DFGL+K + + GT Y+A
Sbjct: 143 HSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-----FCGTVEYMA 194
Query: 531 PEYASSGKLTDRS-DVFSFGVVLLELITGRKP 561
PE + + +S D +SFGV++ E++TG P
Sbjct: 195 PEVV-NRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 2e-21
Identities = 48/210 (22%), Positives = 93/210 (44%), Gaps = 13/210 (6%)
Query: 357 EITNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHH 415
+ + + +G G FG V++ G+V K + + + + E+ I++++HH
Sbjct: 48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHH 107
Query: 416 RHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEW--TKRVKIALGAAKGLAY 473
L++L + +LI EF+ L + + + E ++ A GL +
Sbjct: 108 PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACE---GLKH 164
Query: 474 LHEDCHPKIIHRDIKSANILVDDEFEAQV--ADFGLAKLNDTTQTHVSTRVMGTFGYLAP 531
+HE I+H DIK NI+ + + + V DFGLA + + + T + AP
Sbjct: 165 MHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--IVKVTTATAEFAAP 219
Query: 532 EYASSGKLTDRSDVFSFGVVLLELITGRKP 561
E + +D+++ GV+ L++G P
Sbjct: 220 EIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 2e-21
Identities = 59/212 (27%), Positives = 95/212 (44%), Gaps = 24/212 (11%)
Query: 362 FARENVIGEGGFGCVY----KGNLPEGKVVAVKQLKSGSGQGEREFR---AEVEIISRVH 414
F IG+G FG V K+ A+K + E R E++I+ +
Sbjct: 17 FEILRAIGKGSFGKVCIVQKNDT---KKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE 73
Query: 415 HRHLVSLVGYCISEKNRL-LIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIA-LGAAKGLA 472
H LV+L Y ++ + ++ + + +L +HL + E T ++ I L A L
Sbjct: 74 HPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHL-QQNVHFKEETVKLFICELVMA--LD 129
Query: 473 YLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPE 532
YL +IIHRD+K NIL+D+ + DF +A + + + GT Y+APE
Sbjct: 130 YLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPYMAPE 184
Query: 533 --YASSGKLTDRS-DVFSFGVVLLELITGRKP 561
+ G + D +S GV EL+ GR+P
Sbjct: 185 MFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 2e-21
Identities = 58/215 (26%), Positives = 108/215 (50%), Gaps = 37/215 (17%)
Query: 362 FARENVIGEGGFGCVYKGNLPE-GKVVAVKQLKSGSGQGE-----REFRAEVEIISRVHH 415
+ + + +GEG + VYKG +VA+K+++ +G RE V ++ + H
Sbjct: 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIRE----VSLLKDLKH 59
Query: 416 RHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALG-AAKGLAYL 474
++V+L +EK+ L++E++ + +L+ +L G + VK+ L +GLAY
Sbjct: 60 ANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINM--HNVKLFLFQLLRGLAYC 116
Query: 475 HEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK---LNDTTQTHVSTRVMGTFGYLAP 531
H K++HRD+K N+L+++ E ++ADFGLA+ + T + V+ T Y P
Sbjct: 117 H---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN---EVV-TLWYRPP 169
Query: 532 E-------YASSGKLTDRSDVFSFGVVLLELITGR 559
+ Y++ D++ G + E+ TGR
Sbjct: 170 DILLGSTDYSTQ------IDMWGVGCIFYEMATGR 198
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 2e-21
Identities = 49/228 (21%), Positives = 97/228 (42%), Gaps = 26/228 (11%)
Query: 345 GSKSFFTYEELMEITNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQL--KSGSGQGER 401
+ ++ + ++G+G FG V K + + AVK + S +
Sbjct: 9 SGRENLYFQG--TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS 66
Query: 402 EFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKR- 460
EVE++ ++ H +++ L + ++ E L + + + +++
Sbjct: 67 TILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR----FSEHD 122
Query: 461 ----VKIALGAAKGLAYLHEDCHPKIIHRDIKSANILV---DDEFEAQVADFGLAKLNDT 513
+K + Y+H+ I+HRD+K NIL+ + + + ++ DFGL+
Sbjct: 123 AARIIKQVFSG---ITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176
Query: 514 TQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKP 561
R+ GT Y+APE G ++ DV+S GV+L L++G P
Sbjct: 177 NTKM-KDRI-GTAYYIAPEVL-RGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-21
Identities = 50/213 (23%), Positives = 90/213 (42%), Gaps = 34/213 (15%)
Query: 357 EITNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQL--KSGSGQGEREFRAEVEIISRV 413
T + +G+G F V + + G+ A + K S + ++ E I +
Sbjct: 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL 67
Query: 414 HHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKR-----VKIALGAA 468
H ++V L E + LI++ V L + + +++ ++ L A
Sbjct: 68 KHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREY----YSEADASHCIQQILEA- 122
Query: 469 KGLAYLHEDCHPKIIHRDIKSANILVDDEFE-AQV--ADFGLAKLNDTTQTHVSTRVMGT 525
+ + H+ ++HR++K N+L+ + + A V ADFGLA + Q GT
Sbjct: 123 --VLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GT 176
Query: 526 FGYLAPE------YASSGKLTDRSDVFSFGVVL 552
GYL+PE Y GK D+++ GV+L
Sbjct: 177 PGYLSPEVLRKDPY---GK---PVDLWACGVIL 203
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 4e-21
Identities = 56/250 (22%), Positives = 100/250 (40%), Gaps = 31/250 (12%)
Query: 365 ENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRV-HHRHLVSLV 422
E+V+GEG V NL + AVK ++ G EVE++ + HR+++ L+
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 423 GYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKR--VKIALGAAKGLAYLHEDCHP 480
+ E L++E + ++ H+H + + + + A L +LH
Sbjct: 78 EFFEEEDRFYLVFEKMRGGSILSHIHKRRH----FNELEASVVVQDVASALDFLHN---K 130
Query: 481 KIIHRDIKSANILVDDEFEA---QVADFGLAK-------LNDTTQTHVSTRVMGTFGYLA 530
I HRD+K NIL + + ++ DF L + + + T G+ Y+A
Sbjct: 131 GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC-GSAEYMA 189
Query: 531 PE-----YASSGKLTDRSDVFSFGVVLLELITGRKP----VDPTQPLGDESLVEWARPVL 581
PE + R D++S GV+L L++G P + +L
Sbjct: 190 PEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNML 249
Query: 582 VRAIETGDLS 591
+I+ G
Sbjct: 250 FESIQEGKYE 259
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 5e-21
Identities = 63/220 (28%), Positives = 106/220 (48%), Gaps = 30/220 (13%)
Query: 356 MEITNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGE-----REFRAEVEI 409
M ++ F + +G G + VYKG N G VA+K++K S +G RE + +
Sbjct: 1 MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIRE----ISL 56
Query: 410 ISRVHHRHLVSLVGYCISEKNRLLIYEFVPN---NNLEHHLHGKGQPVLEWTKRVKIALG 466
+ + H ++V L +E L++EF+ N ++ G LE
Sbjct: 57 MKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116
Query: 467 AAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTF 526
+GLA+ HE+ KI+HRD+K N+L++ + ++ DFGLA+ S+ V+ T
Sbjct: 117 LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TL 172
Query: 527 GYLAPE-------YASSGKLTDRSDVFSFGVVLLELITGR 559
Y AP+ Y++S D++S G +L E+ITG+
Sbjct: 173 WYRAPDVLMGSRTYSTS------IDIWSCGCILAEMITGK 206
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 6e-21
Identities = 51/232 (21%), Positives = 98/232 (42%), Gaps = 23/232 (9%)
Query: 332 GYHGGGPDSGVLGGSKSFFTYEELMEITNGFARENVIGEGGFGCVYKG-NLPEGKVVAVK 390
G H G G S F + ++ + + +G+G F V + + G A K
Sbjct: 1 GPHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAK 60
Query: 391 QL--KSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLH 448
+ K S + ++ E I ++ H ++V L E L+++ V L +
Sbjct: 61 IINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV 120
Query: 449 GKGQPVLEWTKR-----VKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQ-- 501
+ +++ ++ L + +AY H + I+HR++K N+L+ + +
Sbjct: 121 AREF----YSEADASHCIQQILES---IAYCHSN---GIVHRNLKPENLLLASKAKGAAV 170
Query: 502 -VADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVL 552
+ADFGLA + ++ GT GYL+PE + D+++ GV+L
Sbjct: 171 KLADFGLAIEVNDSEA-WHGFA-GTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 6e-21
Identities = 51/234 (21%), Positives = 88/234 (37%), Gaps = 33/234 (14%)
Query: 367 VIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYC 425
IG G +G V A K++ + F+ E+EI+ + H +++ L
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 426 ISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKR-----VKIALGAAKGLAYLHEDCHP 480
+ L+ E L + K + + +K L A +AY H+
Sbjct: 76 EDNTDIYLVMELCTGGELFERVVHKRV----FRESDAARIMKDVLSA---VAYCHKL--- 125
Query: 481 KIIHRDIKSANILV---DDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSG 537
+ HRD+K N L + ++ DFGLA + T+V GT Y++P+ G
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM-RTKV-GTPYYVSPQ-VLEG 182
Query: 538 KLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLS 591
D +S GV++ L+ G P + E ++ I G +
Sbjct: 183 LYGPECDEWSAGVMMYVLLCGYPPFS------APTDSE-----VMLKIREGTFT 225
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 6e-21
Identities = 55/230 (23%), Positives = 93/230 (40%), Gaps = 58/230 (25%)
Query: 362 FARENVIGEGGFGCVYKG--NLPEGKVVAVKQLKSGSGQGERE------FRAEVEI---I 410
+ IGEG +G V+K G+ VA+K+++ + E R EV + +
Sbjct: 13 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT---GEEGMPLSTIR-EVAVLRHL 68
Query: 411 SRVHHRHLVSL----VGYCISEKNRL-LIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIAL 465
H ++V L + +L L++E ++ L L+ +
Sbjct: 69 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEH-----VDQDLTT----YLDKVPEPGVPT 119
Query: 466 GAAK--------GLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKL--NDTTQ 515
K GL +LH +++HRD+K NILV + ++ADFGLA++
Sbjct: 120 ETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL 176
Query: 516 THVSTRVMGTFGYLAPE------YASSGKLTDRSDVFSFGVVLLELITGR 559
T V+ T Y APE YA+ D++S G + E+ +
Sbjct: 177 TS---VVV-TLWYRAPEVLLQSSYATP------VDLWSVGCIFAEMFRRK 216
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 9e-21
Identities = 52/237 (21%), Positives = 102/237 (43%), Gaps = 28/237 (11%)
Query: 365 ENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRV-HHRHLVSLV 422
+ +GEG F K + + AVK + + E + E+ + H ++V L
Sbjct: 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLH 72
Query: 423 GYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKR-----VKIALGAAKGLAYLHED 477
+ + L+ E + L + K +++ ++ + A ++++H+
Sbjct: 73 EVFHDQLHTFLVMELLNGGELFERIKKKKH----FSETEASYIMRKLVSA---VSHMHDV 125
Query: 478 CHPKIIHRDIKSANILV---DDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYA 534
++HRD+K N+L +D E ++ DFG A+L + T T Y APE
Sbjct: 126 ---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAPELL 181
Query: 535 SSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLS 591
+ + D++S GV+L +++G+ P D SL + +++ I+ GD S
Sbjct: 182 NQNGYDESCDLWSLGVILYTMLSGQVPFQS----HDRSLTCTSAVEIMKKIKKGDFS 234
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 9e-21
Identities = 66/236 (27%), Positives = 102/236 (43%), Gaps = 41/236 (17%)
Query: 368 IGEGGFGCVYKG-NLPEGKVVAVK-----QLKSGSGQGEREFRAEVEIISRVHHRHLVSL 421
+G G FG V G + G VAVK +++S + R E++ + H H++ L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRS-LDVVGKIKR-EIQNLKLFRHPHIIKL 76
Query: 422 VGY-CISEKNRL-LIYEFVPNNNLEHHLHGKGQPVLEWTKRVK----IALGAAKGLAYLH 475
Y IS ++ E+V L ++ G V E R ++ + Y H
Sbjct: 77 --YQVISTPTDFFMVMEYVSGGELFDYICKHG-RVEEMEARRLFQQILS-----AVDYCH 128
Query: 476 EDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYAS 535
++HRD+K N+L+D A++ADFGL+ N + G+ Y APE
Sbjct: 129 RH---MVVHRDLKPENVLLDAHMNAKIADFGLS--NMMSDGEFLRTSCGSPNYAAPEVI- 182
Query: 536 SGKLTD--RSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGD 589
SG+L D++S GV+L L+ G P D DE + P L + I G
Sbjct: 183 SGRLYAGPEVDIWSCGVILYALLCGTLPFD------DEHV-----PTLFKKIRGGV 227
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 1e-20
Identities = 55/211 (26%), Positives = 89/211 (42%), Gaps = 31/211 (14%)
Query: 368 IGEGGFGCVYKG-NLPEGKVVAVK-----QLKSGSGQGEREFRAEVEIISRVHHRHLVSL 421
+GEG +G V N + VAVK + ++E + I ++H ++V
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE----ICINKMLNHENVVKF 70
Query: 422 VGYCISEKNRL-LIYEFVPNNNLEHHLHGKGQPVLEWTKRVK----IALGAAKGLAYLHE 476
G E N L E+ L + + E + +A G+ YLH
Sbjct: 71 YG-HRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMA-----GVVYLHG 123
Query: 477 DCHPKIIHRDIKSANILVDDEFEAQVADFGLAKL--NDTTQTHVSTRVMGTFGYLAPEYA 534
I HRDIK N+L+D+ +++DFGLA + + + ++ GT Y+APE
Sbjct: 124 I---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELL 179
Query: 535 SSGKLTD--RSDVFSFGVVLLELITGRKPVD 563
+ DV+S G+VL ++ G P D
Sbjct: 180 -KRREFHAEPVDVWSCGIVLTAMLAGELPWD 209
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 1e-20
Identities = 50/205 (24%), Positives = 98/205 (47%), Gaps = 13/205 (6%)
Query: 362 FARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVS 420
++ ++G G FG V+K G +A K +K+ + + E + E+ +++++ H +L+
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 421 LVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEW--TKRVKIALGAAKGLAYLHEDC 478
L S+ + +L+ E+V L + + + E +K G+ ++H+
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICE---GIRHMHQM- 206
Query: 479 HPKIIHRDIKSANILVDDEFEAQV--ADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASS 536
I+H D+K NIL + Q+ DFGLA+ + GT +LAPE +
Sbjct: 207 --YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL--KVNFGTPEFLAPEVVNY 262
Query: 537 GKLTDRSDVFSFGVVLLELITGRKP 561
++ +D++S GV+ L++G P
Sbjct: 263 DFVSFPTDMWSVGVIAYMLLSGLSP 287
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-20
Identities = 50/220 (22%), Positives = 93/220 (42%), Gaps = 42/220 (19%)
Query: 362 FARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGERE------FRAEVEIISRVH 414
+ R +GEG +G VYK + + VA+K+++ E E R EV ++ +
Sbjct: 36 YRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH---EEEGVPGTAIR-EVSLLKELQ 91
Query: 415 HRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYL 474
HR+++ L LI+E+ N+L+ ++ + K L G+ +
Sbjct: 92 HRNIIELKSVIHHNHRLHLIFEYA-ENDLKKYMDKNPDVSMRVIKSFLYQL--INGVNFC 148
Query: 475 HEDCHPKIIHRDIKSANILVDDEFEAQ-----VADFGLAK---LNDTTQTHVSTRVMGTF 526
H + +HRD+K N+L+ ++ + DFGLA+ + TH ++ T
Sbjct: 149 H---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTH---EII-TL 201
Query: 527 GYLAPE-------YASSGKLTDRSDVFSFGVVLLELITGR 559
Y PE Y++S D++S + E++
Sbjct: 202 WYRPPEILLGSRHYSTS------VDIWSIACIWAEMLMKT 235
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 1e-20
Identities = 58/216 (26%), Positives = 89/216 (41%), Gaps = 25/216 (11%)
Query: 362 FARENVIGEGGFGCVY----KGNLPEGKVVAVKQLKSGS--GQGERE-FRAEVEIISRVH 414
F VIG G F V K G+V A+K + +GE FR E +++
Sbjct: 63 FEILKVIGRGAFSEVAVVKMKQT---GQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGD 119
Query: 415 HRHLVSLVGYCISEKNRL-LIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIA-LGAAKGLA 472
R + L + ++N L L+ E+ +L L G+ + R +A + A +
Sbjct: 120 RRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMA--ID 176
Query: 473 YLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPE 532
+H +HRDIK NIL+D ++ADFG T S +GT YL+PE
Sbjct: 177 SVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPE 233
Query: 533 -------YASSGKLTDRSDVFSFGVVLLELITGRKP 561
+G D ++ GV E+ G+ P
Sbjct: 234 ILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 2e-20
Identities = 61/225 (27%), Positives = 97/225 (43%), Gaps = 43/225 (19%)
Query: 357 EITNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHH 415
+ VIG G FG VY+ G++VA+K++ + R E++I+ ++ H
Sbjct: 51 PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK---RFKNR-ELQIMRKLDH 106
Query: 416 RHLVSLVGYCISEKNRL------LIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAA- 468
++V L + S + L+ ++VP ++ V R K L
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPET-----VY----RVARHYSRAKQTLPVIY 157
Query: 469 ---------KGLAYLHEDCHPKIIHRDIKSANILVDDE-FEAQVADFGLAKLNDTTQTHV 518
+ LAY+H I HRDIK N+L+D + ++ DFG AK + +V
Sbjct: 158 VKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV 214
Query: 519 S---TRVMGTFGYLAPEY-ASSGKLTDRSDVFSFGVVLLELITGR 559
S +R Y APE + T DV+S G VL EL+ G+
Sbjct: 215 SYICSRY-----YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 43/215 (20%), Positives = 84/215 (39%), Gaps = 24/215 (11%)
Query: 357 EITNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHH 415
E+ + +G G FG V++ K K +K G + + E+ I++ H
Sbjct: 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARH 60
Query: 416 RHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAK----GL 471
R+++ L S + ++I+EF+ ++ ++ + E + + L
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNE-----REIVSYVHQVCEAL 115
Query: 472 AYLHEDCHPKIIHRDIKSANILVDDEFEAQV--ADFGLAKLNDTTQTHVSTRVMGTFGYL 529
+LH I H DI+ NI+ + + +FG A+ + Y
Sbjct: 116 QFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAPEYY 170
Query: 530 APE---YASSGKLTDRSDVFSFGVVLLELITGRKP 561
APE + T D++S G ++ L++G P
Sbjct: 171 APEVHQHDVVSTAT---DMWSLGTLVYVLLSGINP 202
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-20
Identities = 62/264 (23%), Positives = 103/264 (39%), Gaps = 66/264 (25%)
Query: 368 IGEGGFGCVYKG-NLPEGKVVAVKQL------KSGSGQGEREFRA--------------- 405
IG+G +G V N + A+K L + R
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 406 -----EVEIISRVHHRHLVSL--VGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWT 458
E+ I+ ++ H ++V L V +E + +++E V PV+E
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELV-----------NQGPVMEVP 129
Query: 459 KRVKIALGAAK--------GLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKL 510
++ A+ G+ YLH KIIHRDIK +N+LV ++ ++ADFG++
Sbjct: 130 TLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNE 186
Query: 511 NDTTQTHVSTRVMGTFGYLAPEYASSGKLT---DRSDVFSFGVVLLELITGRKPVDPTQP 567
+ +S V GT ++APE S + DV++ GV L + G+ P
Sbjct: 187 FKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM---- 241
Query: 568 LGDESLVEWARPVLVRAIETGDLS 591
DE + L I++ L
Sbjct: 242 --DERI-----MCLHSKIKSQALE 258
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 3e-20
Identities = 66/272 (24%), Positives = 111/272 (40%), Gaps = 33/272 (12%)
Query: 300 MPPPNNFNEKTVDTYYGSQTPQMHSYGSQRGVGYHGGGPDSGVLGGSKSFFTYEELMEIT 359
M ++ + M S + G PD + G ++ ++
Sbjct: 1 MHHHHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRD--------ALS 52
Query: 360 NGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQL-KSGSGQGEREFRAEVEIISRVHHRH 417
+ F E+ +G G VY+ K A+K L K+ ++ R E+ ++ R+ H +
Sbjct: 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT---VDKKIVRTEIGVLLRLSHPN 109
Query: 418 LVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKR-----VKIALGAAKGLA 472
++ L + L+ E V L + KG +++R VK L A +A
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGELFDRIVEKGY----YSERDAADAVKQILEA---VA 162
Query: 473 YLHEDCHPKIIHRDIKSANILVDDEFEAQ---VADFGLAKLNDTTQTHVSTRVMGTFGYL 529
YLHE+ I+HRD+K N+L +ADFGL+K+ + V GT GY
Sbjct: 163 YLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM--KTVCGTPGYC 217
Query: 530 APEYASSGKLTDRSDVFSFGVVLLELITGRKP 561
APE D++S G++ L+ G +P
Sbjct: 218 APEILRGCAYGPEVDMWSVGIITYILLCGFEP 249
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 3e-20
Identities = 59/214 (27%), Positives = 98/214 (45%), Gaps = 36/214 (16%)
Query: 367 VIGEGGFGCVY---KGNLPE-GKVVAVKQLKSGS---GQGEREF-RAEVEIISRVHHRHL 418
V+G+GG+G V+ K GK+ A+K LK + +AE I+ V H +
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 419 VSLVGYCISEKNRL-LIYEFVPNNNLEHHLHGKGQPVLEWTKRVK-----IALGAAKGLA 472
V L+ Y +L LI E++ L L +G + + I++ L
Sbjct: 84 VDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMED---TACFYLAEISMA----LG 135
Query: 473 YLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLN----DTTQTHVSTRVMGTFGY 528
+LH+ II+RD+K NI+++ + ++ DFGL K + T T GT Y
Sbjct: 136 HLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC-----GTIEY 187
Query: 529 LAPEYASSGKLTDRS-DVFSFGVVLLELITGRKP 561
+APE +R+ D +S G ++ +++TG P
Sbjct: 188 MAPEIL-MRSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 3e-20
Identities = 58/214 (27%), Positives = 88/214 (41%), Gaps = 40/214 (18%)
Query: 367 VIGEGGFGCV----YKGNLPEGKVVAVKQLKSGSGQGEREF---RAEVEIISRVHHRHLV 419
++G+G FG V K G+ A+K L+ + E E ++ H L
Sbjct: 12 LLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 68
Query: 420 SLVGYCISEKNRL-LIYEFVPNNNLEHHLHGKGQPVLEWTK--RVKIALGAAKGLAYLHE 476
+L Y +RL + E+ L HL + E + +I L YLH
Sbjct: 69 ALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSA----LEYLHS 123
Query: 477 DCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLN----DTTQTHVSTRVMGTFGYLAPE 532
+++RDIK N+++D + ++ DFGL K T +T GT YLAPE
Sbjct: 124 R---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-----GTPEYLAPE 175
Query: 533 YASSGKLTDRS-----DVFSFGVVLLELITGRKP 561
L D D + GVV+ E++ GR P
Sbjct: 176 V-----LEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 4e-20
Identities = 54/227 (23%), Positives = 92/227 (40%), Gaps = 40/227 (17%)
Query: 357 EITNGFARENVIGEGGFGCVYK------GNLPEGKVVAVKQLKSGSGQGERE-FRAEVEI 409
++ + + +G G F V K G K + +Q ++ RE EV I
Sbjct: 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68
Query: 410 ISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKG-----------QPVLEWT 458
+ +V H ++++L + + +LI E V L L K + +L+
Sbjct: 69 LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD-- 126
Query: 459 KRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQ----VADFGLAKLNDTT 514
G+ YLH KI H D+K NI++ D+ + DFGLA +
Sbjct: 127 -----------GVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172
Query: 515 QTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKP 561
+ GT ++APE + L +D++S GV+ L++G P
Sbjct: 173 VEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 5e-20
Identities = 45/207 (21%), Positives = 92/207 (44%), Gaps = 23/207 (11%)
Query: 357 EITNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQL--KSGSGQGEREFRAEVEIISRV 413
+ ++ + + +G+G F V + + G A K + K S + ++ E I ++
Sbjct: 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 62
Query: 414 HHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKR-----VKIALGAA 468
H ++V L E L+++ V L + + +++ ++ L +
Sbjct: 63 QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF----YSEADASHCIQQILES- 117
Query: 469 KGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQ---VADFGLAKLNDTTQTHVSTRVMGT 525
+AY H + I+HR++K N+L+ + + +ADFGLA + ++ GT
Sbjct: 118 --IAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-WHGFA-GT 170
Query: 526 FGYLAPEYASSGKLTDRSDVFSFGVVL 552
GYL+PE + D+++ GV+L
Sbjct: 171 PGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 7e-20
Identities = 49/213 (23%), Positives = 86/213 (40%), Gaps = 20/213 (9%)
Query: 357 EITNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISR-VH 414
+ T+G+ + IG G + + + AVK + E+EI+ R
Sbjct: 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE----EIEILLRYGQ 74
Query: 415 HRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKR--VKIALGAAKGLA 472
H ++++L K ++ E + L + + +++R + K +
Sbjct: 75 HPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKF----FSEREASAVLFTITKTVE 130
Query: 473 YLHEDCHPKIIHRDIKSANILVDDEFEAQ----VADFGLAKLNDTTQTHVSTRVMGTFGY 528
YLH ++HRD+K +NIL DE + DFG AK + T T +
Sbjct: 131 YLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YTANF 186
Query: 529 LAPEYASSGKLTDRSDVFSFGVVLLELITGRKP 561
+APE D++S GV+L ++TG P
Sbjct: 187 VAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 7e-20
Identities = 57/207 (27%), Positives = 87/207 (42%), Gaps = 25/207 (12%)
Query: 367 VIGEGGFGCVY----KGNLPEGKVVAVKQLKSGSGQGEREF---RAEVEIISRVHHRHLV 419
++G+G FG V K G+ A+K LK + E E ++ H L
Sbjct: 155 LLGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 211
Query: 420 SLVGYCISEKNRL-LIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDC 478
+L Y +RL + E+ L HL + E R A L YLH +
Sbjct: 212 ALK-YSFQTHDRLCFVMEYANGGELFFHLSRERV-FSEDRARFYGA-EIVSALDYLHSEK 268
Query: 479 HPKIIHRDIKSANILVDDEFEAQVADFGLAKLN----DTTQTHVSTRVMGTFGYLAPEYA 534
+ +++RD+K N+++D + ++ DFGL K T +T GT YLAPE
Sbjct: 269 N--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-----FCGTPEYLAPEVL 321
Query: 535 SSGKLTDRSDVFSFGVVLLELITGRKP 561
D + GVV+ E++ GR P
Sbjct: 322 EDNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 9e-20
Identities = 55/211 (26%), Positives = 89/211 (42%), Gaps = 31/211 (14%)
Query: 368 IGEGGFGCVYKG-NLPEGKVVAVK-----QLKSGSGQGEREFRAEVEIISRVHHRHLVSL 421
+GEG +G V N + VAVK + ++E + I ++H ++V
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE----ICINKMLNHENVVKF 70
Query: 422 VGYCISEKNRL-LIYEFVPNNNLEHHLHGKGQPVLEWTKRVK----IALGAAKGLAYLHE 476
G E N L E+ L + + E + +A G+ YLH
Sbjct: 71 YG-HRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMA-----GVVYLHG 123
Query: 477 DCHPKIIHRDIKSANILVDDEFEAQVADFGLAKL--NDTTQTHVSTRVMGTFGYLAPEYA 534
I HRDIK N+L+D+ +++DFGLA + + + ++ GT Y+APE
Sbjct: 124 I---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELL 179
Query: 535 SSGKLTD--RSDVFSFGVVLLELITGRKPVD 563
+ DV+S G+VL ++ G P D
Sbjct: 180 -KRREFHAEPVDVWSCGIVLTAMLAGELPWD 209
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-19
Identities = 53/232 (22%), Positives = 106/232 (45%), Gaps = 38/232 (16%)
Query: 347 KSFFTYEELM---EITNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGERE 402
+ ++ YE + + + +G G + V++ N+ + V VK LK + ++
Sbjct: 20 REYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKI 77
Query: 403 FRAEVEIISRV-HHRHLVSLVGYCI----SEKNRLLIYEFVPNNNLEHHLHGKGQPVLEW 457
R E++I+ + ++++L I + L++E V N + + Q + ++
Sbjct: 78 KR-EIKILENLRGGPNIITL--ADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDY 130
Query: 458 TKRVKI--ALGAAKGLAYLHEDCHPK-IIHRDIKSANILVDDEF-EAQVADFGLAKLNDT 513
R + L K L Y CH I+HRD+K N+++D E + ++ D+GLA+
Sbjct: 131 DIRFYMYEIL---KALDY----CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183
Query: 514 TQT---HVSTRVMGTFGYLAPEYASSGKLTDRS-DVFSFGVVLLELITGRKP 561
Q V++R + PE ++ D S D++S G +L +I ++P
Sbjct: 184 GQEYNVRVASRY-----FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 49/221 (22%), Positives = 88/221 (39%), Gaps = 45/221 (20%)
Query: 367 VIGEGGFGCVYKG-NLPEGKVVAVKQLK----SGSGQGERE----FRAEVEIISRVHHRH 417
+G G G V K VA+K + + E + E+EI+ +++H
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 418 LVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKG-----------QPVLEWTKRVKIALG 466
++ + + ++ ++ E + L + G +L
Sbjct: 77 IIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL---------- 125
Query: 467 AAKGLAYLHEDCHPKIIHRDIKSANILV---DDEFEAQVADFGLAKLNDTTQTHVSTRVM 523
+ YLHE+ IIHRD+K N+L+ +++ ++ DFG +K+ T + T
Sbjct: 126 ---AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLC- 177
Query: 524 GTFGYLAPE---YASSGKLTDRSDVFSFGVVLLELITGRKP 561
GT YLAPE + D +S GV+L ++G P
Sbjct: 178 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 1e-19
Identities = 57/219 (26%), Positives = 99/219 (45%), Gaps = 41/219 (18%)
Query: 368 IGEGGFGCVYKG---NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGY 424
+G G +G VYK + + K A+KQ++ +G R E+ ++ + H +++SL
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEG-TGISMSACR-EIALLRELKHPNVISLQKV 86
Query: 425 CISEKNRL--LIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAK--------GLAYL 474
+S +R L++++ ++L H + K V++ G K G+ YL
Sbjct: 87 FLSHADRKVWLLFDYA-EHDLWHIIKFHRASKAN-KKPVQLPRGMVKSLLYQILDGIHYL 144
Query: 475 HEDCHPKIIHRDIKSANILVDDEFEAQ----VADFGLAKL---NDTTQTHVSTRVMGTFG 527
H + ++HRD+K ANILV E + +AD G A+L + V+ TF
Sbjct: 145 HAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFW 200
Query: 528 YLAPE-------YASSGKLTDRSDVFSFGVVLLELITGR 559
Y APE Y + D+++ G + EL+T
Sbjct: 201 YRAPELLLGARHYTKA------IDIWAIGCIFAELLTSE 233
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 93.2 bits (231), Expect = 1e-19
Identities = 61/222 (27%), Positives = 85/222 (38%), Gaps = 6/222 (2%)
Query: 29 APPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPAAS 88
+ A+ E +P +N+ G + A A+ P + A P
Sbjct: 1477 SGLVNADLDVKDELMFSPLVDSGSNDAMAGGFTAYGGADYGEATSPFGAYGEAPTSPGFG 1536
Query: 89 PPPGSPPPASPP--PASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPP 146
P SP P S + SP S PT S S P + P S SP P
Sbjct: 1537 VSSPGFSPTSPTYSPTSPAYSPTSPSYSPT---SPSYSPTSPSYSPTSPSYSPTSPSYSP 1593
Query: 147 GQASTPPDSPPPGIQSNQGNPV-PSNGTTDSRDTKWAPPSNPGSPPSPSTSQSGTPSTPN 205
S P SP S +P PS T + +P +P SP TS S +P++P+
Sbjct: 1594 TSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPS 1653
Query: 206 ENSSPNELSPPSNSKSPTSKSSPEESSSSSHSNSKKTPTSSS 247
+ + SP S S SPTS S S S S ++ +PTS +
Sbjct: 1654 YSPTSPAYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPN 1695
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 90.2 bits (223), Expect = 1e-18
Identities = 54/238 (22%), Positives = 88/238 (36%), Gaps = 7/238 (2%)
Query: 24 KEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASP 83
+++ + +P + + + S + A + +
Sbjct: 1456 EQKITEIEDGQDGGVTPYSNESGLVNADLDVKDELMFSPLVDSGSNDAMAGGFTAYGGAD 1515
Query: 84 PPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASP-PPEQSKNSP 142
A+ P G+ A P G +SP + PT S + + P SP P S SP
Sbjct: 1516 YGEATSPFGAYGEAPTSPGFGVSSPGFSPTSPTYSPTSPAYSPTSPSYSPTSPSYSPTSP 1575
Query: 143 PAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPSNPGSPPSPSTSQSGTPS 202
P S P SP S +P + + S P +P SP TS S +P+
Sbjct: 1576 SYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTS------PSYSPTSPSYSPTSPSYSPT 1629
Query: 203 TPNENSSPNELSPPSNSKSPTSKSSPEESSSSSHSNSKKTPTSSSGHSSDSTKGSSSN 260
+P+ + + SP S S SPTS S S + S ++ +PTS S + + +S
Sbjct: 1630 SPSYSPTSPSYSPTSPSYSPTSPSYSPTSPAYSPTSPSYSPTSPSYSPTSPSYSPTSP 1687
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 89.8 bits (222), Expect = 2e-18
Identities = 67/268 (25%), Positives = 98/268 (36%), Gaps = 10/268 (3%)
Query: 1 MANSAETPGPPVANNASSGLGERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNN 60
+ TP + ++ L + E +P + ++ T +
Sbjct: 1465 GQDGGVTPYSNESGLVNADLDVKDELMFSPLVDSGSNDAMAGGFTAYGGADYGEATSPFG 1524
Query: 61 STTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASP--PPASPP-PTR 117
+ A + P P SP + + P SP S P S S SP P SP P+
Sbjct: 1525 AYGEAPTSPGFGVSSPGFSPTSPTYSPTSPAYSPTSPSYSPTSPSYSPTSPSYSPTSPSY 1584
Query: 118 SESQSSPPPGDGGASPP-PEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPV-PSNGTTD 175
S + S P SP P S SP P S P SP S +P PS T
Sbjct: 1585 SPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTS 1644
Query: 176 SRDTKWAPPSNPGSPPSPSTSQSGTPSTPNENSSPNELSPPSNSKSPTSK----SSPEES 231
+ +P +P SP TS S +P++P+ + + SP S S SPTS +SP
Sbjct: 1645 PSYSPTSPSYSPTSPAYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPNYSPTSP-SY 1703
Query: 232 SSSSHSNSKKTPTSSSGHSSDSTKGSSS 259
S +S S +P S + +
Sbjct: 1704 SPTSPGYSPGSPAYSPKQDEQKHNENEN 1731
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 88.6 bits (219), Expect = 3e-18
Identities = 54/224 (24%), Positives = 77/224 (34%), Gaps = 8/224 (3%)
Query: 42 KKVTPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPP 101
K P G T + + P
Sbjct: 1451 VKYMPEQKITEIEDGQDGGVTPYSNESGLVNADLDVKDELMFSPLVDSGSNDAMAGGFTA 1510
Query: 102 ASGSASPPPASPPPTRSESQSSPPPGDGGASPP-----PEQSKNSPPAPPGQASTPPDSP 156
G+ SP E+ +SP G G +SP P S SP P S P SP
Sbjct: 1511 YGGADYGEATSPFGAYGEAPTSP--GFGVSSPGFSPTSPTYSPTSPAYSPTSPSYSPTSP 1568
Query: 157 PPGIQSNQGNPV-PSNGTTDSRDTKWAPPSNPGSPPSPSTSQSGTPSTPNENSSPNELSP 215
S +P PS T + +P +P SP TS S +P++P+ + + SP
Sbjct: 1569 SYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSP 1628
Query: 216 PSNSKSPTSKSSPEESSSSSHSNSKKTPTSSSGHSSDSTKGSSS 259
S S SPTS S S S S ++ +PTS + + + +S
Sbjct: 1629 TSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPAYSPTSPSYSPTS 1672
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 75.5 bits (185), Expect = 4e-14
Identities = 57/232 (24%), Positives = 82/232 (35%), Gaps = 15/232 (6%)
Query: 10 PPVANNASSGLGERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNG----GGGNNSTTPA 65
+ +AP +P SP T P + + T+P+
Sbjct: 1510 AYGGADYGEATSPFGAYGEAPTSPGFGVSSPGFSPTSPTYSPTSPAYSPTSPSYSPTSPS 1569
Query: 66 ASP--PPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSS 123
SP P SP S P SP + + P SP S P S S SP + P S S
Sbjct: 1570 YSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSP---TSPSYSPTSPSY 1626
Query: 124 PPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAP 183
P + P S SP P S P SP S +P + + S P
Sbjct: 1627 SPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPAYSPTSPSYSPTSPSYSPTS------P 1680
Query: 184 PSNPGSPPSPSTSQSGTPSTPNENSSPNELSPPSNSKSPTSKSSPEESSSSS 235
+P SP TS + +P++P+ + + SP S + SP + +S
Sbjct: 1681 SYSPTSPSYSPTSPNYSPTSPSYSPTSPGYSPGSPAYSPKQDEQKHNENENS 1732
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 60.5 bits (146), Expect = 2e-09
Identities = 44/175 (25%), Positives = 63/175 (36%), Gaps = 11/175 (6%)
Query: 2 ANSAETPGPPVANNASSGLGERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNS 61
+ S +P + + S +P + SP P + + + +
Sbjct: 1562 SYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSP 1621
Query: 62 TTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQ 121
T+P+ SP S P SP + P+ SP S P SP + S S P SP S S
Sbjct: 1622 TSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPAYSPTSPSYSPTSP----SYSP 1677
Query: 122 SSP---PPGDGGASPPPEQSKNSP---PAPPGQASTPPD-SPPPGIQSNQGNPVP 169
+SP P + P S SP P PG + P SP Q + N
Sbjct: 1678 TSPSYSPTSPSYSPTSPNYSPTSPSYSPTSPGYSPGSPAYSPKQDEQKHNENENS 1732
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 2e-19
Identities = 54/226 (23%), Positives = 91/226 (40%), Gaps = 40/226 (17%)
Query: 358 ITNGFARENVIGEGGFGCVYKG-NLPEGKVVAVK-----QLKSGSGQGERE-FRAEVEII 410
+ + + +G G F V K GK A K +L S RE EV I+
Sbjct: 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNIL 62
Query: 411 SRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKG-----------QPVLEWTK 459
+ H ++++L ++ + +LI E V L L K + +L+
Sbjct: 63 REIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD--- 119
Query: 460 RVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQ----VADFGLAKLNDTTQ 515
G+ YLH +I H D+K NI++ D+ + DFG+A +
Sbjct: 120 ----------GVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN 166
Query: 516 THVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKP 561
+ GT ++APE + L +D++S GV+ L++G P
Sbjct: 167 EF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 57/213 (26%), Positives = 89/213 (41%), Gaps = 31/213 (14%)
Query: 362 FARENVIGEGGFGCVY----KGNLPEGKVVAVKQLKSGSGQGEREF---RAEVEIISRVH 414
F R +G G FG V K + G A+K L ++ E I+ V+
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKES---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 415 HRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTK----RVKIALGAAKG 470
LV L N ++ E+V + HL G+ + ++ +
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE---- 155
Query: 471 LAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK-LNDTTQTHVSTRVMGTFGYL 529
YLH +I+RD+K N+L+D + QV DFG AK + T T + GT L
Sbjct: 156 --YLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEAL 205
Query: 530 APEYASSGKLTDRS-DVFSFGVVLLELITGRKP 561
APE S K +++ D ++ GV++ E+ G P
Sbjct: 206 APEIILS-KGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 2e-19
Identities = 51/208 (24%), Positives = 91/208 (43%), Gaps = 9/208 (4%)
Query: 357 EITNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHH 415
+ + + +G G FG V++ G A K + + + R E++ +S + H
Sbjct: 154 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRH 213
Query: 416 RHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLH 475
LV+L + ++IYEF+ L + + + E + V+ KGL ++H
Sbjct: 214 PTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSE-DEAVEYMRQVCKGLCHMH 272
Query: 476 EDCHPKIIHRDIKSANILVDDEFEAQV--ADFGLAKLNDTTQTHVSTRVMGTFGYLAPEY 533
E+ +H D+K NI+ + ++ DFGL D Q GT + APE
Sbjct: 273 EN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--SVKVTTGTAEFAAPEV 327
Query: 534 ASSGKLTDRSDVFSFGVVLLELITGRKP 561
A + +D++S GV+ L++G P
Sbjct: 328 AEGKPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 53/224 (23%), Positives = 93/224 (41%), Gaps = 28/224 (12%)
Query: 357 EITNGFARENVIGEGGFGCVYKG-NLPEGKVVAVK--------QLKSGSGQGERE-FRAE 406
+ + ++G G V + + P K AVK + Q RE E
Sbjct: 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKE 73
Query: 407 VEIISRV-HHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKR--VKI 463
V+I+ +V H +++ L + L+++ + L +L K +++ KI
Sbjct: 74 VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT----LSEKETRKI 129
Query: 464 ALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVM 523
+ + LH+ I+HRD+K NIL+DD+ ++ DFG + D + +
Sbjct: 130 MRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK-LREVC- 184
Query: 524 GTFGYLAPE------YASSGKLTDRSDVFSFGVVLLELITGRKP 561
GT YLAPE + D++S GV++ L+ G P
Sbjct: 185 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 3e-19
Identities = 31/276 (11%), Positives = 73/276 (26%), Gaps = 52/276 (18%)
Query: 367 VIGEGGFGCVYKG---NLPEGKVVAVKQLKSGSGQGE---REFRAEVEIISRVHHRHLVS 420
G ++ L + VA+ + + +E + +SR+ +
Sbjct: 38 FHGGVPPLQFWQALDTAL--DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 421 LVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHP 480
++ + L++ E++ +L+ PV ++ A H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPV----GAIRAMQSLAAAADAAHRA--- 148
Query: 481 KIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLT 540
+ + + V + G L +
Sbjct: 149 GVALSIDHPSRVRVSID--------GDVVL-------------AYPATMPDA-------N 180
Query: 541 DRSDVFSFGVVLLELITGRKP---VDPTQPLGDESLVEWARPVLVRAIETG---DLSEIV 594
+ D+ G L L+ R P L +P+ I+ +S +
Sbjct: 181 PQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVA 240
Query: 595 DPRLEKHYVE---SEMFRMIEAAAACVRHSGPKRPR 627
++ S + +++ A A + P
Sbjct: 241 ARSVQGDGGIRSASTLLNLMQQATAVADRTEVLGPI 276
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 4e-19
Identities = 61/215 (28%), Positives = 89/215 (41%), Gaps = 28/215 (13%)
Query: 362 FARENVIGEGGFGCVY----KGNLPEGKVVAVKQLKSGS----GQGEREFRAEVEIISRV 413
+ VIG G FG V K KV A+K L F E +I++
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKST---RKVYAMKLLSKFEMIKRSDSAF-FWEERDIMAFA 126
Query: 414 HHRHLVSLVGYCISEKNRL-LIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIA-LGAAKGL 471
+ +V L Y + L ++ E++P +L + + V E R A + A L
Sbjct: 127 NSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARFYTAEVVLA--L 181
Query: 472 AYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK-LNDTTQTHVSTRVMGTFGYLA 530
+H IHRD+K N+L+D ++ADFG +N T V GT Y++
Sbjct: 182 DAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYIS 237
Query: 531 PE-YASSGKLT--DRS-DVFSFGVVLLELITGRKP 561
PE S G R D +S GV L E++ G P
Sbjct: 238 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 4e-19
Identities = 54/227 (23%), Positives = 92/227 (40%), Gaps = 40/227 (17%)
Query: 357 EITNGFARENVIGEGGFGCVYK------GNLPEGKVVAVKQLKSGSGQGERE-FRAEVEI 409
++ + + +G G F V K G K + +Q ++ RE EV I
Sbjct: 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSI 68
Query: 410 ISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKG-----------QPVLEWT 458
+ +V H ++++L + + +LI E V L L K + +L+
Sbjct: 69 LRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD-- 126
Query: 459 KRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQ----VADFGLAKLNDTT 514
G+ YLH KI H D+K NI++ D+ + DFGLA +
Sbjct: 127 -----------GVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172
Query: 515 QTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKP 561
+ GT ++APE + L +D++S GV+ L++G P
Sbjct: 173 VEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 4e-19
Identities = 47/205 (22%), Positives = 88/205 (42%), Gaps = 18/205 (8%)
Query: 367 VIGEGGFGCVYKG-NLPEGKVVAVKQL-KSGSGQGERE-FRAEVEIISRV-HHRHLVSLV 422
+G G F V + + G+ A K L K GQ R E+ ++ +++L
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 423 GYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVL---EWTKRVKIALGAAKGLAYLHEDCH 479
+ +LI E+ + + ++ + + +K L G+ YLH++
Sbjct: 96 EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILE---GVYYLHQN-- 150
Query: 480 PKIIHRDIKSANILVDDEFEAQ---VADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASS 536
I+H D+K NIL+ + + DFG+++ +MGT YLAPE +
Sbjct: 151 -NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL--REIMGTPEYLAPEILNY 207
Query: 537 GKLTDRSDVFSFGVVLLELITGRKP 561
+T +D+++ G++ L+T P
Sbjct: 208 DPITTATDMWNIGIIAYMLLTHTSP 232
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 6e-19
Identities = 55/226 (24%), Positives = 89/226 (39%), Gaps = 40/226 (17%)
Query: 358 ITNGFARENVIGEGGFGCVYKG-NLPEGKVVAVK-----QLKSGSGQGERE-FRAEVEII 410
+ + + +G G F V K G A K + KS RE EV I+
Sbjct: 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 411 SRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKG-----------QPVLEWTK 459
+ H ++++L ++ + +LI E V L L K + +L
Sbjct: 69 KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN--- 125
Query: 460 RVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQ----VADFGLAKLNDTTQ 515
G+ YLH +I H D+K NI++ D + + DFGLA D
Sbjct: 126 ----------GVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172
Query: 516 THVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKP 561
+ GT ++APE + L +D++S GV+ L++G P
Sbjct: 173 EF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 8e-19
Identities = 67/236 (28%), Positives = 103/236 (43%), Gaps = 42/236 (17%)
Query: 368 IGEGGFGCVYKG-NLPEGKVVAVK-----QLKSGSGQGEREFRAEVEIISRVHHRHLVSL 421
+GEG FG V + + VA+K LK S R R E+ + + H H++ L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKK-SDMHMRVER-EISYLKLLRHPHIIKL 74
Query: 422 VGY-CISEKNRL-LIYEFVPNNNLEHHLHGKGQPVLEWTKRVK----IALGAAKGLAYLH 475
Y I+ + ++ E+ L ++ K + E R I + Y H
Sbjct: 75 --YDVITTPTDIVMVIEYA-GGELFDYIVEKK-RMTEDEGRRFFQQIIC-----AIEYCH 125
Query: 476 EDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYAS 535
KI+HRD+K N+L+DD ++ADFGL+ N T + G+ Y APE
Sbjct: 126 ---RHKIVHRDLKPENLLLDDNLNVKIADFGLS--NIMTDGNFLKTSCGSPNYAAPEVI- 179
Query: 536 SGKLTD--RSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGD 589
+GKL DV+S G+VL ++ GR P D DE + P L + + +
Sbjct: 180 NGKLYAGPEVDVWSCGIVLYVMLVGRLPFD------DEFI-----PNLFKKVNSCV 224
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 89.9 bits (222), Expect = 1e-18
Identities = 26/188 (13%), Positives = 37/188 (19%)
Query: 64 PAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSS 123
A + P P PP G P G+ T ++ Q
Sbjct: 11 QAQLQYGQNATPLQQPAQFMPPQDPAAAGMSYGQMGMPPQGAVPSMGQQQFLTPAQEQLH 70
Query: 124 PPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAP 183
S N P P P G Q +
Sbjct: 71 QQIDQATTSMNDMHLHNVPLVDPNAYMQPQVPVQMGTPLQQQQQPMAAPAYGQPSAAMGQ 130
Query: 184 PSNPGSPPSPSTSQSGTPSTPNENSSPNELSPPSNSKSPTSKSSPEESSSSSHSNSKKTP 243
P + P + P + + P + S S P
Sbjct: 131 NMRPMNQLYPIDLLTELPPPITDLTLPPPPLVIPPERMLVPSELSNASPDYIRSTLNAVP 190
Query: 244 TSSSGHSS 251
+SS
Sbjct: 191 KNSSLLKK 198
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 83.0 bits (204), Expect = 2e-16
Identities = 27/187 (14%), Positives = 40/187 (21%), Gaps = 3/187 (1%)
Query: 61 STTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSES 120
S P A PA PP P A P A P + +
Sbjct: 2 SHHKKRVYPQAQLQYGQNATPLQQPAQFMPPQDPAAAGMSYGQMGMPPQGAVPSMGQQQF 61
Query: 121 QSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTK 180
+ S N P P + G P+ +
Sbjct: 62 LTPAQEQLHQQIDQATTSMNDMHLHNVPLVDPNAYMQPQVPVQMGTPLQQQQQPMAAPAY 121
Query: 181 WAPPSNPGSPPSPSTSQSGTPSTPNENSSPNELSPPSNSKSPTSKSSPEESSSSSHSNSK 240
P + G P + P ++ + P S SN+
Sbjct: 122 GQPSAAMGQNMRP---MNQLYPIDLLTELPPPITDLTLPPPPLVIPPERMLVPSELSNAS 178
Query: 241 KTPTSSS 247
S+
Sbjct: 179 PDYIRST 185
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 81.0 bits (199), Expect = 6e-16
Identities = 24/182 (13%), Positives = 37/182 (20%), Gaps = 7/182 (3%)
Query: 46 PPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGS 105
N PA+ + PP A P G +P
Sbjct: 11 QAQLQYGQNATPLQQPAQFMPPQDPAAAGMSYGQMGMPPQGAVPSMGQQQFLTPAQEQLH 70
Query: 106 ASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQG 165
A+ + P P + P Q + +
Sbjct: 71 QQIDQATTSMNDMHLHNVPLVDPNAYMQPQVPVQMGTPLQQQQQPMAAPAYGQPSAAMGQ 130
Query: 166 NPVPSNGTTDSRDTKWAPPSNPGSPPSPSTSQSGTPSTPNENSSPNELSPPSNSKSPTSK 225
N P N + PP + P S SN+ +
Sbjct: 131 NMRPMNQL-------YPIDLLTELPPPITDLTLPPPPLVIPPERMLVPSELSNASPDYIR 183
Query: 226 SS 227
S+
Sbjct: 184 ST 185
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 75.6 bits (185), Expect = 3e-14
Identities = 22/151 (14%), Positives = 29/151 (19%), Gaps = 1/151 (0%)
Query: 45 TPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASG 104
P + S PP P+ P A+
Sbjct: 19 NATPLQQPAQFMPPQDPAAAGMSYGQMGMPPQGAVPSMGQQQFLTPAQEQLHQQIDQATT 78
Query: 105 SASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQ 164
S + P + P P Q + P A P NQ
Sbjct: 79 SMNDMHLHNVPLVDPNAYMQPQV-PVQMGTPLQQQQQPMAAPAYGQPSAAMGQNMRPMNQ 137
Query: 165 GNPVPSNGTTDSRDTKWAPPSNPGSPPSPST 195
P+ T P P P
Sbjct: 138 LYPIDLLTELPPPITDLTLPPPPLVIPPERM 168
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 71.0 bits (173), Expect = 9e-13
Identities = 26/177 (14%), Positives = 39/177 (22%), Gaps = 7/177 (3%)
Query: 29 APPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPAAS 88
P ++ P A + G + PA A+
Sbjct: 18 QNATPLQQPAQFMPPQDPAAAGMSYGQMGMPPQGAVPSMGQQQFLTPAQEQLHQQIDQAT 77
Query: 89 PPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPPGQ 148
+ P +A P P P P + P A GQ
Sbjct: 78 TSMNDMHLHNVPLVDPNAYMQPQVPV-------QMGTPLQQQQQPMAAPAYGQPSAAMGQ 130
Query: 149 ASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPSNPGSPPSPSTSQSGTPSTPN 205
P + P + P ++ T P + S ST N
Sbjct: 131 NMRPMNQLYPIDLLTELPPPITDLTLPPPPLVIPPERMLVPSELSNASPDYIRSTLN 187
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 66.4 bits (161), Expect = 2e-11
Identities = 29/184 (15%), Positives = 46/184 (25%), Gaps = 4/184 (2%)
Query: 8 PGPPVANNASSGLGERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAAS 67
P + ++ ++ + P PA S + PP + G +
Sbjct: 10 PQAQLQYGQNATPLQQPAQFMPPQDPAAAGMSYGQMGMPPQGAVPSMGQQQFLTPAQEQL 69
Query: 68 PPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPG 127
S P + P G+ P + Q S G
Sbjct: 70 HQQIDQATTSMNDMHLHNVPLVDPNAYMQPQVPVQMGTPLQQQQQPMAAPAYGQPSAAMG 129
Query: 128 DGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRD----TKWAP 183
+ P + PPP + + VPS + S D T A
Sbjct: 130 QNMRPMNQLYPIDLLTELPPPITDLTLPPPPLVIPPERMLVPSELSNASPDYIRSTLNAV 189
Query: 184 PSNP 187
P N
Sbjct: 190 PKNS 193
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 57.1 bits (137), Expect = 2e-08
Identities = 25/170 (14%), Positives = 46/170 (27%), Gaps = 4/170 (2%)
Query: 1 MANSAETPGPPVANNASSGLGERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNN 60
A + P + + G + PP A + ++ +TP +
Sbjct: 19 NATPLQQPAQFMPPQDPAAAGMSYGQMGMPPQGAVPSMGQQQFLTPAQEQLHQQIDQATT 78
Query: 61 STTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSES 120
S P + P G+P P + A P++
Sbjct: 79 SMNDMHLHNVPLVDPNAYMQPQVPVQ----MGTPLQQQQQPMAAPAYGQPSAAMGQNMRP 134
Query: 121 QSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPS 170
+ P D PP + + P PP P + + + + S
Sbjct: 135 MNQLYPIDLLTELPPPITDLTLPPPPLVIPPERMLVPSELSNASPDYIRS 184
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 43.3 bits (101), Expect = 3e-04
Identities = 19/130 (14%), Positives = 33/130 (25%), Gaps = 2/130 (1%)
Query: 134 PPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPSNPGSPPSP 193
P Q + A P Q P PP + G G +P
Sbjct: 10 PQAQLQYGQNATPLQQ--PAQFMPPQDPAAAGMSYGQMGMPPQGAVPSMGQQQFLTPAQE 67
Query: 194 STSQSGTPSTPNENSSPNELSPPSNSKSPTSKSSPEESSSSSHSNSKKTPTSSSGHSSDS 253
Q +T + N P + + P + + + + G S +
Sbjct: 68 QLHQQIDQATTSMNDMHLHNVPLVDPNAYMQPQVPVQMGTPLQQQQQPMAAPAYGQPSAA 127
Query: 254 TKGSSSNDDQ 263
+ +Q
Sbjct: 128 MGQNMRPMNQ 137
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 1e-18
Identities = 64/238 (26%), Positives = 102/238 (42%), Gaps = 45/238 (18%)
Query: 368 IGEGGFGCVYKG-NLPEGKVVAVK-----QLKSGSGQGEREFRAEVEIISRVHHRHLVSL 421
+G G FG V G + G VAVK +++S + R E++ + H H++ L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRS-LDVVGKIRR-EIQNLKLFRHPHIIKL 81
Query: 422 VGY-CISEKNRL-LIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAK------GLAY 473
Y IS + + ++ E+V L ++ G R+ G+ Y
Sbjct: 82 --YQVISTPSDIFMVMEYVSGGELFDYICKNG--------RLDEKESRRLFQQILSGVDY 131
Query: 474 LHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEY 533
H ++HRD+K N+L+D A++ADFGL+ N + G+ Y APE
Sbjct: 132 CH---RHMVVHRDLKPENVLLDAHMNAKIADFGLS--NMMSDGEFLRTSCGSPNYAAPEV 186
Query: 534 ASSGKLTD--RSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGD 589
SG+L D++S GV+L L+ G P D D+ + P L + I G
Sbjct: 187 I-SGRLYAGPEVDIWSSGVILYALLCGTLPFD------DDHV-----PTLFKKICDGI 232
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 52/245 (21%), Positives = 96/245 (39%), Gaps = 43/245 (17%)
Query: 343 LGGSKSFFTYE---ELMEITNGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQG 399
+ + EL + + + + I G +G V G EG VA+K++ + G
Sbjct: 2 MQAKGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDG 61
Query: 400 E------------REFRAEVEIISRVHHRHLVSLVGYCISEKNRL-----LIYEFVPNNN 442
R R E+ +++ HH +++ L + + L+ E + +
Sbjct: 62 RTVNILSDSFLCKRVLR-EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTD- 119
Query: 443 LEHHLHGKGQPVLEWTKRVKI----ALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEF 498
L + + V+ + ++ L GL LHE ++HRD+ NIL+ D
Sbjct: 120 L-AQVIHDQRIVIS-PQHIQYFMYHIL---LGLHVLHE---AGVVHRDLHPGNILLADNN 171
Query: 499 EAQVADFGLAKLNDTTQT---HVSTRVMGTFGYLAPEY-ASSGKLTDRSDVFSFGVVLLE 554
+ + DF LA+ + +V+ R Y APE T D++S G V+ E
Sbjct: 172 DITICDFNLAREDTADANKTHYVTHRW-----YRAPELVMQFKGFTKLVDMWSAGCVMAE 226
Query: 555 LITGR 559
+ +
Sbjct: 227 MFNRK 231
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 56/231 (24%), Positives = 100/231 (43%), Gaps = 35/231 (15%)
Query: 347 KSFFTYE---ELMEITNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLK---SGSGQG 399
K F+ + E+ + +G G +G V + G+ VA+K+L
Sbjct: 8 KGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFA 67
Query: 400 EREFRAEVEIISRVHHRHLVSLVGYCISEKNRL------LIYEFVPNNNLEHHLHG-KGQ 452
+R +R E+ ++ + H +++ L+ + L+ F ++ L G
Sbjct: 68 KRAYR-ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPF-----MQTDLQKIMGL 121
Query: 453 PVLEWTKRVKI--ALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKL 510
E + + L KGL Y+H ++HRD+K N+ V+++ E ++ DFGLA+
Sbjct: 122 KFSEEKIQYLVYQML---KGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARH 175
Query: 511 NDTTQTH-VSTRVMGTFGYLAPEYA-SSGKLTDRSDVFSFGVVLLELITGR 559
D T V TR Y APE S D++S G ++ E++TG+
Sbjct: 176 ADAEMTGYVVTRW-----YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 63/214 (29%), Positives = 102/214 (47%), Gaps = 32/214 (14%)
Query: 367 VIGEGGFGCVY---KGNLPE-GKVVAVKQLKSGSGQGEREF----RAEVEIISRV-HHRH 417
V+G G +G V+ K + + GK+ A+K LK + + + R E +++ +
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120
Query: 418 LVSLVGYCISEKNRL-LIYEFVPNNNLEHHLHGKGQPVLEWTKRVK-----IALGAAKGL 471
LV+L Y + +L LI +++ L HL + + V+ I L L
Sbjct: 121 LVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEH---EVQIYVGEIVLA----L 172
Query: 472 AYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAP 531
+LH+ II+RDIK NIL+D + DFGL+K +T + GT Y+AP
Sbjct: 173 EHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAP 229
Query: 532 E---YASSGKLTDRS-DVFSFGVVLLELITGRKP 561
+ SG D++ D +S GV++ EL+TG P
Sbjct: 230 DIVRGGDSGH--DKAVDWWSLGVLMYELLTGASP 261
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 3e-18
Identities = 61/214 (28%), Positives = 96/214 (44%), Gaps = 33/214 (15%)
Query: 362 FARENVIGEGGFGCVY----KGNLPEGKVVAVKQLKSGSGQGEREF---RAEVEIISRVH 414
F +G G FG V+ + N G+ A+K LK ++ E ++S V
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHN---GRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 64
Query: 415 HRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVK-----IALGAAK 469
H ++ + G + +I +++ L L K Q K + L
Sbjct: 65 HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR-KSQRFPN--PVAKFYAAEVCLA--- 118
Query: 470 GLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK-LNDTTQTHVSTRVMGTFGY 528
L YLH II+RD+K NIL+D ++ DFG AK + D T T + GT Y
Sbjct: 119 -LEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT-----LCGTPDY 169
Query: 529 LAPEYASSGKLTDRS-DVFSFGVVLLELITGRKP 561
+APE S+ K ++S D +SFG+++ E++ G P
Sbjct: 170 IAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 3e-18
Identities = 60/211 (28%), Positives = 98/211 (46%), Gaps = 33/211 (15%)
Query: 367 VIGEGGFGCVY----KGNLPEGKVVAVKQLKSGSGQGEREF---RAEVEIISRV-HHRHL 418
VIG G + V K ++ A+K +K + + + E + + +H L
Sbjct: 16 VIGRGSYAKVLLVRLKKT---DRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFL 72
Query: 419 VSLVGYCISEKNRL-LIYEFVPNNNLEHHLHGKGQPVLEWTK--RVKIALGAAKGLAYLH 475
V L C ++RL + E+V +L H+ + + E + +I+L L YLH
Sbjct: 73 VGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA----LNYLH 127
Query: 476 EDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLN----DTTQTHVSTRVMGTFGYLAP 531
E II+RD+K N+L+D E ++ D+G+ K DTT T GT Y+AP
Sbjct: 128 ER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-----GTPNYIAP 179
Query: 532 EYASSGKLTDRS-DVFSFGVVLLELITGRKP 561
E G+ S D ++ GV++ E++ GR P
Sbjct: 180 EIL-RGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 3e-18
Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 33/211 (15%)
Query: 367 VIGEGGFGCV----YKGNLPEGKVVAVKQLKSGSGQGEREF---RAEVEIISRV-HHRHL 418
++G+G FG V +K + A+K LK + + E ++S H L
Sbjct: 24 MLGKGSFGKVFLAEFKKT---NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 80
Query: 419 VSLVGYCISEKNRL-LIYEFVPNNNLEHHLHGKGQPVLEWTK--RVKIALGAAKGLAYLH 475
+ K L + E++ +L +H+ + L +I LG L +LH
Sbjct: 81 THMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILG----LQFLH 135
Query: 476 EDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLN----DTTQTHVSTRVMGTFGYLAP 531
I++RD+K NIL+D + ++ADFG+ K N T T GT Y+AP
Sbjct: 136 SK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-----GTPDYIAP 187
Query: 532 EYASSGKLTDRS-DVFSFGVVLLELITGRKP 561
E G+ + S D +SFGV+L E++ G+ P
Sbjct: 188 EIL-LGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 4e-18
Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 33/211 (15%)
Query: 367 VIGEGGFGCV----YKGNLPEGKVVAVKQLKSGSGQGEREF---RAEVEIISRV-HHRHL 418
V+G+G FG V KG ++ AVK LK + + E +++ L
Sbjct: 27 VLGKGSFGKVMLSERKGT---DELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFL 83
Query: 419 VSLVGYCISEKNRL-LIYEFVPNNNLEHHLHGKGQPVLEWTK--RVKIALGAAKGLAYLH 475
L C +RL + E+V +L +H+ G+ +IA+G L +L
Sbjct: 84 TQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIG----LFFLQ 138
Query: 476 EDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLN----DTTQTHVSTRVMGTFGYLAP 531
II+RD+K N+++D E ++ADFG+ K N TT+T GT Y+AP
Sbjct: 139 SK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC-----GTPDYIAP 190
Query: 532 EYASSGKLTDRS-DVFSFGVVLLELITGRKP 561
E + + +S D ++FGV+L E++ G+ P
Sbjct: 191 EII-AYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 5e-18
Identities = 52/205 (25%), Positives = 88/205 (42%), Gaps = 22/205 (10%)
Query: 368 IGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCI 426
IG G FG + ++VAVK ++ G+ E R E+ + H ++V +
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQR-EIINHRSLRHPNIVRFKEVIL 86
Query: 427 SEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVK----IALGAAKGLAYLHEDCHPKI 482
+ + +I E+ L + G+ E R ++ G++Y H +I
Sbjct: 87 TPTHLAIIMEYASGGELYERICNAGR-FSEDEARFFFQQLLS-----GVSYCHSM---QI 137
Query: 483 IHRDIKSANILVDDEFEAQ--VADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLT 540
HRD+K N L+D + + DFG +K + + V GT Y+APE +
Sbjct: 138 CHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTV-GTPAYIAPEVL-LRQEY 194
Query: 541 D--RSDVFSFGVVLLELITGRKPVD 563
D +DV+S GV L ++ G P +
Sbjct: 195 DGKIADVWSCGVTLYVMLVGAYPFE 219
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 6e-18
Identities = 51/211 (24%), Positives = 90/211 (42%), Gaps = 24/211 (11%)
Query: 367 VIGEGGFGCVYKG-NLPEGKVVAVKQLK-------SGSGQGEREFRAEVEIISRVHHR-- 416
++G GGFG VY G + + VA+K ++ G R EV ++ +V
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM-EVVLLKKVSSGFS 108
Query: 417 HLVSLVGYCISEKNRLLIYEFV-PNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLH 475
++ L+ + + +LI E P +L + +G + E R + + + H
Sbjct: 109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG-ALQEELAR-SFFWQVLEAVRHCH 166
Query: 476 EDCHPKIIHRDIKSANILVD-DEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYA 534
++HRDIK NIL+D + E ++ DFG T + GT Y PE+
Sbjct: 167 NC---GVLHRDIKDENILIDLNRGELKLIDFGSG--ALLKDTVYTDFD-GTRVYSPPEWI 220
Query: 535 SSGKLTD--RSDVFSFGVVLLELITGRKPVD 563
+ V+S G++L +++ G P +
Sbjct: 221 -RYHRYHGRSAAVWSLGILLYDMVCGDIPFE 250
|
| >3h0g_A DNA-directed RNA polymerase II subunit RPB1; transcription, multi-protein complex, DNA- binding, magnesium; 3.65A {Schizosaccharomyces pombe} Length = 1752 | Back alignment and structure |
|---|
Score = 87.8 bits (217), Expect = 6e-18
Identities = 59/231 (25%), Positives = 85/231 (36%), Gaps = 17/231 (7%)
Query: 45 TPPPADNNNNGGGGNNSTTPAA-----SPPPASPPPASPPPASPPPAASPPPGSPPPASP 99
P D+ G + +P + SP SP ++
Sbjct: 1488 RSPMVDSGFVGSPDAAAFSPLVQGGSEGREGFGDYGLLGAASPYKGVQSPGYTSPFSSAM 1547
Query: 100 PPASGSASPP--PASPPPTRSESQSSPPPGDGGASPP-----PEQSKNSPPAPPGQASTP 152
P G SP P+SP + S + P SP P S SP P S
Sbjct: 1548 SPGYGLTSPSYSPSSPGYSTSPAYMPSSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYS 1607
Query: 153 PDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPSNPGSPPSPS---TSQSGTPSTPNENSS 209
SP S +P + + S ++P S SP SPS TS S +P++P+ + +
Sbjct: 1608 ATSPSYSPTSPSYSPTSPSYSPTS--PSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPT 1665
Query: 210 PNELSPPSNSKSPTSKSSPEESSSSSHSNSKKTPTSSSGHSSDSTKGSSSN 260
SP S S SPTS S S S S ++ +PTS S + + +S
Sbjct: 1666 SPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSP 1716
|
| >3h0g_A DNA-directed RNA polymerase II subunit RPB1; transcription, multi-protein complex, DNA- binding, magnesium; 3.65A {Schizosaccharomyces pombe} Length = 1752 | Back alignment and structure |
|---|
Score = 84.4 bits (208), Expect = 7e-17
Identities = 63/225 (28%), Positives = 86/225 (38%), Gaps = 22/225 (9%)
Query: 45 TPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPP---P 101
+ G + SP SP ++ P + S P SP ++ P P
Sbjct: 1514 EGREGFGDYGLLGAASPYKGVQSPGYTSPFSSAMSPGYGLTSPSYSPSSPGYSTSPAYMP 1573
Query: 102 ASGSASP--PPASPP-PTRSESQSSPPPGDGGASPP-PEQSKNSPPAPPGQASTPPDSPP 157
+S S SP P SP P+ S + S P S P S SP P S P SP
Sbjct: 1574 SSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSATSPSYSPTSPSYSPTSPSYSPTSPS 1633
Query: 158 PGIQSNQGNP---------------VPSNGTTDSRDTKWAPPSNPGSPPSPSTSQSGTPS 202
S +P PS T + +P +P SP TS S +P+
Sbjct: 1634 YSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPT 1693
Query: 203 TPNENSSPNELSPPSNSKSPTSKSSPEESSSSSHSNSKKTPTSSS 247
+P+ + + SP S S SPTS S S S S ++ +PTS S
Sbjct: 1694 SPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPS 1738
|
| >3h0g_A DNA-directed RNA polymerase II subunit RPB1; transcription, multi-protein complex, DNA- binding, magnesium; 3.65A {Schizosaccharomyces pombe} Length = 1752 | Back alignment and structure |
|---|
Score = 82.8 bits (204), Expect = 2e-16
Identities = 61/228 (26%), Positives = 89/228 (39%), Gaps = 17/228 (7%)
Query: 40 PEKKVTPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPAA-SP----PPGSP 94
+ +G G + A +P SP S SP AA SP
Sbjct: 1457 MNYSLGTAVPTLAGSGMGTSQLPEGAGTPYERSPMVDSGFVGSPDAAAFSPLVQGGSEGR 1516
Query: 95 PPASPPPASGSASP-PPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPPGQASTPP 153
G+ASP P S S+ PG G SP + P+ PG +++P
Sbjct: 1517 EGFGDYGLLGAASPYKGVQSPGYTSPFSSAMSPGYGLTSP------SYSPSSPGYSTSPA 1570
Query: 154 DSPPPGIQSNQGNPV-PSNGTTDSRDTKWAPPSNPGSPPSPSTSQSGTPSTPNENSSPNE 212
P S +P PS T + +P +P SP +TS S +P++P+ + +
Sbjct: 1571 YMP----SSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSATSPSYSPTSPSYSPTSPS 1626
Query: 213 LSPPSNSKSPTSKSSPEESSSSSHSNSKKTPTSSSGHSSDSTKGSSSN 260
SP S S SPTS S S S S ++ +PTS S + + +S
Sbjct: 1627 YSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSP 1674
|
| >3h0g_A DNA-directed RNA polymerase II subunit RPB1; transcription, multi-protein complex, DNA- binding, magnesium; 3.65A {Schizosaccharomyces pombe} Length = 1752 | Back alignment and structure |
|---|
Score = 79.7 bits (196), Expect = 2e-15
Identities = 73/252 (28%), Positives = 103/252 (40%), Gaps = 20/252 (7%)
Query: 10 PPVANNASSGLGERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAASPP 69
P V + G +P + +SP T P + + G G + + +SP
Sbjct: 1507 PLVQGGSEGREGFGDYGLLGAASPYKGVQSPG--YTSPFSSAMSPGYGLTSPSYSPSSPG 1564
Query: 70 PASPPPASPP-----PASPP-----PAASPPPGSPPPASPPPASGSASPPPASP---PPT 116
++ P P P SP P+ SP S P SP ++ S S P SP P +
Sbjct: 1565 YSTSPAYMPSSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSATSPSYSPTSPSYSPTS 1624
Query: 117 RSESQSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPV-PSNGTTD 175
S S +SP + P S SP P S P SP S +P PS T
Sbjct: 1625 PSYSPTSPSY----SPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTS 1680
Query: 176 SRDTKWAPPSNPGSPPSPSTSQSGTPSTPNENSSPNELSPPSNSKSPTSKSSPEESSSSS 235
+ +P +P SP TS S +P++P+ + + SP S S SPTS S S S S
Sbjct: 1681 PSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYS 1740
Query: 236 HSNSKKTPTSSS 247
++ +PTS S
Sbjct: 1741 PTSPSYSPTSPS 1752
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 6e-18
Identities = 51/249 (20%), Positives = 97/249 (38%), Gaps = 61/249 (24%)
Query: 358 ITNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHR 416
+ ++ +G G FG V + ++ GK A+K++ + R E++I+ + H
Sbjct: 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ---DPRYKNR-ELDIMKVLDHV 60
Query: 417 HLVSL--VGYCISEKNRL------------------------------------LIYEFV 438
+++ L Y ++ +I E+V
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 439 PNN--NLEHHLHGKGQPVLEWTKRVKIAL-GAAKGLAYLHEDCHPKIIHRDIKSANILVD 495
P+ + G+ + + I + + + ++H I HRDIK N+LV+
Sbjct: 121 PDTLHKVLKSFIRSGRSIPM--NLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVN 175
Query: 496 DE-FEAQVADFGLAKLNDTTQTHVS---TRVMGTFGYLAPE-YASSGKLTDRSDVFSFGV 550
+ ++ DFG AK ++ V+ +R Y APE + + T D++S G
Sbjct: 176 SKDNTLKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPELMLGATEYTPSIDLWSIGC 230
Query: 551 VLLELITGR 559
V ELI G+
Sbjct: 231 VFGELILGK 239
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 7e-18
Identities = 62/211 (29%), Positives = 94/211 (44%), Gaps = 33/211 (15%)
Query: 367 VIGEGGFGCVY----KGNLPEGKVVAVKQLKSGSGQGEREF---RAEVEIISR-VHHRHL 418
VIG+G FG V K AVK L+ + ++E +E ++ + V H L
Sbjct: 45 VIGKGSFGKVLLARHKAE---EVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFL 101
Query: 419 VSLVGYCISEKNRL-LIYEFVPNNNLEHHLHGKGQPVLEWTK--RVKIALGAAKGLAYLH 475
V L + ++L + +++ L +HL + + + +IA L YLH
Sbjct: 102 VGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASA----LGYLH 156
Query: 476 EDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLN----DTTQTHVSTRVMGTFGYLAP 531
I++RD+K NIL+D + + DFGL K N TT T GT YLAP
Sbjct: 157 SL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFC-----GTPEYLAP 208
Query: 532 EYASSGKLTDRS-DVFSFGVVLLELITGRKP 561
E + DR+ D + G VL E++ G P
Sbjct: 209 EVL-HKQPYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 7e-18
Identities = 64/288 (22%), Positives = 114/288 (39%), Gaps = 45/288 (15%)
Query: 286 RGRRRRRDAYATHYMPPPNNFNEKTVDTYYGSQTPQMHSYGSQRGVGYHGGGPDSGVLGG 345
R +RR + P + N P+ + +G PD
Sbjct: 32 LNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWA---A 88
Query: 346 SKSFFTYEELMEITNGFARENVIGEGGFGCVYKG-NLPEGKVVAVK-------QLKSGSG 397
+K F+ + + VIG G V + + G AVK +L
Sbjct: 89 AKEFYQKYDPKD---------VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQL 139
Query: 398 QGERE-FRAEVEIISRVH-HRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVL 455
+ RE R E I+ +V H H+++L+ S L+++ + L +L K
Sbjct: 140 EEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVA--- 196
Query: 456 EWTKR-----VKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKL 510
+++ ++ L A +++LH + I+HRD+K NIL+DD + +++DFG +
Sbjct: 197 -LSEKETRSIMRSLLEA---VSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCH 249
Query: 511 NDTTQTHVSTRVMGTFGYLAPE------YASSGKLTDRSDVFSFGVVL 552
+ + + GT GYLAPE + D+++ GV+L
Sbjct: 250 LEPGEK-LRELC-GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 48/206 (23%), Positives = 83/206 (40%), Gaps = 20/206 (9%)
Query: 365 ENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRV-HHRHLVSLV 422
+ V+G G G V + + G+ A+K L + R EV+ + H+V ++
Sbjct: 34 KQVLGLGVNGKVLECFHRRTGQKCALKLLYD-----SPKARQEVDHHWQASGGPHIVCIL 88
Query: 423 GYC----ISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDC 478
++ L+I E + L + +G + +I + +LH
Sbjct: 89 DVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH- 147
Query: 479 HPKIIHRDIKSANILVDDEFEA---QVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYAS 535
I HRD+K N+L + + ++ DFG AK + T T Y+APE
Sbjct: 148 --NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPC-YTPYYVAPEVLG 202
Query: 536 SGKLTDRSDVFSFGVVLLELITGRKP 561
K D++S GV++ L+ G P
Sbjct: 203 PEKYDKSCDMWSLGVIMYILLCGFPP 228
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 1e-17
Identities = 62/211 (29%), Positives = 92/211 (43%), Gaps = 33/211 (15%)
Query: 367 VIGEGGFGCVY----KGNLPEGKVVAVKQLKSGSGQGEREF---RAEVEIISRV-HHRHL 418
V+G+G FG V K G + AVK LK + + E I+S +H L
Sbjct: 30 VLGKGSFGKVMLARVKET---GDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFL 86
Query: 419 VSLVGYCISEKNRL-LIYEFVPNNNLEHHLHGKGQPVLEWTK--RVKIALGAAKGLAYLH 475
L C +RL + EFV +L H+ + + +I L +LH
Sbjct: 87 TQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISA----LMFLH 141
Query: 476 EDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLN----DTTQTHVSTRVMGTFGYLAP 531
+ II+RD+K N+L+D E ++ADFG+ K TT T GT Y+AP
Sbjct: 142 DK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFC-----GTPDYIAP 193
Query: 532 EYASSGKLTDRS-DVFSFGVVLLELITGRKP 561
E L + D ++ GV+L E++ G P
Sbjct: 194 EIL-QEMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 2e-17
Identities = 66/285 (23%), Positives = 103/285 (36%), Gaps = 93/285 (32%)
Query: 362 FAREN-----VIGEGGFGCVYKGNL------PEGKVVAVKQLKSGSGQGER-EFRAEVEI 409
F R+ +G G FG V + + + VAVK LK G+ E +E++I
Sbjct: 19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI 78
Query: 410 ISRV-HHRHLVSLVGYCISEKNRL-LIYEFVPNNNLEHHLHGK-GQPVLEWTKRVKIALG 466
+ + HH ++V+L+G C L +I EF NL +L K + V TK + G
Sbjct: 79 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQG 138
Query: 467 ------------------------------AAKGLAYLHEDCHPKIIHRDIKSANILVDD 496
K L+ + E+ P+ +++D + L+
Sbjct: 139 KDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLIC- 197
Query: 497 EFEAQVA--------------------------------DFGLAKL---NDTTQTHVSTR 521
+ QVA DFGLA+ + R
Sbjct: 198 -YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 256
Query: 522 V----MGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKP 561
+ M APE T +SDV+SFGV+L E+ + G P
Sbjct: 257 LPLKWM------APETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 2e-17
Identities = 52/217 (23%), Positives = 87/217 (40%), Gaps = 38/217 (17%)
Query: 368 IGEGGFGCVYKG-NLPEGKVVAVKQLK---------SGSGQGEREFRAEVEIISRVHHRH 417
+G G FG V+ + + K V VK +K + + E+ I+SRV H +
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTL-EIAILSRVEHAN 90
Query: 418 LVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPV---LEWTKRVKIALGAAK----- 469
++ ++ ++ L+ E HG G + ++ R+ L +
Sbjct: 91 IIKVLDIFENQGFFQLVMEK----------HGSGLDLFAFIDRHPRLDEPLASYIFRQLV 140
Query: 470 -GLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGY 528
+ YL IIHRDIK NI++ ++F ++ DFG A + + GT Y
Sbjct: 141 SAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSA--AYLERGKLFYTFCGTIEY 195
Query: 529 LAPEYASSGKLTD--RSDVFSFGVVLLELITGRKPVD 563
APE G +++S GV L L+ P
Sbjct: 196 CAPEVL-MGNPYRGPELEMWSLGVTLYTLVFEENPFC 231
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 33/211 (15%)
Query: 367 VIGEGGFGCVY----KGNLPEGKVVAVKQLKSGSGQGEREF---RAEVEIISRV-HHRHL 418
VIG G + V K ++ A++ +K + + + E + + +H L
Sbjct: 59 VIGRGSYAKVLLVRLKKT---DRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFL 115
Query: 419 VSLVGYCISEKNRL-LIYEFVPNNNLEHHLHGKGQPVLEWTK--RVKIALGAAKGLAYLH 475
V L C ++RL + E+V +L H+ + + E + +I+L L YLH
Sbjct: 116 VGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA----LNYLH 170
Query: 476 EDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLN----DTTQTHVSTRVMGTFGYLAP 531
E II+RD+K N+L+D E ++ D+G+ K DTT T GT Y+AP
Sbjct: 171 ER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-----FCGTPNYIAP 222
Query: 532 EYASSGKLTDRS-DVFSFGVVLLELITGRKP 561
E G+ S D ++ GV++ E++ GR P
Sbjct: 223 EIL-RGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 3e-17
Identities = 53/231 (22%), Positives = 98/231 (42%), Gaps = 34/231 (14%)
Query: 347 KSFFTYE---ELMEITNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLK---SGSGQG 399
+F++ E + + IG G G V + + VA+K+L
Sbjct: 9 NNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA 68
Query: 400 EREFRAEVEIISRVHHRHLVSLVGYCISEKNRL------LIYEFVPNNNLEHHLHGKGQP 453
+R +R E+ ++ V+H++++ L+ +K+ ++ E + N L +
Sbjct: 69 KRAYR-ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LCQVIQ---ME 123
Query: 454 VLEWTKRVKI--ALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLN 511
+ + L G+ +LH IIHRD+K +NI+V + ++ DFGLA+
Sbjct: 124 LDHERMSYLLYQML---CGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 177
Query: 512 DTTQT---HVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGR 559
T+ +V TR Y APE + D++S G ++ E+I G
Sbjct: 178 GTSFMMTPYVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 5e-17
Identities = 59/232 (25%), Positives = 104/232 (44%), Gaps = 36/232 (15%)
Query: 347 KSFFTYE---ELMEITNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLK---SGSGQG 399
F+ E E+ + +G G +G V + G VA+K+L
Sbjct: 9 SGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFA 68
Query: 400 EREFRAEVEIISRVHHRHLVSLVGYCISEKNRL------LIYEFVPNNNLEHHLHG--KG 451
+R +R E+ ++ + H +++ L+ ++ L+ F + L K
Sbjct: 69 KRAYR-ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPF-----MGTDLGKLMKH 122
Query: 452 QPVLEWTKRVKI--ALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK 509
+ + E + + L KGL Y+H IIHRD+K N+ V+++ E ++ DFGLA+
Sbjct: 123 EKLGEDRIQFLVYQML---KGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR 176
Query: 510 LNDTTQT-HVSTRVMGTFGYLAPEYA-SSGKLTDRSDVFSFGVVLLELITGR 559
D+ T +V TR Y APE + + T D++S G ++ E+ITG+
Sbjct: 177 QADSEMTGYVVTRW-----YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 9e-17
Identities = 53/213 (24%), Positives = 93/213 (43%), Gaps = 26/213 (12%)
Query: 367 VIGEGGFGCVYKG-NLPEGKVVAVKQLK-------SGSGQGEREFRAEVEIISRVH---- 414
++G+GGFG V+ G L + VA+K + S EV ++ +V
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL-EVALLWKVGAGGG 96
Query: 415 HRHLVSLVGYCISEKNRLLIYEF-VPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAY 473
H ++ L+ + +++ +L+ E +P +L ++ KG P+ E R + +
Sbjct: 97 HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSR-CFFGQVVAAIQH 154
Query: 474 LHEDCHPKIIHRDIKSANILVDDE-FEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPE 532
H ++HRDIK NIL+D A++ DFG L GT Y PE
Sbjct: 155 CHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD---GTRVYSPPE 208
Query: 533 YASSGKLTD--RSDVFSFGVVLLELITGRKPVD 563
+ S + V+S G++L +++ G P +
Sbjct: 209 WI-SRHQYHALPATVWSLGILLYDMVCGDIPFE 240
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 58/232 (25%), Positives = 105/232 (45%), Gaps = 36/232 (15%)
Query: 347 KSFFTYE---ELMEITNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLK---SGSGQG 399
+F+ E + E+ + + +G G +G V + G VAVK+L
Sbjct: 13 PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 72
Query: 400 EREFRAEVEIISRVHHRHLVSLVGYCISEKNRL------LIYEFVPNNNLEHHLHG--KG 451
+R +R E+ ++ + H +++ L+ ++ L+ + L+ K
Sbjct: 73 KRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL-----MGADLNNIVKC 126
Query: 452 QPVLEWTKRVKI--ALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK 509
Q + + + I L +GL Y+H IIHRD+K +N+ V+++ E ++ DFGLA+
Sbjct: 127 QKLTDDHVQFLIYQIL---RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 180
Query: 510 LNDTTQT-HVSTRVMGTFGYLAPEYA-SSGKLTDRSDVFSFGVVLLELITGR 559
T +V+TR Y APE + D++S G ++ EL+TGR
Sbjct: 181 HTADEMTGYVATRW-----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 82.4 bits (203), Expect = 2e-16
Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 31/210 (14%)
Query: 367 VIGEGGFGCV----YKGNLPEGKVVAVKQLKSGSGQGEREF---RAEVEIISRV-HHRHL 418
V+G+G FG V KG ++ AVK LK + + E +++ L
Sbjct: 348 VLGKGSFGKVMLSERKGT---DELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFL 404
Query: 419 VSLVGYCISEKNRL-LIYEFVPNNNLEHHLHGKGQPVLEWTK--RVKIALGAAKGLAYLH 475
L C +RL + E+V +L +H+ G+ +IA+G L +L
Sbjct: 405 TQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIG----LFFLQ 459
Query: 476 EDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLN----DTTQTHVSTRVMGTFGYLAP 531
II+RD+K N+++D E ++ADFG+ K N TT+T GT Y+AP
Sbjct: 460 SK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC-----GTPDYIAP 511
Query: 532 EYASSGKLTDRSDVFSFGVVLLELITGRKP 561
E + D ++FGV+L E++ G+ P
Sbjct: 512 EIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 7e-16
Identities = 53/229 (23%), Positives = 99/229 (43%), Gaps = 30/229 (13%)
Query: 347 KSFFTYE---ELMEITNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLK---SGSGQG 399
F++ E + + IG G G V + + VA+K+L
Sbjct: 46 NQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA 105
Query: 400 EREFRAEVEIISRVHHRHLVSLVGYCISEKNRL------LIYEFVPNNNLEHHLHGKGQP 453
+R +R E+ ++ V+H++++SL+ +K L+ E ++ +L Q
Sbjct: 106 KRAYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL-----MDANLCQVIQM 159
Query: 454 VLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDT 513
L+ + + G+ +LH IIHRD+K +NI+V + ++ DFGLA+ T
Sbjct: 160 ELDHERMSYLLYQMLCGIKHLH-SAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216
Query: 514 TQT---HVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGR 559
+ +V TR Y APE + D++S G ++ E++ +
Sbjct: 217 SFMMTPYVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 3e-15
Identities = 52/223 (23%), Positives = 99/223 (44%), Gaps = 37/223 (16%)
Query: 357 EITNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLK--SGSGQGEREFRAEVEIISRV 413
++ + + IGEG +G V + VA+K++ +R R E++I+ R
Sbjct: 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRF 82
Query: 414 HHRHLVSLVGYCISEKNRL-----LIYEFVPNNNLEHHLHG--KGQPVLEWTKRVKI--A 464
H +++ + + ++ + +E L+ K Q + +
Sbjct: 83 RHENIIGINDIIRAPTIEQMKDVYIVQDL-----METDLYKLLKTQHLSNDHICYFLYQI 137
Query: 465 LGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTH------- 517
L +GL Y+H ++HRD+K +N+L++ + ++ DFGLA++ D H
Sbjct: 138 L---RGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 191
Query: 518 VSTRVMGTFGYLAPEYA-SSGKLTDRSDVFSFGVVLLELITGR 559
V+TR Y APE +S T D++S G +L E+++ R
Sbjct: 192 VATR-----WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 3e-15
Identities = 52/206 (25%), Positives = 85/206 (41%), Gaps = 19/206 (9%)
Query: 365 ENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRV-HHRHLVSLV 422
V+G G G V + N + A+K L+ + R EVE+ R H+V +V
Sbjct: 67 SQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIV 121
Query: 423 GYC----ISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDC 478
K L++ E + L + +G + +I + + YLH
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI- 180
Query: 479 HPKIIHRDIKSANILVDDEFEA---QVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYAS 535
I HRD+K N+L + ++ DFG AK + + ++T T Y+APE
Sbjct: 181 --NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPC-YTPYYVAPEVLG 236
Query: 536 SGKLTDRSDVFSFGVVLLELITGRKP 561
K D++S GV++ L+ G P
Sbjct: 237 PEKYDKSCDMWSLGVIMYILLCGYPP 262
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 3e-15
Identities = 50/234 (21%), Positives = 86/234 (36%), Gaps = 56/234 (23%)
Query: 368 IGEGGFGCVYKG------NLPEGKVVAVKQLKSGSGQGEREFR-----AEVEIISRVHHR 416
IG+GGFGC+Y ++ VK S +G E + A+ E I +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 417 HLVSLVG-----YCISEKNRLLIYEFV------PNNNLEHHLHGKGQP-----VLEWTKR 460
+ +G Y F+ + L+ + VL
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSD--LQKIYEANAKRFSRKTVL----- 155
Query: 461 VKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQV--ADFGLAK--LNDTTQT 516
+++L L Y+HE +H DIK++N+L++ + QV D+GLA +
Sbjct: 156 -QLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHK 211
Query: 517 HVSTR----VMGTFGYLAPEYAS----SGK-LTDRSDVFSFGVVLLELITGRKP 561
+ GT E+ S +G + R D+ G +++ +TG P
Sbjct: 212 AYAADPKRCHDGT-----IEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 4e-15
Identities = 54/234 (23%), Positives = 104/234 (44%), Gaps = 50/234 (21%)
Query: 357 EITNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQL---KSGSGQGEREFRAEVEIISR 412
++ + + +G GG G V+ + K VA+K++ S + R E++II R
Sbjct: 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVK--HALR-EIKIIRR 64
Query: 413 VHHRHLVSLVGYCISEKNRL--------------LIYEFVPNNNLEHHLHG--KGQPVLE 456
+ H ++V + ++L ++ E+ +E L + P+LE
Sbjct: 65 LDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEY-----METDLANVLEQGPLLE 119
Query: 457 WTKRVKI--ALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEF-EAQVADFGLAKLNDT 513
R+ + L +GL Y+H ++HRD+K AN+ ++ E ++ DFGLA++ D
Sbjct: 120 EHARLFMYQLL---RGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDP 173
Query: 514 TQTH-------VSTRVMGTFGYLAPE-YASSGKLTDRSDVFSFGVVLLELITGR 559
+H + T+ Y +P S T D+++ G + E++TG+
Sbjct: 174 HYSHKGHLSEGLVTK-----WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 6e-15
Identities = 50/230 (21%), Positives = 93/230 (40%), Gaps = 54/230 (23%)
Query: 358 ITNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRA---EVEIISRV 413
+ + +++IG+G FG V K + E + VA+K +K+ + EV ++ +
Sbjct: 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELM 107
Query: 414 HHR------HLVSLVGY-------CIS-EKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTK 459
+ ++V L + C+ E +Y+ + N N +G
Sbjct: 108 NKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNF------RGVS----LN 157
Query: 460 RVK-IALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQ--VADFGLA-KLNDTTQ 515
+ A L +L IIH D+K NIL+ + + + DFG + +L
Sbjct: 158 LTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY 216
Query: 516 THVSTRVMGTFGYLAPE------YASSGKLTDRSDVFSFGVVLLELITGR 559
++ +R F Y +PE Y + D++S G +L+E+ TG
Sbjct: 217 QYIQSR----F-YRSPEVLLGMPYDLA------IDMWSLGCILVEMHTGE 255
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 7e-15
Identities = 48/234 (20%), Positives = 87/234 (37%), Gaps = 68/234 (29%)
Query: 367 VIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRA---EVEIISRVH-------- 414
+G G F V+ ++ VA+K ++ + A E++++ RV+
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKED 81
Query: 415 ---HRHLVSLVGY-----------CIS-EKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTK 459
H++ L+ + + E + + +G P+
Sbjct: 82 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE------HRGIPL----I 131
Query: 460 RVK-IALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQ------VADFGLA-KLN 511
VK I+ GL Y+H C IIH DIK N+L++ + +AD G A +
Sbjct: 132 YVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD 189
Query: 512 DTTQTHVSTRVMGTFGYLAPE------YASSGKLTDRSDVFSFGVVLLELITGR 559
+ + TR Y +PE + +D++S ++ ELITG
Sbjct: 190 EHYTNSIQTRE-----YRSPEVLLGAPWGCG------ADIWSTACLIFELITGD 232
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 5e-14
Identities = 57/230 (24%), Positives = 104/230 (45%), Gaps = 44/230 (19%)
Query: 357 EITNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLK--SGSGQGEREFRAEVEIISRV 413
I++ F ++++GEG +G V + P G++VA+K+++ R R E++I+
Sbjct: 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHF 66
Query: 414 HHRHLVSLVGYCISEKNRL-----LIYEFVPNNNLEHHLHG--KGQPVLEWTKRVKI--A 464
H +++++ + +I E ++ LH Q + + + I
Sbjct: 67 KHENIITIFNIQRPDSFENFNEVYIIQEL-----MQTDLHRVISTQMLSDDHIQYFIYQT 121
Query: 465 LGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQT-------- 516
L + + LH +IHRD+K +N+L++ + +V DFGLA++ D +
Sbjct: 122 L---RAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQ 175
Query: 517 ------HVSTRVMGTFGYLAPEY-ASSGKLTDRSDVFSFGVVLLELITGR 559
V+TR Y APE +S K + DV+S G +L EL R
Sbjct: 176 QSGMVEFVATR-----WYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 6e-14
Identities = 51/228 (22%), Positives = 85/228 (37%), Gaps = 47/228 (20%)
Query: 368 IGEGGFGCVYKG-NLPEGKVVAVKQLK---SGSGQGEREFR-----AEVEIISRVHHRHL 418
IG GGFG +Y + + A +K +G E + A+ + I + R
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 419 VSLVG-----YCISEKNRLLIYEFV------PNNNLEHHLHGKGQPVLEWTKRV-KIALG 466
+ +G + + Y F+ + L+ G V ++ +
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERLGID--LQKISGQNGTFKK---STVLQLGIR 159
Query: 467 AAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQV--ADFGLAK--LNDTTQTHVSTRV 522
L Y+HE+ +H DIK+AN+L+ + QV AD+GL+ +
Sbjct: 160 MLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENP 216
Query: 523 ----MGTFGYLAPEYAS----SGK-LTDRSDVFSFGVVLLELITGRKP 561
GT E+ S G L+ RSDV G +L + G+ P
Sbjct: 217 RKGHNGT-----IEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 52/257 (20%), Positives = 100/257 (38%), Gaps = 42/257 (16%)
Query: 344 GGSKSFFTYEELMEITNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLK---SGSGQG 399
G +F + + + + + +++IG G +G VY + K VA+K++
Sbjct: 10 GRENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDC 69
Query: 400 EREFRAEVEIISRVHHRHLVSLVGYCISEKNRL-----LIYEFVPNNNLEHHLHGKGQPV 454
+R R E+ I++R+ +++ L I + ++ E ++ L L +
Sbjct: 70 KRILR-EITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSD-L-KKLFKTPIFL 126
Query: 455 LEWTKRVKI--ALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLA-KLN 511
E + + L G ++HE IIHRD+K AN L++ + +V DFGLA +N
Sbjct: 127 TEEHIKTILYNLL---LGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180
Query: 512 DTTQTHVSTRVMGTFGYLAPEYASSGKLTD-------RS--------------DVFSFGV 550
T++ + +LT R+ D++S G
Sbjct: 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGC 240
Query: 551 VLLELITGRKPVDPTQP 567
+ EL+ +
Sbjct: 241 IFAELLNMLQSHINDPT 257
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 47/229 (20%), Positives = 91/229 (39%), Gaps = 46/229 (20%)
Query: 368 IGEGGFGCVYKG---------NLPEGKVVAVKQLKSGSGQGEREFR--------AEVEII 410
G +Y+ + P+ + ++K L + G+ E +V
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAKPLQVNKW 108
Query: 411 SRVHHRHLV---SLVGYCISEKN-RLLIYEFVPNNNLEHHLHGKGQPVLEWTKRV-KIAL 465
+++ L+ + +G+ + + R L+ + +L+ L + VL + V ++A
Sbjct: 109 KKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLS-ERSVLQVAC 166
Query: 466 GAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQV--ADFGLAKLNDTTQTHVSTR-- 521
L +LHE+ +H ++ + NI VD E ++QV A +G A + HV+
Sbjct: 167 RLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEG 223
Query: 522 ----VMGTFGYLAPEYAS----SGK-LTDRSDVFSFGVVLLELITGRKP 561
G E+ S G + RSD+ S G +L+ + G P
Sbjct: 224 SRSPHEGD-----LEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 5e-13
Identities = 54/222 (24%), Positives = 94/222 (42%), Gaps = 58/222 (26%)
Query: 367 VIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRA----EVEIISRVHHR----- 416
VIG+G FG V K + + VA+K +++ E+ F E+ I+ + +
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRN-----EKRFHRQAAEEIRILEHLRKQDKDNT 158
Query: 417 -HLVSLVGY-------CIS-EKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVK-IALG 466
+++ ++ C++ E + +YE + N +G V+ A
Sbjct: 159 MNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKF------QGFS----LPLVRKFAHS 208
Query: 467 AAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQ--VADFGLA-KLNDTTQTHVSTRVM 523
+ L LH+ +IIH D+K NIL+ + + V DFG + + T++ +R
Sbjct: 209 ILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSR-- 263
Query: 524 GTFGYLAPE------YASSGKLTDRSDVFSFGVVLLELITGR 559
F Y APE Y D++S G +L EL+TG
Sbjct: 264 --F-YRAPEVILGARYGMP------IDMWSLGCILAELLTGY 296
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 6e-13
Identities = 57/219 (26%), Positives = 92/219 (42%), Gaps = 44/219 (20%)
Query: 368 IGEGGFGCVYKG-NLPEGKVVAVKQ--LKSGSGQGEREFRAEVEIISRVHHRHLVSLVGY 424
IGEG FG +++G NL + VA+K +S + Q E+R + + V Y
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYR----TYKLLAGCTGIPNVYY 73
Query: 425 CISE-KNRLLIYEFV-PNNNLEHHLHGKGQPVLEWTKR---VKIALGAAKGLAYLHEDCH 479
E + +L+ + + P+ LE +L+ R VK AAK + + H
Sbjct: 74 FGQEGLHNVLVIDLLGPS--LED--------LLDLCGRKFSVKTVAMAAKQMLARVQSIH 123
Query: 480 PK-IIHRDIKSANILVDDEFEAQ-----VADFGLAK--LNDTTQTHVSTR----VMGTFG 527
K +++RDIK N L+ V DFG+ K + T+ H+ R + GT
Sbjct: 124 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT-- 181
Query: 528 YLAPEYAS----SGK-LTDRSDVFSFGVVLLELITGRKP 561
Y S G+ + R D+ + G V + + G P
Sbjct: 182 ---ARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 52/266 (19%), Positives = 96/266 (36%), Gaps = 53/266 (19%)
Query: 345 GSKSFFTYEELMEITNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLK---SGSGQGE 400
+ S +I + + ++IG G +G V + + E +VVA+K++ +
Sbjct: 38 PTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCK 97
Query: 401 REFRAEVEIISRVHHRHLVSLVGYCISEKNRL-----LIYEFVPNNNLEHHLH---GKGQ 452
R R E+ I++R++H H+V ++ I + ++ E +
Sbjct: 98 RILR-EIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEI-----ADSDFKKLFRTPV 151
Query: 453 PVLEWTKRVKI--ALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLA-- 508
+ E + + L G+ Y+H I+HRD+K AN LV+ + +V DFGLA
Sbjct: 152 YLTELHIKTLLYNLL---VGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLART 205
Query: 509 ----KLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTD-------RS-------------- 543
+ ++ +LT R+
Sbjct: 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAI 265
Query: 544 DVFSFGVVLLELITGRKPVDPTQPLG 569
DV+S G + EL+ K
Sbjct: 266 DVWSIGCIFAELLNMIKENVAYHADR 291
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 69.0 bits (168), Expect = 2e-12
Identities = 27/102 (26%), Positives = 35/102 (34%), Gaps = 2/102 (1%)
Query: 59 NNSTTPAASPPPASPPPASPPPASPPPAAS-PPPGSPPPASPPPA-SGSASPPPASPPPT 116
++S P + AS AA PP P PA PPP + +PP +
Sbjct: 10 HSSGLVPRGSHMVIPSASVTSAASDFLAALHPPVTVPDPAPPPPPAPAAGNPPDTVTGDS 69
Query: 117 RSESQSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPP 158
+ P G G S P P P AS PP +
Sbjct: 70 VLQRILRGPTGPGTTSLAPAVRYGRQPGPEAPASAPPAAGRA 111
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 65.9 bits (160), Expect = 2e-11
Identities = 26/128 (20%), Positives = 35/128 (27%), Gaps = 2/128 (1%)
Query: 30 PPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPAASP 89
+ V P + + P P PA PPP +P +PP +
Sbjct: 8 HHHSSGLVPRGSHMVIPSASVTSAASDFLAALHPPVTVPDPAPPPPPAPAAGNPPDTVTG 67
Query: 90 PPGSPPPASPPPASGSASPPPASPPPT--RSESQSSPPPGDGGASPPPEQSKNSPPAPPG 147
P G+ S PA E+ +S PP G A P P P
Sbjct: 68 DSVLQRILRGPTGPGTTSLAPAVRYGRQPGPEAPASAPPAAGRAVPGLYHHPVPEPDPVR 127
Query: 148 QASTPPDS 155
Sbjct: 128 VEEVSRRI 135
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 61.7 bits (149), Expect = 3e-10
Identities = 26/124 (20%), Positives = 34/124 (27%)
Query: 45 TPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASG 104
+ G + S PP P PA PPP P +G
Sbjct: 8 HHHSSGLVPRGSHMVIPSASVTSAASDFLAALHPPVTVPDPAPPPPPAPAAGNPPDTVTG 67
Query: 105 SASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQ 164
+ PT + S P G P PE ++PPA P P +
Sbjct: 68 DSVLQRILRGPTGPGTTSLAPAVRYGRQPGPEAPASAPPAAGRAVPGLYHHPVPEPDPVR 127
Query: 165 GNPV 168
V
Sbjct: 128 VEEV 131
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 59.0 bits (142), Expect = 3e-09
Identities = 28/123 (22%), Positives = 35/123 (28%), Gaps = 3/123 (2%)
Query: 2 ANSAETPGPPVANNASSGLGERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNS 61
+S P S+ + + A P P P PA N +S
Sbjct: 10 HSSGLVPRGSHMVIPSASVTSAASDFLAALHPPVTVPDPAPPPPPAPAAGNPPDTVTGDS 69
Query: 62 TTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQ 121
P P S PA PG PAS PPA+G A P P +
Sbjct: 70 VLQRILRGPTGPGTTSLAPAVRYG---RQPGPEAPASAPPAAGRAVPGLYHHPVPEPDPV 126
Query: 122 SSP 124
Sbjct: 127 RVE 129
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 56.3 bits (135), Expect = 2e-08
Identities = 12/102 (11%), Positives = 24/102 (23%), Gaps = 3/102 (2%)
Query: 72 SPPPASPPPASPPP--AASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDG 129
S + P + P + ++ + PP P P +
Sbjct: 3 SSHHHHHHSSGLVPRGSHMVIPSASVTSAASDFLAALHPPVTVPDPAPPPPPAPAAGNPP 62
Query: 130 GASPPPEQSKNSPPAPPG-QASTPPDSPPPGIQSNQGNPVPS 170
+ P G ++ + G Q P +
Sbjct: 63 DTVTGDSVLQRILRGPTGPGTTSLAPAVRYGRQPGPEAPASA 104
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 56.3 bits (135), Expect = 2e-08
Identities = 19/123 (15%), Positives = 27/123 (21%), Gaps = 6/123 (4%)
Query: 88 SPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPPG 147
S + P P AS S+ ++ P P P P
Sbjct: 3 SSHHHHHHSSGLVPRGSHMVIPSASVTSAASDFLAALHPPVTVPDPAPPPPPAPAAGNPP 62
Query: 148 QASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPSNPGSPPSPSTSQSGTPSTPNEN 207
T + P+ T S PG S + + P
Sbjct: 63 DTVTGDSVLQRIL------RGPTGPGTTSLAPAVRYGRQPGPEAPASAPPAAGRAVPGLY 116
Query: 208 SSP 210
P
Sbjct: 117 HHP 119
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 49.8 bits (118), Expect = 2e-06
Identities = 17/118 (14%), Positives = 26/118 (22%), Gaps = 7/118 (5%)
Query: 77 SPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPE 136
S + P G P AS +++ + P P A
Sbjct: 3 SSHHHHHHSSGLVPRG--SHMVIPSASVTSAASDFLAALHPPVTVPDPAPPPPPAPAAGN 60
Query: 137 QSKNSPPAPPGQASTPPDSPPP-GIQSNQGNPVPSNGTTDSRDTKWAPPSNPGSPPSP 193
P G + P G + P G + + P G
Sbjct: 61 ----PPDTVTGDSVLQRILRGPTGPGTTSLAPAVRYGRQPGPEAPASAPPAAGRAVPG 114
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 3e-12
Identities = 57/213 (26%), Positives = 88/213 (41%), Gaps = 34/213 (15%)
Query: 368 IGEGGFGCVYKG-NLPEGKVVAVKQ--LKSGSGQGEREFRAEVEIISRVHHRHLVSLVGY 424
IG G FG +Y G ++ G+ VA+K +K+ Q E + I + + + +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESK----IYKMMQGGVGIPTIRW 72
Query: 425 CISE-KNRLLIYEFV-PNNNLEHHLHGKGQPVLEWTKR---VKIALGAAKGLAYLHEDCH 479
C +E +++ E + P+ LE + + R +K L A + E H
Sbjct: 73 CGAEGDYNVMVMELLGPS--LED--------LFNFCSRKFSLKTVLLLADQMISRIEYIH 122
Query: 480 PK-IIHRDIKSANILV---DDEFEAQVADFGLAK--LNDTTQTHVSTR----VMGTFGYL 529
K IHRD+K N L+ + DFGLAK + T H+ R + GT Y
Sbjct: 123 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY- 181
Query: 530 APEYASSGK-LTDRSDVFSFGVVLLELITGRKP 561
A G + R D+ S G VL+ G P
Sbjct: 182 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 54/235 (22%), Positives = 106/235 (45%), Gaps = 44/235 (18%)
Query: 357 EITNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLK---SGSGQGEREFRAEVEIISR 412
+ + +G+G +G V+K + G+VVAVK++ S +R FR E+ I++
Sbjct: 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR-EIMILTE 64
Query: 413 VH-HRHLVSLVGYCISEKNR--LLIYEFVPNNNLEHHLHG--KGQPVLEWTKRVKI--AL 465
+ H ++V+L+ ++ +R L++++ +E LH + + K+ + +
Sbjct: 65 LSGHENIVNLLNVLRADNDRDVYLVFDY-----METDLHAVIRANILEPVHKQYVVYQLI 119
Query: 466 GAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGT 525
K + YLH ++HRD+K +NIL++ E +VADFGL++ + + +
Sbjct: 120 ---KVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSI 173
Query: 526 FGYLAPEYASSGKLTD-------RS--------------DVFSFGVVLLELITGR 559
LTD R+ D++S G +L E++ G+
Sbjct: 174 NENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 8e-12
Identities = 53/217 (24%), Positives = 83/217 (38%), Gaps = 40/217 (18%)
Query: 368 IGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCI 426
IG G FG + G NL + VA+K S + E ++ + V Y
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGIPQVYYFG 74
Query: 427 SE-KNRLLIYEFV-PNNNLEHHLHGKGQPVLEWTKR---VKIALGAAKGLAYLHEDCHPK 481
K ++ E + P+ LE + + R +K L A L E H K
Sbjct: 75 PCGKYNAMVLELLGPS--LED--------LFDLCDRTFSLKTVLMIAIQLISRMEYVHSK 124
Query: 482 -IIHRDIKSANILVDDEFEAQ-----VADFGLAK--LNDTTQTHVSTR----VMGTFGYL 529
+I+RD+K N L+ + DF LAK ++ T+ H+ R + GT
Sbjct: 125 NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGT---- 180
Query: 530 APEYAS----SGK-LTDRSDVFSFGVVLLELITGRKP 561
Y S GK + R D+ + G + + + G P
Sbjct: 181 -ARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216
|
| >3gdb_A Endo-D, putative uncharacterized protein SPR0440; alpha-beta-barrels, cell WALL, peptidoglycan-anchor, secreted, hydrolase; HET: PGE; 1.87A {Streptococcus pneumoniae} PDB: 2xqx_A Length = 937 | Back alignment and structure |
|---|
Score = 68.1 bits (165), Expect = 8e-12
Identities = 19/181 (10%), Positives = 38/181 (20%), Gaps = 8/181 (4%)
Query: 24 KEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASP 83
EE P TE + + + A +
Sbjct: 21 GEETAVPENSGANTELVSGESEHSTNEAD--------KQNEGEHARENKLEKAEGVATAS 72
Query: 84 PPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPP 143
A+ + + AS + AS + S + P D PE +
Sbjct: 73 ETASPASNEAATTETAEAASAAKPEEKASEVVAETPSAEAKPKSDKETEAKPEATNQGDE 132
Query: 144 APPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPSNPGSPPSPSTSQSGTPST 203
+ P + + + PG+ + ++
Sbjct: 133 SKPAAEANKTEKEVQPDVPKNTEKTLKPKEIKFNSWEELLKWEPGAREDDAINRGSVVLA 192
Query: 204 P 204
Sbjct: 193 S 193
|
| >3gdb_A Endo-D, putative uncharacterized protein SPR0440; alpha-beta-barrels, cell WALL, peptidoglycan-anchor, secreted, hydrolase; HET: PGE; 1.87A {Streptococcus pneumoniae} PDB: 2xqx_A Length = 937 | Back alignment and structure |
|---|
Score = 65.4 bits (158), Expect = 4e-11
Identities = 19/212 (8%), Positives = 38/212 (17%), Gaps = 13/212 (6%)
Query: 22 ERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPA 81
+ + E+T PE S +
Sbjct: 9 GHHHQLENLYFQGEETAVPENSGANTE-------------LVSGESEHSTNEADKQNEGE 55
Query: 82 SPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNS 141
AS + S S ++ + A P ++K
Sbjct: 56 HARENKLEKAEGVATASETASPASNEAATTETAEAASAAKPEEKASEVVAETPSAEAKPK 115
Query: 142 PPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPSNPGSPPSPSTSQSGTP 201
+ + + N D +
Sbjct: 116 SDKETEAKPEATNQGDESKPAAEANKTEKEVQPDVPKNTEKTLKPKEIKFNSWEELLKWE 175
Query: 202 STPNENSSPNELSPPSNSKSPTSKSSPEESSS 233
E+ + N S S+ + + S
Sbjct: 176 PGAREDDAINRGSVVLASRRTGHLVNEKASKE 207
|
| >3gdb_A Endo-D, putative uncharacterized protein SPR0440; alpha-beta-barrels, cell WALL, peptidoglycan-anchor, secreted, hydrolase; HET: PGE; 1.87A {Streptococcus pneumoniae} PDB: 2xqx_A Length = 937 | Back alignment and structure |
|---|
Score = 60.7 bits (146), Expect = 1e-09
Identities = 23/197 (11%), Positives = 46/197 (23%), Gaps = 3/197 (1%)
Query: 59 NNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRS 118
N + P + + + + + +
Sbjct: 16 NLYFQGEETAVPENSGANTELVSGESEHS-TNEADKQNEGEHARENKLEKAEGVATASET 74
Query: 119 ESQSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRD 178
S +S + +K A A TP P +S++ T +
Sbjct: 75 ASPASNEAATTETAEAASAAKPEEKASEVVAETPSAEAKP--KSDKETEAKPEATNQGDE 132
Query: 179 TKWAPPSNPGSPPSPSTSQSGTPSTPNENSSPNELSPPSNSKSPTSKSSPEESSSSSHSN 238
+K A +N T T P ++ + S
Sbjct: 133 SKPAAEANKTEKEVQPDVPKNTEKTLKPKEIKFNSWEELLKWEPGAREDDAINRGSVVLA 192
Query: 239 SKKTPTSSSGHSSDSTK 255
S++T + +S K
Sbjct: 193 SRRTGHLVNEKASKEAK 209
|
| >3gdb_A Endo-D, putative uncharacterized protein SPR0440; alpha-beta-barrels, cell WALL, peptidoglycan-anchor, secreted, hydrolase; HET: PGE; 1.87A {Streptococcus pneumoniae} PDB: 2xqx_A Length = 937 | Back alignment and structure |
|---|
Score = 50.3 bits (119), Expect = 2e-06
Identities = 20/181 (11%), Positives = 46/181 (25%), Gaps = 14/181 (7%)
Query: 87 ASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPP 146
+ S + ++E + + A S+ + PA
Sbjct: 21 GEETAVPENSGANTELVSGESEHSTNEADKQNEGEHARENKLEKAEGVATASETASPASN 80
Query: 147 GQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPSNPGSPPSPSTSQSGTPSTPNE 206
A+T + + + S + S T + P
Sbjct: 81 EAATTETAEAASAAKPEEKAS--------------EVVAETPSAEAKPKSDKETEAKPEA 126
Query: 207 NSSPNELSPPSNSKSPTSKSSPEESSSSSHSNSKKTPTSSSGHSSDSTKGSSSNDDQAII 266
+ +E P + + + P+ ++ + K +S + + DD
Sbjct: 127 TNQGDESKPAAEANKTEKEVQPDVPKNTEKTLKPKEIKFNSWEELLKWEPGAREDDAINR 186
Query: 267 G 267
G
Sbjct: 187 G 187
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 65.7 bits (159), Expect = 1e-11
Identities = 46/344 (13%), Positives = 83/344 (24%), Gaps = 84/344 (24%)
Query: 345 GSKSFFTYEELMEITNGFARENVIGEGGFGCVYKGNLPEGKVVAVKQL--------KSGS 396
K + + T R IGEG FG V++ + VA+K +
Sbjct: 6 SQKGPVPFSHCLP-TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSH 63
Query: 397 GQGEREFRAEVEIISRVH---------HRHLVSLVGYCI--------------------- 426
+ E E+ I + + L
Sbjct: 64 QKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKG 123
Query: 427 ---------SEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHED 477
+ ++ EF + K + I LA
Sbjct: 124 SANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK---LSSLATAKSILHQLTASLAVAEAS 180
Query: 478 CHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAP--EYAS 535
HRD+ N+L+ ++ K + + + G +Y
Sbjct: 181 LR--FEHRDLHWGNVLLKKTSLKKLHYTLNGK----------SSTIPSCGLQVSIIDYTL 228
Query: 536 SGKLTDRSDVFSFGVVLLELITG------------RKPV-DPTQPLGDESLVEWARPVLV 582
S D VF + +L TG +K + S V W +
Sbjct: 229 SRLERDGIVVFCDVSMDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTD 288
Query: 583 RAIETGDLSEIVDPRLEKHYVES--EMFRMI---EAAAACVRHS 621
+ ++ + K E R + +A +
Sbjct: 289 KMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFSSATDLLCQH 332
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 41/157 (26%), Positives = 63/157 (40%), Gaps = 27/157 (17%)
Query: 367 VIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRV-HHRHLVSLVGY 424
V+G G G V + N + A+K L+ + R EVE+ R H+V +V
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDV 79
Query: 425 C----ISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKR-----VKIALGAAKGLAYLH 475
K L++ E + L + +G T+R +K A + YLH
Sbjct: 80 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF--TEREASEIMKSIGEA---IQYLH 134
Query: 476 EDCHPKIIHRDIKSANILVDDEFEA---QVADFGLAK 509
I HRD+K N+L + ++ DFG AK
Sbjct: 135 SI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 64.4 bits (155), Expect = 7e-11
Identities = 22/177 (12%), Positives = 35/177 (19%), Gaps = 3/177 (1%)
Query: 60 NSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSE 119
P +P PA P A S P + P R
Sbjct: 12 RRRPGPPRIAPPKLACRTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRLR 71
Query: 120 SQSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDT 179
P + SP +++ PP + + + S
Sbjct: 72 LSVDEVSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISE---LASCLQ 128
Query: 180 KWAPPSNPGSPPSPSTSQSGTPSTPNENSSPNELSPPSNSKSPTSKSSPEESSSSSH 236
+ S +G TP P E + +
Sbjct: 129 RARELGARVRALKASAQDAGESCTPEAEGRPEEPCGEKAPAYQRFHALAQPGLPGLV 185
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 62.1 bits (149), Expect = 3e-10
Identities = 18/173 (10%), Positives = 36/173 (20%)
Query: 68 PPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPG 127
PP PP SP + + + P + P +
Sbjct: 11 ARRRPGPPRIAPPKLACRTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRL 70
Query: 128 DGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPSNP 187
S P P S + Q + S D+ +
Sbjct: 71 RLSVDEVSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQRA 130
Query: 188 GSPPSPSTSQSGTPSTPNENSSPNELSPPSNSKSPTSKSSPEESSSSSHSNSK 240
+ + + E+ +P P + + + +
Sbjct: 131 RELGARVRALKASAQDAGESCTPEAEGRPEEPCGEKAPAYQRFHALAQPGLPG 183
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 57.4 bits (137), Expect = 9e-09
Identities = 29/178 (16%), Positives = 47/178 (26%), Gaps = 3/178 (1%)
Query: 27 AKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPA 86
A+ P P TP PA S + + PPA+P P +
Sbjct: 11 ARRRPGPPRIAPPKLACRTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRL 70
Query: 87 ASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPP 146
P++P A P P + + PP S + + + +
Sbjct: 71 RLSVDEVSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPH---LTSAQDQDTISELASCL 127
Query: 147 GQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPSNPGSPPSPSTSQSGTPSTP 204
+A S Q + R + P + +Q G P
Sbjct: 128 QRARELGARVRALKASAQDAGESCTPEAEGRPEEPCGEKAPAYQRFHALAQPGLPGLV 185
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 55.9 bits (133), Expect = 3e-08
Identities = 23/178 (12%), Positives = 43/178 (24%), Gaps = 7/178 (3%)
Query: 83 PPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSP 142
P P PP P +P A+ + + P D P + + S
Sbjct: 15 PGPPRIAPPKLACRTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRLRLSV 74
Query: 143 PAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPSNPGSPPSPSTSQSGTPS 202
++ P P P S PP + + S+ +
Sbjct: 75 DEVSSPSTPEAPDIPA-------CPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCL 127
Query: 203 TPNENSSPNELSPPSNSKSPTSKSSPEESSSSSHSNSKKTPTSSSGHSSDSTKGSSSN 260
+ ++++ +PE +K P H+
Sbjct: 128 QRARELGARVRALKASAQDAGESCTPEAEGRPEEPCGEKAPAYQRFHALAQPGLPGLV 185
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 55.1 bits (131), Expect = 5e-08
Identities = 31/176 (17%), Positives = 40/176 (22%), Gaps = 3/176 (1%)
Query: 22 ERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAASP---PPASPPPASP 78
APP A +T SP + PA + PPA
Sbjct: 14 RPGPPRIAPPKLACRTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRLRLS 73
Query: 79 PPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQS 138
P+ P P SP ++P PP S +
Sbjct: 74 VDEVSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQRAREL 133
Query: 139 KNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPSNPGSPPSPS 194
A A +S P + P R A P PG
Sbjct: 134 GARVRALKASAQDAGESCTPEAEGRPEEPCGEKAPAYQRFHALAQPGLPGLVLPYK 189
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 47.0 bits (110), Expect = 2e-05
Identities = 21/155 (13%), Positives = 39/155 (25%)
Query: 105 SASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQ 164
PP PP + SP A PP PP +
Sbjct: 13 RRPGPPRIAPPKLACRTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRLRL 72
Query: 165 GNPVPSNGTTDSRDTKWAPPSNPGSPPSPSTSQSGTPSTPNENSSPNELSPPSNSKSPTS 224
S+ +T A PS + + P + S +
Sbjct: 73 SVDEVSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQRARE 132
Query: 225 KSSPEESSSSSHSNSKKTPTSSSGHSSDSTKGSSS 259
+ + +S ++ ++ T + + G +
Sbjct: 133 LGARVRALKASAQDAGESCTPEAEGRPEEPCGEKA 167
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 46.7 bits (109), Expect = 2e-05
Identities = 20/155 (12%), Positives = 43/155 (27%), Gaps = 1/155 (0%)
Query: 94 PPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPPGQASTPP 153
PP +P P R ++ G + A
Sbjct: 11 ARRRPGPPRIAPPKLACRTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRL 70
Query: 154 DSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPSNPGSPPSPSTSQSGTPSTPNENSSPNEL 213
+ S+ P + + S P + P + + T +E +S +
Sbjct: 71 RLSVDEV-SSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQR 129
Query: 214 SPPSNSKSPTSKSSPEESSSSSHSNSKKTPTSSSG 248
+ ++ K+S +++ S ++ P G
Sbjct: 130 ARELGARVRALKASAQDAGESCTPEAEGRPEEPCG 164
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 44.3 bits (103), Expect = 1e-04
Identities = 27/151 (17%), Positives = 46/151 (30%), Gaps = 4/151 (2%)
Query: 114 PPTRSESQSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGT 173
R PP +P P + PA S PP +Q P
Sbjct: 11 ARRRPGPPRIAPPKLACRTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRL 70
Query: 174 TDSRDTKWAPPSNPGSPPSPSTSQSGTPSTPNENSSPNELSPPSNSKSPTSKSSPEESSS 233
S D S+P +P +P +P + S+P PP + + + E +S
Sbjct: 71 RLSVD----EVSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASC 126
Query: 234 SSHSNSKKTPTSSSGHSSDSTKGSSSNDDQA 264
+ + S+ S + + +
Sbjct: 127 LQRARELGARVRALKASAQDAGESCTPEAEG 157
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 63.2 bits (153), Expect = 1e-10
Identities = 23/141 (16%), Positives = 35/141 (24%), Gaps = 4/141 (2%)
Query: 66 ASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPP 125
A ++ ++ P + P S P SP S +
Sbjct: 2 AHHHHHHVDDDDKMFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSPISTLSS 61
Query: 126 PGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPS 185
P +G P S SP P + P +P G + S + P
Sbjct: 62 PINGMGPPFSVIS--SPMGPHSM--SVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPLG 117
Query: 186 NPGSPPSPSTSQSGTPSTPNE 206
G P+ S
Sbjct: 118 LNGVLKVPAHPSGNMASFTKH 138
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 21/135 (15%), Positives = 31/135 (22%), Gaps = 7/135 (5%)
Query: 59 NNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRS 118
++ + + P + P S P P P P S +
Sbjct: 11 DDDKMFSTQVNSSLTSPTGRGSMAAP---SLHPSLGPGIGSP----GQLHSPISTLSSPI 63
Query: 119 ESQSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRD 178
P P S + P +P S P S+ + P G
Sbjct: 64 NGMGPPFSVISSPMGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPLGLNGVLK 123
Query: 179 TKWAPPSNPGSPPSP 193
P N S
Sbjct: 124 VPAHPSGNMASFTKH 138
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 21/135 (15%), Positives = 29/135 (21%), Gaps = 7/135 (5%)
Query: 67 SPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPP 126
S S + + P P P S P S + P
Sbjct: 12 DDKMFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSPISTLSSPINGMGPPFS 71
Query: 127 GDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPSN 186
P S + P +P S P S+ + P G
Sbjct: 72 VISSPMGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPLGLN-------GVLKV 124
Query: 187 PGSPPSPSTSQSGTP 201
P P S +
Sbjct: 125 PAHPSGNMASFTKHI 139
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 53.6 bits (128), Expect = 1e-07
Identities = 26/146 (17%), Positives = 34/146 (23%), Gaps = 15/146 (10%)
Query: 87 ASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPP 146
S S SP S P G G SP S S + P
Sbjct: 6 HHHVDDDDKMFSTQVNSSLTSPTGRGSMAAPS---LHPSLGPGIGSPGQLHSPISTLSSP 62
Query: 147 GQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPSNPGSPPSPSTSQSGTPSTPNE 206
PP S VP+ P+ S SP S P + +E
Sbjct: 63 INGMGPPFSVISSPMGPHSMSVPT------------TPTLGFSTGSPQLSSPMNPVSSSE 110
Query: 207 NSSPNELSPPSNSKSPTSKSSPEESS 232
+ P + +
Sbjct: 111 DIKPPLGLNGVLKVPAHPSGNMASFT 136
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 25/148 (16%), Positives = 38/148 (25%), Gaps = 14/148 (9%)
Query: 97 ASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSP 156
A S S + P G G + P P P S
Sbjct: 2 AHHHHHHVDDDDKMFSTQVN---SSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSPIST 58
Query: 157 PPGIQSNQGNPVPSNGTTDSRDTKWAPPSNPGSPPSPSTSQSG-TPSTPNENSSPNELSP 215
+ G P + P P S P+T G + +P +S N +S
Sbjct: 59 LSSPINGMGPPFSV----------ISSPMGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSS 108
Query: 216 PSNSKSPTSKSSPEESSSSSHSNSKKTP 243
+ K P + + + N
Sbjct: 109 SEDIKPPLGLNGVLKVPAHPSGNMASFT 136
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 48.9 bits (116), Expect = 4e-06
Identities = 16/100 (16%), Positives = 21/100 (21%)
Query: 47 PPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSA 106
P G +S S P P +SP S + P S
Sbjct: 40 PSLGPGIGSPGQLHSPISTLSSPINGMGPPFSVISSPMGPHSMSVPTTPTLGFSTGSPQL 99
Query: 107 SPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPP 146
S P + G P + S
Sbjct: 100 SSPMNPVSSSEDIKPPLGLNGVLKVPAHPSGNMASFTKHI 139
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 48.6 bits (115), Expect = 6e-06
Identities = 28/156 (17%), Positives = 45/156 (28%), Gaps = 8/156 (5%)
Query: 117 RSESQSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDS 176
D S S +P G+ S S P + G+P + +
Sbjct: 2 AHHHHHHVDDDDKMFSTQVNSS---LTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSPIST 58
Query: 177 RDTKWAPPSNPGSPPSPSTSQSGTPSTPNENSSPNELSPPSNSKSPTSKSSPEESSSSSH 236
+ P N PP S P + + ++P L + S +S +P SS
Sbjct: 59 ----LSSPINGMGPPFSVISSPMGPHSMSVPTTP-TLGFSTGSPQLSSPMNPVSSSEDIK 113
Query: 237 SNSKKTPTSSSGHSSDSTKGSSSNDDQAIIGATAAG 272
S + AI G ++G
Sbjct: 114 PPLGLNGVLKVPAHPSGNMASFTKHICAICGDRSSG 149
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 45.9 bits (108), Expect = 4e-05
Identities = 20/107 (18%), Positives = 26/107 (24%), Gaps = 3/107 (2%)
Query: 45 TPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPP-PAASPP--PGSPPPASPPP 101
A + + G +P P S + PP S P P S + P
Sbjct: 30 RGSMAAPSLHPSLGPGIGSPGQLHSPISTLSSPINGMGPPFSVISSPMGPHSMSVPTTPT 89
Query: 102 ASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPPGQ 148
S P S P S P G + S
Sbjct: 90 LGFSTGSPQLSSPMNPVSSSEDIKPPLGLNGVLKVPAHPSGNMASFT 136
|
| >3pgw_B SM B; protein-RNA complex, U1 snRNA, SM fold, SM core, RRM, splici SNRNPS, splicing factors; HET: DNA; 4.40A {Homo sapiens} PDB: 3cw1_A Length = 231 | Back alignment and structure |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 29/132 (21%), Positives = 35/132 (26%)
Query: 38 ESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPA 97
E P K T GG A PA P P P S
Sbjct: 83 EGPPPKDTGIARVPLAGAAGGPGIGRAAGRGIPAGVPMPQAPAGLAGPVRGVGGPSQQVM 142
Query: 98 SPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPP 157
+P A+ A+ PP G P + P PP PP
Sbjct: 143 TPQGRGTVAAAAAAATASIAGAPTQYPPGRGGPPPPMGRGAPPPGMMGPPPGMRPPMGPP 202
Query: 158 PGIQSNQGNPVP 169
GI +G P+
Sbjct: 203 MGIPPGRGTPMG 214
|
| >3pgw_B SM B; protein-RNA complex, U1 snRNA, SM fold, SM core, RRM, splici SNRNPS, splicing factors; HET: DNA; 4.40A {Homo sapiens} PDB: 3cw1_A Length = 231 | Back alignment and structure |
|---|
Score = 56.2 bits (135), Expect = 6e-09
Identities = 27/150 (18%), Positives = 38/150 (25%), Gaps = 6/150 (4%)
Query: 12 VANNASSGLGERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPA 71
V+ + A+ P A A + P
Sbjct: 78 VSMTVEGPPPKDTGIARVPLAGAAGGPGIGRAAGRGIPAGVPMPQAPAGLAGPVRGVGGP 137
Query: 72 SPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGA 131
S +P AA+ + +P PP +PPPG G
Sbjct: 138 SQQVMTPQGRGTVAAAAAAATASIAGAPTQYPPGRGGPPPPMGR------GAPPPGMMGP 191
Query: 132 SPPPEQSKNSPPAPPGQASTPPDSPPPGIQ 161
P P P TP PPPG++
Sbjct: 192 PPGMRPPMGPPMGIPPGRGTPMGMPPPGMR 221
|
| >3pgw_B SM B; protein-RNA complex, U1 snRNA, SM fold, SM core, RRM, splici SNRNPS, splicing factors; HET: DNA; 4.40A {Homo sapiens} PDB: 3cw1_A Length = 231 | Back alignment and structure |
|---|
Score = 56.2 bits (135), Expect = 6e-09
Identities = 33/135 (24%), Positives = 42/135 (31%), Gaps = 6/135 (4%)
Query: 1 MANSAETPGPPVANNASSGLGERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNN 60
+ + GP + A G+ P P + V P G G
Sbjct: 95 VPLAGAAGGPGIGRAAGRGIPA----GVPMPQAPAGLAGPVRGVGGPSQQVMTPQGRGTV 150
Query: 61 STTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASP--PPASPPPTRS 118
+ AA+ + P PP P G+PPP P G P PP PP R
Sbjct: 151 AAAAAAATASIAGAPTQYPPGRGGPPPPMGRGAPPPGMMGPPPGMRPPMGPPMGIPPGRG 210
Query: 119 ESQSSPPPGDGGASP 133
PPPG P
Sbjct: 211 TPMGMPPPGMRPPPP 225
|
| >3pgw_B SM B; protein-RNA complex, U1 snRNA, SM fold, SM core, RRM, splici SNRNPS, splicing factors; HET: DNA; 4.40A {Homo sapiens} PDB: 3cw1_A Length = 231 | Back alignment and structure |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 28/150 (18%), Positives = 35/150 (23%), Gaps = 3/150 (2%)
Query: 4 SAETPGPPVANNASSGLGERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTT 63
S GPP + + + A P P G +
Sbjct: 79 SMTVEGPPPKDTGIARVPLAGAAGGPGIGRAAGRGIPAGVPMPQAPAGLAGPVRGVGGPS 138
Query: 64 PAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSS 123
P A+ A+ A P PP PP PP
Sbjct: 139 QQVMTPQGRGTVAAAAAAATASIAGAPTQYPPGRGGPPPPMGRGAPPPGMMGP---PPGM 195
Query: 124 PPPGDGGASPPPEQSKNSPPAPPGQASTPP 153
PP PP + PPG PP
Sbjct: 196 RPPMGPPMGIPPGRGTPMGMPPPGMRPPPP 225
|
| >3pgw_B SM B; protein-RNA complex, U1 snRNA, SM fold, SM core, RRM, splici SNRNPS, splicing factors; HET: DNA; 4.40A {Homo sapiens} PDB: 3cw1_A Length = 231 | Back alignment and structure |
|---|
Score = 44.3 bits (104), Expect = 6e-05
Identities = 25/158 (15%), Positives = 32/158 (20%), Gaps = 17/158 (10%)
Query: 71 ASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGG 130
S PPP A P G+ A+G P P P + P G GG
Sbjct: 78 VSMTVEGPPPKDTGIARVPLAGAAGGPGIGRAAGRG-IPAGVPMPQAPAGLAGPVRGVGG 136
Query: 131 ASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPSNPGSP 190
S + A+ Q G P
Sbjct: 137 PSQQVMTPQGRGTVAAAAAAATASIAGAPTQYPPGRG----------------GPPPPMG 180
Query: 191 PSPSTSQSGTPSTPNENSSPNELSPPSNSKSPTSKSSP 228
P + P +P P
Sbjct: 181 RGAPPPGMMGPPPGMRPPMGPPMGIPPGRGTPMGMPPP 218
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 57/242 (23%), Positives = 96/242 (39%), Gaps = 78/242 (32%)
Query: 367 VIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRA---EVEIISRV-----HHRH 417
+G+G FG V ++ K AVK +++ ++ R+ E +I+ ++ ++ +
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNN 97
Query: 418 LVSLVGY-------CIS-EKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVK-IALGAA 468
+V G C+ E +YE + NN G + + +K +
Sbjct: 98 IVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNY------NGFHI----EDIKLYCIEIL 147
Query: 469 KGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQ-------------------------VA 503
K L YL + + H D+K NIL+DD + + +
Sbjct: 148 KALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLI 204
Query: 504 DFGLA-KLNDTTQTHVSTRVMGTFGYLAPE------YASSGKLTDRSDVFSFGVVLLELI 556
DFG A +D + ++TR Y APE + S SD++SFG VL EL
Sbjct: 205 DFGCATFKSDYHGSIINTR----Q-YRAPEVILNLGWDVS------SDMWSFGCVLAELY 253
Query: 557 TG 558
TG
Sbjct: 254 TG 255
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 3e-10
Identities = 54/238 (22%), Positives = 88/238 (36%), Gaps = 74/238 (31%)
Query: 367 VIGEGGFGCVYKG--NLPEGKVVAVKQLKSGSGQGEREFRA---EVEIISRVHHR----- 416
+GEG FG V + + G+ VAVK +K+ +R A E++++ ++
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNST 76
Query: 417 -HLVSLVGY-------CIS-EKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVK-IALG 466
V ++ + CI E L Y+F+ N + ++ +A
Sbjct: 77 FRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGF------LPFRL----DHIRKMAYQ 126
Query: 467 AAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVA-------------------DFGL 507
K + +LH K+ H D+K NIL + DFG
Sbjct: 127 ICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGS 183
Query: 508 A-KLNDTTQTHVSTRVMGTFGYLAPE------YASSGKLTDRSDVFSFGVVLLELITG 558
A ++ T VSTR Y APE ++ DV+S G +L+E G
Sbjct: 184 ATYDDEHHSTLVSTRH-----YRAPEVILALGWSQP------CDVWSIGCILIEYYLG 230
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 51/238 (21%), Positives = 86/238 (36%), Gaps = 74/238 (31%)
Query: 367 VIGEGGFGCVYKG--NLPEGKVVAVKQLKSGSGQGEREFRA---EVEIISRVHHR----- 416
+GEG FG V + + VA+K +++ + A E+ ++ ++ +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIKEKDKENK 81
Query: 417 -HLVSLVGY-------CIS-EKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVK-IALG 466
V + + CI+ E +EF+ NN + P+ V+ +A
Sbjct: 82 FLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNF------QPYPL----PHVRHMAYQ 131
Query: 467 AAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVA-------------------DFGL 507
L +LHE ++ H D+K NIL + + DFG
Sbjct: 132 LCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGS 188
Query: 508 A-KLNDTTQTHVSTRVMGTFGYLAPE------YASSGKLTDRSDVFSFGVVLLELITG 558
A ++ T V+TR Y PE +A DV+S G +L E G
Sbjct: 189 ATFDHEHHTTIVATRH-----YRPPEVILELGWAQP------CDVWSIGCILFEYYRG 235
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 54/274 (19%), Positives = 87/274 (31%), Gaps = 88/274 (32%)
Query: 368 IGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVH--------HRHL 418
+G G F V+ ++ K VA+K +KS E E+ ++ V +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD-EIRLLKSVRNSDPNDPNREMV 103
Query: 419 VSLVGY-----------CI-SEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALG 466
V L+ C+ E + +++ +N +G P L K+ I
Sbjct: 104 VQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSN------YQGLP-LPCVKK--IIQQ 154
Query: 467 AAKGLAYLHEDCHPKIIHRDIKSANILV-------------------------------- 494
+GL YLH C IIH DIK NIL+
Sbjct: 155 VLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVST 212
Query: 495 -----------------DDEFEAQVADFGLAKLNDTTQTH-VSTRVMGTFGYLAPEYASS 536
++ + ++AD G A T + TR Y + E
Sbjct: 213 APATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIG 267
Query: 537 GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGD 570
+D++S + EL TG +P
Sbjct: 268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEEY 301
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 53/207 (25%), Positives = 85/207 (41%), Gaps = 22/207 (10%)
Query: 368 IGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCI 426
IG G FG +Y G N+ + VA+K + + E +I + + V +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFG 72
Query: 427 SE-KNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPK-IIH 484
E +L+ + + +LE + + + +K L A + E H K +H
Sbjct: 73 VEGDYNVLVMDLL-GPSLEDLFNFCSRKL-----SLKTVLMLADQMINRVEFVHSKSFLH 126
Query: 485 RDIKSANILV---DDEFEAQVADFGLAKL--NDTTQTHVSTR----VMGTFGYLAPEYAS 535
RDIK N L+ + + DFGLAK + +T H+ R + GT Y A
Sbjct: 127 RDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY-ASVNTH 185
Query: 536 SGK-LTDRSDVFSFGVVLLELITGRKP 561
G + R D+ S G VL+ + G P
Sbjct: 186 LGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 26/104 (25%), Positives = 31/104 (29%), Gaps = 5/104 (4%)
Query: 24 KEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASP 83
KE A E P P +PPP
Sbjct: 342 KETEDDKDAETEIPAGESSDAAPSADAAQMKEMMAMMQKMQQQ-QAAYPPQGYAPPPQGY 400
Query: 84 PPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPG 127
PP PP G PP PP G PP +PP + ++PP G
Sbjct: 401 PPQGYPPQGYPPQGYPPQ--GYPPPPQGAPP--QGAPPAAPPQG 440
|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 34/140 (24%), Positives = 47/140 (33%), Gaps = 19/140 (13%)
Query: 23 RKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPAS 82
R+ ++ P + +K+ G ++ P+A A
Sbjct: 323 REAISQTFPWVLTCCQFDDKETEDDKDAETEIPAGESSDAAPSADAAQMKEMMAMMQKMQ 382
Query: 83 PPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSP 142
AA PP G PP PP PP Q PP G PPP+
Sbjct: 383 QQQAAYPPQGYAPPPQ--------GYPPQGYPPQGYPPQGYPPQGYP---PPPQ------ 425
Query: 143 PAPPGQASTPPDSPPPGIQS 162
APP A PP +PP G+ +
Sbjct: 426 GAPPQGA--PPAAPPQGVDN 443
|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 26/103 (25%), Positives = 34/103 (33%), Gaps = 13/103 (12%)
Query: 2 ANSAETPGPPVANNASSGLGERKEEAK--APPAPAEKTESPEKKVTPPPADNNNNGGGGN 59
E P ++ A S + +E ++ P + PPP
Sbjct: 349 DAETEIPAGESSDAAPSADAAQMKEMMAMMQKMQQQQAAYPPQGYAPPP----------- 397
Query: 60 NSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPA 102
P PP PP PP PPP PP PPA+PP
Sbjct: 398 QGYPPQGYPPQGYPPQGYPPQGYPPPPQGAPPQGAPPAAPPQG 440
|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
Score = 48.8 bits (116), Expect = 4e-06
Identities = 18/106 (16%), Positives = 24/106 (22%), Gaps = 6/106 (5%)
Query: 99 PPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPP 158
+ A ES + P D +PPP
Sbjct: 338 QFDDKETEDDKDAETEIPAGESSDAAPSADAAQMKEMMAMMQKMQQQQAAYPPQGYAPPP 397
Query: 159 GIQSNQGNPVPSNGTTDSRDTKWAPPSNPGSPPSPSTSQSGTPSTP 204
QG P + PP PP + Q P+ P
Sbjct: 398 QGYPPQGYP------PQGYPPQGYPPQGYPPPPQGAPPQGAPPAAP 437
|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 6e-06
Identities = 25/117 (21%), Positives = 34/117 (29%), Gaps = 11/117 (9%)
Query: 84 PPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPP 143
+ PA S+ P++ E + + P Q PP
Sbjct: 338 QFDDKETEDDKDAETEIPAGESSDAAPSADAAQMKEMMAMMQKMQQQQAAYPPQGYAPPP 397
Query: 144 APPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPSN--PGSPPSPSTSQS 198
PP PP QG P P G APP P +PP +Q+
Sbjct: 398 QGYPPQGYPPQGYPPQGYPPQGYPPPPQG---------APPQGAPPAAPPQGVDNQA 445
|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 5e-05
Identities = 23/99 (23%), Positives = 30/99 (30%), Gaps = 3/99 (3%)
Query: 6 ETPGPPVANNASSGLGERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPA 65
+ +A + + + AP A A + E P
Sbjct: 340 DDKETEDDKDAETEIPAGESSDAAPSADA--AQMKEMMAMMQKMQQQQAAYPPQGYAPPP 397
Query: 66 ASPPPASPPP-ASPPPASPPPAASPPPGSPPPASPPPAS 103
PP PP PP PP PPP PP PPA+
Sbjct: 398 QGYPPQGYPPQGYPPQGYPPQGYPPPPQGAPPQGAPPAA 436
|
| >3ghg_A Fibrinogen alpha chain; triple-stranded coiled coil, beta sheets, alpha helices, AMY amyloidosis, blood coagulation, disease mutation, glycoprot phosphoprotein; HET: NAG NDG BMA MAN GAL SIA; 2.90A {Homo sapiens} PDB: 3h32_A* 2a45_G* Length = 562 | Back alignment and structure |
|---|
Score = 55.3 bits (132), Expect = 4e-08
Identities = 44/243 (18%), Positives = 67/243 (27%), Gaps = 12/243 (4%)
Query: 24 KEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASP 83
+ + P A + P N GG + T + + P +P A +
Sbjct: 221 QLQKVPPEWKALTDMPQMRMELERPGGNEITRGGSTSYGTGSETESPRNPSSAGSWNSGS 280
Query: 84 PPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPP 143
S +P + + S SS G +P + ++
Sbjct: 281 SGPGSTGNRNPGSSGTGGTATWKPGSSGPGSTGSWNSGSSGTGSTGNQNPGSPRPGSTGT 340
Query: 144 APPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPSNPGSPPS----PSTSQSG 199
PG + S G+ + + S P SP S P+ G
Sbjct: 341 WNPGSSERGSAGHWTSESSVSGSTGQWHSESGS--------FRPDSPGSGNARPNNPDWG 392
Query: 200 TPSTPNENSSPNELSPPSNSKSPTSKSSPEESSSSSHSNSKKTPTSSSGHSSDSTKGSSS 259
T + N SP K TSK E + S T T+ S TK
Sbjct: 393 TFEEVSGNVSPGTRREYHTEKLVTSKGDKELRTGKEKVTSGSTTTTRRSCSKTVTKTVIG 452
Query: 260 NDD 262
D
Sbjct: 453 PDG 455
|
| >3ghg_A Fibrinogen alpha chain; triple-stranded coiled coil, beta sheets, alpha helices, AMY amyloidosis, blood coagulation, disease mutation, glycoprot phosphoprotein; HET: NAG NDG BMA MAN GAL SIA; 2.90A {Homo sapiens} PDB: 3h32_A* 2a45_G* Length = 562 | Back alignment and structure |
|---|
Score = 47.2 bits (111), Expect = 2e-05
Identities = 30/264 (11%), Positives = 64/264 (24%), Gaps = 10/264 (3%)
Query: 3 NSAETPGPPVANNASSGLGERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNST 62
+++ G + + + P + G G+ +
Sbjct: 255 STSYGTGSETESPRNPSSAGSWNSGSSGPGSTGNRNPGSSGTGGTATWKPGSSGPGSTGS 314
Query: 63 TPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQS 122
+ S S +P P + PGS S + +S
Sbjct: 315 WNSGSSGTGSTGNQNPGSPRPGSTGTWNPGSSERGSAGHWTSESSVS--GSTGQWHSESG 372
Query: 123 SPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWA 182
S P G+ + + + P + + V S G + R K
Sbjct: 373 SFRPDSPGSGNARPNNPDWGTFEEVSGNVSPGTRREY---HTEKLVTSKGDKELRTGKEK 429
Query: 183 PPSNPGSPPSPSTSQSGTPSTPNENSSPNELSPPSNSKSPTSKSSPE-----ESSSSSHS 237
S + S S++ T + + S+ + +
Sbjct: 430 VTSGSTTTTRRSCSKTVTKTVIGPDGHKEVTKEVVTSEDGSDCPEAMDLGTLSGIGTLDG 489
Query: 238 NSKKTPTSSSGHSSDSTKGSSSND 261
+ P ++ + ST +
Sbjct: 490 FRHRHPDEAAFFDTASTGKTFPGF 513
|
| >3ghg_A Fibrinogen alpha chain; triple-stranded coiled coil, beta sheets, alpha helices, AMY amyloidosis, blood coagulation, disease mutation, glycoprot phosphoprotein; HET: NAG NDG BMA MAN GAL SIA; 2.90A {Homo sapiens} PDB: 3h32_A* 2a45_G* Length = 562 | Back alignment and structure |
|---|
Score = 44.1 bits (103), Expect = 1e-04
Identities = 23/227 (10%), Positives = 51/227 (22%)
Query: 46 PPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGS 105
+ + G N + S +P + A + S GS S
Sbjct: 316 NSGSSGTGSTGNQNPGSPRPGSTGTWNPGSSERGSAGHWTSESSVSGSTGQWHSESGSFR 375
Query: 106 ASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQG 165
P + + + G SP + ++ + + + S
Sbjct: 376 PDSPGSGNARPNNPDWGTFEEVSGNVSPGTRREYHTEKLVTSKGDKELRTGKEKVTSGST 435
Query: 166 NPVPSNGTTDSRDTKWAPPSNPGSPPSPSTSQSGTPSTPNENSSPNELSPPSNSKSPTSK 225
+ + T P + TS+ G+ + +
Sbjct: 436 TTTRRSCSKTVTKTVIGPDGHKEVTKEVVTSEDGSDCPEAMDLGTLSGIGTLDGFRHRHP 495
Query: 226 SSPEESSSSSHSNSKKTPTSSSGHSSDSTKGSSSNDDQAIIGATAAG 272
++S + S S S ++ +
Sbjct: 496 DEAAFFDTASTGKTFPGFFSPMLGEFVSETESRGSESGIFTNTKESS 542
|
| >3tx7_B Nuclear receptor subfamily 5 group A member 2; LRH-1, beta-catenin, armadillo repeat, nuclear receptor LIGA binding domain, protein binding; HET: P6L; 2.76A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 54.6 bits (131), Expect = 5e-08
Identities = 26/156 (16%), Positives = 45/156 (28%), Gaps = 6/156 (3%)
Query: 36 KTESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPP 95
K E+ + + P+D + N + P + P + SP + PP
Sbjct: 3 KLEAMSQVIQAMPSDLTISSAIQNIHSASKGLPLNHAALPPTDYDRSPFVTSPISMTMPP 62
Query: 96 PASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPPGQASTP--- 152
S P + + +S P G S +SP + P
Sbjct: 63 HGSLQGYQTYGHFPSRAIKSEYPDPYTSSPESIMGYSYMDSYQTSSPASIPHLILELLKC 122
Query: 153 -PDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPSNP 187
PD P +Q+ + S+ K +
Sbjct: 123 EPDEPQ--VQAKIMAYLQQEQANRSKHEKLSTFGLM 156
|
| >3tx7_B Nuclear receptor subfamily 5 group A member 2; LRH-1, beta-catenin, armadillo repeat, nuclear receptor LIGA binding domain, protein binding; HET: P6L; 2.76A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 24/171 (14%), Positives = 45/171 (26%), Gaps = 15/171 (8%)
Query: 82 SPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNS 141
+ P +S S S P + A PP + ++
Sbjct: 6 AMSQVIQAMPSDLTISS---------------AIQNIHSASKGLPLNHAALPPTDYDRSP 50
Query: 142 PPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPSNPGSPPSPSTSQSGTP 201
P + PP G Q+ P + + +P S G S S
Sbjct: 51 FVTSPISMTMPPHGSLQGYQTYGHFPSRAIKSEYPDPYTSSPESIMGYSYMDSYQTSSPA 110
Query: 202 STPNENSSPNELSPPSNSKSPTSKSSPEESSSSSHSNSKKTPTSSSGHSSD 252
S P+ + P + ++ ++ + K + +D
Sbjct: 111 SIPHLILELLKCEPDEPQVQAKIMAYLQQEQANRSKHEKLSTFGLMCKMAD 161
|
| >3tx7_B Nuclear receptor subfamily 5 group A member 2; LRH-1, beta-catenin, armadillo repeat, nuclear receptor LIGA binding domain, protein binding; HET: P6L; 2.76A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 18/141 (12%), Positives = 27/141 (19%), Gaps = 8/141 (5%)
Query: 30 PPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPAASP 89
P++ T S + + T SP SP + PP
Sbjct: 12 QAMPSDLTISSAIQNIHSASKGLPLNHAALPPTDYDRSPFVTSPISMTMPPHGSLQGYQT 71
Query: 90 PPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASP--------PPEQSKNS 141
P A + P S P E +
Sbjct: 72 YGHFPSRAIKSEYPDPYTSSPESIMGYSYMDSYQTSSPASIPHLILELLKCEPDEPQVQA 131
Query: 142 PPAPPGQASTPPDSPPPGIQS 162
Q S + +
Sbjct: 132 KIMAYLQQEQANRSKHEKLST 152
|
| >3tx7_B Nuclear receptor subfamily 5 group A member 2; LRH-1, beta-catenin, armadillo repeat, nuclear receptor LIGA binding domain, protein binding; HET: P6L; 2.76A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 46.1 bits (109), Expect = 3e-05
Identities = 20/149 (13%), Positives = 29/149 (19%), Gaps = 3/149 (2%)
Query: 8 PGPPVANNASSGLGERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAAS 67
P +S+ P A P P + + + +
Sbjct: 13 AMPSDLTISSAIQNIHSASKGLPLNHA--ALPPTDYDRSPFVTSPISMTMPPHGSLQGYQ 70
Query: 68 PPPASPPPASPPPASPPPAASPPPGSPPPASPP-PASGSASPPPASPPPTRSESQSSPPP 126
P A P +SP S AS P + E
Sbjct: 71 TYGHFPSRAIKSEYPDPYTSSPESIMGYSYMDSYQTSSPASIPHLILELLKCEPDEPQVQ 130
Query: 127 GDGGASPPPEQSKNSPPAPPGQASTPPDS 155
A EQ+ S
Sbjct: 131 AKIMAYLQQEQANRSKHEKLSTFGLMCKM 159
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 53.6 bits (128), Expect = 5e-08
Identities = 22/133 (16%), Positives = 34/133 (25%)
Query: 59 NNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRS 118
+ A P S +P PP A PPP P P P A +
Sbjct: 23 HQVIELPAPAQPISVTMVTPADLEPPQAVQPPPEPVVEPEPEPEPIPEPPKEAPVVIEKP 82
Query: 119 ESQSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRD 178
+ + P P + P + +P S T+ +
Sbjct: 83 KPKPKPKPKPVKKVQEQPKRDVKPVESRPASPFENTAPARLTSSTATAATSKPVTSVASG 142
Query: 179 TKWAPPSNPGSPP 191
+ + P P
Sbjct: 143 PRALSRNQPQYPA 155
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 48.6 bits (115), Expect = 2e-06
Identities = 21/145 (14%), Positives = 30/145 (20%), Gaps = 12/145 (8%)
Query: 2 ANSAETPGPPVANNASSGLGERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNS 61
+ + P S + + P A E + P
Sbjct: 20 MSVHQVIELPAPAQPISVTMVTPADLEPPQAVQPPPEPVVEPEPEPEP------------ 67
Query: 62 TTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQ 121
P P P P P P S ASP + P + S
Sbjct: 68 IPEPPKEAPVVIEKPKPKPKPKPKPVKKVQEQPKRDVKPVESRPASPFENTAPARLTSST 127
Query: 122 SSPPPGDGGASPPPEQSKNSPPAPP 146
++ S S P
Sbjct: 128 ATAATSKPVTSVASGPRALSRNQPQ 152
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 45.5 bits (107), Expect = 2e-05
Identities = 24/139 (17%), Positives = 33/139 (23%)
Query: 2 ANSAETPGPPVANNASSGLGERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNS 61
E P P + + E +A P E PE + P P
Sbjct: 23 HQVIELPAPAQPISVTMVTPADLEPPQAVQPPPEPVVEPEPEPEPIPEPPKEAPVVIEKP 82
Query: 62 TTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQ 121
P P P S P +P + S + S P T S
Sbjct: 83 KPKPKPKPKPVKKVQEQPKRDVKPVESRPASPFENTAPARLTSSTATAATSKPVTSVASG 142
Query: 122 SSPPPGDGGASPPPEQSKN 140
+ P Q+
Sbjct: 143 PRALSRNQPQYPARAQALR 161
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 45.5 bits (107), Expect = 2e-05
Identities = 24/149 (16%), Positives = 34/149 (22%), Gaps = 7/149 (4%)
Query: 64 PAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSS 123
P S P PA P P P P P E
Sbjct: 15 PRGSHMSVHQVIELPAPAQPISVTMVTPADLEPPQAVQPPPEPVVEPEPEPEPIPEPPKE 74
Query: 124 PPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAP 183
P E+ K P P + P ++ + P T +
Sbjct: 75 AP-------VVIEKPKPKPKPKPKPVKKVQEQPKRDVKPVESRPASPFENTAPARLTSST 127
Query: 184 PSNPGSPPSPSTSQSGTPSTPNENSSPNE 212
+ S P S + + N+ P
Sbjct: 128 ATAATSKPVTSVASGPRALSRNQPQYPAR 156
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 44.7 bits (105), Expect = 3e-05
Identities = 24/138 (17%), Positives = 35/138 (25%)
Query: 79 PPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQS 138
S P + P + PP A PP + P P P
Sbjct: 18 SHMSVHQVIELPAPAQPISVTMVTPADLEPPQAVQPPPEPVVEPEPEPEPIPEPPKEAPV 77
Query: 139 KNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPSNPGSPPSPSTSQS 198
P P + P PV S + +T A ++ + + S +
Sbjct: 78 VIEKPKPKPKPKPKPVKKVQEQPKRDVKPVESRPASPFENTAPARLTSSTATAATSKPVT 137
Query: 199 GTPSTPNENSSPNELSPP 216
S P S P
Sbjct: 138 SVASGPRALSRNQPQYPA 155
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 5e-08
Identities = 17/85 (20%), Positives = 29/85 (34%), Gaps = 1/85 (1%)
Query: 74 PPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQ-SSPPPGDGGAS 132
P A P +P AA+ + PA+P P + A+P P + + +PP G +
Sbjct: 2 PAAPTSPGTPGVAAATQAANGGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAGDNA 61
Query: 133 PPPEQSKNSPPAPPGQASTPPDSPP 157
+ D+
Sbjct: 62 TVAAGHATLREHLRDIKAENTDANF 86
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 54.6 bits (131), Expect = 8e-08
Identities = 17/94 (18%), Positives = 31/94 (32%), Gaps = 4/94 (4%)
Query: 69 PPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGD 128
P A P +P A+ AA+ P +P P A+ + P P ++ + P +
Sbjct: 2 PAAPTSPGTPGVAAATQAANGGPATPAP-PALGAAPTGDPKPKKNKKPKNPTPPRPAGDN 60
Query: 129 GGASPPPEQSKNSPPAPPGQASTPP---DSPPPG 159
+ + + + PP G
Sbjct: 61 ATVAAGHATLREHLRDIKAENTDANFYVCPPPTG 94
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 19/91 (20%), Positives = 26/91 (28%), Gaps = 1/91 (1%)
Query: 64 PAASPPPASP-PPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQS 122
PAA P +P A+ A+ PA PP + P P PP + +
Sbjct: 2 PAAPTSPGTPGVAAATQAANGGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAGDNA 61
Query: 123 SPPPGDGGASPPPEQSKNSPPAPPGQASTPP 153
+ G K PP
Sbjct: 62 TVAAGHATLREHLRDIKAENTDANFYVCPPP 92
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 26/115 (22%), Positives = 40/115 (34%), Gaps = 11/115 (9%)
Query: 48 PADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPP---PASPPPASG 104
PA + G G + T AA+ PA+P P + A P P P +
Sbjct: 2 PAAPTSPGTPGVAAATQAANGGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAGDNA 61
Query: 105 SASPPPASPPPTRSESQSSPPPGDGGASPPP--------EQSKNSPPAPPGQAST 151
+ + A+ + ++ + PPP EQ + P P GQ T
Sbjct: 62 TVAAGHATLREHLRDIKAENTDANFYVCPPPTGATVVQFEQPRRCPTRPEGQNYT 116
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 5e-05
Identities = 12/83 (14%), Positives = 26/83 (31%), Gaps = 2/83 (2%)
Query: 184 PSNPGSPPSPST--SQSGTPSTPNENSSPNELSPPSNSKSPTSKSSPEESSSSSHSNSKK 241
P+ P SP +P + P + P + P+ P P+ + +
Sbjct: 2 PAAPTSPGTPGVAAATQAANGGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAGDNA 61
Query: 242 TPTSSSGHSSDSTKGSSSNDDQA 264
T + + + + + A
Sbjct: 62 TVAAGHATLREHLRDIKAENTDA 84
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 7e-05
Identities = 16/100 (16%), Positives = 26/100 (26%), Gaps = 4/100 (4%)
Query: 80 PASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSK 139
PA+P + PG + PPA + + +PP
Sbjct: 2 PAAPTSPGT--PGVAAATQAANGGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAGD 59
Query: 140 NSPPAPPGQASTPPDSPPPGIQSNQGNPV--PSNGTTDSR 177
N+ A ++ V P G T +
Sbjct: 60 NATVAAGHATLREHLRDIKAENTDANFYVCPPPTGATVVQ 99
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 14/96 (14%), Positives = 24/96 (25%), Gaps = 2/96 (2%)
Query: 26 EAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPP 85
+ AP +P + + G T P +PP +
Sbjct: 1 DPAAPTSPGTPGVAAATQAANGGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAGDN 60
Query: 86 AASPPPGSPPPASPP--PASGSASPPPASPPPTRSE 119
A + A + + PPPT +
Sbjct: 61 ATVAAGHATLREHLRDIKAENTDANFYVCPPPTGAT 96
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 54.5 bits (130), Expect = 6e-08
Identities = 19/105 (18%), Positives = 35/105 (33%)
Query: 49 ADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASP 108
+D+N N T P P PPP++ P + P +A+ A+P + + SP
Sbjct: 10 SDSNFMANLPNGYMTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAAPSP 69
Query: 109 PPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPPGQASTPP 153
+ S ++ A+ + G+
Sbjct: 70 GSSGGGGFFSSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAAA 114
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 54.5 bits (130), Expect = 7e-08
Identities = 12/98 (12%), Positives = 21/98 (21%)
Query: 61 STTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSES 120
+ P P PPP S + P + A + + P A P +
Sbjct: 16 ANLPNGYMTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAAPSPGSSGGG 75
Query: 121 QSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPP 158
+ + G +
Sbjct: 76 GFFSSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAA 113
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 54.1 bits (129), Expect = 9e-08
Identities = 18/99 (18%), Positives = 25/99 (25%)
Query: 61 STTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSES 120
S + + P P PPP S P S ++ AS P
Sbjct: 10 SDSNFMANLPNGYMTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAAPSP 69
Query: 121 QSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPG 159
SS G + + + A S G
Sbjct: 70 GSSGGGGFFSSLSNAVKQTTAAAAATFSEQVGGGSGGAG 108
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 52.9 bits (126), Expect = 2e-07
Identities = 15/101 (14%), Positives = 24/101 (23%)
Query: 58 GNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTR 117
N P PPP + PGS ++ ++ + PA+P P
Sbjct: 12 SNFMANLPNGYMTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAAPSPGS 71
Query: 118 SESQSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPP 158
S + + G S
Sbjct: 72 SGGGGFFSSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGA 112
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 46.4 bits (109), Expect = 2e-05
Identities = 15/111 (13%), Positives = 25/111 (22%)
Query: 48 PADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSAS 107
A+ N P PP A+ P A+P A+ + + P S
Sbjct: 15 MANLPNGYMTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAAPSPGSSGG 74
Query: 108 PPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPP 158
S + ++ + D P
Sbjct: 75 GGFFSSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAAARVLLVIDEPHT 125
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 46.0 bits (108), Expect = 3e-05
Identities = 14/96 (14%), Positives = 25/96 (26%)
Query: 46 PPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGS 105
D + + P S ++ ++ P ASP SP + S
Sbjct: 21 GYMTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAAPSPGSSGGGGFFSS 80
Query: 106 ASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNS 141
S + + S G G + +
Sbjct: 81 LSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAAARV 116
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 43.7 bits (102), Expect = 2e-04
Identities = 16/96 (16%), Positives = 29/96 (30%)
Query: 47 PPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSA 106
P + P+A+ P A+P A+ AA + P G
Sbjct: 19 PNGYMTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAAPSPGSSGGGGFF 78
Query: 107 SPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSP 142
S + T + + ++ GG S + +
Sbjct: 79 SSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAAA 114
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 43.7 bits (102), Expect = 2e-04
Identities = 16/94 (17%), Positives = 25/94 (26%)
Query: 46 PPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGS 105
P + AASP A+ + A P +P P S
Sbjct: 19 PNGYMTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAAPSPGSSGGGGFF 78
Query: 106 ASPPPASPPPTRSESQSSPPPGDGGASPPPEQSK 139
+S A T + + + GG+
Sbjct: 79 SSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGA 112
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 42.9 bits (100), Expect = 3e-04
Identities = 18/111 (16%), Positives = 32/111 (28%)
Query: 103 SGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQS 162
+G + PP S +SP G A+ E++ + P A +P S G S
Sbjct: 20 NGYMTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAAPSPGSSGGGGFFS 79
Query: 163 NQGNPVPSNGTTDSRDTKWAPPSNPGSPPSPSTSQSGTPSTPNENSSPNEL 213
+ N V + G + ++ +
Sbjct: 80 SLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAAARVLLVIDEPHTDWAKY 130
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 42.1 bits (98), Expect = 4e-04
Identities = 16/114 (14%), Positives = 27/114 (23%)
Query: 80 PASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSK 139
A+ P P P PPP++ S P S + + ++ P A P
Sbjct: 15 MANLPNGYMTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAAPSPGSSGG 74
Query: 140 NSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPSNPGSPPSP 193
+ A + S Q + +
Sbjct: 75 GGFFSSLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAAARVLLVIDEPHTDWA 128
|
| >3dva_I Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase...; oxidoreductase, multienzyme complex; HET: TPW; 2.35A {Bacillus stearothermophilus} PDB: 3dv0_I* 3duf_I* 1b5s_A 1lab_A 1lac_A 1w3d_A Length = 428 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 4e-07
Identities = 4/53 (7%), Positives = 8/53 (15%)
Query: 61 STTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASP 113
+ +P + +G A P
Sbjct: 81 YENMTFKGQEQEEAKKEEKTETVSKEEKVDAVAPNAPAAEAEAGPNRRVIAMP 133
|
| >3dva_I Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase...; oxidoreductase, multienzyme complex; HET: TPW; 2.35A {Bacillus stearothermophilus} PDB: 3dv0_I* 3duf_I* 1b5s_A 1lab_A 1lac_A 1w3d_A Length = 428 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 1e-05
Identities = 6/54 (11%), Positives = 10/54 (18%)
Query: 55 GGGGNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASP 108
G + A +P + + P A P
Sbjct: 80 GYENMTFKGQEQEEAKKEEKTETVSKEEKVDAVAPNAPAAEAEAGPNRRVIAMP 133
|
| >3dva_I Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase...; oxidoreductase, multienzyme complex; HET: TPW; 2.35A {Bacillus stearothermophilus} PDB: 3dv0_I* 3duf_I* 1b5s_A 1lab_A 1lac_A 1w3d_A Length = 428 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 3e-05
Identities = 4/55 (7%), Positives = 8/55 (14%)
Query: 70 PASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSP 124
P + A +P + + P
Sbjct: 79 PGYENMTFKGQEQEEAKKEEKTETVSKEEKVDAVAPNAPAAEAEAGPNRRVIAMP 133
|
| >3dva_I Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase...; oxidoreductase, multienzyme complex; HET: TPW; 2.35A {Bacillus stearothermophilus} PDB: 3dv0_I* 3duf_I* 1b5s_A 1lab_A 1lac_A 1w3d_A Length = 428 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 3e-04
Identities = 5/59 (8%), Positives = 9/59 (15%), Gaps = 4/59 (6%)
Query: 75 PASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASP 133
P + + P +P + A P
Sbjct: 79 PGYENMTFKGQEQEEAKKEEKTETVSKEEKVDAVAPNAPAAEAEAGPNRRVI----AMP 133
|
| >3dva_I Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase...; oxidoreductase, multienzyme complex; HET: TPW; 2.35A {Bacillus stearothermophilus} PDB: 3dv0_I* 3duf_I* 1b5s_A 1lab_A 1lac_A 1w3d_A Length = 428 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 7e-04
Identities = 6/43 (13%), Positives = 7/43 (16%)
Query: 64 PAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSA 106
A + P A P A S
Sbjct: 93 EAKKEEKTETVSKEEKVDAVAPNAPAAEAEAGPNRRVIAMPSV 135
|
| >1mv3_A MYC box dependent interacting protein 1; tumor suppressor, endocytosis/exocytosis complex; NMR {Homo sapiens} SCOP: b.34.2.1 Length = 213 | Back alignment and structure |
|---|
Score = 49.3 bits (116), Expect = 9e-07
Identities = 21/139 (15%), Positives = 30/139 (21%)
Query: 69 PPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGD 128
+ P P PA PG+ P SP PP E +
Sbjct: 2 GSPAATPEIRVNHEPEPAGGATPGATLPKSPSQLRKGPPVPPPPKHTPSKEVKQEQILSL 61
Query: 129 GGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPSNPG 188
+ PE S +P P + + P G S + S
Sbjct: 62 FEDTFVPEISVTTPSQPAEASEVAGGTQPAAGAQEPGETAASEAASSSLPAVVVETFPAT 121
Query: 189 SPPSPSTSQSGTPSTPNEN 207
+
Sbjct: 122 VNGTVEGGSGAGRLDLPPG 140
|
| >1mv3_A MYC box dependent interacting protein 1; tumor suppressor, endocytosis/exocytosis complex; NMR {Homo sapiens} SCOP: b.34.2.1 Length = 213 | Back alignment and structure |
|---|
Score = 48.5 bits (114), Expect = 2e-06
Identities = 20/137 (14%), Positives = 32/137 (23%)
Query: 61 STTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSES 120
+ TP P P + P + PP PPP + + E
Sbjct: 5 AATPEIRVNHEPEPAGGATPGATLPKSPSQLRKGPPVPPPPKHTPSKEVKQEQILSLFED 64
Query: 121 QSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTK 180
P S P E S+ + P + P ++ P T +
Sbjct: 65 TFVPEISVTTPSQPAEASEVAGGTQPAAGAQEPGETAASEAASSSLPAVVVETFPATVNG 124
Query: 181 WAPPSNPGSPPSPSTSQ 197
+
Sbjct: 125 TVEGGSGAGRLDLPPGF 141
|
| >1mv3_A MYC box dependent interacting protein 1; tumor suppressor, endocytosis/exocytosis complex; NMR {Homo sapiens} SCOP: b.34.2.1 Length = 213 | Back alignment and structure |
|---|
Score = 46.2 bits (108), Expect = 9e-06
Identities = 21/122 (17%), Positives = 29/122 (23%)
Query: 59 NNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRS 118
N+ PA P + P SP P PPP P + P
Sbjct: 13 NHEPEPAGGATPGATLPKSPSQLRKGPPVPPPPKHTPSKEVKQEQILSLFEDTFVPEISV 72
Query: 119 ESQSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRD 178
+ S P A + P + S P + V S
Sbjct: 73 TTPSQPAEASEVAGGTQPAAGAQEPGETAASEAASSSLPAVVVETFPATVNGTVEGGSGA 132
Query: 179 TK 180
+
Sbjct: 133 GR 134
|
| >1mv3_A MYC box dependent interacting protein 1; tumor suppressor, endocytosis/exocytosis complex; NMR {Homo sapiens} SCOP: b.34.2.1 Length = 213 | Back alignment and structure |
|---|
Score = 41.2 bits (95), Expect = 5e-04
Identities = 17/143 (11%), Positives = 33/143 (23%)
Query: 83 PPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSP 142
PAA+P P + + P SP R PPP + ++ S
Sbjct: 2 GSPAATPEIRVNHEPEPAGGATPGATLPKSPSQLRKGPPVPPPPKHTPSKEVKQEQILSL 61
Query: 143 PAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPSNPGSPPSPSTSQSGTPS 202
+P ++++ + A S ++ +
Sbjct: 62 FEDTFVPEISVTTPSQPAEASEVAGGTQPAAGAQEPGETAASEAASSSLPAVVVETFPAT 121
Query: 203 TPNENSSPNELSPPSNSKSPTSK 225
+ K
Sbjct: 122 VNGTVEGGSGAGRLDLPPGFMFK 144
|
| >3odw_A RHO guanine nucleotide exchange factor 1; regulation of RHOA GTPase, rhogef, DH, PH, signaling PR; 3.20A {Homo sapiens} PDB: 3odx_A Length = 536 | Back alignment and structure |
|---|
Score = 48.1 bits (114), Expect = 8e-06
Identities = 22/153 (14%), Positives = 35/153 (22%), Gaps = 4/153 (2%)
Query: 90 PPGSPPPASP---PPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPP 146
P + S P ++E + P S++ P
Sbjct: 22 PAKTKKGLSSILDAARWNRGEPQVPDFRHLKAEVDAEKPGATDRKGGVGMPSRDRNIGAP 81
Query: 147 GQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPSNPGSPPSPSTSQSGTPSTPNE 206
GQ + P + S P + P S S P ++ G + E
Sbjct: 82 GQDTPGVSLHPLSLDSPDREPGADAPLELGDSSPQGPMSL-ESLAPPESTDEGAETESPE 140
Query: 207 NSSPNELSPPSNSKSPTSKSSPEESSSSSHSNS 239
E P E +S
Sbjct: 141 PGDEGEPGRSGLELEPEEPPGWRELVPPDTLHS 173
|
| >3odw_A RHO guanine nucleotide exchange factor 1; regulation of RHOA GTPase, rhogef, DH, PH, signaling PR; 3.20A {Homo sapiens} PDB: 3odx_A Length = 536 | Back alignment and structure |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 26/187 (13%), Positives = 43/187 (22%), Gaps = 17/187 (9%)
Query: 56 GGGNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPP 115
G N + P + S A+ P +
Sbjct: 4 SGRNFFRKKVMGNRRSDEPAKTKKGLSSILDAARWNRGEPQVPDFRHLKAEVDAEKPGAT 63
Query: 116 TRSESQSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTD 175
R P S++ PGQ + P + S P G
Sbjct: 64 DRKGGVGMP-------------SRDRNIGAPGQDTPGVSLHPLSLDS----PDREPGADA 106
Query: 176 SRDTKWAPPSNPGSPPSPSTSQSGTPSTPNENSSPNELSPPSNSKSPTSKSSPEESSSSS 235
+ + P P S S + +S E+ P + P S P
Sbjct: 107 PLELGDSSPQGPMSLESLAPPESTDEGAETESPEPGDEGEPGRSGLELEPEEPPGWRELV 166
Query: 236 HSNSKKT 242
++ +
Sbjct: 167 PPDTLHS 173
|
| >3odw_A RHO guanine nucleotide exchange factor 1; regulation of RHOA GTPase, rhogef, DH, PH, signaling PR; 3.20A {Homo sapiens} PDB: 3odx_A Length = 536 | Back alignment and structure |
|---|
Score = 45.8 bits (108), Expect = 4e-05
Identities = 21/155 (13%), Positives = 31/155 (20%), Gaps = 8/155 (5%)
Query: 101 PASGSASPPPASPPPTRSESQSSPPP-----GDGGASPPPEQSKNSPPAPPGQASTPPDS 155
+ P T+ S G+ PG
Sbjct: 10 RKKVMGNRRSDEPAKTKKGLSSILDAARWNRGEPQVPDFRHLKAEVDAEKPGATDRKGGV 69
Query: 156 PPPGIQSNQGNPVPSNGTTDSRDTKWAPPSNPGSPPSPSTSQSGTPSTPNENSS---PNE 212
P N G P P +P +P P S P
Sbjct: 70 GMPSRDRNIGAPGQDTPGVSLHPLSLDSPDREPGADAPLELGDSSPQGPMSLESLAPPES 129
Query: 213 LSPPSNSKSPTSKSSPEESSSSSHSNSKKTPTSSS 247
+ ++SP E S ++ P
Sbjct: 130 TDEGAETESPEPGDEGEPGRSGLELEPEEPPGWRE 164
|
| >3u3p_A Tumor necrosis factor receptor superfamily member; trigger apoptosis, apoptosis; 2.09A {Homo sapiens} PDB: 3u3q_A 3u3s_A 3u3t_A 3u3v_A 3qo4_A Length = 313 | Back alignment and structure |
|---|
Score = 46.1 bits (108), Expect = 2e-05
Identities = 16/125 (12%), Positives = 31/125 (24%)
Query: 46 PPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGS 105
P + + + G P P P ++ P G+
Sbjct: 174 PSFSSSTSPSPGTAIFPRPEHMETHEVPSSTYVPKGMNSTESNSSASVRPKVLSSIQEGT 233
Query: 106 ASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQG 165
+S +++ P P P +A+ S P +G
Sbjct: 234 VPDNTSSARGKEDVNKTLPNLQVVNHQQGPHHRHILKLLPSMEATGGEKSSTPIKGPKRG 293
Query: 166 NPVPS 170
+P +
Sbjct: 294 HPRQN 298
|
| >3i2d_A E3 SUMO-protein ligase SIZ1; signal transduction, replication, ring E3, PIAS, ubiquitin, UBC9, metal-binding, nucleus; 2.60A {Saccharomyces cerevisiae} Length = 371 | Back alignment and structure |
|---|
Score = 46.1 bits (108), Expect = 3e-05
Identities = 16/98 (16%), Positives = 24/98 (24%), Gaps = 4/98 (4%)
Query: 67 SPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPP 126
S P S P P + + + S +PPPT ++ SS
Sbjct: 1 SLTPLSAITVRSMEGPPTVQQQSPSVIRQSPTQRRKTSTTSSTSRAPPPTNPDASSSSSS 60
Query: 127 GDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQ 164
+ P K SP +
Sbjct: 61 ----FAVPTIHFKESPFYKIQRLIPELVMNVEVTGGRG 94
|
| >3i2d_A E3 SUMO-protein ligase SIZ1; signal transduction, replication, ring E3, PIAS, ubiquitin, UBC9, metal-binding, nucleus; 2.60A {Saccharomyces cerevisiae} Length = 371 | Back alignment and structure |
|---|
Score = 43.4 bits (101), Expect = 2e-04
Identities = 14/64 (21%), Positives = 19/64 (29%)
Query: 61 STTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSES 120
+ PP S SP S +PPP + AS +S
Sbjct: 9 TVRSMEGPPTVQQQSPSVIRQSPTQRRKTSTTSSTSRAPPPTNPDASSSSSSFAVPTIHF 68
Query: 121 QSSP 124
+ SP
Sbjct: 69 KESP 72
|
| >3i2d_A E3 SUMO-protein ligase SIZ1; signal transduction, replication, ring E3, PIAS, ubiquitin, UBC9, metal-binding, nucleus; 2.60A {Saccharomyces cerevisiae} Length = 371 | Back alignment and structure |
|---|
Score = 42.6 bits (99), Expect = 4e-04
Identities = 12/65 (18%), Positives = 16/65 (24%)
Query: 45 TPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASG 104
+ P T SP P S + S P P + +S
Sbjct: 1 SLTPLSAITVRSMEGPPTVQQQSPSVIRQSPTQRRKTSTTSSTSRAPPPTNPDASSSSSS 60
Query: 105 SASPP 109
A P
Sbjct: 61 FAVPT 65
|
| >3i2d_A E3 SUMO-protein ligase SIZ1; signal transduction, replication, ring E3, PIAS, ubiquitin, UBC9, metal-binding, nucleus; 2.60A {Saccharomyces cerevisiae} Length = 371 | Back alignment and structure |
|---|
Score = 42.2 bits (98), Expect = 5e-04
Identities = 14/89 (15%), Positives = 24/89 (26%), Gaps = 2/89 (2%)
Query: 65 AASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSP 124
S P P+ + + +S S +PPP +P + S S +
Sbjct: 4 PLSAITVRSMEGPPTVQQQSPSVIRQSPTQRRKTSTTSSTSRAPPPTNPDASSSSSSFAV 63
Query: 125 PPGDGGASP--PPEQSKNSPPAPPGQAST 151
P SP ++
Sbjct: 64 PTIHFKESPFYKIQRLIPELVMNVEVTGG 92
|
| >3oun_A Putative uncharacterized protein TB39.8; peptidoglycan, Ser/Thr kinase, pseudokinase, FHA domain, REG phosphorylation; HET: TPO; 2.71A {Mycobacterium tuberculosis} Length = 157 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 3e-05
Identities = 9/64 (14%), Positives = 12/64 (18%)
Query: 71 ASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGG 130
+ P + P G + S P P G G
Sbjct: 4 SQHHHHHSSGLVPRGSHMPQGGGYAEPAGRDYDYGQSGAPDYGQPAPGGYSGYGQGGYGS 63
Query: 131 ASPP 134
A
Sbjct: 64 AGTS 67
|
| >3oun_A Putative uncharacterized protein TB39.8; peptidoglycan, Ser/Thr kinase, pseudokinase, FHA domain, REG phosphorylation; HET: TPO; 2.71A {Mycobacterium tuberculosis} Length = 157 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 8e-05
Identities = 12/64 (18%), Positives = 16/64 (25%)
Query: 55 GGGGNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPP 114
G ++ + P S P A P S P PA G S
Sbjct: 2 GSSQHHHHHSSGLVPRGSHMPQGGGYAEPAGRDYDYGQSGAPDYGQPAPGGYSGYGQGGY 61
Query: 115 PTRS 118
+
Sbjct: 62 GSAG 65
|
| >3oun_A Putative uncharacterized protein TB39.8; peptidoglycan, Ser/Thr kinase, pseudokinase, FHA domain, REG phosphorylation; HET: TPO; 2.71A {Mycobacterium tuberculosis} Length = 157 | Back alignment and structure |
|---|
Score = 41.0 bits (96), Expect = 3e-04
Identities = 7/58 (12%), Positives = 11/58 (18%)
Query: 61 STTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRS 118
++ P + G+P P P S S
Sbjct: 10 HSSGLVPRGSHMPQGGGYAEPAGRDYDYGQSGAPDYGQPAPGGYSGYGQGGYGSAGTS 67
|
| >3oun_A Putative uncharacterized protein TB39.8; peptidoglycan, Ser/Thr kinase, pseudokinase, FHA domain, REG phosphorylation; HET: TPO; 2.71A {Mycobacterium tuberculosis} Length = 157 | Back alignment and structure |
|---|
Score = 41.0 bits (96), Expect = 3e-04
Identities = 10/68 (14%), Positives = 14/68 (20%), Gaps = 3/68 (4%)
Query: 65 AASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSP 124
++ P + P P S +P P P
Sbjct: 3 SSQHHHHHSSGLVPRGSHMPQGGGYA---EPAGRDYDYGQSGAPDYGQPAPGGYSGYGQG 59
Query: 125 PPGDGGAS 132
G G S
Sbjct: 60 GYGSAGTS 67
|
| >3oun_A Putative uncharacterized protein TB39.8; peptidoglycan, Ser/Thr kinase, pseudokinase, FHA domain, REG phosphorylation; HET: TPO; 2.71A {Mycobacterium tuberculosis} Length = 157 | Back alignment and structure |
|---|
Score = 40.6 bits (95), Expect = 4e-04
Identities = 12/65 (18%), Positives = 17/65 (26%)
Query: 81 ASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKN 140
+S P + P G A P +S + P GG S +
Sbjct: 3 SSQHHHHHSSGLVPRGSHMPQGGGYAEPAGRDYDYGQSGAPDYGQPAPGGYSGYGQGGYG 62
Query: 141 SPPAP 145
S
Sbjct: 63 SAGTS 67
|
| >3oun_A Putative uncharacterized protein TB39.8; peptidoglycan, Ser/Thr kinase, pseudokinase, FHA domain, REG phosphorylation; HET: TPO; 2.71A {Mycobacterium tuberculosis} Length = 157 | Back alignment and structure |
|---|
Score = 40.3 bits (94), Expect = 5e-04
Identities = 10/65 (15%), Positives = 12/65 (18%)
Query: 71 ASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGG 130
S + P S P A P A + S G
Sbjct: 2 GSSQHHHHHSSGLVPRGSHMPQGGGYAEPAGRDYDYGQSGAPDYGQPAPGGYSGYGQGGY 61
Query: 131 ASPPP 135
S
Sbjct: 62 GSAGT 66
|
| >2uv9_A Fatty acid synthase alpha subunits; fungal, dehydratase, enoyl reductase, ketoacyl synthase, ketoacyl reductase; 3.1A {Thermomyces lanuginosus} PDB: 2uvb_A* Length = 1878 | Back alignment and structure |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 13/56 (23%), Positives = 20/56 (35%)
Query: 62 TTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTR 117
P P +S A A+P + PA P ++G A+P +P
Sbjct: 93 EPIEDEPEPTPAAASSADAAPAAAPAAPAAPAAAPAPAPASAGPAAPVQDAPVTAT 148
|
| >2uv9_A Fatty acid synthase alpha subunits; fungal, dehydratase, enoyl reductase, ketoacyl synthase, ketoacyl reductase; 3.1A {Thermomyces lanuginosus} PDB: 2uvb_A* Length = 1878 | Back alignment and structure |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 16/51 (31%), Positives = 20/51 (39%)
Query: 63 TPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASP 113
P PA+ A PAA+P + P A+P PA SA P
Sbjct: 91 DVEPIEDEPEPTPAAASSADAAPAAAPAAPAAPAAAPAPAPASAGPAAPVQ 141
|
| >2uv9_A Fatty acid synthase alpha subunits; fungal, dehydratase, enoyl reductase, ketoacyl synthase, ketoacyl reductase; 3.1A {Thermomyces lanuginosus} PDB: 2uvb_A* Length = 1878 | Back alignment and structure |
|---|
Score = 43.0 bits (101), Expect = 4e-04
Identities = 10/52 (19%), Positives = 17/52 (32%)
Query: 61 STTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPAS 112
+S A + P A + P P ++ P A +P A+
Sbjct: 97 DEPEPTPAAASSADAAPAAAPAAPAAPAAAPAPAPASAGPAAPVQDAPVTAT 148
|
| >2uv9_A Fatty acid synthase alpha subunits; fungal, dehydratase, enoyl reductase, ketoacyl synthase, ketoacyl reductase; 3.1A {Thermomyces lanuginosus} PDB: 2uvb_A* Length = 1878 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 6e-04
Identities = 12/54 (22%), Positives = 17/54 (31%)
Query: 62 TTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPP 115
P P A+ + P AA P +P A P + + P P
Sbjct: 91 DVEPIEDEPEPTPAAASSADAAPAAAPAAPAAPAAAPAPAPASAGPAAPVQDAP 144
|
| >1dx0_A Prion protein; brain, repeat; NMR {Bos taurus} SCOP: d.6.1.1 PDB: 1dx1_A 1qlx_A 1qlz_A Length = 219 | Back alignment and structure |
|---|
Score = 44.4 bits (104), Expect = 4e-05
Identities = 18/124 (14%), Positives = 23/124 (18%)
Query: 95 PPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPD 154
P P G + P PP G GG P P
Sbjct: 2 SKKRPKPGGGWNTGGSRYPGQGSPGGNRYPPQGGGGWGQPHGGGWGQPHGGGWGQPHGGG 61
Query: 155 SPPPGIQSNQGNPVPSNGTTDSRDTKWAPPSNPGSPPSPSTSQSGTPSTPNENSSPNELS 214
P +W PS P + + + S
Sbjct: 62 WGQPHGGGWGQPHGGGGWGQGGTHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGS 121
Query: 215 PPSN 218
S
Sbjct: 122 AMSR 125
|
| >1dx0_A Prion protein; brain, repeat; NMR {Bos taurus} SCOP: d.6.1.1 PDB: 1dx1_A 1qlx_A 1qlz_A Length = 219 | Back alignment and structure |
|---|
Score = 44.4 bits (104), Expect = 4e-05
Identities = 17/140 (12%), Positives = 25/140 (17%), Gaps = 2/140 (1%)
Query: 42 KKVTPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPP 101
K P P N GG PP P P P
Sbjct: 2 SKKRPKPGGGWNTGGSRYPGQGSPGGNRY--PPQGGGGWGQPHGGGWGQPHGGGWGQPHG 59
Query: 102 ASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQ 161
P P ++ A A +
Sbjct: 60 GGWGQPHGGGWGQPHGGGGWGQGGTHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYML 119
Query: 162 SNQGNPVPSNGTTDSRDTKW 181
+ + + +D D +
Sbjct: 120 GSAMSRPLIHFGSDYEDRYY 139
|
| >1dx0_A Prion protein; brain, repeat; NMR {Bos taurus} SCOP: d.6.1.1 PDB: 1dx1_A 1qlx_A 1qlz_A Length = 219 | Back alignment and structure |
|---|
Score = 44.1 bits (103), Expect = 5e-05
Identities = 16/124 (12%), Positives = 19/124 (15%)
Query: 78 PPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPPPEQ 137
P GS P P P P G G P
Sbjct: 2 SKKRPKPGGGWNTGGSRYPGQGSPGGNRYPPQGGGGWGQPHGGGWGQPHGGGWGQPHGGG 61
Query: 138 SKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPSNPGSPPSPSTSQ 197
GQ G P A + G
Sbjct: 62 WGQPHGGGWGQPHGGGGWGQGGTHGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGS 121
Query: 198 SGTP 201
+ +
Sbjct: 122 AMSR 125
|
| >1dx0_A Prion protein; brain, repeat; NMR {Bos taurus} SCOP: d.6.1.1 PDB: 1dx1_A 1qlx_A 1qlz_A Length = 219 | Back alignment and structure |
|---|
Score = 41.0 bits (95), Expect = 6e-04
Identities = 20/139 (14%), Positives = 22/139 (15%), Gaps = 10/139 (7%)
Query: 56 GGGNNSTTPAASPPPASPPPASPPPAS----PPPAASPPPGSPPPASPPPASGSASPPPA 111
G S P P P P G P
Sbjct: 1 GSKKRPKPGGGWNTGGSRYPGQGSPGGNRYPPQGGGGWGQPHGGGWGQPHGGGWGQPHGG 60
Query: 112 SPPPTRSESQSSPPPGDGGASPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSN 171
P G G N P P + G V
Sbjct: 61 GWGQPHGGGWGQPHGGGGWGQGGTHGQWNKPSKPKTNM------KHVAGAAAAGAVVGGL 114
Query: 172 GTTDSRDTKWAPPSNPGSP 190
G P + GS
Sbjct: 115 GGYMLGSAMSRPLIHFGSD 133
|
| >2uv8_A Fatty acid synthase subunit alpha (FAS2); fatty acid biosynthesis, malonyl/palmitoyl transferase, phosphopantetheine, transferase; HET: GVL FMN; 3.10A {Saccharomyces cerevisiae} PDB: 2vkz_A* 3hmj_A* Length = 1887 | Back alignment and structure |
|---|
Score = 46.1 bits (109), Expect = 4e-05
Identities = 8/52 (15%), Positives = 16/52 (30%)
Query: 62 TTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASP 113
+ +P P A +P +P P + + +A+ P
Sbjct: 93 DPSELAAKEEPAKEEAPAPTPAASAPAPAAAAPAPVAAAAPAAAAAEIADEP 144
|
| >2uv8_A Fatty acid synthase subunit alpha (FAS2); fatty acid biosynthesis, malonyl/palmitoyl transferase, phosphopantetheine, transferase; HET: GVL FMN; 3.10A {Saccharomyces cerevisiae} PDB: 2vkz_A* 3hmj_A* Length = 1887 | Back alignment and structure |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 12/49 (24%), Positives = 17/49 (34%)
Query: 61 STTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPP 109
P P +P ++P PAA+ P A A+ A P
Sbjct: 96 ELAAKEEPAKEEAPAPTPAASAPAPAAAAPAPVAAAAPAAAAAEIADEP 144
|
| >2uv8_A Fatty acid synthase subunit alpha (FAS2); fatty acid biosynthesis, malonyl/palmitoyl transferase, phosphopantetheine, transferase; HET: GVL FMN; 3.10A {Saccharomyces cerevisiae} PDB: 2vkz_A* 3hmj_A* Length = 1887 | Back alignment and structure |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 13/46 (28%), Positives = 20/46 (43%)
Query: 70 PASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPP 115
P+ P PA +P +P PA+ PA +A+ P A+
Sbjct: 94 PSELAAKEEPAKEEAPAPTPAASAPAPAAAAPAPVAAAAPAAAAAE 139
|
| >2uv8_A Fatty acid synthase subunit alpha (FAS2); fatty acid biosynthesis, malonyl/palmitoyl transferase, phosphopantetheine, transferase; HET: GVL FMN; 3.10A {Saccharomyces cerevisiae} PDB: 2vkz_A* 3hmj_A* Length = 1887 | Back alignment and structure |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 13/43 (30%), Positives = 18/43 (41%)
Query: 61 STTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPAS 103
PA +P ++P PA+ PA AA + P AS
Sbjct: 106 EEAPAPTPAASAPAPAAAAPAPVAAAAPAAAAAEIADEPVKAS 148
|
| >2uv8_A Fatty acid synthase subunit alpha (FAS2); fatty acid biosynthesis, malonyl/palmitoyl transferase, phosphopantetheine, transferase; HET: GVL FMN; 3.10A {Saccharomyces cerevisiae} PDB: 2vkz_A* 3hmj_A* Length = 1887 | Back alignment and structure |
|---|
Score = 43.0 bits (101), Expect = 4e-04
Identities = 14/59 (23%), Positives = 20/59 (33%), Gaps = 1/59 (1%)
Query: 62 TTPAASPPPASPPPASPPPASPPPAASPPP-GSPPPASPPPASGSASPPPASPPPTRSE 119
T + P PA P A++P P + P A +A+ A P S
Sbjct: 91 TPDPSELAAKEEPAKEEAPAPTPAASAPAPAAAAPAPVAAAAPAAAAAEIADEPVKASL 149
|
| >2uv8_A Fatty acid synthase subunit alpha (FAS2); fatty acid biosynthesis, malonyl/palmitoyl transferase, phosphopantetheine, transferase; HET: GVL FMN; 3.10A {Saccharomyces cerevisiae} PDB: 2vkz_A* 3hmj_A* Length = 1887 | Back alignment and structure |
|---|
Score = 42.7 bits (100), Expect = 5e-04
Identities = 16/57 (28%), Positives = 21/57 (36%), Gaps = 2/57 (3%)
Query: 60 NSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPT 116
S A P PA P AS P A+ P P A+ PA+ +A +
Sbjct: 94 PSELAAKEEPAKEEAPAPTPAASAPAPAAAAP--APVAAAAPAAAAAEIADEPVKAS 148
|
| >2uv8_A Fatty acid synthase subunit alpha (FAS2); fatty acid biosynthesis, malonyl/palmitoyl transferase, phosphopantetheine, transferase; HET: GVL FMN; 3.10A {Saccharomyces cerevisiae} PDB: 2vkz_A* 3hmj_A* Length = 1887 | Back alignment and structure |
|---|
Score = 42.3 bits (99), Expect = 6e-04
Identities = 12/51 (23%), Positives = 15/51 (29%)
Query: 61 STTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPA 111
PA PA P AS P + A +P A+ A
Sbjct: 100 KEEPAKEEAPAPTPAASAPAPAAAAPAPVAAAAPAAAAAEIADEPVKASLL 150
|
| >2uv8_A Fatty acid synthase subunit alpha (FAS2); fatty acid biosynthesis, malonyl/palmitoyl transferase, phosphopantetheine, transferase; HET: GVL FMN; 3.10A {Saccharomyces cerevisiae} PDB: 2vkz_A* 3hmj_A* Length = 1887 | Back alignment and structure |
|---|
Score = 41.9 bits (98), Expect = 8e-04
Identities = 11/51 (21%), Positives = 21/51 (41%)
Query: 75 PASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPP 125
P+ P P +P ++P PA+ + +P A+ P + + P
Sbjct: 94 PSELAAKEEPAKEEAPAPTPAASAPAPAAAAPAPVAAAAPAAAAAEIADEP 144
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.0 bits (108), Expect = 4e-05
Identities = 50/308 (16%), Positives = 87/308 (28%), Gaps = 109/308 (35%)
Query: 208 SSPNELSP-------------PSNSKSPT----------SKSSPEESSSSSHSNS--KKT 242
SS N L P P ++ PT KS + H S +K
Sbjct: 361 SSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQ 420
Query: 243 PTSS--SGHS-SDSTKGSSSNDDQAIIGATAAGVVLIVLIAIFFLARGRRRRRDAYATHY 299
P S S S K N+ R D Y
Sbjct: 421 PKESTISIPSIYLELKVKLENEYAL-----------------------HRSIVDHYNIPK 457
Query: 300 MPPPNNFNEKTVDTYYGSQTPQMHSYGSQRGVGYHGGGPDSGVLGGSKSFFT--YEELME 357
++ +D Y+ +S+ +G+H + + F + +
Sbjct: 458 TFDSDDLIPPYLDQYF-------YSH-----IGHHLKNIE---HPERMTLFRMVFLDF-- 500
Query: 358 ITNGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRH 417
F + + + N + ++QLK + + I +
Sbjct: 501 ---RFLEQKIRHDS-----TAWNASGSILNTLQQLKF-----YKPY------ICD-NDPK 540
Query: 418 LVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHED 477
LV I +F+P +E +L ++T ++IAL A + E+
Sbjct: 541 YERLVN---------AILDFLP--KIEENLI-----CSKYTDLLRIALMAEDE--AIFEE 582
Query: 478 CHPKIIHR 485
H K + R
Sbjct: 583 AH-KQVQR 589
|
| >2yew_A Capsid protein, coat protein; alphavirus, molecular dynamics; 5.00A {Barmah forest virus} Length = 253 | Back alignment and structure |
|---|
Score = 44.6 bits (105), Expect = 5e-05
Identities = 14/90 (15%), Positives = 16/90 (17%), Gaps = 2/90 (2%)
Query: 70 PASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDG 129
P P P P PPA P G + Q
Sbjct: 5 PTQTFYGRRW--RPAPVQRYIPQPQPPAPPRRRRGPSQLQQLVAALGALALQPKQKQKRA 62
Query: 130 GASPPPEQSKNSPPAPPGQASTPPDSPPPG 159
P + T PG
Sbjct: 63 QKKPKKTPPPKPKKTQKPKKPTQKKKSKPG 92
|
| >2yew_A Capsid protein, coat protein; alphavirus, molecular dynamics; 5.00A {Barmah forest virus} Length = 253 | Back alignment and structure |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 12/91 (13%), Positives = 20/91 (21%), Gaps = 3/91 (3%)
Query: 63 TPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQS 122
T P P P P A P P + + + ++
Sbjct: 6 TQTFYGRRWRPAPVQRYIPQPQPPAPPRRRRGPSQLQQLVAALGALALQPKQKQK---RA 62
Query: 123 SPPPGDGGASPPPEQSKNSPPAPPGQASTPP 153
P P + K P ++
Sbjct: 63 QKKPKKTPPPKPKKTQKPKKPTQKKKSKPGK 93
|
| >2yew_A Capsid protein, coat protein; alphavirus, molecular dynamics; 5.00A {Barmah forest virus} Length = 253 | Back alignment and structure |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 14/87 (16%), Positives = 22/87 (25%), Gaps = 2/87 (2%)
Query: 62 TTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPP--PASPPPTRSE 119
T P P PPA P A+ A + +
Sbjct: 6 TQTFYGRRWRPAPVQRYIPQPQPPAPPRRRRGPSQLQQLVAALGALALQPKQKQKRAQKK 65
Query: 120 SQSSPPPGDGGASPPPEQSKNSPPAPP 146
+ +PPP P + ++ P
Sbjct: 66 PKKTPPPKPKKTQKPKKPTQKKKSKPG 92
|
| >3a58_A Exocyst complex component SEC3; protein complex, PH domain, GTPase, membrane traffic, coiled coil, exocytosis, phosphoprotein; HET: GNP; 2.60A {Saccharomyces cerevisiae} Length = 320 | Back alignment and structure |
|---|
Score = 44.5 bits (104), Expect = 6e-05
Identities = 11/83 (13%), Positives = 15/83 (18%)
Query: 56 GGGNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPP 115
S A P S + P S P S + P
Sbjct: 237 YLDERSYQRAVITNRPGSVSPIKSPTSNFTTNTTQSVGSVPFSAPTERTRRSETESVNPV 296
Query: 116 TRSESQSSPPPGDGGASPPPEQS 138
+ S P +
Sbjct: 297 STPASVEYHAGMKSLNKAPYSSN 319
|
| >3a58_A Exocyst complex component SEC3; protein complex, PH domain, GTPase, membrane traffic, coiled coil, exocytosis, phosphoprotein; HET: GNP; 2.60A {Saccharomyces cerevisiae} Length = 320 | Back alignment and structure |
|---|
Score = 43.8 bits (102), Expect = 1e-04
Identities = 13/89 (14%), Positives = 27/89 (30%)
Query: 50 DNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPP 109
D + + + P S P P ++ + GS P ++P + +
Sbjct: 232 DLSLFYLDERSYQRAVITNRPGSVSPIKSPTSNFTTNTTQSVGSVPFSAPTERTRRSETE 291
Query: 110 PASPPPTRSESQSSPPPGDGGASPPPEQS 138
+P T + + +P S
Sbjct: 292 SVNPVSTPASVEYHAGMKSLNKAPYSSNS 320
|
| >3a58_A Exocyst complex component SEC3; protein complex, PH domain, GTPase, membrane traffic, coiled coil, exocytosis, phosphoprotein; HET: GNP; 2.60A {Saccharomyces cerevisiae} Length = 320 | Back alignment and structure |
|---|
Score = 43.0 bits (100), Expect = 2e-04
Identities = 11/90 (12%), Positives = 20/90 (22%)
Query: 56 GGGNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPP 115
+ + P SP + + + S SA
Sbjct: 230 NWDLSLFYLDERSYQRAVITNRPGSVSPIKSPTSNFTTNTTQSVGSVPFSAPTERTRRSE 289
Query: 116 TRSESQSSPPPGDGGASPPPEQSKNSPPAP 145
T S + S P + +K +
Sbjct: 290 TESVNPVSTPASVEYHAGMKSLNKAPYSSN 319
|
| >3a58_A Exocyst complex component SEC3; protein complex, PH domain, GTPase, membrane traffic, coiled coil, exocytosis, phosphoprotein; HET: GNP; 2.60A {Saccharomyces cerevisiae} Length = 320 | Back alignment and structure |
|---|
Score = 41.5 bits (96), Expect = 7e-04
Identities = 11/80 (13%), Positives = 17/80 (21%)
Query: 73 PPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGAS 132
+ P + P SP + S P S P R+ +
Sbjct: 240 ERSYQRAVITNRPGSVSPIKSPTSNFTTNTTQSVGSVPFSAPTERTRRSETESVNPVSTP 299
Query: 133 PPPEQSKNSPPAPPGQASTP 152
E S+
Sbjct: 300 ASVEYHAGMKSLNKAPYSSN 319
|
| >3ttv_A Catalase HPII; heme orientation, oxidoreductase; HET: HEM; 1.45A {Escherichia coli} PDB: 3ttt_A* 1gge_A* 1iph_A* 4ens_A* 3ttu_A* 3p9p_A* 4enq_A* 1p81_A* 3ttx_A* 4enw_A* 3ttw_A* 4ent_A* 1qws_A* 1cf9_A* 1p80_A* 1qf7_A* 4enu_A* 4enp_A* 1gg9_A* 1ggf_A* ... Length = 753 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 7e-05
Identities = 16/100 (16%), Positives = 23/100 (23%), Gaps = 10/100 (10%)
Query: 72 SPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGA 131
S P P P S P GS P PP +
Sbjct: 2 SQHNEKNPHQHQSPLHDSSEAKPGMDSLAPEDGSHRPAAEPTPPGAQPTAPGSLKAPDTR 61
Query: 132 SPPPEQSKNSPPAPPGQASTPPDSPPPGIQSNQGNPVPSN 171
+ ++ A T +NQG + +
Sbjct: 62 NEKLNSLEDVRKGSENYALT----------TNQGVRIADD 91
|
| >3iz6_A 40S ribosomal protein SA (S2P); eukaryotic ribosome,homology modeling,de novo modeling,ribos proteins,novel ribosomal proteins, ribosome; 5.50A {Triticum aestivum} Length = 305 | Back alignment and structure |
|---|
Score = 42.8 bits (100), Expect = 2e-04
Identities = 24/98 (24%), Positives = 33/98 (33%), Gaps = 7/98 (7%)
Query: 22 ERKEEAKAPPAPAEKTESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPA 81
+ +EE +A + E GG T AA P + A
Sbjct: 215 KEQEEEEAALVAPDYGAVAEYAAPAADT------WGGEWGTDAAAQPAAIPAQAGADWTA 268
Query: 82 SPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSE 119
+P PAA + +P GSA P A+P P E
Sbjct: 269 APAPAA-GGWDTAAAPAPGWEQGSAPVPAAAPTPNWGE 305
|
| >1w7p_D VPS36P, YLR417W; ESCRT-II complex, endosomal protein sorting, protein transpo; 3.60A {Saccharomyces cerevisiae} SCOP: a.4.5.54 a.4.5.54 Length = 566 | Back alignment and structure |
|---|
Score = 41.6 bits (96), Expect = 8e-04
Identities = 16/242 (6%), Positives = 50/242 (20%), Gaps = 9/242 (3%)
Query: 36 KTESPEKKVTPPPADNNNNGGGGNNSTTPAASPPPASPPPASPPPASPPPAASPPPGSPP 95
++ P + + S ++ ++ P P
Sbjct: 86 RSPRLILFFKDPSSKDELGKSAETASADVVSTWVCPICMVSNETQGEFTKDTLPTPICIN 145
Query: 96 PASPPPASGSASPPPASPPPTRSESQSSPPPGDGGAS---------PPPEQSKNSPPAPP 146
P + S S + + + + P + P
Sbjct: 146 CGVPADYELTKSSINCSNAIDPNANPQNQFGVNSENICPACTFANHPQIGNCEICGHRLP 205
Query: 147 GQASTPPDSPPPGIQSNQGNPVPSNGTTDSRDTKWAPPSNPGSPPSPSTSQSGTPSTPNE 206
+ ++ + + + + S+ S S + + +
Sbjct: 206 NASKVRSKLNRLNFHDSRVHIELEKNSLARNKSSHSALSSSSSTGSSTEFVQLSFRKSDG 265
Query: 207 NSSPNELSPPSNSKSPTSKSSPEESSSSSHSNSKKTPTSSSGHSSDSTKGSSSNDDQAII 266
+ + S + +SS ++ + + I
Sbjct: 266 VLFSQATERALENILTEKNKHIFNQNVVSVNGVDMRKGASSHEYNNEVPFIETKLSRIGI 325
Query: 267 GA 268
+
Sbjct: 326 SS 327
|
| >1pcx_A Protein transport protein SEC24; 2.50A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 PDB: 1pd0_A 1pd1_A Length = 810 | Back alignment and structure |
|---|
Score = 41.9 bits (97), Expect = 8e-04
Identities = 16/66 (24%), Positives = 20/66 (30%), Gaps = 3/66 (4%)
Query: 69 PPASPPPASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGD 128
PA P++ + P P PPP + PPP P S
Sbjct: 2 APAYGQPSAAMGQNMRPMNQLYPIDLLTELPPPITDLTLPPPPLVIPPERMLVPSE---L 58
Query: 129 GGASPP 134
ASP
Sbjct: 59 SNASPD 64
|
| >2kpy_A Major pollen allergen ART V 1; defensin-like, poly-proline; NMR {Artemisia vulgaris} Length = 108 | Back alignment and structure |
|---|
Score = 38.6 bits (89), Expect = 8e-04
Identities = 24/63 (38%), Positives = 30/63 (47%), Gaps = 9/63 (14%)
Query: 75 PASPPPASPPPAASPPPGSPPPASPPPASGSASPPPASPPPTRSESQSSPPPGDGGASPP 134
SPP A+P P + PP + + PPA G + PPPA PP DGG+ PP
Sbjct: 54 SKSPPGATPAPPGAAPPPAAGGSPSPPADGGSPPPPAD---------GGSPPVDGGSPPP 104
Query: 135 PEQ 137
P
Sbjct: 105 PST 107
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 723 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.81 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.72 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.43 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.33 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.17 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.15 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.84 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.82 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.81 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.66 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.62 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.6 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.33 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.32 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.17 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.16 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.08 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 98.04 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.9 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.76 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.75 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.61 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.58 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.56 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.53 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 97.39 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 97.34 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 97.31 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.27 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.09 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.67 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 96.47 | |
| 2k9y_A | 41 | Ephrin type-A receptor 2; receptor tyrosine kinase | 95.59 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.57 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.41 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 94.8 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 94.59 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 93.21 | |
| 2l34_A | 33 | TYRO protein tyrosine kinase-binding protein; immu | 92.84 | |
| 2klu_A | 70 | T-cell surface glycoprotein CD4; cell membrane, di | 90.36 | |
| 2knc_A | 54 | Integrin alpha-IIB; transmembrane signaling, prote | 89.81 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 89.65 | |
| 2l8s_A | 54 | Integrin alpha-1; transmembrane region, detergent | 88.05 | |
| 2knc_B | 79 | Integrin beta-3; transmembrane signaling, protein | 86.94 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 86.89 | |
| 1cja_A | 342 | Protein (actin-fragmin kinase); transferase; HET: | 86.75 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 85.89 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 85.4 | |
| 2llm_A | 43 | Amyloid beta A4 protein; alzheimer'S disease, prot | 84.17 | |
| 2k1a_A | 42 | Integrin alpha-IIB; single-PASS transmembrane segm | 81.58 | |
| 2l6w_A | 39 | Beta-type platelet-derived growth factor receptor; | 80.64 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-54 Score=458.08 Aligned_cols=257 Identities=25% Similarity=0.464 Sum_probs=213.5
Q ss_pred cCcccceEEeccCcEEEEEEEcC------CCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLP------EGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLL 433 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~------~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 433 (723)
++|.+.+.||+|+||.||+|++. +++.||||+++.......++|++|+++|++|+|+|||+|+|+|.+.+..||
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 56888999999999999999763 467899999988776777889999999999999999999999999999999
Q ss_pred EEEecCCCchhhccccCC-----------CCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEE
Q 046750 434 IYEFVPNNNLEHHLHGKG-----------QPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQV 502 (723)
Q Consensus 434 V~E~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL 502 (723)
|||||++|+|.++|+..+ ...++|..+++|+.||++||+|||++ +|||||||++||||++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEE
Confidence 999999999999997542 34589999999999999999999998 5999999999999999999999
Q ss_pred eecccccccCCCCcce-eecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhh
Q 046750 503 ADFGLAKLNDTTQTHV-STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPV 580 (723)
Q Consensus 503 ~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~ 580 (723)
+|||+++......... .....||+.|||||++.++.|+.|+|||||||+||||++ |+.||..... ..
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~---~~-------- 238 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---NE-------- 238 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH---HH--------
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HH--------
Confidence 9999998665433322 233569999999999999999999999999999999998 8999975431 11
Q ss_pred hhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccC
Q 046750 581 LVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEG 639 (723)
Q Consensus 581 l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~ 639 (723)
+...+..+....+ +......+.+|+.+||+.||++||+|.||++.|+.+.
T Consensus 239 ~~~~i~~~~~~~~---------p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~ 288 (299)
T 4asz_A 239 VIECITQGRVLQR---------PRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA 288 (299)
T ss_dssp HHHHHHHTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHcCCCCCC---------CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 2223333332211 1122346889999999999999999999999998754
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-53 Score=454.41 Aligned_cols=258 Identities=26% Similarity=0.433 Sum_probs=212.1
Q ss_pred cCcccceEEeccCcEEEEEEEcC------CCcEEEEEEcccCC-chhHHHHHHHHHHHHHccCCceeeEeeeeecccceE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLP------EGKVVAVKQLKSGS-GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRL 432 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~------~g~~VAvK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 432 (723)
..+++.++||+|+||.||+|.+. +++.||||+++... ....++|++|+.+|++|+|||||+|+|+|.+.+..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 34677889999999999999763 46789999997653 334568999999999999999999999999999999
Q ss_pred EEEEecCCCchhhccccCC--------------CCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCC
Q 046750 433 LIYEFVPNNNLEHHLHGKG--------------QPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEF 498 (723)
Q Consensus 433 lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~ 498 (723)
||||||.+|+|.++|+.+. ...++|..+++|+.|||+||+|||++ +|||||||++||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCC
Confidence 9999999999999996532 23589999999999999999999999 599999999999999999
Q ss_pred cEEEeecccccccCCCCc-ceeecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHh
Q 046750 499 EAQVADFGLAKLNDTTQT-HVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEW 576 (723)
Q Consensus 499 ~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~ 576 (723)
.+||+|||+++....... .......||+.|||||++.++.|+.++||||||||||||++ |+.||..... ..
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~---~~---- 255 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---QD---- 255 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH---HH----
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH---HH----
Confidence 999999999986543332 23345679999999999999999999999999999999998 8999975431 11
Q ss_pred hhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCC
Q 046750 577 ARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGE 640 (723)
Q Consensus 577 ~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~ 640 (723)
+.+.+..+....+ .......+.+|+.+||+.||.+||+|.||++.|+....
T Consensus 256 ----~~~~i~~~~~~~~---------p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~n 306 (308)
T 4gt4_A 256 ----VVEMIRNRQVLPC---------PDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGN 306 (308)
T ss_dssp ----HHHHHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC
T ss_pred ----HHHHHHcCCCCCC---------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhccC
Confidence 2233334432222 12233468899999999999999999999999987543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-54 Score=459.80 Aligned_cols=258 Identities=27% Similarity=0.454 Sum_probs=207.2
Q ss_pred cCcccceEEeccCcEEEEEEEcC------CCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLP------EGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLL 433 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~------~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 433 (723)
++|.+.++||+|+||.||+|++. +++.||||+++.......++|++|+++|++|+|+|||+|+|+|.+.+..||
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45778899999999999999764 478899999988776677889999999999999999999999999999999
Q ss_pred EEEecCCCchhhccccCC-------------CCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcE
Q 046750 434 IYEFVPNNNLEHHLHGKG-------------QPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEA 500 (723)
Q Consensus 434 V~E~~~~gsL~~~l~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~v 500 (723)
|||||.+|+|.++|+... ...++|.++++|+.|||+||+|||++ +|||||||++||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcE
Confidence 999999999999997542 23589999999999999999999998 59999999999999999999
Q ss_pred EEeecccccccCCCCc-ceeecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhh
Q 046750 501 QVADFGLAKLNDTTQT-HVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWAR 578 (723)
Q Consensus 501 kL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~ 578 (723)
||+|||+++....... ......+||+.|||||++.+..|+.++||||||||||||++ |+.||..... ..
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~---~~------ 268 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN---TE------ 268 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH---HH------
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH---HH------
Confidence 9999999986644332 23345679999999999999999999999999999999999 8999975431 11
Q ss_pred hhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCC
Q 046750 579 PVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGE 640 (723)
Q Consensus 579 ~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~ 640 (723)
+...+..+.... .+......+.+|+.+||+.||++||+|.||++.|+.+..
T Consensus 269 --~~~~i~~g~~~~---------~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 269 --AIDCITQGRELE---------RPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp --HHHHHHHTCCCC---------CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred --HHHHHHcCCCCC---------CcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 112222332111 111223467899999999999999999999999988654
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-52 Score=443.26 Aligned_cols=258 Identities=29% Similarity=0.492 Sum_probs=201.7
Q ss_pred cCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCC--chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEe
Q 046750 360 NGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGS--GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEF 437 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 437 (723)
++|.+.++||+|+||.||+|++.+ .||||+++... .+..+.|++|+++|++|+|+|||+|+|+|.+ +..||||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 467788999999999999998753 69999987542 3445689999999999999999999999865 568999999
Q ss_pred cCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCC-c
Q 046750 438 VPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ-T 516 (723)
Q Consensus 438 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~-~ 516 (723)
|++|+|.++|+.... .++|..+++|+.|||+||+|||++ +|||||||++||||++++.+||+|||+|+...... .
T Consensus 113 ~~gGsL~~~l~~~~~-~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~ 188 (307)
T 3omv_A 113 CEGSSLYKHLHVQET-KFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS 188 (307)
T ss_dssp CSSCBHHHHHHTSCC-CCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred CCCCCHHHHHhhcCC-CCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence 999999999976543 489999999999999999999998 59999999999999999999999999998665332 2
Q ss_pred ceeecccccccccChhhhcc---CCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccc
Q 046750 517 HVSTRVMGTFGYLAPEYASS---GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEI 593 (723)
Q Consensus 517 ~~~~~~~gt~~y~APE~~~~---~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~ 593 (723)
......+||+.|||||++.+ +.|+.|+||||||||||||++|+.||..... ... +...+..+...
T Consensus 189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~---~~~-------~~~~~~~~~~~-- 256 (307)
T 3omv_A 189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN---RDQ-------IIFMVGRGYAS-- 256 (307)
T ss_dssp -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC---HHH-------HHHHHHTTCCC--
T ss_pred eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh---HHH-------HHHHHhcCCCC--
Confidence 23345679999999999964 4589999999999999999999999975432 111 11112222111
Q ss_pred cchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccC
Q 046750 594 VDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEG 639 (723)
Q Consensus 594 vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~ 639 (723)
+.+. .........+.+|+.+||+.||.+||+|.||++.|+.+.
T Consensus 257 --p~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~ 299 (307)
T 3omv_A 257 --PDLS-KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ 299 (307)
T ss_dssp --CCST-TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred --CCcc-cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 1110 111122346888999999999999999999999998654
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=452.82 Aligned_cols=251 Identities=22% Similarity=0.413 Sum_probs=204.0
Q ss_pred cCcccceEEeccCcEEEEEEE-cCCCcEEEEEEcccCC--chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGN-LPEGKVVAVKQLKSGS--GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYE 436 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~-~~~g~~VAvK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 436 (723)
++|++++.||+|+||.||+|+ ..+|+.||||+++... ....+.|++|+++|++|+|+|||+++++|.+.+.+|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 689999999999999999995 4579999999997543 3344678999999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCc
Q 046750 437 FVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQT 516 (723)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 516 (723)
||.||+|.++|+......+++..++.|+.||+.||+|||++ +||||||||+||||++++.+||+|||+|+.+....
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~- 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV- 179 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCCc-
Confidence 99999999999876666688899999999999999999999 59999999999999999999999999998664321
Q ss_pred ceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccch
Q 046750 517 HVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDP 596 (723)
Q Consensus 517 ~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~ 596 (723)
......+||+.|||||++.+..|+.++||||||||||||++|+.||..... .+ +...+..+.+..+
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~------~~-----~~~~i~~~~~~~~--- 245 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM------KN-----LVLKIISGSFPPV--- 245 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HH-----HHHHHHHTCCCCC---
T ss_pred ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------HH-----HHHHHHcCCCCCC---
Confidence 123446799999999999999999999999999999999999999975431 11 1222333333211
Q ss_pred hhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 597 RLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 597 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
...+ ...+.+|+.+||+.||.+||++.||++.
T Consensus 246 --~~~~----s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 246 --SLHY----SYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp --CTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --CccC----CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1122 2357889999999999999999999864
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-52 Score=445.95 Aligned_cols=250 Identities=21% Similarity=0.322 Sum_probs=207.3
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEec
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFV 438 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 438 (723)
+.|++.++||+|+||.||+|.. .+|+.||||+++.......+.+.+|+++|++|+|+|||+|+++|.+.+.+|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 4689999999999999999954 569999999997655555567899999999999999999999999999999999999
Q ss_pred CCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcce
Q 046750 439 PNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHV 518 (723)
Q Consensus 439 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 518 (723)
++|+|.+++.+. .+++..+..|+.||+.||+|||++ +||||||||+||||+.++.+||+|||+|+.+..... .
T Consensus 154 ~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-~ 226 (346)
T 4fih_A 154 EGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-R 226 (346)
T ss_dssp TTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-C
T ss_pred CCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCC-c
Confidence 999999999753 388999999999999999999999 599999999999999999999999999987654332 2
Q ss_pred eecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhh
Q 046750 519 STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRL 598 (723)
Q Consensus 519 ~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l 598 (723)
....+||+.|||||++.+..|+.++||||||||||||++|+.||..... .. +.+.+..+....+
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~---~~--------~~~~i~~~~~~~~----- 290 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP---LK--------AMKMIRDNLPPRL----- 290 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HH--------HHHHHHHSSCCCC-----
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---HH--------HHHHHHcCCCCCC-----
Confidence 3456899999999999999999999999999999999999999975432 11 1112222111111
Q ss_pred hccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 599 EKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 599 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
. ........+.+|+.+||..||++||++.||++.
T Consensus 291 ~--~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 291 K--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp S--CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred C--ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0 011112367889999999999999999999874
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-52 Score=441.78 Aligned_cols=272 Identities=23% Similarity=0.340 Sum_probs=204.3
Q ss_pred cCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeeccc----ceEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEK----NRLLIY 435 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~----~~~lV~ 435 (723)
++|.+.++||+|+||.||+|++ +|+.||||+++... .....+++|+.++.+|+|+|||+|+|+|.+.+ .+||||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 5678889999999999999988 68999999997532 12223345666677899999999999998764 479999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccC-----CCceeecCCCCCcEEeCCCCcEEEeecccccc
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDC-----HPKIIHRDIKSANILVDDEFEAQVADFGLAKL 510 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g-----~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 510 (723)
|||++|+|.++|+.. .+.|..+++|+.|+++||+|||+++ .++|||||||++||||++++++||+|||+++.
T Consensus 81 Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp ECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred cCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 999999999999764 3899999999999999999999863 34699999999999999999999999999987
Q ss_pred cCCCCcce---eecccccccccChhhhccC------CCCCccceechHHHHHHHHhCCCCCCCCCCCCc----hhhHHhh
Q 046750 511 NDTTQTHV---STRVMGTFGYLAPEYASSG------KLTDRSDVFSFGVVLLELITGRKPVDPTQPLGD----ESLVEWA 577 (723)
Q Consensus 511 ~~~~~~~~---~~~~~gt~~y~APE~~~~~------~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~----~~l~~~~ 577 (723)
........ ....+||+.|||||++.+. .++.|+||||||||||||++|+.+|........ .....+.
T Consensus 158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~ 237 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence 65443322 2345799999999999764 367799999999999999999888754332111 0001111
Q ss_pred hhhhhhhhhcCCcccccchhhhcc-ccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCC
Q 046750 578 RPVLVRAIETGDLSEIVDPRLEKH-YVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGE 640 (723)
Q Consensus 578 ~~~l~~~i~~~~l~~~vd~~l~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~ 640 (723)
...+.+.+..+.+ ++.+... ...+....|.+|+.+||+.||.+||+|.||++.|+++.+
T Consensus 238 ~~~~~~~~~~~~~----rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 238 VEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp HHHHHHHHTTSCC----CCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHhcccC----CCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 1112222222222 2222222 123456678999999999999999999999999987654
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-51 Score=439.55 Aligned_cols=252 Identities=20% Similarity=0.236 Sum_probs=203.7
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEec
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFV 438 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 438 (723)
+.|.+.++||+|+||.||+|+. .+|+.||||+++.... +.+|+++|++|+|||||+++++|.+.+.+|||||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 4588889999999999999954 5689999999975422 246999999999999999999999999999999999
Q ss_pred CCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCC-cEEEeecccccccCCCCcc
Q 046750 439 PNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEF-EAQVADFGLAKLNDTTQTH 517 (723)
Q Consensus 439 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~-~vkL~DFGla~~~~~~~~~ 517 (723)
+||+|.++|++.+ .+++..++.|+.||+.||+|||++ +||||||||+||||+.++ ++||+|||+|+.+......
T Consensus 133 ~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 133 EGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp TTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence 9999999997654 489999999999999999999999 599999999999999987 6999999999876543221
Q ss_pred ----eeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccc
Q 046750 518 ----VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEI 593 (723)
Q Consensus 518 ----~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~ 593 (723)
....++||+.|||||++.+..|+.++||||||||||||++|+.||....... +...+..+...
T Consensus 208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~-----------~~~~i~~~~~~-- 274 (336)
T 4g3f_A 208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP-----------LCLKIASEPPP-- 274 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC-----------CHHHHHHSCCG--
T ss_pred cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-----------HHHHHHcCCCC--
Confidence 1233579999999999999999999999999999999999999997654321 11112111110
Q ss_pred cchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccC
Q 046750 594 VDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEG 639 (723)
Q Consensus 594 vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~ 639 (723)
+ ..+.......+.+|+.+||+.||.+||++.||++.|+...
T Consensus 275 ----~-~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l 315 (336)
T 4g3f_A 275 ----I-REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKAL 315 (336)
T ss_dssp ----G-GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----c-hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 0 0111122346788999999999999999999999886643
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-51 Score=449.96 Aligned_cols=250 Identities=21% Similarity=0.312 Sum_probs=208.0
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEec
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFV 438 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 438 (723)
+.|++.+.||+|+||.||+|+. .+|+.||||++........+.+.+|+++|++|+|+|||+|+++|.+.+.+|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 5699999999999999999954 569999999998766566667899999999999999999999999999999999999
Q ss_pred CCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcce
Q 046750 439 PNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHV 518 (723)
Q Consensus 439 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 518 (723)
.||+|.++++.. .+.+..+..|+.||+.||+|||++ +|||||||++||||+.++.+||+|||+|+.+..... .
T Consensus 231 ~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~-~ 303 (423)
T 4fie_A 231 EGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-R 303 (423)
T ss_dssp TTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-C
T ss_pred CCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCc-c
Confidence 999999999754 388999999999999999999999 599999999999999999999999999987654332 2
Q ss_pred eecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhh
Q 046750 519 STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRL 598 (723)
Q Consensus 519 ~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l 598 (723)
....+||+.|||||++.+..|+.++||||||||||||++|+.||..... ..+ ++.+..+....+- .
T Consensus 304 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~---~~~--------~~~i~~~~~~~~~---~ 369 (423)
T 4fie_A 304 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP---LKA--------MKMIRDNLPPRLK---N 369 (423)
T ss_dssp BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHH--------HHHHHHSCCCCCS---C
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---HHH--------HHHHHcCCCCCCc---c
Confidence 3456799999999999999999999999999999999999999975432 111 1122222111110 0
Q ss_pred hccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 599 EKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 599 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
...+ ...+.+|+.+||..||.+|+++.||++.
T Consensus 370 ~~~~----s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 370 LHKV----SPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp TTSS----CHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cccC----CHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0111 2357889999999999999999999874
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-51 Score=436.76 Aligned_cols=248 Identities=21% Similarity=0.345 Sum_probs=207.0
Q ss_pred cCcccceEEeccCcEEEEEEE-cCCCcEEEEEEcccC---CchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGN-LPEGKVVAVKQLKSG---SGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~-~~~g~~VAvK~l~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 435 (723)
++|++.++||+|+||.||+|+ ..+|+.||||++... .....+.+.+|+++|++|+|||||+++++|.+.+.+||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 569999999999999999995 567999999999643 2234467899999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ 515 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 515 (723)
|||.||+|.++|.+.+ .+++..+..|+.||+.||+|||++ +||||||||+||||++++.+||+|||+|+.+....
T Consensus 112 Ey~~gG~L~~~i~~~~--~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred ecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 9999999999997654 488999999999999999999999 59999999999999999999999999998765433
Q ss_pred c-ceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCccccc
Q 046750 516 T-HVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIV 594 (723)
Q Consensus 516 ~-~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~v 594 (723)
. ......+||+.|||||++.+..|+.++||||||||||||++|+.||..... .. +.+.+..+.+.
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~---~~--------~~~~i~~~~~~--- 252 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE---GL--------IFAKIIKLEYD--- 252 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HH--------HHHHHHHTCCC---
T ss_pred CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HH--------HHHHHHcCCCC---
Confidence 2 234457899999999999999999999999999999999999999975431 11 22233333321
Q ss_pred chhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 046750 595 DPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVR 633 (723)
Q Consensus 595 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~ 633 (723)
+...+ ...+.+|+.+||+.||.+|+++.|++.
T Consensus 253 ---~p~~~----s~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 253 ---FPEKF----FPKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp ---CCTTC----CHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred ---CCccc----CHHHHHHHHHHccCCHhHCcChHHHcC
Confidence 11122 235788999999999999999998743
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-51 Score=443.56 Aligned_cols=261 Identities=26% Similarity=0.399 Sum_probs=211.7
Q ss_pred HhcCcccceEEeccCcEEEEEEEcCC------CcEEEEEEcccCCch-hHHHHHHHHHHHHHccC-CceeeEeeeeecc-
Q 046750 358 ITNGFARENVIGEGGFGCVYKGNLPE------GKVVAVKQLKSGSGQ-GEREFRAEVEIISRVHH-RHLVSLVGYCISE- 428 (723)
Q Consensus 358 ~~~~f~~~~~LG~G~fG~Vy~~~~~~------g~~VAvK~l~~~~~~-~~~~~~~Ei~il~~l~H-pnIv~l~g~~~~~- 428 (723)
-.++|++.++||+|+||.||+|.+.. ++.||||+++..... ..++|.+|+++|.+|+| +|||+|+|+|.+.
T Consensus 62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~ 141 (353)
T 4ase_A 62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 141 (353)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC
Confidence 35689999999999999999996532 368999999876443 34679999999999965 8999999999764
Q ss_pred cceEEEEEecCCCchhhccccCC--------------CCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEe
Q 046750 429 KNRLLIYEFVPNNNLEHHLHGKG--------------QPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILV 494 (723)
Q Consensus 429 ~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl 494 (723)
+.+|||||||.+|+|.++|+... ...+++..++.|+.|||+||+|||++ +|||||||++||||
T Consensus 142 ~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NILl 218 (353)
T 4ase_A 142 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILL 218 (353)
T ss_dssp SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccceee
Confidence 56899999999999999997532 24589999999999999999999999 59999999999999
Q ss_pred CCCCcEEEeecccccccCCCCcc-eeecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchh
Q 046750 495 DDEFEAQVADFGLAKLNDTTQTH-VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDES 572 (723)
Q Consensus 495 ~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~ 572 (723)
++++.+||+|||+|+........ ......||+.|||||++.++.|+.++|||||||+||||++ |+.||...... ..
T Consensus 219 ~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~--~~ 296 (353)
T 4ase_A 219 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EE 296 (353)
T ss_dssp CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS--HH
T ss_pred CCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH--HH
Confidence 99999999999999876544333 3345679999999999999999999999999999999998 99999764321 11
Q ss_pred hHHhhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCC
Q 046750 573 LVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGE 640 (723)
Q Consensus 573 l~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~ 640 (723)
+.+.+..+....+ .......+.+|+.+||+.||.+||+|.||+++|+.+.+
T Consensus 297 --------~~~~i~~g~~~~~---------p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq 347 (353)
T 4ase_A 297 --------FCRRLKEGTRMRA---------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347 (353)
T ss_dssp --------HHHHHHHTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------HHHHHHcCCCCCC---------CccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence 1222333321111 11123367889999999999999999999999987643
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-50 Score=422.77 Aligned_cols=247 Identities=26% Similarity=0.425 Sum_probs=197.2
Q ss_pred ccceEEeccCcEEEEEEEc-CCCcEEEEEEcccC--CchhHHHHHHHHHHHHHccCCceeeEeeeeec----ccceEEEE
Q 046750 363 ARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSG--SGQGEREFRAEVEIISRVHHRHLVSLVGYCIS----EKNRLLIY 435 (723)
Q Consensus 363 ~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~----~~~~~lV~ 435 (723)
++.++||+|+||.||+|.+ .+++.||||++... .....+.|++|+++|++|+|||||+++++|.+ ...+||||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 5667899999999999954 56899999998653 33345679999999999999999999999875 34579999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCC-CCcEEEeecccccccCCC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDD-EFEAQVADFGLAKLNDTT 514 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~-~~~vkL~DFGla~~~~~~ 514 (723)
|||.+|+|.++|++.. .+++..+..|+.||+.||+|||+++ ++||||||||+||||+. ++.+||+|||+|+.....
T Consensus 109 Ey~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~ 185 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 185 (290)
T ss_dssp ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred eCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC
Confidence 9999999999997654 4889999999999999999999983 23999999999999984 789999999999865432
Q ss_pred CcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCccccc
Q 046750 515 QTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIV 594 (723)
Q Consensus 515 ~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~v 594 (723)
.....+||+.|||||++.+ .|+.++||||||||||||++|+.||..... ... +.+.+..+.....
T Consensus 186 ---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~--~~~--------~~~~i~~~~~~~~- 250 (290)
T 3fpq_A 186 ---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQ--------IYRRVTSGVKPAS- 250 (290)
T ss_dssp ---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--HHH--------HHHHHTTTCCCGG-
T ss_pred ---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc--HHH--------HHHHHHcCCCCCC-
Confidence 2345679999999998864 699999999999999999999999965432 111 2222333221111
Q ss_pred chhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 595 DPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 595 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
+..... ..+.+|+.+||+.||.+||++.||++.
T Consensus 251 ---~~~~~~----~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 251 ---FDKVAI----PEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp ---GGGCCC----HHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ---CCccCC----HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111121 257789999999999999999999863
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-50 Score=418.65 Aligned_cols=246 Identities=22% Similarity=0.358 Sum_probs=191.3
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCC---chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS---GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 435 (723)
++|++.+.||+|+||.||+|.. .+|+.||||+++... ......+.+|+++|++|+|||||++++++.+.+..||||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 5799999999999999999954 569999999997542 233457899999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ 515 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 515 (723)
||+ +|+|.++|..++ .+++..+..|+.||+.||+|||++ +||||||||+||||++++++||+|||+|+......
T Consensus 93 Ey~-~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 166 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRD--KMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN 166 (275)
T ss_dssp ECC-CEEHHHHHHHSC--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred eCC-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence 999 789999987654 489999999999999999999999 59999999999999999999999999998654332
Q ss_pred cceeecccccccccChhhhccCCC-CCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCccccc
Q 046750 516 THVSTRVMGTFGYLAPEYASSGKL-TDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIV 594 (723)
Q Consensus 516 ~~~~~~~~gt~~y~APE~~~~~~~-t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~v 594 (723)
.....+||+.|||||++.+..| +.++|||||||+||||++|+.||..... .. +.+.+..+.+.
T Consensus 167 --~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~------~~-----~~~~i~~~~~~--- 230 (275)
T 3hyh_A 167 --FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI------PV-----LFKNISNGVYT--- 230 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HH-----HHHHHHHTCCC---
T ss_pred --ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH------HH-----HHHHHHcCCCC---
Confidence 2334679999999999998876 5799999999999999999999975321 11 22333333321
Q ss_pred chhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 595 DPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 595 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
+...+ ...+.+|+.+||+.||.+||++.||++.
T Consensus 231 ---~p~~~----s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 231 ---LPKFL----SPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp ---CCTTS----CHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred ---CCCCC----CHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 11112 2357789999999999999999999874
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-50 Score=425.73 Aligned_cols=247 Identities=26% Similarity=0.341 Sum_probs=195.1
Q ss_pred cCcccceEEeccCcEEEEEEEc----CCCcEEEEEEcccCC--chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNL----PEGKVVAVKQLKSGS--GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLL 433 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~----~~g~~VAvK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 433 (723)
++|++.++||+|+||.||+|+. ..++.||||+++... ......+++|+++|++|+|||||+++++|.+.+..||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 5699999999999999999954 246899999997542 1233468899999999999999999999999999999
Q ss_pred EEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCC
Q 046750 434 IYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDT 513 (723)
Q Consensus 434 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 513 (723)
|||||.||+|.++|.+.+ .+++..+..|+.||+.||+|||++ +||||||||+||||++++.+||+|||+|+....
T Consensus 104 vmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp EECCCTTCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EEEcCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 999999999999997654 488999999999999999999999 599999999999999999999999999986543
Q ss_pred CCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccc
Q 046750 514 TQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEI 593 (723)
Q Consensus 514 ~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~ 593 (723)
... .....+||+.|||||++.+..|+.++|||||||+||||++|+.||..... .+ +...+..+.+.
T Consensus 179 ~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~------~~-----~~~~i~~~~~~-- 244 (304)
T 3ubd_A 179 HEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR------KE-----TMTMILKAKLG-- 244 (304)
T ss_dssp --C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HH-----HHHHHHHCCCC--
T ss_pred CCc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH------HH-----HHHHHHcCCCC--
Confidence 332 23446799999999999999999999999999999999999999975432 11 11222222221
Q ss_pred cchhhhccccHHHHHHHHHHHHHHhccCCCCCCC-----HHHHHH
Q 046750 594 VDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPR-----MVQVVR 633 (723)
Q Consensus 594 vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~eVl~ 633 (723)
+...+ ...+.+|+.+||+.||.+|++ ++||++
T Consensus 245 ----~p~~~----s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 245 ----MPQFL----SPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp ----CCTTS----CHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred ----CCCcC----CHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 11112 235788999999999999998 456654
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-48 Score=409.77 Aligned_cols=250 Identities=21% Similarity=0.381 Sum_probs=188.5
Q ss_pred cCcccceEEeccCcEEEEEEE-cCCCcEEEEEEcccCCch-hHHHHHHHHHHHHHccCCceeeEeeeeeccc--------
Q 046750 360 NGFARENVIGEGGFGCVYKGN-LPEGKVVAVKQLKSGSGQ-GEREFRAEVEIISRVHHRHLVSLVGYCISEK-------- 429 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~-~~~g~~VAvK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~-------- 429 (723)
++|++.+.||+|+||.||+|+ ..+|+.||||+++..... ..+.+.+|+++|++|+|||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 469999999999999999995 457899999999765433 3457899999999999999999999987654
Q ss_pred ----ceEEEEEecCCCchhhccccCCC-CcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEee
Q 046750 430 ----NRLLIYEFVPNNNLEHHLHGKGQ-PVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVAD 504 (723)
Q Consensus 430 ----~~~lV~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~D 504 (723)
.+|||||||.+|+|.++++.... ...++..++.|+.||++||+|||++ +||||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEcc
Confidence 36899999999999999976543 2345566889999999999999999 599999999999999999999999
Q ss_pred cccccccCCCCcc-----------eeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhh
Q 046750 505 FGLAKLNDTTQTH-----------VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESL 573 (723)
Q Consensus 505 FGla~~~~~~~~~-----------~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l 573 (723)
||+|+.+...... .....+||+.|||||++.+..|+.++||||||||||||++ ||... ...
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~-----~~~ 233 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ-----MER 233 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH-----HHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc-----cHH
Confidence 9999876543221 1233579999999999999999999999999999999996 66421 111
Q ss_pred HHhhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 574 VEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 574 ~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
. .....+....+.... ......+.+|+.+||+.||.+||++.||++.
T Consensus 234 ~-----~~~~~~~~~~~p~~~---------~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 234 V-----RTLTDVRNLKFPPLF---------TQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp H-----HHHHHHHTTCCCHHH---------HHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred H-----HHHHHHhcCCCCCCC---------cccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0 111222222221111 1122345679999999999999999999873
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-47 Score=405.44 Aligned_cols=284 Identities=41% Similarity=0.716 Sum_probs=245.9
Q ss_pred CHHHHHHHhcCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccc
Q 046750 351 TYEELMEITNGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKN 430 (723)
Q Consensus 351 ~~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 430 (723)
.+.++..+.++|++.++||+|+||.||+|.+.+++.||||++........+.+.+|+++|++++|+||++++++|.+.+.
T Consensus 30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 109 (321)
T 2qkw_B 30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNE 109 (321)
T ss_dssp CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTC
T ss_pred cHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCe
Confidence 33445566789999999999999999999988899999999987766677889999999999999999999999999999
Q ss_pred eEEEEEecCCCchhhccccCCC--CcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccc
Q 046750 431 RLLIYEFVPNNNLEHHLHGKGQ--PVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLA 508 (723)
Q Consensus 431 ~~lV~E~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla 508 (723)
.++||||+.+|+|.+++..... ..+.+..++.|+.||++||+|||++ +|+|||||++||||+.++.+||+|||++
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 186 (321)
T 2qkw_B 110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGIS 186 (321)
T ss_dssp CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTC
T ss_pred EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecccc
Confidence 9999999999999999976542 3488999999999999999999998 5999999999999999999999999999
Q ss_pred cccCCCC-cceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhc
Q 046750 509 KLNDTTQ-THVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIET 587 (723)
Q Consensus 509 ~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~ 587 (723)
+...... ........|+..|+|||++.++.++.++|||||||+||||++|+.||..........+..|.. .....
T Consensus 187 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~----~~~~~ 262 (321)
T 2qkw_B 187 KKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAV----ESHNN 262 (321)
T ss_dssp EECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTH----HHHTT
T ss_pred cccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhh----hcccc
Confidence 8654322 222344568999999999999999999999999999999999999998766655556666654 23455
Q ss_pred CCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCCC
Q 046750 588 GDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEM 641 (723)
Q Consensus 588 ~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~~ 641 (723)
+.+..++++.+...........+.+++.+||+.||.+||++.||++.|+....+
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 263 GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp TCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 677888888887778888889999999999999999999999999999987654
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=406.23 Aligned_cols=290 Identities=47% Similarity=0.842 Sum_probs=248.6
Q ss_pred cccCHHHHHHHhcCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCch-hHHHHHHHHHHHHHccCCceeeEeeeee
Q 046750 348 SFFTYEELMEITNGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQ-GEREFRAEVEIISRVHHRHLVSLVGYCI 426 (723)
Q Consensus 348 ~~~~~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~ 426 (723)
..|++.++..+.++|.+.++||+|+||.||+|++.+++.||||+++..... ....|.+|++++++++|+||++++++|.
T Consensus 18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 97 (326)
T 3uim_A 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 97 (326)
T ss_dssp EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence 468889999999999999999999999999999888999999999765322 2336899999999999999999999999
Q ss_pred cccceEEEEEecCCCchhhccccCC--CCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEee
Q 046750 427 SEKNRLLIYEFVPNNNLEHHLHGKG--QPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVAD 504 (723)
Q Consensus 427 ~~~~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~D 504 (723)
+....++||||+.+|+|.++++... ...+.+..++.|+.||+.||+|||+++..+|+|||||++||||++++.+||+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~D 177 (326)
T 3uim_A 98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 177 (326)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECC
T ss_pred cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEecc
Confidence 9999999999999999999997643 33489999999999999999999998444599999999999999999999999
Q ss_pred cccccccCCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCC--CCCchhhHHhhhhhhh
Q 046750 505 FGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQ--PLGDESLVEWARPVLV 582 (723)
Q Consensus 505 FGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~--~~~~~~l~~~~~~~l~ 582 (723)
||+++..............|+..|+|||++.+..++.++|||||||+||||++|+.||+... ......+.+|..
T Consensus 178 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~---- 253 (326)
T 3uim_A 178 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK---- 253 (326)
T ss_dssp CSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT----
T ss_pred CccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH----
Confidence 99998776555555566679999999999999999999999999999999999999996321 112344555544
Q ss_pred hhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCCC
Q 046750 583 RAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEM 641 (723)
Q Consensus 583 ~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~~ 641 (723)
..+....+..+++..+...+...+...+.+++.+||+.||.+||++.||+++|++....
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~ 312 (326)
T 3uim_A 254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLA 312 (326)
T ss_dssp TTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCS
T ss_pred HHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchh
Confidence 33345677788888888888899999999999999999999999999999999986554
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=414.62 Aligned_cols=267 Identities=20% Similarity=0.334 Sum_probs=198.7
Q ss_pred cCcccceEEeccCcEEEEEEE-cCCCcEEEEEEcccCCc--hhHHHHHHHHHHHHHccCCceeeEeeeeec------ccc
Q 046750 360 NGFARENVIGEGGFGCVYKGN-LPEGKVVAVKQLKSGSG--QGEREFRAEVEIISRVHHRHLVSLVGYCIS------EKN 430 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~-~~~g~~VAvK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~------~~~ 430 (723)
++|+++++||+|+||.||+|+ ..+|+.||||+++.... ...+.+.+|+++|++|+|+|||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 579999999999999999995 46799999999976432 334568899999999999999999998764 357
Q ss_pred eEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccc
Q 046750 431 RLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKL 510 (723)
Q Consensus 431 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 510 (723)
+||||||| +|+|.++|...+ .+.+..+..|+.||+.||+|||++ +||||||||+||||+.++.+||+|||+++.
T Consensus 134 ~~ivmE~~-~g~L~~~i~~~~--~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 134 VYVVLDLM-ESDLHQIIHSSQ--PLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp EEEEEECC-SEEHHHHHTSSS--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEeCC-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeee
Confidence 89999999 578999997654 489999999999999999999999 599999999999999999999999999986
Q ss_pred cCCCC---cceeecccccccccChhhhccC-CCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhh------
Q 046750 511 NDTTQ---THVSTRVMGTFGYLAPEYASSG-KLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPV------ 580 (723)
Q Consensus 511 ~~~~~---~~~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~------ 580 (723)
+.... .......+||+.|||||++.+. .|+.++||||||||||||++|+.||....... .+.......
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~--~l~~I~~~~g~p~~~ 285 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVH--QLQLIMMVLGTPSPA 285 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH--HHHHHHHHHCCCCGG
T ss_pred cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHH--HHHHHHHhcCCCChH
Confidence 64322 2223456899999999998875 46999999999999999999999997654211 111000000
Q ss_pred hhhhhhcCCcccccc---hhhh---ccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 581 LVRAIETGDLSEIVD---PRLE---KHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 581 l~~~i~~~~l~~~vd---~~l~---~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
....+....+...+. .... ..........+++|+.+||..||.+|+++.|+++.
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000000000000 0000 00000112357889999999999999999999874
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=402.48 Aligned_cols=201 Identities=25% Similarity=0.384 Sum_probs=171.6
Q ss_pred HHHhcCcccceEEeccCcEEEEEEEc----CCCcEEEEEEcccCCchhHHHHHHHHHHHHHc-cCCceeeEeeeeecccc
Q 046750 356 MEITNGFARENVIGEGGFGCVYKGNL----PEGKVVAVKQLKSGSGQGEREFRAEVEIISRV-HHRHLVSLVGYCISEKN 430 (723)
Q Consensus 356 ~~~~~~f~~~~~LG~G~fG~Vy~~~~----~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~ 430 (723)
-.+.++|++.++||+|+||.||+|+. ..++.||||++.... ....+.+|+++|+++ +|+|||+++++|.+.++
T Consensus 17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 34568899999999999999999954 246789999987643 345688999999998 69999999999999999
Q ss_pred eEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCC-CcEEEeeccccc
Q 046750 431 RLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDE-FEAQVADFGLAK 509 (723)
Q Consensus 431 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~-~~vkL~DFGla~ 509 (723)
+||||||+++|+|.++++ .+++..+..|+.||+.||+|||++ +||||||||+||||+.+ +.+||+|||+|+
T Consensus 95 ~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp EEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 999999999999999984 278889999999999999999999 59999999999999876 799999999997
Q ss_pred ccCCCCcc---------------------------eeecccccccccChhhhccC-CCCCccceechHHHHHHHHhCCCC
Q 046750 510 LNDTTQTH---------------------------VSTRVMGTFGYLAPEYASSG-KLTDRSDVFSFGVVLLELITGRKP 561 (723)
Q Consensus 510 ~~~~~~~~---------------------------~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSlGviL~eLltG~~P 561 (723)
........ .....+||+.|||||++.+. .|+.++||||||||||||++|+.|
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence 65432211 12335799999999999875 589999999999999999999999
Q ss_pred CCCCC
Q 046750 562 VDPTQ 566 (723)
Q Consensus 562 ~~~~~ 566 (723)
|....
T Consensus 247 f~~~~ 251 (361)
T 4f9c_A 247 FYKAS 251 (361)
T ss_dssp SSCCS
T ss_pred CCCCC
Confidence 96543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-46 Score=426.66 Aligned_cols=253 Identities=22% Similarity=0.326 Sum_probs=209.2
Q ss_pred hcCcccceEEeccCcEEEEEEE-cCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEe
Q 046750 359 TNGFARENVIGEGGFGCVYKGN-LPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEF 437 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 437 (723)
.++|++.+.||+|+||.||+|. ..+|+.||||+++.......+.+++|+++|++|+|+|||+|+++|.+...+||||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 4689999999999999999995 457999999999876656667889999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCC--CcEEEeecccccccCCCC
Q 046750 438 VPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDE--FEAQVADFGLAKLNDTTQ 515 (723)
Q Consensus 438 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~--~~vkL~DFGla~~~~~~~ 515 (723)
|.||+|.++|.... ..+++..+..|+.||+.||+|||++ +|||||||++||||+.+ +.+||+|||+++.+....
T Consensus 236 ~~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 236 MSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp CCCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred cCCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 99999999986543 2589999999999999999999999 59999999999999854 899999999998775433
Q ss_pred cceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccc
Q 046750 516 THVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVD 595 (723)
Q Consensus 516 ~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd 595 (723)
. ....+||+.|||||++.+..|+.++||||||||||||++|+.||..... .. ++..+..+.+. + +
T Consensus 312 ~--~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~---~~--------~~~~i~~~~~~-~-~ 376 (573)
T 3uto_A 312 S--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND---DE--------TLRNVKSCDWN-M-D 376 (573)
T ss_dssp E--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH---HH--------HHHHHHTTCCC-C-C
T ss_pred c--eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---HH--------HHHHHHhCCCC-C-C
Confidence 2 3445799999999999999999999999999999999999999975432 11 11222222211 1 1
Q ss_pred hhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 596 PRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 596 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
......+ ...+.+|+.+||+.||.+|+++.|++++
T Consensus 377 ~~~~~~~----s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 377 DSAFSGI----SEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp SGGGTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cccccCC----CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111112 2357789999999999999999999874
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-45 Score=418.15 Aligned_cols=248 Identities=25% Similarity=0.363 Sum_probs=196.9
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCC---chhHHHHHH---HHHHHHHccCCceeeEeeeeecccceE
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS---GQGEREFRA---EVEIISRVHHRHLVSLVGYCISEKNRL 432 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~---~~~~~~~~~---Ei~il~~l~HpnIv~l~g~~~~~~~~~ 432 (723)
++|+++++||+|+||.||+|+. .+|+.||||++++.. ......+.+ ++.+++.++|||||+|+++|.+.+.+|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 5699999999999999999954 569999999986431 122223333 456666778999999999999999999
Q ss_pred EEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccC
Q 046750 433 LIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLND 512 (723)
Q Consensus 433 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 512 (723)
||||||.||+|.++|.+.+ .+++..+..|+.||+.||+|||++ +||||||||+||||+.++++||+|||+|+.+.
T Consensus 269 lVmEy~~GGdL~~~l~~~~--~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp EEECCCCSCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 9999999999999997654 488999999999999999999999 59999999999999999999999999998765
Q ss_pred CCCcceeecccccccccChhhhcc-CCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcc
Q 046750 513 TTQTHVSTRVMGTFGYLAPEYASS-GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLS 591 (723)
Q Consensus 513 ~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~ 591 (723)
... ....+||+.|||||++.. ..|+.++||||||||||||++|+.||......... . +.+.+....+.
T Consensus 344 ~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~---~-----i~~~i~~~~~~ 412 (689)
T 3v5w_A 344 KKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---E-----IDRMTLTMAVE 412 (689)
T ss_dssp SCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHH---H-----HHHHHHHCCCC
T ss_pred CCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH---H-----HHHhhcCCCCC
Confidence 433 234679999999999975 57999999999999999999999999754322111 1 11112122111
Q ss_pred cccchhhhccccHHHHHHHHHHHHHHhccCCCCCCC-----HHHHHH
Q 046750 592 EIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPR-----MVQVVR 633 (723)
Q Consensus 592 ~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~eVl~ 633 (723)
+...+ ...+.+|+.+||+.||.+|++ +.||++
T Consensus 413 ------~p~~~----S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 413 ------LPDSF----SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp ------CCTTS----CHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred ------CCccC----CHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 11112 235788999999999999998 688764
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=380.27 Aligned_cols=259 Identities=28% Similarity=0.425 Sum_probs=210.6
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEec
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFV 438 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 438 (723)
++|.+.++||+|+||.||+|.. .+++.||||++........+.|.+|+++|++|+|+||++++++|.+....++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 5789999999999999999965 568999999997776677788999999999999999999999999999999999999
Q ss_pred CCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcce
Q 046750 439 PNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHV 518 (723)
Q Consensus 439 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 518 (723)
.+++|.++++.... .+.+..++.|+.||++||+|||++ +|+|||||++||||+.++.+||+|||+++.........
T Consensus 90 ~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (310)
T 3s95_A 90 KGGTLRGIIKSMDS-QYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165 (310)
T ss_dssp TTCBHHHHHHHCCT-TSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred CCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence 99999999976433 488999999999999999999999 59999999999999999999999999998664433221
Q ss_pred -------------eecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhh
Q 046750 519 -------------STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAI 585 (723)
Q Consensus 519 -------------~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i 585 (723)
.....||..|+|||++.+..++.++|||||||+||||++|..+|............. ...
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~-~~~------ 238 (310)
T 3s95_A 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN-VRG------ 238 (310)
T ss_dssp --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC-HHH------
T ss_pred cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh-hhc------
Confidence 114579999999999999999999999999999999999999986543321110000 000
Q ss_pred hcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCC
Q 046750 586 ETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGE 640 (723)
Q Consensus 586 ~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~ 640 (723)
.+...........+.+++.+||+.||.+||++.+|++.|+.+..
T Consensus 239 -----------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~ 282 (310)
T 3s95_A 239 -----------FLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282 (310)
T ss_dssp -----------HHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----------cccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 00000111112357889999999999999999999999987654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=373.06 Aligned_cols=252 Identities=21% Similarity=0.376 Sum_probs=207.4
Q ss_pred hcCcccceEEeccCcEEEEEEE-cCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEe
Q 046750 359 TNGFARENVIGEGGFGCVYKGN-LPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEF 437 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 437 (723)
.++|++.++||+|+||.||+|. ..+++.||||++........+.+.+|+.++++++|+||++++++|.+.+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 3679999999999999999995 467899999999766555667889999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcc
Q 046750 438 VPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTH 517 (723)
Q Consensus 438 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 517 (723)
+.+|+|.+++... .+++..++.|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||++.........
T Consensus 99 ~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 172 (297)
T 3fxz_A 99 LAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (297)
T ss_dssp CTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred CCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc
Confidence 9999999999764 378899999999999999999999 5999999999999999999999999999866543332
Q ss_pred eeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchh
Q 046750 518 VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPR 597 (723)
Q Consensus 518 ~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~ 597 (723)
.....|+..|+|||++.+..++.++|||||||+||||++|+.||...... ..+. .....+. ..+.
T Consensus 173 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~--------~~~~~~~-~~~~--- 237 (297)
T 3fxz_A 173 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--RALY--------LIATNGT-PELQ--- 237 (297)
T ss_dssp -BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHH--------HHHHHCS-CCCS---
T ss_pred -cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHH--------HHHhCCC-CCCC---
Confidence 33457999999999999999999999999999999999999999754321 0000 1111111 0110
Q ss_pred hhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 046750 598 LEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRAL 635 (723)
Q Consensus 598 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L 635 (723)
........+.+++.+||+.||.+||++.||++.-
T Consensus 238 ----~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~ 271 (297)
T 3fxz_A 238 ----NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQ 271 (297)
T ss_dssp ----CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCG
T ss_pred ----CccccCHHHHHHHHHHccCChhHCcCHHHHhhCh
Confidence 0111223578899999999999999999998743
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=366.25 Aligned_cols=281 Identities=37% Similarity=0.657 Sum_probs=227.6
Q ss_pred cccCHHHHHHHhcCcccc------eEEeccCcEEEEEEEcCCCcEEEEEEcccCC----chhHHHHHHHHHHHHHccCCc
Q 046750 348 SFFTYEELMEITNGFARE------NVIGEGGFGCVYKGNLPEGKVVAVKQLKSGS----GQGEREFRAEVEIISRVHHRH 417 (723)
Q Consensus 348 ~~~~~~~l~~~~~~f~~~------~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~----~~~~~~~~~Ei~il~~l~Hpn 417 (723)
..|.++++..++++|... ++||+|+||.||+|.. +++.||||++.... ....+.|.+|++++++|+|+|
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 468999999999999887 9999999999999987 68899999986532 234567899999999999999
Q ss_pred eeeEeeeeecccceEEEEEecCCCchhhccccC-CCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCC
Q 046750 418 LVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGK-GQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDD 496 (723)
Q Consensus 418 Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~ 496 (723)
|+++++++.+.+..++||||+.+++|.+++... ....+++..++.|+.||+.||+|||++ +|+|||||++||||++
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~ 168 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDE 168 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECT
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEcC
Confidence 999999999999999999999999999998643 234588999999999999999999999 5999999999999999
Q ss_pred CCcEEEeecccccccCCCCcc-eeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHH
Q 046750 497 EFEAQVADFGLAKLNDTTQTH-VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVE 575 (723)
Q Consensus 497 ~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~ 575 (723)
++.+||+|||+++........ ......|+..|+|||++.+ .++.++|||||||+||||++|+.||....... .+..
T Consensus 169 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~ 245 (307)
T 2nru_A 169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ--LLLD 245 (307)
T ss_dssp TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS--BTTH
T ss_pred CCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH--HHHH
Confidence 999999999999866543322 2334578999999998864 58999999999999999999999997654321 1222
Q ss_pred hhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccC
Q 046750 576 WARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEG 639 (723)
Q Consensus 576 ~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~ 639 (723)
+..... .....+..+++..+ ..........+.+++.+||+.+|.+||++.+|++.|+++.
T Consensus 246 ~~~~~~---~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 246 IKEEIE---DEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HHHHHH---TTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHHhh---hhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 211110 01122333444333 2344566778999999999999999999999999998754
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=383.27 Aligned_cols=259 Identities=27% Similarity=0.428 Sum_probs=210.4
Q ss_pred cCcccceEEeccCcEEEEEEEc--------CCCcEEEEEEcccCCc-hhHHHHHHHHHHHHHc-cCCceeeEeeeeeccc
Q 046750 360 NGFARENVIGEGGFGCVYKGNL--------PEGKVVAVKQLKSGSG-QGEREFRAEVEIISRV-HHRHLVSLVGYCISEK 429 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~--------~~g~~VAvK~l~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~ 429 (723)
++|.+.+.||+|+||.||+|++ .++..||||+++.... ...+.+.+|+++|++| +|+||++++++|.+.+
T Consensus 81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 160 (370)
T 2psq_A 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 160 (370)
T ss_dssp GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence 5789999999999999999964 2356799999986543 3346789999999999 8999999999999999
Q ss_pred ceEEEEEecCCCchhhccccCC--------------CCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeC
Q 046750 430 NRLLIYEFVPNNNLEHHLHGKG--------------QPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVD 495 (723)
Q Consensus 430 ~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~ 495 (723)
..||||||+.+|+|.++|.... ...+.+..++.|+.||++||+|||++ +|||||||++||||+
T Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~ 237 (370)
T 2psq_A 161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVT 237 (370)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEC
T ss_pred CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEEC
Confidence 9999999999999999997643 13478899999999999999999999 599999999999999
Q ss_pred CCCcEEEeecccccccCCCCcce-eecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhh
Q 046750 496 DEFEAQVADFGLAKLNDTTQTHV-STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESL 573 (723)
Q Consensus 496 ~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l 573 (723)
.++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||+||||++ |+.||..... ..+
T Consensus 238 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~---~~~ 314 (370)
T 2psq_A 238 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---EEL 314 (370)
T ss_dssp TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG---GGH
T ss_pred CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHH
Confidence 99999999999998665433221 233457889999999999999999999999999999999 9999975432 111
Q ss_pred HHhhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCCC
Q 046750 574 VEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEM 641 (723)
Q Consensus 574 ~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~~ 641 (723)
...+..+.... ........+.+|+.+||+.||.+||++.||++.|+.+..+
T Consensus 315 --------~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~ 365 (370)
T 2psq_A 315 --------FKLLKEGHRMD---------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 365 (370)
T ss_dssp --------HHHHHTTCCCC---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------HHHHhcCCCCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 12222222111 1112233688999999999999999999999999986543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=377.82 Aligned_cols=273 Identities=26% Similarity=0.356 Sum_probs=209.2
Q ss_pred cCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccc----eEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKN----RLLIY 435 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~----~~lV~ 435 (723)
++|++.++||+|+||.||+|++. ++.||||+++... .....+.+|+.+|++|+|+||++++++|.+... .++||
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~ 101 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT 101 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred hhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence 67999999999999999999874 7999999997542 333456679999999999999999999987543 69999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccC-------CCceeecCCCCCcEEeCCCCcEEEeecccc
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDC-------HPKIIHRDIKSANILVDDEFEAQVADFGLA 508 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g-------~~~ivHrDIkp~NILl~~~~~vkL~DFGla 508 (723)
||+.+|+|.++++.. .+.+..++.|+.||+.||+|||+.. ..+|+|||||++||||+.++.+||+|||++
T Consensus 102 e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a 178 (322)
T 3soc_A 102 AFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA 178 (322)
T ss_dssp ECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred ecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcc
Confidence 999999999999764 3889999999999999999999971 113999999999999999999999999999
Q ss_pred cccCCCCcc-eeecccccccccChhhhccC-----CCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhh-----
Q 046750 509 KLNDTTQTH-VSTRVMGTFGYLAPEYASSG-----KLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWA----- 577 (723)
Q Consensus 509 ~~~~~~~~~-~~~~~~gt~~y~APE~~~~~-----~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~----- 577 (723)
+........ ......|+..|+|||++.+. .++.++|||||||+||||++|+.||..........+..+.
T Consensus 179 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 258 (322)
T 3soc_A 179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPS 258 (322)
T ss_dssp EEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCC
T ss_pred cccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCc
Confidence 766543332 22335799999999999873 4566889999999999999999999765432222221110
Q ss_pred hhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCC
Q 046750 578 RPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGE 640 (723)
Q Consensus 578 ~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~ 640 (723)
...+...+..+.....+...+. .......+.+|+.+||+.||.+||++.||++.|+.+..
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 259 LEDMQEVVVHKKKRPVLRDYWQ---KHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGG---SSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhhhhhhhhcccCCCCcccccc---ccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 0111111122222222221111 12345568999999999999999999999999987654
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=373.34 Aligned_cols=261 Identities=30% Similarity=0.459 Sum_probs=202.1
Q ss_pred hcCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCc--hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEE
Q 046750 359 TNGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSG--QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYE 436 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 436 (723)
.++|++.++||+|+||.||+|++ +|+.||||++..... ...+.|.+|+++|++|+|+||++++++|.+....++|||
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE 114 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred hhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence 46799999999999999999977 688999999876532 334578999999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCC-CcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 046750 437 FVPNNNLEHHLHGKGQ-PVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ 515 (723)
Q Consensus 437 ~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 515 (723)
|+.+|+|.++++.... ..+++..++.|+.||++||+|||+++ ..|+|||||++||||+.++.+||+|||+++......
T Consensus 115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~ 193 (309)
T 3p86_A 115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF 193 (309)
T ss_dssp CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC---------
T ss_pred cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCccccccc
Confidence 9999999999976542 23888999999999999999999982 129999999999999999999999999997544322
Q ss_pred cceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccc
Q 046750 516 THVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVD 595 (723)
Q Consensus 516 ~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd 595 (723)
.......|+..|+|||++.+..++.++|||||||+||||++|+.||..... ....... ........
T Consensus 194 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~---~~~~~~~-------~~~~~~~~--- 259 (309)
T 3p86_A 194 -LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP---AQVVAAV-------GFKCKRLE--- 259 (309)
T ss_dssp ---------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH---HHHHHHH-------HHSCCCCC---
T ss_pred -cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHH-------HhcCCCCC---
Confidence 122345699999999999999999999999999999999999999975432 1111110 00111000
Q ss_pred hhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCCC
Q 046750 596 PRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEM 641 (723)
Q Consensus 596 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~~ 641 (723)
+...+ ...+.+|+.+||+.||.+||++.+|++.|+.....
T Consensus 260 --~~~~~----~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 260 --IPRNL----NPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp --CCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred --CCccC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 11112 23678999999999999999999999999887653
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=378.57 Aligned_cols=258 Identities=26% Similarity=0.430 Sum_probs=207.5
Q ss_pred cCcccceEEeccCcEEEEEEEcC----CCcEEEEEEcccCC-chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLP----EGKVVAVKQLKSGS-GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLI 434 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~----~g~~VAvK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 434 (723)
++|.+.++||+|+||.||+|.+. .+..||||+++... ....+.|.+|+++|++|+|+||++++++|.+.+..|||
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 57899999999999999999763 34569999998653 33456799999999999999999999999999999999
Q ss_pred EEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCC
Q 046750 435 YEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTT 514 (723)
Q Consensus 435 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 514 (723)
|||+.+++|.++++.... .+.+..++.|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++.....
T Consensus 129 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 204 (325)
T 3kul_A 129 TEYMENGSLDTFLRTHDG-QFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204 (325)
T ss_dssp EECCTTCBHHHHHHTTTT-CSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred eeCCCCCcHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence 999999999999965432 488999999999999999999999 5999999999999999999999999999876543
Q ss_pred Ccce--eecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcc
Q 046750 515 QTHV--STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLS 591 (723)
Q Consensus 515 ~~~~--~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~ 591 (723)
.... .....++..|+|||++.+..++.++|||||||+||||++ |+.||..... .. +...+..+...
T Consensus 205 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~---~~--------~~~~~~~~~~~ 273 (325)
T 3kul_A 205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN---RD--------VISSVEEGYRL 273 (325)
T ss_dssp --CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH---HH--------HHHHHHTTCCC
T ss_pred ccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH---HH--------HHHHHHcCCCC
Confidence 3222 223346778999999999999999999999999999999 9999965431 11 11222222111
Q ss_pred cccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCCC
Q 046750 592 EIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEM 641 (723)
Q Consensus 592 ~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~~ 641 (723)
. ........+.+|+.+||+.||.+||++.+|++.|+.+...
T Consensus 274 ~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 274 P---------APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp C---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred C---------CCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 1 1112234688999999999999999999999999987643
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=361.08 Aligned_cols=258 Identities=27% Similarity=0.416 Sum_probs=212.8
Q ss_pred hcCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEec
Q 046750 359 TNGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFV 438 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 438 (723)
.++|++.+.||+|+||.||+|++.++..||||+++.... ..+++.+|++++++++|+||++++++|.+....++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 367999999999999999999988888999999986543 3467899999999999999999999999999999999999
Q ss_pred CCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcce
Q 046750 439 PNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHV 518 (723)
Q Consensus 439 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 518 (723)
.+++|.+++.... ..+++..++.|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||++..........
T Consensus 86 ~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 161 (268)
T 3sxs_A 86 SNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS 161 (268)
T ss_dssp TTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEE
T ss_pred CCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhhc
Confidence 9999999997643 2488999999999999999999999 59999999999999999999999999998766554444
Q ss_pred eecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchh
Q 046750 519 STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPR 597 (723)
Q Consensus 519 ~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~ 597 (723)
.....++..|+|||++.+..++.++|||||||+||||++ |+.||+.... ... ...+..+... ..+
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~--------~~~~~~~~~~--~~~- 227 (268)
T 3sxs_A 162 SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN---SEV--------VLKVSQGHRL--YRP- 227 (268)
T ss_dssp CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH---HHH--------HHHHHTTCCC--CCC-
T ss_pred ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh---HHH--------HHHHHcCCCC--CCC-
Confidence 444556778999999999899999999999999999999 9999975432 111 1111222110 000
Q ss_pred hhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCCC
Q 046750 598 LEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEM 641 (723)
Q Consensus 598 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~~ 641 (723)
..+ ...+.+++.+||+.||.+||++.+|++.|+.+.+.
T Consensus 228 --~~~----~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 228 --HLA----SDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp --TTS----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred --CcC----hHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 011 23578899999999999999999999999987654
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=366.30 Aligned_cols=256 Identities=28% Similarity=0.468 Sum_probs=211.7
Q ss_pred cCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEecC
Q 046750 360 NGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVP 439 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 439 (723)
++|++.+.||+|+||.||+|.+.+++.||||+++... ...+++.+|++++++++|+||++++++|.+....++||||+.
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 5789999999999999999988889999999998653 344679999999999999999999999999999999999999
Q ss_pred CCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCccee
Q 046750 440 NNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVS 519 (723)
Q Consensus 440 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 519 (723)
+++|.++++... ..+++..++.|+.||++||+|||++ +|+|||||++||||+.++.+||+|||+++..........
T Consensus 89 ~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 164 (269)
T 4hcu_A 89 HGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 164 (269)
T ss_dssp TCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred CCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccccccccc
Confidence 999999997543 3588999999999999999999999 499999999999999999999999999986654433333
Q ss_pred ecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhh
Q 046750 520 TRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRL 598 (723)
Q Consensus 520 ~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l 598 (723)
....++..|+|||++.+..++.++|||||||+||||++ |+.||..... ..+ ...+..+.. .. .+
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~---~~~--------~~~~~~~~~-~~-~~-- 229 (269)
T 4hcu_A 165 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---SEV--------VEDISTGFR-LY-KP-- 229 (269)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHH--------HHHHHTTCC-CC-CC--
T ss_pred cCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH---HHH--------HHHHhcCcc-CC-CC--
Confidence 44557788999999999999999999999999999999 9999975431 111 112222211 00 00
Q ss_pred hccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCC
Q 046750 599 EKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGE 640 (723)
Q Consensus 599 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~ 640 (723)
.. ....+.+++.+||+.||.+||++.+|++.|+.+.+
T Consensus 230 -~~----~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 230 -RL----ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp -TT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -Cc----CCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 11 12357889999999999999999999999987643
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=369.20 Aligned_cols=262 Identities=21% Similarity=0.296 Sum_probs=215.1
Q ss_pred ccCHHHHHHHhcC----------cccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCc
Q 046750 349 FFTYEELMEITNG----------FARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRH 417 (723)
Q Consensus 349 ~~~~~~l~~~~~~----------f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~Hpn 417 (723)
.|+++++..+.+. |...+.||+|+||.||+|... +|+.||||+++.......+.+.+|+.+|++++|+|
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n 103 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence 5788888888765 777889999999999999665 79999999998766666778999999999999999
Q ss_pred eeeEeeeeecccceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCC
Q 046750 418 LVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDE 497 (723)
Q Consensus 418 Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~ 497 (723)
|++++++|...+..++||||+.+++|.+++... .+++..++.|+.||+.||+|||++ +|+|||||++||||+.+
T Consensus 104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~ 177 (321)
T 2c30_A 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLD 177 (321)
T ss_dssp BCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT
T ss_pred cceEEEEEEECCEEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCC
Confidence 999999999999999999999999999998653 488999999999999999999999 59999999999999999
Q ss_pred CcEEEeecccccccCCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhh
Q 046750 498 FEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWA 577 (723)
Q Consensus 498 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~ 577 (723)
+.+||+|||++........ ......|+..|+|||++.+..++.++|||||||+||||++|+.||..... ....
T Consensus 178 ~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~---~~~~--- 250 (321)
T 2c30_A 178 GRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP---VQAM--- 250 (321)
T ss_dssp CCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHH---
T ss_pred CcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHH---
Confidence 9999999999986654322 22345799999999999999999999999999999999999999975431 1111
Q ss_pred hhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 046750 578 RPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRAL 635 (723)
Q Consensus 578 ~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L 635 (723)
..+.......+.. .......+.+++.+||+.||.+||++.||++.-
T Consensus 251 -----~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp 296 (321)
T 2c30_A 251 -----KRLRDSPPPKLKN-------SHKVSPVLRDFLERMLVRDPQERATAQELLDHP 296 (321)
T ss_dssp -----HHHHHSSCCCCTT-------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred -----HHHhcCCCCCcCc-------cccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 1111111111100 011123578899999999999999999998754
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=364.91 Aligned_cols=262 Identities=22% Similarity=0.368 Sum_probs=206.7
Q ss_pred hcCcccceEEeccCcEEEEEEE-cCCCcEEEEEEcccCC---chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEE
Q 046750 359 TNGFARENVIGEGGFGCVYKGN-LPEGKVVAVKQLKSGS---GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLI 434 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~VAvK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 434 (723)
.++|++.++||+|+||.||+|+ ..+++.||||++.... ....+.|.+|+.++++++|+||+++++++.+.+..|+|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 4679999999999999999995 4568999999986532 23345789999999999999999999999999999999
Q ss_pred EEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCC
Q 046750 435 YEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTT 514 (723)
Q Consensus 435 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 514 (723)
|||+.+++|.+++.... .+++..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++.....
T Consensus 90 ~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp EECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred EeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 99999999999997654 488999999999999999999999 4999999999999999999999999999876544
Q ss_pred CcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCccccc
Q 046750 515 QTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIV 594 (723)
Q Consensus 515 ~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~v 594 (723)
.........|+..|+|||++.+..++.++|||||||+||||++|+.||..... ... ..+.+.. .+..
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------~~~----~~~~~~~-~~~~-- 231 (294)
T 4eqm_A 165 SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA------VSI----AIKHIQD-SVPN-- 231 (294)
T ss_dssp ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH------HHH----HHHHHSS-CCCC--
T ss_pred cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHH----HHHHhhc-cCCC--
Confidence 43334456799999999999999999999999999999999999999975432 111 1111111 1111
Q ss_pred chhhhccccHHHHHHHHHHHHHHhccCCCCCC-CHHHHHHHHhccCCC
Q 046750 595 DPRLEKHYVESEMFRMIEAAAACVRHSGPKRP-RMVQVVRALDSEGEM 641 (723)
Q Consensus 595 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~eVl~~L~~~~~~ 641 (723)
+...........+.+++.+||+.||.+|| ++.++++.|+.....
T Consensus 232 ---~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 232 ---VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp ---HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred ---cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 11111122234688999999999999999 999999999886654
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=399.62 Aligned_cols=258 Identities=26% Similarity=0.397 Sum_probs=213.6
Q ss_pred hcCcccceEEeccCcEEEEEEEcCC-CcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEe
Q 046750 359 TNGFARENVIGEGGFGCVYKGNLPE-GKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEF 437 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 437 (723)
.++|.+.++||+|+||.||+|.+.. ++.||||+++... ...++|.+|+++|++|+|+|||+++++|.+....||||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 4568889999999999999997654 8899999998653 3456899999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcc
Q 046750 438 VPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTH 517 (723)
Q Consensus 438 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 517 (723)
+.+|+|.++|+......+.+..++.|+.||++||+|||++ +|||||||++||||+.++.+||+|||+++........
T Consensus 298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 374 (495)
T 1opk_A 298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT 374 (495)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEE
T ss_pred cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCcee
Confidence 9999999999876656689999999999999999999999 5999999999999999999999999999876544333
Q ss_pred eeecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccch
Q 046750 518 VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDP 596 (723)
Q Consensus 518 ~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~ 596 (723)
......++..|+|||++.++.++.++|||||||+||||++ |+.||..... ..+. +.+..+...
T Consensus 375 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~---~~~~--------~~~~~~~~~----- 438 (495)
T 1opk_A 375 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVY--------ELLEKDYRM----- 438 (495)
T ss_dssp CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG---GGHH--------HHHHTTCCC-----
T ss_pred ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH---HHHH--------HHHHcCCCC-----
Confidence 3333456789999999999999999999999999999999 9999975432 1111 122222111
Q ss_pred hhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCC
Q 046750 597 RLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGE 640 (723)
Q Consensus 597 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~ 640 (723)
.........+.+|+.+||+.||.+||++.+|++.|+.+..
T Consensus 439 ----~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 439 ----ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred ----CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 1111223467889999999999999999999999998653
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=372.58 Aligned_cols=268 Identities=26% Similarity=0.407 Sum_probs=205.7
Q ss_pred hcCcccceEEeccCcEEEEEEEc-----CCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecc--cce
Q 046750 359 TNGFARENVIGEGGFGCVYKGNL-----PEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISE--KNR 431 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~-----~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~ 431 (723)
.++|++.++||+|+||.||+|++ .+++.||||+++.......+.|.+|+++|++++|+||++++++|... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 36799999999999999999973 36889999999877666667899999999999999999999998654 458
Q ss_pred EEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeeccccccc
Q 046750 432 LLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLN 511 (723)
Q Consensus 432 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 511 (723)
++||||+.+++|.+++..... .+++..++.|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++..
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~ 164 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVL 164 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGG-GCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred EEEEEeCCCCCHHHHHHhccc-ccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence 999999999999999976532 488899999999999999999999 5999999999999999999999999999876
Q ss_pred CCCCcc--eeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCC-----CchhhHHhhhhhhhhh
Q 046750 512 DTTQTH--VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPL-----GDESLVEWARPVLVRA 584 (723)
Q Consensus 512 ~~~~~~--~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~-----~~~~l~~~~~~~l~~~ 584 (723)
...... ......++..|+|||++.+..++.++|||||||+||||++|..+|...... .......+....+.+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (295)
T 3ugc_A 165 PQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 244 (295)
T ss_dssp -----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred cCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHH
Confidence 543322 122345777899999999999999999999999999999999988542100 0000000000011111
Q ss_pred hhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccC
Q 046750 585 IETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEG 639 (723)
Q Consensus 585 i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~ 639 (723)
+..+... .........+.+|+.+||+.||.+||++.||++.|+.+.
T Consensus 245 ~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~ 290 (295)
T 3ugc_A 245 LKNNGRL---------PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 290 (295)
T ss_dssp HHTTCCC---------CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhccCcC---------CCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 2221111 111122346889999999999999999999999998764
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=365.20 Aligned_cols=262 Identities=24% Similarity=0.416 Sum_probs=203.9
Q ss_pred HhcCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHH--ccCCceeeEeeeeecc----cce
Q 046750 358 ITNGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISR--VHHRHLVSLVGYCISE----KNR 431 (723)
Q Consensus 358 ~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~g~~~~~----~~~ 431 (723)
+.++|++.++||+|+||.||+|++ +++.||||++.. .....+.+|.+++.. ++|+||+++++++.+. ...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECG---GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecc---ccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 357899999999999999999987 789999999865 345567778888887 7999999999987653 457
Q ss_pred EEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhc--------ccCCCceeecCCCCCcEEeCCCCcEEEe
Q 046750 432 LLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLH--------EDCHPKIIHRDIKSANILVDDEFEAQVA 503 (723)
Q Consensus 432 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~g~~~ivHrDIkp~NILl~~~~~vkL~ 503 (723)
++||||+.+|+|.++++.. .+++..+++|+.||+.||+||| ++ +|+|||||++||||+.++.+||+
T Consensus 82 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEEECCCTTCBHHHHHTTC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEEC
T ss_pred EEehhhccCCCHHHHHhhc---ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEe
Confidence 8999999999999999643 4899999999999999999999 66 69999999999999999999999
Q ss_pred ecccccccCCCCcce---eecccccccccChhhhccC------CCCCccceechHHHHHHHHhC----------CCCCCC
Q 046750 504 DFGLAKLNDTTQTHV---STRVMGTFGYLAPEYASSG------KLTDRSDVFSFGVVLLELITG----------RKPVDP 564 (723)
Q Consensus 504 DFGla~~~~~~~~~~---~~~~~gt~~y~APE~~~~~------~~t~ksDVwSlGviL~eLltG----------~~P~~~ 564 (723)
|||+++......... .....||..|+|||++.+. .++.++|||||||+||||++| +.||..
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 999997655433322 2234799999999999876 345699999999999999999 777755
Q ss_pred CCCCCchhhHHhhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhcc
Q 046750 565 TQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSE 638 (723)
Q Consensus 565 ~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~ 638 (723)
...... ....+. ..+........+. ...+.......+.+|+.+||+.||.+||++.+|++.|+.+
T Consensus 236 ~~~~~~-~~~~~~-----~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 236 VVPNDP-SFEDMR-----KVVCVDQQRPNIP---NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TSCSSC-CHHHHH-----HHHTTSCCCCCCC---GGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCc-chhhhh-----HHHhccCCCCCCC---hhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 432211 111111 1111111111111 1122334567899999999999999999999999999864
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=381.53 Aligned_cols=268 Identities=26% Similarity=0.397 Sum_probs=213.0
Q ss_pred cCHHHHHHHhcCcccceEEeccCcEEEEEEEc------CCCcEEEEEEcccCCch-hHHHHHHHHHHHHHc-cCCceeeE
Q 046750 350 FTYEELMEITNGFARENVIGEGGFGCVYKGNL------PEGKVVAVKQLKSGSGQ-GEREFRAEVEIISRV-HHRHLVSL 421 (723)
Q Consensus 350 ~~~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~------~~g~~VAvK~l~~~~~~-~~~~~~~Ei~il~~l-~HpnIv~l 421 (723)
+.........++|.+.++||+|+||.||+|++ .+++.||||+++..... ..+.+.+|+++|.+| +|+||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 34445555568899999999999999999953 34678999999865433 346799999999999 79999999
Q ss_pred eeeeecccc-eEEEEEecCCCchhhccccCCC------------------------------------------------
Q 046750 422 VGYCISEKN-RLLIYEFVPNNNLEHHLHGKGQ------------------------------------------------ 452 (723)
Q Consensus 422 ~g~~~~~~~-~~lV~E~~~~gsL~~~l~~~~~------------------------------------------------ 452 (723)
+++|.+.+. .++||||+.+|+|.++++....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 999987654 8999999999999999976432
Q ss_pred ----------------CcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCc
Q 046750 453 ----------------PVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQT 516 (723)
Q Consensus 453 ----------------~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 516 (723)
..+.+..++.|+.||++||+|||++ +|||||||++||||+.++.+||+|||+++.......
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 1288999999999999999999999 599999999999999999999999999986543332
Q ss_pred -ceeecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCccccc
Q 046750 517 -HVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIV 594 (723)
Q Consensus 517 -~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~v 594 (723)
.......|+..|+|||++.+..++.++|||||||+||||++ |+.||...... ..+ ...+..+....+.
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~--------~~~~~~~~~~~~~ 318 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEF--------CRRLKEGTRMRAP 318 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS--HHH--------HHHHHHTCCCCCC
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh--HHH--------HHHHHcCCCCCCC
Confidence 23344568999999999999999999999999999999998 99999765421 111 1112222111111
Q ss_pred chhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccC
Q 046750 595 DPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEG 639 (723)
Q Consensus 595 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~ 639 (723)
.. ....+.+++.+||+.||.+||++.||+++|+.+.
T Consensus 319 -----~~----~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 354 (359)
T 3vhe_A 319 -----DY----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354 (359)
T ss_dssp -----TT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----CC----CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 11 1235788999999999999999999999998764
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=385.17 Aligned_cols=257 Identities=26% Similarity=0.444 Sum_probs=198.2
Q ss_pred cCcccceEEeccCcEEEEEEEcC----CCcEEEEEEcccCC-chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLP----EGKVVAVKQLKSGS-GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLI 434 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~----~g~~VAvK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 434 (723)
++|.+.++||+|+||.||+|++. ++..||||+++... ....++|.+|+++|++|+|+||++++++|.+....+||
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 57899999999999999999764 56789999998653 33456799999999999999999999999999999999
Q ss_pred EEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCC
Q 046750 435 YEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTT 514 (723)
Q Consensus 435 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 514 (723)
|||+.+|+|.++++... ..+.+..++.|+.||++||+|||++ +|+|||||++||||+.++.+||+|||+++.....
T Consensus 125 ~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 200 (373)
T 2qol_A 125 TEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200 (373)
T ss_dssp EECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence 99999999999997653 3588999999999999999999999 5999999999999999999999999999876543
Q ss_pred Cccee--ecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcc
Q 046750 515 QTHVS--TRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLS 591 (723)
Q Consensus 515 ~~~~~--~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~ 591 (723)
..... ....++..|+|||++.+..++.++|||||||+||||++ |+.||..... .. +.+.+..+..
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~---~~--------~~~~i~~~~~- 268 (373)
T 2qol_A 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---QD--------VIKAVDEGYR- 268 (373)
T ss_dssp -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH---HH--------HHHHHHTTEE-
T ss_pred CccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH---HH--------HHHHHHcCCC-
Confidence 32221 22235778999999999999999999999999999998 9999965431 11 1122222110
Q ss_pred cccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCC
Q 046750 592 EIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGE 640 (723)
Q Consensus 592 ~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~ 640 (723)
..........+.+|+.+||+.||.+||++.+|++.|+.+..
T Consensus 269 --------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 309 (373)
T 2qol_A 269 --------LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309 (373)
T ss_dssp --------CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence 01111223468899999999999999999999999988754
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=395.57 Aligned_cols=259 Identities=27% Similarity=0.430 Sum_probs=212.3
Q ss_pred HhcCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEe
Q 046750 358 ITNGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEF 437 (723)
Q Consensus 358 ~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 437 (723)
..++|.+.++||+|+||.||+|.+.++..||||+++... ...++|.+|+++|++|+|+|||++++++. .+..+|||||
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~ 263 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF 263 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence 346788999999999999999998888999999998654 44678999999999999999999999986 5678999999
Q ss_pred cCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcc
Q 046750 438 VPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTH 517 (723)
Q Consensus 438 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 517 (723)
+.+|+|.++|+......+.+..++.|+.||+.||+|||++ +|||||||++||||+.++.+||+|||+++........
T Consensus 264 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 340 (454)
T 1qcf_A 264 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 340 (454)
T ss_dssp CTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHH
T ss_pred cCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCcee
Confidence 9999999999765434578889999999999999999999 5999999999999999999999999999876543322
Q ss_pred eeecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccch
Q 046750 518 VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDP 596 (723)
Q Consensus 518 ~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~ 596 (723)
......++..|+|||++..+.++.++|||||||+||||++ |+.||..... .. +.+.+..+....
T Consensus 341 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~---~~--------~~~~i~~~~~~~---- 405 (454)
T 1qcf_A 341 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN---PE--------VIRALERGYRMP---- 405 (454)
T ss_dssp TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HH--------HHHHHHHTCCCC----
T ss_pred ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH---HH--------HHHHHHcCCCCC----
Confidence 2233456789999999999999999999999999999999 9999975431 11 112222221110
Q ss_pred hhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCCC
Q 046750 597 RLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEM 641 (723)
Q Consensus 597 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~~ 641 (723)
........+.+|+.+||+.||.+||++.+|++.|+.....
T Consensus 406 -----~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 406 -----RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp -----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred -----CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 1111234688999999999999999999999999987543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=373.03 Aligned_cols=249 Identities=23% Similarity=0.336 Sum_probs=205.8
Q ss_pred hcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccC--CchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEE
Q 046750 359 TNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSG--SGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 435 (723)
.++|.+.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+++|++++|+||+++++++.+.+..|+||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 46799999999999999999954 67999999998654 2334567889999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ 515 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 515 (723)
||+.+|+|.+++...+ .+.+..++.++.||++||+|||++ +|+|||||++||||+.++.+||+|||++.......
T Consensus 94 e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 168 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG 168 (328)
T ss_dssp CCCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred ECCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence 9999999999997654 388899999999999999999999 59999999999999999999999999997654332
Q ss_pred cceeecccccccccChhhhccCCCC-CccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCccccc
Q 046750 516 THVSTRVMGTFGYLAPEYASSGKLT-DRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIV 594 (723)
Q Consensus 516 ~~~~~~~~gt~~y~APE~~~~~~~t-~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~v 594 (723)
. ....+|+..|+|||++.+..+. .++|||||||+||||++|+.||..... .. +.+.+..+.+.
T Consensus 169 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~-----~~~~i~~~~~~--- 232 (328)
T 3fe3_A 169 K--LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL------KE-----LRERVLRGKYR--- 232 (328)
T ss_dssp G--GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH------HH-----HHHHHHHCCCC---
T ss_pred c--cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH------HH-----HHHHHHhCCCC---
Confidence 2 3445799999999999988875 799999999999999999999975431 11 11222223221
Q ss_pred chhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 046750 595 DPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRAL 635 (723)
Q Consensus 595 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L 635 (723)
+... ....+.+|+.+||..||.+||++.||++.-
T Consensus 233 ---~p~~----~s~~~~~li~~~L~~dP~~R~t~~eil~h~ 266 (328)
T 3fe3_A 233 ---IPFY----MSTDCENLLKRFLVLNPIKRGTLEQIMKDR 266 (328)
T ss_dssp ---CCTT----SCHHHHHHHHHHCCSSTTTSCCHHHHTTCT
T ss_pred ---CCCC----CCHHHHHHHHHHCCCChhHCcCHHHHhcCH
Confidence 0011 123577899999999999999999998753
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=373.03 Aligned_cols=261 Identities=26% Similarity=0.451 Sum_probs=211.5
Q ss_pred HhcCcccceEEeccCcEEEEEEEcC------CCcEEEEEEcccCCc-hhHHHHHHHHHHHHHccCCceeeEeeeeecccc
Q 046750 358 ITNGFARENVIGEGGFGCVYKGNLP------EGKVVAVKQLKSGSG-QGEREFRAEVEIISRVHHRHLVSLVGYCISEKN 430 (723)
Q Consensus 358 ~~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~VAvK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 430 (723)
..++|.+.+.||+|+||.||+|+.. +++.||||+++.... ...+.|.+|+++|++|+|+||++++++|.+.+.
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 124 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 124 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence 3578999999999999999999763 347899999986543 334679999999999999999999999999999
Q ss_pred eEEEEEecCCCchhhccccCC----------------------CCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCC
Q 046750 431 RLLIYEFVPNNNLEHHLHGKG----------------------QPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIK 488 (723)
Q Consensus 431 ~~lV~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIk 488 (723)
.++||||+.+|+|.+++.... ...+++..++.|+.||++||+|||++ +|+|||||
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlk 201 (343)
T 1luf_A 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLA 201 (343)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCC
Confidence 999999999999999997642 14588999999999999999999999 59999999
Q ss_pred CCcEEeCCCCcEEEeecccccccCCCCc-ceeecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCC
Q 046750 489 SANILVDDEFEAQVADFGLAKLNDTTQT-HVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQ 566 (723)
Q Consensus 489 p~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~ 566 (723)
++||||+.++.+||+|||+++....... .......++..|+|||++.+..++.++|||||||+||||++ |+.||....
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 281 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 281 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence 9999999999999999999976543322 12234568899999999999999999999999999999999 999996543
Q ss_pred CCCchhhHHhhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCCC
Q 046750 567 PLGDESLVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEM 641 (723)
Q Consensus 567 ~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~~ 641 (723)
. .. +...+..+.+..+. .. ....+.+|+.+||+.||.+||++.+|++.|+.+...
T Consensus 282 ~---~~--------~~~~~~~~~~~~~~-----~~----~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 282 H---EE--------VIYYVRDGNILACP-----EN----CPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp H---HH--------HHHHHHTTCCCCCC-----TT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred h---HH--------HHHHHhCCCcCCCC-----CC----CCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 1 11 11222333322111 11 223688999999999999999999999999987654
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=367.40 Aligned_cols=256 Identities=23% Similarity=0.369 Sum_probs=208.2
Q ss_pred hcCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEec
Q 046750 359 TNGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFV 438 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 438 (723)
.++|++.++||+|+||.||+|++.+++.||||+++... ...+++.+|++++++++|+||++++++|.+....++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 36789999999999999999998888899999998653 33467999999999999999999999999999999999999
Q ss_pred CCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcce
Q 046750 439 PNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHV 518 (723)
Q Consensus 439 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 518 (723)
.+++|.+++..... .+++..++.|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++.........
T Consensus 102 ~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 177 (283)
T 3gen_A 102 ANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 177 (283)
T ss_dssp TTCBHHHHHHCGGG-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHS
T ss_pred CCCcHHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccccccc
Confidence 99999999976332 488999999999999999999999 59999999999999999999999999998665443333
Q ss_pred eecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchh
Q 046750 519 STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPR 597 (723)
Q Consensus 519 ~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~ 597 (723)
.....++..|+|||++.+..++.++|||||||+||||++ |+.||..... .. ....+..+.. ....
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~---~~--------~~~~~~~~~~-~~~~-- 243 (283)
T 3gen_A 178 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN---SE--------TAEHIAQGLR-LYRP-- 243 (283)
T ss_dssp TTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH---HH--------HHHHHHTTCC-CCCC--
T ss_pred ccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh---hH--------HHHHHhcccC-CCCC--
Confidence 334456788999999999999999999999999999998 9999975432 11 1111222110 0000
Q ss_pred hhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccC
Q 046750 598 LEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEG 639 (723)
Q Consensus 598 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~ 639 (723)
..+ ...+.+++.+||+.+|.+||++.+|++.|+.+.
T Consensus 244 --~~~----~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 279 (283)
T 3gen_A 244 --HLA----SEKVYTIMYSCWHEKADERPTFKILLSNILDVM 279 (283)
T ss_dssp --TTC----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CcC----CHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence 111 236788999999999999999999999998764
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=377.24 Aligned_cols=256 Identities=20% Similarity=0.329 Sum_probs=207.0
Q ss_pred HHHhcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCC--chhHHHHHHHHHHHHHccCCceeeEeeeeecccceE
Q 046750 356 MEITNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS--GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRL 432 (723)
Q Consensus 356 ~~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 432 (723)
..+.++|.+.+.||+|+||.||+|.. .+++.||||+++... ....+.+.+|+++|++|+|+||++++++|.+.+..|
T Consensus 25 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 104 (362)
T 2bdw_A 25 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 104 (362)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 35567899999999999999999954 568999999997543 234467889999999999999999999999999999
Q ss_pred EEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCC---CcEEEeeccccc
Q 046750 433 LIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDE---FEAQVADFGLAK 509 (723)
Q Consensus 433 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~---~~vkL~DFGla~ 509 (723)
+||||+.+|+|.+++.... .+.+..++.++.||++||+|||++ +|+|||||++||||+.+ +.+||+|||+++
T Consensus 105 lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 105 LVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179 (362)
T ss_dssp EEECCCCSCBHHHHHTTCS--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred EEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence 9999999999999887543 488999999999999999999999 59999999999999865 459999999998
Q ss_pred ccCCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCC
Q 046750 510 LNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGD 589 (723)
Q Consensus 510 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~ 589 (723)
....... .....||..|+|||++.+..++.++||||||||||||++|+.||..... .. +...+..+.
T Consensus 180 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~---~~--------~~~~i~~~~ 246 (362)
T 2bdw_A 180 EVNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---HR--------LYAQIKAGA 246 (362)
T ss_dssp CCTTCCS--CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HH--------HHHHHHHTC
T ss_pred EecCCcc--cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HH--------HHHHHHhCC
Confidence 6653322 2345799999999999999999999999999999999999999975431 11 112222232
Q ss_pred cccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 046750 590 LSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRAL 635 (723)
Q Consensus 590 l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L 635 (723)
+... .+.+ .. ....+.+|+.+||+.||.+||++.|+++.-
T Consensus 247 ~~~~-~~~~-~~----~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 286 (362)
T 2bdw_A 247 YDYP-SPEW-DT----VTPEAKSLIDSMLTVNPKKRITADQALKVP 286 (362)
T ss_dssp CCCC-TTGG-GG----SCHHHHHHHHHHSCSSGGGSCCHHHHTTSH
T ss_pred CCCC-cccc-cC----CCHHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence 2110 0000 11 123578899999999999999999998753
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=374.82 Aligned_cols=253 Identities=23% Similarity=0.312 Sum_probs=206.7
Q ss_pred HhcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCch------hHHHHHHHHHHHHHccCCceeeEeeeeecccc
Q 046750 358 ITNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQ------GEREFRAEVEIISRVHHRHLVSLVGYCISEKN 430 (723)
Q Consensus 358 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~------~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 430 (723)
+.++|.+.+.||+|+||.||+|.. .+|+.||||+++..... ..+.+.+|+++|++|+|+||++++++|.+...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 457899999999999999999955 46899999999765322 34679999999999999999999999999999
Q ss_pred eEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCC----cEEEeecc
Q 046750 431 RLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEF----EAQVADFG 506 (723)
Q Consensus 431 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~----~vkL~DFG 506 (723)
.||||||+.+|+|.+++.... .+++..++.|+.||+.||+|||++ +|+||||||+||||++++ .+||+|||
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTCS--CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 999999999999999997543 489999999999999999999999 599999999999998876 79999999
Q ss_pred cccccCCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhh
Q 046750 507 LAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIE 586 (723)
Q Consensus 507 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~ 586 (723)
+++....... ....+||..|+|||++.+..++.++||||||||||||++|..||..... .. +...+.
T Consensus 165 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~---~~--------~~~~i~ 231 (361)
T 2yab_A 165 LAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---QE--------TLANIT 231 (361)
T ss_dssp SCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH---HH--------HHHHHH
T ss_pred CceEcCCCCc--cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH---HH--------HHHHHH
Confidence 9987654322 2345699999999999999999999999999999999999999975431 11 112222
Q ss_pred cCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 587 TGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 587 ~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
.+.+. .+..+...+ ...+.+|+.+||..||.+||++.|+++.
T Consensus 232 ~~~~~--~~~~~~~~~----s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 232 AVSYD--FDEEFFSQT----SELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp TTCCC--CCHHHHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hcCCC--CCchhccCC----CHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 22211 111111112 2357889999999999999999999864
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=368.02 Aligned_cols=276 Identities=26% Similarity=0.364 Sum_probs=208.3
Q ss_pred cCHHHHHHHhcCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHc--cCCceeeEeeeeec
Q 046750 350 FTYEELMEITNGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRV--HHRHLVSLVGYCIS 427 (723)
Q Consensus 350 ~~~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l--~HpnIv~l~g~~~~ 427 (723)
+.......+.++|++.++||+|+||.||+|++. ++.||||++.. .....+.+|.+++..+ +|+||+++++++.+
T Consensus 27 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~---~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~ 102 (337)
T 3mdy_A 27 LPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFIAADIK 102 (337)
T ss_dssp SCHHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEG---GGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred CCcccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEec---cccchhhhHHHHHHHHhhcCCCeeeEEEEEcc
Confidence 444555567789999999999999999999874 89999999864 2334556666666655 89999999999987
Q ss_pred c----cceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccC-----CCceeecCCCCCcEEeCCCC
Q 046750 428 E----KNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDC-----HPKIIHRDIKSANILVDDEF 498 (723)
Q Consensus 428 ~----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g-----~~~ivHrDIkp~NILl~~~~ 498 (723)
. ...++||||+.+|+|.++++.. .+.+..++.|+.||+.||+|||+++ ..+|||||||++||||+.++
T Consensus 103 ~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~ 179 (337)
T 3mdy_A 103 GTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG 179 (337)
T ss_dssp SCGGGCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTS
T ss_pred CCCCCCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCC
Confidence 7 6789999999999999999654 3889999999999999999999871 22499999999999999999
Q ss_pred cEEEeecccccccCCCCcce---eecccccccccChhhhccCCCCCc------cceechHHHHHHHHhC----------C
Q 046750 499 EAQVADFGLAKLNDTTQTHV---STRVMGTFGYLAPEYASSGKLTDR------SDVFSFGVVLLELITG----------R 559 (723)
Q Consensus 499 ~vkL~DFGla~~~~~~~~~~---~~~~~gt~~y~APE~~~~~~~t~k------sDVwSlGviL~eLltG----------~ 559 (723)
.+||+|||+++......... .....|+..|+|||++.+..+..+ +|||||||+||||++| +
T Consensus 180 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~ 259 (337)
T 3mdy_A 180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ 259 (337)
T ss_dssp CEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccc
Confidence 99999999997654433221 123569999999999988777765 9999999999999999 5
Q ss_pred CCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccC
Q 046750 560 KPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEG 639 (723)
Q Consensus 560 ~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~ 639 (723)
.||....... .....+ ...+....+...+...+ ........+.+|+.+||+.||.+||++.+|++.|+.+.
T Consensus 260 ~p~~~~~~~~-~~~~~~-----~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 330 (337)
T 3mdy_A 260 LPYHDLVPSD-PSYEDM-----REIVCIKKLRPSFPNRW---SSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS 330 (337)
T ss_dssp CTTTTTSCSS-CCHHHH-----HHHHTTSCCCCCCCGGG---GGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccHhhhcCCC-Cchhhh-----HHHHhhhccCccccccc---hhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHH
Confidence 5554332211 111111 11111111111111111 12245667999999999999999999999999999876
Q ss_pred CC
Q 046750 640 EM 641 (723)
Q Consensus 640 ~~ 641 (723)
+.
T Consensus 331 ~~ 332 (337)
T 3mdy_A 331 ES 332 (337)
T ss_dssp HT
T ss_pred hh
Confidence 54
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=363.96 Aligned_cols=268 Identities=22% Similarity=0.337 Sum_probs=202.4
Q ss_pred HhcCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCc--hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEE
Q 046750 358 ITNGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSG--QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 358 ~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 435 (723)
+.++|++.++||+|+||.||+|+..+|+.||||+++.... .....+.+|+++|++++|+||+++++++.+....++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 4578999999999999999999888899999999975432 23457889999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ 515 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 515 (723)
||+. ++|.+++.... ..+.+..++.|+.||++||+|||++ +|+|||||++||||+.++.+||+|||+++......
T Consensus 99 e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 99 EFME-KDLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp ECCS-EEHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred cCCC-CCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 9996 57888776543 3488899999999999999999999 59999999999999999999999999998664332
Q ss_pred cceeecccccccccChhhhcc-CCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhh------------hh
Q 046750 516 THVSTRVMGTFGYLAPEYASS-GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPV------------LV 582 (723)
Q Consensus 516 ~~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~------------l~ 582 (723)
. ......|+..|+|||++.+ ..++.++|||||||+||||++|+.||........ +....... -.
T Consensus 174 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~ 250 (311)
T 3niz_A 174 R-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ--LPKIFSILGTPNPREWPQVQEL 250 (311)
T ss_dssp C----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH--HHHHHHHHCCCCTTTSGGGTTS
T ss_pred c-cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHHCCCChHHhhhhhcc
Confidence 2 2233568999999999876 5689999999999999999999999976543221 11111000 00
Q ss_pred hhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 583 RAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 583 ~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
..+....+ ...+..............+.+|+.+||+.||.+||++.||++.
T Consensus 251 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 251 PLWKQRTF-QVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp HHHHSCCC-CCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred chhhhccc-ccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 00000000 0001000001111122467899999999999999999999873
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=367.60 Aligned_cols=255 Identities=21% Similarity=0.319 Sum_probs=203.7
Q ss_pred hcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCc-hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEE
Q 046750 359 TNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSG-QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYE 436 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 436 (723)
.++|++.++||+|+||.||+|.. .+++.||||++..... ...+.+++|+.++++++|+||+++++++.+.+..|||||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 46899999999999999999955 4789999999865432 233568899999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCc
Q 046750 437 FVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQT 516 (723)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 516 (723)
|+.+++|.+++.... .+.+..++.|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++.+.....
T Consensus 86 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 160 (323)
T 3tki_A 86 YCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (323)
T ss_dssp CCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence 999999999997654 488999999999999999999999 599999999999999999999999999976542222
Q ss_pred -ceeecccccccccChhhhccCCC-CCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCccccc
Q 046750 517 -HVSTRVMGTFGYLAPEYASSGKL-TDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIV 594 (723)
Q Consensus 517 -~~~~~~~gt~~y~APE~~~~~~~-t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~v 594 (723)
.......|+..|+|||++.+..+ +.++|||||||+||||++|+.||...... ...+..|.. .....
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~~~~~--------~~~~~--- 228 (323)
T 3tki_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-CQEYSDWKE--------KKTYL--- 228 (323)
T ss_dssp ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTT-SHHHHHHHT--------TCTTS---
T ss_pred ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchH-HHHHHHHhc--------ccccC---
Confidence 22334679999999999988775 77999999999999999999999765432 122222211 11100
Q ss_pred chhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 046750 595 DPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALD 636 (723)
Q Consensus 595 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~ 636 (723)
+. ... ....+.+|+.+||+.||.+||++.||++.-+
T Consensus 229 ~~--~~~----~~~~~~~li~~~L~~dP~~R~t~~eil~h~~ 264 (323)
T 3tki_A 229 NP--WKK----IDSAPLALLHKILVENPSARITIPDIKKDRW 264 (323)
T ss_dssp TT--GGG----SCHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred Cc--ccc----CCHHHHHHHHHHccCChhhCcCHHHHhhChh
Confidence 00 011 1235678999999999999999999987644
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=401.03 Aligned_cols=258 Identities=28% Similarity=0.430 Sum_probs=211.5
Q ss_pred hcCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEec
Q 046750 359 TNGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFV 438 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 438 (723)
.++|++.++||+|+||.||+|.+.++..||||+++... ...++|++|+++|++|+|+|||+++++|.+ +..||||||+
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~ 343 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 343 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence 45688899999999999999998888889999998654 345689999999999999999999999876 6789999999
Q ss_pred CCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcce
Q 046750 439 PNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHV 518 (723)
Q Consensus 439 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 518 (723)
.+|+|.++|+......+.+..++.|+.||++||+|||++ +|||||||++||||++++.+||+|||+++.........
T Consensus 344 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 420 (535)
T 2h8h_A 344 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 420 (535)
T ss_dssp TTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHT
T ss_pred cCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceec
Confidence 999999999764434588999999999999999999999 59999999999999999999999999998665432222
Q ss_pred eecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchh
Q 046750 519 STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPR 597 (723)
Q Consensus 519 ~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~ 597 (723)
.....++..|+|||++.++.++.++||||||||||||++ |+.||..... .. +.+.+..+....
T Consensus 421 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~---~~--------~~~~i~~~~~~~----- 484 (535)
T 2h8h_A 421 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---RE--------VLDQVERGYRMP----- 484 (535)
T ss_dssp TCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH---HH--------HHHHHHTTCCCC-----
T ss_pred ccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HH--------HHHHHHcCCCCC-----
Confidence 233456789999999999999999999999999999999 8999965431 11 112222222111
Q ss_pred hhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCCC
Q 046750 598 LEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEM 641 (723)
Q Consensus 598 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~~ 641 (723)
........|.+|+.+||+.||++||++.+|++.|+.+...
T Consensus 485 ----~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 485 ----CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp ----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred ----CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 1112234678999999999999999999999999987543
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=382.68 Aligned_cols=250 Identities=28% Similarity=0.470 Sum_probs=206.8
Q ss_pred cCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeeccc-ceEEEEEec
Q 046750 360 NGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEK-NRLLIYEFV 438 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~-~~~lV~E~~ 438 (723)
++|++.++||+|+||.||+|.+. ++.||||+++... ..+.|.+|+++|++|+|+||++++++|.+.. ..||||||+
T Consensus 193 ~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~ 269 (450)
T 1k9a_A 193 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 269 (450)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred HHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence 56888999999999999999874 7899999998653 4568999999999999999999999987665 689999999
Q ss_pred CCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcce
Q 046750 439 PNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHV 518 (723)
Q Consensus 439 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 518 (723)
.+|+|.++|+......+.+..++.|+.||++||+|||++ +|||||||++||||++++.+||+|||+++......
T Consensus 270 ~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--- 343 (450)
T 1k9a_A 270 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 343 (450)
T ss_dssp TTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC------
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc---
Confidence 999999999876665678999999999999999999999 59999999999999999999999999998543221
Q ss_pred eecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchh
Q 046750 519 STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPR 597 (723)
Q Consensus 519 ~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~ 597 (723)
....++..|+|||++.+..++.++|||||||+||||++ |+.||....... +.+.+..+....
T Consensus 344 -~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-----------~~~~i~~~~~~~----- 406 (450)
T 1k9a_A 344 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-----------VVPRVEKGYKMD----- 406 (450)
T ss_dssp ----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT-----------HHHHHHTTCCCC-----
T ss_pred -cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-----------HHHHHHcCCCCC-----
Confidence 12357889999999999999999999999999999998 999997654211 112222222111
Q ss_pred hhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccC
Q 046750 598 LEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEG 639 (723)
Q Consensus 598 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~ 639 (723)
........+.+|+.+||+.||.+||++.+|++.|+.+.
T Consensus 407 ----~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~ 444 (450)
T 1k9a_A 407 ----APDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444 (450)
T ss_dssp ----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 11122346889999999999999999999999998754
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=367.57 Aligned_cols=261 Identities=18% Similarity=0.189 Sum_probs=208.2
Q ss_pred hcCcccceEEeccCcEEEEEEE-cCCCcEEEEEEcccCCchhHHHHHHHHHHHHHc-cCCceeeEeeeeecccceEEEEE
Q 046750 359 TNGFARENVIGEGGFGCVYKGN-LPEGKVVAVKQLKSGSGQGEREFRAEVEIISRV-HHRHLVSLVGYCISEKNRLLIYE 436 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~E 436 (723)
.++|.+.++||+|+||.||+|. ..+++.||||++..... ...+.+|+++|++| +|+||+++++++.+....+||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 4679999999999999999996 46789999999875432 34688999999999 99999999999999999999999
Q ss_pred ecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCc-----EEEeeccccccc
Q 046750 437 FVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFE-----AQVADFGLAKLN 511 (723)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~-----vkL~DFGla~~~ 511 (723)
|+ +++|.+++.... ..+++..++.|+.||+.||+|||++ +|||||||++||||+.++. +||+|||+++.+
T Consensus 86 ~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 86 LL-GPSLEDLFDLCD-RTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred eC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 99 999999997642 3589999999999999999999999 5999999999999998887 999999999865
Q ss_pred CCCCcc------eeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhh
Q 046750 512 DTTQTH------VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAI 585 (723)
Q Consensus 512 ~~~~~~------~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i 585 (723)
...... ......||..|+|||++.+..++.++|||||||+||||++|+.||............... .....
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i---~~~~~ 237 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKI---GDTKR 237 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHH---HHHHH
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHH---Hhhhc
Confidence 443321 123467999999999999999999999999999999999999999875432211111111 00000
Q ss_pred hcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCC
Q 046750 586 ETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGE 640 (723)
Q Consensus 586 ~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~ 640 (723)
.. . ...+...+ . .+.+++..||+.+|.+||++.+|++.|+....
T Consensus 238 ~~-~-----~~~~~~~~----p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~ 281 (330)
T 2izr_A 238 AT-P-----IEVLCENF----P-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFD 281 (330)
T ss_dssp HS-C-----HHHHTTTC----H-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred cC-C-----HHHHhccC----h-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHH
Confidence 00 0 00011111 2 68899999999999999999999999986543
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=372.17 Aligned_cols=256 Identities=26% Similarity=0.452 Sum_probs=200.5
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCc----EEEEEEcccCC-chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGK----VVAVKQLKSGS-GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLL 433 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~----~VAvK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 433 (723)
++|++.++||+|+||.||+|.+ .+++ .||+|.++... ....+.|.+|+++|++++|+||++++++|.+.. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 5699999999999999999964 3444 36888886543 344568999999999999999999999998754 789
Q ss_pred EEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCC
Q 046750 434 IYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDT 513 (723)
Q Consensus 434 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 513 (723)
|+||+.+|+|.+++..... .+.+..++.|+.||++||+|||++ +|+|||||++||||+.++.+||+|||+++....
T Consensus 94 v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEECCTTCBHHHHHHHSTT-SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred EEEecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 9999999999999976443 488999999999999999999999 599999999999999999999999999987654
Q ss_pred CCcc-eeecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcc
Q 046750 514 TQTH-VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLS 591 (723)
Q Consensus 514 ~~~~-~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~ 591 (723)
.... ......++..|+|||++.+..++.++|||||||+||||++ |+.||...... .+ ...+..+...
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~--------~~~~~~~~~~ 238 (327)
T 3poz_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EI--------SSILEKGERL 238 (327)
T ss_dssp TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GH--------HHHHHTTCCC
T ss_pred CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH---HH--------HHHHHcCCCC
Confidence 3332 2233457889999999999999999999999999999999 99999764321 11 1122222111
Q ss_pred cccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCC
Q 046750 592 EIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGE 640 (723)
Q Consensus 592 ~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~ 640 (723)
. ........+.+++.+||+.+|.+||++.+|++.|+.+..
T Consensus 239 ~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 239 P---------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp C---------CCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred C---------CCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 1 111123368889999999999999999999999987654
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=362.86 Aligned_cols=273 Identities=21% Similarity=0.283 Sum_probs=212.0
Q ss_pred cCcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCC-chhHHHHHHHHHHHHHccCCceeeEeeeeeccc--ceEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGS-GQGEREFRAEVEIISRVHHRHLVSLVGYCISEK--NRLLIY 435 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~--~~~lV~ 435 (723)
++|.+.++||+|+||.||+|... +++.||||+++... ....+.+.+|+++|++|+|+||+++++++.... ..+|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 67999999999999999999654 58999999997543 233467889999999999999999999998765 679999
Q ss_pred EecCCCchhhccccCCC-CcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEe----CCCCcEEEeecccccc
Q 046750 436 EFVPNNNLEHHLHGKGQ-PVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILV----DDEFEAQVADFGLAKL 510 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl----~~~~~vkL~DFGla~~ 510 (723)
||+.+++|.+++..... ..+.+..++.|+.||+.||+|||++ +|+|||||++|||| +.++.+||+|||+++.
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 99999999999976432 2389999999999999999999999 59999999999999 7888899999999987
Q ss_pred cCCCCcceeecccccccccChhhhc--------cCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhh
Q 046750 511 NDTTQTHVSTRVMGTFGYLAPEYAS--------SGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLV 582 (723)
Q Consensus 511 ~~~~~~~~~~~~~gt~~y~APE~~~--------~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~ 582 (723)
...... .....|+..|+|||++. +..++.++|||||||+||||++|+.||....... ...+....++.
T Consensus 166 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~ 241 (319)
T 4euu_A 166 LEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR--RNKEVMYKIIT 241 (319)
T ss_dssp CCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGG--GCHHHHHHHHH
T ss_pred cCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccc--hhHHHHHHHhc
Confidence 654332 23356999999999986 5779999999999999999999999997543211 11111111111
Q ss_pred hhhhcCCcccc---c--------chhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCC
Q 046750 583 RAIETGDLSEI---V--------DPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGE 640 (723)
Q Consensus 583 ~~i~~~~l~~~---v--------d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~ 640 (723)
.. ....+..+ . +-.....+.......+.+++.+||+.||.+|+++.|+++.......
T Consensus 242 ~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~ 309 (319)
T 4euu_A 242 GK-PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (319)
T ss_dssp HC-CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred CC-CcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence 10 00000000 0 0011123445666788899999999999999999999999987544
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=362.84 Aligned_cols=258 Identities=26% Similarity=0.395 Sum_probs=214.7
Q ss_pred hcCcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEe
Q 046750 359 TNGFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEF 437 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 437 (723)
.++|++.++||+|+||.||+|.+. +++.||||+++... ...+.+.+|++++++++|+||++++++|.+....++||||
T Consensus 12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 90 (288)
T 3kfa_A 12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 90 (288)
T ss_dssp GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEc
Confidence 467999999999999999999664 48899999997643 4456789999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcc
Q 046750 438 VPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTH 517 (723)
Q Consensus 438 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 517 (723)
+.+++|.+++.......+.+..++.|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||++.........
T Consensus 91 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 167 (288)
T 3kfa_A 91 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 167 (288)
T ss_dssp CTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSE
T ss_pred CCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCccc
Confidence 9999999999876666789999999999999999999999 5999999999999999999999999999877655444
Q ss_pred eeecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccch
Q 046750 518 VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDP 596 (723)
Q Consensus 518 ~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~ 596 (723)
......++..|+|||++.+..++.++|||||||+||||++ |..||..... ..+. +.+..+...
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~---~~~~--------~~~~~~~~~----- 231 (288)
T 3kfa_A 168 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVY--------ELLEKDYRM----- 231 (288)
T ss_dssp EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG---GGHH--------HHHHTTCCC-----
T ss_pred cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHH--------HHHhccCCC-----
Confidence 4445567889999999999999999999999999999999 9999975432 1111 111111110
Q ss_pred hhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCC
Q 046750 597 RLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGE 640 (723)
Q Consensus 597 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~ 640 (723)
.........+.+|+.+||+.||.+||++.+|++.|+....
T Consensus 232 ----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~ 271 (288)
T 3kfa_A 232 ----ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271 (288)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence 0111122468899999999999999999999999987543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=383.48 Aligned_cols=257 Identities=25% Similarity=0.389 Sum_probs=207.4
Q ss_pred hcCcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCCc-hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEE
Q 046750 359 TNGFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGSG-QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYE 436 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 436 (723)
.++|.+.+.||+|+||.||+|.+. +++.||||+++.... ....+|.+|+++|++++|+||++++++|.+.+..|||||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 357889999999999999999765 689999999986533 233468899999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCc
Q 046750 437 FVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQT 516 (723)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 516 (723)
|+.+|+|.++++..+ ..+.+..++.++.||++||+|||++ +|+|||||++||||+.++.+||+|||+++.......
T Consensus 193 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~ 268 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY 268 (377)
T ss_dssp CCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred cCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence 999999999997543 2478899999999999999999999 599999999999999999999999999986543222
Q ss_pred cee-ecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCccccc
Q 046750 517 HVS-TRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIV 594 (723)
Q Consensus 517 ~~~-~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~v 594 (723)
... ....++..|+|||++.++.++.++|||||||+||||++ |+.||..... ... .+.+..+....+
T Consensus 269 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~---~~~--------~~~~~~~~~~~~- 336 (377)
T 3cbl_A 269 AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN---QQT--------REFVEKGGRLPC- 336 (377)
T ss_dssp ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH---HHH--------HHHHHTTCCCCC-
T ss_pred eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHH--------HHHHHcCCCCCC-
Confidence 111 11235778999999999999999999999999999998 9999975431 111 112222221111
Q ss_pred chhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccC
Q 046750 595 DPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEG 639 (723)
Q Consensus 595 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~ 639 (723)
.......+.+|+.+||+.||.+||++.+|++.|+.+.
T Consensus 337 --------~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 337 --------PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp --------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 1112236788999999999999999999999998754
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=389.68 Aligned_cols=258 Identities=28% Similarity=0.430 Sum_probs=206.1
Q ss_pred hcCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEec
Q 046750 359 TNGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFV 438 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 438 (723)
.++|.+.++||+|+||.||+|.+.++..||||+++... ...++|.+|+++|++|+|+||+++++++.+ +..+|||||+
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~ 260 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 260 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence 45688899999999999999998888889999998654 345689999999999999999999999876 6789999999
Q ss_pred CCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcce
Q 046750 439 PNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHV 518 (723)
Q Consensus 439 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 518 (723)
.+|+|.++|+......+.+..++.|+.||+.||+|||++ +|||||||++||||++++.+||+|||+++.........
T Consensus 261 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 337 (452)
T 1fmk_A 261 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 337 (452)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred cCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCceec
Confidence 999999999764444588999999999999999999999 59999999999999999999999999998765433333
Q ss_pred eecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchh
Q 046750 519 STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPR 597 (723)
Q Consensus 519 ~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~ 597 (723)
.....++..|+|||++.++.++.++|||||||+||||++ |+.||..... .. +...+..+....
T Consensus 338 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~---~~--------~~~~i~~~~~~~----- 401 (452)
T 1fmk_A 338 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---RE--------VLDQVERGYRMP----- 401 (452)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HH--------HHHHHHTTCCCC-----
T ss_pred ccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH---HH--------HHHHHHcCCCCC-----
Confidence 333457889999999999999999999999999999999 9999965431 11 112222221111
Q ss_pred hhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCCC
Q 046750 598 LEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEM 641 (723)
Q Consensus 598 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~~ 641 (723)
........+.+|+.+||+.||.+||++.+|++.|+.....
T Consensus 402 ----~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 402 ----CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp ----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred ----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 1112234688999999999999999999999999987643
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-42 Score=375.04 Aligned_cols=260 Identities=28% Similarity=0.424 Sum_probs=211.7
Q ss_pred hcCcccceEEeccCcEEEEEEEc--------CCCcEEEEEEcccCCc-hhHHHHHHHHHHHHHc-cCCceeeEeeeeecc
Q 046750 359 TNGFARENVIGEGGFGCVYKGNL--------PEGKVVAVKQLKSGSG-QGEREFRAEVEIISRV-HHRHLVSLVGYCISE 428 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~--------~~g~~VAvK~l~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~ 428 (723)
.++|.+.++||+|+||.||+|+. ..+..||||+++.... ...+.+.+|+++++++ +|+||++++++|.+.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 46799999999999999999964 2335799999986543 3346789999999999 999999999999999
Q ss_pred cceEEEEEecCCCchhhccccCC--------------CCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEe
Q 046750 429 KNRLLIYEFVPNNNLEHHLHGKG--------------QPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILV 494 (723)
Q Consensus 429 ~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl 494 (723)
+..++||||+.+|+|.+++.... ...+++..++.|+.||+.||+|||++ +|||||||++||||
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEE
Confidence 99999999999999999997643 23589999999999999999999999 59999999999999
Q ss_pred CCCCcEEEeecccccccCCCCc-ceeecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchh
Q 046750 495 DDEFEAQVADFGLAKLNDTTQT-HVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDES 572 (723)
Q Consensus 495 ~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~ 572 (723)
++++.+||+|||+++....... .......++..|+|||++.+..++.++|||||||+||||++ |+.||..... ..
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~---~~ 301 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---EE 301 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HH
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HH
Confidence 9999999999999986654332 22233457889999999999999999999999999999999 9999965431 11
Q ss_pred hHHhhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCCC
Q 046750 573 LVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEM 641 (723)
Q Consensus 573 l~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~~ 641 (723)
+ .+.+..+..... .......+.+|+.+||+.||.+||++.||++.|+.+...
T Consensus 302 ~--------~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 353 (382)
T 3tt0_A 302 L--------FKLLKEGHRMDK---------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 353 (382)
T ss_dssp H--------HHHHHTTCCCCC---------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred H--------HHHHHcCCCCCC---------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 1 122222221111 111223688899999999999999999999999987654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=370.09 Aligned_cols=248 Identities=23% Similarity=0.329 Sum_probs=203.6
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccC---CchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSG---SGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 435 (723)
++|++.++||+|+||.||+|+. .+|+.||||+++.. .......+.+|+++|++++|+||++++++|.+.+..||||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 5799999999999999999965 46899999999753 2234457889999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ 515 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 515 (723)
||+.+|+|.+++.... .+.+..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++......
T Consensus 85 E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 159 (337)
T 1o6l_A 85 EYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp ECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence 9999999999987543 478899999999999999999999 59999999999999999999999999997543322
Q ss_pred cceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccc
Q 046750 516 THVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVD 595 (723)
Q Consensus 516 ~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd 595 (723)
. .....+||..|+|||++.+..++.++|||||||+||||++|+.||..... . . +.+.+..+.+.
T Consensus 160 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~---~-----~~~~i~~~~~~---- 223 (337)
T 1o6l_A 160 A-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---E---R-----LFELILMEEIR---- 223 (337)
T ss_dssp C-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---H---H-----HHHHHHHCCCC----
T ss_pred C-cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH---H---H-----HHHHHHcCCCC----
Confidence 2 23446799999999999999999999999999999999999999975421 1 1 11122222211
Q ss_pred hhhhccccHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 046750 596 PRLEKHYVESEMFRMIEAAAACVRHSGPKRP-----RMVQVVRA 634 (723)
Q Consensus 596 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~eVl~~ 634 (723)
+...+ ...+.+|+.+||+.||.+|+ ++.||++.
T Consensus 224 --~p~~~----s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 224 --FPRTL----SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp --CCTTS----CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred --CCCCC----CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 11111 23678899999999999999 89999864
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=376.98 Aligned_cols=261 Identities=25% Similarity=0.392 Sum_probs=208.8
Q ss_pred hcCcccceEEeccCcEEEEEEEcC------CCcEEEEEEcccC-CchhHHHHHHHHHHHHHccCCceeeEeeeeecccce
Q 046750 359 TNGFARENVIGEGGFGCVYKGNLP------EGKVVAVKQLKSG-SGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNR 431 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~VAvK~l~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 431 (723)
.++|.+.++||+|+||.||+|.+. +++.||||+++.. ......++.+|+.+|++|+|+||++++++|.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 367899999999999999999743 4568999999754 334455789999999999999999999999999999
Q ss_pred EEEEEecCCCchhhccccCC-----CCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCC---cEEEe
Q 046750 432 LLIYEFVPNNNLEHHLHGKG-----QPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEF---EAQVA 503 (723)
Q Consensus 432 ~lV~E~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~---~vkL~ 503 (723)
+|||||+.+|+|.+++.... ...+.+..++.|+.||++||+|||++ +|||||||++||||+.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999997532 23588999999999999999999999 599999999999999554 59999
Q ss_pred ecccccccCCCCc-ceeecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhh
Q 046750 504 DFGLAKLNDTTQT-HVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVL 581 (723)
Q Consensus 504 DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l 581 (723)
|||+++....... .......|+..|+|||++.+..++.++|||||||+||||++ |+.||..... ..+
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~---~~~-------- 295 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---QEV-------- 295 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHH--------
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHH--------
Confidence 9999975432211 22233567899999999999999999999999999999998 9999975431 111
Q ss_pred hhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCCCc
Q 046750 582 VRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEMS 642 (723)
Q Consensus 582 ~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~~~ 642 (723)
.+.+..+..... .......+.+|+.+||+.||.+||++.+|++.|+.+....
T Consensus 296 ~~~i~~~~~~~~---------~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 296 LEFVTSGGRMDP---------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp HHHHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred HHHHHcCCCCCC---------CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 122222221111 1112235789999999999999999999999998876543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=365.79 Aligned_cols=254 Identities=21% Similarity=0.306 Sum_probs=205.9
Q ss_pred HhcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCch------hHHHHHHHHHHHHHccCCceeeEeeeeecccc
Q 046750 358 ITNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQ------GEREFRAEVEIISRVHHRHLVSLVGYCISEKN 430 (723)
Q Consensus 358 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~------~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 430 (723)
+.++|.+.+.||+|+||.||+|.. .+|+.||||+++..... ..+.+.+|+++|++|+|+||++++++|.+...
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 446799999999999999999965 46899999998764322 35679999999999999999999999999999
Q ss_pred eEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCC----cEEEeecc
Q 046750 431 RLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEF----EAQVADFG 506 (723)
Q Consensus 431 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~----~vkL~DFG 506 (723)
.++||||+.+++|.+++.... .+++..++.|+.||+.||.|||++ +|+|||||++||||+.++ .+||+|||
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEEECCCSCBHHHHHTTSS--CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEEcCCCCCHHHHHHhcC--CcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 999999999999999997543 488999999999999999999999 599999999999999887 89999999
Q ss_pred cccccCCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhh
Q 046750 507 LAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIE 586 (723)
Q Consensus 507 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~ 586 (723)
+++....... .....|+..|+|||++.+..++.++|||||||+||||++|+.||..... ... ...+.
T Consensus 164 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~--------~~~~~ 230 (326)
T 2y0a_A 164 LAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---QET--------LANVS 230 (326)
T ss_dssp TCEECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH---HHH--------HHHHH
T ss_pred CCeECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH---HHH--------HHHHH
Confidence 9987653322 2345699999999999999999999999999999999999999965431 111 11111
Q ss_pred cCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 046750 587 TGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRAL 635 (723)
Q Consensus 587 ~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L 635 (723)
...+. + ...+... ....+.+|+.+||+.||.+||++.||++.-
T Consensus 231 ~~~~~-~-~~~~~~~----~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 273 (326)
T 2y0a_A 231 AVNYE-F-EDEYFSN----TSALAKDFIRRLLVKDPKKRMTIQDSLQHP 273 (326)
T ss_dssp HTCCC-C-CHHHHTT----SCHHHHHHHHHHSCSSGGGSCCHHHHHHST
T ss_pred hcCCC-c-Ccccccc----CCHHHHHHHHHHccCChhhCCCHHHHhcCC
Confidence 11110 1 0111111 123578899999999999999999999853
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-42 Score=362.81 Aligned_cols=259 Identities=28% Similarity=0.432 Sum_probs=210.8
Q ss_pred hcCcccceEEeccCcEEEEEEEc------CCCcEEEEEEcccCCc-hhHHHHHHHHHHHHHccCCceeeEeeeeecccce
Q 046750 359 TNGFARENVIGEGGFGCVYKGNL------PEGKVVAVKQLKSGSG-QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNR 431 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~------~~g~~VAvK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 431 (723)
.++|.+.+.||+|+||.||+|.. .+++.||||+++.... ...+.+.+|+++|++|+|+||++++++|.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 36789999999999999999964 3457899999976533 3446789999999999999999999999999999
Q ss_pred EEEEEecCCCchhhccccCCC----------------------CcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCC
Q 046750 432 LLIYEFVPNNNLEHHLHGKGQ----------------------PVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKS 489 (723)
Q Consensus 432 ~lV~E~~~~gsL~~~l~~~~~----------------------~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp 489 (723)
++||||+.+++|.+++..... ..+.+..++.|+.||++||+|||++ +|+|||||+
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccch
Confidence 999999999999999976432 3488999999999999999999999 599999999
Q ss_pred CcEEeCCCCcEEEeecccccccCCCCcce-eecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCC
Q 046750 490 ANILVDDEFEAQVADFGLAKLNDTTQTHV-STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQP 567 (723)
Q Consensus 490 ~NILl~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~ 567 (723)
+||||++++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||+||||++ |+.||.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999999998665433322 233457889999999999999999999999999999999 9999975432
Q ss_pred CCchhhHHhhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCC
Q 046750 568 LGDESLVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGE 640 (723)
Q Consensus 568 ~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~ 640 (723)
..+ .+.+..+....+ .......+.+++.+||+.||.+||++.+|++.|+.+..
T Consensus 259 ---~~~--------~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 259 ---ERL--------FNLLKTGHRMER---------PDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp ---GGH--------HHHHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---HHH--------HHHhhcCCcCCC---------CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 111 122222221111 11122368899999999999999999999999987643
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=354.03 Aligned_cols=252 Identities=29% Similarity=0.480 Sum_probs=195.0
Q ss_pred cCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCc----hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSG----QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 435 (723)
++|++.++||+|+||.||+|.+ .++.||||+++.... ...+.+++|++++++++|+||++++++|.+.+..++||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 5789999999999999999987 488999999875422 23467899999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCC--------CCcEEEeeccc
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDD--------EFEAQVADFGL 507 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~--------~~~vkL~DFGl 507 (723)
||+.+++|.+++... .+++..++.++.||+.||+|||+++..+|+|||||++||||+. ++.+||+|||+
T Consensus 86 e~~~~~~L~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~ 162 (271)
T 3dtc_A 86 EFARGGPLNRVLSGK---RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL 162 (271)
T ss_dssp ECCTTEEHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred EcCCCCCHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence 999999999998643 4889999999999999999999985334999999999999986 67899999999
Q ss_pred ccccCCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhc
Q 046750 508 AKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIET 587 (723)
Q Consensus 508 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~ 587 (723)
++....... ....|+..|+|||++.+..++.++|||||||+||||++|+.||..... ... . ..+..
T Consensus 163 ~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~-~-------~~~~~ 228 (271)
T 3dtc_A 163 AREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG---LAV-A-------YGVAM 228 (271)
T ss_dssp ----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH---HHH-H-------HHHHT
T ss_pred ccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHH-H-------Hhhhc
Confidence 976543322 234689999999999999999999999999999999999999975431 111 0 11111
Q ss_pred CCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhc
Q 046750 588 GDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDS 637 (723)
Q Consensus 588 ~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~ 637 (723)
+..... ........+.+++.+||+.||.+||++.||++.|+.
T Consensus 229 ~~~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 229 NKLALP--------IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp SCCCCC--------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred CCCCCC--------CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 111111 111122468899999999999999999999999975
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=390.99 Aligned_cols=262 Identities=20% Similarity=0.229 Sum_probs=206.9
Q ss_pred HHHHHHhcCcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCC---chhHHHHHHHHHHHHHccCCceeeEeeeeecc
Q 046750 353 EELMEITNGFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGS---GQGEREFRAEVEIISRVHHRHLVSLVGYCISE 428 (723)
Q Consensus 353 ~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 428 (723)
.++....++|++.++||+|+||.||+|+++ +++.||||+++... ......+++|+.+|..++|+||++++++|.+.
T Consensus 67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~ 146 (437)
T 4aw2_A 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDD 146 (437)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred hcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC
Confidence 444445678999999999999999999665 47899999986531 11223488999999999999999999999999
Q ss_pred cceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccc
Q 046750 429 KNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLA 508 (723)
Q Consensus 429 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla 508 (723)
+..||||||+.+|+|.++|.... ..+++..+..|+.||+.||+|||++ +|||||||++||||+.++.+||+|||++
T Consensus 147 ~~~~lV~Ey~~gg~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGla 222 (437)
T 4aw2_A 147 NNLYLVMDYYVGGDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSC 222 (437)
T ss_dssp SEEEEEECCCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CEEEEEEecCCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhhh
Confidence 99999999999999999997633 2488999999999999999999999 5999999999999999999999999999
Q ss_pred cccCCCCcceeecccccccccChhhhc-----cCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhh
Q 046750 509 KLNDTTQTHVSTRVMGTFGYLAPEYAS-----SGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVR 583 (723)
Q Consensus 509 ~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~ 583 (723)
+.............+||..|+|||++. .+.++.++|||||||+||||++|+.||..... .... ..++ .
T Consensus 223 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~---~~~~---~~i~-~ 295 (437)
T 4aw2_A 223 LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL---VETY---GKIM-N 295 (437)
T ss_dssp EECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHH---HHHH-T
T ss_pred hhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh---hHHH---Hhhh-h
Confidence 876655554455568999999999997 56799999999999999999999999975432 1111 1111 0
Q ss_pred hhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCC--CCCHHHHHHH
Q 046750 584 AIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPK--RPRMVQVVRA 634 (723)
Q Consensus 584 ~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~eVl~~ 634 (723)
....-.+... ...+ ...+.+|+.+||..++++ |+++.||++.
T Consensus 296 ~~~~~~~p~~-----~~~~----s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 296 HKERFQFPTQ-----VTDV----SENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp HHHHCCCCSS-----CCCS----CHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred ccccccCCcc-----cccC----CHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 0000011110 0111 235778888999888888 9999999874
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=364.15 Aligned_cols=259 Identities=26% Similarity=0.399 Sum_probs=210.6
Q ss_pred cCcccceEEeccCcEEEEEEEc------CCCcEEEEEEcccCCc-hhHHHHHHHHHHHHHc-cCCceeeEeeeeecccce
Q 046750 360 NGFARENVIGEGGFGCVYKGNL------PEGKVVAVKQLKSGSG-QGEREFRAEVEIISRV-HHRHLVSLVGYCISEKNR 431 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~------~~g~~VAvK~l~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~ 431 (723)
++|.+.+.||+|+||.||+|.+ .+++.||||+++.... ...+.+.+|+++|++| +|+||++++++|.+.+..
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 102 (313)
T 1t46_A 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (313)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCc
Confidence 5789999999999999999964 3467899999986543 3446789999999999 999999999999999999
Q ss_pred EEEEEecCCCchhhccccCCCC----------------cchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeC
Q 046750 432 LLIYEFVPNNNLEHHLHGKGQP----------------VLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVD 495 (723)
Q Consensus 432 ~lV~E~~~~gsL~~~l~~~~~~----------------~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~ 495 (723)
++||||+.+|+|.+++...... .+++..++.++.||+.||+|||++ +|+|||||++||||+
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~ 179 (313)
T 1t46_A 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLT 179 (313)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEE
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEc
Confidence 9999999999999999765422 488999999999999999999999 599999999999999
Q ss_pred CCCcEEEeecccccccCCCCcc-eeecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhh
Q 046750 496 DEFEAQVADFGLAKLNDTTQTH-VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESL 573 (723)
Q Consensus 496 ~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l 573 (723)
.++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||+||||++ |+.||...... ..+
T Consensus 180 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~ 257 (313)
T 1t46_A 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD--SKF 257 (313)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS--HHH
T ss_pred CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch--hHH
Confidence 9999999999999876544332 2233457889999999999999999999999999999999 99999765321 111
Q ss_pred HHhhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCC
Q 046750 574 VEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGE 640 (723)
Q Consensus 574 ~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~ 640 (723)
. +.+..+. .... .......+.+++.+||+.||.+||++.||++.|++...
T Consensus 258 ~--------~~~~~~~-~~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 307 (313)
T 1t46_A 258 Y--------KMIKEGF-RMLS--------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (313)
T ss_dssp H--------HHHHHTC-CCCC--------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H--------HHhccCC-CCCC--------cccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 1 1111111 1111 11122467889999999999999999999999987543
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=357.11 Aligned_cols=256 Identities=25% Similarity=0.384 Sum_probs=195.8
Q ss_pred hcCcccceEEeccCcEEEEEEEcCC----CcEEEEEEcccCCc-hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEE
Q 046750 359 TNGFARENVIGEGGFGCVYKGNLPE----GKVVAVKQLKSGSG-QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLL 433 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~~~----g~~VAvK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 433 (723)
.++|++.++||+|+||.||+|.... +..||||+++.... ...+.|.+|+.++++++|+||+++++++. ++..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 4679999999999999999996543 45799999876533 33457899999999999999999999985 567899
Q ss_pred EEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCC
Q 046750 434 IYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDT 513 (723)
Q Consensus 434 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 513 (723)
||||+.+++|.+++.... ..+++..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++....
T Consensus 93 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168 (281)
T ss_dssp EEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccCc
Confidence 999999999999997543 3488999999999999999999999 599999999999999999999999999987654
Q ss_pred CCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCccc
Q 046750 514 TQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSE 592 (723)
Q Consensus 514 ~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~ 592 (723)
..........++..|+|||++.+..++.++|||||||+||||++ |+.||..... ..+ ...+..+....
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~---~~~--------~~~i~~~~~~~ 237 (281)
T 1mp8_A 169 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---NDV--------IGRIENGERLP 237 (281)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG---GGH--------HHHHHTTCCCC
T ss_pred ccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCH---HHH--------HHHHHcCCCCC
Confidence 43333334457789999999999999999999999999999997 9999975432 111 11222222111
Q ss_pred ccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccC
Q 046750 593 IVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEG 639 (723)
Q Consensus 593 ~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~ 639 (723)
+ .......+.+++.+||+.||.+||++.+|++.|+.+.
T Consensus 238 ~---------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 238 M---------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275 (281)
T ss_dssp C---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred C---------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1 1112246788999999999999999999999998764
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=356.94 Aligned_cols=262 Identities=18% Similarity=0.214 Sum_probs=210.3
Q ss_pred hcCcccceEEeccCcEEEEEEE-cCCCcEEEEEEcccCCchhHHHHHHHHHHHHHc-cCCceeeEeeeeecccceEEEEE
Q 046750 359 TNGFARENVIGEGGFGCVYKGN-LPEGKVVAVKQLKSGSGQGEREFRAEVEIISRV-HHRHLVSLVGYCISEKNRLLIYE 436 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~E 436 (723)
.++|.+.+.||+|+||.||+|. ..+++.||||++.... ....+.+|+++++++ +|+||+++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 4679999999999999999996 4678999999987542 334688999999999 79999999999999999999999
Q ss_pred ecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCc-----EEEeeccccccc
Q 046750 437 FVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFE-----AQVADFGLAKLN 511 (723)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~-----vkL~DFGla~~~ 511 (723)
|+ +++|.+++..... .+++..++.|+.||+.||+|||++ +|+|||||++||||+.++. +||+|||+++..
T Consensus 87 ~~-~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 87 LL-GPSLEDLLDLCGR-KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp CC-CCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred ec-CCCHHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 99 9999999976543 488999999999999999999999 5999999999999987766 999999999876
Q ss_pred CCCCcc------eeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhh
Q 046750 512 DTTQTH------VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAI 585 (723)
Q Consensus 512 ~~~~~~------~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i 585 (723)
...... ......|+..|+|||++.+..++.++|||||||+||||++|+.||............... ....
T Consensus 162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~----~~~~ 237 (298)
T 1csn_A 162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI----GEKK 237 (298)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHH----HHHH
T ss_pred ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHH----Hhhc
Confidence 543321 124457999999999999999999999999999999999999999875433222221111 0110
Q ss_pred hcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCC
Q 046750 586 ETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGE 640 (723)
Q Consensus 586 ~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~ 640 (723)
....+ ..+... ....+.+++.+||+.||.+||++.+|++.|+.+..
T Consensus 238 ~~~~~-----~~~~~~----~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~ 283 (298)
T 1csn_A 238 QSTPL-----RELCAG----FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 283 (298)
T ss_dssp HHSCH-----HHHTTT----SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred cCccH-----HHHHhh----CcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence 00010 011111 23468899999999999999999999999988654
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=370.24 Aligned_cols=261 Identities=25% Similarity=0.369 Sum_probs=207.9
Q ss_pred hcCcccceEEeccCcEEEEEEEc------CCCcEEEEEEcccCC-chhHHHHHHHHHHHHHc-cCCceeeEeeeeecccc
Q 046750 359 TNGFARENVIGEGGFGCVYKGNL------PEGKVVAVKQLKSGS-GQGEREFRAEVEIISRV-HHRHLVSLVGYCISEKN 430 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~------~~g~~VAvK~l~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~ 430 (723)
.++|.+.+.||+|+||.||+|.. ..++.||||+++... ....+.+.+|+++|++| +|+||++++++|.+.+.
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 123 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence 36799999999999999999964 245689999997542 23446789999999999 89999999999999999
Q ss_pred eEEEEEecCCCchhhccccCCC---------------------CcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCC
Q 046750 431 RLLIYEFVPNNNLEHHLHGKGQ---------------------PVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKS 489 (723)
Q Consensus 431 ~~lV~E~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp 489 (723)
.+|||||+.+|+|.+++..... ..+++..++.|+.||+.||+|||++ +|+|||||+
T Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp 200 (344)
T 1rjb_A 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAA 200 (344)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSG
T ss_pred cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCh
Confidence 9999999999999999976532 2378899999999999999999999 599999999
Q ss_pred CcEEeCCCCcEEEeecccccccCCCCcc-eeecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCC
Q 046750 490 ANILVDDEFEAQVADFGLAKLNDTTQTH-VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQP 567 (723)
Q Consensus 490 ~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~ 567 (723)
+||||+.++.+||+|||++......... ......|+..|+|||++.+..++.++|||||||+||||++ |+.||.....
T Consensus 201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 280 (344)
T 1rjb_A 201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 280 (344)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence 9999999999999999999865433322 2334567889999999999999999999999999999998 9999976542
Q ss_pred CCchhhHHhhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCCC
Q 046750 568 LGDESLVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEM 641 (723)
Q Consensus 568 ~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~~ 641 (723)
. ..+. ..+..+.... ........+.+|+.+||+.||.+||++.+|++.|+.....
T Consensus 281 ~--~~~~--------~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 281 D--ANFY--------KLIQNGFKMD---------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp S--HHHH--------HHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred H--HHHH--------HHHhcCCCCC---------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 1 1111 1111111100 1111124688899999999999999999999999987654
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=372.48 Aligned_cols=255 Identities=23% Similarity=0.342 Sum_probs=204.6
Q ss_pred HhcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccC-----CchhHHHHHHHHHHHHHccCCceeeEeeeeecccce
Q 046750 358 ITNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSG-----SGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNR 431 (723)
Q Consensus 358 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~-----~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 431 (723)
+.++|++.++||+|+||.||+|.. .+++.||||+++.. .....+.+.+|+++|++|+|+||++++++|.+.+..
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 456799999999999999999954 56899999998532 122456799999999999999999999999999999
Q ss_pred EEEEEecCCCchhhccccC--CCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCc---EEEeecc
Q 046750 432 LLIYEFVPNNNLEHHLHGK--GQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFE---AQVADFG 506 (723)
Q Consensus 432 ~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~---vkL~DFG 506 (723)
||||||+.+++|.+++... ....+++..++.|+.||++||+|||++ +|+|||||++||||+.++. +||+|||
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCc
Confidence 9999999999998887543 233478899999999999999999999 5999999999999986654 9999999
Q ss_pred cccccCCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhh
Q 046750 507 LAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIE 586 (723)
Q Consensus 507 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~ 586 (723)
+++....... .....+||..|+|||++.+..++.++||||||||||||++|+.||.... .. +.+.+.
T Consensus 179 ~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~--------~~~~i~ 245 (351)
T 3c0i_A 179 VAIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK----ER--------LFEGII 245 (351)
T ss_dssp TCEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH----HH--------HHHHHH
T ss_pred ceeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH----HH--------HHHHHH
Confidence 9987654332 2334569999999999999999999999999999999999999997531 11 112222
Q ss_pred cCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 587 TGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 587 ~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
.+.+. .++.....+ ...+.+|+.+||+.||.+||++.|+++.
T Consensus 246 ~~~~~--~~~~~~~~~----s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 246 KGKYK--MNPRQWSHI----SESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp HTCCC--CCHHHHTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cCCCC--CCccccccC----CHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 22221 111111112 2367889999999999999999999864
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=359.87 Aligned_cols=257 Identities=28% Similarity=0.437 Sum_probs=210.1
Q ss_pred hcCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEec
Q 046750 359 TNGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFV 438 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 438 (723)
.++|++.+.||+|+||.||+|...+++.||||+++... ...+.|.+|+++|++|+|+||+++++++.+ +..++||||+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 89 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecC
Confidence 36789999999999999999998888899999997643 345689999999999999999999999874 5689999999
Q ss_pred CCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcce
Q 046750 439 PNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHV 518 (723)
Q Consensus 439 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 518 (723)
.+++|.+++.......+++..++.++.||+.||+|||++ +|+|||||++||||++++.+||+|||++..........
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 166 (279)
T 1qpc_A 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166 (279)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCccccc
Confidence 999999999764433588999999999999999999999 59999999999999999999999999998765544333
Q ss_pred eecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchh
Q 046750 519 STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPR 597 (723)
Q Consensus 519 ~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~ 597 (723)
.....++..|+|||++.++.++.++|||||||+||||++ |+.||..... ..+ .+.+..+... ..
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~--------~~~~~~~~~~-~~--- 231 (279)
T 1qpc_A 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN---PEV--------IQNLERGYRM-VR--- 231 (279)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHH--------HHHHHTTCCC-CC---
T ss_pred ccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH---HHH--------HHHHhcccCC-CC---
Confidence 334457889999999998999999999999999999999 8999975431 111 1222222111 00
Q ss_pred hhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCC
Q 046750 598 LEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGE 640 (723)
Q Consensus 598 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~ 640 (723)
.......+.+++.+||+.||.+||++.+|++.|+....
T Consensus 232 -----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 269 (279)
T 1qpc_A 232 -----PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (279)
T ss_dssp -----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 11112368899999999999999999999999987643
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=372.32 Aligned_cols=270 Identities=17% Similarity=0.259 Sum_probs=203.4
Q ss_pred cCcccceEEecc--CcEEEEEEEcC-CCcEEEEEEcccCC--chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEE
Q 046750 360 NGFARENVIGEG--GFGCVYKGNLP-EGKVVAVKQLKSGS--GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLI 434 (723)
Q Consensus 360 ~~f~~~~~LG~G--~fG~Vy~~~~~-~g~~VAvK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 434 (723)
++|++.++||+| +||.||+|+.. +++.||||+++... ....+.+++|+++|++++|+|||+++++|.+.+..|||
T Consensus 25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 104 (389)
T 3gni_B 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV 104 (389)
T ss_dssp GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEE
Confidence 579999999999 99999999654 68999999997542 23346788899999999999999999999999999999
Q ss_pred EEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCC
Q 046750 435 YEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTT 514 (723)
Q Consensus 435 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 514 (723)
|||+.+|+|.+++.......+.+..++.|+.||+.||+|||++ +|||||||++||||+.++.+||+|||++......
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~ 181 (389)
T 3gni_B 105 TSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISH 181 (389)
T ss_dssp EECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECEET
T ss_pred EEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeeccc
Confidence 9999999999999876555689999999999999999999999 5999999999999999999999999998644221
Q ss_pred Cc------ceeecccccccccChhhhcc--CCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhh
Q 046750 515 QT------HVSTRVMGTFGYLAPEYASS--GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIE 586 (723)
Q Consensus 515 ~~------~~~~~~~gt~~y~APE~~~~--~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~ 586 (723)
.. .......|+..|+|||++.+ ..++.++||||||||||||++|+.||....... .+.......+...+.
T Consensus 182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~ 259 (389)
T 3gni_B 182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKLNGTVPCLLD 259 (389)
T ss_dssp TEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTT--HHHHC----------
T ss_pred cccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHhcCCCCcccc
Confidence 11 11122468999999999987 579999999999999999999999997654321 111111000000000
Q ss_pred c------------------CCcccccc---hh------hhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 587 T------------------GDLSEIVD---PR------LEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 587 ~------------------~~l~~~vd---~~------l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
. ..+...+. .+ ....+.......+.+|+.+||+.||.+||++.||++.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 0 00000000 00 0000111223468899999999999999999999865
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-42 Score=366.55 Aligned_cols=255 Identities=18% Similarity=0.277 Sum_probs=207.2
Q ss_pred HhcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEE
Q 046750 358 ITNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYE 436 (723)
Q Consensus 358 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 436 (723)
+.++|.+.+.||+|+||.||+|.. .+++.||+|+++... .....+.+|+++|++++|+||++++++|.+.+..++|||
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 357899999999999999999955 468899999987543 445678899999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCC--CCcEEEeecccccccCCC
Q 046750 437 FVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDD--EFEAQVADFGLAKLNDTT 514 (723)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~--~~~vkL~DFGla~~~~~~ 514 (723)
|+.+++|.+++.... ..+++..++.++.||+.||+|||++ +|+|||||++||||+. ++.+||+|||+++.....
T Consensus 82 ~~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 82 FISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred eCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 999999999997543 2488999999999999999999999 5999999999999997 789999999999876543
Q ss_pred CcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCccccc
Q 046750 515 QTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIV 594 (723)
Q Consensus 515 ~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~v 594 (723)
.. .....|+..|+|||++.+..++.++|||||||+||||++|+.||..... .. +...+..+.+. .
T Consensus 158 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~--------~~~~i~~~~~~--~ 222 (321)
T 1tki_A 158 DN--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN---QQ--------IIENIMNAEYT--F 222 (321)
T ss_dssp CE--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH---HH--------HHHHHHHTCCC--C
T ss_pred Cc--cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH---HH--------HHHHHHcCCCC--C
Confidence 32 3345689999999999988899999999999999999999999975431 11 11122222211 0
Q ss_pred chhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 046750 595 DPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALD 636 (723)
Q Consensus 595 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~ 636 (723)
+......+ ...+.+++.+||..||.+||++.|+++.-.
T Consensus 223 ~~~~~~~~----s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~ 260 (321)
T 1tki_A 223 DEEAFKEI----SIEAMDFVDRLLVKERKSRMTASEALQHPW 260 (321)
T ss_dssp CHHHHTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred ChhhhccC----CHHHHHHHHHHcCCChhHCcCHHHHhcChh
Confidence 11111111 236789999999999999999999998544
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=357.71 Aligned_cols=249 Identities=22% Similarity=0.305 Sum_probs=195.6
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCch--------------------------hHHHHHHHHHHHHH
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQ--------------------------GEREFRAEVEIISR 412 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~--------------------------~~~~~~~Ei~il~~ 412 (723)
++|.+.+.||+|+||.||+|.. .+++.||||+++..... ..+.+.+|+++|++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 6799999999999999999954 56889999998654211 12468899999999
Q ss_pred ccCCceeeEeeeeec--ccceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCC
Q 046750 413 VHHRHLVSLVGYCIS--EKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSA 490 (723)
Q Consensus 413 l~HpnIv~l~g~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~ 490 (723)
|+|+||+++++++.+ ....|+||||+.+++|.+++... .+++..++.++.||++||+|||++ +|+|||||++
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~ 166 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK---PLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPS 166 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGG
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHH
Confidence 999999999999986 56789999999999999877543 488999999999999999999999 5999999999
Q ss_pred cEEeCCCCcEEEeecccccccCCCCcceeecccccccccChhhhccCC---CCCccceechHHHHHHHHhCCCCCCCCCC
Q 046750 491 NILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGK---LTDRSDVFSFGVVLLELITGRKPVDPTQP 567 (723)
Q Consensus 491 NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~---~t~ksDVwSlGviL~eLltG~~P~~~~~~ 567 (723)
||||+.++.+||+|||+++....... ......|+..|+|||++.+.. ++.++|||||||+||||++|+.||.....
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 245 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI 245 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred HEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence 99999999999999999987654332 233457999999999998765 37789999999999999999999975321
Q ss_pred CCchhhHHhhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 568 LGDESLVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 568 ~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
..+. ..+..+.+.... ...+ ...+.+|+.+||+.||.+||++.||++.
T Consensus 246 ------~~~~-----~~~~~~~~~~~~----~~~~----~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 246 ------MCLH-----SKIKSQALEFPD----QPDI----AEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp ------HHHH-----HHHHHCCCCCCS----SSCC----CHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred ------HHHH-----HHHhcccCCCCC----cccc----CHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 1111 111222111000 0111 2357889999999999999999998753
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=356.03 Aligned_cols=253 Identities=23% Similarity=0.342 Sum_probs=205.1
Q ss_pred cCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCC--chhHHHHHHHHHHHHHccCCceeeEeeeeecc--cceEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGS--GQGEREFRAEVEIISRVHHRHLVSLVGYCISE--KNRLLIY 435 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~~lV~ 435 (723)
++|.+.++||+|+||.||+|++ +++.||||+++... ....+.|.+|++++++++|+||++++++|.+. ...++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 5789999999999999999987 48899999997653 33446799999999999999999999999887 7789999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ 515 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 515 (723)
||+.+|+|.++++......+++..++.|+.||+.||+|||+++ ..|+|||||++||||++++.++|+|||+......
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~-- 165 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-- 165 (271)
T ss_dssp ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC--
T ss_pred cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc--
Confidence 9999999999998776656899999999999999999999982 1299999999999999999999999998764322
Q ss_pred cceeecccccccccChhhhccCCCCC---ccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCccc
Q 046750 516 THVSTRVMGTFGYLAPEYASSGKLTD---RSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSE 592 (723)
Q Consensus 516 ~~~~~~~~gt~~y~APE~~~~~~~t~---ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~ 592 (723)
....|+..|+|||++.+..+.. ++|||||||+||||++|+.||..... . .. .......+....
T Consensus 166 ----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~---~~----~~~~~~~~~~~~ 231 (271)
T 3kmu_A 166 ----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN---M---EI----GMKVALEGLRPT 231 (271)
T ss_dssp ----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH---H---HH----HHHHHHSCCCCC
T ss_pred ----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh---H---HH----HHHHHhcCCCCC
Confidence 2245899999999998766555 79999999999999999999975431 1 11 111111111111
Q ss_pred ccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccC
Q 046750 593 IVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEG 639 (723)
Q Consensus 593 ~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~ 639 (723)
+ .......+.+++.+||+.||.+||++.+|++.|+.+.
T Consensus 232 -----~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 232 -----I----PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp -----C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred -----C----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 1 1112236789999999999999999999999998764
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=353.33 Aligned_cols=256 Identities=27% Similarity=0.442 Sum_probs=210.7
Q ss_pred cCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEecC
Q 046750 360 NGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVP 439 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 439 (723)
++|++.+.||+|+||.||+|.+.+++.||||+++.... ..+++.+|++++++++|+||+++++++.+.+..++||||+.
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 57899999999999999999888889999999986543 34679999999999999999999999999999999999999
Q ss_pred CCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCccee
Q 046750 440 NNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVS 519 (723)
Q Consensus 440 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 519 (723)
+++|.+++.... ..+++..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++..........
T Consensus 87 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 162 (267)
T 3t9t_A 87 HGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 162 (267)
T ss_dssp TCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred CCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccccccccc
Confidence 999999997643 3578999999999999999999999 599999999999999999999999999986654332223
Q ss_pred ecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhh
Q 046750 520 TRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRL 598 (723)
Q Consensus 520 ~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l 598 (723)
....++..|+|||++.+..++.++||||||++||||++ |+.||..... ..+ ...+..+.. ....
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~--------~~~i~~~~~-~~~~--- 227 (267)
T 3t9t_A 163 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---SEV--------VEDISTGFR-LYKP--- 227 (267)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHH--------HHHHHTTCC-CCCC---
T ss_pred ccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH---HHH--------HHHHhcCCc-CCCC---
Confidence 33457788999999999999999999999999999999 8999875431 111 112222211 0000
Q ss_pred hccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCC
Q 046750 599 EKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGE 640 (723)
Q Consensus 599 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~ 640 (723)
. .....+.+++.+||+.||.+||++.+|++.|+.+.+
T Consensus 228 -~----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 228 -R----LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp -T----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -c----cCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1 112367889999999999999999999999987643
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=373.55 Aligned_cols=248 Identities=25% Similarity=0.355 Sum_probs=198.8
Q ss_pred hcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccC---CchhHHHHHHHHHHHHHc-cCCceeeEeeeeecccceEE
Q 046750 359 TNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSG---SGQGEREFRAEVEIISRV-HHRHLVSLVGYCISEKNRLL 433 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~---~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~l 433 (723)
.++|++.++||+|+||.||+|+. .+++.||||+++.. .....+.+.+|+++|+++ +|+||++++++|.+.+..||
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 47899999999999999999965 46899999999753 122345678899999998 79999999999999999999
Q ss_pred EEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCC
Q 046750 434 IYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDT 513 (723)
Q Consensus 434 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 513 (723)
||||+.+|+|.+++.... .+++..++.|+.||+.||+|||++ +|||||||++||||+.++.+||+|||+++....
T Consensus 102 v~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSR--RFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp EEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 999999999999997654 388999999999999999999999 599999999999999999999999999975432
Q ss_pred CCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccc
Q 046750 514 TQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEI 593 (723)
Q Consensus 514 ~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~ 593 (723)
.. ......+||..|+|||++.+..++.++|||||||+||||++|+.||..... . + +.+.+..+.+.
T Consensus 177 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~---~---~-----~~~~i~~~~~~-- 242 (353)
T 3txo_A 177 NG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE---D---D-----LFEAILNDEVV-- 242 (353)
T ss_dssp ----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH---H---H-----HHHHHHHCCCC--
T ss_pred CC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH---H---H-----HHHHHHcCCCC--
Confidence 22 223446799999999999999999999999999999999999999975432 1 1 11222222211
Q ss_pred cchhhhccccHHHHHHHHHHHHHHhccCCCCCCCH------HHHHH
Q 046750 594 VDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRM------VQVVR 633 (723)
Q Consensus 594 vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~------~eVl~ 633 (723)
+.......+.+|+.+||+.||.+|+++ .||++
T Consensus 243 --------~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 243 --------YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp --------CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred --------CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 111122357889999999999999998 77765
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=372.74 Aligned_cols=257 Identities=21% Similarity=0.321 Sum_probs=201.1
Q ss_pred hcCcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCC---chhHHHHHHHHHHHHHc-cCCceeeEeeeeecccceEE
Q 046750 359 TNGFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGS---GQGEREFRAEVEIISRV-HHRHLVSLVGYCISEKNRLL 433 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~---~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~l 433 (723)
.++|++.++||+|+||.||+|+.+ +++.||||+++... ....+.+.+|+.+|.++ +|+|||+++++|.+....||
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 367999999999999999999654 57899999997542 22334678999999987 89999999999999999999
Q ss_pred EEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCC
Q 046750 434 IYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDT 513 (723)
Q Consensus 434 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 513 (723)
||||+.+|+|.+++.... .+.+..+..++.||+.||+|||++ +|||||||++||||+.++.+||+|||+++....
T Consensus 131 V~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEcCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 999999999999997654 488999999999999999999999 599999999999999999999999999975332
Q ss_pred CCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccc
Q 046750 514 TQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEI 593 (723)
Q Consensus 514 ~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~ 593 (723)
.. ......+||..|+|||++.+..++.++||||||||||||++|+.||.......... ......+.+.+..+.+.
T Consensus 206 ~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~--~~~~~~~~~~i~~~~~~-- 280 (396)
T 4dc2_A 206 PG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD--QNTEDYLFQVILEKQIR-- 280 (396)
T ss_dssp TT-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC--------CCHHHHHHHHHHCCCC--
T ss_pred CC-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccc--hhhHHHHHHHHhccccC--
Confidence 22 22344679999999999999999999999999999999999999997543211100 00011122222222211
Q ss_pred cchhhhccccHHHHHHHHHHHHHHhccCCCCCCCH------HHHHH
Q 046750 594 VDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRM------VQVVR 633 (723)
Q Consensus 594 vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~------~eVl~ 633 (723)
+.......+.+|+.+||+.||.+|+++ .||++
T Consensus 281 --------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~ 318 (396)
T 4dc2_A 281 --------IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 318 (396)
T ss_dssp --------CCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred --------CCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence 111122367889999999999999985 56654
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=379.99 Aligned_cols=255 Identities=20% Similarity=0.288 Sum_probs=206.0
Q ss_pred HHhcCcccceEEeccCcEEEEEEE-cCCCcEEEEEEcccCCc--hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEE
Q 046750 357 EITNGFARENVIGEGGFGCVYKGN-LPEGKVVAVKQLKSGSG--QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLL 433 (723)
Q Consensus 357 ~~~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~VAvK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 433 (723)
.+.++|++.++||+|+||.||+|. ..+|+.||+|++..... ...+.+.+|+++|++|+|+||++++++|.+.+..||
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 456789999999999999999994 56789999999876532 334578999999999999999999999999999999
Q ss_pred EEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeC---CCCcEEEeecccccc
Q 046750 434 IYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVD---DEFEAQVADFGLAKL 510 (723)
Q Consensus 434 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~---~~~~vkL~DFGla~~ 510 (723)
||||+.+|+|.+++.... .+.+..+..++.||+.||+|||++ +|+||||||+||||+ +++.+||+|||+++.
T Consensus 88 v~E~~~gg~L~~~i~~~~--~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 88 IFDLVTGGELFEDIVARE--YYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp EECCCBCCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 999999999999987654 488999999999999999999999 599999999999998 567899999999976
Q ss_pred cCCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCc
Q 046750 511 NDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDL 590 (723)
Q Consensus 511 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l 590 (723)
...... ......||..|+|||++.+..++.++||||||||||||++|+.||..... .. +.+.+..+.+
T Consensus 163 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~---~~--------~~~~i~~~~~ 230 (444)
T 3soa_A 163 VEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ---HR--------LYQQIKAGAY 230 (444)
T ss_dssp CCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HH--------HHHHHHHTCC
T ss_pred ecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH---HH--------HHHHHHhCCC
Confidence 654332 22346799999999999999999999999999999999999999965431 11 1222333322
Q ss_pred ccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 591 SEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 591 ~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
... .+.+ ..+ ...+.+|+.+||+.||.+||++.|+++.
T Consensus 231 ~~~-~~~~-~~~----s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 231 DFP-SPEW-DTV----TPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp CCC-TTTT-TTS----CHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCC-cccc-ccC----CHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 111 1111 111 2357889999999999999999999874
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=369.91 Aligned_cols=253 Identities=21% Similarity=0.350 Sum_probs=196.7
Q ss_pred cCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCC--chhHHHHHHHHHHHHHccC--CceeeEeeeeecccceEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGS--GQGEREFRAEVEIISRVHH--RHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~--~~~~~~~~~Ei~il~~l~H--pnIv~l~g~~~~~~~~~lV~ 435 (723)
++|++.++||+|+||.||++...+++.||||++.... ....+.|.+|+++|++|+| +||+++++++.+....||||
T Consensus 9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 88 (343)
T 3dbq_A 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 88 (343)
T ss_dssp CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEE
Confidence 5699999999999999999988889999999987543 2334678999999999976 99999999999999999999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ 515 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 515 (723)
| +.+++|.+++.... .+++..++.|+.||+.||+|||++ +|+|||||++||||+ ++.+||+|||+++......
T Consensus 89 e-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~ 161 (343)
T 3dbq_A 89 E-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 161 (343)
T ss_dssp C-CCSEEHHHHHHHSC--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred e-CCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence 9 55899999997654 478889999999999999999999 599999999999997 5689999999998665433
Q ss_pred cc-eeecccccccccChhhhcc-----------CCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhh
Q 046750 516 TH-VSTRVMGTFGYLAPEYASS-----------GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVR 583 (723)
Q Consensus 516 ~~-~~~~~~gt~~y~APE~~~~-----------~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~ 583 (723)
.. ......||..|+|||++.+ ..++.++|||||||+||||++|+.||..... .... +..
T Consensus 162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~~-----~~~ 232 (343)
T 3dbq_A 162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN----QISK-----LHA 232 (343)
T ss_dssp --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS----HHHH-----HHH
T ss_pred ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh----HHHH-----HHH
Confidence 22 2334579999999999975 6789999999999999999999999965321 1110 111
Q ss_pred hhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhc
Q 046750 584 AIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDS 637 (723)
Q Consensus 584 ~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~ 637 (723)
.+.. .....+.......+.+|+.+||+.||.+||++.||++...-
T Consensus 233 ~~~~---------~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~ 277 (343)
T 3dbq_A 233 IIDP---------NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 277 (343)
T ss_dssp HHCT---------TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred HhcC---------CcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccc
Confidence 1111 11111111112367889999999999999999999986543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=363.87 Aligned_cols=267 Identities=27% Similarity=0.382 Sum_probs=205.4
Q ss_pred cCcccceEEeccCcEEEEEEE-----cCCCcEEEEEEcccCC-chhHHHHHHHHHHHHHccCCceeeEeeeeecc--cce
Q 046750 360 NGFARENVIGEGGFGCVYKGN-----LPEGKVVAVKQLKSGS-GQGEREFRAEVEIISRVHHRHLVSLVGYCISE--KNR 431 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~-----~~~g~~VAvK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~ 431 (723)
+.|++.++||+|+||.||+|+ ..+++.||||+++... ....+.+.+|+++|++|+|+||++++++|.+. ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 458899999999999999997 3468899999997543 33446789999999999999999999999876 668
Q ss_pred EEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeeccccccc
Q 046750 432 LLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLN 511 (723)
Q Consensus 432 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 511 (723)
++||||+.+++|.+++..... .+++..++.|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++..
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNKN-KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAI 176 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHTT-TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEEeCCCCcHHHHHHhccc-cCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccccc
Confidence 999999999999999965432 488999999999999999999999 5999999999999999999999999999876
Q ss_pred CCCCcc--eeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCch----hhHHhhhhhhhhhh
Q 046750 512 DTTQTH--VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDE----SLVEWARPVLVRAI 585 (723)
Q Consensus 512 ~~~~~~--~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~----~l~~~~~~~l~~~i 585 (723)
...... ......|+..|+|||++.+..++.++|||||||+||||++|+.|+......... ....+....+...+
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (302)
T 4e5w_A 177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL 256 (302)
T ss_dssp CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHH
T ss_pred cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHH
Confidence 554332 223456888899999999999999999999999999999999886422100000 00000011111222
Q ss_pred hcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccC
Q 046750 586 ETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEG 639 (723)
Q Consensus 586 ~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~ 639 (723)
..+... .........+.+|+.+||+.||.+||++.+|++.|+.+.
T Consensus 257 ~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 257 KEGKRL---------PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HTTCCC---------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hccCCC---------CCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 222111 111122346889999999999999999999999998753
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=373.25 Aligned_cols=254 Identities=20% Similarity=0.291 Sum_probs=207.1
Q ss_pred hcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEe
Q 046750 359 TNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEF 437 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 437 (723)
.++|.+.++||+|+||.||+|.. .+|+.||+|++..........+.+|+++|++|+|+||++++++|.+....+|||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 46799999999999999999955 56899999999876555666899999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCC--CCcEEEeecccccccCCCC
Q 046750 438 VPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDD--EFEAQVADFGLAKLNDTTQ 515 (723)
Q Consensus 438 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~--~~~vkL~DFGla~~~~~~~ 515 (723)
+.+|+|.+++.... ..+++..++.|+.||+.||+|||++ +|+|||||++||||+. ++.+||+|||+++......
T Consensus 130 ~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 205 (387)
T 1kob_A 130 LSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205 (387)
T ss_dssp CCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence 99999999997543 2488999999999999999999999 5999999999999974 5789999999998765433
Q ss_pred cceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccc
Q 046750 516 THVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVD 595 (723)
Q Consensus 516 ~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd 595 (723)
. .....||..|+|||++.+..++.++|||||||+||||++|+.||..... ... ...+....+. .+
T Consensus 206 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~---~~~--------~~~i~~~~~~--~~ 270 (387)
T 1kob_A 206 I--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD---LET--------LQNVKRCDWE--FD 270 (387)
T ss_dssp C--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH---HHH--------HHHHHHCCCC--CC
T ss_pred c--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH---HHH--------HHHHHhCCCC--CC
Confidence 2 2334699999999999999999999999999999999999999975431 111 1112222111 01
Q ss_pred hhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 046750 596 PRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRAL 635 (723)
Q Consensus 596 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L 635 (723)
......+ ...+.+|+.+||+.||.+||++.||++.-
T Consensus 271 ~~~~~~~----s~~~~~li~~~L~~dP~~Rpt~~ell~hp 306 (387)
T 1kob_A 271 EDAFSSV----SPEAKDFIKNLLQKEPRKRLTVHDALEHP 306 (387)
T ss_dssp SSTTTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHTST
T ss_pred ccccccC----CHHHHHHHHHHcCCChhHCcCHHHHhhCc
Confidence 1111112 23678999999999999999999998753
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=363.29 Aligned_cols=252 Identities=19% Similarity=0.346 Sum_probs=197.6
Q ss_pred HhcCcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCC-chhHHHHHHHHHHHHHccCCceeeEeeeeecccc-----
Q 046750 358 ITNGFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGS-GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKN----- 430 (723)
Q Consensus 358 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~----- 430 (723)
+.++|++.++||+|+||.||+|+.. +|+.||||+++... ....+.+.+|+++|++|+|+||++++++|.+...
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 4577999999999999999999664 78999999997543 3345679999999999999999999999865432
Q ss_pred ----------------------------------------------------eEEEEEecCCCchhhccccCCC-CcchH
Q 046750 431 ----------------------------------------------------RLLIYEFVPNNNLEHHLHGKGQ-PVLEW 457 (723)
Q Consensus 431 ----------------------------------------------------~~lV~E~~~~gsL~~~l~~~~~-~~l~~ 457 (723)
.++||||+.+++|.+++..... ....+
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 7899999999999999976543 23455
Q ss_pred HHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCc-----------ceeecccccc
Q 046750 458 TKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQT-----------HVSTRVMGTF 526 (723)
Q Consensus 458 ~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~-----------~~~~~~~gt~ 526 (723)
..++.|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++....... .......|+.
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 67899999999999999999 599999999999999999999999999987654421 1123356999
Q ss_pred cccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhhhccccHHH
Q 046750 527 GYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEKHYVESE 606 (723)
Q Consensus 527 ~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~ 606 (723)
.|+|||++.+..++.++|||||||+||||++|..++.. ... +...+..+.+... ....
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--------~~~-----~~~~~~~~~~~~~---------~~~~ 298 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--------RVR-----IITDVRNLKFPLL---------FTQK 298 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--------HHH-----HHHHHHTTCCCHH---------HHHH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--------HHH-----HHHHhhccCCCcc---------cccC
Confidence 99999999999999999999999999999998665321 000 1112222221111 1122
Q ss_pred HHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 607 MFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 607 ~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
...+.+|+.+||+.||.+||++.||++.
T Consensus 299 ~~~~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 299 YPQEHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp CHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred ChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence 3356789999999999999999999874
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=359.92 Aligned_cols=273 Identities=26% Similarity=0.384 Sum_probs=214.7
Q ss_pred ccCHHHHHHHhcCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHH--ccCCceeeEeeeee
Q 046750 349 FFTYEELMEITNGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISR--VHHRHLVSLVGYCI 426 (723)
Q Consensus 349 ~~~~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~g~~~ 426 (723)
.........+.++|.+.+.||+|+||.||+|++ +++.||||++.. .....+.+|++++.. ++|+||+++++++.
T Consensus 31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~ 106 (342)
T 1b6c_B 31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADN 106 (342)
T ss_dssp SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECG---GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEE
T ss_pred CCceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCc---hhHHHHHHHHHHHHHhhcCCCcEEEEEeeec
Confidence 455555667788999999999999999999987 589999999965 345678889999998 78999999999998
Q ss_pred ccc----ceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhc--------ccCCCceeecCCCCCcEEe
Q 046750 427 SEK----NRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLH--------EDCHPKIIHRDIKSANILV 494 (723)
Q Consensus 427 ~~~----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~g~~~ivHrDIkp~NILl 494 (723)
... ..++||||+.+|+|.+++.+. .+.+..++.++.||+.||+||| ++ +|+|||||++||||
T Consensus 107 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll 180 (342)
T 1b6c_B 107 KDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILV 180 (342)
T ss_dssp CCCSSCCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEE
T ss_pred ccCCccceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEE
Confidence 876 789999999999999999754 3889999999999999999999 66 69999999999999
Q ss_pred CCCCcEEEeecccccccCCCCcc---eeecccccccccChhhhccCC------CCCccceechHHHHHHHHhC-------
Q 046750 495 DDEFEAQVADFGLAKLNDTTQTH---VSTRVMGTFGYLAPEYASSGK------LTDRSDVFSFGVVLLELITG------- 558 (723)
Q Consensus 495 ~~~~~vkL~DFGla~~~~~~~~~---~~~~~~gt~~y~APE~~~~~~------~t~ksDVwSlGviL~eLltG------- 558 (723)
+.++.+||+|||+++........ ......|+..|+|||++.+.. ++.++|||||||+||||++|
T Consensus 181 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~ 260 (342)
T 1b6c_B 181 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 260 (342)
T ss_dssp CTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred CCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcc
Confidence 99999999999999766544322 123456999999999998763 33689999999999999999
Q ss_pred ---CCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 046750 559 ---RKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRAL 635 (723)
Q Consensus 559 ---~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L 635 (723)
+.||...... ......+. +.+..+.+...+..++ ........|.+|+.+||+.||.+||++.+|++.|
T Consensus 261 ~~~~~p~~~~~~~-~~~~~~~~-----~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L 331 (342)
T 1b6c_B 261 EDYQLPYYDLVPS-DPSVEEMR-----KVVCEQKLRPNIPNRW---QSCEALRVMAKIMRECWYANGAARLTALRIKKTL 331 (342)
T ss_dssp CCCCCTTTTTSCS-SCCHHHHH-----HHHTTSCCCCCCCGGG---GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHH
T ss_pred cccccCccccCcC-cccHHHHH-----HHHHHHHhCCCCcccc---cchhHHHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence 6777554321 11122221 1121222211111111 2235566899999999999999999999999999
Q ss_pred hccCC
Q 046750 636 DSEGE 640 (723)
Q Consensus 636 ~~~~~ 640 (723)
+.+..
T Consensus 332 ~~i~~ 336 (342)
T 1b6c_B 332 SQLSQ 336 (342)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 88654
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=365.72 Aligned_cols=261 Identities=21% Similarity=0.288 Sum_probs=202.2
Q ss_pred HHHHHhcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccC-----CchhHHHHHHHHHHHHHccCCceeeEeeeeec
Q 046750 354 ELMEITNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSG-----SGQGEREFRAEVEIISRVHHRHLVSLVGYCIS 427 (723)
Q Consensus 354 ~l~~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~-----~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~ 427 (723)
++..+.++|.+.++||+|+||.||+|.. .+++.||||++... .....+.+.+|+++|++|+|+||++++++|.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 4567889999999999999999999954 56889999998643 23445679999999999999999999999999
Q ss_pred ccceEEEEEecCCCchhhccccC--------------------------------------CCCcchHHHHHHHHHHHHh
Q 046750 428 EKNRLLIYEFVPNNNLEHHLHGK--------------------------------------GQPVLEWTKRVKIALGAAK 469 (723)
Q Consensus 428 ~~~~~lV~E~~~~gsL~~~l~~~--------------------------------------~~~~l~~~~~~~i~~~ia~ 469 (723)
.+..+|||||+.+|+|.+++... ....+.+..++.|+.||+.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 99999999999999999988521 1223567788899999999
Q ss_pred hhchhcccCCCceeecCCCCCcEEeCCCC--cEEEeecccccccCCCCc---ceeecccccccccChhhhcc--CCCCCc
Q 046750 470 GLAYLHEDCHPKIIHRDIKSANILVDDEF--EAQVADFGLAKLNDTTQT---HVSTRVMGTFGYLAPEYASS--GKLTDR 542 (723)
Q Consensus 470 gL~yLH~~g~~~ivHrDIkp~NILl~~~~--~vkL~DFGla~~~~~~~~---~~~~~~~gt~~y~APE~~~~--~~~t~k 542 (723)
||+|||++ +|+|||||++||||+.++ .+||+|||+++.+..... .......|+..|+|||++.+ ..++.+
T Consensus 180 ~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 99999999 599999999999998766 899999999986533221 12344569999999999975 678999
Q ss_pred cceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCC
Q 046750 543 SDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSG 622 (723)
Q Consensus 543 sDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP 622 (723)
+|||||||+||||++|+.||..... . +. +.+.+ .+... +..+.. .. ....+.+|+.+||+.||
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~---~---~~----~~~~~-~~~~~-~~~~~~-~~----~~~~~~~li~~~l~~~p 319 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVND---A---DT----ISQVL-NKKLC-FENPNY-NV----LSPLARDLLSNLLNRNV 319 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSH---H---HH----HHHHH-HCCCC-TTSGGG-GG----SCHHHHHHHHHHSCSCT
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCCh---H---HH----HHHHH-hcccc-cCCccc-cc----CCHHHHHHHHHHcCCCh
Confidence 9999999999999999999975432 1 11 11111 11110 001111 11 12367889999999999
Q ss_pred CCCCCHHHHHHH
Q 046750 623 PKRPRMVQVVRA 634 (723)
Q Consensus 623 ~~RPs~~eVl~~ 634 (723)
.+||++.+|++.
T Consensus 320 ~~Rps~~~~l~h 331 (345)
T 3hko_A 320 DERFDAMRALQH 331 (345)
T ss_dssp TTSCCHHHHHHS
T ss_pred hHCCCHHHHhcC
Confidence 999999999874
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=354.40 Aligned_cols=254 Identities=33% Similarity=0.566 Sum_probs=201.0
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCchhH-------HHHHHHHHHHHHccCCceeeEeeeeecccce
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQGE-------REFRAEVEIISRVHHRHLVSLVGYCISEKNR 431 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~~~-------~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 431 (723)
++|++.+.||+|+||.||+|+. .+++.||||++........ +.+.+|++++++++|+||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 6799999999999999999965 5789999999865432211 67899999999999999999999986554
Q ss_pred EEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCc-----EEEeecc
Q 046750 432 LLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFE-----AQVADFG 506 (723)
Q Consensus 432 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~-----vkL~DFG 506 (723)
++||||+.+++|.+++.... ..+++..++.++.||+.||+|||+++ .+|+|||||++||||+.++. +||+|||
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg 174 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174 (287)
T ss_dssp EEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCCT
T ss_pred eEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCCC
Confidence 79999999999998886544 35889999999999999999999982 12999999999999988776 9999999
Q ss_pred cccccCCCCcceeecccccccccChhhhc--cCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhh
Q 046750 507 LAKLNDTTQTHVSTRVMGTFGYLAPEYAS--SGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRA 584 (723)
Q Consensus 507 la~~~~~~~~~~~~~~~gt~~y~APE~~~--~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~ 584 (723)
+++.... ......|+..|+|||++. ...++.++|||||||+||||++|+.||....... ..+.. .
T Consensus 175 ~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~--------~ 241 (287)
T 4f0f_A 175 LSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK-IKFIN--------M 241 (287)
T ss_dssp TCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH-HHHHH--------H
T ss_pred ccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH-HHHHH--------H
Confidence 9975432 234456899999999984 4557889999999999999999999997654321 11111 1
Q ss_pred hhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhcc
Q 046750 585 IETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSE 638 (723)
Q Consensus 585 i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~ 638 (723)
+....+... ........+.+++.+||+.||.+||++.+|++.|+.+
T Consensus 242 ~~~~~~~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 242 IREEGLRPT--------IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HHHSCCCCC--------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred HhccCCCCC--------CCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 111111111 1112234688999999999999999999999999863
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=363.64 Aligned_cols=256 Identities=25% Similarity=0.402 Sum_probs=202.5
Q ss_pred cCcccceEEeccCcEEEEEEEcC-CCc----EEEEEEcccCC-chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLP-EGK----VVAVKQLKSGS-GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLL 433 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~----~VAvK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 433 (723)
++|++.++||+|+||.||+|.+. +++ .||+|.+.... ....+.+.+|+.++++++|+||++++++|. +...++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 57899999999999999999653 444 38888876543 233456788999999999999999999986 566899
Q ss_pred EEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCC
Q 046750 434 IYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDT 513 (723)
Q Consensus 434 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 513 (723)
||||+.+|+|.+++.... ..+.+..++.|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++....
T Consensus 92 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp EEECCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred EEEeCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 999999999999997642 3588899999999999999999999 599999999999999999999999999987654
Q ss_pred CCcc-eeecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcc
Q 046750 514 TQTH-VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLS 591 (723)
Q Consensus 514 ~~~~-~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~ 591 (723)
.... ......|+..|+|||++.++.++.++|||||||+||||++ |+.||....... + ...+..+...
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~--------~~~~~~~~~~ 236 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE---V--------PDLLEKGERL 236 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH---H--------HHHHHTTCBC
T ss_pred ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH---H--------HHHHHcCCCC
Confidence 4332 2344567889999999999999999999999999999999 999997654211 1 1112222111
Q ss_pred cccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCC
Q 046750 592 EIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGE 640 (723)
Q Consensus 592 ~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~ 640 (723)
... ......+.+++.+||+.||.+||++.+|++.|+.+..
T Consensus 237 ~~~---------~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 237 AQP---------QICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp CCC---------TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred CCC---------CcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 110 0011246789999999999999999999999988754
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=362.34 Aligned_cols=260 Identities=24% Similarity=0.366 Sum_probs=194.3
Q ss_pred hcCcccceEEeccCcEEEEEEEcCCCc----EEEEEEcccC--CchhHHHHHHHHHHHHHccCCceeeEeeeeecccce-
Q 046750 359 TNGFARENVIGEGGFGCVYKGNLPEGK----VVAVKQLKSG--SGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNR- 431 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~----~VAvK~l~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~- 431 (723)
.++|.+.++||+|+||.||+|.+.... .||||+++.. .....+.+.+|++++++|+|+||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 467999999999999999999765432 7999999765 334557899999999999999999999999877655
Q ss_pred -----EEEEEecCCCchhhccccCC----CCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEE
Q 046750 432 -----LLIYEFVPNNNLEHHLHGKG----QPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQV 502 (723)
Q Consensus 432 -----~lV~E~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL 502 (723)
++||||+.+|+|.+++.... ...+++..++.|+.||++||+|||++ +|+|||||++||||++++.+||
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~kl 178 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCV 178 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEE
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEEE
Confidence 99999999999999985422 22488999999999999999999999 5999999999999999999999
Q ss_pred eecccccccCCCCcc-eeecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhh
Q 046750 503 ADFGLAKLNDTTQTH-VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPV 580 (723)
Q Consensus 503 ~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~ 580 (723)
+|||+++........ ......++..|+|||++.+..++.++|||||||+||||++ |+.||...... .+
T Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~------- 248 (323)
T 3qup_A 179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA---EI------- 248 (323)
T ss_dssp CCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GH-------
T ss_pred eeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH---HH-------
Confidence 999999865443322 2233456788999999999999999999999999999999 89999764321 11
Q ss_pred hhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCCC
Q 046750 581 LVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEM 641 (723)
Q Consensus 581 l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~~ 641 (723)
...+..+..... .......+.+|+.+||+.||.+||++.+|++.|+++...
T Consensus 249 -~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~ 299 (323)
T 3qup_A 249 -YNYLIGGNRLKQ---------PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH 299 (323)
T ss_dssp -HHHHHTTCCCCC---------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -HHHHhcCCCCCC---------CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 111112211111 111224688999999999999999999999999987654
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=364.39 Aligned_cols=263 Identities=27% Similarity=0.397 Sum_probs=205.6
Q ss_pred cccceEEeccCcEEEEEEEc-----CCCcEEEEEEcccCCc-hhHHHHHHHHHHHHHccCCceeeEeeeeecc--cceEE
Q 046750 362 FARENVIGEGGFGCVYKGNL-----PEGKVVAVKQLKSGSG-QGEREFRAEVEIISRVHHRHLVSLVGYCISE--KNRLL 433 (723)
Q Consensus 362 f~~~~~LG~G~fG~Vy~~~~-----~~g~~VAvK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~~l 433 (723)
|++.++||+|+||.||++.+ .+++.||||+++.... ...+.|.+|+++|++|+|+||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 48999999999999988854 2578999999986543 3356789999999999999999999999874 56789
Q ss_pred EEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCC
Q 046750 434 IYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDT 513 (723)
Q Consensus 434 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 513 (723)
||||+.+++|.+++.... +++..++.|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++....
T Consensus 113 v~e~~~~~~L~~~l~~~~---~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp EECCCTTCBHHHHGGGSC---CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred EEecccCCcHHHHHhhCC---CCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 999999999999997653 78999999999999999999999 499999999999999999999999999987654
Q ss_pred CCcc--eeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHH-----hhhhhhhhhhh
Q 046750 514 TQTH--VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVE-----WARPVLVRAIE 586 (723)
Q Consensus 514 ~~~~--~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~-----~~~~~l~~~i~ 586 (723)
.... ......++..|+|||++.+..++.++|||||||+||||++|+.||...... ...+.. +....+.+.+.
T Consensus 187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 265 (318)
T 3lxp_A 187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTK-FLELIGIAQGQMTVLRLTELLE 265 (318)
T ss_dssp TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH-HHHHHCSCCHHHHHHHHHHHHH
T ss_pred cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchh-hhhhhcccccchhHHHHHHHHh
Confidence 4332 223346788899999999999999999999999999999999998642110 000000 00111112222
Q ss_pred cCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCC
Q 046750 587 TGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGE 640 (723)
Q Consensus 587 ~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~ 640 (723)
.+.. ..........+.+|+.+||+.||.+||++.||++.|+.+.+
T Consensus 266 ~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 310 (318)
T 3lxp_A 266 RGER---------LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310 (318)
T ss_dssp TTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccC---------CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 2211 11122233478899999999999999999999999987543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=358.99 Aligned_cols=255 Identities=30% Similarity=0.498 Sum_probs=199.2
Q ss_pred cCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEecC
Q 046750 360 NGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVP 439 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 439 (723)
++|++.++||+|+||.||+|++ .++.||||+++.. ...+.|.+|+++|++++|+||+++++++.+ ..++||||+.
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence 5688999999999999999987 4789999999753 345679999999999999999999999873 5799999999
Q ss_pred CCchhhccccCCC-CcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCc-EEEeecccccccCCCCcc
Q 046750 440 NNNLEHHLHGKGQ-PVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFE-AQVADFGLAKLNDTTQTH 517 (723)
Q Consensus 440 ~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~-vkL~DFGla~~~~~~~~~ 517 (723)
+++|.++++.... ..+.+..++.++.||++||+|||+.+..+|+|||||++||||+.++. +||+|||++......
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--- 159 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--- 159 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence 9999999976543 24678889999999999999999943236999999999999998876 799999999755322
Q ss_pred eeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchh
Q 046750 518 VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPR 597 (723)
Q Consensus 518 ~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~ 597 (723)
.....|+..|+|||++.+..++.++|||||||+||||++|+.||...... .....|. +..+....+.
T Consensus 160 -~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~-------~~~~~~~~~~--- 226 (307)
T 2eva_A 160 -MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP--AFRIMWA-------VHNGTRPPLI--- 226 (307)
T ss_dssp ------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS--HHHHHHH-------HHTTCCCCCB---
T ss_pred -cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc--HHHHHHH-------HhcCCCCCcc---
Confidence 12345899999999999999999999999999999999999999754321 1111111 1122111111
Q ss_pred hhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCCC
Q 046750 598 LEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEM 641 (723)
Q Consensus 598 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~~ 641 (723)
..+ ...+.+|+.+||+.||.+||++.+|++.|+.+...
T Consensus 227 --~~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 264 (307)
T 2eva_A 227 --KNL----PKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY 264 (307)
T ss_dssp --TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGG
T ss_pred --ccc----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 111 23578899999999999999999999999887653
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=369.81 Aligned_cols=268 Identities=17% Similarity=0.240 Sum_probs=205.3
Q ss_pred hcCcccceEEeccCcEEEEEEEcCC------CcEEEEEEcccCCchhH-----------HHHHHHHHHHHHccCCceeeE
Q 046750 359 TNGFARENVIGEGGFGCVYKGNLPE------GKVVAVKQLKSGSGQGE-----------REFRAEVEIISRVHHRHLVSL 421 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~~~------g~~VAvK~l~~~~~~~~-----------~~~~~Ei~il~~l~HpnIv~l 421 (723)
.++|.+.++||+|+||.||+|.+.. ++.||||++........ ..+..|+..+.+++|+||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 3579999999999999999997654 47899999876532111 123345556666789999999
Q ss_pred eeeeecc----cceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeC--
Q 046750 422 VGYCISE----KNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVD-- 495 (723)
Q Consensus 422 ~g~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~-- 495 (723)
++++... ...||||||+ +++|.+++.... ..+++..++.|+.||+.||+|||++ +|||||||++||||+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA-KRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYK 188 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESS
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecC
Confidence 9999875 4479999999 999999997643 3589999999999999999999999 599999999999999
Q ss_pred CCCcEEEeecccccccCCCCcce------eecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCC
Q 046750 496 DEFEAQVADFGLAKLNDTTQTHV------STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLG 569 (723)
Q Consensus 496 ~~~~vkL~DFGla~~~~~~~~~~------~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~ 569 (723)
.++.+||+|||+++.+....... .....||..|+|||++.+..++.++|||||||+||||++|+.||.....
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~-- 266 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK-- 266 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT--
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc--
Confidence 88999999999997664332221 1234599999999999999999999999999999999999999975332
Q ss_pred chhhHHhhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCCC
Q 046750 570 DESLVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEM 641 (723)
Q Consensus 570 ~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~~ 641 (723)
+..+..+....+ ...+..+++..+.... ....+.+++..||+.+|.+||++.+|++.|+.+...
T Consensus 267 ~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~---~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~ 330 (364)
T 3op5_A 267 DPKYVRDSKIRY-----RENIASLMDKCFPAAN---APGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKA 330 (364)
T ss_dssp CHHHHHHHHHHH-----HHCHHHHHHHHSCTTC---CCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHh-----hhhHHHHHHHhccccc---CHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Confidence 222222222111 1123344444442211 123678889999999999999999999999876653
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=365.38 Aligned_cols=259 Identities=25% Similarity=0.359 Sum_probs=207.1
Q ss_pred hcCcccceEEeccCcEEEEEEEcCC------CcEEEEEEcccCCc-hhHHHHHHHHHHHHHc-cCCceeeEeeeeecccc
Q 046750 359 TNGFARENVIGEGGFGCVYKGNLPE------GKVVAVKQLKSGSG-QGEREFRAEVEIISRV-HHRHLVSLVGYCISEKN 430 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~~~------g~~VAvK~l~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~ 430 (723)
.++|.+.+.||+|+||.||+|.... ++.||||+++.... ...+.+.+|+++|++| +|+||++++++|.+.+.
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 124 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence 3679999999999999999996532 24799999976543 3446789999999999 89999999999999999
Q ss_pred eEEEEEecCCCchhhccccCC------------CCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCC
Q 046750 431 RLLIYEFVPNNNLEHHLHGKG------------QPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEF 498 (723)
Q Consensus 431 ~~lV~E~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~ 498 (723)
.++||||+.+|+|.+++.... ...+++..++.++.||+.||+|||++ +|+|||||++||||+.++
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGH 201 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGGG
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCCC
Confidence 999999999999999986432 23478899999999999999999999 599999999999999999
Q ss_pred cEEEeecccccccCCCCcc-eeecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHh
Q 046750 499 EAQVADFGLAKLNDTTQTH-VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEW 576 (723)
Q Consensus 499 ~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~ 576 (723)
.+||+|||+++........ ......|+..|+|||++.+..++.++|||||||+||||++ |..||...... ..+..
T Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~~~~~- 278 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN--SKFYK- 278 (333)
T ss_dssp EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS--HHHHH-
T ss_pred eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh--HHHHH-
Confidence 9999999999865433222 2233457889999999999999999999999999999998 89999754321 11111
Q ss_pred hhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccC
Q 046750 577 ARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEG 639 (723)
Q Consensus 577 ~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~ 639 (723)
.+..+... . ........+.+|+.+||+.||.+||++.+|++.|+...
T Consensus 279 -------~~~~~~~~-~--------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 325 (333)
T 2i1m_A 279 -------LVKDGYQM-A--------QPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 325 (333)
T ss_dssp -------HHHHTCCC-C--------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------HHhcCCCC-C--------CCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence 11111100 0 00111236788999999999999999999999998754
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=378.53 Aligned_cols=194 Identities=26% Similarity=0.412 Sum_probs=153.6
Q ss_pred hcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCC--chhHHHHHHHHHHHHHccCCceeeEeeeeecc-----cc
Q 046750 359 TNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS--GQGEREFRAEVEIISRVHHRHLVSLVGYCISE-----KN 430 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-----~~ 430 (723)
.++|.+.++||+|+||.||+|.. .+++.||||++.... ....+.+.+|+++|++|+|+|||+++++|... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 36799999999999999999954 578999999986542 23446788999999999999999999999543 56
Q ss_pred eEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccc
Q 046750 431 RLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKL 510 (723)
Q Consensus 431 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 510 (723)
.||||||+ +++|.+++.... .+.+..++.|+.||++||+|||++ +|||||||++||||+.++.+||+|||+++.
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTPV--YLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEecc-ccchhhhcccCC--CCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchh
Confidence 89999988 689999987543 488999999999999999999999 599999999999999999999999999986
Q ss_pred cCCCCc--------------------------ceeecccccccccChhhh-ccCCCCCccceechHHHHHHHHhC
Q 046750 511 NDTTQT--------------------------HVSTRVMGTFGYLAPEYA-SSGKLTDRSDVFSFGVVLLELITG 558 (723)
Q Consensus 511 ~~~~~~--------------------------~~~~~~~gt~~y~APE~~-~~~~~t~ksDVwSlGviL~eLltG 558 (723)
...... ......+||.+|+|||++ .+..|+.++||||||||||||++|
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 643211 122445789999999986 456799999999999999999994
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=370.84 Aligned_cols=249 Identities=25% Similarity=0.341 Sum_probs=202.2
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCC---chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS---GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 435 (723)
++|.+.++||+|+||.||++.. .+++.||||++.... ....+.+.+|+++|++++|+|||+++++|.+....|+||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 6799999999999999999954 458899999986431 233467889999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ 515 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 515 (723)
||+.+|+|.+++.... .+.+..++.|+.||+.||+|||++ +|||||||++||||+.++.+||+|||+++......
T Consensus 95 e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 169 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQNV--HFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET 169 (384)
T ss_dssp CCCTTEEHHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred ecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCCC
Confidence 9999999999997654 488999999999999999999999 49999999999999999999999999998664332
Q ss_pred cceeecccccccccChhhhcc---CCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCccc
Q 046750 516 THVSTRVMGTFGYLAPEYASS---GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSE 592 (723)
Q Consensus 516 ~~~~~~~~gt~~y~APE~~~~---~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~ 592 (723)
.....+||..|+|||++.+ ..++.++||||||||||||++|+.||..........+... +....+
T Consensus 170 --~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~--------~~~~~~-- 237 (384)
T 4fr4_A 170 --QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT--------FETTVV-- 237 (384)
T ss_dssp --CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHH--------HHHCCC--
T ss_pred --ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHH--------Hhhccc--
Confidence 2344679999999999974 4589999999999999999999999976543222211111 111111
Q ss_pred ccchhhhccccHHHHHHHHHHHHHHhccCCCCCCC-HHHHHH
Q 046750 593 IVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPR-MVQVVR 633 (723)
Q Consensus 593 ~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~eVl~ 633 (723)
.+.......+.+|+.+||+.||.+|++ +.+|++
T Consensus 238 --------~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 238 --------TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp --------CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred --------CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 111112246789999999999999998 777764
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=372.35 Aligned_cols=254 Identities=22% Similarity=0.284 Sum_probs=193.7
Q ss_pred cCcccc-eEEeccCcEEEEEEEc-CCCcEEEEEEcccCCchhHHHHHHHHHHHHHc-cCCceeeEeeeeec----ccceE
Q 046750 360 NGFARE-NVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQGEREFRAEVEIISRV-HHRHLVSLVGYCIS----EKNRL 432 (723)
Q Consensus 360 ~~f~~~-~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~----~~~~~ 432 (723)
++|.+. ++||+|+||.||+|.. .+++.||||+++. ...+.+|++++.++ +|+||++++++|.. ....|
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 456665 7899999999999954 5689999999964 24677899988554 89999999998875 56789
Q ss_pred EEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCC---CCcEEEeeccccc
Q 046750 433 LIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDD---EFEAQVADFGLAK 509 (723)
Q Consensus 433 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~---~~~vkL~DFGla~ 509 (723)
|||||+.+|+|.++|.......+++..++.|+.||+.||+|||++ +|||||||++||||+. ++.+||+|||+++
T Consensus 136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~ 212 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212 (400)
T ss_dssp EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEeccccc
Confidence 999999999999999876656789999999999999999999998 5999999999999997 7899999999998
Q ss_pred ccCCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCC
Q 046750 510 LNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGD 589 (723)
Q Consensus 510 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~ 589 (723)
...... .....+||..|+|||++.+..++.++||||||||||||++|+.||.......... . +...+..+.
T Consensus 213 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~---~----~~~~i~~~~ 283 (400)
T 1nxk_A 213 ETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP---G----MKTRIRMGQ 283 (400)
T ss_dssp ECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCC---S----HHHHHHHTC
T ss_pred ccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccH---H----HHHHHHcCc
Confidence 654322 2234568999999999999999999999999999999999999997654321100 0 111122222
Q ss_pred cccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 046750 590 LSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALD 636 (723)
Q Consensus 590 l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~ 636 (723)
+.. ....+ .. ....+.+|+.+||+.||.+||++.||++.-+
T Consensus 284 ~~~-~~~~~-~~----~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 324 (400)
T 1nxk_A 284 YEF-PNPEW-SE----VSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 324 (400)
T ss_dssp CCC-CTTTT-TT----SCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred ccC-CCccc-cc----CCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 211 00000 11 1235788999999999999999999998643
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=369.72 Aligned_cols=206 Identities=26% Similarity=0.352 Sum_probs=179.8
Q ss_pred HHHHHHHhcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCchhHHHHHHHHHHHHHcc-----CCceeeEeeee
Q 046750 352 YEELMEITNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQGEREFRAEVEIISRVH-----HRHLVSLVGYC 425 (723)
Q Consensus 352 ~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~-----HpnIv~l~g~~ 425 (723)
+.+...+.++|.+.++||+|+||.||+|+. .+++.||||+++.. ....+.+..|+++|++++ |+||+++++++
T Consensus 27 ~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~ 105 (360)
T 3llt_A 27 WKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKF 105 (360)
T ss_dssp CCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEE
T ss_pred eecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeeccccee
Confidence 333444568899999999999999999955 56899999999753 244557788999999996 99999999999
Q ss_pred ecccceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCC---------
Q 046750 426 ISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDD--------- 496 (723)
Q Consensus 426 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~--------- 496 (723)
...+..+|||||+ +++|.+++.......+.+..++.|+.||+.||+|||++ +|||||||++||||+.
T Consensus 106 ~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~~ 181 (360)
T 3llt_A 106 MYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLIT 181 (360)
T ss_dssp EETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEEE
T ss_pred eECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccccc
Confidence 9999999999999 99999999876655689999999999999999999999 5999999999999975
Q ss_pred ----------------CCcEEEeecccccccCCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCC
Q 046750 497 ----------------EFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRK 560 (723)
Q Consensus 497 ----------------~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~ 560 (723)
++.+||+|||+++..... .....|+..|+|||++.+..++.++|||||||+||||++|+.
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~ 257 (360)
T 3llt_A 182 VRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSL 257 (360)
T ss_dssp EECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred hhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCC
Confidence 789999999999865432 234568999999999999999999999999999999999999
Q ss_pred CCCCCC
Q 046750 561 PVDPTQ 566 (723)
Q Consensus 561 P~~~~~ 566 (723)
||....
T Consensus 258 pf~~~~ 263 (360)
T 3llt_A 258 LFRTHE 263 (360)
T ss_dssp SCCCSS
T ss_pred CCCCCc
Confidence 997643
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=380.75 Aligned_cols=260 Identities=21% Similarity=0.256 Sum_probs=206.0
Q ss_pred HHHHHhcCcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCC---chhHHHHHHHHHHHHHccCCceeeEeeeeeccc
Q 046750 354 ELMEITNGFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGS---GQGEREFRAEVEIISRVHHRHLVSLVGYCISEK 429 (723)
Q Consensus 354 ~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 429 (723)
++....++|.+.++||+|+||.||+|+.+ +++.||||+++... ......+.+|+++|+.++|+|||+++++|.+..
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 142 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 142 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 33344678999999999999999999654 58899999986521 122235789999999999999999999999999
Q ss_pred ceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeeccccc
Q 046750 430 NRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK 509 (723)
Q Consensus 430 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 509 (723)
..||||||+.+|+|.++++.. .+.+..+..++.||+.||+|||++ +|||||||++||||+.++.+||+|||+++
T Consensus 143 ~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~ 216 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCM 216 (410)
T ss_dssp EEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeE
Confidence 999999999999999999754 378889999999999999999999 59999999999999999999999999998
Q ss_pred ccCCCCcceeecccccccccChhhhccCC----CCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhh
Q 046750 510 LNDTTQTHVSTRVMGTFGYLAPEYASSGK----LTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAI 585 (723)
Q Consensus 510 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~----~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i 585 (723)
.............+||..|+|||++.+.. ++.++|||||||+||||++|+.||..... ......++ +..
T Consensus 217 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~-~~~ 289 (410)
T 3v8s_A 217 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKIM-NHK 289 (410)
T ss_dssp ECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHH-THH
T ss_pred eeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh------hhHHHHHH-hcc
Confidence 76654443444568999999999998765 88999999999999999999999975432 11111111 000
Q ss_pred hcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCC--CCCHHHHHHHHh
Q 046750 586 ETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPK--RPRMVQVVRALD 636 (723)
Q Consensus 586 ~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~eVl~~L~ 636 (723)
..-.+.. ...+ ...+.+|+.+||..++.+ |+++.||+++-.
T Consensus 290 ~~~~~p~------~~~~----s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~ 332 (410)
T 3v8s_A 290 NSLTFPD------DNDI----SKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 332 (410)
T ss_dssp HHCCCCT------TCCC----CHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGG
T ss_pred ccccCCC------cccc----cHHHHHHHHHHccChhhhCCCCCHHHHhcCcc
Confidence 0000000 0011 235778999999999988 999999997643
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=354.62 Aligned_cols=259 Identities=29% Similarity=0.529 Sum_probs=195.3
Q ss_pred hcCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCC--chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEE
Q 046750 359 TNGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGS--GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYE 436 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 436 (723)
.++|++.++||+|+||.||+|++.. .||||+++... ....+.|.+|+++|++++|+||+++++++ .....++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 3579999999999999999998643 59999987543 33446789999999999999999999966 4556899999
Q ss_pred ecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCC-
Q 046750 437 FVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ- 515 (723)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~- 515 (723)
|+.+++|.+++.... ..+++..++.|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++......
T Consensus 100 ~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 175 (289)
T 3og7_A 100 WCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175 (289)
T ss_dssp CCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred ecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccccccc
Confidence 999999999996543 3588999999999999999999999 59999999999999999999999999997554322
Q ss_pred cceeecccccccccChhhhc---cCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCccc
Q 046750 516 THVSTRVMGTFGYLAPEYAS---SGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSE 592 (723)
Q Consensus 516 ~~~~~~~~gt~~y~APE~~~---~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~ 592 (723)
........|+..|+|||++. +..++.++|||||||+||||++|+.||..... ...+ .+.+..+.+..
T Consensus 176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~--------~~~~~~~~~~~ 245 (289)
T 3og7_A 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--RDQI--------IEMVGRGSLSP 245 (289)
T ss_dssp --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC--HHHH--------HHHHHHTSCCC
T ss_pred cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch--HHHH--------HHHhcccccCc
Confidence 22233456899999999987 56788899999999999999999999976432 1111 12222222211
Q ss_pred ccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccC
Q 046750 593 IVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEG 639 (723)
Q Consensus 593 ~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~ 639 (723)
.+. .+ .......+.+|+.+||+.+|.+||++.+|++.|+.+.
T Consensus 246 ~~~-~~----~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 246 DLS-KV----RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp CTT-SS----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred chh-hc----cccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 111 01 1112346889999999999999999999999998764
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=353.93 Aligned_cols=262 Identities=24% Similarity=0.364 Sum_probs=198.7
Q ss_pred cCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCch--hHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEe
Q 046750 360 NGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQ--GEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEF 437 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 437 (723)
++|++.+.||+|+||.||+|+..+++.||||+++..... ..+.+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 579999999999999999998888999999998754322 236788999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcc
Q 046750 438 VPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTH 517 (723)
Q Consensus 438 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 517 (723)
+. ++|.+++.... ..+.+..++.++.||++||+|||++ +|+|||||++||||+.++.+||+|||+++.......
T Consensus 82 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 155 (288)
T 1ob3_A 82 LD-QDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR- 155 (288)
T ss_dssp CS-EEHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred cC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcccc-
Confidence 96 58988887543 2478889999999999999999999 599999999999999999999999999976543222
Q ss_pred eeecccccccccChhhhccC-CCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcC---Cc---
Q 046750 518 VSTRVMGTFGYLAPEYASSG-KLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETG---DL--- 590 (723)
Q Consensus 518 ~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~---~l--- 590 (723)
......|+..|+|||++.+. .++.++|||||||+||||++|+.||...... ..+.... +.+... .+
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~-----~~~~~~~~~~~~~~ 228 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA--DQLMRIF-----RILGTPNSKNWPNV 228 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHH-----HHHCCCCTTTSTTG
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHH-----HHHCCCChhhchhh
Confidence 22334689999999999764 5899999999999999999999999754321 1111110 100000 00
Q ss_pred cc--ccchhh-------hccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 591 SE--IVDPRL-------EKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 591 ~~--~vd~~l-------~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
.+ ..++.+ ...+.......+.+|+.+||+.||.+||++.|+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00 000000 001111123467899999999999999999999864
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=366.96 Aligned_cols=266 Identities=28% Similarity=0.376 Sum_probs=210.0
Q ss_pred cCcccceEEeccCcEEEEEEEc-----CCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeee--cccceE
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-----PEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCI--SEKNRL 432 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-----~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~--~~~~~~ 432 (723)
++|++.++||+|+||.||+|++ .+++.||||+++.......+.+.+|+++|++|+|+||+++++++. +....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5799999999999999999973 467899999998876666678999999999999999999999887 445688
Q ss_pred EEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccC
Q 046750 433 LIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLND 512 (723)
Q Consensus 433 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 512 (723)
+||||+.+++|.+++..... .+++..++.|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++...
T Consensus 103 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRA-RLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLP 178 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGG-GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred EEEeecCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceecc
Confidence 99999999999999975332 488999999999999999999999 59999999999999999999999999998765
Q ss_pred CCCcc--eeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhh-------hhhhhh
Q 046750 513 TTQTH--VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWA-------RPVLVR 583 (723)
Q Consensus 513 ~~~~~--~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~-------~~~l~~ 583 (723)
..... ......|+..|+|||++.+..++.++|||||||+||||++|+.||..... ..+..+. ...+.+
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~ 255 (327)
T 3lxl_A 179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSA---EFLRMMGCERDVPALSRLLE 255 (327)
T ss_dssp TTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH---HHHHHCC----CCHHHHHHH
T ss_pred cCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccc---hhhhhcccccccccHHHHHH
Confidence 44332 22334578889999999999999999999999999999999999864221 0000000 000111
Q ss_pred hhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCCC
Q 046750 584 AIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEM 641 (723)
Q Consensus 584 ~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~~ 641 (723)
.+..+.. ..........+.+|+.+||+.||.+||++.||++.|+.+...
T Consensus 256 ~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 304 (327)
T 3lxl_A 256 LLEEGQR---------LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG 304 (327)
T ss_dssp HHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred HhhcccC---------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 1111111 111222334688999999999999999999999999987553
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=354.58 Aligned_cols=266 Identities=21% Similarity=0.318 Sum_probs=198.7
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCc--hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSG--QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYE 436 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 436 (723)
++|++.++||+|+||.||+|.. .+++.||||+++.... .....+.+|+++|++++|+||+++++++.+.+..+||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 5799999999999999999955 4689999999975432 334678899999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCc
Q 046750 437 FVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQT 516 (723)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 516 (723)
|+.+ +|.+++.... ..+++..++.|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++.......
T Consensus 82 ~~~~-~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 156 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp CCSE-EHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS
T ss_pred cCCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCccc
Confidence 9965 5555554332 2488999999999999999999999 599999999999999999999999999986643322
Q ss_pred ceeecccccccccChhhhccCC-CCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcc---c
Q 046750 517 HVSTRVMGTFGYLAPEYASSGK-LTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLS---E 592 (723)
Q Consensus 517 ~~~~~~~gt~~y~APE~~~~~~-~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~---~ 592 (723)
......|+..|+|||++.+.. ++.++|||||||+||||++|..||...... ...+....+ .+ .......+. .
T Consensus 157 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~-~~~~~~i~~-~~-~~~~~~~~~~~~~ 232 (292)
T 3o0g_A 157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-DDQLKRIFR-LL-GTPTEEQWPSMTK 232 (292)
T ss_dssp -CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH-HHHHHHHHH-HH-CCCCTTTCTTGGG
T ss_pred -cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCH-HHHHHHHHH-Hh-CCCChhhhhhhcc
Confidence 223456899999999998766 899999999999999999999886443221 111111110 00 000000000 0
Q ss_pred ccc---------hhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 593 IVD---------PRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 593 ~vd---------~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
+.+ ..............+.+|+.+||+.||.+||++.||++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000 000001111223467899999999999999999999864
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=363.05 Aligned_cols=256 Identities=22% Similarity=0.324 Sum_probs=201.6
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCC---chhHHHHHHHHHHHHHc-cCCceeeEeeeeecccceEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS---GQGEREFRAEVEIISRV-HHRHLVSLVGYCISEKNRLLI 434 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~---~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV 434 (723)
++|++.++||+|+||.||+|+. .+++.||||+++... ....+.+.+|+.+|+++ +|+||++++++|.+....|||
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 5699999999999999999965 458899999997542 23345688999999998 899999999999999999999
Q ss_pred EEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCC
Q 046750 435 YEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTT 514 (723)
Q Consensus 435 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 514 (723)
|||+.+|+|.+++.... .+.+..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++.....
T Consensus 89 ~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp ECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 99999999999997644 488999999999999999999999 5999999999999999999999999999854322
Q ss_pred CcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCccccc
Q 046750 515 QTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIV 594 (723)
Q Consensus 515 ~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~v 594 (723)
.. .....+||..|+|||++.+..++.++|||||||+||||++|+.||........... .....+.+.+..+.+.
T Consensus 164 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~--~~~~~~~~~i~~~~~~--- 237 (345)
T 3a8x_A 164 GD-TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ--NTEDYLFQVILEKQIR--- 237 (345)
T ss_dssp TC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC---------CHHHHHHHHHHCCCC---
T ss_pred CC-cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCccccccccc--ccHHHHHHHHHcCCCC---
Confidence 22 23446799999999999999999999999999999999999999975322111000 0011122222222211
Q ss_pred chhhhccccHHHHHHHHHHHHHHhccCCCCCCCH------HHHHH
Q 046750 595 DPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRM------VQVVR 633 (723)
Q Consensus 595 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~------~eVl~ 633 (723)
+ .......+.+|+.+||+.||.+|+++ .||++
T Consensus 238 ---~----p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~ 275 (345)
T 3a8x_A 238 ---I----PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 275 (345)
T ss_dssp ---C----CTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred ---C----CCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence 1 11122367889999999999999985 56654
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=365.00 Aligned_cols=260 Identities=27% Similarity=0.427 Sum_probs=209.4
Q ss_pred hcCcccceEEeccCcEEEEEEEc--------CCCcEEEEEEcccCCc-hhHHHHHHHHHHHHHc-cCCceeeEeeeeecc
Q 046750 359 TNGFARENVIGEGGFGCVYKGNL--------PEGKVVAVKQLKSGSG-QGEREFRAEVEIISRV-HHRHLVSLVGYCISE 428 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~--------~~g~~VAvK~l~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~ 428 (723)
.++|.+.+.||+|+||.||+|++ .+++.||||+++.... ...+.+.+|+++|+++ +|+||++++++|.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 36799999999999999999965 3467899999986533 3446789999999999 899999999999999
Q ss_pred cceEEEEEecCCCchhhccccCCC--------------CcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEe
Q 046750 429 KNRLLIYEFVPNNNLEHHLHGKGQ--------------PVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILV 494 (723)
Q Consensus 429 ~~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl 494 (723)
+..++||||+.+|+|.+++..... ..+.+..++.|+.||++||+|||++ +|+|||||++||||
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEE
Confidence 999999999999999999976432 2478899999999999999999999 59999999999999
Q ss_pred CCCCcEEEeecccccccCCCCcce-eecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchh
Q 046750 495 DDEFEAQVADFGLAKLNDTTQTHV-STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDES 572 (723)
Q Consensus 495 ~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~ 572 (723)
+.++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||+||||++ |+.||..... ..
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~ 267 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---EE 267 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH---HH
Confidence 999999999999998665433222 233457889999999999999999999999999999999 9999965421 11
Q ss_pred hHHhhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCCC
Q 046750 573 LVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEM 641 (723)
Q Consensus 573 l~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~~ 641 (723)
+ ...+..+....+ .......+.+++.+||+.+|.+||++.||++.|+.+...
T Consensus 268 ~--------~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~ 319 (334)
T 2pvf_A 268 L--------FKLLKEGHRMDK---------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319 (334)
T ss_dssp H--------HHHHHHTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred H--------HHHHhcCCCCCC---------CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 1 112222221111 111223678899999999999999999999999987654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=365.29 Aligned_cols=253 Identities=24% Similarity=0.367 Sum_probs=190.5
Q ss_pred HHhcCcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEE
Q 046750 357 EITNGFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 357 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 435 (723)
.+.++|.+.++||+|+||.||+|+.. +++.||||+++... ..+.+.+|+++|++|+|+||++++++|.+....+|||
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 127 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL 127 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence 34578999999999999999999664 57899999998642 3456889999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCC---CCcEEEeecccccccC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDD---EFEAQVADFGLAKLND 512 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~---~~~vkL~DFGla~~~~ 512 (723)
||+.+++|.+++.... .+.+..++.++.||+.||+|||++ +|+|||||++||||+. ++.+||+|||+++...
T Consensus 128 e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 128 ELVTGGELFDRIVEKG--YYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp CCCCSCBHHHHHTTCS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred EeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 9999999999997654 488999999999999999999999 5999999999999975 8899999999998654
Q ss_pred CCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCccc
Q 046750 513 TTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSE 592 (723)
Q Consensus 513 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~ 592 (723)
... ......|+..|+|||++.+..++.++|||||||+||||++|+.||..... ... +.+.+..+...
T Consensus 203 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~--------~~~~i~~~~~~- 269 (349)
T 2w4o_A 203 HQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERG--DQF--------MFRRILNCEYY- 269 (349)
T ss_dssp ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTC--HHH--------HHHHHHTTCCC-
T ss_pred ccc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcc--cHH--------HHHHHHhCCCc-
Confidence 322 22345689999999999999999999999999999999999999965432 111 11122222211
Q ss_pred ccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 593 IVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 593 ~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
+..+ +.. .....+.+|+.+||+.||++||++.|+++.
T Consensus 270 ~~~~-~~~----~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 270 FISP-WWD----EVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp CCTT-TTT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cCCc-hhh----hCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111 111 122367899999999999999999999875
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=361.61 Aligned_cols=245 Identities=23% Similarity=0.324 Sum_probs=202.4
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCC---chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS---GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 435 (723)
++|++.++||+|+||.||+++. .+|+.||||+++... ....+.+.+|+.+|+.++|+||++++++|.+....|+||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 5799999999999999999965 468999999987531 233456889999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ 515 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 515 (723)
||+.+|+|.+++.... .+++..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++.....
T Consensus 86 e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~- 159 (318)
T 1fot_A 86 DYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 159 (318)
T ss_dssp CCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCCc-
Confidence 9999999999997654 478889999999999999999999 5999999999999999999999999999865432
Q ss_pred cceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccc
Q 046750 516 THVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVD 595 (723)
Q Consensus 516 ~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd 595 (723)
....+||..|+|||++.+..++.++|||||||+||||++|+.||..... ... .+.+..+.+.
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~-----~~~i~~~~~~---- 221 (318)
T 1fot_A 160 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------MKT-----YEKILNAELR---- 221 (318)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHH-----HHHHHHCCCC----
T ss_pred ---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH------HHH-----HHHHHhCCCC----
Confidence 2345799999999999999999999999999999999999999975431 111 1112222211
Q ss_pred hhhhccccHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 046750 596 PRLEKHYVESEMFRMIEAAAACVRHSGPKRP-----RMVQVVRA 634 (723)
Q Consensus 596 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~eVl~~ 634 (723)
+...+ ...+.+++.+||+.||.+|+ ++.+|++.
T Consensus 222 --~p~~~----~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 222 --FPPFF----NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp --CCTTS----CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred --CCCCC----CHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 11111 23678899999999999999 88888754
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=362.67 Aligned_cols=249 Identities=24% Similarity=0.348 Sum_probs=194.0
Q ss_pred hcCcccceEEeccCcEEEEEEEc----CCCcEEEEEEcccCC----chhHHHHHHHHHHHHHccCCceeeEeeeeecccc
Q 046750 359 TNGFARENVIGEGGFGCVYKGNL----PEGKVVAVKQLKSGS----GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKN 430 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~----~~g~~VAvK~l~~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 430 (723)
.++|++.++||+|+||.||+++. .+++.||||+++... ......+.+|+++|++|+|+||++++++|.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 36799999999999999999965 478999999997642 2234567889999999999999999999999999
Q ss_pred eEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccc
Q 046750 431 RLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKL 510 (723)
Q Consensus 431 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 510 (723)
.||||||+.+++|.+++.... .+.+..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++.
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREG--IFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred EEEEEeCCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 999999999999999997644 478889999999999999999999 599999999999999999999999999975
Q ss_pred cCCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCc
Q 046750 511 NDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDL 590 (723)
Q Consensus 511 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l 590 (723)
...... ......|+..|+|||++.+..++.++|||||||+||||++|+.||..... . .. .+.+..+.+
T Consensus 171 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~---~~-----~~~i~~~~~ 238 (327)
T 3a62_A 171 SIHDGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR---K---KT-----IDKILKCKL 238 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---H---HH-----HHHHHHTCC
T ss_pred cccCCc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH---H---HH-----HHHHHhCCC
Confidence 432222 22345799999999999999999999999999999999999999975431 1 11 111111111
Q ss_pred ccccchhhhccccHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 046750 591 SEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRP-----RMVQVVRA 634 (723)
Q Consensus 591 ~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~eVl~~ 634 (723)
. +.......+.+|+.+||+.||.+|| ++.||++.
T Consensus 239 ~----------~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 239 N----------LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp C----------CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred C----------CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 0 1111123678899999999999999 77888764
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=361.39 Aligned_cols=268 Identities=26% Similarity=0.392 Sum_probs=212.9
Q ss_pred CHHHHHHHhcCcccceEEeccCcEEEEEEEc------CCCcEEEEEEcccCCch-hHHHHHHHHHHHHHc-cCCceeeEe
Q 046750 351 TYEELMEITNGFARENVIGEGGFGCVYKGNL------PEGKVVAVKQLKSGSGQ-GEREFRAEVEIISRV-HHRHLVSLV 422 (723)
Q Consensus 351 ~~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~------~~g~~VAvK~l~~~~~~-~~~~~~~Ei~il~~l-~HpnIv~l~ 422 (723)
...+.....++|.+.+.||+|+||.||+|++ .+++.||||+++..... ..+.+.+|+++|.++ +|+||++++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 3344444567899999999999999999963 35688999999865433 345789999999999 799999999
Q ss_pred eeeeccc-ceEEEEEecCCCchhhccccCCC--------------CcchHHHHHHHHHHHHhhhchhcccCCCceeecCC
Q 046750 423 GYCISEK-NRLLIYEFVPNNNLEHHLHGKGQ--------------PVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDI 487 (723)
Q Consensus 423 g~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDI 487 (723)
++|...+ ..++||||+.+++|.+++..... ..+.+..++.++.||++||.|||++ +|+||||
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~di 174 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDL 174 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccC
Confidence 9988754 48999999999999999976543 2288999999999999999999999 5999999
Q ss_pred CCCcEEeCCCCcEEEeecccccccCCCCcc-eeecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCC
Q 046750 488 KSANILVDDEFEAQVADFGLAKLNDTTQTH-VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPT 565 (723)
Q Consensus 488 kp~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~ 565 (723)
|++||||+.++.+||+|||+++........ ......|+..|+|||++.+..++.++|||||||+||||++ |+.||...
T Consensus 175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 254 (316)
T 2xir_A 175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254 (316)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence 999999999999999999999866543332 2334567889999999999999999999999999999998 99999764
Q ss_pred CCCCchhhHHhhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCC
Q 046750 566 QPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGE 640 (723)
Q Consensus 566 ~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~ 640 (723)
... ..+ ...+..+....+ ... ....+.+++.+||+.||.+||++.+|++.|+.+..
T Consensus 255 ~~~--~~~--------~~~~~~~~~~~~-----~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 310 (316)
T 2xir_A 255 KID--EEF--------CRRLKEGTRMRA-----PDY----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310 (316)
T ss_dssp CCS--HHH--------HHHHHHTCCCCC-----CTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred chh--HHH--------HHHhccCccCCC-----CCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 321 111 111222211111 011 12357889999999999999999999999987653
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=372.39 Aligned_cols=252 Identities=20% Similarity=0.339 Sum_probs=196.9
Q ss_pred cCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCC--chhHHHHHHHHHHHHHcc--CCceeeEeeeeecccceEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGS--GQGEREFRAEVEIISRVH--HRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~--~~~~~~~~~Ei~il~~l~--HpnIv~l~g~~~~~~~~~lV~ 435 (723)
++|.+.++||+|+||.||+|...+++.||||++.... ....+.|++|+++|++|+ |+||+++++++...+..||||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 4599999999999999999988889999999986542 334567899999999996 599999999999999999999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ 515 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 515 (723)
| +.+++|.+++.... .+.+..++.|+.||+.||+|||++ +|||||||++||||+ ++.+||+|||+++.+....
T Consensus 136 E-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp E-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred e-cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 9 56899999997654 478888999999999999999999 599999999999996 5799999999998765433
Q ss_pred cc-eeecccccccccChhhhcc-----------CCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhh
Q 046750 516 TH-VSTRVMGTFGYLAPEYASS-----------GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVR 583 (723)
Q Consensus 516 ~~-~~~~~~gt~~y~APE~~~~-----------~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~ 583 (723)
.. .....+||..|+|||++.+ ..++.++||||||||||||++|+.||...... ... + .
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-----~~~----~-~ 278 (390)
T 2zmd_A 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISK----L-H 278 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-----HHH----H-H
T ss_pred ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-----HHH----H-H
Confidence 22 2344579999999999975 46889999999999999999999999653210 111 1 1
Q ss_pred hhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 046750 584 AIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALD 636 (723)
Q Consensus 584 ~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~ 636 (723)
.+..+... ..+.......+.+|+.+||+.||.+||++.||++.-.
T Consensus 279 ~~~~~~~~--------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~ 323 (390)
T 2zmd_A 279 AIIDPNHE--------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 323 (390)
T ss_dssp HHHCTTSC--------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred HHhCcccc--------CCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcC
Confidence 11111111 0111111236788999999999999999999997644
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=357.42 Aligned_cols=252 Identities=21% Similarity=0.345 Sum_probs=202.4
Q ss_pred cCcccceEEeccCcEEEEEEEcCC-C-------cEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccce
Q 046750 360 NGFARENVIGEGGFGCVYKGNLPE-G-------KVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNR 431 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~~-g-------~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 431 (723)
++|.+.+.||+|+||.||+|.... + +.||||++........+.|.+|+++|++++|+||++++++|.+.+..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 579999999999999999995533 3 47999999776666677899999999999999999999999999999
Q ss_pred EEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCc--------EEEe
Q 046750 432 LLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFE--------AQVA 503 (723)
Q Consensus 432 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~--------vkL~ 503 (723)
++||||+.+++|.+++.... ..+++..++.|+.||+.||+|||++ +|+|||||++||||+.++. +||+
T Consensus 88 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~ 163 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLS 163 (289)
T ss_dssp EEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred EEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeeec
Confidence 99999999999999997653 2478899999999999999999999 4999999999999998877 9999
Q ss_pred ecccccccCCCCcceeecccccccccChhhhcc-CCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhh
Q 046750 504 DFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASS-GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLV 582 (723)
Q Consensus 504 DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~ 582 (723)
|||++...... ....|+..|+|||++.+ ..++.++|||||||+||||++|..++..... ........
T Consensus 164 Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~--~~~~~~~~----- 231 (289)
T 4fvq_A 164 DPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD--SQRKLQFY----- 231 (289)
T ss_dssp CCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC--HHHHHHHH-----
T ss_pred cCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc--hHHHHHHh-----
Confidence 99998754322 23458899999999987 6799999999999999999996655433221 11111110
Q ss_pred hhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCCC
Q 046750 583 RAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEM 641 (723)
Q Consensus 583 ~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~~ 641 (723)
.....+... . ...+.+|+.+||+.||.+||++.+|++.|+.+..-
T Consensus 232 --~~~~~~~~~--------~----~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 232 --EDRHQLPAP--------K----AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp --HTTCCCCCC--------S----SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred --hccCCCCCC--------C----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 001111111 1 12467899999999999999999999999987653
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=351.03 Aligned_cols=258 Identities=26% Similarity=0.380 Sum_probs=203.2
Q ss_pred hcCcccceEEeccCcEEEEEEEcCC----CcEEEEEEcccCC-chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEE
Q 046750 359 TNGFARENVIGEGGFGCVYKGNLPE----GKVVAVKQLKSGS-GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLL 433 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~~~----g~~VAvK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 433 (723)
.++|.+.++||+|+||.||+|.+.. +..||||+++... ....+.|.+|++++++|+|+||+++++++.+ +..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 3679999999999999999996533 3469999998653 3345679999999999999999999999875 45789
Q ss_pred EEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCC
Q 046750 434 IYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDT 513 (723)
Q Consensus 434 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 513 (723)
||||+.+++|.+++.... ..+++..++.++.||++||+|||++ +|+|||||++||||+.++.+||+|||++.....
T Consensus 90 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 165 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIED 165 (281)
T ss_dssp EEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred EEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence 999999999999997543 2478899999999999999999999 599999999999999999999999999987654
Q ss_pred CCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCccc
Q 046750 514 TQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSE 592 (723)
Q Consensus 514 ~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~ 592 (723)
..........++..|+|||++.+..++.++|||||||+||||++ |+.||...... .+. ..+..+....
T Consensus 166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~---~~~--------~~~~~~~~~~ 234 (281)
T 3cc6_A 166 EDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK---DVI--------GVLEKGDRLP 234 (281)
T ss_dssp -------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG---GHH--------HHHHHTCCCC
T ss_pred ccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH---HHH--------HHHhcCCCCC
Confidence 44333344557889999999999999999999999999999998 99999754321 111 1111221111
Q ss_pred ccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCCC
Q 046750 593 IVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEM 641 (723)
Q Consensus 593 ~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~~ 641 (723)
.. .. ....+.+++.+||+.||.+||++.||++.|+.+..+
T Consensus 235 ~~-----~~----~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 235 KP-----DL----CPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp CC-----TT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CC-----CC----CCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 10 11 123578899999999999999999999999876543
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=353.73 Aligned_cols=251 Identities=25% Similarity=0.421 Sum_probs=206.5
Q ss_pred HHhcCcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeec--------
Q 046750 357 EITNGFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCIS-------- 427 (723)
Q Consensus 357 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-------- 427 (723)
.+.++|++.++||+|+||.||+|... +++.||||+++... ..+.+|++++++|+|+||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 45678999999999999999999664 78999999997643 357789999999999999999998864
Q ss_pred --------ccceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCc
Q 046750 428 --------EKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFE 499 (723)
Q Consensus 428 --------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~ 499 (723)
....++||||+.+++|.++++......+++..++.|+.||+.||.|||++ +|+|||||++||||++++.
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCC
Confidence 34579999999999999999765545689999999999999999999999 5999999999999999999
Q ss_pred EEEeecccccccCCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhh
Q 046750 500 AQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARP 579 (723)
Q Consensus 500 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~ 579 (723)
+||+|||++........ .....|+..|+|||++.+..++.++|||||||+||||++|..++... ..
T Consensus 161 ~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--------~~---- 226 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--------SK---- 226 (284)
T ss_dssp EEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--------HH----
T ss_pred EEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--------HH----
Confidence 99999999986654332 23346899999999999999999999999999999999998876321 01
Q ss_pred hhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCCC
Q 046750 580 VLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEM 641 (723)
Q Consensus 580 ~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~~ 641 (723)
+...+..+.+... +. ..+.+++.+||+.||.+||++.||++.|+.....
T Consensus 227 -~~~~~~~~~~~~~--------~~----~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 227 -FFTDLRDGIISDI--------FD----KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp -HHHHHHTTCCCTT--------SC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred -HHHHhhccccccc--------CC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 1122222222222 11 2467899999999999999999999999886543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=355.08 Aligned_cols=264 Identities=24% Similarity=0.348 Sum_probs=201.1
Q ss_pred HhcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCC-----chhHHHHHHHHHHHHHcc---CCceeeEeeeeecc
Q 046750 358 ITNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS-----GQGEREFRAEVEIISRVH---HRHLVSLVGYCISE 428 (723)
Q Consensus 358 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~-----~~~~~~~~~Ei~il~~l~---HpnIv~l~g~~~~~ 428 (723)
+.++|++.++||+|+||.||+|+. .+++.||||+++... ......+.+|++++++|+ |+||++++++|...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 457899999999999999999964 578999999986432 122346778888888775 99999999999875
Q ss_pred c-----ceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEe
Q 046750 429 K-----NRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVA 503 (723)
Q Consensus 429 ~-----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~ 503 (723)
. ..++||||+. ++|.+++.......+++..++.|+.||+.||+|||+++ |+|||||++||||+.++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEEC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEEe
Confidence 5 4789999995 69999998776666899999999999999999999994 9999999999999999999999
Q ss_pred ecccccccCCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhh
Q 046750 504 DFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVR 583 (723)
Q Consensus 504 DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~ 583 (723)
|||+++....... .....||..|+|||++.+..++.++|||||||+||||++|+.||..... ...... +.+
T Consensus 163 Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~----i~~ 233 (308)
T 3g33_A 163 DFGLARIYSYQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE---ADQLGK----IFD 233 (308)
T ss_dssp SCSCTTTSTTCCC--SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSH---HHHHHH----HHH
T ss_pred eCccccccCCCcc--cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHH----HHH
Confidence 9999986543322 2445789999999999999999999999999999999999999976432 111111 111
Q ss_pred hhhc---CCccc---ccchhh-------hccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 584 AIET---GDLSE---IVDPRL-------EKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 584 ~i~~---~~l~~---~vd~~l-------~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
.+.. ..+.. +.+..+ ......+....+.+|+.+||+.||.+||++.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 234 LIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp HHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 1100 00000 000000 000111223467899999999999999999999874
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=356.58 Aligned_cols=246 Identities=24% Similarity=0.295 Sum_probs=194.1
Q ss_pred hcCcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCCc--hhHHHHHHHHHHHHHc-cCCceeeEeeeeecccceEEE
Q 046750 359 TNGFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGSG--QGEREFRAEVEIISRV-HHRHLVSLVGYCISEKNRLLI 434 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~~--~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV 434 (723)
.++|++.++||+|+||.||+|++. +++.||||++..... .....+..|+..+.++ +|+||++++++|.+.+..|||
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 467999999999999999999664 789999999865432 2334556666666666 899999999999999999999
Q ss_pred EEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCC
Q 046750 435 YEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTT 514 (723)
Q Consensus 435 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 514 (723)
|||+ +++|.+++.... ..+++..++.|+.||+.||+|||++ +|||||||++||||+.++.+||+|||+++.....
T Consensus 136 ~e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp EECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred Eecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence 9999 778988886643 3589999999999999999999999 5999999999999999999999999999766433
Q ss_pred CcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCccccc
Q 046750 515 QTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIV 594 (723)
Q Consensus 515 ~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~v 594 (723)
.. .....||..|+|||++.+ .++.++|||||||+||||++|..++... .. | ..+..+.+
T Consensus 211 ~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~-----~~---~------~~~~~~~~---- 269 (311)
T 3p1a_A 211 GA--GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG-----EG---W------QQLRQGYL---- 269 (311)
T ss_dssp ------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH-----HH---H------HHHTTTCC----
T ss_pred CC--CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc-----cH---H------HHHhccCC----
Confidence 22 234568999999999875 7999999999999999999997766432 11 1 11111111
Q ss_pred chhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 595 DPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 595 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
...+... ....+.+++.+||+.||.+||++.||++.
T Consensus 270 ~~~~~~~----~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 270 PPEFTAG----LSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp CHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CcccccC----CCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 1111111 23468899999999999999999999874
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=363.76 Aligned_cols=253 Identities=21% Similarity=0.295 Sum_probs=182.1
Q ss_pred ceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCchhHHHHHHHHHHHHHcc-CCceeeEeeeeecccceEEEEEecCCCc
Q 046750 365 ENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQGEREFRAEVEIISRVH-HRHLVSLVGYCISEKNRLLIYEFVPNNN 442 (723)
Q Consensus 365 ~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~E~~~~gs 442 (723)
.++||+|+||.||+|.. .+++.||||++.. .....+.+|+.+|+++. |+||++++++|.+....||||||+.+|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 47899999999999955 4689999999975 34567889999999997 9999999999999999999999999999
Q ss_pred hhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCC---cEEEeecccccccCCCCccee
Q 046750 443 LEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEF---EAQVADFGLAKLNDTTQTHVS 519 (723)
Q Consensus 443 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~---~vkL~DFGla~~~~~~~~~~~ 519 (723)
|.+++.... .+++..++.|+.||+.||+|||++ +|+|||||++||||+.++ .+||+|||+++........ .
T Consensus 93 L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~-~ 166 (325)
T 3kn6_A 93 LFERIKKKK--HFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-L 166 (325)
T ss_dssp HHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred HHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc-c
Confidence 999997654 488999999999999999999999 599999999999997665 8999999999865443322 2
Q ss_pred ecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhhh
Q 046750 520 TRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLE 599 (723)
Q Consensus 520 ~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~ 599 (723)
....|+..|+|||++.+..++.++|||||||+||||++|+.||............ ..+.+.+..+.+... . ..
T Consensus 167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~----~~~~~~i~~~~~~~~-~-~~- 239 (325)
T 3kn6_A 167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSA----VEIMKKIKKGDFSFE-G-EA- 239 (325)
T ss_dssp -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCH----HHHHHHHTTTCCCCC-S-HH-
T ss_pred cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccH----HHHHHHHHcCCCCCC-c-cc-
Confidence 3456899999999999999999999999999999999999999764321110000 112233333332111 0 01
Q ss_pred ccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 046750 600 KHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALD 636 (723)
Q Consensus 600 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~ 636 (723)
.......+.+|+.+||+.||.+||++.||++.-+
T Consensus 240 ---~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w 273 (325)
T 3kn6_A 240 ---WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEW 273 (325)
T ss_dssp ---HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGG
T ss_pred ---ccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChh
Confidence 0112346789999999999999999999886543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=354.56 Aligned_cols=270 Identities=20% Similarity=0.309 Sum_probs=197.8
Q ss_pred hcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCch--hHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEE
Q 046750 359 TNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQ--GEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 435 (723)
.++|++.++||+|+||.||+|.. .+|+.||||++...... ..+.+.+|++++++++|+||++++++|.+.+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 46899999999999999999965 45899999998655332 2456889999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ 515 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 515 (723)
||+.+++|.+++.... .+++..++.|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||++.......
T Consensus 82 e~~~~~~l~~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 82 EYCDHTVLHELDRYQR--GVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp ECCSEEHHHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EeCCCchHHHHHhhhc--CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 9999999999886543 488999999999999999999999 49999999999999999999999999998665332
Q ss_pred cceeecccccccccChhhhcc-CCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhh-hhhh---hhhhhcCCc
Q 046750 516 THVSTRVMGTFGYLAPEYASS-GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWA-RPVL---VRAIETGDL 590 (723)
Q Consensus 516 ~~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~-~~~l---~~~i~~~~l 590 (723)
.. .....|+..|+|||++.+ ..++.++|||||||+||||++|+.||............... .... ...+.....
T Consensus 157 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
T 4agu_A 157 DY-YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY 235 (311)
T ss_dssp ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGG
T ss_pred cc-cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccc
Confidence 22 234568999999999976 56899999999999999999999999765421111110000 0000 000000000
Q ss_pred ---ccccchhhhc---cccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 591 ---SEIVDPRLEK---HYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 591 ---~~~vd~~l~~---~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
..+.++.... .........+.+|+.+||+.||.+||++.||++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000000000 0001123357899999999999999999999875
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=366.31 Aligned_cols=245 Identities=25% Similarity=0.324 Sum_probs=203.1
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCC---chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS---GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 435 (723)
++|++.+.||+|+||.||+|+. .+|+.||||+++... ....+.+.+|+++|++++|+||+++++++.+....||||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 5799999999999999999965 468999999986531 233457889999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ 515 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 515 (723)
||+.+|+|.+++...+ .+++..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence 9999999999997654 378899999999999999999999 5999999999999999999999999999866432
Q ss_pred cceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccc
Q 046750 516 THVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVD 595 (723)
Q Consensus 516 ~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd 595 (723)
....+||..|+|||++.+..++.++|||||||+||||++|+.||..... .. +.+.+..+.+.
T Consensus 195 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~-----~~~~i~~~~~~---- 256 (350)
T 1rdq_E 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP------IQ-----IYEKIVSGKVR---- 256 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HH-----HHHHHHHCCCC----
T ss_pred ---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH------HH-----HHHHHHcCCCC----
Confidence 2345699999999999999999999999999999999999999975431 11 11222223221
Q ss_pred hhhhccccHHHHHHHHHHHHHHhccCCCCCCC-----HHHHHHH
Q 046750 596 PRLEKHYVESEMFRMIEAAAACVRHSGPKRPR-----MVQVVRA 634 (723)
Q Consensus 596 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~eVl~~ 634 (723)
+...+ ...+.+|+.+||+.||.+|++ +.+|++.
T Consensus 257 --~p~~~----~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 257 --FPSHF----SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp --CCTTC----CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred --CCCCC----CHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 11112 236789999999999999998 8888754
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=359.96 Aligned_cols=261 Identities=25% Similarity=0.432 Sum_probs=210.2
Q ss_pred HHhcCcccceEEeccCcEEEEEEEcC------CCcEEEEEEcccCCc-hhHHHHHHHHHHHHHccCCceeeEeeeeeccc
Q 046750 357 EITNGFARENVIGEGGFGCVYKGNLP------EGKVVAVKQLKSGSG-QGEREFRAEVEIISRVHHRHLVSLVGYCISEK 429 (723)
Q Consensus 357 ~~~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~VAvK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 429 (723)
...++|.+.+.||+|+||.||+|.+. .++.||||+++.... .....|.+|+++|++++|+||+++++++.+.+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 101 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 101 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCC
Confidence 34578999999999999999999653 367899999976533 33457899999999999999999999999999
Q ss_pred ceEEEEEecCCCchhhccccCC--------CCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEE
Q 046750 430 NRLLIYEFVPNNNLEHHLHGKG--------QPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQ 501 (723)
Q Consensus 430 ~~~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vk 501 (723)
..++||||+.+|+|.++++... ...+.+..++.|+.||+.||+|||++ +|+|||||++||||+.++.+|
T Consensus 102 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~k 178 (322)
T 1p4o_A 102 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVK 178 (322)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEE
T ss_pred ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCeEE
Confidence 9999999999999999986532 13468889999999999999999999 599999999999999999999
Q ss_pred EeecccccccCCCCcce-eecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhh
Q 046750 502 VADFGLAKLNDTTQTHV-STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARP 579 (723)
Q Consensus 502 L~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~ 579 (723)
|+|||+++......... .....++..|+|||++.+..++.++|||||||+||||++ |+.||..... ..+
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~------ 249 (322)
T 1p4o_A 179 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN---EQV------ 249 (322)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH---HHH------
T ss_pred ECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH---HHH------
Confidence 99999997654332221 223457889999999999999999999999999999999 8898865421 111
Q ss_pred hhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCC
Q 046750 580 VLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGE 640 (723)
Q Consensus 580 ~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~ 640 (723)
...+..+.+.... ......+.+++.+||+.||.+||++.||++.|+....
T Consensus 250 --~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 250 --LRFVMEGGLLDKP---------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp --HHHHHTTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred --HHHHHcCCcCCCC---------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 1222222221111 1122357889999999999999999999999998755
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=354.22 Aligned_cols=261 Identities=21% Similarity=0.373 Sum_probs=198.9
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccC---CchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSG---SGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 435 (723)
++|++.++||+|+||.||+|.. .+|+.||||+++.. .......+.+|+++|++|+|+||++++++|.+.+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 5799999999999999999954 57899999998753 2334467889999999999999999999999999999999
Q ss_pred EecCCCchhhcccc--CCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCC
Q 046750 436 EFVPNNNLEHHLHG--KGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDT 513 (723)
Q Consensus 436 E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 513 (723)
||+.+++|.+++.. .....+++..++.++.||++||.|||++ +|+|||||++||||+.++.+||+|||+++....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 99999999999864 2234588899999999999999999999 599999999999999999999999999976543
Q ss_pred CCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccc
Q 046750 514 TQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEI 593 (723)
Q Consensus 514 ~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~ 593 (723)
... ......|+..|+|||++.+..++.++|||||||+||||++|+.||...... ... +.+.+..+.+..+
T Consensus 189 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~-----~~~~~~~~~~~~~ 258 (310)
T 2wqm_A 189 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYS-----LCKKIEQCDYPPL 258 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC----HHH-----HHHHHHTTCSCCC
T ss_pred CCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh----HHH-----HHHHhhcccCCCC
Confidence 322 223346899999999999999999999999999999999999999654321 111 1122223332222
Q ss_pred cchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCCC
Q 046750 594 VDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEM 641 (723)
Q Consensus 594 vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~~ 641 (723)
.. ..+ ...+.+|+.+||+.||.+||++.+|++.|+.+...
T Consensus 259 ~~----~~~----~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~ 298 (310)
T 2wqm_A 259 PS----DHY----SEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHAC 298 (310)
T ss_dssp CT----TTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cc----ccc----CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 11 111 23678899999999999999999999999886543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=367.72 Aligned_cols=248 Identities=23% Similarity=0.362 Sum_probs=201.8
Q ss_pred HhcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCC---chhHHHHHHHHHHHHHc-cCCceeeEeeeeecccceE
Q 046750 358 ITNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS---GQGEREFRAEVEIISRV-HHRHLVSLVGYCISEKNRL 432 (723)
Q Consensus 358 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~---~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~ 432 (723)
..++|.+.++||+|+||.||+|+. .+|+.||||+++... ....+.+..|.++|.++ +|+||++++++|.+.+..|
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~ 94 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence 357899999999999999999965 468899999997532 23345678899999987 8999999999999999999
Q ss_pred EEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccC
Q 046750 433 LIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLND 512 (723)
Q Consensus 433 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 512 (723)
|||||+.+|+|.+++.... .+++..++.++.||+.||+|||++ +|||||||++||||+.++.+||+|||+++...
T Consensus 95 lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 169 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM 169 (345)
T ss_dssp EEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence 9999999999999997644 378899999999999999999999 59999999999999999999999999997543
Q ss_pred CCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCccc
Q 046750 513 TTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSE 592 (723)
Q Consensus 513 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~ 592 (723)
.... .....+||..|+|||++.+..++.++|||||||+||||++|+.||..... .. +.+.+..+...
T Consensus 170 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~--------~~~~i~~~~~~- 236 (345)
T 1xjd_A 170 LGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE---EE--------LFHSIRMDNPF- 236 (345)
T ss_dssp CTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HH--------HHHHHHHCCCC-
T ss_pred cCCC-cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH---HH--------HHHHHHhCCCC-
Confidence 2222 23446799999999999999999999999999999999999999975431 11 11222222210
Q ss_pred ccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHH-HHH
Q 046750 593 IVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMV-QVV 632 (723)
Q Consensus 593 ~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-eVl 632 (723)
+... ....+.+|+.+||+.||.+|+++. +|+
T Consensus 237 -----~p~~----~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 237 -----YPRW----LEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp -----CCTT----SCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred -----CCcc----cCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 1111 123578899999999999999997 665
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=347.90 Aligned_cols=253 Identities=21% Similarity=0.277 Sum_probs=205.1
Q ss_pred HHhcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEE
Q 046750 357 EITNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 357 ~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 435 (723)
.+.++|.+.++||+|+||.||+|.. .++..||+|++........+.+.+|+++|++++|+||++++++|.+....++||
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (277)
T 3f3z_A 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 85 (277)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence 3557899999999999999999965 457799999998765566778999999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEe---CCCCcEEEeecccccccC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILV---DDEFEAQVADFGLAKLND 512 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl---~~~~~vkL~DFGla~~~~ 512 (723)
||+.+++|.+++.... .+.+..++.|+.||+.||+|||++ +|+|||||++|||| +.++.+||+|||++....
T Consensus 86 e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 86 ELCTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp ECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred eccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 9999999999887644 388999999999999999999999 49999999999999 788999999999998665
Q ss_pred CCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCccc
Q 046750 513 TTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSE 592 (723)
Q Consensus 513 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~ 592 (723)
.... .....|+..|+|||++.+ .++.++|||||||+||||++|+.||..... .. +...+..+.+..
T Consensus 161 ~~~~--~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~--------~~~~~~~~~~~~ 226 (277)
T 3f3z_A 161 PGKM--MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTD---SE--------VMLKIREGTFTF 226 (277)
T ss_dssp TTSC--BCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HH--------HHHHHHHCCCCC
T ss_pred Cccc--hhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCH---HH--------HHHHHHhCCCCC
Confidence 4332 233468999999999865 499999999999999999999999975431 11 111222222111
Q ss_pred ccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 593 IVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 593 ~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
. . .....+ ...+.+++.+||+.||.+||++.++++.
T Consensus 227 ~-~-~~~~~~----~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 227 P-E-KDWLNV----SPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp C-H-HHHTTS----CHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred C-c-hhhhcC----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 0 000111 2367889999999999999999999863
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=367.58 Aligned_cols=204 Identities=25% Similarity=0.449 Sum_probs=164.4
Q ss_pred HHHhcCcccceEEeccCcEEEEEEE-cCCCcEEEEEEcccC--CchhHHHHHHHHHHHHHcc-CCceeeEeeeeeccc--
Q 046750 356 MEITNGFARENVIGEGGFGCVYKGN-LPEGKVVAVKQLKSG--SGQGEREFRAEVEIISRVH-HRHLVSLVGYCISEK-- 429 (723)
Q Consensus 356 ~~~~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~VAvK~l~~~--~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~-- 429 (723)
..+.++|++.++||+|+||.||+|. ..+|+.||||++... .....+.+.+|+.+|+++. |+||++++++|...+
T Consensus 5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 84 (388)
T 3oz6_A 5 RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84 (388)
T ss_dssp HHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred CcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence 3567899999999999999999995 467899999998654 2334456889999999997 999999999997544
Q ss_pred ceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeeccccc
Q 046750 430 NRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK 509 (723)
Q Consensus 430 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 509 (723)
..||||||+. ++|.+++... .+.+..+..|+.||++||+|||++ +||||||||+||||+.++.+||+|||+++
T Consensus 85 ~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 85 DVYLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp CEEEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 6899999996 6899988753 478889999999999999999999 59999999999999999999999999998
Q ss_pred ccCCC--------------------CcceeecccccccccChhhhcc-CCCCCccceechHHHHHHHHhCCCCCCCCC
Q 046750 510 LNDTT--------------------QTHVSTRVMGTFGYLAPEYASS-GKLTDRSDVFSFGVVLLELITGRKPVDPTQ 566 (723)
Q Consensus 510 ~~~~~--------------------~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSlGviL~eLltG~~P~~~~~ 566 (723)
.+... ........+||.+|+|||++.+ ..++.++||||||||||||++|+.||....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 235 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS 235 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 65321 1112334579999999999986 679999999999999999999999997653
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=365.88 Aligned_cols=265 Identities=20% Similarity=0.287 Sum_probs=199.4
Q ss_pred cCcccceEEeccCcEEEEEEEcC----CCcEEEEEEcccCCch-----------hHHHHHHHHHHHHHccCCceeeEeee
Q 046750 360 NGFARENVIGEGGFGCVYKGNLP----EGKVVAVKQLKSGSGQ-----------GEREFRAEVEIISRVHHRHLVSLVGY 424 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~----~g~~VAvK~l~~~~~~-----------~~~~~~~Ei~il~~l~HpnIv~l~g~ 424 (723)
++|.+.++||+|+||.||+|... .+..||||++...... ....+.+|+.+++.++|+||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 57999999999999999999765 5678999998765322 12346678889999999999999999
Q ss_pred eec----ccceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCC--
Q 046750 425 CIS----EKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEF-- 498 (723)
Q Consensus 425 ~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~-- 498 (723)
+.+ ....||||||+ +++|.+++.... .+++..++.|+.||+.||+|||++ +|+|||||++||||+.++
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSSTT
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCCC
Confidence 988 67889999999 999999997654 589999999999999999999999 599999999999999887
Q ss_pred cEEEeecccccccCCCCcc------eeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchh
Q 046750 499 EAQVADFGLAKLNDTTQTH------VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDES 572 (723)
Q Consensus 499 ~vkL~DFGla~~~~~~~~~------~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~ 572 (723)
.+||+|||+++.+...... ......|+..|+|||++.+..++.++|||||||+||||++|+.||..... ...
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~--~~~ 268 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLK--DPV 268 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTT--CHH
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccc--ccH
Confidence 9999999999866432221 11345799999999999999999999999999999999999999964321 111
Q ss_pred hHHhhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCC
Q 046750 573 LVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGE 640 (723)
Q Consensus 573 l~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~ 640 (723)
...+....+.. .+...+...+.. ......+.+++.+||..||.+||++.+|++.|+....
T Consensus 269 ~~~~~~~~~~~-----~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 269 AVQTAKTNLLD-----ELPQSVLKWAPS---GSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHHHHHHHHH-----TTTHHHHHHSCT---TSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHHHHHHhhcc-----cccHHHHhhccc---cccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 11111111100 111111100000 0123368899999999999999999999999988543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=358.68 Aligned_cols=268 Identities=23% Similarity=0.345 Sum_probs=188.4
Q ss_pred hcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCc-hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEE
Q 046750 359 TNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSG-QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYE 436 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 436 (723)
.++|++.++||+|+||.||+|.. .+|+.||||+++.... ...+.+.+|+++|++|+|+||+++++++.+.+..+||||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 35789999999999999999965 4689999999976532 234678899999999999999999999999999999999
Q ss_pred ecCCCchhhccccC----CCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccC
Q 046750 437 FVPNNNLEHHLHGK----GQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLND 512 (723)
Q Consensus 437 ~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 512 (723)
|+. |+|.+++... ....+.+..+..++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 997 6898888542 123488899999999999999999999 59999999999999999999999999998664
Q ss_pred CCCcceeecccccccccChhhhccC-CCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhh-------hh
Q 046750 513 TTQTHVSTRVMGTFGYLAPEYASSG-KLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLV-------RA 584 (723)
Q Consensus 513 ~~~~~~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~-------~~ 584 (723)
.... ......|+..|+|||++.+. .++.++|||||||+||||++|+.||..... ..........+. ..
T Consensus 160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~ 235 (317)
T 2pmi_A 160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND---EEQLKLIFDIMGTPNESLWPS 235 (317)
T ss_dssp SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCSCCTTTCGG
T ss_pred CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCChhHhhh
Confidence 3222 22345689999999999764 689999999999999999999999976432 111111000000 00
Q ss_pred h-hcCCccc--------ccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 585 I-ETGDLSE--------IVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 585 i-~~~~l~~--------~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
+ ....+.. .+...+...........+.+|+.+||+.||.+||++.||++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp GGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 0 0000000 000001111111122368899999999999999999999864
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=369.20 Aligned_cols=249 Identities=21% Similarity=0.306 Sum_probs=196.8
Q ss_pred ccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEecCCC
Q 046750 363 ARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPNN 441 (723)
Q Consensus 363 ~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 441 (723)
...++||+|+||.||+|.. .+|+.||||+++.......+.|.+|+++|++|+|+||++++++|.+.+..+|||||+.++
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 3467899999999999954 568999999998766566778999999999999999999999999999999999999999
Q ss_pred chhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEe--CCCCcEEEeecccccccCCCCccee
Q 046750 442 NLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILV--DDEFEAQVADFGLAKLNDTTQTHVS 519 (723)
Q Consensus 442 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl--~~~~~vkL~DFGla~~~~~~~~~~~ 519 (723)
+|.+++.... ..+.+..++.|+.||++||+|||++ +|+|||||++|||| ++++.+||+|||+++....... .
T Consensus 172 ~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~ 245 (373)
T 2x4f_A 172 ELFDRIIDES-YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--L 245 (373)
T ss_dssp EEHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--C
T ss_pred cHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--c
Confidence 9999886543 2478899999999999999999999 49999999999999 6678999999999987654332 2
Q ss_pred ecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhhh
Q 046750 520 TRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLE 599 (723)
Q Consensus 520 ~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~ 599 (723)
...+|+..|+|||++.+..++.++||||||||||||++|+.||..... .. .. ..+....+. +.+.. .
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---~~---~~-----~~i~~~~~~-~~~~~-~ 312 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND---AE---TL-----NNILACRWD-LEDEE-F 312 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH---HH---HH-----HHHHHTCCC-SCSGG-G
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH---HH---HH-----HHHHhccCC-CChhh-h
Confidence 334699999999999999999999999999999999999999975431 11 11 111111110 11111 1
Q ss_pred ccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 600 KHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 600 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
..+ ...+.+|+.+||+.||.+||++.|+++.
T Consensus 313 ~~~----~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 313 QDI----SEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp TTS----CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ccC----CHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 112 2367889999999999999999999873
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=360.19 Aligned_cols=257 Identities=24% Similarity=0.385 Sum_probs=195.1
Q ss_pred hcCcccceEEeccCcEEEEEEE-cCCCcEEEEEEcccCCc---hhHHHHHHHHHHHHHccCCceeeEeeeeecccce---
Q 046750 359 TNGFARENVIGEGGFGCVYKGN-LPEGKVVAVKQLKSGSG---QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNR--- 431 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~VAvK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~--- 431 (723)
.++|++.++||+|+||.||+|+ ..+++.||||+++.... .....|.+|++++++++|+||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 4689999999999999999996 46789999999976532 2235788999999999999999999998876544
Q ss_pred -EEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccc
Q 046750 432 -LLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKL 510 (723)
Q Consensus 432 -~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 510 (723)
|+||||+.+++|.++++..+ .+.+..++.|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++.
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred cEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 99999999999999997654 488999999999999999999999 599999999999999999999999999986
Q ss_pred cCCCCcc--eeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcC
Q 046750 511 NDTTQTH--VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETG 588 (723)
Q Consensus 511 ~~~~~~~--~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~ 588 (723)
....... ......|+..|+|||++.+..++.++|||||||+||||++|+.||..... ... +.+.+...
T Consensus 166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------~~~----~~~~~~~~ 235 (311)
T 3ork_A 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSV----AYQHVRED 235 (311)
T ss_dssp ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHH----HHHHHHCC
T ss_pred ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHH----HHHHhcCC
Confidence 6543222 22345689999999999999999999999999999999999999975432 111 11111111
Q ss_pred CcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHH-HHHhc
Q 046750 589 DLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVV-RALDS 637 (723)
Q Consensus 589 ~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl-~~L~~ 637 (723)
... ....... ....+.+++.+||+.||.+||++.+++ +.|..
T Consensus 236 ~~~---~~~~~~~----~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 278 (311)
T 3ork_A 236 PIP---PSARHEG----LSADLDAVVLKALAKNPENRYQTAAEMRADLVR 278 (311)
T ss_dssp CCC---HHHHSTT----CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CCC---cccccCC----CCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence 110 0000111 223678899999999999999766655 44433
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=361.77 Aligned_cols=278 Identities=21% Similarity=0.350 Sum_probs=199.7
Q ss_pred cCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHH--HHHccCCceeeEeeeeec-----ccceE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEI--ISRVHHRHLVSLVGYCIS-----EKNRL 432 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~i--l~~l~HpnIv~l~g~~~~-----~~~~~ 432 (723)
++|++.++||+|+||.||+|++ +++.||||+++.. ....+..|.++ +..++|+||+++++++.. ....+
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 88 (336)
T 3g2f_A 13 DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL 88 (336)
T ss_dssp TSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred HHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence 6799999999999999999977 7899999999753 33444545554 445899999999985542 23568
Q ss_pred EEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccC------CCceeecCCCCCcEEeCCCCcEEEeecc
Q 046750 433 LIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDC------HPKIIHRDIKSANILVDDEFEAQVADFG 506 (723)
Q Consensus 433 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g------~~~ivHrDIkp~NILl~~~~~vkL~DFG 506 (723)
|||||+.+|+|.+++.... +.+..+++|+.||++||+|||+++ ..+|||||||++||||+.++.+||+|||
T Consensus 89 lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG 165 (336)
T 3g2f_A 89 LVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG 165 (336)
T ss_dssp EEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCT
T ss_pred EEEecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeecc
Confidence 9999999999999997554 478889999999999999999981 1149999999999999999999999999
Q ss_pred cccccCCCCc-------ceeecccccccccChhhhcc-------CCCCCccceechHHHHHHHHhCCCCCCCCCCCCchh
Q 046750 507 LAKLNDTTQT-------HVSTRVMGTFGYLAPEYASS-------GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDES 572 (723)
Q Consensus 507 la~~~~~~~~-------~~~~~~~gt~~y~APE~~~~-------~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~ 572 (723)
+++....... .......||..|+|||++.+ ..++.++|||||||+||||++|+.||..........
T Consensus 166 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~ 245 (336)
T 3g2f_A 166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ 245 (336)
T ss_dssp TCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCC
T ss_pred ceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHH
Confidence 9986643221 11223569999999999986 356678999999999999999987764433211100
Q ss_pred --hHH-h-h---hhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCCCcccc
Q 046750 573 --LVE-W-A---RPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEMSDLS 645 (723)
Q Consensus 573 --l~~-~-~---~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~~~~~~ 645 (723)
+.. . . ...+...+........+...+ .........+.+|+.+||+.||.+||++.||++.|+.+.......
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~ 323 (336)
T 3g2f_A 246 MAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAW--KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERN 323 (336)
T ss_dssp CTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTC--CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC-
T ss_pred HhhhcccCCCchHHHHHhhhcccccCCCCCccc--ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhc
Confidence 000 0 0 000000111111111111111 112234557899999999999999999999999999988664433
Q ss_pred C
Q 046750 646 N 646 (723)
Q Consensus 646 ~ 646 (723)
+
T Consensus 324 ~ 324 (336)
T 3g2f_A 324 K 324 (336)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=361.94 Aligned_cols=258 Identities=29% Similarity=0.455 Sum_probs=201.5
Q ss_pred cCcccceEEeccCcEEEEEEEcCC-----CcEEEEEEcccCCc-hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLPE-----GKVVAVKQLKSGSG-QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLL 433 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~~-----g~~VAvK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 433 (723)
++|.+.++||+|+||.||+|.+.. +..||||+++.... ....+|.+|++++++|+|+||+++++++.+.+..+|
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 467888999999999999996543 23599999986533 334578999999999999999999999999999999
Q ss_pred EEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCC
Q 046750 434 IYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDT 513 (723)
Q Consensus 434 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 513 (723)
||||+.+++|.+++.... ..+++..++.|+.||++||+|||++ +|+|||||++||||+.++.+||+|||+++....
T Consensus 124 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 199 (333)
T 1mqb_A 124 ITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 199 (333)
T ss_dssp EEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence 999999999999997643 3588999999999999999999999 499999999999999999999999999986654
Q ss_pred CCcce--eecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCc
Q 046750 514 TQTHV--STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDL 590 (723)
Q Consensus 514 ~~~~~--~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l 590 (723)
..... .....++..|+|||++.+..++.++|||||||+||||++ |+.||..... .. +.+.+..+..
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~---~~--------~~~~~~~~~~ 268 (333)
T 1mqb_A 200 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN---HE--------VMKAINDGFR 268 (333)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HH--------HHHHHHTTCC
T ss_pred ccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH---HH--------HHHHHHCCCc
Confidence 32211 222346788999999999999999999999999999999 9999965421 11 1122222211
Q ss_pred ccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCCC
Q 046750 591 SEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEM 641 (723)
Q Consensus 591 ~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~~ 641 (723)
... .......+.+|+.+||+.+|.+||++.+|++.|+.+...
T Consensus 269 ~~~---------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 269 LPT---------PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp CCC---------CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CCC---------cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 110 111233678999999999999999999999999887654
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=356.71 Aligned_cols=266 Identities=21% Similarity=0.297 Sum_probs=201.4
Q ss_pred hcCcccc-eEEeccCcEEEEEEEc-CCCcEEEEEEcccCCchhHHHHHHHHHHHHHc-cCCceeeEeeeeecccceEEEE
Q 046750 359 TNGFARE-NVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQGEREFRAEVEIISRV-HHRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 359 ~~~f~~~-~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~ 435 (723)
.+.|.+. ++||+|+||.||+|.. .+++.||||+++.........+.+|+++|.++ +|+||+++++++.+.+..|+||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 3567774 7899999999999964 57899999999876656667899999999995 7999999999999999999999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCc---EEEeecccccccC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFE---AQVADFGLAKLND 512 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~---vkL~DFGla~~~~ 512 (723)
||+.+++|.+++.... .+++..++.|+.||+.||+|||++ +|+|||||++||||+.++. +||+|||++....
T Consensus 91 e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 91 EKMRGGSILSHIHKRR--HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp ECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred EcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 9999999999997653 478899999999999999999999 5999999999999998766 9999999997553
Q ss_pred CCCc------ceeecccccccccChhhhcc-----CCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhh----HHhh
Q 046750 513 TTQT------HVSTRVMGTFGYLAPEYASS-----GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESL----VEWA 577 (723)
Q Consensus 513 ~~~~------~~~~~~~gt~~y~APE~~~~-----~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l----~~~~ 577 (723)
.... .......|+..|+|||++.+ ..++.++|||||||+||||++|+.||........... ..-.
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 245 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence 2211 11223469999999999975 5588999999999999999999999976543211000 0000
Q ss_pred hhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 046750 578 RPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRAL 635 (723)
Q Consensus 578 ~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L 635 (723)
...+.+.+..+.+. +.+. .... ....+.+|+.+||+.||.+||++.||++.-
T Consensus 246 ~~~~~~~i~~~~~~-~~~~-~~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 297 (316)
T 2ac3_A 246 QNMLFESIQEGKYE-FPDK-DWAH----ISCAAKDLISKLLVRDAKQRLSAAQVLQHP 297 (316)
T ss_dssp HHHHHHHHHHCCCC-CCHH-HHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHHST
T ss_pred HHHHHHHHhccCcc-cCch-hccc----CCHHHHHHHHHHhhCChhhCCCHHHHhcCh
Confidence 11122333333221 1110 0011 123678999999999999999999999853
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=356.19 Aligned_cols=254 Identities=24% Similarity=0.314 Sum_probs=206.6
Q ss_pred HhcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCch------hHHHHHHHHHHHHHccCCceeeEeeeeecccc
Q 046750 358 ITNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQ------GEREFRAEVEIISRVHHRHLVSLVGYCISEKN 430 (723)
Q Consensus 358 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~------~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 430 (723)
+.++|.+.+.||+|+||.||+|.. .+|+.||||+++..... ..+.+.+|+++|++++|+||+++++++.+...
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 456799999999999999999965 46899999998764322 35679999999999999999999999999999
Q ss_pred eEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCC----cEEEeecc
Q 046750 431 RLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEF----EAQVADFG 506 (723)
Q Consensus 431 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~----~vkL~DFG 506 (723)
.++||||+.+++|.+++.... .+++..++.++.||+.||+|||++ +|+|||||++||||++++ .+||+|||
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTCS--CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 999999999999999997643 489999999999999999999999 599999999999999887 79999999
Q ss_pred cccccCCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhh
Q 046750 507 LAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIE 586 (723)
Q Consensus 507 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~ 586 (723)
++........ .....|+..|+|||++.+..++.++|||||||+||||++|+.||..... ... ...+.
T Consensus 165 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~--------~~~i~ 231 (321)
T 2a2a_A 165 LAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---QET--------LANIT 231 (321)
T ss_dssp TCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH---HHH--------HHHHH
T ss_pred cceecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH---HHH--------HHHHH
Confidence 9986654322 2345689999999999999999999999999999999999999975431 111 11111
Q ss_pred cCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 046750 587 TGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRAL 635 (723)
Q Consensus 587 ~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L 635 (723)
.+.. ..+..+...+ ...+.+++.+||+.||.+||++.||++.-
T Consensus 232 ~~~~--~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~e~l~hp 274 (321)
T 2a2a_A 232 SVSY--DFDEEFFSHT----SELAKDFIRKLLVKETRKRLTIQEALRHP 274 (321)
T ss_dssp TTCC--CCCHHHHTTC----CHHHHHHHHTTSCSSTTTSCCHHHHHHST
T ss_pred hccc--ccChhhhccc----CHHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence 1111 0111111122 23578899999999999999999999753
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=365.02 Aligned_cols=248 Identities=21% Similarity=0.300 Sum_probs=201.6
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCC---chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS---GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 435 (723)
++|.+.+.||+|+||.||+|.. .+++.||||++.... ......+.+|+++|++++|+||++++++|.+....++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5799999999999999999964 678999999986431 122357889999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ 515 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 515 (723)
||+ +|+|.+++.... .+.+..++.|+.||+.||+|||++ +|+|||||++||||++++.+||+|||++.......
T Consensus 89 E~~-~g~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 89 EYA-GGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp CCC-CEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred ECC-CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence 999 789998886554 388999999999999999999999 49999999999999999999999999998665433
Q ss_pred cceeecccccccccChhhhccCCC-CCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCccccc
Q 046750 516 THVSTRVMGTFGYLAPEYASSGKL-TDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIV 594 (723)
Q Consensus 516 ~~~~~~~~gt~~y~APE~~~~~~~-t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~v 594 (723)
. ....+|+..|+|||++.+..+ +.++|||||||+||||++|+.||+...... +.+.+..+..
T Consensus 163 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~-----------~~~~i~~~~~---- 225 (336)
T 3h4j_B 163 F--LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN-----------LFKKVNSCVY---- 225 (336)
T ss_dssp T--TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT-----------CBCCCCSSCC----
T ss_pred c--cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH-----------HHHHHHcCCC----
Confidence 2 234569999999999988776 689999999999999999999997543211 1111111111
Q ss_pred chhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 046750 595 DPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALD 636 (723)
Q Consensus 595 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~ 636 (723)
.........+.+|+.+||+.||.+||++.||++.-+
T Consensus 226 ------~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 261 (336)
T 3h4j_B 226 ------VMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPW 261 (336)
T ss_dssp ------CCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHH
T ss_pred ------CCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChh
Confidence 001111235778999999999999999999987543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-42 Score=378.35 Aligned_cols=262 Identities=22% Similarity=0.226 Sum_probs=205.4
Q ss_pred HHHHHHHhcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCc---hhHHHHHHHHHHHHHccCCceeeEeeeeec
Q 046750 352 YEELMEITNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSG---QGEREFRAEVEIISRVHHRHLVSLVGYCIS 427 (723)
Q Consensus 352 ~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~ 427 (723)
++++....++|++.++||+|+||.||+++. .+|+.||||+++.... ...+.+++|+++|.+++|+||++++++|.+
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 344444568899999999999999999965 4689999999975321 222358899999999999999999999999
Q ss_pred ccceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeeccc
Q 046750 428 EKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGL 507 (723)
Q Consensus 428 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGl 507 (723)
.+..||||||+.+|+|.++|.+.+. .+++..++.++.||+.||+|||++ +|||||||++||||+.++++||+|||+
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGl 208 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKFGE-RIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGS 208 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHSS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CCEEEEEEcCCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechh
Confidence 9999999999999999999976432 488899999999999999999999 599999999999999999999999999
Q ss_pred ccccCCCCcceeecccccccccChhhhc-------cCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhh
Q 046750 508 AKLNDTTQTHVSTRVMGTFGYLAPEYAS-------SGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPV 580 (723)
Q Consensus 508 a~~~~~~~~~~~~~~~gt~~y~APE~~~-------~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~ 580 (723)
++.............+||..|+|||++. ...|+.++||||||||||||++|+.||..... . +....+
T Consensus 209 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~---~---~~~~~i 282 (412)
T 2vd5_A 209 CLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST---A---ETYGKI 282 (412)
T ss_dssp CEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH---H---HHHHHH
T ss_pred heeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH---H---HHHHHH
Confidence 9876554443344567999999999997 35689999999999999999999999975432 1 111101
Q ss_pred hhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCC---CCHHHHHHH
Q 046750 581 LVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKR---PRMVQVVRA 634 (723)
Q Consensus 581 l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~R---Ps~~eVl~~ 634 (723)
+ +....-.+ +.+...+ ...+.+|+.+||. +|.+| +++.||+++
T Consensus 283 ~-~~~~~~~~-----p~~~~~~----s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 283 V-HYKEHLSL-----PLVDEGV----PEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp H-THHHHCCC-----C----CC----CHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred H-hcccCcCC-----CccccCC----CHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 1 00000000 0111111 2367889999999 99998 589998764
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=357.99 Aligned_cols=260 Identities=22% Similarity=0.283 Sum_probs=199.0
Q ss_pred hcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCc---hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEE
Q 046750 359 TNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSG---QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLI 434 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 434 (723)
.++|++.++||+|+||.||+|.. .+++.||||+++.... ...+.+.+|++++++++|+||+++++++.+.+..|+|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 47899999999999999999965 4688999999975422 2236788999999999999999999999999999999
Q ss_pred EEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCC
Q 046750 435 YEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTT 514 (723)
Q Consensus 435 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 514 (723)
|||+.+++|.+++.... .+++..++.|+.||++||+|||++ +|+|||||++||||+.++.+||+|||++......
T Consensus 113 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred EEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 99999999999997644 488999999999999999999999 5999999999999999999999999999866544
Q ss_pred CcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCccccc
Q 046750 515 QTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIV 594 (723)
Q Consensus 515 ~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~v 594 (723)
.........|+..|+|||++.+..++.++|||||||+||||++|+.||..... . . +...+... ....
T Consensus 188 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~---~----~~~~~~~~-~~~~- 254 (309)
T 2h34_A 188 KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL----S---V----MGAHINQA-IPRP- 254 (309)
T ss_dssp ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH----H---H----HHHHHHSC-CCCG-
T ss_pred ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH----H---H----HHHHhccC-CCCc-
Confidence 33333455689999999999999999999999999999999999999975321 1 1 11111111 1100
Q ss_pred chhhhccccHHHHHHHHHHHHHHhccCCCCCC-CHHHHHHHHhccCCC
Q 046750 595 DPRLEKHYVESEMFRMIEAAAACVRHSGPKRP-RMVQVVRALDSEGEM 641 (723)
Q Consensus 595 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~eVl~~L~~~~~~ 641 (723)
..+...+ ...+.+++.+||+.||.+|| ++.+|++.|+.....
T Consensus 255 -~~~~~~~----~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~ 297 (309)
T 2h34_A 255 -STVRPGI----PVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT 297 (309)
T ss_dssp -GGTSTTC----CTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred -cccCCCC----CHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence 0111111 23678899999999999999 999999999987654
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=366.76 Aligned_cols=256 Identities=25% Similarity=0.314 Sum_probs=204.6
Q ss_pred cCcccceEEeccCcEEEEEEEc----CCCcEEEEEEcccCC----chhHHHHHHHHHHHHHc-cCCceeeEeeeeecccc
Q 046750 360 NGFARENVIGEGGFGCVYKGNL----PEGKVVAVKQLKSGS----GQGEREFRAEVEIISRV-HHRHLVSLVGYCISEKN 430 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~----~~g~~VAvK~l~~~~----~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~ 430 (723)
++|++.++||+|+||.||+|+. .+++.||||+++... ....+.+.+|+++|+++ +|+||+++++++.....
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 5799999999999999999966 468999999987532 12335677899999999 69999999999999999
Q ss_pred eEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccc
Q 046750 431 RLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKL 510 (723)
Q Consensus 431 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 510 (723)
.+|||||+.+++|.++|.... .+.+..++.++.||++||+|||++ +|+|||||++||||+.++.+||+|||+++.
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred EEEEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 999999999999999997644 488899999999999999999999 599999999999999999999999999986
Q ss_pred cCCCCcceeecccccccccChhhhccC--CCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcC
Q 046750 511 NDTTQTHVSTRVMGTFGYLAPEYASSG--KLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETG 588 (723)
Q Consensus 511 ~~~~~~~~~~~~~gt~~y~APE~~~~~--~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~ 588 (723)
+............||..|+|||++.++ .++.++||||||||||||++|+.||........ ...+.. .+...
T Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~~~~-----~~~~~ 281 (355)
T 1vzo_A 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--QAEISR-----RILKS 281 (355)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC--HHHHHH-----HHHHC
T ss_pred cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch--HHHHHH-----HHhcc
Confidence 654444444456799999999999863 478999999999999999999999975443211 111111 11111
Q ss_pred CcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHHHhc
Q 046750 589 DLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRP-----RMVQVVRALDS 637 (723)
Q Consensus 589 ~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~eVl~~L~~ 637 (723)
.. .+.......+.+|+.+||..||.+|| ++.||++.+.-
T Consensus 282 ~~----------~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f 325 (355)
T 1vzo_A 282 EP----------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 325 (355)
T ss_dssp CC----------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGG
T ss_pred CC----------CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcch
Confidence 10 11111223578899999999999999 99999887643
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=349.12 Aligned_cols=264 Identities=20% Similarity=0.283 Sum_probs=201.7
Q ss_pred HHhcCcccceEEeccCcEEEEEEE-cCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeee-ecccceEEE
Q 046750 357 EITNGFARENVIGEGGFGCVYKGN-LPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYC-ISEKNRLLI 434 (723)
Q Consensus 357 ~~~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~-~~~~~~~lV 434 (723)
.+.++|++.+.||+|+||.||+|. ..+++.||||++.... ....+.+|++++++++|+|++..++++ .+....++|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 456889999999999999999996 4678999999876542 223588899999999988776666655 566778999
Q ss_pred EEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEe---CCCCcEEEeeccccccc
Q 046750 435 YEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILV---DDEFEAQVADFGLAKLN 511 (723)
Q Consensus 435 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl---~~~~~vkL~DFGla~~~ 511 (723)
|||+ +++|.+++..... .+++..++.|+.||+.||+|||++ +|+|||||++|||| ++++.+||+|||+++..
T Consensus 84 ~e~~-~~~L~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFCSR-KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EECC-CCBHHHHHHHTTS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred EEcc-CCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 9999 9999999875433 488999999999999999999999 59999999999999 78899999999999876
Q ss_pred CCCCcc------eeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhh
Q 046750 512 DTTQTH------VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAI 585 (723)
Q Consensus 512 ~~~~~~------~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i 585 (723)
...... ......|+..|+|||++.+..++.++|||||||+||||++|+.||................ ...+
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~---~~~~ 235 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS---EKKM 235 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHH---HHHH
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhh---cccc
Confidence 544321 1234578999999999999999999999999999999999999997654322211111110 0000
Q ss_pred hcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCC
Q 046750 586 ETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGE 640 (723)
Q Consensus 586 ~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~ 640 (723)
. ... ..+...+ ...+.+|+.+||+.||.+||++.+|++.|+.+..
T Consensus 236 ~-~~~-----~~~~~~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~ 280 (296)
T 4hgt_A 236 S-TPI-----EVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp H-SCH-----HHHTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred c-chh-----hhhhccC----CHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence 0 000 0111111 2368899999999999999999999999988654
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=365.20 Aligned_cols=249 Identities=24% Similarity=0.339 Sum_probs=202.2
Q ss_pred hcCcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCC---chhHHHHHHHHHHHHHc-cCCceeeEeeeeecccceEE
Q 046750 359 TNGFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGS---GQGEREFRAEVEIISRV-HHRHLVSLVGYCISEKNRLL 433 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~---~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~l 433 (723)
.++|++.++||+|+||.||+|+.+ +++.||||+++... ....+.+..|.++|..+ +|+||+++++++.+.+..||
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 467999999999999999999665 47899999997531 23345688899999988 89999999999999999999
Q ss_pred EEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCC
Q 046750 434 IYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDT 513 (723)
Q Consensus 434 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 513 (723)
||||+.+|+|.+++...+ .+++..++.++.||+.||+|||++ +|||||||++||||+.++.+||+|||+++....
T Consensus 99 v~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp EEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 999999999999997644 388899999999999999999999 599999999999999999999999999985432
Q ss_pred CCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccc
Q 046750 514 TQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEI 593 (723)
Q Consensus 514 ~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~ 593 (723)
... .....+||..|+|||++.+..++.++|||||||+||||++|+.||..... . + +.+.+..+.+.
T Consensus 174 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~---~---~-----~~~~i~~~~~~-- 239 (353)
T 2i0e_A 174 DGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---D---E-----LFQSIMEHNVA-- 239 (353)
T ss_dssp TTC-CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH---H---H-----HHHHHHHCCCC--
T ss_pred CCc-ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH---H---H-----HHHHHHhCCCC--
Confidence 222 23446799999999999999999999999999999999999999975431 1 1 11222222211
Q ss_pred cchhhhccccHHHHHHHHHHHHHHhccCCCCCCC-----HHHHHHH
Q 046750 594 VDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPR-----MVQVVRA 634 (723)
Q Consensus 594 vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~eVl~~ 634 (723)
+.......+.+|+.+||+.||.+|++ +.+|++.
T Consensus 240 --------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 240 --------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp --------CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred --------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 11112236788999999999999995 5777654
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=361.98 Aligned_cols=252 Identities=20% Similarity=0.269 Sum_probs=192.7
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEec
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFV 438 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 438 (723)
++|.+.++||+|+||.||+++. .+++.||||++.... ...+.+++|+.++++|+|+||++++++|.+....++||||+
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 98 (361)
T 3uc3_A 20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA 98 (361)
T ss_dssp TTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeC
Confidence 5799999999999999999965 478999999997643 33467889999999999999999999999999999999999
Q ss_pred CCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCc--EEEeecccccccCCCCc
Q 046750 439 PNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFE--AQVADFGLAKLNDTTQT 516 (723)
Q Consensus 439 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~--vkL~DFGla~~~~~~~~ 516 (723)
.+|+|.+++...+ .+.+..++.|+.||+.||+|||++ +|+|||||++||||+.++. +||+|||+++......
T Consensus 99 ~~~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~- 172 (361)
T 3uc3_A 99 SGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 172 (361)
T ss_dssp CSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccccC-
Confidence 9999999987544 388999999999999999999999 5999999999999987765 9999999997433221
Q ss_pred ceeecccccccccChhhhccCCCCCc-cceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccc
Q 046750 517 HVSTRVMGTFGYLAPEYASSGKLTDR-SDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVD 595 (723)
Q Consensus 517 ~~~~~~~gt~~y~APE~~~~~~~t~k-sDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd 595 (723)
......||..|+|||++.+..+..+ +|||||||+||||++|+.||........ +.... +.+....+....+
T Consensus 173 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~~~-----~~~~~~~~~~~~~ 244 (361)
T 3uc3_A 173 -QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD--YRKTI-----QRILSVKYSIPDD 244 (361)
T ss_dssp ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC--HHHHH-----HHHHTTCCCCCTT
T ss_pred -CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH--HHHHH-----HHHhcCCCCCCCc
Confidence 2234569999999999988888766 8999999999999999999976543211 11111 1111111100000
Q ss_pred hhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 596 PRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 596 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
..+ ...+.+|+.+||+.||.+||++.||++.
T Consensus 245 ----~~~----s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 245 ----IRI----SPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp ----SCC----CHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ----CCC----CHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 011 2357889999999999999999999975
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=362.61 Aligned_cols=256 Identities=27% Similarity=0.452 Sum_probs=198.9
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCc----EEEEEEcccC-CchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGK----VVAVKQLKSG-SGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLL 433 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~----~VAvK~l~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 433 (723)
++|++.++||+|+||.||+|.+ .+++ .||+|.++.. .....+.+.+|+.+|++++|+||++++++|.... .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 5799999999999999999964 3444 3678877654 3345678999999999999999999999998754 789
Q ss_pred EEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCC
Q 046750 434 IYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDT 513 (723)
Q Consensus 434 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 513 (723)
|+||+.+|+|.+++..... .+.+..++.|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++....
T Consensus 94 v~~~~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~ 169 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EECCCSSCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred EEEecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence 9999999999999976433 488899999999999999999999 599999999999999999999999999986643
Q ss_pred CCcc-eeecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcc
Q 046750 514 TQTH-VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLS 591 (723)
Q Consensus 514 ~~~~-~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~ 591 (723)
.... ......++..|+|||++.+..++.++|||||||+||||++ |+.||...... .+ .+.+..+...
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~--------~~~~~~~~~~ 238 (327)
T 3lzb_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EI--------SSILEKGERL 238 (327)
T ss_dssp ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GH--------HHHHHTTCCC
T ss_pred ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH---HH--------HHHHHcCCCC
Confidence 3222 2233456789999999999999999999999999999999 99999765321 11 1122222111
Q ss_pred cccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCC
Q 046750 592 EIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGE 640 (723)
Q Consensus 592 ~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~ 640 (723)
.. .......+.+|+.+||+.||.+||++.||++.|+.+..
T Consensus 239 ~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 239 PQ---------PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp CC---------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred CC---------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 11 11122357889999999999999999999999988664
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=367.34 Aligned_cols=274 Identities=21% Similarity=0.282 Sum_probs=211.4
Q ss_pred cCcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCC-chhHHHHHHHHHHHHHccCCceeeEeeeeeccc--ceEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGS-GQGEREFRAEVEIISRVHHRHLVSLVGYCISEK--NRLLIY 435 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~--~~~lV~ 435 (723)
++|.+.++||+|+||.||+|... +|+.||||+++... ....+.+.+|+++|++|+|+||+++++++.+.. ..+|||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 67999999999999999999654 58999999997543 233467889999999999999999999998765 679999
Q ss_pred EecCCCchhhccccCCC-CcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEe----CCCCcEEEeecccccc
Q 046750 436 EFVPNNNLEHHLHGKGQ-PVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILV----DDEFEAQVADFGLAKL 510 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl----~~~~~vkL~DFGla~~ 510 (723)
||+.+|+|.+++..... ..+.+..++.|+.||+.||+|||++ +|+|||||++|||| +.++.+||+|||+++.
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 99999999999976432 2389999999999999999999999 59999999999999 7888899999999987
Q ss_pred cCCCCcceeecccccccccChhhhcc--------CCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhh
Q 046750 511 NDTTQTHVSTRVMGTFGYLAPEYASS--------GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLV 582 (723)
Q Consensus 511 ~~~~~~~~~~~~~gt~~y~APE~~~~--------~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~ 582 (723)
...... .....|+..|+|||++.+ ..++.++|||||||+||||++|+.||......... .+....++.
T Consensus 166 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~--~~~~~~~~~ 241 (396)
T 4eut_A 166 LEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYKIIT 241 (396)
T ss_dssp CCCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC--HHHHHHHHH
T ss_pred ccCCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch--HHHHHHHhc
Confidence 654332 234569999999999875 56788999999999999999999999654321111 111111110
Q ss_pred hhhhcCCcccc---c--------chhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCCC
Q 046750 583 RAIETGDLSEI---V--------DPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEM 641 (723)
Q Consensus 583 ~~i~~~~l~~~---v--------d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~~ 641 (723)
. .....+..+ . +-.....+.......+.+++.+||+.||++|+++.|+++.|+.+...
T Consensus 242 ~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 242 G-KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp S-CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred C-CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 0 000000000 0 00111233456667888999999999999999999999999887654
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=387.76 Aligned_cols=253 Identities=25% Similarity=0.404 Sum_probs=200.9
Q ss_pred cccce-EEeccCcEEEEEEEcC---CCcEEEEEEcccCCc-hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEE
Q 046750 362 FAREN-VIGEGGFGCVYKGNLP---EGKVVAVKQLKSGSG-QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYE 436 (723)
Q Consensus 362 f~~~~-~LG~G~fG~Vy~~~~~---~g~~VAvK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 436 (723)
|.+.+ .||+|+||.||+|.+. ++..||||+++.... ...++|.+|+++|++|+|+|||+++++|.+ +..+||||
T Consensus 337 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E 415 (613)
T 2ozo_A 337 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVME 415 (613)
T ss_dssp EEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEE
T ss_pred eeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEE
Confidence 44444 7999999999999653 456799999987533 355789999999999999999999999976 56899999
Q ss_pred ecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCc
Q 046750 437 FVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQT 516 (723)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 516 (723)
|+.+|+|.++|.... ..+.+..++.|+.||++||+|||++ +|||||||++||||++++.+||+|||+++.......
T Consensus 416 ~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~ 491 (613)
T 2ozo_A 416 MAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS 491 (613)
T ss_dssp CCTTCBHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----
T ss_pred eCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCc
Confidence 999999999997543 3588999999999999999999999 599999999999999999999999999987654332
Q ss_pred cee--ecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccc
Q 046750 517 HVS--TRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEI 593 (723)
Q Consensus 517 ~~~--~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~ 593 (723)
... ....++..|+|||++.++.++.++|||||||+||||++ |+.||..... .. +.+.+..+....+
T Consensus 492 ~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~---~~--------~~~~i~~~~~~~~ 560 (613)
T 2ozo_A 492 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PE--------VMAFIEQGKRMEC 560 (613)
T ss_dssp ----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS---HH--------HHHHHHTTCCCCC
T ss_pred eeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH---HH--------HHHHHHcCCCCCC
Confidence 222 22235689999999999999999999999999999998 9999976542 11 1222333321111
Q ss_pred cchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccC
Q 046750 594 VDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEG 639 (723)
Q Consensus 594 vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~ 639 (723)
.......+.+|+.+||+.+|.+||++.+|++.|+...
T Consensus 561 ---------p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 597 (613)
T 2ozo_A 561 ---------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 597 (613)
T ss_dssp ---------CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ---------CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 1122346889999999999999999999999998754
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=362.40 Aligned_cols=268 Identities=26% Similarity=0.395 Sum_probs=208.8
Q ss_pred hcCcccceEEeccCcEEEEEEEc-----CCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeeccc--ce
Q 046750 359 TNGFARENVIGEGGFGCVYKGNL-----PEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEK--NR 431 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~-----~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~--~~ 431 (723)
.++|++.++||+|+||.||+|++ .+++.||||+++.......+.|.+|+++|++|+|+||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 35689999999999999999973 468899999998876667778999999999999999999999987654 68
Q ss_pred EEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeeccccccc
Q 046750 432 LLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLN 511 (723)
Q Consensus 432 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 511 (723)
++||||+.+++|.+++..... .+++..++.++.||++||+|||++ +|+|||||++||||+.++.+||+|||+++..
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVL 195 (326)
T ss_dssp EEEECCCTTCBHHHHHHHSTT-SSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEECCCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence 999999999999999976532 488999999999999999999999 5999999999999999999999999999876
Q ss_pred CCCCcce--eecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCC-----CchhhHHhhhhhhhhh
Q 046750 512 DTTQTHV--STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPL-----GDESLVEWARPVLVRA 584 (723)
Q Consensus 512 ~~~~~~~--~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~-----~~~~l~~~~~~~l~~~ 584 (723)
....... .....++..|+|||++.+..++.++|||||||+||||++|+.+|...... .......+....+.+.
T Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (326)
T 2w1i_A 196 PQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 275 (326)
T ss_dssp CSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred cccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHH
Confidence 5443321 22345678899999999988999999999999999999999887532100 0000000111111122
Q ss_pred hhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccC
Q 046750 585 IETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEG 639 (723)
Q Consensus 585 i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~ 639 (723)
+..+... .........+.+|+.+||+.||.+||++.+|++.|+.+.
T Consensus 276 ~~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 276 LKNNGRL---------PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp HHTTCCC---------CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhcCCCC---------CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 2221111 111122346889999999999999999999999998754
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=348.58 Aligned_cols=256 Identities=25% Similarity=0.401 Sum_probs=206.5
Q ss_pred cCcccce-EEeccCcEEEEEEEcC---CCcEEEEEEcccCCc-hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEE
Q 046750 360 NGFAREN-VIGEGGFGCVYKGNLP---EGKVVAVKQLKSGSG-QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLI 434 (723)
Q Consensus 360 ~~f~~~~-~LG~G~fG~Vy~~~~~---~g~~VAvK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 434 (723)
++|.+.+ .||+|+||.||+|.+. +++.||||+++.... ...+.+.+|+++|++|+|+||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4566666 9999999999999643 577899999987533 3456789999999999999999999999 45668999
Q ss_pred EEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCC
Q 046750 435 YEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTT 514 (723)
Q Consensus 435 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 514 (723)
|||+.+++|.+++.... ..+++..++.++.||+.||.|||++ +|+|||||++||||+.++.+||+|||+++.....
T Consensus 88 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 163 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 163 (287)
T ss_dssp EECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEeCCCCCHHHHHHhCC-ccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence 99999999999996543 3488999999999999999999999 5999999999999999999999999999876543
Q ss_pred Ccce--eecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcc
Q 046750 515 QTHV--STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLS 591 (723)
Q Consensus 515 ~~~~--~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~ 591 (723)
.... .....++..|+|||++.+..++.++|||||||+||||++ |+.||..... ..+ ...+..+...
T Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~--------~~~i~~~~~~ 232 (287)
T 1u59_A 164 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEV--------MAFIEQGKRM 232 (287)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT---HHH--------HHHHHTTCCC
T ss_pred cceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH---HHH--------HHHHhcCCcC
Confidence 3322 122346889999999998899999999999999999998 9999976432 111 1222222211
Q ss_pred cccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCC
Q 046750 592 EIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGE 640 (723)
Q Consensus 592 ~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~ 640 (723)
.+ .......+.+++.+||+.+|.+||++.+|++.|+.+..
T Consensus 233 ~~---------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 272 (287)
T 1u59_A 233 EC---------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 272 (287)
T ss_dssp CC---------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CC---------CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11 11223468899999999999999999999999988654
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=351.06 Aligned_cols=262 Identities=21% Similarity=0.349 Sum_probs=206.3
Q ss_pred hcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCC--chhHHHHHHHHHHHHHccCCceeeEeeeeec--ccceEE
Q 046750 359 TNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS--GQGEREFRAEVEIISRVHHRHLVSLVGYCIS--EKNRLL 433 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~~~l 433 (723)
.++|++.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|++++++++|+||++++++|.+ ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 36799999999999999999965 468999999997543 2344678999999999999999999998854 567899
Q ss_pred EEEecCCCchhhccccC--CCCcchHHHHHHHHHHHHhhhchhcccC--CCceeecCCCCCcEEeCCCCcEEEeeccccc
Q 046750 434 IYEFVPNNNLEHHLHGK--GQPVLEWTKRVKIALGAAKGLAYLHEDC--HPKIIHRDIKSANILVDDEFEAQVADFGLAK 509 (723)
Q Consensus 434 V~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~g--~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 509 (723)
||||+.+++|.+++... ....+++..++.|+.||+.||+|||+++ ...|+|||||++||||+.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 99999999999998653 2334889999999999999999999983 1129999999999999999999999999998
Q ss_pred ccCCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCC
Q 046750 510 LNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGD 589 (723)
Q Consensus 510 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~ 589 (723)
....... ......|+..|+|||++.+..++.++|||||||+||||++|+.||..... .. +...+..+.
T Consensus 165 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~--------~~~~i~~~~ 232 (279)
T 2w5a_A 165 ILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KE--------LAGKIREGK 232 (279)
T ss_dssp HC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HH--------HHHHHHHTC
T ss_pred eeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH---HH--------HHHHHhhcc
Confidence 6543322 12234689999999999999999999999999999999999999975431 11 122233333
Q ss_pred cccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCCC
Q 046750 590 LSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEM 641 (723)
Q Consensus 590 l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~~ 641 (723)
+..+. ..+ ...+.+++.+||+.||.+||++.||++.++.....
T Consensus 233 ~~~~~-----~~~----~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~ 275 (279)
T 2w5a_A 233 FRRIP-----YRY----SDELNEIITRMLNLKDYHRPSVEEILENPLILEHH 275 (279)
T ss_dssp CCCCC-----TTS----CHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred cccCC-----ccc----CHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence 32211 112 23678899999999999999999999988765443
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=356.82 Aligned_cols=261 Identities=24% Similarity=0.355 Sum_probs=203.3
Q ss_pred hcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeee----cccceEE
Q 046750 359 TNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCI----SEKNRLL 433 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~----~~~~~~l 433 (723)
.++|++.++||+|+||.||+++. .+++.||||++........+.+.+|++++++++|+||+++++++. .....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 36799999999999999999965 678999999997766566678999999999999999999999987 3446789
Q ss_pred EEEecCCCchhhccccC--CCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeeccccccc
Q 046750 434 IYEFVPNNNLEHHLHGK--GQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLN 511 (723)
Q Consensus 434 V~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 511 (723)
||||+.+|+|.+++... ....+++..++.|+.||++||+|||++ +|+|||||++||||+.++.+||+|||++...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 99999999999998652 234588999999999999999999999 5999999999999999999999999998754
Q ss_pred CCCCcc--------eeecccccccccChhhhccCC---CCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhh
Q 046750 512 DTTQTH--------VSTRVMGTFGYLAPEYASSGK---LTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPV 580 (723)
Q Consensus 512 ~~~~~~--------~~~~~~gt~~y~APE~~~~~~---~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~ 580 (723)
...... ......|+..|+|||++.+.. ++.++|||||||+||||++|+.||.........
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--------- 255 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS--------- 255 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC---------
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch---------
Confidence 321110 012235799999999987554 788999999999999999999998532110000
Q ss_pred hhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCC
Q 046750 581 LVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGE 640 (723)
Q Consensus 581 l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~ 640 (723)
+...+.. .+. + .........+.+++.+||+.||.+||++.+|++.|+.+..
T Consensus 256 ~~~~~~~-~~~-~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 256 VALAVQN-QLS-I-------PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp HHHHHHC-C---C-------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred hhHHhhc-cCC-C-------CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 0011111 000 0 0011112368899999999999999999999999998654
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=363.18 Aligned_cols=263 Identities=17% Similarity=0.234 Sum_probs=206.1
Q ss_pred cCcccceEEeccCcEEEEEEEcCC---------CcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceee----------
Q 046750 360 NGFARENVIGEGGFGCVYKGNLPE---------GKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVS---------- 420 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~~---------g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~---------- 420 (723)
++|.+.++||+|+||.||+|.... ++.||||++... +.+.+|++++++++|+||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 579999999999999999997653 789999999754 46889999999999999987
Q ss_pred -----Eeeeeec-ccceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEe
Q 046750 421 -----LVGYCIS-EKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILV 494 (723)
Q Consensus 421 -----l~g~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl 494 (723)
+++++.. ....||||||+ +++|.+++.......+++..++.|+.||+.||+|||++ +|+|||||++||||
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFV 192 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEEE
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEE
Confidence 5667765 67789999999 99999999876445689999999999999999999999 59999999999999
Q ss_pred CCCC--cEEEeecccccccCCCCcc------eeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCC
Q 046750 495 DDEF--EAQVADFGLAKLNDTTQTH------VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQ 566 (723)
Q Consensus 495 ~~~~--~vkL~DFGla~~~~~~~~~------~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~ 566 (723)
+.++ .+||+|||+++.+...... ......|+..|+|||++.+..++.++|||||||+||||++|+.||....
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 9998 9999999999866533221 1133479999999999999999999999999999999999999997653
Q ss_pred CCCchhhHHhhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCCC
Q 046750 567 PLGDESLVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEM 641 (723)
Q Consensus 567 ~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~~ 641 (723)
.. ...+..+.. .+ ......+.+....... ....+.+|+.+||+.||.+||++.+|++.|+.+...
T Consensus 273 ~~-~~~~~~~~~-----~~-~~~~~~~~~~~~~~~~---~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 337 (352)
T 2jii_A 273 PN-TEDIMKQKQ-----KF-VDKPGPFVGPCGHWIR---PSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQD 337 (352)
T ss_dssp TC-HHHHHHHHH-----HH-HHSCCCEECTTSCEEC---CCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred cC-HHHHHHHHH-----hc-cCChhhhhhhccccCC---CcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHh
Confidence 21 111211111 11 1112222222211111 123688899999999999999999999999887644
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=360.15 Aligned_cols=250 Identities=15% Similarity=0.168 Sum_probs=202.0
Q ss_pred cCcccceEEeccCcEEEEEE------EcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHcc---CCceeeEeeeeecccc
Q 046750 360 NGFARENVIGEGGFGCVYKG------NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVH---HRHLVSLVGYCISEKN 430 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~------~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~g~~~~~~~ 430 (723)
++|.+.++||+|+||.||+| ....++.||||+++.. ...++..|++++++|+ |+||+++++++...+.
T Consensus 65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~ 141 (365)
T 3e7e_A 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNG 141 (365)
T ss_dssp SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSC
T ss_pred EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCC
Confidence 67999999999999999999 3556889999999764 3457888999998886 9999999999999999
Q ss_pred eEEEEEecCCCchhhccccC---CCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCC-----------
Q 046750 431 RLLIYEFVPNNNLEHHLHGK---GQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDD----------- 496 (723)
Q Consensus 431 ~~lV~E~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~----------- 496 (723)
.||||||+.+|+|.++++.. ....+++..++.|+.||++||+|||++ +|||||||++||||+.
T Consensus 142 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~~ 218 (365)
T 3e7e_A 142 SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDL 218 (365)
T ss_dssp EEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC------
T ss_pred cEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccccccc
Confidence 99999999999999999642 234589999999999999999999998 5999999999999998
Q ss_pred CCcEEEeecccccccCC-CCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHH
Q 046750 497 EFEAQVADFGLAKLNDT-TQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVE 575 (723)
Q Consensus 497 ~~~vkL~DFGla~~~~~-~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~ 575 (723)
++.+||+|||+++.... .........+||..|+|||++.+..++.++||||||||||||++|+.||...... .
T Consensus 219 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------~ 292 (365)
T 3e7e_A 219 SAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG------E 292 (365)
T ss_dssp CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT------E
T ss_pred cCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC------c
Confidence 89999999999975432 2223345567999999999999999999999999999999999999998543211 0
Q ss_pred hhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCC-CCHHHHHHHHhccCC
Q 046750 576 WARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKR-PRMVQVVRALDSEGE 640 (723)
Q Consensus 576 ~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~R-Ps~~eVl~~L~~~~~ 640 (723)
|. ++..+..... ...+.+++..||+.++.+| +++.++.+.|+....
T Consensus 293 ~~----------------~~~~~~~~~~---~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~ 339 (365)
T 3e7e_A 293 CK----------------PEGLFRRLPH---LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ 339 (365)
T ss_dssp EE----------------ECSCCTTCSS---HHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred ee----------------echhccccCc---HHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence 10 0001111111 2246678889999999998 578888888877543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=348.47 Aligned_cols=253 Identities=21% Similarity=0.341 Sum_probs=204.1
Q ss_pred HhcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccC--CchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEE
Q 046750 358 ITNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSG--SGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLI 434 (723)
Q Consensus 358 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 434 (723)
+.++|++.+.||+|+||.||+|.. .+++.||||++... .....+.+.+|++++++++|+||+++++++.+....++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 457899999999999999999954 56899999998654 233446788999999999999999999999999999999
Q ss_pred EEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCc---EEEeeccccccc
Q 046750 435 YEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFE---AQVADFGLAKLN 511 (723)
Q Consensus 435 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~---vkL~DFGla~~~ 511 (723)
|||+.+++|.+++.... .+++..++.++.||+.||+|||++ +|+|||||++||||+.++. +||+|||++...
T Consensus 84 ~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 84 FDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp ECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 99999999998887543 488899999999999999999999 5999999999999986655 999999999766
Q ss_pred CCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcc
Q 046750 512 DTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLS 591 (723)
Q Consensus 512 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~ 591 (723)
..... .....|+..|+|||++.+..++.++|||||||+||||++|+.||..... .. +...+..+.+.
T Consensus 159 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---~~--------~~~~~~~~~~~ 225 (284)
T 3kk8_A 159 NDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---HR--------LYAQIKAGAYD 225 (284)
T ss_dssp CSSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HH--------HHHHHHHTCCC
T ss_pred ccCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch---hH--------HHHHHHhcccc
Confidence 54332 2345689999999999999999999999999999999999999965431 11 11122222211
Q ss_pred cccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 592 EIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 592 ~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
.. .+.+ ..+ ...+.+++.+||+.||.+||++.|+++.
T Consensus 226 ~~-~~~~-~~~----~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 226 YP-SPEW-DTV----TPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp CC-TTTT-TTS----CHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred CC-chhh-ccc----CHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 11 0000 111 2357889999999999999999999874
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=362.87 Aligned_cols=255 Identities=22% Similarity=0.317 Sum_probs=202.6
Q ss_pred HHhcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCchhHHHHHHHHHHHHHc-cCCceeeEeeeeecccceEEE
Q 046750 357 EITNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQGEREFRAEVEIISRV-HHRHLVSLVGYCISEKNRLLI 434 (723)
Q Consensus 357 ~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV 434 (723)
.+.++|++.+.||+|+||.||+|.. .+++.||||+++.... .+.+|+++|.++ +|+||++++++|.+....|+|
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv 94 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV 94 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence 3567899999999999999999955 4688999999976432 345788899888 799999999999999999999
Q ss_pred EEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCC----CcEEEeecccccc
Q 046750 435 YEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDE----FEAQVADFGLAKL 510 (723)
Q Consensus 435 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~----~~vkL~DFGla~~ 510 (723)
|||+.+|+|.+++.... .+++..++.|+.||+.||+|||++ +|+|||||++||||.++ +.+||+|||+++.
T Consensus 95 ~E~~~gg~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 95 TELMKGGELLDKILRQK--FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp ECCCCSCBHHHHHHTCT--TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred EeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 99999999999987654 488999999999999999999999 59999999999998543 3599999999986
Q ss_pred cCCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCc
Q 046750 511 NDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDL 590 (723)
Q Consensus 511 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l 590 (723)
....... ....+||..|+|||++.+..++.++|||||||+||||++|+.||......... + +...+..+.+
T Consensus 170 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~---~-----~~~~i~~~~~ 240 (342)
T 2qr7_A 170 LRAENGL-LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPE---E-----ILARIGSGKF 240 (342)
T ss_dssp CBCTTCC-BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHH---H-----HHHHHHHCCC
T ss_pred CcCCCCc-eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHH---H-----HHHHHccCCc
Confidence 6543322 23456899999999998888999999999999999999999999754321111 1 2223333333
Q ss_pred ccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 046750 591 SEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRAL 635 (723)
Q Consensus 591 ~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L 635 (723)
... ..+.......+.+|+.+||+.||.+||++.+|++.-
T Consensus 241 ~~~------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp 279 (342)
T 2qr7_A 241 SLS------GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHP 279 (342)
T ss_dssp CCC------STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSH
T ss_pred ccC------ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCC
Confidence 211 111111223678899999999999999999998743
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=359.73 Aligned_cols=258 Identities=22% Similarity=0.319 Sum_probs=188.0
Q ss_pred hcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCchhHHHHHHHHHHHHHcc-CCceeeEeeeee--------cc
Q 046750 359 TNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQGEREFRAEVEIISRVH-HRHLVSLVGYCI--------SE 428 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~--------~~ 428 (723)
..+|++.++||+|+||.||+|+. .+++.||||++........+.+.+|+.+|+++. |+||+++++++. ..
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 35799999999999999999964 578999999997766666678999999999996 999999999984 33
Q ss_pred cceEEEEEecCCCchhhcccc-CCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeeccc
Q 046750 429 KNRLLIYEFVPNNNLEHHLHG-KGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGL 507 (723)
Q Consensus 429 ~~~~lV~E~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGl 507 (723)
...++||||+ +|+|.+++.. .....+++..++.|+.||+.||+|||+++ ++|+|||||++||||+.++.+||+|||+
T Consensus 107 ~~~~lv~e~~-~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 107 AEFLLLTELC-KGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp EEEEEEEECC-SEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred ceEEEEEEec-CCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCcc
Confidence 4478999999 5899888864 22335899999999999999999999982 1299999999999999999999999999
Q ss_pred ccccCCCCcce-----------eecccccccccChhhh---ccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhh
Q 046750 508 AKLNDTTQTHV-----------STRVMGTFGYLAPEYA---SSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESL 573 (723)
Q Consensus 508 a~~~~~~~~~~-----------~~~~~gt~~y~APE~~---~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l 573 (723)
++......... .....|+..|+|||++ .+..++.++|||||||+||||++|+.||....... +
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---~ 261 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR---I 261 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH---h
Confidence 98665432211 1134589999999998 56678899999999999999999999996543210 0
Q ss_pred HHhhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCCC
Q 046750 574 VEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEM 641 (723)
Q Consensus 574 ~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~~ 641 (723)
+ .+.+..... ... ...+.+|+.+||+.||.+||++.||++.|+.+...
T Consensus 262 -------~-----~~~~~~~~~----~~~----~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~ 309 (337)
T 3ll6_A 262 -------V-----NGKYSIPPH----DTQ----YTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA 309 (337)
T ss_dssp ----------------CCCCTT----CCS----SGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------h-----cCcccCCcc----ccc----chHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 0 001000000 011 12367899999999999999999999999886543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=377.91 Aligned_cols=249 Identities=22% Similarity=0.319 Sum_probs=194.1
Q ss_pred hcCcccceEEeccCcEEEEEEE-cCCCcEEEEEEcccC---CchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEE
Q 046750 359 TNGFARENVIGEGGFGCVYKGN-LPEGKVVAVKQLKSG---SGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLI 434 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~VAvK~l~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 434 (723)
.++|++.++||+|+||.||+|+ ..+|+.||||+++.. .......+.+|+++|++++|+||++++++|.+.+..|||
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 3679999999999999999995 456899999998753 223345678899999999999999999999999999999
Q ss_pred EEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcc-cCCCceeecCCCCCcEEeCCCCcEEEeecccccccCC
Q 046750 435 YEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHE-DCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDT 513 (723)
Q Consensus 435 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 513 (723)
|||+.+|+|.+++.... .+++..++.|+.||++||+|||+ + +|||||||++||||+.++.+||+|||+++....
T Consensus 227 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 227 MEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp ECCCSSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EeeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 99999999999997644 48899999999999999999998 6 599999999999999999999999999975433
Q ss_pred CCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccc
Q 046750 514 TQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEI 593 (723)
Q Consensus 514 ~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~ 593 (723)
... .....+||..|+|||++.+..++.++||||||||||||++|+.||..... ..+ ...+..+.+.
T Consensus 302 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~--------~~~i~~~~~~-- 367 (446)
T 4ejn_A 302 DGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKL--------FELILMEEIR-- 367 (446)
T ss_dssp ------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHH--------HHHHHHCCCC--
T ss_pred CCc-ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH---HHH--------HHHHHhCCCC--
Confidence 222 23446799999999999999999999999999999999999999975431 111 1111112111
Q ss_pred cchhhhccccHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 046750 594 VDPRLEKHYVESEMFRMIEAAAACVRHSGPKRP-----RMVQVVRA 634 (723)
Q Consensus 594 vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~eVl~~ 634 (723)
+...+ ...+.+|+.+||+.||.+|| ++.||++.
T Consensus 368 ----~p~~~----~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 368 ----FPRTL----GPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp ----CCTTS----CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ----CCccC----CHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 11111 23678899999999999999 99999864
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=347.38 Aligned_cols=264 Identities=20% Similarity=0.268 Sum_probs=205.6
Q ss_pred HhcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeee-ecccceEEEE
Q 046750 358 ITNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYC-ISEKNRLLIY 435 (723)
Q Consensus 358 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~-~~~~~~~lV~ 435 (723)
+.++|++.++||+|+||.||+|+. .+++.||||++..... ..++.+|++++++++|++++..++++ .+....++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 357899999999999999999964 6789999999876432 34688999999999988766655555 5566779999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEe---CCCCcEEEeecccccccC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILV---DDEFEAQVADFGLAKLND 512 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl---~~~~~vkL~DFGla~~~~ 512 (723)
||+ +++|.+++..... .+++..++.|+.||+.||+|||++ +|+|||||++|||| ++++.+||+|||+++...
T Consensus 85 e~~-~~~L~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFCSR-KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp ECC-CCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred Eec-CCCHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 999 9999999974332 488999999999999999999999 59999999999999 488899999999998765
Q ss_pred CCCcc------eeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhh
Q 046750 513 TTQTH------VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIE 586 (723)
Q Consensus 513 ~~~~~------~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~ 586 (723)
..... ......|+..|+|||++.+..++.++|||||||+||||++|+.||................ ...+.
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~---~~~~~ 236 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS---EKKMS 236 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHH---HHHHH
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhc---ccccC
Confidence 44331 1234579999999999999999999999999999999999999997654322211111110 00000
Q ss_pred cCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCCC
Q 046750 587 TGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEM 641 (723)
Q Consensus 587 ~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~~ 641 (723)
. . ...+...+ ...+.+++.+||+.||.+||++.+|++.|+.+...
T Consensus 237 ~-~-----~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 281 (296)
T 3uzp_A 237 T-P-----IEVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281 (296)
T ss_dssp S-C-----HHHHTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred C-c-----hHHHHhhC----CHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHh
Confidence 0 0 00111112 23688999999999999999999999999886543
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=375.53 Aligned_cols=262 Identities=20% Similarity=0.273 Sum_probs=207.2
Q ss_pred hcCcccceEEeccCcEEEEEEE-cCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccC-CceeeEeeeeecccceEEEEE
Q 046750 359 TNGFARENVIGEGGFGCVYKGN-LPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHH-RHLVSLVGYCISEKNRLLIYE 436 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~g~~~~~~~~~lV~E 436 (723)
.++|++.++||+|+||.||+|. ..+++.||||++..... ..++.+|+++++.|+| .+|..+..++.+.+..+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 4689999999999999999996 46789999999875532 2358899999999976 566667777777888899999
Q ss_pred ecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEe---CCCCcEEEeecccccccCC
Q 046750 437 FVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILV---DDEFEAQVADFGLAKLNDT 513 (723)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl---~~~~~vkL~DFGla~~~~~ 513 (723)
|+ +++|.++++.... .+.+..++.|+.||+.||+|||++ +|||||||++|||| ++++.+||+|||+++.+..
T Consensus 84 ~~-g~sL~~ll~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp CC-CCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred CC-CCCHHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 99 9999999975433 489999999999999999999999 59999999999999 6889999999999987654
Q ss_pred CCcce------eecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhc
Q 046750 514 TQTHV------STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIET 587 (723)
Q Consensus 514 ~~~~~------~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~ 587 (723)
..... .....|+..|+|||++.+..++.++||||||||||||++|+.||...........+.... ...
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~---~~~--- 232 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS---EKK--- 232 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHH---HHH---
T ss_pred CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHh---hcc---
Confidence 43321 225679999999999999999999999999999999999999998755432222222111 010
Q ss_pred CCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCC
Q 046750 588 GDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGE 640 (723)
Q Consensus 588 ~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~ 640 (723)
+...++ .+...+ ...|.+|+.+||+.+|++||++.+|++.|+.+..
T Consensus 233 --~~~~~~-~l~~~~----p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~ 278 (483)
T 3sv0_A 233 --VATSIE-ALCRGY----PTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI 278 (483)
T ss_dssp --HHSCHH-HHHTTS----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred --ccccHH-HHhcCC----cHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 001111 111112 2368899999999999999999999999987654
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=363.66 Aligned_cols=257 Identities=28% Similarity=0.445 Sum_probs=194.3
Q ss_pred CcccceEEeccCcEEEEEEEcC--CC--cEEEEEEcccCC-chhHHHHHHHHHHHHHccCCceeeEeeeeec-ccceEEE
Q 046750 361 GFARENVIGEGGFGCVYKGNLP--EG--KVVAVKQLKSGS-GQGEREFRAEVEIISRVHHRHLVSLVGYCIS-EKNRLLI 434 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~~~--~g--~~VAvK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~~~~lV 434 (723)
.|.+.++||+|+||.||+|.+. ++ ..||||.++... ....++|.+|+.+|++|+|+||++++++|.+ ++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4777899999999999999653 22 368999987643 3445689999999999999999999998754 4578999
Q ss_pred EEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCC
Q 046750 435 YEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTT 514 (723)
Q Consensus 435 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 514 (723)
|||+.+|+|.+++.... ..+.+..++.|+.||++||+|||++ +|+|||||++||||++++.+||+|||+++.....
T Consensus 170 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EECCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccccc
Confidence 99999999999997543 3478899999999999999999999 5999999999999999999999999999865433
Q ss_pred Ccc---eeecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCc
Q 046750 515 QTH---VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDL 590 (723)
Q Consensus 515 ~~~---~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l 590 (723)
... ......++..|+|||++.+..++.++|||||||+||||++ |..||....... +. ..+..+..
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---~~--------~~~~~~~~ 314 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---IT--------VYLLQGRR 314 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---HH--------HHHHTTCC
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---HH--------HHHHcCCC
Confidence 221 1233457789999999999999999999999999999999 667776543221 11 11112211
Q ss_pred ccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCCC
Q 046750 591 SEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEM 641 (723)
Q Consensus 591 ~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~~ 641 (723)
. ..+ ......+.+++.+||+.||.+||++.||++.|+.+...
T Consensus 315 ~--~~p-------~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~ 356 (373)
T 3c1x_A 315 L--LQP-------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 356 (373)
T ss_dssp C--CCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred C--CCC-------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 1 000 11123678899999999999999999999999886643
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=352.93 Aligned_cols=252 Identities=22% Similarity=0.373 Sum_probs=202.9
Q ss_pred HhcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEE
Q 046750 358 ITNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYE 436 (723)
Q Consensus 358 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 436 (723)
+.++|.+.++||+|+||.||+++. .+|+.||||+++.........+.+|+++|++|+|+||+++++++.+....++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 457899999999999999999965 4789999999987655555678999999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEe---CCCCcEEEeecccccccCC
Q 046750 437 FVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILV---DDEFEAQVADFGLAKLNDT 513 (723)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl---~~~~~vkL~DFGla~~~~~ 513 (723)
|+.+++|.+++.... .+++..++.++.||+.||.|||++ +|+|||||++|||| ++++.+||+|||+++....
T Consensus 87 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 87 LVSGGELFDRILERG--VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred cCCCccHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 999999999886543 478899999999999999999999 59999999999999 7889999999999975443
Q ss_pred CCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccc
Q 046750 514 TQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEI 593 (723)
Q Consensus 514 ~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~ 593 (723)
. ......|+..|+|||++.+..++.++|||||||+||||++|+.||..... .. +...+..+.+. +
T Consensus 162 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~--------~~~~i~~~~~~-~ 226 (304)
T 2jam_A 162 G---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE---SK--------LFEKIKEGYYE-F 226 (304)
T ss_dssp B---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH---HH--------HHHHHHHCCCC-C
T ss_pred C---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HH--------HHHHHHcCCCC-C
Confidence 2 12334689999999999999999999999999999999999999975431 11 11222222211 1
Q ss_pred cchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 594 VDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 594 vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
. ..+... ....+.+++.+||+.||.+||++.||++.
T Consensus 227 ~-~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 227 E-SPFWDD----ISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp C-TTTTTT----SCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred C-cccccc----CCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0 011111 22367899999999999999999999874
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=348.69 Aligned_cols=251 Identities=28% Similarity=0.470 Sum_probs=198.8
Q ss_pred hcCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecc-cceEEEEEe
Q 046750 359 TNGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISE-KNRLLIYEF 437 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-~~~~lV~E~ 437 (723)
.++|++.+.||+|+||.||+|+. .|+.||||+++... ..+.|.+|++++++++|+||+++++++.+. +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 36799999999999999999987 58899999997643 456789999999999999999999987654 478999999
Q ss_pred cCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcc
Q 046750 438 VPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTH 517 (723)
Q Consensus 438 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 517 (723)
+.+++|.+++.......+++..++.++.||+.||+|||++ +|+|||||++|||++.++.+||+|||++.......
T Consensus 97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 171 (278)
T 1byg_A 97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 171 (278)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccccc--
Confidence 9999999999765444478889999999999999999999 59999999999999999999999999997544321
Q ss_pred eeecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccch
Q 046750 518 VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDP 596 (723)
Q Consensus 518 ~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~ 596 (723)
....++..|+|||++.+..++.++|||||||+||||++ |+.||..... .. +...+..+....+
T Consensus 172 --~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~---~~--------~~~~~~~~~~~~~--- 235 (278)
T 1byg_A 172 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KD--------VVPRVEKGYKMDA--- 235 (278)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG---GG--------HHHHHTTTCCCCC---
T ss_pred --cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH---HH--------HHHHHhcCCCCCC---
Confidence 22347889999999999999999999999999999998 9999975431 11 1122222211111
Q ss_pred hhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccC
Q 046750 597 RLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEG 639 (723)
Q Consensus 597 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~ 639 (723)
.......+.+++.+||+.||.+||++.+|++.|+.+.
T Consensus 236 ------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~ 272 (278)
T 1byg_A 236 ------PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 272 (278)
T ss_dssp ------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence 1112236888999999999999999999999998754
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=348.67 Aligned_cols=249 Identities=25% Similarity=0.423 Sum_probs=200.0
Q ss_pred hcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCC---chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEE
Q 046750 359 TNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS---GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLI 434 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 434 (723)
.++|++.+.||+|+||.||+|.. .+++.||||++.... ......+.+|++++++++|+||++++++|.+....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 36799999999999999999954 557899999986432 12245688999999999999999999999999999999
Q ss_pred EEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCC
Q 046750 435 YEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTT 514 (723)
Q Consensus 435 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 514 (723)
|||+.+++|.+++.... .+++..++.|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||++......
T Consensus 88 ~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp ECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 99999999999987644 378899999999999999999998 5999999999999999999999999998654332
Q ss_pred CcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCccccc
Q 046750 515 QTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIV 594 (723)
Q Consensus 515 ~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~v 594 (723)
. .....|+..|+|||++.+..++.++|||||||+||||++|+.||..... .+ ..+.+....+
T Consensus 163 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~-----~~~~~~~~~~---- 224 (279)
T 3fdn_A 163 R---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY------QE-----TYKRISRVEF---- 224 (279)
T ss_dssp --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HH-----HHHHHHHTCC----
T ss_pred c---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH------HH-----HHHHHHhCCC----
Confidence 2 2345689999999999999999999999999999999999999975431 11 1111111111
Q ss_pred chhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 046750 595 DPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALD 636 (723)
Q Consensus 595 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~ 636 (723)
.+.......+.+|+.+||+.||.+||++.||++.-.
T Consensus 225 ------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~ 260 (279)
T 3fdn_A 225 ------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 260 (279)
T ss_dssp ------CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHH
T ss_pred ------CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCcc
Confidence 011111235778999999999999999999997543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=370.03 Aligned_cols=266 Identities=20% Similarity=0.273 Sum_probs=195.1
Q ss_pred HhcCcccceEEeccCcEEEEEEE-cCCCcEEEEEEcccC--CchhHHHHHHHHHHHHHccCCceeeEeeeeeccc-----
Q 046750 358 ITNGFARENVIGEGGFGCVYKGN-LPEGKVVAVKQLKSG--SGQGEREFRAEVEIISRVHHRHLVSLVGYCISEK----- 429 (723)
Q Consensus 358 ~~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~VAvK~l~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~----- 429 (723)
+.++|++.++||+|+||.||+|. ..+++.||||++... .....+.+.+|+.+|++++|+|||+++++|....
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 35789999999999999999994 556899999999754 2334567889999999999999999999997553
Q ss_pred -ceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccc
Q 046750 430 -NRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLA 508 (723)
Q Consensus 430 -~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla 508 (723)
..||||||+.+ +|.+++.. .+++..+..|+.||++||+|||++ +|||||||++||||+.++.+||+|||++
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred CeEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEee
Confidence 46999999965 56666643 278889999999999999999999 5999999999999999999999999999
Q ss_pred cccCCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhh----------
Q 046750 509 KLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWAR---------- 578 (723)
Q Consensus 509 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~---------- 578 (723)
+...... .....+||..|+|||++.+..|+.++||||||||||||++|+.||...... ..+.....
T Consensus 212 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~--~~~~~i~~~lg~p~~~~~ 287 (464)
T 3ttj_A 212 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI--DQWNKVIEQLGTPCPEFM 287 (464)
T ss_dssp -----CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCSCCHHHH
T ss_pred eecCCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcCCCCHHHH
Confidence 8664322 234467999999999999999999999999999999999999999765421 11110000
Q ss_pred ----hhhhhhhhc-CCccc-----ccchhhh---ccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 046750 579 ----PVLVRAIET-GDLSE-----IVDPRLE---KHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRAL 635 (723)
Q Consensus 579 ----~~l~~~i~~-~~l~~-----~vd~~l~---~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L 635 (723)
..+...++. ..+.. ++...+. ..........+.+|+.+||+.||.+||++.|+++.-
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp 357 (464)
T 3ttj_A 288 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 357 (464)
T ss_dssp TTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred HHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcCh
Confidence 000000000 00000 0000000 001112245688999999999999999999999753
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=348.97 Aligned_cols=258 Identities=24% Similarity=0.346 Sum_probs=202.8
Q ss_pred CcccceEEeccCcEEEEEEEcCC-C---cEEEEEEcccCCc-hhHHHHHHHHHHHHHccCCceeeEeeeeecccce-EEE
Q 046750 361 GFARENVIGEGGFGCVYKGNLPE-G---KVVAVKQLKSGSG-QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNR-LLI 434 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~~~~-g---~~VAvK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~-~lV 434 (723)
.|...++||+|+||.||+|.+.+ + ..||||+++.... ...+.|.+|++++++++|+||++++++|.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 36667999999999999996432 2 3799999976543 3446789999999999999999999999876665 999
Q ss_pred EEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCC
Q 046750 435 YEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTT 514 (723)
Q Consensus 435 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 514 (723)
|||+.+++|.+++.... ..+.+..++.|+.||+.||+|||++ +|+|||||++||||++++.+||+|||+++.....
T Consensus 102 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp ECCCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred EecccCCCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 99999999999997643 3578899999999999999999999 5999999999999999999999999999765433
Q ss_pred Cc---ceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcc
Q 046750 515 QT---HVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLS 591 (723)
Q Consensus 515 ~~---~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~ 591 (723)
.. .......++..|+|||.+.+..++.++|||||||+||||++|..|+..... ...+. ..+..+...
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~--~~~~~--------~~~~~~~~~ 247 (298)
T 3pls_A 178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID--PFDLT--------HFLAQGRRL 247 (298)
T ss_dssp GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC--GGGHH--------HHHHTTCCC
T ss_pred cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC--HHHHH--------HHhhcCCCC
Confidence 22 112334678899999999999999999999999999999997666543221 11111 111222111
Q ss_pred cccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCCC
Q 046750 592 EIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEM 641 (723)
Q Consensus 592 ~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~~ 641 (723)
.. .......+.+++.+||+.||.+||++.+|++.|+.+...
T Consensus 248 ~~---------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 288 (298)
T 3pls_A 248 PQ---------PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA 288 (298)
T ss_dssp CC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CC---------CccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 10 011123678999999999999999999999999886543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=345.70 Aligned_cols=255 Identities=21% Similarity=0.317 Sum_probs=204.9
Q ss_pred HhcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCC-chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEE
Q 046750 358 ITNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS-GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 358 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 435 (723)
+.++|++.+.||+|+||.||+|.. .+++.||||+++... ....+.+.+|++++++++|+||+++++++.+.+..++||
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 457899999999999999999965 468999999986542 334567899999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ 515 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 515 (723)
||+.+++|.+++.... .+++..++.++.||++||+|||++ +|+|||||++||||+.++.+||+|||++.......
T Consensus 85 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 85 EYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp ECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred EecCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 9999999999997543 488899999999999999999999 59999999999999999999999999997654322
Q ss_pred c-ceeecccccccccChhhhccCCC-CCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccc
Q 046750 516 T-HVSTRVMGTFGYLAPEYASSGKL-TDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEI 593 (723)
Q Consensus 516 ~-~~~~~~~gt~~y~APE~~~~~~~-t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~ 593 (723)
. .......|+..|+|||++.+..+ +.++|||||||+||||++|+.||...... ...+..|.. ....
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~--------~~~~--- 227 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-CQEYSDWKE--------KKTY--- 227 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTT-SHHHHHHHT--------TCTT---
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH-HHHHHHhhh--------cccc---
Confidence 1 12234568999999999987765 77999999999999999999999765432 122222211 0000
Q ss_pred cchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 046750 594 VDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRAL 635 (723)
Q Consensus 594 vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L 635 (723)
.. ....+ ...+.+++.+||+.||.+||++.||++.-
T Consensus 228 ~~--~~~~~----~~~~~~li~~~l~~~p~~Rps~~~il~~~ 263 (276)
T 2yex_A 228 LN--PWKKI----DSAPLALLHKILVENPSARITIPDIKKDR 263 (276)
T ss_dssp ST--TGGGS----CHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred cC--chhhc----CHHHHHHHHHHCCCCchhCCCHHHHhcCc
Confidence 00 00111 23577899999999999999999998743
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=379.90 Aligned_cols=254 Identities=28% Similarity=0.388 Sum_probs=207.1
Q ss_pred hcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCC---chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEE
Q 046750 359 TNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS---GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLI 434 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 434 (723)
.++|.+.++||+|+||.||+|+. .+|+.||||++.... ......+.+|+++|++++|+|||+++++|.+.+..|||
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 35699999999999999999965 468999999986531 23345688999999999999999999999999999999
Q ss_pred EEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCC
Q 046750 435 YEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTT 514 (723)
Q Consensus 435 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 514 (723)
|||+.+|+|.+++.......+++..++.|+.||+.||+|||++ +|||||||++||||+.++.+||+|||+++.....
T Consensus 263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 9999999999999876655689999999999999999999999 5999999999999999999999999999876543
Q ss_pred CcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCccccc
Q 046750 515 QTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIV 594 (723)
Q Consensus 515 ~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~v 594 (723)
.. ....+||..|+|||++.+..++.++||||||||||||++|+.||.......... . +.+.+.....
T Consensus 340 ~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~--~-----i~~~i~~~~~---- 406 (576)
T 2acx_A 340 QT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE--E-----VERLVKEVPE---- 406 (576)
T ss_dssp CC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHH--H-----HHHHHHHCCC----
T ss_pred cc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHH--H-----HHHHhhcccc----
Confidence 32 234579999999999999999999999999999999999999997654321111 1 1111111110
Q ss_pred chhhhccccHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 046750 595 DPRLEKHYVESEMFRMIEAAAACVRHSGPKRP-----RMVQVVRA 634 (723)
Q Consensus 595 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~eVl~~ 634 (723)
.+.......+.+|+.+||+.||.+|+ ++.||+++
T Consensus 407 ------~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 407 ------EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred ------cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 11111223678899999999999999 78888754
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=368.41 Aligned_cols=251 Identities=25% Similarity=0.334 Sum_probs=192.9
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCC---chhHHHHHHHHHH-HHHccCCceeeEeeeeecccceEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS---GQGEREFRAEVEI-ISRVHHRHLVSLVGYCISEKNRLLI 434 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~---~~~~~~~~~Ei~i-l~~l~HpnIv~l~g~~~~~~~~~lV 434 (723)
++|++.++||+|+||.||+|+. .+++.||||+++... ......+.+|..+ ++.++|+||++++++|.+.+..|||
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 5799999999999999999965 458899999997642 2233456677776 5678999999999999999999999
Q ss_pred EEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCC
Q 046750 435 YEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTT 514 (723)
Q Consensus 435 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 514 (723)
|||+.+|+|.+++.+.. .+.+..++.++.||+.||+|||++ +|||||||++||||+.++++||+|||+++.....
T Consensus 118 ~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 118 LDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred EeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 99999999999997644 477888899999999999999999 5999999999999999999999999999854322
Q ss_pred CcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCccccc
Q 046750 515 QTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIV 594 (723)
Q Consensus 515 ~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~v 594 (723)
.. .....+||..|+|||++.+..++.++|||||||+||||++|+.||..... .+ +.+.+..+.+.
T Consensus 193 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~-----~~~~i~~~~~~--- 257 (373)
T 2r5t_A 193 NS-TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT------AE-----MYDNILNKPLQ--- 257 (373)
T ss_dssp CC-CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH------HH-----HHHHHHHSCCC---
T ss_pred CC-ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HH-----HHHHHHhcccC---
Confidence 22 23446799999999999999999999999999999999999999975421 11 11122222111
Q ss_pred chhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhc
Q 046750 595 DPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDS 637 (723)
Q Consensus 595 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~ 637 (723)
+...+ ...+.+|+.+||+.||.+|+++.+.++.+..
T Consensus 258 ---~~~~~----~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~ 293 (373)
T 2r5t_A 258 ---LKPNI----TNSARHLLEGLLQKDRTKRLGAKDDFMEIKS 293 (373)
T ss_dssp ---CCSSS----CHHHHHHHHHHTCSSGGGSTTTTTTHHHHHT
T ss_pred ---CCCCC----CHHHHHHHHHHcccCHHhCCCCCCCHHHHhC
Confidence 11112 2357889999999999999998654444433
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=358.68 Aligned_cols=269 Identities=17% Similarity=0.263 Sum_probs=194.2
Q ss_pred HHhcCcccceEEeccCcEEEEEEE-cCCCcEEEEEEcccCCch--hHHHHHHHHHHHHHccCCceeeEeeeeecccceEE
Q 046750 357 EITNGFARENVIGEGGFGCVYKGN-LPEGKVVAVKQLKSGSGQ--GEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLL 433 (723)
Q Consensus 357 ~~~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~VAvK~l~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 433 (723)
...++|.+.++||+|+||.||+|. ..+++.||||+++..... ..+.+.+|+++|++|+|+||+++++++.+....+|
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 345789999999999999999995 557899999999755322 23567899999999999999999999999999999
Q ss_pred EEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEe-----CCCCcEEEeecccc
Q 046750 434 IYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILV-----DDEFEAQVADFGLA 508 (723)
Q Consensus 434 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl-----~~~~~vkL~DFGla 508 (723)
||||+. |+|.+++.... .+.+..++.|+.||+.||+|||++ +|+|||||++|||| ++++.+||+|||++
T Consensus 111 v~e~~~-~~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 111 IFEYAE-NDLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp EEECCS-EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred EEecCC-CCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 999996 69999997654 388899999999999999999999 59999999999999 45566999999999
Q ss_pred cccCCCCcceeecccccccccChhhhccC-CCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhh-----
Q 046750 509 KLNDTTQTHVSTRVMGTFGYLAPEYASSG-KLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLV----- 582 (723)
Q Consensus 509 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~----- 582 (723)
+....... ......|+..|+|||++.+. .++.++|||||||+||||++|+.||...... ..+.......-.
T Consensus 185 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~ 261 (329)
T 3gbz_A 185 RAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI--DQLFKIFEVLGLPDDTT 261 (329)
T ss_dssp HHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCTTT
T ss_pred cccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH--HHHHHHHHHhCCCchhh
Confidence 86643322 22345689999999999875 4899999999999999999999999764321 111111100000
Q ss_pred -hhh-h----cCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 583 -RAI-E----TGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 583 -~~i-~----~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
..+ . ...+..+....+...........+.+|+.+||+.||.+||++.||++.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 262 WPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp STTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 000 0 000111111111111111123467899999999999999999999874
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=346.68 Aligned_cols=257 Identities=27% Similarity=0.412 Sum_probs=200.5
Q ss_pred cCcccceEEeccCcEEEEEEEcCC----CcEEEEEEcccCCc-hhHHHHHHHHHHHHHccCCceeeEeeeee-cccceEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLPE----GKVVAVKQLKSGSG-QGEREFRAEVEIISRVHHRHLVSLVGYCI-SEKNRLL 433 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~~----g~~VAvK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~-~~~~~~l 433 (723)
.+|++.++||+|+||.||+|.+.+ +..||||.++.... ...+.+.+|+.++++++|+||++++++|. .++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 458889999999999999997543 23589999876543 34467899999999999999999999865 4567899
Q ss_pred EEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCC
Q 046750 434 IYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDT 513 (723)
Q Consensus 434 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 513 (723)
||||+.+|+|.+++.... ..+.+..++.|+.||+.||+|||++ +|+|||||++||||++++.+||+|||+++....
T Consensus 105 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EEECCTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred EEeCCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccccc
Confidence 999999999999997543 3578899999999999999999999 599999999999999999999999999986654
Q ss_pred CCcc---eeecccccccccChhhhccCCCCCccceechHHHHHHHHhCC-CCCCCCCCCCchhhHHhhhhhhhhhhhcCC
Q 046750 514 TQTH---VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGR-KPVDPTQPLGDESLVEWARPVLVRAIETGD 589 (723)
Q Consensus 514 ~~~~---~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~-~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~ 589 (723)
.... ......++..|+|||++.+..++.++|||||||+||||++|. .||....... +. ..+..+.
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---~~--------~~~~~~~ 249 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---IT--------VYLLQGR 249 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT---HH--------HHHHTTC
T ss_pred cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH---HH--------HHHhcCC
Confidence 3321 123345778999999999999999999999999999999954 5554433211 11 1111111
Q ss_pred cccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCC
Q 046750 590 LSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGE 640 (723)
Q Consensus 590 l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~ 640 (723)
... .. ..+ ...+.+++.+||+.||.+||++.+|++.|+.+..
T Consensus 250 ~~~-~~----~~~----~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 291 (298)
T 3f66_A 250 RLL-QP----EYC----PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291 (298)
T ss_dssp CCC-CC----TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCC-CC----ccC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 100 00 111 2357889999999999999999999999988654
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=359.04 Aligned_cols=248 Identities=22% Similarity=0.365 Sum_probs=203.0
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccC---CchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSG---SGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 435 (723)
++|.+.++||+|+||.||++.. .+++.||+|++... .....+.+.+|+.++++++|+||++++++|.+.+..|+||
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 120 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 120 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 6799999999999999999965 45789999998654 2234467889999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ 515 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 515 (723)
||+.+++|.+++.... .+.+..++.|+.||++||+|||++ +|+|||||++||||+.++.+||+|||+++......
T Consensus 121 e~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 195 (335)
T 2owb_A 121 ELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 195 (335)
T ss_dssp CCCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred ecCCCCCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence 9999999999887543 488999999999999999999999 59999999999999999999999999998664332
Q ss_pred cceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccc
Q 046750 516 THVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVD 595 (723)
Q Consensus 516 ~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd 595 (723)
. ......|+..|+|||++.+..++.++|||||||+||||++|+.||..... .+.. ..+..+.+.
T Consensus 196 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~-----~~~~~~~~~---- 259 (335)
T 2owb_A 196 E-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL------KETY-----LRIKKNEYS---- 259 (335)
T ss_dssp C-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHH-----HHHHHTCCC----
T ss_pred c-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH------HHHH-----HHHhcCCCC----
Confidence 2 22345689999999999999999999999999999999999999975431 1111 111111111
Q ss_pred hhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 596 PRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 596 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
+...+ ...+.+|+.+||+.||.+||++.||++.
T Consensus 260 --~~~~~----~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 260 --IPKHI----NPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp --CCTTS----CHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred --CCccC----CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11111 2357789999999999999999999874
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=360.20 Aligned_cols=267 Identities=22% Similarity=0.276 Sum_probs=203.8
Q ss_pred hcCcccceEEeccCcEEEEEEE-cCCCcEEEEEEcccCCchhHHHHHHHHHHHHHcc--------CCceeeEeeeee---
Q 046750 359 TNGFARENVIGEGGFGCVYKGN-LPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVH--------HRHLVSLVGYCI--- 426 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~--------HpnIv~l~g~~~--- 426 (723)
.++|.+.++||+|+||.||+|+ ..+++.||||+++.. ....+.+.+|+++|++|+ |+||++++++|.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 4679999999999999999995 456889999999753 234567889999999995 788999999988
Q ss_pred -cccceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCC-------
Q 046750 427 -SEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEF------- 498 (723)
Q Consensus 427 -~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~------- 498 (723)
+....||||||+ +++|.+++.......+.+..++.|+.||+.||+|||+++ +|||||||++||||+.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~~ 191 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLA 191 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhhh
Confidence 566789999999 666666665554456899999999999999999999973 499999999999999775
Q ss_pred ------------------------------------------cEEEeecccccccCCCCcceeecccccccccChhhhcc
Q 046750 499 ------------------------------------------EAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASS 536 (723)
Q Consensus 499 ------------------------------------------~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~ 536 (723)
.+||+|||+++..... .....||..|+|||++.+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~ 267 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIG 267 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHHT
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhcC
Confidence 7999999999865432 233568999999999999
Q ss_pred CCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhh--------hh-----------cCCcccccch-
Q 046750 537 GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRA--------IE-----------TGDLSEIVDP- 596 (723)
Q Consensus 537 ~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~--------i~-----------~~~l~~~vd~- 596 (723)
..++.++|||||||+||||++|+.||................. +.+. +. .+.+..+.+.
T Consensus 268 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (397)
T 1wak_A 268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIAL-IIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLK 346 (397)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHH-HHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCC
T ss_pred CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHH-HHHhcCCCChHHhhcccccccccCCccccccccccC
Confidence 9999999999999999999999999976543221111111000 0000 00 0111111100
Q ss_pred ------hh--hccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 597 ------RL--EKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 597 ------~l--~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
.+ ...+.......+.+|+.+||+.||.+||++.||++.
T Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 347 PWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred CcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 00 012345666789999999999999999999999864
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=354.47 Aligned_cols=259 Identities=19% Similarity=0.271 Sum_probs=204.0
Q ss_pred HHHHhcCcccc-eEEeccCcEEEEEEEc-CCCcEEEEEEcccCC--chhHHHHHHHHHHHHHc-cCCceeeEeeeeeccc
Q 046750 355 LMEITNGFARE-NVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS--GQGEREFRAEVEIISRV-HHRHLVSLVGYCISEK 429 (723)
Q Consensus 355 l~~~~~~f~~~-~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~ 429 (723)
...+.++|.+. ++||+|+||.||+|.. .+++.||||+++... ......+.+|+.+++++ +|+||++++++|.+..
T Consensus 23 ~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~ 102 (327)
T 3lm5_A 23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS 102 (327)
T ss_dssp HHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred HHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC
Confidence 44566778887 8999999999999955 468999999987542 23456889999999999 5699999999999999
Q ss_pred ceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCC---CCcEEEeecc
Q 046750 430 NRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDD---EFEAQVADFG 506 (723)
Q Consensus 430 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~---~~~vkL~DFG 506 (723)
..++||||+.+|+|.+++.......+.+..++.|+.||+.||+|||++ +|+|||||++||||+. ++.+||+|||
T Consensus 103 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~Dfg 179 (327)
T 3lm5_A 103 EIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFG 179 (327)
T ss_dssp EEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECCGG
T ss_pred eEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEeeCc
Confidence 999999999999999999766556789999999999999999999999 5999999999999998 7899999999
Q ss_pred cccccCCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhh
Q 046750 507 LAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIE 586 (723)
Q Consensus 507 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~ 586 (723)
+++....... .....|+..|+|||++.+..++.++|||||||+||||++|+.||..... .... ..+.
T Consensus 180 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~--------~~i~ 246 (327)
T 3lm5_A 180 MSRKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN---QETY--------LNIS 246 (327)
T ss_dssp GCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH--------HHHH
T ss_pred cccccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---hHHH--------HHHH
Confidence 9986643322 2345699999999999999999999999999999999999999975432 1110 1111
Q ss_pred cCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 046750 587 TGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRAL 635 (723)
Q Consensus 587 ~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L 635 (723)
...... . ..........+.+|+.+||+.||.+||++.+|++.-
T Consensus 247 ~~~~~~-~-----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~ 289 (327)
T 3lm5_A 247 QVNVDY-S-----EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHS 289 (327)
T ss_dssp HTCCCC-C-----TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCG
T ss_pred hccccc-C-----chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCH
Confidence 111100 0 000111223578899999999999999999998753
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=359.18 Aligned_cols=250 Identities=24% Similarity=0.409 Sum_probs=200.1
Q ss_pred hcCcccceEEeccCcEEEEEEE-cCCCcEEEEEEcccCCc---hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEE
Q 046750 359 TNGFARENVIGEGGFGCVYKGN-LPEGKVVAVKQLKSGSG---QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLI 434 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~VAvK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 434 (723)
.+.|...+.||+|+||.||+|+ ..+++.||||++..... ...++|.+|+++|++|+|+||++++++|.+.+..+||
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 3558999999999999999996 46789999999975432 2235788999999999999999999999999999999
Q ss_pred EEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCC
Q 046750 435 YEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTT 514 (723)
Q Consensus 435 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 514 (723)
|||+. |+|.+++.... ..+++..++.|+.||++||+|||++ +|+|||||++||||+.++.+||+|||+++.....
T Consensus 133 ~e~~~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 207 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 207 (348)
T ss_dssp EECCS-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred EecCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence 99996 68888775433 3488999999999999999999999 5999999999999999999999999999765432
Q ss_pred CcceeecccccccccChhhhc---cCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcc
Q 046750 515 QTHVSTRVMGTFGYLAPEYAS---SGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLS 591 (723)
Q Consensus 515 ~~~~~~~~~gt~~y~APE~~~---~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~ 591 (723)
....|+..|+|||++. .+.++.++||||||||||||++|+.||..... ... +.. +..+...
T Consensus 208 -----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~------~~~----~~~-~~~~~~~ 271 (348)
T 1u5q_A 208 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSA----LYH-IAQNESP 271 (348)
T ss_dssp -----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHH----HHH-HHHSCCC
T ss_pred -----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh------HHH----HHH-HHhcCCC
Confidence 2356899999999985 56789999999999999999999999965431 111 111 1111111
Q ss_pred cccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhc
Q 046750 592 EIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDS 637 (723)
Q Consensus 592 ~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~ 637 (723)
.+.. ..+ ...+.+|+.+||+.||.+||++.+|++...-
T Consensus 272 ~~~~----~~~----~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~ 309 (348)
T 1u5q_A 272 ALQS----GHW----SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 309 (348)
T ss_dssp CCCC----TTS----CHHHHHHHHHHTCSSGGGSCCHHHHTTCHHH
T ss_pred CCCC----CCC----CHHHHHHHHHHcccChhhCcCHHHHhhChhh
Confidence 1111 111 2357789999999999999999999876543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=346.12 Aligned_cols=253 Identities=22% Similarity=0.321 Sum_probs=202.0
Q ss_pred HhcCcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCCc------hhHHHHHHHHHHHHHccCCceeeEeeeeecccc
Q 046750 358 ITNGFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGSG------QGEREFRAEVEIISRVHHRHLVSLVGYCISEKN 430 (723)
Q Consensus 358 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~~------~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 430 (723)
+.++|.+.+.||+|+||.||+|... +++.||||+++.... ...+.|.+|+++|++|+|+||++++++|.+...
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 82 (283)
T 3bhy_A 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTD 82 (283)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCe
Confidence 3467999999999999999999664 689999999875422 135679999999999999999999999999999
Q ss_pred eEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCC----cEEEeecc
Q 046750 431 RLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEF----EAQVADFG 506 (723)
Q Consensus 431 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~----~vkL~DFG 506 (723)
.++||||+.+++|.+++.... .+++..++.++.||+.||+|||++ +|+|||||++||||+.++ .+||+|||
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 83 VVLILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 999999999999999997543 488999999999999999999999 599999999999999877 89999999
Q ss_pred cccccCCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhh
Q 046750 507 LAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIE 586 (723)
Q Consensus 507 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~ 586 (723)
++........ .....|+..|+|||++.+..++.++|||||||+||||++|+.||..... ... ...+.
T Consensus 158 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~--------~~~~~ 224 (283)
T 3bhy_A 158 IAHKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK---QET--------LTNIS 224 (283)
T ss_dssp TCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH---HHH--------HHHHH
T ss_pred cceeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch---HHH--------HHHhH
Confidence 9986643322 2345689999999999999999999999999999999999999975431 111 11111
Q ss_pred cCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 587 TGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 587 ~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
..... .+..+...+ ...+.+++.+||+.||.+||++.++++.
T Consensus 225 ~~~~~--~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 225 AVNYD--FDEEYFSNT----SELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp TTCCC--CCHHHHTTC----CHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred hcccC--CcchhcccC----CHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 11110 111111111 2357889999999999999999999873
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=355.21 Aligned_cols=260 Identities=25% Similarity=0.408 Sum_probs=204.7
Q ss_pred hcCcccceEEeccCcEEEEEEEc------CCCcEEEEEEcccCC-chhHHHHHHHHHHHHHccCCceeeEeeeeecccce
Q 046750 359 TNGFARENVIGEGGFGCVYKGNL------PEGKVVAVKQLKSGS-GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNR 431 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~------~~g~~VAvK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 431 (723)
.++|.+.+.||+|+||.||+|++ .+++.||||++.... .....++.+|+.++++|+|+||+++++++.+....
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 36799999999999999999974 346789999997543 34456789999999999999999999999999999
Q ss_pred EEEEEecCCCchhhccccCCC-----CcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCC---CCcEEEe
Q 046750 432 LLIYEFVPNNNLEHHLHGKGQ-----PVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDD---EFEAQVA 503 (723)
Q Consensus 432 ~lV~E~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~---~~~vkL~ 503 (723)
||||||+.+++|.+++..... ..+.+..++.++.||+.||.|||++ +|+|||||++||||+. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999976432 3488899999999999999999999 5999999999999994 4569999
Q ss_pred ecccccccCCCCc-ceeecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhh
Q 046750 504 DFGLAKLNDTTQT-HVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVL 581 (723)
Q Consensus 504 DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l 581 (723)
|||+++....... .......|+..|+|||++.+..++.++|||||||+||||++ |+.||..... ..+.
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~------- 255 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---QEVL------- 255 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHH-------
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH---HHHH-------
Confidence 9999975433222 12233567899999999999999999999999999999998 9999865431 1111
Q ss_pred hhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCCC
Q 046750 582 VRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEM 641 (723)
Q Consensus 582 ~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~~ 641 (723)
..+..+..... ... ....+.+|+.+||+.||.+||++.+|++.|+.+...
T Consensus 256 -~~~~~~~~~~~-----~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 256 -EFVTSGGRMDP-----PKN----CPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp -HHHHTTCCCCC-----CTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -HHHhcCCCCCC-----CCC----CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 12222221111 111 223678899999999999999999999999876553
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=347.68 Aligned_cols=255 Identities=25% Similarity=0.380 Sum_probs=203.5
Q ss_pred cCcccce-EEeccCcEEEEEEEc---CCCcEEEEEEcccCC--chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEE
Q 046750 360 NGFAREN-VIGEGGFGCVYKGNL---PEGKVVAVKQLKSGS--GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLL 433 (723)
Q Consensus 360 ~~f~~~~-~LG~G~fG~Vy~~~~---~~g~~VAvK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 433 (723)
++|.+.+ .||+|+||.||+|.+ ..++.||||+++... ....++|.+|++++++++|+||+++++++ ..+..++
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l 94 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML 94 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence 5678877 999999999999943 346789999997653 23356799999999999999999999999 5667899
Q ss_pred EEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCC
Q 046750 434 IYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDT 513 (723)
Q Consensus 434 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 513 (723)
||||+.+++|.+++.... .+++..++.|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++....
T Consensus 95 v~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (291)
T 1xbb_A 95 VMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 169 (291)
T ss_dssp EEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred EEEeCCCCCHHHHHHhCc--CCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence 999999999999997654 388899999999999999999999 599999999999999999999999999987654
Q ss_pred CCccee--ecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCc
Q 046750 514 TQTHVS--TRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDL 590 (723)
Q Consensus 514 ~~~~~~--~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l 590 (723)
...... ....++..|+|||++.+..++.++|||||||+||||++ |+.||..... ..+ ...+..+..
T Consensus 170 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~--------~~~~~~~~~ 238 (291)
T 1xbb_A 170 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEV--------TAMLEKGER 238 (291)
T ss_dssp TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHH--------HHHHHTTCC
T ss_pred CCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH---HHH--------HHHHHcCCC
Confidence 433222 22346788999999998889999999999999999999 9999975431 111 122222221
Q ss_pred ccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCC
Q 046750 591 SEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGE 640 (723)
Q Consensus 591 ~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~ 640 (723)
..+ .......+.+++.+||+.||.+||++.+|++.|+.+..
T Consensus 239 ~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 279 (291)
T 1xbb_A 239 MGC---------PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 279 (291)
T ss_dssp CCC---------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 111 11123468899999999999999999999999987543
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=362.86 Aligned_cols=200 Identities=25% Similarity=0.365 Sum_probs=166.7
Q ss_pred HhcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCC--chhHHHHHHHHHHHHHccCCceeeEeeeeecc-----c
Q 046750 358 ITNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS--GQGEREFRAEVEIISRVHHRHLVSLVGYCISE-----K 429 (723)
Q Consensus 358 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-----~ 429 (723)
+.++|.+.++||+|+||.||+|.. .+++.||||+++... ....+.+.+|+++|++|+|+||+++++++... .
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 457899999999999999999954 568899999997642 23446789999999999999999999999776 5
Q ss_pred ceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeeccccc
Q 046750 430 NRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK 509 (723)
Q Consensus 430 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 509 (723)
..||||||+. ++|.+++.... .+++..++.|+.||++||+|||++ +|+|||||++||||+.++.+||+|||+++
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~~~--~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKTPI--FLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecCC-cCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 6899999984 69999997643 489999999999999999999999 59999999999999999999999999998
Q ss_pred ccCCCCcc---------------------eeecccccccccChhhh-ccCCCCCccceechHHHHHHHHhCCCCCC
Q 046750 510 LNDTTQTH---------------------VSTRVMGTFGYLAPEYA-SSGKLTDRSDVFSFGVVLLELITGRKPVD 563 (723)
Q Consensus 510 ~~~~~~~~---------------------~~~~~~gt~~y~APE~~-~~~~~t~ksDVwSlGviL~eLltG~~P~~ 563 (723)
........ .....+||.+|+|||++ ....++.++||||||||||||++|..||.
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 76433211 12456799999999986 55669999999999999999998655543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=346.94 Aligned_cols=253 Identities=23% Similarity=0.340 Sum_probs=197.0
Q ss_pred HhcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCC-chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEE
Q 046750 358 ITNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS-GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 358 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 435 (723)
+.++|.+.++||+|+||.||++.. .+++.||||++.... ....+.+.+|+++|++++|+||++++++|.+....++||
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 346799999999999999999955 568899999987643 334578999999999999999999999999999999999
Q ss_pred EecCCCchhhccccC--CCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEe---CCCCcEEEeecccccc
Q 046750 436 EFVPNNNLEHHLHGK--GQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILV---DDEFEAQVADFGLAKL 510 (723)
Q Consensus 436 E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl---~~~~~vkL~DFGla~~ 510 (723)
||+.+|+|.+++... ....+.+..++.|+.||++||+|||++ +|+|||||++|||| +.++.+||+|||+++.
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~ 176 (285)
T 3is5_A 100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176 (285)
T ss_dssp CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence 999999999988542 224588999999999999999999999 59999999999999 4567899999999976
Q ss_pred cCCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCc
Q 046750 511 NDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDL 590 (723)
Q Consensus 511 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l 590 (723)
...... .....|+..|+|||++. +.++.++|||||||+||||++|+.||..... ..+. ..+.....
T Consensus 177 ~~~~~~--~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~---~~~~--------~~~~~~~~ 242 (285)
T 3is5_A 177 FKSDEH--STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL---EEVQ--------QKATYKEP 242 (285)
T ss_dssp ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH--------HHHHHCCC
T ss_pred cCCccc--CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH---HHHH--------hhhccCCc
Confidence 543322 23456899999999885 5789999999999999999999999975431 1111 11111111
Q ss_pred ccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 591 SEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 591 ~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
..... ...+ ...+.+|+.+||+.||.+||++.||++.
T Consensus 243 ~~~~~---~~~~----~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 243 NYAVE---CRPL----TPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp CCCC-----CCC----CHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred ccccc---cCcC----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 0111 2357789999999999999999999863
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=364.49 Aligned_cols=254 Identities=22% Similarity=0.341 Sum_probs=193.4
Q ss_pred HHhcCcccceEEeccCcEEEEEEE-cCCCcEEEEEEcccCC--------chhHHHHHHHHHHHHHccCCceeeEeeeeec
Q 046750 357 EITNGFARENVIGEGGFGCVYKGN-LPEGKVVAVKQLKSGS--------GQGEREFRAEVEIISRVHHRHLVSLVGYCIS 427 (723)
Q Consensus 357 ~~~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~VAvK~l~~~~--------~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~ 427 (723)
.+.++|.+.++||+|+||.||+|. ..+++.||||++.... ......+.+|+++|++|+|+||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 467899999999999999999995 4568999999986531 1122358899999999999999999999864
Q ss_pred ccceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCC---CcEEEee
Q 046750 428 EKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDE---FEAQVAD 504 (723)
Q Consensus 428 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~---~~vkL~D 504 (723)
+..||||||+.+|+|.+++.... .+.+..++.|+.||+.||+|||++ +|+|||||++||||+.+ +.+||+|
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~D 285 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD 285 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSSSC--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred -CceEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEee
Confidence 45799999999999999987654 488999999999999999999999 59999999999999754 4599999
Q ss_pred cccccccCCCCcceeecccccccccChhhhcc---CCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhh
Q 046750 505 FGLAKLNDTTQTHVSTRVMGTFGYLAPEYASS---GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVL 581 (723)
Q Consensus 505 FGla~~~~~~~~~~~~~~~gt~~y~APE~~~~---~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l 581 (723)
||+++...... ......|+..|+|||++.+ ..++.++|||||||+||||++|+.||....... . +
T Consensus 286 FG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~--------~ 353 (419)
T 3i6u_A 286 FGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--S--------L 353 (419)
T ss_dssp SSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC--C--------H
T ss_pred cccceecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH--H--------H
Confidence 99998765322 2344679999999999863 568889999999999999999999997543221 1 1
Q ss_pred hhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 582 VRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 582 ~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
...+..+.+..+ +..... ....+.+|+.+||+.||.+||++.|+++.
T Consensus 354 ~~~i~~~~~~~~--~~~~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 354 KDQITSGKYNFI--PEVWAE----VSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp HHHHHTTCCCCC--HHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHhcCCCCCC--chhhcc----cCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 122222222111 111111 12367899999999999999999999875
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=360.27 Aligned_cols=246 Identities=22% Similarity=0.304 Sum_probs=202.7
Q ss_pred HHhcCcccceEEeccCcEEEEEEE-cCCCcEEEEEEcccCCch--------hHHHHHHHHHHHHHccCCceeeEeeeeec
Q 046750 357 EITNGFARENVIGEGGFGCVYKGN-LPEGKVVAVKQLKSGSGQ--------GEREFRAEVEIISRVHHRHLVSLVGYCIS 427 (723)
Q Consensus 357 ~~~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~VAvK~l~~~~~~--------~~~~~~~Ei~il~~l~HpnIv~l~g~~~~ 427 (723)
.+.++|.+.++||+|+||.||+|. ..+++.||||+++..... ....+.+|+++|++|+|+||++++++|.+
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 456789999999999999999995 567899999999765321 23357789999999999999999999999
Q ss_pred ccceEEEEEecCCC-chhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecc
Q 046750 428 EKNRLLIYEFVPNN-NLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFG 506 (723)
Q Consensus 428 ~~~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFG 506 (723)
.+..++||||+.+| +|.+++.... .+++..++.|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHTCC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecc
Confidence 99999999999777 9999997654 488999999999999999999999 59999999999999999999999999
Q ss_pred cccccCCCCcceeecccccccccChhhhccCCC-CCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhh
Q 046750 507 LAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKL-TDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAI 585 (723)
Q Consensus 507 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i 585 (723)
+++....... .....|+..|+|||++.+..+ +.++|||||||+||||++|+.||..... .+
T Consensus 176 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----------------~~ 237 (335)
T 3dls_A 176 SAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE----------------TV 237 (335)
T ss_dssp TCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG----------------GT
T ss_pred cceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH----------------HH
Confidence 9987654332 233569999999999988876 7899999999999999999999964211 00
Q ss_pred hcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 046750 586 ETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALD 636 (723)
Q Consensus 586 ~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~ 636 (723)
. ..+. ....+ ...+.+|+.+||+.||.+||++.+|++.-.
T Consensus 238 ~-~~~~------~~~~~----~~~l~~li~~~L~~dP~~Rps~~ell~hp~ 277 (335)
T 3dls_A 238 E-AAIH------PPYLV----SKELMSLVSGLLQPVPERRTTLEKLVTDPW 277 (335)
T ss_dssp T-TCCC------CSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHHCTT
T ss_pred h-hccC------CCccc----CHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 0 0000 00011 235788999999999999999999998643
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=350.44 Aligned_cols=258 Identities=26% Similarity=0.386 Sum_probs=195.1
Q ss_pred hcCcccceEEeccCcEEEEEEEcC----CCcEEEEEEcccCC--chhHHHHHHHHHHHHHccCCceeeEeeeeecccc--
Q 046750 359 TNGFARENVIGEGGFGCVYKGNLP----EGKVVAVKQLKSGS--GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKN-- 430 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~~----~g~~VAvK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~-- 430 (723)
.++|.+.++||+|+||.||+|.+. .++.||||+++... ....+.+.+|++++++++|+||++++++|.+...
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 112 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG 112 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-----
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccC
Confidence 467899999999999999999653 24589999997543 2334678999999999999999999999987653
Q ss_pred ---eEEEEEecCCCchhhcccc----CCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEe
Q 046750 431 ---RLLIYEFVPNNNLEHHLHG----KGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVA 503 (723)
Q Consensus 431 ---~~lV~E~~~~gsL~~~l~~----~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~ 503 (723)
.++||||+.+++|.+++.. .....+++..++.|+.||++||.|||++ +|+|||||++||||+.++.+||+
T Consensus 113 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl~ 189 (313)
T 3brb_A 113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVA 189 (313)
T ss_dssp --CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEEEC
T ss_pred CcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEEe
Confidence 4999999999999998843 2334589999999999999999999999 59999999999999999999999
Q ss_pred ecccccccCCCCcc-eeecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhh
Q 046750 504 DFGLAKLNDTTQTH-VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVL 581 (723)
Q Consensus 504 DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l 581 (723)
|||+++........ ......++..|+|||++.+..++.++|||||||+||||++ |+.||..... ..+.
T Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~------- 259 (313)
T 3brb_A 190 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN---HEMY------- 259 (313)
T ss_dssp SCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG---GGHH-------
T ss_pred ecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCH---HHHH-------
Confidence 99999765433222 1233457889999999999999999999999999999999 8888865432 1111
Q ss_pred hhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccC
Q 046750 582 VRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEG 639 (723)
Q Consensus 582 ~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~ 639 (723)
..+..+..... .......+.+++.+||+.||.+||++.+|++.|+.+.
T Consensus 260 -~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~ 307 (313)
T 3brb_A 260 -DYLLHGHRLKQ---------PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307 (313)
T ss_dssp -HHHHTTCCCCC---------BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -HHHHcCCCCCC---------CccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11112211111 1112236889999999999999999999999998764
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=357.23 Aligned_cols=267 Identities=24% Similarity=0.372 Sum_probs=198.9
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCc--hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSG--QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYE 436 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 436 (723)
++|++.++||+|+||.||+|+. .+++.||||++..... ...+.+.+|++++++++|+||++++++|.+....++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 6799999999999999999965 4589999999865432 234567899999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCc
Q 046750 437 FVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQT 516 (723)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 516 (723)
|+.+++|.+++.... .+++..++.|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++.......
T Consensus 105 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 179 (331)
T 4aaa_A 105 FVDHTILDDLELFPN--GLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 179 (331)
T ss_dssp CCSEEHHHHHHHSTT--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred cCCcchHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence 999999988876443 388999999999999999999999 599999999999999999999999999976543322
Q ss_pred ceeecccccccccChhhhccC-CCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhh----------hhhhh--
Q 046750 517 HVSTRVMGTFGYLAPEYASSG-KLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWAR----------PVLVR-- 583 (723)
Q Consensus 517 ~~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~----------~~l~~-- 583 (723)
......|+..|+|||++.+. .++.++|||||||+||||++|+.||...... ..+..... ..+..
T Consensus 180 -~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (331)
T 4aaa_A 180 -VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDI--DQLYHIMMCLGNLIPRHQELFNKNP 256 (331)
T ss_dssp -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCSCCHHHHHHHHHCG
T ss_pred -ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHHHhCCCChhhhhHhhhcc
Confidence 22335689999999999875 7899999999999999999999999765421 11111100 00000
Q ss_pred hhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 584 AIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 584 ~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
......+.++.+..............+.+|+.+||+.||.+||++.||++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000001111111111111111223468899999999999999999998864
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=346.40 Aligned_cols=250 Identities=23% Similarity=0.389 Sum_probs=182.6
Q ss_pred hcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCC---chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEE
Q 046750 359 TNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS---GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLI 434 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 434 (723)
.++|.+.+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 36799999999999999999965 578999999986432 12236789999999999999999999999999999999
Q ss_pred EEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCC
Q 046750 435 YEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTT 514 (723)
Q Consensus 435 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 514 (723)
|||+.+++|.+++.... ..+++..++.++.||++||+|||++ +|+|||||++||||+.++.+||+|||++......
T Consensus 90 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp EECCTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EecCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence 99999999999997643 3578999999999999999999999 5999999999999999999999999999865432
Q ss_pred CcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCccccc
Q 046750 515 QTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIV 594 (723)
Q Consensus 515 ~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~v 594 (723)
... .....|+..|+|||++.+..++.++|||||||+||||++|+.||........ ...+....+
T Consensus 166 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----------~~~~~~~~~---- 229 (278)
T 3cok_A 166 HEK-HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-----------LNKVVLADY---- 229 (278)
T ss_dssp ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------------CCSSCC----
T ss_pred CCc-ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-----------HHHHhhccc----
Confidence 221 2235689999999999998999999999999999999999999976432110 011111111
Q ss_pred chhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 595 DPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 595 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
.+... ....+.+++.+||+.||.+||++.+|++.
T Consensus 230 --~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 230 --EMPSF----LSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp --CCCTT----SCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred --CCccc----cCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 01111 12367889999999999999999999874
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=389.15 Aligned_cols=248 Identities=25% Similarity=0.400 Sum_probs=197.7
Q ss_pred ceEEeccCcEEEEEEEc---CCCcEEEEEEcccCC--chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEecC
Q 046750 365 ENVIGEGGFGCVYKGNL---PEGKVVAVKQLKSGS--GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVP 439 (723)
Q Consensus 365 ~~~LG~G~fG~Vy~~~~---~~g~~VAvK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 439 (723)
.++||+|+||.||+|.+ ..++.||||+++... ....++|.+|+++|++|+|+|||+++++|.. +..+|||||+.
T Consensus 374 ~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~ 452 (635)
T 4fl3_A 374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 452 (635)
T ss_dssp EEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccC
Confidence 35899999999999954 245789999997643 2335789999999999999999999999964 56899999999
Q ss_pred CCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcc--
Q 046750 440 NNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTH-- 517 (723)
Q Consensus 440 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~-- 517 (723)
+|+|.++|+... .+.+..++.|+.||+.||+|||++ +|||||||++||||++++.+||+|||+++.+......
T Consensus 453 ~g~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 453 LGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp TEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 999999997544 488999999999999999999999 5999999999999999999999999999876543322
Q ss_pred eeecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccch
Q 046750 518 VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDP 596 (723)
Q Consensus 518 ~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~ 596 (723)
......++..|+|||++.+..++.++||||||||||||++ |+.||..... .. +.+.+..+....+
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~---~~--------~~~~i~~~~~~~~--- 593 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SE--------VTAMLEKGERMGC--- 593 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HH--------HHHHHHTTCCCCC---
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH---HH--------HHHHHHcCCCCCC---
Confidence 2233456789999999999999999999999999999998 9999976432 11 1222333322111
Q ss_pred hhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhcc
Q 046750 597 RLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSE 638 (723)
Q Consensus 597 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~ 638 (723)
.......+.+|+.+||+.||.+||++.+|++.|+..
T Consensus 594 ------p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 594 ------PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp ------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ------CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 112234688999999999999999999999999864
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=356.19 Aligned_cols=260 Identities=23% Similarity=0.366 Sum_probs=207.4
Q ss_pred CHHHHHHHhcCcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCCc--------hhHHHHHHHHHHHHHc-cCCceee
Q 046750 351 TYEELMEITNGFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGSG--------QGEREFRAEVEIISRV-HHRHLVS 420 (723)
Q Consensus 351 ~~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~~--------~~~~~~~~Ei~il~~l-~HpnIv~ 420 (723)
.++....+.++|.+.+.||+|+||.||+|.+. +|+.||||+++.... ...+.+.+|+++++++ +|+||++
T Consensus 85 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 164 (365)
T 2y7j_A 85 DWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIIT 164 (365)
T ss_dssp HHHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCC
T ss_pred cchhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 34455667788999999999999999999764 799999999875431 1134678999999999 7999999
Q ss_pred EeeeeecccceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcE
Q 046750 421 LVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEA 500 (723)
Q Consensus 421 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~v 500 (723)
++++|......||||||+.+++|.+++.... .+.+..++.|+.||+.||.|||++ +|+|||||+.||||+.++.+
T Consensus 165 ~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~i 239 (365)
T 2y7j_A 165 LIDSYESSSFMFLVFDLMRKGELFDYLTEKV--ALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQI 239 (365)
T ss_dssp EEEEEEBSSEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCE
T ss_pred EEEEEeeCCEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCE
Confidence 9999999999999999999999999997543 488999999999999999999999 49999999999999999999
Q ss_pred EEeecccccccCCCCcceeecccccccccChhhhccC------CCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhH
Q 046750 501 QVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSG------KLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLV 574 (723)
Q Consensus 501 kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~------~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~ 574 (723)
||+|||++........ .....|+..|+|||++.+. .++.++|||||||+||||++|+.||..... ..
T Consensus 240 kl~DfG~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~---~~-- 312 (365)
T 2y7j_A 240 RLSDFGFSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ---IL-- 312 (365)
T ss_dssp EECCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HH--
T ss_pred EEEecCcccccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH---HH--
Confidence 9999999986654322 2345799999999998643 588899999999999999999999965321 11
Q ss_pred HhhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 575 EWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 575 ~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
+...+..+.+.. ..+.+ ..+ ...+.+++.+||+.||.+||++.+|++.
T Consensus 313 ------~~~~i~~~~~~~-~~~~~-~~~----~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 313 ------MLRMIMEGQYQF-SSPEW-DDR----SSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp ------HHHHHHHTCCCC-CHHHH-SSS----CHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ------HHHHHHhCCCCC-CCccc-ccC----CHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111222222111 00111 111 2357889999999999999999999874
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=342.84 Aligned_cols=247 Identities=20% Similarity=0.314 Sum_probs=199.6
Q ss_pred HhcCcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccC--CchhHHHHHHHHHHHHHc-cCCceeeEeeeeecccceEE
Q 046750 358 ITNGFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSG--SGQGEREFRAEVEIISRV-HHRHLVSLVGYCISEKNRLL 433 (723)
Q Consensus 358 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~--~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~l 433 (723)
+.++|++.++||+|+||.||+|... +++.||||+++.. ......++.+|+.++.++ +|+||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 4578999999999999999999654 7899999998764 334456788999999999 99999999999999999999
Q ss_pred EEEecCCCchhhccccCC--CCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCC---------------
Q 046750 434 IYEFVPNNNLEHHLHGKG--QPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDD--------------- 496 (723)
Q Consensus 434 V~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~--------------- 496 (723)
||||+.+++|.+++.... ...+++..++.|+.||+.||+|||++ +|+|||||++||||+.
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 999999999999997542 13588999999999999999999999 5999999999999984
Q ss_pred ----CCcEEEeecccccccCCCCcceeecccccccccChhhhccC-CCCCccceechHHHHHHHHhCCCCCCCCCCCCch
Q 046750 497 ----EFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSG-KLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDE 571 (723)
Q Consensus 497 ----~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~ 571 (723)
...+||+|||++....... ...|+..|+|||++.+. .++.++|||||||+||||++|..++... .
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-----~ 235 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG-----D 235 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS-----H
T ss_pred ccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch-----h
Confidence 4489999999998665432 23489999999999866 5668999999999999999998776422 1
Q ss_pred hhHHhhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 046750 572 SLVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRAL 635 (723)
Q Consensus 572 ~l~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L 635 (723)
.+ ..+..+.+..+ ...+ ...+.+++.+||+.||.+||++.||++.-
T Consensus 236 ~~---------~~~~~~~~~~~-----~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~h~ 281 (289)
T 1x8b_A 236 QW---------HEIRQGRLPRI-----PQVL----SQEFTELLKVMIHPDPERRPSAMALVKHS 281 (289)
T ss_dssp HH---------HHHHTTCCCCC-----SSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHTCT
T ss_pred HH---------HHHHcCCCCCC-----Cccc----CHHHHHHHHHHhCCCcccCCCHHHHhhCh
Confidence 11 11222222211 1112 23678899999999999999999998753
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=371.34 Aligned_cols=247 Identities=24% Similarity=0.371 Sum_probs=203.6
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCC---chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS---GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 435 (723)
++|.+.+.||+|+||.||+|+. .+|+.||||+++... ......+.+|+++|++++|+||+++++++.+....||||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 5799999999999999999965 478999999986532 123457889999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ 515 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 515 (723)
||+.+|+|.+++...+ .+++..++.|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++......
T Consensus 96 E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~ 170 (476)
T 2y94_A 96 EYVSGGELFDYICKNG--RLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170 (476)
T ss_dssp ECCSSEEHHHHTTSSS--SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence 9999999999997654 488999999999999999999999 59999999999999999999999999998765432
Q ss_pred cceeecccccccccChhhhccCCC-CCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCccccc
Q 046750 516 THVSTRVMGTFGYLAPEYASSGKL-TDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIV 594 (723)
Q Consensus 516 ~~~~~~~~gt~~y~APE~~~~~~~-t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~v 594 (723)
. ....+|+..|+|||++.+..+ +.++|||||||+||||++|+.||+.... .. +.+.+..+.+..
T Consensus 171 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~---~~--------~~~~i~~~~~~~-- 235 (476)
T 2y94_A 171 F--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV---PT--------LFKKICDGIFYT-- 235 (476)
T ss_dssp C--BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS---HH--------HHHHHHTTCCCC--
T ss_pred c--ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH---HH--------HHHHHhcCCcCC--
Confidence 2 234569999999999988765 6799999999999999999999975432 11 112222232210
Q ss_pred chhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 595 DPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 595 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
...+ ...+.+|+.+||+.||.+||++.||++.
T Consensus 236 ----p~~~----s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 236 ----PQYL----NPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp ----CTTC----CHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred ----CccC----CHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 0111 2357889999999999999999999973
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=345.35 Aligned_cols=251 Identities=27% Similarity=0.423 Sum_probs=206.1
Q ss_pred hcCcccceEEeccCcEEEEEEE-cCCCcEEEEEEcccCC-chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEE
Q 046750 359 TNGFARENVIGEGGFGCVYKGN-LPEGKVVAVKQLKSGS-GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYE 436 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~VAvK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 436 (723)
.+.|.+.+.||+|+||.||+|. ..+++.||||++.... ....+.+.+|+.++++++|+||++++++|.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 3569999999999999999995 4568999999997653 3445789999999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCc
Q 046750 437 FVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQT 516 (723)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 516 (723)
|+.+++|.+++... .+++..++.++.||+.||.|||++ +|+|||||++||||+.++.+||+|||++........
T Consensus 101 ~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 174 (303)
T 3a7i_A 101 YLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 174 (303)
T ss_dssp CCTTEEHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC
T ss_pred eCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcccc
Confidence 99999999999653 488999999999999999999999 599999999999999999999999999976654322
Q ss_pred ceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccch
Q 046750 517 HVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDP 596 (723)
Q Consensus 517 ~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~ 596 (723)
......|+..|+|||++.+..++.++|||||||+||||++|+.||..... .... ..+..+...
T Consensus 175 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~--------~~~~~~~~~----- 237 (303)
T 3a7i_A 175 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP---MKVL--------FLIPKNNPP----- 237 (303)
T ss_dssp -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHH--------HHHHHSCCC-----
T ss_pred -ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH---HHHH--------HHhhcCCCC-----
Confidence 22345689999999999999999999999999999999999999975431 1111 111111111
Q ss_pred hhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 046750 597 RLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALD 636 (723)
Q Consensus 597 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~ 636 (723)
.+...+ ...+.+|+.+||+.||.+||++.+|++...
T Consensus 238 ~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~~~ 273 (303)
T 3a7i_A 238 TLEGNY----SKPLKEFVEACLNKEPSFRPTAKELLKHKF 273 (303)
T ss_dssp CCCSSC----CHHHHHHHHHHCCSSGGGSCCHHHHTTCHH
T ss_pred CCcccc----CHHHHHHHHHHcCCChhhCcCHHHHhhChh
Confidence 111222 235789999999999999999999987643
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=357.47 Aligned_cols=257 Identities=28% Similarity=0.455 Sum_probs=202.9
Q ss_pred cCcccceEEeccCcEEEEEEEcC-CCcE--EEEEEcccCC-chhHHHHHHHHHHHHHc-cCCceeeEeeeeecccceEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLP-EGKV--VAVKQLKSGS-GQGEREFRAEVEIISRV-HHRHLVSLVGYCISEKNRLLI 434 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~--VAvK~l~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV 434 (723)
++|++.++||+|+||.||+|+.. +++. ||||+++... ....+.+.+|+++|+++ +|+||+++++++.+.+..+||
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 57899999999999999999653 4554 4999987542 23445789999999999 899999999999999999999
Q ss_pred EEecCCCchhhccccCC--------------CCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcE
Q 046750 435 YEFVPNNNLEHHLHGKG--------------QPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEA 500 (723)
Q Consensus 435 ~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~v 500 (723)
|||+.+++|.+++.... ...+.+..++.|+.||+.||+|||++ +|+|||||++||||+.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeE
Confidence 99999999999997643 23588999999999999999999999 59999999999999999999
Q ss_pred EEeecccccccCCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhh
Q 046750 501 QVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARP 579 (723)
Q Consensus 501 kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~ 579 (723)
||+|||+++...... ......++..|+|||++.+..++.++|||||||+||||++ |+.||..... ..
T Consensus 182 kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~---~~------- 249 (327)
T 1fvr_A 182 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AE------- 249 (327)
T ss_dssp EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HH-------
T ss_pred EEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH---HH-------
Confidence 999999997432211 1222346889999999999889999999999999999998 9999975431 11
Q ss_pred hhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCCC
Q 046750 580 VLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEM 641 (723)
Q Consensus 580 ~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~~ 641 (723)
+.+.+..+.... ........+.+|+.+||+.||.+||++.+|++.|+.+...
T Consensus 250 -~~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 301 (327)
T 1fvr_A 250 -LYEKLPQGYRLE---------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 301 (327)
T ss_dssp -HHHHGGGTCCCC---------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred -HHHHhhcCCCCC---------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 112222221110 0111123688999999999999999999999999876543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=359.12 Aligned_cols=199 Identities=28% Similarity=0.468 Sum_probs=173.9
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCc-hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEe
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSG-QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEF 437 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 437 (723)
++|.+.++||+|+||.||+|.. .+++.||||+++.... ...+.+.+|+++|++++|+||++++++|.+.+..+|||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 5799999999999999999965 4689999999986533 3346789999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcc
Q 046750 438 VPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTH 517 (723)
Q Consensus 438 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 517 (723)
+.+++|.+++.... .+.+..++.|+.+|+.||+|||+.. +|+|||||++||||+.++.+||+|||++......
T Consensus 113 ~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 185 (360)
T 3eqc_A 113 MDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 185 (360)
T ss_dssp CTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---
T ss_pred CCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccc---
Confidence 99999999997654 3788999999999999999999852 4999999999999999999999999999654321
Q ss_pred eeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCC
Q 046750 518 VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPT 565 (723)
Q Consensus 518 ~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~ 565 (723)
......|+..|+|||++.+..++.++|||||||+||||++|+.||...
T Consensus 186 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 233 (360)
T 3eqc_A 186 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 233 (360)
T ss_dssp C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 123356899999999999999999999999999999999999999754
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=348.10 Aligned_cols=248 Identities=22% Similarity=0.369 Sum_probs=202.9
Q ss_pred cCcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCC---chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGS---GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 435 (723)
++|.+.++||+|+||.||++... +++.||+|++.... ....+.+.+|++++++++|+||++++++|.+.+..++||
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence 67999999999999999999654 57899999986542 234467889999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ 515 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 515 (723)
||+.+++|.+++.... .+++..++.|+.||++||+|||++ +|+|||||++||||+.++.+||+|||++.......
T Consensus 95 e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 95 ELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp ECCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred ecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence 9999999999886543 478999999999999999999999 59999999999999999999999999998654322
Q ss_pred cceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccc
Q 046750 516 THVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVD 595 (723)
Q Consensus 516 ~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd 595 (723)
. ......|+..|+|||++.+..++.++|||||||+||||++|+.||..... . +. ...+..+.+.
T Consensus 170 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~---~~-----~~~~~~~~~~---- 233 (294)
T 2rku_A 170 E-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL---K---ET-----YLRIKKNEYS---- 233 (294)
T ss_dssp C-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH---H---HH-----HHHHHTTCCC----
T ss_pred c-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---H---HH-----HHHHhhccCC----
Confidence 2 22335689999999999999999999999999999999999999975431 1 11 1111112110
Q ss_pred hhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 596 PRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 596 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
+...+ ...+.+++.+||+.||.+||++.||++.
T Consensus 234 --~~~~~----~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 234 --IPKHI----NPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp --CCTTS----CHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred --Ccccc----CHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 11111 2357789999999999999999999874
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=353.96 Aligned_cols=273 Identities=21% Similarity=0.297 Sum_probs=199.3
Q ss_pred CHHHHHHHhcCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCch-----------hHHHHHHHHHHHHHccCCcee
Q 046750 351 TYEELMEITNGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQ-----------GEREFRAEVEIISRVHHRHLV 419 (723)
Q Consensus 351 ~~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~-----------~~~~~~~Ei~il~~l~HpnIv 419 (723)
...++..+.++|.+.++||+|+||.||+|...+|+.||||++...... ..+.+.+|+++|++++|+||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 356778889999999999999999999998888999999998653221 126789999999999999999
Q ss_pred eEeeeeecc-----cceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEe
Q 046750 420 SLVGYCISE-----KNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILV 494 (723)
Q Consensus 420 ~l~g~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl 494 (723)
+++++|... ...|+||||+. |+|.+++.... ..+++..++.|+.||+.||+|||++ +|+|||||++||||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR-IVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILL 167 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEE
Confidence 999998543 35799999996 68888876543 3588999999999999999999999 59999999999999
Q ss_pred CCCCcEEEeecccccccCCCCcceeecccccccccChhhhcc-CCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhh
Q 046750 495 DDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASS-GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESL 573 (723)
Q Consensus 495 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l 573 (723)
+.++.+||+|||+++...... ......|+..|+|||++.+ ..++.++|||||||+||||++|+.||...... ..+
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~ 243 (362)
T 3pg1_A 168 ADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY--NQL 243 (362)
T ss_dssp CTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHH
T ss_pred cCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH--HHH
Confidence 999999999999997543322 2234568999999999887 67999999999999999999999999764321 000
Q ss_pred HHhh---------------hhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 574 VEWA---------------RPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 574 ~~~~---------------~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
.... .......+ ...+..+....+ ..........+.+|+.+||+.||.+||++.||++.
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 244 NKIVEVVGTPKIEDVVMFSSPSARDYL-RNSLSNVPARAW-TAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHHHCCCCHHHHHHTSCHHHHHHT-TTCCCCCCCCCH-HHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHcCCCChHHhhhccchhhhHHH-HhhcccCChhhH-HhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 0000 00000000 001111100000 01111123457899999999999999999999974
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=353.22 Aligned_cols=265 Identities=21% Similarity=0.367 Sum_probs=193.8
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCchh-HHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEe
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQG-EREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEF 437 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~~-~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 437 (723)
++|.+.++||+|+||.||+|+. .+++.||||+++...... ...+.+|+++|++++|+||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 5799999999999999999965 478999999997543221 12456799999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcc
Q 046750 438 VPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTH 517 (723)
Q Consensus 438 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 517 (723)
+. |+|.+++..... .+++..++.|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++.......
T Consensus 82 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~- 155 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGN-IINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK- 155 (324)
T ss_dssp CS-EEHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred cc-cCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCcc-
Confidence 96 689888876543 588899999999999999999999 599999999999999999999999999976543322
Q ss_pred eeecccccccccChhhhcc-CCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccch
Q 046750 518 VSTRVMGTFGYLAPEYASS-GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDP 596 (723)
Q Consensus 518 ~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~ 596 (723)
......|+..|+|||++.+ ..++.++|||||||+||||++|+.||..... ..........+.. .....+..+.+.
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~i~~~~~~-~~~~~~~~~~~~ 231 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV---EEQLHFIFRILGT-PTEETWPGILSN 231 (324)
T ss_dssp -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCC-CCTTTSTTGGGC
T ss_pred ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCC-CChHhchhhhcc
Confidence 2233468999999999876 5689999999999999999999999976532 1111111100000 000000000000
Q ss_pred ---------hhh----ccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 597 ---------RLE----KHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 597 ---------~l~----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
... ..........+.+|+.+||+.||.+||++.||++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000 00001112357899999999999999999999873
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=345.52 Aligned_cols=252 Identities=23% Similarity=0.352 Sum_probs=197.3
Q ss_pred CcccceEEeccCcEEEEEEE-cCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEecC
Q 046750 361 GFARENVIGEGGFGCVYKGN-LPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVP 439 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~-~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 439 (723)
.|....+||+|+||.||+|. ..+++.||||++........+.+.+|+.++++++|+||++++++|.+.+..++||||+.
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 34556699999999999996 45688999999987766666789999999999999999999999999999999999999
Q ss_pred CCchhhccccCC-CCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCC-CCcEEEeecccccccCCCCcc
Q 046750 440 NNNLEHHLHGKG-QPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDD-EFEAQVADFGLAKLNDTTQTH 517 (723)
Q Consensus 440 ~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~-~~~vkL~DFGla~~~~~~~~~ 517 (723)
+++|.+++.... ...+.+..++.++.||+.||+|||++ +|+|||||++||||+. ++.+||+|||++........
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~- 178 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP- 178 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCC-
Confidence 999999997643 33467888899999999999999999 5999999999999987 89999999999986543322
Q ss_pred eeecccccccccChhhhccCC--CCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccc
Q 046750 518 VSTRVMGTFGYLAPEYASSGK--LTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVD 595 (723)
Q Consensus 518 ~~~~~~gt~~y~APE~~~~~~--~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd 595 (723)
......|+..|+|||++.+.. ++.++|||||||+||||++|+.||..... .....+.. . .....
T Consensus 179 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~~~-----~-~~~~~----- 244 (295)
T 2clq_A 179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE---PQAAMFKV-----G-MFKVH----- 244 (295)
T ss_dssp --CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSS---HHHHHHHH-----H-HHCCC-----
T ss_pred cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCc---hhHHHHhh-----c-ccccc-----
Confidence 123456899999999997654 88999999999999999999999964321 11111100 0 00000
Q ss_pred hhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 596 PRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 596 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
..+ .......+.+++.+||+.||.+||++.+|++.
T Consensus 245 ~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 245 PEI----PESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp CCC----CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred ccc----cccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 011 11122367889999999999999999999864
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=362.17 Aligned_cols=253 Identities=12% Similarity=0.077 Sum_probs=181.7
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCc---hhHHHHHHHHHHHHHc--cCCceeeEe-------eeee
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSG---QGEREFRAEVEIISRV--HHRHLVSLV-------GYCI 426 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~---~~~~~~~~Ei~il~~l--~HpnIv~l~-------g~~~ 426 (723)
..|.+.++||+|+||.||+|.+ .+++.||||+++.... ...+.+++|+++++.| +|+||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 4588999999999999999964 5789999999987543 2345678887666666 599988755 3333
Q ss_pred cc-----------------cceEEEEEecCCCchhhccccCCCCcchHHHH------HHHHHHHHhhhchhcccCCCcee
Q 046750 427 SE-----------------KNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKR------VKIALGAAKGLAYLHEDCHPKII 483 (723)
Q Consensus 427 ~~-----------------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~------~~i~~~ia~gL~yLH~~g~~~iv 483 (723)
.. ...||||||+. |+|.+++...+. .+.+..+ +.|+.||++||+|||++ +||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~iv 216 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAANLQSK---GLV 216 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCc
Confidence 22 33799999998 999999976432 2455566 78889999999999999 599
Q ss_pred ecCCCCCcEEeCCCCcEEEeecccccccCCCCcceeecccccccccChhhhcc--CCCCCccceechHHHHHHHHhCCCC
Q 046750 484 HRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASS--GKLTDRSDVFSFGVVLLELITGRKP 561 (723)
Q Consensus 484 HrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~t~ksDVwSlGviL~eLltG~~P 561 (723)
|||||++||||+.++.+||+|||+++..... .....++..|+|||++.+ ..++.++|||||||+||||++|+.|
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~P 292 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999866432 113457799999999987 6799999999999999999999999
Q ss_pred CCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 046750 562 VDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVR 633 (723)
Q Consensus 562 ~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~ 633 (723)
|......... .|....+ .......+...........+.+|+.+||+.||.+||++.++++
T Consensus 293 f~~~~~~~~~---~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 293 FGLVTPGIKG---SWKRPSL---------RVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp TTBCCTTCTT---CCCBCCT---------TSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCcCccccc---chhhhhh---------hhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 9765432111 1111000 0000001111111122346888999999999999999999875
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=352.03 Aligned_cols=267 Identities=23% Similarity=0.313 Sum_probs=197.1
Q ss_pred HHhcCcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCCch-----hHHHHHHHHHHHHHccCCceeeEeeeeecccc
Q 046750 357 EITNGFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGSGQ-----GEREFRAEVEIISRVHHRHLVSLVGYCISEKN 430 (723)
Q Consensus 357 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~~~-----~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 430 (723)
...++|.+.++||+|+||.||+|... +|+.||||+++..... ..+.+.+|+++|++|+|+||++++++|.+...
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 44578999999999999999999664 5899999999753221 12468899999999999999999999999999
Q ss_pred eEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccc
Q 046750 431 RLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKL 510 (723)
Q Consensus 431 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 510 (723)
.++||||+.+ +|.+++.... ..+++..++.++.||++||+|||++ +|+|||||++||||+.++.+||+|||+++.
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred eEEEEEcCCC-CHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 9999999965 8888886543 3578889999999999999999999 499999999999999999999999999986
Q ss_pred cCCCCcceeecccccccccChhhhccC-CCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcC-
Q 046750 511 NDTTQTHVSTRVMGTFGYLAPEYASSG-KLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETG- 588 (723)
Q Consensus 511 ~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~- 588 (723)
...... ......|+..|+|||++.+. .++.++|||||||+||||++|..+|..... ...+... .+.....
T Consensus 162 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~--~~~~~~i-----~~~~~~~~ 233 (346)
T 1ua2_A 162 FGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD--LDQLTRI-----FETLGTPT 233 (346)
T ss_dssp TTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHH-----HHHHCCCC
T ss_pred ccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH--HHHHHHH-----HHHcCCCC
Confidence 643322 23345689999999999764 489999999999999999999999876432 1111111 1110000
Q ss_pred --Ccc---cccchhh---hc-----cccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 046750 589 --DLS---EIVDPRL---EK-----HYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALD 636 (723)
Q Consensus 589 --~l~---~~vd~~l---~~-----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~ 636 (723)
.+. .+.+... .. .........+.+|+.+||+.||.+||++.||++.-.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~ 294 (346)
T 1ua2_A 234 EEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294 (346)
T ss_dssp TTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGG
T ss_pred hhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChh
Confidence 000 0000000 00 000112346889999999999999999999998654
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=349.94 Aligned_cols=254 Identities=22% Similarity=0.339 Sum_probs=197.7
Q ss_pred HHhcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCc--------hhHHHHHHHHHHHHHccCCceeeEeeeeec
Q 046750 357 EITNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSG--------QGEREFRAEVEIISRVHHRHLVSLVGYCIS 427 (723)
Q Consensus 357 ~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~--------~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~ 427 (723)
.+.++|.+.+.||+|+||.||+|.. .+++.||||++..... .....+.+|+++|++|+|+||+++++++..
T Consensus 7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 86 (322)
T 2ycf_A 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 86 (322)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence 3557899999999999999999955 5688999999865321 122358899999999999999999999876
Q ss_pred ccceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCc---EEEee
Q 046750 428 EKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFE---AQVAD 504 (723)
Q Consensus 428 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~---vkL~D 504 (723)
.. .|+||||+.+++|.+++.... .+.+..++.++.||+.||+|||++ +|+|||||++||||+.++. +||+|
T Consensus 87 ~~-~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 87 ED-YYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp SS-EEEEEECCTTEETHHHHSTTC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred Cc-eEEEEecCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEcc
Confidence 54 899999999999999987543 488899999999999999999999 5999999999999987654 99999
Q ss_pred cccccccCCCCcceeecccccccccChhhhc---cCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhh
Q 046750 505 FGLAKLNDTTQTHVSTRVMGTFGYLAPEYAS---SGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVL 581 (723)
Q Consensus 505 FGla~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l 581 (723)
||+++...... ......|+..|+|||++. ...++.++|||||||+||||++|+.||....... .+
T Consensus 161 fg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~-------- 228 (322)
T 2ycf_A 161 FGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SL-------- 228 (322)
T ss_dssp CTTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CH--------
T ss_pred Cccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HH--------
Confidence 99998664322 123356899999999974 5678999999999999999999999997644321 11
Q ss_pred hhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 582 VRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 582 ~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
...+..+.+..+ +.+...+ ...+.+|+.+||+.||.+||++.+|++.
T Consensus 229 ~~~~~~~~~~~~--~~~~~~~----~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 229 KDQITSGKYNFI--PEVWAEV----SEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp HHHHHHTCCCCC--HHHHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHhCccccC--chhhhhc----CHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 111222221110 1111111 2367899999999999999999999864
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=340.39 Aligned_cols=249 Identities=26% Similarity=0.413 Sum_probs=197.2
Q ss_pred CcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccC--CchhHHHHHHHHHHHHHccCCceeeEeeeeec----ccceEE
Q 046750 361 GFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSG--SGQGEREFRAEVEIISRVHHRHLVSLVGYCIS----EKNRLL 433 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~----~~~~~l 433 (723)
.|.+.+.||+|+||.||+|.. .++..||||++... .....+.+.+|+++|++++|+||++++++|.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 378889999999999999954 56789999998754 23345678999999999999999999999875 355799
Q ss_pred EEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeC-CCCcEEEeecccccccC
Q 046750 434 IYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVD-DEFEAQVADFGLAKLND 512 (723)
Q Consensus 434 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~-~~~~vkL~DFGla~~~~ 512 (723)
||||+.+++|.+++.... .+.+..++.|+.||+.||+|||+++ .+|+|||||++||||+ +++.+||+|||++....
T Consensus 107 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEecCCCCHHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 999999999999997643 4788999999999999999999982 1299999999999998 78999999999997554
Q ss_pred CCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCccc
Q 046750 513 TTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSE 592 (723)
Q Consensus 513 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~ 592 (723)
... .....|+..|+|||++. +.++.++|||||||+||||++|+.||..... ...+ ...+..+....
T Consensus 184 ~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--~~~~--------~~~~~~~~~~~ 249 (290)
T 1t4h_A 184 ASF---AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQI--------YRRVTSGVKPA 249 (290)
T ss_dssp TTS---BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--HHHH--------HHHHTTTCCCG
T ss_pred ccc---cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCc--HHHH--------HHHHhccCCcc
Confidence 332 23456899999999886 5699999999999999999999999975432 1111 11122221111
Q ss_pred ccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 593 IVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 593 ~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
.+.... ...+.+|+.+||+.||.+||++.||++.
T Consensus 250 ----~~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 250 ----SFDKVA----IPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp ----GGGGCC----CHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ----ccCCCC----CHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 111111 2357899999999999999999999874
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=344.63 Aligned_cols=246 Identities=27% Similarity=0.423 Sum_probs=201.9
Q ss_pred cCcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCC---chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGS---GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 435 (723)
++|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++|+||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 67999999999999999999654 57899999986431 123467899999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ 515 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 515 (723)
||+.+++|.+++.... .+++..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||++.......
T Consensus 94 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 168 (284)
T 2vgo_A 94 EFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR 168 (284)
T ss_dssp CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC
T ss_pred EeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcccc
Confidence 9999999999997654 378899999999999999999999 59999999999999999999999999997654322
Q ss_pred cceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccc
Q 046750 516 THVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVD 595 (723)
Q Consensus 516 ~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd 595 (723)
.....|+..|+|||++.+..++.++|||||||+||||++|+.||..... . +. .+.+....+.
T Consensus 169 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~---~~-----~~~~~~~~~~---- 230 (284)
T 2vgo_A 169 ---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH---T---ET-----HRRIVNVDLK---- 230 (284)
T ss_dssp ---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH---H---HH-----HHHHHTTCCC----
T ss_pred ---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH---h---HH-----HHHHhccccC----
Confidence 2335689999999999999999999999999999999999999975431 1 11 1111111110
Q ss_pred hhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 596 PRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 596 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
+...+ ...+.+++.+||+.||.+||++.+|++.
T Consensus 231 --~~~~~----~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 231 --FPPFL----SDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp --CCTTS----CHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred --CCCcC----CHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 11111 2357889999999999999999999863
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=366.22 Aligned_cols=240 Identities=15% Similarity=0.203 Sum_probs=188.0
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccC---CchhHHHHHHHHH---HHHHccCCceeeEe-------eee
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSG---SGQGEREFRAEVE---IISRVHHRHLVSLV-------GYC 425 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~---~~~~~~~~~~Ei~---il~~l~HpnIv~l~-------g~~ 425 (723)
++|.+.++||+|+||.||+|.. .+|+.||||+++.. .....+.|.+|++ +|++++|+|||+++ +++
T Consensus 73 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~ 152 (377)
T 3byv_A 73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 152 (377)
T ss_dssp EEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEE
T ss_pred ceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhh
Confidence 5789999999999999999975 56899999999743 3345578899994 55555899999998 555
Q ss_pred eccc-----------------ceEEEEEecCCCchhhccccCC-----CCcchHHHHHHHHHHHHhhhchhcccCCCcee
Q 046750 426 ISEK-----------------NRLLIYEFVPNNNLEHHLHGKG-----QPVLEWTKRVKIALGAAKGLAYLHEDCHPKII 483 (723)
Q Consensus 426 ~~~~-----------------~~~lV~E~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~iv 483 (723)
.+.+ ..||||||+ +|+|.+++.... ...+.+..++.|+.||++||+|||++ +||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iv 228 (377)
T 3byv_A 153 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLV 228 (377)
T ss_dssp ECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred hccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 5443 278999999 789999997532 22355688899999999999999999 599
Q ss_pred ecCCCCCcEEeCCCCcEEEeecccccccCCCCcceeecccccccccChhhhccC-----------CCCCccceechHHHH
Q 046750 484 HRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSG-----------KLTDRSDVFSFGVVL 552 (723)
Q Consensus 484 HrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~-----------~~t~ksDVwSlGviL 552 (723)
||||||+||||+.++.+||+|||+++.... ......| ..|+|||++.+. .++.++|||||||+|
T Consensus 229 HrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il 303 (377)
T 3byv_A 229 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI 303 (377)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHH
T ss_pred cCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHH
Confidence 999999999999999999999999985432 2334567 999999999887 899999999999999
Q ss_pred HHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHH
Q 046750 553 LELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVV 632 (723)
Q Consensus 553 ~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl 632 (723)
|||++|+.||........ . ..+... . ..+ ...+.+|+.+||+.||.+||++.||+
T Consensus 304 ~elltg~~Pf~~~~~~~~---~--------~~~~~~-~---------~~~----~~~~~~li~~~L~~dp~~Rpt~~e~l 358 (377)
T 3byv_A 304 YWIWCADLPITKDAALGG---S--------EWIFRS-C---------KNI----PQPVRALLEGFLRYPKEDRLLPLQAM 358 (377)
T ss_dssp HHHHHSSCCC------CC---S--------GGGGSS-C---------CCC----CHHHHHHHHHHTCSSGGGCCCHHHHH
T ss_pred HHHHHCCCCCcccccccc---h--------hhhhhh-c---------cCC----CHHHHHHHHHHcCCCchhCCCHHHHh
Confidence 999999999965432110 0 000000 0 111 23578899999999999999999998
Q ss_pred H
Q 046750 633 R 633 (723)
Q Consensus 633 ~ 633 (723)
+
T Consensus 359 ~ 359 (377)
T 3byv_A 359 E 359 (377)
T ss_dssp T
T ss_pred h
Confidence 6
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=347.41 Aligned_cols=261 Identities=18% Similarity=0.277 Sum_probs=199.5
Q ss_pred cCcccceEEeccCcEEEEEEE-cCCCcEEEEEEcccCCchhHHHHHHHHHHHHHcc-CCceeeEeeeeec--ccceEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGN-LPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVH-HRHLVSLVGYCIS--EKNRLLIY 435 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~-~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~--~~~~~lV~ 435 (723)
++|++.++||+|+||.||+|. ..+++.||||+++.. ..+.+.+|+++|++|+ |+||+++++++.+ ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 679999999999999999995 567899999999753 3467899999999997 9999999999987 66789999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCC-cEEEeecccccccCCC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEF-EAQVADFGLAKLNDTT 514 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~-~vkL~DFGla~~~~~~ 514 (723)
||+.+++|.+++.. +.+..++.|+.||+.||+|||++ +|+|||||++||||+.++ .+||+|||+++.....
T Consensus 113 e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 113 EHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184 (330)
T ss_dssp ECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred eccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence 99999999999853 67888999999999999999999 599999999999999776 8999999999866543
Q ss_pred CcceeecccccccccChhhhcc-CCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhh----hhhhhhhcCC
Q 046750 515 QTHVSTRVMGTFGYLAPEYASS-GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARP----VLVRAIETGD 589 (723)
Q Consensus 515 ~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~----~l~~~i~~~~ 589 (723)
.. .....|+..|+|||++.+ ..++.++|||||||+||||++|+.||...... ...+...... .+...+....
T Consensus 185 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~-~~~l~~~~~~~~~~~~~~~~~~~~ 261 (330)
T 3nsz_A 185 QE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN-YDQLVRIAKVLGTEDLYDYIDKYN 261 (330)
T ss_dssp CC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH-HHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred Cc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCch-HHHHHHHHHhcCCchhhhHHHHhc
Confidence 32 233468999999999987 67999999999999999999999999654321 1111111110 0011111110
Q ss_pred c--------------ccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 590 L--------------SEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 590 l--------------~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
+ ....+..+...........+.+|+.+||+.||.+||++.||++.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0 00000001111111123468899999999999999999999974
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=348.65 Aligned_cols=254 Identities=24% Similarity=0.442 Sum_probs=197.2
Q ss_pred HHhcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCchhHHHHHHHHHHHHHc-cCCceeeEeeeeec------c
Q 046750 357 EITNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQGEREFRAEVEIISRV-HHRHLVSLVGYCIS------E 428 (723)
Q Consensus 357 ~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~------~ 428 (723)
...++|++.++||+|+||.||+|+. .+++.||||++.... .....+.+|+.+++++ +|+||+++++++.. .
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 99 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 99 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCC
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcccc
Confidence 3457899999999999999999965 578999999987543 3456889999999999 89999999999986 4
Q ss_pred cceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccc
Q 046750 429 KNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLA 508 (723)
Q Consensus 429 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla 508 (723)
...++||||+.+++|.+++.......+.+..++.|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||++
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 176 (326)
T 2x7f_A 100 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVS 176 (326)
T ss_dssp CEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCTTT
T ss_pred ceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCcCc
Confidence 5789999999999999999865545688899999999999999999999 5999999999999999999999999999
Q ss_pred cccCCCCcceeecccccccccChhhhc-----cCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhh
Q 046750 509 KLNDTTQTHVSTRVMGTFGYLAPEYAS-----SGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVR 583 (723)
Q Consensus 509 ~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~ 583 (723)
........ ......|+..|+|||++. +..++.++|||||||+||||++|+.||..... .... .
T Consensus 177 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~--------~ 244 (326)
T 2x7f_A 177 AQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP---MRAL--------F 244 (326)
T ss_dssp C--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH---HHHH--------H
T ss_pred eecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH---HHHH--------H
Confidence 76543221 123356899999999997 56789999999999999999999999965431 1110 0
Q ss_pred hhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 584 AIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 584 ~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
.+..+....+.. ..+ ...+.+++.+||..||.+||++.+|++.
T Consensus 245 ~~~~~~~~~~~~----~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 245 LIPRNPAPRLKS----KKW----SKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp HHHHSCCCCCSC----SCS----CHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HhhcCccccCCc----ccc----CHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 111111111111 111 2367889999999999999999999874
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=364.05 Aligned_cols=262 Identities=25% Similarity=0.348 Sum_probs=193.4
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecc------cceE
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISE------KNRL 432 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~------~~~~ 432 (723)
.+|.+.++||+|+||.||+|++ .+|+.||||++.... +.+.+|+++|++|+|+|||+++++|... ...+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 4688999999999999999966 468999999987542 2345799999999999999999998542 2357
Q ss_pred EEEEecCCCchhhcccc--CCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCC-CcEEEeeccccc
Q 046750 433 LIYEFVPNNNLEHHLHG--KGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDE-FEAQVADFGLAK 509 (723)
Q Consensus 433 lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~-~~vkL~DFGla~ 509 (723)
|||||+.+ +|.+++.. .....+.+..++.|+.||++||+|||++ +|||||||++||||+.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 89999965 66655532 2234588999999999999999999998 59999999999999955 678999999998
Q ss_pred ccCCCCcceeecccccccccChhhhccC-CCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhh------hh
Q 046750 510 LNDTTQTHVSTRVMGTFGYLAPEYASSG-KLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPV------LV 582 (723)
Q Consensus 510 ~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~------l~ 582 (723)
....... ....+|+..|+|||++.+. .++.++||||||||||||++|+.||..... ...+..+...+ ..
T Consensus 206 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~--~~~l~~i~~~lg~p~~~~~ 281 (420)
T 1j1b_A 206 QLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG--VDQLVEIIKVLGTPTREQI 281 (420)
T ss_dssp ECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHHHCSCCHHHH
T ss_pred hcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCCHHHH
Confidence 6643322 2345689999999999765 799999999999999999999999976532 12222221100 00
Q ss_pred hhhhcCCcccccchh-----hhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 583 RAIETGDLSEIVDPR-----LEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 583 ~~i~~~~l~~~vd~~-----l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
..+ ..++.++..+. +...+.......+.+|+.+||..||.+||++.|+++.
T Consensus 282 ~~~-~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 282 REM-NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHH-CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred Hhh-ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 001 11111111111 1111122223468899999999999999999999864
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=355.39 Aligned_cols=259 Identities=19% Similarity=0.308 Sum_probs=205.3
Q ss_pred hcCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchh-----------------HHHHHHHHHHHHHccCCceeeE
Q 046750 359 TNGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQG-----------------EREFRAEVEIISRVHHRHLVSL 421 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~-----------------~~~~~~Ei~il~~l~HpnIv~l 421 (723)
.++|.+.+.||+|+||.||+|.. +++.||||++....... .+.|.+|++++++|+|+||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 36799999999999999999988 99999999986431111 1789999999999999999999
Q ss_pred eeeeecccceEEEEEecCCCchhhc------cccCCCCcchHHHHHHHHHHHHhhhchhcc-cCCCceeecCCCCCcEEe
Q 046750 422 VGYCISEKNRLLIYEFVPNNNLEHH------LHGKGQPVLEWTKRVKIALGAAKGLAYLHE-DCHPKIIHRDIKSANILV 494 (723)
Q Consensus 422 ~g~~~~~~~~~lV~E~~~~gsL~~~------l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~g~~~ivHrDIkp~NILl 494 (723)
++++.+.+..++||||+.+++|.++ +.......+++..++.|+.||+.||+|||+ + +|+|||||++||||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILM 185 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEE
Confidence 9999999999999999999999999 665445678999999999999999999998 7 59999999999999
Q ss_pred CCCCcEEEeecccccccCCCCcceeecccccccccChhhhccC-CCCC-ccceechHHHHHHHHhCCCCCCCCCCCCchh
Q 046750 495 DDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSG-KLTD-RSDVFSFGVVLLELITGRKPVDPTQPLGDES 572 (723)
Q Consensus 495 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~-ksDVwSlGviL~eLltG~~P~~~~~~~~~~~ 572 (723)
+.++.+||+|||++...... ......|+..|+|||++.+. .++. ++|||||||+||||++|+.||...... ..
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~ 260 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL--VE 260 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS--HH
T ss_pred cCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH--HH
Confidence 99999999999999865433 23445689999999999877 6666 999999999999999999999765431 11
Q ss_pred hHHhhhhhhhhhhhcCCcccccc------hhhh---ccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 573 LVEWARPVLVRAIETGDLSEIVD------PRLE---KHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 573 l~~~~~~~l~~~i~~~~l~~~vd------~~l~---~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
+. +.+..+.+....+ .... ..........+.+|+.+||+.||.+||++.||++.
T Consensus 261 ~~--------~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 261 LF--------NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp HH--------HHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HH--------HHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11 1122221111100 0000 00001123467899999999999999999999874
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=345.91 Aligned_cols=253 Identities=20% Similarity=0.304 Sum_probs=198.9
Q ss_pred HhcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCC----chhHHHHHHHHHHHHHccCCceeeEeeeee--cccc
Q 046750 358 ITNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS----GQGEREFRAEVEIISRVHHRHLVSLVGYCI--SEKN 430 (723)
Q Consensus 358 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~--~~~~ 430 (723)
+.++|.+.++||+|+||.||++.. .+++.||||+++... ......+.+|++++++|+|+||+++++++. +...
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 457899999999999999999965 568899999987532 234567899999999999999999999984 4557
Q ss_pred eEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccc
Q 046750 431 RLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKL 510 (723)
Q Consensus 431 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 510 (723)
.++||||+.++ |.+++.......+++..++.|+.||++||+|||++ +|+|||||++||||+.++.+||+|||++..
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccc
Confidence 89999999776 77777665555689999999999999999999999 599999999999999999999999999986
Q ss_pred cCCCC-cceeecccccccccChhhhccCC--CCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhc
Q 046750 511 NDTTQ-THVSTRVMGTFGYLAPEYASSGK--LTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIET 587 (723)
Q Consensus 511 ~~~~~-~~~~~~~~gt~~y~APE~~~~~~--~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~ 587 (723)
..... ........|+..|+|||++.+.. ++.++|||||||+||||++|+.||..... .. +.+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~-----~~~~i~~ 227 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI------YK-----LFENIGK 227 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH------HH-----HHHHHHH
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH------HH-----HHHHHhc
Confidence 64322 22233456899999999997654 37799999999999999999999975421 11 1122222
Q ss_pred CCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 046750 588 GDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRAL 635 (723)
Q Consensus 588 ~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L 635 (723)
+.+. +...+ ...+.+++.+||+.||.+||++.||++.-
T Consensus 228 ~~~~------~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 265 (305)
T 2wtk_C 228 GSYA------IPGDC----GPPLSDLLKGMLEYEPAKRFSIRQIRQHS 265 (305)
T ss_dssp CCCC------CCSSS----CHHHHHHHHHHTCSSTTTSCCHHHHHHSH
T ss_pred CCCC------CCCcc----CHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence 2211 11112 23677899999999999999999999753
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=372.80 Aligned_cols=253 Identities=25% Similarity=0.370 Sum_probs=203.9
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCC---chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS---GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 435 (723)
++|.+.++||+|+||.||+|+. .+|+.||||+++... ......+.+|+++|++++|+||++++++|.+....||||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 5688899999999999999966 468999999996532 123457889999999999999999999999999999999
Q ss_pred EecCCCchhhccccCC--CCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCC
Q 046750 436 EFVPNNNLEHHLHGKG--QPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDT 513 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 513 (723)
||+.+|+|.++|.... ...+.+..++.|+.||+.||+|||++ +|||||||++||||+.++.+||+|||+++....
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 9999999999987643 44688999999999999999999999 599999999999999999999999999987654
Q ss_pred CCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccc
Q 046750 514 TQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEI 593 (723)
Q Consensus 514 ~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~ 593 (723)
.... ....+||..|+|||++.+..++.++||||||||||||++|+.||........ ...+. +.+..+.+
T Consensus 342 ~~~~-~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~--~~~~~-----~~i~~~~~--- 410 (543)
T 3c4z_A 342 GQTK-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELK-----QRVLEQAV--- 410 (543)
T ss_dssp TCCC-BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC--HHHHH-----HHHHHCCC---
T ss_pred CCcc-cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh--HHHHH-----HHHhhccc---
Confidence 3322 2335799999999999999999999999999999999999999976543211 11111 11111111
Q ss_pred cchhhhccccHHHHHHHHHHHHHHhccCCCCCCCH-----HHHHH
Q 046750 594 VDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRM-----VQVVR 633 (723)
Q Consensus 594 vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~-----~eVl~ 633 (723)
.+.......+.+|+.+||+.||.+||++ .+|++
T Consensus 411 -------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 411 -------TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp -------CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred -------CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 0111122367889999999999999975 56654
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=364.26 Aligned_cols=200 Identities=23% Similarity=0.321 Sum_probs=174.4
Q ss_pred HhcCcccceEEeccCcEEEEEEE-cCCCcEEEEEEcccCCchhHHHHHHHHHHHHHc------cCCceeeEeeeeecccc
Q 046750 358 ITNGFARENVIGEGGFGCVYKGN-LPEGKVVAVKQLKSGSGQGEREFRAEVEIISRV------HHRHLVSLVGYCISEKN 430 (723)
Q Consensus 358 ~~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l------~HpnIv~l~g~~~~~~~ 430 (723)
+..+|++.++||+|+||.||+|. ..+++.||||+++.. ....+.+.+|+++++.| +|+||++++++|.....
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 34679999999999999999995 456899999999753 23446788899999988 46799999999999999
Q ss_pred eEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCc--EEEeecccc
Q 046750 431 RLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFE--AQVADFGLA 508 (723)
Q Consensus 431 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~--vkL~DFGla 508 (723)
.+|||||+. ++|.+++.......+++..++.|+.||+.||+|||++ +|||||||++||||+.++. +||+|||++
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccc
Confidence 999999995 7899998876655689999999999999999999999 5999999999999999887 999999999
Q ss_pred cccCCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCC
Q 046750 509 KLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQ 566 (723)
Q Consensus 509 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~ 566 (723)
+..... ....+|+..|+|||++.+..++.++||||||||||||++|+.||....
T Consensus 250 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 250 CYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp EETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 765432 233568999999999999999999999999999999999999997654
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=350.89 Aligned_cols=259 Identities=25% Similarity=0.437 Sum_probs=185.2
Q ss_pred hcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCC-chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEE
Q 046750 359 TNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS-GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYE 436 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 436 (723)
.++|.+.+.||+|+||.||+|.. .+++.||||++.... ....+++.+|++++++++|+||+++++++...+..++|||
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 93 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK 93 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence 46899999999999999999965 468999999987543 2344678899999999999999999999999999999999
Q ss_pred ecCCCchhhcccc------CCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccc
Q 046750 437 FVPNNNLEHHLHG------KGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKL 510 (723)
Q Consensus 437 ~~~~gsL~~~l~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 510 (723)
|+.+++|.+++.. .....+++..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||++..
T Consensus 94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 170 (303)
T 2vwi_A 94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAF 170 (303)
T ss_dssp CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHHH
T ss_pred hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchhe
Confidence 9999999998863 1234588999999999999999999999 599999999999999999999999999976
Q ss_pred cCCCCc----ceeecccccccccChhhhcc-CCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhh
Q 046750 511 NDTTQT----HVSTRVMGTFGYLAPEYASS-GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAI 585 (723)
Q Consensus 511 ~~~~~~----~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i 585 (723)
...... .......|+..|+|||++.+ ..++.++|||||||+||||++|+.||....... .+. ..+
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~--------~~~ 240 (303)
T 2vwi_A 171 LATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK--VLM--------LTL 240 (303)
T ss_dssp CC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG--HHH--------HHH
T ss_pred eccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh--HHH--------HHh
Confidence 543221 11233568999999999876 568999999999999999999999997654211 110 011
Q ss_pred hcC--Ccc-cccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 586 ETG--DLS-EIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 586 ~~~--~l~-~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
... .+. ...+..+...+ ...+.+++.+||+.||.+||++.+|++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 241 QNDPPSLETGVQDKEMLKKY----GKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp TSSCCCTTC-----CCCCCC----CHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ccCCCccccccccchhhhhh----hHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 100 010 01111111222 2367889999999999999999999874
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=352.88 Aligned_cols=269 Identities=20% Similarity=0.300 Sum_probs=200.1
Q ss_pred HhcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCch-hHHHHHHHHHHHHHccCCceeeEeeeeecc-----cc
Q 046750 358 ITNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQ-GEREFRAEVEIISRVHHRHLVSLVGYCISE-----KN 430 (723)
Q Consensus 358 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-----~~ 430 (723)
+.++|++.++||+|+||.||+|.. .+++.||||++...... ..+.+.+|+++|++|+|+||+++++++... ..
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 346799999999999999999954 56889999999754333 336788999999999999999999998754 36
Q ss_pred eEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccc
Q 046750 431 RLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKL 510 (723)
Q Consensus 431 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 510 (723)
.|+||||+. ++|.+++... .+.+..++.|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++.
T Consensus 105 ~~iv~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEEEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 799999995 6999988654 388899999999999999999999 599999999999999999999999999986
Q ss_pred cCCCCcce--eecccccccccChhhhcc-CCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhh---hhhhhh
Q 046750 511 NDTTQTHV--STRVMGTFGYLAPEYASS-GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWAR---PVLVRA 584 (723)
Q Consensus 511 ~~~~~~~~--~~~~~gt~~y~APE~~~~-~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~---~~l~~~ 584 (723)
........ .....|+..|+|||++.+ ..++.++|||||||+||||++|+.||........ +..... ......
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~ 255 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ--LNHILGILGSPSQED 255 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH--HHHHHHHHCSCCHHH
T ss_pred cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH--HHHHHHHhCCCCHHH
Confidence 65332221 234579999999998765 4589999999999999999999999976543211 111100 000000
Q ss_pred hhcCC-------cccccch-hh-hccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 046750 585 IETGD-------LSEIVDP-RL-EKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRAL 635 (723)
Q Consensus 585 i~~~~-------l~~~vd~-~l-~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L 635 (723)
+..-. +..+... .. ...+.......+.+|+.+||+.||.+||++.||++.-
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 315 (364)
T 3qyz_A 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 315 (364)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 00000 0000000 00 0000011223678999999999999999999999753
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=346.28 Aligned_cols=258 Identities=25% Similarity=0.391 Sum_probs=196.0
Q ss_pred cCcccceEEeccCcEEEEEEEcC--CCc--EEEEEEcccC---CchhHHHHHHHHHHHHHccCCceeeEeeeeecccceE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLP--EGK--VVAVKQLKSG---SGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRL 432 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~--~g~--~VAvK~l~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 432 (723)
++|++.++||+|+||.||+|.+. +++ .||||+++.. .....+.|.+|++++++++|+||+++++++.+.. .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 57999999999999999999642 333 6899998754 2344567899999999999999999999998764 89
Q ss_pred EEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccC
Q 046750 433 LIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLND 512 (723)
Q Consensus 433 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 512 (723)
+||||+.+++|.+++.... ..+.+..++.++.||++||+|||++ +|+|||||++||||+.++.+||+|||++....
T Consensus 97 ~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172 (291)
T ss_dssp EEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccccccccc
Confidence 9999999999999987543 2478899999999999999999999 59999999999999999999999999998765
Q ss_pred CCCcce--eecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCC
Q 046750 513 TTQTHV--STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGD 589 (723)
Q Consensus 513 ~~~~~~--~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~ 589 (723)
...... .....++..|+|||++.+..++.++|||||||+||||++ |+.||..... ..+. ..+....
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~--------~~~~~~~ 241 (291)
T 1u46_A 173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG---SQIL--------HKIDKEG 241 (291)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHH--------HHHHTSC
T ss_pred ccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH---HHHH--------HHHHccC
Confidence 443322 223457889999999999889999999999999999999 9999975431 1111 1111111
Q ss_pred cccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCCC
Q 046750 590 LSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEM 641 (723)
Q Consensus 590 l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~~ 641 (723)
.... ........+.+++.+||+.||.+||++.+|++.|+.....
T Consensus 242 ~~~~--------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 242 ERLP--------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp CCCC--------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred CCCC--------CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 1100 0111234688999999999999999999999999886543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=357.13 Aligned_cols=262 Identities=22% Similarity=0.348 Sum_probs=194.0
Q ss_pred hcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCC--chhHHHHHHHHHHHHHccCCceeeEeeeeeccc------
Q 046750 359 TNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS--GQGEREFRAEVEIISRVHHRHLVSLVGYCISEK------ 429 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~------ 429 (723)
.++|.+.+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+++|++|+|+||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 46799999999999999999954 578999999996542 233457889999999999999999999997653
Q ss_pred ceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeeccccc
Q 046750 430 NRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK 509 (723)
Q Consensus 430 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 509 (723)
..|+||||+ +++|.+++... .+.+..+..++.||++||+|||++ +|+|||||++||||+.++.+||+|||+++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 176 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR 176 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence 459999999 89999998753 478899999999999999999999 59999999999999999999999999998
Q ss_pred ccCCCCcceeecccccccccChhhhcc-CCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhh------hhh
Q 046750 510 LNDTTQTHVSTRVMGTFGYLAPEYASS-GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARP------VLV 582 (723)
Q Consensus 510 ~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~------~l~ 582 (723)
..... ....+||..|+|||++.+ ..++.++||||||||||||++|+.||...... ..+...... .+.
T Consensus 177 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~l~~i~~~~g~~~~~~~ 250 (367)
T 1cm8_A 177 QADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL--DQLKEIMKVTGTPPAEFV 250 (367)
T ss_dssp ECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCHHHH
T ss_pred ccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcCCCCHHHH
Confidence 65432 234568999999999987 67999999999999999999999999765321 111100000 000
Q ss_pred hhhhcC-------CcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 583 RAIETG-------DLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 583 ~~i~~~-------~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
+.+... .+.......+. .........+.+|+.+||..||.+||++.|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 251 QRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHhhhHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 000000 00000000010 0111223467899999999999999999999984
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=369.38 Aligned_cols=252 Identities=21% Similarity=0.345 Sum_probs=202.4
Q ss_pred HhcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccC--CchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEE
Q 046750 358 ITNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSG--SGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLI 434 (723)
Q Consensus 358 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 434 (723)
+.++|.+.++||+|+||.||+|.. .+++.||||++... .......+.+|+++|++|+|+||++++++|.+....|+|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 457899999999999999999965 47899999998642 223456789999999999999999999999999999999
Q ss_pred EEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeC---CCCcEEEeeccccccc
Q 046750 435 YEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVD---DEFEAQVADFGLAKLN 511 (723)
Q Consensus 435 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~---~~~~vkL~DFGla~~~ 511 (723)
|||+.+|+|.+++.... .+.+..++.|+.||+.||.|||++ +||||||||+||||+ .++.+||+|||+++..
T Consensus 100 ~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 100 GELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp ECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 99999999999886544 488999999999999999999999 599999999999995 5567999999999866
Q ss_pred CCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcc
Q 046750 512 DTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLS 591 (723)
Q Consensus 512 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~ 591 (723)
..... ....+|+..|+|||++.+ .++.++||||||||||||++|+.||..... .. +...+..+.+.
T Consensus 175 ~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~--------~~~~i~~~~~~ 240 (486)
T 3mwu_A 175 QQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE---YD--------ILKRVETGKYA 240 (486)
T ss_dssp CCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HH--------HHHHHHHTCCC
T ss_pred CCCCc--cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HH--------HHHHHHhCCCC
Confidence 44322 234569999999999875 599999999999999999999999975431 11 12223333221
Q ss_pred cccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 592 EIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 592 ~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
.... .+ . .....+.+|+.+||+.||.+||++.|+++.
T Consensus 241 ~~~~-~~-~----~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 241 FDLP-QW-R----TISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp SCSG-GG-G----GSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred CCCc-cc-C----CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1110 11 1 112357899999999999999999999875
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=370.28 Aligned_cols=252 Identities=21% Similarity=0.373 Sum_probs=205.0
Q ss_pred HhcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCC---chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEE
Q 046750 358 ITNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS---GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLL 433 (723)
Q Consensus 358 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 433 (723)
+.++|++.++||+|+||.||+|.. .+++.||||++.... ....+.+.+|+++|++|+|+||++++++|.+....|+
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 456799999999999999999965 478999999986542 3345679999999999999999999999999999999
Q ss_pred EEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEe---CCCCcEEEeecccccc
Q 046750 434 IYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILV---DDEFEAQVADFGLAKL 510 (723)
Q Consensus 434 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl---~~~~~vkL~DFGla~~ 510 (723)
||||+.+|+|.+++.... .+.+..++.|+.||+.||+|||++ +|+||||||+|||| +.++.+||+|||+++.
T Consensus 104 v~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp EECCCCSCBHHHHHHTCS--CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 999999999999987654 488999999999999999999999 59999999999999 5678999999999986
Q ss_pred cCCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCc
Q 046750 511 NDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDL 590 (723)
Q Consensus 511 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l 590 (723)
...... .....|+..|+|||++.+ .++.++||||||||||||++|+.||..... .. +...+..+.+
T Consensus 179 ~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~--------~~~~i~~~~~ 244 (484)
T 3nyv_A 179 FEASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE---YD--------ILKKVEKGKY 244 (484)
T ss_dssp BCCCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HH--------HHHHHHHCCC
T ss_pred cccccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH---HH--------HHHHHHcCCC
Confidence 654332 234569999999999875 699999999999999999999999976432 11 1222333332
Q ss_pred ccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 591 SEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 591 ~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
.... +.+ . .....+.+|+.+||+.+|.+||++.|+++.
T Consensus 245 ~~~~-~~~-~----~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 245 TFEL-PQW-K----KVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp CCCS-GGG-G----GSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCC-ccc-c----cCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 1111 011 1 122367899999999999999999999864
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=369.94 Aligned_cols=252 Identities=22% Similarity=0.380 Sum_probs=198.8
Q ss_pred HhcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCC--chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEE
Q 046750 358 ITNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS--GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLI 434 (723)
Q Consensus 358 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 434 (723)
+.++|.+.++||+|+||.||+|+. .+++.||||+++... ......+.+|+++|++|+|+|||+++++|.+....|||
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 456799999999999999999965 468899999987642 23356789999999999999999999999999999999
Q ss_pred EEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCC---CCcEEEeeccccccc
Q 046750 435 YEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDD---EFEAQVADFGLAKLN 511 (723)
Q Consensus 435 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~---~~~vkL~DFGla~~~ 511 (723)
|||+.+|+|.+++.... .+.+..++.|+.||+.||+|||++ +|||||||++||||+. ++.+||+|||+++..
T Consensus 115 ~e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 115 MECYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp EECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 99999999999886543 378889999999999999999999 5999999999999976 455999999999876
Q ss_pred CCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcc
Q 046750 512 DTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLS 591 (723)
Q Consensus 512 ~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~ 591 (723)
..... ....+||..|+|||++. +.++.++|||||||+||||++|+.||..... .. +.+.+..+.+.
T Consensus 190 ~~~~~--~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~--------~~~~i~~~~~~ 255 (494)
T 3lij_A 190 ENQKK--MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD---QE--------ILRKVEKGKYT 255 (494)
T ss_dssp BTTBC--BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HH--------HHHHHHHTCCC
T ss_pred CCCcc--ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH---HH--------HHHHHHhCCCC
Confidence 54322 33456999999999886 5799999999999999999999999975432 11 12223333221
Q ss_pred cccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 592 EIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 592 ~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
. ..+.+ ..+ ...+.+|+.+||+.||.+||++.|+++.
T Consensus 256 ~-~~~~~-~~~----s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 256 F-DSPEW-KNV----SEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp C-CSGGG-TTS----CHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred C-Cchhc-ccC----CHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 1 11111 111 2357889999999999999999998853
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=343.19 Aligned_cols=254 Identities=23% Similarity=0.385 Sum_probs=198.1
Q ss_pred HhcCcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEE
Q 046750 358 ITNGFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYE 436 (723)
Q Consensus 358 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 436 (723)
..++|++.+.||+|+||.||+|... +++.||||++........+.+.+|+++|++++|+||++++++|.+.+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 3467999999999999999999664 589999999987666667789999999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCc
Q 046750 437 FVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQT 516 (723)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 516 (723)
|+.+++|.+++..... .+++..++.++.||+.||.|||++ +|+|||||++||||+.++.+||+|||++.......
T Consensus 97 ~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 171 (302)
T 2j7t_A 97 FCPGGAVDAIMLELDR-GLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL- 171 (302)
T ss_dssp CCTTEEHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-
T ss_pred eCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccccc-
Confidence 9999999998865332 488999999999999999999999 59999999999999999999999999975322111
Q ss_pred ceeecccccccccChhhhc-----cCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcc
Q 046750 517 HVSTRVMGTFGYLAPEYAS-----SGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLS 591 (723)
Q Consensus 517 ~~~~~~~gt~~y~APE~~~-----~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~ 591 (723)
.......|+..|+|||++. +..++.++|||||||+||||++|+.||..... . .. + ..+..+...
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~---~~----~-~~~~~~~~~ 240 (302)
T 2j7t_A 172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP---M---RV----L-LKIAKSDPP 240 (302)
T ss_dssp HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH---H---HH----H-HHHHHSCCC
T ss_pred cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH---H---HH----H-HHHhccCCc
Confidence 1122346899999999984 66789999999999999999999999975431 1 11 1 111111111
Q ss_pred cccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 592 EIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 592 ~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
.+.. ...+ ...+.+++.+||+.||.+||++.+|++.
T Consensus 241 ~~~~---~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 241 TLLT---PSKW----SVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp CCSS---GGGS----CHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred ccCC---cccc----CHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 1111 0111 2367889999999999999999998764
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=360.93 Aligned_cols=203 Identities=26% Similarity=0.413 Sum_probs=155.7
Q ss_pred HhcCccc-ceEEeccCcEEEEEEEcC---CCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeec--ccce
Q 046750 358 ITNGFAR-ENVIGEGGFGCVYKGNLP---EGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCIS--EKNR 431 (723)
Q Consensus 358 ~~~~f~~-~~~LG~G~fG~Vy~~~~~---~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~~ 431 (723)
+.+.|.+ .++||+|+||.||+|++. +++.||||++.... ....+.+|+++|++|+|+||++++++|.. ....
T Consensus 18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (405)
T 3rgf_A 18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKV 95 (405)
T ss_dssp HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence 3445666 458999999999999764 57899999997542 23578899999999999999999999954 6678
Q ss_pred EEEEEecCCCchhhccccC-------CCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEe----CCCCcE
Q 046750 432 LLIYEFVPNNNLEHHLHGK-------GQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILV----DDEFEA 500 (723)
Q Consensus 432 ~lV~E~~~~gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl----~~~~~v 500 (723)
||||||+. ++|.+++... ....+.+..++.|+.||+.||+|||+++ |||||||++|||| +.++.+
T Consensus 96 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~ 171 (405)
T 3rgf_A 96 WLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRV 171 (405)
T ss_dssp EEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCE
T ss_pred EEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcE
Confidence 99999995 6787776421 1224888999999999999999999994 9999999999999 678899
Q ss_pred EEeecccccccCCCCc--ceeecccccccccChhhhccC-CCCCccceechHHHHHHHHhCCCCCCCCC
Q 046750 501 QVADFGLAKLNDTTQT--HVSTRVMGTFGYLAPEYASSG-KLTDRSDVFSFGVVLLELITGRKPVDPTQ 566 (723)
Q Consensus 501 kL~DFGla~~~~~~~~--~~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSlGviL~eLltG~~P~~~~~ 566 (723)
||+|||+++....... ......+||..|+|||++.+. .++.++||||||||||||++|+.||....
T Consensus 172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp EECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred EEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 9999999987653322 223346789999999999874 58999999999999999999999997554
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=357.37 Aligned_cols=266 Identities=22% Similarity=0.289 Sum_probs=195.3
Q ss_pred HHHhcCcccceEEeccCcEEEEEEE-cCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecc------
Q 046750 356 MEITNGFARENVIGEGGFGCVYKGN-LPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISE------ 428 (723)
Q Consensus 356 ~~~~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~------ 428 (723)
....++|.+.++||+|+||.||+|. ..+|+.||||++..... .+.+|+++|++|+|+||++++++|...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 3456789999999999999999995 46789999999875432 234799999999999999999998543
Q ss_pred --------------------------------cceEEEEEecCCCchhhcccc--CCCCcchHHHHHHHHHHHHhhhchh
Q 046750 429 --------------------------------KNRLLIYEFVPNNNLEHHLHG--KGQPVLEWTKRVKIALGAAKGLAYL 474 (723)
Q Consensus 429 --------------------------------~~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yL 474 (723)
...++||||+. |+|.+++.. .....+++..++.|+.||++||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 33789999997 677776653 2234588999999999999999999
Q ss_pred cccCCCceeecCCCCCcEEeC-CCCcEEEeecccccccCCCCcceeecccccccccChhhhccC-CCCCccceechHHHH
Q 046750 475 HEDCHPKIIHRDIKSANILVD-DEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSG-KLTDRSDVFSFGVVL 552 (723)
Q Consensus 475 H~~g~~~ivHrDIkp~NILl~-~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSlGviL 552 (723)
|++ +|+|||||++||||+ +++.+||+|||+++....... .....|+..|+|||++.+. .++.++|||||||+|
T Consensus 158 H~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 158 HSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp HTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 999 599999999999998 688999999999986644332 2334689999999998875 499999999999999
Q ss_pred HHHHhCCCCCCCCCCCCchhhHHhhhhh---h---hhhh----hcCCcccccchhhhccccHHHHHHHHHHHHHHhccCC
Q 046750 553 LELITGRKPVDPTQPLGDESLVEWARPV---L---VRAI----ETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSG 622 (723)
Q Consensus 553 ~eLltG~~P~~~~~~~~~~~l~~~~~~~---l---~~~i----~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP 622 (723)
|||++|+.||..... ...+....... . ...+ ..-.+..+....+...+.......+.+|+.+||+.||
T Consensus 233 ~ell~g~~pf~~~~~--~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 310 (383)
T 3eb0_A 233 GELILGKPLFSGETS--IDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP 310 (383)
T ss_dssp HHHHHSSCSSCCSSH--HHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred HHHHhCCCCCCCCCh--HHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence 999999999976432 11111111000 0 0000 0001111111112111222233468899999999999
Q ss_pred CCCCCHHHHHH
Q 046750 623 PKRPRMVQVVR 633 (723)
Q Consensus 623 ~~RPs~~eVl~ 633 (723)
.+||++.|+++
T Consensus 311 ~~R~t~~e~l~ 321 (383)
T 3eb0_A 311 DLRINPYEAMA 321 (383)
T ss_dssp GGSCCHHHHHT
T ss_pred hhCCCHHHHhc
Confidence 99999999985
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=340.31 Aligned_cols=247 Identities=23% Similarity=0.363 Sum_probs=194.5
Q ss_pred cCcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCC---chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGS---GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 435 (723)
++|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++|+||+++++++.+....++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 67999999999999999999654 78999999986531 223457889999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ 515 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 515 (723)
||+.+++|.+++.... .+.+..++.++.||+.||+|||++ +|+|||||++|||++.++.+||+|||++.......
T Consensus 91 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 91 EYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165 (276)
T ss_dssp ECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred eccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence 9999999999997654 378899999999999999999999 49999999999999999999999999998664432
Q ss_pred cceeecccccccccChhhhccCCC-CCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCccccc
Q 046750 516 THVSTRVMGTFGYLAPEYASSGKL-TDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIV 594 (723)
Q Consensus 516 ~~~~~~~~gt~~y~APE~~~~~~~-t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~v 594 (723)
. .....|+..|+|||++.+..+ +.++||||||++||||++|+.||..... .. +.+.+..+...
T Consensus 166 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~--------~~~~~~~~~~~--- 229 (276)
T 2h6d_A 166 F--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV---PT--------LFKKIRGGVFY--- 229 (276)
T ss_dssp -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH---HH--------HHHHHHHCCCC---
T ss_pred c--eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH---HH--------HHHHhhcCccc---
Confidence 2 233468999999999987765 6899999999999999999999975321 11 11222222210
Q ss_pred chhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 595 DPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 595 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
+...+ ...+.+++.+||+.||.+||++.+|++.
T Consensus 230 ---~~~~~----~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 230 ---IPEYL----NRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp ---CCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ---Cchhc----CHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 01111 2357889999999999999999999985
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=345.68 Aligned_cols=252 Identities=26% Similarity=0.400 Sum_probs=198.5
Q ss_pred HhcCcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEE
Q 046750 358 ITNGFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYE 436 (723)
Q Consensus 358 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 436 (723)
..++|++.+.||+|+||.||+|... +|+.||||++.... ..+.+.+|+++|++++|+||+++++++.+....++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 4578999999999999999999654 58999999997642 34678999999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCc
Q 046750 437 FVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQT 516 (723)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 516 (723)
|+.+++|.+++.... ..+++..++.++.+|+.||.|||++ +|+|||||++||||+.++.+||+|||++........
T Consensus 105 ~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (314)
T 3com_A 105 YCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA 180 (314)
T ss_dssp CCTTEEHHHHHHHHT-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred cCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence 999999999986332 2478999999999999999999999 599999999999999999999999999976544322
Q ss_pred ceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccch
Q 046750 517 HVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDP 596 (723)
Q Consensus 517 ~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~ 596 (723)
......|+..|+|||++.+..++.++|||||||+||||++|+.||...... ... ..+..+....+..
T Consensus 181 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~--------~~~~~~~~~~~~~- 247 (314)
T 3com_A 181 -KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM---RAI--------FMIPTNPPPTFRK- 247 (314)
T ss_dssp -CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH---HHH--------HHHHHSCCCCCSS-
T ss_pred -ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH---HHH--------HHHhcCCCcccCC-
Confidence 223456899999999999999999999999999999999999999754311 000 0111111111100
Q ss_pred hhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 597 RLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 597 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
...+ ...+.+|+.+||+.||.+||++.+|++.
T Consensus 248 --~~~~----~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 248 --PELW----SDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp --GGGS----CHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred --cccC----CHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0111 2367889999999999999999999863
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=351.11 Aligned_cols=265 Identities=20% Similarity=0.278 Sum_probs=192.0
Q ss_pred hcCcccceEEeccCcEEEEEEE-cCCCcEEEEEEcccCC--chhHHHHHHHHHHHHHccCCceeeEeeeeeccc------
Q 046750 359 TNGFARENVIGEGGFGCVYKGN-LPEGKVVAVKQLKSGS--GQGEREFRAEVEIISRVHHRHLVSLVGYCISEK------ 429 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~VAvK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~------ 429 (723)
.++|.+.+.||+|+||.||+|. ..+++.||||++.... ....+.+.+|+.++++++|+||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 4689999999999999999995 4568999999997542 233457889999999999999999999997665
Q ss_pred ceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeeccccc
Q 046750 430 NRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK 509 (723)
Q Consensus 430 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 509 (723)
..|+||||+. ++|.+++.. .+++..+..++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++
T Consensus 104 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 175 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 175 (371)
T ss_dssp EEEEEEECCS-EEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred ceEEEEEcCC-CCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeeccc
Confidence 6799999996 578887753 378889999999999999999999 59999999999999999999999999998
Q ss_pred ccCCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhh-----------
Q 046750 510 LNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWAR----------- 578 (723)
Q Consensus 510 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~----------- 578 (723)
...... ......|+..|+|||++.+..++.++|||||||+||||++|+.||...... ..+.....
T Consensus 176 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~ 251 (371)
T 2xrw_A 176 TAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI--DQWNKVIEQLGTPCPEFMK 251 (371)
T ss_dssp ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHC-CCCCCHHHHT
T ss_pred cccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHHHH
Confidence 654322 223456899999999999999999999999999999999999999764321 00000000
Q ss_pred ---hhhhhhhhc-CC-----cccccchhhh---ccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 046750 579 ---PVLVRAIET-GD-----LSEIVDPRLE---KHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRAL 635 (723)
Q Consensus 579 ---~~l~~~i~~-~~-----l~~~vd~~l~---~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L 635 (723)
..+...+.. .. +..++...+. ..........+.+|+.+||+.||.+||++.|+++.-
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 320 (371)
T 2xrw_A 252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 320 (371)
T ss_dssp TSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred HhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCc
Confidence 000000000 00 0000000000 001122345788999999999999999999998743
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=349.48 Aligned_cols=267 Identities=22% Similarity=0.339 Sum_probs=198.0
Q ss_pred HhcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCc-hhHHHHHHHHHHHHHccCCceeeEeeeeecc-----cc
Q 046750 358 ITNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSG-QGEREFRAEVEIISRVHHRHLVSLVGYCISE-----KN 430 (723)
Q Consensus 358 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-----~~ 430 (723)
+.++|.+.++||+|+||.||+|.. .+|+.||||+++.... .....+.+|+++|++|+|+||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 346899999999999999999965 4689999999975433 3345788999999999999999999988764 66
Q ss_pred eEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccc
Q 046750 431 RLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKL 510 (723)
Q Consensus 431 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 510 (723)
.++||||+. ++|.+++... .+++..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++.
T Consensus 89 ~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp EEEEECCCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEeccC-ccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 899999995 7899988753 488999999999999999999999 599999999999999999999999999986
Q ss_pred cCCCCcc---------eeecccccccccChhhhcc-CCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhh
Q 046750 511 NDTTQTH---------VSTRVMGTFGYLAPEYASS-GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPV 580 (723)
Q Consensus 511 ~~~~~~~---------~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~ 580 (723)
....... ......|+..|+|||++.+ ..++.++|||||||+||||++|+.||...... ..+... ...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~-~~~ 238 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYR--HQLLLI-FGI 238 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHH-HHH
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHH-HHH
Confidence 6532221 1123468999999998765 67899999999999999999999999765321 111100 000
Q ss_pred hhhhhhcCCcccccchhhh--------------ccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 581 LVRAIETGDLSEIVDPRLE--------------KHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 581 l~~~i~~~~l~~~vd~~l~--------------~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
+........+..+.+.+.. ..........+.+|+.+||+.||.+||++.||++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp HCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000000000000000000 00001123467899999999999999999999974
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=341.43 Aligned_cols=253 Identities=23% Similarity=0.333 Sum_probs=202.8
Q ss_pred HhcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCc---------hhHHHHHHHHHHHHHcc-CCceeeEeeeee
Q 046750 358 ITNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSG---------QGEREFRAEVEIISRVH-HRHLVSLVGYCI 426 (723)
Q Consensus 358 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~---------~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~ 426 (723)
+.++|.+.++||+|+||.||+|.. .+++.||||+++.... ...+.+.+|+++|+++. |+||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 457899999999999999999965 4689999999875431 12346789999999995 999999999999
Q ss_pred cccceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecc
Q 046750 427 SEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFG 506 (723)
Q Consensus 427 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFG 506 (723)
+....++||||+.+++|.+++.... .+++..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred cCCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEeccc
Confidence 9999999999999999999997643 488899999999999999999999 59999999999999999999999999
Q ss_pred cccccCCCCcceeecccccccccChhhhc------cCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhh
Q 046750 507 LAKLNDTTQTHVSTRVMGTFGYLAPEYAS------SGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPV 580 (723)
Q Consensus 507 la~~~~~~~~~~~~~~~gt~~y~APE~~~------~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~ 580 (723)
++........ .....|+..|+|||++. ...++.++|||||||+||||++|+.||..... ..
T Consensus 170 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~-------- 236 (298)
T 1phk_A 170 FSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ---ML-------- 236 (298)
T ss_dssp TCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HH--------
T ss_pred chhhcCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH---HH--------
Confidence 9986654322 23356899999999985 45688999999999999999999999965421 11
Q ss_pred hhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 581 LVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 581 l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
+.+.+..+.+... .+.+ ......+.+++.+||+.||.+||++.||++.
T Consensus 237 ~~~~~~~~~~~~~-~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 237 MLRMIMSGNYQFG-SPEW-----DDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp HHHHHHHTCCCCC-TTTG-----GGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHHHhcCCcccC-cccc-----cccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 1112222222111 0110 1123368899999999999999999999863
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=351.82 Aligned_cols=266 Identities=21% Similarity=0.302 Sum_probs=200.8
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCchhHHHHHHHHHHHHHcc-----------CCceeeEeeeeec
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQGEREFRAEVEIISRVH-----------HRHLVSLVGYCIS 427 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~-----------HpnIv~l~g~~~~ 427 (723)
++|.+.++||+|+||.||+|+. .+++.||||+++.. ......+.+|++++++++ |+||+++++++..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 5799999999999999999964 67899999999753 234567889999999986 8899999999986
Q ss_pred cc----ceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeC------CC
Q 046750 428 EK----NRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVD------DE 497 (723)
Q Consensus 428 ~~----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~------~~ 497 (723)
.. ..++||||+ +++|.+++.......+++..++.|+.||+.||+|||+++ +|+|||||++||||+ ..
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~~~ 174 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENL 174 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTE
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCcCc
Confidence 54 689999999 999999998765556899999999999999999999972 399999999999994 45
Q ss_pred CcEEEeecccccccCCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhh
Q 046750 498 FEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWA 577 (723)
Q Consensus 498 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~ 577 (723)
+.+||+|||+++..... .....|+..|+|||++.+..++.++|||||||+||||++|+.||...............
T Consensus 175 ~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 250 (373)
T 1q8y_A 175 IQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 250 (373)
T ss_dssp EEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred ceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHH
Confidence 58999999999865432 23346899999999999999999999999999999999999999764321110000000
Q ss_pred hhhhhhhh--------hc-----------CCcccccc-------hhh--hccccHHHHHHHHHHHHHHhccCCCCCCCHH
Q 046750 578 RPVLVRAI--------ET-----------GDLSEIVD-------PRL--EKHYVESEMFRMIEAAAACVRHSGPKRPRMV 629 (723)
Q Consensus 578 ~~~l~~~i--------~~-----------~~l~~~vd-------~~l--~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 629 (723)
.. +.+.+ .. +.+..+.. ..+ ...+.......+.+|+.+||+.||.+||++.
T Consensus 251 ~~-~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 329 (373)
T 1q8y_A 251 AQ-IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 329 (373)
T ss_dssp HH-HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HH-HHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHH
Confidence 00 00000 00 00000000 000 1124456677899999999999999999999
Q ss_pred HHHHH
Q 046750 630 QVVRA 634 (723)
Q Consensus 630 eVl~~ 634 (723)
||++.
T Consensus 330 ell~h 334 (373)
T 1q8y_A 330 GLVNH 334 (373)
T ss_dssp HHHTC
T ss_pred HHhhC
Confidence 99974
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=349.27 Aligned_cols=267 Identities=20% Similarity=0.291 Sum_probs=198.3
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCc--hhHHHHHHHHHHHHHccCCceeeEeeeeecc--------
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSG--QGEREFRAEVEIISRVHHRHLVSLVGYCISE-------- 428 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-------- 428 (723)
++|++.++||+|+||.||+|.. .+|+.||||++..... .....+.+|+++|++++|+||++++++|.+.
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 6799999999999999999965 6789999999865432 2345788999999999999999999999873
Q ss_pred cceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccc
Q 046750 429 KNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLA 508 (723)
Q Consensus 429 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla 508 (723)
+..+|||||+. ++|.+++..... .+.+..++.|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||++
T Consensus 97 ~~~~lv~e~~~-~~l~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 97 GSIYLVFDFCE-HDLAGLLSNVLV-KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp CEEEEEEECCS-EEHHHHHHCTTS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred ceEEEEEeccC-CCHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 45799999996 577777654432 488999999999999999999999 5999999999999999999999999999
Q ss_pred cccCCCCc---ceeecccccccccChhhhcc-CCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhh
Q 046750 509 KLNDTTQT---HVSTRVMGTFGYLAPEYASS-GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRA 584 (723)
Q Consensus 509 ~~~~~~~~---~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~ 584 (723)
+.+..... .......|+..|+|||++.+ ..++.++|||||||+||||++|+.||...... .........+ ..
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~i~~~~-~~ 247 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ---HQLALISQLC-GS 247 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHH-CC
T ss_pred ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHh-CC
Confidence 86543222 22234568999999999876 45899999999999999999999999765321 1111110000 00
Q ss_pred hhcCCcccc--------cch-hhhccccHHH------HHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 046750 585 IETGDLSEI--------VDP-RLEKHYVESE------MFRMIEAAAACVRHSGPKRPRMVQVVRAL 635 (723)
Q Consensus 585 i~~~~l~~~--------vd~-~l~~~~~~~~------~~~l~~l~~~cl~~dP~~RPs~~eVl~~L 635 (723)
+....+..+ +.. .......... ...+.+|+.+||+.||.+||++.|+++.-
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 313 (351)
T 3mi9_A 248 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 313 (351)
T ss_dssp CCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred CChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCC
Confidence 000000000 000 0000000111 12478999999999999999999999853
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=345.28 Aligned_cols=267 Identities=20% Similarity=0.301 Sum_probs=203.7
Q ss_pred hcCcccceEEeccCcEEEEEEEc--CCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCc------eeeEeeeeecccc
Q 046750 359 TNGFARENVIGEGGFGCVYKGNL--PEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRH------LVSLVGYCISEKN 430 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~--~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~Hpn------Iv~l~g~~~~~~~ 430 (723)
.++|++.++||+|+||.||+|.. .+++.||||+++.. ....+.+.+|++++++++|+| |+++++++.+.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 46799999999999999999964 46889999999753 234567889999999997654 9999999999999
Q ss_pred eEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCC--------------
Q 046750 431 RLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDD-------------- 496 (723)
Q Consensus 431 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~-------------- 496 (723)
.++||||+ +++|.+++.......+.+..++.|+.||++||+|||++ +|+|||||++||||+.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCccccc
Confidence 99999999 89999999876655688999999999999999999999 5999999999999987
Q ss_pred -----CCcEEEeecccccccCCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCch
Q 046750 497 -----EFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDE 571 (723)
Q Consensus 497 -----~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~ 571 (723)
++.+||+|||+++..... .....|+..|+|||++.+..++.++|||||||+||||++|+.||.........
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 243 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL 243 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHH
T ss_pred cccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 668999999999865432 23356899999999999999999999999999999999999999765321110
Q ss_pred hhHHhhhhh----hhhhhhcCCc--------cc----------ccchhh-hccccHHHHHHHHHHHHHHhccCCCCCCCH
Q 046750 572 SLVEWARPV----LVRAIETGDL--------SE----------IVDPRL-EKHYVESEMFRMIEAAAACVRHSGPKRPRM 628 (723)
Q Consensus 572 ~l~~~~~~~----l~~~i~~~~l--------~~----------~vd~~l-~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 628 (723)
......... +.+......+ .. ...... ...........+.+|+.+||+.||.+||++
T Consensus 244 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 323 (339)
T 1z57_A 244 AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITL 323 (339)
T ss_dssp HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCH
Confidence 000000000 0000000000 00 000000 001122345678999999999999999999
Q ss_pred HHHHHH
Q 046750 629 VQVVRA 634 (723)
Q Consensus 629 ~eVl~~ 634 (723)
.||++.
T Consensus 324 ~ell~h 329 (339)
T 1z57_A 324 REALKH 329 (339)
T ss_dssp HHHTTS
T ss_pred HHHhcC
Confidence 999864
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=347.52 Aligned_cols=268 Identities=22% Similarity=0.333 Sum_probs=201.7
Q ss_pred HHhcCcccceEEeccCcEEEEEEEc--CCCcEEEEEEcccCCc--hhHHHHHHHHHHHHHc---cCCceeeEeeeee---
Q 046750 357 EITNGFARENVIGEGGFGCVYKGNL--PEGKVVAVKQLKSGSG--QGEREFRAEVEIISRV---HHRHLVSLVGYCI--- 426 (723)
Q Consensus 357 ~~~~~f~~~~~LG~G~fG~Vy~~~~--~~g~~VAvK~l~~~~~--~~~~~~~~Ei~il~~l---~HpnIv~l~g~~~--- 426 (723)
.+.++|++.+.||+|+||.||+|.. .+++.||||+++.... .....+.+|+.++++| +|+||++++++|.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 3457899999999999999999976 4678999999865321 2223567788888777 8999999999987
Q ss_pred --cccceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEee
Q 046750 427 --SEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVAD 504 (723)
Q Consensus 427 --~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~D 504 (723)
.....++||||+. |+|.+++.......+.+..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEec
Confidence 5567899999996 6999999876655689999999999999999999999 499999999999999999999999
Q ss_pred cccccccCCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhh--
Q 046750 505 FGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLV-- 582 (723)
Q Consensus 505 FGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~-- 582 (723)
||+++...... ......|+..|+|||++.+..++.++|||||||+||||++|+.||..... ..........+.
T Consensus 164 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~i~~~~~~~ 238 (326)
T 1blx_A 164 FGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD---VDQLGKILDVIGLP 238 (326)
T ss_dssp CCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCC
T ss_pred CcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHHHcCCC
Confidence 99997654322 22345689999999999999999999999999999999999999976432 111111000000
Q ss_pred --hhhhc------CCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 583 --RAIET------GDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 583 --~~i~~------~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
..+.. ..+.......+ ..+.......+.+|+.+||+.||.+||++.||++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 239 GEEDWPRDVALPRQAFHSKSAQPI-EKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCG-GGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CcccCccccccchhhhcccCcchh-hhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00000 00000000000 01111223467889999999999999999999864
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=368.76 Aligned_cols=252 Identities=22% Similarity=0.339 Sum_probs=201.3
Q ss_pred HhcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCc-------------hhHHHHHHHHHHHHHccCCceeeEee
Q 046750 358 ITNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSG-------------QGEREFRAEVEIISRVHHRHLVSLVG 423 (723)
Q Consensus 358 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~-------------~~~~~~~~Ei~il~~l~HpnIv~l~g 423 (723)
+.++|.+.++||+|+||.||+|.. .+++.||||+++.... ...+.+.+|+++|++|+|+||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 457899999999999999999965 4578999999875421 23467899999999999999999999
Q ss_pred eeecccceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCC---cE
Q 046750 424 YCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEF---EA 500 (723)
Q Consensus 424 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~---~v 500 (723)
+|.+....||||||+.+|+|.+++.... .+++..++.|+.||+.||+|||++ +|+|||||++||||+.++ .+
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~ 188 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNI 188 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSE
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccE
Confidence 9999999999999999999999887543 488999999999999999999999 599999999999998775 69
Q ss_pred EEeecccccccCCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhh
Q 046750 501 QVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPV 580 (723)
Q Consensus 501 kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~ 580 (723)
||+|||+++....... .....|+..|+|||++. +.++.++|||||||+||||++|+.||..... ..
T Consensus 189 kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~-------- 254 (504)
T 3q5i_A 189 KIVDFGLSSFFSKDYK--LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND---QD-------- 254 (504)
T ss_dssp EECCCTTCEECCTTSC--BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HH--------
T ss_pred EEEECCCCEEcCCCCc--cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH---HH--------
Confidence 9999999987654322 23456999999999987 5699999999999999999999999976432 11
Q ss_pred hhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 581 LVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 581 l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
+...+..+.+.... .....+ ...+.+|+.+||+.||.+||++.|+++.
T Consensus 255 ~~~~i~~~~~~~~~--~~~~~~----s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 255 IIKKVEKGKYYFDF--NDWKNI----SDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HHHHHHHCCCCCCH--HHHTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHcCCCCCCc--cccCCC----CHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 22233333321110 011111 2367899999999999999999999864
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=357.45 Aligned_cols=264 Identities=23% Similarity=0.309 Sum_probs=194.8
Q ss_pred cCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccc------eEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKN------RLL 433 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~------~~l 433 (723)
.+|.+.++||+|+||.||+|+...+..||||++..... ...+|+++|++|+|+||++++++|..... .++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 56999999999999999999887777799998865422 23469999999999999999999965443 789
Q ss_pred EEEecCCCchhhcccc-CCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeC-CCCcEEEeeccccccc
Q 046750 434 IYEFVPNNNLEHHLHG-KGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVD-DEFEAQVADFGLAKLN 511 (723)
Q Consensus 434 V~E~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~-~~~~vkL~DFGla~~~ 511 (723)
||||+.++.+..+.+. .....+.+..++.|+.||++||+|||++ +|+|||||++||||+ .++.+||+|||+++..
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 9999976544433321 1233588899999999999999999999 599999999999999 7999999999999866
Q ss_pred CCCCcceeecccccccccChhhhccC-CCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhh-------h--
Q 046750 512 DTTQTHVSTRVMGTFGYLAPEYASSG-KLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPV-------L-- 581 (723)
Q Consensus 512 ~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~-------l-- 581 (723)
..... .....|+..|+|||++.+. .++.++||||||||||||++|+.||..... ...+......+ +
T Consensus 193 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~--~~~l~~i~~~~g~p~~~~~~~ 268 (394)
T 4e7w_A 193 IAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG--IDQLVEIIKVLGTPSREQIKT 268 (394)
T ss_dssp CTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHHHCCCCHHHHHH
T ss_pred cCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCCHHHHHh
Confidence 43332 2345689999999999765 599999999999999999999999976542 11121111100 0
Q ss_pred -hhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 582 -VRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 582 -~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
...+....+..+....+...+.......+.+|+.+||+.||.+||++.|+++.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 00000111111111111111222233468899999999999999999999975
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=344.52 Aligned_cols=252 Identities=21% Similarity=0.366 Sum_probs=184.6
Q ss_pred hcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCch-hH-HHHHHHHHHHHHccCCceeeEeeeeecccceEEEE
Q 046750 359 TNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQ-GE-REFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~-~~-~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 435 (723)
.++|++.++||+|+||.||+|+. .+++.||||+++..... .. +.+..+..+++.++|+||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 46799999999999999999954 67899999999765322 22 23445555678889999999999999999999999
Q ss_pred EecCCCchhhcccc--CCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCC
Q 046750 436 EFVPNNNLEHHLHG--KGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDT 513 (723)
Q Consensus 436 E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 513 (723)
||+. |+|.+++.. .....+++..++.|+.||+.||+|||+++ +|+|||||++||||+.++.+||+|||+++....
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 9996 588777653 12345899999999999999999999972 399999999999999999999999999976544
Q ss_pred CCcceeecccccccccChhhh----ccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCC
Q 046750 514 TQTHVSTRVMGTFGYLAPEYA----SSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGD 589 (723)
Q Consensus 514 ~~~~~~~~~~gt~~y~APE~~----~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~ 589 (723)
... .....|+..|+|||++ .+..++.++|||||||+||||++|+.||..... .... +.+.+....
T Consensus 163 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~-----~~~~~~~~~ 231 (290)
T 3fme_A 163 DVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT----PFQQ-----LKQVVEEPS 231 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC----HHHH-----HHHHHHSCC
T ss_pred ccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc----hHHH-----HHHHhccCC
Confidence 322 2234689999999996 556789999999999999999999999975322 1111 111111111
Q ss_pred cccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 046750 590 LSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVR 633 (723)
Q Consensus 590 l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~ 633 (723)
..+.. ..+ ...+.+++.+||+.||.+||++.||++
T Consensus 232 -~~~~~----~~~----~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 232 -PQLPA----DKF----SAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp -CCCCT----TTS----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -CCccc----ccC----CHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 11111 111 235789999999999999999999987
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=355.16 Aligned_cols=263 Identities=21% Similarity=0.327 Sum_probs=182.6
Q ss_pred HhcCcccceEEeccCcEEEEEEE-cCCCcEEEEEEcccCC--chhHHHHHHHHHHHHHccCCceeeEeeeeecc------
Q 046750 358 ITNGFARENVIGEGGFGCVYKGN-LPEGKVVAVKQLKSGS--GQGEREFRAEVEIISRVHHRHLVSLVGYCISE------ 428 (723)
Q Consensus 358 ~~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~VAvK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~------ 428 (723)
+.++|.+.+.||+|+||.||+|. ..+|+.||||++.... ....+.+.+|+++|++|+|+||++++++|...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 34789999999999999999995 5678999999997542 23446788999999999999999999998754
Q ss_pred cceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccc
Q 046750 429 KNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLA 508 (723)
Q Consensus 429 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla 508 (723)
...|+|+||+ +++|.+++... .+++..++.|+.||++||+|||++ +|+|||||++||||+.++.+||+|||++
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CCCEEEEECC-CEECC-----C---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC----
T ss_pred CeEEEEeccc-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecccc
Confidence 5579999999 89999998653 488999999999999999999999 5999999999999999999999999999
Q ss_pred cccCCCCcceeecccccccccChhhhcc-CCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhh------hh
Q 046750 509 KLNDTTQTHVSTRVMGTFGYLAPEYASS-GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARP------VL 581 (723)
Q Consensus 509 ~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~------~l 581 (723)
+..... .....||..|+|||++.+ ..++.++||||||||||||++|+.||...... ..+....+. .+
T Consensus 180 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~l~~i~~~~g~p~~~~ 253 (367)
T 2fst_X 180 RHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI--DQLKLILRLVGTPGAEL 253 (367)
T ss_dssp ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCSCCHHH
T ss_pred cccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHH
Confidence 865432 234568999999999987 67999999999999999999999999765321 111110000 00
Q ss_pred hhhhhcCCccccc-------chhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 582 VRAIETGDLSEIV-------DPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 582 ~~~i~~~~l~~~v-------d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
...+.......++ ...+.. ........+.+|+.+||+.||.+||++.|+++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 254 LKKISSESARNYIQSLTQMPKMNFAN-VFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HTTCCCHHHHHHHHTSCCCCCCCHHH-HTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHhhhHHHHHHHhccCCCCCCCHHH-HCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0000000000000 000000 000112357899999999999999999999975
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=382.84 Aligned_cols=248 Identities=25% Similarity=0.343 Sum_probs=203.1
Q ss_pred hcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccC---CchhHHHHHHHHHHHHHc-cCCceeeEeeeeecccceEE
Q 046750 359 TNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSG---SGQGEREFRAEVEIISRV-HHRHLVSLVGYCISEKNRLL 433 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~---~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~l 433 (723)
.++|++.++||+|+||.||+|+. .+++.||||+++.. .....+.+..|.++|..+ +|+||+++++++.+.+.+||
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 46799999999999999999965 46889999998753 223345678899999988 79999999999999999999
Q ss_pred EEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCC
Q 046750 434 IYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDT 513 (723)
Q Consensus 434 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 513 (723)
||||+.+|+|.++|+..+ .+++..++.|+.||+.||+|||++ +|||||||++||||+.++.+||+|||+++....
T Consensus 420 V~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 494 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 494 (674)
T ss_dssp EEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred EEeCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence 999999999999998654 388999999999999999999999 599999999999999999999999999985433
Q ss_pred CCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccc
Q 046750 514 TQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEI 593 (723)
Q Consensus 514 ~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~ 593 (723)
... .....+||..|+|||++.+..|+.++||||||||||||++|+.||..... . + +.+.+..+.+.
T Consensus 495 ~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~---~---~-----~~~~i~~~~~~-- 560 (674)
T 3pfq_A 495 DGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---D---E-----LFQSIMEHNVA-- 560 (674)
T ss_dssp TTC-CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH---H---H-----HHHHHHSSCCC--
T ss_pred CCc-ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH---H---H-----HHHHHHhCCCC--
Confidence 222 23456799999999999999999999999999999999999999976431 1 1 12222222211
Q ss_pred cchhhhccccHHHHHHHHHHHHHHhccCCCCCCCH-----HHHHH
Q 046750 594 VDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRM-----VQVVR 633 (723)
Q Consensus 594 vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~-----~eVl~ 633 (723)
+.......+.+|+.+||+.||.+|+++ .||++
T Consensus 561 --------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 561 --------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp --------CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred --------CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 111123367889999999999999997 66654
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=345.08 Aligned_cols=254 Identities=20% Similarity=0.338 Sum_probs=195.7
Q ss_pred HhcCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCC--chhHHHHHHHHHHHHHcc--CCceeeEeeeeecccceEE
Q 046750 358 ITNGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGS--GQGEREFRAEVEIISRVH--HRHLVSLVGYCISEKNRLL 433 (723)
Q Consensus 358 ~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~--~~~~~~~~~Ei~il~~l~--HpnIv~l~g~~~~~~~~~l 433 (723)
..++|++.++||+|+||.||++...+++.||||++.... ....+.+.+|+++|++|+ |+||+++++++.+....++
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 105 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 105 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence 346799999999999999999988889999999986542 334567899999999997 5999999999999999999
Q ss_pred EEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCC
Q 046750 434 IYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDT 513 (723)
Q Consensus 434 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 513 (723)
||| +.+++|.+++.... .+++..++.|+.||++||.|||++ +|+|||||++||||++ +.+||+|||+++....
T Consensus 106 v~e-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~ 178 (313)
T 3cek_A 106 VME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQP 178 (313)
T ss_dssp EEC-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC---
T ss_pred EEe-cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccccccC
Confidence 999 56899999997654 478889999999999999999999 5999999999999975 7999999999986644
Q ss_pred CCcc-eeecccccccccChhhhcc-----------CCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhh
Q 046750 514 TQTH-VSTRVMGTFGYLAPEYASS-----------GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVL 581 (723)
Q Consensus 514 ~~~~-~~~~~~gt~~y~APE~~~~-----------~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l 581 (723)
.... ......|+..|+|||++.+ ..++.++|||||||+||||++|+.||...... . .. +
T Consensus 179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~----~-~~----~ 249 (313)
T 3cek_A 179 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ----I-SK----L 249 (313)
T ss_dssp -----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH----H-HH----H
T ss_pred ccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH----H-HH----H
Confidence 3322 2234568999999999876 46888999999999999999999999654321 1 11 1
Q ss_pred hhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 046750 582 VRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALD 636 (723)
Q Consensus 582 ~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~ 636 (723)
...+.... . ..+.......+.+++.+||+.||.+||++.||++.-.
T Consensus 250 ~~~~~~~~-~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~ 295 (313)
T 3cek_A 250 HAIIDPNH-E--------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 295 (313)
T ss_dssp HHHHCTTS-C--------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred HHHHhccc-c--------cCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCcc
Confidence 11111111 0 0111111236788999999999999999999997543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=349.05 Aligned_cols=257 Identities=24% Similarity=0.381 Sum_probs=198.6
Q ss_pred hcCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCC--chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEE
Q 046750 359 TNGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGS--GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYE 436 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 436 (723)
.++|++.++||+|+||.||+|++.. .||||+++... ....+.|.+|+.++++++|+||+++++++.+....++|||
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 109 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS 109 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence 4678999999999999999998743 49999987542 2233567889999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCc
Q 046750 437 FVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQT 516 (723)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 516 (723)
|+.+++|.+++.... ..+++..++.|+.||+.||+|||++ +|+|||||++||||+ ++.+||+|||+++.......
T Consensus 110 ~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~ 184 (319)
T 2y4i_B 110 LCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQA 184 (319)
T ss_dssp CCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC-------
T ss_pred cccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCccccccccc
Confidence 999999999997644 3588999999999999999999999 599999999999998 67999999999875432211
Q ss_pred ----ceeecccccccccChhhhcc---------CCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhh
Q 046750 517 ----HVSTRVMGTFGYLAPEYASS---------GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVR 583 (723)
Q Consensus 517 ----~~~~~~~gt~~y~APE~~~~---------~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~ 583 (723)
.......|+..|+|||++.+ ..++.++|||||||+||||++|+.||..... ..+ ..
T Consensus 185 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~--------~~ 253 (319)
T 2y4i_B 185 GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA---EAI--------IW 253 (319)
T ss_dssp ---CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH---HHH--------HH
T ss_pred cccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHH--------HH
Confidence 11223458999999999874 4578899999999999999999999975431 111 11
Q ss_pred hhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCCC
Q 046750 584 AIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEM 641 (723)
Q Consensus 584 ~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~~ 641 (723)
.+..+....+... .+ ...+.+|+.+||+.||.+||++.+|++.|+.+...
T Consensus 254 ~~~~~~~~~~~~~----~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 254 QMGTGMKPNLSQI----GM----GKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp HHHTTCCCCCCCS----SC----CTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred HhccCCCCCCCcC----CC----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 1222221111111 11 12578899999999999999999999999987654
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=337.00 Aligned_cols=254 Identities=21% Similarity=0.387 Sum_probs=193.5
Q ss_pred HhcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeec---------
Q 046750 358 ITNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCIS--------- 427 (723)
Q Consensus 358 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--------- 427 (723)
+.++|++.+.||+|+||.||+|.. .+++.||||+++.. ....+.+.+|++++++++|+||++++++|.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 467899999999999999999964 57899999999653 2344678999999999999999999998865
Q ss_pred ----ccceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEe
Q 046750 428 ----EKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVA 503 (723)
Q Consensus 428 ----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~ 503 (723)
....|+||||+.+++|.++++... ..+.+..++.++.||++||+|||++ +|+|||||++||||+.++.+||+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEEC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEe
Confidence 456789999999999999997543 3477888999999999999999999 59999999999999999999999
Q ss_pred ecccccccCCCC-------------cceeecccccccccChhhhccC-CCCCccceechHHHHHHHHhCCCCCCCCCCCC
Q 046750 504 DFGLAKLNDTTQ-------------THVSTRVMGTFGYLAPEYASSG-KLTDRSDVFSFGVVLLELITGRKPVDPTQPLG 569 (723)
Q Consensus 504 DFGla~~~~~~~-------------~~~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~ 569 (723)
|||+++...... ........|+..|+|||++.+. .++.++|||||||+||||++ ||...
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~---- 231 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG---- 231 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH----
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc----
Confidence 999997654321 1112345689999999999864 68999999999999999998 44321
Q ss_pred chhhHHhhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 046750 570 DESLVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRAL 635 (723)
Q Consensus 570 ~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L 635 (723)
..... +...+..... .+...+.......+.+++.+||+.||.+||++.+|++.-
T Consensus 232 -~~~~~-----~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~ 285 (303)
T 1zy4_A 232 -MERVN-----ILKKLRSVSI------EFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSG 285 (303)
T ss_dssp -HHHHH-----HHHHHHSTTC------CCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSS
T ss_pred -hhHHH-----HHHhcccccc------ccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCC
Confidence 11111 1122222111 111122223334678999999999999999999999753
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=348.27 Aligned_cols=262 Identities=21% Similarity=0.333 Sum_probs=195.4
Q ss_pred HhcCcccceEEeccCcEEEEEEE-cCCCcEEEEEEcccCCc--hhHHHHHHHHHHHHHccCCceeeEeeeeecccce---
Q 046750 358 ITNGFARENVIGEGGFGCVYKGN-LPEGKVVAVKQLKSGSG--QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNR--- 431 (723)
Q Consensus 358 ~~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~VAvK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~--- 431 (723)
+.++|.+.++||+|+||.||+|. ..+|+.||||+++.... ...+.+.+|+.++++++|+||++++++|......
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 45789999999999999999995 45689999999976432 2346788999999999999999999999877655
Q ss_pred ---EEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccc
Q 046750 432 ---LLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLA 508 (723)
Q Consensus 432 ---~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla 508 (723)
|+||||+. ++|.+++.. .+++..++.|+.||+.||+|||++ +|+|||||++||||+.++.+||+|||++
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred eeEEEEEcccc-ccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 99999995 788888743 288999999999999999999999 5999999999999999999999999999
Q ss_pred cccCCCCcceeecccccccccChhhhcc-CCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhh------hh
Q 046750 509 KLNDTTQTHVSTRVMGTFGYLAPEYASS-GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARP------VL 581 (723)
Q Consensus 509 ~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~------~l 581 (723)
+..... .....|+..|+|||++.+ ..++.++|||||||+||||++|+.||...... ..+...... .+
T Consensus 192 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~ 265 (371)
T 4exu_A 192 RHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL--DQLTQILKVTGVPGTEF 265 (371)
T ss_dssp ------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCHHH
T ss_pred cccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCcHHH
Confidence 755432 234568999999999987 67999999999999999999999999764321 111110000 00
Q ss_pred hhhhhcCC-------cccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 582 VRAIETGD-------LSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 582 ~~~i~~~~-------l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
...+.... +.......+ ..+.......+.+|+.+||+.||.+||++.|+++.
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 266 VQKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HTTCSCHHHHHHHHHSCCCCCCCH-HHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHhhhhhhhhhhhccCCCcchhH-HHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 00000000 000000000 00011123468899999999999999999999875
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=348.05 Aligned_cols=202 Identities=23% Similarity=0.291 Sum_probs=172.3
Q ss_pred HhcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCchhHHHHHHHHHHHHHcc-CC-----ceeeEeeeeecccc
Q 046750 358 ITNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQGEREFRAEVEIISRVH-HR-----HLVSLVGYCISEKN 430 (723)
Q Consensus 358 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~-Hp-----nIv~l~g~~~~~~~ 430 (723)
+.++|.+.++||+|+||.||+|.. .+++.||||+++.. .....++..|+++++.++ |+ +|++++++|...+.
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 357899999999999999999954 46889999999753 233457788999999985 54 49999999999999
Q ss_pred eEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeC--CCCcEEEeecccc
Q 046750 431 RLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVD--DEFEAQVADFGLA 508 (723)
Q Consensus 431 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~--~~~~vkL~DFGla 508 (723)
.+|||||+. ++|.+++.......+.+..++.|+.||+.||.|||.+ ..+|||||||++||||+ .++.+||+|||++
T Consensus 131 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a 208 (382)
T 2vx3_A 131 LCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208 (382)
T ss_dssp EEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred eEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence 999999995 6999999876555689999999999999999999953 12699999999999995 4788999999999
Q ss_pred cccCCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCC
Q 046750 509 KLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQ 566 (723)
Q Consensus 509 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~ 566 (723)
+..... .....|+..|+|||++.+..++.++|||||||+||||++|+.||....
T Consensus 209 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 209 CQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp EETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 876432 234568999999999999999999999999999999999999998653
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=344.85 Aligned_cols=264 Identities=19% Similarity=0.293 Sum_probs=200.1
Q ss_pred hcCcccceEEeccCcEEEEEEEcC-CC-cEEEEEEcccCCchhHHHHHHHHHHHHHccCCc------eeeEeeeeecccc
Q 046750 359 TNGFARENVIGEGGFGCVYKGNLP-EG-KVVAVKQLKSGSGQGEREFRAEVEIISRVHHRH------LVSLVGYCISEKN 430 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g-~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~Hpn------Iv~l~g~~~~~~~ 430 (723)
.++|++.++||+|+||.||+|... ++ +.||||+++.. ....+.+.+|+++|++|+|.| ++.+++++.....
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 468999999999999999999653 44 68999999753 244567889999999997765 8999999999999
Q ss_pred eEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEe----------------
Q 046750 431 RLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILV---------------- 494 (723)
Q Consensus 431 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl---------------- 494 (723)
.+|||||+ +++|.+++.......+++..++.|+.||+.||+|||++ +|+|||||++||||
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccccccc
Confidence 99999999 67777777665545689999999999999999999999 59999999999999
Q ss_pred ---CCCCcEEEeecccccccCCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCch
Q 046750 495 ---DDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDE 571 (723)
Q Consensus 495 ---~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~ 571 (723)
+.++.+||+|||+++..... .....|+..|+|||++.+..++.++|||||||+||||++|+.||..... .
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---~ 245 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN---R 245 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---H
T ss_pred ccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH---H
Confidence 56789999999999864432 2335689999999999999999999999999999999999999976432 1
Q ss_pred hhHHhhhhhh-------hhhhhcCCc--------ccc----------cch-hhhccccHHHHHHHHHHHHHHhccCCCCC
Q 046750 572 SLVEWARPVL-------VRAIETGDL--------SEI----------VDP-RLEKHYVESEMFRMIEAAAACVRHSGPKR 625 (723)
Q Consensus 572 ~l~~~~~~~l-------~~~i~~~~l--------~~~----------vd~-~l~~~~~~~~~~~l~~l~~~cl~~dP~~R 625 (723)
.........+ ........+ ... ... .........+...+.+|+.+||+.||.+|
T Consensus 246 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 325 (355)
T 2eu9_A 246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR 325 (355)
T ss_dssp HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence 1111110000 000000000 000 000 00001122334578899999999999999
Q ss_pred CCHHHHHHH
Q 046750 626 PRMVQVVRA 634 (723)
Q Consensus 626 Ps~~eVl~~ 634 (723)
|++.||++.
T Consensus 326 pt~~e~l~h 334 (355)
T 2eu9_A 326 ITLAEALLH 334 (355)
T ss_dssp CCHHHHTTS
T ss_pred cCHHHHhcC
Confidence 999999854
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=334.84 Aligned_cols=254 Identities=21% Similarity=0.341 Sum_probs=203.3
Q ss_pred HHHhcCcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCC--chhHHHHHHHHHHHHHccCCceeeEeeeeecccceE
Q 046750 356 MEITNGFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGS--GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRL 432 (723)
Q Consensus 356 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 432 (723)
..+.++|++.++||+|+||.||+|... +++.||||++.... ....+.+.+|++++++|+|+||+++++++.+....+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 455678999999999999999999654 68999999986532 234567899999999999999999999999999999
Q ss_pred EEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCC---CcEEEeeccccc
Q 046750 433 LIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDE---FEAQVADFGLAK 509 (723)
Q Consensus 433 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~---~~vkL~DFGla~ 509 (723)
+||||+.+++|.+++.... .+++..++.|+.||+.||+|||++ +|+|||||++||||+.+ +.+||+|||++.
T Consensus 98 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp EEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 9999999999999886543 478999999999999999999999 59999999999999754 479999999998
Q ss_pred ccCCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCC
Q 046750 510 LNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGD 589 (723)
Q Consensus 510 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~ 589 (723)
....... .....|+..|+|||++.+ .++.++|||||||+||||++|+.||..... .. +.+.+..+.
T Consensus 173 ~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~--------~~~~~~~~~ 238 (287)
T 2wei_A 173 CFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE---YD--------ILKRVETGK 238 (287)
T ss_dssp TBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HH--------HHHHHHHCC
T ss_pred eecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH---HH--------HHHHHHcCC
Confidence 6644322 223458899999999875 589999999999999999999999975431 11 112222332
Q ss_pred cccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 590 LSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 590 l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
+..... .+ ..+ ...+.+++.+||+.||.+||++.||++.
T Consensus 239 ~~~~~~-~~-~~~----~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 239 YAFDLP-QW-RTI----SDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp CCCCSG-GG-TTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred CCCCch-hh-hhc----CHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 211110 00 111 2367889999999999999999999873
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-39 Score=374.78 Aligned_cols=257 Identities=25% Similarity=0.387 Sum_probs=203.7
Q ss_pred hcCcccceEEeccCcEEEEEEEcCC----CcEEEEEEcccCCc-hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEE
Q 046750 359 TNGFARENVIGEGGFGCVYKGNLPE----GKVVAVKQLKSGSG-QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLL 433 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~~~----g~~VAvK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 433 (723)
.++|.+.+.||+|+||.||+|.+.. +..||||+++.... ...+.|.+|+.+|++++|+||+++++++. ++..++
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~l 467 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 467 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEE
Confidence 4679999999999999999996532 45799999876533 33467899999999999999999999985 456899
Q ss_pred EEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCC
Q 046750 434 IYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDT 513 (723)
Q Consensus 434 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 513 (723)
||||+.+|+|.++++... ..+++..++.|+.||++||+|||++ +|+|||||++||||+.++.+||+|||+++....
T Consensus 468 v~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~~~ 543 (656)
T 2j0j_A 468 IMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 543 (656)
T ss_dssp EEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred EEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence 999999999999997543 2488999999999999999999999 599999999999999999999999999987655
Q ss_pred CCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCccc
Q 046750 514 TQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSE 592 (723)
Q Consensus 514 ~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~ 592 (723)
..........++..|+|||++.+..++.++|||||||+||||++ |..||..... ..+ ...+..+....
T Consensus 544 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~---~~~--------~~~i~~~~~~~ 612 (656)
T 2j0j_A 544 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---NDV--------IGRIENGERLP 612 (656)
T ss_dssp ----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHH--------HHHHHHTCCCC
T ss_pred CcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH---HHH--------HHHHHcCCCCC
Confidence 44333344557889999999999999999999999999999997 9999975431 111 11222222111
Q ss_pred ccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCC
Q 046750 593 IVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGE 640 (723)
Q Consensus 593 ~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~ 640 (723)
+ .......+.+|+.+||+.||.+||++.+|++.|+.+.+
T Consensus 613 ~---------~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 613 M---------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp C---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred C---------CccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 1 11122467899999999999999999999999987643
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=344.51 Aligned_cols=266 Identities=19% Similarity=0.298 Sum_probs=192.7
Q ss_pred hcCcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeee-----------
Q 046750 359 TNGFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCI----------- 426 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~----------- 426 (723)
.++|.+.++||+|+||.||+|... +++.||||++........+.+.+|++++++|+|+||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 467999999999999999999664 48999999998766666678999999999999999999999874
Q ss_pred ---cccceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeC-CCCcEEE
Q 046750 427 ---SEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVD-DEFEAQV 502 (723)
Q Consensus 427 ---~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~-~~~~vkL 502 (723)
+....++||||+. |+|.+++... .+.+..++.++.||++||+|||++ +|+|||||++||||+ +++.+||
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQG---PLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhcC---CccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEE
Confidence 3466799999996 7999998643 478889999999999999999999 599999999999997 5779999
Q ss_pred eecccccccCCCCcc--eeecccccccccChhhhcc-CCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhh
Q 046750 503 ADFGLAKLNDTTQTH--VSTRVMGTFGYLAPEYASS-GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARP 579 (723)
Q Consensus 503 ~DFGla~~~~~~~~~--~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~ 579 (723)
+|||+++........ ......++..|+|||++.+ ..++.++|||||||+||||++|+.||...... ..+......
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--~~~~~~~~~ 240 (320)
T 2i6l_A 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL--EQMQLILES 240 (320)
T ss_dssp CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHH
T ss_pred ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHh
Confidence 999999866432211 1233457899999998876 67899999999999999999999999765421 111000000
Q ss_pred h------hhhhhhcCCcccccchhhhc------cccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 580 V------LVRAIETGDLSEIVDPRLEK------HYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 580 ~------l~~~i~~~~l~~~vd~~l~~------~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
. ..+.+. ..+...++..+.. .........+.+++.+||+.||.+||++.||++.
T Consensus 241 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 241 IPVVHEEDRQELL-SVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp SCCCCHHHHHHHH-TTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cCCCchhhhhhhh-hcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 0 000000 0000000000000 0001123468899999999999999999999874
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=344.43 Aligned_cols=273 Identities=20% Similarity=0.278 Sum_probs=190.1
Q ss_pred HHHHHHhcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccc-
Q 046750 353 EELMEITNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKN- 430 (723)
Q Consensus 353 ~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~- 430 (723)
+......++|.+.++||+|+||.||+|+. .+++.||||++.... .....+.+|++.++.++|+||++++++|.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 45666778999999999999999999965 568999999986543 223456778999999999999999999976443
Q ss_pred ------eEEEEEecCCCchhhcccc--CCCCcchHHHHHHHHHHHHhhhchhc--ccCCCceeecCCCCCcEEeCC-CCc
Q 046750 431 ------RLLIYEFVPNNNLEHHLHG--KGQPVLEWTKRVKIALGAAKGLAYLH--EDCHPKIIHRDIKSANILVDD-EFE 499 (723)
Q Consensus 431 ------~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH--~~g~~~ivHrDIkp~NILl~~-~~~ 499 (723)
.++||||+.++ |.+.+.. .....+.+..++.|+.||+.||.||| ++ +|+|||||++||||+. ++.
T Consensus 95 ~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp CTTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTE
T ss_pred cccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCc
Confidence 78999999764 4433321 23335788899999999999999999 77 5999999999999996 899
Q ss_pred EEEeecccccccCCCCcceeecccccccccChhhhccCC-CCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhh
Q 046750 500 AQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGK-LTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWAR 578 (723)
Q Consensus 500 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~ 578 (723)
+||+|||+++....... .....|+..|+|||++.+.. ++.++|||||||+||||++|+.||..... ...+..+.+
T Consensus 171 ~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~--~~~~~~~~~ 246 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS--AGQLHEIVR 246 (360)
T ss_dssp EEECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHH
T ss_pred EEEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCCh--HHHHHHHHH
Confidence 99999999986654332 23456899999999987654 89999999999999999999999976532 111111111
Q ss_pred h------hhhhhhhcCCc-ccccc------hhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 579 P------VLVRAIETGDL-SEIVD------PRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 579 ~------~l~~~i~~~~l-~~~vd------~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
. .+...+..... ..+.+ ..+...........+.+|+.+||+.||.+||++.||++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 247 VLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0 00011100000 00000 000011111234578899999999999999999999975
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=344.16 Aligned_cols=248 Identities=23% Similarity=0.359 Sum_probs=191.6
Q ss_pred HHHHHhcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCch------hHHHHHHHHHHHHHc----cCCceeeEe
Q 046750 354 ELMEITNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQ------GEREFRAEVEIISRV----HHRHLVSLV 422 (723)
Q Consensus 354 ~l~~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~------~~~~~~~Ei~il~~l----~HpnIv~l~ 422 (723)
+...+.++|.+.++||+|+||.||+|+. .+++.||||+++..... ....+.+|+.++.++ +|+||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 3455678899999999999999999955 56889999999765322 223456799999999 899999999
Q ss_pred eeeecccceEEEEEe-cCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeC-CCCcE
Q 046750 423 GYCISEKNRLLIYEF-VPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVD-DEFEA 500 (723)
Q Consensus 423 g~~~~~~~~~lV~E~-~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~-~~~~v 500 (723)
+++.+.+..++|||| +.+++|.+++.... .+.+..++.|+.||++||+|||++ +|+|||||++||||+ +++.+
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEE
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeE
Confidence 999999999999999 78999999997644 488999999999999999999999 599999999999999 88999
Q ss_pred EEeecccccccCCCCcceeecccccccccChhhhccCCCC-CccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhh
Q 046750 501 QVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLT-DRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARP 579 (723)
Q Consensus 501 kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t-~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~ 579 (723)
||+|||+++...... .....|+..|+|||++.+..+. .++|||||||+||||++|+.||.... ..
T Consensus 180 kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~~------ 245 (312)
T 2iwi_A 180 KLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-----EI------ 245 (312)
T ss_dssp EECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HH------
T ss_pred EEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-----HH------
Confidence 999999998765432 2345689999999999877764 48999999999999999999996421 00
Q ss_pred hhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 046750 580 VLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALD 636 (723)
Q Consensus 580 ~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~ 636 (723)
+ ...+ .+...+ ...+.+++.+||+.||.+||++.||++.-.
T Consensus 246 -~-----~~~~------~~~~~~----~~~~~~li~~~l~~~p~~Rps~~e~l~~~~ 286 (312)
T 2iwi_A 246 -L-----EAEL------HFPAHV----SPDCCALIRRCLAPKPSSRPSLEEILLDPW 286 (312)
T ss_dssp -H-----HTCC------CCCTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHHSTT
T ss_pred -h-----hhcc------CCcccC----CHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 0 0110 011111 235788999999999999999999998543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=343.64 Aligned_cols=255 Identities=20% Similarity=0.260 Sum_probs=174.2
Q ss_pred HhcCcccce-EEeccCcEEEEEEEcC-CCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeec----ccce
Q 046750 358 ITNGFAREN-VIGEGGFGCVYKGNLP-EGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCIS----EKNR 431 (723)
Q Consensus 358 ~~~~f~~~~-~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~----~~~~ 431 (723)
+.++|.+.+ +||+|+||.||+|... +++.||||++... ..........++.++|+||+++++++.. ....
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 457888854 6999999999999654 6899999999653 2222333344667799999999999876 4457
Q ss_pred EEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCC---CCcEEEeecccc
Q 046750 432 LLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDD---EFEAQVADFGLA 508 (723)
Q Consensus 432 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~---~~~vkL~DFGla 508 (723)
+|||||+.+|+|.+++.......+++..++.|+.||+.||+|||++ +|+|||||++||||+. ++.+||+|||++
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 9999999999999999877666799999999999999999999999 5999999999999986 455999999999
Q ss_pred cccCCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcC
Q 046750 509 KLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETG 588 (723)
Q Consensus 509 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~ 588 (723)
+...... .....|+..|+|||++.+..++.++|||||||+||||++|+.||........ ... +.+.+..+
T Consensus 179 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~-----~~~~~~~~ 248 (336)
T 3fhr_A 179 KETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAI--SPG-----MKRRIRLG 248 (336)
T ss_dssp EEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------------------
T ss_pred eeccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhh--hhh-----HHHhhhcc
Confidence 7654322 2335689999999999888899999999999999999999999965432110 000 00111111
Q ss_pred CcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 046750 589 DLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRAL 635 (723)
Q Consensus 589 ~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L 635 (723)
.+. +.. .........+.+|+.+||+.||.+||++.||++.-
T Consensus 249 ~~~-~~~-----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 289 (336)
T 3fhr_A 249 QYG-FPN-----PEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHP 289 (336)
T ss_dssp --C-CCT-----TTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred ccc-cCc-----hhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 110 000 00011233678899999999999999999999843
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=341.06 Aligned_cols=261 Identities=21% Similarity=0.326 Sum_probs=194.7
Q ss_pred hcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCc--hhHHHHHHHHHHHHHccCCceeeEeeeeecccc-----
Q 046750 359 TNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSG--QGEREFRAEVEIISRVHHRHLVSLVGYCISEKN----- 430 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~----- 430 (723)
.++|.+.+.||+|+||.||+|.. .+|+.||||++..... ...+.+.+|+.+|++++|+||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 46799999999999999999954 5689999999976432 234578899999999999999999999987654
Q ss_pred -eEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeeccccc
Q 046750 431 -RLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK 509 (723)
Q Consensus 431 -~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 509 (723)
.|+||||+. ++|.+++.. .+++..++.++.||+.||+|||++ +|+|||||++||||+.++.+||+|||+++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLAR 174 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred eEEEEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccccc
Confidence 499999996 789888753 378899999999999999999999 59999999999999999999999999997
Q ss_pred ccCCCCcceeecccccccccChhhhcc-CCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhh------hhh
Q 046750 510 LNDTTQTHVSTRVMGTFGYLAPEYASS-GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARP------VLV 582 (723)
Q Consensus 510 ~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~------~l~ 582 (723)
..... .....|+..|+|||++.+ ..++.++|||||||+||||++|+.||...... ..+...... .+.
T Consensus 175 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~ 248 (353)
T 3coi_A 175 HADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL--DQLTQILKVTGVPGTEFV 248 (353)
T ss_dssp C------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH--HHHHHHHHHHCBCCHHHH
T ss_pred CCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHHH
Confidence 65422 233568999999999987 67899999999999999999999999764321 111100000 000
Q ss_pred hhhhcC-------CcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 583 RAIETG-------DLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 583 ~~i~~~-------~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
+.+... .+.......+. .........+.+|+.+||+.||.+||++.|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 249 QKLNDKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp TTCSCHHHHHHHHTSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHhhHHHHHHHHhCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000000 00000000000 0111223468899999999999999999999875
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=340.84 Aligned_cols=254 Identities=26% Similarity=0.395 Sum_probs=177.0
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCc-hhHHHHHHHHH-HHHHccCCceeeEeeeeecccceEEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSG-QGEREFRAEVE-IISRVHHRHLVSLVGYCISEKNRLLIYE 436 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~-~~~~~~~~Ei~-il~~l~HpnIv~l~g~~~~~~~~~lV~E 436 (723)
++|.+.+.||+|+||.||+|.. .+|+.||||+++.... ....++..|+. +++.++|+||+++++++.+.+..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 6788999999999999999965 4689999999976533 33345666666 6777899999999999999999999999
Q ss_pred ecCCCchhhcccc---CCCCcchHHHHHHHHHHHHhhhchhccc-CCCceeecCCCCCcEEeCCCCcEEEeecccccccC
Q 046750 437 FVPNNNLEHHLHG---KGQPVLEWTKRVKIALGAAKGLAYLHED-CHPKIIHRDIKSANILVDDEFEAQVADFGLAKLND 512 (723)
Q Consensus 437 ~~~~gsL~~~l~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~-g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 512 (723)
|+. ++|.+++.. .....+.+..++.|+.||+.||.|||+. + |+|||||++||||+.++.+||+|||+++...
T Consensus 102 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 102 LMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred ecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 996 577776652 2234588999999999999999999997 5 9999999999999999999999999997654
Q ss_pred CCCcceeecccccccccChhhh----ccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcC
Q 046750 513 TTQTHVSTRVMGTFGYLAPEYA----SSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETG 588 (723)
Q Consensus 513 ~~~~~~~~~~~gt~~y~APE~~----~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~ 588 (723)
.... .....|+..|+|||++ .+..++.++|||||||+||||++|+.||....... +. + ..+..+
T Consensus 178 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~----~-~~~~~~ 245 (327)
T 3aln_A 178 DSIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-----DQ----L-TQVVKG 245 (327)
T ss_dssp ------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----------------CCCCCS
T ss_pred cccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH-----HH----H-HHHhcC
Confidence 3322 2334689999999998 46678999999999999999999999997543210 00 0 111111
Q ss_pred CcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 589 DLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 589 ~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
....+ ...........+.+|+.+||+.||.+||++.+|++.
T Consensus 246 ~~~~~-----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 246 DPPQL-----SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp CCCCC-----CCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCCCC-----CCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 11111 111111122368899999999999999999999763
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=349.52 Aligned_cols=251 Identities=25% Similarity=0.349 Sum_probs=187.5
Q ss_pred cCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHc-cCCceeeEeeeeecccceEEEEEec
Q 046750 360 NGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRV-HHRHLVSLVGYCISEKNRLLIYEFV 438 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~E~~ 438 (723)
+.|...++||+|+||.||.+...+|+.||||++... ..+.+.+|+++|+++ +|+|||++++++.+....||||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 446667899999999998776678999999998752 345678999999987 8999999999999999999999999
Q ss_pred CCCchhhccccCCCCc-----chHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCC-------------CcE
Q 046750 439 PNNNLEHHLHGKGQPV-----LEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDE-------------FEA 500 (723)
Q Consensus 439 ~~gsL~~~l~~~~~~~-----l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~-------------~~v 500 (723)
+|+|.+++....... ..+..++.|+.||+.||+|||++ +|||||||++||||+.+ +.+
T Consensus 92 -~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 -NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp -SEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred -CCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEE
Confidence 579999997653211 13334578999999999999999 59999999999999654 589
Q ss_pred EEeecccccccCCCCcce---eecccccccccChhhhcc-------CCCCCccceechHHHHHHHHh-CCCCCCCCCCCC
Q 046750 501 QVADFGLAKLNDTTQTHV---STRVMGTFGYLAPEYASS-------GKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLG 569 (723)
Q Consensus 501 kL~DFGla~~~~~~~~~~---~~~~~gt~~y~APE~~~~-------~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~ 569 (723)
||+|||+++......... .....||..|+|||++.+ ..++.++|||||||+||||++ |+.||......
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~- 246 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR- 246 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH-
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh-
Confidence 999999998765433221 234579999999999976 678999999999999999999 99999654321
Q ss_pred chhhHHhhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 046750 570 DESLVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVR 633 (723)
Q Consensus 570 ~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~ 633 (723)
. ..+ +........+ ...........+.+|+.+||+.||.+||++.+|++
T Consensus 247 -~--~~i----~~~~~~~~~~--------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 247 -E--SNI----IRGIFSLDEM--------KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp -H--HHH----HHTCCCCCCC--------TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -H--HHH----hcCCCCcccc--------cccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 0 111 1010111111 11112334567889999999999999999999986
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=345.76 Aligned_cols=249 Identities=22% Similarity=0.353 Sum_probs=199.1
Q ss_pred HHHHHHHhcCcccceEEeccCcEEEEEEE-cCCCcEEEEEEcccCCch------hHHHHHHHHHHHHHcc--CCceeeEe
Q 046750 352 YEELMEITNGFARENVIGEGGFGCVYKGN-LPEGKVVAVKQLKSGSGQ------GEREFRAEVEIISRVH--HRHLVSLV 422 (723)
Q Consensus 352 ~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~VAvK~l~~~~~~------~~~~~~~Ei~il~~l~--HpnIv~l~ 422 (723)
..+...+.++|++.++||+|+||.||+|. ..+++.||||+++..... ....+.+|+.++++++ |+||++++
T Consensus 35 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~ 114 (320)
T 3a99_A 35 GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 114 (320)
T ss_dssp -----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEE
T ss_pred ccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEE
Confidence 34445567889999999999999999995 567899999998754221 2245778999999996 59999999
Q ss_pred eeeecccceEEEEEecCC-CchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeC-CCCcE
Q 046750 423 GYCISEKNRLLIYEFVPN-NNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVD-DEFEA 500 (723)
Q Consensus 423 g~~~~~~~~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~-~~~~v 500 (723)
+++.+.+..++||||+.+ ++|.+++.... .+.+..++.|+.||++||+|||++ +|+|||||++||||+ +++.+
T Consensus 115 ~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~ 189 (320)
T 3a99_A 115 DWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGEL 189 (320)
T ss_dssp EEEECSSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEE
T ss_pred EEEecCCcEEEEEEcCCCCccHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCE
Confidence 999999999999999976 89999987643 478899999999999999999999 599999999999999 78999
Q ss_pred EEeecccccccCCCCcceeecccccccccChhhhccCCC-CCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhh
Q 046750 501 QVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKL-TDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARP 579 (723)
Q Consensus 501 kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~ 579 (723)
||+|||+++...... .....|+..|+|||++.+..+ +.++|||||||+||||++|+.||.... ..
T Consensus 190 kL~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-----~~------ 255 (320)
T 3a99_A 190 KLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EI------ 255 (320)
T ss_dssp EECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HH------
T ss_pred EEeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-----hh------
Confidence 999999998765332 233568999999999987765 678999999999999999999996421 00
Q ss_pred hhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 046750 580 VLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRAL 635 (723)
Q Consensus 580 ~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L 635 (723)
..+.+. +...+ ...+.+|+.+||+.||.+||++.||++.-
T Consensus 256 ------~~~~~~------~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~hp 295 (320)
T 3a99_A 256 ------IRGQVF------FRQRV----SSECQHLIRWCLALRPSDRPTFEEIQNHP 295 (320)
T ss_dssp ------HHCCCC------CSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred ------hccccc------ccccC----CHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 011100 11112 23578899999999999999999998743
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=330.19 Aligned_cols=252 Identities=24% Similarity=0.365 Sum_probs=178.1
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCchh-H-HHHHHHHHHHHHccCCceeeEeeeeecccceEEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQG-E-REFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYE 436 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~~-~-~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 436 (723)
++|++.+.||+|+||.||+|.. .+|+.||||+++...... . +.+..+..+++.++|+||+++++++.+.+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e 104 (318)
T 2dyl_A 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME 104 (318)
T ss_dssp GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Confidence 6789999999999999999965 468999999997653322 2 334455567888899999999999999999999999
Q ss_pred ecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCc
Q 046750 437 FVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQT 516 (723)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 516 (723)
|+ ++.+..++... ...+.+..++.|+.||++||.|||++. +|+|||||++||||+.++.+||+|||++........
T Consensus 105 ~~-~~~~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (318)
T 2dyl_A 105 LM-GTCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA 180 (318)
T ss_dssp CC-SEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHHH--CCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred cc-CCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhhC--CEEeCCCCHHHEEECCCCCEEEEECCCchhccCCcc
Confidence 99 55555555432 235789999999999999999999841 499999999999999999999999999976543222
Q ss_pred ceeecccccccccChhhhc-----cCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcc
Q 046750 517 HVSTRVMGTFGYLAPEYAS-----SGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLS 591 (723)
Q Consensus 517 ~~~~~~~gt~~y~APE~~~-----~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~ 591 (723)
.....|+..|+|||++. ...++.++|||||||+||||++|+.||..... .... + ..+..+...
T Consensus 181 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~-------~-~~~~~~~~~ 248 (318)
T 2dyl_A 181 --KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT--DFEV-------L-TKVLQEEPP 248 (318)
T ss_dssp --------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS--HHHH-------H-HHHHHSCCC
T ss_pred --ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc--cHHH-------H-HHHhccCCC
Confidence 23356899999999994 56789999999999999999999999975321 1111 1 111111111
Q ss_pred cccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 592 EIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 592 ~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
.+.. ...+ ...+.+++.+||+.||.+||++.+|++.
T Consensus 249 ~~~~---~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 249 LLPG---HMGF----SGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp CCCS---SSCC----CHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CCCc---cCCC----CHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1100 0111 2357889999999999999999999863
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-38 Score=348.50 Aligned_cols=248 Identities=23% Similarity=0.318 Sum_probs=185.6
Q ss_pred cCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHc-cCCceeeEeeeeecccceEEEEEec
Q 046750 360 NGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRV-HHRHLVSLVGYCISEKNRLLIYEFV 438 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~E~~ 438 (723)
.+|...++||+|+||.||.....+++.||||++..... ..+.+|+++|+++ +|+|||++++++.+....||||||+
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence 45889999999999997666556899999999975432 2357899999999 7999999999999999999999999
Q ss_pred CCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeC-----CCCcEEEeecccccccCC
Q 046750 439 PNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVD-----DEFEAQVADFGLAKLNDT 513 (723)
Q Consensus 439 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~-----~~~~vkL~DFGla~~~~~ 513 (723)
. |+|.+++...... +.+..++.|+.||++||+|||++ +|||||||++||||+ ....+||+|||+++....
T Consensus 101 ~-g~L~~~l~~~~~~-~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~ 175 (432)
T 3p23_A 101 A-ATLQEYVEQKDFA-HLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175 (432)
T ss_dssp S-EEHHHHHHSSSCC-CCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred C-CCHHHHHHhcCCC-ccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence 5 7999999765432 34445678999999999999999 599999999999994 334688999999986653
Q ss_pred CCc--ceeecccccccccChhhhc---cCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhc
Q 046750 514 TQT--HVSTRVMGTFGYLAPEYAS---SGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIET 587 (723)
Q Consensus 514 ~~~--~~~~~~~gt~~y~APE~~~---~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~ 587 (723)
... .......||..|+|||++. ...++.++||||||||||||++ |..||...... ... ..+..
T Consensus 176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~----~~~-------~~~~~ 244 (432)
T 3p23_A 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR----QAN-------ILLGA 244 (432)
T ss_dssp ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH----HHH-------HHTTC
T ss_pred CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH----HHH-------HHhcc
Confidence 322 2234467999999999997 4567889999999999999999 89998543210 000 00111
Q ss_pred CCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 046750 588 GDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVR 633 (723)
Q Consensus 588 ~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~ 633 (723)
..+. ... ........+.+|+.+||+.||.+||++.+|++
T Consensus 245 ~~~~-~~~------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 245 CSLD-CLH------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp CCCT-TSC------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCcc-ccC------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 1111 111 11122335778999999999999999999984
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=360.64 Aligned_cols=272 Identities=26% Similarity=0.337 Sum_probs=203.6
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccC-CchhHHHHHHHHHHHHHccCCceeeEeeeeec------ccce
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSG-SGQGEREFRAEVEIISRVHHRHLVSLVGYCIS------EKNR 431 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~------~~~~ 431 (723)
++|.+.++||+|+||.||+|.. .+|+.||||+++.. .....+.|.+|+++|++|+|+||+++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 6799999999999999999965 56899999998765 33345678999999999999999999998765 6678
Q ss_pred EEEEEecCCCchhhccccCC-CCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCc---EEEeeccc
Q 046750 432 LLIYEFVPNNNLEHHLHGKG-QPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFE---AQVADFGL 507 (723)
Q Consensus 432 ~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~---vkL~DFGl 507 (723)
++||||+.+|+|.+++.... ...+.+..++.|+.+|+.||+|||+. +|+|||||++||||+.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 99999999999999997643 23588899999999999999999999 5999999999999997654 99999999
Q ss_pred ccccCCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhc
Q 046750 508 AKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIET 587 (723)
Q Consensus 508 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~ 587 (723)
+........ .....|+..|+|||++.+..++.++|||||||+||||++|+.||.... ....|...........
T Consensus 171 a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~-----~~~~~~~~i~~~~~~~ 243 (676)
T 3qa8_A 171 AKELDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNW-----QPVQWHGKVREKSNEH 243 (676)
T ss_dssp CCBTTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSC-----HHHHSSTTCC------
T ss_pred ccccccccc--cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCccc-----chhhhhhhhhcccchh
Confidence 987654332 234579999999999999999999999999999999999999997532 1223322111110000
Q ss_pred CCcccccch--------hhhccccHHHHHHHHHHHHHHhccCCCCCCCHHH-----HHHHHhccCCC
Q 046750 588 GDLSEIVDP--------RLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQ-----VVRALDSEGEM 641 (723)
Q Consensus 588 ~~l~~~vd~--------~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~e-----Vl~~L~~~~~~ 641 (723)
..+...... .............+.+++.+||+.||.+||++.+ +++.|+.+...
T Consensus 244 ~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~ 310 (676)
T 3qa8_A 244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSL 310 (676)
T ss_dssp CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCC
T ss_pred hhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhc
Confidence 000000000 0011233345567899999999999999999987 45666555544
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=326.02 Aligned_cols=233 Identities=12% Similarity=0.100 Sum_probs=182.5
Q ss_pred hcCcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCCc---hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEE
Q 046750 359 TNGFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGSG---QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLI 434 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 434 (723)
.++|++.++||+|+||.||+|+.. +++.||||+++.... ...+.|.+|++++.+++|+||+++++++.+.+..|||
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 357999999999999999999654 589999999986533 2336789999999999999999999999999999999
Q ss_pred EEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCC
Q 046750 435 YEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTT 514 (723)
Q Consensus 435 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 514 (723)
|||+.+++|.+++... .....+++|+.||+.||+|||++ +|+|||||++||||++++.+||++++
T Consensus 110 ~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~-------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA-------- 174 (286)
T ss_dssp EECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred EEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc--------
Confidence 9999999999999543 23346788999999999999999 59999999999999999999998554
Q ss_pred CcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCccccc
Q 046750 515 QTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIV 594 (723)
Q Consensus 515 ~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~v 594 (723)
|++ .++.++|||||||+||||++|+.||.......... . ..+.+ .+.. .
T Consensus 175 -------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~---~----~~~~~-~~~~---~ 223 (286)
T 3uqc_A 175 -------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA---P----AERDT-AGQP---I 223 (286)
T ss_dssp -------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE---E----CCBCT-TSCB---C
T ss_pred -------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH---H----HHHHh-ccCC---C
Confidence 332 36889999999999999999999998654321100 0 00000 0000 0
Q ss_pred chhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCCC
Q 046750 595 DPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEM 641 (723)
Q Consensus 595 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~~ 641 (723)
.. ..........+.+|+.+||+.||.+| ++.||++.|+.....
T Consensus 224 ~~---~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 224 EP---ADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp CH---HHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred Ch---hhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 00 01111123358899999999999999 999999999987654
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=361.60 Aligned_cols=239 Identities=20% Similarity=0.297 Sum_probs=191.7
Q ss_pred hcCcccceEEeccCcEEEEEEEcC--CCcEEEEEEcccCC-chhHHHHHHHHHHHHHccCCceeeEeeeeecccc-----
Q 046750 359 TNGFARENVIGEGGFGCVYKGNLP--EGKVVAVKQLKSGS-GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKN----- 430 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~~--~g~~VAvK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~----- 430 (723)
.++|.+.++||+|+||.||+|.+. +++.||||++.... ......|.+|+++|++|+|+||++++++|.+.+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 478999999999999999999664 58999999987543 2344578899999999999999999999987766
Q ss_pred eEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccc
Q 046750 431 RLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKL 510 (723)
Q Consensus 431 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 510 (723)
.||||||+.+++|.+++.. .+++..++.|+.||+.||.|||++ +|||||||++||||+.+ .+||+|||+++.
T Consensus 159 ~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp EEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred eEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccchh
Confidence 6999999999999988754 488999999999999999999999 49999999999999986 999999999986
Q ss_pred cCCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCc
Q 046750 511 NDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDL 590 (723)
Q Consensus 511 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l 590 (723)
.... ....||..|+|||++.++ ++.++||||||||||||++|..+|....... +
T Consensus 231 ~~~~-----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~--------------------~ 284 (681)
T 2pzi_A 231 INSF-----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG--------------------L 284 (681)
T ss_dssp TTCC-----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS--------------------C
T ss_pred cccC-----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc--------------------c
Confidence 6543 345699999999999765 4889999999999999999988875421100 0
Q ss_pred ccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCC-HHHHHHHHhcc
Q 046750 591 SEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPR-MVQVVRALDSE 638 (723)
Q Consensus 591 ~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~eVl~~L~~~ 638 (723)
.. ..........+.+|+.+||+.||.+||+ ++++++.|...
T Consensus 285 ~~-------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 285 PE-------DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp CT-------TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred cc-------cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 00 0000111236788999999999999994 66666666543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=320.86 Aligned_cols=232 Identities=21% Similarity=0.283 Sum_probs=179.7
Q ss_pred hcCcccc-eEEeccCcEEEEEEEc-CCCcEEEEEEcccCCchhHHHHHHHHHHH-HHccCCceeeEeeeeec----ccce
Q 046750 359 TNGFARE-NVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQGEREFRAEVEII-SRVHHRHLVSLVGYCIS----EKNR 431 (723)
Q Consensus 359 ~~~f~~~-~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~~~~~~~~Ei~il-~~l~HpnIv~l~g~~~~----~~~~ 431 (723)
.++|.+. ++||+|+||.||+|.. .+++.||||+++. ...+.+|++++ +.++|+||++++++|.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 3567776 7899999999999954 6789999999964 24678899988 55589999999999887 6778
Q ss_pred EEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCC---CCcEEEeecccc
Q 046750 432 LLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDD---EFEAQVADFGLA 508 (723)
Q Consensus 432 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~---~~~vkL~DFGla 508 (723)
+|||||+.+|+|.+++.......+++..++.|+.||+.||+|||++ +|+|||||++||||+. ++.+||+|||++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 9999999999999999876656789999999999999999999999 5999999999999998 789999999998
Q ss_pred cccCCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcC
Q 046750 509 KLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETG 588 (723)
Q Consensus 509 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~ 588 (723)
.... +..++.++|||||||+||||++|+.||........ ... +...+..+
T Consensus 168 ~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~---~~~----~~~~~~~~ 217 (299)
T 3m2w_A 168 KETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---SPG----MKTRIRMG 217 (299)
T ss_dssp EECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC----------CC----SCCSSCTT
T ss_pred cccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh---hHH----HHHHHhhc
Confidence 6432 23467799999999999999999999965432110 000 00011111
Q ss_pred CcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 589 DLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 589 ~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
.+. +.. .... .....+.+++.+||+.||.+||++.||++.
T Consensus 218 ~~~-~~~-~~~~----~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 218 QYE-FPN-PEWS----EVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp CCS-SCH-HHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccc-CCc-hhcc----cCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 100 000 0001 123368889999999999999999999974
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-37 Score=338.57 Aligned_cols=240 Identities=15% Similarity=0.210 Sum_probs=179.5
Q ss_pred cCcccceEEeccCcEEEEEEE-cCCCcEEEEEEcccCCc---hhHHHHHHHHHHHHHccC-Cceee--------------
Q 046750 360 NGFARENVIGEGGFGCVYKGN-LPEGKVVAVKQLKSGSG---QGEREFRAEVEIISRVHH-RHLVS-------------- 420 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~-~~~g~~VAvK~l~~~~~---~~~~~~~~Ei~il~~l~H-pnIv~-------------- 420 (723)
..|...++||+|+||.||+|. ..+|+.||||+++.... ...+.|++|+.+++.|+| .|+..
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 457788999999999999996 56799999999884322 235679999999999977 32211
Q ss_pred -------Eeeeeec-----ccceEEEEEecCCCchhhccc-----cCCCCcchHHHHHHHHHHHHhhhchhcccCCCcee
Q 046750 421 -------LVGYCIS-----EKNRLLIYEFVPNNNLEHHLH-----GKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKII 483 (723)
Q Consensus 421 -------l~g~~~~-----~~~~~lV~E~~~~gsL~~~l~-----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~iv 483 (723)
++.++.. ....+++|+++ +++|.++++ ......+.+..++.|+.||++||+|||++ +||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence 1111111 12345666655 789998884 23344688999999999999999999999 599
Q ss_pred ecCCCCCcEEeCCCCcEEEeecccccccCCCCcceeecccccccccChhhh----------ccCCCCCccceechHHHHH
Q 046750 484 HRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYA----------SSGKLTDRSDVFSFGVVLL 553 (723)
Q Consensus 484 HrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~----------~~~~~t~ksDVwSlGviL~ 553 (723)
|||||++||||+.++.+||+|||+++..... ....+| ..|+|||++ ....++.++|||||||+||
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 9999999999999999999999999865432 334567 999999999 5556888999999999999
Q ss_pred HHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 046750 554 ELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVR 633 (723)
Q Consensus 554 eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~ 633 (723)
||++|+.||....... +.. .++... ..+ ...+.+|+.+||+.||.+||++.++++
T Consensus 309 elltg~~Pf~~~~~~~------~~~-------------~~~~~~--~~~----~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 309 WIWCADLPNTDDAALG------GSE-------------WIFRSC--KNI----PQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHSSCCCCTTGGGS------CSG-------------GGGSSC--CCC----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHCCCCCCCcchhh------hHH-------------HHHhhc--ccC----CHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 9999999997543211 000 000000 111 246889999999999999999988865
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=326.41 Aligned_cols=242 Identities=15% Similarity=0.165 Sum_probs=183.4
Q ss_pred hcCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCc--------hhHHHHHHHHHHHHHcc---------CCceeeE
Q 046750 359 TNGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSG--------QGEREFRAEVEIISRVH---------HRHLVSL 421 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~--------~~~~~~~~Ei~il~~l~---------HpnIv~l 421 (723)
.++|++.++||+|+||.||+|+. +|+.||||+++.... ...+.+.+|+++|++|+ |+|||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 35688999999999999999987 789999999976432 23367899999999996 6666666
Q ss_pred eeee-----------------ec-------------ccceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhh
Q 046750 422 VGYC-----------------IS-------------EKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGL 471 (723)
Q Consensus 422 ~g~~-----------------~~-------------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL 471 (723)
++++ .+ ....||||||+.+|+|.+.+.+ ..+++..++.|+.||+.||
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHH
Confidence 6553 32 6788999999999977776643 3478999999999999999
Q ss_pred chhc-ccCCCceeecCCCCCcEEeCCCC--------------------cEEEeecccccccCCCCcceeecccccccccC
Q 046750 472 AYLH-EDCHPKIIHRDIKSANILVDDEF--------------------EAQVADFGLAKLNDTTQTHVSTRVMGTFGYLA 530 (723)
Q Consensus 472 ~yLH-~~g~~~ivHrDIkp~NILl~~~~--------------------~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~A 530 (723)
+||| ++ +||||||||+||||+.++ .+||+|||+++..... ..+||..|+|
T Consensus 175 ~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~a 245 (336)
T 2vuw_A 175 AVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMD 245 (336)
T ss_dssp HHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTC
T ss_pred HHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccC
Confidence 9999 88 599999999999999886 8999999999865432 3469999999
Q ss_pred hhhhccCCCCCccceechHHH-HHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhhhccccHHHHHH
Q 046750 531 PEYASSGKLTDRSDVFSFGVV-LLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFR 609 (723)
Q Consensus 531 PE~~~~~~~t~ksDVwSlGvi-L~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~ 609 (723)
||++.+.. +.++|||||+++ +++++.|..||.. ..|........+....+... ............
T Consensus 246 PE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~---------~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~s~~ 311 (336)
T 2vuw_A 246 EDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN---------VLWLHYLTDKMLKQMTFKTK----CNTPAMKQIKRK 311 (336)
T ss_dssp SGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH---------HHHHHHHHHHHHHTCCCSSC----CCSHHHHHHHHH
T ss_pred hhhhcCCC-ccceehhhhhCCCCcccccccCCCcc---------hhhhhHHHHhhhhhhccCcc----cchhhhhhcCHH
Confidence 99998666 889999998777 7778889888732 12322211111111111111 011122344567
Q ss_pred HHHHHHHHhccCCCCCCCHHHHH
Q 046750 610 MIEAAAACVRHSGPKRPRMVQVV 632 (723)
Q Consensus 610 l~~l~~~cl~~dP~~RPs~~eVl 632 (723)
+.+|+.+||+.| ++.|++
T Consensus 312 ~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 312 IQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHHhccC-----CHHHHH
Confidence 899999999977 888888
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.3e-30 Score=296.80 Aligned_cols=184 Identities=16% Similarity=0.124 Sum_probs=129.5
Q ss_pred EEeccCcEEEEEE-EcCCCcEEEEEEcccCC----------chhHHHHHHHHHHHHHc-cCCceeeEeeeeecccceEEE
Q 046750 367 VIGEGGFGCVYKG-NLPEGKVVAVKQLKSGS----------GQGEREFRAEVEIISRV-HHRHLVSLVGYCISEKNRLLI 434 (723)
Q Consensus 367 ~LG~G~fG~Vy~~-~~~~g~~VAvK~l~~~~----------~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV 434 (723)
.++.|++|.++.+ ++.-|+.|+||++.... ....++|.+|+++|+++ +|+||++|+++++++...|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 3566777766665 34458899999986542 12235699999999999 799999999999999999999
Q ss_pred EEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCC
Q 046750 435 YEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTT 514 (723)
Q Consensus 435 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 514 (723)
|||++|++|.++|...+. ++.. +|+.||+.||+|||++| ||||||||+||||++++++||+|||+|+.....
T Consensus 321 MEyv~G~~L~d~i~~~~~--l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEE--IDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp EECCCSEEHHHHHHTTCC--CCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred EecCCCCcHHHHHHhCCC--CCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 999999999999986553 4443 57899999999999995 999999999999999999999999999876543
Q ss_pred CcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCC
Q 046750 515 QTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRK 560 (723)
Q Consensus 515 ~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~ 560 (723)
.. .....+||++|||||++.+ .+..++|+|++|+++++|+++..
T Consensus 393 ~~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 393 CS-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp -C-CSHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred Cc-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccc
Confidence 32 2344679999999999864 57788999999999888766543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.3e-27 Score=271.58 Aligned_cols=184 Identities=16% Similarity=0.233 Sum_probs=145.6
Q ss_pred ccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCch--------hHHHHHHHHHHHHHccCCceeeEeeeeecccceEEE
Q 046750 363 ARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQ--------GEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLI 434 (723)
Q Consensus 363 ~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~--------~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 434 (723)
...++||+|+||.||+|.+ .++.+++|++...... ..+.|++|+++|++|+|+||+++..++...+..|||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4467999999999999955 6788888886443211 124588999999999999999777677777888999
Q ss_pred EEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCC
Q 046750 435 YEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTT 514 (723)
Q Consensus 435 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 514 (723)
|||+++++|.++++. ++.|+.||++||+|||++ +|+|||||++||||++ ++||+|||+++.....
T Consensus 418 mE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 418 MSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp EECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred EECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 999999999999975 457999999999999999 5999999999999999 9999999999877543
Q ss_pred Ccce------eecccccccccChhhhcc--CCCCCccceechHHHHHHHHhCCCCC
Q 046750 515 QTHV------STRVMGTFGYLAPEYASS--GKLTDRSDVFSFGVVLLELITGRKPV 562 (723)
Q Consensus 515 ~~~~------~~~~~gt~~y~APE~~~~--~~~t~ksDVwSlGviL~eLltG~~P~ 562 (723)
.... .....||..|||||++.. ..|+.+.|+|+..+-.++.+.++..|
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 2221 234679999999999987 56888899999999888888877655
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=3.2e-24 Score=225.49 Aligned_cols=150 Identities=17% Similarity=0.115 Sum_probs=121.5
Q ss_pred HHHhcCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCc------------------hhHHHHHHHHHHHHHccCCc
Q 046750 356 MEITNGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSG------------------QGEREFRAEVEIISRVHHRH 417 (723)
Q Consensus 356 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~------------------~~~~~~~~Ei~il~~l~Hpn 417 (723)
..-...|.+.+.||+|+||.||+|.+.+|+.||||+++.... .....+.+|+++|++|+ |
T Consensus 86 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~ 163 (282)
T 1zar_A 86 VRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G 163 (282)
T ss_dssp HHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T
T ss_pred HhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C
Confidence 333455778899999999999999877799999999964321 13456889999999999 5
Q ss_pred eeeEeeeeecccceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCC
Q 046750 418 LVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDE 497 (723)
Q Consensus 418 Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~ 497 (723)
+++++++. .+..|+||||+.+++|.+ +.. .....++.||++||.|||++ +||||||||.||||+ +
T Consensus 164 -~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~ 228 (282)
T 1zar_A 164 -LAVPKVYA-WEGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-E 228 (282)
T ss_dssp -SSSCCEEE-EETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-T
T ss_pred -CCcCeEEe-ccceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-C
Confidence 77777654 356799999999999998 532 12446999999999999999 499999999999999 9
Q ss_pred CcEEEeecccccccCCCCcceeecccccccccChhhhcc
Q 046750 498 FEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASS 536 (723)
Q Consensus 498 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~ 536 (723)
+.+||+|||+++. +..|+|||++..
T Consensus 229 ~~vkl~DFG~a~~--------------~~~~~a~e~l~r 253 (282)
T 1zar_A 229 EGIWIIDFPQSVE--------------VGEEGWREILER 253 (282)
T ss_dssp TEEEECCCTTCEE--------------TTSTTHHHHHHH
T ss_pred CcEEEEECCCCeE--------------CCCCCHHHHHHH
Confidence 9999999999863 345889998853
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=4.1e-20 Score=191.48 Aligned_cols=136 Identities=21% Similarity=0.197 Sum_probs=105.7
Q ss_pred cccceEEeccCcEEEEEEEc-CCCcE--EEEEEcccCCch------------------------hHHHHHHHHHHHHHcc
Q 046750 362 FARENVIGEGGFGCVYKGNL-PEGKV--VAVKQLKSGSGQ------------------------GEREFRAEVEIISRVH 414 (723)
Q Consensus 362 f~~~~~LG~G~fG~Vy~~~~-~~g~~--VAvK~l~~~~~~------------------------~~~~~~~Ei~il~~l~ 414 (723)
|.+.+.||+|+||.||+|.+ .+|+. ||||+++..... ....+.+|+++|.+|+
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56789999999999999977 68888 999987543111 1135789999999999
Q ss_pred CCce--eeEeeeeecccceEEEEEecCC-C----chhhccccCCCCcchHHHHHHHHHHHHhhhchhc-ccCCCceeecC
Q 046750 415 HRHL--VSLVGYCISEKNRLLIYEFVPN-N----NLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLH-EDCHPKIIHRD 486 (723)
Q Consensus 415 HpnI--v~l~g~~~~~~~~~lV~E~~~~-g----sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~g~~~ivHrD 486 (723)
|.+| ..++++ ...+|||||+.+ | .|.+++.. +.+..+..++.||+.+|.||| +. +|||||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~---givHrD 196 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEA---ELVHAD 196 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTS---CEECSS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHC---CEEeCC
Confidence 8864 334432 467899999942 4 45544321 234567889999999999999 87 599999
Q ss_pred CCCCcEEeCCCCcEEEeeccccccc
Q 046750 487 IKSANILVDDEFEAQVADFGLAKLN 511 (723)
Q Consensus 487 Ikp~NILl~~~~~vkL~DFGla~~~ 511 (723)
|||.||||++ .++|+|||++...
T Consensus 197 lkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 197 LSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSTTSEEESS--SEEECCCTTCEET
T ss_pred CCHHHEEEcC--cEEEEECcccccC
Confidence 9999999998 9999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.72 E-value=5.3e-18 Score=184.01 Aligned_cols=147 Identities=14% Similarity=0.129 Sum_probs=105.1
Q ss_pred HHHHHHHhcC---cccceEEeccCcEEEEEEEcCCCcEEEEEEcccCC--------------chhHHHH--------HHH
Q 046750 352 YEELMEITNG---FARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGS--------------GQGEREF--------RAE 406 (723)
Q Consensus 352 ~~~l~~~~~~---f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~--------------~~~~~~~--------~~E 406 (723)
+..|..+.++ |.+.++||+|+||.||+|...+|+.||||+++... ....... .+|
T Consensus 84 ~LAL~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE 163 (397)
T 4gyi_A 84 YLALHTHAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKE 163 (397)
T ss_dssp HHHHHHHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHH
Confidence 3444555544 89999999999999999988899999999975321 0011122 345
Q ss_pred HHHHHHccCCceeeEeeeeecccceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecC
Q 046750 407 VEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRD 486 (723)
Q Consensus 407 i~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrD 486 (723)
+..|.+|.+.++....-+ .....+|||||+.++.|.+++... ....++.||+.+|.|||++| |||||
T Consensus 164 ~~nL~rL~~~gv~vp~p~--~~~~~~LVME~i~G~~L~~l~~~~--------~~~~l~~qll~~l~~lH~~g---IVHrD 230 (397)
T 4gyi_A 164 FAFMKALYEEGFPVPEPI--AQSRHTIVMSLVDALPMRQVSSVP--------DPASLYADLIALILRLAKHG---LIHGD 230 (397)
T ss_dssp HHHHHHHHHTTCSCCCEE--EEETTEEEEECCSCEEGGGCCCCS--------CHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHHHHHHhcCCCCCeee--eccCceEEEEecCCccHhhhcccH--------HHHHHHHHHHHHHHHHHHCC---CcCCC
Confidence 666666654443211111 112347999999999987765321 23467889999999999985 99999
Q ss_pred CCCCcEEeCCCC----------cEEEeeccccccc
Q 046750 487 IKSANILVDDEF----------EAQVADFGLAKLN 511 (723)
Q Consensus 487 Ikp~NILl~~~~----------~vkL~DFGla~~~ 511 (723)
||+.||||++++ .+.|+||+.+...
T Consensus 231 LKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 231 FNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp CSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCHHHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence 999999998776 3899999988643
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.43 E-value=3.1e-13 Score=139.27 Aligned_cols=148 Identities=14% Similarity=0.057 Sum_probs=115.6
Q ss_pred HHHHHhcCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHcc-CCceeeEeeeeecccceE
Q 046750 354 ELMEITNGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVH-HRHLVSLVGYCISEKNRL 432 (723)
Q Consensus 354 ~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~ 432 (723)
.+.....+|.+...++.|+++.||++... ++.++||+...........+.+|+++|+.|. |.++.++++++.+.+..|
T Consensus 8 ~l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~ 86 (263)
T 3tm0_A 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceE
Confidence 34555678988889999999999999764 6899999987532122346899999999995 667889999998888899
Q ss_pred EEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhccc-----------------------------------
Q 046750 433 LIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHED----------------------------------- 477 (723)
Q Consensus 433 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~----------------------------------- 477 (723)
+||||++|.+|.+.+.. ......++.+++++|+.||+.
T Consensus 87 lv~e~i~G~~l~~~~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T 3tm0_A 87 LLMSEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEECCSSEEHHHHCCT-------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred EEEEecCCeehhhccCC-------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence 99999999999876421 122346778888899999981
Q ss_pred ---------------------CCCceeecCCCCCcEEeCCCCcEEEeeccccc
Q 046750 478 ---------------------CHPKIIHRDIKSANILVDDEFEAQVADFGLAK 509 (723)
Q Consensus 478 ---------------------g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 509 (723)
....++|+|+++.|||++++..+.|+||+.+.
T Consensus 160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 01358999999999999876666799999874
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.33 E-value=1.9e-12 Score=132.45 Aligned_cols=137 Identities=18% Similarity=0.121 Sum_probs=100.4
Q ss_pred cCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCc--eeeEeeeeecccceEEEEEe
Q 046750 360 NGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRH--LVSLVGYCISEKNRLLIYEF 437 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~g~~~~~~~~~lV~E~ 437 (723)
.+|.+..+.+.|.++.||++...+|+.|+||+.... ....+.+|+.+|+.|.+.+ +.++++++...+..++||||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 345444333456669999998877888999997654 2246789999999996545 55688888877788999999
Q ss_pred cCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccC---------------------------------------
Q 046750 438 VPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDC--------------------------------------- 478 (723)
Q Consensus 438 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g--------------------------------------- 478 (723)
++|..|. +... . ...++.++++.|+.||+..
T Consensus 97 i~G~~l~--~~~~-----~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (264)
T 1nd4_A 97 VPGQDLL--SSHL-----A---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA 166 (264)
T ss_dssp CSSEETT--TSCC-----C---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred cCCcccC--cCcC-----C---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence 9999884 2211 1 1245566666777777532
Q ss_pred ----------------CCceeecCCCCCcEEeCCCCcEEEeeccccc
Q 046750 479 ----------------HPKIIHRDIKSANILVDDEFEAQVADFGLAK 509 (723)
Q Consensus 479 ----------------~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 509 (723)
...++|+|+++.|||++++..+.|+||+.+.
T Consensus 167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1139999999999999887667799999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.17 E-value=7.4e-11 Score=127.44 Aligned_cols=143 Identities=17% Similarity=0.204 Sum_probs=106.5
Q ss_pred ccceEEeccCcEEEEEEEcCCCcEEEEEEcc--cCC-chhHHHHHHHHHHHHHcc--CCceeeEeeeeecc---cceEEE
Q 046750 363 ARENVIGEGGFGCVYKGNLPEGKVVAVKQLK--SGS-GQGEREFRAEVEIISRVH--HRHLVSLVGYCISE---KNRLLI 434 (723)
Q Consensus 363 ~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~--~~~-~~~~~~~~~Ei~il~~l~--HpnIv~l~g~~~~~---~~~~lV 434 (723)
...+.|+.|.++.||+....+ ..+++|+.. ... ......+.+|+.+|+.|. +-++.+++.++.+. +..|+|
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp CEEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred ceEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 346789999999999998754 678888876 332 123457889999999997 45578889888776 347999
Q ss_pred EEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccC------------------------------------
Q 046750 435 YEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDC------------------------------------ 478 (723)
Q Consensus 435 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g------------------------------------ 478 (723)
|||++|..|.+... ..++...+..++.++++.|+.||...
T Consensus 120 me~v~G~~l~~~~~----~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 120 MEFVSGRVLWDQSL----PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp EECCCCBCCCCTTC----TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EEecCCeecCCCcc----ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 99999988854221 12566777888999999999999731
Q ss_pred -------------------CCceeecCCCCCcEEeCCCCc--EEEeecccccc
Q 046750 479 -------------------HPKIIHRDIKSANILVDDEFE--AQVADFGLAKL 510 (723)
Q Consensus 479 -------------------~~~ivHrDIkp~NILl~~~~~--vkL~DFGla~~ 510 (723)
...+||+|+++.|||++.++. +.|+||+++..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246999999999999997653 69999999864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.15 E-value=1.8e-11 Score=129.24 Aligned_cols=186 Identities=22% Similarity=0.257 Sum_probs=118.2
Q ss_pred ceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHcc-CCc--eeeEeeeeeccc---ceEEEEEec
Q 046750 365 ENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVH-HRH--LVSLVGYCISEK---NRLLIYEFV 438 (723)
Q Consensus 365 ~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~-Hpn--Iv~l~g~~~~~~---~~~lV~E~~ 438 (723)
.+.|+.|.+..||+.. +.++||+.... .....+.+|+++|+.|. +-. +.+++.++.... ..|+||||+
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4679999999999864 46888886532 34567899999999984 332 345555443333 347899999
Q ss_pred CCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhccc-----------------------------------------
Q 046750 439 PNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHED----------------------------------------- 477 (723)
Q Consensus 439 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~----------------------------------------- 477 (723)
+|..|...+.. .++..++..++.++++.|+.||+.
T Consensus 99 ~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 99 KGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred CCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 99888653221 134445556666666666666641
Q ss_pred --------------CCCceeecCCCCCcEEeCC--CCcEEEeecccccccCCCCccee-------------ecccccccc
Q 046750 478 --------------CHPKIIHRDIKSANILVDD--EFEAQVADFGLAKLNDTTQTHVS-------------TRVMGTFGY 528 (723)
Q Consensus 478 --------------g~~~ivHrDIkp~NILl~~--~~~vkL~DFGla~~~~~~~~~~~-------------~~~~gt~~y 528 (723)
....++|+|+++.|||+++ ...+.|+||+.+........... ..+...+++
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~ 254 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKH 254 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTC
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCC
Confidence 1235899999999999998 56689999999865322111000 001111122
Q ss_pred cC-hhhhccCCCCCccceechHHHHHHHHhCCCCC
Q 046750 529 LA-PEYASSGKLTDRSDVFSFGVVLLELITGRKPV 562 (723)
Q Consensus 529 ~A-PE~~~~~~~t~ksDVwSlGviL~eLltG~~P~ 562 (723)
.. |+++... ....++|++++++|++.+|+.+|
T Consensus 255 ~~~~~~~~r~--~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 255 KDIPTVLEKY--RMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp SCHHHHHHHH--HHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCcHHHHHHH--HHHHHHHHHHHHHHHHHcCCHHH
Confidence 22 3322211 22358999999999999997654
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.66 E-value=1.3e-07 Score=99.77 Aligned_cols=136 Identities=22% Similarity=0.227 Sum_probs=89.2
Q ss_pred ceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCC---ceeeEeeeee-cccceEEEEEecCC
Q 046750 365 ENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHR---HLVSLVGYCI-SEKNRLLIYEFVPN 440 (723)
Q Consensus 365 ~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~Hp---nIv~l~g~~~-~~~~~~lV~E~~~~ 440 (723)
.+.|+.|....||+. |+.++||+-.. ......+.+|+++|+.|.+. .|.+++.++. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 467899999999997 56788888532 23446789999999999753 2556666664 44557899999999
Q ss_pred CchhhccccCCCCcchHHHHHHHHHHHHhhhchhccc-------------------------------------------
Q 046750 441 NNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHED------------------------------------------- 477 (723)
Q Consensus 441 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------------------------------------------- 477 (723)
..|...... .+....+..++.++++.|+.||+.
T Consensus 98 ~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 98 QILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp EECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred eECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 888652110 011222222333333333333321
Q ss_pred --------------CCCceeecCCCCCcEEeCC---CCc-EEEeecccccc
Q 046750 478 --------------CHPKIIHRDIKSANILVDD---EFE-AQVADFGLAKL 510 (723)
Q Consensus 478 --------------g~~~ivHrDIkp~NILl~~---~~~-vkL~DFGla~~ 510 (723)
....++|+|+++.|||++. ++. +.|+||+.+..
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2235799999999999997 455 48999998763
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.62 E-value=2.1e-07 Score=95.81 Aligned_cols=139 Identities=16% Similarity=0.134 Sum_probs=94.6
Q ss_pred CcccceEEeccCcE-EEEEEEcC-CCcEEEEEEcccCCchhHHHHHHHHHHHHHcc-CCceeeEeeeeecccceEEEEEe
Q 046750 361 GFARENVIGEGGFG-CVYKGNLP-EGKVVAVKQLKSGSGQGEREFRAEVEIISRVH-HRHLVSLVGYCISEKNRLLIYEF 437 (723)
Q Consensus 361 ~f~~~~~LG~G~fG-~Vy~~~~~-~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~E~ 437 (723)
+|+. +.+..|..| .||+.... ++..++||+... ....++.+|+.+|+.|. +-.|-++++++.+.+..++|||+
T Consensus 26 g~~~-~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~ 101 (272)
T 4gkh_A 26 GYRW-ARDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTA 101 (272)
T ss_dssp TCEE-EEEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred CCeE-EEccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEe
Confidence 3443 345556655 69988654 456788998654 34567889999999995 33467888888888889999999
Q ss_pred cCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhccc----------------------------------------
Q 046750 438 VPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHED---------------------------------------- 477 (723)
Q Consensus 438 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~---------------------------------------- 477 (723)
++|..+.+..... ......++.+++..|+.||..
T Consensus 102 l~G~~~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (272)
T 4gkh_A 102 IPGKTAFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWP 175 (272)
T ss_dssp CCSEEHHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCC
T ss_pred eCCccccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchH
Confidence 9988776543211 011122333344444444421
Q ss_pred ---------------CCCceeecCCCCCcEEeCCCCcEEEeeccccc
Q 046750 478 ---------------CHPKIIHRDIKSANILVDDEFEAQVADFGLAK 509 (723)
Q Consensus 478 ---------------g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 509 (723)
....++|+|+++.|||+++++.+-|+||+.+.
T Consensus 176 ~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 176 VEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 11248999999999999988777899999875
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.60 E-value=8.8e-08 Score=102.95 Aligned_cols=82 Identities=7% Similarity=-0.024 Sum_probs=58.2
Q ss_pred cceEE-eccCcEEEEEEEcC-------CCcEEEEEEcccCC---chhHHHHHHHHHHHHHccC---CceeeEeeeeecc-
Q 046750 364 RENVI-GEGGFGCVYKGNLP-------EGKVVAVKQLKSGS---GQGEREFRAEVEIISRVHH---RHLVSLVGYCISE- 428 (723)
Q Consensus 364 ~~~~L-G~G~fG~Vy~~~~~-------~g~~VAvK~l~~~~---~~~~~~~~~Ei~il~~l~H---pnIv~l~g~~~~~- 428 (723)
..+.| +.|....+|+.... +++.+++|+..... ......+.+|+.+|+.|.. -.+.+++.++.+.
T Consensus 24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~ 103 (357)
T 3ats_A 24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD 103 (357)
T ss_dssp EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence 34677 88889999998664 26788899865432 1112467889999999853 3567788877655
Q ss_pred --cceEEEEEecCCCchhh
Q 046750 429 --KNRLLIYEFVPNNNLEH 445 (723)
Q Consensus 429 --~~~~lV~E~~~~gsL~~ 445 (723)
...++||||++|..|.+
T Consensus 104 ~~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 104 VLGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TTSSCEEEEECCCCBCCCB
T ss_pred ccCCceEEEEecCCCChhh
Confidence 34689999998877654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.33 E-value=1.3e-06 Score=95.34 Aligned_cols=75 Identities=15% Similarity=0.126 Sum_probs=50.6
Q ss_pred ceEEeccCcEEEEEEEcC-CCcEEEEEEcccCCc-------hhHHHHHHHHHHHHHccC--Cc-eeeEeeeeecccceEE
Q 046750 365 ENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGSG-------QGEREFRAEVEIISRVHH--RH-LVSLVGYCISEKNRLL 433 (723)
Q Consensus 365 ~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~~-------~~~~~~~~Ei~il~~l~H--pn-Iv~l~g~~~~~~~~~l 433 (723)
.+.||.|.++.||++... +++.|+||....... .....+..|+++|+.+.. +. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 568999999999999654 468899998654221 123456789999998843 33 4455543 3455789
Q ss_pred EEEecCCC
Q 046750 434 IYEFVPNN 441 (723)
Q Consensus 434 V~E~~~~g 441 (723)
||||+.+.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.32 E-value=1.9e-06 Score=91.33 Aligned_cols=140 Identities=16% Similarity=0.266 Sum_probs=81.5
Q ss_pred ceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccC--CceeeEee------eeecccceEEEEE
Q 046750 365 ENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHH--RHLVSLVG------YCISEKNRLLIYE 436 (723)
Q Consensus 365 ~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~g------~~~~~~~~~lV~E 436 (723)
.+.|+.|.++.||+....+| .+++|+.... ..++..|+.+++.|.. -.+.+++. +....+..++|||
T Consensus 37 ~~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EEECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 34566677899999987555 4889988752 2345567777777742 12344443 1234556789999
Q ss_pred ecCCCchh--------------hccccC--C---C-------CcchHHHH------------------------------
Q 046750 437 FVPNNNLE--------------HHLHGK--G---Q-------PVLEWTKR------------------------------ 460 (723)
Q Consensus 437 ~~~~gsL~--------------~~l~~~--~---~-------~~l~~~~~------------------------------ 460 (723)
|++|..+. ..||.. . . ....|...
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99986542 112210 0 0 01122111
Q ss_pred -HHHHHHHHhhhchhcc----------cCCCceeecCCCCCcEEeCCCCcEEEeeccccc
Q 046750 461 -VKIALGAAKGLAYLHE----------DCHPKIIHRDIKSANILVDDEFEAQVADFGLAK 509 (723)
Q Consensus 461 -~~i~~~ia~gL~yLH~----------~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 509 (723)
..+...+.+++.+|+. .....+||+|+++.|||++.++.+.|+||+.+.
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 0111123345566653 023469999999999999888899999999874
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.17 E-value=6e-06 Score=85.92 Aligned_cols=80 Identities=21% Similarity=0.250 Sum_probs=60.3
Q ss_pred cCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCC---ceeeEeeeeecccceEEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHR---HLVSLVGYCISEKNRLLIYE 436 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~Hp---nIv~l~g~~~~~~~~~lV~E 436 (723)
..+...+.+|.|..+.||+.++.+|+.|+||+...........|.+|+..|+.|.-- .+.+++++ +..++|||
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e 90 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAME 90 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEE
Confidence 356677889999999999999999999999987655444445688999999999422 24455543 23478999
Q ss_pred ecCCCch
Q 046750 437 FVPNNNL 443 (723)
Q Consensus 437 ~~~~gsL 443 (723)
|+.++.+
T Consensus 91 ~l~~~~~ 97 (288)
T 3f7w_A 91 WVDERPP 97 (288)
T ss_dssp CCCCCCC
T ss_pred eecccCC
Confidence 9987643
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.16 E-value=1.1e-05 Score=85.19 Aligned_cols=77 Identities=18% Similarity=0.170 Sum_probs=61.8
Q ss_pred ccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHcc---CCceeeEeeeeecccceEEEEEecC
Q 046750 363 ARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVH---HRHLVSLVGYCISEKNRLLIYEFVP 439 (723)
Q Consensus 363 ~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~g~~~~~~~~~lV~E~~~ 439 (723)
...+.|+.|.+..+|+... +++.++||+.... ....|.+|++.|+.|. .-.+.+++.++...+..++||||++
T Consensus 39 ~~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp CEEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eeeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 3456799999999999986 5678889987642 3567889999999994 2567888888887788999999999
Q ss_pred CCch
Q 046750 440 NNNL 443 (723)
Q Consensus 440 ~gsL 443 (723)
+..+
T Consensus 115 G~~~ 118 (312)
T 3jr1_A 115 KSKN 118 (312)
T ss_dssp CCCC
T ss_pred CCCC
Confidence 8765
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.08 E-value=5e-06 Score=91.52 Aligned_cols=74 Identities=14% Similarity=0.161 Sum_probs=46.1
Q ss_pred cceEEeccCcEEEEEEEcCCCcEEEEEEcccC-----Cc----hhHHHHHHHHHHHHH-ccCCceeeEeeeeecccceEE
Q 046750 364 RENVIGEGGFGCVYKGNLPEGKVVAVKQLKSG-----SG----QGEREFRAEVEIISR-VHHRHLVSLVGYCISEKNRLL 433 (723)
Q Consensus 364 ~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~-----~~----~~~~~~~~Ei~il~~-l~HpnIv~l~g~~~~~~~~~l 433 (723)
..+.||.|....||++.. +++.|+||..... .. .....+..|+..+.. ..+-.+.+++.+. ....++
T Consensus 38 ~i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~l 114 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALI 114 (420)
T ss_dssp EEEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEE
T ss_pred EEEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEE
Confidence 456789999999999965 5678999953221 00 122234444433322 2234566676665 466799
Q ss_pred EEEec-CC
Q 046750 434 IYEFV-PN 440 (723)
Q Consensus 434 V~E~~-~~ 440 (723)
||||+ .+
T Consensus 115 v~e~l~~g 122 (420)
T 2pyw_A 115 GMRYLEPP 122 (420)
T ss_dssp EECCCCTT
T ss_pred EEeecCCc
Confidence 99999 76
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.04 E-value=2e-05 Score=82.97 Aligned_cols=158 Identities=13% Similarity=0.092 Sum_probs=91.1
Q ss_pred ccCHHHHHHHhcCccc-----ceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCc--eeeE
Q 046750 349 FFTYEELMEITNGFAR-----ENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRH--LVSL 421 (723)
Q Consensus 349 ~~~~~~l~~~~~~f~~-----~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l 421 (723)
.++.+++..+...|.. .+.|+.|....+|+....+| .+++|+.... ....++..|+.+++.|.... +.++
T Consensus 6 ~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~ 82 (322)
T 2ppq_A 6 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLP 82 (322)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred cCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcc
Confidence 3566778877777765 34566788899999987655 5788988652 12245677889988885322 2333
Q ss_pred eee------eecccceEEEEEecCCCchhh--------------ccccC----CC------CcchHHHHHHHH-------
Q 046750 422 VGY------CISEKNRLLIYEFVPNNNLEH--------------HLHGK----GQ------PVLEWTKRVKIA------- 464 (723)
Q Consensus 422 ~g~------~~~~~~~~lV~E~~~~gsL~~--------------~l~~~----~~------~~l~~~~~~~i~------- 464 (723)
+.. ....+..++||+|++|..+.. .||.. .. ....|...+.-+
T Consensus 83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~ 162 (322)
T 2ppq_A 83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 162 (322)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence 321 122345689999998865421 11210 00 112233211110
Q ss_pred -----HHHHhhhchhccc----CCCceeecCCCCCcEEeCCCCcEEEeeccccc
Q 046750 465 -----LGAAKGLAYLHED----CHPKIIHRDIKSANILVDDEFEAQVADFGLAK 509 (723)
Q Consensus 465 -----~~ia~gL~yLH~~----g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 509 (723)
..+.+.+++|+.. ....+||+|+++.|||++++..+.|+||+.+.
T Consensus 163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 0122233333321 12369999999999999987666899999875
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.90 E-value=0.00013 Score=76.84 Aligned_cols=157 Identities=13% Similarity=0.142 Sum_probs=90.6
Q ss_pred cCHHHHHHHhcCcc-----cceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCc--eeeEe
Q 046750 350 FTYEELMEITNGFA-----RENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRH--LVSLV 422 (723)
Q Consensus 350 ~~~~~l~~~~~~f~-----~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~ 422 (723)
.+.+.+..+...|. ....|+ |....||+....+|+.+++|+..... .....+..|+.+++.|.... +.+++
T Consensus 11 l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~ 88 (328)
T 1zyl_A 11 LHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPV 88 (328)
T ss_dssp CCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCC
T ss_pred CCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeeccee
Confidence 44455555544443 234577 88889999987778789999986432 23456778999999885322 44444
Q ss_pred ee-----eecccceEEEEEecCCCchhh--------------cccc----C---CCCcchHHHH----------------
Q 046750 423 GY-----CISEKNRLLIYEFVPNNNLEH--------------HLHG----K---GQPVLEWTKR---------------- 460 (723)
Q Consensus 423 g~-----~~~~~~~~lV~E~~~~gsL~~--------------~l~~----~---~~~~l~~~~~---------------- 460 (723)
.. ....+..++||+|++|..+.. .||. . ....+++...
T Consensus 89 ~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 168 (328)
T 1zyl_A 89 AFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPS 168 (328)
T ss_dssp CBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCT
T ss_pred ecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCH
Confidence 43 122345578999998865431 0111 0 0111221111
Q ss_pred ------HHHHHHHHhhhchhc-ccCCCceeecCCCCCcEEeCCCCcEEEeecccccc
Q 046750 461 ------VKIALGAAKGLAYLH-EDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKL 510 (723)
Q Consensus 461 ------~~i~~~ia~gL~yLH-~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 510 (723)
..++..++..|+-+. ......+||+|+++.|||++ + .+.|+||+.+..
T Consensus 169 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 169 GLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp TTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 011111111122111 11223589999999999999 4 899999998753
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.76 E-value=5.1e-05 Score=80.48 Aligned_cols=141 Identities=14% Similarity=0.094 Sum_probs=73.0
Q ss_pred eEEeccCcEE-EEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCC--ceeeEeeeeecccceEEEEEecCCCc
Q 046750 366 NVIGEGGFGC-VYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHR--HLVSLVGYCISEKNRLLIYEFVPNNN 442 (723)
Q Consensus 366 ~~LG~G~fG~-Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~g~~~~~~~~~lV~E~~~~gs 442 (723)
+.|+.|.... +|+....+|+.+++|...... ..++..|+.+++.|... .+.+++.+..+. .++|||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcc
Confidence 4555554444 677766446778888654421 13456678888887432 345666654332 378999997655
Q ss_pred hhhccc---------------------cCC---CCcchHHHHH-------HHH-------------HHHHhhhchhc---
Q 046750 443 LEHHLH---------------------GKG---QPVLEWTKRV-------KIA-------------LGAAKGLAYLH--- 475 (723)
Q Consensus 443 L~~~l~---------------------~~~---~~~l~~~~~~-------~i~-------------~~ia~gL~yLH--- 475 (723)
+.+++. ... ...++..... .+. ..+...++.|.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 543221 110 0001110000 000 00111122221
Q ss_pred ccCCCceeecCCCCCcEEeCCC----CcEEEeeccccccc
Q 046750 476 EDCHPKIIHRDIKSANILVDDE----FEAQVADFGLAKLN 511 (723)
Q Consensus 476 ~~g~~~ivHrDIkp~NILl~~~----~~vkL~DFGla~~~ 511 (723)
......+||||+++.|||++.+ ..+.|+||+.+...
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 0112369999999999999875 68999999988643
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.75 E-value=4e-05 Score=80.19 Aligned_cols=74 Identities=5% Similarity=0.057 Sum_probs=48.2
Q ss_pred cccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCce-eeEeeeeecccceEEEEEec-C
Q 046750 362 FARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHL-VSLVGYCISEKNRLLIYEFV-P 439 (723)
Q Consensus 362 f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~g~~~~~~~~~lV~E~~-~ 439 (723)
|...+.|+.|....+|+. +.+++|+....... ..+..+|+.+++.+...++ .++++++ .+..++|+||+ .
T Consensus 20 ~~~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~ 91 (301)
T 3dxq_A 20 YTGPLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAG 91 (301)
T ss_dssp CCSCEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTT
T ss_pred ccceeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCC
Confidence 334688999999999998 56888887653211 1234568888888853333 3555543 34457899999 6
Q ss_pred CCch
Q 046750 440 NNNL 443 (723)
Q Consensus 440 ~gsL 443 (723)
+..|
T Consensus 92 g~~l 95 (301)
T 3dxq_A 92 AQTM 95 (301)
T ss_dssp CEEC
T ss_pred CccC
Confidence 6555
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.61 E-value=0.00022 Score=79.27 Aligned_cols=74 Identities=12% Similarity=0.055 Sum_probs=49.4
Q ss_pred ceEEeccCcEEEEEEEcCC-CcEEEEEEcccCCchhHHHHHHHHHHHHHccCCce-eeEeeeeecccceEEEEEecCCCc
Q 046750 365 ENVIGEGGFGCVYKGNLPE-GKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHL-VSLVGYCISEKNRLLIYEFVPNNN 442 (723)
Q Consensus 365 ~~~LG~G~fG~Vy~~~~~~-g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~g~~~~~~~~~lV~E~~~~gs 442 (723)
.+.|+.|-...+|+....+ ++.|++|+....... .-+..+|+.+|+.|...++ .++++++. + .+||||++|..
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 4678888889999998755 478889987543211 1123689999999965444 56777663 2 36999998765
Q ss_pred h
Q 046750 443 L 443 (723)
Q Consensus 443 L 443 (723)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.58 E-value=0.00034 Score=77.18 Aligned_cols=74 Identities=24% Similarity=0.286 Sum_probs=51.9
Q ss_pred cceEEeccCcEEEEEEEcCC--------CcEEEEEEcccCCchhHHHHHHHHHHHHHccCCce-eeEeeeeecccceEEE
Q 046750 364 RENVIGEGGFGCVYKGNLPE--------GKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHL-VSLVGYCISEKNRLLI 434 (723)
Q Consensus 364 ~~~~LG~G~fG~Vy~~~~~~--------g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~g~~~~~~~~~lV 434 (723)
..+.|+.|....||++...+ ++.|++|+.... .....+.+|+.+++.|...++ .++++++.+ .+|
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v 150 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL 150 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEE
Confidence 34678888899999997653 578999988442 112456689999999854343 567766542 389
Q ss_pred EEecCCCch
Q 046750 435 YEFVPNNNL 443 (723)
Q Consensus 435 ~E~~~~gsL 443 (723)
|||++|..|
T Consensus 151 ~e~l~G~~l 159 (429)
T 1nw1_A 151 EEYIPSRPL 159 (429)
T ss_dssp ECCCCEEEC
T ss_pred EEEeCCccc
Confidence 999986554
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.56 E-value=0.00015 Score=78.01 Aligned_cols=74 Identities=16% Similarity=0.077 Sum_probs=46.4
Q ss_pred ceEEeccCcEEEEEEEcCC---------CcEEEEEEcccCCchhHHHHHHHHHHHHHccCCc-eeeEeeeeecccceEEE
Q 046750 365 ENVIGEGGFGCVYKGNLPE---------GKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRH-LVSLVGYCISEKNRLLI 434 (723)
Q Consensus 365 ~~~LG~G~fG~Vy~~~~~~---------g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~g~~~~~~~~~lV 434 (723)
.+.|+.|....+|+....+ ++.|++|+...... ...+...|+++++.|...+ +.++++.+ ..++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec----CCcEE
Confidence 4567788888999997654 26888998754321 1123467899999885434 34666544 23789
Q ss_pred EEecCCCch
Q 046750 435 YEFVPNNNL 443 (723)
Q Consensus 435 ~E~~~~gsL 443 (723)
|||++|..|
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999987654
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.53 E-value=0.00041 Score=75.17 Aligned_cols=139 Identities=17% Similarity=0.196 Sum_probs=82.6
Q ss_pred eEEeccCcEEEEEEEcC--------CCcEEEEEEcccCCchhHHHHHHHHHHHHHcc-CCceeeEeeeeecccceEEEEE
Q 046750 366 NVIGEGGFGCVYKGNLP--------EGKVVAVKQLKSGSGQGEREFRAEVEIISRVH-HRHLVSLVGYCISEKNRLLIYE 436 (723)
Q Consensus 366 ~~LG~G~fG~Vy~~~~~--------~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~E 436 (723)
+.|..|--..+|+.... +++.|++|+.-.. .....++.+|+++++.|. +.-..++++++.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 56777777889998764 3478999986332 123456779999999985 3333566766643 29999
Q ss_pred ecCCCchhhc-----------------cccC----CCCcc-hHHHHHHHHHHHHhh-------------------hchhc
Q 046750 437 FVPNNNLEHH-----------------LHGK----GQPVL-EWTKRVKIALGAAKG-------------------LAYLH 475 (723)
Q Consensus 437 ~~~~gsL~~~-----------------l~~~----~~~~l-~~~~~~~i~~~ia~g-------------------L~yLH 475 (723)
|++|..|... ||.. .+... -|.++.++..++... +.+|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9988765421 1221 11111 234444444333221 22221
Q ss_pred ----cc-CCCceeecCCCCCcEEeCCC----CcEEEeeccccc
Q 046750 476 ----ED-CHPKIIHRDIKSANILVDDE----FEAQVADFGLAK 509 (723)
Q Consensus 476 ----~~-g~~~ivHrDIkp~NILl~~~----~~vkL~DFGla~ 509 (723)
.. ....++|+|+...|||++.+ +.+.|+||.++.
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 11 12358999999999999876 789999999875
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.39 E-value=8.8e-05 Score=53.27 Aligned_cols=24 Identities=13% Similarity=0.365 Sum_probs=14.2
Q ss_pred CCCCceeehhhhHHHHHHHHHHHH
Q 046750 259 SNDDQAIIGATAAGVVLIVLIAIF 282 (723)
Q Consensus 259 ~~~~~~ii~~~~~~~~~l~~l~~~ 282 (723)
+.++.+|++.|+++++++++++++
T Consensus 6 ~s~~~aIA~gVVgGv~~v~ii~~~ 29 (44)
T 2l2t_A 6 HARTPLIAAGVIGGLFILVIVGLT 29 (44)
T ss_dssp SCSSHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCcceEEEeehHHHHHHHHHHHH
Confidence 345567777777766555444433
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=97.34 E-value=9.9e-05 Score=51.60 Aligned_cols=33 Identities=18% Similarity=0.164 Sum_probs=21.0
Q ss_pred CCCCCCceeehhhhHHHHHHHHHHHHHHhhhcc
Q 046750 257 SSSNDDQAIIGATAAGVVLIVLIAIFFLARGRR 289 (723)
Q Consensus 257 ~~~~~~~~ii~~~~~~~~~l~~l~~~~~~~~rr 289 (723)
+++++.++|+|+++++++.+++++++.||++||
T Consensus 5 ~~~ls~GaIAGiVvG~v~gv~li~~l~~~~~rr 37 (38)
T 2k1k_A 5 SRGLTGGEIVAVIFGLLLGAALLLGILVFRSRR 37 (38)
T ss_dssp STTCCHHHHHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCCCceeeeehHHHHHHHHHHHHHHHHeec
Confidence 456778899999988776555554444444433
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.31 E-value=0.00016 Score=52.09 Aligned_cols=23 Identities=13% Similarity=0.247 Sum_probs=13.0
Q ss_pred CCCceeehhhhHHHHHHHHHHHH
Q 046750 260 NDDQAIIGATAAGVVLIVLIAIF 282 (723)
Q Consensus 260 ~~~~~ii~~~~~~~~~l~~l~~~ 282 (723)
.++.+|++.|+++++++++++++
T Consensus 8 s~~~~IA~gVVgGv~~~~ii~~~ 30 (44)
T 2ks1_B 8 PKIPSIATGMVGALLLLLVVALG 30 (44)
T ss_dssp SCSSSSTHHHHHHHHHHHHHHHH
T ss_pred CCcceEEeehhHHHHHHHHHHHH
Confidence 34456777777666554444433
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.27 E-value=0.0012 Score=70.41 Aligned_cols=72 Identities=14% Similarity=0.189 Sum_probs=46.6
Q ss_pred ceEEecc--CcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccC---CceeeEeee------eecccceEE
Q 046750 365 ENVIGEG--GFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHH---RHLVSLVGY------CISEKNRLL 433 (723)
Q Consensus 365 ~~~LG~G--~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~H---pnIv~l~g~------~~~~~~~~l 433 (723)
.+.|..| ....||+....+| .+++|+...... ..|+.+++.|.. +++.+++.. +...+..++
T Consensus 26 ~~~l~~G~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~ 98 (339)
T 3i1a_A 26 AQFIQGGADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKII 98 (339)
T ss_dssp EEEETTTSCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEE
T ss_pred eEEeeccCccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEE
Confidence 3445333 3679999988777 899998765431 457777777732 224455432 233456789
Q ss_pred EEEecCCCch
Q 046750 434 IYEFVPNNNL 443 (723)
Q Consensus 434 V~E~~~~gsL 443 (723)
||+|++|..+
T Consensus 99 l~~~i~G~~~ 108 (339)
T 3i1a_A 99 AYPFIHAPNG 108 (339)
T ss_dssp EEECCCCCBT
T ss_pred EEeccCCCcC
Confidence 9999998766
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.67 E-value=0.0092 Score=65.42 Aligned_cols=74 Identities=9% Similarity=0.055 Sum_probs=49.8
Q ss_pred ceEEeccCcEEEEEEEcCC--------CcEEEEEEcccCCchhHHHHHHHHHHHHHccCCc-eeeEeeeeecccceEEEE
Q 046750 365 ENVIGEGGFGCVYKGNLPE--------GKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRH-LVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 365 ~~~LG~G~fG~Vy~~~~~~--------g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~g~~~~~~~~~lV~ 435 (723)
.+.|..|--..+|+....+ ++.|++|+..... ...-+..+|+.+++.|.-.+ ..++++.+. .++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence 4567778888999997653 5789999865432 11223467999999885333 345555332 37899
Q ss_pred EecCCCch
Q 046750 436 EFVPNNNL 443 (723)
Q Consensus 436 E~~~~gsL 443 (723)
||++|..|
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99998765
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=96.47 E-value=0.0014 Score=46.94 Aligned_cols=28 Identities=29% Similarity=0.417 Sum_probs=12.6
Q ss_pred eeehhhhHHHHHHHHHHHHHHhhhcccc
Q 046750 264 AIIGATAAGVVLIVLIAIFFLARGRRRR 291 (723)
Q Consensus 264 ~ii~~~~~~~~~l~~l~~~~~~~~rr~r 291 (723)
.|+++++++++++++++++++|+|||+.
T Consensus 13 ~Ia~~vVGvll~vi~~l~~~~~~RRR~~ 40 (44)
T 2jwa_A 13 SIISAVVGILLVVVLGVVFGILIKRRQQ 40 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHCS
T ss_pred chHHHHHHHHHHHHHHHHHHhheehhhh
Confidence 3556666543333333344444444433
|
| >2k9y_A Ephrin type-A receptor 2; receptor tyrosine kinase, membrane protein, dimeric transmembrane domain, ephrin receptor, ATP-binding, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.59 E-value=0.0052 Score=43.82 Aligned_cols=16 Identities=50% Similarity=0.868 Sum_probs=8.8
Q ss_pred CceeehhhhHHHHHHH
Q 046750 262 DQAIIGATAAGVVLIV 277 (723)
Q Consensus 262 ~~~ii~~~~~~~~~l~ 277 (723)
..+|++.+++++++++
T Consensus 12 ~~~I~~~vv~Gv~ll~ 27 (41)
T 2k9y_A 12 NLAVIGGVAVGVVLLL 27 (41)
T ss_dssp STHHHHHHHHHHHHHH
T ss_pred eEEEEeehhHHHHHHH
Confidence 3455555555655555
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.57 E-value=0.042 Score=59.65 Aligned_cols=29 Identities=24% Similarity=0.436 Sum_probs=24.8
Q ss_pred ceeecCCCCCcEEe------CCCCcEEEeeccccc
Q 046750 481 KIIHRDIKSANILV------DDEFEAQVADFGLAK 509 (723)
Q Consensus 481 ~ivHrDIkp~NILl------~~~~~vkL~DFGla~ 509 (723)
-++|+|+...|||+ +++..++|+||.+|.
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 36899999999999 456779999999885
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.41 E-value=0.038 Score=54.52 Aligned_cols=101 Identities=15% Similarity=0.081 Sum_probs=64.3
Q ss_pred chhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcceeec
Q 046750 442 NLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTR 521 (723)
Q Consensus 442 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 521 (723)
+|.++|...+. .|.++++|.+++|.++.|.-+-... .-..+=+.+..|+|..+|.|.+.+ +.+.
T Consensus 34 SL~eIL~~~~~-PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------ 97 (229)
T 2yle_A 34 SLEEILRLYNQ-PINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD------------ 97 (229)
T ss_dssp EHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred cHHHHHHHcCC-CcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc------------
Confidence 78888876554 6899999999999999887662111 011223456899999999888764 2111
Q ss_pred ccccccccChhhhccCCCCCccceechHHHHHHHHhCCC
Q 046750 522 VMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRK 560 (723)
Q Consensus 522 ~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~ 560 (723)
.....|.+||... ...+.+.=|||||++||.-+-=..
T Consensus 98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL 134 (229)
T 2yle_A 98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGL 134 (229)
T ss_dssp ----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC
Confidence 0122366888653 345678899999999999886333
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.80 E-value=0.021 Score=41.04 Aligned_cols=21 Identities=19% Similarity=0.270 Sum_probs=13.8
Q ss_pred HHHHHHHHHHHHHhhhccccc
Q 046750 272 GVVLIVLIAIFFLARGRRRRR 292 (723)
Q Consensus 272 ~~~~l~~l~~~~~~~~rr~r~ 292 (723)
++++++++++||++|||+++|
T Consensus 23 ~~~ii~~~~~~~~RRr~~~~k 43 (44)
T 2ks1_B 23 LLLVVALGIGLFMRRRHIVRK 43 (44)
T ss_dssp HHHHHHHHHHHHHHTTTCCSC
T ss_pred HHHHHHHHHHHHhhhhHhhcc
Confidence 445566777788877666554
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.59 E-value=0.011 Score=42.45 Aligned_cols=22 Identities=14% Similarity=0.286 Sum_probs=14.7
Q ss_pred HHHHHHHHHHHHHhhhcccccc
Q 046750 272 GVVLIVLIAIFFLARGRRRRRD 293 (723)
Q Consensus 272 ~~~~l~~l~~~~~~~~rr~r~~ 293 (723)
++++++++++||++|||+++|+
T Consensus 22 ~v~ii~~~~~~~~RRRr~~~kr 43 (44)
T 2l2t_A 22 ILVIVGLTFAVYVRRKSIKKKR 43 (44)
T ss_dssp HHHHHHHHHHHHHHTTCSSCCC
T ss_pred HHHHHHHHHHHHhhhhhhhhcc
Confidence 4455667778888777666653
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=93.21 E-value=0.018 Score=40.11 Aligned_cols=27 Identities=26% Similarity=0.314 Sum_probs=16.6
Q ss_pred CCCceeehhhhHHHHHHHHHHHHHHhhh
Q 046750 260 NDDQAIIGATAAGVVLIVLIAIFFLARG 287 (723)
Q Consensus 260 ~~~~~ii~~~~~~~~~l~~l~~~~~~~~ 287 (723)
...+++||+ ++++++++++++|+|+||
T Consensus 12 aIAGiVvG~-v~gv~li~~l~~~~~rrr 38 (38)
T 2k1k_A 12 EIVAVIFGL-LLGAALLLGILVFRSRRA 38 (38)
T ss_dssp HHHHHHHHH-HHHHHHHHHHHHHHHCCC
T ss_pred ceeeeehHH-HHHHHHHHHHHHHHeecC
Confidence 334455554 456666666777888875
|
| >2l34_A TYRO protein tyrosine kinase-binding protein; immunoreceptor, transmembrane assembly, DAP12, protein bindi; NMR {Homo sapiens} PDB: 2l35_B | Back alignment and structure |
|---|
Probab=92.84 E-value=0.06 Score=36.19 Aligned_cols=29 Identities=31% Similarity=0.403 Sum_probs=20.5
Q ss_pred CCCceeehhhhHHHHHHHHHHHHHHhhhc
Q 046750 260 NDDQAIIGATAAGVVLIVLIAIFFLARGR 288 (723)
Q Consensus 260 ~~~~~ii~~~~~~~~~l~~l~~~~~~~~r 288 (723)
.+.++|+|++++-+++++++++.+||+.|
T Consensus 4 L~~gaIaGIVvgdi~~t~~i~~~vy~~~r 32 (33)
T 2l34_A 4 VSPGVLAGIVVGDLVLTVLIALAVYFLGR 32 (33)
T ss_dssp CCTHHHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred cCcceEEeEeHHHHHHHHHHHHHHhheec
Confidence 56678999998877777766666555543
|
| >2klu_A T-cell surface glycoprotein CD4; cell membrane, disulfide bond, HOST- virus interaction, immune response, immunoglobulin domain, lipoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=90.36 E-value=0.18 Score=38.94 Aligned_cols=23 Identities=43% Similarity=0.715 Sum_probs=10.7
Q ss_pred HHHHHHHHHHHhhhccccccccc
Q 046750 274 VLIVLIAIFFLARGRRRRRDAYA 296 (723)
Q Consensus 274 ~~l~~l~~~~~~~~rr~r~~~~~ 296 (723)
++++.++||+..++|+||++++.
T Consensus 21 ll~~glcI~ccvkcrhRrrqAeR 43 (70)
T 2klu_A 21 LLFIGLGIFFSVRSRHRRRQAER 43 (70)
T ss_dssp HHHHHHHHHHHHHSSCCSSSCTT
T ss_pred HHHHHHHHHHhhHHHHHHHHHHH
Confidence 33334444444455555555443
|
| >2knc_A Integrin alpha-IIB; transmembrane signaling, protein structure, cell A cleavage on PAIR of basic residues, disease mutation, disul bond, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=89.81 E-value=0.26 Score=36.94 Aligned_cols=23 Identities=9% Similarity=0.225 Sum_probs=13.3
Q ss_pred CCCCceeehhhhHHHHHHHHHHH
Q 046750 259 SNDDQAIIGATAAGVVLIVLIAI 281 (723)
Q Consensus 259 ~~~~~~ii~~~~~~~~~l~~l~~ 281 (723)
....+.|++.+++++++++++++
T Consensus 9 ~vp~wiIi~svl~GLllL~li~~ 31 (54)
T 2knc_A 9 AIPIWWVLVGVLGGLLLLTILVL 31 (54)
T ss_dssp TCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CcchHHHHHHHHHHHHHHHHHHH
Confidence 45566666666666655554443
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=89.65 E-value=0.99 Score=44.26 Aligned_cols=116 Identities=7% Similarity=0.050 Sum_probs=74.8
Q ss_pred cCCceeeEeeeeecccceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEE
Q 046750 414 HHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANIL 493 (723)
Q Consensus 414 ~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NIL 493 (723)
.|++++.. .+-.+++.+.+.|+.- .....+-.- ..++...+++++.+|+....+++. -+|--|+|.||+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~--~~~~~f~~i---k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL~ 111 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDIN--DNHTPFDNI---KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDELF 111 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCC--TTSEEGGGG---GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGEE
T ss_pred cCCcccce-EEEEcccEEEEEEEcC--cccCCHHHH---HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceEE
Confidence 57777755 3444555444444433 333333221 136778899999999998877765 467789999999
Q ss_pred eCCCCcEEEeecccccccCCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCC
Q 046750 494 VDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVD 563 (723)
Q Consensus 494 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~ 563 (723)
++.++.++|.-.|+-..+.... +..| .=+-.+=|++..++.++..|+
T Consensus 112 f~~~~~p~i~~RGik~~l~P~~-------------~~ee----------~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 112 FTRDGLPIAKTRGLQNVVDPLP-------------VSEA----------EFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp ECTTSCEEESCCEETTTBSCCC-------------CCHH----------HHHHHHHHHHHHHHCTTCCHH
T ss_pred EcCCCCEEEEEccCccCCCCCC-------------CCHH----------HHHHHHHHHHHHHHcCCCCHH
Confidence 9999999998888643222110 1111 123356688899999888764
|
| >2l8s_A Integrin alpha-1; transmembrane region, detergent micelle, CE adhesion; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=88.05 E-value=0.47 Score=35.47 Aligned_cols=24 Identities=21% Similarity=0.274 Sum_probs=13.9
Q ss_pred CCCCceeehhhhHHHHHHHHHHHH
Q 046750 259 SNDDQAIIGATAAGVVLIVLIAIF 282 (723)
Q Consensus 259 ~~~~~~ii~~~~~~~~~l~~l~~~ 282 (723)
....+.||+.++++++++++++++
T Consensus 6 ~vp~WiIi~svl~GLLLL~Lii~~ 29 (54)
T 2l8s_A 6 RVPLWVILLSAFAGLLLLMLLILA 29 (54)
T ss_dssp CCCTHHHHHHHHHHHHHHHHHHHH
T ss_pred cCchHHHHHHHHHHHHHHHHHHHH
Confidence 355666776666666555554433
|
| >2knc_B Integrin beta-3; transmembrane signaling, protein structure, cell A cleavage on PAIR of basic residues, disease mutation, disul bond, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=86.94 E-value=0.19 Score=41.09 Aligned_cols=25 Identities=20% Similarity=0.291 Sum_probs=14.0
Q ss_pred CCCceeehhhhHHHHHHHHHHHHHH
Q 046750 260 NDDQAIIGATAAGVVLIVLIAIFFL 284 (723)
Q Consensus 260 ~~~~~ii~~~~~~~~~l~~l~~~~~ 284 (723)
.+.++||+.+++++++|.++++++|
T Consensus 8 ~n~~~Iv~gvi~gilliGllllliw 32 (79)
T 2knc_B 8 PDILVVLLSVMGAILLIGLAALLIW 32 (79)
T ss_dssp SCSHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CCchhhHHHHHHHHHHHHHHHHHHH
Confidence 4556676666666555555544433
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=86.89 E-value=1.4 Score=43.42 Aligned_cols=115 Identities=10% Similarity=0.066 Sum_probs=72.7
Q ss_pred cCCceeeEeeeeecccceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhc-hhcccCCCceeecCCCCCcE
Q 046750 414 HHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLA-YLHEDCHPKIIHRDIKSANI 492 (723)
Q Consensus 414 ~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~-yLH~~g~~~ivHrDIkp~NI 492 (723)
.|+++ -..+-.+++.+.+.|+.-.++.=...++ .++...+++++.+|+.... +++. -+|--|+|.||
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-----~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~NL 115 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-----KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPENL 115 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-----TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGGE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-----hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCceE
Confidence 46666 3333355555555555443332222232 2567889999999999888 6665 56778999999
Q ss_pred EeCCCCcEEEeecccccccCCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCC
Q 046750 493 LVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVD 563 (723)
Q Consensus 493 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~ 563 (723)
+++.++.++|.-.|+-..+.... +..|-+ +-.+=|++..++.++.-|+
T Consensus 116 ~f~~~~~p~i~hRGi~~~lpP~e-------------~~ee~f----------l~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 116 MFNRALEPFFLHVGVKESLPPDE-------------WDDERL----------LREVKATVLALTEGEYRFD 163 (219)
T ss_dssp EECTTCCEEESCCEETTTBSSCS-------------CCHHHH----------HHHHHHHHHHHTTCSSCHH
T ss_pred EEeCCCcEEEEEcCCcccCCCCC-------------CCHHHH----------HHHHHHHHHHHHcCCCCHH
Confidence 99999999998888743221111 122211 2356688888888877663
|
| >1cja_A Protein (actin-fragmin kinase); transferase; HET: AMP; 2.90A {Physarum polycephalum} SCOP: d.144.1.3 | Back alignment and structure |
|---|
Probab=86.75 E-value=2.7 Score=43.88 Aligned_cols=142 Identities=15% Similarity=0.160 Sum_probs=73.3
Q ss_pred cccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeee----------------
Q 046750 362 FARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYC---------------- 425 (723)
Q Consensus 362 f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~---------------- 425 (723)
+..++.+-.| .+.||.+.. ++..|+||-.. ....+-|-.++...-.|.-|+..-+. +.
T Consensus 71 v~~I~~s~~G-stgvff~~t-d~~~~VVK~s~---~l~~E~l~s~LA~~LGlpiP~~Riv~-~~~~E~~e~~~~L~~~~~ 144 (342)
T 1cja_A 71 FKGIERSEKG-TEGLFFVET-ESGVFIVKRST---NIESETFCSLLCMRLGLHAPKVRVVS-SNSEEGTNMLECLAAIDK 144 (342)
T ss_dssp EEEEEECCST-TSCEEEEEE-SSCEEEEECCT---THHHHHHHHHHHHHHTCCCCCEEEEE-SSSHHHHHHHHHHHHHCS
T ss_pred eeEEEeccCC-CCCeEEEEe-CCCEEEEeCcH---HHHHHHHHHHHHHHhCCCCCCeeEEe-eCcHHHHHHHHHHHHhhh
Confidence 3334444555 456666655 67899999552 22333344444444444555532221 11
Q ss_pred -------ecccceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCc-e-eecCCCCCcEEeCC
Q 046750 426 -------ISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPK-I-IHRDIKSANILVDD 496 (723)
Q Consensus 426 -------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~-i-vHrDIkp~NILl~~ 496 (723)
......+++|||+.|..|.+.-+..-...+....... ++-+-++.++..++++- + .+.--.+.|||+++
T Consensus 145 ~~~~l~~l~~~~~~l~meyv~G~~L~e~~~~~~~~~f~~~~~k~--LG~Ii~FDi~InN~DR~Pl~W~n~GN~~NIL~~~ 222 (342)
T 1cja_A 145 SFRVITTLANQANILLMELVRGITLNKLTTTSAPEVLTKSTMQQ--LGSLMALDVIVNNSDRLPIAWTNEGNLDNIMLSE 222 (342)
T ss_dssp SSCHHHHHTTCSEEEEEECCCEEESTTCCSSSHHHHSCHHHHHH--HHHHHHHHHHHTCCSSSCSSSCSCCCGGGEEEES
T ss_pred hhHHHHHhhcccceehhhhcCCCccccchhhhhhhhcCHHHHHh--hchhheehhhhcCCccCcccccCCCChhheEEeC
Confidence 0112456999999877766543321111122222221 12233455555554321 1 11225789999986
Q ss_pred CC-cEEEeeccccccc
Q 046750 497 EF-EAQVADFGLAKLN 511 (723)
Q Consensus 497 ~~-~vkL~DFGla~~~ 511 (723)
+. .+.++|-+++...
T Consensus 223 ~n~~~~~IDhn~af~~ 238 (342)
T 1cja_A 223 RGATVVPIDSKIIPLD 238 (342)
T ss_dssp BTTCEEECSCCCCCCC
T ss_pred CCCeEEEEcCCccccC
Confidence 54 4999999998643
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=85.89 E-value=0.36 Score=34.53 Aligned_cols=30 Identities=30% Similarity=0.396 Sum_probs=21.5
Q ss_pred CceeehhhhHHHHHHHHHHHHHHhhhccccc
Q 046750 262 DQAIIGATAAGVVLIVLIAIFFLARGRRRRR 292 (723)
Q Consensus 262 ~~~ii~~~~~~~~~l~~l~~~~~~~~rr~r~ 292 (723)
.+++|| +++++++.+++++|+-+|+.+++|
T Consensus 15 a~~vVG-vll~vi~~l~~~~~~RRR~~~~kK 44 (44)
T 2jwa_A 15 ISAVVG-ILLVVVLGVVFGILIKRRQQKIRK 44 (44)
T ss_dssp HHHHHH-HHHHHHHHHHHHHHHHHHCSCCCC
T ss_pred HHHHHH-HHHHHHHHHHHHhheehhhhhccC
Confidence 344556 557777777778888888887765
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=85.40 E-value=0.074 Score=58.94 Aligned_cols=60 Identities=3% Similarity=0.013 Sum_probs=17.4
Q ss_pred ceEEeccCcEEEEEEEcCC-CcEEEE------EEcccCC--chhHHHHHHHHHHHHHccCCceeeEeeeeec
Q 046750 365 ENVIGEGGFGCVYKGNLPE-GKVVAV------KQLKSGS--GQGEREFRAEVEIISRVHHRHLVSLVGYCIS 427 (723)
Q Consensus 365 ~~~LG~G~fG~Vy~~~~~~-g~~VAv------K~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~ 427 (723)
.+.|| ||.||+|.+.. ...||| |.++... .+....|.+|..+++.++|+|+++.++|...
T Consensus 147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 45565 99999998754 357888 7766532 2233468889999999999999999887653
|
| >2llm_A Amyloid beta A4 protein; alzheimer'S disease, protein fibril; NMR {Homo sapiens} PDB: 2loh_A | Back alignment and structure |
|---|
Probab=84.17 E-value=0.22 Score=35.12 Aligned_cols=28 Identities=32% Similarity=0.514 Sum_probs=16.8
Q ss_pred CCceeehhhhHHHHHHHHHHHHHHhhhc
Q 046750 261 DDQAIIGATAAGVVLIVLIAIFFLARGR 288 (723)
Q Consensus 261 ~~~~ii~~~~~~~~~l~~l~~~~~~~~r 288 (723)
+.+++||+.++++.++.++++-++..||
T Consensus 15 srga~iGL~v~gVai~~vIVvsl~mlRr 42 (43)
T 2llm_A 15 NKGAIIGLMVGGVVIATVIVITLVMLKK 42 (43)
Confidence 5568888887766555555444444433
|
| >2k1a_A Integrin alpha-IIB; single-PASS transmembrane segment, alternative splicing, calcium, cell adhesion, cleavage on PAIR of basic residues; NMR {Homo sapiens} PDB: 2k9j_A | Back alignment and structure |
|---|
Probab=81.58 E-value=1.1 Score=31.76 Aligned_cols=26 Identities=8% Similarity=0.181 Sum_probs=14.4
Q ss_pred CCCCceeehhhhHHHHHHHHHHHHHH
Q 046750 259 SNDDQAIIGATAAGVVLIVLIAIFFL 284 (723)
Q Consensus 259 ~~~~~~ii~~~~~~~~~l~~l~~~~~ 284 (723)
....+.|++.+++++++++++++++|
T Consensus 7 ~vp~wiIi~s~l~GLllL~li~~~Lw 32 (42)
T 2k1a_A 7 AIPIWWVLVGVLGGLLLLTILVLAMW 32 (42)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CcchHHHHHHHHHHHHHHHHHHHHHH
Confidence 45556666666666655555443333
|
| >2l6w_A Beta-type platelet-derived growth factor receptor; transmembrane helix, receptor tyrosine kinase, heptad repeat membrane protein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=80.64 E-value=0.38 Score=33.12 Aligned_cols=26 Identities=19% Similarity=0.257 Sum_probs=11.3
Q ss_pred eehhhhHHHHHHHHHHHHHHhhhccc
Q 046750 265 IIGATAAGVVLIVLIAIFFLARGRRR 290 (723)
Q Consensus 265 ii~~~~~~~~~l~~l~~~~~~~~rr~ 290 (723)
++|+++.++++++.+++++..|++|-
T Consensus 11 l~avlal~vi~iisLIiLi~~w~qKP 36 (39)
T 2l6w_A 11 ISAILALVVLTIISLIILIMLWQKKP 36 (39)
Confidence 34444444444444444444444443
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 723 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-75 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-71 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-70 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-69 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-68 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 9e-68 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-67 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-66 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 7e-66 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-64 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-64 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-63 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-63 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-63 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-63 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 7e-63 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-62 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-61 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-61 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-60 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 8e-60 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-59 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 7e-59 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-57 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-57 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-56 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-56 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-56 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-55 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 7e-53 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 9e-53 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-50 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-50 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-50 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-50 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-49 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 7e-49 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-48 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-48 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-47 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-47 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-46 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-46 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 7e-46 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 8e-46 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-45 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-45 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-44 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-43 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 6e-43 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-42 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-42 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-41 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-40 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-39 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-39 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-37 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-37 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-35 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-34 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-32 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-31 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-27 | |
| d1jvra_ | 137 | a.61.1.2 (A:) HTLV-II matrix protein {Human T-cell | 0.001 | |
| d1jvra_ | 137 | a.61.1.2 (A:) HTLV-II matrix protein {Human T-cell | 0.002 | |
| d2gqba1 | 130 | a.282.1.1 (A:1-130) Hypothetical protein RPA2825 { | 0.002 | |
| d2gqba1 | 130 | a.282.1.1 (A:1-130) Hypothetical protein RPA2825 { | 0.003 | |
| d2gqba1 | 130 | a.282.1.1 (A:1-130) Hypothetical protein RPA2825 { | 0.004 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 242 bits (619), Expect = 2e-75
Identities = 75/286 (26%), Positives = 139/286 (48%), Gaps = 25/286 (8%)
Query: 357 EITNG-FARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHH 415
EI +G IG G FG VYKG V + + + + Q + F+ EV ++ + H
Sbjct: 4 EIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 63
Query: 416 RHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLH 475
+++ +GY + ++ ++ ++L HHLH E K + IA A+G+ YLH
Sbjct: 64 VNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLH 121
Query: 476 EDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKL-NDTTQTHVSTRVMGTFGYLAPEYA 534
IIHRD+KS NI + ++ ++ DFGLA + + + +H ++ G+ ++APE
Sbjct: 122 ---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 535 ---SSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLS 591
+ +SDV++FG+VL EL+TG+ P + + + ++ R + DLS
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS------NINNRDQIIFMVGRGYLSPDLS 232
Query: 592 EIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDS 637
++ M R++ C++ +RP Q++ +++
Sbjct: 233 KVRS------NCPKAMKRLMA---ECLKKKRDERPLFPQILASIEL 269
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (590), Expect = 3e-71
Identities = 76/287 (26%), Positives = 127/287 (44%), Gaps = 25/287 (8%)
Query: 351 TYEELMEIT-NGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEI 409
+E+ E+ +G G FG V+ G VAVK LK GS F AE +
Sbjct: 3 WWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANL 61
Query: 410 ISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAK 469
+ ++ H+ LV L ++ +I E++ N +L L L K + +A A+
Sbjct: 62 MKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 120
Query: 470 GLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYL 529
G+A++ E IHRD+++ANILV D ++ADFGLA+L + + +
Sbjct: 121 GMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT 177
Query: 530 APEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGD 589
APE + G T +SDV+SFG++L E++T + P P +++ +E G
Sbjct: 178 APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP----------GMTNPEVIQNLERGY 227
Query: 590 LSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALD 636
D E+++++ C + RP + L+
Sbjct: 228 RMVRPD------NCPEELYQLMR---LCWKERPEDRPTFDYLRSVLE 265
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 229 bits (585), Expect = 6e-70
Identities = 72/285 (25%), Positives = 125/285 (43%), Gaps = 13/285 (4%)
Query: 356 MEI-TNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGERE-FRAEVEIISR 412
ME+ + F + + +G G G V+K + P G V+A K + R E++++
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 413 VHHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLA 472
+ ++V G S+ + E + +L+ L G+ + K+++ KGL
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLT 118
Query: 473 YLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPE 532
YL E KI+HRD+K +NILV+ E ++ DFG++ + +GT Y++PE
Sbjct: 119 YLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSYMSPE 173
Query: 533 YASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSE 592
+ +SD++S G+ L+E+ GR P+ P E + + V A ET
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA--KELELMFGCQVEGDAAETPPRPR 231
Query: 593 IVDPRLEKHYVESE-MFRMIEAAAACVRHSGPKRPRMVQVVRALD 636
L + ++S + E V PK P V + D
Sbjct: 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQD 276
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (581), Expect = 1e-69
Identities = 68/303 (22%), Positives = 122/303 (40%), Gaps = 32/303 (10%)
Query: 365 ENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGY 424
+ IG+G FG V++G G+ VAVK S + AE+ + H +++ +
Sbjct: 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAA 65
Query: 425 CISEKNRL----LIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDC-- 478
+ L+ ++ + +L +L+ + +K+AL A GLA+LH +
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 479 ---HPKIIHRDIKSANILVDDEFEAQVADFGLAKLND---TTQTHVSTRVMGTFGYLAPE 532
P I HRD+KS NILV +AD GLA +D T +GT Y+APE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 533 YASS------GKLTDRSDVFSFGVVLLELITGRKP----VDPTQPLGDESLVEWARPVLV 582
+ R+D+++ G+V E+ D P D + + +
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242
Query: 583 RAIETGDLSEIVDPRLEKHYVESEMFR-MIEAAAACVRHSGPKRPRMVQVVRALDSEGEM 641
+ + + + P + + E R M + C +G R +++ + L +
Sbjct: 243 KVV----CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298
Query: 642 SDL 644
+
Sbjct: 299 EGI 301
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (569), Expect = 2e-68
Identities = 74/276 (26%), Positives = 129/276 (46%), Gaps = 30/276 (10%)
Query: 362 FARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSL 421
IG+G FG V G+ G VAVK +K+ + + F AE +++++ H +LV L
Sbjct: 9 LKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQL 65
Query: 422 VGYCISEKNRL-LIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHP 480
+G + EK L ++ E++ +L +L +G+ VL +K +L + + YL
Sbjct: 66 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GN 122
Query: 481 KIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLT 540
+HRD+ + N+LV ++ A+V+DFGL K +TQ + APE K +
Sbjct: 123 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG----KLPVKWTAPEALREKKFS 178
Query: 541 DRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEK 600
+SDV+SFG++L E+ + + P PL D +V +E G + D
Sbjct: 179 TKSDVWSFGILLWEIYSFGRVPYPRIPLKD----------VVPRVEKGYKMDAPD----- 223
Query: 601 HYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALD 636
++ +++ C RP +Q+ L+
Sbjct: 224 -GCPPAVYEVMK---NCWHLDAAMRPSFLQLREQLE 255
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (565), Expect = 9e-68
Identities = 72/271 (26%), Positives = 125/271 (46%), Gaps = 24/271 (8%)
Query: 366 NVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYC 425
IG G FG V+ G VA+K ++ G+ E +F E E++ ++ H LV L G C
Sbjct: 11 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 426 ISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHR 485
+ + L++EF+ + L +L + + + L +G+AYL +IHR
Sbjct: 70 LEQAPICLVFEFMEHGCLSDYLRTQRGLF-AAETLLGMCLDVCEGMAYL---EEACVIHR 125
Query: 486 DIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDV 545
D+ + N LV + +V+DFG+ + Q ST + +PE S + + +SDV
Sbjct: 126 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 185
Query: 546 FSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEKHYVES 605
+SFGV++ E+ + K P + S E +V I TG + PRL +
Sbjct: 186 WSFGVLMWEVFSEGKI-----PYENRSNSE-----VVEDISTGF--RLYKPRL----AST 229
Query: 606 EMFRMIEAAAACVRHSGPKRPRMVQVVRALD 636
+++++ C + RP +++R L
Sbjct: 230 HVYQIMN---HCWKERPEDRPAFSRLLRQLA 257
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 222 bits (566), Expect = 2e-67
Identities = 85/305 (27%), Positives = 132/305 (43%), Gaps = 41/305 (13%)
Query: 350 FTYEELMEITNGFARE---------NVIGEGGFGCVYKGNLP----EGKVVAVKQLKSG- 395
FT+E+ E FA+E VIG G FG V G+L VA+K LKSG
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 396 SGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVL 455
+ + R+F +E I+ + H +++ L G ++I EF+ N +L+ L
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 456 EWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK-LNDTT 514
+ V + G A G+ YL +HRD+ + NILV+ +V+DFGL++ L D T
Sbjct: 126 TVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182
Query: 515 QTHVSTRV---MGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDE 571
T + APE K T SDV+S+G+V+ E+++ + P D
Sbjct: 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER-----PYWDM 237
Query: 572 SLVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQV 631
+ + ++ AIE D RL + C + RP+ Q+
Sbjct: 238 TNQD-----VINAIEQ-------DYRLPPPMDCPSALHQL--MLDCWQKDRNHRPKFGQI 283
Query: 632 VRALD 636
V LD
Sbjct: 284 VNTLD 288
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (556), Expect = 1e-66
Identities = 64/270 (23%), Positives = 115/270 (42%), Gaps = 24/270 (8%)
Query: 366 NVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYC 425
+G G FG V G VA+K +K GS E EF E +++ + H LV L G C
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 426 ISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHR 485
++ +I E++ N L ++L + + +++ + + YL + +HR
Sbjct: 69 TKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLE---SKQFLHR 124
Query: 486 DIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDV 545
D+ + N LV+D+ +V+DFGL++ + S + PE K + +SD+
Sbjct: 125 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDI 184
Query: 546 FSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEKHYVES 605
++FGV++ E+ + K P + E I G RL + ++ S
Sbjct: 185 WAFGVLMWEIYSLGKM-----PYERFTNSE-----TAEHIAQG-------LRLYRPHLAS 227
Query: 606 EMFRMIEAAAACVRHSGPKRPRMVQVVRAL 635
E I +C +RP ++ +
Sbjct: 228 EKVYTI--MYSCWHEKADERPTFKILLSNI 255
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (556), Expect = 7e-66
Identities = 74/282 (26%), Positives = 125/282 (44%), Gaps = 32/282 (11%)
Query: 365 ENVIGEGGFGCVYKGNLPEGK----VVAVKQLKSGSGQGE-REFRAEVEIISRVHHRHLV 419
VIG G FGCVY G L + AVK L + GE +F E I+ H +++
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 420 SLVGYCI-SEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDC 478
SL+G C+ SE + L++ ++ + +L + + + + L AKG+
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQVAKGM---KFLA 147
Query: 479 HPKIIHRDIKSANILVDDEFEAQVADFGLAKL---NDTTQTHVSTRVMGTFGYLAPEYAS 535
K +HRD+ + N ++D++F +VADFGLA+ + H T ++A E
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 207
Query: 536 SGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVD 595
+ K T +SDV+SFGV+L EL+T P P D + + +L ++
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLL-------QGRRLLQ 255
Query: 596 PRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDS 637
P Y ++ ++ C RP ++V + +
Sbjct: 256 PE----YCPDPLYEVML---KCWHPKAEMRPSFSELVSRISA 290
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 213 bits (543), Expect = 2e-64
Identities = 71/283 (25%), Positives = 125/283 (44%), Gaps = 24/283 (8%)
Query: 365 ENVIGEGGFGCVYKGNLPE-GKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVG 423
++ +G G +G VY+G + VAVK LK + + E EF E ++ + H +LV L+G
Sbjct: 22 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLG 80
Query: 424 YCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKII 483
C E +I EF+ NL +L + + + +A + + YL + I
Sbjct: 81 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFI 137
Query: 484 HRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRS 543
HRD+ + N LV + +VADFGL++L + APE + K + +S
Sbjct: 138 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 197
Query: 544 DVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEKHYV 603
DV++FGV+L E+ T P I+ + E+++
Sbjct: 198 DVWAFGVLLWEIATYGMSPYP-------------------GIDLSQVYELLEKDYRMERP 238
Query: 604 ESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEMSDLSN 646
E ++ E AC + + RP ++ +A ++ + S +S+
Sbjct: 239 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 281
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (544), Expect = 3e-64
Identities = 74/321 (23%), Positives = 129/321 (40%), Gaps = 49/321 (15%)
Query: 352 YEELMEIT-NGFARENVIGEGGFGCVYKG------NLPEGKVVAVKQLKSGSGQGERE-F 403
Y+ E N + +G G FG V + VAVK LK + ERE
Sbjct: 14 YDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREAL 73
Query: 404 RAEVEIISRV-HHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKG----------- 451
+E++++S + +H ++V+L+G C L+I E+ +L + L K
Sbjct: 74 MSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPA 133
Query: 452 -----QPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFG 506
+ L+ + + AKG+A+L IHRD+ + NIL+ ++ DFG
Sbjct: 134 IMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFG 190
Query: 507 LAK-LNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPT 565
LA+ + + + V ++APE + T SDV+S+G+ L EL + P
Sbjct: 191 LARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG 250
Query: 566 QPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKR 625
P+ + +++ E M + C KR
Sbjct: 251 MPVDSK------------------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKR 292
Query: 626 PRMVQVVRALDSEGEMSDLSN 646
P Q+V+ + E ++S+ +N
Sbjct: 293 PTFKQIVQLI--EKQISESTN 311
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 2e-63
Identities = 64/280 (22%), Positives = 116/280 (41%), Gaps = 32/280 (11%)
Query: 365 ENVIGEGGFGCVYKGNLPE---GKVVAVKQLKSGSGQGE--REFRAEVEIISRVHHRHLV 419
+ +G G FG V KG K VAVK LK+ + E AE ++ ++ + ++V
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 420 SLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCH 479
++G C +E + +L+ E L +L ++ +++ + G+ YL
Sbjct: 72 RMIGICEAE-SWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLE---E 125
Query: 480 PKIIHRDIKSANILVDDEFEAQVADFGLAKL--NDTTQTHVSTRVMGTFGYLAPEYASSG 537
+HRD+ + N+L+ + A+++DFGL+K D T + APE +
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185
Query: 538 KLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPR 597
K + +SDV+SFGV++ E + + P E + +E G+
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQK-----PYRGMKGSE-----VTAMLEKGERMGCPA-- 233
Query: 598 LEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDS 637
EM+ ++ C + RP V L +
Sbjct: 234 ----GCPREMYDLMN---LCWTYDVENRPGFAAVELRLRN 266
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (537), Expect = 2e-63
Identities = 74/273 (27%), Positives = 119/273 (43%), Gaps = 24/273 (8%)
Query: 365 ENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGY 424
E +G+G FG V+ G VA+K LK G+ F E +++ ++ H LV L
Sbjct: 22 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV 80
Query: 425 CISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIH 484
SE+ ++ E++ +L L G+ L + V +A A G+AY+ +H
Sbjct: 81 V-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 136
Query: 485 RDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSD 544
RD+++ANILV + +VADFGLA+L + + + APE A G+ T +SD
Sbjct: 137 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 196
Query: 545 VFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEKHYVE 604
V+SFG++L EL T + P ++ +E G E
Sbjct: 197 VWSFGILLTELTTKGRVPYP----------GMVNREVLDQVERG-----YRMPCPPECPE 241
Query: 605 SEMFRMIEAAAACVRHSGPKRPRMVQVVRALDS 637
S + + C R +RP + L+
Sbjct: 242 S----LHDLMCQCWRKEPEERPTFEYLQAFLED 270
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 2e-63
Identities = 63/279 (22%), Positives = 121/279 (43%), Gaps = 30/279 (10%)
Query: 365 ENVIGEGGFGCVYKG---NLPEGKVVAVKQLKSGSGQGERE-FRAEVEIISRVHHRHLVS 420
+ +G G FG V +G + VA+K LK G+ + + E E +I+ ++ + ++V
Sbjct: 14 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 73
Query: 421 LVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHP 480
L+G C + +L+ E L L GK + + + ++ + G+ YL
Sbjct: 74 LIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYLE---EK 128
Query: 481 KIIHRDIKSANILVDDEFEAQVADFGLAKL--NDTTQTHVSTRVMGTFGYLAPEYASSGK 538
+HRD+ + N+L+ + A+++DFGL+K D + + + APE + K
Sbjct: 129 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 188
Query: 539 LTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRL 598
+ RSDV+S+GV + E ++ + P E ++ IE G E
Sbjct: 189 FSSRSDVWSYGVTMWEALSYGQK-----PYKKMKGPE-----VMAFIEQGKRMECPP--- 235
Query: 599 EKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDS 637
E++ ++ C + RP + V + + +
Sbjct: 236 ---ECPPELYALMS---DCWIYKWEDRPDFLTVEQRMRA 268
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (534), Expect = 5e-63
Identities = 72/290 (24%), Positives = 123/290 (42%), Gaps = 32/290 (11%)
Query: 357 EI-TNGFARENVIGEGGFGCVYKGNLPEG-----KVVAVKQLKSGSGQGER-EFRAEVEI 409
EI + R+ VIG G FG VYKG L VA+K LK+G + +R +F E I
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62
Query: 410 ISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAK 469
+ + H +++ L G K ++I E+ N + + V + G A
Sbjct: 63 MGQFSHHNIIRLEGVISKYKPMMIITEY-MENGALDKFLREKDGEFSVLQLVGMLRGIAA 121
Query: 470 GLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKL--NDTTQTHVSTRVMGTFG 527
G+ YL + +HRD+ + NILV+ +V+DFGL+++ +D T+ ++
Sbjct: 122 GMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178
Query: 528 YLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIET 587
+ APE S K T SDV+SFG+V+ E++T +
Sbjct: 179 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-------------------N 219
Query: 588 GDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDS 637
++ + ++ + + C + +RP+ +V LD
Sbjct: 220 HEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 210 bits (534), Expect = 7e-63
Identities = 68/310 (21%), Positives = 117/310 (37%), Gaps = 57/310 (18%)
Query: 362 FAREN-----VIGEGGFGCVYKG------NLPEGKVVAVKQLK-SGSGQGEREFRAEVEI 409
+ R N IGEG FG V++ +VAVK LK S + +F+ E +
Sbjct: 10 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAAL 69
Query: 410 ISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQ----------------- 452
++ + ++V L+G C K L++E++ +L L
Sbjct: 70 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 129
Query: 453 -----PVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGL 507
P L +++ IA A G+AYL K +HRD+ + N LV + ++ADFGL
Sbjct: 130 SSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGL 186
Query: 508 AK-LNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQ 566
++ + ++ PE + T SDV+++GVVL E+ +
Sbjct: 187 SRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ----- 241
Query: 567 PLGDESLVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRP 626
P + E ++ + G++ E+ + C RP
Sbjct: 242 PYYGMAHEE-----VIYYVRDGNILAC---------PENCPLELYNLMRLCWSKLPADRP 287
Query: 627 RMVQVVRALD 636
+ R L
Sbjct: 288 SFCSIHRILQ 297
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 2e-62
Identities = 70/320 (21%), Positives = 127/320 (39%), Gaps = 52/320 (16%)
Query: 350 FTYEELMEIT-NGFARENVIGEGGFGCVYKG------NLPEGKVVAVKQLKSGSGQGERE 402
+ Y+ E V+G G FG V VAVK LK + ERE
Sbjct: 26 YEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSERE 85
Query: 403 -FRAEVEIISRV-HHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQP------- 453
+E+++++++ H ++V+L+G C LI+E+ +L ++L K +
Sbjct: 86 ALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIE 145
Query: 454 --------------VLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFE 499
VL + + A AKG+ +L +HRD+ + N+LV
Sbjct: 146 YENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKV 202
Query: 500 AQVADFGLAK-LNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITG 558
++ DFGLA+ + + V ++APE G T +SDV+S+G++L E+ +
Sbjct: 203 VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL 262
Query: 559 RKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACV 618
P + + I+ G ++++ + +E +I +C
Sbjct: 263 GVN-----PYPGIPVDA----NFYKLIQNG-------FKMDQPFYATEEIYII--MQSCW 304
Query: 619 RHSGPKRPRMVQVVRALDSE 638
KRP + L +
Sbjct: 305 AFDSRKRPSFPNLTSFLGCQ 324
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 2e-61
Identities = 60/281 (21%), Positives = 112/281 (39%), Gaps = 30/281 (10%)
Query: 362 FARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGS--GQGEREFRAEVEIISRVHHRHL 418
+ IG G +G K +GK++ K+L GS ++ +EV ++ + H ++
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 419 VSLVGYCISEKNRLL--IYEFVPNNNLEHHLH--GKGQPVLEWTKRVKIALGAAKGLAYL 474
V I N L + E+ +L + K + L+ +++ L
Sbjct: 66 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125
Query: 475 HE--DCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPE 532
H D ++HRD+K AN+ +D + ++ DFGLA++ + + +GT Y++PE
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA-FVGTPYYMSPE 184
Query: 533 YASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSE 592
+ ++SD++S G +L EL P S E L I G
Sbjct: 185 QMNRMSYNEKSDIWSLGCLLYELCALMPPFT------AFSQKE-----LAGKIREGKFRR 233
Query: 593 IVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVR 633
I + E+ +I + RP + +++
Sbjct: 234 I------PYRYSDELNEIIT---RMLNLKDYHRPSVEEILE 265
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 5e-61
Identities = 67/277 (24%), Positives = 114/277 (41%), Gaps = 33/277 (11%)
Query: 365 ENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSG--SGQGEREFRAEVEIISRVHHRHLVSL 421
+ IG G F VYKG + VA +L+ + + F+ E E++ + H ++V
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 422 VGYCIS----EKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHED 477
S +K +L+ E + + L+ +L V++ KGL +LH
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHT- 130
Query: 478 CHPKIIHRDIKSANILVDDE-FEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASS 536
P IIHRD+K NI + ++ D GLA L + V+GT ++APE
Sbjct: 131 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA---KAVIGTPEFMAPEMYE- 186
Query: 537 GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDP 596
K + DV++FG+ +LE+ T P + R + +G V P
Sbjct: 187 EKYDESVDVYAFGMCMLEMATSEYPYSE----------CQNAAQIYRRVTSG-----VKP 231
Query: 597 RLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVR 633
E+ +IE C+R + +R + ++
Sbjct: 232 ASFDKVAIPEVKEIIE---GCIRQNKDERYSIKDLLN 265
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 202 bits (516), Expect = 4e-60
Identities = 62/279 (22%), Positives = 117/279 (41%), Gaps = 36/279 (12%)
Query: 362 FARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGE---REFRAEVEIISRVHHRH 417
F+ IG G FG VY ++ +VVA+K++ Q ++ EV + ++ H +
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 418 LVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHED 477
+ G + E L+ E+ + + K L+ + + GA +GLAYLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP--LQEVEIAAVTHGALQGLAYLHS- 133
Query: 478 CHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASS- 536
+IHRD+K+ NIL+ + ++ DFG A + + V GT ++APE +
Sbjct: 134 --HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVILAM 186
Query: 537 --GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIV 594
G+ + DV+S G+ +EL + P+ + + I +
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----------SALYHIAQNE----- 230
Query: 595 DPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVR 633
P L+ + ++ +C++ RP +++
Sbjct: 231 SPALQSGHWSEYFRNFVD---SCLQKIPQDRPTSEVLLK 266
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 8e-60
Identities = 63/278 (22%), Positives = 114/278 (41%), Gaps = 29/278 (10%)
Query: 365 ENVIGEGGFGCVYKGNLP----EGKVVAVKQLKSGSGQGERE-FRAEVEIISRVHHRHLV 419
IGEG FG V++G VA+K K+ + RE F E + + H H+V
Sbjct: 12 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 71
Query: 420 SLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCH 479
L+G +E +I E L L + L+ + A + LAYL
Sbjct: 72 KLIGVI-TENPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAYLES--- 126
Query: 480 PKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKL 539
+ +HRDI + N+LV ++ DFGL++ + + + +++ ++APE + +
Sbjct: 127 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 186
Query: 540 TDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLE 599
T SDV+ FGV + E++ P + ++ IE G+ +
Sbjct: 187 TSASDVWMFGVCMWEILMHGVK-----PFQGVKNND-----VIGRIENGERLPMPP---- 232
Query: 600 KHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDS 637
++ ++ C + +RPR ++ L +
Sbjct: 233 --NCPPTLYSLMT---KCWAYDPSRRPRFTELKAQLST 265
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 2e-59
Identities = 62/274 (22%), Positives = 117/274 (42%), Gaps = 29/274 (10%)
Query: 366 NVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGY 424
+G+G FG VYK N + A K + + S + ++ E++I++ H ++V L+
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 425 CISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIH 484
E N ++ EF ++ + +P L ++ + L YLH+ KIIH
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLELERP-LTESQIQVVCKQTLDALNYLHD---NKIIH 133
Query: 485 RDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTD--- 541
RD+K+ NIL + + ++ADFG++ N T + + GT ++APE D
Sbjct: 134 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDRPY 192
Query: 542 --RSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLE 599
++DV+S G+ L+E+ P P+ ++ I + + P
Sbjct: 193 DYKADVWSLGITLIEMAEIEPPHHELNPMR-----------VLLKIAKSEPPTLAQPS-- 239
Query: 600 KHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVR 633
S ++ C+ + R Q+++
Sbjct: 240 --RWSSNFKDFLK---KCLEKNVDARWTTSQLLQ 268
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (503), Expect = 7e-59
Identities = 64/276 (23%), Positives = 112/276 (40%), Gaps = 33/276 (11%)
Query: 362 FARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSG---SGQGEREFRAEVEIISRVHHRH 417
F +G+G FG VY ++A+K L E + R EVEI S + H +
Sbjct: 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67
Query: 418 LVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHED 477
++ L GY LI E+ P + L + + + A L+Y H
Sbjct: 68 ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCHS- 124
Query: 478 CHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSG 537
++IHRDIK N+L+ E ++ADFG + +++ + GT YL PE
Sbjct: 125 --KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLDYLPPEMIEGR 179
Query: 538 KLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPR 597
++ D++S GV+ E + G+ P + + E + I + +
Sbjct: 180 MHDEKVDLWSLGVLCYEFLVGKPPFE------ANTYQE-----TYKRISRVEFT------ 222
Query: 598 LEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVR 633
+V +I ++H+ +RP + +V+
Sbjct: 223 -FPDFVTEGARDLIS---RLLKHNPSQRPMLREVLE 254
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 1e-57
Identities = 70/283 (24%), Positives = 122/283 (43%), Gaps = 31/283 (10%)
Query: 362 FARENVIGEGGFGCVYKG-NLPEGKV----VAVKQLK-SGSGQGEREFRAEVEIISRVHH 415
F + V+G G FG VYKG +PEG+ VA+K+L+ + S + +E E +++ V +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 416 RHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLH 475
H+ L+G C+ LI + +P L ++ + + + AKG+ YL
Sbjct: 71 PHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNI-GSQYLLNWCVQIAKGMNYL- 127
Query: 476 EDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK-LNDTTQTHVSTRVMGTFGYLAPEYA 534
+++HRD+ + N+LV ++ DFGLAK L + + + ++A E
Sbjct: 128 --EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 535 SSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIV 594
T +SDV+S+GV + EL+T P E + +E G
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGSK-----PYDGIPASE-----ISSILEKG------ 229
Query: 595 DPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDS 637
RL + + + MI C RP+ +++
Sbjct: 230 -ERLPQPPICTIDVYMI--MVKCWMIDADSRPKFRELIIEFSK 269
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 1e-57
Identities = 75/296 (25%), Positives = 128/296 (43%), Gaps = 43/296 (14%)
Query: 360 NGFARENVIGEGGFGCVYKGNLPEG---KVVAVKQLK-SGSGQGEREFRAEVEIISRV-H 414
N ++VIGEG FG V K + + A+K++K S R+F E+E++ ++ H
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 415 HRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGK--------------GQPVLEWTKR 460
H ++++L+G C L E+ P+ NL L L +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 461 VKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVST 520
+ A A+G+ YL + + IHRD+ + NILV + + A++ADFGL++ + T
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--T 184
Query: 521 RVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPV 580
++A E + T SDV+S+GV+L E+++ P + E
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT-----PYCGMTCAE----- 234
Query: 581 LVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALD 636
L + G RLEK + + C R +RP Q++ +L+
Sbjct: 235 LYEKLPQG-------YRLEKPLNCDDEVYDL--MRQCWREKPYERPSFAQILVSLN 281
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 1e-56
Identities = 51/210 (24%), Positives = 86/210 (40%), Gaps = 9/210 (4%)
Query: 362 FARENVIGEGGFGCVYKG-NLPEGKVVAVKQL-KSGSGQGEREFRAEVEIISRVHHRHLV 419
+ +GEG +G V N + VAVK + + + E+ I ++H ++V
Sbjct: 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66
Query: 420 SLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCH 479
G+ + L E+ L + + + G+ YLH
Sbjct: 67 KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLH---G 121
Query: 480 PKIIHRDIKSANILVDDEFEAQVADFGLAK-LNDTTQTHVSTRVMGTFGYLAPEYASSGK 538
I HRDIK N+L+D+ +++DFGLA + + ++ GT Y+APE +
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 539 LTDR-SDVFSFGVVLLELITGRKPVDPTQP 567
DV+S G+VL ++ G P D
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSD 211
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 1e-56
Identities = 74/297 (24%), Positives = 120/297 (40%), Gaps = 45/297 (15%)
Query: 365 ENVIGEGGFGCVYKG------NLPEGKVVAVKQLKSGSGQGE-REFRAEVEIISR-VHHR 416
+G G FG V + + VAVK LK G+ E R +E++I+ HH
Sbjct: 18 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 77
Query: 417 HLVSLVGYCISEKNRLLI-YEFVPNNNLEHHLHGKG--------------QPVLEWTKRV 461
++V+L+G C L++ EF NL +L K + L +
Sbjct: 78 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 137
Query: 462 KIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHV-ST 520
+ AKG+ +L K IHRD+ + NIL+ ++ ++ DFGLA+ +V
Sbjct: 138 CYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 194
Query: 521 RVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPV 580
++APE T +SDV+SFGV+L E+ + P + E
Sbjct: 195 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDEE---- 245
Query: 581 LVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDS 637
R ++ G D Y EM++ + C +RP ++V L +
Sbjct: 246 FCRRLKEGTRMRAPD------YTTPEMYQTML---DCWHGEPSQRPTFSELVEHLGN 293
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 2e-56
Identities = 61/279 (21%), Positives = 106/279 (37%), Gaps = 32/279 (11%)
Query: 366 NVIGEGGFGCVYKGNLP----EGKVVAVKQLKS---GSGQGEREFRAEVEIISRVHHRHL 418
+G+G FG V +G + VAVK LK + +F EV + + HR+L
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 419 VSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDC 478
+ L G ++ + ++ E P +L L + A+ A+G+ YL
Sbjct: 74 IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQVAEGMGYLES-- 129
Query: 479 HPKIIHRDIKSANILVDDEFEAQVADFGLAKL--NDTTQTHVSTRVMGTFGYLAPEYASS 536
+ IHRD+ + N+L+ ++ DFGL + + + F + APE +
Sbjct: 130 -KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 537 GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDP 596
+ SD + FGV L E+ T + P + + ++ I+
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQE-----PWIGLNGSQ-----ILHKIDKE------GE 232
Query: 597 RLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRAL 635
RL + + + C H RP V + L
Sbjct: 233 RLPRPEDCPQDIYNV--MVQCWAHKPEDRPTFVALRDFL 269
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 5e-55
Identities = 51/222 (22%), Positives = 102/222 (45%), Gaps = 18/222 (8%)
Query: 351 TYEELME-----ITNG-----FARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQG 399
+ EE++E ++ G + R IG+G G VY ++ G+ VA++Q+
Sbjct: 1 SDEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK 60
Query: 400 EREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTK 459
+ E+ ++ + ++V+ + + ++ E++ +L + +
Sbjct: 61 KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD---EGQ 117
Query: 460 RVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVS 519
+ + L +LH + ++IHRDIKS NIL+ + ++ DFG Q+ S
Sbjct: 118 IAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174
Query: 520 TRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKP 561
T V GT ++APE + + D++S G++ +E+I G P
Sbjct: 175 TMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (464), Expect = 7e-53
Identities = 69/292 (23%), Positives = 127/292 (43%), Gaps = 38/292 (13%)
Query: 365 ENVIGEGGFGCVYKG------NLPEGKVVAVKQLKSGSGQGER-EFRAEVEIISRVHHRH 417
+G+G FG VY+G VA+K + + ER EF E ++ + H
Sbjct: 25 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 84
Query: 418 LVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQ--------PVLEWTKRVKIALGAAK 469
+V L+G + L+I E + +L+ +L +K +++A A
Sbjct: 85 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 144
Query: 470 GLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK-LNDTTQTHVSTRVMGTFGY 528
G+AYL K +HRD+ + N +V ++F ++ DFG+ + + +T + + +
Sbjct: 145 GMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 201
Query: 529 LAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETG 588
++PE G T SDV+SFGVVL E+ T + P S + ++R + G
Sbjct: 202 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ-----PYQGLSNEQ-----VLRFVMEG 251
Query: 589 DLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGE 640
L + D + + E C +++ RP ++++ ++ E E
Sbjct: 252 GLLDKPDNCPD---------MLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 9e-53
Identities = 75/300 (25%), Positives = 124/300 (41%), Gaps = 47/300 (15%)
Query: 362 FARENVIGEGGFGCVYKGNLPE--------GKVVAVKQLKSGSGQGE-REFRAEVEIISR 412
+GEG FG V VAVK LKS + + + + +E+E++
Sbjct: 15 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKM 74
Query: 413 V-HHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQP--------------VLEW 457
+ H+++++L+G C + +I E+ NL +L + P L
Sbjct: 75 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 134
Query: 458 TKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTH 517
V A A+G+ YL K IHRD+ + N+LV ++ ++ADFGLA+ +
Sbjct: 135 KDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191
Query: 518 VSTRVM-GTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEW 576
T ++APE T +SDV+SFGV+L E+ T P P+ +
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE------ 245
Query: 577 ARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALD 636
L + ++ G R++K + M+ C +RP Q+V LD
Sbjct: 246 ----LFKLLKEG-------HRMDKPSNCTNELYMM--MRDCWHAVPSQRPTFKQLVEDLD 292
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 1e-50
Identities = 51/205 (24%), Positives = 88/205 (42%), Gaps = 10/205 (4%)
Query: 362 FARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGE---REFRAEVEIISRVHHRH 417
F ++GEG F V L + A+K L+ E E +++SR+ H
Sbjct: 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 418 LVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHED 477
V L ++ + N L ++ G + T L YLH
Sbjct: 70 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHG- 126
Query: 478 CHPKIIHRDIKSANILVDDEFEAQVADFGLAKL-NDTTQTHVSTRVMGTFGYLAPEYASS 536
IIHRD+K NIL++++ Q+ DFG AK+ + ++ + +GT Y++PE +
Sbjct: 127 --KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184
Query: 537 GKLTDRSDVFSFGVVLLELITGRKP 561
SD+++ G ++ +L+ G P
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGLPP 209
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 177 bits (451), Expect = 2e-50
Identities = 51/208 (24%), Positives = 92/208 (44%), Gaps = 9/208 (4%)
Query: 357 EITNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHH 415
+ + + +G G FG V++ G A K + + + R E++ +S + H
Sbjct: 23 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRH 82
Query: 416 RHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLH 475
LV+L + ++IYEF+ L + + + + V+ KGL ++H
Sbjct: 83 PTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHMH 141
Query: 476 EDCHPKIIHRDIKSANILVDDEFEAQV--ADFGLAKLNDTTQTHVSTRVMGTFGYLAPEY 533
E+ +H D+K NI+ + ++ DFGL D Q+ T GT + APE
Sbjct: 142 ENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEV 196
Query: 534 ASSGKLTDRSDVFSFGVVLLELITGRKP 561
A + +D++S GV+ L++G P
Sbjct: 197 AEGKPVGYYTDMWSVGVLSYILLSGLSP 224
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 175 bits (444), Expect = 2e-50
Identities = 65/288 (22%), Positives = 126/288 (43%), Gaps = 32/288 (11%)
Query: 357 EITNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGE---REFRAEVEIISR 412
+++ + ++G GG V+ +L + VAVK L++ + FR E + +
Sbjct: 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 63
Query: 413 VHHRHLVSLVGYCISEKNRL----LIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAA 468
++H +V++ +E ++ E+V L +H +G + + +++ A
Sbjct: 64 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADAC 121
Query: 469 KGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKL--NDTTQTHVSTRVMGTF 526
+ L + H+ IIHRD+K ANI++ +V DFG+A+ + + V+GT
Sbjct: 122 QALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178
Query: 527 GYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIE 586
YL+PE A + RSDV+S G VL E++TG P +S V A +
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT------GDSPVSVAYQHV----- 227
Query: 587 TGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634
+ + P + +++ ++ + + R + +RA
Sbjct: 228 ---REDPIPPSARHEGLSADLDAVVL---KALAKNPENRYQTAAEMRA 269
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 177 bits (449), Expect = 3e-50
Identities = 48/208 (23%), Positives = 93/208 (44%), Gaps = 9/208 (4%)
Query: 357 EITNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHH 415
+ + + +G G FG V++ G+V K + + + + E+ I++++HH
Sbjct: 26 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHH 85
Query: 416 RHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLH 475
L++L + +LI EF+ L + + + + + A +GL ++H
Sbjct: 86 PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEGLKHMH 144
Query: 476 EDCHPKIIHRDIKSANILVDDEFEAQV--ADFGLAKLNDTTQTHVSTRVMGTFGYLAPEY 533
E I+H DIK NI+ + + + V DFGLA + + T T + APE
Sbjct: 145 E---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT--TATAEFAAPEI 199
Query: 534 ASSGKLTDRSDVFSFGVVLLELITGRKP 561
+ +D+++ GV+ L++G P
Sbjct: 200 VDREPVGFYTDMWAIGVLGYVLLSGLSP 227
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 174 bits (442), Expect = 1e-49
Identities = 54/215 (25%), Positives = 101/215 (46%), Gaps = 12/215 (5%)
Query: 352 YEELMEITNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGERE-FRAEVEI 409
+++ +I + + +V+G G F V + K+VA+K + + +G+ E+ +
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 410 ISRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAK 469
+ ++ H ++V+L S + LI + V L + KG ++
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF--YTERDASRLIFQVLD 118
Query: 470 GLAYLHEDCHPKIIHRDIKSANILV---DDEFEAQVADFGLAKLNDTTQTHVSTRVMGTF 526
+ YLH+ I+HRD+K N+L D++ + ++DFGL+K+ D V + GT
Sbjct: 119 AVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED--PGSVLSTACGTP 173
Query: 527 GYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKP 561
GY+APE + + D +S GV+ L+ G P
Sbjct: 174 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 208
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 173 bits (440), Expect = 7e-49
Identities = 61/225 (27%), Positives = 95/225 (42%), Gaps = 16/225 (7%)
Query: 360 NGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSG---SGQGEREFRAEVEIISRVH- 414
N F+ +IG GGFG VY GK+ A+K L QGE E ++S V
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 415 --HRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLA 472
+V + + I + + +L +HL G + A GL
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF--YAAEIILGLE 121
Query: 473 YLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPE 532
++H +++RD+K ANIL+D+ +++D GLA + H +GT GY+APE
Sbjct: 122 HMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTHGYMAPE 175
Query: 533 YASSGKLTD-RSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEW 576
G D +D FS G +L +L+ G P + +
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM 220
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (433), Expect = 3e-48
Identities = 43/208 (20%), Positives = 85/208 (40%), Gaps = 10/208 (4%)
Query: 357 EITNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHH 415
E+ + +G G FG V++ K K +K G + + E+ I++ H
Sbjct: 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARH 60
Query: 416 RHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLH 475
R+++ L S + ++I+EF+ ++ ++ L + V + L +LH
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFE-LNEREIVSYVHQVCEALQFLH 119
Query: 476 EDCHPKIIHRDIKSANILVDDEFEAQV--ADFGLAKLNDTTQTHVSTRVMGTFGYLAPEY 533
I H DI+ NI+ + + +FG A+ + Y APE
Sbjct: 120 S---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAPEYYAPEV 174
Query: 534 ASSGKLTDRSDVFSFGVVLLELITGRKP 561
++ +D++S G ++ L++G P
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 170 bits (430), Expect = 3e-48
Identities = 62/317 (19%), Positives = 108/317 (34%), Gaps = 38/317 (11%)
Query: 356 ME--ITNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISR 412
ME + N + IG G FG +Y G ++ G+ VA+K + + E +I
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKM 58
Query: 413 VHHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLA 472
+ + + +C +E + ++ + +LE + + + +A +
Sbjct: 59 MQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK-FSLKTVLLLADQMISRIE 117
Query: 473 YLHEDCHPKIIHRDIKSANILV---DDEFEAQVADFGLAKLNDTTQTHV------STRVM 523
Y+H IHRD+K N L+ + DFGLAK +TH + +
Sbjct: 118 YIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT 174
Query: 524 GTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVR 583
GT Y + + + R D+ S G VL+ G P + E +
Sbjct: 175 GTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 234
Query: 584 AIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALD----SEG 639
L K Y E + C +P + + +G
Sbjct: 235 ---------TPIEVLCKGYPS-EFATYLN---FCRSLRFDDKPDYSYLRQLFRNLFHRQG 281
Query: 640 EMSDLS---NGVKYGQS 653
D N +K+G S
Sbjct: 282 FSYDYVFDWNMLKFGAS 298
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 167 bits (424), Expect = 1e-47
Identities = 53/217 (24%), Positives = 91/217 (41%), Gaps = 24/217 (11%)
Query: 362 FARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSG---------QGEREFRAEVEIIS 411
+ + ++G G V + + P K AVK + G + EV+I+
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 412 RVH-HRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKG 470
+V H +++ L + L+++ + L +L K L + KI +
Sbjct: 65 KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALLEV 122
Query: 471 LAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLA 530
+ LH+ I+HRD+K NIL+DD+ ++ DFG + D + V GT YLA
Sbjct: 123 ICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--REVCGTPSYLA 177
Query: 531 PEYASSGKLTDR------SDVFSFGVVLLELITGRKP 561
PE + D++S GV++ L+ G P
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 214
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 166 bits (422), Expect = 3e-47
Identities = 48/198 (24%), Positives = 90/198 (45%), Gaps = 7/198 (3%)
Query: 366 NVIGEGGFGCVYKGNLPEGKVVAVKQLK--SGSGQGEREFRAEVEIISRVHHRHLVSLVG 423
IGEG +G VYK G+ A+K+++ E+ I+ + H ++V L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 424 YCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKII 483
++K +L++E + + + +G LE L G+AY H+ +++
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCEGG--LESVTAKSFLLQLLNGIAYCHD---RRVL 122
Query: 484 HRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRS 543
HRD+K N+L++ E E ++ADFGLA+ + ++ + S K +
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTI 182
Query: 544 DVFSFGVVLLELITGRKP 561
D++S G + E++ G
Sbjct: 183 DIWSVGCIFAEMVNGTPL 200
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 165 bits (418), Expect = 1e-46
Identities = 51/305 (16%), Positives = 94/305 (30%), Gaps = 37/305 (12%)
Query: 365 ENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVG 423
IGEG FG +++G NL + VA+K S + R E + + V
Sbjct: 10 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVY 67
Query: 424 YCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKII 483
Y E ++ + +LE L G+ A + +HE ++
Sbjct: 68 YFGQEGLHNVLVIDLLGPSLEDLLDLCGRK-FSVKTVAMAAKQMLARVQSIHE---KSLV 123
Query: 484 HRDIKSANILVDDEFEAQ-----VADFGLAKL------NDTTQTHVSTRVMGTFGYLAPE 532
+RDIK N L+ V DFG+ K + GT Y++
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183
Query: 533 YASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSE 592
+ + R D+ + G V + + G P + ++ E G+ +
Sbjct: 184 THLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI----------GEKKQ 233
Query: 593 IVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEMSDLSNGVKYGQ 652
R E ++ + + P + + + +
Sbjct: 234 STPLRELCAGFPEEFYKYMH---YARNLAFDATPDYDYLQGLFS------KVLERLNTTE 284
Query: 653 STVYD 657
+D
Sbjct: 285 DENFD 289
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 6e-46
Identities = 48/203 (23%), Positives = 94/203 (46%), Gaps = 7/203 (3%)
Query: 362 FARENVIGEGGFGCVYKG-NLPEGKVVAVKQLK--SGSGQGEREFRAEVEIISRVHHRHL 418
F + IGEG +G VYK N G+VVA+K+++ + + E+ ++ ++H ++
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 419 VSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDC 478
V L+ +E L++EF+ + +L+ + + +GLA+ H
Sbjct: 64 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 479 HPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGK 538
++HRD+K N+L++ E ++ADFGLA+ + V+ +
Sbjct: 123 ---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 539 LTDRSDVFSFGVVLLELITGRKP 561
+ D++S G + E++T R
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRAL 202
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 7e-46
Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 11/205 (5%)
Query: 362 FARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGERE---FRAEVEIISRV-HHR 416
F ++G+G FG V+ + A+K LK + + E ++S H
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 417 HLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHE 476
L + +++N + E++ +L +H+ + + ++ A GL +LH
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFLHS 121
Query: 477 DCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASS 536
I++RD+K NIL+D + ++ADFG+ K N +T GT Y+APE
Sbjct: 122 ---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEILLG 177
Query: 537 GKLTDRSDVFSFGVVLLELITGRKP 561
K D +SFGV+L E++ G+ P
Sbjct: 178 QKYNHSVDWWSFGVLLYEMLIGQSP 202
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 163 bits (414), Expect = 8e-46
Identities = 49/204 (24%), Positives = 81/204 (39%), Gaps = 13/204 (6%)
Query: 362 FARENVIGEGGFGCVYKG-NLPEGKVVAVKQLK---SGSGQGEREFRAEVEIISRVHHRH 417
F +G G FG V+ + G+ A+K LK + E ++S V H
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 418 LVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHED 477
++ + G + +I +++ L L + K + L
Sbjct: 66 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV-----CLALEYL 120
Query: 478 CHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSG 537
II+RD+K NIL+D ++ DFG AK + GT Y+APE S+
Sbjct: 121 HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT----YTLCGTPDYIAPEVVSTK 176
Query: 538 KLTDRSDVFSFGVVLLELITGRKP 561
D +SFG+++ E++ G P
Sbjct: 177 PYNKSIDWWSFGILIYEMLAGYTP 200
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 2e-45
Identities = 48/217 (22%), Positives = 96/217 (44%), Gaps = 15/217 (6%)
Query: 354 ELMEITNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGERE-FRAEVEIIS 411
++ ++ + + IGEG +G V + VA+K++ Q + E++I+
Sbjct: 2 QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61
Query: 412 RVHHRHLVSLVGYCISE----KNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGA 467
R H +++ + + + + + +L L + L
Sbjct: 62 RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH---LSNDHICYFLYQI 118
Query: 468 AKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKL--NDTTQTHVSTRVMGT 525
+GL Y+H ++HRD+K +N+L++ + ++ DFGLA++ D T T + T
Sbjct: 119 LRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 175
Query: 526 FGYLAPEYASSGKLTDRS-DVFSFGVVLLELITGRKP 561
Y APE + K +S D++S G +L E+++ R
Sbjct: 176 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 212
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 4e-45
Identities = 50/213 (23%), Positives = 90/213 (42%), Gaps = 16/213 (7%)
Query: 366 NVIGEGGFGCVYKG--NLPEGKVVAVKQLKSGSGQGEREFRAEVEI-----ISRVHHRHL 418
IGEG +G V+K G+ VA+K+++ +G+ E+ + H ++
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 419 VSLVGYCIS----EKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYL 474
V L C + +L + + +L +L +P + + +GL +L
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132
Query: 475 HEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYA 534
H +++HRD+K NILV + ++ADFGLA++ T V+ T Y APE
Sbjct: 133 HSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTLWYRAPEVL 187
Query: 535 SSGKLTDRSDVFSFGVVLLELITGRKPVDPTQP 567
D++S G + E+ + +
Sbjct: 188 LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 220
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 1e-44
Identities = 51/215 (23%), Positives = 86/215 (40%), Gaps = 18/215 (8%)
Query: 358 ITNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLK------SGSGQGEREFRAEVEII 410
+ + + +G G F V K G A K +K S G + EV I+
Sbjct: 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 67
Query: 411 SRVHHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKG 470
+ H ++++L ++ + +LI E V L L K E +
Sbjct: 68 KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF-----LKQI 122
Query: 471 LAYLHEDCHPKIIHRDIKSANILVDDE----FEAQVADFGLAKLNDTTQTHVSTRVMGTF 526
L ++ +I H D+K NI++ D ++ DFGLA D + GT
Sbjct: 123 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTP 180
Query: 527 GYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKP 561
++APE + L +D++S GV+ L++G P
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 2e-43
Identities = 61/278 (21%), Positives = 102/278 (36%), Gaps = 32/278 (11%)
Query: 365 ENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRV-HHRHLVSLV 422
V+G G G V + N + A+K L+ + R EVE+ R H+V +V
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIV 71
Query: 423 GYC----ISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDC 478
K L++ E + L + +G + +I + + YLH
Sbjct: 72 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS-- 129
Query: 479 HPKIIHRDIKSANILVDDEFE---AQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYAS 535
I HRD+K N+L + ++ DFG AK + + + T Y+APE
Sbjct: 130 -INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYYVAPEVLG 186
Query: 536 SGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVD 595
K D++S GV++ L+ G P L P + I G
Sbjct: 187 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL-------AISPGMKTRIRMGQYE---F 236
Query: 596 PRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVR 633
P E V E+ +I ++ +R + + +
Sbjct: 237 PNPEWSEVSEEVKMLIR---NLLKTEPTQRMTITEFMN 271
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 6e-43
Identities = 52/203 (25%), Positives = 94/203 (46%), Gaps = 13/203 (6%)
Query: 366 NVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQG-----EREFRAEVEIISRVHHRHLV 419
+ +GEG F VYK + ++VA+K++K G R E++++ + H +++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 420 SLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCH 479
L+ + N L+++F+ + K L +GL YLH+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKA--YMLMTLQGLEYLHQHW- 120
Query: 480 PKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKL 539
I+HRD+K N+L+D+ ++ADFGLAK + + +V T Y APE ++
Sbjct: 121 --ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGARM 177
Query: 540 TD-RSDVFSFGVVLLELITGRKP 561
D+++ G +L EL+
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPF 200
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 1e-42
Identities = 50/215 (23%), Positives = 88/215 (40%), Gaps = 18/215 (8%)
Query: 358 ITNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGERE------FRAEVEII 410
+ + + ++G GGFG VY G + + VA+K ++ E EV ++
Sbjct: 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 411 SRVHHRH--LVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAA 468
+V ++ L+ + + +LI E + L+
Sbjct: 62 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVL 120
Query: 469 KGLAYLHEDCHPKIIHRDIKSANILVD-DEFEAQVADFGLAKLNDTTQTHVSTRVMGTFG 527
+ + + H ++HRDIK NIL+D + E ++ DFG L T T GT
Sbjct: 121 EAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY---TDFDGTRV 174
Query: 528 YLAPEYASSGKLTDRS-DVFSFGVVLLELITGRKP 561
Y PE+ + RS V+S G++L +++ G P
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 209
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 2e-42
Identities = 47/208 (22%), Positives = 89/208 (42%), Gaps = 8/208 (3%)
Query: 366 NVIGEGGFGCVYKG-NLPEGKVVAVKQLK--SGSGQGEREFRAEVEIISRVHHRHLVSLV 422
IGEG +G V+K N ++VA+K+++ E+ ++ + H+++V L
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 423 GYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKI 482
S+K L++EF + ++ G E K + L L +
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSF-----LFQLLKGLGFCHSRNV 122
Query: 483 IHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDR 542
+HRD+K N+L++ E ++A+FGLA+ S V+ + + +
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTS 182
Query: 543 SDVFSFGVVLLELITGRKPVDPTQPLGD 570
D++S G + EL +P+ P + D
Sbjct: 183 IDMWSAGCIFAELANAGRPLFPGNDVDD 210
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 2e-41
Identities = 55/209 (26%), Positives = 92/209 (44%), Gaps = 17/209 (8%)
Query: 362 FARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVS 420
+ VIG G FG VY+ G++VA+K++ Q +R E++I+ ++ H ++V
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 77
Query: 421 LVGYCISEKNR------LLIYEFVPNNNLEHHLH-GKGQPVLEWTKRVKIALGAAKGLAY 473
L + S + L+ ++VP H + + L + LAY
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 474 LHEDCHPKIIHRDIKSANILVD-DEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPE 532
+H I HRDIK N+L+D D ++ DFG AK + +V + + +
Sbjct: 138 IHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV-SYICSRYYRAPEL 193
Query: 533 YASSGKLTDRSDVFSFGVVLLELITGRKP 561
+ T DV+S G VL EL+ G+
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPI 222
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 5e-40
Identities = 49/206 (23%), Positives = 81/206 (39%), Gaps = 10/206 (4%)
Query: 360 NGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGERE---FRAEVEIISRVHH 415
N F ++G+G FG V G+ A+K L+ + E E ++ H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 416 RHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLH 475
L +L + + E+ L HL + E + A+ ++ L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY-----GAEIVSALE 119
Query: 476 EDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYAS 535
+++RDIK N+++D + ++ DFGL K + GT YLAPE
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLAPEVLE 178
Query: 536 SGKLTDRSDVFSFGVVLLELITGRKP 561
D + GVV+ E++ GR P
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 2e-39
Identities = 52/215 (24%), Positives = 100/215 (46%), Gaps = 20/215 (9%)
Query: 362 FARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQG--EREFRAEVEIISRVHHRHL 418
+ + IG+G FG V+K + G+ VA+K++ + + E++I+ + H ++
Sbjct: 12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71
Query: 419 VSLVGYCISEKNR--------LLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKG 470
V+L+ C ++ + L+++F ++ + + L KRV L
Sbjct: 72 VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML----- 126
Query: 471 LAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK---LNDTTQTHVSTRVMGTFG 527
L L+ KI+HRD+K+AN+L+ + ++ADFGLA+ L +Q + T + T
Sbjct: 127 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
Query: 528 YLAPEYASSGKL-TDRSDVFSFGVVLLELITGRKP 561
Y PE + D++ G ++ E+ T
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI 221
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 5e-39
Identities = 50/228 (21%), Positives = 97/228 (42%), Gaps = 23/228 (10%)
Query: 347 KSFFTYEELM----EITNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSG--SGQG 399
+S F +E+ E+ + +G G +G V + G VA+K+L S
Sbjct: 1 RSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELF 60
Query: 400 EREFRAEVEIISRVHHRHLVSLVGYCISEKNR------LLIYEFVPNNNLEHHLHGKGQP 453
+ E+ ++ + H +++ L+ ++ L+ F+ + + H K
Sbjct: 61 AKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK--- 117
Query: 454 VLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDT 513
L + + KGL Y+H HRD+K N+ V+++ E ++ DFGLA+ D+
Sbjct: 118 -LGEDRIQFLVYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQADS 173
Query: 514 TQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKP 561
T V+ + + + T D++S G ++ E+ITG+
Sbjct: 174 EMT---GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL 218
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 141 bits (355), Expect = 2e-37
Identities = 54/206 (26%), Positives = 79/206 (38%), Gaps = 13/206 (6%)
Query: 360 NGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGERE---FRAEVEIISRVHH 415
+ F R +G G FG V + G A+K L ++ E I+ V+
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 416 RHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLH 475
LV L N ++ E+V + HL G+ A YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLH 158
Query: 476 EDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYAS 535
+I+RD+K N+L+D + QV DFG AK + GT LAPE
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT----LCGTPEALAPEIIL 211
Query: 536 SGKLTDRSDVFSFGVVLLELITGRKP 561
S D ++ GV++ E+ G P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 2e-37
Identities = 55/213 (25%), Positives = 88/213 (41%), Gaps = 16/213 (7%)
Query: 360 NGFARENVIGEGGFGCVYKG----NLPEGKVVAVKQLK----SGSGQGEREFRAEVEIIS 411
F V+G G +G V+ GK+ A+K LK + R E +++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 412 RV-HHRHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKG 470
+ LV+L +E LI +++ L HL + + + + +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHE-----VQIYVGEI 138
Query: 471 LAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFGYLA 530
+ L II+RDIK NIL+D + DFGL+K +T + GT Y+A
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMA 198
Query: 531 PEYASSGK--LTDRSDVFSFGVVLLELITGRKP 561
P+ G D +S GV++ EL+TG P
Sbjct: 199 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 231
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 6e-35
Identities = 45/214 (21%), Positives = 89/214 (41%), Gaps = 19/214 (8%)
Query: 357 EITNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSG--SGQGEREFRAEVEIISRV 413
+ + IG G G V + + VA+K+L + + E+ ++ V
Sbjct: 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 73
Query: 414 HHRHLVSLVGYCISEK------NRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGA 467
+H++++SL+ +K + L+ E + N + + + +
Sbjct: 74 NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-----DHERMSYLLYQM 128
Query: 468 AKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVSTRVMGTFG 527
G+ +LH IHRD+K +NI+V + ++ DFGLA+ T+ T + T
Sbjct: 129 LCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY 183
Query: 528 YLAPEYASSGKLTDRSDVFSFGVVLLELITGRKP 561
Y APE + D++S G ++ E++ +
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKIL 217
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 130 bits (328), Expect = 5e-34
Identities = 46/227 (20%), Positives = 97/227 (42%), Gaps = 22/227 (9%)
Query: 347 KSFFTYEELM---EITNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGERE 402
+ ++ YE + + + +G G + V++ N+ + V VK LK +++
Sbjct: 19 REYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKK 75
Query: 403 FRAEVEIISRV-HHRHLVSLVGYCISEKNRL--LIYEFVPNNNLEHHLHGKGQPVLEWTK 459
+ E++I+ + ++++L +R L++E V N + + L
Sbjct: 76 IKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYD 130
Query: 460 RVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEF-EAQVADFGLAKLNDTTQTHV 518
K L Y H I+HRD+K N+++D E + ++ D+GLA+ Q +
Sbjct: 131 IRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY- 186
Query: 519 STRVMGTFGYLAPEYASSGKLTD-RSDVFSFGVVLLELITGRKPVDP 564
+ + + PE ++ D D++S G +L +I ++P
Sbjct: 187 -NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 232
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 2e-32
Identities = 49/224 (21%), Positives = 93/224 (41%), Gaps = 21/224 (9%)
Query: 350 FTYEEL----MEITNGFARENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSG--SGQGERE 402
F +EL E+ + + +G G +G V + G VAVK+L S +
Sbjct: 4 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 63
Query: 403 FRAEVEIISRVHHRHLVSLVGYC-----ISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEW 457
E+ ++ + H +++ L+ + E N + + + +L + + + L
Sbjct: 64 TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTD 120
Query: 458 TKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTH 517
+ +GL Y+H HRD+K +N+ V+++ E ++ DFGLA+ D T
Sbjct: 121 DHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDEMT- 176
Query: 518 VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKP 561
V + + D++S G ++ EL+TGR
Sbjct: 177 --GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 218
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 123 bits (310), Expect = 2e-31
Identities = 42/217 (19%), Positives = 77/217 (35%), Gaps = 20/217 (9%)
Query: 365 ENVIGEGGFGCVYKG-NLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVG 423
+G G F V+ ++ VA+K ++ E E++++ RV+
Sbjct: 18 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEA-AEDEIKLLQRVNDADNTKEDS 76
Query: 424 YCISEKNRLLIYEFVPNNNLEH--------------HLHGKGQPVLEWTKRVKIALGAAK 469
+ +LL + N H + + +I+
Sbjct: 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136
Query: 470 GLAYLHEDCHPKIIHRDIKSANILVD-DEFEAQVADFGLAKLNDTTQTHVSTR-VMGTFG 527
GL Y+H IIH DIK N+L++ + + +A L + + T
Sbjct: 137 GLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194
Query: 528 YLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDP 564
Y +PE +D++S ++ ELITG +P
Sbjct: 195 YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 231
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 108 bits (270), Expect = 1e-27
Identities = 28/154 (18%), Positives = 51/154 (33%), Gaps = 19/154 (12%)
Query: 366 NVIGEGGFGCVYKGNLPEGKVVAVKQLKSGS----------GQGEREFRAEVEIISRVHH 415
++GEG V+ + VK K G G+ F +R
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 416 RHLVSLVGYCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLH 475
R L L G + + +Y + N L + K + ++ + +A +
Sbjct: 66 RALQKLQGLAVPK-----VYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120
Query: 476 EDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK 509
I+H D+ N+LV + + DF +
Sbjct: 121 HRG---IVHGDLSQYNVLVSE-EGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 723 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.89 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.83 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.43 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.93 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.69 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.52 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.36 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-52 Score=430.34 Aligned_cols=256 Identities=27% Similarity=0.443 Sum_probs=200.5
Q ss_pred cCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEecC
Q 046750 360 NGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVP 439 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 439 (723)
++|++.+.||+|+||.||+|++.+++.||||+++... ...++|.+|+++|++|+|+|||+++|+|.+.+..+|||||+.
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 4688999999999999999999889999999997643 445689999999999999999999999999999999999999
Q ss_pred CCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCccee
Q 046750 440 NNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVS 519 (723)
Q Consensus 440 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 519 (723)
+|+|.++++... ..+.+..++.|+.|||+||+|||++ +|+|||||++||||++++.+||+|||+++..........
T Consensus 84 ~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~ 159 (263)
T d1sm2a_ 84 HGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 159 (263)
T ss_dssp TCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred CCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCceee
Confidence 999999987653 3588999999999999999999999 599999999999999999999999999987765544444
Q ss_pred ecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhhh
Q 046750 520 TRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLE 599 (723)
Q Consensus 520 ~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~ 599 (723)
....||..|+|||++.+..|+.++|||||||+||||+++..++..... ...+ .+.+..+.. +..+
T Consensus 160 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~--~~~~--------~~~i~~~~~--~~~p--- 224 (263)
T d1sm2a_ 160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--NSEV--------VEDISTGFR--LYKP--- 224 (263)
T ss_dssp -----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC--HHHH--------HHHHHHTCC--CCCC---
T ss_pred cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC--HHHH--------HHHHHhcCC--CCCc---
Confidence 456789999999999999999999999999999999996555433221 1111 122222211 1111
Q ss_pred ccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccC
Q 046750 600 KHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEG 639 (723)
Q Consensus 600 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~ 639 (723)
......+.+|+.+||+.||.+||+|+||++.|+++.
T Consensus 225 ----~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~ 260 (263)
T d1sm2a_ 225 ----RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260 (263)
T ss_dssp ----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 111236789999999999999999999999998754
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.1e-51 Score=431.56 Aligned_cols=258 Identities=26% Similarity=0.372 Sum_probs=215.5
Q ss_pred cCcccceEEeccCcEEEEEEEcC-CCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEec
Q 046750 360 NGFARENVIGEGGFGCVYKGNLP-EGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFV 438 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 438 (723)
++|++.+.||+|+||.||+|.+. +++.||||+++... ...++|++|+++|++|+|+|||+++++|.+.+..+|||||+
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~ 95 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 95 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecc
Confidence 57889999999999999999664 58899999997653 34568999999999999999999999999999999999999
Q ss_pred CCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcce
Q 046750 439 PNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHV 518 (723)
Q Consensus 439 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 518 (723)
.+|+|.++|.......+++..+++|+.||++||+|||++ +|||||||++||||++++.+||+|||+++.........
T Consensus 96 ~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~ 172 (287)
T d1opja_ 96 TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 172 (287)
T ss_dssp TTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEE
T ss_pred cCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCCcee
Confidence 999999999877667799999999999999999999999 59999999999999999999999999999776655555
Q ss_pred eecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhh
Q 046750 519 STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRL 598 (723)
Q Consensus 519 ~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l 598 (723)
.....|+..|+|||++.++.|+.++|||||||+||||++|..||..... ... +.+.+..+...
T Consensus 173 ~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~--~~~--------~~~~i~~~~~~------- 235 (287)
T d1opja_ 173 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQ--------VYELLEKDYRM------- 235 (287)
T ss_dssp ETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC--HHH--------HHHHHHTTCCC-------
T ss_pred eccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch--HHH--------HHHHHhcCCCC-------
Confidence 5556689999999999999999999999999999999998777654322 111 11222222111
Q ss_pred hccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCC
Q 046750 599 EKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGE 640 (723)
Q Consensus 599 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~ 640 (723)
.........+.+|+.+||+.||++||+|.||++.|+.+..
T Consensus 236 --~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 236 --ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred --CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1111223468899999999999999999999999987543
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-51 Score=427.97 Aligned_cols=255 Identities=28% Similarity=0.426 Sum_probs=210.6
Q ss_pred cCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEecC
Q 046750 360 NGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVP 439 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 439 (723)
++|++.+.||+|+||.||+|.+++++.||||+++... ...++|.+|+++|++|+|+|||+++|+|.+ +..+|||||+.
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~ 90 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME 90 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCC
Confidence 5788999999999999999999888999999997643 445679999999999999999999998865 56799999999
Q ss_pred CCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCccee
Q 046750 440 NNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVS 519 (723)
Q Consensus 440 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 519 (723)
+|+|.++++......+++..+++|+.||++||+|||++ +|||||||++||||++++.+||+|||+++..........
T Consensus 91 ~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~ 167 (272)
T d1qpca_ 91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR 167 (272)
T ss_dssp TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECC
T ss_pred CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCccccc
Confidence 99999988765555589999999999999999999998 599999999999999999999999999998765555445
Q ss_pred ecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhhh
Q 046750 520 TRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLE 599 (723)
Q Consensus 520 ~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~ 599 (723)
....|+..|||||++.++.++.++|||||||+||||++|..|+..... ... +.+.+..+....+ .
T Consensus 168 ~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~--~~~--------~~~~i~~~~~~~~-----p 232 (272)
T d1qpca_ 168 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--NPE--------VIQNLERGYRMVR-----P 232 (272)
T ss_dssp TTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHH--------HHHHHHTTCCCCC-----C
T ss_pred cccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC--HHH--------HHHHHHhcCCCCC-----c
Confidence 556789999999999999999999999999999999997666543321 111 1222333211111 0
Q ss_pred ccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhcc
Q 046750 600 KHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSE 638 (723)
Q Consensus 600 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~ 638 (723)
.. ....+.+|+.+||+.||++||+|.+|++.|+..
T Consensus 233 ~~----~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 233 DN----CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp TT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cc----ChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 11 223678899999999999999999999999863
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-50 Score=419.16 Aligned_cols=258 Identities=29% Similarity=0.494 Sum_probs=201.7
Q ss_pred cCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccC--CchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEe
Q 046750 360 NGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSG--SGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEF 437 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 437 (723)
++|.+.++||+|+||.||+|+++ ..||||+++.. .....+.|++|+++|++++|+|||++++++.+ ...+|||||
T Consensus 8 ~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey 84 (276)
T d1uwha_ 8 GQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQW 84 (276)
T ss_dssp TCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred ccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEec
Confidence 56889999999999999999874 36999998754 34455789999999999999999999998864 568999999
Q ss_pred cCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCc-
Q 046750 438 VPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQT- 516 (723)
Q Consensus 438 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~- 516 (723)
+++|+|.++|+.... .+++..++.|+.||++||+|||++ +|||||||++||||++++.+||+|||+++.......
T Consensus 85 ~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~ 160 (276)
T d1uwha_ 85 CEGSSLYHHLHIIET-KFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160 (276)
T ss_dssp CCEEEHHHHHHTSCC-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred CCCCCHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence 999999999975443 489999999999999999999998 599999999999999999999999999987654322
Q ss_pred ceeecccccccccChhhhcc---CCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccc
Q 046750 517 HVSTRVMGTFGYLAPEYASS---GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEI 593 (723)
Q Consensus 517 ~~~~~~~gt~~y~APE~~~~---~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~ 593 (723)
.......||+.|||||++.+ +.|+.++|||||||+||||++|+.||...... .. +...+..+.....
T Consensus 161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~--~~--------~~~~~~~~~~~p~ 230 (276)
T d1uwha_ 161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR--DQ--------IIFMVGRGYLSPD 230 (276)
T ss_dssp -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--HH--------HHHHHHHTSCCCC
T ss_pred ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH--HH--------HHHHHhcCCCCCc
Confidence 23345679999999999964 35899999999999999999999999764321 11 1111222211111
Q ss_pred cchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccC
Q 046750 594 VDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEG 639 (723)
Q Consensus 594 vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~ 639 (723)
+ ..........+.+|+.+||+.||.+||+|.||++.|+.+.
T Consensus 231 ~-----~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~ 271 (276)
T d1uwha_ 231 L-----SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271 (276)
T ss_dssp G-----GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred c-----hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1 0111122346889999999999999999999999998754
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.3e-50 Score=426.15 Aligned_cols=256 Identities=29% Similarity=0.445 Sum_probs=197.8
Q ss_pred cCcccceEEeccCcEEEEEEEcCC-C---cEEEEEEcccCCc-hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLPE-G---KVVAVKQLKSGSG-QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLI 434 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~~-g---~~VAvK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 434 (723)
++|++.++||+|+||.||+|+++. + ..||||++..... ...++|.+|+++|++|+|+|||+++|+|.+.+..+||
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 456778999999999999997643 3 2589999876533 3456799999999999999999999999999999999
Q ss_pred EEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCC
Q 046750 435 YEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTT 514 (723)
Q Consensus 435 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 514 (723)
|||+.+|+|.+++..... .+++..+++|+.||++||+|||++ +|||||||++||||+.++.+||+|||+++.....
T Consensus 106 ~Ey~~~g~L~~~~~~~~~-~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQNDG-QFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp EECCTTEEHHHHHHTTTT-CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEecCCCcceeeeccccC-CCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEccCC
Confidence 999999999998876433 589999999999999999999998 5999999999999999999999999999876543
Q ss_pred Ccce----eecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCC
Q 046750 515 QTHV----STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGD 589 (723)
Q Consensus 515 ~~~~----~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~ 589 (723)
.... .....|+..|||||++.++.++.++|||||||+||||++ |+.||..... ..+ ...+..+.
T Consensus 182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~---~~~--------~~~i~~~~ 250 (299)
T d1jpaa_ 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN---QDV--------INAIEQDY 250 (299)
T ss_dssp --------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHH--------HHHHHTTC
T ss_pred CCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH---HHH--------HHHHHcCC
Confidence 3221 122457899999999999999999999999999999998 8999975431 111 12222221
Q ss_pred cccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccC
Q 046750 590 LSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEG 639 (723)
Q Consensus 590 l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~ 639 (723)
.. .........+.+|+.+||+.||.+||+|.||++.|+.+.
T Consensus 251 ~~---------~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l 291 (299)
T d1jpaa_ 251 RL---------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI 291 (299)
T ss_dssp CC---------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CC---------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 11 111122346889999999999999999999999998754
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-50 Score=416.44 Aligned_cols=252 Identities=21% Similarity=0.315 Sum_probs=202.0
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCc-hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEe
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSG-QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEF 437 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 437 (723)
++|++.++||+|+||.||+|.. .+|+.||||+++.... +..+.+++|+++|++|+|+|||++++++.+.+..||||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 5799999999999999999955 5689999999875432 3345689999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCC-c
Q 046750 438 VPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ-T 516 (723)
Q Consensus 438 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~-~ 516 (723)
+.+|+|.++|.... .+++..+..|+.||+.||+|||++ +||||||||+||||++++.+||+|||+|+...... .
T Consensus 85 ~~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 85 CSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp CTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred cCCCcHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 99999999997544 588999999999999999999999 59999999999999999999999999998764332 2
Q ss_pred ceeecccccccccChhhhccCCC-CCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccc
Q 046750 517 HVSTRVMGTFGYLAPEYASSGKL-TDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVD 595 (723)
Q Consensus 517 ~~~~~~~gt~~y~APE~~~~~~~-t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd 595 (723)
......+||+.|||||++.+..+ +.++|||||||+||||++|+.||....... ..+..+ .........
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~-~~~~~~---------~~~~~~~~~- 228 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDW---------KEKKTYLNP- 228 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS-HHHHHH---------HTTCTTSTT-
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH-HHHHHH---------hcCCCCCCc-
Confidence 23345679999999999988876 578999999999999999999997654321 111111 111110000
Q ss_pred hhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 596 PRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 596 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
...+ ...+.+|+.+||+.||++||++.||++.
T Consensus 229 ---~~~~----s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 229 ---WKKI----DSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp ---GGGS----CHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ---cccC----CHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0111 2356788999999999999999998763
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-49 Score=416.79 Aligned_cols=249 Identities=21% Similarity=0.363 Sum_probs=206.1
Q ss_pred cCcccceEEeccCcEEEEEEE-cCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEec
Q 046750 360 NGFARENVIGEGGFGCVYKGN-LPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFV 438 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~-~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 438 (723)
++|++.+.||+|+||.||+|. ..+|+.||||+++.......+.+.+|+++|++++|+|||+++++|.+.+..||||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 469999999999999999995 4579999999997655555678999999999999999999999999999999999999
Q ss_pred CCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcce
Q 046750 439 PNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHV 518 (723)
Q Consensus 439 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 518 (723)
.+|+|.+++.++ .+++..+..|+.||+.||+|||++ +||||||||+||||+.++++||+|||+++.+..... .
T Consensus 100 ~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-~ 172 (293)
T d1yhwa1 100 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 172 (293)
T ss_dssp TTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-C
T ss_pred CCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccccc-c
Confidence 999999988654 388999999999999999999999 599999999999999999999999999987654332 2
Q ss_pred eecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhh
Q 046750 519 STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRL 598 (723)
Q Consensus 519 ~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l 598 (723)
....+||+.|+|||++.++.|+.++|||||||+||||++|+.||..... ... +...+..+.. .+.
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~---~~~-------~~~~~~~~~~-~~~---- 237 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP---LRA-------LYLIATNGTP-ELQ---- 237 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHH-------HHHHHHHCSC-CCS----
T ss_pred ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH---HHH-------HHHHHhCCCC-CCC----
Confidence 3445799999999999999999999999999999999999999965431 111 1111111111 110
Q ss_pred hccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 046750 599 EKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVR 633 (723)
Q Consensus 599 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~ 633 (723)
........+.+|+.+||+.||.+||++.||++
T Consensus 238 ---~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 238 ---NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp ---SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ---CcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01111235788999999999999999999976
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-50 Score=415.48 Aligned_cols=253 Identities=23% Similarity=0.402 Sum_probs=213.1
Q ss_pred cCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEecC
Q 046750 360 NGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVP 439 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 439 (723)
++|++.++||+|+||.||+|++++++.||||+++... ...++|++|++++++++|+|||+++|+|.+.+..++||||+.
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 5789999999999999999999888899999998654 345689999999999999999999999999999999999999
Q ss_pred CCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCccee
Q 046750 440 NNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVS 519 (723)
Q Consensus 440 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 519 (723)
+|+|.+++..... .+.+..+++|+.||++||+|||++ +|+|||||++||||++++.+||+|||+++..........
T Consensus 83 ~g~l~~~~~~~~~-~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 158 (258)
T d1k2pa_ 83 NGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 158 (258)
T ss_dssp TEEHHHHHHSGGG-CCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCC
T ss_pred CCcHHHhhhcccc-CCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCceee
Confidence 9999998765433 478889999999999999999998 599999999999999999999999999987765555555
Q ss_pred ecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhh
Q 046750 520 TRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRL 598 (723)
Q Consensus 520 ~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l 598 (723)
....|+..|+|||++.+..++.|+|||||||+||||++ |+.||..... .. +.+.+..+.. +..+
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~---~~--------~~~~i~~~~~--~~~p-- 223 (258)
T d1k2pa_ 159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN---SE--------TAEHIAQGLR--LYRP-- 223 (258)
T ss_dssp CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH---HH--------HHHHHHTTCC--CCCC--
T ss_pred cccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH---HH--------HHHHHHhCCC--CCCc--
Confidence 55679999999999999999999999999999999998 8999975431 11 1222333221 1111
Q ss_pred hccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhc
Q 046750 599 EKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDS 637 (723)
Q Consensus 599 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~ 637 (723)
......+.+|+.+||+.||.+||++.+|++.|.+
T Consensus 224 -----~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 224 -----HLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp -----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred -----ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 1122368899999999999999999999999864
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-50 Score=413.67 Aligned_cols=245 Identities=25% Similarity=0.443 Sum_probs=204.4
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccC---CchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSG---SGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 435 (723)
++|++.+.||+|+||.||+|+. .+++.||||++... .....+.+.+|+++|++++|+|||++++++.+.+..||||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 5699999999999999999965 56899999998643 1233467899999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ 515 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 515 (723)
||+.+|+|.++|.... .+++..+..|+.||++||+|||++ +||||||||+||||++++.+||+|||+++......
T Consensus 86 Ey~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~ 160 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 160 (263)
T ss_dssp ECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC
T ss_pred eecCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCCc
Confidence 9999999999997654 488999999999999999999999 59999999999999999999999999998654332
Q ss_pred cceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccc
Q 046750 516 THVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVD 595 (723)
Q Consensus 516 ~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd 595 (723)
.....||+.|||||++.+..|+.++|||||||+||||++|+.||..... .. +.+.+..+.+.
T Consensus 161 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~---~~--------~~~~i~~~~~~---- 222 (263)
T d2j4za1 161 ---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY---QE--------TYKRISRVEFT---- 222 (263)
T ss_dssp ---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH---HH--------HHHHHHTTCCC----
T ss_pred ---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH---HH--------HHHHHHcCCCC----
Confidence 2346799999999999999999999999999999999999999975431 11 11222222221
Q ss_pred hhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 046750 596 PRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVR 633 (723)
Q Consensus 596 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~ 633 (723)
+... ....+.+|+.+||+.||.+||++.||++
T Consensus 223 --~p~~----~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 223 --FPDF----VTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp --CCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CCcc----CCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 1111 1235778999999999999999999986
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-50 Score=418.90 Aligned_cols=259 Identities=28% Similarity=0.425 Sum_probs=201.9
Q ss_pred cCcccceEEeccCcEEEEEEEcCCC-----cEEEEEEcccCCch-hHHHHHHHHHHHHHccCCceeeEeeeeecccceEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLPEG-----KVVAVKQLKSGSGQ-GEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLL 433 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~~g-----~~VAvK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 433 (723)
..|++.++||+|+||.||+|.++.. ..||||+++..... ...+|++|+++|++|+|+|||+++|+|.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4688999999999999999976542 36999999765333 34578999999999999999999999999999999
Q ss_pred EEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCC
Q 046750 434 IYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDT 513 (723)
Q Consensus 434 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 513 (723)
||||+.+++|.+++.... ..+.+..+++|+.||+.||+|||++ +|||||||++||||+.++.+||+|||+++....
T Consensus 87 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp EEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccC
Confidence 999999999998876543 3589999999999999999999998 599999999999999999999999999987654
Q ss_pred CCcc--eeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcc
Q 046750 514 TQTH--VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLS 591 (723)
Q Consensus 514 ~~~~--~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~ 591 (723)
.... ......||..|||||++.++.++.++|||||||+||||++|..++..... ... +.+.+..+...
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~--~~~--------~~~~i~~~~~~ 232 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS--NHE--------VMKAINDGFRL 232 (283)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHH--------HHHHHHTTCCC
T ss_pred CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC--HHH--------HHHHHhccCCC
Confidence 3322 23345689999999999999999999999999999999997766643321 111 12223333211
Q ss_pred cccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCCC
Q 046750 592 EIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGEM 641 (723)
Q Consensus 592 ~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~~ 641 (723)
.........+.+|+.+||+.||++||+|.||++.|+.+...
T Consensus 233 ---------~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 233 ---------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp ---------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ---------CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 11112234688999999999999999999999999876543
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-50 Score=418.99 Aligned_cols=257 Identities=27% Similarity=0.424 Sum_probs=205.1
Q ss_pred cCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEecC
Q 046750 360 NGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVP 439 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 439 (723)
++|++.+.||+|+||.||+|++++++.||||+++... ...+.|.+|+++|++++|+|||+++|+|.+ +..++||||+.
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence 5799999999999999999999888899999997543 445689999999999999999999999864 56899999999
Q ss_pred CCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCccee
Q 046750 440 NNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHVS 519 (723)
Q Consensus 440 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 519 (723)
+|+|..++.......++|..+++|+.||+.||+|||++ +|+|||||++||||++++++||+|||+++..........
T Consensus 95 ~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 171 (285)
T d1fmka3 95 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 171 (285)
T ss_dssp TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred CCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCceee
Confidence 99999998765555689999999999999999999999 599999999999999999999999999987765544444
Q ss_pred ecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchhhh
Q 046750 520 TRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPRLE 599 (723)
Q Consensus 520 ~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~ 599 (723)
....|+..|+|||++..+.++.++|||||||+||||++|..|+..... ...+.. .+..+....
T Consensus 172 ~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~--~~~~~~--------~i~~~~~~~------- 234 (285)
T d1fmka3 172 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--NREVLD--------QVERGYRMP------- 234 (285)
T ss_dssp ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHH--------HHHTTCCCC-------
T ss_pred ccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC--HHHHHH--------HHHhcCCCC-------
Confidence 556799999999999999999999999999999999998777654332 122222 222221111
Q ss_pred ccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCC
Q 046750 600 KHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGE 640 (723)
Q Consensus 600 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~ 640 (723)
........+.+|+.+||+.||++||+|.+|++.|+....
T Consensus 235 --~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 235 --CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp --CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred --CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 111123368899999999999999999999999987553
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=414.09 Aligned_cols=253 Identities=21% Similarity=0.377 Sum_probs=194.8
Q ss_pred cCcccceEEeccCcEEEEEEE-cCCCcEEEEEEcccCC--chhHHHHHHHHHHHHHccCCceeeEeeeeec--ccceEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGN-LPEGKVVAVKQLKSGS--GQGEREFRAEVEIISRVHHRHLVSLVGYCIS--EKNRLLI 434 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~-~~~g~~VAvK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~~~lV 434 (723)
++|++.+.||+|+||.||+|+ ..+|+.||||+++... ....+.|.+|+++|++|+|+|||+++++|.+ .+.+|||
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 579999999999999999995 4578999999987653 2334568899999999999999999999865 4557999
Q ss_pred EEecCCCchhhccccC--CCCcchHHHHHHHHHHHHhhhchhcccC--CCceeecCCCCCcEEeCCCCcEEEeecccccc
Q 046750 435 YEFVPNNNLEHHLHGK--GQPVLEWTKRVKIALGAAKGLAYLHEDC--HPKIIHRDIKSANILVDDEFEAQVADFGLAKL 510 (723)
Q Consensus 435 ~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~g--~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 510 (723)
|||+.+|+|.+++.+. ....+++..++.|+.||+.||+|||+++ ..+||||||||+||||+.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998642 2346899999999999999999999874 12599999999999999999999999999987
Q ss_pred cCCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCc
Q 046750 511 NDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDL 590 (723)
Q Consensus 511 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l 590 (723)
...... ......||+.|||||++.+..|+.++|||||||+||||++|+.||..... .. +...+..+.+
T Consensus 164 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~---~~--------~~~~i~~~~~ 231 (269)
T d2java1 164 LNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KE--------LAGKIREGKF 231 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HH--------HHHHHHHTCC
T ss_pred cccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH---HH--------HHHHHHcCCC
Confidence 654332 23446799999999999999999999999999999999999999975431 11 2233334443
Q ss_pred ccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 046750 591 SEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVR 633 (723)
Q Consensus 591 ~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~ 633 (723)
..+- ..+. ..+.+|+.+||+.||.+||++.||++
T Consensus 232 ~~~~-----~~~s----~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 232 RRIP-----YRYS----DELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp CCCC-----TTSC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCC-----cccC----HHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 3221 1222 35788999999999999999999975
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-49 Score=414.72 Aligned_cols=252 Identities=23% Similarity=0.370 Sum_probs=205.4
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEec
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFV 438 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 438 (723)
+.|++.+.||+|+||.||+|+. .+++.||||+++.......+.|.+|+++|++|+|+|||+++++|.+.+..||||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 4689999999999999999964 568999999998776677778999999999999999999999999999999999999
Q ss_pred CCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcce
Q 046750 439 PNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHV 518 (723)
Q Consensus 439 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 518 (723)
.+|+|.+++.+... .+++..+..|+.||+.||.|||++ +||||||||+||||+.++.+||+|||+++...... ..
T Consensus 92 ~~g~L~~~~~~~~~-~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~ 166 (288)
T d2jfla1 92 AGGAVDAVMLELER-PLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QR 166 (288)
T ss_dssp TTEEHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HH
T ss_pred CCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCc-cc
Confidence 99999998765432 488999999999999999999999 59999999999999999999999999997543221 12
Q ss_pred eecccccccccChhhhc-----cCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccc
Q 046750 519 STRVMGTFGYLAPEYAS-----SGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEI 593 (723)
Q Consensus 519 ~~~~~gt~~y~APE~~~-----~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~ 593 (723)
.....||+.|||||++. ...|+.++|||||||+||||++|+.||...... + +...+..+....+
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~--~---------~~~~i~~~~~~~~ 235 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM--R---------VLLKIAKSEPPTL 235 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG--G---------HHHHHHHSCCCCC
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH--H---------HHHHHHcCCCCCC
Confidence 23457999999999984 455899999999999999999999999765321 1 1111222222111
Q ss_pred cchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 594 VDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 594 vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
.. .......+.+|+.+||+.||.+||++.||++.
T Consensus 236 ~~-------~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 236 AQ-------PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp SS-------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred Cc-------cccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11 11122367889999999999999999998763
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-49 Score=411.42 Aligned_cols=254 Identities=25% Similarity=0.418 Sum_probs=206.2
Q ss_pred cCcccceE-EeccCcEEEEEEEcC---CCcEEEEEEcccCCc-hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEE
Q 046750 360 NGFARENV-IGEGGFGCVYKGNLP---EGKVVAVKQLKSGSG-QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLI 434 (723)
Q Consensus 360 ~~f~~~~~-LG~G~fG~Vy~~~~~---~g~~VAvK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 434 (723)
++|.+.+. ||+|+||.||+|.++ ++..||||+++.... ...++|++|+++|++|+|+|||+++|+|.+ +..|||
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 45677775 999999999999653 345799999976543 345679999999999999999999999875 468999
Q ss_pred EEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCC
Q 046750 435 YEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTT 514 (723)
Q Consensus 435 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 514 (723)
|||+++|+|.+++.... ..+++..+++|+.||++||+|||++ +|||||||++||||+.++.+||+|||+++.....
T Consensus 87 mE~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp EECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEeCCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccccc
Confidence 99999999999986543 3589999999999999999999998 5999999999999999999999999999877654
Q ss_pred Ccce--eecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcc
Q 046750 515 QTHV--STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLS 591 (723)
Q Consensus 515 ~~~~--~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~ 591 (723)
.... .....||..|||||++.++.++.++|||||||+||||++ |+.||..... .. +...+..+...
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~---~~--------~~~~i~~~~~~ 231 (285)
T d1u59a_ 163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PE--------VMAFIEQGKRM 231 (285)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT---HH--------HHHHHHTTCCC
T ss_pred ccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH---HH--------HHHHHHcCCCC
Confidence 3322 233468999999999999999999999999999999998 8999975432 11 12233333322
Q ss_pred cccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhcc
Q 046750 592 EIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSE 638 (723)
Q Consensus 592 ~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~ 638 (723)
++ .......+.+|+.+||+.||++||+|.+|++.|+..
T Consensus 232 ~~---------p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 232 EC---------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp CC---------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC---------CCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 21 112234678999999999999999999999998754
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-49 Score=422.46 Aligned_cols=255 Identities=25% Similarity=0.381 Sum_probs=204.9
Q ss_pred cCcccceEEeccCcEEEEEEEcCC-C-----cEEEEEEcccC-CchhHHHHHHHHHHHHHc-cCCceeeEeeeeecccce
Q 046750 360 NGFARENVIGEGGFGCVYKGNLPE-G-----KVVAVKQLKSG-SGQGEREFRAEVEIISRV-HHRHLVSLVGYCISEKNR 431 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~~-g-----~~VAvK~l~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~ 431 (723)
++|++.++||+|+||.||+|++.. + ..||||++... .......|.+|+.+|.++ +|+|||+++++|.+.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 578999999999999999996532 2 36999998654 334456789999999998 899999999999999999
Q ss_pred EEEEEecCCCchhhccccCCC---------------------CcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCC
Q 046750 432 LLIYEFVPNNNLEHHLHGKGQ---------------------PVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSA 490 (723)
Q Consensus 432 ~lV~E~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~ 490 (723)
||||||+++|+|.++|+.+.. ..+++..++.|+.||++||+|||++ +||||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchh
Confidence 999999999999999975432 3478999999999999999999999 5999999999
Q ss_pred cEEeCCCCcEEEeecccccccCCCCcc-eeecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCC
Q 046750 491 NILVDDEFEAQVADFGLAKLNDTTQTH-VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPL 568 (723)
Q Consensus 491 NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~ 568 (723)
||||+.++.+||+|||+|+........ ......||+.|||||++.++.++.++|||||||+||||++ |+.||......
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999999866544333 2345668999999999999999999999999999999997 89999764421
Q ss_pred CchhhHHhhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHh
Q 046750 569 GDESLVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALD 636 (723)
Q Consensus 569 ~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~ 636 (723)
..+ .+.+..+.. ..........+.+|+.+||+.||++||+|+||+++|.
T Consensus 274 --~~~--------~~~~~~~~~---------~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 274 --ANF--------YKLIQNGFK---------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp --HHH--------HHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred --HHH--------HHHHhcCCC---------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 111 122222211 0111112346889999999999999999999999995
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-49 Score=421.39 Aligned_cols=201 Identities=27% Similarity=0.464 Sum_probs=177.0
Q ss_pred hcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCC-chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEE
Q 046750 359 TNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS-GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYE 436 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 436 (723)
.++|++.++||+|+||.||+|+. .+|+.||||+++... ......+.+|+++|++|+|+|||+++++|.+..+.|||||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 46899999999999999999964 578999999997653 3334678999999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCc
Q 046750 437 FVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQT 516 (723)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 516 (723)
|+.+|+|.+++.+.+ .+.+..+..++.||+.||.|||++. +||||||||+||||++++++||+|||+|+.....
T Consensus 85 y~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-- 158 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 158 (322)
T ss_dssp CCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred cCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHhC--CEEccccCHHHeeECCCCCEEEeeCCCccccCCC--
Confidence 999999999997654 3889999999999999999999742 4999999999999999999999999999865322
Q ss_pred ceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCC
Q 046750 517 HVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQ 566 (723)
Q Consensus 517 ~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~ 566 (723)
.....+||..|||||++.+..|+.++||||||||||||++|+.||....
T Consensus 159 -~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~ 207 (322)
T d1s9ja_ 159 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207 (322)
T ss_dssp -TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred -ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 2234679999999999999999999999999999999999999997654
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-48 Score=402.62 Aligned_cols=246 Identities=26% Similarity=0.424 Sum_probs=195.9
Q ss_pred ccceEEeccCcEEEEEEEc-CCCcEEEEEEcccC--CchhHHHHHHHHHHHHHccCCceeeEeeeeec----ccceEEEE
Q 046750 363 ARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSG--SGQGEREFRAEVEIISRVHHRHLVSLVGYCIS----EKNRLLIY 435 (723)
Q Consensus 363 ~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~----~~~~~lV~ 435 (723)
++.+.||+|+||.||+|.. .+++.||||++... .....+.|.+|+++|++|+|+|||+++++|.+ ...+||||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 5667899999999999954 56889999998654 33344678999999999999999999999865 34579999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeC-CCCcEEEeecccccccCCC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVD-DEFEAQVADFGLAKLNDTT 514 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~-~~~~vkL~DFGla~~~~~~ 514 (723)
||+.+|+|.+++.+.. .+++..++.|+.||++||+|||+++ .+||||||||+||||+ +++.+||+|||+++.....
T Consensus 92 E~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~ 168 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 168 (270)
T ss_dssp ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred eCCCCCcHHHHHhccc--cccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC
Confidence 9999999999997654 4889999999999999999999982 2399999999999996 5789999999999865432
Q ss_pred CcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCccccc
Q 046750 515 QTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIV 594 (723)
Q Consensus 515 ~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~v 594 (723)
. ....+||+.|||||++.+ .++.++|||||||+||||++|+.||..... ... +.+.+..+....
T Consensus 169 ~---~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~--~~~--------~~~~i~~~~~~~-- 232 (270)
T d1t4ha_ 169 F---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQ--------IYRRVTSGVKPA-- 232 (270)
T ss_dssp S---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--HHH--------HHHHHTTTCCCG--
T ss_pred c---cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc--HHH--------HHHHHHcCCCCc--
Confidence 2 234679999999998865 699999999999999999999999965432 111 122232222111
Q ss_pred chhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 046750 595 DPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVR 633 (723)
Q Consensus 595 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~ 633 (723)
.+.... ...+.+|+.+||+.||++||++.||++
T Consensus 233 --~~~~~~----~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 233 --SFDKVA----IPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp --GGGGCC----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --ccCccC----CHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 111122 225778999999999999999999986
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-49 Score=410.21 Aligned_cols=246 Identities=26% Similarity=0.402 Sum_probs=197.9
Q ss_pred eEEeccCcEEEEEEEcCC---CcEEEEEEcccCC--chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEecCC
Q 046750 366 NVIGEGGFGCVYKGNLPE---GKVVAVKQLKSGS--GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEFVPN 440 (723)
Q Consensus 366 ~~LG~G~fG~Vy~~~~~~---g~~VAvK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 440 (723)
++||+|+||.||+|.+.+ ++.||||+++... ....++|.+|+++|++|+|+|||+++|+|.+ +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999996543 4689999997542 2334679999999999999999999999965 467899999999
Q ss_pred CchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcce--
Q 046750 441 NNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHV-- 518 (723)
Q Consensus 441 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~-- 518 (723)
|+|.++++... .+++..+++|+.||++||+|||++ +|||||||++||||+.++.+||+|||+++.........
T Consensus 92 g~L~~~l~~~~--~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 166 (277)
T d1xbba_ 92 GPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 166 (277)
T ss_dssp EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred CcHHHHHhhcc--CCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence 99999997654 489999999999999999999998 59999999999999999999999999998765443332
Q ss_pred eecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchh
Q 046750 519 STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPR 597 (723)
Q Consensus 519 ~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~ 597 (723)
.....||..|||||++.++.++.++|||||||+||||++ |+.||..... .. +...+..+....+
T Consensus 167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~---~~--------~~~~i~~~~~~~~---- 231 (277)
T d1xbba_ 167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SE--------VTAMLEKGERMGC---- 231 (277)
T ss_dssp ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HH--------HHHHHHTTCCCCC----
T ss_pred ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH---HH--------HHHHHHcCCCCCC----
Confidence 233568999999999999999999999999999999998 8999975431 11 1222333322111
Q ss_pred hhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhc
Q 046750 598 LEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDS 637 (723)
Q Consensus 598 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~ 637 (723)
.......+.+|+.+||+.||.+||+|.+|++.|+.
T Consensus 232 -----p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 232 -----PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp -----CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred -----CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 11123467889999999999999999999998865
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.1e-48 Score=419.57 Aligned_cols=253 Identities=23% Similarity=0.324 Sum_probs=208.5
Q ss_pred hcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEe
Q 046750 359 TNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEF 437 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 437 (723)
.++|++.++||+|+||.||+|+. .+|+.||||++........+.+++|+++|++|+|+|||+++++|.+.+..||||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 46899999999999999999954 57899999999877666667899999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeC--CCCcEEEeecccccccCCCC
Q 046750 438 VPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVD--DEFEAQVADFGLAKLNDTTQ 515 (723)
Q Consensus 438 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~--~~~~vkL~DFGla~~~~~~~ 515 (723)
|.+|+|.++|..... .+++..++.|+.||+.||+|||++ +||||||||+||||+ .++.+||+|||+++.+....
T Consensus 105 ~~gg~L~~~l~~~~~-~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 105 MSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CCSCBHHHHHTCTTS-CBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred CCCCCHHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 999999999865432 489999999999999999999999 599999999999996 46789999999998765443
Q ss_pred cceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccc
Q 046750 516 THVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVD 595 (723)
Q Consensus 516 ~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd 595 (723)
. .....||+.|||||++.+..|+.++|||||||+||||++|+.||..... . + +.+.+..+.... +
T Consensus 181 ~--~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~---~---~-----~~~~i~~~~~~~--~ 245 (350)
T d1koaa2 181 S--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND---D---E-----TLRNVKSCDWNM--D 245 (350)
T ss_dssp C--EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH---H---H-----HHHHHHHTCCCS--C
T ss_pred c--cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH---H---H-----HHHHHHhCCCCC--C
Confidence 3 3345799999999999999999999999999999999999999975431 1 1 112222222110 1
Q ss_pred hhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 596 PRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 596 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
......+ ...+.+|+.+||+.||.+||++.||++.
T Consensus 246 ~~~~~~~----s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 246 DSAFSGI----SEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp CGGGGGC----CHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred cccccCC----CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111111 2357889999999999999999999885
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-49 Score=415.28 Aligned_cols=249 Identities=21% Similarity=0.332 Sum_probs=203.0
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccC---CchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSG---SGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 435 (723)
++|++.++||+|+||.||+|+. .+|+.||||+++.. .....+.+.+|+++|++|+|+|||+++++|.+.+..||||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 5699999999999999999965 57899999998643 1233467899999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ 515 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 515 (723)
||+.+|+|.+++...+ .+++..++.++.||+.||+|||++ +||||||||+||||++++.+||+|||+++.+....
T Consensus 88 Ey~~gg~L~~~~~~~~--~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EccCCCCHHHhhhccC--CCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCC
Confidence 9999999999987654 488999999999999999999999 59999999999999999999999999998765433
Q ss_pred c-ceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCccccc
Q 046750 516 T-HVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIV 594 (723)
Q Consensus 516 ~-~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~v 594 (723)
. ......+||+.|||||++.+..|+.++|||||||+||||++|+.||..... .. +.+.+..+.+.
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---~~--------~~~~i~~~~~~--- 228 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE---YL--------IFQKIIKLEYD--- 228 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HH--------HHHHHHTTCCC---
T ss_pred cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH---HH--------HHHHHHcCCCC---
Confidence 2 223446799999999999999999999999999999999999999975431 11 12223333221
Q ss_pred chhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 595 DPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 595 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
+...+ ...+.+|+.+||+.||.+||+++|+++.
T Consensus 229 ---~p~~~----s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 229 ---FPEKF----FPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp ---CCTTC----CHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred ---CCccC----CHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 11112 2357889999999999999999987543
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.3e-48 Score=417.52 Aligned_cols=253 Identities=20% Similarity=0.291 Sum_probs=208.5
Q ss_pred hcCcccceEEeccCcEEEEEEE-cCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEe
Q 046750 359 TNGFARENVIGEGGFGCVYKGN-LPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEF 437 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 437 (723)
.++|++.++||+|+||.||+|. ..+|+.||||+++.......+.+++|+++|++|+|+|||+++++|.+++.+||||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 3579999999999999999995 467999999999876656667789999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeC--CCCcEEEeecccccccCCCC
Q 046750 438 VPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVD--DEFEAQVADFGLAKLNDTTQ 515 (723)
Q Consensus 438 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~--~~~~vkL~DFGla~~~~~~~ 515 (723)
|.+|+|.+++.... ..+++..++.|+.||+.||+|||++ +||||||||+||||+ +++.+||+|||+++.+....
T Consensus 108 ~~gg~L~~~~~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 108 LSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp CCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCCChHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 99999998876543 2489999999999999999999999 599999999999998 67899999999998775433
Q ss_pred cceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccc
Q 046750 516 THVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVD 595 (723)
Q Consensus 516 ~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd 595 (723)
. .....|+..|||||++.+..|+.++|||||||+||||++|+.||..... .. +...+..+.+.- .
T Consensus 184 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~---~~--------~~~~i~~~~~~~--~ 248 (352)
T d1koba_ 184 I--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD---LE--------TLQNVKRCDWEF--D 248 (352)
T ss_dssp C--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH---HH--------HHHHHHHCCCCC--C
T ss_pred c--eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH---HH--------HHHHHHhCCCCC--C
Confidence 2 3445699999999999999999999999999999999999999975431 11 112222222210 0
Q ss_pred hhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 596 PRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 596 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
..+... ....+.+|+.+||+.||.+||++.||++.
T Consensus 249 ~~~~~~----~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 249 EDAFSS----VSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp SSTTTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cccccC----CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 011111 22357889999999999999999999874
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-48 Score=413.02 Aligned_cols=253 Identities=23% Similarity=0.341 Sum_probs=190.9
Q ss_pred HhcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCc-hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEE
Q 046750 358 ITNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSG-QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 358 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 435 (723)
+.+.|++.++||+|+||.||+|+. .+++.||||++..... .....+.+|+++|++|+|+|||+++++|.+++..||||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 457799999999999999999965 5689999999975432 23456889999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeC---CCCcEEEeecccccccC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVD---DEFEAQVADFGLAKLND 512 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~---~~~~vkL~DFGla~~~~ 512 (723)
||+.+|+|.++|...+ .+++..+..|+.||+.||+|||++ +||||||||+||||. +++.+||+|||+++...
T Consensus 87 E~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 87 QLVSGGELFDRIVEKG--FYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCCCSCBHHHHHHTCS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred eccCCCcHHHhhhccc--CCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 9999999999997654 489999999999999999999999 599999999999995 57899999999998664
Q ss_pred CCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCccc
Q 046750 513 TTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSE 592 (723)
Q Consensus 513 ~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~ 592 (723)
.... ....+||+.|||||++.+..|+.++|||||||+||||++|+.||..... ..+ ...+..+....
T Consensus 162 ~~~~--~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---~~~--------~~~i~~~~~~~ 228 (307)
T d1a06a_ 162 PGSV--LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND---AKL--------FEQILKAEYEF 228 (307)
T ss_dssp -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHH--------HHHHHTTCCCC
T ss_pred CCCe--eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH---HHH--------HHHHhccCCCC
Confidence 4322 2345799999999999999999999999999999999999999975431 111 11222222110
Q ss_pred ccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 593 IVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 593 ~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
+..+...+ ...+.+|+.+||+.||.+||++.||++.
T Consensus 229 --~~~~~~~~----s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 229 --DSPYWDDI----SDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp --CTTTTTTS----CHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred --CCccccCC----CHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 01111122 2357899999999999999999999884
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-48 Score=405.56 Aligned_cols=253 Identities=22% Similarity=0.316 Sum_probs=206.0
Q ss_pred HhcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCC------chhHHHHHHHHHHHHHccCCceeeEeeeeecccc
Q 046750 358 ITNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS------GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKN 430 (723)
Q Consensus 358 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~------~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 430 (723)
+.++|++.+.||+|+||.||+|+. .+|+.||||+++... ....+.|++|+++|++|+|+|||+++++|.+.+.
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 347899999999999999999965 578999999986532 1235679999999999999999999999999999
Q ss_pred eEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCC----cEEEeecc
Q 046750 431 RLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEF----EAQVADFG 506 (723)
Q Consensus 431 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~----~vkL~DFG 506 (723)
.|||||||.+|+|.++|...+ .+++..++.|+.||+.||+|||++ +|||||||++||||+.++ .+||+|||
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchh
Confidence 999999999999999997654 489999999999999999999999 599999999999998776 59999999
Q ss_pred cccccCCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhh
Q 046750 507 LAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIE 586 (723)
Q Consensus 507 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~ 586 (723)
+++....... .....|+..|+|||++.+..++.++|||||||+||||++|+.||..... .. +...+.
T Consensus 163 ~a~~~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---~~--------~~~~i~ 229 (293)
T d1jksa_ 163 LAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---QE--------TLANVS 229 (293)
T ss_dssp TCEECTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HH--------HHHHHH
T ss_pred hhhhcCCCcc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH---HH--------HHHHHH
Confidence 9987654332 2345689999999999999999999999999999999999999975431 11 111222
Q ss_pred cCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 587 TGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 587 ~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
.+... + ...+... ....+.+|+.+||+.||.+||++.||++.
T Consensus 230 ~~~~~-~-~~~~~~~----~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 230 AVNYE-F-EDEYFSN----TSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp TTCCC-C-CHHHHTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hcCCC-C-CchhcCC----CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 22211 0 0111111 12357789999999999999999999873
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.4e-48 Score=409.48 Aligned_cols=245 Identities=25% Similarity=0.421 Sum_probs=199.9
Q ss_pred cCcccceEEeccCcEEEEEEE-cCCCcEEEEEEcccCCch---hHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGN-LPEGKVVAVKQLKSGSGQ---GEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~-~~~g~~VAvK~l~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 435 (723)
+.|+..+.||+|+||.||+|+ ..+++.||||+++..... ..+.|.+|+++|++|+|+|||+++++|.+.+..||||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 349999999999999999995 567899999999765332 2356889999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ 515 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 515 (723)
|||.+|+|..++..+. .+++..++.|+.||+.||.|||++ +||||||||+||||++++.+||+|||+++.....
T Consensus 95 E~~~~g~l~~~~~~~~--~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~- 168 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (309)
T ss_dssp ECCSEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred EecCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCCC-
Confidence 9999999987665443 489999999999999999999999 5999999999999999999999999999865432
Q ss_pred cceeecccccccccChhhhcc---CCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCccc
Q 046750 516 THVSTRVMGTFGYLAPEYASS---GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSE 592 (723)
Q Consensus 516 ~~~~~~~~gt~~y~APE~~~~---~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~ 592 (723)
....||+.|||||++.+ +.|+.++|||||||+||||++|+.||..... . + .+ ..+..+....
T Consensus 169 ----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~---~---~----~~-~~i~~~~~~~ 233 (309)
T d1u5ra_ 169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---M---S----AL-YHIAQNESPA 233 (309)
T ss_dssp ----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---H---H----HH-HHHHHSCCCC
T ss_pred ----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH---H---H----HH-HHHHhCCCCC
Confidence 33569999999999864 4589999999999999999999999965421 0 0 01 1122222222
Q ss_pred ccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 046750 593 IVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVR 633 (723)
Q Consensus 593 ~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~ 633 (723)
+.+. .+ ...+.+|+.+||+.||.+||++.||++
T Consensus 234 ~~~~----~~----s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 234 LQSG----HW----SEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp CSCT----TS----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCC----CC----CHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 2111 12 236788999999999999999999986
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.2e-48 Score=406.56 Aligned_cols=258 Identities=26% Similarity=0.443 Sum_probs=209.5
Q ss_pred hcCcccceEEeccCcEEEEEEEcC------CCcEEEEEEcccCCch-hHHHHHHHHHHHHHccCCceeeEeeeeecccce
Q 046750 359 TNGFARENVIGEGGFGCVYKGNLP------EGKVVAVKQLKSGSGQ-GEREFRAEVEIISRVHHRHLVSLVGYCISEKNR 431 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~VAvK~l~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 431 (723)
.++|++.+.||+|+||.||+|+++ +++.||||+++..... ..++|.+|+++|++|+|+||++++++|.+.+..
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 91 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 91 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCce
Confidence 467999999999999999999753 4578999999765433 346799999999999999999999999999999
Q ss_pred EEEEEecCCCchhhccccCC----------------------CCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCC
Q 046750 432 LLIYEFVPNNNLEHHLHGKG----------------------QPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKS 489 (723)
Q Consensus 432 ~lV~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp 489 (723)
++||||+.+|+|.++|+... ...+.+..+++|+.||+.||+|||++ +|||||||+
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlKp 168 (301)
T d1lufa_ 92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLAT 168 (301)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEcc
Confidence 99999999999999986422 23478899999999999999999998 599999999
Q ss_pred CcEEeCCCCcEEEeecccccccCCCCcc-eeecccccccccChhhhccCCCCCccceechHHHHHHHHhCC-CCCCCCCC
Q 046750 490 ANILVDDEFEAQVADFGLAKLNDTTQTH-VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGR-KPVDPTQP 567 (723)
Q Consensus 490 ~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~-~P~~~~~~ 567 (723)
+||||+.++.+||+|||+++........ ......|+..|+|||++.+..|+.++||||||||||||++|. .||.....
T Consensus 169 ~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~ 248 (301)
T d1lufa_ 169 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 248 (301)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred cceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCH
Confidence 9999999999999999999865443332 234467889999999999999999999999999999999986 45654321
Q ss_pred CCchhhHHhhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccC
Q 046750 568 LGDESLVEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEG 639 (723)
Q Consensus 568 ~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~ 639 (723)
.. +...+..+....+- ......+.+|+.+||+.+|.+||+|.||++.|+++.
T Consensus 249 ---~e--------~~~~v~~~~~~~~p---------~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 249 ---EE--------VIYYVRDGNILACP---------ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp ---HH--------HHHHHHTTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ---HH--------HHHHHHcCCCCCCC---------ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 11 12233344432221 112236889999999999999999999999999864
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-48 Score=401.04 Aligned_cols=249 Identities=28% Similarity=0.471 Sum_probs=198.5
Q ss_pred cCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeec-ccceEEEEEec
Q 046750 360 NGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCIS-EKNRLLIYEFV 438 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~~~~lV~E~~ 438 (723)
++|++.++||+|+||.||+|++ .|+.||||+++.. ...++|++|+++|++|+|+|||+++|+|.+ .+.+||||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 4688899999999999999988 5789999999764 344679999999999999999999999865 45689999999
Q ss_pred CCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcce
Q 046750 439 PNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTHV 518 (723)
Q Consensus 439 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 518 (723)
.+|+|.++|+......+++..+++|+.||++||.|||+. +|||||||++|||++.++.+||+|||+++......
T Consensus 84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~--- 157 (262)
T d1byga_ 84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 157 (262)
T ss_dssp TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCCC---
Confidence 999999999766555689999999999999999999998 59999999999999999999999999998654322
Q ss_pred eecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccchh
Q 046750 519 STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVDPR 597 (723)
Q Consensus 519 ~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd~~ 597 (723)
....++..|+|||++.++.++.++|||||||+||||++ |+.||..... ..+.. .+..+...++
T Consensus 158 -~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~---~~~~~--------~i~~~~~~~~---- 221 (262)
T d1byga_ 158 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVP--------RVEKGYKMDA---- 221 (262)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG---GGHHH--------HHTTTCCCCC----
T ss_pred -ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH---HHHHH--------HHHcCCCCCC----
Confidence 22357899999999999999999999999999999998 6777764421 22222 2222222221
Q ss_pred hhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhcc
Q 046750 598 LEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSE 638 (723)
Q Consensus 598 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~ 638 (723)
.......+.+|+.+||+.||.+||+|.+|+++|+.+
T Consensus 222 -----~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 222 -----PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp -----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 111223678999999999999999999999999874
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-48 Score=400.70 Aligned_cols=255 Identities=25% Similarity=0.387 Sum_probs=196.3
Q ss_pred cCcccceEEeccCcEEEEEEEcCC----CcEEEEEEcccCCchh-HHHHHHHHHHHHHccCCceeeEeeeeecccceEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLPE----GKVVAVKQLKSGSGQG-EREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLI 434 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~~----g~~VAvK~l~~~~~~~-~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 434 (723)
++|++.++||+|+||.||+|.+.. +..||||+++...... .+.|.+|+++|++++|||||+++++|. ++..|+|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence 579999999999999999996533 3468999987654333 457999999999999999999999996 4678999
Q ss_pred EEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCC
Q 046750 435 YEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTT 514 (723)
Q Consensus 435 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 514 (723)
|||+.+|+|.+++.... ..+++..++.++.||++||+|||++ +|||||||++||||+.++.+||+|||+++.....
T Consensus 86 ~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~ 161 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161 (273)
T ss_dssp EECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EEeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccCC
Confidence 99999999999876543 3588999999999999999999999 5999999999999999999999999999876654
Q ss_pred CcceeecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccc
Q 046750 515 QTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEI 593 (723)
Q Consensus 515 ~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~ 593 (723)
.........||+.|+|||++.++.++.++|||||||+||||++ |..||...... . +...+..+....+
T Consensus 162 ~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~---~--------~~~~i~~~~~~~~ 230 (273)
T d1mp8a_ 162 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---D--------VIGRIENGERLPM 230 (273)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---G--------HHHHHHTTCCCCC
T ss_pred cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH---H--------HHHHHHcCCCCCC
Confidence 4444555678999999999999999999999999999999998 88888765421 1 1222333322111
Q ss_pred cchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccC
Q 046750 594 VDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEG 639 (723)
Q Consensus 594 vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~ 639 (723)
.......+.+|+.+||..||.+||++.||++.|+.+.
T Consensus 231 ---------~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 231 ---------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp ---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---------CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1112346889999999999999999999999998654
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=408.88 Aligned_cols=255 Identities=26% Similarity=0.440 Sum_probs=201.2
Q ss_pred cCcccceEEeccCcEEEEEEEcC-CCc----EEEEEEcccC-CchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLP-EGK----VVAVKQLKSG-SGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLL 433 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~----~VAvK~l~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 433 (723)
.+|+++++||+|+||.||+|.+. +|+ .||||+++.. ..+..++|++|+++|++|+|+|||+++|+|.+. ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 35999999999999999999653 443 5899988754 334567899999999999999999999999865 5788
Q ss_pred EEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCC
Q 046750 434 IYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDT 513 (723)
Q Consensus 434 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 513 (723)
|+||+.+|+|.+++.... ..+++..+++|+.||++||+|||++ +|||||||++||||+.++.+||+|||+++....
T Consensus 88 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EEECCTTCBHHHHHHHTS-SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EEEeccCCcccccccccc-cCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 899999999999887653 3588999999999999999999998 599999999999999999999999999987654
Q ss_pred CCcce-eecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcc
Q 046750 514 TQTHV-STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGDLS 591 (723)
Q Consensus 514 ~~~~~-~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~ 591 (723)
..... .....||..|||||++.++.|+.++|||||||+||||++ |+.||+..... . +...+..+...
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~---~--------~~~~i~~~~~~ 232 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---E--------ISSILEKGERL 232 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG---G--------HHHHHHHTCCC
T ss_pred ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH---H--------HHHHHHcCCCC
Confidence 43332 234568999999999999999999999999999999998 78888754321 1 11222222211
Q ss_pred cccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccC
Q 046750 592 EIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEG 639 (723)
Q Consensus 592 ~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~ 639 (723)
. ........+.+|+.+||+.||.+||++.||++.|+.+.
T Consensus 233 ~---------~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 233 P---------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271 (317)
T ss_dssp C---------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred C---------CCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence 1 11122346789999999999999999999999987653
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=405.78 Aligned_cols=270 Identities=24% Similarity=0.363 Sum_probs=202.6
Q ss_pred cCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHH--HHHHHHHHccCCceeeEeeeeeccc----ceEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFR--AEVEIISRVHHRHLVSLVGYCISEK----NRLL 433 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~--~Ei~il~~l~HpnIv~l~g~~~~~~----~~~l 433 (723)
..|...++||+|+||.||+|++ +|+.||||+++.. ..+++. .|+..+.+++|+|||+++++|.+.+ ..||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 5678889999999999999987 6899999999653 233443 4555556789999999999998654 4789
Q ss_pred EEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccC-----CCceeecCCCCCcEEeCCCCcEEEeecccc
Q 046750 434 IYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDC-----HPKIIHRDIKSANILVDDEFEAQVADFGLA 508 (723)
Q Consensus 434 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g-----~~~ivHrDIkp~NILl~~~~~vkL~DFGla 508 (723)
||||+.+|+|.++|++. .++|..+++++.+++.||+|||+.+ .++|||||||++||||++++.+||+|||++
T Consensus 79 v~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 99999999999999865 3889999999999999999999742 247999999999999999999999999999
Q ss_pred cccCCCCcc---eeecccccccccChhhhccCC------CCCccceechHHHHHHHHhCCCCCCCCCCCCch----hhHH
Q 046750 509 KLNDTTQTH---VSTRVMGTFGYLAPEYASSGK------LTDRSDVFSFGVVLLELITGRKPVDPTQPLGDE----SLVE 575 (723)
Q Consensus 509 ~~~~~~~~~---~~~~~~gt~~y~APE~~~~~~------~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~----~l~~ 575 (723)
+........ .....+||..|+|||++.+.. ++.|+|||||||+||||++|..+|......... ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence 876543332 223467999999999987643 567899999999999999999887543221110 0111
Q ss_pred hhhhhhhhhhhcCCcccccchhhhccc-cHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCC
Q 046750 576 WARPVLVRAIETGDLSEIVDPRLEKHY-VESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGE 640 (723)
Q Consensus 576 ~~~~~l~~~i~~~~l~~~vd~~l~~~~-~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~ 640 (723)
+....+.+.+..+.+ ++.+...+ ..+....|.+|+.+||+.||++||+|.||++.|+++.+
T Consensus 236 ~~~~~~~~~~~~~~~----~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 297 (303)
T d1vjya_ 236 PSVEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp CCHHHHHHHHTTSCC----CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred chHHHHHHHHhcccc----CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 111111122222222 22222222 23455678999999999999999999999999987643
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-47 Score=405.44 Aligned_cols=248 Identities=23% Similarity=0.327 Sum_probs=205.4
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccC---CchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSG---SGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 435 (723)
++|+++++||+|+||.||+|+. .+|+.||||+++.. .....+.+.+|+++|++++|+|||+++++|.+.+.+|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 5799999999999999999954 67999999998753 2234567889999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ 515 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 515 (723)
||+.+|+|.+++...+ .+++..+..++.||+.||+|||++ +||||||||+||||+.++.+||+|||+++......
T Consensus 85 ey~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 85 EYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp ECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred eccCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 9999999999997654 378888999999999999999999 59999999999999999999999999998654332
Q ss_pred cceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccc
Q 046750 516 THVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVD 595 (723)
Q Consensus 516 ~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd 595 (723)
. .....+||+.|||||++.+..|+.++|||||||+||||++|+.||..... .. +.+.+..+.+.
T Consensus 160 ~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~---~~--------~~~~i~~~~~~---- 223 (337)
T d1o6la_ 160 A-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---ER--------LFELILMEEIR---- 223 (337)
T ss_dssp C-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HH--------HHHHHHHCCCC----
T ss_pred c-ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH---HH--------HHHHHhcCCCC----
Confidence 2 23456799999999999999999999999999999999999999976432 11 12223333221
Q ss_pred hhhhccccHHHHHHHHHHHHHHhccCCCCCCC-----HHHHHHH
Q 046750 596 PRLEKHYVESEMFRMIEAAAACVRHSGPKRPR-----MVQVVRA 634 (723)
Q Consensus 596 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~eVl~~ 634 (723)
+...+ ...+.+|+.+||+.||.+|++ +.||+++
T Consensus 224 --~p~~~----s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 224 --FPRTL----SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp --CCTTS----CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred --CCccC----CHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 11122 235778999999999999995 7888763
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-47 Score=399.42 Aligned_cols=258 Identities=27% Similarity=0.400 Sum_probs=196.8
Q ss_pred cCcccceEEeccCcEEEEEEEcC------CCcEEEEEEcccCCc-hhHHHHHHHHHHHHHc-cCCceeeEeeeeecc-cc
Q 046750 360 NGFARENVIGEGGFGCVYKGNLP------EGKVVAVKQLKSGSG-QGEREFRAEVEIISRV-HHRHLVSLVGYCISE-KN 430 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~------~g~~VAvK~l~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~-~~ 430 (723)
++|++.++||+|+||.||+|.+. +++.||||+++.... ...+.+.+|+.++.++ +|+|||.+++++.+. ..
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 92 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 92 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence 67999999999999999999642 346899999976533 3445788888888887 688999999988764 46
Q ss_pred eEEEEEecCCCchhhccccCC--------------CCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCC
Q 046750 431 RLLIYEFVPNNNLEHHLHGKG--------------QPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDD 496 (723)
Q Consensus 431 ~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~ 496 (723)
.++||||+++|+|.++|+... ...+++..++.|+.||++||+|||++ +||||||||+||||++
T Consensus 93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSE 169 (299)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECG
T ss_pred EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeECC
Confidence 899999999999999986532 23488999999999999999999999 5999999999999999
Q ss_pred CCcEEEeecccccccCCCCcc-eeecccccccccChhhhccCCCCCccceechHHHHHHHHhCC-CCCCCCCCCCchhhH
Q 046750 497 EFEAQVADFGLAKLNDTTQTH-VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGR-KPVDPTQPLGDESLV 574 (723)
Q Consensus 497 ~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~-~P~~~~~~~~~~~l~ 574 (723)
++.+||+|||+++........ ......||..|||||++.++.++.++|||||||+||||++|. .||...... ..
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~--~~-- 245 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EE-- 245 (299)
T ss_dssp GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS--HH--
T ss_pred CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH--HH--
Confidence 999999999999866543332 234467999999999999999999999999999999999975 566543321 11
Q ss_pred HhhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccC
Q 046750 575 EWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEG 639 (723)
Q Consensus 575 ~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~ 639 (723)
+.+.+..+....+. ......+.+|+.+||+.||.+||+|.||+++|+.++
T Consensus 246 ------~~~~~~~~~~~~~~---------~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il 295 (299)
T d1ywna1 246 ------FCRRLKEGTRMRAP---------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295 (299)
T ss_dssp ------HHHHHHHTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------HHHHHhcCCCCCCC---------ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 11222233221111 111235789999999999999999999999998764
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=8.1e-47 Score=394.46 Aligned_cols=258 Identities=24% Similarity=0.385 Sum_probs=200.4
Q ss_pred hcCcccceEEeccCcEEEEEEE-cCCCcEEEEEEcccCCc---hhHHHHHHHHHHHHHccCCceeeEeeeeecccc----
Q 046750 359 TNGFARENVIGEGGFGCVYKGN-LPEGKVVAVKQLKSGSG---QGEREFRAEVEIISRVHHRHLVSLVGYCISEKN---- 430 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~VAvK~l~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~---- 430 (723)
.++|++.+.||+|+||.||+|. ..+|+.||||+++.... .....|.+|+++|++++|+|||++++++...+.
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 4779999999999999999995 46799999999976432 234578999999999999999999999986543
Q ss_pred eEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccc
Q 046750 431 RLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKL 510 (723)
Q Consensus 431 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 510 (723)
.||||||+.+++|.+++...+ .+++..++.|+.||++||+|||++ +||||||||+||||+.++.++|+|||+++.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred EEEEEECCCCCEehhhhcccC--CCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhh
Confidence 789999999999999887654 488999999999999999999999 599999999999999999999999999875
Q ss_pred cCCCCc--ceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcC
Q 046750 511 NDTTQT--HVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETG 588 (723)
Q Consensus 511 ~~~~~~--~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~ 588 (723)
...... ......+||..|||||++.+..++.++|||||||+||||++|+.||..... .+ .+.+.+..+
T Consensus 161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~----~~~~~~~~~ 230 (277)
T d1o6ya_ 161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VS----VAYQHVRED 230 (277)
T ss_dssp CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HH----HHHHHHHCC
T ss_pred hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH------HH----HHHHHHhcC
Confidence 543322 223446799999999999999999999999999999999999999975432 11 111222222
Q ss_pred CcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCC-CHHHHHHHHhcc
Q 046750 589 DLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRP-RMVQVVRALDSE 638 (723)
Q Consensus 589 ~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~eVl~~L~~~ 638 (723)
.... ......+ ...+.+++.+||+.||.+|| ++++|++.|.+.
T Consensus 231 ~~~~---~~~~~~~----s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 231 PIPP---SARHEGL----SADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp CCCG---GGTSSSC----CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CCCC---chhccCC----CHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 1110 0111112 23678899999999999999 899999888753
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9.9e-47 Score=401.08 Aligned_cols=245 Identities=23% Similarity=0.334 Sum_probs=203.2
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccC---CchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSG---SGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 435 (723)
++|+++++||+|+||.||+|+. .+|+.||||+++.. .....+.+.+|+.+|++++|||||++++++.+.+..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 5699999999999999999965 56999999998643 2233467899999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ 515 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 515 (723)
||+.+|+|..++..... +.+..+..++.||+.||+|||++ +||||||||+||||+.++.+||+|||+++.....
T Consensus 84 E~~~gg~l~~~~~~~~~--~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~- 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQR--FPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 157 (316)
T ss_dssp CCCCSCBHHHHHHHTSS--CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred eecCCcccccccccccc--ccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEeccc-
Confidence 99999999998876553 67788888999999999999999 5999999999999999999999999999876533
Q ss_pred cceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccc
Q 046750 516 THVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVD 595 (723)
Q Consensus 516 ~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd 595 (723)
....+||+.|||||++.+..|+.++|||||||+||||++|+.||..... .+ +.+.+..+.+.
T Consensus 158 ---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~------~~-----~~~~i~~~~~~---- 219 (316)
T d1fota_ 158 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------MK-----TYEKILNAELR---- 219 (316)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HH-----HHHHHHHCCCC----
T ss_pred ---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH------HH-----HHHHHHcCCCC----
Confidence 2346799999999999999999999999999999999999999975431 11 11222222221
Q ss_pred hhhhccccHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 046750 596 PRLEKHYVESEMFRMIEAAAACVRHSGPKRP-----RMVQVVRA 634 (723)
Q Consensus 596 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~eVl~~ 634 (723)
+...+ ...+.+++.+||..||.+|+ ++++|++.
T Consensus 220 --~p~~~----s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 220 --FPPFF----NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp --CCTTS----CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred --CCCCC----CHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 11111 23578899999999999996 89998864
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-47 Score=401.64 Aligned_cols=258 Identities=26% Similarity=0.394 Sum_probs=208.2
Q ss_pred cCcccceEEeccCcEEEEEEEc------CCCcEEEEEEcccCCch-hHHHHHHHHHHHHHc-cCCceeeEeeeeecccce
Q 046750 360 NGFARENVIGEGGFGCVYKGNL------PEGKVVAVKQLKSGSGQ-GEREFRAEVEIISRV-HHRHLVSLVGYCISEKNR 431 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~------~~g~~VAvK~l~~~~~~-~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~ 431 (723)
++|++.++||+|+||.||+|++ ..++.||||+++..... ...+|.+|+.+++++ +|+|||+++++|.+....
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 5788999999999999999964 34578999999865433 345789999999999 699999999999999999
Q ss_pred EEEEEecCCCchhhccccCC----------------CCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeC
Q 046750 432 LLIYEFVPNNNLEHHLHGKG----------------QPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVD 495 (723)
Q Consensus 432 ~lV~E~~~~gsL~~~l~~~~----------------~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~ 495 (723)
+|||||+.+|+|.++|+... ...+++..+++|+.||++||+|||++ +|||||||++||||+
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLT 179 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEE
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccccccc
Confidence 99999999999999987543 23488899999999999999999999 599999999999999
Q ss_pred CCCcEEEeecccccccCCCCcc-eeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhH
Q 046750 496 DEFEAQVADFGLAKLNDTTQTH-VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLV 574 (723)
Q Consensus 496 ~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~ 574 (723)
.++.+||+|||+++........ ......|++.|+|||++.++.++.++|||||||+||||+++..|+....... ..+.
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~-~~~~ 258 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-SKFY 258 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS-HHHH
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH-HHHH
Confidence 9999999999999877654433 3345679999999999999999999999999999999999555543332211 1111
Q ss_pred HhhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhcc
Q 046750 575 EWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSE 638 (723)
Q Consensus 575 ~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~ 638 (723)
+.+..+.. . .........+.+|+.+||+.||++||+|.||+++|++.
T Consensus 259 --------~~i~~~~~-~--------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 259 --------KMIKEGFR-M--------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp --------HHHHHTCC-C--------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------HHHhcCCC-C--------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 11222211 1 11111234688999999999999999999999999875
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-47 Score=395.37 Aligned_cols=255 Identities=24% Similarity=0.393 Sum_probs=195.3
Q ss_pred cCcccceEEeccCcEEEEEEEcC--CC--cEEEEEEcccC---CchhHHHHHHHHHHHHHccCCceeeEeeeeecccceE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLP--EG--KVVAVKQLKSG---SGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRL 432 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~--~g--~~VAvK~l~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 432 (723)
++|++.+.||+|+||.||+|++. ++ ..||||+++.. ..+..++|.+|+++|++|+|+|||+++|+|.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 56899999999999999999653 23 36899998754 23344689999999999999999999999976 4678
Q ss_pred EEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccC
Q 046750 433 LIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLND 512 (723)
Q Consensus 433 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 512 (723)
+||||+.+|+|.+++..+.. .+.+..+++++.||++||.|||++ +|+|||||++||||+.++.+||+|||+++...
T Consensus 87 lv~e~~~~~~l~~~~~~~~~-~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGG-GSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeeeecCcchhhhhhcccC-CCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 99999999999988865433 488999999999999999999998 59999999999999999999999999998775
Q ss_pred CCCcce--eecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhhHHhhhhhhhhhhhcCC
Q 046750 513 TTQTHV--STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESLVEWARPVLVRAIETGD 589 (723)
Q Consensus 513 ~~~~~~--~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~ 589 (723)
...... .....|+..|+|||++.+..++.++|||||||+||||++ |+.||..... .....+ ....+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~---~~~~~~-------i~~~~~ 232 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG---SQILHK-------IDKEGE 232 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHH-------HHTSCC
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH---HHHHHH-------HHhCCC
Confidence 543332 233567889999999999999999999999999999998 8999965431 112111 111221
Q ss_pred cccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhcc
Q 046750 590 LSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSE 638 (723)
Q Consensus 590 l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~ 638 (723)
.... ...+ ...+.+|+.+||+.||++||+|.||++.|++.
T Consensus 233 ~~~~-----~~~~----~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 233 RLPR-----PEDC----PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp CCCC-----CTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCC-----cccc----cHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1111 0112 23678999999999999999999999999764
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-46 Score=397.77 Aligned_cols=253 Identities=28% Similarity=0.442 Sum_probs=201.0
Q ss_pred ceEEeccCcEEEEEEEcCCC----cEEEEEEcccC-CchhHHHHHHHHHHHHHccCCceeeEeeeeec-ccceEEEEEec
Q 046750 365 ENVIGEGGFGCVYKGNLPEG----KVVAVKQLKSG-SGQGEREFRAEVEIISRVHHRHLVSLVGYCIS-EKNRLLIYEFV 438 (723)
Q Consensus 365 ~~~LG~G~fG~Vy~~~~~~g----~~VAvK~l~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~~~~lV~E~~ 438 (723)
.++||+|+||.||+|.+.++ ..||||+++.. .....++|.+|+++|++|+|+|||+++|+|.+ +...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 57899999999999976442 25899999754 33445689999999999999999999999875 45789999999
Q ss_pred CCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcc-
Q 046750 439 PNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTH- 517 (723)
Q Consensus 439 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~- 517 (723)
.+|+|.++++.... .+.+..+++|+.||++||.|||+. +|+|||||++||||++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~~~-~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 112 KHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp TTCBHHHHHHCTTC-CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred ecCchhhhhccccc-cchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 99999999876543 467888999999999999999999 5999999999999999999999999999876543332
Q ss_pred --eeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccc
Q 046750 518 --VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVD 595 (723)
Q Consensus 518 --~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd 595 (723)
......|+..|+|||++..+.++.++|||||||+||||++|+.||...... ..+. ..+..|... .+
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~--~~~~--------~~i~~g~~~--~~ 255 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDIT--------VYLLQGRRL--LQ 255 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CH--------HHHHTTCCC--CC
T ss_pred ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH--HHHH--------HHHHcCCCC--CC
Confidence 223356899999999999999999999999999999999988887643321 1111 122222211 11
Q ss_pred hhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCC
Q 046750 596 PRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGE 640 (723)
Q Consensus 596 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~ 640 (723)
+ ......+.+|+.+||+.||++||+|.||++.|+.+..
T Consensus 256 p-------~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 256 P-------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp C-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred c-------ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1 1112367889999999999999999999999988754
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=399.41 Aligned_cols=258 Identities=26% Similarity=0.419 Sum_probs=209.2
Q ss_pred cCcccceEEeccCcEEEEEEEcC------CCcEEEEEEcccCCc-hhHHHHHHHHHHHHHccCCceeeEeeeeecccceE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLP------EGKVVAVKQLKSGSG-QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRL 432 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~------~g~~VAvK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 432 (723)
++|.+.+.||+|+||.||+|.+. +++.||||+++.... .....|.+|++++++++|+|||+++++|......+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 67889999999999999999653 357899999976533 33456899999999999999999999999999999
Q ss_pred EEEEecCCCchhhccccC--------CCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEee
Q 046750 433 LIYEFVPNNNLEHHLHGK--------GQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVAD 504 (723)
Q Consensus 433 lV~E~~~~gsL~~~l~~~--------~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~D 504 (723)
+||||+.+|+|.++++.. ....+.+..+++|+.||++||.|||++ +|||||||++||||++++++||+|
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEee
Confidence 999999999999988642 123468889999999999999999998 599999999999999999999999
Q ss_pred cccccccCCCCcce-eecccccccccChhhhccCCCCCccceechHHHHHHHHhCC-CCCCCCCCCCchhhHHhhhhhhh
Q 046750 505 FGLAKLNDTTQTHV-STRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGR-KPVDPTQPLGDESLVEWARPVLV 582 (723)
Q Consensus 505 FGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~-~P~~~~~~~~~~~l~~~~~~~l~ 582 (723)
||+++......... .....|+..|+|||.+.++.++.++|||||||+||||++|+ .||.... ..++ .
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~------~~~~-----~ 245 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS------NEQV-----L 245 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC------HHHH-----H
T ss_pred cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC------HHHH-----H
Confidence 99998665443332 23346899999999999999999999999999999999985 5564332 1111 1
Q ss_pred hhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCC
Q 046750 583 RAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGE 640 (723)
Q Consensus 583 ~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~ 640 (723)
+.+..+....+.+ .....|.+|+.+||+.+|.+||+|.+|+++|++..+
T Consensus 246 ~~i~~~~~~~~p~---------~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 246 RFVMEGGLLDKPD---------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp HHHHTTCCCCCCT---------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHHhCCCCCCcc---------cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 2233333222211 112368899999999999999999999999988654
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=397.83 Aligned_cols=257 Identities=28% Similarity=0.420 Sum_probs=204.7
Q ss_pred cCcccceEEeccCcEEEEEEEcCC--------CcEEEEEEcccCCc-hhHHHHHHHHHHHHHc-cCCceeeEeeeeeccc
Q 046750 360 NGFARENVIGEGGFGCVYKGNLPE--------GKVVAVKQLKSGSG-QGEREFRAEVEIISRV-HHRHLVSLVGYCISEK 429 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~~--------g~~VAvK~l~~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~ 429 (723)
++|.++++||+|+||.||+|+... +..||||+++.... ....++.+|+.++.++ +|+|||+++++|.++.
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 578899999999999999996422 24799999987644 3446889999999999 8999999999999999
Q ss_pred ceEEEEEecCCCchhhccccCC--------------CCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeC
Q 046750 430 NRLLIYEFVPNNNLEHHLHGKG--------------QPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVD 495 (723)
Q Consensus 430 ~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~ 495 (723)
..++||||+.+|+|.++|.... ...+++..+++|+.||+.||+|||++ +|||||||++||||+
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeec
Confidence 9999999999999999996543 23589999999999999999999999 599999999999999
Q ss_pred CCCcEEEeecccccccCCCCcc-eeecccccccccChhhhccCCCCCccceechHHHHHHHHh-CCCCCCCCCCCCchhh
Q 046750 496 DEFEAQVADFGLAKLNDTTQTH-VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT-GRKPVDPTQPLGDESL 573 (723)
Q Consensus 496 ~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~l 573 (723)
.++.+||+|||+++........ ......|+..|+|||++.++.|+.++|||||||+||||++ |..||..... ..
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~---~~- 245 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---EE- 245 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HH-
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH---HH-
Confidence 9999999999999866543332 2344578999999999999999999999999999999998 6777764331 11
Q ss_pred HHhhhhhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccC
Q 046750 574 VEWARPVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEG 639 (723)
Q Consensus 574 ~~~~~~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~ 639 (723)
+.+.+..+....+ ... ....+.+|+.+||+.||.+||++.||++.|+.+.
T Consensus 246 -------~~~~i~~~~~~~~-----p~~----~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 246 -------LFKLLKEGHRMDK-----PSN----CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp -------HHHHHHTTCCCCC-----CSS----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------HHHHHHcCCCCCC-----Ccc----chHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 1122333321111 111 2236889999999999999999999999998764
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-47 Score=401.17 Aligned_cols=256 Identities=29% Similarity=0.444 Sum_probs=202.8
Q ss_pred cCcccceEEeccCcEEEEEEEcCC-Cc--EEEEEEcccC-CchhHHHHHHHHHHHHHc-cCCceeeEeeeeecccceEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNLPE-GK--VVAVKQLKSG-SGQGEREFRAEVEIISRV-HHRHLVSLVGYCISEKNRLLI 434 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~--~VAvK~l~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV 434 (723)
++|++.++||+|+||.||+|.+++ |. .||||+++.. .....++|.+|+++|.++ +|+|||+++|+|.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 578899999999999999996644 43 4788888654 333455799999999999 799999999999999999999
Q ss_pred EEecCCCchhhccccC--------------CCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcE
Q 046750 435 YEFVPNNNLEHHLHGK--------------GQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEA 500 (723)
Q Consensus 435 ~E~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~v 500 (723)
|||+++|+|.++|+.. ....+++..+++++.||++||.|||++ +|||||||++|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence 9999999999999754 234689999999999999999999999 59999999999999999999
Q ss_pred EEeecccccccCCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCC-CCCCCCCCCchhhHHhhhh
Q 046750 501 QVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRK-PVDPTQPLGDESLVEWARP 579 (723)
Q Consensus 501 kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~-P~~~~~~~~~~~l~~~~~~ 579 (723)
||+|||+++....... .....||..|+|||.+.++.++.++|||||||+||||++|.. ||.... ...
T Consensus 167 kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~---~~~------- 234 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT---CAE------- 234 (309)
T ss_dssp EECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHH-------
T ss_pred EEcccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC---HHH-------
Confidence 9999999976543222 223458999999999999999999999999999999999765 564432 111
Q ss_pred hhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCC
Q 046750 580 VLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGE 640 (723)
Q Consensus 580 ~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~ 640 (723)
+.+.+..+.... ........+.+|+.+||+.||++||+|.||++.|+++.+
T Consensus 235 -~~~~i~~~~~~~---------~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 235 -LYEKLPQGYRLE---------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp -HHHHGGGTCCCC---------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHHHHHhcCCCC---------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 122222222111 111122368889999999999999999999999988754
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-46 Score=399.24 Aligned_cols=253 Identities=18% Similarity=0.291 Sum_probs=205.9
Q ss_pred HhcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEE
Q 046750 358 ITNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYE 436 (723)
Q Consensus 358 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 436 (723)
+.++|.+.+.||+|+||.||+|.. .+|+.||||+++... .....+.+|+++|++++|+|||+++++|.+.+.+|||||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 457899999999999999999955 568899999997653 334568899999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCC--CCcEEEeecccccccCCC
Q 046750 437 FVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDD--EFEAQVADFGLAKLNDTT 514 (723)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~--~~~vkL~DFGla~~~~~~ 514 (723)
||.+|+|.++|...+. .+++..++.|+.||+.||+|||++ +||||||||+||||+. ...+||+|||+++.....
T Consensus 82 ~~~gg~L~~~i~~~~~-~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 82 FISGLDIFERINTSAF-ELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCCBHHHHHTSSSC-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred cCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 9999999999976542 488999999999999999999999 5999999999999985 458999999999876443
Q ss_pred CcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCccccc
Q 046750 515 QTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIV 594 (723)
Q Consensus 515 ~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~v 594 (723)
.. .....|+..|+|||.+.+..|+.++||||||||||||++|+.||..... .. +...+..+.+. +
T Consensus 158 ~~--~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~---~~--------~~~~i~~~~~~--~ 222 (321)
T d1tkia_ 158 DN--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN---QQ--------IIENIMNAEYT--F 222 (321)
T ss_dssp CE--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH---HH--------HHHHHHHTCCC--C
T ss_pred Cc--ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH---HH--------HHHHHHhCCCC--C
Confidence 22 3345689999999999999999999999999999999999999976432 11 11222222211 1
Q ss_pred chhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 595 DPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 595 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
+......+ ...+.+|+.+||..||.+||++.||++.
T Consensus 223 ~~~~~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 223 DEEAFKEI----SIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp CHHHHTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ChhhccCC----CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11111112 2357889999999999999999999873
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.7e-46 Score=388.54 Aligned_cols=252 Identities=24% Similarity=0.344 Sum_probs=203.9
Q ss_pred hcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCch---------hHHHHHHHHHHHHHcc-CCceeeEeeeeec
Q 046750 359 TNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQ---------GEREFRAEVEIISRVH-HRHLVSLVGYCIS 427 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~---------~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~ 427 (723)
.++|++.+.||+|+||.||+|+. .+|+.||||+++..... ..+.+.+|+.+|++|+ |+|||+++++|.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 36899999999999999999954 67899999998654221 1235789999999997 9999999999999
Q ss_pred ccceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeeccc
Q 046750 428 EKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGL 507 (723)
Q Consensus 428 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGl 507 (723)
.+..||||||+++|+|.++|+.++ .+++..+..|+.||++||+|||++ +||||||||+||||+.++.+||+|||+
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred CcceEEEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchh
Confidence 999999999999999999997654 489999999999999999999999 599999999999999999999999999
Q ss_pred ccccCCCCcceeecccccccccChhhhcc------CCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhh
Q 046750 508 AKLNDTTQTHVSTRVMGTFGYLAPEYASS------GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVL 581 (723)
Q Consensus 508 a~~~~~~~~~~~~~~~gt~~y~APE~~~~------~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l 581 (723)
++....... .....||..|+|||++.+ ..++.++||||||||||||++|+.||..... .. +
T Consensus 157 a~~~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~---~~--------~ 223 (277)
T d1phka_ 157 SCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ---ML--------M 223 (277)
T ss_dssp CEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HH--------H
T ss_pred eeEccCCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH---HH--------H
Confidence 987654332 344679999999999864 3468899999999999999999999976431 11 1
Q ss_pred hhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 582 VRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 582 ~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
.+.+..+... +..+. ...+ ...+.+|+.+||+.||.+||++.||++.
T Consensus 224 ~~~i~~~~~~-~~~~~-~~~~----s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 224 LRMIMSGNYQ-FGSPE-WDDY----SDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HHHHHHTCCC-CCTTT-GGGS----CHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHHHhCCCC-CCCcc-cccC----CHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1222222221 11001 1112 2368899999999999999999999764
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-46 Score=398.88 Aligned_cols=253 Identities=22% Similarity=0.283 Sum_probs=200.2
Q ss_pred hcCcccce-EEeccCcEEEEEEE-cCCCcEEEEEEcccCCchhHHHHHHHHHHHHHc-cCCceeeEeeeeec----ccce
Q 046750 359 TNGFAREN-VIGEGGFGCVYKGN-LPEGKVVAVKQLKSGSGQGEREFRAEVEIISRV-HHRHLVSLVGYCIS----EKNR 431 (723)
Q Consensus 359 ~~~f~~~~-~LG~G~fG~Vy~~~-~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~----~~~~ 431 (723)
.++|.+.+ +||+|+||.||+|+ ..+++.||||+++. ...+.+|++++.++ +|+|||+++++|.+ ...+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 46788765 69999999999995 46789999999964 25678899997765 89999999999875 4668
Q ss_pred EEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCC---CCcEEEeecccc
Q 046750 432 LLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDD---EFEAQVADFGLA 508 (723)
Q Consensus 432 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~---~~~vkL~DFGla 508 (723)
|||||||.||+|.++|..++...+++..+..|+.||+.||+|||++ +||||||||+||||++ ++.+||+|||++
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccccccccee
Confidence 9999999999999999876656799999999999999999999999 5999999999999985 467999999999
Q ss_pred cccCCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcC
Q 046750 509 KLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETG 588 (723)
Q Consensus 509 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~ 588 (723)
+....... .....||+.|||||++.+..|+.++||||||||||||++|+.||........ ... +...+..+
T Consensus 162 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~---~~~----~~~~i~~~ 232 (335)
T d2ozaa1 162 KETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---SPG----MKTRIRMG 232 (335)
T ss_dssp EECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------------CCCSC
T ss_pred eeccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH---HHH----HHHHHhcC
Confidence 87654332 2345799999999999999999999999999999999999999975443210 000 11112222
Q ss_pred CcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 589 DLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 589 ~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
.+. +. ..........+.+|+.+||+.||.+||++.||++.
T Consensus 233 ~~~-~~-----~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 233 QYE-FP-----NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp SSS-CC-----TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCC-CC-----CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 111 00 01111223468899999999999999999999874
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.6e-46 Score=403.33 Aligned_cols=244 Identities=25% Similarity=0.317 Sum_probs=202.9
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccC---CchhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSG---SGQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIY 435 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 435 (723)
++|++++.||+|+||.||+|+. .+|+.||||+++.. .....+.+.+|+++|++|+|+|||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 5799999999999999999955 57999999998642 1233457889999999999999999999999999999999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQ 515 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 515 (723)
||+.+|+|.+++...+ .+++..++.|+.||+.||.|||++ +||||||||+||||+.++.+||+|||+++.....
T Consensus 121 e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~- 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred ccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence 9999999999997654 488999999999999999999999 5999999999999999999999999999876532
Q ss_pred cceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcccccc
Q 046750 516 THVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIVD 595 (723)
Q Consensus 516 ~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~vd 595 (723)
.....||+.|||||++.+..|+.++|||||||+||||++|+.||..... .. +...+..+.+.
T Consensus 195 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~---~~--------~~~~i~~~~~~---- 256 (350)
T d1rdqe_ 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQ--------IYEKIVSGKVR---- 256 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HH--------HHHHHHHCCCC----
T ss_pred ---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH---HH--------HHHHHhcCCCC----
Confidence 2345799999999999999999999999999999999999999975421 11 11222222221
Q ss_pred hhhhccccHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHH
Q 046750 596 PRLEKHYVESEMFRMIEAAAACVRHSGPKRP-----RMVQVVR 633 (723)
Q Consensus 596 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~eVl~ 633 (723)
+...+ ...+.+|+.+||+.||.+|+ ++++|++
T Consensus 257 --~p~~~----s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 257 --FPSHF----SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp --CCTTC----CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred --CCccC----CHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 11112 23578899999999999995 8888876
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=8.4e-46 Score=401.39 Aligned_cols=249 Identities=25% Similarity=0.366 Sum_probs=196.6
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCC---chhHHHHHHH---HHHHHHccCCceeeEeeeeecccceE
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS---GQGEREFRAE---VEIISRVHHRHLVSLVGYCISEKNRL 432 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~---~~~~~~~~~E---i~il~~l~HpnIv~l~g~~~~~~~~~ 432 (723)
++|++.++||+|+||.||+|+. .+|+.||||++.... ......+.+| +++++.++|+|||+++++|.+.+..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 5799999999999999999964 569999999986421 1122334444 66666778999999999999999999
Q ss_pred EEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccC
Q 046750 433 LIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLND 512 (723)
Q Consensus 433 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 512 (723)
|||||+.+|+|.++|.... .+.+..++.|+.||+.||+|||++ +||||||||+||||+.++.+||+|||+++.+.
T Consensus 84 ivmE~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEECCCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEEEecCCCcHHHHHHhcc--cccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 9999999999999997654 478889999999999999999999 59999999999999999999999999998765
Q ss_pred CCCcceeecccccccccChhhhcc-CCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCcc
Q 046750 513 TTQTHVSTRVMGTFGYLAPEYASS-GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLS 591 (723)
Q Consensus 513 ~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~ 591 (723)
... .....||+.|||||++.. ..|+.++|||||||+||||++|+.||.......... +.+.+.....
T Consensus 159 ~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~--------~~~~~~~~~~- 226 (364)
T d1omwa3 159 KKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE--------IDRMTLTMAV- 226 (364)
T ss_dssp SSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH--------HHHHSSSCCC-
T ss_pred CCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH--------HHHhcccCCC-
Confidence 432 234579999999999975 468999999999999999999999997654322111 1111111111
Q ss_pred cccchhhhccccHHHHHHHHHHHHHHhccCCCCCCC-----HHHHHHH
Q 046750 592 EIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPR-----MVQVVRA 634 (723)
Q Consensus 592 ~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~eVl~~ 634 (723)
.+...+ ...+.+|+.+||+.||.+|++ ++||++.
T Consensus 227 -----~~~~~~----s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 227 -----ELPDSF----SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp -----CCCSSS----CHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred -----CCCCCC----CHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 111112 235788999999999999999 6888753
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=389.93 Aligned_cols=261 Identities=23% Similarity=0.303 Sum_probs=194.1
Q ss_pred cceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCchh-----HHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEe
Q 046750 364 RENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQG-----EREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEF 437 (723)
Q Consensus 364 ~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~~-----~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 437 (723)
.+++||+|+||.||+|+. .+|+.||||+++...... .+.+++|+++|++++|+|||+++++|.+.+..||||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 468999999999999965 568999999987543221 24688999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcc
Q 046750 438 VPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTH 517 (723)
Q Consensus 438 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 517 (723)
+.++++..++.... .+++..+..|+.||+.||+|||++ +||||||||+|||++.++.+||+|||+++........
T Consensus 82 ~~~~~~~~~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~ 156 (299)
T d1ua2a_ 82 METDLEVIIKDNSL--VLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 156 (299)
T ss_dssp CSEEHHHHHTTCCS--SCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred hcchHHhhhhhccc--CCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCccc
Confidence 98888777765433 488889999999999999999999 5999999999999999999999999999866543322
Q ss_pred eeecccccccccChhhhccC-CCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhh----hhh-------
Q 046750 518 VSTRVMGTFGYLAPEYASSG-KLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLV----RAI------- 585 (723)
Q Consensus 518 ~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~----~~i------- 585 (723)
....+||..|+|||++... .|+.++|||||||+||||++|+.||...... ..+....+ .+. ..+
T Consensus 157 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~--~~l~~i~~-~~~~~~~~~~~~~~~~~ 232 (299)
T d1ua2a_ 157 -YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL--DQLTRIFE-TLGTPTEEQWPDMCSLP 232 (299)
T ss_dssp -CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHH-HHCCCCTTTSSSTTSST
T ss_pred -ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHH--HHHHHHHH-hcCCCChhhccchhccc
Confidence 2345699999999998755 5799999999999999999999999754321 11111000 000 000
Q ss_pred hcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 586 ETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 586 ~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
....+..+.+..+. .........+.+|+.+||+.||++||++.|++++
T Consensus 233 ~~~~~~~~~~~~~~-~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 233 DYVTFKSFPGIPLH-HIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp TCCCCCCCCCCCHH-HHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhhccCCCCChH-HhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 00000000000000 0011112368899999999999999999999873
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=389.02 Aligned_cols=267 Identities=22% Similarity=0.345 Sum_probs=198.8
Q ss_pred cCcccceEEeccCcEEEEEEE-cCCCcEEEEEEcccCCc--hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGN-LPEGKVVAVKQLKSGSG--QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYE 436 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~-~~~g~~VAvK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 436 (723)
++|+++++||+|+||.||+|. ..+|+.||||+++.... .....+.+|+++|++|+|+|||+++++|.+....|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 589999999999999999995 46799999999965432 234678999999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCc
Q 046750 437 FVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQT 516 (723)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 516 (723)
|+.+ .+.+++.......+++..+..|+.||+.||+|||++ +||||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~ 157 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 157 (298)
T ss_dssp CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred ecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCcc
Confidence 9965 455555444445689999999999999999999999 599999999999999999999999999986654332
Q ss_pred ceeecccccccccChhhhccCC-CCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhh------hhhhh-hcC
Q 046750 517 HVSTRVMGTFGYLAPEYASSGK-LTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPV------LVRAI-ETG 588 (723)
Q Consensus 517 ~~~~~~~gt~~y~APE~~~~~~-~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~------l~~~i-~~~ 588 (723)
......|+..|+|||++.... ++.++|||||||+||||++|+.||...... ..+....... ....+ ...
T Consensus 158 -~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (298)
T d1gz8a_ 158 -TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--DQLFRIFRTLGTPDEVVWPGVTSMP 234 (298)
T ss_dssp -CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred -cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHH--HHHHHHHHhcCCCchhhcccccccc
Confidence 233456999999999887765 578999999999999999999999754321 1111100000 00000 000
Q ss_pred ----CcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 589 ----DLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 589 ----~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
.+....+..+. .........+.+|+.+||+.||.+||++.||++.
T Consensus 235 ~~~~~~~~~~~~~~~-~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 235 DYKPSFPKWARQDFS-KVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TCCTTSCCCCCCCHH-HHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccchh-hhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00000000000 0001112467889999999999999999999875
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-46 Score=395.80 Aligned_cols=247 Identities=23% Similarity=0.375 Sum_probs=200.7
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCC---chhHHHHHHHHHHHH-HccCCceeeEeeeeecccceEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS---GQGEREFRAEVEIIS-RVHHRHLVSLVGYCISEKNRLLI 434 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~---~~~~~~~~~Ei~il~-~l~HpnIv~l~g~~~~~~~~~lV 434 (723)
++|.+++.||+|+||.||+|+. .+++.||||+++... ....+.+..|+.++. .++|+|||++++++.+.+..|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 5799999999999999999954 568999999996431 233445667777765 68999999999999999999999
Q ss_pred EEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCC
Q 046750 435 YEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTT 514 (723)
Q Consensus 435 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 514 (723)
|||+.+|+|.++++.... +++..+..++.||+.||+|||++ +|||||||++|||+++++++||+|||+++.....
T Consensus 82 mEy~~~g~L~~~i~~~~~--~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EeecCCCcHHHHhhccCC--CCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcccc
Confidence 999999999999976543 78889999999999999999999 5999999999999999999999999999865433
Q ss_pred CcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcCCccccc
Q 046750 515 QTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETGDLSEIV 594 (723)
Q Consensus 515 ~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~~l~~~v 594 (723)
.. ......||..|+|||++.+..|+.++|||||||+||||++|+.||..... .. +...+..+...
T Consensus 157 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~---~~--------~~~~i~~~~~~--- 221 (320)
T d1xjda_ 157 DA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE---EE--------LFHSIRMDNPF--- 221 (320)
T ss_dssp TC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HH--------HHHHHHHCCCC---
T ss_pred cc-cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH---HH--------HHHHHHcCCCC---
Confidence 32 23446799999999999999999999999999999999999999975431 11 12222223221
Q ss_pred chhhhccccHHHHHHHHHHHHHHhccCCCCCCCHH-HHHH
Q 046750 595 DPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMV-QVVR 633 (723)
Q Consensus 595 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-eVl~ 633 (723)
+...+ ...+.+|+.+||..||.+||++. +|++
T Consensus 222 ---~p~~~----s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 222 ---YPRWL----EKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ---CCTTS----CHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ---CCccC----CHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 11111 23578899999999999999985 6654
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=6.4e-45 Score=381.58 Aligned_cols=266 Identities=22% Similarity=0.325 Sum_probs=199.4
Q ss_pred cCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCc--hhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEEe
Q 046750 360 NGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSG--QGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYEF 437 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 437 (723)
++|++.+.||+|+||.||+|+.++|+.||||+++.... ...+.+.+|+.+|++|+|+|||+++++|.+.+..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 68999999999999999999888999999999976432 2346899999999999999999999999999999999999
Q ss_pred cCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCcc
Q 046750 438 VPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQTH 517 (723)
Q Consensus 438 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 517 (723)
+.++.|..+....+ .+++..+..|+.||+.||+|||++ +||||||||+||||+.++.+||+|||++........
T Consensus 82 ~~~~~~~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~- 155 (286)
T d1ob3a_ 82 LDQDLKKLLDVCEG--GLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR- 155 (286)
T ss_dssp CSEEHHHHHHTSTT--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred ehhhhHHHHHhhcC--CcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCcc-
Confidence 98777777665443 589999999999999999999998 599999999999999999999999999987654322
Q ss_pred eeecccccccccChhhhccC-CCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhh-------hhhhhhcCC
Q 046750 518 VSTRVMGTFGYLAPEYASSG-KLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPV-------LVRAIETGD 589 (723)
Q Consensus 518 ~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~-------l~~~i~~~~ 589 (723)
......|+..|++||.+.+. .++.++|||||||+||||++|+.||...... ..+....... +........
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA--DQLMRIFRILGTPNSKNWPNVTELPK 233 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHH--HHHHHHHHhhCCCChhhccchhhhhh
Confidence 22334689999999998764 4689999999999999999999999754321 1111100000 000000000
Q ss_pred c---ccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 046750 590 L---SEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVR 633 (723)
Q Consensus 590 l---~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~ 633 (723)
. ....+......+.......+.+|+.+||+.||++||++.||++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0000000001111112246789999999999999999999985
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-45 Score=381.28 Aligned_cols=241 Identities=23% Similarity=0.369 Sum_probs=194.8
Q ss_pred hcCcccceEEeccCcEEEEEEE-cCCCcEEEEEEcccCCc------hhHHHHHHHHHHHHHcc--CCceeeEeeeeeccc
Q 046750 359 TNGFARENVIGEGGFGCVYKGN-LPEGKVVAVKQLKSGSG------QGEREFRAEVEIISRVH--HRHLVSLVGYCISEK 429 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~VAvK~l~~~~~------~~~~~~~~Ei~il~~l~--HpnIv~l~g~~~~~~ 429 (723)
.++|++.++||+|+||.||+|+ ..+|+.||||+++.... .....+.+|+.+|++++ |+|||+++++|.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 3679999999999999999995 46789999999865321 11234678999999996 899999999999999
Q ss_pred ceEEEEEecCC-CchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCC-CCcEEEeeccc
Q 046750 430 NRLLIYEFVPN-NNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDD-EFEAQVADFGL 507 (723)
Q Consensus 430 ~~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~-~~~vkL~DFGl 507 (723)
..|+||||+.+ ++|.+++.... .+++..++.|+.||++||+|||++ +||||||||+||||+. ++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~--~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred eEEEEEEeccCcchHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcccc
Confidence 99999999976 57777776543 488999999999999999999999 5999999999999985 57999999999
Q ss_pred ccccCCCCcceeecccccccccChhhhccCCC-CCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhh
Q 046750 508 AKLNDTTQTHVSTRVMGTFGYLAPEYASSGKL-TDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIE 586 (723)
Q Consensus 508 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~ 586 (723)
++..... ......||..|+|||++.+..+ +.++|||||||+||||++|+.||.... . +.
T Consensus 158 a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~------------i~ 217 (273)
T d1xwsa_ 158 GALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----E------------II 217 (273)
T ss_dssp CEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----H------------HH
T ss_pred ceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----H------------Hh
Confidence 9865432 2344679999999999987765 567999999999999999999996421 1 11
Q ss_pred cCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 587 TGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 587 ~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
.+.+ .+...++ ..+.+|+.+||+.||.+||++.||++.
T Consensus 218 ~~~~------~~~~~~s----~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 218 RGQV------FFRQRVS----SECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp HCCC------CCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hccc------CCCCCCC----HHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 1111 0111222 357889999999999999999999864
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-44 Score=376.10 Aligned_cols=267 Identities=21% Similarity=0.312 Sum_probs=195.4
Q ss_pred hcCcccceEEeccCcEEEEEEEc-CC-CcEEEEEEcccCC--chhHHHHHHHHHHHHHc---cCCceeeEeeeeec----
Q 046750 359 TNGFARENVIGEGGFGCVYKGNL-PE-GKVVAVKQLKSGS--GQGEREFRAEVEIISRV---HHRHLVSLVGYCIS---- 427 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~-~~-g~~VAvK~l~~~~--~~~~~~~~~Ei~il~~l---~HpnIv~l~g~~~~---- 427 (723)
.++|+++++||+|+||.||+|+. ++ ++.||||+++... ......+.+|+++|+.| +|+||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 47899999999999999999964 44 5679999986532 22233567788888776 79999999999853
Q ss_pred -ccceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecc
Q 046750 428 -EKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFG 506 (723)
Q Consensus 428 -~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFG 506 (723)
....+++|||+.++.+..+... ....+++..+..|+.||+.||+|||++ +||||||||+|||+++++.+||+|||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred cCceEEEEEEeccCCchhhhhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchh
Confidence 3467899999988877654433 334578889999999999999999999 59999999999999999999999999
Q ss_pred cccccCCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhh---hh
Q 046750 507 LAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVL---VR 583 (723)
Q Consensus 507 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l---~~ 583 (723)
+++...... ......||+.|+|||++.+..|+.++|||||||+||||++|+.||...... ..+........ ..
T Consensus 162 ~~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~--~~~~~i~~~~~~~~~~ 237 (305)
T d1blxa_ 162 LARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV--DQLGKILDVIGLPGEE 237 (305)
T ss_dssp SCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCGG
T ss_pred hhhhhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH--HHHHHHHHhhCCCchh
Confidence 997654322 234467999999999999999999999999999999999999999765321 11111000000 00
Q ss_pred hhhcC------CcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 584 AIETG------DLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 584 ~i~~~------~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
.+... .+.......+ ..+.......+.+|+.+||+.||.+||++.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 238 DWPRDVALPRQAFHSKSAQPI-EKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp GSCTTCSSCGGGSCCCCCCCG-GGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccccccchhhhhccccccch-hhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000 0000000000 01111122357789999999999999999999874
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-43 Score=380.51 Aligned_cols=273 Identities=19% Similarity=0.265 Sum_probs=198.5
Q ss_pred HhcCcccceEEeccCcEEEEEEE-cCCCcEEEEEEcccCCc-hhHHHHHHHHHHHHHccCCceeeEeeeeeccc----ce
Q 046750 358 ITNGFARENVIGEGGFGCVYKGN-LPEGKVVAVKQLKSGSG-QGEREFRAEVEIISRVHHRHLVSLVGYCISEK----NR 431 (723)
Q Consensus 358 ~~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~VAvK~l~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~----~~ 431 (723)
+..+|+++++||+|+||.||+|. ..+|+.||||+++.... ...+.+++|+++|++|+|+||+++++++.... ..
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 45679999999999999999994 56899999999976433 33457889999999999999999999987653 23
Q ss_pred EEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeeccccccc
Q 046750 432 LLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLN 511 (723)
Q Consensus 432 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 511 (723)
+++++|+.+|+|.+++... .+++..+..|+.||++||+|||++ +||||||||+||||++++.+||+|||+++..
T Consensus 86 ~~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 5666777899999999654 388999999999999999999999 5999999999999999999999999999865
Q ss_pred CCCCcc--eeecccccccccChhhhcc-CCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhh--
Q 046750 512 DTTQTH--VSTRVMGTFGYLAPEYASS-GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIE-- 586 (723)
Q Consensus 512 ~~~~~~--~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~-- 586 (723)
...... .....+|+..|+|||++.. ..++.++|||||||+||||++|+.||........................
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 239 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence 443222 2244579999999999854 46789999999999999999999999765321110000000000000000
Q ss_pred ------------cCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH--HhccCC
Q 046750 587 ------------TGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA--LDSEGE 640 (723)
Q Consensus 587 ------------~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~--L~~~~~ 640 (723)
........-..+.... ...+++|+.+||+.||.+||++.||++. |+....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~ 303 (345)
T d1pmea_ 240 IINLKARNYLLSLPHKNKVPWNRLFPNA----DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303 (345)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred hhhhhhhcccccCCccCCCCHHHhCCCC----CHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCC
Confidence 0000000000000111 1257899999999999999999999975 554433
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-43 Score=374.69 Aligned_cols=266 Identities=18% Similarity=0.257 Sum_probs=193.5
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccC--CchhHHHHHHHHHHHHHccCCceeeEeeeeec--------c
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSG--SGQGEREFRAEVEIISRVHHRHLVSLVGYCIS--------E 428 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--------~ 428 (723)
++|++.+.||+|+||.||+|+. .+|+.||||+++.. .....+.+.+|+++|++|+|+||++++++|.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 6899999999999999999964 67999999998654 22344678899999999999999999998865 3
Q ss_pred cceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccc
Q 046750 429 KNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLA 508 (723)
Q Consensus 429 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla 508 (723)
...|+||||+.++.+..+..... .+.+..+..|+.||+.||.|||++ +|||||||++||||+.++.+||+|||++
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~~~--~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNVLV--KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCTTC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred ceEEEEEeccCCCccchhhhccc--ccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeeccee
Confidence 45789999998777766554433 467788899999999999999999 5999999999999999999999999999
Q ss_pred cccCCCCcc---eeecccccccccChhhhccC-CCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhh
Q 046750 509 KLNDTTQTH---VSTRVMGTFGYLAPEYASSG-KLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRA 584 (723)
Q Consensus 509 ~~~~~~~~~---~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~ 584 (723)
+.+...... .....+||..|+|||++.+. .|+.++|||||||+||||++|+.||...... .........+ ..
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~---~~~~~i~~~~-~~ 240 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ---HQLALISQLC-GS 240 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHH-CC
T ss_pred eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHH---HHHHHHHHhc-CC
Confidence 766533221 22335699999999998765 6899999999999999999999999754321 1111000000 00
Q ss_pred hhcCCcccc--------cchhhhccccH-HH------HHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 585 IETGDLSEI--------VDPRLEKHYVE-SE------MFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 585 i~~~~l~~~--------vd~~l~~~~~~-~~------~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
........+ +.......... .. ...+++|+.+||+.||++|+++.||++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp CCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 000000000 00000000000 11 1246789999999999999999999875
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-43 Score=379.31 Aligned_cols=267 Identities=21% Similarity=0.327 Sum_probs=194.9
Q ss_pred HhcCcccceEEeccCcEEEEEEE-cCCCcEEEEEEcccCCc--hhHHHHHHHHHHHHHccCCceeeEeeeeeccc-----
Q 046750 358 ITNGFARENVIGEGGFGCVYKGN-LPEGKVVAVKQLKSGSG--QGEREFRAEVEIISRVHHRHLVSLVGYCISEK----- 429 (723)
Q Consensus 358 ~~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~VAvK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~----- 429 (723)
+.++|+++++||+|+||.||+|. ..+|+.||||+++.... ...+.+.+|+++|++|+|+|||+++++|...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 35789999999999999999995 45699999999975432 33457889999999999999999999997654
Q ss_pred -ceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccc
Q 046750 430 -NRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLA 508 (723)
Q Consensus 430 -~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla 508 (723)
++||||||+ +.+|..+++.. .+++..++.|+.||+.||+|||++ +||||||||+|||++.++.+||+|||++
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred ceEEEEEecc-cccHHHHHHhc---cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccce
Confidence 469999999 67787777543 389999999999999999999999 5999999999999999999999999999
Q ss_pred cccCCCCcceeecccccccccChhhhccC-CCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhh---------
Q 046750 509 KLNDTTQTHVSTRVMGTFGYLAPEYASSG-KLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWAR--------- 578 (723)
Q Consensus 509 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~--------- 578 (723)
+..... .....|+..|+|||++.+. .++.++|||||||+||||++|+.||....... .+.....
T Consensus 169 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~ 242 (346)
T d1cm8a_ 169 RQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD--QLKEIMKVTGTPPAEF 242 (346)
T ss_dssp EECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCHHH
T ss_pred eccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHH--HHHHHHhccCCCcHHH
Confidence 866432 2345699999999998764 57899999999999999999999997653211 1110000
Q ss_pred -----hhhhhhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH--HhccC
Q 046750 579 -----PVLVRAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA--LDSEG 639 (723)
Q Consensus 579 -----~~l~~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~--L~~~~ 639 (723)
......... .+.++....+.. ........+++|+.+||..||.+||++.||++. |+.+.
T Consensus 243 ~~~~~~~~~~~~~~-~~~~~~~~~~~~-~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 243 VQRLQSDEAKNYMK-GLPELEKKDFAS-ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HHTCSCHHHHHHHH-HSCCCCCCCGGG-TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred Hhhhcchhhhhhhc-cCCcccccchHH-hccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 000000000 000000000000 001112356789999999999999999999985 55543
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-43 Score=378.82 Aligned_cols=263 Identities=24% Similarity=0.317 Sum_probs=192.1
Q ss_pred CcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCceeeEeeeeecc------cceEE
Q 046750 361 GFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLVSLVGYCISE------KNRLL 433 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~------~~~~l 433 (723)
.|+..++||+|+||.||+|+. .+|+.||||+++.... .+.+|+++|++|+|+|||+++++|... .++||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 588899999999999999965 5699999999976432 234799999999999999999998543 34689
Q ss_pred EEEecCCCchhhcccc-CCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCC-cEEEeeccccccc
Q 046750 434 IYEFVPNNNLEHHLHG-KGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEF-EAQVADFGLAKLN 511 (723)
Q Consensus 434 V~E~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~-~vkL~DFGla~~~ 511 (723)
||||+.++.+..+++. .....+++..+..|+.||+.||+|||++ +||||||||+||||+.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999976644443321 2334589999999999999999999998 599999999999999764 8999999999876
Q ss_pred CCCCcceeecccccccccChhhhcc-CCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhh-------hhhh-
Q 046750 512 DTTQTHVSTRVMGTFGYLAPEYASS-GKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWAR-------PVLV- 582 (723)
Q Consensus 512 ~~~~~~~~~~~~gt~~y~APE~~~~-~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~-------~~l~- 582 (723)
..... .....|+..|+|||.+.+ ..|+.++|||||||+||||++|+.||...... ..+....+ ..+.
T Consensus 174 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~--~~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 174 VRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV--DQLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp CTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH--HHHHHHHHHHCCCCHHHHHH
T ss_pred cCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHH--HHHHHHHHHhCCChHHhhhh
Confidence 54332 233569999999998875 46899999999999999999999999755321 11111110 0000
Q ss_pred --hhhhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 583 --RAIETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 583 --~~i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
.......+..+....+...........+.+|+.+||+.||++||++.|+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0001111111111111111111223357889999999999999999999863
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-43 Score=367.30 Aligned_cols=267 Identities=19% Similarity=0.272 Sum_probs=201.9
Q ss_pred cCcccceEEeccCcEEEEEEE-cCCCcEEEEEEcccCC--chhHHHHHHHHHHHHHccCCceeeEeeeeecccceEEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGN-LPEGKVVAVKQLKSGS--GQGEREFRAEVEIISRVHHRHLVSLVGYCISEKNRLLIYE 436 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~-~~~g~~VAvK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 436 (723)
++|+++++||+|+||.||+|+ ..+++.||||+++... ......+++|+.+|++++|+|||+++++|.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 579999999999999999995 4678999999986543 2345678999999999999999999999999999999999
Q ss_pred ecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccccCCCCc
Q 046750 437 FVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKLNDTTQT 516 (723)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 516 (723)
++.+++|..++...+ .+.+..+..++.|+++||+|||++ +||||||||+||||+.++.+||+|||+++.......
T Consensus 82 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 82 FCDQDLKKYFDSCNG--DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp CCSEEHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred ecccccccccccccc--ccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence 999999888876554 478889999999999999999998 599999999999999999999999999987654333
Q ss_pred ceeecccccccccChhhhccCC-CCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhh-----------hhh
Q 046750 517 HVSTRVMGTFGYLAPEYASSGK-LTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVL-----------VRA 584 (723)
Q Consensus 517 ~~~~~~~gt~~y~APE~~~~~~-~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l-----------~~~ 584 (723)
. .....++..|++||++.... ++.++|||||||+||||++|+.||..... ............ ...
T Consensus 157 ~-~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (292)
T d1unla_ 157 C-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp C-CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS--HHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred c-ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCC--HHHHHHHHHhhcCCCChhhhhhhhhc
Confidence 2 23345788999999987665 68999999999999999999999754332 111111000000 000
Q ss_pred hhcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 585 IETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 585 i~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
.+.......................+.+|+.+||+.||++||+++||++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000000000000011111223357889999999999999999999863
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.4e-43 Score=368.18 Aligned_cols=260 Identities=20% Similarity=0.241 Sum_probs=196.2
Q ss_pred hcCcccceEEeccCcEEEEEEE-cCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCce-eeEeeeeecccceEEEEE
Q 046750 359 TNGFARENVIGEGGFGCVYKGN-LPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHL-VSLVGYCISEKNRLLIYE 436 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~g~~~~~~~~~lV~E 436 (723)
.++|++.+.||+|+||.||+|. ..+|+.||||++..... ..++..|++++++++|+|+ +.+.+++.+....++|||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 3679999999999999999995 45689999999876432 3457899999999987665 555556677778889999
Q ss_pred ecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeC---CCCcEEEeecccccccCC
Q 046750 437 FVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVD---DEFEAQVADFGLAKLNDT 513 (723)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~---~~~~vkL~DFGla~~~~~ 513 (723)
|+ +++|.+++.... ..+++..++.++.||+.||+|||++ +||||||||+|||++ .+..+||+|||+++.+..
T Consensus 84 ~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 84 LL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred Ec-CCchhhhhhhcc-CCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 99 566666554433 2488999999999999999999999 599999999999986 456799999999987654
Q ss_pred CCcc------eeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhH-Hhhhhhhhhhhh
Q 046750 514 TQTH------VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLV-EWARPVLVRAIE 586 (723)
Q Consensus 514 ~~~~------~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~-~~~~~~l~~~i~ 586 (723)
.... ......||..|||||++.+..++.++|||||||+||||++|+.||............ .+....+ .
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~----~ 234 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM----S 234 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHH----H
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccC----C
Confidence 4322 223457999999999999999999999999999999999999999765432211111 1111000 0
Q ss_pred cCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccC
Q 046750 587 TGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEG 639 (723)
Q Consensus 587 ~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~ 639 (723)
... +.+...+ ...+.+++..||+.+|.+||++.+|.+.|+...
T Consensus 235 -~~~-----~~~~~~~----p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~ 277 (299)
T d1ckia_ 235 -TPI-----EVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277 (299)
T ss_dssp -SCH-----HHHTTTS----CHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred -CCh-----hHhccCC----CHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 000 0111112 235788999999999999999999988887643
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.2e-42 Score=365.77 Aligned_cols=262 Identities=18% Similarity=0.224 Sum_probs=206.1
Q ss_pred hcCcccceEEeccCcEEEEEEE-cCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccC-CceeeEeeeeecccceEEEEE
Q 046750 359 TNGFARENVIGEGGFGCVYKGN-LPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHH-RHLVSLVGYCISEKNRLLIYE 436 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~g~~~~~~~~~lV~E 436 (723)
.++|+++++||+|+||.||+|+ ..+|+.||||++.... ....+++|+++++.|+| +|++.+++++.+....++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 4689999999999999999996 4568999999986542 23457889999999975 899999999999999999999
Q ss_pred ecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCC-----CCcEEEeeccccccc
Q 046750 437 FVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDD-----EFEAQVADFGLAKLN 511 (723)
Q Consensus 437 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~-----~~~vkL~DFGla~~~ 511 (723)
|+ +++|.++++.... .+.+..++.|+.|++.||+|||++ +||||||||+||||+. ++.+||+|||+++.+
T Consensus 82 ~~-~~~l~~~~~~~~~-~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 82 LL-GPSLEDLLDLCGR-KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp CC-CCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred ec-CCCHHHHHHhhcc-chhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 99 7899998876543 588899999999999999999999 5999999999999974 568999999999876
Q ss_pred CCCCcc------eeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhh
Q 046750 512 DTTQTH------VSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAI 585 (723)
Q Consensus 512 ~~~~~~------~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i 585 (723)
...... ......||+.|||||++.+..++.++|||||||+||||++|+.||............... ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i----~~~~ 232 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI----GEKK 232 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHH----HHHH
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHH----Hhcc
Confidence 543221 123457999999999999999999999999999999999999999765443222111111 0100
Q ss_pred hcCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHhccCC
Q 046750 586 ETGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRALDSEGE 640 (723)
Q Consensus 586 ~~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~L~~~~~ 640 (723)
....+. .+.... ...|.+++..|++.++++||+++.|.+.|+.+..
T Consensus 233 ~~~~~~-----~l~~~~----p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~ 278 (293)
T d1csna_ 233 QSTPLR-----ELCAGF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278 (293)
T ss_dssp HHSCHH-----HHTTTS----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred CCCChH-----HhcCCC----CHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHH
Confidence 000111 111122 2357888999999999999999999988877543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=8.1e-42 Score=364.94 Aligned_cols=260 Identities=19% Similarity=0.295 Sum_probs=194.8
Q ss_pred cCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCchhHHHHHHHHHHHHHcc-CCceeeEeeeeec--ccceEEEE
Q 046750 360 NGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQGEREFRAEVEIISRVH-HRHLVSLVGYCIS--EKNRLLIY 435 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~--~~~~~lV~ 435 (723)
++|+++++||+|+||.||+|+. .+|+.||||+++.. ..+++++|+++|++|+ |+||++++++|.. ....++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5799999999999999999954 67899999999753 3467889999999995 9999999999874 35689999
Q ss_pred EecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCC-cEEEeecccccccCCC
Q 046750 436 EFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEF-EAQVADFGLAKLNDTT 514 (723)
Q Consensus 436 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~-~vkL~DFGla~~~~~~ 514 (723)
||+.+++|..+++ .+.+..+..|+.||+.||+|||++ +||||||||+||||+.++ .+||+|||+++.....
T Consensus 112 e~~~~~~L~~~~~-----~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 112 EHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp ECCCSCBGGGTTT-----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred eecCCCcHHHHhc-----CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCC
Confidence 9999999987753 378889999999999999999999 599999999999998654 6999999999876543
Q ss_pred CcceeecccccccccChhhhccCC-CCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhh----hhhhhhhhcCC
Q 046750 515 QTHVSTRVMGTFGYLAPEYASSGK-LTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWAR----PVLVRAIETGD 589 (723)
Q Consensus 515 ~~~~~~~~~gt~~y~APE~~~~~~-~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~----~~l~~~i~~~~ 589 (723)
.. .....||..|+|||.+.+.. ++.++|||||||+||||++|+.||.......+. ...... ......+....
T Consensus 184 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~-~~~i~~~~g~~~~~~~~~~~~ 260 (328)
T d3bqca1 184 QE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ-LVRIAKVLGTEDLYDYIDKYN 260 (328)
T ss_dssp CC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH-HHHHHHHHCHHHHHHHHHHTT
T ss_pred Cc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHH-HHHHHHHHCCchhhhhhhhcc
Confidence 32 23456899999999987654 799999999999999999999999765431110 000000 00000000000
Q ss_pred c------cccc--------chhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 046750 590 L------SEIV--------DPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVR 633 (723)
Q Consensus 590 l------~~~v--------d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~ 633 (723)
+ ..+. ...+...........+++|+.+||+.||++|++++||++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0000 000000011112235788999999999999999999986
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-42 Score=370.97 Aligned_cols=252 Identities=25% Similarity=0.337 Sum_probs=200.0
Q ss_pred cCcccceEEeccCcEEEEEEEc----CCCcEEEEEEcccCC----chhHHHHHHHHHHHHHccC-CceeeEeeeeecccc
Q 046750 360 NGFARENVIGEGGFGCVYKGNL----PEGKVVAVKQLKSGS----GQGEREFRAEVEIISRVHH-RHLVSLVGYCISEKN 430 (723)
Q Consensus 360 ~~f~~~~~LG~G~fG~Vy~~~~----~~g~~VAvK~l~~~~----~~~~~~~~~Ei~il~~l~H-pnIv~l~g~~~~~~~ 430 (723)
++|++++.||+|+||.||+|+. .+|+.||||+++... ....+.+.+|+++|++|+| +||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5699999999999999999953 247899999986432 2234568899999999977 799999999999999
Q ss_pred eEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeecccccc
Q 046750 431 RLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAKL 510 (723)
Q Consensus 431 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 510 (723)
.++||||+.+|+|.+++..... +....++.++.||+.||+|||++ +||||||||+||||+.++.+||+|||+++.
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~--~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRER--FTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eeeeeecccccHHHHHHHhccc--ccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhh
Confidence 9999999999999999976553 56677888999999999999998 599999999999999999999999999987
Q ss_pred cCCCCcceeecccccccccChhhhccC--CCCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhhcC
Q 046750 511 NDTTQTHVSTRVMGTFGYLAPEYASSG--KLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIETG 588 (723)
Q Consensus 511 ~~~~~~~~~~~~~gt~~y~APE~~~~~--~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~~~ 588 (723)
+............|+..|++||.+.+. .++.++|||||||+||||++|+.||......... .. +.+.....
T Consensus 179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~--~~-----i~~~~~~~ 251 (322)
T d1vzoa_ 179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ--AE-----ISRRILKS 251 (322)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH--HH-----HHHHHHHC
T ss_pred hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH--HH-----HHHhcccC
Confidence 655444444556799999999999765 4788999999999999999999999765432211 11 11111111
Q ss_pred CcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCC-----HHHHHH
Q 046750 589 DLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPR-----MVQVVR 633 (723)
Q Consensus 589 ~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~eVl~ 633 (723)
.. .+.......+.+|+.+||+.||.+|++ ++||++
T Consensus 252 ~~----------~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 252 EP----------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp CC----------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred CC----------CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 11 111122346888999999999999994 788876
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-41 Score=366.97 Aligned_cols=266 Identities=21% Similarity=0.296 Sum_probs=193.9
Q ss_pred HhcCcccceEEeccCcEEEEEEE-cCCCcEEEEEEcccCCc--hhHHHHHHHHHHHHHccCCceeeEeeeeecc-----c
Q 046750 358 ITNGFARENVIGEGGFGCVYKGN-LPEGKVVAVKQLKSGSG--QGEREFRAEVEIISRVHHRHLVSLVGYCISE-----K 429 (723)
Q Consensus 358 ~~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~VAvK~l~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-----~ 429 (723)
+.++|++.++||+|+||.||+|+ ..+|+.||||+++.... ...+.+.+|+++|++|+|+|||++++++... .
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 35689999999999999999995 56799999999976432 3345688999999999999999999998643 3
Q ss_pred ceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeeccccc
Q 046750 430 NRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK 509 (723)
Q Consensus 430 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 509 (723)
..++||+|+.+|+|.++++.+ .+++..+..|+.||+.||+|||++ +||||||||+|||++.++.+||+|||++.
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----
T ss_pred ceEEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhc
Confidence 457778888899999999654 388999999999999999999999 49999999999999999999999999997
Q ss_pred ccCCCCcceeecccccccccChhhhccCC-CCCccceechHHHHHHHHhCCCCCCCCCCCCchhhHHhhhhhhhhhhh--
Q 046750 510 LNDTTQTHVSTRVMGTFGYLAPEYASSGK-LTDRSDVFSFGVVLLELITGRKPVDPTQPLGDESLVEWARPVLVRAIE-- 586 (723)
Q Consensus 510 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~l~~~~~~~l~~~i~-- 586 (723)
.... ......|+..|+|||++.+.. ++.++|||||||+||||++|+.||...........+..........+.
T Consensus 170 ~~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (348)
T d2gfsa1 170 HTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 245 (348)
T ss_dssp CCTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred ccCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence 5432 223456899999999877654 688999999999999999999999765321100000000000000000
Q ss_pred ---------cCCcccccchhhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 587 ---------TGDLSEIVDPRLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 587 ---------~~~l~~~vd~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
...+..+....+... .......+.+|+.+||+.||.+|+++.||++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 246 ISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp CCCHHHHHHHTTSCCCCCCCHHHH-STTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccchhhhhhhhhcccCCCcchhhh-cCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 000000000000000 00112357889999999999999999999973
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-41 Score=361.63 Aligned_cols=266 Identities=19% Similarity=0.250 Sum_probs=188.5
Q ss_pred hcCcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCC--chhHHHHHHHHHHHHHccCCceeeEeeeeec------cc
Q 046750 359 TNGFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGS--GQGEREFRAEVEIISRVHHRHLVSLVGYCIS------EK 429 (723)
Q Consensus 359 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~------~~ 429 (723)
.++|+++++||+|+||+||+|.. .+|+.||||+++... ......+.+|+.+|++++|+|||+++++|.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 36799999999999999999964 569999999997543 2334568899999999999999999999964 36
Q ss_pred ceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEeeccccc
Q 046750 430 NRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVADFGLAK 509 (723)
Q Consensus 430 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 509 (723)
+.|+||||+.++.| +.++. .+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~~iv~Ey~~~~l~-~~~~~----~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 96 DVYLVMELMDANLC-QVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEEECCSEEHH-HHHTS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eeEEEEeccchHHH-Hhhhc----CCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence 78999999965544 44432 3788899999999999999999994 9999999999999999999999999987
Q ss_pred ccCCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchh-hH---------Hhh--
Q 046750 510 LNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDES-LV---------EWA-- 577 (723)
Q Consensus 510 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~-l~---------~~~-- 577 (723)
...... ......||..|+|||++.+..++.++|||||||++|||++|+.||.......... .. .|.
T Consensus 168 ~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 245 (355)
T d2b1pa1 168 TAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_dssp ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTS
T ss_pred cccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHh
Confidence 654332 2344578999999999999999999999999999999999999996543110000 00 000
Q ss_pred hhhhhhhhhcC-Cc-----ccccchhhh---ccccHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 046750 578 RPVLVRAIETG-DL-----SEIVDPRLE---KHYVESEMFRMIEAAAACVRHSGPKRPRMVQVVRA 634 (723)
Q Consensus 578 ~~~l~~~i~~~-~l-----~~~vd~~l~---~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl~~ 634 (723)
...+....... .. ..++...+. ..........+.+|+.+||..||++||+++||++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000000100 00 000100110 11122334568899999999999999999999865
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.2e-37 Score=333.06 Aligned_cols=267 Identities=19% Similarity=0.238 Sum_probs=189.2
Q ss_pred CcccceEEeccCcEEEEEEEc-CCCcEEEEEEcccCCchhHHHHHHHHHHHHHcc-----------CCceeeEeeeeecc
Q 046750 361 GFARENVIGEGGFGCVYKGNL-PEGKVVAVKQLKSGSGQGEREFRAEVEIISRVH-----------HRHLVSLVGYCISE 428 (723)
Q Consensus 361 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~-----------HpnIv~l~g~~~~~ 428 (723)
+|+++++||+|+||.||+|+. .+|+.||||+++... ...+.+.+|+++|++++ |+|||++++++...
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 499999999999999999964 679999999998642 23456788999998885 57899999888654
Q ss_pred --cceEEEEEecCCCch-hhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCC------c
Q 046750 429 --KNRLLIYEFVPNNNL-EHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEF------E 499 (723)
Q Consensus 429 --~~~~lV~E~~~~gsL-~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~------~ 499 (723)
...+++|+++..+.+ ..+........+.+..+..++.||++||+|||+.. +|+||||||+||||+.++ .
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~--~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTEEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc--CcccccCChhHeeeeccCcccccce
Confidence 345566666655543 33333344456788899999999999999999832 699999999999998654 4
Q ss_pred EEEeecccccccCCCCcceeecccccccccChhhhccCCCCCccceechHHHHHHHHhCCCCCCCCCCCCchh----hHH
Q 046750 500 AQVADFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDPTQPLGDES----LVE 575 (723)
Q Consensus 500 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~----l~~ 575 (723)
++|+|||.+...... ....+|+..|+|||++.+..++.++|||||||+|+||++|+.||.......... +..
T Consensus 171 ~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~ 246 (362)
T d1q8ya_ 171 IKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246 (362)
T ss_dssp EEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred eeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence 999999999755322 234569999999999999999999999999999999999999997543221111 111
Q ss_pred hhhhh---hhhhhhc----------C----Ccccccc----h--hhhccccHHHHHHHHHHHHHHhccCCCCCCCHHHHH
Q 046750 576 WARPV---LVRAIET----------G----DLSEIVD----P--RLEKHYVESEMFRMIEAAAACVRHSGPKRPRMVQVV 632 (723)
Q Consensus 576 ~~~~~---l~~~i~~----------~----~l~~~vd----~--~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~eVl 632 (723)
+...+ ....+.. . .+..... . .............+.+|+.+||..||.+||+++|||
T Consensus 247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L 326 (362)
T d1q8ya_ 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV 326 (362)
T ss_dssp HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 10000 0000000 0 0000000 0 011223455667899999999999999999999998
Q ss_pred HH
Q 046750 633 RA 634 (723)
Q Consensus 633 ~~ 634 (723)
+.
T Consensus 327 ~H 328 (362)
T d1q8ya_ 327 NH 328 (362)
T ss_dssp TC
T ss_pred cC
Confidence 74
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.89 E-value=6.5e-24 Score=207.59 Aligned_cols=171 Identities=17% Similarity=0.141 Sum_probs=121.9
Q ss_pred cccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCc------------------hhHHHHHHHHHHHHHccCCceeeEee
Q 046750 362 FARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSG------------------QGEREFRAEVEIISRVHHRHLVSLVG 423 (723)
Q Consensus 362 f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~------------------~~~~~~~~Ei~il~~l~HpnIv~l~g 423 (723)
+.+.++||+|+||.||+|...+|+.||||+++.... .....+.+|+.+|.++.|.+++.+++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 356799999999999999888899999998753210 01123456889999999999998876
Q ss_pred eeecccceEEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhcccCCCceeecCCCCCcEEeCCCCcEEEe
Q 046750 424 YCISEKNRLLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHEDCHPKIIHRDIKSANILVDDEFEAQVA 503 (723)
Q Consensus 424 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~g~~~ivHrDIkp~NILl~~~~~vkL~ 503 (723)
+. ..+|||||+.+..+.++ .......++.||+++|+|||++ +|+||||||+||||+++ .++|+
T Consensus 82 ~~----~~~lvme~~~~~~~~~l---------~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 82 WE----GNAVLMELIDAKELYRV---------RVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp EE----TTEEEEECCCCEEGGGC---------CCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEEC
T ss_pred ec----CCEEEEEeeccccccch---------hhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEE
Confidence 53 34799999987766543 2233567899999999999999 49999999999999976 59999
Q ss_pred ecccccccCCCCcceeecccccccccChhhhccCCCCCccceechHHHHH
Q 046750 504 DFGLAKLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLL 553 (723)
Q Consensus 504 DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~t~ksDVwSlGviL~ 553 (723)
|||+|+............ .....+ -|++ .+.|..++||||+.--++
T Consensus 145 DFG~a~~~~~~~~~~~l~--rd~~~~-~~~f-~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 145 DFPQSVEVGEEGWREILE--RDVRNI-ITYF-SRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp CCTTCEETTSTTHHHHHH--HHHHHH-HHHH-HHHHCCCCCHHHHHHHHH
T ss_pred ECCCcccCCCCCcHHHHH--HHHHHH-HHHH-cCCCCCcccHHHHHHHHh
Confidence 999997654322111000 000000 1222 356888999999765443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.83 E-value=4.5e-09 Score=105.33 Aligned_cols=149 Identities=15% Similarity=0.075 Sum_probs=100.9
Q ss_pred HHHHHHhcCcccceEEeccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHcc-CCceeeEeeeeecccce
Q 046750 353 EELMEITNGFARENVIGEGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVH-HRHLVSLVGYCISEKNR 431 (723)
Q Consensus 353 ~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~ 431 (723)
.++......|+..+..+.+....||+... +++.++||+...........+.+|+.+|..|. +=-+.+++.++.+++..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 46777778888776655555578999875 55667788876544344446788999999884 33356778888888888
Q ss_pred EEEEEecCCCchhhccccCCCCcchHHHHHHHHHHHHhhhchhccc----------------------------------
Q 046750 432 LLIYEFVPNNNLEHHLHGKGQPVLEWTKRVKIALGAAKGLAYLHED---------------------------------- 477 (723)
Q Consensus 432 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~---------------------------------- 477 (723)
++||++++|..+.+...... ....++.++++.|+.||+.
T Consensus 86 ~lv~~~l~G~~~~~~~~~~~-------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDEQ-------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEEECCSSEEHHHHTTTCS-------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEEEecccccccccccccc-------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence 99999999887755432111 0112223333333333321
Q ss_pred ----------------------CCCceeecCCCCCcEEeCCCCcEEEeeccccc
Q 046750 478 ----------------------CHPKIIHRDIKSANILVDDEFEAQVADFGLAK 509 (723)
Q Consensus 478 ----------------------g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 509 (723)
....++|+|+.+.|||++++..+.|+||+.+.
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 01238999999999999987667799999875
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.43 E-value=3.5e-07 Score=90.64 Aligned_cols=76 Identities=18% Similarity=0.172 Sum_probs=56.9
Q ss_pred EEeccCc-EEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCC--ceeeEeeeeecccceEEEEEecCCCch
Q 046750 367 VIGEGGF-GCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHR--HLVSLVGYCISEKNRLLIYEFVPNNNL 443 (723)
Q Consensus 367 ~LG~G~f-G~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~g~~~~~~~~~lV~E~~~~gsL 443 (723)
.+..|.. ..||+....++..++||...... ..++..|+.+|+.|... .+.+++.++.+.+..++||+|++|..+
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 4455553 58999988888889999876543 23578899999888543 356778888888888999999988776
Q ss_pred hh
Q 046750 444 EH 445 (723)
Q Consensus 444 ~~ 445 (723)
.+
T Consensus 94 ~~ 95 (255)
T d1nd4a_ 94 LS 95 (255)
T ss_dssp TT
T ss_pred cc
Confidence 44
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.93 E-value=1.5e-05 Score=84.28 Aligned_cols=77 Identities=16% Similarity=0.144 Sum_probs=49.5
Q ss_pred ceEEeccCcEEEEEEEcCC-CcEEEEEEcccC----C---chhHHHHHHHHHHHHHcc-C--CceeeEeeeeecccceEE
Q 046750 365 ENVIGEGGFGCVYKGNLPE-GKVVAVKQLKSG----S---GQGEREFRAEVEIISRVH-H--RHLVSLVGYCISEKNRLL 433 (723)
Q Consensus 365 ~~~LG~G~fG~Vy~~~~~~-g~~VAvK~l~~~----~---~~~~~~~~~Ei~il~~l~-H--pnIv~l~g~~~~~~~~~l 433 (723)
.+.||.|....||+....+ ++.|+||+-... . .........|+++|+.+. + ..+.+++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 4578999999999997654 678999974321 1 112234566888888773 3 345556544 4456789
Q ss_pred EEEecCCCch
Q 046750 434 IYEFVPNNNL 443 (723)
Q Consensus 434 V~E~~~~gsL 443 (723)
||||+.+..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999977543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.69 E-value=7.9e-05 Score=76.43 Aligned_cols=134 Identities=16% Similarity=0.168 Sum_probs=78.8
Q ss_pred cEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCce--eeEee-----eeecccceEEEEEecCCCchhh
Q 046750 373 FGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHL--VSLVG-----YCISEKNRLLIYEFVPNNNLEH 445 (723)
Q Consensus 373 fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnI--v~l~g-----~~~~~~~~~lV~E~~~~gsL~~ 445 (723)
--.||++..++|+.|++|+.+... ...+++..|+.+|..|....| +..+. .+......+.|++|+.|..+..
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred cceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 348999999999999999987642 345678889999999853332 11111 2233455688999997754421
Q ss_pred c--------------ccc----C---CCCcchHHH----------------------HHHHHHHHHhhhch-hcccCCCc
Q 046750 446 H--------------LHG----K---GQPVLEWTK----------------------RVKIALGAAKGLAY-LHEDCHPK 481 (723)
Q Consensus 446 ~--------------l~~----~---~~~~l~~~~----------------------~~~i~~~ia~gL~y-LH~~g~~~ 481 (723)
. +|. . .+..+++.. ...++..++..+.- +.......
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 0 010 0 011111111 11122222222221 11222346
Q ss_pred eeecCCCCCcEEeCCCCcEEEeeccccc
Q 046750 482 IIHRDIKSANILVDDEFEAQVADFGLAK 509 (723)
Q Consensus 482 ivHrDIkp~NILl~~~~~vkL~DFGla~ 509 (723)
+||+|+.+.|||++++ ..|+||+.+.
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred eecCCCCcccEEEeCC--ceEEechhcc
Confidence 8999999999999754 4589999876
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.52 E-value=0.00014 Score=73.96 Aligned_cols=157 Identities=12% Similarity=0.064 Sum_probs=86.1
Q ss_pred cCHHHHHHHhcCcccceEEe-----ccCcEEEEEEEcCCCcEEEEEEcccCCchhHHHHHHHHHHHHHccCCcee--eEe
Q 046750 350 FTYEELMEITNGFARENVIG-----EGGFGCVYKGNLPEGKVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHLV--SLV 422 (723)
Q Consensus 350 ~~~~~l~~~~~~f~~~~~LG-----~G~fG~Vy~~~~~~g~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnIv--~l~ 422 (723)
.+.+++..+..+|.+.++.. .|---..|+.+..+|+ +++|++... ....++..|+++|..|.+.++. ..+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~--~~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCC--CCHHHHHHHHHHHHhhhhccccccccc
Confidence 45688999999998765543 4445678999876665 889988653 2334566788888888543321 111
Q ss_pred e------eeecccceEEEEEecCCCchhhcc--------------cc--------C-CCCcchHH---------------
Q 046750 423 G------YCISEKNRLLIYEFVPNNNLEHHL--------------HG--------K-GQPVLEWT--------------- 458 (723)
Q Consensus 423 g------~~~~~~~~~lV~E~~~~gsL~~~l--------------~~--------~-~~~~l~~~--------------- 458 (723)
- +.........++.++.+..+.... +. . ......+.
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 1 112233456677777665332111 00 0 00000000
Q ss_pred -HHHHHHHHHHhhhchhcc-cCCCceeecCCCCCcEEeCCCCcEEEeeccccc
Q 046750 459 -KRVKIALGAAKGLAYLHE-DCHPKIIHRDIKSANILVDDEFEAQVADFGLAK 509 (723)
Q Consensus 459 -~~~~i~~~ia~gL~yLH~-~g~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 509 (723)
.....+..+...+..++. ....++||+|+...|||++++...-|+||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 001111122222222221 113369999999999999998777899999875
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.36 E-value=0.00029 Score=74.08 Aligned_cols=74 Identities=23% Similarity=0.258 Sum_probs=51.1
Q ss_pred ceEEeccCcEEEEEEEcCCC--------cEEEEEEcccCCchhHHHHHHHHHHHHHccCCce-eeEeeeeecccceEEEE
Q 046750 365 ENVIGEGGFGCVYKGNLPEG--------KVVAVKQLKSGSGQGEREFRAEVEIISRVHHRHL-VSLVGYCISEKNRLLIY 435 (723)
Q Consensus 365 ~~~LG~G~fG~Vy~~~~~~g--------~~VAvK~l~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~g~~~~~~~~~lV~ 435 (723)
++.|+.|--=.+|+....++ +.|.+++.-.. ....+..+|..+++.+.-.+| .+++++|.+ .+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 46788888889999976543 46777766432 233466789999999853344 577777642 6899
Q ss_pred EecCCCchh
Q 046750 436 EFVPNNNLE 444 (723)
Q Consensus 436 E~~~~gsL~ 444 (723)
||++|..|.
T Consensus 121 efi~g~~l~ 129 (395)
T d1nw1a_ 121 EYIPSRPLS 129 (395)
T ss_dssp CCCCEEECC
T ss_pred EEeccccCC
Confidence 999876553
|